pmid	title_e	journal
34425415	Genome interaction of the virus and the host genes and non-coding RNAs in SARS-CoV-2 infection.	Immunobiology
34425240	"Brief report: Tempol, a novel antioxidant, inhibits both activated T cell and antigen presenting cell derived cytokines in-vitro from COVID-19 patients."	Clin Immunol
34424997	SARS-CoV-2-reactive T cell receptors isolated from convalescent COVID-19 patients confer potent T cell effector function.	Eur J Immunol
34424945	Acute SARS-CoV-2 infections harbor limited within-host diversity and transmit via tight transmission bottlenecks.	PLoS Pathog
34424815	In silico screening of Pueraria tuberosa (PTY-2) for targeting COVID-19 by countering dual targets M(pro) and TMPRSS2.	J Biomol Struct Dyn
34424256	Emergence of the First Strains of SARS-CoV-2 Lineage B.1.1.7 in Romania: Genomic Analysis.	JMIRx Med
34424156	The emerging role of perivascular cells (pericytes) in viral pathogenesis.	J Gen Virol
34424151	Venetoclax: a promising repurposed drug against SARS-CoV-2 main protease.	J Biomol Struct Dyn
34424130	The role of GLP-1 receptor agonists during COVID-19 pandemia: a hypothetical molecular mechanism.	Expert Opin Drug Saf
34423606	Captopril alleviates lung inflammation in SARS-CoV-2-infected hypertensive mice.	Zool Res
34423563	Drug Repurposing for the SARS-CoV-2 Papain-Like Protease.	ChemMedChem
34423318	Fluorogenic in vitro activity assay for the main protease M(pro) from SARS-CoV-2 and its adaptation to the identification of inhibitors.	STAR Protoc
34423145	Drugs repurposing against SARS-CoV2 and the new variant B.1.1.7 (Alpha Strain) targeting the spike protein: Molecular docking and Simulation studies.	Heliyon
34423108	A network-based systems biology approach for identification of shared Gene signatures between male and female in COVID-19 datasets.	Inform Med Unlocked
34422917	"Clinical Implications of IL-32, IL-34 and IL-37 in Atherosclerosis: Speculative Role in Cardiovascular Manifestations of COVID-19."	Front Cardiovasc Med
34422699	Perspectives on passive antibody therapy and peptide-based vaccines against emerging pathogens like SARS-CoV-2.	Germs
34421902	BCG Vaccine Derived Peptides Induce SARS-CoV-2 T Cell Cross-Reactivity.	Front Immunol
34421600	NETosis and the Immune System in COVID-19: Mechanisms and Potential Treatments.	Front Pharmacol
34421587	The Hyperlipidaemic Drug Fenofibrate Significantly Reduces Infection by SARS-CoV-2 in Cell Culture Models.	Front Pharmacol
34421325	Repurposing the inhibitors of COVID-19 key proteins through molecular docking approach.	Process Biochem
34421291	Coronavirus disease and male fertility: a systematic review.	Middle East Fertil Soc J
34421159	Structural Deformability Induced in Proteins of Potential Interest Associated with COVID-19 by binding of Homologues present in Ivermectin: Comparative Study Based in Elastic Networks Models.	J Mol Liq
34421121	Deep survey for designing a vaccine against SARS-CoV-2 and its new mutations.	Biologia (Bratisl)
34420994	"The secret identities of TMPRSS2: Fertility factor, virus trafficker, inflammation moderator, prostate protector and tumor suppressor."	Tumour Biol
34420993	"The expression of hACE2 receptor protein and its involvement in SARS-CoV-2 entry, pathogenesis, and its application as potential therapeutic target."	Tumour Biol
34420786	Immunisation of ferrets and mice with recombinant SARS-CoV-2 spike protein formulated with Advax-SM adjuvant protects against COVID-19 infection.	Vaccine
34420502	Cordycepin as a Promising Inhibitor of SARS-CoV-2 RNA dependent RNA polymerase (RdRp).	Curr Med Chem
34420372	Distinct Regulation of U-ACE2 and P-ACE2 (Urinary and Plasma Angiotensin-Converting Enzyme 2) in a Japanese General Population.	Hypertension
34420183	Evaluating Stability and Activity of SARS-CoV-2 PLpro for High-throughput Screening of Inhibitors.	Mol Biotechnol
34419773	"Which ones, when and why should renin-angiotensin system inhibitors work against COVID-19?"	Adv Biol Regul
34419736	Effect of dihydromyricetin on SARS-CoV-2 viral replication and pulmonary inflammation and fibrosis.	Phytomedicine
34419671	Association of Apolipoprotein e polymorphism with SARS-CoV-2 infection.	Infect Genet Evol
34419496	An angiotensin-converting enzyme-2-derived heptapeptide GK-7 for SARS-CoV-2 spike blockade.	Peptides
34419160	Characterization of SARS-CoV-2 worldwide transmission based on evolutionary dynamics and specific viral mutations in the spike protein.	Infect Dis Poverty
34418570	Challenges of short substrate analogues as SARS-CoV-2 main protease inhibitors.	Bioorg Med Chem Lett
34418279	"Tissue factor expression, extracellular vesicles and thrombosis after infection with the respiratory viruses influenza A virus and coronavirus."	J Thromb Haemost
34418270	2-Deoxy-D-glucose Exploits Increased Glucose Metabolism in Cancer and Viral- infected cells: Relevance to its use in INDIA Against SARS-CoV-2.	IUBMB Life
34417704	Neurological manifestations of COVID-19 in patients: from path physiology to therapy.	Neurol Sci
34417590	mRNA-1273 protects against SARS-CoV-2 beta infection in nonhuman primates.	Nat Immunol
34417462	Haplotype-resolved de novo assembly of the Vero cell line genome.	NPJ Vaccines
34417349	SARS-CoV-2 escape from a highly neutralizing COVID-19 convalescent plasma.	Proc Natl Acad Sci U S A
34417262	LTB4-Driven Inflammation and Increased Expression of ALOX5/ACE2 During Severe COVID-19 in Individuals With Diabetes.	Diabetes
34417260	SARS-CoV-2 Infection Drives a Glycan Switch of Peripheral T Cells at Diagnosis.	J Immunol
34416799	[Analysis of Nucleotide Changes in RT-PCR Primer/Probe Binding Regions in SARS-CoV-2 Isolates Reported from Turkey].	Mikrobiyol Bul
34416777	[SARS-CoV-2 vaccines and reaction of the immune system. Can the epidemic spread of the virus be prevented by vaccination?]	Dtsch Med Wochenschr
34416512	Antiviral strategies targeting host factors and mechanisms obliging +ssRNA viral pathogens.	Bioorg Med Chem
34416436	A model for COVID-19-induced dysregulation of ACE2 shedding by ADAM17.	Biochem Biophys Res Commun
34416332	Fluoxetine hydrochloride loaded lipid polymer hybrid nanoparticles showed possible efficiency against SARS-CoV-2 infection.	Int J Pharm
34416267	Hypoxia alters the expression of ACE2 and TMPRSS2 SARS-CoV-2 cell entry mediators in hCMEC/D3 cells.	Microvasc Res
34416153	One-shot identification of SARS-CoV-2 S RBD escape mutants using yeast screening.	Cell Rep
34416121	Neurologic Manifestations and Complications of COVID-19.	Annu Rev Med
34415804	Targetting ferroptosis for blood cell-related diseases.	J Drug Target
34415583	Evolution of viral variants in remdesivir treated and untreated SARS-CoV-2 infected paediatrics patients.	J Med Virol
34415218	Vitamin D3 and its hydroxyderivatives as promising drugs against COVID-19: a computational study.	J Biomol Struct Dyn
34415156	Probing the Allosteric Inhibition Mechanism of a Spike Protein Using Molecular Dynamics Simulations and Active Compound Identifications.	J Med Chem
34414841	Renin-angiotensin system modulators in COVID-19 patients with hypertension: friend or foe?	Clin Exp Hypertens
34414383	Protective heterologous T cell immunity in COVID-19 induced by the trivalent Measles-Mumps-Rubella and Tetanus-Diptheria-Pertussis vaccine antigens.	Med (N Y)
34414379	Optimization of antigen specific CD8(+) T cell activation conditions for infectious diseases including COVID-19.	STAR Protoc
34414360	"Rational Design of Hybrid SARS-CoV-2 Main Protease Inhibitors Guided by the Superimposed Cocrystal Structures with the Peptidomimetic Inhibitors GC-376, Telaprevir, and Boceprevir."	ACS Pharmacol Transl Sci
34414260	Angiotensin Converting Enzyme-2 (ACE-2) role in disease and future in research.	J Lung Pulm Respir Res
34414206	Poliovirus Vaccination Induces a Humoral Immune Response That Cross Reacts With SARS-CoV-2.	Front Med (Lausanne)
34414199	"Downregulation of CD45 Signaling in COVID-19 Patients Is Reversed by C24D, a Novel CD45 Targeting Peptide."	Front Med (Lausanne)
34414185	N439K Variant in Spike Protein Alter the Infection Efficiency and Antigenicity of SARS-CoV-2 Based on Molecular Dynamics Simulation.	Front Cell Dev Biol
34413782	"Rarely Recognized Antibody Diversification in Covid-19 Evolution to Counteract Advanced SARS-CoV-2 Evasion Strategies, and Implications for Prophylactic Treatment."	Front Physiol
34413500	A glycan gate controls opening of the SARS-CoV-2 spike protein.	Nat Chem
34413488	Activation or exhaustion of CD8(+) T cells in patients with COVID-19.	Cell Mol Immunol
34413390	"Tissue-specific expression of the SARS-CoV-2 receptor, angiotensin-converting enzyme 2, in mouse models of chronic kidney disease."	Sci Rep
34413339	SARS-CoV-2 infection initiates interleukin-17-enriched transcriptional response in different cells from multiple organs.	Sci Rep
34413267	The potential role of abnormal angiotensin-converting enzyme 2 expression correlated with immune infiltration after SARS-CoV-2 infection in the prognosis of breast cancer.	Aging (Albany NY)
34413211	Morphological cell profiling of SARS-CoV-2 infection identifies drug repurposing candidates for COVID-19.	Proc Natl Acad Sci U S A
34412732	The role of ACE2 in the renin-angiotensin-system: Etiology and therapy of COVID-19 from a pharmaceutical perspective.	Pharmazie
34411989	"COVID-19, what could sepsis, severe acute pancreatitis, gender differences, and aging teach us?"	Cytokine
34411900	"Camphor, Artemisinin and Sumac Phytochemicals as inhibitors against COVID-19: Computational approach."	Comput Biol Med
34411541	Convergent antibody responses to the SARS-CoV-2 spike protein in convalescent and vaccinated individuals.	Cell Rep
34410443	Identification and characterization of mutations in the SARS-CoV-2 RNA-dependent RNA polymerase as a promising antiviral therapeutic target.	Arch Microbiol
34410305	Association of Antineoplastic Therapy With Decreased SARS-CoV-2 Infection Rates in Patients With Cancer.	JAMA Oncol
34409778	Effectiveness of Mavrilimumab in Viral Infections Including SARS-CoV-2 Infection - A Brief Review.	Infect Chemother
34409597	Interface-based design of the favipiravir-binding site in SARS-CoV-2 RNA-dependent RNA polymerase reveals mutations conferring resistance to chain termination.	FEBS Lett
34409594	Genome-scale metabolic modelling of SARS-CoV-2 in cancer cells reveals an increased shift to glycolytic energy production.	FEBS Lett
34408808	Optimization of Triarylpyridinone Inhibitors of the Main Protease of SARS-CoV-2 to Low-Nanomolar Antiviral Potency.	ACS Med Chem Lett
34408749	Long Noncoding RNAs as Emerging Regulators of COVID-19.	Front Immunol
34408743	Fast and Efficient Genome Editing of Human FOXP3(+) Regulatory T Cells.	Front Immunol
34408462	"Characterization of Virus Replication, Pathogenesis, and Cytokine Responses in Syrian Hamsters Inoculated with SARS-CoV-2."	J Inflamm Res
34408131	HIF-1alpha promotes SARS-CoV-2 infection and aggravates inflammatory responses to COVID-19.	Signal Transduct Target Ther
34408130	Yeast-produced RBD-based recombinant protein vaccines elicit broadly neutralizing antibodies and durable protective immunity against SARS-CoV-2 infection.	Cell Discov
34407944	Immune checkpoint inhibitors increase T cell immunity during SARS-CoV-2 infection.	Sci Adv
34407940	Age-dependent regulation of SARS-CoV-2 cell entry genes and cell death programs correlates with COVID-19 severity.	Sci Adv
34407648	Activation of the trigeminal system as a likely target of SARS-CoV-2 may contribute to anosmia in COVID-19.	Cephalalgia
34407240	Molecular mimicry between SARS-CoV-2 and the female reproductive system.	Am J Reprod Immunol
34407143	"Genomics-guided identification of potential modulators of SARS-CoV-2 entry proteases, TMPRSS2 and Cathepsins B/L."	PLoS One
34406867	Natural isolate and recombinant SARS-CoV-2 rapidly evolve in vitro to higher infectivity through more efficient binding to heparan sulfate and reduced S1/S2 cleavage.	J Virol
34406858	Synergistic block of SARS-CoV-2 infection by combined drug inhibition of the host entry factors PIKfyve kinase and TMPRSS2 protease.	J Virol
34406390	Immunoinflammatory role of apolipoprotein E4 in malnutrition and enteric infections and the increased risk for chronic diseases under adverse environments.	Nutr Rev
34406358	Intravenous injection of COVID-19 mRNA vaccine can induce acute myopericarditis in mouse model.	Clin Infect Dis
34406356	coronaSPAdes: from biosynthetic gene clusters to RNA viral assemblies.	Bioinformatics
34406303	Diabetes in the COVID-19 pandemic era.	Rev Assoc Med Bras (1992)
34406302	Cardiovascular damage due to COVID-19: what do we need to know?	Rev Assoc Med Bras (1992)
34406239	"Telomere length: biological marker of cellular vitality, aging, and health-disease process."	Rev Assoc Med Bras (1992)
34405870	"Immune complexes, innate immunity, and NETosis in ChAdOx1 vaccine-induced thrombocytopenia."	Eur Heart J
34405765	"Molecular dynamics simulation, 3D-pharmacophore and scaffold hopping analysis in the design of multi-target drugs to inhibit potential targets of COVID-19."	J Biomol Struct Dyn
34405764	A Combination of alpha-Lipoic Acid (ALA) and Palmitoylethanolamide (PEA) Blocks Endotoxin-Induced Oxidative Stress and Cytokine Storm: A Possible Intervention for COVID-19.	J Diet Suppl
34405154	Luciferase reporter assays to monitor interferon signaling modulation by SARS-CoV-2 proteins.	STAR Protoc
34405122	"Potential of diterpene compounds as antivirals, a review."	Heliyon
34404999	Antiviral nanoparticles for sanitizing surfaces: a roadmap to self-sterilizing against COVID-19.	Nano Today
34404990	Cardiovascular injuries and SARS-COV-2 infection: focus on elderly people.	J Geriatr Cardiol
34404957	"Molecular docking and dynamic simulations of Cefixime, Etoposide and Nebrodenside A against the pathogenic proteins of SARS-CoV-2."	J Mol Struct
34404919	Repurposing the estrogen receptor modulator raloxifene to treat SARS-CoV-2 infection.	Cell Death Differ
34404832	"Inhibiting SARS-CoV-2 infection in vitro by suppressing its receptor, angiotensin-converting enzyme 2, via aryl-hydrocarbon receptor signal."	Sci Rep
34404805	A broadly neutralizing humanized ACE2-targeting antibody against SARS-CoV-2 variants.	Nat Commun
34404803	Protective humoral and cellular immune responses to SARS-CoV-2 persist up to 1 year after recovery.	Nat Commun
34404775	Two doses of SARS-CoV-2 vaccination induce robust immune responses to emerging SARS-CoV-2 variants of concern.	Nat Commun
34404759	Dynamic landscape mapping of humoral immunity to SARS-CoV-2 identifies non-structural protein antibodies associated with the survival of critical COVID-19 patients.	Signal Transduct Target Ther
34404754	Respiratory epithelial cell responses to SARS-CoV-2 in COVID-19.	Thorax
34404266	The Influence of Coronavirus Disease-2019 (COVID-19) On Parkinson's Disease: An Updated Systematic Review.	J Prim Care Community Health
34404118	Natural infection of Delta mutant of SARS-CoV-2 in Asiatic Lions of India.	Transbound Emerg Dis
34403938	Computational screening of 645 antiviral peptides against the receptor-binding domain of the spike protein in SARS-CoV-2.	Comput Biol Med
34403832	Characterization of the emerging B.1.621 variant of interest of SARS-CoV-2.	Infect Genet Evol
34403732	Identification of Natural Compounds as SARS-CoV-2 Entry Inhibitors by Molecular Docking-based Virtual Screening with Bio-layer Interferometry.	Pharmacol Res
34403681	Deliver the promise: RNAs as a new class of molecular entities for therapy and vaccination.	Pharmacol Ther
34403674	"SARS-CoV-2 (Covid-19) vaccines structure, mechanisms and effectiveness: A review."	Int J Biol Macromol
34403650	Cardiomyocytes recruit monocytes upon SARS-CoV-2 infection by secreting CCL2.	Stem Cell Reports
34403647	Near-physiological-temperature serial crystallography reveals conformations of SARS-CoV-2 main protease active site for improved drug repurposing.	Structure
34403366	Self-sustaining interleukin-8 loops drive a prothrombotic neutrophil phenotype in severe COVID-19.	JCI Insight
34403259	Discovery of Novel Small-Molecule Inhibitors of SARS-CoV-2 Main Protease as Potential Leads for COVID-19 Treatment.	J Chem Inf Model
34403258	Targeting Ribosomal Frameshifting as an Antiviral Strategy: From HIV-1 to SARS-CoV-2.	Acc Chem Res
34403043	Autonomic dysfunction in SARS-COV-2 infection acute and long-term implications COVID-19 editor's page series.	J Thromb Thrombolysis
34403037	Generation and Characterization of a Nanobody Against SARS-CoV.	Virol Sin
34402744	Host-dependent editing of SARS-CoV-2 in COVID-19 patients.	Emerg Microbes Infect
34402717	Resveratrol supplementation reduces ACE2 expression in human adipose tissue.	Adipocyte
34402498	Infection outcome needs two to tango: human host and the pathogen.	Brief Funct Genomics
34402426	A proteome-wide genetic investigation identifies several SARS-CoV-2-exploited host targets of clinical relevance.	Elife
34402155	Impact of the SARS-CoV-2 Virus on Male Reproductive Health.	BJU Int
34401749	"Structural basis for the binding of the cancer targeting scorpion toxin, ClTx, to the vascular endothelia growth factor receptor neuropilin-1."	Curr Res Struct Biol
34401711	Environmental factors and their role in the transmission of SARS-CoV-2.	Biosaf Health
34401607	Systems level insights into the impact of airborne exposure on SARS-CoV-2 pathogenesis and COVID-19 outcome - A multi-omics big data study.	Gene Rep
34401047	Non-conventional interactions of N3 inhibitor with the main protease of SARS-CoV and SARS-CoV-2.	Comput Struct Biotechnol J
34400893	The role of NK cells in fighting the virus infection and sepsis.	Int J Med Sci
34400870	Salvadora persica L.: Toothbrush tree with health benefits and industrial applications - An updated evidence-based review.	Saudi Pharm J
34400835	SARS-CoV-2 variant prediction and antiviral drug design are enabled by RBD in vitro evolution.	Nat Microbiol
34400651	Distinguishing features of current COVID-19 vaccines: knowns and unknowns of antigen presentation and modes of action.	NPJ Vaccines
34400612	Systematic profiling of SARS-CoV-2-specific IgG responses elicited by an inactivated virus vaccine identifies peptides and proteins for predicting vaccination efficacy.	Cell Discov
34400495	Redox imbalance links COVID-19 and myalgic encephalomyelitis/chronic fatigue syndrome.	Proc Natl Acad Sci U S A
34400346	Proteomic signature of host response to SARS-CoV-2 infection in the nasopharynx.	Mol Cell Proteomics
34400158	ACE2 expression in rat brain: Implications for COVID-19 associated neurological manifestations.	Exp Neurol
34399986	Innate lymphoid cells (ILC) in SARS-CoV-2 infection.	Mol Aspects Med
34399825	SELP Asp603Asn and severe thrombosis in COVID-19 males.	J Hematol Oncol
34399734	"Gastrointestinal cancers, ACE-2/TMPRSS2 expression and susceptibility to COVID-19."	Cancer Cell Int
34399617	Oral Bacteria Combined with an Intranasal Vaccine Protect from Influenza A Virus and SARS-CoV-2 Infection.	mBio
34399606	Regulation of the Dimerization and Activity of SARS-CoV-2 Main Protease through Reversible Glutathionylation of Cysteine 300.	mBio
34399542	"Sphingolipids in foodstuff: Compositions, distribution, digestion, metabolism and health effects - A comprehensive review."	Food Res Int
34399188	Evolutionary analysis of the Delta and Delta Plus variants of the SARS-CoV-2 viruses.	J Autoimmun
34399157	Drug-repurposing against COVID-19 by targeting a key signaling pathway: An in silico study.	Med Hypotheses
34399021	COVID-19 AND COAGULOPATHY.	Clin Respir J
34398611	"Water-Triggered, Irreversible Conformational Change of SARS-CoV-2 Main Protease on Passing from the Solid State to Aqueous Solution."	J Am Chem Soc
34398430	Structure and Function of N-Terminal Zinc Finger Domain of SARS-CoV-2 NSP2.	Virol Sin
34398427	"Pandemic COVID-19 caused by SARS-CoV-2: genetic structure, vaccination, and therapeutic approaches."	Mol Biol Rep
34398244	Sensitive Immunodetection of Severe Acute Respiratory Syndrome Coronavirus 2 Variants of Concern 501Y.V2 and 501Y.V1.	J Infect Dis
34398243	Immunoglobulin G Immune Complexes May Contribute to Neutrophil Activation in the Course of Severe Coronavirus Disease 2019.	J Infect Dis
34398242	Nature and Dimensions of Systemic Hyperinflammation and its Attenuation by Convalescent Plasma in Severe COVID-19.	J Infect Dis
34398234	Recovery of deleted deep sequencing data sheds more light on the early Wuhan SARS-CoV-2 epidemic.	Mol Biol Evol
34398188	Acute and chronic neurological disorders in COVID-19: potential mechanisms of disease.	Brain
34398142	"User-friendly, High-throughput, and Fully Automated Data Acquisition Software for Single-particle Cryo-electron Microscopy."	J Vis Exp
34397905	Network pharmacology study on the mechanism of the Chinese medicine Radix Isatidis (Banlangen) for COVID-19.	Medicine (Baltimore)
34397376	"[Obesity, inflammation and COVID-19: preventive interest of ketogenic diet?]"	Biol Aujourdhui
34397373	[Induced degradation of proteins by PROTACs and other strategies: towards promising drugs].	Biol Aujourdhui
34397331	Low pH and temperature of airway surface liquid are key determinants that potentiate SARS-CoV-2 infectivity.	Curr Mol Med
34396938	Computational study for identifying promising therapeutic agents of hydroxychloroquine analogues against SARS-CoV-2.	J Biomol Struct Dyn
34396793	Obesity and Cardiomyopathy.	Physiol Rev
34396612	Combination of natural antivirals and potent immune invigorators: A natural remedy to combat COVID-19.	Phytother Res
34396603	Large-Sized Graphene Oxide Nanosheets Increase DC-T-Cell Synaptic Contact and the Efficacy of DC Vaccines against SARS-CoV-2.	Adv Mater
34396395	BPIFB4 Circulating Levels and Its Prognostic Relevance in COVID-19.	J Gerontol A Biol Sci Med Sci
34396391	T-CoV: a comprehensive portal of HLA-peptide interactions affected by SARS-CoV-2 mutations.	Nucleic Acids Res
34396374	Zinc thiotropolone combinations as inhibitors of the SARS-CoV-2 main protease.	Dalton Trans
34396355	Mucormycosis in COVID-19 pandemic: Risk factors and linkages.	Curr Res Microb Sci
34396354	"COVID-19 and Progesterone: Part 2. Unraveling High Severity, Immunity Patterns, Immunity grading, Progesterone and its potential clinical use."	Endocr Metab Sci
34396353	"COVID-19 and Progesterone: Part 1.SARS-CoV-2, Progesterone and its potential clinical use."	Endocr Metab Sci
34396086	SARS-CoV-2 spike protein and RNA dependent RNA polymerase as targets for drug and vaccine development: A review.	Biosaf Health
34396083	Distinct Lipid Metabolic Dysregulation in Asymptomatic COVID-19.	iScience
34396059	Identification of Novel Neutralizing Monoclonal Antibodies against SARS-CoV-2 Spike Glycoprotein.	ACS Pharmacol Transl Sci
34396046	COVID-19: a Disease with a Potpourri of Histopathologic Findings-a Literature Review and Comparison to the Closely Related SARS and MERS.	SN Compr Clin Med
34396040	Application of an integrated computational antibody engineering platform to design SARS-CoV-2 neutralizers.	Antib Ther
34395931	Massive surge of mRNA expression of clonal B-cell receptor in patients with COVID-19.	Heliyon
34395929	"Molecular encapsulation of andrographolide in 2-hydroxypropyl-beta-cyclodextrin cavity: synthesis, characterization, pharmacokinetic and in vitro antiviral activity analysis against SARS-CoV-2."	Heliyon
34395639	A review on corona virus and treatment approaches with Allium sativam.	Futur J Pharm Sci
34395638	Flavonoid compounds of buah merah (Pandanus conoideus Lamk) as a potent SARS-CoV-2 main protease inhibitor: in silico approach.	Futur J Pharm Sci
34395515	SARS-CoV-2 Spike Protein Extrapolation for COVID Diagnosis and Vaccine Development.	Front Mol Biosci
34395368	A Machine-Generated View of the Role of Blood Glucose Levels in the Severity of COVID-19.	Front Public Health
34395364	Molecular Phylogenesis and Spatiotemporal Spread of SARS-CoV-2 in Southeast Asia.	Front Public Health
34395341	Age-Related Differences in the Expression of Most Relevant Mediators of SARS-CoV-2 Infection in Human Respiratory and Gastrointestinal Tract.	Front Pediatr
34395311	Combination Treatment With Remdesivir and Ivermectin Exerts Highly Synergistic and Potent Antiviral Activity Against Murine Coronavirus Infection.	Front Cell Infect Microbiol
34395179	SARS-CoV spike proteins can compete for electrolytes in physiological fluids according to structure-based quantum-chemical calculations.	Comput Theor Chem
34395160	"Identification of lead compounds from large natural product library targeting 3C-like protease of SARS-CoV-2 using E-pharmacophore modelling, QSAR and molecular dynamics simulation."	In Silico Pharmacol
34395033	"Coronavirus Disease 2019 Infection among Children: Pathogenesis, Treatment, and Outcome."	J Pediatr Intensive Care
34394844	Discovery of Small Molecule Entry Inhibitors Targeting the Fusion Peptide of SARS-CoV-2 Spike Protein.	ACS Med Chem Lett
34394299	Corona viruses: reaching far beyond the common cold.	Afr Health Sci
34394207	What cellular mechanisms are related to thromboembolic events in patients with COVID-19?	J Vasc Bras
34394197	"poreCov-An Easy to Use, Fast, and Robust Workflow for SARS-CoV-2 Genome Reconstruction via Nanopore Sequencing."	Front Genet
34394132	Regulation of Inflammatory Cytokine Storms by Mesenchymal Stem Cells.	Front Immunol
34394127	Combination of a Sindbis-SARS-CoV-2 Spike Vaccine and alphaOX40 Antibody Elicits Protective Immunity Against SARS-CoV-2 Induced Disease and Potentiates Long-Term SARS-CoV-2-Specific Humoral and T-Cell Immunity.	Front Immunol
34394121	Diverse Effects of Exosomes on COVID-19: A Perspective of Progress From Transmission to Therapeutic Developments.	Front Immunol
34394120	Transcriptome Analysis of Peripheral Blood Mononuclear Cells Reveals Distinct Immune Response in Asymptomatic and Re-Detectable Positive COVID-19 Patients.	Front Immunol
34394108	Identification of COVID-19 and Dengue Host Factor Interaction Networks Based on Integrative Bioinformatics Analyses.	Front Immunol
34394094	Single-Cell Transcriptomic Profiling of MAIT Cells in Patients With COVID-19.	Front Immunol
34394090	CD169 Defines Activated CD14(+) Monocytes With Enhanced CD8(+) T Cell Activation Capacity.	Front Immunol
34394051	Genomic Surveillance and Phylodynamic Analyses Reveal the Emergence of Novel Mutations and Co-mutation Patterns Within SARS-CoV-2 Variants Prevalent in India.	Front Microbiol
34394046	Generation of a Sleeping Beauty Transposon-Based Cellular System for Rapid and Sensitive Screening for Compounds and Cellular Factors Limiting SARS-CoV-2 Replication.	Front Microbiol
34394024	Profiling of Oral Microbiota and Cytokines in COVID-19 Patients.	Front Microbiol
34393976	The Immunopathogenesis of Neuroinvasive Lesions of SARS-CoV-2 Infection in COVID-19 Patients.	Front Neurol
34393787	Drug Design Strategies for the Treatment of Viral Disease. Plant Phenolic Compounds and Their Derivatives.	Front Pharmacol
34393433	Molecular docking analysis of SARS-CoV-2 linked RNA dependent RNA polymerase (RdRp) with compounds from Plectranthus amboinicus.	Bioinformation
34393413	Molecular docking analysis of azithromycin and hydroxychloroquine with spike surface glycoprotein of SARS-CoV-2.	Bioinformation
34393265	Computational studies reveal Fluorine based quinolines to be potent inhibitors for proteins involved in SARS-CoV-2 assembly.	J Fluor Chem
34392930	Endolysosomal Ca(2+) signaling in cardiovascular health and disease.	Int Rev Cell Mol Biol
34392751	"Molecular modelling on SARS-CoV-2 papain-like protease: an integrated study with homology modelling, molecular docking, and molecular dynamics simulations."	SAR QSAR Environ Res
34392451	How SARS-CoV-2 might affect potassium balance via impairing epithelial sodium channels?	Mol Biol Rep
34392148	Identification of COVID-19 prognostic markers and therapeutic targets through meta-analysis and validation of Omics data from nasopharyngeal samples.	EBioMedicine
34392110	"Reduction and exhausted features of T lymphocytes under serological changes, and prognostic factors in COVID-19 progression."	Mol Immunol
34392108	"Age, obesity and hyperglycaemia: Activation of innate immunity initiates a series of molecular interactions involving anionic surfaces leading to COVID-19 morbidity and mortality."	Med Hypotheses
34391943	Immunosenescence and inflammaging in the aging process: age-related diseases or longevity?	Ageing Res Rev
34391936	Systemic DPP4/CD26 is associated with natural HIV-1 control: Implications for COVID-19 susceptibility.	Clin Immunol
34391794	Genome-wide covariation in SARS-CoV-2.	Math Biosci
34391155	Exploring the diversity of coronavirus in sewage during COVID-19 pandemic: Don't miss the forest for the trees.	Sci Total Environ
34391096	Cellular and humoral immunogenicity of a SARS-CoV-2 mRNA vaccine in patients on haemodialysis.	EBioMedicine
34391087	B and T cell response to SARS-CoV-2 vaccination in health care professionals with and without previous COVID-19.	EBioMedicine
34391075	Target capture sequencing of SARS-CoV-2 genomes using the ONETest Coronaviruses Plus.	Diagn Microbiol Infect Dis
34391037	Emerging potential mechanisms and predispositions to the neurological manifestations of COVID-19.	J Neurol Sci
34390895	The use of negative oxygen ion clusters [O2(-)(H2O)n] and bicarbonate ions [HCO3(-)] as the supportive treatment of COVID-19 infections: A possibility.	Med Hypotheses
34390682	Post-Covid-19 Tachycardia Syndrome: A distinct phenotype of Post-acute Covid-19 Syndrome.	Am J Med
34390675	CRISPR-based peptide library display and programmable microarray self-assembly for rapid quantitative protein binding assays.	Mol Cell
34390647	Differential effects of the second SARS-CoV-2 mRNA vaccine dose on T cell immunity in naive and COVID-19 recovered individuals.	Cell Rep
34390597	"The ""Oral"" History of COVID-19: Primary Infection, Salivary Transmission, and Post-Acute Implications."	J Periodontol
34390301	Endoplasmic reticulum stress and NF-kB activation in SARS-CoV-2 infected cells and their response to antiviral therapy.	IUBMB Life
34390282	SARS-CoV-2 and the brain: A review of the current knowledge on neuropathology in COVID-19.	Brain Pathol
34390216	Cardiovascular ACE2 receptor expression in patients undergoing heart transplantation.	ESC Heart Fail
34389878	The challenge of structural heterogeneity in the native mass spectrometry studies of the SARS-CoV-2 spike protein interactions with its host cell-surface receptor.	Anal Bioanal Chem
34389625	Protracted yet Coordinated Differentiation of Long-Lived SARS-CoV-2-Specific CD8(+) T Cells during Convalescence.	J Immunol
34389403	In Vivo protection from SARS-CoV-2 infection by ATN-161 in k18-hACE2 transgenic mice.	Life Sci
34389387	Brilliant glycans and glycosylation: Seq and ye shall find.	Int J Biol Macromol
34389380	EGCG as an anti-SARS-CoV-2 agent: Preventive versus therapeutic potential against original and mutant virus.	Biochimie
34389110	Iron metabolism in infections: Focus on COVID-19.	Semin Hematol
34389034	Evolutionary trajectory of SARS-CoV-2 and emerging variants.	Virol J
34388849	Platelet Surface Protein Expression and Reactivity upon TRAP Stimulation after BNT162b2 Vaccination.	Thromb Haemost
34388843	Involvement of Inflammation in Venous Thromboembolic Disease: An Update in the Age of COVID-19.	Semin Thromb Hemost
34388683	"Review of COVID-19, part 2: Musculoskeletal and neuroimaging manifestations including vascular involvement of the aorta and extremities."	Clin Imaging
34388530	GB-2 blocking the interaction between ACE2 and wild type and mutation of spike protein of SARS-CoV-2.	Biomed Pharmacother
34388463	Computational repurposing of tamibarotene against triple mutant variant of SARS-CoV-2.	Comput Biol Med
34388358	"Rapid Increase in SARS-CoV-2 P.1 Lineage Leading to Codominance with B.1.1.7 Lineage, British Columbia, Canada, January-April 2021."	Emerg Infect Dis
34388333	The effect of SARS-CoV-2 on the nervous system: a review of neurological impacts caused by human coronaviruses.	Rev Neurosci
34388240	Pathophysiology of Takotsubo Cardiomyopathy: Reopened Debate.	Tex Heart Inst J
34387990	Machine Learning Models Identify Inhibitors of SARS-CoV-2.	J Chem Inf Model
34387884	Vaccination versus infection with SARS-CoV-2: Establishment of a high avidity IgG response versus incomplete avidity maturation.	J Med Virol
34387838	Overview of SARS-CoV-2 genome-encoded proteins.	Sci China Life Sci
34387835	Lower Serum Angiotensin-Converting Enzyme Level in Relation to Hyperinflammation and Impaired Antiviral Immune Response Contributes to Progression of COVID-19 Infection.	Infect Dis Ther
34387545	Patterns of within-host genetic diversity in SARS-CoV-2.	Elife
34386902	Association of CNS demyelination and COVID-19 infection: an updated systematic review.	J Neurol
34386694	SARS-CoV-2 receptor-binding mutations and antibody contact sites.	Antib Ther
34386518	Non-RBM Mutations Impaired SARS-CoV-2 Spike Protein Regulated to the ACE2 Receptor Based on Molecular Dynamic Simulation.	Front Mol Biosci
34386498	ORF3a-Mediated Incomplete Autophagy Facilitates Severe Acute Respiratory Syndrome Coronavirus-2 Replication.	Front Cell Dev Biol
34386359	Sudden onset of olfactory and gustatory dysfunctions in coronavirus disease 2019 (COVID-19) is momentous marker.	Tzu Chi Med J
34386018	HLA Does Not Impact on Short-Medium-Term Antibody Response to Preventive Anti-SARS-Cov-2 Vaccine.	Front Immunol
34386007	SARS-CoV-2 Poorly Replicates in Cells of the Human Blood-Brain Barrier Without Associated Deleterious Effects.	Front Immunol
34385863	Synthesis and molecular docking study of novel COVID-19 inhibitors.	Turk J Chem
34385830	Synthesis of the Data on COVID-19 Skin Manifestations: Underlying Mechanisms and Potential Outcomes.	Clin Cosmet Investig Dermatol
34385690	Effect of SARS-CoV-2 B.1.1.7 mutations on spike protein structure and function.	Nat Struct Mol Biol
34385593	The janus-kinase inhibitor ruxolitinib in SARS-CoV-2 induced acute respiratory distress syndrome (ARDS).	Leukemia
34385425	Looking for pathways related to COVID-19: confirmation of pathogenic mechanisms by SARS-CoV-2-host interactome.	Cell Death Dis
34385423	Potent prophylactic and therapeutic efficacy of recombinant human ACE2-Fc against SARS-CoV-2 infection in vivo.	Cell Discov
34385356	Durability of mRNA-1273 vaccine-induced antibodies against SARS-CoV-2 variants.	Science
34385103	The mechanisms and clinical application of Traditional Chinese Medicine Lianhua-Qingwen capsule.	Biomed Pharmacother
34385045	Supportive therapy during COVID-19: The proposed mechanism of short-chain fatty acids to prevent cytokine storm and multi-organ failure.	Med Hypotheses
34384810	Infection-enhancing anti-SARS-CoV-2 antibodies recognize both the original Wuhan/D614G strain and Delta variants. A potential risk for mass vaccination ?	J Infect
34384783	Structural basis of biased T cell receptor recognition of an immunodominant HLA-A2 epitope of the SARS-CoV-2 spike protein.	J Biol Chem
34384361	Mass spectrometry-based proteomics in basic and translational research of SARS-CoV-2 coronavirus and its emerging mutants.	Clin Proteomics
34384355	"HMGB1, NLRP3, IL-6 and ACE2 levels are elevated in COVID-19 with headache: a window to the infection-related headache mechanism."	J Headache Pain
34384321	Alterations in platelets during SARS-CoV-2 infection.	Platelets
34383488	Perturbation of ACE2 Structural Ensembles by SARS-CoV-2 Spike Protein Binding.	J Chem Theory Comput
34383378	CD99 and polymeric immunoglobulin receptor peptides deregulation in critical COVID-19: A potential link to molecular pathophysiology?	Proteomics
34383284	[Mucociliary clearance in COVID-19 - an underestimated danger area in early phase of disease?]	MMW Fortschr Med
34383283	[How does COVID-19 affect intestinal microbiota?]	MMW Fortschr Med
34383242	Genomic evolution of the human and animal coronavirus diseases.	Mol Biol Rep
34383213	Deciphering epigenetic(s) role in modulating susceptibility to and severity of COVID-19 infection and/or outcome: a systematic rapid review.	Environ Sci Pollut Res Int
34382995	A nano perspective behind the COVID-19 pandemic.	Nanoscale Horiz
34382946	Cellular senescence in lymphoid organs and immunosenescence.	Aging (Albany NY)
34382906	SARS-CoV-2 effects on male reproduction: should men be worried??	Hum Fertil (Camb)
34382897	Zinc nutrition and dietary zinc supplements.	Crit Rev Food Sci Nutr
34382513	Comprehensive analysis of SARS-COV-2 drug targets and pharmacological aspects in treating the COVID-19.	Curr Mol Pharmacol
34382337	"Bithiazole Inhibitors of Phosphatidylinositol 4-Kinase (PI4KIIIbeta) as Broad-Spectrum Antivirals Blocking the Replication of SARS-CoV-2, Zika Virus and Human Rhinoviruses."	ChemMedChem
34382228	Sensitive detection of anti-spike antibodies enables improved understanding of SARS-CoV-2 pathogenesis.	Immunology
34382151	"Pneumocytes are distinguished by highly elevated expression of the ER stress biomarker GRP78, a co-receptor for SARS-CoV-2, in COVID-19 autopsies."	Cell Stress Chaperones
34382120	Anti-CD20 therapies for multiple sclerosis: current status and future perspectives.	J Neurol
34382087	Data-driven identification of SARS-CoV-2 subpopulations using PhenoGraph and binary-coded genomic data.	Brief Bioinform
34381939	"Novel pulmonary vascular imaging signs in COVID-19: pathophysiology, significance and management."	BJR Open
34381495	"Inflammation and kidney involvement in human viral diseases caused by SARS-CoV-2, HIV, HCV and HBV."	J Venom Anim Toxins Incl Trop Dis
34381460	Structural Basis for SARS-CoV-2 Nucleocapsid Protein Recognition by Single-Domain Antibodies.	Front Immunol
34381451	"Individual HLA-A, -B, -C, and -DRB1 Genotypes Are No Major Factors Which Determine COVID-19 Severity."	Front Immunol
34381216	Mechanism of molnupiravir-induced SARS-CoV-2 mutagenesis.	Nat Struct Mol Biol
34381159	Ionization and structural properties of mRNA lipid nanoparticles influence expression in intramuscular and intravascular administration.	Commun Biol
34381116	A computational study of cooperative binding to multiple SARS-CoV-2 proteins.	Sci Rep
34381049	Downregulation of exhausted cytotoxic T cells in gene expression networks of multisystem inflammatory syndrome in children.	Nat Commun
34381043	Temporal omics analysis in Syrian hamsters unravel cellular effector responses to moderate COVID-19.	Nat Commun
34381037	"Structure, mechanism and crystallographic fragment screening of the SARS-CoV-2 NSP13 helicase."	Nat Commun
34381015	Decreased inhibition of exosomal miRNAs on SARS-CoV-2 replication underlies poor outcomes in elderly people and diabetic patients.	Signal Transduct Target Ther
34380619	Cell therapy strategies for COVID-19: Current approaches and potential applications.	Sci Adv
34380260	Environmental impacts of COVID-19 treatment: Toxicological evaluation of azithromycin and hydroxychloroquine in adult zebrafish.	Sci Total Environ
34352471	"Advanced glycation end products (AGEs) and its receptor, RAGE, modulate age-dependent COVID-19 morbidity and mortality. A review and hypothesis."	Int Immunopharmacol
34352457	An in-depth in silico and immunoinformatics approach for designing a potential multi-epitope construct for the effective development of vaccine to combat against SARS-CoV-2 encompassing variants of concern and interest.	Comput Biol Med
34352360	A discernable increase in the severe acute respiratory syndrome coronavirus 2 R.1 lineage carrying an E484K spike protein mutation in Japan.	Infect Genet Evol
34352228	Impaired local intrinsic immunity to SARS-CoV-2 infection in severe COVID-19.	Cell
34352226	"Systemic IL-15, IFN-gamma, and IP-10/CXCL10 signature associated with effective immune response to SARS-CoV-2 in BNT162b2 mRNA vaccine recipients."	Cell Rep
34352169	Health concerns regarding the effect of the COVID-19 pandemic on male fertility.	Clin Exp Reprod Med
34352160	"New pyrazine conjugates: Synthesis, computational studies, and antiviral properties against SARS-CoV-2."	ChemMedChem
34352148	Immunity to SARS-CoV-2 induced by infection or vaccination.	J Intern Med
34352100	NMPylation and de-NMPylation of SARS-CoV-2 nsp9 by the NiRAN domain.	Nucleic Acids Res
34352039	Signatures in SARS-CoV-2 spike protein conferring escape to neutralizing antibodies.	PLoS Pathog
34351770	SARS-CoV-2 Unrevealed: Ultrastructural and Nanomechanical Analysis.	Langmuir
34351742	Aromatic Cadinane Sesquiterpenoids from the Fruiting Bodies of Phellinus pini Block SARS-CoV-2 Spike-ACE2 Interaction.	J Nat Prod
34351542	SARS-CoV-2 host cell entry: an in silico investigation of potential inhibitory roles of terpenoids.	J Genet Eng Biotechnol
34351418	Host ADP-ribosylation and the SARS-CoV-2 macrodomain.	Biochem Soc Trans
34351228	Near-Complete Genome Sequences of Nine SARS-CoV-2 Strains Harboring the D614G Mutation in Malaysia.	Microbiol Resour Announc
34351227	Whole-Genome Sequences of SARS-CoV-2 Lineage B.1.525 Strains (Variant eta) Detected from Patients in the Abruzzo Region (Central Italy) during Spring 2021.	Microbiol Resour Announc
34351057	To Clot or Not to Clot? Ad is the Question - Insights on Mechanisms Related to Vaccine Induced Thrombotic Thrombocytopenia.	J Thromb Haemost
34350893	Possible Therapeutic Potential of Cysteinyl Leukotriene Receptor Antagonist Montelukast in Treatment of SARS-CoV-2-Induced COVID-19.	Pharmacology
34350827	"Unsupervised machine learning reveals key immune cell subsets in COVID-19, rhinovirus infection, and cancer therapy."	Elife
34350693	Comprehensive investigation of RNA-sequencing dataset reveals the hub genes and molecular mechanisms of coronavirus disease 2019 acute respiratory distress syndrome.	IET Syst Biol
34350541	COVID-19 and biomarkers of thrombosis: focus on von Willebrand factor and extracellular vesicles.	J Thromb Thrombolysis
34350099	"An Overview of the Perspective of Cellular Autophagy: Mechanism, Regulation, and the Role of Autophagy Dysregulation in the Pathogenesis of Diseases."	J Microsc Ultrastruct
34349756	Influence of HLA Class II Polymorphism on Predicted Cellular Immunity Against SARS-CoV-2 at the Population and Individual Level.	Front Immunol
34349473	Bidirectional Relationship between COVID-19 and Diabetes: Role of Renin-Angiotensin-Aldosterone System and Drugs Modulating It.	J Pharm Bioallied Sci
34349236	Discovery of potential small molecular SARS-CoV-2 entry blockers targeting the spike protein.	Acta Pharmacol Sin
34349111	GIANA allows computationally-efficient TCR clustering and multi-disease repertoire classification by isometric transformation.	Nat Commun
34349096	Dysregulated hematopoiesis in bone marrow marks severe COVID-19.	Cell Discov
34348612	Role of potential COVID-19 immune system associated genes and the potential pathways linkage with type-2 diabetes.	Comb Chem High Throughput Screen
34348599	"A novel SARS-CoV-2 related coronavirus with complex recombination isolated from bats in Yunnan province, China."	Emerg Microbes Infect
34348081	"Flavan-based phytoconstituents inhibit Mpro, a SARS-COV-2 molecular target, in silico."	J Biomol Struct Dyn
34348076	Development of potent and effective synthetic SARS-CoV-2 neutralizing nanobodies.	MAbs
34348021	Pharmacophore Model for SARS-CoV-2 3CLpro Small-Molecule Inhibitors and in Vitro Experimental Validation of Computationally Screened Inhibitors.	J Chem Inf Model
34347801	Impaired immune response mediated by prostaglandin E2 promotes severe COVID-19 disease.	PLoS One
34347470	"Structure-Based Optimization of ML300-Derived, Noncovalent Inhibitors Targeting the Severe Acute Respiratory Syndrome Coronavirus 3CL Protease (SARS-CoV-2 3CL(pro))."	J Med Chem
34347374	A bond between rheumatic diseases and cancer in the elderly: The interleukin-6 pathway.	Int J Rheum Dis
34347309	TMEM106B in humans and Vac7 and Tag1 in yeast are predicted to be lipid transfer proteins.	Proteins
34346744	SARS-CoV-2 Quasispecies Provides an Advantage Mutation Pool for the Epidemic Variants.	Microbiol Spectr
34346525	Differential expression and regulation of MS4A family members in myeloid cells in physiological and pathological conditions.	J Leukoc Biol
34346317	Investigation of nonsynonymous mutations in the spike protein of SARS-CoV-2 and its interaction with the ACE2 receptor by molecular docking and MM/GBSA approach.	Comput Biol Med
34345815	Bruton tyrosine kinase inhibitors as potential therapeutic agents for COVID-19: A review.	Metabol Open
34345808	JAK inhibitors dampen activation of interferon-activated transcriptomes and the SARS-CoV-2 receptor ACE2 in human renal proximal tubules.	iScience
34345614	Complement Inhibition and COVID-19: The Story so Far.	Immunotargets Ther
34345611	"Working goal of Brazilein sappan wood as a candidate for SARS-coV-2 antivirus drug against spike (S) glycoprotein, papain-like proteinase, and main protease: In silico study."	J Adv Pharm Technol Res
34345609	The interaction of alpha-mangostin and its derivatives against main protease enzyme in COVID-19 using in silico methods.	J Adv Pharm Technol Res
34345605	In silico identification of natural products from Centella asiatica as severe acute respiratory syndromecoronavirus 2 main protease inhibitor.	J Adv Pharm Technol Res
34345293	Overview of the pathogenesis of COVID-19 (Review).	Exp Ther Med
34345219	Inhibition of SARS-CoV-2 pseudovirus invasion by ACE2 protecting and Spike neutralizing peptides: An alternative approach to COVID19 prevention and therapy.	Int J Biol Sci
34345157	Synthesis of Hetaryl-Substituted Asymmetric Porphyrins and Their Affinity to SARS-CoV-2 Helicase.	Russ J Gen Chem
34345117	Korean traditional foods as antiviral and respiratory disease prevention and treatments: A detailed review.	Trends Food Sci Technol
34344959	Induction of interferon response by high viral loads at early stage infection may protect against severe outcomes in COVID-19 patients.	Sci Rep
34344900	Potent neutralizing nanobodies resist convergent circulating variants of SARS-CoV-2 by targeting diverse and conserved epitopes.	Nat Commun
34344823	Broad betacoronavirus neutralization by a stem helix-specific human antibody.	Science
34344757	Impaired CD4 T-cell Response to SARS-CoV-2: Rationale for PD-1 Blockade in Patients with Cancer and COVID-19?	Cancer Discov
34344455	"Predicted antiviral drugs Darunavir, Amprenavir, Rimantadine and Saquinavir can potentially bind to neutralize SARS-CoV-2 conserved proteins."	J Biol Res (Thessalon)
34343897	Engineering of the current nucleoside-modified mRNA-LNP vaccines against SARS-CoV-2.	Biomed Pharmacother
34343818	Structure-based study of immune receptors as eligible binding targets of coronavirus SARS-CoV-2 spike protein.	J Mol Graph Model
34343536	Bacille Calmette-Guerin: An Ophthalmic perspective.	Surv Ophthalmol
34342578	Endomembrane targeting of human OAS1 p46 augments antiviral activity.	Elife
34341772	Discovery of SARS-CoV-2 Papain-like Protease Inhibitors through a Combination of High-Throughput Screening and a FlipGFP-Based Reporter Assay.	ACS Cent Sci
34341771	An mRNA SARS-CoV-2 Vaccine Employing Charge-Altering Releasable Transporters with a TLR-9 Agonist Induces Neutralizing Antibodies and T Cell Memory.	ACS Cent Sci
34341769	CD209L/L-SIGN and CD209/DC-SIGN Act as Receptors for SARS-CoV-2.	ACS Cent Sci
34341700	Polyphenols Could Prevent SARS-CoV-2 Infection by Modulating the Expression of miRNAs in the Host Cells.	Aging Dis
34341659	Severe COVID-19 Is Characterized by an Impaired Type I Interferon Response and Elevated Levels of Arginase Producing Granulocytic Myeloid Derived Suppressor Cells.	Front Immunol
34341593	All in the family: A comparative look at coronaviruses.	Can Vet J
34341401	Computational design of SARS-CoV-2 peptide binders with better predicted binding affinities than human ACE2 receptor.	Sci Rep
34341353	SARS-CoV-2 N protein promotes NLRP3 inflammasome activation to induce hyperinflammation.	Nat Commun
34340720	COVID-19 pandemic: insights into molecular mechanisms leading to sex-based differences in patient outcomes.	Expert Rev Mol Med
34340553	The TMPRSS2 Inhibitor Nafamostat Reduces SARS-CoV-2 Pulmonary Infection in Mouse Models of COVID-19.	mBio
34340303	Why All the Fury over Furin?	J Med Chem
34340125	Potential inhibitors of the main protease of SARS-CoV-2 and modulators of arachidonic acid pathway: Non-steroidal anti-inflammatory drugs against COVID-19.	Comput Biol Med
34340124	Identifying molecular insight of synergistic complexities for SARS-CoV-2 infection with pre-existing type 2 diabetes.	Comput Biol Med
34339963	Evaluation of S-RBD and high specificity ACE-2-binding antibodies on SARS-CoV-2 patients after six months from infection.	Int Immunopharmacol
34339917	Potential protective role of the anti-PD-1 blockade against SARS-CoV-2 infection.	Biomed Pharmacother
34339772	"Origin, phylogeny, variability and epitope conservation of SARS-CoV-2 worldwide."	Virus Res
34339634	Bucket brigade using lysine residues in RNA-dependent RNA polymerase of SARS-CoV-2.	Biophys J
34339582	A systems-level study reveals host-targeted repurposable drugs against SARS-CoV-2 infection.	Mol Syst Biol
34339474	"Identification of cell lines CL-14, CL-40 and CAL-51 as suitable models for SARS-CoV-2 infection studies."	PLoS One
34339171	Salicylanilides Reduce SARS-CoV-2 Replication and Suppress Induction of Inflammatory Cytokines in a Rodent Model.	ACS Infect Dis
34339073	An overview on the seven pathogenic human coronaviruses.	Rev Med Virol
34339064	S100A8 may govern hyper-inflammation in severe COVID-19.	FASEB J
34339040	"SARS-CoV-2 spike protein: pathogenesis, vaccines, and potential therapies."	Infection
34338634	The development of Nanosota-1 as anti-SARS-CoV-2 nanobody drug candidates.	Elife
34338602	In silico analysis of marine natural product from sponge (Clathria Sp.) for their activity as inhibitor of SARS-CoV-2 Main Protease.	J Biomol Struct Dyn
34338446	HLA genetic polymorphism in patients with Coronavirus Disease 2019 in Midwestern United States.	HLA
34337272	Production of Proteins of the SARS-CoV-2 Proteome for Drug Discovery.	ACS Omega
34337139	Emerging mutations in envelope protein of SARS-CoV-2 and their effect on thermodynamic properties.	Inform Med Unlocked
34337109	"Computational Identification of SARS-CoV-2 Inhibitor in Tinospora cordifolia, Cinnamomum zeylanicum and Myristica fragrans."	Virusdisease
34337108	Do inflammasome impact COVID-19 severity?	Virusdisease
34337036	Characterization of the Modulatory Effect of Hydroxychloroquine on ACE2 Activity: New Insights in relation to COVID-19.	Biomed Res Int
34336545	In-silico study of peptide-protein interaction of antimicrobial peptides potentially targeting SARS and SARS-CoV-2 nucleocapsid protein.	In Silico Pharmacol
34336544	A machine learning regression model for the screening and design of potential SARS-CoV-2 protease inhibitors.	Netw Model Anal Health Inform Bioinform
34336361	"A Review on Expression, Pathological Roles, and Inhibition of TMPRSS2, the Serine Protease Responsible for SARS-CoV-2 Spike Protein Activation."	Scientifica (Cairo)
34336189	Increase of SARS-CoV-2 RNA load in faecal samples prompts for rethinking of SARS-CoV-2 biology and COVID-19 epidemiology.	F1000Res
34336146	Binding affinity and mechanisms of SARS-CoV-2 variants.	Comput Struct Biotechnol J
34336145	Immune evasion of SARS-CoV-2 from interferon antiviral system.	Comput Struct Biotechnol J
34336138	Prevalence of the SNP rs10774671 of the OAS1 gene in Mexico as a possible predisposing factor for RNA virus disease.	Int J Mol Epidemiol Genet
34335981	"Endothelial cell infection and dysfunction, immune activation in severe COVID-19."	Theranostics
34335977	Multi-omic profiling of plasma reveals molecular alterations in children with COVID-19.	Theranostics
34335974	Environmentally-induced mdig contributes to the severity of COVID-19 through fostering expression of SARS-CoV-2 receptor NRPs and glycan metabolism.	Theranostics
34335703	Th2/Th1 Cytokine Imbalance Is Associated With Higher COVID-19 Risk Mortality.	Front Genet
34335621	The Role of Macrophages During Mammalian Tissue Remodeling and Regeneration Under Infectious and Non-Infectious Conditions.	Front Immunol
34335604	The Pathogenic Features of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Possible Mechanisms for Immune Evasion?	Front Immunol
34335580	Chronic Obstructive Pulmonary Disease Patients Have Increased Levels of Plasma Inflammatory Mediators Reported Upregulated in Severe COVID-19.	Front Immunol
34335566	Comprehensive Profiling of Inflammatory Factors Revealed That Growth Differentiation Factor-15 Is an Indicator of Disease Severity in COVID-19 Patients.	Front Immunol
34335530	Comprehensive Deep Mutational Scanning Reveals the Immune-Escaping Hotspots of SARS-CoV-2 Receptor-Binding Domain Targeting Neutralizing Antibodies.	Front Microbiol
34335287	A Contemporary View of Natriuretic Peptides in the SARS-CoV-2 Era.	Front Physiol
34335279	The Role of High-Density Lipoprotein in COVID-19.	Front Pharmacol
34335050	The Relationship Between Vitamin D and Infections Including COVID-19: Any Hopes?	Int J Gen Med
34334813	"In search of SARS CoV-2 replication inhibitors: Virtual screening, molecular dynamics simulations and ADMET analysis."	J Mol Struct
34334300	Coagulation and wound repair during COVID-19.	J Heart Lung Transplant
34334126	A phenomics approach for antiviral drug discovery.	BMC Biol
34333809	An in silico scientific basis for LL-37 as a therapeutic for Covid-19.	Proteins
34333764	Maturation signatures of conventional dendritic cell subtypes in COVID-19 suggest direct viral sensing.	Eur J Immunol
34333732	Basic mechanisms of SARS-CoV-2 infection. What endocrine systems could be implicated?	Rev Endocr Metab Disord
34333425	Discovery and evolution of 12N-substituted aloperine derivatives as anti-SARS-CoV-2 agents through targeting late entry stage.	Bioorg Chem
34333286	"Kidney injury in COVID-19 patients, drug development and their renal complications: Review study."	Biomed Pharmacother
34333284	An ACE2/Mas-related receptor MrgE axis in dopaminergic neuron mitochondria.	Redox Biol
34333072	Host metabolic reprogramming in response to SARS-CoV-2 infection: A systems biology approach.	Microb Pathog
34333006	"Flavonoids in Ampelopsis grossedentata as covalent inhibitors of SARS-CoV-2 3CL(pro): Inhibition potentials, covalent binding sites and inhibitory mechanisms."	Int J Biol Macromol
34332853	Synthetic and computational efforts towards the development of peptidomimetics and small-molecule SARS-CoV 3CLpro inhibitors.	Bioorg Med Chem
34332518	Could metabolomics drive the fate of COVID-19 pandemic? A narrative review on lights and shadows.	Clin Chem Lab Med
34332351	Computational identification of repurposed drugs against viruses causing epidemics and pandemics via drug-target network analysis.	Comput Biol Med
34332348	Structure-based virtual screening suggests inhibitors of 3-Chymotrypsin-Like Protease of SARS-CoV-2 from Vernonia amygdalina and Occinum gratissimum.	Comput Biol Med
34332145	Direct Reprogramming Induces Vascular Regeneration Post Muscle Ischemic Injury.	Mol Ther
34332025	Sialic acid-conjugate modified doxorubicin nanoplatform for treating neutrophil-related inflammation.	J Control Release
34332019	Epidemiological data and genome sequencing reveals that nosocomial transmission of SARS-CoV-2 is underestimated and mostly mediated by a small number of highly infectious individuals.	J Infect
34331944	Binding of a pyrimidine RNA base-mimic to SARS-CoV-2 non-structural protein 9.	J Biol Chem
34331873	"Affinity maturation of SARS-CoV-2 neutralizing antibodies confers potency, breadth, and resilience to viral escape mutations."	Immunity
34331769	Single-dose immunisation with a multimerised SARS-CoV-2 receptor binding domain (RBD) induces an enhanced and protective response in mice.	FEBS Lett
34331459	Hypothesis: Possible influence of antivector immunity and SARS-CoV-2 variants on efficacy of ChAdOx1 nCoV-19 vaccine.	Br J Pharmacol
34331297	Viral-induced inflammatory coagulation disorders: Preparing for another epidemic.	Thromb Haemost
34330917	Correlative multi-scale cryo-imaging unveils SARS-CoV-2 assembly and egress.	Nat Commun
34330908	A synthetic nanobody targeting RBD protects hamsters from SARS-CoV-2 infection.	Nat Commun
34330889	Multimodal single-cell omics analysis identifies epithelium-immune cell interactions and immune vulnerability associated with sex differences in COVID-19.	Signal Transduct Target Ther
34330510	Gene signatures of autopsy lungs from obese patients with COVID-19.	Clin Nutr ESPEN
34329980	Modelling the adsorption of proteins to nanoparticles at the solid-liquid interface.	J Colloid Interface Sci
34329865	Classification of SARS-CoV-2 and non-SARS-CoV-2 using machine learning algorithms.	Comput Biol Med
34329860	"Targeting COVID-19 (SARS-CoV-2) main protease through active phytocompounds of ayurvedic medicinal plants - Emblica officinalis (Amla), Phyllanthus niruri Linn. (Bhumi Amla) and Tinospora cordifolia (Giloy) - A molecular docking and simulation study."	Comput Biol Med
34329818	"Potent antiviral activity of Agrimonia pilosa, Galla rhois, and their components against SARS-CoV-2."	Bioorg Med Chem
34329696	SARS-CoV-2 specific memory T cell epitopes identified in COVID-19-recovered subjects.	Virus Res
34329676	"Latent tuberculosis co-infection is associated with heightened levels of humoral, cytokine and acute phase responses in seropositive SARS-CoV-2 infection."	J Infect
34329642	Tetravalent SARS-CoV-2 Neutralizing Antibodies Show Enhanced Potency and Resistance to Escape Mutations.	J Mol Biol
34329631	What we know and what we need to know about the origin of SARS-CoV-2.	Environ Res
34329486	A cluster of the new SARS-CoV-2 B.1.621 lineage in Italy and sensitivity of the viral isolate to the BNT162b2 vaccine.	J Med Virol
34329437	Single-cell RNA Sequencing of SARS-CoV-2 Cell Entry Factors in the Preconceptional Human Endometrium.	Hum Reprod
34328954	Explorative assessment of coronavirus-like short sequences from host-associated and environmental metagenomes.	Sci Total Environ
34328740	Role of ATP in the RNA Translocation Mechanism of SARS-CoV-2 NSP13 Helicase.	J Phys Chem B
34328734	The SARS-CoV-2 Programmed -1 Ribosomal Frameshifting Element Crystal Structure Solved to 2.09 A Using Chaperone-Assisted RNA Crystallography.	ACS Chem Biol
34328726	Synthetic Peptides That Antagonize the Angiotensin-Converting Enzyme-2 (ACE-2) Interaction with SARS-CoV-2 Receptor Binding Spike Protein.	J Med Chem
34328683	Discovery and characterization of spike N-terminal domain-binding aptamers for rapid SARS-CoV-2 detection.	Angew Chem Int Ed Engl
34328636	Post-COVID-19 acute sarcopenia: physiopathology and management.	Aging Clin Exp Res
34328586	Quantum simulations of SARS-CoV-2 main protease M(pro) enable high-quality scoring of diverse ligands.	J Comput Aided Mol Des
34328382	Protein degradation: a novel computational approach to design protein degrader probes for main protease of SARS-CoV-2.	J Biomol Struct Dyn
34328374	In-silico study on viability of MXenes in suppressing the coronavirus infection and distribution.	J Biomol Struct Dyn
34328324	Structural O-Glycoform Heterogeneity of the SARS-CoV-2 Spike Protein Receptor-Binding Domain Revealed by Top-Down Mass Spectrometry.	J Am Chem Soc
34328284	The smoker's paradox during the COVID-19 pandemic? The influence of smoking and vaping on the incidence and course of SARS-CoV-2 virus infection as well as possibility of using nicotine in the treatment of COVID-19 - Review of the literature.	Przegl Epidemiol
34328182	Roles of steroid receptors in the lung and COVID-19.	Essays Biochem
34328172	SARS-CoV-2 spike protein S1 induces fibrin(ogen) resistant to fibrinolysis: Implications for microclot formation in COVID-19.	Biosci Rep
34328074	"Vaccine breakthrough infection and onward transmission of SARS-CoV-2 Beta (B.1.351) variant, Bavaria, Germany, February to March 2021."	Euro Surveill
34327998	Representing and Comparing Site-Specific Glycan Abundance Distributions of Glycoproteins.	J Proteome Res
34327666	Is there a common pathophysiological mechanism between COVID-19 and depression?	Acta Neurol Belg
34327214	Discovery of Small-Molecule Inhibitors of SARS-CoV-2 Proteins Using a Computational and Experimental Pipeline.	Front Mol Biosci
34327127	Impact of SARS-CoV-2 on neuropsychiatric disorders.	World J Psychiatry
34327118	The Dual/Global Value of SARS-CoV-2 Genome Surveillance on Migrants Arriving to Europe via the Mediterranean Routes.	Ann Glob Health
34327049	Hematopoietic stem and progenitor cells directly participate in host immune response.	Am J Stem Cells
34326952	Immunometabolic bases of type 2 diabetes in the severity of COVID-19.	World J Diabetes
34326844	Impaired Priming of SARS-CoV-2-Specific Naive CD8(+) T Cells in Older Subjects.	Front Immunol
34326843	The Many Faces of JAKs and STATs Within the COVID-19 Storm.	Front Immunol
34326616	Inflammatory effect on the gastrointestinal system associated with COVID-19.	World J Gastroenterol
34326607	Liver dysfunction and SARS-CoV-2 infection.	World J Gastroenterol
34326460	Human embryonic stem cell-derived cardiomyocyte platform screens inhibitors of SARS-CoV-2 infection.	Commun Biol
34326429	Comprehensive virtual screening of 4.8 k flavonoids reveals novel insights into allosteric inhibition of SARS-CoV-2 M(PRO).	Sci Rep
34326343	SARS-CoV-2 specific T cell responses are lower in children and increase with age and time after infection.	Nat Commun
34326336	Endogenous control of inflammation characterizes pregnant women with asymptomatic or paucisymptomatic SARS-CoV-2 infection.	Nat Commun
34326317	Immune responses to a single dose of the AZD1222/Covishield vaccine in health care workers.	Nat Commun
34326311	Differential immune responses in pregnant patients recovered from COVID-19.	Signal Transduct Target Ther
34326308	Structural and functional basis for pan-CoV fusion inhibitors against SARS-CoV-2 and its variants with preclinical evaluation.	Signal Transduct Target Ther
34326184	Cross-reactive antibodies against human coronaviruses and the animal coronavirome suggest diagnostics for future zoonotic spillovers.	Sci Immunol
34326009	Rilpivirine inhibits SARS-CoV-2 protein targets: A potential multi-target drug.	J Infect Public Health
34325716	Expression of SARS-CoV-2-related receptors in cells of the neurovascular unit: implications for HIV-1 infection.	J Neuroinflammation
34325659	Cospeciation of coronavirus and paramyxovirus with their bat hosts in the same geographical areas.	BMC Ecol Evol
34325286	SARS-CoV-2 and other coronaviruses bind to phosphorylated glycans from the human lung.	Virology
34325131	A non-RBM targeted RBD specific antibody neutralizes SARS-CoV-2 inducing S1 shedding.	Biochem Biophys Res Commun
34324997	Rescue of recombinant canine distemper virus that expresses S1 subunit of SARS-CoV-2 spike protein in vitro.	Microb Pathog
34324964	Can Covid-19 attack our nervous system?	J Chem Neuroanat
34324908	Chitosan derivatives: A suggestive evaluation for novel inhibitor discovery against wild type and variants of SARS-CoV-2 virus.	Int J Biol Macromol
34324884	Strategies for controlling the innate immune activity of conventional and self-amplifying mRNA therapeutics: Getting the message across.	Adv Drug Deliv Rev
34324734	Dimethyl sulfoxide reduces the stability but enhances catalytic activity of the main SARS-CoV-2 protease 3CLpro.	FASEB J
34324704	SARS-CoV-2 infection as a trigger of humoral response against apolipoprotein A-1.	Eur J Clin Invest
34324605	Modeling neutral viral mutations in the spread of SARS-CoV-2 epidemics.	PLoS One
34324563	Topological network based drug repurposing for coronavirus 2019.	PLoS One
34324336	One-Component Multifunctional Sequence-Defined Ionizable Amphiphilic Janus Dendrimer Delivery Systems for mRNA.	J Am Chem Soc
34324210	"SARS-CoV-2 pseudovirus infectivity and expression of viral entry-related factors ACE2, TMPRSS2, Kim-1, and NRP-1 in human cells from the respiratory, urinary, digestive, reproductive, and immune systems."	J Med Virol
34324175	A Novel Therapeutic Peptide Blocks SARS-CoV-2 Spike Protein Binding with Host Cell ACE2 Receptor.	Drugs R D
34324165	Waning antibody responses in COVID-19: what can we learn from the analysis of other coronaviruses?	Infection
34324157	In Silico Mutagenesis-Based Remodelling of SARS-CoV-1 Peptide (ATLQAIAS) to Inhibit SARS-CoV-2: Structural-Dynamics and Free Energy Calculations.	Interdiscip Sci
34324152	Synthesis and Identification of Novel Potential Molecules Against COVID-19 Main Protease Through Structure-Guided Virtual Screening Approach.	Appl Biochem Biotechnol
34323931	Presumed SARS-CoV-2 Viral Particles in the Human Retina of Patients With COVID-19.	JAMA Ophthalmol
34323811	Detection of SARS-CoV-2 variants by genomic analysis of wastewater samples in Israel.	Sci Total Environ
34323691	Reduced antibody cross-reactivity following infection with B.1.1.7 than with parental SARS-CoV-2 strains.	Elife
34323299	A functional assay for serum detection of antibodies against SARS-CoV-2 nucleoprotein.	EMBO J
34323189	Advancement of prodrug approaches for nucleotide antiviral agents.	Curr Top Med Chem
34323071	"Molecular Plasticity of Crystalline CK2alpha' Leads to KN2, a Bivalent Inhibitor of Protein Kinase CK2 with Extraordinary Selectivity."	J Med Chem
34322844	"Vitamin D, infections and immunity."	Rev Endocr Metab Disord
34322810	Bioinformatic analyses suggest augmented interleukin-17 signaling as the mechanism of COVID-19-associated herpes zoster.	Environ Sci Pollut Res Int
34322559	CD8+ T-Cell Responses in COVID-19 Convalescent Individuals Target Conserved Epitopes From Multiple Prominent SARS-CoV-2 Circulating Variants.	Open Forum Infect Dis
34322518	Mathematical Model of SARS-Cov-2 Propagation Versus ACE2 Fits COVID-19 Lethality Across Age and Sex and Predicts That of SARS.	Front Mol Biosci
34322517	Current Perspectives in the Discovery of Newer Medications Against the Outbreak of COVID-19.	Front Mol Biosci
34322507	Dairy-Derived and Egg White Proteins in Enhancing Immune System Against COVID-19.	Front Nutr
34322316	The impact of curcumin derived polyphenols on the structure and flexibility COVID-19 main protease binding pocket: a molecular dynamics simulation study.	PeerJ
34322129	SARS-CoV-2 Vaccines Based on the Spike Glycoprotein and Implications of New Viral Variants.	Front Immunol
34322127	A Single-Cell Atlas of Lymphocyte Adaptive Immune Repertoires and Transcriptomes Reveals Age-Related Differences in Convalescent COVID-19 Patients.	Front Immunol
34322120	Reactive T Cells in Convalescent COVID-19 Patients With Negative SARS-CoV-2 Antibody Serology.	Front Immunol
34321474	IFITM proteins promote SARS-CoV-2 infection and are targets for virus inhibition in vitro.	Nat Commun
34321401	The role of hypertension on the severity of COVID-19: a review.	J Cardiovasc Pharmacol
34321200	Disassembly of HIV envelope glycoprotein trimer immunogens is driven by antibodies elicited via immunization.	Sci Adv
34321156	"Coenzyme Q10 supplementation mitigates piroxicam-induced oxidative injury and apoptotic pathways in the stomach, liver, and kidney."	Biomed Pharmacother
34321065	Natural products provide a new perspective for anti-complement treatment of severe COVID-19: a review.	Chin Med
34320905	One microsecond MD simulations of the SARS-CoV-2 main protease and hydroxychloroquine complex reveal the intricate nature of binding.	J Biomol Struct Dyn
34320843	Renin-Angiotensin Aldosterone System Inhibitors in Primary Prevention and COVID-19.	J Am Heart Assoc
34320609	Rapid and stable mobilization of CD8+ T cells by SARS-CoV-2 mRNA vaccine.	Nature
34320442	Decrypting the role of predicted SARS-CoV-2 miRNAs in COVID-19 pathogenesis: A bioinformatics approach.	Comput Biol Med
34320401	Inhibitors of VPS34 and fatty-acid metabolism suppress SARS-CoV-2 replication.	Cell Rep
34320390	"Cross-neutralization of SARS-CoV-2 B.1.1.7 and P.1 variants in vaccinated, convalescent and P.1 infected."	J Infect
34320275	Influence of angiotensin converting enzyme inhibitors/angiotensin receptor blockers on the risk of all-cause mortality and other clinical outcomes in patients with confirmed COVID-19: A systemic review and meta-analysis.	J Clin Hypertens (Greenwich)
34320263	Facing the wrath of enigmatic mutations: a review on the emergence of severe acute respiratory syndrome coronavirus 2 variants amid coronavirus disease-19 pandemic.	Environ Microbiol
34320031	Altered microRNA expression in COVID-19 patients enables identification of SARS-CoV-2 infection.	PLoS Pathog
34319871	Losartan Inhibits SARS-CoV-2 Replication in Vitro.	J Pharm Pharm Sci
34319869	Combined computational and cellular screening identifies synergistic inhibition of SARS-CoV-2 by lenvatinib and remdesivir.	J Gen Virol
34319802	Assessment of SARS-CoV-2 genome sequencing: quality criteria and low frequency variants.	J Clin Microbiol
34319784	Kinetic multi-omic analysis of responses to SARS-CoV-2 infection in a model of severe COVID-19.	J Virol
34319496	The potential role of neopterin in Covid-19: a new perspective.	Mol Cell Biochem
34319169	A Novel Small Molecule Inhibits Hepatitis C Virus Propagation in Cell Culture.	Microbiol Spectr
34319150	SARS-CoV-2 Antiviral Therapy.	Clin Microbiol Rev
34319130	Long-Term Evolution of SARS-CoV-2 in an Immunocompromised Patient with Non-Hodgkin Lymphoma.	mSphere
34319126	Rapid and Flexible Platform To Assess Anti-SARS-CoV-2 Antibody Neutralization and Spike Protein-Specific Antivirals.	mSphere
34319118	Accelerating COVID-19 Research Using Molecular Dynamics Simulation.	J Phys Chem B
34318516	COVID-19 Acute Respiratory Distress Syndrome (ARDS): a Simulation Study of the Effects of Combination Therapy with Tocilizumab and Siltuximab.	Br J Clin Pharmacol
34316508	First detection of an Italian human-to-cat outbreak of SARS-CoV-2 Alpha variant - lineage B.1.1.7.	One Health
34316461	Role of Pegylated Interferon in Patients with Chronic Liver Diseases in the Context of SARS-CoV-2 Infection.	Euroasian J Hepatogastroenterol
34316355	iCAT: diagnostic assessment tool of immunological history using high-throughput T-cell receptor sequencing.	F1000Res
34316082	"The iron(III) and nickel(II) complexes with tetradentate thiosemicarbazones. Synthesis, experimental, theoretical characterization, and antiviral effect against SARS-CoV-2."	J Mol Struct
34315957	Lower peripheral blood Toll-like receptor 3 expression is associated with an unfavorable outcome in severe COVID-19 patients.	Sci Rep
34315945	Virus Induced Lymphocytes (VIL) as a novel viral antigen-specific T cell therapy for COVID-19 and potential future pandemics.	Sci Rep
34315903	Integrative genomic analyses identify susceptibility genes underlying COVID-19 hospitalization.	Nat Commun
34315893	Single-cell transcriptome of bronchoalveolar lavage fluid reveals sequential change of macrophages during SARS-CoV-2 infection in ferrets.	Nat Commun
34315889	The trans-omics landscape of COVID-19.	Nat Commun
34315862	Screening of potent neutralizing antibodies against SARS-CoV-2 using convalescent patients-derived phage-display libraries.	Cell Discov
34315827	Structural basis of mismatch recognition by a SARS-CoV-2 proofreading enzyme.	Science
34315825	Protective antibodies elicited by SARS-CoV-2 spike protein vaccination are boosted in the lung after challenge in nonhuman primates.	Sci Transl Med
34315815	SARS-CoV-2 infection triggers widespread host mRNA decay leading to an mRNA export block.	RNA
34315622	Cardiovascular Diseases: Consider Netosis.	Curr Probl Cardiol
34315369	Exploring the COVID-19 Potential Targets: Big Challenges to Quest Specific Treatment.	Curr Top Med Chem
34315340	Combined molecular docking and dynamics simulations studies of natural compounds as potent inhibitors against SARS-CoV-2 main protease.	J Biomol Struct Dyn
34315339	Remdesivir analogs against SARS-CoV-2 RNA-dependent RNA polymerase.	J Biomol Struct Dyn
34315206	Parkinson's Disease and the COVID-19 Pandemic: A Review Article on the Association between SARS-CoV-2 and alpha-Synucleinopathy.	J Mov Disord
34315200	Interplays between human microbiota and microRNAs in COVID-19 pathogenesis: a literature review.	Phys Act Nutr
34315173	Aberrant glycosylation of anti-SARS-CoV-2 IgG is a pro-thrombotic stimulus for platelets.	Blood
34315010	Dynamics of breast milk antibody titer in the six months following SARS-CoV-2 infection.	J Clin Virol
34314863	Ultraviolet-A light reduces cellular cytokine release from human endotracheal cells infected with Coronavirus.	Photodiagnosis Photodyn Ther
34314772	Structural modelling of SARS-CoV-2 alpha variant (B.1.1.7) suggests enhanced furin binding and infectivity.	Virus Res
34314723	The origins and potential future of SARS-CoV-2 variants of concern in the evolving COVID-19 pandemic.	Curr Biol
34314668	Emergence of SARS-COV-2 Spike Protein Escape Mutation Q493R after Treatment for COVID-19.	Emerg Infect Dis
34314576	SARS-CoV-2 spike glycoprotein-reactive T cells can be readily expanded from COVID-19 vaccinated donors.	Immun Inflamm Dis
34314391	COVID-19 generates hyaluronan fragments that directly induce endothelial barrier dysfunction.	JCI Insight
34314051	Evaluation of the relationship between pentraxin 3 (PTX3) rs2305619 (281A/G) and rs1840680 (1449A/G) polymorphisms and the clinical course of COVID-19.	J Med Virol
34314050	SARS-CoV-2 R.1 lineage variants that prevailed in Tokyo in March 2021.	J Med Virol
34314048	"Sequencing on an imported case in China of COVID-19 Delta variant emerging from India in a cargo ship in Zhoushan, China."	J Med Virol
34313734	Translation from bats to humans beyond infectious diseases.	J Exp Med
34313585	Network pharmacology and molecular docking analysis on mechanisms of Tibetan Hongjingtian (Rhodiola crenulata) in the treatment of COVID-19.	J Med Microbiol
34313527	"Characterization of MW06, a human monoclonal antibody with cross-neutralization activity against both SARS-CoV-2 and SARS-CoV."	MAbs
34313428	3CL Protease Inhibitors with an Electrophilic Arylketone Moiety as Anti-SARS-CoV-2 Agents.	J Med Chem
34313421	Determination of Ligand Binding Modes in Hydrated Viral Ion Channels to Foster Drug Design and Repositioning.	J Chem Inf Model
34313294	A lipidomic view of SARS-CoV-2.	Biosci Rep
34313197	"Natural Products with tandem Anti-inflammatory, Immunomodulatory and Anti-SARS-CoV/2 effects: A Drug Discovery Perspective against SARS-CoV-2."	Curr Med Chem
34313128	Strengths and Weaknesses of Docking Simulations in the SARS-CoV-2 Era: the Main Protease (Mpro) Case Study.	J Chem Inf Model
34312846	Sequence requirements of the FFAT-like motif for specific binding to VAP-A are revealed by NMR.	FEBS Lett
34312772	Genetic Exchange of Lung-Derived Exosome to Brain Causing Neuronal Changes on COVID-19 Infection.	Mol Neurobiol
34312610	"Saffron for ""toning down"" COVID-19-related cytokine storm: Hype or hope? A mini-review of current evidence."	Metabol Open
34312598	Bracing NK cell based therapy to relegate pulmonary inflammation in COVID-19.	Heliyon
34312587	In silico studies of Potency and safety assessment of selected trial drugs for the treatment of COVID-19.	In Silico Pharmacol
34312578	Evaluation of liver histopathological findings of COVID-19 by minimally invasive autopsies.	J Clin Exp Hepatol
34312571	Identification of Food Compounds as inhibitors of SARS-CoV-2 main protease using molecular docking and molecular dynamics simulations.	Chemometr Intell Lab Syst
34312554	Immunogenicity and reactogenicity of heterologous ChAdOx1 nCoV-19/mRNA vaccination.	Nat Med
34312520	Mucosal vaccines - fortifying the frontiers.	Nat Rev Immunol
34312487	ChAdOx1 nCoV-19 protection against SARS-CoV-2 in rhesus macaque and ferret challenge models.	Commun Biol
34312429	S494 O-glycosylation site on the SARS-CoV-2 RBD affects the virus affinity to ACE2 and its infectivity; a molecular dynamics study.	Sci Rep
34312390	Neutralizing activity of Sputnik V vaccine sera against SARS-CoV-2 variants.	Nat Commun
34312385	Single-cell RNA sequencing reveals ex vivo signatures of SARS-CoV-2-reactive T cells through 'reverse phenotyping'.	Nat Commun
34312258	"The Quality of SARS-CoV-2-Specific T Cell Functions Differs in Patients with Mild/Moderate versus Severe Disease, and T Cells Expressing Coinhibitory Receptors Are Highly Activated."	J Immunol
34312178	"Long covid-mechanisms, risk factors, and management."	BMJ
34311684	"Subacute and chronic post-covid myoendocarditis: clinical presentation, role of coronavirus persistence and autoimmune mechanisms."	Kardiologiia
34311587	B.1.526 SARS-CoV-2 Variants Identified in New York City are Neutralized by Vaccine-Elicited and Therapeutic Monoclonal Antibodies.	mBio
34311586	D614G Substitution of SARS-CoV-2 Spike Protein Increases Syncytium Formation and Virus Titer via Enhanced Furin-Mediated Spike Cleavage.	mBio
34311582	Recovery from Acute SARS-CoV-2 Infection and Development of Anamnestic Immune Responses in T Cell-Depleted Rhesus Macaques.	mBio
34311574	Murine Monoclonal Antibodies against the Receptor Binding Domain of SARS-CoV-2 Neutralize Authentic Wild-Type SARS-CoV-2 as Well as B.1.1.7 and B.1.351 Viruses and Protect In Vivo in a Mouse Model in a Neutralization-Dependent Manner.	mBio
34311543	Dipeptidyl Peptidase-4 Inhibitors and COVID-19-Related Deaths among Patients with Type 2 Diabetes Mellitus: A Meta-Analysis of Observational Studies.	Endocrinol Metab (Seoul)
34311539	"Identification of FDA approved drugs against SARS-CoV-2 RNA dependent RNA polymerase (RdRp) and 3-chymotrypsin-like protease (3CLpro), drug repurposing approach."	Biomed Pharmacother
34311478	[SARS-CoV-2 and the digestive tract - Organoids to model gastrointestinal infection].	Z Gastroenterol
34311326	SARS-CoV-2 activates lung epithelial cell proinflammatory signaling and leads to immune dysregulation in COVID-19 patients.	EBioMedicine
34311261	Identifying potential human and medicinal plant microRNAs against SARS-CoV-2 3'UTR region: A computational genomics assessment.	Comput Biol Med
34311260	Transcription factor NF-kappaB as target for SARS-CoV-2 drug discovery efforts using inflammation-based QSAR screening model.	J Mol Graph Model
34311241	"Computational modeling predicts potential effects of the herbal infusion ""horchata"" against COVID-19."	Food Chem
34311073	The potential role of thymoquinone in preventing the cardiovascular complications of COVID-19.	Vascul Pharmacol
34311016	"Interferon beta, an enhancer of the innate immune response against SARS-CoV-2 infection."	Microb Pathog
34310402	A mild deficiency of ADAMTS13 is associated with severity in COVID-19: comparison of the coagulation profile in critically and noncritically ill patients.	Blood Coagul Fibrinolysis
34310359	Learning about Kawasaki disease from COVID-19 and the Multisystem Inflammatory Syndrome in Children.	Curr Opin Pediatr
34310217	"Rethinking Remdesivir: Synthesis, Antiviral Activity and Pharmacokinetics of Oral Lipid Prodrugs."	Antimicrob Agents Chemother
34309902	Neutralizing type-I interferon autoantibodies are associated with delayed viral clearance and intensive care unit admission in patients with COVID-19.	Immunol Cell Biol
34309648	Impact of SARS-CoV-2 variant-associated RBD mutations on the susceptibility to serum antibodies elicited by COVID-19 infection or vaccination.	Clin Infect Dis
34309463	Could Immunonutrition Help in the Fight against COVID-19 in Cancer Patient?	Nutr Cancer
34309055	Personalized health and the coronavirus vaccines-Do individual genetics matter?	Bioessays
34308962	Genetic mechanisms of COVID-19 and its association with smoking and alcohol consumption.	Brief Bioinform
34308790	Design and in silico investigation of novel Maraviroc analogues as dual inhibition of CCR-5/SARS-CoV-2 M(pro).	J Biomol Struct Dyn
34308530	Target-Based In Silico Screening for Phytoactive Compounds Targeting SARS-CoV-2.	Interdiscip Sci
34308480	scAdapt: virtual adversarial domain adaptation network for single cell RNA-seq data classification across platforms and species.	Brief Bioinform
34308388	Maternal immune activation as a risk factor for psychiatric illness in the context of the SARS-CoV-2 pandemic.	Brain Behav Immun Health
34308376	SARS-CoV-2 spike linear epitope scanning via a peptide microarray through sera profiling.	STAR Protoc
34308375	ACE2 chromogenic immunostaining protocol optimized for formalin-fixed paraffin-embedded human tissue sections.	STAR Protoc
34308298	Multi-omics analysis of respiratory specimen characterizes baseline molecular determinants associated with SARS-CoV-2 outcome.	iScience
34308004	Repurposing FDA-approved drugs against multiple proteins of SARS-CoV-2: An in silico study.	Sci Afr
34307909	"Analysis of SARS-CoV-2 infection associated cell entry proteins ACE2, CD147, PPIA, and PPIB in datasets from non SARS-CoV-2 infected neuroblastoma patients, as potential prognostic and infection biomarkers in neuroblastoma."	Biochem Biophys Rep
34307830	In-Silico analysis reveals lower transcription efficiency of C241T variant of SARS-CoV-2 with host replication factors MADP1 and hnRNP-1.	Inform Med Unlocked
34307771	Mutational analysis in international isolates and drug repurposing against SARS-CoV-2 spike protein: molecular docking and simulation approach.	Virusdisease
34307600	Effects of angiotensin receptor blockers and angiotensin-converting enzyme inhibitors on COVID-19.	World J Clin Cases
34307596	Role of gastrointestinal system on transmission and pathogenesis of SARS-CoV-2.	World J Clin Cases
34307551	Insights into the virologic and immunologic features of SARS-COV-2.	World J Clin Cases
34307549	COVID-19 and gastroenteric manifestations.	World J Clin Cases
34307547	Remarkable gastrointestinal and liver manifestations of COVID-19: A clinical and radiologic overview.	World J Clin Cases
34307393	Elevation of Serum Cytokine Profiles and Liver Metabolomic Normalization in Early Convalescence of COVID-19 Patients.	Front Med (Lausanne)
34307358	Potential Impact of Diabetes and Obesity on Alveolar Type 2 (AT2)-Lipofibroblast (LIF) Interactions After COVID-19 Infection.	Front Cell Dev Biol
34307267	Factors Behind the Higher COVID-19 Risk in Diabetes: A Critical Review.	Front Public Health
34307238	"Angiotensin-converting enzyme 2, the SARS-CoV-2 cellular receptor, is widely expressed in human myometrium and uterine leiomyoma."	J Endometr Pelvic Pain Disord
34307198	SARS-CoV-2 Infects Endothelial Cells In Vivo and In Vitro.	Front Cell Infect Microbiol
34307196	Developing Recombinant Antibodies by Phage Display Against Infectious Diseases and Toxins for Diagnostics and Therapy.	Front Cell Infect Microbiol
34307057	SARS-CoV 2 spike protein S1 subunit as an ideal target for stable vaccines: A bioinformatic study.	Mater Today Proc
34307051	"Rapid, inexpensive methods for exploring SARS CoV-2 D614G mutation."	Meta Gene
34306990	Preliminary investigation of drug impurities associated with the anti-influenza drug Favipiravir - An insilico approach.	Comput Theor Chem
34306988	"Phytocompounds of Rheum emodi, Thymus serpyllum, and Artemisia annua Inhibit Spike Protein of SARS-CoV-2 Binding to ACE2 Receptor: In Silico Approach."	Curr Pharmacol Rep
34306960	Computational assessment of select antiviral phytochemicals as potential SARS-Cov-2 main protease inhibitors: molecular dynamics guided ensemble docking and extended molecular dynamics.	In Silico Pharmacol
34306570	Exploiting the molecular basis of age and gender differences in outcomes of SARS-CoV-2 infections.	Comput Struct Biotechnol J
34306190	Guillain-Barre syndrome associated with Covid-19: A close relationship or just a coincidence? (Review).	Exp Ther Med
34306168	"Potential drugs against COVID-19 revealed by gene expression profile, molecular docking and molecular dynamic simulation."	Future Virol
34306167	An overview of sex hormones in relation to SARS-CoV-2 infection.	Future Virol
34306166	In silico discovery of SARS-CoV-2 main protease inhibitors from the carboline and quinoline database.	Future Virol
34305949	SARS-CoV-2 Accessory Proteins in Viral Pathogenesis: Knowns and Unknowns.	Front Immunol
34305916	Exploring the Immunopathogenesis of Pregnancy With COVID-19 at the Vaccination Era.	Front Immunol
34305909	From COVID-19 to Cancer mRNA Vaccines: Moving From Bench to Clinic in the Vaccine Landscape.	Front Immunol
34305903	"ROS/RNS Balancing, Aerobic Fermentation Regulation and Cell Cycle Control - a Complex Early Trait ('CoV-MAC-TED') for Combating SARS-CoV-2-Induced Cell Reprogramming."	Front Immunol
34305894	The Spike of SARS-CoV-2: Uniqueness and Applications.	Front Immunol
34305892	Modulation of Host Immune Response Is an Alternative Strategy to Combat SARS-CoV-2 Pathogenesis.	Front Immunol
34305888	Identification of the SARS-CoV-2 Entry Receptor ACE2 as a Direct Target for Transcriptional Repression by Miz1.	Front Immunol
34305860	Host- and Species-Dependent Quasispecies Divergence of Severe Acute Respiratory Syndrome Coronavirus-2 in Non-human Primate Models.	Front Microbiol
34305855	Inhibition of SARS CoV Envelope Protein by Flavonoids and Classical Viroporin Inhibitors.	Front Microbiol
34305826	Introduction and Characteristics of SARS-CoV-2 in North-East of Romania During the First COVID-19 Outbreak.	Front Microbiol
34305617	"Remdesivir Strongly Binds to RNA-Dependent RNA Polymerase, Membrane Protein, and Main Protease of SARS-CoV-2: Indication From Molecular Modeling and Simulations."	Front Pharmacol
34305613	Glycyrrhizic Acid: A Natural Plant Ingredient as a Drug Candidate to Treat COVID-19.	Front Pharmacol
34305589	"Exploring Phytochemicals of Traditional Medicinal Plants Exhibiting Inhibitory Activity Against Main Protease, Spike Glycoprotein, RNA-dependent RNA Polymerase and Non-Structural Proteins of SARS-CoV-2 Through Virtual Screening."	Front Pharmacol
34305582	"Herbal Medicine, Gut Microbiota, and COVID-19."	Front Pharmacol
34305429	Relevance Between COVID-19 and Host Genetics of Immune Response.	Saudi J Biol Sci
34305426	"RAAS, ACE2 and COVID-19; a mechanistic review."	Saudi J Biol Sci
34305416	Coagulopathy in SARS-CoV-2 Infected Patients: Implication for the Management of COVID-19.	J Blood Med
34305356	Synthesis of modified beta bismuth oxide by titanium oxide and highly efficient solar photocatalytic properties on hydroxychloroquine degradation and pathways.	J Photochem Photobiol A Chem
34305233	[The miRNA neuroinflammatory biomarkers in COVID-19 patients with different severity of illness].	Neurologia
34305216	"Molecular docking, DFT analysis, and dynamics simulation of natural bioactive compounds targeting ACE2 and TMPRSS2 dual binding sites of spike protein of SARS CoV-2."	J Mol Liq
34305198	Flavonoids from Siparuna cristata as Potential Inhibitors of SARS-CoV-2 Replication.	Rev Bras Farmacogn
34305175	"Targeting SARS-CoV-2 main protease by teicoplanin: A mechanistic insight by docking, MM/GBSA and molecular dynamics simulation."	J Mol Struct
34305174	"Seq12, Seq12m, and Seq13m, peptide analogues of the spike glycoprotein shows antiviral properties against SARS-CoV-2: An in silico study through molecular docking, molecular dynamics simulation, and MM-PB/GBSA calculations."	J Mol Struct
34305173	Discovery of Taroxaz-104: The first potent antidote of SARS-CoV-2 VOC-202012/01 strain.	J Mol Struct
34305155	In silico investigation to identify potential small molecule inhibitors of the RNA-dependent RNA polymerase (RdRp) nidovirus RdRp-associated nucleotidyltransferase domain.	Chem Phys Lett
34305135	"Editorial: Targets for Disease-Modifying Therapies in Alzheimer's Disease, Including Amyloid beta and Tau Protein."	Med Sci Monit
34304938	Soluble HLA-G is upregulated in serum of patients with severe COVID-19.	Hum Immunol
34304928	An enveloped virus-like particle vaccine expressing a stabilized prefusion form of the SARS-CoV-2 spike protein elicits highly potent immunity.	Vaccine
34304899	Dysregulation of host cell calcium signaling during viral infections: Emerging paradigm with high clinical relevance.	Mol Aspects Med
34304742	Humoral immune responses during SARS-CoV-2 mRNA vaccine administration in seropositive and seronegative individuals.	BMC Med
34304724	A human cell-based SARS-CoV-2 vaccine elicits potent neutralizing antibody responses and protects mice from SARS-CoV-2 challenge.	Emerg Microbes Infect
34304698	"Expression of SARS-CoV-2 receptor ""ACE2"" in human pancreatic beta cells: to be or not to be!"	Islets
34304364	"Production of scFv, Fab, and IgG of CR3022 Antibodies Against SARS-CoV-2 Using Silkworm-Baculovirus Expression System."	Mol Biotechnol
34304141	Neurological manifestations of COVID-19: A comprehensive literature review and discussion of mechanisms.	J Neuroimmunol
34304092	Melatonin interferes with COVID-19 at several distinct ROS-related steps.	J Inorg Biochem
34304001	Platelets in the perspective of COVID-19; pathophysiology of thrombocytopenia and its implication as prognostic and therapeutic opportunity.	Int Immunopharmacol
34303920	Antigenic sites in SARS-CoV-2 spike RBD show molecular similarity with pathogenic antigenic determinants and harbors peptides for vaccine development.	Immunobiology
34303849	Understanding the immunological aspects of SARS-CoV-2 causing COVID-19 pandemic: A therapeutic approach.	Clin Immunol
34303828	Pathophysiology and molecular mechanisms of liver injury in severe forms of COVID-19: An integrative review.	Clin Res Hepatol Gastroenterol
34303814	GPCR-ErbB transactivation pathways and clinical implications.	Cell Signal
34303749	Identification and evaluation of potential SARS-CoV-2 antiviral agents targeting mRNA cap guanine N7-Methyltransferase.	Antiviral Res
34303698	"Trajectory of Growth of Severe Acute Respiratory (SARS-CoV-2) Syndrome Coronavirus 2 Variants in Houston, Texas, January through May 2021, Based on 12,476 Genome Sequences."	Am J Pathol
34303694	Differential mutation profile of SARS-CoV-2 proteins across deceased and asymptomatic patients.	Chem Biol Interact
34303662	SARS-CoV-2 attenuates corticosteroid sensitivity by suppressing DUSP1 expression and activating p38 MAPK pathway.	Eur J Pharmacol
34303337	Nanovaccine: A hope to triumph the battle against novel Coronavirus disease 2019 (COVID-19).	Recent Pat Nanotechnol
34303192	Repurposing nonnucleoside antivirals against SARS-CoV2 NSP12 (RNA dependent RNA polymerase): In silico-molecular insight.	Biochem Biophys Res Commun
34303107	Nonsteroidal anti-inflammatory drugs and glucocorticoids in COVID-19.	Adv Biol Regul
34302964	BCG vaccination induces enhanced frequencies of dendritic cells and altered plasma levels of type I and type III interferons in elderly individuals.	Int J Infect Dis
34302557	Cancer and COVID-19: Why are cancer patients more susceptible to COVID-19?	Med Oncol
34302465	Ancient adaptative evolution of ACE2 in East Asians.	Genome Biol Evol
34302458	Neutralizing antibodies against SARS-CoV-2 variants induced by natural infection or vaccination: a systematic review and pooled meta-analysis.	Clin Infect Dis
34302450	SARS-CoV-2 research using human pluripotent stem cells and organoids.	Stem Cells Transl Med
34302370	"Neutralization of SARS-CoV-2 by highly potent, hyperthermostable, and mutation-tolerant nanobodies."	EMBO J
34302047	G6PD distribution in sub-Saharan Africa and potential risks of using chloroquine/hydroxychloroquine based treatments for COVID-19.	Pharmacogenomics J
34301919	RBM15-mediated N6-methyladenosine modification affects COVID-19 severity by regulating the expression of multitarget genes.	Cell Death Dis
34301854	Spatiotemporal invasion dynamics of SARS-CoV-2 lineage B.1.1.7 emergence.	Science
34301847	SARS-CoV-2 Neutralizing Antibody Responses towards Full-Length Spike Protein and the Receptor-Binding Domain.	J Immunol
34301768	Nopp140-chaperoned 2'-O-methylation of small nuclear RNAs in Cajal bodies ensures splicing fidelity.	Genes Dev
34301275	Keep out! SARS-CoV-2 entry inhibitors: their role and utility as COVID-19 therapeutics.	Virol J
34301158	Molecular docking and dynamics study to explore phytochemical ligand molecules against the main protease of SARS-CoV-2 from extensive phytochemical datasets.	Expert Rev Clin Pharmacol
34300311	Impact of Chronic RAAS Use in Elderly COVID-19 Patients: A Retrospective Analysis.	J Clin Med
34300181	"The Link between SARS-CoV-2 Infection, Inflammation and Hypercoagulability-Impact of Hemorheologic Alterations on Cardiovascular Mortality."	J Clin Med
34299654	"Synthesis, Biological and In Silico Studies of a Tripodal Schiff Base Derived from 2,4,6-Triamino-1,3,5-triazine and Its Trinuclear Dy(III), Er(III), and Gd(III) Salen Capped Complexes."	Molecules
34299505	Ebselen and Analogues: Pharmacological Properties and Synthetic Strategies for Their Preparation.	Molecules
34299333	Support Vector Machine as a Supervised Learning for the Prioritization of Novel Potential SARS-CoV-2 Main Protease Inhibitors.	Int J Mol Sci
34299289	Cigarette Smoke Stimulates SARS-CoV-2 Internalization by Activating AhR and Increasing ACE2 Expression in Human Gingival Epithelial Cells.	Int J Mol Sci
34299265	Cigarette Smoke Specifically Affects Small Airway Epithelial Cell Populations and Triggers the Expansion of Inflammatory and Squamous Differentiation Associated Basal Cells.	Int J Mol Sci
34299259	Btk Inhibitors: A Medicinal Chemistry and Drug Delivery Perspective.	Int J Mol Sci
34299225	Therapy of Type 2 Diabetes in Patients with SARS-CoV-2 Infection.	Int J Mol Sci
34299201	Problems of Pathogenesis and Pathogenetic Therapy of COVID-19 from the Perspective of the General Theory of Pathological Systems (General Pathological Processes).	Int J Mol Sci
34299162	"IgA Vasculitis: Etiology, Treatment, Biomarkers and Epigenetic Changes."	Int J Mol Sci
34299155	Variable Induction of Pro-Inflammatory Cytokines by Commercial SARS CoV-2 Spike Protein Reagents: Potential Impacts of LPS on In Vitro Modeling and Pathogenic Mechanisms In Vivo.	Int J Mol Sci
34299101	"COVID-19 in Children: Expressions of Type I/II/III Interferons, TRIM28, SETDB1, and Endogenous Retroviruses in Mild and Severe Cases."	Int J Mol Sci
34299089	Role of Extracellular Vimentin in Cancer-Cell Functionality and Its Influence on Cell Monolayer Permeability Changes Induced by SARS-CoV-2 Receptor Binding Domain.	Int J Mol Sci
34299045	Structural Evaluation of the Spike Glycoprotein Variants on SARS-CoV-2 Transmission and Immune Evasion.	Int J Mol Sci
34298809	The Next-Generation of Combination Cancer Immunotherapy: Epigenetic Immunomodulators Transmogrify Immune Training to Enhance Immunotherapy.	Cancers (Basel)
34298379	Emerging SARS-CoV-2 variant B.1.1.7 reduces neutralisation activity of antibodies against wild-type SARS-CoV-2.	J Clin Virol
34298343	"Review of COVID-19, part 1: Abdominal manifestations in adults and multisystem inflammatory syndrome in children."	Clin Imaging
34297909	Compartmentalization-aided interaction screening reveals extensive high-order complexes within the SARS-CoV-2 proteome.	Cell Rep
34297870	"The role of thymoquinone, a major constituent of Nigella sativa, in the treatment of inflammatory and infectious diseases."	Clin Exp Pharmacol Physiol
34297817	ENNAVIA is a novel method which employs neural networks for antiviral and anti-coronavirus activity prediction for therapeutic peptides.	Brief Bioinform
34297794	"Hofbauer cells and coronavirus disease 2019 (COVID-19) in pregnancy: Molecular pathology analysis of villous macrophages, endothelial cells, and placental findings from 22 placentas infected by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with and without fetal transmission."	Arch Pathol Lab Med
34297786	SARS-CoV-2 variant evolution in the United States: High accumulation of viral mutations over time likely through serial Founder Events and mutational bursts.	PLoS One
34297627	Pathogenesis of Coronaviruses Through Human Monocytes and Tissue Macrophages.	Viral Immunol
34297554	Structural Decoding of a Small Molecular Inhibitor on the Binding of SARS-CoV-2 to the ACE 2 Receptor.	J Phys Chem B
34297311	TNF-alpha Blockers Showed Prophylactic Effects in Preventing COVID-19 in Patients with Rheumatoid Arthritis and Seronegative Spondyloarthropathies: A Case-Control Study.	Rheumatol Ther
34297037	Epigenetic and transcriptional control of interferon-beta.	J Exp Med
34296442	SARS-CoV-2 nucleocapsid suppresses host pyroptosis by blocking Gasdermin D cleavage.	EMBO J
34296352	Pathogenesis of the inflammatory bowel disease in context of SARS-COV-2 infection.	Mol Biol Rep
34296023	Recent advance of ACE2 and microbiota dysfunction in COVID-19 pathogenesis.	Heliyon
34295915	"Original Hosts, Clinical Features, Transmission Routes, and Vaccine Development for Coronavirus Disease (COVID-19)."	Front Med (Lausanne)
34295715	Coronavirus disease and the cardiovascular system: a narrative review of the mechanisms of injury and management implications.	Cardiovasc Diagn Ther
34295314	Co-infections as Modulators of Disease Outcome: Minor Players or Major Players?	Front Microbiol
34295250	Research Progress on the Antiviral Activity of Glycyrrhizin and its Derivatives in Liquorice.	Front Pharmacol
34294887	Discovery of SARS-CoV-2-E channel inhibitors as antiviral candidates.	Acta Pharmacol Sin
34294757	"High-throughput human primary cell-based airway model for evaluating influenza, coronavirus, or other respiratory viruses in vitro."	Sci Rep
34294728	A single dose of replication-competent VSV-vectored vaccine expressing SARS-CoV-2 S1 protects against virus replication in a hamster model of severe COVID-19.	NPJ Vaccines
34294722	Altered oral and gut microbiota and its association with SARS-CoV-2 viral load in COVID-19 patients during hospitalization.	NPJ Biofilms Microbiomes
34294460	HLA-DRB1*04 may predict the severity of disease in a group of Iranian COVID-19 patients.	Hum Immunol
34294412	Interplay between hypoxia and inflammation contributes to the progression and severity of respiratory viral diseases.	Mol Aspects Med
34294374	Computational study of the therapeutic potentials of a new series of imidazole derivatives against SARS-CoV-2.	J Pharmacol Sci
34294141	Genome-wide analysis of protein-protein interactions and involvement of viral proteins in SARS-CoV-2 replication.	Cell Biosci
34293992	The QSAR-search of effective agents towards coronaviruses applying the Monte Carlo method.	SAR QSAR Environ Res
34293954	Paracetamol safety in COVID-19: Re: Antioxid Redox Signal 2021;10.1089/ars.2021.0017.	Antioxid Redox Signal
34293929	SARS-CoV-2 Initiates Programmed Cell Death in Platelets.	Circ Res
34280951	Broad sarbecovirus neutralization by a human monoclonal antibody.	Nature
34280732	Exploring peptide studies related to SARS-CoV to accelerate the development of novel therapeutic and prophylactic solutions against COVID-19.	J Infect Public Health
34280256	Anti-Platelet Factor 4 Antibodies Causing VITT do not Cross-React with SARS-CoV-2 Spike Protein.	Blood
34280241	Subacute SARS-CoV-2 replication can be controlled in the absence of CD8+ T cells in cynomolgus macaques.	PLoS Pathog
34280196	Short Report: Early genomic detection of SARS-CoV-2 P.1 variant in Northeast Brazil.	PLoS Negl Trop Dis
34280038	Traces of SARS-CoV-2 RNA in Peripheral Blood Cells of Patients with COVID-19.	OMICS
34280026	Quantitative Insight into Immunopathology of SARS-CoV-2 Infection.	J Interferon Cytokine Res
34279930	Potent Neutralizing Antibodies Elicited by RBD-Fc-Based COVID-19 Vaccine Candidate Adjuvanted by the Th2-Skewing iNKT Cell Agonist.	J Med Chem
34279924	Structure-Based Discovery of Novel Nonpeptide Inhibitors Targeting SARS-CoV-2 M(pro).	J Chem Inf Model
34279891	COVID-19 and Stroke: A Neurological Perspective	Stroke
34279841	"Associastion of In-hospital Use of Statins, Aspirin, and Renin-Angiotensin-Aldosterone Inhibitors with Mortality and ICU Admission Due to COVID-19."	Adv Exp Med Biol
34279840	Curcumin and Piperine in COVID-19: A Promising Duo to the Rescue?	Adv Exp Med Biol
34279837	"COVID-19, Coenzyme Q10 and Selenium."	Adv Exp Med Biol
34279832	SARS-CoV-2 Infection and the Kidneys: An Evolving Picture.	Adv Exp Med Biol
34279831	Intestinal Microbiota in the SARS-CoV-2 Infection: What Is Known?	Adv Exp Med Biol
34279830	Sex Differences and COVID-19.	Adv Exp Med Biol
34279825	Genetic Aspects and Immune Responses in Covid-19: Important Organ Involvement.	Adv Exp Med Biol
34279520	SARS-CoV-2 Variants in Rhode Island.	R I Med J (2013)
34279439	Plants and Natural Products with Activity against Various Types of Coronaviruses: A Review with Focus on SARS-CoV-2.	Molecules
34279108	RBD-Modified Bacterial Vesicles Elicited Potential Protective Immunity against SARS-CoV-2.	Nano Lett
34278995	Potential Mechanisms of the SARS-CoV-2-induced AKI Progression to CKD: A Forward-Looking Perspective.	Iran J Kidney Dis
34278967	Lentil lectin derived from Lens culinaris exhibit broad antiviral activities against SARS-CoV-2 variants.	Emerg Microbes Infect
34278965	"Identification of potential phytochemicals from Citrus Limon against main protease of SARS-CoV-2: molecular docking, molecular dynamic simulations and quantum computations."	J Biomol Struct Dyn
34278954	Computational studies on phylogeny and drug designing using molecular simulations for COVID-19.	J Biomol Struct Dyn
34278755	[Clinical and morphological characteristics of SARS-CoV-2-related myocarditis proven by the presence of viral RNA and proteins in myocardial tissue].	Arkh Patol
34278671	Efficient Inhibition of SARS-CoV-2 Using Chimeric oligonucleotides through RNase L Activation.	Angew Chem Int Ed Engl
34278613	Secreted Expression of mRNA-Encoded Truncated ACE2 Variants for SARS-CoV-2 via Lipid-Like Nanoassemblies.	Adv Mater
34278528	The potential use of microRNAs as a therapeutic strategy for SARS-CoV-2 infection.	Arch Virol
34278402	SARS-CoV-2 M(pro) inhibition by a zinc ion: structural features and hints for drug design.	Chem Commun (Camb)
34278371	Emergence of the E484K mutation in SARS-COV-2-infected immunocompromised patients treated with bamlanivimab in Germany.	Lancet Reg Health Eur
34278363	Integrative resource for network-based investigation of COVID-19 combinatoric drug repositioning and mechanism of action.	Patterns (N Y)
34278249	The strand-biased transcription of SARS-CoV-2 and unbalanced inhibition by remdesivir.	iScience
34278148	Low pH-Based Method to Increase the Yield of Plant-Derived Nanoparticles from Fresh Ginger Rhizomes.	ACS Omega
34277894	A theoretical strategy for acceleration of human immune response against SARS-CoV-2: a fusion protein harboring virus-binding and pre-exposed antigen domains.	Virusdisease
34277698	Indian Ethnomedicinal Phytochemicals as Promising Inhibitors of RNA-Binding Domain of SARS-CoV-2 Nucleocapsid Phosphoprotein: An In Silico Study.	Front Mol Biosci
34277453	Comparison of COVID-19 and Lung Cancer via Reactive Oxygen Species Signaling.	Front Oncol
34276947	Determination of intermediate state structures in the opening pathway of SARS-CoV-2 spike using cryo-electron microscopy.	Chem Sci
34276914	The Prothrombotic State Associated with SARS-CoV-2 Infection: Pathophysiological Aspects.	Mediterr J Hematol Infect Dis
34276680	AID and APOBECs as Multifaceted Intrinsic Virus-Restricting Factors: Emerging Concepts in the Light of COVID-19.	Front Immunol
34276672	Enhanced Expression of Autoantigens During SARS-CoV-2 Viral Infection.	Front Immunol
34276671	Unraveling the Mystery Surrounding Post-Acute Sequelae of COVID-19.	Front Immunol
34276659	Complement Anaphylatoxins and Inflammatory Cytokines as Prognostic Markers for COVID-19 Severity and In-Hospital Mortality.	Front Immunol
34276652	Potential Therapeutic Targets and Vaccine Development for SARS-CoV-2/COVID-19 Pandemic Management: A Review on the Recent Update.	Front Immunol
34276587	AmpliCoV: Rapid Whole-Genome Sequencing Using Multiplex PCR Amplification and Real-Time Oxford Nanopore MinION Sequencing Enables Rapid Variant Identification of SARS-CoV-2.	Front Microbiol
34276567	Coronavirus Disease 2019 and the Thyroid - Progress and Perspectives.	Front Endocrinol (Lausanne)
34276356	Remdesivir Inhibits Tubulointerstitial Fibrosis in Obstructed Kidneys.	Front Pharmacol
34276349	Mechanistic Analysis of Age-Related Clinical Manifestations in Down Syndrome.	Front Aging Neurosci
34276298	The Role of the Gastrointestinal System in Neuroinvasion by SARS-CoV-2.	Front Neurosci
34276267	"[SARS-CoV-2 variants, a still unfinished story]."	Vacunas
34276265	New Computational Approach for Peptide Vaccine Design Against SARS-COV-2.	Int J Pept Res Ther
34276059	Multistep rational molecular design and combined docking for discovery of novel classes of inhibitors of SARS-CoV-2 main protease 3CLpro.	Chem Phys Lett
34276042	"Editorial: Tocilizumab, a Humanized Therapeutic IL-6 Receptor (IL-6R) Monoclonal Antibody, and Future Combination Therapies for Severe COVID-19."	Med Sci Monit
34275860	Immunoinformatics approaches to explore B and T cell epitope-based vaccine designing for SARS-CoV-2 Virus.	Pak J Pharm Sci
34275565	A systematic review of Bell's Palsy as the only major neurological manifestation in COVID-19 patients.	J Clin Neurosci
34275539	Infectious and immune-mediated central nervous system disease in 48 COVID-19 patients.	J Clin Neurosci
34275492	SARS-CoV-2: preliminary study of infected human nasopharyngeal tissue by high resolution microscopy.	Virol J
34275164	COVID-19 vulnerabilities are intensified by declining human serum albumin levels.	Exp Physiol
34274727	Molecular insight on the formation structure and dynamics of melatonin in an aqueous solution and at the Water-Air interface: A molecular dynamics study.	J Mol Graph Model
34274540	"Similarities between COVID-19 and systemic sclerosis early vasculopathy: A ""viral"" challenge for future research in scleroderma."	Autoimmun Rev
34274504	Lung cancer models reveal SARS-CoV-2-induced EMT contributes to COVID-19 pathophysiology.	J Thorac Oncol
34274478	No association between the SARS-CoV-2 variants and mortality rates in the Eastern Mediterranean Region.	Gene
34274470	Therapeutic perceptions in antisense RNA-mediated gene regulation for COVID-19.	Gene
34274468	HA of H1N1 enhanced the expression of ICAM-1 and IL-6 in HUVECs and pathological injury in the lungs in mice.	Gene
34274319	Membranotropic and biological activities of the membrane fusion peptides from SARS-CoV spike glycoprotein: The importance of the complete internal fusion peptide domain.	Biochim Biophys Acta Biomembr
34273961	"HAVoC, a bioinformatic pipeline for reference-based consensus assembly and lineage assignment for SARS-CoV-2 sequences."	BMC Bioinformatics
34273770	Identification of potential plant bioactive as SARS-CoV-2 Spike protein and human ACE2 fusion inhibitors.	Comput Biol Med
34273661	"System-oriented optimization of multi-target 2,6-diaminopurine derivatives: Easily accessible broad-spectrum antivirals active against flaviviruses, influenza virus and SARS-CoV-2."	Eur J Med Chem
34273592	Loss-of-function mutations in IFNAR2 in COVID-19 severe infection susceptibility.	J Glob Antimicrob Resist
34273582	SARS-CoV-2 infection in the immunodeficient host: necessary and dispensable immune pathways.	J Allergy Clin Immunol Pract
34273512	Immunity against seasonal human coronavirus OC43 mitigates fatal deterioration of COVID-19.	Int J Infect Dis
34273397	Revealing the Threat of Emerging SARS-CoV-2 Mutations to Antibody Therapies.	J Mol Biol
34273271	A SARS-CoV-2 neutralizing antibody selected from COVID-19 patients binds to the ACE2-RBD interface and is tolerant to most known RBD mutations.	Cell Rep
34273263	T-Cell Activation: Post-Infection Diagnostic Tool for COVID-19.	Folia Biol (Praha)
34273146	Transfer learning via multi-scale convolutional neural layers for human-virus protein-protein interaction prediction.	Bioinformatics
34273008	Platelet activation in critically ill COVID-19 patients.	Ann Intensive Care
34272947	An Update on SARS-CoV-2 Diversity in the United States National Capital Region: Evolution of Novel and Variants of Concern.	Clin Infect Dis
34272933	Redox-Mediated Artificial Non-Enzymatic Antioxidant MXene Nanoplatforms for Acute Kidney Injury Alleviation.	Adv Sci (Weinh)
34272720	Mesenchymal stem cells: ideal seeds for treating diseases.	Hum Cell
34272669	The contribution of bovines to human health against viral infections.	Environ Sci Pollut Res Int
34272647	Anti-HIV reverse transcriptase plant polyphenolic natural products with in silico inhibitory properties on seven non-structural proteins vital in SARS-CoV-2 pathogenesis.	J Genet Eng Biotechnol
34272434	Proteomics and metabonomics analyses of Covid-19 complications in patients with pulmonary fibrosis.	Sci Rep
34272374	SARS-CoV-2 infection induces the dedifferentiation of multiciliated cells and impairs mucociliary clearance.	Nat Commun
34272088	Alterations of Lipid Profile in COVID-19: A Narrative Review.	Curr Probl Cardiol
34271511	B cell receptor (BCR) guided mechanotransduction: Critical hypothesis to instruct SARS-CoV-2 specific B cells to trigger proximal signalling and antibody reshaping.	Med Hypotheses
34271432	"Natto extract, a Japanese fermented soybean food, directly inhibits viral infections including SARS-CoV-2 in vitro."	Biochem Biophys Res Commun
34271420	Efficient machine learning model for predicting drug-target interactions with case study for Covid-19.	Comput Biol Chem
34271305	First detection and molecular analysis of SARS-CoV-2 from a naturally infected cat from Argentina.	Vet Microbiol
34271250	Emerging Mutation in SARS-CoV-2 Spike: Widening Distribution Over Time in Different Geographic Areas.	Biomed J
34271187	"Genetic and evolutionary analysis of SARS-CoV-2 circulating in the region surrounding Islamabad, Pakistan."	Infect Genet Evol
34271099	Gut probiotic Lactobacillus rhamnosus attenuates PDE4B-mediated interleukin-6 induced by SARS-CoV-2 membrane glycoprotein.	J Nutr Biochem
34271072	A head-to-head comparison of the inhibitory activities of 15 peptidomimetic SARS-CoV-2 3CLpro inhibitors.	Bioorg Med Chem Lett
34270996	HIV-1 genetic diversity and drug resistance mutations in the northern Brazilian region.	Braz J Infect Dis
34270939	COVID-19 vaccine mRNA-1273 elicits a protective immune profile in mice that is not associated with vaccine-enhanced disease upon SARS-CoV-2 challenge.	Immunity
34270919	SARS-CoV-2 variant B.1.617 is resistant to bamlanivimab and evades antibodies induced by infection and vaccination.	Cell Rep
34270918	Generation of glucocorticoid-resistant SARS-CoV-2 T cells for adoptive cell therapy.	Cell Rep
34270631	SARS-CoV-2-specific circulating T follicular helper cells correlate with neutralizing antibodies and increase during early convalescence.	PLoS Pathog
34270613	Mutants of human ACE2 differentially promote SARS-CoV and SARS-CoV-2 spike mediated infection.	PLoS Pathog
34270554	Biochemical characterization of protease activity of Nsp3 from SARS-CoV-2 and its inhibition by nanobodies.	PLoS One
34270530	Blood system ABO antigens as risk factor for severity of SARS-CoV-2 infection.	Gac Med Mex
34270232	Free Energy Landscapes from SARS-CoV-2 Spike Glycoprotein Simulations Suggest that RBD Opening Can Be Modulated via Interactions in an Allosteric Pocket.	J Am Chem Soc
34269657	The role of PCSK9 in infectious diseases.	Curr Med Chem
34268806	In vitro inhibition and molecular docking of a new ciprofloxacin-chalcone against SARS-CoV-2 main protease.	Fundam Clin Pharmacol
34268533	Role of nitazoxanide as a repurposed drug in the treatment and management of various diseases.	Drugs Today (Barc)
34268443	Computational pathology reveals unique spatial patterns of immune response in H&E images from COVID-19 autopsies: preliminary findings.	J Med Imaging (Bellingham)
34268203	An Introduction to SARS Coronavirus 2; Comparative Analysis with MERS and SARS Coronaviruses: A Brief Review.	Iran J Public Health
34268202	Frontier Therapeutics and Vaccine Strategies for SARS-CoV-2 (COVID-19): A Review.	Iran J Public Health
34267839	Review of COVID-19 Variants and COVID-19 Vaccine Efficacy: What the Clinician Should Know?	J Clin Med Res
34267764	Stabilization of the SARS-CoV-2 Spike Receptor-Binding Domain Using Deep Mutational Scanning and Structure-Based Design.	Front Immunol
34267735	Meta-Analysis and Structural Dynamics of the Emergence of Genetic Variants of SARS-CoV-2.	Front Microbiol
34267671	How and to What Extent Immunological Responses to SARS-CoV-2 Shape Pulmonary Function in COVID-19 Patients.	Front Physiol
34267664	The Role of Pulmonary Surfactants in the Treatment of Acute Respiratory Distress Syndrome in COVID-19.	Front Pharmacol
34267528	Detection of Representative Mutant Strains and a Case of Prolonged Infection by SARS-CoV-2 with Spike 69/70 Deletion in Japan.	Infect Drug Resist
34267349	Interferon-armed RBD dimer enhances the immunogenicity of RBD for sterilizing immunity against SARS-CoV-2.	Cell Res
34267343	Danshensu alleviates pseudo-typed SARS-CoV-2 induced mouse acute lung inflammation.	Acta Pharmacol Sin
34267318	Age-dependent appearance of SARS-CoV-2 entry sites in mouse chemosensory systems reflects COVID-19 anosmia-ageusia symptoms.	Commun Biol
34267316	DeepEMhancer: a deep learning solution for cryo-EM volume post-processing.	Commun Biol
34267263	A hybrid computational framework for intelligent inter-continent SARS-CoV-2 sub-strains characterization and prediction.	Sci Rep
34267262	Sex and age bias viral burden and interferon responses during SARS-CoV-2 infection in ferrets.	Sci Rep
34267138	The Risk of Osseointegration in the Coronavirus Disease 19 Pandemic.	J Craniofac Surg
34266981	A yeast expressed RBD-based SARS-CoV-2 vaccine formulated with 3M-052-alum adjuvant promotes protective efficacy in non-human primates.	Sci Immunol
34266903	Longitudinal Outcomes for Multisystem Inflammatory Syndrome in Children.	Pediatrics
34266783	[Kidney damage in COVID-19].	Nephrol Ther
34266486	Combination of mesenchymal stem cells and nicorandil: an emerging therapeutic challenge against COVID-19 infection-induced multiple organ dysfunction.	Stem Cell Res Ther
34265888	"Computational drug repurposing study of antiviral drugs against main protease, RNA polymerase, and spike proteins of SARS-CoV-2 using molecular docking method."	J Basic Clin Physiol Pharmacol
34265628	Study on SARS-CoV-2 strains in Iran reveals potential contribution of co-infection with and recombination between different strains to the emergence of new strains.	Virology
34265624	N-acylethanolamine regulation of TLR3-induced hyperthermia and neuroinflammatory gene expression: A role for PPARalpha.	J Neuroimmunol
34265589	Monogenic autoimmunity and infectious diseases: the double-edged sword of immune dysregulation.	Curr Opin Immunol
34265539	Preparing for the long-haul: Autonomic complications of COVID-19.	Auton Neurosci
34265281	Structure-guided T cell vaccine design for SARS-CoV-2 variants and sarbecoviruses.	Cell
34265245	The success of SARS-CoV-2 vaccines and challenges ahead.	Cell Host Microbe
34265243	An aberrant inflammatory response in severe COVID-19.	Cell Host Microbe
34265242	Children and SARS-CoV-2.	Cell Host Microbe
34265240	Beyond neutralization for BNT162b2 mRNA vaccination.	Cell Host Microbe
34265239	Virus hunters: Discovering the evolutionary origins of SARS-CoV-2.	Cell Host Microbe
34265150	Hidden in Plain Sight: Natural Products of Commensal Microbiota as an Environmental Selection Pressure for the Rise of New Variants of SARS-CoV-2.	Chembiochem
34265044	Effects of Renin-Angiotensin-Aldosterone Inhibitors on Early Outcomes of Hypertensive COVID-19 Patients: A Randomized Triple-Blind Clinical Trial.	Am J Hypertens
34265022	SARS-CoV-2 infection in the Syrian hamster model causes inflammation as well as type I interferon dysregulation in both respiratory and non-respiratory tissues including the heart and kidney.	PLoS Pathog
34265018	Intranasal gene therapy to prevent infection by SARS-CoV-2 variants.	PLoS Pathog
34264880	Is severe COVID-19 a cytokine storm syndrome: a hyperinflammatory debate.	Curr Opin Rheumatol
34264868	"Endothelium-protective, histone-neutralizing properties of the polyanionic agent defibrotide."	JCI Insight
34264519	Rapid and cost-effective process based on insect larvae for scale-up production of SARS-COV-2 spike protein for serological COVID-19 testing.	Biotechnol Bioeng
34264250	"1,10/1,11-Cyclization catalyzed by diverged plant sesquiterpene synthases is dependent on a single residue."	Org Biomol Chem
34264104	"Coding-Complete Genome Sequences of 11 SARS-CoV-2 B.1.1.7 and B.1.351 Variants from Metro Manila, Philippines."	Microbiol Resour Announc
34264100	Genome Sequences of 15 SARS-CoV-2 Sublineage B.1.617.2 Strains in Bangladesh.	Microbiol Resour Announc
34263709	Identification of a novel lineage bat SARS-related coronaviruses that use bat ACE2 receptor.	Emerg Microbes Infect
34263708	Human microRNA hsa-miR-15b-5p targets the RNA template component of the RNA-dependent RNA polymerase structure in severe acute respiratory syndrome coronavirus 2.	Nucleosides Nucleotides Nucleic Acids
34262921	Novel Highly Divergent SARS-CoV-2 Lineage With the Spike Substitutions L249S and E484K.	Front Med (Lausanne)
34262673	Extracellular vesicle-mediated endothelial apoptosis and EV-associated proteins correlate with COVID-19 disease severity.	J Extracell Vesicles
34262570	Immune-Based Prediction of COVID-19 Severity and Chronicity Decoded Using Machine Learning.	Front Immunol
34262569	Single-Dose Immunization With a Chimpanzee Adenovirus-Based Vaccine Induces Sustained and Protective Immunity Against SARS-CoV-2 Infection.	Front Immunol
34262564	Differential Cytokine Responses in Hospitalized COVID-19 Patients Limit Efficacy of Remdesivir.	Front Immunol
34262555	Systems Immunology Analysis Reveals the Contribution of Pulmonary and Extrapulmonary Tissues to the Immunopathogenesis of Severe COVID-19 Patients.	Front Immunol
34262317	Assessment and Management of Diabetic Patients During the COVID-19 Pandemic.	Diabetes Metab Syndr Obes
34262047	Chronic lung diseases are associated with gene expression programs favoring SARS-CoV-2 entry and severity.	Nat Commun
34261901	Arrhythmogenesis and COVID-19.	Cardiol Rev
34261667	Optimizing Flow Cytometric Analysis of Immune Cells in Samples Requiring Cryopreservation from Tumor-Bearing Mice.	J Immunol
34261487	SARS-CoV-2: is there neuroinvasion?	Fluids Barriers CNS
34261445	"Whole genome sequencing and phylogenetic analysis of six SARS-CoV-2 strains isolated during COVID-19 pandemic in Tunisia, North Africa."	BMC Genomics
34261300	"Comparative study: nonsynonymous and synonymous substitution of SARS-CoV-2, SARS-CoV, and MERS-CoV genome."	Genomics Inform
34261299	A protein interactions map of multiple organ systems associated with COVID-19 disease.	Genomics Inform
34261126	SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape.	Nature
34260965	Distinctive features of SARS-CoV-2-specific T cells predict recovery from severe COVID-19.	Cell Rep
34260951	"Viral populations of SARS-CoV-2 in upper respiratory tract, placenta, amniotic fluid and umbilical cord blood support viral replication in placenta."	Clin Microbiol Infect
34260780	A systematic meta-analysis of immune signatures in patients with COVID-19.	Rev Med Virol
34260717	SARS-CoV-2 B.1.617 mutations L452 and E484Q are not synergistic for antibody evasion.	J Infect Dis
34260684	Discovering common pathogenetic processes between COVID-19 and diabetes mellitus by differential gene expression pattern analysis.	Brief Bioinform
34260666	COVID-19 virtual patient cohort suggests immune mechanisms driving disease outcomes.	PLoS Pathog
34260589	COVIDomic: A multi-modal cloud-based platform for identification of risk factors associated with COVID-19 severity.	PLoS Comput Biol
34260328	Platelet-leukocyte interactions in the pathogenesis of viral infections.	Platelets
34260266	SARS-CoV-2 disrupts proximal elements in the JAK-STAT pathway.	J Virol
34260218	"Immunogenicity and Protective Efficacy of a Highly Thermotolerant, Trimeric SARS-CoV-2 Receptor Binding Domain Derivative."	ACS Infect Dis
34260159	Individual COVID-19 disease trajectories revealed by plasma proteomics.	EMBO Mol Med
34260088	SARS-CoV-2 B.1.617 Indian variants: Are electrostatic potential changes responsible for a higher transmission rate?	J Med Virol
34259961	Clinical-Pathological Correlation of the Pathophysiology and Mechanism of Action of COVID-19 - a Primer for Clinicians.	Curr Allergy Asthma Rep
34259944	The Role of Antiphospholipid Antibodies in COVID-19.	Curr Rheumatol Rep
34259942	Myeloid phenotypes in severe COVID-19 predict secondary infection and mortality: a pilot study.	Ann Intensive Care
34259776	The Impact of COVID-19 on the Cardiovascular System.	Rev Assoc Med Bras (1992)
34259775	Possible role of exogenous melatonin in preventing more serious COVID-19 infection in patients with type 2 diabetes mellitus.	Rev Assoc Med Bras (1992)
34259761	Physical Exercise and Immune System: Perspectives on the COVID-19 pandemic.	Rev Assoc Med Bras (1992)
34258966	Effects of Smoking on ACE2 Expression Pattern: Risk and Severity of SARS-CoV-2 Infection.	Clin Lab
34258904	Cardiac manifestations of COVID-19.	Rev Cardiovasc Med
34258902	COVID-19 and cardiovascular system-a comprehensive review.	Rev Cardiovasc Med
34258896	Thrombotic risk in patients with COVID-19.	Rev Cardiovasc Med
34258762	Analysis of T cell responses directed against the spike and/or membrane and/or nucleocapsid proteins in chilblain-like lesions patients during the COVID-19 pandemic.	Br J Dermatol
34258745	Covalent Antiviral Agents.	Adv Exp Med Biol
34258743	"Search, Identification, and Design of Effective Antiviral Drugs Against Pandemic Human Coronaviruses."	Adv Exp Med Biol
34258664	Evolutionary insights into the furin cleavage sites of SARS-CoV-2 variants from humans and animals.	Arch Virol
34258628	"The interplay of DAMPs, TLR4, and proinflammatory cytokines in pulmonary fibrosis."	J Mol Med (Berl)
34258603	Neutralisation of SARS-CoV-2 lineage P.1 by antibodies elicited through natural SARS-CoV-2 infection or vaccination with an inactivated SARS-CoV-2 vaccine: an immunological study.	Lancet Microbe
34258278	Genome Features and In Vitro Activity against Influenza A and SARS-CoV-2 Viruses of Six Probiotic Strains.	Biomed Res Int
34258267	Relevant SARS-CoV-2 Genome Variation through Six Months of Worldwide Monitoring.	Biomed Res Int
34258101	Periodic thermomechanical modulation of toll-like receptor expression and distribution in mesenchymal stromal cells.	MRS Commun
34257967	SARS-CoV-2-specific humoral and cellular immunity persists through 9 months irrespective of COVID-19 severity at hospitalisation.	Clin Transl Immunology
34257831	Potent SARS-CoV-2 mRNA Cap Methyltransferase Inhibitors by Bioisosteric Replacement of Methionine in SAM Cosubstrate.	ACS Med Chem Lett
34257762	Pathogenesis of taste impairment and salivary dysfunction in COVID-19 patients.	Jpn Dent Sci Rev
34257580	"Colorectal Cancer that Highly Express Both ACE2 and TMPRSS2, Suggesting Severe Symptoms to SARS-CoV-2 Infection."	Pathol Oncol Res
34257504	An outline of SARS-CoV-2 pathogenesis and the complement cascade of immune system.	Bull Natl Res Cent
34257406	ATG9A protects the plasma membrane from programmed and incidental permeabilization.	Nat Cell Biol
34257394	Placental response to maternal SARS-CoV-2 infection.	Sci Rep
34257311	Reprogrammed CRISPR-Cas13b suppresses SARS-CoV-2 replication and circumvents its mutational escape through mismatch tolerance.	Nat Commun
34257144	A high-throughput cell- and virus-free assay shows reduced neutralization of SARS-CoV-2 variants by COVID-19 convalescent plasma.	Sci Transl Med
34257044	"Gut microbiota, inflammation, and molecular signatures of host response to infection."	J Genet Genomics
34256840	"The relative expression of miR-31, miR-29, miR-126, and miR-17 and their mRNA targets in the serum of COVID-19 patients with different grades during hospitalization."	Eur J Med Res
34256681	Dietary factors and SARS-CoV-2 contagion: in silico studies on modulation of viral and host proteins by spice actives.	J Biomol Struct Dyn
34256409	[Update 2021: COVID-19 from the perspective of neurology].	Dtsch Med Wochenschr
34256407	[Update 2021: COVID-19 from the perspective of cardiology].	Dtsch Med Wochenschr
34256255	Drug repurposing against SARS-CoV-2 receptor binding domain using ensemble-based virtual screening and molecular dynamics simulations.	Comput Biol Med
34256245	Highly expressed ACE-2 receptors during pregnancy: A protective factor for SARS-COV-2 infection?	Med Hypotheses
34256141	The potential clinical utility of measuring severe acute respiratory syndrome coronavirus 2-specific T-cell responses.	Clin Microbiol Infect
34255991	Fluid Dynamics of Respiratory Infectious Diseases.	Annu Rev Biomed Eng
34255838	Are the healthy vulnerable? Cytomegalovirus seropositivity in healthy adults is associated with accelerated epigenetic age and immune-dysregulation.	J Infect Dis
34255583	Lactoferrin: The Natural Protector of the Eye against Coronavirus-19.	Ocul Immunol Inflamm
34255566	Secretory phospholipase A2 in SARS-CoV-2 infection and multisystem inflammatory syndrome in children (MIS-C).	Exp Biol Med (Maywood)
34255499	Binding of SARS-CoV-2 Fusion Peptide to Host Endosome and Plasma Membrane.	J Phys Chem B
34255352	The variants question: What is the problem?	J Med Virol
34255304	SARS-CoV-2 Infection and Racial Disparities in Children: Protective Mechanisms and Severe Complications Related to MIS-C.	J Racial Ethn Health Disparities
34255214	Andrographolide binds to spike glycoprotein and RNA-dependent RNA polymerase (NSP12) of SARS-CoV-2 by in silico approach: a probable molecule in the development of anti-coronaviral drug.	J Genet Eng Biotechnol
34254996	ADEIP: an integrated platform of age-dependent expression and immune profiles across human tissues.	Brief Bioinform
34254928	The World Against Versatile SARS-Cov-2 Nanomachines; Mythological or Reality?	Curr Stem Cell Res Ther
34254927	Visualized analyses of investigations upon mesenchymal stem/stromal cell-based cytotherapy and underlying mechanisms for COVID-19 associated ARDS.	Curr Stem Cell Res Ther
34254925	Computational and synthetic biology approaches for the biosynthesis of antiviral and anticancer terpenoids from Bacillus subtilis.	Med Chem
34254909	COVID-19 candidate genes and pathways potentially share the association with lung cancer.	Comb Chem High Throughput Screen
34254825	RNA-Protein Interaction Analysis of SARS-CoV-2 5' and 3' Untranslated Regions Reveals a Role of Lysosome-Associated Membrane Protein-2a during Viral Infection.	mSystems
34254633	Interaction of serum proteins with SARS-CoV-2 RBD.	Nanoscale
34254564	"Emetine, a potent alkaloid for the treatment of SARS-CoV-2 targeting papain-like protease and non-structural proteins: pharmacokinetics, molecular docking and dynamic studies."	J Biomol Struct Dyn
34254465	SSRIs: Applications in inflammatory lung disease and implications for COVID-19.	Neuropsychopharmacol Rep
34254040	Comparative Analysis of Emerging B.1.1.7+E484K SARS-CoV-2 Isolates.	Open Forum Infect Dis
34253862	Interplay between interleukin-6 signaling and the vascular endothelium in cytokine storms.	Exp Mol Med
34253798	Inferring the ecological niche of bat viruses closely related to SARS-CoV-2 using phylogeographic analyses of Rhinolophus species.	Sci Rep
34253751	Deep learning identifies antigenic determinants of severe SARS-CoV-2 infection within T-cell repertoires.	Sci Rep
34253708	"The zinc finger transcription factor, KLF2, protects against COVID-19 associated endothelial dysfunction."	Signal Transduct Target Ther
34253645	Cationic Compounds with SARS-CoV-2 Antiviral Activity and their Interaction with OCT/MATE Secretory Transporters.	J Pharmacol Exp Ther
34253247	Emerging SARS-CoV-2 variants of concern and potential intervention approaches.	Crit Care
34253149	"Design, synthesis, and molecular dynamics simulation studies of quinoline derivatives as protease inhibitors against SARS-CoV-2."	J Biomol Struct Dyn
34253126	Enteroviruses and coronaviruses: similarities and therapeutic targets.	Expert Opin Ther Targets
34253053	Sex Differences in Lung Imaging and SARS-CoV-2 Antibody Responses in a COVID-19 Golden Syrian Hamster Model.	mBio
34252919	Systems vaccinology of the BNT162b2 mRNA vaccine in humans.	Nature
34252691	Biogenic and biocompatible silver nanoparticles for an apoptotic anti-ovarian activity and as polydopamine-functionalized antibiotic carrier for an augmented antibiofilm activity.	Colloids Surf B Biointerfaces
34252682	Unravelling the therapeutic potential of marine drugs as SARS-CoV-2 inhibitors: An insight from essential dynamics and free energy landscape.	Comput Biol Med
34252574	"Complement activation and increased expression of Syk, mucin-1 and CaMK4 in kidneys of patients with COVID-19."	Clin Immunol
34252446	Impact of inhaled pollutants on response to viral infection in controlled exposures.	J Allergy Clin Immunol
34252365	"Genomics-informed responses in the elimination of COVID-19 in Victoria, Australia: an observational, genomic epidemiological study."	Lancet Public Health
34252234	Long noncoding RNAs in respiratory viruses: A review.	Rev Med Virol
34252180	Surviving older patients show preserved cellular and humoral immunological memory several months after SARS-CoV-2 infection.	J Gerontol A Biol Sci Med Sci
34252168	Strategies to target SARS-CoV-2 entry and infection using dual mechanisms of inhibition by acidification inhibitors.	PLoS Pathog
34252054	HIV infection drives interferon signalling within intestinal SARS-CoV-2 target cells.	JCI Insight
34251989	"The journey of SARS-CoV-2 in human hosts: a review of immune responses, immunosuppression, and their consequences."	Virulence
34251748	"A computational study of the interface interaction between SARS-CoV-2 RBD and ACE2 from human, cat, dog, and ferret."	Transbound Emerg Dis
34251655	COVID-19: Zinc and Angiotensin-Converting Enzyme 2 (ACE2) Deficiencies as Determinants of Risk and Severity of Disease: A Narrative Review.	Infect Dis Ther
34251644	Role of L-Arginine in Nitric Oxide Synthesis and Health in Humans.	Adv Exp Med Biol
34251592	Temporal landscape of mutational frequencies in SARS-CoV-2 genomes of Bangladesh: possible implications from the ongoing outbreak in Bangladesh.	Virus Genes
34251356	Simultaneous evaluation of antibodies that inhibit SARS-CoV-2 variants via multiplex assay.	JCI Insight
34250513	Transmission of infectious viruses in the natural setting at human-animal interface.	Curr Res Virol Sci
34250512	Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells.	Cell Rep Med
34250510	Immunohistochemistry for protein detection in PFA-fixed paraffin-embedded SARS-CoV-2-infected COPD airway epithelium.	STAR Protoc
34250458	Vitamin D in infectious complications in critically ill patients with or without COVID-19.	Metabol Open
34250348	Anti-Covid-19 Drug Analogues: Synthesis of Novel Pyrimidine Thioglycosides as Antiviral Agents Against SARS-COV-2 and Avian Influenza H5N1 Viruses.	ACS Omega
34250342	SOD1 is a Possible Predictor of COVID-19 Progression as Revealed by Plasma Proteomics.	ACS Omega
34250324	Silent hypoxia in COVID-19: a gut microbiota connection.	Curr Opin Physiol
34250314	Relevance of vitamin D3 in COVID-19 infection.	Gene Rep
34250275	Peptide inhibitors against SARS-CoV-2 2'-O-methyltransferase involved in RNA capping: A computational approach.	Biochem Biophys Rep
34250222	Current vaccine technology with an emphasis on recombinant measles virus as a new perspective for vaccination against SARS-CoV-2.	EuroMediterr J Environ Integr
34249938	The Altered Anatomical Distribution of ACE2 in the Brain With Alzheimer's Disease Pathology.	Front Cell Dev Biol
34249902	PNPLA3 and TLL-1 Polymorphisms as Potential Predictors of Disease Severity in Patients With COVID-19.	Front Cell Dev Biol
34249864	Catalytic Dyad Residues His41 and Cys145 Impact the Catalytic Activity and Overall Conformational Fold of the Main SARS-CoV-2 Protease 3-Chymotrypsin-Like Protease.	Front Chem
34249607	Recent advances in developing small-molecule inhibitors against SARS-CoV-2.	Acta Pharm Sin B
34249606	Development and comparison of cell-free protein synthesis systems derived from typical bacterial chassis.	Bioresour Bioprocess
34249513	A synthetic defective interfering SARS-CoV-2.	PeerJ
34249284	Pulmonary Covid Fibrosis a New Pharmaceutic Approach.	Int J Prev Med
34249228	Review of the potential of mesenchymal stem cells for the treatment of infectious diseases.	World J Stem Cells
34249143	TiO2 supported single Ag atoms nanozyme for elimination of SARS-CoV2.	Nano Today
34249101	A Peptide Vaccine Candidate Tailored to Individuals' Genetics Mimics the Multi-Targeted T Cell Immunity of COVID-19 Convalescent Subjects.	Front Genet
34249006	RIG-I-Like Receptor-Mediated Recognition of Viral Genomic RNA of Severe Acute Respiratory Syndrome Coronavirus-2 and Viral Escape From the Host Innate Immune Responses.	Front Immunol
34248993	Live Virus Neutralisation of the 501Y.V1 and 501Y.V2 SARS-CoV-2 Variants following INO-4800 Vaccination of Ferrets.	Front Immunol
34248984	Severe COVID-19 Recovery Is Associated with Timely Acquisition of a Myeloid Cell Immune-Regulatory Phenotype.	Front Immunol
34248968	SARS-CoV-2/ACE2 Interaction Suppresses IRAK-M Expression and Promotes Pro-Inflammatory Cytokine Production in Macrophages.	Front Immunol
34248955	"Kinetics of Neutrophil Subsets in Acute, Subacute, and Chronic Inflammation."	Front Immunol
34248940	"Endothelial Immunity Trained by Coronavirus Infections, DAMP Stimulations and Regulated by Anti-Oxidant NRF2 May Contribute to Inflammations, Myelopoiesis, COVID-19 Cytokine Storms and Thromboembolism."	Front Immunol
34248936	A Computational Approach Identified Andrographolide as a Potential Drug for Suppressing COVID-19-Induced Cytokine Storm.	Front Immunol
34248930	Immune Dysregulation and the Increased Risk of Complications and Mortality Following Respiratory Tract Infections in Adults With Down Syndrome.	Front Immunol
34248922	In vitro Characterization of Fitness and Convalescent Antibody Neutralization of SARS-CoV-2 Cluster 5 Variant Emerging in Mink at Danish Farms.	Front Microbiol
34248921	Long COVID or Post-acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent Symptoms.	Front Microbiol
34248910	Oral Microbiome Dysbiosis Is Associated With Symptoms Severity and Local Immune/Inflammatory Response in COVID-19 Patients: A Cross-Sectional Study.	Front Microbiol
34248841	Soluble Neuropilin-1 Response to Hypoglycemia in Type 2 Diabetes: Increased Risk or Protection in SARS-CoV-2 Infection?	Front Endocrinol (Lausanne)
34248840	Type 2 Diabetes Coagulopathy Proteins May Conflict With Biomarkers Reflective of COVID-19 Severity.	Front Endocrinol (Lausanne)
34248655	Modeling NO Biotransport in Brain Using a Space-Fractional Reaction-Diffusion Equation.	Front Physiol
34248502	"Endothelial Senescence and Chronic Fatigue Syndrome, a COVID-19 Based Hypothesis."	Front Cell Neurosci
34248355	In Silico Exploration of Phytoconstituents From Phyllanthus emblica and Aegle marmelos as Potential Therapeutics Against SARS-CoV-2 RdRp.	Bioinform Biol Insights
34248311	Genetic Control of Human Infection with SARS-CoV-2.	Russ J Genet
34248221	Viral transmission and evolution dynamics of SARS-CoV-2 in shipboard quarantine.	Bull World Health Organ
34248201	Novel piperazine based compounds as potential inhibitors for SARS-CoV-2 Protease Enzyme: Synthesis and molecular docking study.	J Mol Struct
34247339	Anti-inflammatory Therapy by Cholinergic and Purinergic Modulation in Multiple Sclerosis Associated with SARS-CoV-2 Infection.	Mol Neurobiol
34247039	Clinical applications of thrombopoietin silencing: A possible therapeutic role in COVID-19?	Cytokine
34247016	Cyanorona-20: The first potent anti-SARS-CoV-2 agent.	Int Immunopharmacol
34246969	Pomegranate peel extract polyphenols attenuate the SARS-CoV-2 S-glycoprotein binding ability to ACE2 Receptor: In silico and in vitro studies.	Bioorg Chem
34246957	Syncope and silent hypoxemia in COVID-19: Implications for the autonomic field.	Auton Neurosci
34246830	Analysis of SARS-CoV-2 nucleocapsid phosphoprotein N variations in the binding site to human 14-3-3 proteins.	Biochem Biophys Res Commun
34246735	A mouse model of lethal respiratory dysfunction for SARS-CoV-2 infection.	Antiviral Res
34246414	SARS-COV-2 spike binding to ACE2 in living cells monitored by TR-FRET.	Cell Chem Biol
34246326	Temporal maturation of neutralizing antibodies in COVID-19 convalescent individuals improves potency and breadth to circulating SARS-CoV-2 variants.	Immunity
34246322	The urgent need for metallo-beta-lactamase inhibitors: an unattended global threat.	Lancet Infect Dis
34246161	High-throughput analysis of the interactions between viral proteins and host cell RNAs.	Comput Biol Med
34245672	A single intranasal or intramuscular immunization with chimpanzee adenovirus-vectored SARS-CoV-2 vaccine protects against pneumonia in hamsters.	Cell Rep
34245662	"Differential susceptibility of SARS-CoV-2 in animals: Evidence of ACE2 host receptor distribution in companion animals, livestock and wildlife by immunohistochemical characterisation."	Transbound Emerg Dis
34245591	A bird's eye view on the role of dendritic cells in SARS-CoV-2 infection: Perspectives for immune-based vaccines.	Allergy
34245452	Updated SARS-CoV-2 single nucleotide variants and mortality association.	J Med Virol
34245241	Published anti-SARS-CoV-2 in vitro hits share common mechanisms of action that synergize with antivirals.	Brief Bioinform
34245187	A fast protein binding site comparison algorithm for proteome-wide protein function prediction and drug repurposing.	Proteins
34244768	Molnupiravir inhibits the replication of the emerging SARS-CoV-2 variants of concern (VoCs) in a hamster infection model.	J Infect Dis
34244682	A human three-dimensional neural-perivascular 'assembloid' promotes astrocytic development and enables modeling of SARS-CoV-2 neuropathology.	Nat Med
34244522	Potent and protective IGHV3-53/3-66 public antibodies and their shared escape mutant on the spike of SARS-CoV-2.	Nat Commun
34244417	An isoform of Dicer protects mammalian stem cells against multiple RNA viruses.	Science
34244331	"Diabetes, Obesity, COVID-19, Insulin, and Other Antidiabetes Drugs."	Diabetes Care
34243689	Prophylactic and therapeutic potential of selected immunomodulatory agents from Ayurveda against coronaviruses amidst the current formidable scenario: an in silico analysis.	J Biomol Struct Dyn
34243220	Transition of cutaneous into systemic lupus erythematosus following adenoviral vector-based SARS-CoV-2 vaccination.	J Eur Acad Dermatol Venereol
34243074	"3-Alkenyl-2-oxindoles: Synthesis, antiproliferative and antiviral properties against SARS-CoV-2."	Bioorg Chem
34242919	Untangling COVID-19 and autoimmunity: Identification of plausible targets suggests multi organ involvement.	Mol Immunol
34242899	Between immunomodulation and immunotolerance: The role of IFNgamma in SARS-CoV-2 disease.	Cytokine
34242876	Energetic and structural basis for the differences in infectivity between the wild-type and mutant spike proteins of SARS-CoV-2 in the Mexican population.	J Mol Graph Model
34242870	In silico investigation on the inhibitory effect of fungal secondary metabolites on RNA dependent RNA polymerase of SARS-CoV-II: A docking and molecular dynamic simulation study.	Comput Biol Med
34242806	Ageing mechanisms that contribute to tissue remodeling in lung disease.	Ageing Res Rev
34242582	HIV-1 and SARS-CoV-2: Patterns in the evolution of two pandemic pathogens.	Cell Host Microbe
34242578	Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum.	Cell
34242577	In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodies.	Cell
34242574	Antibody landscape against SARS-CoV-2 reveals significant differences between non-structural/accessory and structural proteins.	Cell Rep
34242492	MPI8 is Potent against SARS-CoV-2 by Inhibiting Dually and Selectively the SARS-CoV-2 Main Protease and the Host Cathepsin L*.	ChemMedChem
34242469	Pathogenic lipid-binding antiphospholipid antibodies are associated with severity of COVID-19.	J Thromb Haemost
34242467	Hide and seek in a pandemic: review of SARS-CoV-2 infection and sequelae in children.	Exp Physiol
34242356	Immune response dynamics in COVID-19 patients to SARS-CoV-2 and other human coronaviruses.	PLoS One
34242027	"Peptidomimetic alpha-Acyloxymethylketone Warheads with Six-Membered Lactam P1 Glutamine Mimic: SARS-CoV-2 3CL Protease Inhibition, Coronavirus Antiviral Activity, and in Vitro Biological Stability."	J Med Chem
34241906	Genomic characterization of SARS-CoV-2 isolates from patients in Turkey reveals the presence of novel mutations in spike and nsp12 proteins.	J Med Virol
34241897	Genomic monitoring unveil the early detection of the SARS-CoV-2 B.1.351 (beta) variant (20H/501Y.V2) in Brazil.	J Med Virol
34241787	Renin-angiotensin system inhibitor is associated with the reduced risk of all-cause mortality in COVID-19 among patients with/without hypertension.	Front Med
34241783	SARS-CoV-2 may trigger inflammasome and pyroptosis in the central nervous system: a mechanistic view of neurotropism.	Inflammopharmacology
34241776	"A Comprehensive Review of COVID-19 Virology, Vaccines, Variants, and Therapeutics."	Curr Med Sci
34241772	Hemagglutinin-esterase cannot be considered as a candidate for designing drug against COVID-19.	Mol Divers
34241676	Poor humoral and T-cell response to two-dose SARS-CoV-2 messenger RNA vaccine BNT162b2 in cardiothoracic transplant recipients.	Clin Res Cardiol
34241597	SARS-CoV-2 infection of the pancreas promotes thrombo-fibrosis and is associated with new-onset diabetes.	JCI Insight
34241570	Targeting autophagy in disease: established and new strategies.	Autophagy
34241335	The role of the envelope protein in the stability of a coronavirus model membrane against an ethanolic disinfectant.	J Chem Phys
34240889	A near analytic solution of a stochastic immune response model considering variability in virus and T-cell dynamics.	J Chem Phys
34240742	"Invasive fungal infections in patients with COVID-19: a review on pathogenesis, epidemiology, clinical features, treatment, and outcomes."	New Microbiol
34240429	Molecular definition of severe acute respiratory syndrome coronavirus 2 receptor-binding domain mutations: Receptor affinity versus neutralization of receptor interaction.	Allergy
34240083	Targeting immunometabolism to treat COVID-19.	Immunother Adv
34239977	Deep sequence modelling for predicting COVID-19 mRNA vaccine degradation.	PeerJ Comput Sci
34239932	"In Vitro Models for Studying Entry, Tissue Tropism, and Therapeutic Approaches of Highly Pathogenic Coronaviruses."	Biomed Res Int
34239884	Severe Clinical Worsening in COVID-19 and Potential Mechanisms of Immune-Enhanced Disease.	Front Med (Lausanne)
34239361	Capivasertib restricts SARS-CoV-2 cellular entry: a potential clinical application for COVID-19.	Int J Biol Sci
34239286	Potential SARS-COV preclinical (in vivo) compounds targeting COVID-19 main protease: a meta-analysis and molecular docking studies.	Hippokratia
34239266	Neuropilin-1: A feasible link between liver pathologies and COVID-19.	World J Gastroenterol
34239265	COVID-19 and its effects on the digestive system.	World J Gastroenterol
34239064	Targeting liquid-liquid phase separation of SARS-CoV-2 nucleocapsid protein promotes innate antiviral immunity by elevating MAVS activity.	Nat Cell Biol
34239034	Discovery of potential imaging and therapeutic targets for severe inflammation in COVID-19 patients.	Sci Rep
34238985	In vitro Interleukin-7 treatment partially rescues MAIT cell dysfunction caused by SARS-CoV-2 infection.	Sci Rep
34238376	"Pathogenic implications, incidence, and outcomes of COVID-19 in autoimmune inflammatory joint diseases and autoinflammatory disorders."	Adv Rheumatol
34238372	Immunoinformatics approach for multi-epitope vaccine design against structural proteins and ORF1a polyprotein of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2).	Trop Dis Travel Med Vaccines
34238357	A bivalent protein targeting glycans and HR1 domain in spike protein potently inhibited infection of SARS-CoV-2 and other human coronaviruses.	Cell Biosci
34238338	Single-cell analysis reveals cell communication triggered by macrophages associated with the reduction and exhaustion of CD8(+) T cells in COVID-19.	Cell Commun Signal
34238021	Disrupted Resolution Mechanisms Favor Altered Phagocyte Responses in COVID-19.	Circ Res
34237774	Mapping the human genetic architecture of COVID-19.	Nature
34237773	Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization.	Nature
34237666	"Multifunctional inhibitors of SARS-CoV-2 by MM/PBSA, essential dynamics, and molecular dynamic investigations."	J Mol Graph Model
34237598	Pharmacological properties and underlying mechanisms of curcumin and prospects in medicinal potential.	Biomed Pharmacother
34237472	In silico analysis of the aggregation propensity of the SARS-CoV-2 proteome: Insight into possible cellular pathologies.	Biochim Biophys Acta Proteins Proteom
34237371	Treatment and prevention strategies for the COVID 19 pandemic: A review of immunotherapeutic approaches for neutralizing SARS-CoV-2.	Int J Biol Macromol
34237335	Mucormycosis: An opportunistic pathogen during COVID-19.	Environ Res
34237302	Recombinant SARS-CoV-2 envelope protein traffics to the trans-Golgi network following amphipol-mediated delivery into human cells.	J Biol Chem
34237284	Resistance of SARS-CoV-2 variants to neutralization by antibodies induced in convalescent patients with COVID-19.	Cell Rep
34237283	Isolation and characterization of cross-neutralizing coronavirus antibodies from COVID-19+ subjects.	Cell Rep
34237248	SARS-CoV-2 human T cell epitopes: Adaptive immune response against COVID-19.	Cell Host Microbe
34237151	Protective role of cortistatin in pulmonary inflammation and fibrosis.	Br J Pharmacol
34237054	The interplay of SARS-CoV-2 evolution and constraints imposed by the structure and functionality of its proteins.	PLoS Comput Biol
34237028	Health care worker sero-monitoring reveals complex relationships between common coronavirus antibodies and COVID-19 symptom duration.	JCI Insight
34236922	Drugs that offer the potential to reduce hospitalization and mortality from SARS-CoV-2 infection: The possible role of the sigma-1 receptor and autophagy.	Expert Opin Ther Targets
34236752	Tissue factor upregulation is associated with SARS-CoV-2 in the lungs of COVID-19 patients.	J Thromb Haemost
34236527	Potential activity of Linezolid against SARS-CoV-2 using electronic and molecular docking study.	J Mol Model
34236507	"Luteolin: a blocker of SARS-CoV-2 cell entry based on relaxed complex scheme, molecular dynamics simulation, and metadynamics."	J Mol Model
34236361	A facile chemoenzymatic synthesis of SARS-CoV-2 glycopeptides for probing glycosylation functions.	Chem Commun (Camb)
34236278	Pathological diagnosis of Coronavirus-related nephropathy: insight from postmortem studies.	Crit Rev Clin Lab Sci
34236232	"Genome Sequences of Two Novel Coronavirus (SARS-CoV-2) Isolates from Dhaka, Bangladesh."	Microbiol Resour Announc
34236224	Genome Sequence of a SARS-CoV-2 P.1 Variant of Concern (20J/501Y.V3) from Bangladesh.	Microbiol Resour Announc
34236082	Therapeutic potential of phytoconstituents of edible fruits in combating emerging viral infections.	J Food Biochem
34235728	Advocacy of targeting protease-activated receptors in severe coronavirus disease 2019.	Br J Pharmacol
34235568	Glycosylation of SARS-CoV-2: structural and functional insights.	Anal Bioanal Chem
34235496	Genetic Liability to Cannabis Use Disorder and COVID-19 Hospitalization.	Biol Psychiatry Glob Open Sci
34235495	"Asymmetric dynamics of dimeric SARS-CoV-2 and SARS-CoV main proteases in an apo form: Molecular dynamics study on fluctuations of active site, catalytic dyad, and hydration water."	BBA Adv
34235433	RENET2: high-performance full-text gene-disease relation extraction with iterative training data expansion.	NAR Genom Bioinform
34235425	Brief review: Cardiac complications and platelet activation in COVID-19 infection.	Afr J Thorac Crit Care Med
34235421	Cardiac complications in community-acquired pneumonia and COVID-19.	Afr J Thorac Crit Care Med
34235400	COVID-19 in Patients Receiving CD20-depleting Immunochemotherapy for B-cell Lymphoma.	Hemasphere
34235330	Inhibition of the 3CL Protease and SARS-CoV-2 Replication by Dalcetrapib.	ACS Omega
34235261	Heparan Sulfate Proteoglycans as Attachment Factor for SARS-CoV-2.	ACS Cent Sci
34235176	Ramping Up Antimicrobial Peptides Against Severe Acute Respiratory Syndrome Coronavirus-2.	Front Mol Biosci
34234921	Predicted structural mimicry of spike receptor-binding motifs from highly pathogenic human coronaviruses.	Comput Struct Biotechnol J
34234774	Detection and Neutralization of SARS-CoV-2 Using Non-conventional Variable Lymphocyte Receptor Antibodies of the Evolutionarily Distant Sea Lamprey.	Front Immunol
34234758	A Novel SARS-CoV-2 Viral Sequence Bioinformatic Pipeline Has Found Genetic Evidence That the Viral 3' Untranslated Region (UTR) Is Evolving and Generating Increased Viral Diversity.	Front Microbiol
34234668	"Overview of Viral Pneumonia Associated With Influenza Virus, Respiratory Syncytial Virus, and Coronavirus, and Therapeutics Based on Natural Products of Medicinal Plants."	Front Pharmacol
34234442	Therapeutic Agents Rounding Up the Immunopathology of COVID-19.	Ther Clin Risk Manag
34234394	Differential binding of SARS-CoV-2 Spike protein variants to its cognate receptor hACE2 using molecular modeling based binding analysis.	Bioinformation
34234248	An artificial neural network approach integrating plasma proteomics and genetic data identifies PLXNA4 as a new susceptibility locus for pulmonary embolism.	Sci Rep
34234167	"Genomic epidemiology of SARS-CoV-2 in the UAE reveals novel virus mutation, patterns of co-infection and tissue specific host immune response."	Sci Rep
34234131	Mapping mutations to the SARS-CoV-2 RBD that escape binding by different classes of antibodies.	Nat Commun
34234119	The molecular basis for SARS-CoV-2 binding to dog ACE2.	Nat Commun
34234112	The signal pathways and treatment of cytokine storm in COVID-19.	Signal Transduct Target Ther
34234102	SARS-CoV-2-specific immune response in COVID-19 convalescent individuals.	Signal Transduct Target Ther
34234013	Design and proof of concept for targeted phage-based COVID-19 vaccination strategies with a streamlined cold-free supply chain.	Proc Natl Acad Sci U S A
34234012	"Drugs repurposed for COVID-19 by virtual screening of 6,218 drugs and cell-based assay."	Proc Natl Acad Sci U S A
34233864	"MCP-1: Function, regulation, and involvement in disease."	Int Immunopharmacol
34233672	"Up-regulation of ACE2, the SARS-CoV-2 receptor, in asthmatics on maintenance inhaled corticosteroids."	Respir Res
34233346	Antibody epitopes in vaccine-induced immune thrombotic thrombocytopaenia.	Nature
34232998	Diverse high-affinity DNA aptamers for wild-type and B.1.1.7 SARS-CoV-2 spike proteins from a pre-structured DNA library.	Nucleic Acids Res
34232992	SARS-CoV-2 Nsp3 unique domain SUD interacts with guanine quadruplexes and G4-ligands inhibit this interaction.	Nucleic Acids Res
34232978	"A Comparison of the Clinical, Viral, Pathologic, and Immunologic Features of Severe Acute Respiratory Syndrome (SARS), Middle East Respiratory Syndrome (MERS), and Coronavirus 2019 (COVID-19) Diseases."	Arch Pathol Lab Med
34232823	The blood-gas barrier in COVID-19: an overview of the effects of SARS-CoV-2 infection on the alveolar epithelial and endothelial cells of the lung.	Tissue Barriers
34232805	Inhibitory activities of bipyrazoles: a patent review.	Expert Opin Ther Pat
34232801	Neuromodulatory effects of SARS-CoV2 infection: Possible therapeutic targets.	Expert Opin Ther Targets
34232770	Regulation of the Expression of SARS-CoV-2 Receptor Angiotensin-Converting Enzyme 2 in Nasal Mucosa.	Am J Rhinol Allergy
34232708	Indeterminate QuantiFERON Gold Plus results reveal deficient IFN-gamma responses in severely ill COVID-19 patients.	J Clin Microbiol
34232570	High-resolution serum proteome trajectories in COVID-19 reveal patient-specific seroconversion.	EMBO Mol Med
34232536	Interactomes of SARS-CoV-2 and human coronaviruses reveal host factors potentially affecting pathogenesis.	EMBO J
34232441	"Elevated Expression Levels of Lung Complement Anaphylatoxin, Neutrophil Chemoattractant Chemokine IL-8, and RANTES in MERS-CoV-Infected Patients: Predictive Biomarkers for Disease Severity and Mortality."	J Clin Immunol
34232425	COVID-19 and male reproductive system: pathogenic features and possible mechanisms.	J Mol Histol
34232139	Mechanisms of immunothrombosis in COVID-19.	Curr Opin Hematol
34232065	Porcine epidemic diarrhea virus inhibits HDAC1 expression to facilitate its replication via binding of its nucleocapsid protein to host transcription factor Sp1.	J Virol
34231935	Identification of HLA-A2 restricted CD8(+) T cell epitopes in SARS-CoV-2 structural proteins.	J Leukoc Biol
34231823	Early detection of SARS-CoV-2 P.1 variant in Southern Brazil and reinfection of the same patient by P.2.	Rev Inst Med Trop Sao Paulo
34231390	Erythrocytes identify complement activation in patients with COVID-19.	Am J Physiol Lung Cell Mol Physiol
34230917	Impact of SARS-CoV-2 variants on the total CD4(+) and CD8(+) T cell reactivity in infected or vaccinated individuals.	Cell Rep Med
34230916	Brain imaging in patients with COVID-19: A systematic review.	Brain Behav Immun Health
34230907	All-Atom Simulations and Free-Energy Calculations of Antibodies Bound to the Spike Protein of SARS-CoV-2: The Binding Strength and Multivalent Hydrogen-Bond Interactions.	Adv Theory Simul
34230895	"Preexisting vs. de novo antibodies against SARS-CoV-2 in individuals without or with virus infection: impact on antibody therapy, vaccine research and serological testing."	Transl Med Commun
34230894	Discovery of Cyclic Peptide Ligands to the SARS-CoV-2 Spike Protein Using mRNA Display.	ACS Cent Sci
34230893	"Novel 1,2,3-Triazole Derivatives as Potential Inhibitors against Covid-19 Main Protease: Synthesis, Characterization, Molecular Docking and DFT Studies."	ChemistrySelect
34230886	De Novo Movement Disorders and COVID-19: Exploring the Interface.	Mov Disord Clin Pract
34230874	In silico analysis of echinocandins binding to the main proteases of coronaviruses PEDV (3CL(pro)) and SARS-CoV-2 (M(pro)).	In Silico Pharmacol
34230841	"Emerging infectious diseases, vaccines and Guillain-Barre syndrome."	Clin Exp Neuroimmunol
34230799	Angiotensin-converting enzyme 2 gene expression in human male urological tissues: implications for pathogenesis and virus transmission pathways.	Afr J Urol
34230709	Magnetization Transfer to Enhance NOE Cross-Peaks among Labile Protons: Applications to Imino-Imino Sequential Walks in SARS-CoV-2-Derived RNAs.	Angew Chem Weinheim Bergstr Ger
34230708	A SARS-CoV-2 Spike Binding DNA Aptamer that Inhibits Pseudovirus Infection by an RBD-Independent Mechanism.	Angew Chem Weinheim Bergstr Ger
34230707	Neutralizing Aptamers Block S/RBD-ACE2 Interactions and Prevent Host Cell Infection.	Angew Chem Weinheim Bergstr Ger
34230687	Synthesis of antimicrobial azoloazines and molecular docking for inhibiting COVID-19.	J Heterocycl Chem
34230672	A Continuous Model of Three Scenarios of the Infection Process with Delayed Immune Response Factors.	Biophysics (Oxf)
34230615	Prolonged SARS-CoV-2 RNA virus shedding and lymphopenia are hallmarks of COVID-19 in cancer patients with poor prognosis.	Cell Death Differ
34230476	Twelve-month specific IgG response to SARS-CoV-2 receptor-binding domain among COVID-19 convalescent plasma donors in Wuhan.	Nat Commun
34230457	SARS-CoV-2 infection in the mouse olfactory system.	Cell Discov
34230210	Kynurenic acid may underlie sex-specific immune responses to COVID-19.	Sci Signal
34230209	Long-chain polyphosphates impair SARS-CoV-2 infection and replication.	Sci Signal
34229864	Humoral immune mechanisms involved in protective and pathological immunity during COVID-19.	Hum Immunol
34229805	Interactions of Ozone-Functionalized Activated Charcoal with SARS-Cov-2 Proteases Using Molecular Docking and Dynamics.	J Nanosci Nanotechnol
34229735	Infectious disease-associated encephalopathies.	Crit Care
34229605	The vicious cycle: a history of obesity and COVID-19.	BMC Cardiovasc Disord
34229582	The molecular dynamics of possible inhibitors for SARS-CoV-2.	J Biomol Struct Dyn
34229570	Comparative analysis of SARS-CoV-2 envelope viroporin mutations from COVID-19 deceased and surviving patients revealed implications on its ion-channel activities and correlation with patient mortality.	J Biomol Struct Dyn
34198328	Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of Nsp14 RNA cap methyltransferase.	Biochem J
34198327	Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of Nsp5 main protease.	Biochem J
34198326	Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp14/nsp10 exoribonuclease.	Biochem J
34198325	Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of Nsp3 papain-like protease.	Biochem J
34198324	Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp15 endoribonuclease.	Biochem J
34198323	Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp12/7/8 RNA-dependent RNA polymerase.	Biochem J
34198322	Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp13 helicase.	Biochem J
34198321	An all-out assault on SARS-CoV-2 replication.	Biochem J
34198320	Author's overview: identifying SARS-CoV-2 antiviral compounds.	Biochem J
34197884	Evolutionary selectivity of amino acid is inspired from the enhanced structural stability and flexibility of the folded protein.	Life Sci
34197807	Regulation of epithelial sodium channel activity by SARS-CoV-1 and SARS-CoV-2 proteins.	Biophys J
34197805	"Transient and stabilized complexes of Nsp7, Nsp8, and Nsp12 in SARS-CoV-2 replication."	Biophys J
34197802	Dynamics of the SARS-CoV-2 nucleoprotein N-terminal domain triggers RNA duplex destabilization.	Biophys J
34197564	Complement Decay-Accelerating Factor is a modulator of influenza A virus lung immunopathology.	PLoS Pathog
34197543	High rate of HSV-1 reactivation in invasively ventilated COVID-19 patients: Immunological findings.	PLoS One
34197207	New SARS-CoV-2 Variant from Jordan.	Microbiol Resour Announc
34196647	Selenium atom on phosphate enhances specificity and sensitivity of DNA polymerization and detection.	J Mater Chem B
34196620	Structural insights into the interaction of papain-like protease 2 from the alphacoronavirus porcine epidemic diarrhea virus and ubiquitin.	Acta Crystallogr D Struct Biol
34196568	Interfacial Water Many-Body Effects Drive Structural Dynamics and Allosteric Interactions in SARS-CoV-2 Main Protease Dimerization Interface.	J Phys Chem Lett
34196550	Regulation Mechanism for the Binding between the SARS-CoV-2 Spike Protein and Host Angiotensin-Converting Enzyme II.	J Phys Chem Lett
34196543	Protein Engineering in the Design of Protein-Protein Interactions: SARS-CoV-2 Inhibitors as a Test Case.	Biochemistry
34196506	Brief Report: Humoral and cellular immune responses to SARS-CoV-2 infection and vaccination in B cell depleted autoimmune patients.	Arthritis Rheumatol
34196475	Testicular pathology in fatal COVID-19: A descriptive autopsy study.	Andrology
34196431	"SARS-CoV-2 virulence evolution: Avirulence theory, immunity and trade-offs."	J Evol Biol
34196300	SARS-CoV-2 viremia is associated with distinct proteomic pathways and predicts COVID-19 outcomes.	J Clin Invest
34196258	Ibuprofen and COVID-19 disease: separating the myths from facts.	Expert Rev Respir Med
34196208	Pathogenesis of COVID-19; Acute Auto-inflammatory Disease (Endotheliopathica & Leukocytoclastica COVIDicus).	Arch Iran Med
34195965	Functional ACE2 deficiency leading to angiotensin imbalance in the pathophysiology of COVID-19.	Rev Endocr Metab Disord
34195882	"A brief molecular insight of COVID-19: epidemiology, clinical manifestation, molecular mechanism, cellular tropism and immuno-pathogenesis."	Mol Cell Biochem
34195671	Optimized immunofluorescence staining protocol for imaging germinal centers in secondary lymphoid tissues of vaccinated mice.	STAR Protoc
34195465	Immunological response to COVID-19 and its role as a predisposing factor in invasive aspergillosis.	Curr Med Mycol
34195193	COVID-19 Pathology on Various Organs and Regenerative Medicine and Stem Cell-Based Interventions.	Front Cell Dev Biol
34194615	Acute pancreatitis and COVID-19: A literature review.	World J Gastrointest Surg
34194613	Association between acute pancreatitis and COVID-19 infection: What do we know?	World J Gastrointest Surg
34194534	V483A: an emerging mutation hotspot of SARS-CoV-2.	Future Virol
34194438	Potent SARS-CoV-2-Specific T Cell Immunity and Low Anaphylatoxin Levels Correlate With Mild Disease Progression in COVID-19 Patients.	Front Immunol
34194434	"Role of Tunneling Nanotubes in Viral Infection, Neurodegenerative Disease, and Cancer."	Front Immunol
34194429	Neutrophil Extracellular Traps Induce the Epithelial-Mesenchymal Transition: Implications in Post-COVID-19 Fibrosis.	Front Immunol
34194422	"Expression of ACE2, Soluble ACE2, Angiotensin I, Angiotensin II and Angiotensin-(1-7) Is Modulated in COVID-19 Patients."	Front Immunol
34194420	sMAdCAM: IL-6 Ratio Influences Disease Progression and Anti-Viral Responses in SARS-CoV-2 Infection.	Front Immunol
34194331	A Repurposed Drug Screen Identifies Compounds That Inhibit the Binding of the COVID-19 Spike Protein to ACE2.	Front Pharmacol
34193877	Increased risk of acute kidney injury in coronavirus disease patients with renin-angiotensin-aldosterone-system blockade use: a systematic review and meta-analysis.	Sci Rep
34193870	SARS-CoV-2-specific T cell memory is sustained in COVID-19 convalescent patients for 10 months with successful development of stem cell-like memory T cells.	Nat Commun
34193869	CVnCoV and CV2CoV protect human ACE2 transgenic mice from ancestral B BavPat1 and emerging B.1.351 SARS-CoV-2.	Nat Commun
34193809	Effects of Infection with SARS-CoV-2 on the Male and Female Reproductive Systems: A Review.	Med Sci Monit
34193667	"Less frequent sequence mismatches in variants of concern (VOCs) of SARS-CoV-2 in the real-time RT-PCR assays developed by the National Institute of Infectious Diseases, Japan."	Jpn J Infect Dis
34193597	Nucleocapsid Vaccine Elicits Spike-Independent SARS-CoV-2 Protective Immunity.	J Immunol
34193524	Scalable live-attenuated SARS-CoV-2 vaccine candidate demonstrates preclinical safety and efficacy.	Proc Natl Acad Sci U S A
34193418	Identification of SARS-CoV-2-induced pathways reveals drug repurposing strategies.	Sci Adv
34193390	Role of SARS-CoV-2 and ACE2 variations in COVID-19.	Biomed J
34193364	Innate immune response analysis in COVID-19 and kawasaki disease reveals MIS-C predictors.	J Formos Med Assoc
34193239	COVID-19 (SARS-CoV-2) lymphocyte responses are associated with inflammatory biomarkers in total joint replacement surgery candidates pre-operatively.	J Orthop Surg Res
34192965	Probing the SAM Binding Site of SARS-CoV-2 Nsp14 In Vitro Using SAM Competitive Inhibitors Guides Developing Selective Bisubstrate Inhibitors.	SLAS Discov
34192737	Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2.	Nature
34192695	CRISPR-Cas System: The Powerful Modulator of Accessory Genomes in Prokaryotes.	Microb Physiol
34192529	"SARS-CoV-2 mRNA vaccination induces functionally diverse antibodies to NTD, RBD, and S2."	Cell
34192518	Ultrapotent miniproteins targeting the SARS-CoV-2 receptor-binding domain protect against infection and disease.	Cell Host Microbe
34192289	Post-Acute COVID-19 Syndrome and the cardiovascular system: What is known?	Am Heart J Plus
34192279	Human Coronavirus Infections and Pregnancy.	Matern Fetal Med
34192271	What can neuroimmunology teach us about the symptoms of long-COVID?	Oxf Open Immunol
34192270	The role and uses of antibodies in COVID-19 infections: a living review.	Oxf Open Immunol
34192269	Impact of obesity and SARS-CoV-2 infection: implications for host defence - a living review.	Oxf Open Immunol
34192268	Innate immunology in COVID-19-a living review. Part II: dysregulated inflammation drives immunopathology.	Oxf Open Immunol
34192267	"Innate immunology in COVID-19-a living review. Part I: viral entry, sensing and evasion."	Oxf Open Immunol
34192266	Adaptive immunity to SARS-CoV-2.	Oxf Open Immunol
34192264	Ultrafast enzymatic digestion of deoxyribonucleic acid in aqueous microdroplets for sequence discrimination and identification.	QRB Discov
34192263	A 3.4-A cryo-electron microscopy structure of the human coronavirus spike trimer computationally derived from vitrified NL63 virus particles.	QRB Discov
34192262	Biovacc-19: A Candidate Vaccine for Covid-19 (SARS-CoV-2) Developed from Analysis of its General Method of Action for Infectivity.	QRB Discov
34192260	QTY Code-designed Water-soluble Fc-fusion Cytokine Receptors Bind to their Respective Ligands.	QRB Discov
34192218	SARS-CoV-2 found in semen.	Glob Reprod Health
34192201	Understanding COVID-19: are children the key?	BMJ Paediatr Open
34192090	Multiscale Simulations of SARS-CoV-2 3CL Protease Inhibition with Aldehyde Derivatives. Role of Protein and Inhibitor Conformational Changes in the Reaction Mechanism.	ACS Catal
34192089	Unraveling the SARS-CoV-2 Main Protease Mechanism Using Multiscale Methods.	ACS Catal
34191933	Electron beam irradiation on novel coronavirus (COVID-19): A Monte-Carlo simulation.	Chin Phys B
34191753	"Renal Considerations in COVID-19: Part 1 Biology, Pathology and Pathophysiology."	ASAIO J
34191699	The impact of SARS-Cov-2 on the Nervous system and Mental Health.	Curr Neuropharmacol
34191697	Neurological Effects of Sars-Cov-2 And Neurotoxicity of Antiviral Drugs Against Covid-19.	Mini Rev Med Chem
34191617	"Broadening COVID-19 Interventions to Drug Innovation: Neprilysin Pathway as a Friend, Foe, or Promising Molecular Target?"	OMICS
34191580	Construction of a non-infectious SARS-CoV-2 replicon for antiviral drug testing and gene function studies.	J Virol
34191369	Persistence of humoral response upon SARS-CoV-2 infection.	Rev Med Virol
34191362	CyDisCo production of functional recombinant SARS-CoV-2 spike receptor binding domain.	Protein Sci
34191346	Plasma ACE2 species are differentially altered in COVID-19 patients.	FASEB J
34191146	Can the host immune response against SARS-CoV2 also cause an anticancer effect?	Med Oncol
34190748	Triple-target stimuli-responsive anti-COVID-19 face mask with physiological virus-inactivating agents.	Biomater Sci
34190608	Biofilms and coronaviruses reservoirs: a perspective review.	Appl Environ Microbiol
34190409	A Membrane-Targeting Photosensitizer with Aggregation-Induced Emission Characteristics for Highly Efficient Photodynamic Combat of Human Coronaviruses.	Small
34190246	Effective ACE2 peptide-nanoparticle conjugation and its binding with the SARS-Cov-2 RBD quantified by dynamic light scattering.	Chem Commun (Camb)
34189948	Indications for and contraindications of immune checkpoint inhibitors in cancer patients with coronavirus disease 2019 vaccination.	Future Oncol
34189678	"Hypertension, Obesity, and COVID-19: a Collision of Pandemics."	Curr Hypertens Rep
34189546	SARS-CoV-2 and the kidney.	Aust J Gen Pract
34189489	SARS-CoV-2 NSP1 C-terminal (residues 131-180) is an intrinsically disordered region in isolation.	Curr Res Virol Sci
34189428	ACE2 interaction with cytoplasmic PDZ protein enhances SARS-CoV-2 invasion.	iScience
34189426	The zoonotic and natural foci characteristics of SARS-CoV-2.	J Biosaf Biosecur
34189381	COVID-19 and Thyroid Diseases: A Bidirectional Impact.	J Endocr Soc
34189273	Mass spectrometric based detection of protein nucleotidylation in the RNA polymerase of SARS-CoV-2.	Commun Chem
34189252	In silico study of medicinal plants with cyclodextrin inclusion complex as the potential inhibitors against SARS-CoV-2 main protease (M(pro)) and spike (S) receptor.	Inform Med Unlocked
34189187	Efficacy of phytochemicals as immunomodulators in managing COVID-19: a comprehensive view.	Virusdisease
34189012	Correlation-Based Analysis of COVID-19 Virus Genome Versus Other Fatal Virus Genomes.	Arab J Sci Eng
34188786	Extracellular vesicles carry SARS-CoV-2 spike protein and serve as decoys for neutralizing antibodies.	J Extracell Vesicles
34188776	"Evolution, correlation, structural impact and dynamics of emerging SARS-CoV-2 variants."	Comput Struct Biotechnol J
34188665	Dual inhibition of COVID-19 spike glycoprotein and main protease 3CLpro by Withanone from Withania somnifera.	Chin Herb Med
34188314	Synthesis and characterization of new thiazole-based Co(II) and Cu(II) complexes; therapeutic function of thiazole towards COVID-19 in comparing to current antivirals in treatment protocol.	J Mol Struct
34188167	Activation of NF-kappaB and induction of proinflammatory cytokine expressions mediated by ORF7a protein of SARS-CoV-2.	Sci Rep
34188154	Increased colonic expression of ACE2 associates with poor prognosis in Crohn's disease.	Sci Rep
34188006	Relationship between angiotensin-converting enzyme inhibitors or angiotensin receptor blockers and COVID-19 incidence or severe disease.	J Hypertens
34188005	The interaction of the severe acute respiratory syndrome coronavirus 2 spike protein with drug-inhibited angiotensin converting enzyme 2 studied by molecular dynamics simulation.	J Hypertens
34187969	Experimental Models for SARS-CoV-2 Infection.	Mol Cells
34187722	Cell entry by SARS-CoV-2.	Trends Biochem Sci
34187690	"Measles Sclerosing Subacute PanEncephalitis (SSPE), an intriguing and ever-present disease: Data, assumptions and new perspectives."	Rev Neurol (Paris)
34187304	Expression and functional identification of recombinant SARS-CoV-2 receptor binding domain (RBD) from E. coli system.	Prep Biochem Biotechnol
34187224	"Circulating furin, IL-6, and presepsin levels and disease severity in SARS-CoV-2-infected patients."	Sci Prog
34186336	"Innate immunity, inflammation activation and heat-shock protein in COVID-19 pathogenesis."	J Neuroimmunol
34186311	Non-permissive SARS-CoV-2 infection in human neurospheres.	Stem Cell Res
34186245	Comparative host interactomes of the SARS-CoV-2 nonstructural protein 3 and human coronavirus homologs.	Mol Cell Proteomics
34186206	Upregulation of oxidative stress gene markers during SARS-COV-2 viral infection.	Free Radic Biol Med
34186107	A robust SARS-CoV-2 replication model in primary human epithelial cells at the air liquid interface to assess antiviral agents.	Antiviral Res
34185889	An epigenome-wide DNA methylation study of patients with COVID-19.	Ann Hum Genet
34185793	Alteration of L-Dopa decarboxylase expression in SARS-CoV-2 infection and its association with the interferon-inducible ACE2 isoform.	PLoS One
34185704	IL-13 is a driver of COVID-19 severity.	JCI Insight
34185681	AI-based spectroscopic monitoring of real-time interactions between SARS-CoV-2 and human ACE2.	Proc Natl Acad Sci U S A
34185680	Restriction of SARS-CoV-2 replication by targeting programmed -1 ribosomal frameshifting.	Proc Natl Acad Sci U S A
34185437	Targeting neuropilins as a viable SARS-CoV-2 treatment.	FEBS J
34185310	Phylogenomics reveals multiple introductions and early spread of SARS-CoV-2 into Peru.	J Med Virol
34185200	Shedding light on vitamin D: the shared mechanistic and pathophysiological role between hypovitaminosis D and COVID-19 risk factors and complications.	Inflammopharmacology
34185052	PolarProtPred: Predicting apical and basolateral localization of transmembrane proteins using putative short linear motifs and deep learning.	Bioinformatics
34184982	Large-scale sequencing of SARS-CoV-2 genomes from one region allows detailed epidemiology and enables local outbreak management.	Microb Genom
34184973	Emergence of the novel SARS-CoV-2 lineage VUI-NP13L and massive spread of P.2 in South Brazil.	Emerg Microbes Infect
34184910	"Molecular Mechanisms of the Toll-Like Receptor, STING, MAVS, Inflammasome, and Interferon Pathways."	mSystems
34184738	DeepIPs: comprehensive assessment and computational identification of phosphorylation sites of SARS-CoV-2 infection using a deep learning-based approach.	Brief Bioinform
34184491	[Prospects for pharmacological adaptation of neurovascular unit in conditions of neurotropic viral infection].	Zh Nevrol Psikhiatr Im S S Korsakova
34184164	COVID-19 is a systemic vascular hemopathy: insight for mechanistic and clinical aspects.	Angiogenesis
34184073	Dysregulated inflammation may predispose patients with serious mental illnesses to severe COVID19 (Review).	Mol Med Rep
34183961	In Silico Comparison of Separate or Combinatorial Effects of Potential Inhibitors of the SARS-CoV-2 Binding Site of ACE2.	Iran J Public Health
34183916	"SARS-Cov-2 and COVID-19, Basic and Clinical Aspects of the Human Pandemic: A Review."	Iran J Public Health
34183871	Potent inhibition of Severe Acute Respiratory Syndrome Coronavirus 2 by photosensitizers compounds.	Dyes Pigm
34183789	An integrative multiomics analysis identifies putative causal genes for COVID-19 severity.	Genet Med
34183756	Inhibition of drug-metabolizing enzymes by Jingyin granules: implications of herb-drug interactions in antiviral therapy.	Acta Pharmacol Sin
34183752	Structural characterisation of inhibitory and non-inhibitory MMP-9-TIMP-1 complexes and implications for regulatory mechanisms of MMP-9.	Sci Rep
34183681	COVID-19 mRNA vaccine induced antibody responses against three SARS-CoV-2 variants.	Nat Commun
34183391	IgA potentiates NETosis in response to viral infection.	Proc Natl Acad Sci U S A
34183364	SARS-CoV-2 Proteins Induce Endotoxin Tolerance Hallmarks: A Demonstration in Patients with COVID-19.	J Immunol
34183243	"The NLRP3 inflammasome and COVID-19: Activation, pathogenesis and therapeutic strategies."	Cytokine Growth Factor Rev
34182889	In silico screening of phytopolyphenolics for the identification of bioactive compounds as novel protease inhibitors effective against SARS-CoV-2.	J Biomol Struct Dyn
34182880	Study of potentiality of dexamethasone and its derivatives against Covid-19.	J Biomol Struct Dyn
34182794	Mapping the Nonstructural Transmembrane Proteins of Severe Acute Respiratory Syndrome Coronavirus 2.	J Comput Biol
34182784	Identification of a High-Frequency Intrahost SARS-CoV-2 Spike Variant with Enhanced Cytopathic and Fusogenic Effects.	mBio
34182776	Effectors of the Stenotrophomonas maltophilia Type IV Secretion System Mediate Killing of Clinical Isolates of Pseudomonas aeruginosa.	mBio
34182775	Diverse Humoral Immune Responses in Younger and Older Adult COVID-19 Patients.	mBio
34182569	SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses.	Nature
34182162	"Common Variable Immunodeficiency Disorders, T-Cell Responses to SARS-CoV-2 Vaccines, and the Risk of Chronic COVID-19."	J Allergy Clin Immunol Pract
34182038	An optimized and robust SARS-CoV-2 pseudovirus system for viral entry research.	J Virol Methods
34182016	Drug delivery systems as Immunomodulators for therapy of infectious disease: relevance to COVID-19.	Adv Drug Deliv Rev
34181887	Nuclear factor-kappa B and its role in inflammatory lung disease.	Chem Biol Interact
34181691	The endogenous cellular protease inhibitor SPINT2 controls SARS-CoV-2 viral infection and is associated to disease severity.	PLoS Pathog
34181666	Hydroxychloroquine (HCQ) decreases the benefit of anti-PD-1 immune checkpoint blockade in tumor immunotherapy.	PLoS One
34181461	Vitamin D and lumisterol novel metabolites can inhibit SARS-CoV-2 replication machinery enzymes.	Am J Physiol Endocrinol Metab
34181394	"Lipid Nanoparticles-From Liposomes to mRNA Vaccine Delivery, a Landscape of Research Diversity and Advancement."	ACS Nano
34181203	Safety and Efficacy of Renin-Angiotensin-Aldosterone System Inhibitors in COVID-19 Population.	High Blood Press Cardiovasc Prev
34181169	SARS-CoV-2 signaling pathway map: A functional landscape of molecular mechanisms in COVID-19.	J Cell Commun Signal
34181102	The Neurological Manifestations of Post-Acute Sequelae of SARS-CoV-2 infection.	Curr Neurol Neurosci Rep
34180984	Computational design of ultrashort peptide inhibitors of the receptor-binding domain of the SARS-CoV-2 S protein.	Brief Bioinform
34180678	Genetic Variability of the SARS-CoV-2 Pocketome.	J Proteome Res
34180562	miRNAs; a novel strategy for the treatment of COVID-19.	Cell Biol Int
34180374	"The novel tetrahydropyrimidine derivative as inhibitor of SARS CoV-2: synthesis, modeling and molecular docking analysis."	J Biomol Struct Dyn
34180156	A Decade of Jakinibs: what have we learned and what may be the future.	Arthritis Rheumatol
34179862	A recombinant receptor-binding domain in trimeric form generates protective immunity against SARS-CoV-2 infection in nonhuman primates.	Innovation (N Y)
34179744	Vaccine induced thrombotic thrombocytopenia: The shady chapter of a success story.	Metabol Open
34179743	Autoimmune diseases - New insights into a troublesome field.	J Transl Autoimmun
34179732	Dissecting the common and compartment-specific features of COVID-19 severity in the lung and periphery with single-cell resolution.	iScience
34179695	"Untangling the Intricacies of Infection, Thrombosis, Vaccination, and Antiphospholipid Antibodies for COVID-19."	SN Compr Clin Med
34179666	Landscape-Based Mutational Sensitivity Cartography and Network Community Analysis of the SARS-CoV-2 Spike Protein Structures: Quantifying Functional Effects of the Circulating D614G Variant.	ACS Omega
34179644	Impact of Expressing Cells on Glycosylation and Glycan of the SARS-CoV-2 Spike Glycoprotein.	ACS Omega
34179542	Influence of APOE locus on poor prognosis of COVID-19.	Heliyon
34179538	Computational search of hybrid human/SARS-CoV-2 dsRNA reveals unique viral sequences that diverge from those of other coronavirus strains.	Heliyon
34179514	In silico investigation of pro-arrhythmic effects of azithromycin on the human ventricle.	Biochem Biophys Rep
34179347	Discovery of Small Anti-ACE2 Peptides to Inhibit SARS-CoV-2 Infectivity.	Adv Ther (Weinh)
34179330	Furin cleavage sites in the spike proteins of bat and rodent coronaviruses: Implications for virus evolution and zoonotic transfer from rodent species.	One Health
34179304	In silico approach for identification of natural compounds as potential COVID 19 main protease (M(pro)) inhibitors.	Virusdisease
34179146	SARS-CoV-2 Spike Protein Induces Degradation of Junctional Proteins That Maintain Endothelial Barrier Integrity.	Front Cardiovasc Med
34179095	In-Silico Evidence for a Two Receptor Based Strategy of SARS-CoV-2.	Front Mol Biosci
34179075	Heparan Sulfate Facilitates Spike Protein-Mediated SARS-CoV-2 Host Cell Invasion and Contributes to Increased Infection of SARS-CoV-2 G614 Mutant and in Lung Cancer.	Front Mol Biosci
34179022	Targeted Mitochondrial Therapy With Over-Expressed MAVS Protein From Mesenchymal Stem Cells: A New Therapeutic Approach for COVID-19.	Front Cell Dev Biol
34178985	SARS-CoV-2 Host Receptor ACE2 Protein Expression Atlas in Human Gastrointestinal Tract.	Front Cell Dev Biol
34178794	The Reasons for Higher Mortality Rate in Opium Addicted Patients with COVID-19: A Narrative Review.	Iran J Public Health
34178790	Mechanisms in Which Smoking Increases the Risk of COVID-19 Infection: A Narrative Review.	Iran J Public Health
34178722	COVID-19: Lung-Centric Immunothrombosis.	Front Cell Infect Microbiol
34178717	Angiotensin II Receptor Blockers (ARBs Antihypertensive Agents) Increase Replication of SARS-CoV-2 in Vero E6 Cells.	Front Cell Infect Microbiol
34178414	Application of lung microphysiological systems to COVID-19 modeling and drug discovery: a review.	Biodes Manuf
34178377	The COVID-19 Menace.	Glob Chall
34178310	An improved method for the incorporation of fluoromethyl ketones into solid phase peptide synthesis techniques.	RSC Adv
34178236	Coronavirus disease 2019 (COVID-19) pathogenesis: a concise narrative review.	Pan Afr Med J
34177967	Immunomodulation: Immunoglobulin Preparations Suppress Hyperinflammation in a COVID-19 Model via FcgammaRIIA and FcalphaRI.	Front Immunol
34177962	Detailed Multiplex Analysis of SARS-CoV-2 Specific Antibodies in COVID-19 Disease.	Front Immunol
34177959	"Targeting Future Pandemics, a Case for De Novo Purine Synthesis and Basic Research."	Front Immunol
34177935	Plasma Markers of Disrupted Gut Permeability in Severe COVID-19 Patients.	Front Immunol
34177926	Antibody Responses to SARS-CoV-2 Following an Outbreak Among Marine Recruits With Asymptomatic or Mild Infection.	Front Immunol
34177923	SARS-CoV-2 ORF8 Forms Intracellular Aggregates and Inhibits IFNgamma-Induced Antiviral Gene Expression in Human Lung Epithelial Cells.	Front Immunol
34177907	Treg: A Promising Immunotherapeutic Target in Oral Diseases.	Front Immunol
34177897	"Unbiased Analysis of Temporal Changes in Immune Serum Markers in Acute COVID-19 Infection With Emphasis on Organ Failure, Anti-Viral Treatment, and Demographic Characteristics."	Front Immunol
34177896	Thromboplasminflammation in COVID-19 Coagulopathy: Three Viewpoints for Diagnostic and Therapeutic Strategies.	Front Immunol
34177895	"How Children Are Protected From COVID-19? A Historical, Clinical, and Pathophysiological Approach to Address COVID-19 Susceptibility."	Front Immunol
34177879	Antibody Responses and the Effects of Clinical Drugs in COVID-19 Patients.	Front Immunol
34177838	"Expression of Human ACE2 N-terminal Domain, Part of the Receptor for SARS-CoV-2, in Fusion With Maltose-Binding Protein, E. coli Ribonuclease I and Human RNase A."	Front Microbiol
34177827	Phycobilins as Potent Food Bioactive Broad-Spectrum Inhibitors Against Proteases of SARS-CoV-2 and Other Coronaviruses: A Preliminary Study.	Front Microbiol
34177593	A Dual-Route Perspective of SARS-CoV-2 Infection: Lung- vs. Gut-specific Effects of ACE-2 Deficiency.	Front Pharmacol
34177566	Glycyrrhizic Acid for COVID-19: Findings of Targeting Pivotal Inflammatory Pathways Triggered by SARS-CoV-2.	Front Pharmacol
34177418	Effect of Methylene Blue Pathogen Inactivation on the Integrity of Immunoglobulin M and G.	Transfus Med Hemother
34177317	Theoretical benefits of yogurt-derived bioactive peptides and probiotics in COVID-19 patients - A narrative review and hypotheses.	Saudi J Biol Sci
34177193	Exploring AyuGenomics approach for understanding COVID-19 predisposition and progression.	J Ayurveda Integr Med
34177139	Interleukin-6 Perpetrator of the COVID-19 Cytokine Storm.	Indian J Clin Biochem
34177077	Synchronized attachment and the Darwinian evolution of coronaviruses CoV-1 and CoV-2.	Physica A
34176996	SARS-CoV-2 (COVID-19) as a Predictor of Neuroinflammation and Neurodegeneration: Potential Treatment Strategies.	Neurosci Behav Physiol
34176789	Clinical characterization and therapeutic targets of vitamin A in patients with hepatocholangiocarcinoma and coronavirus disease.	Aging (Albany NY)
34176764	Gene signatures and potential therapeutic targets of Middle East respiratory syndrome coronavirus (MERS-CoV)-infected human lung adenocarcinoma epithelial cells.	J Microbiol Immunol Infect
34176716	Virological and genomic analysis of SARS-CoV-2 from a favipiravir clinical trial cohort.	J Infect Chemother
34176527	Review of Sertoli cell dysfunction caused by COVID-19 that could affect male fertility.	Zygote
34176237	Key Considerations for the Development of Safe and Effective SARS-CoV-2 Subunit Vaccine: A Peptide-Based Vaccine Alternative.	Adv Sci (Weinh)
34176174	Metabolic reprogramming and immune regulation in viral diseases.	Rev Med Virol
34176095	COVID-19 Infection and Circulating Microparticles-Reviewing Evidence as Microthrombogenic Risk Factor for Cerebral Small Vessel Disease.	Mol Neurobiol
34176080	Understanding the role of ACE-2 receptor in pathogenesis of COVID-19 disease: a potential approach for therapeutic intervention.	Pharmacol Rep
34175563	A bilirubin-derived nanomedicine attenuates the pathological cascade of pulmonary fibrosis.	Biomaterials
34175433	Daytime variation in SARS-CoV-2 infection and cytokine production.	Microb Pathog
34175230	Insights from myalgic encephalomyelitis/chronic fatigue syndrome may help unravel the pathogenesis of postacute COVID-19 syndrome.	Trends Mol Med
34174992	Antibody and B cell responses to SARS-CoV-2 infection and vaccination.	Cell Host Microbe
34174875	Exploratory analysis to identify the best antigen and the best immune biomarkers to study SARS-CoV-2 infection.	J Transl Med
34174835	A newly identified linear epitope on non-RBD region of SARS-CoV-2 spike protein improves the serological detection rate of COVID-19 patients.	BMC Microbiol
34174806	Innate immunity in COVID-19: Drivers of pathogenesis and potential therapeutic targets.	Asian Pac J Allergy Immunol
34174757	"Sterenin M as a potential inhibitor of SARS-CoV-2 main protease identified from MeFSAT database using molecular docking, molecular dynamics simulation and binding free energy calculation."	Comput Biol Med
34174588	"Altered expression of SARS-CoV-2 entry and processing genes by Porphyromonas gingivalis-derived lipopolysaccharide, inflammatory cytokines and prostaglandin E2 in human gingival fibroblasts."	Arch Oral Biol
34174559	Nanotherapies for sepsis by regulating inflammatory signals and reactive oxygen and nitrogen species: New insight for treating COVID-19.	Redox Biol
34174479	"Molecular surveillance of the on-going SARS-COV-2 epidemic in Ribeirao Preto City, Brazil."	Infect Genet Evol
34174415	COVID-19 myocarditis: quantitative analysis of the inflammatory infiltrate and a proposed mechanism.	Cardiovasc Pathol
34174328	A Crystallographic Snapshot of SARS-CoV-2 Main Protease Maturation Process.	J Mol Biol
34174194	An automatic pipeline for the design of irreversible derivatives identifies a potent SARS-CoV-2 M(pro) inhibitor.	Cell Chem Biol
34174183	Deep spatial profiling of human COVID-19 brains reveals neuroinflammation with distinct microanatomical microglia-T-cell interactions.	Immunity
34174177	Molecular PET/CT Profiling of ACE2 Expression In Vivo: Implications for Infection and Outcome from SARS-CoV-2.	Adv Sci (Weinh)
34174102	Virological and immunological features of SARS-COV-2 infected children with distinct symptomatology.	Pediatr Allergy Immunol
34173942	Covid and Cardiovascular Diseases: Direct and Indirect Damages and Future Perspective.	High Blood Press Cardiovasc Prev
34173853	How could perfluorocarbon affect cytokine storm and angiogenesis in coronavirus disease 2019 (COVID-19): role of hypoxia-inducible factor 1alpha.	Inflamm Res
34173452	Analysis of the intestinal microbiota in COVID-19 patients and its correlation with the inflammatory factor IL-18.	Med Microecol
34172790	Pulmonary adverse drug event data in hypertension with implications on COVID-19 morbidity.	Sci Rep
34172783	"Limited intestinal inflammation despite diarrhea, fecal viral RNA and SARS-CoV-2-specific IgA in patients with acute COVID-19."	Sci Rep
34172713	In silico screening of Allium cepa phytochemicals for their binding abilities to SARS and SARS-CoV-2 3C-like protease and COVID-19 human receptor ACE-2.	Trop Biomed
34172612	Pathomechanisms Underlying Hypoxemia in Two COVID-19-Associated Acute Respiratory Distress Syndrome Phenotypes: Insights from Thrombosis and Hemostasis.	Shock
34171587	"SARS-CoV-2 and helminth co-infections, and environmental pollution exposure: An epidemiological and immunological perspective."	Environ Int
34171559	COVID-19 and Malignancy: Exploration of the possible genetic and epigenetic interlinks and overview of the vaccination scenario.	Cancer Treat Res Commun
34171548	A SARS-CoV-2 Nucleocapsid Variant that Affects Antigen Test Performance.	J Clin Virol
34171504	A computational analysis of molecular evolution for virulence genes of zoonotic novel coronavirus (COVID-19).	Comput Biol Chem
34171407	Phylogenetic analysis in the clinical risk management of an outbreak of hepatitis C virus infection among transfused thalassaemia patients in Italy.	J Hosp Infect
34171382	Zinc supplementation augments the suppressive effects of repurposed NF-kappaB inhibitors on ACE2 expression in human lung cell lines.	Life Sci
34171326	The role of CD71(+) erythroid cells in the regulation of the immune response.	Pharmacol Ther
34171305	Profiling SARS-CoV-2 HLA-I peptidome reveals T cell epitopes from out-of-frame ORFs.	Cell
34171302	"An ancient viral epidemic involving host coronavirus interacting genes more than 20,000 years ago in East Asia."	Curr Biol
34171266	SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity.	Cell Host Microbe
34171229	Directed evolution of potent neutralizing nanobodies against SARS-CoV-2 using CDR-swapping mutagenesis.	Cell Chem Biol
34171156	"Caffeoylquinic acids: chemistry, biosynthesis, occurrence, analytical challenges, and bioactivity."	Plant J
34171050	SARS-CoV-2 infection in patients with serious mental illness and possible benefits of prophylaxis with Memantine and Amantadine.	Rom J Morphol Embryol
34170561	"Polymorphisms of ACE (I/D) and ACE2 receptor gene (Rs2106809, Rs2285666) are not related to the clinical course of COVID-19: A case study."	J Med Virol
34170525	Specific allelic discrimination of N501Y and other SARS-CoV-2 mutations by ddPCR detects B.1.1.7 lineage in Washington State.	J Med Virol
34170074	Attenuation of clinical and immunological outcomes during SARS-CoV-2 infection by ivermectin.	EMBO Mol Med
34169908	"Can emapalumab be life saving for refractory, recurrent, and progressive cytokine storm caused by COVID-19, which is resistant to anakinra, tocilizumab, and Janus kinase inhibitors."	Indian J Pharmacol
34169729	Identification of known drugs as potential SARS-CoV-2 Mpro inhibitors using ligand- and structure-based virtual screening.	Future Med Chem
34169728	Rapid structure-based identification of potential SARS-CoV-2 main protease inhibitors.	Future Med Chem
34169568	Repurposing of FDA-approved drugs against active site and potential allosteric drug-binding sites of COVID-19 main protease.	Proteins
34169450	New insights into the catalytic mechanism of the SARS-CoV-2 main protease: an ONIOM QM/MM approach.	Mol Divers
34169443	Emerging COVID-19 Neurological Manifestations: Present Outlook and Potential Neurological Challenges in COVID-19 Pandemic.	Mol Neurobiol
34169437	Aging and diabetes drive the COVID-19 forwards; unveiling nature and existing therapies for the treatment.	Mol Cell Biochem
34169404	Comprehensive Review on Neuro-COVID-19 Pathophysiology and Clinical Consequences.	Neurotox Res
34169390	Molecular screening of glycyrrhizin-based inhibitors against ACE2 host receptor of SARS-CoV-2.	J Mol Model
34169297	Sex and gender differences in COVID-19: More to be learned!	Am Heart J Plus
34169296	Repurposing Interleukin-6 Inhibitors to Combat COVID-19.	J Immunother Precis Oncol
34168762	High-resolution mining of the SARS-CoV-2 main protease conformational space: supercomputer-driven unsupervised adaptive sampling.	Chem Sci
34168732	New perspectives on angiotensin-converting enzyme 2 and its related diseases.	World J Diabetes
34168726	Diabetes and inflammatory diseases: An overview from the perspective of Ca(2+)/3'-5'-cyclic adenosine monophosphate signaling.	World J Diabetes
34168484	Gut Microbiota Dysbiosis Correlates with Abnormal Immune Response in Moderate COVID-19 Patients with Fever.	J Inflamm Res
34168408	COVID-19 and pediatric fatty liver disease: Is there interplay?	World J Gastroenterol
34168405	"Liver injury in COVID-19: Detection, pathogenesis, and treatment."	World J Gastroenterol
34168400	Interplay between nuclear factor erythroid 2-related factor 2 and inflammatory mediators in COVID-19-related liver injury.	World J Gastroenterol
34168368	Rapid generation of potent antibodies by autonomous hypermutation in yeast.	Nat Chem Biol
34168183	Bispecific repurposed medicines targeting the viral and immunological arms of COVID-19.	Sci Rep
34168168	In silico comparison of SARS-CoV-2 spike protein-ACE2 binding affinities across species and implications for virus origin.	Sci Rep
34168138	The architecture of the SARS-CoV-2 RNA genome inside virion.	Nat Commun
34168111	Nutrition and immunity: lessons for COVID-19.	Nutr Diabetes
34168100	Triglyceride regulate ACE2 level through MTHFD1.	J Biosci
34168096	In silico analysis identifies neuropilin-1 as a potential therapeutic target for SARS-Cov-2 infected lung cancer patients.	Aging (Albany NY)
34168071	"Effect of natural mutations of SARS-CoV-2 on spike structure, conformation, and antigenicity."	Science
34168070	Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants.	Science
34168039	Targeting the m(6)A RNA modification pathway blocks SARS-CoV-2 and HCoV-OC43 replication.	Genes Dev
34167431	Defibrotide: potential for treating endothelial dysfunction related to viral and post-infectious syndromes.	Expert Opin Ther Targets
34166886	Molecular insight into the genomic variation of SARS-CoV-2 strains from current outbreak.	Comput Biol Chem
34166652	TRP channels in COVID-19 disease: Potential targets for prevention and treatment.	Chem Biol Interact
34166623	Analysis of SARS-CoV-2 variant mutations reveals neutralization escape mechanisms and the ability to use ACE2 receptors from additional species.	Immunity
34166618	Identification of presented SARS-CoV-2 HLA class I and HLA class II peptides using HLA peptidomics.	Cell Rep
34166617	Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7.	Cell Rep
34166473	"Rapid, reliable, and reproducible cell fusion assay to quantify SARS-Cov-2 spike interaction with hACE2."	PLoS Pathog
34166421	SARS-CoV-2 detection and genomic sequencing from hospital surface samples collected at UC Davis.	PLoS One
34166398	SARS-CoV-2 viral proteins NSP1 and NSP13 inhibit interferon activation through distinct mechanisms.	PLoS One
34166232	Association of rare predicted loss-of-function variants of influenza-related type I IFN genes with critical COVID-19 pneumonia.	J Clin Invest
34166229	Autoantibodies stabilize neutrophil extracellular traps in COVID-19.	JCI Insight
34165771	Novel adenosine derivatives against SARS-CoV-2 RNA-dependent RNA polymerase: an in silico perspective.	Pharmacol Rep
34165431	[Myocardial injury in coronavirus disease 19 (Covid-19): main pathophysiological mechanisms and clinical utility of cardiac biomarkers].	Ann Biol Clin (Paris)
34165401	Interfering Reactive Cysteine Proteome in Covid-19 Disease.	Curr Med Chem
34165257	HLA-A homozygosis is associated with susceptibility to COVID-19.	HLA
34164564	Umbilical Cord-derived Mesenchymal Stem Cells for COVID-19 Patients with Acute Respiratory Distress Syndrome (ARDS).	CellR4 Repair Replace Regen Reprogram
34164147	"Crystal structure and mol-ecular docking study of (E)-2-{[(E)-2-hy-droxy-5-methyl-benzyl-idene]hydrazinyl-idene}-1,2-di-phenyl-etha n-1-one."	Acta Crystallogr E Crystallogr Commun
34163908	Probing conformational hotspots for the recognition and intervention of protein complexes by lysine reactivity profiling.	Chem Sci
34163906	Mechanism of inhibition of SARS-CoV-2 M(pro) by N3 peptidyl Michael acceptor explained by QM/MM simulations and design of new derivatives with tunable chemical reactivity.	Chem Sci
34163793	Inhibitors of thiol-mediated uptake.	Chem Sci
34163728	"CRISPR technology incorporating amplification strategies: molecular assays for nucleic acids, proteins, and small molecules."	Chem Sci
34163622	A microscopic description of SARS-CoV-2 main protease inhibition with Michael acceptors. Strategies for improving inhibitor design.	Chem Sci
34163532	Circulating Cytokines and Coronavirus Disease: A Bi-Directional Mendelian Randomization Study.	Front Genet
34163530	Human MicroRNAs Interacting With SARS-CoV-2 RNA Sequences: Computational Analysis and Experimental Target Validation.	Front Genet
34163490	PD-L1 Dysregulation in COVID-19 Patients.	Front Immunol
34163488	Cytokine/Chemokine Expression Is Closely Associated Disease Severity of Human Adenovirus Infections in Immunocompetent Adults and Predicts Disease Progression.	Front Immunol
34163462	Regulated Intramembrane Proteolysis of ACE2: A Potential Mechanism Contributing to COVID-19 Pathogenesis?	Front Immunol
34163359	Therapeutic Targeting of Transcription Factors to Control the Cytokine Release Syndrome in COVID-19.	Front Pharmacol
34163357	Pulmonary Edema in COVID-19 Patients: Mechanisms and Treatment Potential.	Front Pharmacol
34163216	KDELC1 and TRMT1 Serve as Prognosis-Related SARS-CoV-2 Proteins Binding Human mRNAs and Promising Biomarkers in Clear Cell Renal Cell Carcinoma.	Int J Gen Med
34163208	"Longitudinal Antibody Dynamics Against Structural Proteins of SARS-CoV-2 in Three COVID-19 Patients Shows Concurrent Development of IgA, IgM, and IgG."	J Inflamm Res
34163190	Understanding the Molecular Biology of SARS-CoV-2 and the COVID-19 Pandemic: A Review.	Infect Drug Resist
34163183	Effect of Genomic and Amino Acid Sequence Mutation on Virulence and Therapeutic Target of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS COV-2).	Infect Drug Resist
34163151	Inhibitory Potential of Phytochemicals on Interleukin-6-Mediated T-Cell Reduction in COVID-19 Patients: A Computational Approach.	Bioinform Biol Insights
34163149	"DGraph Clusters Flaviviruses and beta-Coronaviruses According to Their Hosts, Disease Type, and Human Cell Receptors."	Bioinform Biol Insights
34163106	COVID-19-associated diarrhea.	World J Gastroenterol
34163035	Emergence and spread of a SARS-CoV-2 lineage A variant (A.23.1) with altered spike protein in Uganda.	Nat Microbiol
34163017	Nutrition and immunity: lessons for COVID-19.	Eur J Clin Nutr
34162970	Natural variants in SARS-CoV-2 Spike protein pinpoint structural and functional hotspots with implications for prophylaxis and therapeutic strategies.	Sci Rep
34162945	Immunodominant T-cell epitopes from the SARS-CoV-2 spike antigen reveal robust pre-existing T-cell immunity in unexposed individuals.	Sci Rep
34162861	A high-throughput screen for TMPRSS2 expression identifies FDA-approved compounds that can limit SARS-CoV-2 entry.	Nat Commun
34162747	SARS-CoV-2 Neuronal Invasion and Complications: Potential Mechanisms and Therapeutic Approaches.	J Neurosci
34162739	Immunogenicity and efficacy of the COVID-19 candidate vector vaccine MVA-SARS-2-S in preclinical vaccination.	Proc Natl Acad Sci U S A
34162440	Deletion of ER-retention motif on SARS-CoV-2 spike protein reduces cell hybrid during cell-cell fusion.	Cell Biosci
34162159	The preparation of N-IgY targeting SARS-CoV-2 and its immunomodulation to IFN-gamma production in vitro.	Int Immunopharmacol
34162139	Regulatory T cells and vaccine effectiveness in older adults. Challenges and prospects.	Int Immunopharmacol
34162042	Current knowledge about the connection between health status and gut microbiota from birth to elderly. A narrative review.	Front Biosci (Landmark Ed)
34161984	"The Role of Exosomes in the Treatment, Prevention, Diagnosis, and Pathogenesis of COVID-19."	Eur J Pediatr Surg
34161961	Protective efficacy of Ad26.COV2.S against SARS-CoV-2 B.1.351 in macaques.	Nature
34161778	The Inherent Dynamics and Interaction Sites of the SARS-CoV-2 Nucleocapsid N-Terminal Region.	J Mol Biol
34161776	The monoclonal antibody combination REGEN-COV protects against SARS-CoV-2 mutational escape in preclinical and human studies.	Cell
34161756	Structure-guided design of a perampanel-derived pharmacophore targeting the SARS-CoV-2 main protease.	Structure
34161644	Exploring the Druggability of Conserved RNA Regulatory Elements in the SARS-CoV-2 Genome.	Angew Chem Int Ed Engl
34161567	Detection of serum cross-reactive antibodies and memory response to SARS-CoV-2 in pre-pandemic and post-COVID-19 convalescent samples.	J Infect Dis
34161386	"The Fc-mediated effector functions of a potent SARS-CoV-2 neutralizing antibody, SC31, isolated from an early convalescent COVID-19 patient, are essential for the optimal therapeutic efficacy of the antibody."	PLoS One
34161337	SARS-CoV-2 uses major endothelial integrin alphavbeta3 to cause vascular dysregulation in-vitro during COVID-19.	PLoS One
34161223	"Genomic Evolution of SARS-CoV-2 Virus in Immunocompromised Patient, Ireland."	Emerg Infect Dis
34161189	Emerging SARS-CoV-2 variants: impact on vaccine efficacy and neutralizing antibodies.	Hum Vaccin Immunother
34161170	Control of Innate Immune Activation by Severe Acute Respiratory Syndrome Coronavirus 2 and Other Coronaviruses.	J Interferon Cytokine Res
34161118	Determination of inhibitor activity of drugs against the COVID-19.	Bratisl Lek Listy
34161095	Allosteric Cross-Talk among Spike's Receptor-Binding Domain Mutations of the SARS-CoV-2 South African Variant Triggers an Effective Hijacking of Human Cell Receptor.	J Phys Chem Lett
34160586	The immunopathobiology of SARS-CoV-2 infection.	FEMS Microbiol Rev
34160563	ACE2 Expression Is Upregulated in Inflammatory Corneal Epithelial Cells and Attenuated by Resveratrol.	Invest Ophthalmol Vis Sci
34160551	Local memory CD4 T cell niches in respiratory viral infection.	J Exp Med
34160366	Zonulin as a biomarker and potential therapeutic target in multisystem inflammatory syndrome in children.	J Clin Invest
34160253	Structural basis of covalent inhibitory mechanism of TMPRSS2-related serine proteases by camostat.	J Virol
34160250	SARS-CoV-2 Spike Protein Induces Paracrine Senescence and Leukocyte Adhesion in Endothelial Cells.	J Virol
34160239	"Replication Kinetics, Cell Tropism, and Associated Immune Responses in SARS-CoV-2- and H5N1 Virus-Infected Human Induced Pluripotent Stem Cell-Derived Neural Models."	mSphere
34160124	Preliminary Structural Data Revealed That the SARS-CoV-2 B.1.617 Variant's RBD Binds to ACE2 Receptor Stronger Than the Wild Type to Enhance the Infectivity.	Chembiochem
34159807	"Caloric Restriction and Cardiovascular Health: the Good, the Bad, and the Renin-Angiotensin System."	Physiology (Bethesda)
34159794	Endothelial metabolism in pulmonary vascular homeostasis and acute respiratory distress syndrome.	Am J Physiol Lung Cell Mol Physiol
34159729	"Interplay between SARS-CoV-2-derived miRNAs, immune system, vitamin D pathway and respiratory system."	J Cell Mol Med
34159627	Genome-wide association analysis of COVID-19 mortality risk in SARS-CoV-2 genomes identifies mutation in the SARS-CoV-2 spike protein that colocalizes with P.1 of the Brazilian strain.	Genet Epidemiol
34159616	TMPRSS2 expression dictates the entry route used by SARS-CoV-2 to infect host cells.	EMBO J
34159564	Computational Lock and Key and Dynamic Trajectory Analysis of Natural Biophors Against COVID-19 Spike Protein to Identify Effective Lead Molecules.	Mol Biotechnol
34159380	Nsp2 has the potential to be a drug target revealed by global identification of SARS-CoV-2 Nsp2-interacting proteins.	Acta Biochim Biophys Sin (Shanghai)
34159203	The Current Status and Challenges in the Development of Vaccines and Drugs against Severe Acute Respiratory Syndrome-Corona Virus-2 (SARS-CoV-2).	Biomed Res Int
34159141	Structure-based virtual screening of bioactive compounds from Indonesian medical plants against severe acute respiratory syndrome coronavirus-2.	J Adv Pharm Technol Res
34158856	TRPV2-spike protein interaction mediates the entry of SARS-CoV-2 into macrophages in febrile conditions.	Theranostics
34158771	Functional and Structural Characterization of SARS-Cov-2 Spike Protein: An In Silico Study.	Ethiop J Health Sci
34158670	A multi-omics investigation of the composition and function of extracellular vesicles along the temporal trajectory of COVID-19.	Nat Metab
34158638	Cryo-EM structure of SARS-CoV-2 ORF3a in lipid nanodiscs.	Nat Struct Mol Biol
34158414	"Mesenchymal Stem Cell-Derived Exosomes for COVID-19 Therapy, Preclinical and Clinical Evidence."	Int J Stem Cells
34158111	Aging and respiratory viral infection: from acute morbidity to chronic sequelae.	Cell Biosci
34157565	Age- and airway disease related gene expression patterns of key SARS-CoV-2 entry factors in human nasal epithelia.	Virology
34157514	SARS-CoV-2 spike protein removes lipids from model membranes and interferes with the capacity of high density lipoprotein to exchange lipids.	J Colloid Interface Sci
34157472	Multilevel systems biology analysis of lung transcriptomics data identifies key miRNAs and potential miRNA target genes for SARS-CoV-2 infection.	Comput Biol Med
34157321	"Selinexor, a novel selective inhibitor of nuclear export, reduces SARS-CoV-2 infection and protects the respiratory system in vivo."	Antiviral Res
34157282	"Effect of clinical isolate or cleavage site mutations in the SARS-CoV-2 spike protein on protein stability, cleavage, and cell-cell fusion."	J Biol Chem
34157151	Cutaneous and systemic hyperinflammation drives maculopapular drug exanthema in severely ill COVID-19 patients.	Allergy
34157110	Accelerating the evolution of SARS-CoV-2 - a risk of combining dexamethasone and tocilizumab for severe COVID-19.	J Infect Dis
34157054	Diabetes and coronavirus (SARS-CoV-2): Molecular mechanism of Metformin intervention and the scientific basis of drug repurposing.	PLoS Pathog
34156980	Association of rare predicted loss-of-function variants of influenza-related type I IFN genes with critical COVID-19 pneumonia. Reply.	J Clin Invest
34156923	Genomic epidemiology of the first epidemic wave of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Palestine.	Microb Genom
34156871	The SARS-CoV-2 spike protein subunit S1 induces COVID-19-like acute lung injury in Kappa18-hACE2 transgenic mice and barrier dysfunction in human endothelial cells.	Am J Physiol Lung Cell Mol Physiol
34156699	Immunomodulatory agents as potential therapeutic or preventive strategies for COVID-19.	Eur Rev Med Pharmacol Sci
34156698	Antiviral drugs proposed for COVID-19: action mechanism and pharmacological data.	Eur Rev Med Pharmacol Sci
34156227	Anchor-Locker Binding Mechanism of the Coronavirus Spike Protein to Human ACE2: Insights from Computational Analysis.	J Chem Inf Model
34155961	Integrated docking and enhanced sampling-based selection of repurposing drugs for SARS-CoV-2 by targeting host dependent factors.	J Biomol Struct Dyn
34155814	"Compositional biases in RNA viruses: Causes, consequences and applications."	Wiley Interdiscip Rev RNA
34155789	COVID-19 and the liver - Lessons learned.	Liver Int
34155611	Stress Decreases Host Viral Resistance and Increases Covid Susceptibility in Embryonic Stem Cells.	Stem Cell Rev Rep
34155559	Association of CXCR6 with COVID-19 severity: delineating the host genetic factors in transcriptomic regulation.	Hum Genet
34155551	Simultaneous enrichment and separation of neutral and sialyl glycopeptides of SARS-CoV-2 spike protein enabled by dual-functionalized Ti-IMAC material.	Anal Bioanal Chem
34155432	"New Cr(III), Mn(II), Fe(III), Co(II), Ni(II), Zn(II), Cd(II), and Hg(II) Gibberellate Complexes: Synthesis, Structure, and Inhibitory Activity Against COVID-19 Protease."	Russ J Gen Chem
34155426	Current Understanding in the Pathophysiology of SARS-CoV-2-Associated Rhino-Orbito-Cerebral Mucormycosis: A Comprehensive Review.	J Maxillofac Oral Surg
34155232	The risk of pancreatic adenocarcinoma following SARS-CoV family infection.	Sci Rep
34155214	Engineered ACE2 receptor therapy overcomes mutational escape of SARS-CoV-2.	Nat Commun
34155209	Sequence signatures of two public antibody clonotypes that bind SARS-CoV-2 receptor binding domain.	Nat Commun
34155207	SARS-CoV-2-mediated dysregulation of metabolism and autophagy uncovers host-targeting antivirals.	Nat Commun
34154921	Development of a genotyping platform for SARS-CoV-2 variants using high-resolution melting analysis.	J Infect Chemother
34154407	Allosteric Activation of SARS-CoV-2 RNA-Dependent RNA Polymerase by Remdesivir Triphosphate and Other Phosphorylated Nucleotides.	mBio
34153975	In vivo monoclonal antibody efficacy against SARS-CoV-2 variant strains.	Nature
34153974	Dysregulation of brain and choroid plexus cell types in severe COVID-19.	Nature
34153851	Role of toll-like receptor 7/8 pathways in regulation of interferon response and inflammatory mediators during SARS-CoV2 infection and potential therapeutic options.	Biomed Pharmacother
34153649	C-C motive chemokine ligand 2 and thromboinflammation in COVID-19-associated pneumonia: A retrospective study.	Thromb Res
34153515	"Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Genome Sequencing from Post-Mortem Formalin-Fixed, Paraffin-Embedded Lung Tissues."	J Mol Diagn
34153419	Potential biomarkers for the early prediction of SARS-COV-2 disease outcome.	Microb Pathog
34153417	Construction of an autophagy interaction network based on competitive endogenous RNA reveals the key pathways and central genes of SARS-CoV-2 infection in vivo.	Microb Pathog
34153377	"Coronaviruses, cholesterol and statins: Involvement and application for Covid-19."	Biochimie
34153340	Pulmonary Thrombosis and Thromboembolism in COVID-19.	Chest
34152956	Susceptibility of Well-Differentiated Airway Epithelial Cell Cultures from Domestic and Wild Animals to Severe Acute Respiratory Syndrome Coronavirus 2.	Emerg Infect Dis
34152728	The Structure-Based Design of SARS-CoV-2 nsp14 Methyltransferase Ligands Yields Nanomolar Inhibitors.	ACS Infect Dis
34152702	The Role of Type III Interferons in Human Disease.	Clin Invest Med
34152690	COVID-19 and the liver: A 2021 update.	Liver Int
34152583	Potential for the Repurposing of Adamantane Antivirals for COVID-19.	Drugs R D
34152577	Comparative study of predicted miRNA between Indonesia and China (Wuhan) SARS-CoV-2: a bioinformatics analysis.	Genes Genomics
34152044	SARS-CoV-2 infects an upper airway model derived from induced pluripotent stem cells.	Stem Cells
34151773	Ketogenic diet restrains aging-induced exacerbation of coronavirus infection in mice.	Elife
34151745	Inhibitory activity of marine sponge metabolites on SARS-CoV-2 RNA dependent polymerase: virtual screening and molecular dynamics simulation.	J Biomol Struct Dyn
34151735	"Computational study of novel inhibitory molecule, 1-(4-((2S,3S)-3-amino-2-hydroxy-4-phenylbutyl)piperazin-1-yl)-3-phenylurea, with high potential to competitively block ATP binding to the RNA dependent RNA polymerase of SARS-CoV-2 virus."	J Biomol Struct Dyn
34151733	Screening of potential bio-molecules from Moringa olifera against SARS-CoV-2 main protease using computational approaches.	J Biomol Struct Dyn
34151722	Induction of the NEK family of kinases in the lungs of mice subjected to cecal ligation and puncture model of sepsis.	Tissue Barriers
34151629	High-Throughput Affinity Selection Mass Spectrometry Using SAMDI-MS to Identify Small-Molecule Binders of the Human Rhinovirus 3C Protease.	SLAS Discov
34151620	Efficiency Improvements and Discovery of New Substrates for a SARS-CoV-2 Main Protease FRET Assay.	SLAS Discov
34151460	Lewis and ABO histo-blood types and the secretor status of patients hospitalized with COVID-19 implicate a role for ABO antibodies in susceptibility to infection with SARS-CoV-2.	Transfusion
34151392	The renin-angiotensin system and specifically angiotensin-converting enzyme 2 as a potential therapeutic target in SARS-CoV-2 infections.	Naunyn Schmiedebergs Arch Pharmacol
34151306	Serological analysis reveals an imbalanced IgG subclass composition associated with COVID-19 disease severity.	Cell Rep Med
34151246	Cardiovascular and renal risk factors and complications associated with COVID-19.	CJC Open
34151202	Identification of Novel MicroRNAs Targeting SARS-CoV-2 through the Regulation of TMPRSS2/PI3K/AKT/PTEN Alignment in Lung Cancer: An in Silico Analysis.	ACS Pharmacol Transl Sci
34151035	Association between the nasopharyngeal microbiome and metabolome in patients with COVID-19.	Synth Syst Biotechnol
34150933	Production of the Receptor-binding Domain of the Viral Spike Proteins from 2003 and 2019 SARS CoVs and the Four Common Human Coronaviruses for Serologic Assays and Inhibitor Screening.	Bio Protoc
34150913	"Virtual screenings of the bioactive constituents of tea, prickly chaff, catechu, lemon, black pepper, and synthetic compounds with the main protease (Mpro) and human angiotensin-converting enzyme 2 (ACE 2) of SARS-CoV-2."	Futur J Pharm Sci
34150910	Analysis of Lymphocyte Subpopulations and Cytokines in COVID-19-Associated Pneumonia and Community-Acquired Pneumonia.	J Immunol Res
34150851	Hyperbaric Oxygen Ameliorates Bleomycin-Induced Pulmonary Fibrosis in Mice.	Front Mol Biosci
34150848	Sex-Related Overactivation of NLRP3 Inflammasome Increases Lethality of the Male COVID-19 Patients.	Front Mol Biosci
34150833	"Association of Vitamin D, Zinc and Selenium Related Genetic Variants With COVID-19 Disease Severity."	Front Nutr
34150793	Nanomedicine: A Diagnostic and Therapeutic Approach to COVID-19.	Front Med (Lausanne)
34150760	Targeting Bruton's Tyrosine Kinase in Inflammatory and Autoimmune Pathologies.	Front Cell Dev Biol
34150735	"Engineering of Chinese Hamster Ovary Cells With NDPK-A to Enhance DNA Nuclear Delivery Combined With EBNA1 Plasmid Maintenance Gives Improved Exogenous Transient Reporter, mAb and SARS-CoV-2 Spike Protein Expression."	Front Bioeng Biotechnol
34150487	Molecular basis of quercetin as a plausible common denominator of macrophage-cholesterol-fenofibrate dependent potential COVID-19 treatment axis.	Results Chem
34150352	Identification of Monocytes Associated with Severe COVID-19 in the PBMCs of Severely Infected patients Through Single-Cell Transcriptome Sequencing.	Engineering (Beijing)
34150335	Surface adhesion of viruses and bacteria: Defend only and/or vibrationally extinguish also?! A perspective.	MRS Adv
34150021	Expression of SARS-CoV-2 entry genes ACE2 and TMPRSS2 at single cell resolution in the peripartum decidua.	Am J Transl Res
34149990	Mechanisms of COVID-19 thrombosis in an inflammatory environment and new anticoagulant targets.	Am J Transl Res
34149740	Inefficient Placental Virus Replication and Absence of Neonatal Cell-Specific Immunity Upon Sars-CoV-2 Infection During Pregnancy.	Front Immunol
34149735	Epitope Classification and RBD Binding Properties of Neutralizing Antibodies Against SARS-CoV-2 Variants of Concern.	Front Immunol
34149717	Neutrophils and COVID-19: Active Participants and Rational Therapeutic Targets.	Front Immunol
34149714	A Bittersweet Response to Infection in Diabetes; Targeting Neutrophils to Modify Inflammation and Improve Host Immunity.	Front Immunol
34149697	Cytokine Overproduction and Immune System Dysregulation in alloHSCT and COVID-19 Patients.	Front Immunol
34149696	SARS-CoV-2 Spike Protein Suppresses ACE2 and Type I Interferon Expression in Primary Cells From Macaque Lung Bronchoalveolar Lavage.	Front Immunol
34149692	Immunothrombosis in Acute Respiratory Dysfunction of COVID-19.	Front Immunol
34149667	SARS-CoV-2-Host Chimeric RNA-Sequencing Reads Do Not Necessarily Arise From Virus Integration Into the Host DNA.	Front Microbiol
34149429	Discovery of New Potent anti-MERS CoV Fusion Inhibitors.	Front Pharmacol
34149397	"COVID-19, Neuropathology, and Aging: SARS-CoV-2 Neurological Infection, Mechanism, and Associated Complications."	Front Aging Neurosci
34149298	The viability of SARS-CoV-2 on solid surfaces.	Curr Opin Colloid Interface Sci
34149296	Surfactants - Compounds for inactivation of SARS-CoV-2 and other enveloped viruses.	Curr Opin Colloid Interface Sci
34149065	COVID-19: In silico identification of potent alpha-ketoamide inhibitors targeting the main protease of the SARS-CoV-2.	J Mol Struct
34149046	Editorial: Revised World Health Organization (WHO) Terminology for Variants of Concern and Variants of Interest of SARS-CoV-2.	Med Sci Monit
34148541	"Discovery of a ""Cocktail"" of Potential SARS-COV-2 Main Protease Inhibitors through Virtual Screening of Known Chemical Components of Vitex negundo L. (""Lagundi"")."	Med Chem
34148292	Fragment-based in silico design of SARS-CoV-2 main protease inhibitors.	Chem Biol Drug Des
34147856	Rational optimization of a human neutralizing antibody of SARS-CoV-2.	Comput Biol Med
34147855	Entry-inhibitory role of catechins against SARS-CoV-2 and its UK variant.	Comput Biol Med
34147744	Discovery and optimization of 2-((1H-indol-3-yl)thio)-N-benzyl-acetamides as novel SARS-CoV-2 RdRp inhibitors.	Eur J Med Chem
34147667	Detection of SARS-CoV-2 variants requires urgent global coordination.	Int J Infect Dis
34147651	Global variation in SARS-CoV-2 proteome and its implication in pre-lockdown emergence and dissemination of 5 dominant SARS-CoV-2 clades.	Infect Genet Evol
34147139	Identification of novel bat coronaviruses sheds light on the evolutionary origins of SARS-CoV-2 and related viruses.	Cell
34147082	Evaluation of expression of VDR-associated lncRNAs in COVID-19 patients.	BMC Infect Dis
34146958	SARS-CoV2 infection impairs the metabolism and redox function of cellular glutathione.	Redox Biol
34146731	Recent progress on the mutations of SARS-CoV-2 spike protein and suggestions for prevention and controlling of the pandemic.	Infect Genet Evol
34146663	In-silico analysis of Covid-19 genome sequences of Indian origin: Impact of mutations in identification of SARS-Co-V2.	Mol Cell Probes
34146659	TRIM28 regulates SARS-CoV-2 cell entry by targeting ACE2.	Cell Signal
34146538	Peptides of H. sapiens and P. falciparum that are predicted to bind strongly to HLA-A*24:02 and homologous to a SARS-CoV-2 peptide.	Acta Trop
34146478	Memory B cells targeting SARS-CoV-2 spike protein and their dependence on CD4(+) T cell help.	Cell Rep
34145723	From Cancer to COVID-19: A Perspective on Targeting Heparan Sulfate-Protein Interactions.	Chem Rec
34145702	COVID-19 and celiac disease: A pathogenetic hypothesis for a celiac outbreak.	Int J Clin Pract
34145550	"COVID-19: Structural Considerations for Virus Pathogenesis, Therapeutic Strategies and Vaccine Design in the Novel SARS-CoV-2 Variants Era."	Mol Biotechnol
34145459	Large-scale identification of T cell epitopes derived from SARS-CoV-2 for the development of peptide vaccines against COVID-19.	J Infect Dis
34145263	Immunological imprinting of the antibody response in COVID-19 patients.	Nat Commun
34145211	A Review of Neurological Involvement in Patients with SARS-CoV-2 Infection.	Med Sci Monit
34145066	Activation of mTORC1 at late endosomes misdirects T cell fate decision in older individuals.	Sci Immunol
34144455	Identification of oligopeptides from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) non structural protein 8 (NSP8) and their similarities with type 1 angiotensin II receptor key sites.	Biomed Pharmacother
34144392	Topical hypochlorous acid (HOCl) blocks inflammatory gene expression and tumorigenic progression in UV-exposed SKH-1 high risk mouse skin.	Redox Biol
34144328	Autoantibodies against ACE2 and angiotensin type-1 receptors increase severity of COVID-19.	J Autoimmun
34144270	A computational approach for rational discovery of inhibitors for non-structural protein 1 of SARS-CoV-2.	Comput Biol Med
34144250	"Spontaneous HIT syndrome: Knee replacement, infection, and parallels with vaccine-induced immune thrombotic thrombocytopenia."	Thromb Res
34144245	Could treatment with botulinum toxin protect against subsequent infection with COVID-19?	J Stomatol Oral Maxillofac Surg
34143953	Coupling of N7-methyltransferase and 3'-5' exoribonuclease with SARS-CoV-2 polymerase reveals mechanisms for capping and proofreading.	Cell
34143766	The landscape of antibody binding in SARS-CoV-2 infection.	PLoS Biol
34143756	COVID-19 and RA share an SPP1 myeloid pathway that drives PD-L1+ neutrophils and CD14+ monocytes.	JCI Insight
34143754	Duration of post-COVID-19 symptoms is associated with sustained SARS-CoV-2-specific immune responses.	JCI Insight
34143752	SARS-CoV-2-Specific Antibody and T Cell Response Kinetics According to Symptom Severity.	Am J Trop Med Hyg
34143707	The design and discovery of phospholipase A2 inhibitors for the treatment of inflammatory diseases.	Expert Opin Drug Discov
34143202	Understanding structural malleability of the SARS-CoV-2 proteins and relation to the comorbidities.	Brief Bioinform
34142945	"Renal manifestations, incidence, pathogenesis and implications on prognosis and mortality in COVID-19 patients: A review of current evidence and the potential for future directions."	Clin Nephrol
34142714	The angiotensin converting enzyme 2 (ACE2) system in the brain: possible involvement in Neuro-Covid.	Histol Histopathol
34142560	Pharmacogenomic landscape of COVID-19 therapies from Indian population genomes.	Pharmacogenomics
34142533	[Development of antiviral drugs based on inhibitors of the SARS-COV-2 main protease].	Biomed Khim
34142531	[Peptide inhibitors of the interaction of the SARS-CoV-2 receptor-binding domain with the ACE2 cell receptor].	Biomed Khim
34142459	In Silico Characterization of Masitinib Interaction with SARS-CoV-2 Main Protease.	ChemMedChem
34142428	Inclusion of cGAMP within virus-like particle vaccines enhances their immunogenicity.	EMBO Rep
34142358	The role of estradiol in the immune response against COVID-19.	Hormones (Athens)
34141776	Nonalcoholic fatty liver disease and COVID-19: An epidemic that begets pandemic.	World J Clin Cases
34141737	COVID-19 and the digestive system: A comprehensive review.	World J Clin Cases
34141447	Structural phylogenetic analysis reveals lineage-specific RNA repetitive structural motifs in all coronaviruses and associated variations in SARS-CoV-2.	Virus Evol
34141432	Genetic risk for severe COVID-19 correlates with lower inflammatory marker levels in a SARS-CoV-2-negative cohort.	Clin Transl Immunology
34140855	Purification and characterization of the receptor-binding domain of SARS-CoV-2 spike protein from Escherichia coli.	Eng Life Sci
34140674	Cell-mimicking nanodecoys neutralize SARS-CoV-2 and mitigate lung injury in a non-human primate model of COVID-19.	Nat Nanotechnol
34140652	Role of DAMPs in respiratory virus-induced acute respiratory distress syndrome-with a preliminary reference to SARS-CoV-2 pneumonia.	Genes Immun
34140611	"ELV-N32 and RvD6 isomer decrease pro-inflammatory cytokines, senescence programming, ACE2 and SARS-CoV-2-spike protein RBD binding in injured cornea."	Sci Rep
34140558	An ACE2 Triple Decoy that neutralizes SARS-CoV-2 shows enhanced affinity for virus variants.	Sci Rep
34140522	A cautionary perspective regarding the isolation and serial propagation of SARS-CoV-2 in Vero cells.	NPJ Vaccines
34140350	Characterization of a new SARS-CoV-2 variant that emerged in Brazil.	Proc Natl Acad Sci U S A
34140294	"Rapid, simplified whole blood-based multiparameter assay to quantify and phenotype SARS-CoV-2 specific T cells."	Eur Respir J
34140221	Immune response to COVID-19 in older adults.	J Heart Lung Transplant
34139879	Tergitol-15-S-9 inactivates SARS-CoV-2 and boosts immunoassay signals.	Biotechniques
34139599	Diseased lungs may hinder COVID-19 development: A possible reason for the low prevalence of COPD in COVID-19 patients.	Med Hypotheses
34139598	"Does serotonin deficiency lead to anosmia, ageusia, dysfunctional chemesthesis and increased severity of illness in COVID-19?"	Med Hypotheses
34139362	Proteome Profiling of Recombinant DNase Therapy in Reducing NETs and Aiding Recovery in COVID-19 Patients.	Mol Cell Proteomics
34139325	Development of potent and selective Cathepsin C inhibitors free of aortic binding liability by application of a conformational restriction strategy.	Bioorg Med Chem Lett
34139177	Binding and molecular basis of the bat coronavirus RaTG13 virus to ACE2 in humans and other species.	Cell
34139176	An infectivity-enhancing site on the SARS-CoV-2 spike protein targeted by antibodies.	Cell
34139154	A time-resolved proteomic and prognostic map of COVID-19.	Cell Syst
34139040	Melatonin and other indoles show antiviral activities against swine coronaviruses in vitro at pharmacological concentrations.	J Pineal Res
34138976	Manipulation of the unfolded protein response: A pharmacological strategy against coronavirus infection.	PLoS Pathog
34138966	Phenolic compounds disrupt spike-mediated receptor-binding and entry of SARS-CoV-2 pseudo-virions.	PLoS One
34138559	Dynamic Profiling of Binding and Allosteric Propensities of the SARS-CoV-2 Spike Protein with Different Classes of Antibodies: Mutational and Perturbation-Based Scanning Reveals the Allosteric Duality of Functionally Adaptable Hotspots.	J Chem Theory Comput
34138483	Soluble angiotensin-converting enzyme 2 is transiently elevated in COVID-19 and correlates with specific inflammatory and endothelial markers.	J Med Virol
34138474	High-resolution melting curve FRET-PCR rapidly identifies SARS-CoV-2 mutations.	J Med Virol
34137759	Quantitative analysis of ACE2 binding to coronavirus spike proteins: SARS-CoV-2 vs. SARS-CoV and RaTG13.	Phys Chem Chem Phys
34137751	Nanocapsule designs for antimicrobial resistance.	Nanoscale
34137703	SARS-CoV-2 variants and the so-called resistance to vaccines.	Medicina (B Aires)
34137279	Potential Dexamethasone-Direct Oral Anticoagulant Drug Interaction: Is This a Concern in COVID?	Ann Pharmacother
34137203	Pulmonary ACE2 expression in neonatal and adult rats.	FEBS Open Bio
34137202	Optimization of a modeling platform to predict oncogenes from genome-scale metabolic networks of non-small-cell lung cancers.	FEBS Open Bio
34137173	Single-cell RNA sequencing identify SDCBP in ACE2-positive bronchial epithelial cells negatively correlates with COVID-19 severity.	J Cell Mol Med
34136764	COVID-19 and neurological symptoms: is the SARS-CoV-2 virus neurotropic?	Cond Med
34136758	Discovery of TMPRSS2 Inhibitors from Virtual Screening as a Potential Treatment of COVID-19.	ACS Pharmacol Transl Sci
34136757	A Blueprint for High Affinity SARS-CoV-2 Mpro Inhibitors from Activity-Based Compound Library Screening Guided by Analysis of Protein Dynamics.	ACS Pharmacol Transl Sci
34136730	Antibody Responses to SARS-CoV-2 mRNA Vaccines Are Detectable in Saliva.	Pathog Immun
34136572	Bioinformatic HLA Studies in the Context of SARS-CoV-2 Pandemic and Review on Association of HLA Alleles with Preexisting Medical Conditions.	Biomed Res Int
34136537	Association of ACEi/ARB Use and Clinical Outcomes of COVID-19 Patients With Hypertension.	Front Cardiovasc Med
34136533	Potent Molecular Feature-based Neutralizing Monoclonal Antibodies as Promising Therapeutics Against SARS-CoV-2 Infection.	Front Mol Biosci
34136511	Bioactive Molecules of Tea as Potential Inhibitors for RNA-Dependent RNA Polymerase of SARS-CoV-2.	Front Med (Lausanne)
34136484	SARS-CoV-2 Causes Acute Kidney Injury by Directly Infecting Renal Tubules.	Front Cell Dev Biol
34136461	Proliferation of SARS-CoV-2 B.1.1.7 Variant in Pakistan-A Short Surveillance Account.	Front Public Health
34136131	Interactive SARS-CoV-2 mutation timemaps.	F1000Res
34135895	Transcriptomic Signature Differences Between SARS-CoV-2 and Influenza Virus Infected Patients.	Front Immunol
34135558	Insight into molecular mechanisms underlying hepatic dysfunction in severe COVID-19 patients using systems biology.	World J Gastroenterol
34135479	A cohort autopsy study defines COVID-19 systemic pathogenesis.	Cell Res
34135340	Multivalency transforms SARS-CoV-2 antibodies into ultrapotent neutralizers.	Nat Commun
34135107	Encephalopathies Associated With Severe COVID-19 Present Neurovascular Unit Alterations Without Evidence for Strong Neuroinflammation.	Neurol Neuroimmunol Neuroinflamm
34135013	Association Between Glucagon-Like Peptide 1 Receptor Agonist and Sodium-Glucose Cotransporter 2 Inhibitor Use and COVID-19 Outcomes.	Diabetes Care
34134991	Targeting highly pathogenic coronavirus-induced apoptosis reduces viral pathogenesis and disease severity.	Sci Adv
34134983	Structural basis of the activation of the CC chemokine receptor 5 by a chemokine agonist.	Sci Adv
34134920	Vasoactive Peptides: Their Role in COVID-19 Pathogenesis and Potential Use as Biomarkers and Therapeutic Targets.	Arch Med Res
34134134	Humoral and cellular immune responses against SARS-CoV-2 variants and human coronaviruses after single BNT162b2 vaccination.	Clin Infect Dis
34134034	Rapid and simultaneous identification of three mutations by the Novaplex SARS-CoV-2 variants I assay kit.	J Clin Virol
34133982	Synthetic modified messenger RNA for therapeutic applications.	Acta Biomater
34133950	A single dose of the SARS-CoV-2 vaccine BNT162b2 elicits Fc-mediated antibody effector functions and T cell responses.	Cell Host Microbe
34133899	Contribution of SARS-CoV-2 Accessory Proteins to Viral Pathogenicity in K18 Human ACE2 Transgenic Mice.	J Virol
34133897	SARS-CoV-2 NSP12 Protein Is Not an Interferon-beta Antagonist.	J Virol
34133435	Metagenomic analysis of fecal and tissue samples from 18 endemic bat species in Switzerland revealed a diverse virus composition including potentially zoonotic viruses.	PLoS One
34133415	Human IgG and IgA responses to COVID-19 mRNA vaccines.	PLoS One
34132301	"Molecular insights into the binding variance of the SARS-CoV-2 spike with human, cat and dog ACE2 proteins."	Phys Chem Chem Phys
34131597	A bioinformatics approach for identifying potential molecular mechanisms and key genes involved in COVID-19 associated cardiac remodeling.	Gene Rep
34131596	SARS-CoV-2 mutations altering regulatory properties: Deciphering host's and virus's perspectives.	Gene Rep
34131589	Gamma irradiation-mediated inactivation of enveloped viruses with conservation of genome integrity: Potential application for SARS-CoV-2 inactivated vaccine development.	Open Life Sci
34131556	Molecular docking and dynamics studies of curcumin with COVID-19 proteins.	Netw Model Anal Health Inform Bioinform
34131467	COVID-19 and the liver: What do we know so far?	World J Hepatol
34131407	COVID-19 one year later: a retrospect of CRISPR-Cas system in combating COVID-19.	Int J Biol Sci
34131396	Downregulation of ACE2 expression by SARS-CoV-2 worsens the prognosis of KIRC and KIRP patients via metabolism and immunoregulation.	Int J Biol Sci
34131372	Secretome of Multipotent Mesenchymal Stromal Cells as a Promising Treatment and for Rehabilitation of Patients with the Novel Coronaviral Infection.	Her Russ Acad Sci
34131210	Attractive and repulsive residue fragments at the interface of SARS-CoV-2 and hACE2.	Sci Rep
34131209	Design and in silico validation of polymerase chain reaction primers to detect severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).	Sci Rep
34131192	Cytokine signatures of end organ injury in COVID-19.	Sci Rep
34131072	Mn(2+) coordinates Cap-0-RNA to align substrates for efficient 2'-O-methyl transfer by SARS-CoV-2 nsp16.	Sci Signal
34131024	SARS-CoV-2 vaccines elicit durable immune responses in infant rhesus macaques.	Sci Immunol
34131023	Impaired humoral immunity to SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients and dialysis patients.	Sci Immunol
34130467	Computational screening of dual inhibitors from FDA approved antiviral drugs on SARS-CoV-2 spike protein and the main protease using molecular docking approach.	Acta Virol
34130463	Severe acute respiratory syndrome coronavirus 2 invasion in the central nervous system: a host-virus deadlock.	Acta Virol
34130462	Relational interaction between T-lymphocytes and SARS-CoV-2: A review.	Acta Virol
34130375	Blocking the interactions between human ACE2 and coronavirus spike glycoprotein by selected drugs: a computational perspective.	Environ Anal Health Toxicol
34130121	COVID-19 versus SARS: A comparative review.	J Infect Public Health
34130119	The immunological response among COVID-19 patients with acute respiratory distress syndrome.	J Infect Public Health
34130040	The impact of high-resolution structural data on stemming the COVID-19 pandemic.	Curr Opin Virol
34129909	"The role of sexual dimorphism in susceptibility to SARS-CoV-2 infection, disease severity, and mortality: facts, controversies and future perspectives."	Microbes Infect
34129317	Screening a Library of FDA-Approved and Bioactive Compounds for Antiviral Activity against SARS-CoV-2.	ACS Infect Dis
34128960	Dynamic innate immune response determines susceptibility to SARS-CoV-2 infection and early replication kinetics.	J Exp Med
34128959	Multi-omic profiling reveals widespread dysregulation of innate immunity and hematopoiesis in COVID-19.	J Exp Med
34128696	Rapid Increase of SARS-CoV-2 Variant B.1.1.7 Detected in Sewage Samples from England between October 2020 and January 2021.	mSystems
34128459	Antiviral and Immunological Activity of Zinc and Possible Role in COVID-19.	Br J Nutr
34128351	p-cymene impairs SARS-CoV-2 and Influenza A (H1N1) viral replication: In silico predicted interaction with SARS-CoV-2 nucleocapsid protein and H1N1 nucleoprotein.	Pharmacol Res Perspect
34128218	Thromboinflammation in coronavirus disease 2019: The clot thickens.	Br J Pharmacol
34127958	"CD177, a specific marker of neutrophil activation, is associated with coronavirus disease 2019 severity and death."	iScience
34127926	Deconvoluting the T Cell Response to SARS-CoV-2: Specificity Versus Chance and Cognate Cross-Reactivity.	Front Immunol
34127904	Network-Based Transcriptomic Analysis Identifies the Genetic Effect of COVID-19 to Chronic Kidney Disease Patients: A Bioinformatics Approach.	Saudi J Biol Sci
34127868	Dynamic properties of SARS-CoV and SARS-CoV-2 RNA-dependent RNA polymerases studied by molecular dynamics simulations.	Chem Phys Lett
34127807	The mechanisms of action of Ivermectin against SARS-CoV-2: An evidence-based clinical review article.	J Antibiot (Tokyo)
34127709	Glycan reactive anti-HIV-1 antibodies bind the SARS-CoV-2 spike protein but do not block viral entry.	Sci Rep
34127650	Potential transmission chains of variant B.1.1.7 and co-mutations of SARS-CoV-2.	Cell Discov
34127534	Genes with 5' terminal oligopyrimidine tracts preferentially escape global suppression of translation by the SARS-CoV-2 Nsp1 protein.	RNA
34127431	AI-guided discovery of the invariant host response to viral pandemics.	EBioMedicine
34127062	Antiviral effects of ergosterol peroxide in a pig model of porcine deltacoronavirus (PDCoV) infection involves modulation of apoptosis and tight junction in the small intestine.	Vet Res
34127050	Landscape and selection of vaccine epitopes in SARS-CoV-2.	Genome Med
34126900	COVID-19 and diabetes mellitus: potential metabolic associations.	Curr Top Med Chem
34126880	Natural Substances in the Fight of SARS-CoV-2: A Critical Evaluation Resulting from the Cross-Fertilization of Molecular Modeling Data with the Pharmacological Aspects.	Curr Med Chem
34126817	Infectious bronchitis virus in Australia: a model of coronavirus evolution - a review.	Avian Pathol
34126625	Naturally enhanced neutralizing breadth against SARS-CoV-2 one year after infection.	Nature
34126387	"Review: SARS-CoV-2 infection in farmed minks - an overview of current knowledge on occurrence, disease and epidemiology."	Animal
34126316	Therapeutic use of specific tumour necrosis factor inhibitors in inflammatory diseases including COVID-19.	Biomed Pharmacother
34126315	Antiviral activities of flavonoids.	Biomed Pharmacother
34126164	Ciclesonide activates glucocorticoid signaling in neonatal rat lung but does not trigger adverse effects in the cortex and cerebellum.	Neurobiol Dis
34126110	Adaptive lymphocyte profile analysis discriminates mild and severe forms of COVID-19 after solid organ transplantation.	Kidney Int
34126084	Understanding the Role of Blood Vessels in the Neurologic Manifestations of Coronavirus Disease 2019 (COVID-19).	Am J Pathol
34126079	Renin-angiotensin-aldosterone system inhibitors and SARS-CoV-2 infection: an analysis from the veteran's affairs healthcare system.	Am Heart J
34126053	"Discontinuation versus continuation of renin-angiotensin-system inhibitors in COVID-19 (ACEI-COVID): a prospective, parallel group, randomised, controlled, open-label trial."	Lancet Respir Med
34126010	Chemical Synthesis of the Antiviral Nucleotide Analogue ddhCTP.	J Org Chem
34125824	"SARS-CoV-2: basic concepts, origin and treatment advances."	Gac Med Mex
34125658	Rapidly emerging SARS-CoV-2 B.1.1.7 sub-lineage in the United States of America with spike protein D178H and membrane protein V70L mutations.	Emerg Microbes Infect
34125594	Key Metabolic Enzymes Involved in Remdesivir Activation in Human Lung Cells.	Antimicrob Agents Chemother
34125495	Impact of age and gender on lymphocyte subset counts in patients with COVID-19.	Cytometry A
34125455	Molecular biology of the SARs-CoV-2 spike protein: A review of current knowledge.	J Med Virol
34125095	Achieving Efficient Fragment Screening at XChem Facility at Diamond Light Source.	J Vis Exp
34124934	Understanding individual SARS-CoV-2 proteins for targeted drug development against COVID-19.	Mol Cell Biol
34124906	Dynamic Cooperativity of Ligand-Residue Interactions Evaluated with the Fragment Molecular Orbital Method.	J Phys Chem B
34124899	Dynamic Profiling of beta-Coronavirus 3CL M(pro) Protease Ligand-Binding Sites.	J Chem Inf Model
34124710	Blood group type A secretors are associated with a higher risk of COVID-19 cardiovascular disease complications.	EJHaem
34124701	Young infants exhibit robust functional antibody responses and restrained IFN-gamma production to SARS-CoV-2.	Cell Rep Med
34124695	Protein purification and crystallization of HLA-A *02:01 in complex with SARS-CoV-2 peptides.	STAR Protoc
34124612	A novel mouse AAV6 hACE2 transduction model of wild-type SARS-CoV-2 infection studied using synDNA immunogens.	iScience
34124322	Are mesenchymal stem cells able to manage cytokine storm in COVID-19 patients? A review of recent studies.	Regen Ther
34124300	Computational Analysis and Phylogenetic Clustering of SARS-CoV-2 Genomes.	Bio Protoc
34124259	Active Learning and the Potential of Neural Networks Accelerate Molecular Screening for the Design of a New Molecule Effective against SARS-CoV-2.	Biomed Res Int
34124207	The Notch Pathway: A Link Between COVID-19 Pathophysiology and Its Cardiovascular Complications.	Front Cardiovasc Med
34124187	COVID-19 in Relation to Hyperglycemia and Diabetes Mellitus.	Front Cardiovasc Med
34124140	Appraisals of the Bangladeshi Medicinal Plant Calotropis gigantea Used by Folk Medicine Practitioners in the Management of COVID-19: A Biochemical and Computational Approach.	Front Mol Biosci
34123972	Coronavirus Disease 2019 in Children.	Front Pediatr
34123871	Metabolic Implications of Oxidative Stress and Inflammatory Process in SARS-CoV-2 Pathogenesis: Therapeutic Potential of Natural Antioxidants.	Front Cell Infect Microbiol
34123401	L-arginine as a potential GLP-1-mediated immunomodulator of Th17-related cytokines in people with obesity and asthma.	Obes Sci Pract
34123321	Prediction and mitigation of mutation threats to COVID-19 vaccines and antibody therapies.	Chem Sci
34123223	A serological aptamer-assisted proximity ligation assay for COVID-19 diagnosis and seeking neutralizing aptamers.	Chem Sci
34123218	Unveiling the molecular mechanism of SARS-CoV-2 main protease inhibition from 137 crystal structures using algebraic topology and deep learning.	Chem Sci
34122779	Extracellular Vesicle Capture by AnTibody of CHoice and Enzymatic Release (EV-CATCHER): A customizable purification assay designed for small-RNA biomarker identification and evaluation of circulating small-EVs.	J Extracell Vesicles
34122778	Early prediction of COVID-19 severity using extracellular vesicle COPB2.	J Extracell Vesicles
34122515	Transcriptional Start Site Coverage Analysis in Plasma Cell-Free DNA Reveals Disease Severity and Tissue Specificity of COVID-19 Patients.	Front Genet
34122423	Impaired Cytotoxic Response in PBMCs From Patients With COVID-19 Admitted to the ICU: Biomarkers to Predict Disease Severity.	Front Immunol
34122416	Potent and Persistent Antibody Response in COVID-19 Recovered Patients.	Front Immunol
34122413	"Comprehensive Comparison of RNA-Seq Data of SARS-CoV-2, SARS-CoV and MERS-CoV Infections: Alternative Entry Routes and Innate Immune Responses."	Front Immunol
34122407	Macrophages and Dendritic Cells Are Not the Major Source of Pro-Inflammatory Cytokines Upon SARS-CoV-2 Infection.	Front Immunol
34122369	Recurrent Dissemination of SARS-CoV-2 Through the Uruguayan-Brazilian Border.	Front Microbiol
34122366	Respiratory Co-Infections: Modulators of SARS-CoV-2 Patients' Clinical Sub-Phenotype.	Front Microbiol
34122351	Effect of COVID-19 on Male Reproductive System - A Systematic Review.	Front Endocrinol (Lausanne)
34122129	Persistently Increased Systemic ACE2 Activity Is Associated With an Increased Inflammatory Response in Smokers With COVID-19.	Front Physiol
34122126	"Chronic E-Cigarette Aerosol Inhalation Alters the Immune State of the Lungs and Increases ACE2 Expression, Raising Concern for Altered Response and Susceptibility to SARS-CoV-2."	Front Physiol
34122058	Anti-SARS-CoV-2 Natural Products as Potentially Therapeutic Agents.	Front Pharmacol
34121921	"The supramolecularly complexes of calix[4]arene derivatives toward favipiravir antiviral drug (used to treatment of COVID-19): a DFT study on the geometry optimization, electronic structure and infrared spectroscopy of adsorption and sensing."	J Incl Phenom Macrocycl Chem
34121839	Bioinformatics Analysis Unveils Certain Mutations Implicated in Spike Structure Damage and Ligand-Binding Site of Severe Acute Respiratory Syndrome Coronavirus 2.	Bioinform Biol Insights
34121824	"Screening of FDA-approved compound library identifies potential small-molecule inhibitors of SARS-CoV-2 non-structural proteins NSP1, NSP4, NSP6 and NSP13: molecular modeling and molecular dynamics studies."	J Proteins Proteom
34121768	Comparative analysis of non structural protein 1 of SARS-CoV2 with SARS-CoV1 and MERS-CoV: An in silico study.	J Mol Struct
34121618	Elucidation of the inhibitory activity of plant-derived SARS-CoV inhibitors and their potential as SARS-CoV-2 inhibitors.	J Biomol Struct Dyn
34121561	Statistical optimization of bile salt deployed nanovesicles as a potential platform for oral delivery of piperine: accentuated antiviral and anti-inflammatory activity in MERS-CoV challenged mice.	Drug Deliv
34121407	Revealing the Structural Plasticity of SARS-CoV-2 nsp7 and nsp8 Using Structural Proteomics.	J Am Soc Mass Spectrom
34121359	SARS-CoV-2 and hypertension.	Physiol Rep
34121337	Immune-viral dynamics modeling for SARS-CoV-2 drug development.	Clin Transl Sci
34121111	Co-mutation modules capture the evolution and transmission patterns of SARS-CoV-2.	Brief Bioinform
34120892	Phenotypes and Functions of SARS-CoV-2-Reactive T Cells.	Mol Cells
34120861	SARS-CoV-2 and Multisystem Inflammatory Syndrome In Children (MIS-C).	Curr Probl Pediatr Adolesc Health Care
34120849	Gastrointestinal manifestations of human immunodeficiency virus and coronavirus disease 2019: Understanding the intersecting regions between the two epidemics.	Arab J Gastroenterol
34120764	"Immunogenic potential of DNA vaccine candidate, ZyCoV-D against SARS-CoV-2 in animal models."	Vaccine
34120640	"Drosophila, a powerful model to study virus-host interactions and pathogenicity in the fight against SARS-CoV-2."	Cell Biosci
34120579	"Prior aerosol infection with lineage A SARS-CoV-2 variant protects hamsters from disease, but not reinfection with B.1.351 SARS-CoV-2 variant."	Emerg Microbes Infect
34120577	Potent RBD-specific neutralizing rabbit monoclonal antibodies recognize emerging SARS-CoV-2 variants elicited by DNA prime-protein boost vaccination.	Emerg Microbes Infect
34120531	COVID-19 vaccine-induced immune thrombotic thrombocytopenia: A review of the potential mechanisms and proposed management.	Sci Prog
34119951	"Examining the interactions scorpion venom peptides (HP1090, Meucin-13, and Meucin-18) with the receptor binding domain of the coronavirus spike protein to design a mutated therapeutic peptide."	J Mol Graph Model
34119855	Interleukin-6 as potential mediator of long-term neuropsychiatric symptoms of COVID-19.	Psychoneuroendocrinology
34119848	Design of a novel multiple epitope-based vaccine: An immunoinformatics approach to combat SARS-CoV-2 strains.	J Infect Public Health
34119846	COVID-19 infection and the kidneys: Learning the lesson.	J Infect Public Health
34119826	Therapeutic effect of CT-P59 against SARS-CoV-2 South African variant.	Biochem Biophys Res Commun
34119708	Is haem the real target of COVID-19?	Photodiagnosis Photodyn Ther
34119626	Conformational dynamics of 13 amino acids long NSP11 of SARS-CoV-2 under membrane mimetics and different solvent conditions.	Microb Pathog
34119448	Perilla (Perilla frutescens) leaf extract inhibits SARS-CoV-2 via direct virus inactivation.	Biomed J
34118974	Severe COVID-19 in Alzheimer's disease: APOE4's fault again?	Alzheimers Res Ther
34118740	"Large variations in disease severity, death and ICU admission of 2993 patients infected with SARS-CoV-2: The potential impact of genetic vulnerability."	J Infect Public Health
34118735	New perspective towards therapeutic regimen against SARS-CoV-2 infection.	J Infect Public Health
34118724	"Improved SARS-CoV-2 M(pro) inhibitors based on feline antiviral drug GC376: Structural enhancements, increased solubility, and micellar studies."	Eur J Med Chem
34118455	Autoimmunity and COVID-19 - The microbiotal connection.	Autoimmun Rev
34118414	7-Ketocholesterol: Effects on viral infections and hypothetical contribution in COVID-19.	J Steroid Biochem Mol Biol
34118406	"Pregnancy and viral infections: Mechanisms of fetal damage, diagnosis and prevention of neonatal adverse outcomes from cytomegalovirus to SARS-CoV-2 and Zika virus."	Biochim Biophys Acta Mol Basis Dis
34118402	Seroprevalence and SARS-CoV-2 cross-reactivity of endemic coronavirus OC43 and 229E antibodies in Finnish children and adults.	Clin Immunol
34118359	"Positive selection as a key player for SARS-CoV-2 pathogenicity: Insights into ORF1ab, S and E genes."	Virus Res
34118347	Recent advances in potential drug therapies combating COVID-19 and related coronaviruses-A perspective.	Food Chem Toxicol
34118307	Guillain Barre syndrome and myelitis associated with SARS-CoV-2 infection.	Neurosci Lett
34118289	Molecular mechanism of anti-SARS-CoV2 activity of Ashwagandha-derived withanolides.	Int J Biol Macromol
34118236	Decoding molnupiravir-induced mutagenesis in SARS-CoV-2.	J Biol Chem
34118193	Global analysis of protein-RNA interactions in SARS-CoV-2-infected cells reveals key regulators of infection.	Mol Cell
34118117	"The lethal internal face of the coronaviruses: Kidney tropism of the SARS, MERS, and COVID19 viruses."	IUBMB Life
34117994	"Emerging Infection, Vaccination, and Guillain-Barre Syndrome: A Review."	Neurol Ther
34117992	Potential phytochemical inhibitors of SARS-CoV-2 helicase Nsp13: a molecular docking and dynamic simulation study.	Mol Divers
34117968	Mitochondrial DNA Heteroplasmy as an Informational Reservoir Dynamically Linked to Metabolic and Immunological Processes Associated with COVID-19 Neurological Disorders.	Cell Mol Neurobiol
34117887	COVID-19 related cardiac complications - from clinical evidences to basic mechanisms. Opinion paper of the ESC Working Group on Cellular Biology of the Heart.	Cardiovasc Res
34117878	"The SARS-CoV-2 mRNA vaccine breakthrough infection phenotype includes significant symptoms, live virus shedding, and viral genetic diversity."	Clin Infect Dis
34117873	COVID-19 mRNA vaccination generates greater IgG levels in women compared to men.	J Infect Dis
34117484	Natural killer cells in antiviral immunity.	Nat Rev Immunol
34117370	Yeast display of MHC-II enables rapid identification of peptide ligands from protein antigens (RIPPA).	Cell Mol Immunol
34117354	Structural basis of coronavirus E protein interactions with human PALS1 PDZ domain.	Commun Biol
34117310	The major genetic risk factor for severe COVID-19 does not show any association among South Asian populations.	Sci Rep
34117252	SARS-CoV-2 RBD trimer protein adjuvanted with Alum-3M-052 protects from SARS-CoV-2 infection and immune pathology in the lung.	Nat Commun
34117216	Molecular mechanism of interaction between SARS-CoV-2 and host cells and interventional therapy.	Signal Transduct Target Ther
34117195	Gastrointestinal Perspective of COVID-19 in Children - an Updated Review.	J Pediatr Gastroenterol Nutr
34117117	Implications of mRNA-based SARS-CoV-2 vaccination for cancer patients.	J Immunother Cancer
34117116	COVID-19 in immunocompromised populations: implications for prognosis and repurposing of immunotherapies.	J Immunother Cancer
34116863	Antigen presentation in SARS-CoV-2 infection: the role of class I HLA and ERAP polymorphisms.	Hum Immunol
34116667	A blood RNA transcriptome signature for COVID-19.	BMC Med Genomics
34116654	C-type lectins and extracellular vesicles in virus-induced NETosis.	J Biomed Sci
34116393	Magnesium treatment on methylation changes of transmembrane serine protease 2 (TMPRSS2).	Nutrition
34116362	Interaction of selected terpenoids with two SARS-CoV-2 key therapeutic targets: An in silico study through molecular docking and dynamics simulations.	Comput Biol Med
34116356	Analysis of the molecular mechanism of SARS-CoV-2 antibodies.	Biochem Biophys Res Commun
34116286	Variant-genetic and transcript-expression analysis showed a role for the chemokine-receptor CCR5 in COVID-19 severity.	Int Immunopharmacol
34116123	Can We AlphaFold Our Way Out of the Next Pandemic?	J Mol Biol
34115965	"Pan-ancestry exome-wide association analyses of COVID-19 outcomes in 586,157 individuals."	Am J Hum Genet
34115964	Metformin inhibition of mitochondrial ATP and DNA synthesis abrogates NLRP3 inflammasome activation and pulmonary inflammation.	Immunity
34115949	Lack of Effects of the Genetic Polymorphisms of Interleukin-10 in Clinical Outcomes of COVID-19.	Viral Immunol
34115881	Diabetes and susceptibility to infections: Implication for COVID-19.	Immunology
34115763	Ayurveda botanicals in COVID-19 management: An in silico multi-target approach.	PLoS One
34115612	The key role of the level of ACE2 gene expression in SARS-CoV-2 infection.	Aging (Albany NY)
34115524	Recent Trends in Multipotent Human Mesenchymal Stem/Stromal Cells: Learning from History and Advancing Clinical Applications.	OMICS
34115179	[Impact of SARS-CoV-2/COVID-19 on the placenta].	Pathologe
34114951	Alpha-1 adrenergic receptor antagonists to prevent hyperinflammation and death from lower respiratory tract infection.	Elife
34114940	The pivotal roles of the host immune response in the fine-tuning the infection and the development of the vaccines for SARS-CoV-2.	Hum Vaccin Immunother
34114829	Targeting SARS-CoV-2 Receptor Binding Domain with Stapled Peptides: An In Silico Study.	J Phys Chem B
34114614	Progress in cardiac research - from rebooting cardiac regeneration to a complete cell atlas of the heart.	Cardiovasc Res
34114541	The SARS-CoV-2 B.1.351 lineage (VOC beta) is outgrowing the B.1.1.7 lineage (VOC alpha) in some French regions in April 2021.	Euro Surveill
34114287	Role of ABO blood system in COVID-19: Findings from a southern Italian study.	Transfus Med
34114208	Immunothrombosis: a COVID-19 concerto.	Br J Haematol
34114204	COVID-19 and immunothrombosis: emerging understanding and clinical management.	Br J Haematol
34114198	Complexities in viral replication strategies as a potential explanation for prevalence of asymptomatic carriers in Covid-19 infections: analytical observation on SARS-Cov2 genome characteristics.	Theory Biosci
34113347	A Virus-Specific Immune Rheostat in the Immunome of Patients Recovering From Mild COVID-19.	Front Immunol
34113249	COVID-19-Associated Pneumonia: Radiobiological Insights.	Front Pharmacol
34113150	"Viral Nephropathies, Adding SARS-CoV-2 to the List."	Int J Nephrol Renovasc Dis
34112954	SARS-CoV-2 envelope protein causes acute respiratory distress syndrome (ARDS)-like pathological damages and constitutes an antiviral target.	Cell Res
34112906	"Elovanoids downregulate SARS-CoV-2 cell-entry, canonical mediators and enhance protective signaling in human alveolar cells."	Sci Rep
34112887	I(nsp1)ecting SARS-CoV-2-ribosome interactions.	Commun Biol
34112801	Viral infiltration of pancreatic islets in patients with COVID-19.	Nat Commun
34112705	Human Kidney Spheroids and Monolayers Provide Insights into SARS-CoV-2 Renal Interactions.	J Am Soc Nephrol
34112579	Persistent behavioral and neurobiological consequences of social isolation during adolescence.	Semin Cell Dev Biol
34112359	Selenium.	Adv Food Nutr Res
34112355	Zinc.	Adv Food Nutr Res
34112226	Comparison of renal histopathology and gene expression profiles between severe COVID-19 and bacterial sepsis in critically ill patients.	Crit Care
34112217	Does methotrexate influence COVID-19 infection? Case series and mechanistic data.	Arthritis Res Ther
34112203	Macrophage biomimetic nanocarriers for anti-inflammation and targeted antiviral treatment in COVID-19.	J Nanobiotechnology
34112171	Comparative analysis of viral infection outcomes in human seminal fluid from prior viral epidemics and Sars-CoV-2 may offer trends for viral sexual transmissibility and long-term reproductive health implications.	Reprod Health
34112082	Migraine and neuroinflammation: the inflammasome perspective.	J Headache Pain
34112056	Distinct transcriptional responses to fatal Ebola virus infection in cynomolgus and rhesus macaques suggest species-specific immune responses.	Emerg Microbes Infect
34112047	"Vitamin D attenuates COVID-19 complications via modulation of proinflammatory cytokines, antiviral proteins, and autophagy."	Expert Rev Anti Infect Ther
34111888	BNT162b2-elicited neutralization of B.1.617 and other SARS-CoV-2 variants.	Nature
34111482	A potential antiviral activity of Esculentoside A against binding interactions of SARS-COV-2 spike protein and angiotensin converting enzyme 2 (ACE2).	Int J Biol Macromol
34111453	Chemokines and eicosanoids fuel the hyperinflammation within the lungs of patients with severe COVID-19.	J Allergy Clin Immunol
34111431	Coronavirus Disease 2019 during Pregnancy: Clinical and in Vitro Evidence against Placenta Infection at Term by Severe Acute Respiratory Syndrome Coronavirus 2.	Am J Pathol
34111408	Structural basis for accommodation of emerging B.1.351 and B.1.1.7 variants by two potent SARS-CoV-2 neutralizing antibodies.	Structure
34111397	"Efficacy and safety of dihydroorotate dehydrogenase (DHODH) inhibitors ""leflunomide"" and ""teriflunomide"" in Covid-19: A narrative review."	Eur J Pharmacol
34111060	"Genomic Surveillance for SARS-CoV-2 Variants Circulating in the United States, December 2020-May 2021."	MMWR Morb Mortal Wkly Rep
34110602	Neurological Implications of COVID-19: Role of Redox Imbalance and Mitochondrial Dysfunction.	Mol Neurobiol
34110554	Immunothrombotic dysregulation in chagas disease and COVID-19: a comparative study of anticoagulation.	Mol Cell Biochem
34110264	SARS-CoV-2 Nonstructural Protein 1 Inhibits the Interferon Response by Causing Depletion of Key Host Signaling Factors.	J Virol
34110168	Conformational Dynamics in the Interaction of SARS-CoV-2 Papain-like Protease with Human Interferon-Stimulated Gene 15 Protein.	J Phys Chem Lett
34110159	Structural and Dynamical Differences in the Spike Protein RBD in the SARS-CoV-2 Variants B.1.1.7 and B.1.351.	J Phys Chem B
34110129	Mechanism of Inhibition of the Reproduction of SARS-CoV-2 and Ebola Viruses by Remdesivir.	Biochemistry
34110032	Potential use of serum-derived bovine immunoglobulin/protein isolate for the management of COVID-19.	Drug Dev Res
34109885	SARS-CoV2 spike protein gene variants with N501T and G142D mutation-dominated infections in mink in the United States.	J Vet Diagn Invest
34109607	Mapping the effect of drugs on ACE2 as a novel target site for COVID-19 therapy.	Eur Rev Med Pharmacol Sci
34109605	Punicalagin and zinc (II) ions inhibit the activity of SARS-CoV-2 3CL-protease in vitro.	Eur Rev Med Pharmacol Sci
34109598	Reasons why COVID-19 survivors should follow dietary World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR) recommendations: from hyper-inflammation to cardiac dysfunctions.	Eur Rev Med Pharmacol Sci
34109597	Infectious agents including COVID-19 and the involvement of blood coagulation and fibrinolysis. A narrative review.	Eur Rev Med Pharmacol Sci
34109586	"Trace elements and the carotid plaque: the GOOD (Mg, Zn, Se), the UGLY (Fe, Cu), and the BAD (P, Ca)?"	Eur Rev Med Pharmacol Sci
34109491	Mechanisms of thrombosis in ANCA-associated vasculitis.	Clin Rheumatol
34109302	"JAK out of the Box; The Rationale behind Janus Kinase Inhibitors in the COVID-19 setting, and their potential in obese and diabetic populations."	Cardiovasc Endocrinol Metab
34109284	Profiling COVID-19 Genetic Research: A Data-Driven Study Utilizing Intelligent Bibliometrics.	Front Res Metr Anal
34109260	Understanding the SARS-CoV-2 virus to mitigate current and future pandemic(s).	Virusdisease
34109257	In Silico Evaluation of Cyclophilin Inhibitors as Potential Treatment for SARS-CoV-2.	Open Forum Infect Dis
34109214	Scrutinizing Coronaviruses Using Publicly Available Bioinformatic Tools: The Viral Structural Proteins as a Case Study.	Front Mol Biosci
34109213	The Therapeutic Potential of Galectin-3 in the Treatment of Intrahepatic Cholangiocarcinoma Patients and Those Compromised With COVID-19.	Front Mol Biosci
34109148	Features of Cytokine Storm Identified by Distinguishing Clinical Manifestations in COVID-19.	Front Public Health
34109031	SARS-CoV-2 Brazil variants in Latin America: More serious research urgently needed on public health and vaccine protection.	Ann Med Surg (Lond)
34109017	The evolving proteome of SARS-CoV-2 predominantly uses mutation combination strategy for survival.	Comput Struct Biotechnol J
34109016	Interaction of 8-anilinonaphthalene-1-sulfonate with SARS-CoV-2 main protease and its application as a fluorescent probe for inhibitor identification.	Comput Struct Biotechnol J
34108966	Transcriptional Changes in CD16+ Monocytes May Contribute to the Pathogenesis of COVID-19.	Front Immunol
34108961	Comparative Immunomodulatory Evaluation of the Receptor Binding Domain of the SARS-CoV-2 Spike Protein; a Potential Vaccine Candidate Which Imparts Potent Humoral and Th1 Type Immune Response in a Mouse Model.	Front Immunol
34108657	Single-cell epigenomic landscape of peripheral immune cells reveals establishment of trained immunity in individuals convalescing from COVID-19.	Nat Cell Biol
34108608	A single transcript for the prognosis of disease severity in COVID-19 patients.	Sci Rep
34108510	Endothelial glycocalyx shields the interaction of SARS-CoV-2 spike protein with ACE2 receptors.	Sci Rep
34108465	Clinical and molecular characteristics of COVID-19 patients with persistent SARS-CoV-2 infection.	Nat Commun
34108245	HIF-1alpha is a negative regulator of interferon regulatory factors: Implications for interferon production by hypoxic monocytes.	Proc Natl Acad Sci U S A
34108016	Network medicine links SARS-CoV-2/COVID-19 infection to brain microvascular injury and neuroinflammation in dementia-like cognitive impairment.	Alzheimers Res Ther
34108015	Liver injury in COVID-19: clinical features and treatment management.	Virol J
34107824	Of mitochondrion and COVID-19.	J Enzyme Inhib Med Chem
34107799	"Virtual screening, ADMET profiling, PASS prediction, and bioactivity studies of potential inhibitory roles of alkaloids, phytosterols, and flavonoids against COVID-19 main protease (M(pro))."	Nat Prod Res
34107529	Immunogenicity of Ad26.COV2.S vaccine against SARS-CoV-2 variants in humans.	Nature
34107203	CROI 2021: Neurologic Complications of HIV-1 Infection or COVID-19.	Top Antivir Med
34107055	Tofacitinib therapy intercepts macrophage metabolic reprogramming instigated by SARS-CoV-2 Spike protein.	Eur J Immunol
34107016	VirusViz: comparative analysis and effective visualization of viral nucleotide and amino acid variants.	Nucleic Acids Res
34106957	SARS-CoV-2 Envelope (E) protein interacts with PDZ-domain-2 of host tight junction protein ZO1.	PLoS One
34106949	Coronavirus surveillance in wildlife from two Congo basin countries detects RNA of multiple species circulating in bats and rodents.	PLoS One
34106944	Identification and evaluation of the inhibitory effect of Prunella vulgaris extract on SARS-coronavirus 2 virus entry.	PLoS One
34106888	Heterologous immunization with Covishield and Pfizer vaccines against SARS-CoV-2 elicits a robust humoral immune response.	J Infect Dev Ctries
34106748	N-(4-Hydroxyphenyl) Retinamide Suppresses SARS-CoV-2 Spike Protein-Mediated Cell-Cell Fusion by a Dihydroceramide Delta4-Desaturase 1-Independent Mechanism.	J Virol
34106658	Sarilumab (IL-6R antagonist) in critically ill patients with cytokine release syndrome by SARS-CoV2.	Medicine (Baltimore)
34106569	Genomic and Phenotypic Analysis of COVID-19-Associated Pulmonary Aspergillosis Isolates of Aspergillus fumigatus.	Microbiol Spectr
34106438	SARS-CoV-2 plays a pivotal role in inducing hyperthyroidism of Graves' disease.	Endocrine
34106169	[What do we know about Kawasaki disease and COVID-19?]	Andes Pediatr
34106062	Comparison of hypertension prevalence and the use of renin-angiotensin-aldosterone system blockers in hospitalized patients with COVID-19 and non-COVID-19 viral pneumonia.	Turk Kardiyol Dern Ars
34106002	Viral and host transcriptomes in SARS-CoV-2 infected human lung cells.	J Virol
34105996	V367F Mutation in SARS-CoV-2 Spike RBD Emerging during the Early Transmission Phase Enhances Viral Infectivity through Increased Human ACE2 Receptor Binding Affinity.	J Virol
34105713	"Inflammation at the Crossroads: the Combined Effects of COVID-19, Ageing, and Air Pollution."	J Frailty Aging
34105503	[Bioinformatics Analysis of the Influence of Coronavirus Infection on Hematopoietic System and Potential Intervention Drugs and Their Significance for COVID-19].	Zhongguo Shi Yan Xue Ye Xue Za Zhi
34105336	Anaphylaxis is a rare reaction in COVID-19 vaccination.	J Biol Regul Homeost Agents
34105201	Quantitative proteomics of hamster lung tissues infected with SARS-CoV-2 reveal host factors having implication in the disease pathogenesis and severity.	FASEB J
34105049	Investigating the active compounds and mechanism of HuaShi XuanFei formula for prevention and treatment of COVID-19 based on network pharmacology and molecular docking analysis.	Mol Divers
34104880	"Current knowledge of COVID-19: advances, challenges and future perspectives."	Biosaf Health
34104872	Potent germline-like monoclonal antibodies: rapid identification of promising candidates for antibody-based antiviral therapy.	Antib Ther
34104818	Coronavirus Disease and Cardiovascular Disease: A Literature Review.	J Clin Transl Res
34104708	"Is there any role of intermittent fasting in the prevention and improving clinical outcomes of COVID-19?: intersection between inflammation, mTOR pathway, autophagy and calorie restriction."	Virusdisease
34104664	Virtual screening on the web for drug repurposing: a primer.	J Biol Methods
34104622	A review on nanostructured silver as a basic ingredient in medicine: physicochemical parameters and characterization.	Beilstein J Nanotechnol
34104394	"Testosterone target therapy: focus on immune response, controversies and clinical implications in patients with COVID-19 infection."	Ther Adv Endocrinol Metab
34104357	Screening of world approved drugs against highly dynamical spike glycoprotein of SARS-CoV-2 using CaverDock and machine learning.	Comput Struct Biotechnol J
34104356	Dissecting nucleotide selectivity in viral RNA polymerases.	Comput Struct Biotechnol J
34104202	Alkaloids as Potential Phytochemicals against SARS-CoV-2: Approaches to the Associated Pivotal Mechanisms.	Evid Based Complement Alternat Med
34104125	"Comparative phytochemistry of flavaglines (= rocaglamides), a group of highly bioactive flavolignans from Aglaia species (Meliaceae)."	Phytochem Rev
34104087	SARS-CoV-2 infection activates a subset of intrinsic pathways to inhibit type I interferons in vitro and in vivo.	Int J Med Sci
34103921	"COVID-19 Sepsis: Pathogenesis and Endothelial Molecular Mechanisms Based on ""Two-Path Unifying Theory"" of Hemostasis and Endotheliopathy-Associated Vascular Microthrombotic Disease, and Proposed Therapeutic Approach with Antimicrothrombotic Therapy."	Vasc Health Risk Manag
34103506	Structural basis for SARS-CoV-2 envelope protein recognition of human cell junction protein PALS1.	Nat Commun
34103499	A versatile reverse genetics platform for SARS-CoV-2 and other positive-strand RNA viruses.	Nat Commun
34103487	Integrating longitudinal clinical laboratory tests with targeted proteomic and transcriptomic analyses reveal the landscape of host responses in COVID-19.	Cell Discov
34103408	Plasma from patients with bacterial sepsis or severe COVID-19 induces suppressive myeloid cell production from hematopoietic progenitors in vitro.	Sci Transl Med
34103407	Antibodies elicited by mRNA-1273 vaccination bind more broadly to the receptor binding domain than do those from SARS-CoV-2 infection.	Sci Transl Med
34103349	Senolytics reduce coronavirus-related mortality in old mice.	Science
34103214	Selective Lobe Ventilation and a Novel Platform for Pulmonary Drug Delivery.	J Cardiothorac Vasc Anesth
34103090	Characterization of SARS-CoV-2 different variants and related morbidity and mortality: a systematic review.	Eur J Med Res
34102962	The roles of vitamin D in increasing the body's immunity and reducing injuries due to viral infections: With an emphasis on its possible role in SARS-CoV-2 (COVID-19).	Curr Pharm Des
34102600	"A tale of two diseases: Sarcoidosis, COVID-19 and new therapeutic options with dual RAS inhibition and tetanus-diphtheria vaccine."	Med Hypotheses
34102269	Active components in Ephedra sinica stapf disrupt the interaction between ACE2 and SARS-CoV-2 RBD: Potent COVID-19 therapeutic agents.	J Ethnopharmacol
34102107	Human Type II Taste Cells Express Angiotensin-Converting Enzyme 2 and Are Infected by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).	Am J Pathol
34102081	Exploring the therapeutic potential of forkhead box O for outfoxing COVID-19.	Open Biol
34101725	Potential G-quadruplexes and i-Motifs in the SARS-CoV-2.	PLoS One
34101623	Impaired humoral and cellular immunity after SARS-CoV-2 BNT162b2 (tozinameran) prime-boost vaccination in kidney transplant recipients.	J Clin Invest
34101517	An Overview About the Role of Adaptive Immunity in Keeping SARS-CoV-2 Reinfections at Bay.	Viral Immunol
34101213	SARS-CoV-2 sensing by RIG-I and MDA5 links epithelial infection to macrophage inflammation.	EMBO J
34100287	Inflammatory Response Leads to Neuronal Death in Human Post-Mortem Cerebral Cortex in Patients with COVID-19.	ACS Chem Neurosci
34100279	Be aware of SARS-CoV-2 spike protein: There is more than meets the eye.	J Biol Regul Homeost Agents
34099985	In silico molecular docking analysis for repurposing approved antiviral drugs against SARS-CoV-2 main protease.	Biochem Biophys Rep
34099976	In-silico evaluation of bioactive compounds from tea as potential SARS-CoV-2 nonstructural protein 16 inhibitors.	J Tradit Complement Med
34099962	Druggability of cavity pockets within SARS-CoV-2 spike glycoprotein and pharmacophore-based drug discovery.	Future Virol
34099831	A metabolic modeling approach reveals promising therapeutic targets and antiviral drugs to combat COVID-19.	Sci Rep
34099808	SARS-CoV-2 mutations in Brazil: from genomics to putative clinical conditions.	Sci Rep
34099703	Assessment of protein-protein interfaces in cryo-EM derived assemblies.	Nat Commun
34099652	SARS-CoV-2 RNAemia and proteomic trajectories inform prognostication in COVID-19 patients admitted to intensive care.	Nat Commun
34099556	Middle East respiratory syndrome coronavirus Spike protein variants exhibit geographic differences in virulence.	Proc Natl Acad Sci U S A
34099547	CDCP1 on Dendritic Cells Contributes to the Development of a Model of Kawasaki Disease.	J Immunol
34099197	Post covid 19 pulmonary fibrosis. Is it real threat?	Indian J Tuberc
34099172	"SARS-CoV-2 3a expression, purification, and reconstitution into lipid nanodiscs."	Methods Enzymol
34099051	Crucial mutation in the exoribonuclease domain of nsp14 of PEDV leads to high genetic instability during viral replication.	Cell Biosci
34098986	A comprehensive review on clinical and mechanistic pathophysiological aspects of COVID-19 Malady: How far have we come?	Virol J
34098950	Identification of COVID-19 B-cell epitopes with phage-displayed peptide library.	J Biomed Sci
34098591	An Impaired Inflammatory and Innate Immune Response in COVID-19.	Mol Cells
34098567	Nanobodies from camelid mice and llamas neutralize SARS-CoV-2 variants.	Nature
34098482	"Computational details of molecular structure, spectroscopic properties, topological studies and SARS-Cov-2 enzyme molecular docking simulation of substituted triazolo pyrimidine thione heterocycles."	Spectrochim Acta A Mol Biomol Spectrosc
34098463	Decorin as a possible strategy for the amelioration of COVID-19.	Med Hypotheses
34098342	SARS-CoV-2 elicits robust adaptive immune responses regardless of disease severity.	EBioMedicine
34098108	Comparative immunogenicity analysis of intradermal versus intramuscular administration of SARS-CoV-2 RBD epitope peptide-based immunogen In vivo.	Microbes Infect
34097986	What do secreted phospholipases A2 have to offer in combat against different viruses up to SARS-CoV-2?	Biochimie
34097796	Combining High-Throughput Synthesis and High-Throughput Protein Crystallography for Accelerated Hit Identification.	Angew Chem Int Ed Engl
34097716	Detection of R.1 lineage severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with spike protein W152L/E484K/G769V mutations in Japan.	PLoS Pathog
34097709	Signal-regulatory protein alpha is an anti-viral entry factor targeting viruses using endocytic pathways.	PLoS Pathog
34097590	Identification of novel drug candidates for the inhibition of catalytic cleavage activity of coronavirus 3CL-like protease enzyme.	Curr Pharm Biotechnol
34097572	Thrombosis in Covid-19 and non-Covid-19 pneumonia: role of platelets.	Platelets
34097570	A human antibody of potent efficacy against SARS-CoV-2 in rhesus macaques showed strong blocking activity to B.1.351.	MAbs
34097489	Hepatitis C Virus Protease Inhibitors Show Differential Efficacy and Interactions with Remdesivir for Treatment of SARS-CoV-2 In Vitro.	Antimicrob Agents Chemother
34097314	Recent Advances in Pathology: the 2021 Annual Review Issue of The Journal of Pathology.	J Pathol
34097193	Is the Endothelium the Missing Link in the Pathophysiology and Treatment of COVID-19 Complications?	Cardiovasc Drugs Ther
34097003	Detecting SARS-CoV-2 and its variant strains with a full genome tiling array.	Brief Bioinform
34096848	"Cutaneous Manifestations of COVID-19: Characteristics, Pathogenesis, and the Role of Dermatology in the Pandemic."	Cutis
34096704	Finding Druggable Sites in Proteins Using TACTICS.	J Chem Inf Model
34096383	Immune system and COVID-19 by sex differences and age.	Womens Health (Lond)
34096226	Is There any Alternative Receptor for SARS-CoV-2?	Cell J
34095859	Protocol for constructing large size human antibody heavy chain variable domain (VH) library and selection of SARS-CoV-2 neutralizing antibody domains.	STAR Protoc
34095806	"Virology features of a family cluster of SARS-CoV-2 infections in Shanghai, China."	Biosaf Health
34095780	Characterization of SARS-CoV-2 nucleocapsid protein reveals multiple functional consequences of the C-terminal domain.	iScience
34095755	Pathophysiology of Coagulopathy in Hematological Malignancies and in COVID-19.	Hemasphere
34095559	Ephrin-A1 and the sheddase ADAM12 are upregulated in COVID-19.	Heliyon
34095334	High Prevalence of SARS-CoV-2 Genetic Variation and D614G Mutation in Pediatric Patients With COVID-19.	Open Forum Infect Dis
34095308	"Virtual Screening of Phytochemicals by Targeting HR1 Domain of SARS-CoV-2 S Protein: Molecular Docking, Molecular Dynamics Simulations, and DFT Studies."	Biomed Res Int
34095271	"Evolution, Ecology, and Zoonotic Transmission of Betacoronaviruses: A Review."	Front Vet Sci
34095193	Encapsulated Food Products as a Strategy to Strengthen Immunity Against COVID-19.	Front Nutr
34094930	High Expression of ACE2 and TMPRSS2 at the Resection Margin Makes Lung Cancer Survivors Susceptible to SARS-CoV-2 With Unfavorable Prognosis.	Front Oncol
34094885	Phenolic compounds as promising drug candidates against COVID-19 - An integrated molecular docking and dynamics simulation study.	Mater Today Proc
34094684	Epithelial-mesenchymal transition induced by SARS-CoV-2 required transcriptional upregulation of Snail.	Am J Cancer Res
34094637	Cellular Tropism of SARS-CoV-2 across Human Tissues and Age-related Expression of ACE2 and TMPRSS2 in Immune-inflammatory Stromal Cells.	Aging Dis
34094635	Construction of a Human Cell Landscape of COVID-19 Infection at Single-cell Level.	Aging Dis
34094634	Ischemic Stroke: An Underestimated Complication of COVID-19.	Aging Dis
34094317	Revealing the molecular mechanisms of proteolysis of SARS-CoV-2 M(pro) by QM/MM computational methods.	Chem Sci
34094251	Multi-targeting of functional cysteines in multiple conserved SARS-CoV-2 domains by clinically safe Zn-ejectors.	Chem Sci
34093595	Broad T Cell Targeting of Structural Proteins After SARS-CoV-2 Infection: High Throughput Assessment of T Cell Reactivity Using an Automated Interferon Gamma Release Assay.	Front Immunol
34093568	Global Trends in Research of Macrophages Associated With Acute Lung Injury Over Past 10 Years: A Bibliometric Analysis.	Front Immunol
34093495	Genomic Epidemiology of SARS-CoV-2 From Mainland China With Newly Obtained Genomes From Henan Province.	Front Microbiol
34093454	Antigenic Evolution on a Global Scale Reveals the Potential Natural Selection of Severe Acute Respiratory Syndrome-Coronavirus 2 by Pre-existing Cross-Reactive T-Cell Immunity.	Front Microbiol
34093097	Plant-derived lignans as potential antiviral agents: a systematic review.	Phytochem Rev
34093061	SARS-CoV-2 virion physicochemical characteristics pertinent to abiotic substrate attachment.	Curr Opin Colloid Interface Sci
34092976	"COVID-19 in normal, diseased and transplanted liver."	World J Gastroenterol
34092964	D614G substitution at the hinge region enhances the stability of trimeric SARS-CoV-2 spike protein.	Bioinformation
34092842	Cardiovascular Complications Related to COVID-19 Disease.	Anesth Essays Res
34092840	Chemical constituents from coconut waste and their in silico evaluation as potential antiviral agents against SARS-CoV-2.	S Afr J Bot
34092811	"mRNA Targeting, Transport and Local Translation in Eukaryotic Cells: From the Classical View to a Diversity of New Concepts."	Mol Biol
34092799	"Origin, Pathogenesis, Diagnosis and Treatment Options for SARS-CoV-2: A Review."	Biologia (Bratisl)
34092778	Is the Intestine a Portal of Entry for the Serious COVID-19 Complications of Endotoxemia and Thrombosis?	Clin Transl Gastroenterol
34092298	"Chemical profiling of Huashi Baidu prescription, an effective anti-COVID-19 TCM formula, by UPLC-Q-TOF/MS."	Chin J Nat Med
34092050	History repeats itself: Horse originated Hyperimmune sera production against SARS CoV-2.	Turk J Med Sci
34091654	The effect of coronaviruses on olfaction: systematic review.	Rhinology
34091532	Angiotensin-converting enzyme 2: a key enzyme in key organs.	J Cardiovasc Med (Hagerstown)
34091116	Different T cell related immunological profiles in COVID-19 patients compared to healthy controls.	Int Immunopharmacol
34091092	This is not a pipe - But how harmful is electronic cigarette smoke.	Biomed J
34091054	Highly efficient CD4+ T cell targeting and genetic recombination using engineered CD4+ cell-homing mRNA-LNP.	Mol Ther
34090983	Immune mediating molecules and pathogenesis of COVID-19-associated neurological disease.	Microb Pathog
34090962	The folate antagonist methotrexate diminishes replication of the coronavirus SARS-CoV-2 and enhances the antiviral efficacy of remdesivir in cell culture models.	Virus Res
34090785	Antiphospholipid antibodies and risk of post-COVID-19 vaccination thrombophilia: The straw that breaks the camel's back?	Cytokine Growth Factor Rev
34090468	SARS-CoV-2 complete genome sequencing from the Italian Campania region using a highly automated next generation sequencing system.	J Transl Med
34090396	Covid-19 and non-communicable diseases: evidence from a systematic literature review.	BMC Public Health
34090358	Comparison of renin-angiotensin-aldosterone system inhibitors with other antihypertensives in association with coronavirus disease-19 clinical outcomes.	BMC Infect Dis
34090218	COVID-19 patients' sera induce epithelial mesenchymal transition in cancer cells.	Cancer Treat Res Commun
34090015	Screening of natural compounds from Cyperus rotundus Linn against SARS-CoV-2 main protease (M(pro)): An integrated computational approach.	Comput Biol Med
34089978	A computational evaluation of targeted oxidation strategy (TOS) for potential inhibition of SARS-CoV-2 by disulfiram and analogues.	Biophys Chem
34089909	Designing an effective therapeutic siRNA to silence RdRp gene of SARS-CoV-2.	Infect Genet Evol
34089886	Inverse association between hypertension treatment and COVID-19 prevalence in Japan.	Int J Infect Dis
34089862	Proteomics-Based Insights Into the SARS-CoV-2-Mediated COVID-19 Pandemic: A Review of the First Year of Research.	Mol Cell Proteomics
34089859	Effective DNA damage response after acute but not chronic immune challenge: SARS-CoV-2 vaccine versus Systemic Lupus Erythematosus.	Clin Immunol
34089793	Tagged extracellular vesicles with the RBD of the viral spike protein for delivery of antiviral agents against SARS-COV-2 infection.	J Control Release
34089757	Structural dynamics of SARS-CoV-2 variants: A health monitoring strategy for anticipating Covid-19 outbreaks.	J Infect
34089699	Inhibition of nonspecific polymerase activity using Poly(Aspartic) acid as a model anionic polyelectrolyte.	Anal Biochem
34089595	Do Anti-androgens Have Potential as Therapeutics for COVID-19?	Endocrinology
34089541	Homologous and heterologous serological response to the N-terminal domain of SARS-CoV-2 in humans and mice.	Eur J Immunol
34089508	"A Review on SARS-CoV-2-Induced Neuroinflammation, Neurodevelopmental Complications, and Recent Updates on the Vaccine Development."	Mol Neurobiol
34089367	Transcriptome analysis of primary chicken cells infected with infectious bronchitis virus strain K047-12 isolated in Korea.	Arch Virol
34089082	SNPs at 3'UTR of APOL1 and miR-6741-3p target sites associated with kidney diseases more susceptible to SARS-COV-2 infection: in silco and in vitro studies.	Mamm Genome
34088975	Regulation of the acetylcholine/alpha7nAChR anti-inflammatory pathway in COVID-19 patients.	Sci Rep
34088957	Atomic force microscopy analysis of native infectious and inactivated SARS-CoV-2 virions.	Sci Rep
34088885	Revealing the therapeutic targets and molecular mechanisms of emodin-treated coronavirus disease 2019 via a systematic study of network pharmacology.	Aging (Albany NY)
34088867	Endothelial Dysfunction in Atherosclerotic Cardiovascular Diseases and Beyond: From Mechanism to Pharmacotherapies.	Pharmacol Rev
34088718	Renin-Angiotensin System Blockers and the Risk of COVID-19-Related Mortality in Patients with Kidney Failure.	Clin J Am Soc Nephrol
34088524	Chronic use of renin-angiotensin-aldosterone inhibitors in hypertensive COVID-19 patients: Results from a Spanish registry and meta-analysis.	Med Clin (Barc)
34087613	Does COVID 19 generate a milieu for propagation of mucormycosis?	Med Hypotheses
34087261	Adenoviral Vector DNA- and SARS-CoV-2 mRNA-Based Covid-19 Vaccines: Possible Integration into the Human Genome - Are Adenoviral Genes Expressed in Vector-based Vaccines?	Virus Res
34087220	Synthetic proteins for COVID-19 diagnostics.	Peptides
34087218	Neuropilin-1 assists SARS-CoV-2 infection by stimulating the separation of Spike protein S1 and S2.	Biophys J
34087216	Physical phenotype of blood cells is altered in COVID-19.	Biophys J
34087207	Enhanced sampling protocol to elucidate fusion peptide opening of SARS-CoV-2 spike protein.	Biophys J
34087172	Tackling COVID-19 with neutralizing monoclonal antibodies.	Cell
34087062	"Insights into the potential role of alpha1-antitrypsin in COVID-19 patients: Mechanisms, current update, and future perspectives."	Clin Respir J
34087041	"Synthesis, comparative in vitro antibacterial, antioxidant and UV fluorescence studies of bis indole Schiff bases and molecular docking with ct-DNA and SARS-CoV-2 M(pro)."	Luminescence
34086878	Emergence of the E484K Mutation in SARS-CoV-2 Lineage B.1.1.345 in Upstate New York.	Clin Infect Dis
34086837	Plasma ACE2 predicts outcome of COVID-19 in hospitalized patients.	PLoS One
34086487	Pharmacogenomic considerations for repurposing of dexamethasone as a potential drug against SARS-CoV-2 infection.	Per Med
34086459	Machine Learning Reveals the Critical Interactions for SARS-CoV-2 Spike Protein Binding to ACE2.	J Phys Chem Lett
34086443	A Trimeric Hydrophobic Zipper Mediates the Intramembrane Assembly of SARS-CoV-2 Spike.	J Am Chem Soc
34086357	SARS-CoV-2-specific CD8(+) T-cell responses and TCR signatures in the context of a prominent HLA-A*24:02 allomorph.	Immunol Cell Biol
34086061	The role of 5-lipoxygenase in the pathophysiology of COVID-19 and its therapeutic implications.	Inflamm Res
34086044	Expression of the SARS-CoV-2 Receptor ACE2 in Human Retina and Diabetes-Implications for Retinopathy.	Invest Ophthalmol Vis Sci
34085882	Potential role of free-radical processes in biomolecules damage during COVID-19 and ways of their regulation.	Free Radic Res
34085542	Angiotensin-converting enzyme-1 gene insertion/deletion polymorphism may be associated with COVID-19 clinical severity: a prospective cohort study.	Ann Saudi Med
34085278	Single dose of BNT162b2 mRNA vaccine against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) induces neutralising antibody and polyfunctional T-cell responses in patients with chronic myeloid leukaemia.	Br J Haematol
34085038	"EyeDiseases: an integrated resource for dedicating to genetic variants, gene expression and epigenetic factors of human eye diseases."	NAR Genom Bioinform
34085037	pyrpipe: a Python package for RNA-Seq workflows.	NAR Genom Bioinform
34085003	[Obesity in the COVID era: A global health challenge].	Endocrinol Diabetes Nutr
34084248	Sexual dimorphism in SARS-COV-2 infection.	Acta Endocrinol (Buchar)
34084167	SARS-CoV-2 Membrane Protein Inhibits Type I Interferon Production Through Ubiquitin-Mediated Degradation of TBK1.	Front Immunol
34084077	SARS-Cov2 S Protein Features Potential Estrogen Binding Site.	Food Technol Biotechnol
34083848	A Narrative Review of a Pulmonary Aerosolized Formulation or a Nasal Drop Using Sera Containing Neutralizing Antibodies Collected from COVID-19-Recovered Patients as a Probable Therapy for COVID-19.	Iran J Med Sci
34083759	SARS-CoV-2 proteins and anti-COVID-19 drugs induce lytic reactivation of an oncogenic virus.	Commun Biol
34083758	Single-nucleotide conservation state annotation of the SARS-CoV-2 genome.	Commun Biol
34083682	Generation of restriction endonucleases barcode map to trace SARS-CoV-2 origin and evolution.	Sci Rep
34083527	Drug repurposing screens identify chemical entities for the development of COVID-19 interventions.	Nat Commun
34083499	Association of hypercoagulation with severe acute respiratory syndrome coronavirus 2 infection.	Blood Res
34083449	Fe-S cofactors in the SARS-CoV-2 RNA-dependent RNA polymerase are potential antiviral targets.	Science
34083352	The total number and mass of SARS-CoV-2 virions.	Proc Natl Acad Sci U S A
34082680	"The interplay among epilepsy, Parkinson s disease, and inflammation: revisiting the link through Ca2+/cAMPsignalling."	Curr Neurovasc Res
34082475	Establishing the prevalence of common tissue-specific autoantibodies following severe acute respiratory syndrome coronavirus 2 infection.	Clin Exp Immunol
34082440	Differentials of SARS-CoV-2 Viral RNA Re-positivity in Discharged COVID-19 Patients.	AIDS Rev
34082438	Nasal delivery of an IgM offers broad protection from SARS-CoV-2 variants.	Nature
34082137	"Hemostatic alterations linked to body fat distribution, fatty liver, and insulin resistance."	Mol Metab
34081913	SARS-CoV-2 infection induces beta cell transdifferentiation.	Cell Metab
34081912	SARS-CoV-2 infects human pancreatic beta cells and elicits beta cell impairment.	Cell Metab
34081788	Does autoimmune vitiligo protect against COVID-19 disease?	Exp Dermatol
34081630	Epitope-specific antibody responses differentiate COVID-19 outcomes and variants of concern.	JCI Insight
34081443	"Environmental Fe, Ti, Al, Cu, Hg, Bi, and Si Nanoparticles in the Atrioventricular Conduction Axis and the Associated Ultrastructural Damage in Young Urbanites: Cardiac Arrhythmias Caused by Anthropogenic, Industrial, E-Waste, and Indoor Nanoparticles."	Environ Sci Technol
34081439	Kinases as Potential Therapeutic Targets for Anti-coronaviral Therapy.	J Med Chem
34081354	Correlation between interleukin gene polymorphisms and current prevalence and mortality rates due to novel coronavirus disease 2019 (COVID-2019) in 23 countries.	J Med Virol
34081334	SARS-CoV-2 infection and cancer: Evidence for and against a role of SARS-CoV-2 in cancer onset.	Bioessays
34081326	Flow cytometry data mining by cytoChain identifies determinants of exhaustion and stemness in TCR-engineered T cells.	Eur J Immunol
34081219	Pericardial Diseases in COVID19: a Contemporary Review.	Curr Cardiol Rep
34081143	A transferable deep learning approach to fast screen potential antiviral drugs against SARS-CoV-2.	Brief Bioinform
34080738	Critical COVID-19 is associated with distinct leukocyte phenotypes and transcriptome patterns.	J Intern Med
34080714	Covid-19 Infection and Parkinsonism: Is There a Link?	Mov Disord
34080435	Proteomic Analysis Identifies Prolonged Disturbances in Pathways Related to Cholesterol Metabolism and Myocardium Function in the COVID-19 Recovery Stage.	J Proteome Res
34080135	"Autoantibodies to heat shock protein 60, 70, and 90 are not altered in the anti-SARS-CoV-2 IgG-seropositive humans without or with mild symptoms."	Cell Stress Chaperones
34080133	Three-Dimensional Cell Cultures as a Research Platform in Lung Diseases and COVID-19.	Tissue Eng Regen Med
34079818	An Integrated Computational and Experimental Approach to Identifying Inhibitors for SARS-CoV-2 3CL Protease.	Front Mol Biosci
34079691	"Angiotensin-converting enzyme 2 receptors, chronic liver diseases, common medications, and clinical outcomes in coronavirus disease 2019 patients."	World J Virol
34079547	Quantification of Cytokine Storms During Virus Infections.	Front Immunol
34079487	COVID-19 in People With Schizophrenia: Potential Mechanisms Linking Schizophrenia to Poor Prognosis.	Front Psychiatry
34079462	Marine Sponge is a Promising Natural Source of Anti-SARS-CoV-2 Scaffold.	Front Pharmacol
34079452	Transcriptional Regulation of Drug Metabolizing CYP Enzymes by Proinflammatory Wnt5A Signaling in Human Coronary Artery Endothelial Cells.	Front Pharmacol
34079337	Angiotensin System Polymorphisms' in SARS-CoV-2 Positive Patients: Assessment Between Symptomatic and Asymptomatic Patients: A Pilot Study.	Pharmgenomics Pers Med
34079332	Obesity-Related Inflammation and Endothelial Dysfunction in COVID-19: Impact on Disease Severity.	J Inflamm Res
34079299	"Role of Serine Proteases and Host Cell Receptors Involved in Proteolytic Activation, Entry of SARS-CoV-2 and Its Current Therapeutic Options."	Infect Drug Resist
34079039	JAK inhibitors dampen activation of interferon-stimulated transcription of ACE2 isoforms in human airway epithelial cells.	Commun Biol
34078924	Covid-19 diagnosis by combining RT-PCR and pseudo-convolutional machines to characterize virus sequences.	Sci Rep
34078893	A metal ion orients SARS-CoV-2 mRNA to ensure accurate 2'-O methylation of its first nucleotide.	Nat Commun
34078869	[Novel coronavirus disease (COVID-19) and obstructive sleep apnea: age aspects of comorbidity].	Zh Nevrol Psikhiatr Im S S Korsakova
34078711	Surface Proteins of SARS-CoV-2 Drive Airway Epithelial Cells to Induce IFN-Dependent Inflammation.	J Immunol
34078386	SARS-CoV-2 in hospital indoor environments is predominantly non-infectious.	Virol J
34078269	A multi-task CNN learning model for taxonomic assignment of human viruses.	BMC Bioinformatics
34077991	SARS-CoV-2 Infection and Placental Pathology.	Rev Bras Ginecol Obstet
34077666	"Coronavirus Disease Update on Epidemiology, Virology, and Prevention."	Compend Contin Educ Dent
34077451	Identification of naturally processed Zika virus peptides by mass spectrometry and validation of memory T cell recall responses in Zika convalescent subjects.	PLoS One
34077352	"Evaluation of Dual Inhibitory Effect of Anagliptin, Ramipril, and Lisinopril on Angiotensin-Converting Enzyme and DPP-4 Activities."	Curr Mol Pharmacol
34077350	Fatal Outcomes from COVID-19 in Diabetes Patients and its Management: Impact of Diabetes and Other Comorbidities on COVID-19.	Curr Diabetes Rev
34077341	Identification of Generalized Peptide Regions for Designing Vaccine Effective for All Significant Mutated Strains of SARS-CoV-2.	Comb Chem High Throughput Screen
34077310	Identifying the molecular targets and mechanisms of xuebijing injection for the treatment of COVID-19 via network parmacology and molecular docking.	Bioengineered
34077217	Mass Spectrometric Analysis of Urine from COVID-19 Patients for Detection of SARS-CoV-2 Viral Antigen and to Study Host Response.	J Proteome Res
34076828	Is the mechanism of COVID-19 coagulopathy still a rabbit's hole?	J Cell Commun Signal
34076792	COVID-19 disrupts spermatogenesis through the oxidative stress pathway following induction of apoptosis.	Apoptosis
34076588	The missing link: covalent linkages in structural models.	Acta Crystallogr D Struct Biol
34076402	New variants of SARS-CoV-2.	Rev Esp Quimioter
34076249	Transcriptomic studies revealed pathophysiological impact of COVID-19 to predominant health conditions.	Brief Bioinform
34076204	POTENTIAL RISK OF BRAIN DAMAGE AND POOR DEVELOPMENTAL OUTCOMES IN CHILDREN PRENATALLY EXPOSED TO SARS-COV-2: A SYSTEMATIC REVIEW.	Rev Paul Pediatr
34075603	Genetic and epigenetic control of ACE2 expression and its possible role in COVID-19.	Cell Biochem Funct
34075562	The Effect of COVID-19 on NF-kappaB and Neurological Manifestations of Disease.	Mol Neurobiol
34075554	Vaccine Considerations for Multiple Sclerosis in the COVID-19 Era.	Adv Ther
34075401	SARS-CoV-2 infection induces the activation of tissue factor-mediated coagulation by activation of acid sphingomyelinase.	Blood
34075365	"Broad auto-reactive IgM responses are common in critically ill patients, including those with COVID-19."	Cell Rep Med
34075364	Intrinsic signal amplification by type III CRISPR-Cas systems provides a sequence-specific SARS-CoV-2 diagnostic.	Cell Rep Med
34075347	SARS-CoV-2 infection paralyzes cytotoxic and metabolic functions of the immune cells.	Heliyon
34075346	Simeprevir Potently Suppresses SARS-CoV-2 Replication and Synergizes with Remdesivir.	ACS Cent Sci
34075345	Molecular Aspects Concerning the Use of the SARS-CoV-2 Receptor Binding Domain as a Target for Preventive Vaccines.	ACS Cent Sci
34075344	Modifications in an Emergency: The Role of N1-Methylpseudouridine in COVID-19 Vaccines.	ACS Cent Sci
34075339	Computational prediction of nimbanal as potential antagonist of respiratory syndrome coronavirus.	Inform Med Unlocked
34075338	"Structural insights and inhibition mechanism of TMPRSS2 by experimentally known inhibitors Camostat mesylate, Nafamostat and Bromhexine hydrochloride to control SARS-coronavirus-2: A molecular modeling approach."	Inform Med Unlocked
34075330	A variant in TMPRSS2 is associated with decreased disease severity in COVID-19.	Meta Gene
34075268	[Role of the immune system in SARS-CoV-2 infection: immunopathology of COVID-19].	Medicine (Madr)
34075253	"[From SARS, MERS to COVID-19: A journey to understand bat coronaviruses]."	Bull Acad Natl Med
34075212	"SARS-CoV-2 variants, spike mutations and immune escape."	Nat Rev Microbiol
34075090	Targeting of the CD80/86 proinflammatory axis as a therapeutic strategy to prevent severe COVID-19.	Sci Rep
34074585	"The cytokine storms of COVID-19, H1N1 influenza, CRS and MAS compared. Can one sized treatment fit all?"	Cytokine
34074305	A potential association between immunosenescence and high COVID-19 related mortality among elderly patients with cardiovascular diseases.	Immun Ageing
34074255	Molecular epidemiology of SARS-CoV-2 isolated from COVID-19 family clusters.	BMC Med Genomics
34074219	501Y.V2 and 501Y.V3 variants of SARS-CoV-2 lose binding to bamlanivimab in vitro.	MAbs
34074129	Wharton's Jelly Mesenchymal Stem Cell-Derived Extracellular Vesicles Reduce SARS-CoV2-Induced Inflammatory Cytokines Under High Glucose and Uremic Toxin Conditions.	Stem Cells Dev
34073716	Genome-Scale Metabolic Model of Infection with SARS-CoV-2 Mutants Confirms Guanylate Kinase as Robust Potential Antiviral Target.	Genes (Basel)
34073591	Lower Gene Expression of Angiotensin Converting Enzyme 2 Receptor in Lung Tissues of Smokers with COVID-19 Pneumonia.	Biomolecules
34073578	Ceramide and Related Molecules in Viral Infections.	Int J Mol Sci
34073577	"Kinetics of Neutralizing Antibodies of COVID-19 Patients Tested Using Clinical D614G, B.1.1.7, and B 1.351 Isolates in Microneutralization Assays."	Viruses
34073529	Could Histamine H1 Receptor Antagonists Be Used for Treating COVID-19?	Int J Mol Sci
34073283	Induction of the Proinflammatory Chemokine Interleukin-8 Is Regulated by Integrated Stress Response and AP-1 Family Proteins Activated during Coronavirus Infection.	Int J Mol Sci
34073231	3D Cell Culture Models in COVID-19 Times: A Review of 3D Technologies to Understand and Accelerate Therapeutic Drug Discovery.	Biomedicines
34073159	Production of SARS-CoV-2 Virus-Like Particles in Insect Cells.	Vaccines (Basel)
34073119	"Extracellular Vesicles: Versatile Nanomediators, Potential Biomarkers and Therapeutic Agents in Atherosclerosis and COVID-19-Related Thrombosis."	Int J Mol Sci
34073053	Innovative Approach to Fast Electron Microscopy Using the Example of a Culture of Virus-Infected Cells: An Application to SARS-CoV-2.	Microorganisms
34073047	"Comparative Transcriptomic and Molecular Pathway Analyses of HL-CZ Human Pro-Monocytic Cells Expressing SARS-CoV-2 Spike S1, S2, NP, NSP15 and NSP16 Genes."	Microorganisms
34072720	Requirement of Fc-Fc Gamma Receptor Interaction for Antibody-Based Protection against Emerging Virus Infections.	Viruses
34072569	Characterization of a Novel SARS-CoV-2 Genetic Variant with Distinct Spike Protein Mutations.	Viruses
34072434	S-Acylation of Proteins of Coronavirus and Influenza Virus: Conservation of Acylation Sites in Animal Viruses and DHHC Acyltransferases in Their Animal Reservoirs.	Pathogens
34072390	Insights into SARS-CoV-2 Persistence and Its Relevance.	Viruses
34072295	Trypsin-Like Proteases and Their Role in Muco-Obstructive Lung Diseases.	Int J Mol Sci
34072181	Mutational Asymmetries in the SARS-CoV-2 Genome May Lead to Increased Hydrophobicity of Virus Proteins.	Genes (Basel)
34072088	"SARS-CoV-2: One Year in the Pandemic. What Have We Learned, the New Vaccine Era and the Threat of SARS-CoV-2 Variants."	Biomedicines
34072087	Identification of SARS-CoV-2 Receptor Binding Inhibitors by In Vitro Screening of Drug Libraries.	Molecules
34071984	The Spike of Concern-The Novel Variants of SARS-CoV-2.	Viruses
34071883	Thrombotic Thrombocytopenia after COVID-19 Vaccination: In Search of the Underlying Mechanism.	Vaccines (Basel)
34071880	"The Potential Mechanisms of High-Velocity, Low-Amplitude, Controlled Vertebral Thrusts on Neuroimmune Function: A Narrative Review."	Medicina (Kaunas)
34071688	SARS-CoV-2-Induced Gut Microbiome Dysbiosis: Implications for Colorectal Cancer.	Cancers (Basel)
34071591	Applications of Deep Mutational Scanning in Virology.	Viruses
34071582	Binding of SARS-CoV Covalent Non-Covalent Inhibitors to the SARS-CoV-2 Papain-Like Protease and Ovarian Tumor Domain Deubiquitinases.	Biomolecules
34071557	COVID-19 Severity Potentially Modulated by Cardiovascular-Disease-Associated Immune Dysregulation.	Viruses
34071527	"The Immunological Role of the Placenta in SARS-CoV-2 Infection-Viral Transmission, Immune Regulation, and Lactoferrin Activity."	Int J Mol Sci
34071484	Hybrid Nanofibrous Membranes as a Promising Functional Layer for Personal Protection Equipment: Manufacturing and Antiviral/Antibacterial Assessments.	Polymers (Basel)
34071430	Lymphopenia in COVID-19: gammadelta T Cells-Based Therapeutic Opportunities.	Vaccines (Basel)
34071309	"Association between Interferon-Lambda-3 rs12979860, TLL1 rs17047200 and DDR1 rs4618569 Variant Polymorphisms with the Course and Outcome of SARS-CoV-2 Patients."	Genes (Basel)
34071251	"COVID-19 Infection during Pregnancy: Risk of Vertical Transmission, Fetal, and Neonatal Outcomes."	J Pers Med
34071206	Protease Inhibition-An Established Strategy to Combat Infectious Diseases.	Int J Mol Sci
34071149	Immunosuppression as a Hallmark of Critical COVID-19: Prospective Study.	Cells
34071116	"Lipophilicity, Pharmacokinetic Properties, and Molecular Docking Study on SARS-CoV-2 Target for Betulin Triazole Derivatives with Attached 1,4-Quinone."	Pharmaceutics
34071060	Attacking COVID-19 Progression Using Multi-Drug Therapy for Synergetic Target Engagement.	Biomolecules
34071034	GABAA-Receptor Agonists Limit Pneumonitis and Death in Murine Coronavirus-Infected Mice.	Viruses
34070998	Presence of SARS-CoV-2 and Its Entry Factors in Oral Tissues and Cells: A Systematic Review.	Medicina (Kaunas)
34070971	Innate and Adaptive Immune Genes Associated with MERS-CoV Infection in Dromedaries.	Cells
34070672	Thromboembolic Complications of SARS-CoV-2 and Metabolic Derangements: Suggestions from Clinical Practice Evidence to Causative Agents.	Metabolites
34070628	Role of Iron Chelation and Protease Inhibition of Natural Products on COVID-19 Infection.	J Clin Med
34070524	Noble Metal Organometallic Complexes Display Antiviral Activity against SARS-CoV-2.	Viruses
34070152	A Synthetic Peptide CTL Vaccine Targeting Nucleocapsid Confers Protection from SARS-CoV-2 Challenge in Rhesus Macaques.	Vaccines (Basel)
34070140	Prioritisation of Compounds for 3CL(pro) Inhibitor Development on SARS-CoV-2 Variants.	Molecules
34070055	Prediction and Evolution of the Molecular Fitness of SARS-CoV-2 Variants: Introducing SpikePro.	Viruses
34069869	Povidone-Iodine Attenuates Viral Replication in Ocular Cells: Implications for Ocular Transmission of RNA Viruses.	Biomolecules
34069852	Neutralizing Antibody Response of Vaccinees to SARS-CoV-2 Variants.	Vaccines (Basel)
34069835	Evaluation of SARS-CoV-2 Spike S1 Protein Response on PI3K-Mediated IL-8 Release.	Med Sci (Basel)
34069827	Aptamer BC 007's Affinity to Specific and Less-Specific Anti-SARS-CoV-2 Neutralizing Antibodies.	Viruses
34069708	ROS Cocktails as an Adjuvant for Personalized Antitumor Vaccination?	Vaccines (Basel)
34069681	Global Genomic Analysis of SARS-CoV-2 RNA Dependent RNA Polymerase Evolution and Antiviral Drug Resistance.	Microorganisms
34069591	Metabolic Profiling from an Asymptomatic Ferret Model of SARS-CoV-2 Infection.	Metabolites
34069575	Immunogenicity of Adjuvanted Psoralen-Inactivated SARS-CoV-2 Vaccines and SARS-CoV-2 Spike Protein DNA Vaccines in BALB/c Mice.	Pathogens
34069460	Strong Inhibitory Activity and Action Modes of Synthetic Maslinic Acid Derivative on Highly Pathogenic Coronaviruses: COVID-19 Drug Candidate.	Pathogens
34069441	Contribution of Syndecans to the Cellular Entry of SARS-CoV-2.	Int J Mol Sci
34069418	"Analysis of COVID-19 on Diagnosis, Vaccine, Treatment, and Pathogenesis with Clinical Scenarios."	Clin Pract
34069355	Targeting the Complement Cascade in the Pathophysiology of COVID-19 Disease.	J Clin Med
34069206	Compelling Evidence for the Activity of Antiviral Peptides against SARS-CoV-2.	Viruses
34068970	Targeting Multiple Signal Transduction Pathways of SARS-CoV-2: Approaches to COVID-19 Therapeutic Candidates.	Molecules
34068715	Non-Immunotherapy Application of LNP-mRNA: Maximizing Efficacy and Safety.	Biomedicines
34068703	Virological Correlates of IgM-IgG Patterns of Response to SARS-CoV-2 Infection According to Targeted Antigens.	Viruses
34068686	The Repurposed Drugs Suramin and Quinacrine Cooperatively Inhibit SARS-CoV-2 3CL(pro) In Vitro.	Viruses
34068677	Local Sustained GM-CSF Delivery by Genetically Engineered Encapsulated Cells Enhanced Both Cellular and Humoral SARS-CoV-2 Spike-Specific Immune Response in an Experimental Murine Spike DNA Vaccination Model.	Vaccines (Basel)
34068579	In Silico Studies of Some Isoflavonoids as Potential Candidates against COVID-19 Targeting Human ACE2 (hACE2) and Viral Main Protease (M(pro)).	Molecules
34068473	Impact of Inflammatory Immune Dysfunction in Psoriasis Patients at Risk for COVID-19.	Vaccines (Basel)
34068374	Selenium as a Bioactive Micronutrient in the Human Diet and Its Cancer Chemopreventive Activity.	Nutrients
34068221	Should We Be Concerned about the Association of Diabetes Mellitus and Periodontal Disease in the Risk of Infection by SARS-CoV-2? A Systematic Review and Hypothesis.	Medicina (Kaunas)
34067890	Structural Analysis of the Novel Variants of SARS-CoV-2 and Forecasting in North America.	Viruses
34067878	Exploring the Role of Glycans in the Interaction of SARS-CoV-2 RBD and Human Receptor ACE2.	Viruses
34067854	Viral Interactions with Adaptor-Protein Complexes: A Ubiquitous Trait among Viral Species.	Int J Mol Sci
34067850	Evaluation of the Prognosis of COVID-19 Patients According to the Presence of Underlying Diseases and Drug Treatment.	Int J Environ Res Public Health
34067745	An Epidemiological Analysis of SARS-CoV-2 Genomic Sequences from Different Regions of India.	Viruses
34067685	Antimicrobial Activity of Cyclic-Monomeric and Dimeric Derivatives of the Snail-Derived Peptide Cm-p5 against Viral and Multidrug-Resistant Bacterial Strains.	Biomolecules
34067683	Circulating Soluble ACE2 and Upstream microRNA Expressions in Serum of Type 2 Diabetes Mellitus Patients.	Int J Mol Sci
34067609	Predicting COVID-19-Comorbidity Pathway Crosstalk-Based Targets and Drugs: Towards Personalized COVID-19 Management.	Biomedicines
34067588	Neonatal SARS-CoV-2 Infection: Practical Tips.	Pathogens
34067427	Ingestion of Okinawa Island Vegetables Increases IgA Levels and Prevents the Spread of Influenza RNA Viruses.	Nutrients
34067349	Repeated Exposure to Subinfectious Doses of SARS-CoV-2 May Promote T Cell Immunity and Protection against Severe COVID-19.	Viruses
34067272	Altered Local Interactions and Long-Range Communications in UK Variant (B.1.1.7) Spike Glycoprotein.	Int J Mol Sci
34067243	Possible Beneficial Actions of Caffeine in SARS-CoV-2.	Int J Mol Sci
34067072	High Levels of the Cleaved Form of Galectin-9 and Osteopontin in the Plasma Are Associated with Inflammatory Markers That Reflect the Severity of COVID-19 Pneumonia.	Int J Mol Sci
34067054	The Discovery of Naringenin as Endolysosomal Two-Pore Channel Inhibitor and Its Emerging Role in SARS-CoV-2 Infection.	Cells
34066998	Cnicin as an Anti-SARS-CoV-2: An Integrated In Silico and In Vitro Approach for the Rapid Identification of Potential COVID-19 Therapeutics.	Antibiotics (Basel)
34066983	"Diverse Immunological Factors Influencing Pathogenesis in Patients with COVID-19: A Review on Viral Dissemination, Immunotherapeutic Options to Counter Cytokine Storm and Inflammatory Responses."	Pathogens
34066920	IgM and IgG Immunoreactivity of SARS-CoV-2 Recombinant M Protein.	Int J Mol Sci
34066850	Human Gut Microbiome and Liver Diseases: From Correlation to Causation.	Microorganisms
34066804	Does Genetic Predisposition Contribute to the Exacerbation of COVID-19 Symptoms in Individuals with Comorbidities and Explain the Huge Mortality Disparity between the East and the West?	Int J Mol Sci
34066729	Mutations in the B.1.1.7 SARS-CoV-2 Spike Protein Reduce Receptor-Binding Affinity and Induce a Flexible Link to the Fusion Peptide.	Biomedicines
34066608	Methodical Design of Viral Vaccines Based on Avant-Garde Nanocarriers: A Multi-Domain Narrative Review.	Biomedicines
34066443	Probiotic-Based Vaccines May Provide Effective Protection against COVID-19 Acute Respiratory Disease.	Vaccines (Basel)
34066434	Multifaceted Role of AMPK in Viral Infections.	Cells
34066389	Comparison of Immunological Profiles of SARS-CoV-2 Variants in the COVID-19 Pandemic Trends: An Immunoinformatics Approach.	Antibiotics (Basel)
34066385	Immunothrombosis in COVID-19: Implications of Neutrophil Extracellular Traps.	Biomolecules
34066226	Pathophysiological Association of Endothelial Dysfunction with Fatal Outcome in COVID-19.	Int J Mol Sci
34066091	Cascading from SARS-CoV-2 to Parkinson's Disease through Protein-Protein Interactions.	Viruses
34066016	Mice Immunized with the Vaccine Candidate HexaPro Spike Produce Neutralizing Antibodies against SARS-CoV-2.	Vaccines (Basel)
34066007	Post-COVID Syndrome: An Insight on Its Pathogenesis.	Vaccines (Basel)
34065953	Physiological and Pathological Inflammation Induced by Antibodies and Pentraxins.	Cells
34065789	Molecular Analysis of SARS-CoV-2 Circulating in Bangladesh during 2020 Revealed Lineage Diversity and Potential Mutations.	Microorganisms
34065735	Immunological Aspects of SARS-CoV-2 Infection and the Putative Beneficial Role of Vitamin-D.	Int J Mol Sci
34065289	Regulatory Noncoding and Predicted Pathogenic Coding Variants of CCR5 Predispose to Severe COVID-19.	Int J Mol Sci
34065210	The Emerging Role of Neutrophils in the Pathogenesis of Thrombosis in COVID-19.	Int J Mol Sci
34065123	Type 1 Diabetes Mellitus in the SARS-CoV-2 Pandemic: Oxidative Stress as a Major Pathophysiological Mechanism Linked to Adverse Clinical Outcomes.	Antioxidants (Basel)
34064904	Mutation in a SARS-CoV-2 Haplotype from Sub-Antarctic Chile Reveals New Insights into the Spike's Dynamics.	Viruses
34064802	Cytokines and Leukocytes Subpopulations Profile in SARS-CoV-2 Patients Depending on the CT Score Severity.	Viruses
34064568	Role of Resveratrol in Prevention and Control of Cardiovascular Disorders and Cardiovascular Complications Related to COVID-19 Disease: Mode of Action and Approaches Explored to Increase Its Bioavailability.	Molecules
34064553	Endothelial Dysfunction and SARS-CoV-2 Infection: Association and Therapeutic Strategies.	Pathogens
34064525	Identification of the SHREK Family of Proteins as Broad-Spectrum Host Antiviral Factors.	Viruses
34064516	The Anti-Infectious Role of Sphingosine in Microbial Diseases.	Cells
34064383	Control of Macrophage Inflammation by P2Y Purinergic Receptors.	Cells
34064279	A Portrait of the OPE as a Biological Agent.	Molecules
34064210	Dolosigranulum pigrum Modulates Immunity against SARS-CoV-2 in Respiratory Epithelial Cells.	Pathogens
34064163	Viewing SARS-CoV-2 Nucleocapsid Protein in Terms of Molecular Flexibility.	Biology (Basel)
34064143	The Emerging Concern and Interest SARS-CoV-2 Variants.	Pathogens
34064125	How DNA and RNA Viruses Exploit Host Chaperones to Promote Infection.	Viruses
34064104	Dysregulation of Pulmonary Responses in Severe COVID-19.	Viruses
34064066	Human Immunodeficiency Viruses Pseudotyped with SARS-CoV-2 Spike Proteins Infect a Broad Spectrum of Human Cell Lines through Multiple Entry Mechanisms.	Viruses
34064039	"The Molecular Basis of COVID-19 Pathogenesis, Conventional and Nanomedicine Therapy."	Int J Mol Sci
34063766	Strategies for the Production of Soluble Interferon-Alpha Consensus and Potential Application in Arboviruses and SARS-CoV-2.	Life (Basel)
34063739	Pathogenesis and Management of COVID-19.	J Xenobiot
34063562	Rotavirus as an Expression Platform of Domains of the SARS-CoV-2 Spike Protein.	Vaccines (Basel)
34063554	The Effects of Insulin-Like Growth Factor I and BTP-2 on Acute Lung Injury.	Int J Mol Sci
34063463	Persistent COVID-19 Symptoms Minimally Impact the Development of SARS-CoV-2-Specific T Cell Immunity.	Viruses
34063426	Label-Free Comparative Proteomics of Differentially Expressed Mycobacterium tuberculosis Protein in Rifampicin-Related Drug-Resistant Strains.	Pathogens
34063247	Scutellaria barbata D. Don Inhibits the Main Proteases (M(pro) and TMPRSS2) of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection.	Viruses
34063231	The Interference between SARS-CoV-2 and Tyrosine Kinase Receptor Signaling in Cancer.	Int J Mol Sci
34062964	The Systemic Immune Response in COVID-19 Is Associated with a Shift to Formyl-Peptide Unresponsive Eosinophils.	Cells
34062737	Olive-Derived Triterpenes Suppress SARS COV-2 Main Protease: A Promising Scaffold for Future Therapeutics.	Molecules
34062724	Molecular Docking and Dynamics Simulation Study of Hyrtios erectus Isolated Scalarane Sesterterpenes as Potential SARS-CoV-2 Dual Target Inhibitors.	Biology (Basel)
34062392	"Similarities and differences in the conformational stability and reversibility of ORF8, an accessory protein of SARS-CoV-2, and its L84S variant."	Biochem Biophys Res Commun
34062119	Integrated analysis of multimodal single-cell data.	Cell
34062110	Chemical system biology approach to identify multi-targeting FDA inhibitors for treating COVID-19 and associated health complications.	J Biomol Struct Dyn
34061905	"Extensive C->U transition biases in the genomes of a wide range of mammalian RNA viruses; potential associations with transcriptional mutations, damage- or host-mediated editing of viral RNA."	PLoS Pathog
34061785	Use of renin-angiotensin system inhibitors and clinical predictors of COVID-19 severity in a tertiary hospital in the city of Buenos Aires.	Infez Med
34061781	Immunopathogenesis and immunobiology of SARS-CoV-2.	Infez Med
34061779	Cardiovascular complications of COVID-19.	JCI Insight
34061775	Do monogenic inborn errors of immunity cause susceptibility to severe COVID-19?	J Clin Invest
34061468	Poly-l-lysine Glycoconjugates Inhibit DC-SIGN-mediated Attachment of Pandemic Viruses.	ChemMedChem
34061414	COVID-19 spreading across world correlates with C677T allele of the methylenetetrahydrofolate reductase (MTHFR) gene prevalence.	J Clin Lab Anal
34061395	Relative expression of proinflammatory molecules in COVID-19 patients who manifested disease severities.	J Med Virol
34061377	Inhibitory effect on SARS-CoV-2 infection of neferine by blocking Ca(2+) -dependent membrane fusion.	J Med Virol
34061349	Human CD4(+) T cells specific for dominant epitopes of SARS-CoV-2 Spike and Nucleocapsid proteins with therapeutic potential.	Clin Exp Immunol
34061288	SARS coronavirus outbreaks past and present-a comparative analysis of SARS-CoV-2 and its predecessors.	Virus Genes
34060982	H1N1 exposure during the convalescent stage of SARS-CoV-2 infection results in enhanced lung pathologic damage in hACE2 transgenic mice.	Emerg Microbes Infect
34060900	Emergence of Resistance to Novel Cephalosporin-beta-Lactamase Inhibitor Combinations through the Modification of the Pseudomonas aeruginosa MexCD-OprJ Efflux Pump.	Antimicrob Agents Chemother
34060490	Coronavirus-specific antibody production in middle-aged mice requires phospholipase A2G2D.	J Clin Invest
34060486	Histone deficiency and accelerated replication stress in T cell aging.	J Clin Invest
34060442	[Prediction of the epitopes of SARS-CoV-2 by immunoinformatics].	Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi
34060425	Computational analysis of protein stability and allosteric interaction networks in distinct conformational forms of the SARS-CoV-2 spike D614G mutant: reconciling functional mechanisms through allosteric model of spike regulation.	J Biomol Struct Dyn
34060418	Molecular modeling of potent novel sulfonamide derivatives as non-peptide small molecule anti-COVID 19 agents.	J Biomol Struct Dyn
34060390	"SARS-CoV-2 vs. human gametes, embryos and cryopreservation."	Syst Biol Reprod Med
34060379	An Update on the Pathogenesis of COVID-19 and the Reportedly Rare Thrombotic Events Following Vaccination.	Clin Appl Thromb Hemost
34060334	Convalescent-Phase Sera and Vaccine-Elicited Antibodies Largely Maintain Neutralizing Titer against Global SARS-CoV-2 Variant Spikes.	mBio
34060150	Formulation of a Composite Nasal Spray Enabling Enhanced Surface Coverage and Prophylaxis of SARS-COV-2.	Adv Mater
34059786	"Are adipokines the missing link between obesity, immune response, and outcomes in severe COVID-19?"	Int J Obes (Lond)
34059617	A core-shell structured COVID-19 mRNA vaccine with favorable biodistribution pattern and promising immunity.	Signal Transduct Target Ther
34059562	Humoral Immunity against SARS-CoV-2 and the Impact on COVID-19 Pathogenesis.	Mol Cells
34059561	"Molecular Perspectives of SARS-CoV-2: Pathology, Immune Evasion, and Therapeutic Interventions."	Mol Cells
34059141	Platelet-driven coagulopathy in COVID-19 patients: in comparison to seasonal influenza cases.	Exp Hematol Oncol
34059140	"Hypertension, renin-angiotensin-aldosterone-system-blocking agents, and COVID-19."	Clin Hypertens
34059098	Natural drug sources for respiratory diseases from Fritillaria: chemical and biological analyses.	Chin Med
34058787	The role of lactate in sepsis and COVID-19: Perspective from contracting skeletal muscle metabolism.	Exp Physiol
34058750	Quercetin for COVID-19 and DENGUE co-infection: a potential therapeutic strategy of targeting critical host signal pathways triggered by SARS-CoV-2 and DENV.	Brief Bioinform
34058746	TLR7 Ligation Inhibits TLR8 Responsiveness in IL-27-Primed Human THP-1 Monocytes and Macrophages.	J Innate Immun
34058526	Cryo-EM to visualize the structural organization of viruses.	Curr Opin Virol
34058321	"Nrf2 Activator PB125(R) as a Carnosic Acid-Based Therapeutic Agent against Respiratory Viral Diseases, including COVID-19."	Free Radic Biol Med
34058304	Identification of E484K and other novel SARS-COV-2 variants from the Kingdom of Bahrain.	Microb Pathog
34058295	Computational and experimental studies on the inhibitory mechanism of hydroxychloroquine on hERG.	Toxicology
34058271	Systemic dendrimer nanotherapies for targeted suppression of choroidal inflammation and neovascularization in age-related macular degeneration.	J Control Release
34058265	Immune characterization and profiles of SARS-CoV-2 infected patients reveals potential host therapeutic targets and SARS-CoV-2 oncogenesis mechanism.	Virus Res
34058196	Role of host factors in SARS-CoV-2 entry.	J Biol Chem
34058052	Impaired anti-SARS-CoV-2 humoral and cellular immune response induced by Pfizer-BioNTech BNT162b2 mRNA vaccine in solid organ transplanted patients.	Am J Transplant
34057983	A review of Covid-19 and acute kidney injury: from pathophysiology to clinical results.	J Bras Nefrol
34057973	Pulmocrinology: Interplay of pulmonary and endocrine diseases.	J Pak Med Assoc
34057871	Promising drug repurposing approach targeted for cytokine storm implicated in SARS-CoV-2 complications.	Immunopharmacol Immunotoxicol
34057870	Repurposing metformin for covid-19 complications in patients with type 2 diabetes and insulin resistance.	Immunopharmacol Immunotoxicol
34057760	Inflammasome regulation in driving COVID-19 severity in humans and immune tolerance in bats.	J Leukoc Biol
34057753	Severe COVID-19 is marked by dysregulated serum levels of carboxypeptidase A3 and serotonin.	J Leukoc Biol
34057647	Plausible blockers of Spike RBD in SARS-CoV2-molecular design and underlying interaction dynamics from high-level structural descriptors.	J Mol Model
34057608	"Upregulation of INF-gamma, IL-6, and IL-8 expression during replication of turkey coronavirus in nonepithelial cells obtained from Meleagris gallopavo."	Arch Virol
34057580	"PPAR agonists as effective adjuvants for COVID-19 vaccines, by modifying immunogenetics: a review of literature."	J Genet Eng Biotechnol
34057039	Structure-based design and characterization of novel fusion-inhibitory lipopeptides against SARS-CoV-2 and emerging variants.	Emerg Microbes Infect
34056843	The COVID-19 world - Are we there yet?	J Diabetes Investig
34056628	Cross-reactive coronavirus antibodies with diverse epitope specificities and Fc effector functions.	Cell Rep Med
34056627	"Landscape of epitopes targeted by T cells in 852 individuals recovered from COVID-19: Meta-analysis, immunoprevalence, and web platform."	Cell Rep Med
34056406	Artificial Intelligence-Guided De Novo Molecular Design Targeting COVID-19.	ACS Omega
34056141	Pulmonary stromal expansion and intra-alveolar coagulation are primary causes of COVID-19 death.	Heliyon
34056140	Accommodating receptor flexibility and free energy calculation to reduce false positive binders in the discovery of natural products blockers of SARS-COV-2 spike RBD-ACE2 interface.	Biochem Biophys Rep
34056095	Synthetic Siglec-9 Agonists Inhibit Neutrophil Activation Associated with COVID-19.	ACS Cent Sci
34056089	Native-like SARS-CoV-2 Spike Glycoprotein Expressed by ChAdOx1 nCoV-19/AZD1222 Vaccine.	ACS Cent Sci
34056088	Assessing Antigen Structural Integrity through Glycosylation Analysis of the SARS-CoV-2 Viral Spike.	ACS Cent Sci
34056008	Induction of Humoral and Cellular Immunity by Intradermal Delivery of SARS-CoV-2 Nucleocapsid Protein Using Dissolvable Microneedles.	J Immunol Res
34055939	Cardiovascular Impacts on COVID-19 Infected Patients.	Front Cardiovasc Med
34055746	"The First Insight Into the Supramolecular System of D,L-alpha-Difluoromethylornithine: A New Antiviral Perspective."	Front Chem
34055688	"Vaping, SARS-CoV-2, and Multisystem Inflammatory Syndrome: A Perfect Storm."	Front Pediatr
34055582	SARS-CoV-2 infection with lytic and non-lytic immune responses: A fractional order optimal control theoretical study.	Results Phys
34055238	Prediction of repurposed drugs for Coronaviruses using artificial intelligence and machine learning.	Comput Struct Biotechnol J
34054974	"A Correlation among the COVID-19 Spread, Particulate Matters, and Angiotensin-Converting Enzyme 2: A Review."	J Environ Public Health
34054961	Is SARS-CoV-2 an Etiologic Agent or Predisposing Factor for Oral Lesions in COVID-19 Patients? A Concise Review of Reported Cases in the Literature.	Int J Dent
34054909	Plant-Produced Receptor-Binding Domain of SARS-CoV-2 Elicits Potent Neutralizing Responses in Mice and Non-human Primates.	Front Plant Sci
34054866	Intestinal Microbiota-A Promising Target for Antiviral Therapy?	Front Immunol
34054832	Pulmonary Procoagulant and Innate Immune Responses in Critically Ill COVID-19 Patients.	Front Immunol
34054828	The Role of IL-36 in Infectious Diseases: Potential Target for COVID-19?	Front Immunol
34054808	Human Surfactant Protein D Binds Spike Protein and Acts as an Entry Inhibitor of SARS-CoV-2 Pseudotyped Viral Particles.	Front Immunol
34054806	Medicinal Plants and Isolated Molecules Demonstrating Immunomodulation Activity as Potential Alternative Therapies for Viral Diseases Including COVID-19.	Front Immunol
34054793	Identify. Quantify. Predict. Why Immunologists Should Widely Use Molecular Imaging for Coronavirus Disease 2019.	Front Immunol
34054782	Therapeutic Potential of Exploiting Autophagy Cascade Against Coronavirus Infection.	Front Microbiol
34054572	The Cholinergic and ACE-2-Dependent Anti-Inflammatory Systems in the Lung: New Scenarios Emerging From COVID-19.	Front Physiol
34054557	Synergy Between Vitamin D and Sex Hormones in Respiratory Functionality of Patients Affected by COVID-19.	Front Pharmacol
34054532	Multi-Omics Approach in the Identification of Potential Therapeutic Biomolecule for COVID-19.	Front Pharmacol
34054522	Broad Anti-Viral Capacities of Lian-Hua-Qing-Wen Capsule and Jin-Hua-Qing-Gan Granule and Rational use Against COVID-19 Based on Literature Mining.	Front Pharmacol
34054510	"beta-Caryophyllene, A Natural Dietary CB2 Receptor Selective Cannabinoid can be a Candidate to Target the Trinity of Infection, Immunity, and Inflammation in COVID-19."	Front Pharmacol
34054381	Inflammatory and coagulative pathophysiology for the management of burn patients with COVID-19: systematic review of the evidence.	Ann Burns Fire Disasters
34054380	Flavonoids are promising safe therapy against COVID-19.	Phytochem Rev
34054314	Prophylactic effects of probiotics on respiratory viruses including COVID-19: a review.	Food Sci Biotechnol
34054300	"Shift in the Dominant Sequence Type of Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infection from ST11 to ST15 at a Medical Center in Northeast China, 2015-2020."	Infect Drug Resist
34054246	Evaluation of potency of the selected bioactive molecules from Indian medicinal plants with M(Pro) of SARS-CoV-2 through in silico analysis.	J Ayurveda Integr Med
34054222	Potential protective mechanisms of green tea polyphenol EGCG against COVID-19.	Trends Food Sci Technol
34054142	"DFT, molecular docking and molecular dynamics simulation studies on some newly introduced natural products for their potential use against SARS-CoV-2."	J Mol Struct
34053902	Severe asthma in the era of COVID-19: A narrative review.	Pulmonology
34053187	ADAMTS13 regulation of VWF multimer distribution in severe COVID-19.	J Thromb Haemost
34053084	Alpha-defensins: risk factor for thrombosis in COVID-19 infection.	Br J Haematol
34052981	"The application of in silico experimental model in the assessment of ciprofloxacin and levofloxacin interaction with main SARS-CoV-2 targets: S-, E- and TMPRSS2 proteins, RNA-dependent RNA polymerase and papain-like protease (PLpro)-preliminary molecular docking analysis."	Pharmacol Rep
34052732	Remdesivir for the treatment of Covid-19: the value of biochemical studies.	Curr Opin Virol
34052578	Azelastine inhibits viropexis of SARS-CoV-2 spike pseudovirus by binding to SARS-CoV-2 entry receptor ACE2.	Virology
34052565	Main protease inhibitors and drug surface hotspots for the treatment of COVID-19: A drug repurposing and molecular docking approach.	Biomed Pharmacother
34052441	Machine learning enabled identification of potential SARS-CoV-2 3CLpro inhibitors based on fixed molecular fingerprints and Graph-CNN neural representations.	J Biomed Inform
34052418	"Pathomechanisms, therapeutic targets and potent inhibitors of some beta-coronaviruses from bench-to-bedside."	Infect Genet Evol
34051873	"A traditional medicine, respiratory detox shot (RDS), inhibits the infection of SARS-CoV, SARS-CoV-2, and the influenza A virus in vitro."	Cell Biosci
34051791	Dysregulation of COVID-19 related gene expression in the COPD lung.	Respir Res
34051617	Theobroma cacao L. compounds: Theoretical study and molecular modeling as inhibitors of main SARS-CoV-2 protease.	Biomed Pharmacother
34051613	Mechanisms of Immunothrombosis in Vaccine-Induced Thrombotic Thrombocytopenia (VITT) Compared to Natural SARS-CoV-2 Infection.	J Autoimmun
34051372	"Crosstalk of TLR4, vascular NADPH oxidase, and COVID-19 in diabetes: What are the potential implications?"	Vascul Pharmacol
34051176	"COVID-19-associated Aspergillus tracheobronchitis: the interplay between viral tropism, host defence, and fungal invasion."	Lancet Respir Med
34051148	Longitudinal analysis reveals that delayed bystander CD8+ T cell activation and early immune pathology distinguish severe COVID-19 from mild disease.	Immunity
34051147	Distinct immunological signatures discriminate severe COVID-19 from non-SARS-CoV-2-driven critical pneumonia.	Immunity
34050887	The role of unconventional T cells in COVID-19.	Ir J Med Sci
34050837	MHC Haplotyping of SARS-CoV-2 Patients: HLA Subtypes Are Not Associated with the Presence and Severity of COVID-19 in the Israeli Population.	J Clin Immunol
34049971	Cutting Edge: Distinct B Cell Repertoires Characterize Patients with Mild and Severe COVID-19.	J Immunol
34049969	Metabolic Defects of Peripheral T Cells in COVID-19 Patients.	J Immunol
34049881	Immunization with RBD-P2 and N protects against SARS-CoV-2 in nonhuman primates.	Sci Adv
34049471	Intra-species sialic acid polymorphism in humans: a common niche for influenza and coronavirus pandemics?	Emerg Microbes Infect
34049240	Comparing infectivity and virulence of emerging SARS-CoV-2 variants in Syrian hamsters.	EBioMedicine
34049205	"Recognition through GRP78 is enhanced in the UK, South African, and Brazilian variants of SARS-CoV-2; An in silico perspective."	Biochem Biophys Res Commun
34048987	Hypothesis for renin-angiotensin inhibitor mitigation of COVID-19.	Med Hypotheses
34048906	Do inflammaging and coagul-aging play a role as conditions contributing to the co-occurrence of the severe hyper-inflammatory state and deadly coagulopathy during COVID-19 in older people?	Exp Gerontol
34048833	"Classification, structure and mechanism of antiviral polysaccharides derived from edible and medicinal fungus."	Int J Biol Macromol
34048708	SARS-CoV-2 exacerbates proinflammatory responses in myeloid cells through C-type lectin receptors and Tweety family member 2.	Immunity
34048668	Role of OATP4C1 in Renal Handling of Remdesivir and its Nucleoside Analog GS-441524: The First Approved Drug for Patients with COVID-19.	J Pharm Pharm Sci
34048518	Synthesis and characterisation of N-gene targeted NIR-II fluorescent probe for selective localisation of SARS-CoV-2.	Chem Commun (Camb)
34048457	Avian antibodies (IgY) targeting spike glycoprotein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) inhibit receptor binding and viral replication.	PLoS One
34047913	NPC1-regulated dynamic of clathrin-coated pits is essential for viral entry.	Sci China Life Sci
34047837	Alterations of the male and female reproductive systems induced by COVID-19.	Wien Klin Wochenschr
34047817	Endophytes: the novel sources for plant terpenoid biosynthesis.	Appl Microbiol Biotechnol
34047762	Difference in SARS-CoV-2 Antibody Status Between Patients With Cancer and Health Care Workers During the COVID-19 Pandemic in Japan.	JAMA Oncol
34047686	"Hospital mortality in COVID-19 patients in Belgium treated with statins, ACE inhibitors and/or ARBs."	Hum Vaccin Immunother
34047654	Temporal Kinetics of RNAemia and Associated Systemic Cytokines in Hospitalized COVID-19 Patients.	mSphere
34047452	SARS-CoV-2 first contact: Spike-ACE2 interactions in COVID-19.	Chem Biol Drug Des
34047305	Increased ACE2 Levels and Mortality Risk of Patients With COVID-19 on Proton Pump Inhibitor Therapy.	Am J Gastroenterol
34047290	COVID-19 and central nervous system interplay: A big picture beyond clinical manifestation.	J Biosci
34047261	A short review on key role of plants and their extracts in boosting up immune response to combat COVID-19.	Infect Disord Drug Targets
34047191	Benchmarking the Ability of Common Docking Programs to Correctly Reproduce and Score Binding Modes in SARS-CoV-2 Protease Mpro.	J Chem Inf Model
34046923	"SARS-CoV-2's claimed natural origin is undermined by issues with genome sequences of its relative strains: Coronavirus sequences RaTG13, MP789 and RmYN02 raise multiple questions to be critically addressed by the scientific community."	Bioessays
34046852	Cardiac complications during the active phase of COVID-19: review of the current evidence.	Intern Emerg Med
34046618	Recent advances in the discovery of potent RNA-dependent RNA-polymerase (RdRp) inhibitors targeting viruses.	RSC Med Chem
34046603	Identification of LASSBio-1945 as an inhibitor of SARS-CoV-2 main protease (M(PRO)) through in silico screening supported by molecular docking and a fragment-based pharmacophore model.	RSC Med Chem
34046592	A map of the SARS-CoV-2 RNA structurome.	NAR Genom Bioinform
34046449	COVID-19 combined with liver injury: Current challenges and management.	World J Clin Cases
34046428	Synthesis and Cytotoxic Activity of Novel Indole Derivatives and Their in silico Screening on Spike Glycoprotein of SARS-CoV-2.	Front Mol Biosci
34046177	Vitamin D regulation of the immune system and its implications for COVID-19: A mini review.	SAGE Open Med
34046161	Mechanisms of SARS-CoV-2-induced lung vascular disease: potential role of complement.	Pulm Circ
34046036	Profile of Circulatory Cytokines and Chemokines in Human Coronaviruses: A Systematic Review and Meta-Analysis.	Front Immunol
34046033	Infection and Immune Memory: Variables in Robust Protection by Vaccines Against SARS-CoV-2.	Front Immunol
34045976	Alteration in the Lipid Profile and the Desaturases Activity in Patients With Severe Pneumonia by SARS-CoV-2.	Front Physiol
34045800	Comparison of Severity of COVID-19 Infection among Patients Using RAAS Inhibitors and Non-RAAS Inhibitors.	Indian J Crit Care Med
34045585	Viral fibrotic scoring and drug screen based on MAPK activity uncovers EGFR as a key regulator of COVID-19 fibrosis.	Sci Rep
34045524	Dynamic changes in gene-to-gene regulatory networks in response to SARS-CoV-2 infection.	Sci Rep
34045511	"Androgen regulation of pulmonary AR, TMPRSS2 and ACE2 with implications for sex-discordant COVID-19 outcomes."	Sci Rep
34045440	Exploring protein hotspots by optimized fragment pharmacophores.	Nat Commun
34045361	Translational shutdown and evasion of the innate immune response by SARS-CoV-2 NSP14 protein.	Proc Natl Acad Sci U S A
34044706	Immune Responses in Patients with COVID-19: An Overview.	Pediatr Ann
34044428	BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans.	Nature
34044348	Bio-inspired Ag nanovilli-based sandwich-type SERS aptasensor for ultrasensitive and selective detection of 25-hydroxy vitamin D3.	Biosens Bioelectron
34044308	Probing nano-QSAR to assess the interactions between carbon nanoparticles and a SARS-CoV-2 RNA fragment.	Ecotoxicol Environ Saf
34044192	E484K as an innovative phylogenetic event for viral evolution: Genomic analysis of the E484K spike mutation in SARS-CoV-2 lineages from Brazil.	Infect Genet Evol
34044007	Application of a novel mathematical model to identify intermediate hosts of SARS-CoV-2.	J Theor Biol
34043946	SARS-CoV-2 genomic surveillance identifies naturally occurring truncation of ORF7a that limits immune suppression.	Cell Rep
34043881	Regulatory KIR(+) RA(+) T cells accumulate with age and are highly activated during viral respiratory disease.	Aging Cell
34043740	TMEM41B is a host factor required for the replication of diverse coronaviruses including SARS-CoV-2.	PLoS Pathog
34043733	Molecular dynamics analysis of N-acetyl-D-glucosamine against specific SARS-CoV-2's pathogenicity factors.	PLoS One
34043618	DNA vaccination induced protective immunity against SARS CoV-2 infection in hamsterss.	PLoS Negl Trop Dis
34043590	Rare loss-of-function variants in type I IFN immunity genes are not associated with severe COVID-19.	J Clin Invest
34043356	"Insight into the LFA-1/SARS-CoV-2 Orf7a Complex by Protein-Protein Docking, Molecular Dynamics, and MM-GBSA Calculations."	J Chem Inf Model
34043164	Microbiota's role in health and diseases.	Environ Sci Pollut Res Int
34043002	Identification of evolutionarily stable functional and immunogenic sites across the SARS-CoV-2 proteome and greater coronavirus family.	Bioinformatics
34042772	"A Knowledge Graph of Mechanistic Associations Between COVID-19, Diabetes Mellitus and Kidney Diseases."	Stud Health Technol Inform
34042528	"Alarmins, COVID-19 and comorbidities."	Ann Med
34042476	Genome Sequences of SARS-CoV-2 P.1 (Variant of Concern) and P.2 (Variant of Interest) Identified in Uruguay.	Microbiol Resour Announc
34042471	"Genome Sequencing Identified a SARS-CoV-2 Lineage B.1.1.7 Strain with a High Number of Mutations from Dhaka, Bangladesh."	Microbiol Resour Announc
34042415	Phageome-based vaccination and human innate immune modulation could be a useful strategy to control human Coronavirus infections.	J Biol Regul Homeost Agents
34042186	Genome-wide analysis of SARS-CoV-2 strains circulating in Vietnam: Understanding the nature of the epidemic and role of the D614G mutation.	J Med Virol
34042182	Unknown/enigmatic functions of extracellular ASC.	Immunology
34042167	"[Post-COVID-19 syndrome: epidemiology, diagnostic criteria and pathogenic mechanisms involved]."	Rev Neurol
34042036	COVID-19 IN CHILDREN: A NARRATIVE REVIEW.	Curr Pediatr Rev
34042026	Interfering with Host Proteases in SARS-CoV-2 Entry as a Promising Therapeutic Strategy.	Curr Med Chem
34042025	"COVID-19: The significance of platelets, mitochondria, vitamin D, serotonin and the gut microbiota."	Curr Med Chem
34041821	Pathophysiology of infection with SARS-CoV-2-What is known and what remains a mystery.	Respirology
34041486	Repurposing the HCV NS3-4A protease drug boceprevir as COVID-19 therapeutics.	RSC Med Chem
34041482	Targeting the SARS-CoV-2-spike protein: from antibodies to miniproteins and peptides.	RSC Med Chem
34041264	Large-Scale Recombinant Production of the SARS-CoV-2 Proteome for High-Throughput and Structural Biology Applications.	Front Mol Biosci
34041263	Prospective Role of Peptide-Based Antiviral Therapy Against the Main Protease of SARS-CoV-2.	Front Mol Biosci
34041221	Pharmacophore Modelling-Based Drug Repurposing Approaches for SARS-CoV-2 Therapeutics.	Front Chem
34041049	Association of coronavirus pathogencity with the level of antioxidants and immune system.	J Family Med Prim Care
34040616	The Role of Macrophages in the Pathogenesis of SARS-CoV-2-Associated Acute Respiratory Distress Syndrome.	Front Immunol
34040615	SARS-CoV-2 Infection and Guillain-Barre Syndrome: A Review on Potential Pathogenic Mechanisms.	Front Immunol
34040540	Vaping Exacerbates Coronavirus-Related Pulmonary Infection in a Murine Model.	Front Physiol
34040501	Selenium to selenoproteins - role in COVID-19.	EXCLI J
34040326	Pathophysiological mechanisms underlying gastrointestinal symptoms in patients with COVID-19.	World J Gastroenterol
34040321	Receptor for advanced glycation end-products axis and coronavirus disease 2019 in inflammatory bowel diseases: A dangerous liaison?	World J Gastroenterol
34040048	A method for the rational selection of drug repurposing candidates from multimodal knowledge harmonization.	Sci Rep
34040046	Novel human neutralizing mAbs specific for Spike-RBD of SARS-CoV-2.	Sci Rep
34039497	An mRNA-based vaccine candidate against SARS-CoV-2 elicits stable immuno-response with single dose.	Vaccine
34039006	Conformational Ensembles of Noncoding Elements in the SARS-CoV-2 Genome from Molecular Dynamics Simulations.	J Am Chem Soc
34038715	Direct derivation of human alveolospheres for SARS-CoV-2 infection modeling and drug screening.	Cell Rep
34038700	Engineering a multi epitope vaccine against SARS-CoV-2 by exploiting its non structural and structural proteins.	J Biomol Struct Dyn
34038639	Quinoline and Quinazoline Derivatives Inhibit Viral RNA Synthesis by SARS-CoV-2 RdRp.	ACS Infect Dis
34038630	"The COVID-19 pandemic, heart and cardiovascular diseases: What we have learned."	Dent Med Probl
34038475	Differential association between inflammatory cytokines and multiorgan dysfunction in COVID-19 patients with obesity.	PLoS One
34038453	Increased elastase sensitivity and decreased intramolecular interactions in the more transmissible 501Y.V1 and 501Y.V2 SARS-CoV-2 variants' spike protein-an in silico analysis.	PLoS One
34038423	SARS-CoV-2 mutations among minks show reduced lethality and infectivity to humans.	PLoS One
34038246	Reckoning gamma-Glutamyl-S-allylcysteine as a potential main protease (m(pro)) inhibitor of novel SARS-CoV-2 virus identified using docking and molecular dynamics simulation.	Drug Dev Ind Pharm
34038190	The role of mediator complex subunit 19 in human diseases.	Exp Biol Med (Maywood)
34038115	"Thermostability, Tunability, and Tenacity of RNA as Rubbery Anionic Polymeric Materials in Nanotechnology and Nanomedicine-Specific Cancer Targeting with Undetectable Toxicity."	Chem Rev
34038103	Activatable Carbocyanine Dimers for Photoacoustic and Fluorescent Detection of Protease Activity.	ACS Sens
34037874	Compartmental Model Suggests Importance of Innate Immune Response to COVID-19 Infection in Rhesus Macaques.	Bull Math Biol
34037640	Immune evasion of SARS-CoV-2 variants of concern is driven by low affinity to neutralizing antibodies.	Chem Commun (Camb)
34037476	The Role of Viruses in Carcinogenesis and Molecular Targeting: From Infection to Being a Component of the Tumor Microenvironment.	OMICS
34037422	Coronavirus Porcine Epidemic Diarrhea Virus Nucleocapsid Protein Interacts with p53 To Induce Cell Cycle Arrest in S-Phase and Promotes Viral Replication.	J Virol
34037417	Genome-Wide Variation in Betacoronaviruses.	J Virol
34037044	Chemical probes targeting the kinase CK2: a journey outside the catalytic box.	Org Biomol Chem
34036855	Unravelling Pathophysiology of Neurological and Psychiatric Complications of COVID-19 Using Brain Organoids.	Neuroscientist
34036720	Cellular and humoral response after MRNA-1273 SARS-CoV-2 vaccine in kidney transplant recipients.	Am J Transplant
34036353	"Type I, II, and III interferon signatures correspond to COVID-19 disease severity."	J Infect Dis
34036326	A multi-modal data harmonisation approach for discovery of COVID-19 drug targets.	Brief Bioinform
34035963	"Getting to the Heart of the Matter: Myocardial Injury, Coagulopathy, and Other Potential Cardiovascular Implications of COVID-19."	Int J Vasc Med
34035952	Transmission dynamics of SARS-CoV-2 within-host diversity in two major hospital outbreaks in South Africa.	Virus Evol
34035891	Renin-angiotensin-aldosterone system blockers and region-specific variations in COVID-19 outcomes: findings from a systematic review and meta-analysis.	Ther Adv Drug Saf
34035845	Cyclodextrins in the antiviral therapy.	J Drug Deliv Sci Technol
34035697	Smoking and Liver Disease.	Gastroenterol Hepatol (N Y)
34035654	SARS-CoV-2 and Pre-existing Vascular Diseases: Guilt by Association?	Clin Med Insights Cardiol
34035555	Severe Acute Respiratory Syndrome Coronavirus 2: The Emergence of Important Genetic Variants and Testing Options for Clinical Laboratories.	Clin Microbiol Newsl
34035535	"COVID-19 in Amazonas, Brazil, was driven by the persistence of endemic lineages and P.1 emergence."	Nat Med
34035463	"Platycodin D, a natural component of Platycodon grandiflorum, prevents both lysosome- and TMPRSS2-driven SARS-CoV-2 infection by hindering membrane fusion."	Exp Mol Med
34035401	Genetics of symptom remission in outpatients with COVID-19.	Sci Rep
34035301	Immune response to SARS-CoV-2 variants of concern in vaccinated individuals.	Nat Commun
34035220	Proteomics of extracellular vesicles in plasma reveals the characteristics and residual traces of COVID-19 patients without underlying diseases after 3 months of recovery.	Cell Death Dis
34035218	SARS-CoV-2 nucleocapsid protein impairs stress granule formation to promote viral replication.	Cell Discov
34035118	SARS-CoV-2 variants of concern partially escape humoral but not T-cell responses in COVID-19 convalescent donors and vaccinees.	Sci Immunol
34035116	Polyclonal expansion of TCR Vbeta 21.3(+) CD4(+) and CD8(+) T cells is a hallmark of Multisystem Inflammatory Syndrome in Children.	Sci Immunol
34035081	Navigating in Deep Waters: How Tissue Damage and Inflammation Shape Effector and Memory CD8(+) T Cell Responses.	Immunohorizons
34034806	Blood DNA methylation and COVID-19 outcomes.	Clin Epigenetics
34034760	Long non-coding RNAs in Epstein-Barr virus-related cancer.	Cancer Cell Int
34034620	A 'deep dive' into the SARS-Cov-2 polymerase assembly: identifying novel allosteric sites and analyzing the hydrogen bond networks and correlated dynamics.	J Biomol Struct Dyn
34034617	Time-dependent viral interference between influenza virus and coronavirus in the infection of differentiated porcine airway epithelial cells.	Virulence
34034298	Increased Glucocorticoid Receptor Alpha Expression and Signaling in Critically Ill Coronavirus Disease 2019 Patients.	Crit Care Med
34034082	Invasive pulmonary aspergillosis associated with viral pneumonitis.	Curr Opin Microbiol
34033999	Sulforaphane inhibits the expression of interleukin-6 and interleukin-8 induced in bronchial epithelial IB3-1 cells by exposure to the SARS-CoV-2 Spike protein.	Phytomedicine
34033891	Phytochemicals present in Indian ginseng possess potential to inhibit SARS-CoV-2 virulence: A molecular docking and MD simulation study.	Microb Pathog
34033836	Coronavirus disease 2019 (COVID-19): Biophysical and biochemical aspects of SARS-CoV-2 and general characteristics.	Prog Biophys Mol Biol
34033751	COVID-19 Vasculopathy: Mounting Evidence for an Indirect Mechanism of Endothelial Injury.	Am J Pathol
34033727	How to face COVID-19: proposed treatments based on remdesivir and hydroxychloroquine in the presence of zinc sulfate. Docking/DFT/POM structural analysis.	J Biomol Struct Dyn
34033716	Penetrating the Blood-Brain Barrier with New Peptide-Porphyrin Conjugates Having anti-HIV Activity.	Bioconjug Chem
34033650	SARS-CoV-2: Possible recombination and emergence of potentially more virulent strains.	PLoS One
34033365	Monoclonal Antibody Therapy For High-Risk Coronavirus (COVID 19) Patients With Mild To Moderate Disease Presentations	StatPearls
34033342	Emerging Variants of SARS-CoV-2 And Novel Therapeutics Against Coronavirus (COVID-19)	StatPearls
34033224	Androgenetic alopecia and COVID-19: A review of the hypothetical role of androgens.	Dermatol Ther
34033145	High levels of eicosanoids and docosanoids in the lungs of intubated COVID-19 patients.	FASEB J
34033061	"The Intersection of Parkinson's Disease, Viral Infections, and COVID-19."	Mol Neurobiol
34032881	Integrative omics provide biological and clinical insights into acute respiratory distress syndrome.	Intensive Care Med
34032635	Multisystem inflammatory syndrome in children is driven by zonulin-dependent loss of gut mucosal barrier.	J Clin Invest
34032550	Antibodies: what makes us stronger.	Hum Vaccin Immunother
34032527	The understanding of the immunopathology in COVID-19 infection.	Scand J Clin Lab Invest
34032435	Lipid Nanoparticle RBD-hFc mRNA Vaccine Protects hACE2 Transgenic Mice against a Lethal SARS-CoV-2 Infection.	Nano Lett
34032232	Cell-free hemoglobin is a marker of systemic inflammation in mouse models of sepsis: a Raman spectroscopic study.	Analyst
34032180	Virtual screening of quinoline derived library for SARS-COV-2 targeting viral entry and replication.	J Biomol Struct Dyn
34031932	Autoantibodies in Covid-19 - a model for viral induced autoimmunity.	J Eur Acad Dermatol Venereol
34031864	Eosinophils as Major Player in Type 2 Inflammation: Autoimmunity and Beyond.	Adv Exp Med Biol
34031621	Molecular basis of the new COVID-19 target neuropilin-1 in complex with SARS-CoV-2 S1 C-end rule peptide and small-molecule antagonists.	J Mol Liq
34031619	Chemical reactivities and molecular docking studies of parthenolide with the main protease of HEP-G2 and SARS-CoV-2.	J Mol Struct
34031561	SARS-CoV-2 simulations go exascale to predict dramatic spike opening and cryptic pockets across the proteome.	Nat Chem
34031543	Patients with COVID-19: in the dark-NETs of neutrophils.	Cell Death Differ
34031537	Histopathological findings and clinicopathologic correlation in COVID-19: a systematic review.	Mod Pathol
34031464	"Estimates of gene ensemble noise highlight critical pathways and predict disease severity in H1N1, COVID-19 and mortality in sepsis patients."	Sci Rep
34031435	Integrative web-based analysis of omics data for study of drugs against SARS-CoV-2.	Sci Rep
34031419	Comparative transcriptome analysis reveals key epigenetic targets in SARS-CoV-2 infection.	NPJ Syst Biol Appl
34031399	Inhibition mechanism of SARS-CoV-2 main protease by ebselen and its derivatives.	Nat Commun
34031383	Targeting novel LSD1-dependent ACE2 demethylation domains inhibits SARS-CoV-2 replication.	Cell Discov
34031243	Transfer transcriptomic signatures for infectious diseases.	Proc Natl Acad Sci U S A
34031189	Cysteine modification by ebselen reduces the stability and cellular levels of 14-3-3 proteins.	Mol Pharmacol
34030677	"Extremes of age are associated with differences in the expression of selected pattern recognition receptor genes and ACE2, the receptor for SARS-CoV-2: implications for the epidemiology of COVID-19 disease."	BMC Med Genomics
34030593	Quasispecies of SARS-CoV-2 revealed by single nucleotide polymorphisms (SNPs) analysis.	Virulence
34030176	SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans.	Nature
34029993	Considerations for the discovery and development of 3-chymotrypsin-like cysteine protease inhibitors targeting SARS-CoV-2 infection.	Curr Opin Virol
34029937	Corilagin prevents SARS-CoV-2 infection by targeting RBD-ACE2 binding.	Phytomedicine
34029832	Organotypic human ex vivo models for coronavirus disease 2019 research and drug development.	Curr Opin Pharmacol
34029587	"Arginine methylation of SARS-Cov-2 nucleocapsid protein regulates RNA binding, its ability to suppress stress granule formation, and viral replication."	J Biol Chem
34029506	Binding mode characterization of 13b in the monomeric and dimeric states of SARS-CoV-2 main protease using molecular dynamics simulations.	J Biomol Struct Dyn
34029337	Thrombotic thrombocytopenia associated with COVID-19 infection or vaccination: Possible paths to platelet factor 4 autoimmunity.	PLoS Med
34029205	Structural basis of ribosomal frameshifting during translation of the SARS-CoV-2 RNA genome.	Science
34028807	COVID-19 and pulmonary fibrosis: A potential role for lung epithelial cells and fibroblasts.	Immunol Rev
34028308	The classical and potential novel healthy functions of rice bran protein and its hydrolysates.	Crit Rev Food Sci Nutr
34028178	Targeting the glycans: A paradigm for host-targeted and COVID-19 drug design.	J Cell Mol Med
34028129	Oral manifestations of Covid-19-A literature review.	Rev Med Virol
34027906	Coronavirus disease 2019 and kidney injury.	Curr Opin Nephrol Hypertens
34027897	The relationship between cytokine and neutrophil gene network distinguishes SARS-CoV-2-infected patients by sex and age.	JCI Insight
34027770	Natural metabolites from the soft coral Nephthea sp. as potential SARS-CoV-2 main protease inhibitors.	Nat Prod Res
34027650	Phytotherapy for treatment of cytokine storm in COVID-19.	Front Biosci (Landmark Ed)
34027561	Infections at the nexus of metabolic-associated fatty liver disease.	Arch Toxicol
34027540	High-performance antiviral nano-systems as a shield to inhibit viral infections: SARS-CoV-2 as a model case study.	J Mater Chem B
34027499	SARS-CoV-2 variants: Subversion of antibody response and predicted impact on T cell recognition.	Cell Rep Med
34027498	Highly specific monoclonal antibodies and epitope identification against SARS-CoV-2 nucleocapsid protein for antigen detection tests.	Cell Rep Med
34027422	Platelet and Haemostasis are the Main Targets in Severe Cases of COVID-19 Infection; a System Biology Study.	Arch Acad Emerg Med
34027421	Fibrinogen Dysregulation is a Prominent Process in Fatal Conditions of COVID-19 Infection; a Proteomic Analysis.	Arch Acad Emerg Med
34027383	Comprehensive interactome analysis of the spike protein of swine acute diarrhea syndrome coronavirus.	Biosaf Health
34027315	Phenome-wide and expression quantitative trait locus associations of coronavirus disease 2019 genetic risk loci.	iScience
34027207	A comprehensive review and update on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and Coronavirus disease 2019 (COVID-19): what do we know now in 2021?	Arch Med Sci Atheroscler Dis
34027204	Interleukin-13 as a target to alleviate severe coronavirus disease 2019 and restore lung homeostasis.	J Clin Transl Res
34026833	A Strategy Based on Loop Analysis to Develop Peptide Epitopes: Application to SARS-CoV-2 Spike Protein.	Front Mol Biosci
34026798	Phytochemical Moieties From Indian Traditional Medicine for Targeting Dual Hotspots on SARS-CoV-2 Spike Protein: An Integrative in-silico Approach.	Front Med (Lausanne)
34026781	Human-Based Advanced in vitro Approaches to Investigate Lung Fibrosis and Pulmonary Effects of COVID-19.	Front Med (Lausanne)
34026780	"Implications of the Novel Mutations in the SARS-CoV-2 Genome for Transmission, Disease Severity, and the Vaccine Development."	Front Med (Lausanne)
34026588	Molecular Docking Analysis of Anti-Severe Acute Respiratory Syndrome-Coronavirus 2 Ligands against Spike Glycoprotein and the 3-Chymotrypsin-Like Protease.	J Med Signals Sens
34026584	"Calendulaglycoside A Showing Potential Activity Against SARS-CoV-2 Main Protease: Molecular Docking, Molecular Dynamics, and SAR Studies."	J Tradit Complement Med
34026476	"Viral inhibitors derived from macroalgae, microalgae, and cyanobacteria: A review of antiviral potential throughout pathogenesis."	Algal Res
34026182	Successful treatment of interstitial pneumonia with autoimmune features using rituximab as salvage therapy.	Clin Case Rep
34026045	Most Japanese individuals are genetically predisposed to recognize an immunogenic protein fragment shared between COVID-19 and common cold coronaviruses.	F1000Res
34025826	Flavonoids as an effective sensitizer for anti-cancer therapy: insights into multi-faceted mechanisms and applicability towards individualized patient profiles.	EPMA J
34025675	Longitudinal Analysis of COVID-19 Patients Shows Age-Associated T Cell Changes Independent of Ongoing Ill-Health.	Front Immunol
34025658	Molecular and Biological Mechanisms Underlying Gender Differences in COVID-19 Severity and Mortality.	Front Immunol
34025650	Anti-TNF-alpha agents Modulate SARS-CoV-2 Receptors and Increase the Risk of Infection Through Notch-1 Signaling.	Front Immunol
34025406	The Anti-Viral and Anti-Inflammatory Properties of Edible Bird's Nest in Influenza and Coronavirus Infections: From Pre-Clinical to Potential Clinical Application.	Front Pharmacol
34025115	A review on SARS-CoV-2 and stroke pathogenesis and outcome.	Egypt J Neurol Psychiatr Neurosurg
34025036	Theoretical investigation of favipiravir antiviral drug based on fullerene and boron nitride nanocages.	Diam Relat Mater
34025012	Discovery of (E)-N-(4-cyanobenzylidene)- 6-fluoro- 3-hydroxypyrazine-2 -carboxamide (cyanorona-20): the first potent and specific anti-COVID-19 drug.	Chem Zvesti
34024911	"Non-competitive interactions between hydroxychloroquine and azithromycin: Systematic density functional, molecular dynamics, and docking calculations."	Chem Phys Lett
34024514	Glucose-6-phosphate dehydrogenase inhibitor for treatment of severe COVID-19: Polydatin.	Clin Nutr ESPEN
34024246	Potent SARS-CoV-2 binding and neutralization through maturation of iconic SARS-CoV-1 antibodies.	MAbs
34024217	"Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments."	Infect Dis (Lond)
34024159	SARS-CoV-2 variants: A double-edged sword?	Exp Biol Med (Maywood)
34023987	Targeting the intestinal TMPRSS2 protease to prevent SARS-CoV-2 entry into enterocytes-prospects and challenges.	Mol Biol Rep
34023935	Glycosylation is a key in SARS-CoV-2 infection.	J Mol Med (Berl)
34023769	The emerging role of cellular senescence in complications of COVID-19.	Cancer Treat Res Commun
34023738	A cyclic peptide inhibitor of the SARS-CoV-2 main protease.	Eur J Med Chem
34023511	Exploration of hosts and transmission traits for SARS-CoV-2 based on the k-mer natural vector.	Infect Genet Evol
34023458	"SARS-CoV-2 suppresses mRNA expression of selenoproteins associated with ferroptosis, endoplasmic reticulum stress and DNA synthesis."	Food Chem Toxicol
34023401	Experimental Evidence for Enhanced Receptor Binding by Rapidly Spreading SARS-CoV-2 Variants.	J Mol Biol
34023234	Immunological map in COVID-19.	J Microbiol Immunol Infect
34022793	Possible inhibition of GM-CSF production by SARS-CoV-2 spike-based vaccines.	Mol Med
34022735	Susceptibility to SARS-CoV-2 infection in patients undergoing chemotherapy and radiation therapy.	J Infect Public Health
34022708	Discovery of anti-infective adipostatins through bioactivity-guided isolation and heterologous expression of a type III polyketide synthase.	Bioorg Chem
34022670	"Acquired decrease of the C3b/C4b receptor (CR1, CD35) and increased C4d deposits on erythrocytes from ICU COVID-19 patients."	Immunobiology
34022485	Structural and conformational analysis of SARS CoV 2 N-CTD revealing monomeric and dimeric active sites during the RNA-binding and stabilization: Insights towards potential inhibitors for N-CTD.	Comput Biol Med
34022369	Detection of SARS-CoV-2 genome and whole transcriptome sequencing in frontal cortex of COVID-19 patients.	Brain Behav Immun
34022205	"Endothelial cell dysfunction, coagulation, and angiogenesis in coronavirus disease 2019 (COVID-19)."	Microvasc Res
34022154	Innate immune and inflammatory responses to SARS-CoV-2: Implications for COVID-19.	Cell Host Microbe
34022129	SARS-CoV-2 infects human adult donor eyes and hESC-derived ocular epithelium.	Cell Stem Cell
34022127	Profiling B cell immunodominance after SARS-CoV-2 infection reveals antibody evolution to non-neutralizing viral targets.	Immunity
34021454	Uncurtaining the effect of COVID-19 in diabetes mellitus: a complex clinical management approach.	Environ Sci Pollut Res Int
34021265	Humoral immune response to circulating SARS-CoV-2 variants elicited by inactivated and RBD-subunit vaccines.	Cell Res
34021237	SARS-CoV-2 and other human coronavirus show genome patterns previously associated to reduced viral recognition and altered immune response.	Sci Rep
34021148	Peripheral and lung resident memory T cell responses against SARS-CoV-2.	Nat Commun
34021143	Severe T cell hyporeactivity in ventilated COVID-19 patients correlates with prolonged virus persistence and poor outcomes.	Nat Commun
34021074	The ORF8 protein of SARS-CoV-2 mediates immune evasion through down-regulating MHC-Iota.	Proc Natl Acad Sci U S A
34020832	Chemotherapy vs. Immunotherapy in combating nCOVID19: An update.	Hum Immunol
34020746	[Influence of coronavirus disease 2019 on the nervous system of children].	Zhongguo Dang Dai Er Ke Za Zhi
34020688	COVID-19 in Africa: an ovarian victory?	J Ovarian Res
34020394	Insights on the mechanisms of action of ozone in the medical therapy against COVID-19.	Int Immunopharmacol
34020392	Intragastric and atomized administration of canagliflozin inhibit inflammatory cytokine storm in lipopolysaccharide-treated sepsis in mice: A potential COVID-19 treatment.	Int Immunopharmacol
34020254	Perspectives on vaccine induced thrombotic thrombocytopenia.	J Autoimmun
34020131	Identification and host response interaction study of SARS-CoV-2 encoded miRNA-like sequences: an in silico approach.	Comput Biol Med
34020130	The interaction of the bioflavonoids with five SARS-CoV-2 proteins targets: An in silico study.	Comput Biol Med
34020129	QSAR modeling and pharmacoinformatics of SARS coronavirus 3C-like protease inhibitors.	Comput Biol Med
34020127	Unraveling the molecular crosstalk between Atherosclerosis and COVID-19 comorbidity.	Comput Biol Med
34019999	Comparative analysis of human coronaviruses focusing on nucleotide variability and synonymous codon usage patterns.	Genomics
34019795	Fab-dimerized glycan-reactive antibodies are a structural category of natural antibodies.	Cell
34019767	The SARS-CoV-2 SSHHPS Recognized by the Papain-like Protease.	ACS Infect Dis
34019703	Evaluation of the relationship between KIM-1 and suPAR levels and clinical severity in COVID-19 patients: A different perspective on suPAR.	J Med Virol
34019655	KEA3: improved kinase enrichment analysis via data integration.	Nucleic Acids Res
34019643	eVITTA: a web-based visualization and inference toolbox for transcriptome analysis.	Nucleic Acids Res
34019602	ACE2 glycans preferentially interact with SARS-CoV-2 over SARS-CoV.	Chem Commun (Camb)
34019466	Multiple detection and spread of novel strains of the SARS-CoV-2 B.1.177 (B.1.177.75) lineage that test negative by a commercially available nucleocapsid gene real-time RT-PCR.	Emerg Microbes Infect
34019274	Sex Hormones and Lung Inflammation.	Adv Exp Med Biol
34019273	Sex and Gender Differences in Lung Disease.	Adv Exp Med Biol
34019272	Serine Protease Inhibitors to Treat Lung Inflammatory Diseases.	Adv Exp Med Biol
34019270	Redox Role of ROS and Inflammation in Pulmonary Diseases.	Adv Exp Med Biol
34019265	Molecular Mechanisms of Vascular Damage During Lung Injury.	Adv Exp Med Biol
34019263	Innate Immune Responses and Pulmonary Diseases.	Adv Exp Med Biol
34019218	"A brief, highly selective history of acute phase proteins as indicators of infection, inflammation and injury."	Inflammopharmacology
34019093	Karyopherin abnormalities in neurodegenerative proteinopathies.	Brain
34018907	Proposition of a new allosteric binding site for potential SARS-CoV-2 3CL protease inhibitors by utilizing molecular dynamics simulations and ensemble docking.	J Biomol Struct Dyn
34018828	Exploring SARS-CoV-2 Spikes Glycoproteins for Designing Potential Antiviral Targets.	Viral Immunol
34018723	NMR Based SARS-CoV-2 Antibody Screening.	J Am Chem Soc
34018687	"In silico Studies on the Interaction between Mpro and PLpro From SARS-CoV-2 and Ebselen, its Metabolites and Derivatives."	Mol Inform
34018464	Anti-IgE monoclonal antibodies as potential treatment in COVID-19.	Immunopharmacol Immunotoxicol
34018280	Humoral Immune Response of SARS-CoV-2-Infected Patients with Cancer: Influencing Factors and Mechanisms.	Oncologist
34018203	Molecular basis of cross-species ACE2 interactions with SARS-CoV-2-like viruses of pangolin origin.	EMBO J
34017865	In silico Exploration of Interactions Between Potential COVID-19 Antiviral Treatments and the Pore of the hERG Potassium Channel-A Drug Antitarget.	Front Cardiovasc Med
34017843	"ACE2 and SARS-CoV-2 Infection Risk: Insights From Patients With Two Rare Genetic Tubulopathies, Gitelman's and Bartter's Syndromes."	Front Med (Lausanne)
34017819	Molecular Docking and Dynamics Simulation Revealed the Potential Inhibitory Activity of ACEIs Against SARS-CoV-2 Targeting the hACE2 Receptor.	Front Chem
34017703	An immune-centric investigation of Coronavirus in the women with cancers; A review article.	J Family Med Prim Care
34017249	The Cholinergic Drug Pyridostigmine Alleviates Inflammation During LPS-Induced Acute Respiratory Distress Syndrome.	Front Pharmacol
34017166	Analysis of Emerging Variants in Structured Regions of the SARS-CoV-2 Genome.	Evol Bioinform Online
34017137	CD8(+) T cells contribute to survival in patients with COVID-19 and hematologic cancer.	Nat Med
34017039	Metabolomics and computational analysis of the role of monoamine oxidase activity in delirium and SARS-COV-2 infection.	Sci Rep
34016949	"Sequential infection with H1N1 and SARS-CoV-2 aggravated COVID-19 pathogenesis in a mammalian model, and co-vaccination as an effective method of prevention of COVID-19 and influenza."	Signal Transduct Target Ther
34016942	"Editorial: The Pathogenesis of Long-Term Neuropsychiatric COVID-19 and the Role of Microglia, Mitochondria, and Persistent Neuroinflammation: A Hypothesis."	Med Sci Monit
34016740	Structural and functional ramifications of antigenic drift in recent SARS-CoV-2 variants.	Science
34016683	"Complete Genome Sequence of a SARS-CoV-2 Strain Sampled in Morocco in May 2020, Obtained Using Sanger Sequencing."	Microbiol Resour Announc
34016243	Development of a Unique Rapid Test to Detect Anti-bodies Directed Against an Extended RBD of SARS-CoV-2 Spike Protein.	Chimia (Aarau)
34016183	Genetic susceptibility of COVID-19: a systematic review of current evidence.	Eur J Med Res
34016096	Systematic review: cystic fibrosis in the SARS-CoV-2/COVID-19 pandemic.	BMC Pulm Med
34016042	"Genomic epidemiology of SARS-CoV-2 in Esteio, Rio Grande do Sul, Brazil."	BMC Genomics
34015983	SARS-COV-2-related immune-inflammatory thyroid disorders: facts and perspectives.	Expert Rev Clin Immunol
34015982	Tranilast: a potential anti-Inflammatory and NLRP3 inflammasome inhibitor drug for COVID-19.	Immunopharmacol Immunotoxicol
34015930	Epigallocatechin Gallate Inhibits the Uridylate-Specific Endoribonuclease Nsp15 and Efficiently Neutralizes the SARS-CoV-2 Strain.	J Agric Food Chem
34015823	COVID-19 biomarkers and their overlap with comorbidities in a disease biomarker data model.	Brief Bioinform
34015809	Global characterization of B cell receptor repertoire in COVID-19 patients by single-cell V(D)J sequencing.	Brief Bioinform
34015720	Marine sulfated polysaccharides as potential antiviral drug candidates to treat Corona Virus disease (COVID-19).	Carbohydr Res
34015671	Facilitating SARS CoV-2 RNA-Dependent RNA polymerase (RdRp) drug discovery by the aid of HCV NS5B palm subdomain binders: In silico approaches and benchmarking.	Comput Biol Med
34015627	Cerebral venous thrombosis in COVID-19.	Diabetes Metab Syndr
34015620	Frequency of HLA alleles among COVID-19 infected patients: Preliminary data from Saudi Arabia.	Virology
34015585	COVID-19 and metabolic comorbidities: An update on emerging evidences for optimal therapies.	Biomed Pharmacother
34015535	Novel SARS-CoV-2 variants: the pandemics within the pandemic.	Clin Microbiol Infect
34015528	Long COVID and the brain network of Proust's madeleine: targeting the olfactory pathway.	Clin Microbiol Infect
34015317	Azithromycin: Immunomodulatory and antiviral properties for SARS-CoV-2 infection.	Eur J Pharmacol
34015316	Evaluation of Th1 and Th2 mediated cellular and humoral immunity in patients with COVID-19 following the use of melatonin as an adjunctive treatment.	Eur J Pharmacol
34015271	B cell genomics behind cross-neutralization of SARS-CoV-2 variants and SARS-CoV.	Cell
34015061	DC/L-SIGN recognition of spike glycoprotein promotes SARS-CoV-2 trans-infection and can be inhibited by a glycomimetic antagonist.	PLoS Pathog
34015003	DPP-4 inhibitors may improve the mortality of coronavirus disease 2019: A meta-analysis.	PLoS One
34014798	Interleukin-6 Inhibition Reduces Neuronal Injury In A Murine Model of Ventilator-Induced Lung Injury.	Am J Respir Cell Mol Biol
34014628	Covid-19 Monoclonal Antibodies: Monoclonal Antibodies to SARS-CoV-2	LiverTox: Clinical and Research Information on Drug-Induced Liver Injury
34014150	Marine algal antagonists targeting 3CL protease and spike glycoprotein of SARS-CoV-2: a computational approach for anti-COVID-19 drug discovery.	J Biomol Struct Dyn
34013835	"Hypoxia reduces cell attachment of SARS-CoV-2 spike protein by modulating the expression of ACE2, neuropilin-1, syndecan-1 and cellular heparan sulfate."	Emerg Microbes Infect
34013612	Coronary microvascular dysfunction pathophysiology in COVID-19.	Microcirculation
34013402	Heterogeneity of SARS-CoV-2 virus produced in cell culture revealed by shotgun proteomics and supported by genome sequencing.	Anal Bioanal Chem
34013346	In silico binding profile characterization of SARS-CoV-2 spike protein and its mutants bound to human ACE2 receptor.	Brief Bioinform
34013339	Differential Cytokine Signatures of SARS-CoV-2 and Influenza Infection Highlight Key Differences in Pathobiology.	Clin Infect Dis
34013321	"Novel Canine Coronavirus Isolated from a Hospitalized Pneumonia Patient, East Malaysia."	Clin Infect Dis
34013072	Sequence and structural analysis of COVID-19 E and M proteins with MERS virus E and M proteins-A comparative study.	Biochem Biophys Rep
34012547	"Do gene-environment interactions play a role in COVID-19 distribution? The case of Alpha-1 Antitrypsin, air pollution and COVID-19."	Multidiscip Respir Med
34012458	Immune Response to COVID-19 During Pregnancy.	Front Immunol
34012456	Regulation of Tissue Immune Responses by Local Glucocorticoids at Epithelial Barriers and Their Impact on Interorgan Crosstalk.	Front Immunol
34012431	CD4(+) T Cells of Prostate Cancer Patients Have Decreased Immune Responses to Antigens Derived From SARS-CoV-2 Spike Glycoprotein.	Front Immunol
34012410	"COVID-19 and Hypertension: The What, the Why, and the How."	Front Physiol
34012391	Natural Products Modulating Angiotensin Converting Enzyme 2 (ACE2) as Potential COVID-19 Therapies.	Front Pharmacol
34012165	Cutaneous Manifestations in Patients With COVID-19: Clinical Characteristics and Possible Pathophysiologic Mechanisms.	Actas Dermosifiliogr
34012108	A super-potent tetramerized ACE2 protein displays enhanced neutralization of SARS-CoV-2 virus infection.	Sci Rep
34011939	Cross-reactive serum and memory B-cell responses to spike protein in SARS-CoV-2 and endemic coronavirus infection.	Nat Commun
34011679	Shedding of Viable Virus in Asymptomatic SARS-CoV-2 Carriers.	mSphere
34011563	Preexisting and Post-COVID-19 Immune Responses to SARS-CoV-2 in Patients with Cancer.	Cancer Discov
34011548	Structural Analysis of the OC43 Coronavirus 2'-O-RNA Methyltransferase.	J Virol
34011547	"Unique Mutations in the Murine Hepatitis Virus Macrodomain Differentially Attenuate Virus Replication, Indicating Multiple Roles for the Macrodomain in Coronavirus Replication."	J Virol
34011224	Robust classification-based molecular modelling of diverse chemical entities as potential SARS-CoV-2 3CL(pro) inhibitors: theoretical justification in light of experimental evidences.	SAR QSAR Environ Res
34011150	Development and Application of Human Coronavirus Protein Microarray for Specificity Analysis.	Anal Chem
34010947	Diverse functional autoantibodies in patients with COVID-19.	Nature
34010841	Previous and First Detected Cardiovascular Diseases in Patients with New Coronavirus Pneumonia: Possible Mechanisms and Place in a Unified Prognostic Model.	Int Arch Allergy Immunol
34010739	SARS-CoV-2 infection in alpha1-antitrypsin deficiency.	Respir Med
34010661	Virucidal and antiviral activity of astodrimer sodium against SARS-CoV-2 in vitro.	Antiviral Res
34010620	High-resolution profiling of pathways of escape for SARS-CoV-2 spike-binding antibodies.	Cell
34010501	Computational Approaches to Discover Novel Natural Compounds for SARS-CoV-2 Therapeutics.	ChemistryOpen
34010445	Endocrine and metabolic aspects of COVID-19.	Endokrynol Pol
34010360	"SARS-CoV-2 infection, neuropathogenesis and transmission among deer mice: Implications for spillback to New World rodents."	PLoS Pathog
34010326	Unraveling the unbinding pathways of SARS-CoV-2 Papain-like proteinase known inhibitors by Supervised Molecular Dynamics simulation.	PLoS One
34010142	Pharmacological activation of STING blocks SARS-CoV-2 infection.	Sci Immunol
34010139	A diamidobenzimidazole STING agonist protects against SARS-CoV-2 infection.	Sci Immunol
34010070	Effect of aspirin on short-term outcomes in hospitalized patients with COVID-19.	Vasc Med
34010015	Peroxisomes exhibit compromised structure and matrix protein content in SARS-CoV-2-infected cells.	Mol Biol Cell
34010002	Toll-like Receptor-4 (TLR4) Agonist-Based Intranasal Nanovaccine Delivery System for Inducing Systemic and Mucosal Immunity.	Mol Pharm
34009691	Genome-wide screening of SARS-CoV-2 infection-related genes based on the blood leukocytes sequencing data set of patients with COVID-19.	J Med Virol
34009387	ReFOLD3: refinement of 3D protein models with gradual restraints based on predicted local quality and residue contacts.	Nucleic Acids Res
34009288	Multi-omics data integration and network-based analysis drives a multiplex drug repurposing approach to a shortlist of candidate drugs against COVID-19.	Brief Bioinform
34009266	DeepImmuno: deep learning-empowered prediction and generation of immunogenic peptides for T-cell immunity.	Brief Bioinform
34009036	A pilot study to assess the circulating renin-angiotensin system in COVID-19 acute respiratory failure.	Am J Physiol Lung Cell Mol Physiol
34009033	Critical appraisal of the mechanisms of gastrointestinal and hepatobiliary infection by COVID-19.	Am J Physiol Gastrointest Liver Physiol
34008647	Antiviral drug design based on the opening mechanism of spike glycoprotein in SARS-CoV-2.	Phys Chem Chem Phys
34008627	Discovery of SARS-CoV-2 main protease inhibitors using a synthesis-directed de novo design model.	Chem Commun (Camb)
34008220	Structures of MERS-CoV macro domain in aqueous solution with dynamics: Impacts of parallel tempering simulation techniques and CHARMM36m and AMBER99SB force field parameters.	Proteins
34008129	"Meticulous assessment of natural compounds from NPASS database for identifying analogue of GRL0617, the only known inhibitor for SARS-CoV2 papain-like protease (PLpro) using rigorous computational workflow."	Mol Divers
34007862	Engineering mesenchymal stromal cells with neutralizing and anti-inflammatory capability against SARS-CoV-2 infection.	Mol Ther Methods Clin Dev
34007808	Cytokine Storm of COVID-19 and Its Impact on Patients with and without Chronic Liver Disease.	J Clin Transl Hepatol
34007807	Coronavirus Disease-2019 (COVID-19) and the Liver.	J Clin Transl Hepatol
34007806	Progress in the Clinical Features and Pathogenesis of Abnormal Liver Enzymes in Coronavirus Disease 2019.	J Clin Transl Hepatol
34007460	Control theory helps to resolve the measles paradox.	R Soc Open Sci
34007129	Mesenchymal stromal cell secretome in liver failure: Perspectives on COVID-19 infection treatment.	World J Gastroenterol
34007088	Design and synthesis of pyrazolone-based compounds as potent blockers of SARS-CoV-2 viral entry into the host cells.	J Mol Struct
34007086	Antiviral nucleoside analogs.	Chem Heterocycl Compd (N Y)
34007082	"Modeling the binding of protoporphyrin IX, verteporfin, and chlorin e6 to SARS-CoV-2 proteins."	Chem Heterocycl Compd (N Y)
34007019	Is COVID-19 a risk factor for progression of benign prostatic hyperplasia and exacerbation of its related symptoms?: a systematic review.	Prostate Cancer Prostatic Dis
34006961	Implementing a method for engineering multivalency to substantially enhance binding of clinical trial anti-SARS-CoV-2 antibodies to wildtype spike and variants of concern proteins.	Sci Rep
34006825	Type-I interferon signatures in SARS-CoV-2 infected Huh7 cells.	Cell Death Discov
34006644	Old vaccines for new infections: Exploiting innate immunity to control COVID-19 and prevent future pandemics.	Proc Natl Acad Sci U S A
34006597	Clonal analysis of immunodominance and cross-reactivity of the CD4 T cell response to SARS-CoV-2.	Science
34004573	Image processing unravels the evolutionary pattern of SARS-CoV-2 against SARS and MERS through position-based pattern recognition.	Comput Biol Med
34004375	Membrane cofactor protein (MCP; CD46): deficiency states and pathogen connections.	Curr Opin Immunol
34004362	Analyzing host-viral interactome of SARS-CoV-2 for identifying vulnerable host proteins during COVID-19 pathogenesis.	Infect Genet Evol
34004360	Differential host circRNA expression profiles in human lung epithelial cells infected with SARS-CoV-2.	Infect Genet Evol
34004284	"Vaccine-escape and fast-growing mutations in the United Kingdom, the United States, Singapore, Spain, India, and other COVID-19-devastated countries."	Genomics
34004232	Further insights into the molecular complexity of the human sinus node - The role of 'novel' transcription factors and microRNAs.	Prog Biophys Mol Biol
34004207	Role of leukotriene pathway and montelukast in pulmonary and extrapulmonary manifestations of Covid-19: The enigmatic entity.	Eur J Pharmacol
34004174	Mapping the SARS-CoV-2 spike glycoprotein-derived peptidome presented by HLA class II on dendritic cells.	Cell Rep
34004074	"Does tocilizumab have a role in dermatology? A review of clinical applications, its adverse side effects and practical considerations."	Dermatol Ther
34004056	Disruption of disulfides within RBD of SARS-CoV-2 spike protein prevents fusion and represents a target for viral entry inhibition by registered drugs.	FASEB J
34003853	Interactions of SARS-CoV-2 envelope protein with amilorides correlate with antiviral activity.	PLoS Pathog
34003827	"Computational designing of a peptide that potentially blocks the entry of SARS-CoV, SARS-CoV-2 and MERS-CoV."	PLoS One
34003804	Nasal ciliated cells are primary targets for SARS-CoV-2 replication in the early stage of COVID-19.	J Clin Invest
34003736	ZMPSTE24 Regulates SARS-CoV-2 Spike Protein-enhanced Expression of Endothelial Plasminogen Activator Inhibitor-1.	Am J Respir Cell Mol Biol
34003706	Serum ACE activity and plasma ACE concentration in patients with SARS-CoV-2 infection.	Scand J Clin Lab Invest
34003375	Hypoxia-dependent signaling in perioperative and critical care medicine.	J Anesth
34003284	Effects of SARS-CoV-2 infection on human reproduction.	J Mol Cell Biol
34003254	Opposing forces fight over the same ground to regulate interferon signaling.	Biochem J
34003073	Mining of linear B cell epitopes of SARS-CoV-2 ORF8 protein from COVID-19 patients.	Emerg Microbes Infect
34002456	Metal Complexes as Antiviral Agents for SARS-CoV-2.	Chembiochem
34002169	Sample processing and single cell RNA-sequencing of peripheral blood immune cells from COVID-19 patients.	STAR Protoc
34002130	SARS-CoV-2 cell entry and targeted antiviral development.	Acta Pharm Sin B
34002118	Computational optimization of angiotensin-converting enzyme 2 for SARS-CoV-2 Spike molecular recognition.	Comput Struct Biotechnol J
34002102	Global dynamics of SARS-CoV-2/cancer model with immune responses.	Appl Math Comput
34002013	Genome-wide bioinformatic analyses predict key host and viral factors in SARS-CoV-2 pathogenesis.	Commun Biol
34001897	Heterologous vaccination regimens with self-amplifying RNA and adenoviral COVID vaccines induce robust immune responses in mice.	Nat Commun
34001847	Rapid isolation and immune profiling of SARS-CoV-2 specific memory B cell in convalescent COVID-19 patients via LIBRA-seq.	Signal Transduct Target Ther
34001841	ACE2 polymorphism and susceptibility for SARS-CoV-2 infection and severity of COVID-19.	Pharmacogenet Genomics
34001691	Comparison of Circulating Immune Cells Profiles and Kinetics Between Coronavirus Disease 2019 and Bacterial Sepsis.	Crit Care Med
34001664	Detection of differentially abundant cell subpopulations in scRNA-seq data.	Proc Natl Acad Sci U S A
34001511	"Nodosome Inhibition as a Novel Broad-Spectrum Antiviral Strategy against Arboviruses, Enteroviruses, and SARS-CoV-2."	Antimicrob Agents Chemother
34001248	Initial study on TMPRSS2 p.Val160Met genetic variant in COVID-19 patients.	Hum Genomics
34001247	An atlas connecting shared genetic architecture of human diseases and molecular phenotypes provides insight into COVID-19 susceptibility.	Genome Med
34001199	Lung histopathological findings in COVID-19 disease - a systematic review.	Infect Agent Cancer
34001144	The intersection of COVID-19 and cancer: signaling pathways and treatment implications.	Mol Cancer
34000641	Microbiota as a potentially-modifiable factor influencing COVID-19.	Curr Opin Virol
34000623	Defective NET clearance contributes to sustained FXII activation in COVID-19-associated pulmonary thrombo-inflammation.	EBioMedicine
34000512	SARS-Cov-2 spike protein fragment 674-685 protects mitochondria from releasing cytochrome c in response to apoptogenic influence.	Biochem Biophys Res Commun
34000358	Abnormal apelin-ACE2 and SGLT2 signaling contribute to adverse cardiorenal injury in patients with COVID-19.	Int J Cardiol
34000327	Review of antiviral peptides for use against zoonotic and selected non-zoonotic viruses.	Peptides
34000237	A tricompartmental model of lung oxygenation disruption to explain pulmonary and systemic pathology in severe COVID-19.	Lancet Respir Med
34000089	The complicated relationships of heparin-induced thrombocytopenia and platelet factor 4 antibodies with COVID-19.	Int J Lab Hematol
33999778	"Distinct phenotypes of platelet, monocyte, and neutrophil activation occur during the acute and convalescent phase of COVID-19."	Platelets
33999630	Mechanism of Ligand Recognition by Human ACE2 Receptor.	J Phys Chem Lett
33999370	Can COVID-19 Increase the Risk of Herpes Zoster? A Narrative Review.	Dermatol Ther (Heidelb)
33999369	A Convenient and Biosafe Replicon with Accessory Genes of SARS-CoV-2 and Its Potential Application in Antiviral Drug Discovery.	Virol Sin
33999203	PredictProtein - Predicting Protein Structure and Function for 29 Years.	Nucleic Acids Res
33999154	Two conserved oligomer interfaces of NSP7 and NSP8 underpin the dynamic assembly of SARS-CoV-2 RdRP.	Nucleic Acids Res
33999091	Key residues of the receptor binding domain in the spike protein of SARS-CoV-2 mediating the interactions with ACE2: a molecular dynamics study.	Nanoscale
33998954	A large-scale computational screen identifies strong potential inhibitors for disrupting SARS-CoV-2 S-protein and human ACE2 interaction.	J Biomol Struct Dyn
33998950	Computational basis of SARS-CoV 2 main protease inhibition: an insight from molecular dynamics simulation based findings.	J Biomol Struct Dyn
33998787	Sequential Therapy of Acute Kidney Injury with a DNA Nanodevice.	Nano Lett
33998773	Neurological consequences of neurovascular unit and brain vasculature damages: potential risks for pregnancy infections and COVID-19-babies.	FEBS J
33998533	"A review of monoclonal antibodies in COVID-19: Role in immunotherapy, vaccine development and viral detection."	Hum Antibodies
33998404	[Cardiac Involvement in COVID-19].	Kardiologiia
33998182	Northern pig-tailed macaques ( Macaca leonina) infected with SARS-CoV-2 show rapid viral clearance and persistent immune response.	Zool Res
33998180	Particulate matter exposure exacerbates susceptibility to SARS-CoV-2 infection in humanized ACE2 mice.	Zool Res
33998143	Current status of the COVID-19 and male reproduction: A review of the literature.	Andrology
33997890	Variable post-translational modifications of SARS-CoV-2 nucleocapsid protein.	Glycobiology
33997827	"Genomic variation, origin tracing, and vaccine development of SARS-CoV-2: A systematic review."	Innovation (N Y)
33997824	Decay of Fc-dependent antibody functions after mild to moderate COVID-19.	Cell Rep Med
33997662	Energetic and structural features of SARS-CoV-2 N-protein co-assemblies with nucleic acids.	iScience
33997298	"-------A type I IFN, prothrombotic hyperinflammatory neutrophil signature is distinct for COVID-19 ARDS--."	Wellcome Open Res
33996911	Computational Identification of a Putative Allosteric Binding Pocket in TMPRSS2.	Front Mol Biosci
33996744	Pomegranate Peel Extract as an Inhibitor of SARS-CoV-2 Spike Binding to Human ACE2 Receptor (in vitro): A Promising Source of Novel Antiviral Drugs.	Front Chem
33996694	An Overview of Asthma and COVID-19: Protective Factors Against SARS-COV-2 in Pediatric Patients.	Front Pediatr
33996683	COVID-19 in Immunosuppressed Children.	Front Pediatr
33996638	The Unfolded Protein Response and Autophagy on the Crossroads of Coronaviruses Infections.	Front Cell Infect Microbiol
33996501	Design of advanced siRNA therapeutics for the treatment of COVID-19.	Meta Gene
33996172	Nucleocapsid and Spike Proteins of SARS-CoV-2 Drive Neutrophil Extracellular Trap Formation.	Immune Netw
33996168	Experimental Animal Models of Coronavirus Infections: Strengths and Limitations.	Immune Netw
33995851	COVID-19 and hyperglycemia/diabetes.	World J Diabetes
33995847	Advanced-glycation end-products axis: A contributor to the risk of severe illness from COVID-19 in diabetes patients.	World J Diabetes
33995679	A SCID mouse-human lung xenograft model of SARS-CoV-2 infection.	Theranostics
33995653	The therapeutic potential of inorganic polyphosphate: A versatile physiological polymer to control coronavirus disease (COVID-19).	Theranostics
33995410	Plasma Lectin Pathway Complement Proteins in Patients With COVID-19 and Renal Disease.	Front Immunol
33995382	SARS-CoV-2 Induces Lymphocytopenia by Promoting Inflammation and Decimates Secondary Lymphoid Organs.	Front Immunol
33995366	A Structural Landscape of Neutralizing Antibodies Against SARS-CoV-2 Receptor Binding Domain.	Front Immunol
33995364	Cellular Immune Response to COVID-19 and Potential Immune Modulators.	Front Immunol
33995361	Mini-Factor H Modulates Complement-Dependent IL-6 and IL-10 Release in an Immune Cell Culture (PBMC) Model: Potential Benefits Against Cytokine Storm.	Front Immunol
33995351	SARS-CoV-2-Seronegative Subjects Target CTL Epitopes in the SARS-CoV-2 Nucleoprotein Cross-Reactive to Common Cold Coronaviruses.	Front Immunol
33995342	Clinical and Immunological Factors That Distinguish COVID-19 From Pandemic Influenza A(H1N1).	Front Immunol
33995341	Cytokine Storm: The Primary Determinant for the Pathophysiological Evolution of COVID-19 Deterioration.	Front Immunol
33995308	"Mefloquine, a Potent Anti-severe Acute Respiratory Syndrome-Related Coronavirus 2 (SARS-CoV-2) Drug as an Entry Inhibitor in vitro."	Front Microbiol
33995281	Review: Obesity and COVID-19: A Detrimental Intersection.	Front Endocrinol (Lausanne)
33995121	Proteomics and Machine Learning Approaches Reveal a Set of Prognostic Markers for COVID-19 Severity With Drug Repurposing Potential.	Front Physiol
33995062	Profiling Ribonucleotide and Deoxyribonucleotide Pools Perturbed by Remdesivir in Human Bronchial Epithelial Cells.	Front Pharmacol
33995033	SARS-CoV-2 Switches 'on' MAPK and NFkappaB Signaling via the Reduction of Nuclear DUSP1 and DUSP5 Expression.	Front Pharmacol
33994673	SARS-CoV-PL(pro)-Inhibitoren als mogliche Breitspektrum-Virostatika.	Biospektrum (Heidelb)
33994655	An insight into the inhibitory mechanism of phytochemicals and FDA-approved drugs on the ACE2-Spike complex of SARS-CoV-2 using computational methods.	Chem Zvesti
33994607	Inhibition of SARS-CoV-2 reproduction using Boswellia carterii: A theoretical study.	J Mol Liq
33994548	Obesity - A Risk Factor for Psoriasis and COVID-19.	Actas Dermosifiliogr
33994545	Protein kinase CK2: a potential therapeutic target for diverse human diseases.	Signal Transduct Target Ther
33994374	Dialysis-Induced Immune Dysregulations and Their Possible Impacts on COVID-19.	Iran J Kidney Dis
33993845	Prime-boost vaccination of mice and rhesus macaques with two novel adenovirus vectored COVID-19 vaccine candidates.	Emerg Microbes Infect
33993812	Type I and II interferons toward ideal vaccine and immunotherapy.	Expert Rev Vaccines
33993681	[Bats of the subtropical climate zone of the Krasnodar Territory of Russia as a possible reservoir of zoonotic viral infections].	Vopr Virusol
33993680	[Susceptibility of animal species to experimental SARS-CoV-2 (Coronaviridae: Coronavirinae: Betacoronavirus; Sarbecovirus) infection].	Vopr Virusol
33993665	[Significance of platelets in inflammatory and thrombotic reactions in the elderly.]	Adv Gerontol
33993519	"Recombinant CD137-Fc, its synthesis, and applications for improving the immune system functions, such as tumor immunotherapy and to reduce the inflammation due to the novel coronavirus."	J Cell Biochem
33993490	Caspases and therapeutic potential of caspase inhibitors in moderate-severe SARS CoV2 infection and long COVID.	Allergy
33993372	The Evolution of Severe Acute Respiratory Syndrome Coronavirus-2 during Pandemic and Adaptation to the Host.	J Mol Evol
33993223	Bioinformatics and system biology approaches to identify the diseasome and comorbidities complexities of SARS-CoV-2 infection with the digestive tract disorders.	Brief Bioinform
33993052	Q493K and Q498H substitutions in Spike promote adaptation of SARS-CoV-2 in mice.	EBioMedicine
33992926	PdCl2-catalyzed synthesis of a new class of isocoumarin derivatives containing aminosulfonyl / aminocarboxamide moiety: First identification of a isocoumarin based PDE4 inhibitor.	Eur J Med Chem
33992907	New insights into human immunity from ancient genomics.	Curr Opin Immunol
33992887	COVID-19 as a mediator of interferon deficiency and hyperinflammation: Rationale for the use of JAK1/2 inhibitors in combination with interferon.	Cytokine Growth Factor Rev
33992805	A SARS-CoV-2 targeted siRNA-nanoparticle therapy for COVID-19.	Mol Ther
33992695	Viral respiratory infections and psychosis: A review of the literature and the implications of COVID-19.	Neurosci Biobehav Rev
33992693	Structural Modeling of the SARS-CoV-2 Spike/Human ACE2 Complex Interface can Identify High-Affinity Variants Associated with Increased Transmissibility.	J Mol Biol
33992187	Post-COVID 19 neurological syndrome: Implications for sequelae's treatment.	J Clin Neurosci
33992179	Drug repurposing of selective serotonin reuptake inhibitors: Could these drugs help fight COVID-19 and save lives?	J Clin Neurosci
33992054	Structural Basis for the Understanding of Entry Inhibitors Against SARS Viruses.	Curr Med Chem
33992044	Pediatric Inflammatory Multisystem Syndrome (PIMS) - Potential role for cytokines such Is IL-6.	Physiol Res
33991784	Diffuse interstitial pneumonia-like/macrophage activation syndrome-like changes in patients with COVID-19 correlate with length of illness.	Ann Diagn Pathol
33991677	Spreading of a new SARS-CoV-2 N501Y spike variant in a new lineage.	Clin Microbiol Infect
33991637	Liver injury in COVID-19 and IL-6 trans-signaling-induced endotheliopathy.	J Hepatol
33991580	Basophil reactivity to BNT162b2 is mediated by PEGylated lipid nanoparticles in patients with PEG allergy.	J Allergy Clin Immunol
33991531	Immunoinformatics and Pepscan strategies on the path of a peptide-based serological diagnosis of COVID19.	J Immunol Methods
33991511	Epitope profiling reveals binding signatures of SARS-CoV-2 immune response in natural infection and cross-reactivity with endemic human CoVs.	Cell Rep
33991510	Dynamics of B cell repertoires and emergence of cross-reactive responses in patients with different severities of COVID-19.	Cell Rep
33991505	A novel nano therapeutic using convalescent plasma derived exosomal (CP(Exo)) for COVID-19: A combined hyperactive immune modulation and diagnostics.	Chem Biol Interact
33991487	"Transmission, infectivity, and neutralization of a spike L452R SARS-CoV-2 variant."	Cell
33991451	Hypoxia induces expression of angiotensin-converting enzyme II in alveolar epithelial cells: Implications for the pathogenesis of acute lung injury in COVID-19.	Physiol Rep
33991349	"A weak COPI binding motif in the cytoplasmic tail of SARS-CoV-2 spike glycoprotein is necessary for its cleavage, glycosylation, and localization."	FEBS Lett
33990973	Association of GSTM1 and GSTT1 gene polymorphisms with COVID-19 susceptibility and its outcome.	J Med Virol
33990972	Immunological aspects and gender bias during respiratory viral infections including novel Coronavirus disease-19 (COVID-19): A scoping review.	J Med Virol
33990955	"Vitamin D and COVID-19: Role of ACE2, age, gender, and ethnicity."	J Med Virol
33990585	Crystal structure of SARS-CoV-2 Orf9b in complex with human TOM70 suggests unusual virus-host interactions.	Nat Commun
33990387	Nasal expression of SARS-CoV-2 entry receptors in newborns.	Arch Dis Child Fetal Neonatal Ed
33989977	"Tuning the Computational Evaluation of Spectroscopic, ELF, LOL, NCI analysis and Molecular Docking of Novel Anti COVID-19 Molecule 4-Dimethylamino Pyridinium 3, 5-Dichlorosalicylate."	Spectrochim Acta A Mol Biomol Spectrosc
33989761	COVID-19 and Parkinson's disease: Defects in neurogenesis as the potential cause of olfactory system impairments and anosmia.	J Chem Neuroanat
33989635	Molnupiravir promotes SARS-CoV-2 mutagenesis via the RNA template.	J Biol Chem
33989516	The SARS-CoV-2 RNA interactome.	Mol Cell
33989051	"Molecular Insights into COVID-19 Pathophysiology, Immune Pathogenesis, Detection, and Treatment."	DNA Cell Biol
33988903	Graphene Oxide Nanosheets Interact and Interfere with SARS-CoV-2 Surface Proteins and Cell Receptors to Inhibit Infectivity.	Small
33988334	The Magnitude and Functionality of SARS-CoV-2 Reactive Cellular and Humoral Immunity in Transplant Population Is Similar to the General Population Despite Immunosuppression.	Transplantation
33988184	"Identification of and Surveillance for the SARS-CoV-2 Variants B.1.427 and B.1.429 - Colorado, January-March 2021."	MMWR Morb Mortal Wkly Rep
33988162	Cardiovascular impact of COVID-19: an array of presentations.	Acta Biomed
33988079	Repurposing of the herbal formulations: molecular docking and molecular dynamics simulation studies to validate the efficacy of phytocompounds against SARS-CoV-2 proteins.	J Biomol Struct Dyn
33988066	Target SARS-CoV-2: theoretical exploration on clinical suitability of certain drugs.	J Biomol Struct Dyn
33988001	"COVID-19 Endothelial Dysfunction Can Cause Erectile Dysfunction: Histopathological, Immunohistochemical, and Ultrastructural Study of the Human Penis."	World J Mens Health
33987944	Proteomic and metabolomic investigation of serum lactate dehydrogenase elevation in COVID-19 patients.	Proteomics
33987897	Influence of daily aspirin therapy on ACE2 expression and function-implications for SARS-CoV-2 and patients with aspirin-exacerbated respiratory disease.	Clin Exp Allergy
33987376	Bioinformatic and mouse model reveal the potential high vulnerability of Leydig cells on SARS-CoV-2.	Ann Transl Med
33987176	The Mechanisms and Animal Models of SARS-CoV-2 Infection.	Front Cell Dev Biol
33986661	Potential Mechanism Prediction of Herbal Medicine for Pulmonary Fibrosis Associated with SARS-CoV-2 Infection Based on Network Analysis and Molecular Docking.	Front Pharmacol
33986591	Neuropilin 1: A Novel Entry Factor for SARS-CoV-2 Infection and a Potential Therapeutic Target.	Biologics
33986405	Repurposing potential of posaconazole and grazoprevir as inhibitors of SARS-CoV-2 helicase.	Sci Rep
33986382	Exploring antibody repurposing for COVID-19: beyond presumed roles of therapeutic antibodies.	Sci Rep
33986354	"Surge of severe acute respiratory syndrome coronavirus 2 infections linked to single introduction of a virus strain in Myanmar, 2020."	Sci Rep
33986351	In silico analysis suggests the RNAi-enhancing antibiotic enoxacin as a potential inhibitor of SARS-CoV-2 infection.	Sci Rep
33986292	"Highly conserved, non-human-like, and cross-reactive SARS-CoV-2 T cell epitopes for COVID-19 vaccine design and validation."	NPJ Vaccines
33986287	Protein-based antigen presentation platforms for nanoparticle vaccines.	NPJ Vaccines
33986286	Characterization of an attenuated SARS-CoV-2 variant with a deletion at the S1/S2 junction of the spike protein.	Nat Commun
33986253	Metagenomic analysis reveals oropharyngeal microbiota alterations in patients with COVID-19.	Signal Transduct Target Ther
33986193	A specific low-density neutrophil population correlates with hypercoagulation and disease severity in hospitalized COVID-19 patients.	JCI Insight
33986127	Shared inflammatory pathways and therapeutic strategies in COVID-19 and cancer immunotherapy.	J Immunother Cancer
33985433	IPD 2.0: To derive insights from an evolving SARS-CoV-2 genome.	BMC Bioinformatics
33985343	COVID-19: A Redox Disease-What a Stress Pandemic Can Teach Us About Resilience and What We May Learn from the Reactive Species Interactome About Its Treatment.	Antioxid Redox Signal
33984877	Role of ACE2 polymorphism in COVID-19: impact of age.	Clin Chem Lab Med
33984653	Designing potential siRNA molecule for the nucleocapsid(N) gene silencing of different SARS-CoV-2 strains of Bangladesh: Computational approach.	Comput Biol Chem
33984520	Plant-derived exosomal microRNAs inhibit lung inflammation induced by exosomes SARS-CoV-2 Nsp12.	Mol Ther
33984473	Promising anti-SARS-CoV-2 drugs by effective dual targeting against the viral and host proteases.	Bioorg Med Chem Lett
33984466	Molecular scaffolds from mother nature as possible lead compounds in drug design and discovery against coronaviruses: A landscape analysis of published literature and molecular docking studies.	Microb Pathog
33984400	Molecular simulation studies of the interactions between the human/pangolin/cat/bat ACE2 and the receptor binding domain of the SARS-CoV-2 spike protein.	Biochimie
33984360	"Beclin-1, an autophagy-related protein, is associated with the disease severity of COVID-19."	Life Sci
33984310	Computational optimization of the SARS-CoV-2 receptor-binding-motif affinity for human ACE2.	Biophys J
33984285	Kinetics and correlates of the neutralizing antibody response to SARS-CoV-2 infection in humans.	Cell Host Microbe
33984277	An NTD supersite of attack.	Cell Host Microbe
33984267	Hepatitis C virus drugs that inhibit SARS-CoV-2 papain-like protease synergize with remdesivir to suppress viral replication in cell culture.	Cell Rep
33984103	The Neurologic Manifestations of Coronavirus Disease 2019.	J Neurol Res
33984094	SARS-CoV-2 and Nervous System - Neurological Manifestations in Patients With COVID-19: A Systematic Review.	J Neurol Res
33984041	Natural plant products as potential inhibitors of RNA dependent RNA polymerase of Severe Acute Respiratory Syndrome Coronavirus-2.	PLoS One
33984040	Does blood type affect the COVID-19 infection pattern?	PLoS One
33983915	"Rapid Emergence and Epidemiologic Characteristics of the SARS-CoV-2 B.1.526 Variant - New York City, New York, January 1-April 5, 2021."	MMWR Morb Mortal Wkly Rep
33983857	Liver Damage and Exposure to Toxic Concentrations of Endogenous Retinoids in the Pathogenesis of COVID-19 Disease: Hypothesis.	Viral Immunol
33983654	Comparative protein structure network analysis on 3CL(pro) from SARS-CoV-1 and SARS-CoV-2.	Proteins
33983615	Targeting Sphingosine-1-Phosphate Signaling in Immune-Mediated Diseases: Beyond Multiple Sclerosis.	Drugs
33983545	Robust Antibody and T Cell Responses to SARS-CoV-2 in Patients with Antibody Deficiency.	J Clin Immunol
33983506	Neuropathies and neurological dysfunction induced by coronaviruses.	J Neurovirol
33983397	Rapid detection of inter-clade recombination in SARS-CoV-2 with Bolotie.	Genetics
33982646	Problems associated with antiviral drugs and vaccines development for COVID-19: approach to intervention using expression vectors via GPI anchor.	Nucleosides Nucleotides Nucleic Acids
33982533	Glycyrrhizin for topical use and prophylaxis of COVID-19: an interesting pharmacological perspective.	J Biol Regul Homeost Agents
33982355	Androgenetic alopecia in women and men is not related to COVID-19 infection severity: a prospective cohort study of hospitalized COVID-19 patients.	J Eur Acad Dermatol Venereol
33981731	Associations Between the Use of Renin-Angiotensin System Inhibitors and the Risks of Severe COVID-19 and Mortality in COVID-19 Patients With Hypertension: A Meta-Analysis of Observational Studies.	Front Cardiovasc Med
33981715	How Genetics Might Explain the Unusual Link Between Malaria and COVID-19.	Front Med (Lausanne)
33981629	Fluticasone Propionate Suppresses Poly(I:C)-Induced ACE2 in Primary Human Nasal Epithelial Cells.	Front Cell Infect Microbiol
33981493	A molecular dynamics simulation study of the ACE2 receptor with screened natural inhibitors to identify novel drug candidate against COVID-19.	PeerJ
33981434	The up-to-date pathophysiology of Kawasaki disease.	Clin Transl Immunology
33981314	"Interleukin-6, CXCL10 and Infiltrating Macrophages in COVID-19-Related Cytokine Storm: Not One for All But All for One!"	Front Immunol
33981312	Neurological Symptoms of COVID-19: The Zonulin Hypothesis.	Front Immunol
33981235	Phytochemicals as Potential Therapeutics for SARS-CoV-2-Induced Cardiovascular Complications: Thrombosis and Platelet Perspective.	Front Pharmacol
33981229	"Ruxolitinib, a JAK1/2 Inhibitor, Ameliorates Cytokine Storm in Experimental Models of Hyperinflammation Syndrome."	Front Pharmacol
33981021	Structural basis for broad coronavirus neutralization.	Nat Struct Mol Biol
33980808	The interferon-stimulated exosomal hACE2 potently inhibits SARS-CoV-2 replication through competitively blocking the virus entry.	Signal Transduct Target Ther
33980688	Critical Determinants of Cytokine Storm and Type I Interferon Response in COVID-19 Pathogenesis.	Clin Microbiol Rev
33980675	A Cytopathic Effect-Based Tissue Culture Method for HCoV-OC43 Titration Using TMPRSS2-Expressing VeroE6 Cells.	mSphere
33980671	"Leptin Deficiency, Caused by Malnutrition, Makes You Susceptible to SARS-CoV-2 Infection but Could Offer Protection from Severe COVID-19."	mSphere
33980601	Host-Virus Chimeric Events in SARS-CoV-2-Infected Cells Are Infrequent and Artifactual.	J Virol
33980582	Identification of T Cell Epitopes in the Spike Glycoprotein of Severe Acute Respiratory Syndrome Coronavirus 2 in Rhesus Macaques.	J Immunol
33980349	A Combined Molecular Docking and Density Functional Theory Nuclear Magnetic Resonance Study of Trans-Dehydrocrotonin Interacting with COVID-19 Main Protease and Severe Acute Respiratory Syndrome Coronavirus 2 3C-Like Protease.	J Nanosci Nanotechnol
33980331	"Coronavirus disease 2019, allergic diseases, and allergen immunotherapy: Possible favorable mechanisms of interaction."	Allergy Asthma Proc
33980308	"Echinacea purpurea (L.) Moench treatment of monocytes promotes tonic interferon signaling, increased innate immunity gene expression and DNA repeat hypermethylated silencing of endogenous retroviral sequences."	BMC Complement Med Ther
33980119	Flavonoids as inhibitors of human neutrophil elastase.	J Enzyme Inhib Med Chem
33980089	Reinforcing our defense or weakening the enemy? A comparative overview of defensive and offensive strategies developed to confront COVID-19.	Drug Metab Rev
33979833	SARS-CoV-2 uses a multipronged strategy to impede host protein synthesis.	Nature
33979758	Blood neutrophils from children with COVID-19 exhibit both inflammatory and anti-inflammatory markers.	EBioMedicine
33979649	Development of potent and selective inhibitors targeting the papain-like protease of SARS-CoV-2.	Cell Chem Biol
33979601	Erythroid precursors and progenitors suppress adaptive immunity and get invaded by SARS-CoV-2.	Stem Cell Reports
33979600	SARS-CoV-2 targets glial cells in human cortical organoids.	Stem Cell Reports
33979391	Discovery of human ACE2 variants with altered recognition by the SARS-CoV-2 spike protein.	PLoS One
33979301	High titers and low fucosylation of early human anti-SARS-CoV-2 IgG promote inflammation by alveolar macrophages.	Sci Transl Med
33979162	Critical Interactions Between the SARS-CoV-2 Spike Glycoprotein and the Human ACE2 Receptor.	J Phys Chem B
33979123	Small-Molecule Inhibitors of the Coronavirus Spike: ACE2 Protein-Protein Interaction as Blockers of Viral Attachment and Entry for SARS-CoV-2.	ACS Infect Dis
33978940	Enriched Opportunistic Pathogens Revealed by Metagenomic Sequencing Hint Potential Linkages between Pharyngeal Microbiota and COVID-19.	Virol Sin
33978754	Persistence of Antibody and Cellular Immune Responses in COVID-19 patients over Nine Months after Infection.	J Infect Dis
33978563	From cellular function to global impact: the vascular perspective on COVID-19.	Can J Surg
33978550	Tapping the immunological imprints to design chimeric SARS-CoV-2 vaccine for elderly population.	Int Rev Immunol
33978304	Dysbalance of ACE2 levels - a possible cause for severe COVID-19 outcome in COPD.	J Pathol Clin Res
33977847	"Computational and experimental insights on the interaction of artemisinin, dihydroartemisinin and chloroquine with SARS-CoV-2 spike protein receptor-binding domain (RBD)."	Nat Prod Res
33977807	Lactoferrin for Mental Health: Neuro-Redox Regulation and Neuroprotective Effects across the Blood-Brain Barrier with Special Reference to Neuro-COVID-19.	J Diet Suppl
33977671	Detection of coronavirus in vampire bats (Desmodus rotundus) in southern Brazil.	Transbound Emerg Dis
33977663	An update on emerging therapeutics to combat COVID-19.	Basic Clin Pharmacol Toxicol
33977496	SARS-CoV-2 in patients with cancer: possible role of mimicry of human molecules by viral proteins and the resulting anti-cancer immunity.	Cell Stress Chaperones
33977466	The probable destructive mechanisms behind COVID-19 on male reproduction system and fertility.	J Assist Reprod Genet
33977284	Targeting the biology of ageing with mTOR inhibitors to improve immune function in older adults: phase 2b and phase 3 randomised trials.	Lancet Healthy Longev
33977279	Comparative immune profiling of acute respiratory distress syndrome patients with or without SARS-CoV-2 infection.	Cell Rep Med
33977168	Diversity and genomic determinants of the microbiomes associated with COVID-19 and non-COVID respiratory diseases.	Gene Rep
33977096	"NAFLD and Infection, a Nuanced Relationship."	Can J Gastroenterol Hepatol
33976895	A mini-review on sofosbuvir and daclatasvir treatment in coronavirus disease 2019.	New Microbes New Infect
33976879	Heterogeneous magnitude of immunological memory to SARS-CoV-2 in recovered individuals.	Clin Transl Immunology
33976534	Thymoquinone: A Promising Natural Compound with Potential Benefits for COVID-19 Prevention and Cure.	Drug Des Devel Ther
33976430	RIG-I triggers a signaling-abortive anti-SARS-CoV-2 defense in human lung cells.	Nat Immunol
33976375	Dengue virus-free defective interfering particles have potent and broad anti-dengue virus activity.	Commun Biol
33976229	A SARS-CoV-2 antibody curbs viral nucleocapsid protein-induced complement hyperactivation.	Nat Commun
33976198	A SARS-CoV-2 neutralizing antibody with extensive Spike binding coverage and modified for optimal therapeutic outcomes.	Nat Commun
33976165	Neutralizing antibody responses to SARS-CoV-2 in symptomatic COVID-19 is persistent and critical for survival.	Nat Commun
33976134	SARS-CoV-2 gene content and COVID-19 mutation impact by comparing 44 Sarbecovirus genomes.	Nat Commun
33975939	The SARS-CoV-2 Transcriptome and the Dynamics of the S Gene Furin Cleavage Site in Primary Human Airway Epithelia.	mBio
33975938	An Engineered Receptor-Binding Domain Improves the Immunogenicity of Multivalent SARS-CoV-2 Vaccines.	mBio
33975613	COVID-19 and periodontitis: reflecting on a possible association.	Head Face Med
33975397	Will Mutations in the Spike Protein of SARS-CoV-2 Lead to the Failure of COVID-19 Vaccines?	J Korean Med Sci
33975232	"Synthesis, molecular docking, and in silico ADMET studies of 4-benzyl-1-(2,4,6-trimethyl-benzyl)-piperidine: Potential Inhibitor of SARS-CoV2."	Bioorg Chem
33975021	A Sanger-based approach for scaling up screening of SARS-CoV-2 variants of interest and concern.	Infect Genet Evol
33974910	Structural insight into SARS-CoV-2 neutralizing antibodies and modulation of syncytia.	Cell
33974898	Elucidating of oxidative distress in COVID-19 and methods of its prevention.	Chem Biol Interact
33974890	Gene selection using hybrid dragonfly black hole algorithm: A case study on RNA-seq COVID-19 data.	Anal Biochem
33974846	Systematic functional analysis of SARS-CoV-2 proteins uncovers viral innate immune antagonists and remaining vulnerabilities.	Cell Rep
33974614	Implications of Low-grade Inflammation in SARS-CoV-2 Immunopathology.	MEDICC Rev
33974566	Mice with induced pulmonary morbidities display severe lung inflammation and mortality following exposure to SARS-CoV-2.	JCI Insight
33974296	Comparative analyses of ACE2 and TMPRSS2 gene: Implications for the risk to which vertebrate animals are susceptible to SARS-CoV-2.	J Med Virol
33973912	An Eye on COVID-19: A Meta-analysis of Positive Conjunctival Reverse Transcriptase-Polymerase Chain Reaction and SARS-CoV-2 Conjunctivitis Prevalence.	Optom Vis Sci
33973805	Activation of Interleukin-1beta Release and Pyroptosis by Transmissible Gastroenteritis Virus Is Dependent on the NOD-Like Receptor Protein 3 Inflammasome in Porcine Intestinal Epithelial Cell Line.	Viral Immunol
33973446	[Optimization of expression conditions and determination the proteolytic activity of codon-optimized SARS-CoV-2 main protease in Escherichia coli].	Sheng Wu Gong Cheng Xue Bao
33973262	ACE2-based decoy receptors for SARS coronavirus 2.	Proteins
33973215	Retrieval and Investigation of Data on SARS-CoV-2 and COVID-19 Using Bioinformatics Approach.	Adv Exp Med Biol
33973199	The COVID-19 Vaccine Landscape.	Adv Exp Med Biol
33973194	Immune-Based Therapy for COVID-19.	Adv Exp Med Biol
33973189	Autoimmune Processes Involved in Organ System Failure Following Infection with SARS-CoV-2.	Adv Exp Med Biol
33973188	Neurologic Manifestations of COVID-19.	Adv Exp Med Biol
33973184	COVID-19 and Cardiovascular Diseases.	Adv Exp Med Biol
33973183	COVID-19 in Patients with Hypertension.	Adv Exp Med Biol
33973182	"Coronavirus Diseases in Pregnant Women, the Placenta, Fetus, and Neonate."	Adv Exp Med Biol
33973181	Geriatrics and COVID-19.	Adv Exp Med Biol
33973180	Pediatrics and COVID-19.	Adv Exp Med Biol
33973178	COVID-19 and Cell Stress.	Adv Exp Med Biol
33973177	Potential Antiviral Immune Response Against COVID-19: Lessons Learned from SARS-CoV.	Adv Exp Med Biol
33973176	"How COVID-19 Has Globalized: Unknown Origin, Rapid Transmission, and the Immune System Nourishment."	Adv Exp Med Biol
33973175	Genetic Polymorphisms in the Host and COVID-19 Infection.	Adv Exp Med Biol
33973174	Coronavirus: Pure Infectious Disease or Genetic Predisposition.	Adv Exp Med Biol
33973171	Ecology and Evolution of Betacoronaviruses.	Adv Exp Med Biol
33973170	Coronaviruses: What Should We Know About the Characteristics of Viruses?	Adv Exp Med Biol
33973169	Introduction on Coronavirus Disease (COVID-19) Pandemic: The Global Challenge.	Adv Exp Med Biol
33973157	Antiphospholipid antibodies in critically ill COVID-19 patients with thromboembolism: cause of disease or epiphenomenon?	J Thromb Thrombolysis
33972780	Ultrafast Sample placement on Existing tRees (UShER) enables real-time phylogenetics for the SARS-CoV-2 pandemic.	Nat Genet
33972731	Single-cell RNA sequencing of blood antigen-presenting cells in severe COVID-19 reveals multi-process defects in antiviral immunity.	Nat Cell Biol
33972602	African Americans and European Americans exhibit distinct gene expression patterns across tissues and tumors associated with immunologic functions and environmental exposures.	Sci Rep
33972535	Identification and characterization of a SARS-CoV-2 specific CD8(+) T cell response with immunodominant features.	Nat Commun
33972410	2'-O methylation of RNA cap in SARS-CoV-2 captured by serial crystallography.	Proc Natl Acad Sci U S A
33972374	Cellular and Humoral Immune Responses in Mice Immunized with Vaccinia Virus Expressing the SARS-CoV-2 Spike Protein.	J Immunol
33972373	Conserved and Novel Mouse CD8 T Cell Epitopes within SARS-CoV-2 Spike Receptor Binding Domain Protein Identified following Subunit Vaccination.	J Immunol
33972366	Viral Proteases as Targets for COVID-19 Drug Development.	J Pharmacol Exp Ther
33972054	Autoimmune connective tissue diseases in the COVID-19 pandemic.	Clin Dermatol
33971907	Therapeutic mechanisms of mesenchymal stem cells in acute respiratory distress syndrome reveal potentials for Covid-19 treatment.	J Transl Med
33971807	A rigorous evaluation of optimal peptide targets for MS-based clinical diagnostics of Coronavirus Disease 2019 (COVID-19).	Clin Proteomics
33971803	Impacts of reference selection on the assembly of suspicious coronavirus genome.	J Bioinform Comput Biol
33971664	Neutralizing antibody vaccine for pandemic and pre-emergent coronaviruses.	Nature
33971585	An autoantigen profile of human A549 lung cells reveals viral and host etiologic molecular attributes of autoimmunity in COVID-19.	J Autoimmun
33971404	Circulating extracellular vesicles are endowed with enhanced procoagulant activity in SARS-CoV-2 infection.	EBioMedicine
33971305	Paired SARS-CoV-2 spike protein mutations observed during ongoing SARS-CoV-2 viral transfer from humans to minks and back to humans.	Infect Genet Evol
33971084	Infection-induced inflammation from specific inborn errors of immunity to COVID-19.	FEBS J
33970839	SARS-CoV-2 Induced Neurological Manifestations Entangles Cytokine Storm That Implicates For Therapeutic Strategies.	Curr Med Chem
33970805	Medicinal plant compounds as promising inhibitors of coronavirus (COVID-19) main protease: an in silico study.	J Biomol Struct Dyn
33970798	A higher flexibility at the SARS-CoV-2 main protease active site compared to SARS-CoV and its potentialities for new inhibitor virtual screening targeting multi-conformers.	J Biomol Struct Dyn
33970787	Not so sweet and simple: impacts of SARS-CoV-2 on the beta cell.	Islets
33970560	"An Androsterone-H2 @C60 hybrid: Synthesis, Properties and Molecular Docking Simulations with SARS-Cov-2."	Chempluschem
33970450	Rifampicin and Letermovir as potential repurposed drug candidate for COVID-19 treatment: insights from an in-silico study.	Pharmacol Rep
33969672	"COVID-19 - neuropathological point of view, pathobiology, and dilemmas after the first year of the pandemic struggle."	Folia Neuropathol
33969601	Interplay between SARS-CoV-2 and human long non-coding RNAs.	J Cell Mol Med
33969357	Structural Consequences of Variation in SARS-CoV-2 B.1.1.7.	J Cell Immunol
33969332	Maternal respiratory SARS-CoV-2 infection in pregnancy is associated with a robust inflammatory response at the maternal-fetal interface.	Med (N Y)
33969329	Interferon antagonism by SARS-CoV-2: a functional study using reverse genetics.	Lancet Microbe
33969322	Longitudinal analysis of humoral immunity against SARS-CoV-2 Spike in convalescent individuals up to 8 months post-symptom onset.	Cell Rep Med
33969321	Divergent and self-reactive immune responses in the CNS of COVID-19 patients with neurological symptoms.	Cell Rep Med
33969320	"Longitudinal proteomic analysis of severe COVID-19 reveals survival-associated signatures, tissue-specific cell death, and cell-cell interactions."	Cell Rep Med
33969287	Reduced A-to-I editing of endogenous Alu RNAs in lung after SARS-CoV-2 infection.	Curr Res Immunol
33969281	Comparative analysis of antibodies to SARS-CoV-2 between asymptomatic and convalescent patients.	iScience
33969249	Alpha 1 Antitrypsin is an Inhibitor of the SARS-CoV-2-Priming Protease TMPRSS2.	Pathog Immun
33969248	The Intersection of COVID-19 and Autoimmunity: What is Our Current Understanding?	Pathog Immun
33969236	Analysis of single nucleotide polymorphisms between 2019-nCoV genomes and its impact on codon usage.	Gene Rep
33969150	Mechanism involved in the pathogenesis and immune response against SARS-CoV-2 infection.	Virusdisease
33969146	Potent programmable antiviral against dengue virus in primary human cells by Cas13b RNP with short spacer and delivery by VLP.	Mol Ther Methods Clin Dev
33969059	Paradoxical relationship between proton pump inhibitors and COVID-19: A systematic review and meta-analysis.	World J Clin Cases
33969054	Polycystic ovary syndrome: Pathways and mechanisms for possible increased susceptibility to COVID-19.	World J Clin Cases
33969006	Anti-cancer Therapy Leads to Increased Cardiovascular Susceptibility to COVID-19.	Front Cardiovasc Med
33968996	Antibodies and Vaccines Target RBD of SARS-CoV-2.	Front Mol Biosci
33968947	Single-Cell RNA-seq Reveals Angiotensin-Converting Enzyme 2 and Transmembrane Serine Protease 2 Expression in TROP2(+) Liver Progenitor Cells: Implications in Coronavirus Disease 2019-Associated Liver Dysfunction.	Front Med (Lausanne)
33968806	SARS CoV-2 Nucleoprotein Enhances the Infectivity of Lentiviral Spike Particles.	Front Cell Infect Microbiol
33968405	Kinetics of peripheral blood neutrophils in severe coronavirus disease 2019.	Clin Transl Immunology
33968364	Identifying potential drug targets and candidate drugs for COVID-19: biological networks and structural modeling approaches.	F1000Res
33968333	Evidence of a putative glycosaminoglycan binding site on the glycosylated SARS-CoV-2 spike protein N-terminal domain.	Comput Struct Biotechnol J
33968188	Facing coronavirus disease 2019: What do we know so far? (Review).	Exp Ther Med
33968142	Transmembrane serine protease 2 Polymorphisms and Susceptibility to Severe Acute Respiratory Syndrome Coronavirus Type 2 Infection: A German Case-Control Study.	Front Genet
33968082	Regulation and Function of ILC3s in Pulmonary Infections.	Front Immunol
33968063	Enhancing the Prefusion Conformational Stability of SARS-CoV-2 Spike Protein Through Structure-Guided Design.	Front Immunol
33968060	"HLA-A*11:01:01:01, HLA-C*12:02:02:01-HLA-B*52:01:02:02, Age and Sex Are Associated With Severity of Japanese COVID-19 With Respiratory Failure."	Front Immunol
33967984	Computational Simulations Identified Marine-Derived Natural Bioactive Compounds as Replication Inhibitors of SARS-CoV-2.	Front Microbiol
33967772	"SARS-CoV-2: Pathogenesis, Molecular Targets and Experimental Models."	Front Pharmacol
33967626	Recombinant Human Thymosin Beta-4 Protects against Mouse Coronavirus Infection.	Mediators Inflamm
33967575	Guillain-Barre syndrome in 220 patients with COVID-19.	Egypt J Neurol Psychiatr Neurosurg
33967554	Coronavirus disease 2019 severity in obesity: Metabolic dysfunction-associated fatty liver disease in the spotlight.	World J Gastroenterol
33967407	A fractional-order differential equation model of COVID-19 infection of epithelial cells.	Chaos Solitons Fractals
33967344	Screening of cryptogamic secondary metabolites as putative inhibitors of SARS-CoV-2 main protease and ribosomal binding domain of spike glycoprotein by molecular docking and molecular dynamics approaches.	J Mol Struct
33967343	In silico detection of inhibitor potential of Passiflora compounds against SARS-Cov-2(Covid-19) main protease by using molecular docking and dynamic analyses.	J Mol Struct
33967342	In silico identification of RBD subdomain of spike protein from Pro(322)-Thr(581) for applications in vaccine development against SARS-CoV2.	J Mol Struct
33967109	[Basic information of Coronavirus].	Uirusu
33966962	Sex steroids and COVID-19 mortality in women.	Trends Endocrinol Metab
33966930	SARS-CoV-2 vaccines: Lights and shadows.	Eur J Intern Med
33966359	Genetic drift of MERS-CoV in Saudi Arabia during 2012-2019.	Zoonoses Public Health
33966351	Tracing genetic signatures of bat-to-human coronaviruses and early transmission of North American SARS-CoV-2.	Transbound Emerg Dis
33965992	Neurologic Manifestations of COVID-19 in Children: Emerging Pathophysiologic Insights.	Pediatr Crit Care Med
33965680	Intestinal expression of ACE2 in mice with high-fat diet-induced obesity and neonates exposed to maternal high-fat diet.	Nutrition
33965637	A scheme for inferring viral-host associations based on codon usage patterns identifies the most affected signaling pathways during COVID-19.	J Biomed Inform
33965601	"SARS-CoV-2, hemoglobin and protoporphyrin IX: Interactions and perspectives."	Photodiagnosis Photodyn Ther
33965375	The chaperone GRP78 is a host auxiliary factor for SARS-CoV-2 and GRP78 depleting antibody blocks viral entry and infection.	J Biol Chem
33965353	Pathophysiological relationship between COVID-19 and olfactory dysfunction: A systematic review.	Braz J Otorhinolaryngol
33965234	[Diabetes and COVID-19].	Therapie
33965003	The COVID-19 puzzle: deciphering pathophysiology and phenotypes of a new disease entity.	Lancet Respir Med
33964992	Inhibition effects of eight anti-coronavirus drugs on glycosides metabolism and glycosidases in human gut microflora.	Pharmazie
33964965	"Epidemiology and evolution of Middle East respiratory syndrome coronavirus, 2012-2020."	Infect Dis Poverty
33964815	COVID-19 infection in severe Alpha 1-antitrypsin deficiency: Looking for a rationale.	Respir Med
33964216	ACE2 Down-Regulation May Act as a Transient Molecular Disease Causing RAAS Dysregulation and Tissue Damage in the Microcirculatory Environment Among COVID-19 Patients.	Am J Pathol
33964132	Alignment free sequence comparison methods and reservoir host prediction.	Bioinformatics
33963942	Analysis of natural compounds against the activity of SARS-CoV-2 NSP15 protein towards an effective treatment against COVID-19: a theoretical and computational biology approach.	J Mol Model
33963867	ModFOLD8: accurate global and local quality estimates for 3D protein models.	Nucleic Acids Res
33963845	COVIDOUTCOME-estimating COVID severity based on mutation signatures in the SARS-CoV-2 genome.	Database (Oxford)
33963726	[Impact of cardiovascular metabolic diseases on COVID-19: review of recent progress].	Nan Fang Yi Ke Da Xue Xue Bao
33963705	[Salvianolic acid B and its magnesium salt inhibit SARS-CoV-2 infection of Vero-E6 cells by blocking spike protein-mediated membrane fusion].	Nan Fang Yi Ke Da Xue Xue Bao
33963679	'Accidents waiting to happen'-Insights from a simple model on the emergence of infectious agents in new hosts.	Transbound Emerg Dis
33963333	TLR2 senses the SARS-CoV-2 envelope protein to produce inflammatory cytokines.	Nat Immunol
33963249	Angiotensin converting enzyme 2 is a novel target of the gamma-secretase complex.	Sci Rep
33963094	SARS-CoV-2 encoded microRNAs are involved in the process of virus infection and host immune response.	J Biomed Res
33963055	SARS-CoV-2 Spike Protein Stabilized in the Closed State Induces Potent Neutralizing Responses.	J Virol
33963054	ILRUN Downregulates ACE2 Expression and Blocks Infection of Human Cells by SARS-CoV-2.	J Virol
33963053	Targeting the Conserved Stem Loop 2 Motif in the SARS-CoV-2 Genome.	J Virol
33963016	Immune profiling of COVID-19: preliminary findings and implications for the pandemic.	J Immunother Cancer
33962695	Neurological pathogenesis of SARS-CoV-2 (COVID-19): from virological features to clinical symptoms.	Inflamm Regen
33962680	An application of slow feature analysis to the genetic sequences of coronaviruses and influenza viruses.	Hum Genomics
33962629	Glycated ACE2 receptor in diabetes: open door for SARS-COV-2 entry in cardiomyocyte.	Cardiovasc Diabetol
33962399	Low plasma angiotensin-converting enzyme 2 level in diabetics increases the risk of severe COVID-19 infection.	Aging (Albany NY)
33962341	Proposal of novel natural inhibitors of severe acute respiratory syndrome coronavirus 2 main protease: Molecular docking and ab initio fragment molecular orbital calculations.	Biophys Chem
33962311	"1,2,4-Triazolo[1,5-a]pyrimidines: Efficient one-step synthesis and functionalization as influenza polymerase PA-PB1 interaction disruptors."	Eur J Med Chem
33962011	Therapeutic approaches for SARS-CoV-2 infection.	Methods
33962007	Microbial co-infections in COVID-19: Associated microbiota and underlying mechanisms of pathogenesis.	Microb Pathog
33961897	Epitope mapping of severe acute respiratory syndrome-related coronavirus nucleocapsid protein with a rabbit monoclonal antibody.	Virus Res
33961839	Tissue-based SARS-CoV-2 detection in fatal COVID-19 infections: Sustained direct viral-induced damage is not necessary to drive disease progression.	Hum Pathol
33961823	METTL3 regulates viral m6A RNA modification and host cell innate immune responses during SARS-CoV-2 infection.	Cell Rep
33961822	Transcriptional and epi-transcriptional dynamics of SARS-CoV-2 during cellular infection.	Cell Rep
33961735	Asymptomatic COVID-19: disease tolerance with efficient anti-viral immunity against SARS-CoV-2.	EMBO Mol Med
33961695	beta-d-N4-hydroxycytidine Inhibits SARS-CoV-2 Through Lethal Mutagenesis But Is Also Mutagenic To Mammalian Cells.	J Infect Dis
33961690	Progressive and Parallel Decline of Humoral and T-Cell Immunity in Convalescent Healthcare Workers with Asymptomatic or Mild-to-Moderate Severe Acute Respiratory Syndrome Coronavirus 2 Infection.	J Infect Dis
33961632	Multiplex qPCR discriminates variants of concern to enhance global surveillance of SARS-CoV-2.	PLoS Biol
33961621	Structural basis for SARS-CoV-2 neutralizing antibodies with novel binding epitopes.	PLoS Biol
33961545	Association of COVID-19 transmission with high levels of ambient pollutants: Initiation and impact of the inflammatory response on cardiopulmonary disease.	Sci Total Environ
33961540	Human convalescent plasma protects K18-hACE2 mice against severe respiratory disease.	J Gen Virol
33961399	Dual-Fluorescence Labeling Pseudovirus for Real-Time Imaging of Single SARS-CoV-2 Entry in Respiratory Epithelial Cells.	ACS Appl Mater Interfaces
33961290	Serum levels of the IgA isotype switch factor TGF-beta1 are elevated in patients with COVID-19.	FEBS Lett
33961167	"Identification of phytocompounds from Houttuynia cordata Thunb. as potential inhibitors for SARS-CoV-2 replication proteins through GC-MS/LC-MS characterization, molecular docking and molecular dynamics simulation."	Mol Divers
33961065	Current understanding on molecular drug targets and emerging treatment strategy for novel coronavirus-19.	Naunyn Schmiedebergs Arch Pharmacol
33960807	Glimpses into evolutionary trajectories of SARS-CoV-2: emerging variants and potential immune evasion routes.	Future Microbiol
33960696	Maintenance of neutralizing antibodies over ten months in convalescent SARS-CoV-2 afflicted patients.	Transbound Emerg Dis
33960608	"Glucose-regulated protein (GRP78) is an important cell surface receptor for viral invasion, cancers, and neurological disorders."	IUBMB Life
33960563	Intrapulmonary distal airway stem cell transplantation repairs lung injury in chronic obstructive pulmonary disease.	Cell Prolif
33960271	Tuberculosis vaccine BCG: the magical effect of the old vaccine in the fight against the COVID-19 pandemic.	Int Rev Immunol
33960170	[Acute kidney injury in the pathogenesis of coronavirus infection].	Urologiia
33959781	"Process development and scale-up optimization of the SARS-CoV-2 receptor binding domain-based vaccine candidate, RBD219-N1C1."	Appl Microbiol Biotechnol
33959697	mRNA technology as one of the promising platforms for the SARS-CoV-2 vaccine development.	Vavilovskii Zhurnal Genet Selektsii
33959636	Impact of Ribosome Activity on SARS-CoV-2 LNP - Based mRNA Vaccines.	Front Mol Biosci
33959218	Calcium channels and their role in regenerative medicine.	World J Stem Cells
33959165	Update on Immunology of COVID-19 Disease and Potential Strategy for Controlling.	Tanaffos
33959123	Circulating Adaptive Immune Cells Expressing the Gut Homing Marker alpha4beta7 Integrin Are Decreased in COVID-19.	Front Immunol
33959029	The Role of Renin-Angiotensin-Aldosterone System in the Heart and Lung: Focus on COVID-19.	Front Pharmacol
33959018	Fluvoxamine: A Review of Its Mechanism of Action and Its Role in COVID-19.	Front Pharmacol
33958887	"A Working Hypothesis on Vesicular Lesions Related to COVID-19 Infection, Koebner Phenomena Type V, and a Short Review of Related Data."	Clin Cosmet Investig Dermatol
33958841	Impact of cytokine storm and systemic inflammation on liver impairment patients infected by SARS-CoV-2: Prospective therapeutic challenges.	World J Gastroenterol
33958774	Interplay between inflammation and thrombosis in cardiovascular pathology.	Nat Rev Cardiol
33958704	Adipocyte inflammation and pathogenesis of viral pneumonias: an overlooked contribution.	Mucosal Immunol
33958627	Association between ACE2 and TMPRSS2 nasopharyngeal expression and COVID-19 respiratory distress.	Sci Rep
33958613	Rapid development of neutralizing and diagnostic SARS-COV-2 mouse monoclonal antibodies.	Sci Rep
33958444	Reverse-transcribed SARS-CoV-2 RNA can integrate into the genome of cultured human cells and can be expressed in patient-derived tissues.	Proc Natl Acad Sci U S A
33958417	Detection and Genome Sequencing of SARS-CoV-2 Variants Belonging to the B.1.1.7 Lineage in the Philippines.	Microbiol Resour Announc
33958322	Structural insights into the cross-neutralization of SARS-CoV and SARS-CoV-2 by the human monoclonal antibody 47D11.	Sci Adv
33957463	Genome-wide comparison of coronaviruses derived from veterinary animals: A canine and feline perspective.	Comp Immunol Microbiol Infect Dis
33957338	The differences in SARS-CoV and SARS-CoV-2 specific co-expression network mediated biological process in human gut enterocytes.	Infect Genet Evol
33957246	Identification of non-covalent 3C-like protease inhibitors against severe acute respiratory syndrome coronavirus-2 via virtual screening of a Korean compound library.	Bioorg Med Chem Lett
33957119	50 Years of structural immunology.	J Biol Chem
33957095	ACE I/D polymorphism in Czech first-wave SARS-CoV-2-positive survivors.	Clin Chim Acta
33957057	The Contribution of Biophysics and Structural Biology to Current Advances in COVID-19.	Annu Rev Biophys
33956950	The peripheral and core regions of virus-host network of COVID-19.	Brief Bioinform
33956935	Role of epithelial-endothelial cell interaction in the pathogenesis of SARS-CoV-2 infection.	Clin Infect Dis
33956645	Whole Genome Sequencing and Phylogenetic Analysis of SARSCoV2 strains in Turkey.	J Infect Dev Ctries
33956593	"Differential role of sphingomyelin in influenza virus, rhinovirus and SARS-CoV-2 infection of Calu-3 cells."	J Gen Virol
33956592	SARS-CoV-2 replicon for high-throughput antiviral screening.	J Gen Virol
33956332	Functional and tissue enrichment analyses suggest that SARS-CoV-2 infection affects host metabolism and catabolism mediated by interference on host proteins.	Braz J Microbiol
33956156	Crystal structure of SARS-CoV-2 nsp10 bound to nsp14-ExoN domain reveals an exoribonuclease with both structural and functional integrity.	Nucleic Acids Res
33955590	Effects of mesenchymal stromal cell-derived extracellular vesicles in acute respiratory distress syndrome (ARDS): Current understanding and future perspectives.	J Leukoc Biol
33955543	SARS-CoV-2 infection in patients with atopic dermatitis: a cross-sectional study.	Br J Dermatol
33955468	Molecular diversity of coronavirus host cell entry receptors.	FEMS Microbiol Rev
33955313	The effect of RAAS inhibitors on acute hypoxemic respiratory failure and in-hospital mortality in the hypertensive Covid-19 patients.	Clin Exp Hypertens
33955213	Single-Domain Antibodies for the Detection of SARS-CoV-2 Nucleocapsid Protein.	Anal Chem
33955183	The angiotensin II type 1 receptor blocker valsartan in the battle against COVID-19.	Obesity (Silver Spring)
33954990	Trachyspermum ammi and Cinnamomum verum as nutraceuticals: Spices rich in therapeutically significant protein tyrosine phosphatases.	J Food Biochem
33954061	Natural resources to control COVID-19: could lactoferrin amend SARS-CoV-2 infectivity?	PeerJ
33954055	Identification of a novel inhibitor of SARS-CoV-2 3CL-PRO through virtual screening and molecular dynamics simulation.	PeerJ
33953960	Back to the future: lessons from past viral infections and the link with Parkinson's disease.	Neuronal Signal
33953920	Structural biology in the time of COVID-19: perspectives on methods and milestones.	IUCrJ
33953911	Global prevalence and pathogenesis of headache in COVID-19: A systematic review and meta-analysis.	F1000Res
33953756	"Drug Repurposing Approach, Potential Drugs, and Novel Drug Targets for COVID-19 Treatment."	J Environ Public Health
33953732	Role of ILC2 in Viral-Induced Lung Pathogenesis.	Front Immunol
33953674	Giloy Ghanvati (Tinospora cordifolia (Willd.) Hook. f. and Thomson) Reversed SARS-CoV-2 Viral Spike-Protein Induced Disease Phenotype in the Xenotransplant Model of Humanized Zebrafish.	Front Pharmacol
33953641	From the Role of Microbiota in Gut-Lung Axis to SARS-CoV-2 Pathogenesis.	Mediators Inflamm
33953595	Factors Associated with the Expression of ACE2 in Human Lung Tissue: Pathological Evidence from Patients with Normal FEV1 and FEV1/FVC.	J Inflamm Res
33953384	Delayed production of neutralizing antibodies correlates with fatal COVID-19.	Nat Med
33953325	Innate immune sensing of coronavirus and viral evasion strategies.	Exp Mol Med
33953323	Type I and III interferon responses in SARS-CoV-2 infection.	Exp Mol Med
33953295	Efficacy of GC-376 against SARS-CoV-2 virus infection in the K18 hACE2 transgenic mouse model.	Sci Rep
33953223	Network pharmacology approach to decipher signaling pathways associated with target proteins of NSAIDs against COVID-19.	Sci Rep
33952771	Frequency of interleukin-6 rs1800795 (-174G/C) and rs1800797 (-597G/A) polymorphisms in COVID-19 patients in Turkey who develop macrophage activation syndrome.	Jpn J Infect Dis
33952657	"Temporal Dynamics and Evolution of SARS-CoV-2 Demonstrate the Necessity of Ongoing Viral Genome Sequencing in Ontario, Canada."	mSphere
33952647	CCR2 Regulates Vaccine-Induced Mucosal T-Cell Memory to Influenza A Virus.	J Virol
33952616	Evaluation of Cellular and Serological Responses to Acute SARS-CoV-2 Infection Demonstrates the Functional Importance of the Receptor-Binding Domain.	J Immunol
33952614	Zebrafish as a Translational Model: An Experimental Alternative to Study the Mechanisms Involved in Anosmia and Possible Neurodegenerative Aspects of COVID-19?	eNeuro
33952598	"Genomic Elucidation of a COVID-19 Resurgence and Local Transmission of SARS-CoV-2 in Guangzhou, China."	J Clin Microbiol
33952596	A SARS-CoV-2 Variant with L452R and E484Q Neutralization Resistance Mutations.	J Clin Microbiol
33952432	Systemic inflammation may induce cardiac injury in COVID-19 patients including children and adolescents without underlying cardiovascular diseases: A systematic review.	Cardiovasc Revasc Med
33952256	Immune response induced by oral administration with a Saccharomyces cerevisiae-based SARS-CoV-2 vaccine in mice.	Microb Cell Fact
33951913	Self-Assembling Nanoparticle Vaccines Displaying the Receptor Binding Domain of SARS-CoV-2 Elicit Robust Protective Immune Responses in Rhesus Monkeys.	Bioconjug Chem
33951640	The Immune Responses against Coronavirus Infections: Friend or Foe?	Int Arch Allergy Immunol
33951604	"Exploring the effectiveness of the TSR-based protein 3-D structural comparison method for protein clustering, and structural motif identification and discovery of protein kinases, hydrolases, and SARS-CoV-2's protein via the application of amino acid grouping."	Comput Biol Chem
33951560	Immunological and inflammatory profiles during acute and convalescent phases of severe/ critically ill COVID-19 patients.	Int Immunopharmacol
33951417	CD8(+) T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope display high naive precursor frequency and TCR promiscuity.	Immunity
33951416	Uncoupling of macrophage inflammation from self-renewal modulates host recovery from respiratory viral infection.	Immunity
33951227	The role and significance of angiotensin-converting enzyme 2 peptides in the treatment of coronavirus disease 2019.	J Clin Lab Anal
33951211	Preliminary report on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Spike mutation T478K.	J Med Virol
33951208	The surveillance of spike protein for patients with COVID-19 detected in Hong Kong in 2020.	J Med Virol
33950784	Mechanistic insights into the inhibitory activity of FDA approved ivermectin against SARS-CoV-2: old drug with new implications.	J Biomol Struct Dyn
33950776	Experimental studies using OMV in a new platform of SARS-CoV-2 vaccines.	Hum Vaccin Immunother
33950349	Investigation of potential inhibitor properties of ethanolic propolis extracts against ACE-II receptors for COVID-19 treatment by molecular docking study.	Arch Microbiol
33950324	Profiling of T Cell Repertoire in SARS-CoV-2-Infected COVID-19 Patients Between Mild Disease and Pneumonia.	J Clin Immunol
33950300	Human cell receptors: potential drug targets to combat COVID-19.	Amino Acids
33950288	The interplay between the immune system and SARS-CoV-2 in COVID-19 patients.	Arch Virol
33950285	Histomorphological patterns of regional lymph nodes in COVID-19 lungs.	Pathologe
33950278	Potential role of IFN-alpha in COVID-19 patients and its underlying treatment options.	Appl Microbiol Biotechnol
33950107	Should COVID-19 be branded to viral thrombotic fever?	Mem Inst Oswaldo Cruz
33949925	"Severe Acute Respiratory Syndrome Coronavirus -2 (SARS-CoV-2): A Review on Pathophysiology, Diagnosis and Investigational Therapeutics."	Curr Med Chem
33949876	"Obesity Cardiomyopathy: Evidence, Mechanisms and Therapeutic Implications."	Physiol Rev
33949668	Integrative genomics analysis reveals a 21q22.11 locus contributing risk to COVID-19.	Hum Mol Genet
33949647	SARS-CoV-2 Genomic Surveillance in Northeast Brazil: Timing of Emergence of the Brazilian Variant of Concern P1.	J Travel Med
33949414	Selenium-atom-modified thymidine enhances the specificity and sensitivity of DNA polymerization and detection.	Chem Commun (Camb)
33949286	"Quantum biochemistry, molecular docking, and dynamics simulation revealed synthetic peptides induced conformational changes affecting the topology of the catalytic site of SARS-CoV-2 main protease."	J Biomol Struct Dyn
33949279	Antivirals virtual screening to SARS-CoV-2 non-structural proteins.	J Biomol Struct Dyn
33949277	Molecular docking of compounds from Clinacanthus nutans extract detected by GC-MS analysis with the SARS-CoV-2 main protease and ACE2 protein.	Nat Prod Res
33949276	Potential of (Citrus nobilis Lour x Citrus deliciosa Tenora) metabolites on COVID-19 virus main protease supported by in silico analysis.	Nat Prod Res
33949212	The effect of estrogen in coronavirus disease 2019.	Am J Physiol Lung Cell Mol Physiol
33949207	Role of the Immune Microenvironment in SARS-CoV-2 Infection.	Cell Transplant
33949163	Putative mechanism of neurological damage in COVID-19 infection.	Acta Neurobiol Exp (Wars)
33949124	Atomistic De-novo Inhibitor Generation-Guided Drug Repurposing for SARS-CoV-2 Spike Protein with Free-Energy Validation by Well-Tempered Metadynamics.	Chem Asian J
33948708	Yeast proteins do not practice social distancing as species hybridize.	Curr Genet
33948452	Direct acting anti-hepatitis C combinations as potential COVID-19 protease inhibitors.	Virusdisease
33948424	Inhibitory effect of anti-HIV compounds extracted from Indian medicinal plants to retard the replication and transcription process of SARS-CoV-2: an insight from molecular docking and MD-simulation studies.	Netw Model Anal Health Inform Bioinform
33947851	Human kidney is a target for novel severe acute respiratory syndrome coronavirus 2 infection.	Nat Commun
33947832	The SARS-CoV-2 protein ORF3a inhibits fusion of autophagosomes with lysosomes.	Cell Discov
33947773	"Prevalent, protective, and convergent IgG recognition of SARS-CoV-2 non-RBD spike epitopes."	Science
33947753	"Galectin-9, a Player in Cytokine Release Syndrome and a Surrogate Diagnostic Biomarker in SARS-CoV-2 Infection."	mBio
33947467	Role of interferon gamma in SARS-CoV-2-positive patients with parasitic infections.	Gut Pathog
33947317	"The non-specific antiviral activity of polysulfates to fight SARS-CoV-2, its mutants and viruses with cationic spikes."	J Biomater Sci Polym Ed
33947170	Metal-Promoted Heterocyclization: A Heterosynthetic Approach to Face a Pandemic Crisis.	Molecules
33947034	In Vitro Inhibitory Analysis of Rationally Designed siRNAs against MERS-CoV Replication in Huh7 Cells.	Molecules
33946935	Type I Interferon-Mediated Regulation of Antiviral Capabilities of Neutrophils.	Int J Mol Sci
33946869	Remdesivir and Ledipasvir among the FDA-Approved Antiviral Drugs Have Potential to Inhibit SARS-CoV-2 Replication.	Cells
33946802	Antiviral Properties of the NSAID Drug Naproxen Targeting the Nucleoprotein of SARS-CoV-2 Coronavirus.	Molecules
33946747	Emergence and Spread of SARS-CoV-2 Lineages B.1.1.7 and P.1 in Italy.	Viruses
33946736	"Role of Inflammatory Cytokines in COVID-19 Patients: A Review on Molecular Mechanisms, Immune Functions, Immunopathology and Immunomodulatory Drugs to Counter Cytokine Storm."	Vaccines (Basel)
33946649	ACE2 Is an Adjacent Element of Atherosclerosis and COVID-19 Pathogenesis.	Int J Mol Sci
33946644	Computational Identification of Potential Anti-Inflammatory Natural Compounds Targeting the p38 Mitogen-Activated Protein Kinase (MAPK): Implications for COVID-19-Induced Cytokine Storm.	Biomolecules
33946341	Proteomics: A Tool to Study Platelet Function.	Int J Mol Sci
33946306	"D936Y and Other Mutations in the Fusion Core of the SARS-CoV-2 Spike Protein Heptad Repeat 1: Frequency, Geographical Distribution, and Structural Effect."	Molecules
33946304	Inhibitors of Protein Glycosylation Are Active against the Coronavirus Severe Acute Respiratory Syndrome Coronavirus SARS-CoV-2.	Viruses
33945951	Structure and function of SARS-CoV-2 polymerase.	Curr Opin Virol
33945786	CD8(+) T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope cross-react with selective seasonal coronaviruses.	Immunity
33945677	Longitudinal proteomic profiling provides insights into host response and proteome dynamics in COVID-19 progression.	Proteomics
33945651	COVID-19-related coagulopathy: A review of pathophysiology and pharmaceutical management.	Cell Biol Int
33945643	Immunological analysis of the murine anti-CD3-induced cytokine release syndrome model and therapeutic efficacy of anti-cytokine antibodies.	Eur J Immunol
33945513	Relationship of SARS-CoV-2-specific CD4 response to COVID-19 severity and impact of HIV-1 and tuberculosis coinfection.	J Clin Invest
33945504	Is complement the culprit behind COVID-19 vaccine-related adverse reactions?	J Clin Invest
33945070	"Longitudinal virological changes and underlying pathogenesis in hospitalized COVID-19 patients in Guangzhou, China."	Sci China Life Sci
33945026	Immunological and physiopathological approach of COVID-19 in pregnancy.	Arch Gynecol Obstet
33944741	The impact of obesity on the cellular and molecular pathophysiology of COVID-19.	S Afr Med J
33944709	Saliva and its potential in coronavirus disease 2019 (COVID-19) cannot be ignored: A point of view.	Infect Control Hosp Epidemiol
33944697	Germline IGHV3-53-encoded RBD-targeting neutralizing antibodies are commonly present in the antibody repertoires of COVID-19 patients.	Emerg Microbes Infect
33944644	Unleashing the potential of cell membrane-based nanoparticles for COVID-19 treatment and vaccination.	Expert Opin Drug Deliv
33943040	In Vitro Models for Studying Respiratory Host-Pathogen Interactions.	Adv Biol (Weinh)
33942847	An Evolutionary Portrait of the Progenitor SARS-CoV-2 and Its Dominant Offshoots in COVID-19 Pandemic.	Mol Biol Evol
33942835	Influence of charge configuration on substrate binding to SARS-CoV-2 main protease.	Chem Commun (Camb)
33942417	Temperature dependent viral tropism: understanding viral seasonality and pathogenicity as applied to the avoidance and treatment of endemic viral respiratory illnesses.	Rev Med Virol
33942026	Neutralizing Antibody Responses After SARS-CoV-2 Infection in End-Stage Kidney Disease and Protection Against Reinfection.	Kidney Int Rep
33942008	In vitro cell culture model of human nasal-associated lymphoid tissue (NALT) to evaluate the humoral immune response to SARS-CoV-2 spike proteins.	Saudi J Biol Sci
33941770	Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing.	Cell Discov
33941687	Reversed-engineered human alveolar lung-on-a-chip model.	Proc Natl Acad Sci U S A
33941681	DNA-inspired nanomaterials for enhanced endosomal escape.	Proc Natl Acad Sci U S A
33941660	Transglutaminase 2 Regulates Innate Immunity by Modulating the STING/TBK1/IRF3 Axis.	J Immunol
33941657	Comparative Analysis of Antigen-Specific Anti-SARS-CoV-2 Antibody Isotypes in COVID-19 Patients.	J Immunol
33941622	COVID-19-related anosmia is associated with viral persistence and inflammation in human olfactory epithelium and brain infection in hamsters.	Sci Transl Med
33941621	Viral genomes reveal patterns of the SARS-CoV-2 outbreak in Washington State.	Sci Transl Med
33941272	COVID-19 and Alzheimer's disease: how one crisis worsens the other.	Transl Neurodegener
33941271	Multi-omics reveals age-related differences in the diaphragm response to mechanical ventilation: a pilot study.	Skelet Muscle
33941085	The Coronavirus Network Explorer: mining a large-scale knowledge graph for effects of SARS-CoV-2 on host cell function.	BMC Bioinformatics
33941061	COVID-19 Pandemic and Male Fertility: Clinical Manifestations and Pathogenic Mechanisms.	Biochemistry (Mosc)
33940513	Mechanistic understanding of innate and adaptive immune responses in SARS-CoV-2 infection.	Mol Immunol
33940506	Disease-drug and drug-drug interaction in COVID-19: Risk and assessment.	Biomed Pharmacother
33940136	"Exploring the potential of novel phenolic compounds as potential therapeutic candidates against SARS-CoV-2, using quantum chemistry, molecular docking and dynamic studies."	Bioorg Med Chem Lett
33940003	Pathogenic perspective of missense mutations of ORF3a protein of SARS-CoV-2.	Virus Res
33939913	Elucidation of Cryptic and Allosteric Pockets within the SARS-CoV-2 Main Protease.	J Chem Inf Model
33939590	In silico identification and validation of triarylchromones as potential inhibitor against main protease of severe acute respiratory syndrome coronavirus 2.	J Biomol Struct Dyn
33939057	COVID-19 and the pituitary.	Pituitary
33939044	Epigenetic alterations and genetic variations of angiotensin-converting enzyme 2 (ACE2) as a functional receptor for SARS-CoV-2: potential clinical implications.	Eur J Clin Microbiol Infect Dis
33938476	Coronavirus disease 2019 respiratory disease in children: clinical presentation and pathophysiology.	Curr Opin Pediatr
33937889	ROS-Driven selection pressure on COVID-19 patients with cardiovascular comorbidities.	Innovation (N Y)
33937741	Unbiased interrogation of memory B cells from convalescent COVID-19 patients reveals a broad antiviral humoral response targeting SARS-CoV-2 antigens beyond the spike protein.	Vaccine X
33937725	"Therapeutic antibodies, targeting the SARS-CoV-2 spike N-terminal domain, protect lethally infected K18-hACE2 mice."	iScience
33937724	Experimental and natural evidence of SARS-CoV-2-infection-induced activation of type I interferon responses.	iScience
33937569	Epidemiological correlation between COVID-19 epidemic and prevalence of alpha-1 antitrypsin deficiency in the world.	Glob Health Med
33937568	COVID-19 and bronchial asthma: current perspectives.	Glob Health Med
33937545	Current updates on adaptive immune response by B cell and T cell stimulation and therapeutic strategies for novel coronavirus disease 2019 (COVID-19) treatment.	Heliyon
33937326	Developmental Landscape of Potential Vaccine Candidates Based on Viral Vector for Prophylaxis of COVID-19.	Front Mol Biosci
33937299	Uremia-Associated Immunological Aging and Severity of COVID-19 Infection.	Front Med (Lausanne)
33937270	"5-Hydroxytryptamine, Glutamate, and ATP: Much More Than Neurotransmitters."	Front Cell Dev Biol
33937168	Genomic Analysis and Lineage Identification of SARS-CoV-2 Strains in Migrants Accessing Europe Through the Libyan Route.	Front Public Health
33937104	The Building Blocks of Antimicrobial Resistance in Pseudomonas aeruginosa: Implications for Current Resistance-Breaking Therapies.	Front Cell Infect Microbiol
33936927	Mutational heterogeneity in spike glycoproteins of severe acute respiratory syndrome coronavirus 2.	3 Biotech
33936746	"Extensive genetic diversity with novel mutations in spike glycoprotein of severe acute respiratory syndrome coronavirus 2, Bangladesh in late 2020."	New Microbes New Infect
33936565	Targeting protein-protein interaction interfaces in COVID-19 drug discovery.	Comput Struct Biotechnol J
33936347	Immunoinformatics Identification of B- and T-Cell Epitopes in the RNA-Dependent RNA Polymerase of SARS-CoV-2.	Can J Infect Dis Med Microbiol
33936086	SARS-CoV-2 Spike Targets USP33-IRF9 Axis via Exosomal miR-148a to Activate Human Microglia.	Front Immunol
33936072	Single-Cell RNA Sequencing Analysis of the Immunometabolic Rewiring and Immunopathogenesis of Coronavirus Disease 2019.	Front Immunol
33936053	Involvement of Interleukin-1 Receptor-Associated Kinase 4 and Interferon Regulatory Factor 5 in the Immunopathogenesis of SARS-CoV-2 Infection: Implications for the Treatment of COVID-19.	Front Immunol
33936047	SARS-CoV-2 Infection Induces Psoriatic Arthritis Flares and Enthesis Resident Plasmacytoid Dendritic Cell Type-1 Interferon Inhibition by JAK Antagonism Offer Novel Spondyloarthritis Pathogenesis Insights.	Front Immunol
33936045	Antibody Responses in COVID-19: A Review.	Front Immunol
33935803	"Severe Acute Respiratory Syndrome Coronavirus 2 and Male Reproduction: Relationship, Explanations, and Clinical Remedies."	Front Physiol
33935717	Na(+)/K(+)-ATPase as a Target of Cardiac Glycosides for the Treatment of SARS-CoV-2 Infection.	Front Pharmacol
33935562	Therapeutic development by repurposing drugs targeting SARS-CoV-2 spike protein interactions by simulation studies.	Saudi J Biol Sci
33935396	Acute Kidney Injury in COVID-19: a Brief Review.	Indian J Surg
33935376	Learning vector quantization as an interpretable classifier for the detection of SARS-CoV-2 types based on their RNA sequences.	Neural Comput Appl
33935292	[Meta-analysis evaluating the risk of respiratory tract infections and acute respiratory distress syndrome with glucagon-like peptide-1 receptor agonists in cardiovascular outcome trials: useful implications for the COVID-19 pandemic].	Rev Clin Esp
33935221	The pathology of the brain and the eye in SARS-Co-V2 infected patients: A review.	J Neuroophthalmol
33934609	Mechanisms of Cardiovascular Toxicities Associated With Immunotherapies.	Circ Res
33934527	Recent advances on smart glycoconjugate vaccines in infections and cancer.	FEBS J
33934422	Predictable fold switching by the SARS-CoV-2 protein ORF9b.	Protein Sci
33934387	Betacoronaviruses genome analysis reveals evolution toward specific codons usage: Implications for SARS-CoV-2 mitigation strategies.	J Med Virol
33934306	In silico screening of potent bioactive compounds from honeybee products against COVID-19 target enzymes.	Environ Sci Pollut Res Int
33934300	Demyelination as a result of an immune response in patients with COVID-19.	Acta Neurol Belg
33934196	Human gene polymorphisms and their possible impact on the clinical outcome of SARS-CoV-2 infection.	Arch Virol
33933885	Modelling studies reveal the importance of the C-terminal inter motif loop of NSP1 as a promising target site for drug discovery and screening of potential phytochemicals to combat SARS-CoV-2.	J Mol Graph Model
33933817	The pig as a medical model for acquired respiratory diseases and dysfunctions: An immunological perspective.	Mol Immunol
33933634	Disparities in COVID-19 severities and casualties across ethnic groups around the globe and patterns of ACE2 and PIR variants.	Infect Genet Evol
33933633	Genetic polymorphisms as multi-biomarkers in severe acute respiratory syndrome (SARS) by coronavirus infection: A systematic review of candidate gene association studies.	Infect Genet Evol
33933612	Reconstitution and functional characterization of SARS-CoV-2 proofreading complex.	Protein Expr Purif
33933611	Endothelin antagonism and sodium glucose Co-transporter 2 inhibition. A potential combination therapeutic strategy for COVID-19.	Pulm Pharmacol Ther
33933603	Promising role of defensins peptides as therapeutics to combat against viral infection.	Microb Pathog
33933189	"SARS-CoV-2 seroprevalence, and IgG concentration and pseudovirus neutralising antibody titres after infection, compared by HIV status: a matched case-control observational study."	Lancet HIV
33932869	The central role of mitochondrial fitness on antiviral defenses: An advocacy for physical activity during the COVID-19 pandemic.	Redox Biol
33932696	A possible pathogenic role of Syndecan-1 in the pathogenesis of coronavirus disease 2019 (COVID-19).	Int Immunopharmacol
33932694	"Mesenchymal stromal/stem cells (MSCs) and MSC-derived extracellular vesicles in COVID-19-induced ARDS: Mechanisms of action, research progress, challenges, and opportunities."	Int Immunopharmacol
33932622	The systemic pro-inflammatory response: targeting the dangerous liaison between COVID-19 and cancer.	ESMO Open
33932618	Anaphylaxis associated with the mRNA COVID-19 vaccines: Approach to allergy investigation.	Clin Immunol
33932551	Causal impact of local inflammation in the nasal cavity on higher brain function and cognition.	Neurosci Res
33932547	Astemizole as a drug to inhibit the effect of SARS-COV-2 in vitro.	Microb Pathog
33932525	Genome sequencing of SARS-CoV-2 in a cohort of Egyptian patients revealed mutation hotspots that are related to clinical outcomes.	Biochim Biophys Acta Mol Basis Dis
33932453	Nrf2 activation putatively mediates clinical benefits of low-dose radiotherapy in COVID-19 pneumonia and acute respiratory distress syndrome (ARDS): Novel mechanistic considerations.	Radiother Oncol
33932326	Diverse immunoglobulin gene usage and convergent epitope targeting in neutralizing antibody responses to SARS-CoV-2.	Cell Rep
33931941	SARS-CoV-2 worldwide replication drives rapid rise and selection of mutations across the viral genome: a time-course study - potential challenge for vaccines and therapies.	EMBO Mol Med
33931765	Pharmacokinetics-based identification of pseudoaldosterogenic compounds originating from Glycyrrhiza uralensis roots (Gancao) after dosing LianhuaQingwen capsule.	Acta Pharmacol Sin
33931664	A SARS-CoV-2 (COVID-19) biological network to find targets for drug repurposing.	Sci Rep
33931567	Prior SARS-CoV-2 infection rescues B and T cell responses to variants after first vaccine dose.	Science
33931245	Moments in autophagy and disease: Past and present.	Mol Aspects Med
33931105	"Etiology and clinical characteristics of SARS-CoV-2 and other human coronaviruses among children in Zhejiang Province, China 2017-2019."	Virol J
33930996	Distance matrices for nitrogenous bases and amino acids of SARS-CoV-2 via structural metric.	J Bioinform Comput Biol
33930819	Expression of SARS coronavirus 1 spike protein from a herpesviral vector induces innate immune signaling and neutralizing antibody responses.	Virology
33930764	"Immunogenomics guided design of immunomodulatory multi-epitope subunit vaccine against the SARS-CoV-2 new variants, and its validation through in silico cloning and immune simulation."	Comput Biol Med
33930705	The role of vitamin D in reducing SARS-CoV-2 infection: An update.	Int Immunopharmacol
33930563	"Assessment of basic reproduction number (R0), spatial and temporal epidemiological determinants, and genetic characterization of SARS-CoV-2 in Bangladesh."	Infect Genet Evol
33930332	Functional landscape of SARS-CoV-2 cellular restriction.	Mol Cell
33930306	A monoclonal antibody against staphylococcal enterotoxin B superantigen inhibits SARS-CoV-2 entry in vitro.	Structure
33930293	SARS-CoV-2 RNA: Exclusive friends and common foes.	Cell
33930273	Glycyrrhizic Acid Nanoparticles as Antiviral and Anti-inflammatory Agents for COVID-19 Treatment.	ACS Appl Mater Interfaces
33930196	JAK inhibitors: Ten years after.	Eur J Immunol
33930189	The breadth of concomitant virological features in a family cluster outbreak of COVID-19 pneumonia.	J Med Virol
33930144	Role of von Willebrand Factor in COVID-19 Associated Coagulopathy.	J Appl Lab Med
33929934	A real-time and high-throughput neutralization test based on SARS-CoV-2 pseudovirus containing monomeric infrared fluorescent protein as reporter.	Emerg Microbes Infect
33929853	Integrated Biophysical Modeling of the SARS-CoV-2 Spike Protein Binding and Allosteric Interactions with Antibodies.	J Phys Chem B
33929758	Andrographis paniculata (Burm. F) Wall ex Nees: Antiviral properties.	Phytother Res
33929617	Neurological update: COVID-19.	J Neurol
33929200	Supercoiling Structure-Based Design of a Trimeric Coiled-Coil Peptide with High Potency against HIV-1 and Human beta-Coronavirus Infection.	J Med Chem
33929003	An update on Sars-CoV-2: a review.	Theor Biol Forum
33928870	In a search for potential drug candidates for combating COVID-19: computational study revealed salvianolic acid B as a potential therapeutic targeting 3CLpro and spike proteins.	J Biomol Struct Dyn
33928690	New perspectives on natural flavonoids on COVID-19-induced lung injuries.	Phytother Res
33928531	A review on the immune responses against novel emerging coronavirus (SARS-CoV-2).	Immunol Res
33928512	"(1)H, (13)C, (15)N and (31)P chemical shift assignment for stem-loop 4 from the 5'-UTR of SARS-CoV-2."	Biomol NMR Assign
33928494	Screening for inhibitory effects of crude drugs on furin-like enzymatic activities.	J Nat Med
33928374	Activating Killer-Cell Immunoglobulin-Like Receptors Are Associated With the Severity of Coronavirus Disease 2019.	J Infect Dis
33928117	Glycans of SARS-CoV-2 Spike Protein in Virus Infection and Antibody Production.	Front Mol Biosci
33927728	Interplay of Opposing Effects of the WNT/beta-Catenin Pathway and PPARgamma and Implications for SARS-CoV2 Treatment.	Front Immunol
33927594	Selective Vagus Nerve Stimulation as a Therapeutic Approach for the Treatment of ARDS: A Rationale for Neuro-Immunomodulation in COVID-19 Disease.	Front Neurosci
33927374	Prospects for durable immune control of SARS-CoV-2 and prevention of reinfection.	Nat Rev Immunol
33927258	The dimer-monomer equilibrium of SARS-CoV-2 main protease is affected by small molecule inhibitors.	Sci Rep
33926967	Sex differences in the induction of angiotensin converting enzyme 2 (ACE-2) in mouse lungs after e-cigarette vapor exposure and its relevance to COVID-19.	J Investig Med
33926623	COVID-2019 fundamentals.	J Am Dent Assoc
33926589	Inflammatory neuropsychiatric disorders and COVID-19 neuroinflammation.	Acta Neuropsychiatr
33926500	SARS-CoV-2 interacts with platelets and megakaryocytes via ACE2-independent mechanism.	J Hematol Oncol
33926459	A novel pseudovirus-based mouse model of SARS-CoV-2 infection to test COVID-19 interventions.	J Biomed Sci
33926110	Effects of SARS-CoV-2 on Cardiovascular System: The Dual Role of Angiotensin-Converting Enzyme 2 (ACE2) as the Virus Receptor and Homeostasis Regulator-Review.	Int J Mol Sci
33925881	Dysregulation of the Renin-Angiotensin-Aldosterone System (RAA) in Patients Infected with SARS-CoV-2-Possible Clinical Consequences.	Int J Mol Sci
33925854	Mutation Signatures and In Silico Docking of Novel SARS-CoV-2 Variants of Concern.	Microorganisms
33925831	Hypoalbuminemia as Surrogate and Culprit of Infections.	Int J Mol Sci
33925812	AC2: An Efficient Protein Sequence Compression Tool Using Artificial Neural Networks and Cache-Hash Models.	Entropy (Basel)
33925783	Nutritional Interventions for COVID-19: A Role for Carnosine?	Nutrients
33925779	"PIMS-TS, the New Paediatric Systemic Inflammatory Disease Related to Previous Exposure to SARS-CoV-2 Infection-""Rheumatic Fever"" of the 21st Century?"	Int J Mol Sci
33925715	Next-Generation Probiotics and Their Metabolites in COVID-19.	Microorganisms
33925446	A Nanoscaffolded Spike-RBD Vaccine Provides Protection against SARS-CoV-2 with Minimal Anti-Scaffold Response.	Vaccines (Basel)
33925394	Linking COVID-19 and Heme-Driven Pathophysiologies: A Combined Computational-Experimental Approach.	Biomolecules
33925388	Identification of Epidemiological Traits by Analysis of SARS-CoV-2 Sequences.	Viruses
33925334	Thromboembolic Complications in Covid-19: From Clinical Scenario to Laboratory Evidence.	Life (Basel)
33925255	In Vitro Lung Models and Their Application to Study SARS-CoV-2 Pathogenesis and Disease.	Viruses
33925069	Identification of Highly Conserved SARS-CoV-2 Antigenic Epitopes with Wide Coverage Using Reverse Vaccinology Approach.	Viruses
33925055	"Age, Disease Severity and Ethnicity Influence Humoral Responses in a Multi-Ethnic COVID-19 Cohort."	Viruses
33924982	Endothelial Extracellular Vesicles: From Keepers of Health to Messengers of Disease.	Int J Mol Sci
33924778	Global Discrepancies between Numbers of Available SARS-CoV-2 Genomes and Human Development Indexes at Country Scales.	Viruses
33924631	Comorbidities and Susceptibility to COVID-19: A Generalized Gene Set Data Mining Approach.	J Clin Med
33924596	The Impact of Oral Health on Respiratory Viral Infection.	Dent J (Basel)
33924395	"Identification of Anti-SARS-CoV-2 Compounds from Food Using QSAR-Based Virtual Screening, Molecular Docking, and Molecular Dynamics Simulation Analysis."	Pharmaceuticals (Basel)
33924302	Broad-Spectrum Antiviral Strategies and Nucleoside Analogues.	Viruses
33923909	An Effective MM/GBSA Protocol for Absolute Binding Free Energy Calculations: A Case Study on SARS-CoV-2 Spike Protein and the Human ACE2 Receptor.	Molecules
33923828	Characteristics of Anti-SARS-CoV-2 Antibodies in Recovered COVID-19 Subjects.	Viruses
33923792	"Lymphopenia, Lymphopenia-Induced Proliferation, and Autoimmunity."	Int J Mol Sci
33923573	Development of a Vaccine against SARS-CoV-2 Based on the Receptor-Binding Domain Displayed on Virus-Like Particles.	Vaccines (Basel)
33923537	Inflammasome Activation-Induced Hypercoagulopathy: Impact on Cardiovascular Dysfunction Triggered in COVID-19 Patients.	Cells
33923369	Cyanobacteria-From the Oceans to the Potential Biotechnological and Biomedical Applications.	Mar Drugs
33923363	Designing a SARS-CoV-2 T-Cell-Inducing Vaccine for High-Risk Patient Groups.	Vaccines (Basel)
33923155	Investigating Cellular Trajectories in the Severity of COVID-19 and Their Transcriptional Programs Using Machine Learning Approaches.	Genes (Basel)
33923138	Microscopic Observation of SARS-Like Particles in RT-qPCR SARS-CoV-2 Positive Sewage Samples.	Pathogens
33922936	Within-Host and Between-Host Evolution in SARS-CoV-2-New Variant's Source.	Viruses
33922918	SARS-CoV-2 Viral Entry Proteins in Hyperandrogenemic Female Mice: Implications for Women with PCOS and COVID-19.	Int J Mol Sci
33922914	Dieckol and Its Derivatives as Potential Inhibitors of SARS-CoV-2 Spike Protein (UK Strain: VUI 202012/01): A Computational Study.	Mar Drugs
33922613	Semicovariance Coefficient Analysis of Spike Proteins from SARS-CoV-2 and Other Coronaviruses for Viral Evolution and Characteristics Associated with Fatality.	Entropy (Basel)
33922476	Cell-Type Apoptosis in Lung during SARS-CoV-2 Infection.	Pathogens
33922257	Genomic Surveillance of Circulating SARS-CoV-2 in South East Italy: A One-Year Retrospective Genetic Study.	Viruses
33922049	Can Prophylactic High Flow of Humidified and Warmed Filtered Air Improve Survival from Bacterial Pneumonia and SARS-CoV-2 in Elderly Individuals? The Role of Surfactant Protein A.	Antioxidants (Basel)
33921971	Baicalein and Baicalin Inhibit SARS-CoV-2 RNA-Dependent-RNA Polymerase.	Microorganisms
33921959	Biodegradation of Chloroxylenol by Cunninghamella elegans IM 1785/21GP and Trametes versicolor IM 373: Insight into Ecotoxicity and Metabolic Pathways.	Int J Mol Sci
33921938	Temporal Dominance of B.1.1.7 over B.1.354 SARS-CoV-2 Variant: A Hypothesis Based on Areas of Variant Co-Circulation.	Life (Basel)
33921886	SARS-CoV-2 M(pro): A Potential Target for Peptidomimetics and Small-Molecule Inhibitors.	Biomolecules
33921873	Arthropod Ectoparasites Have Potential to Bind SARS-CoV-2 via ACE.	Viruses
33921689	Protective Role of a TMPRSS2 Variant on Severe COVID-19 Outcome in Young Males and Elderly Women.	Genes (Basel)
33921677	AP205 VLPs Based on Dimerized Capsid Proteins Accommodate RBM Domain of SARS-CoV-2 and Serve as an Attractive Vaccine Candidate.	Vaccines (Basel)
33921378	Molecular Dynamic Simulation Search for Possible Amphiphilic Drug Discovery for Covid-19.	Molecules
33921289	Efficacy of Phytochemicals Derived from Avicennia officinalis for the Management of COVID-19: A Combined In Silico and Biochemical Study.	Molecules
33921228	SARS-CoV-2 Papain-Like Protease Potential Inhibitors-In Silico Quantitative Assessment.	Int J Mol Sci
33921215	The C-Terminal Domain of Nef(mut) Is Dispensable for the CD8(+) T Cell Immunogenicity of In Vivo Engineered Extracellular Vesicles.	Vaccines (Basel)
33921174	Inhibition of SARS-CoV-2 Virus Entry by the Crude Polysaccharides of Seaweeds and Abalone Viscera In Vitro.	Mar Drugs
33921021	Lights and Shadows on Managing Immune Checkpoint Inhibitors in Oncology during the COVID-19 Era.	Cancers (Basel)
33920986	Stress Response Is the Main Trigger of Sporadic Amyloidoses.	Int J Mol Sci
33920917	The Intersection of Age and Influenza Severity: Utility of Ferrets for Dissecting the Age-Dependent Immune Responses and Relevance to Age-Specific Vaccine Development.	Viruses
33920915	The Emerging Role of Epigenetic Mechanisms in the Causation of Aberrant MMP Activity during Human Pathologies and the Use of Medicinal Drugs.	Biomolecules
33920904	Neurological Complications of COVID-19: Underlying Mechanisms and Management.	Int J Mol Sci
33920814	Molecular Pathology Analysis of SARS-CoV-2 in Syncytiotrophoblast and Hofbauer Cells in Placenta from a Pregnant Woman and Fetus with COVID-19.	Pathogens
33920790	Cardiovascular Outcomes in the Acute Phase of COVID-19.	Int J Mol Sci
33920748	Pharmacological Modulators of Autophagy as a Potential Strategy for the Treatment of COVID-19.	Int J Mol Sci
33920724	"Current Status of Putative Animal Sources of SARS-CoV-2 Infection in Humans: Wildlife, Domestic Animals and Pets."	Microorganisms
33920709	COVID-19: Direct and Indirect Mechanisms of Statins.	Int J Mol Sci
33920628	Aptamers for Anti-Viral Therapeutics and Diagnostics.	Int J Mol Sci
33920604	Obesity as a Risk Factor for Severe COVID-19 and Complications: A Review.	Cells
33920583	Immunomodulating Effects of Fungal Beta-Glucans: From Traditional Use to Medicine.	Nutrients
33920487	Genetic Diversity of SARS-CoV-2 over a One-Year Period of the COVID-19 Pandemic: A Global Perspective.	Biomedicines
33920428	Endocrine-Disrupting Chemicals and Infectious Diseases: From Endocrine Disruption to Immunosuppression.	Int J Mol Sci
33920366	Sinapic Acid Suppresses SARS CoV-2 Replication by Targeting Its Envelope Protein.	Antibiotics (Basel)
33920220	Cockayne Syndrome Group B (CSB): The Regulatory Framework Governing the Multifunctional Protein and Its Plausible Role in Cancer.	Cells
33920179	SARS-CoV-2 Disease through Viral Genomic and Receptor Implications: An Overview of Diagnostic and Immunology Breakthroughs.	Microorganisms
33920011	Could Antigen Presenting Cells Represent a Protective Element during SARS-CoV-2 Infection in Children?	Pathogens
33919991	L-Carnitine Tartrate Downregulates the ACE2 Receptor and Limits SARS-CoV-2 Infection.	Nutrients
33919952	Transcriptional Landscape of Vero E6 Cells during Early Swine Acute Diarrhea Syndrome Coronavirus Infection.	Viruses
33919907	The Role of Bifidobacteria in Predictive and Preventive Medicine: A Focus on Eczema and Hypercholesterolemia.	Microorganisms
33919870	Molecular Simulation-Based Investigation of Highly Potent Natural Products to Abrogate Formation of the nsp10-nsp16 Complex of SARS-CoV-2.	Biomolecules
33919784	The Role of Macrophages in the Development of Acute and Chronic Inflammatory Lung Diseases.	Cells
33919780	Potential Effects of Melatonin and Micronutrients on Mitochondrial Dysfunction during a Cytokine Storm Typical of Oxidative/Inflammatory Diseases.	Diseases
33919584	"Bromodomain and Extraterminal Protein Inhibitor, Apabetalone (RVX-208), Reduces ACE2 Expression and Attenuates SARS-Cov-2 Infection In Vitro."	Biomedicines
33919537	Long-COVID and Post-COVID Health Complications: An Up-to-Date Review on Clinical Conditions and Their Possible Molecular Mechanisms.	Viruses
33919314	A Potential SARS-CoV-2 Variant of Interest (VOI) Harboring Mutation E484K in the Spike Protein Was Identified within Lineage B.1.1.33 Circulating in Brazil.	Viruses
33919308	"The Effect of Proinflammatory Cytokines on the Proliferation, Migration and Secretory Activity of Mesenchymal Stem/Stromal Cells (WJ-MSCs) under 5% O2 and 21% O2 Culture Conditions."	J Clin Med
33919284	SARS-CoV-2 and Placenta: New Insights and Perspectives.	Viruses
33918914	"Broad-Spectrum Antiviral Activity of 3D8, a Nucleic Acid-Hydrolyzing Single-Chain Variable Fragment (scFv), Targeting SARS-CoV-2 and Multiple Coronaviruses In Vitro."	Viruses
33918670	Quinine Inhibits Infection of Human Cell Lines with SARS-CoV-2.	Viruses
33918615	The Photosensitizer Octakis(cholinyl)zinc Phthalocyanine with Ability to Bind to a Model Spike Protein Leads to a Loss of SARS-CoV-2 Infectivity In Vitro When Exposed to Far-Red LED.	Viruses
33918600	Assembly and Entry of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2): Evaluation Using Virus-Like Particles.	Cells
33918599	The Spike Glycoprotein of SARS-CoV-2 Binds to beta1 Integrins Expressed on the Surface of Lung Epithelial Cells.	Viruses
33918595	Native Structure-Based Peptides as Potential Protein-Protein Interaction Inhibitors of SARS-CoV-2 Spike Protein and Human ACE2 Receptor.	Molecules
33918402	Rutin Is a Low Micromolar Inhibitor of SARS-CoV-2 Main Protease 3CLpro: Implications for Drug Design of Quercetin Analogs.	Biomedicines
33918371	FIB-SEM as a Volume Electron Microscopy Approach to Study Cellular Architectures in SARS-CoV-2 and Other Viral Infections: A Practical Primer for a Virologist.	Viruses
33918332	Surveillance of SARS-CoV-2 in Frankfurt am Main from October to December 2020 Reveals High Viral Diversity Including Spike Mutation N501Y in B.1.1.70 and B.1.1.7.	Microorganisms
33918318	The Transmission of SARS-CoV-2 Infection on the Ocular Surface and Prevention Strategies.	Cells
33918313	A COVID-19 Drug Repurposing Strategy through Quantitative Homological Similarities Using a Topological Data Analysis-Based Framework.	Pharmaceutics
33918301	Glycyrrhizin Effectively Inhibits SARS-CoV-2 Replication by Inhibiting the Viral Main Protease.	Viruses
33918079	Vascular Inflammation Is Associated with Loss of Aquaporin 1 Expression on Endothelial Cells and Increased Fluid Leakage in SARS-CoV-2 Infected Golden Syrian Hamsters.	Viruses
33918060	Inferring the Association between the Risk of COVID-19 Case Fatality and N501Y Substitution in SARS-CoV-2.	Viruses
33917837	Contribution of Pro-Inflammatory Molecules Induced by Respiratory Virus Infections to Neurological Disorders.	Pharmaceuticals (Basel)
33917694	Algae-Derived Bioactive Molecules for the Potential Treatment of SARS-CoV-2.	Molecules
33917481	Role of Structural and Non-Structural Proteins and Therapeutic Targets of SARS-CoV-2 for COVID-19.	Cells
33917442	The Role of Vitamin K in Humans: Implication in Aging and Age-Associated Diseases.	Antioxidants (Basel)
33917411	Intervention Strategies for Seasonal and Emerging Respiratory Viruses with Drugs and Vaccines Targeting Viral Surface Glycoproteins.	Viruses
33917313	Host-Directed FDA-Approved Drugs with Antiviral Activity against SARS-CoV-2 Identified by Hierarchical In Silico/In Vitro Screening Methods.	Pharmaceuticals (Basel)
33917138	The Impact on Infectivity and Neutralization Efficiency of SARS-CoV-2 Lineage B.1.351 Pseudovirus.	Viruses
33916917	"Systemic Inflammation and COVID-19 Mortality in Patients with Major Noncommunicable Diseases: Chronic Coronary Syndromes, Diabetes and Obesity."	J Clin Med
33916747	A Study of 3CLpros as Promising Targets against SARS-CoV and SARS-CoV-2.	Microorganisms
33916702	Population Disequilibrium as Promoter of Adaptive Explorations in Hepatitis C Virus.	Viruses
33916607	RGD-Binding Integrins Revisited: How Recently Discovered Functions and Novel Synthetic Ligands (Re-)Shape an Ever-Evolving Field.	Cancers (Basel)
33916492	Genotyping of the Major SARS-CoV-2 Clade by Short-Amplicon High-Resolution Melting (SA-HRM) Analysis.	Genes (Basel)
33916461	In Silico Mining of Terpenes from Red-Sea Invertebrates for SARS-CoV-2 Main Protease (M(pro)) Inhibitors.	Molecules
33916205	"Nosocomial Outbreak of SARS-CoV-2 in a ""Non-COVID-19"" Hospital Ward: Virus Genome Sequencing as a Key Tool to Understand Cryptic Transmission."	Viruses
33916100	Rescue of Infectious Sindbis Virus by Yeast Spheroplast-Mammalian Cell Fusion.	Viruses
33915773	BNT162b2 Vaccine Encoding the SARS-CoV-2 P2 S Protects Transgenic hACE2 Mice against COVID-19.	Vaccines (Basel)
33915711	Previous Humoral Immunity to the Endemic Seasonal Alphacoronaviruses NL63 and 229E Is Associated with Worse Clinical Outcome in COVID-19 and Suggests Original Antigenic Sin.	Life (Basel)
33915569	COVID-19 tissue atlases reveal SARS-CoV-2 pathology and cellular targets.	Nature
33915568	A molecular single-cell lung atlas of lethal COVID-19.	Nature
33915502	Novel and emerging mutations of SARS-CoV-2: Biomedical implications.	Biomed Pharmacother
33915479	Dual targeting of cytokine storm and viral replication in COVID-19 by plant-derived steroidal pregnanes: An in silico perspective.	Comput Biol Med
33915460	Ebsulfur and Ebselen as highly potent scaffolds for the development of potential SARS-CoV-2 antivirals.	Bioorg Chem
33915361	Promising phytochemicals of traditional Himalayan medicinal plants against putative replication and transmission targets of SARS-CoV-2 by computational investigation.	Comput Biol Med
33915216	One year into the pandemic: Short-term evolution of SARS-CoV-2 and emergence of new lineages.	Infect Genet Evol
33915212	Heparin: A simplistic repurposing to prevent SARS-CoV-2 transmission in light of its in-vitro nanomolar efficacy.	Int J Biol Macromol
33915202	Lipid homeostasis and mevalonate pathway in COVID-19: Basic concepts and potential therapeutic targets.	Prog Lipid Res
33915132	Human respiratory viral infections: Current status and future prospects of nanotechnology-based approaches for prophylaxis and treatment.	Life Sci
33915112	Detect and destroy: CRISPR-based technologies for the response against viruses.	Cell Host Microbe
33915108	Notch4 signaling limits regulatory T-cell-mediated tissue repair and promotes severe lung inflammation in viral infections.	Immunity
33915014	Supramolecular Cylinders Target Bulge Structures in the 5' UTR of the RNA Genome of SARS-CoV-2 and Inhibit Viral Replication*.	Angew Chem Int Ed Engl
33914986	Adamantiades-Behcet's disease (Behcet's disease) and COVID-19.	J Eur Acad Dermatol Venereol
33914873	Animal Models of COVID-19 II. Comparative Immunology.	ILAR J
33914789	"Analysis of cytokines in SARS-CoV-2 or COVID-19 patients in Erbil city, Kurdistan Region of Iraq."	PLoS One
33914787	Fast and efficient purification of SARS-CoV-2 RNA dependent RNA polymerase complex expressed in Escherichia coli.	PLoS One
33914735	Cryo-electron microscopy structures of the N501Y SARS-CoV-2 spike protein in complex with ACE2 and 2 potent neutralizing antibodies.	PLoS Biol
33914724	"Linked Clusters of SARS-CoV-2 Variant B.1.351 - Maryland, January-February 2021."	MMWR Morb Mortal Wkly Rep
33914685	Detection of Binding Sites on SARS-CoV-2 Spike Protein Receptor-Binding Domain by Molecular Dynamics Simulations in Mixed Solvents.	IEEE/ACM Trans Comput Biol Bioinform
33914346	Cancer as a prospective sequela of long COVID-19.	Bioessays
33914244	"The (1)H, (15)N, and (13)C resonance assignments of the N-terminal domain of the nucleocapsid protein from the Middle East respiratory syndrome coronavirus."	Biomol NMR Assign
33913550	"SARS-CoV-2 ORF9b antagonizes type I and III interferons by targeting multiple components of the RIG-I/MDA-5-MAVS, TLR3-TRIF, and cGAS-STING signaling pathways."	J Med Virol
33913546	Comparable endemic coronavirus nucleoprotein-specific antibodies in mild and severe Covid-19 patients.	J Med Virol
33913544	Characterization of T lymphocytes in severe COVID-19 patients.	J Med Virol
33913542	Can molecular mimicry explain the cytokine storm of SARS-CoV-2?: An in silico approach.	J Med Virol
33913206	Potential 3-chymotrypsin-like cysteine protease cleavage sites in the coronavirus polyproteins pp1a and pp1ab and their possible relevance to COVID-19 vaccine and drug development.	FASEB J
33913101	Expression map of entry receptors and infectivity factors for pan-coronaviruses in preimplantation and implantation stage human embryos.	J Assist Reprod Genet
33912797	"Neutralizing antibodies against SARS-CoV-2: current understanding, challenge and perspective."	Antib Ther
33912796	Mini-review: antibody therapeutics targeting G protein-coupled receptors and ion channels.	Antib Ther
33912795	Emerging antibody-based therapeutics against SARS-CoV-2 during the global pandemic.	Antib Ther
33912794	Innate immune-mediated antiviral response to SARS-CoV-2 and convalescent sera a potential prophylactic and therapeutic agent to tackle COVID-19.	Antib Ther
33912793	Rapid exploration of the epitope coverage produced by an Ebola survivor to guide the discovery of therapeutic antibody cocktails.	Antib Ther
33912790	Isolation of a human monoclonal antibody specific for the receptor binding domain of SARS-CoV-2 using a competitive phage biopanning strategy.	Antib Ther
33912590	Gastrointestinal Microenvironment and the Gut-Lung Axis in the Immune Responses of Severe COVID-19.	Front Mol Biosci
33912588	The Deadly Duo of COVID-19 and Cancer!	Front Mol Biosci
33912587	Inhibition of SARS-CoV-2 3CL M(pro) by Natural and Synthetic Inhibitors: Potential Implication for Vaccine Production Against COVID-19.	Front Mol Biosci
33912475	No Evidence for Human Monocyte-Derived Macrophage Infection and Antibody-Mediated Enhancement of SARS-CoV-2 Infection.	Front Cell Infect Microbiol
33912411	Reactivity of human antisera to codon optimized SARS-CoV2 viral proteins expressed in Escherichia coli.	Tzu Chi Med J
33912167	Vasculitis and Neutrophil Extracellular Traps in Lungs of Golden Syrian Hamsters With SARS-CoV-2.	Front Immunol
33912161	Virus Caused Imbalance of Type I IFN Responses and Inflammation in COVID-19.	Front Immunol
33912129	Elucidating the Neuropathologic Mechanisms of SARS-CoV-2 Infection.	Front Neurol
33912041	"Phytoconstituents, In Vitro Anti-Infective Activity of Buddleja indica Lam., and In Silico Evaluation of its SARS-CoV-2 Inhibitory Potential."	Front Pharmacol
33912030	Repurposing Chloroquine Against Multiple Diseases With Special Attention to SARS-CoV-2 and Associated Toxicity.	Front Pharmacol
33911464	COVID-19 and the gastrointestinal tract: Source of infection or merely a target of the inflammatory process following SARS-CoV-2 infection?	World J Gastroenterol
33911163	Unraveling the stability landscape of mutations in the SARS-CoV-2 receptor-binding domain.	Sci Rep
33911109	Coiled-coil heterodimers with increased stability for cellular regulation and sensing SARS-CoV-2 spike protein-mediated cell fusion.	Sci Rep
33911008	"Genome-Wide B Cell, CD4(+), and CD8(+) T Cell Epitopes That Are Highly Conserved between Human and Animal Coronaviruses, Identified from SARS-CoV-2 as Targets for Preemptive Pan-Coronavirus Vaccines."	J Immunol
33910954	Inhibitors of Coronavirus 3CL Proteases Protect Cells from Protease-Mediated Cytotoxicity.	J Virol
33910818	Coronavirus Disease 2019 and Nasal Conditions: A Review of Current Evidence.	In Vivo
33910809	On the Origin of SARS-CoV-2: Did Cell Culture Experiments Lead to Increased Virulence of the Progenitor Virus for Humans?	In Vivo
33910569	Impact of the N501Y substitution of SARS-CoV-2 Spike on neutralizing monoclonal antibodies targeting diverse epitopes.	Virol J
33910372	Platelet Activation and Plasma Levels of Furin Are Associated With Prognosis of Patients With Coronary Artery Disease and COVID-19.	Arterioscler Thromb Vasc Biol
33910211	"Evolution of SARS-CoV-2: Review of Mutations, Role of the Host Immune System."	Nephron
33910207	SARS-CoV-2 Infection in Pregnant Women: Neuroimmune-Endocrine Changes at the Maternal-Fetal Interface.	Neuroimmunomodulation
33910079	PEGylated nanoparticle albumin-bound steroidal ginsenoside derivatives ameliorate SARS-CoV-2-mediated hyper-inflammatory responses.	Biomaterials
33909917	Emergence of immunosuppressive LOX-1+ PMN-MDSC in septic shock and severe COVID-19 patients with acute respiratory distress syndrome.	J Leukoc Biol
33909683	Hypertension as a sequela in patients of SARS-CoV-2 infection.	PLoS One
33909660	Risk of rapid evolutionary escape from biomedical interventions targeting SARS-CoV-2 spike protein.	PLoS One
33909265	"Understanding the Co-Epidemic of Obesity and COVID-19: Current Evidence, Comparison with Previous Epidemics, Mechanisms, and Preventive and Therapeutic Perspectives."	Curr Obes Rep
33909259	Neutralizing monoclonal antibodies present new prospects to treat SARS-CoV-2 infections.	Front Med
33909065	The Role of Cell Surface Sialic Acids for SARS-CoV-2 Infection.	Glycobiology
33908720	[Pathophysiology of COVID-19 related happy hypoxemia].	Rev Med Suisse
33908716	[COVID-19-related acute encephalopathy: physiopathological hypothesis].	Rev Med Suisse
33908688	Rapid endotheliitis and vascular damage characterize SARS-CoV-2 infection in a human lung-on-chip model.	EMBO Rep
33908595	Electrostatic interactions between the SARS-CoV-2 virus and a charged electret fibre.	Soft Matter
33908318	Cameroonian medicinal plants as potential candidates of SARS-CoV-2 inhibitors.	J Biomol Struct Dyn
33908208	Roles of Type I and III Interferons in COVID-19.	Yonsei Med J
33908152	Limited cross-species transmission and absence of mutations associated with SARS-CoV-2 adaptation in cats: A case study of infection in a small household setting.	Transbound Emerg Dis
33907833	Interleukin6 signalling as a valuable cornerstone for molecular medicine (Review).	Int J Mol Med
33907801	Analyzing master regulators and scRNA-seq of COVID-19 patients reveals an underlying anti-SARS-CoV-2 mechanism of ZNF proteins.	Brief Bioinform
33907739	Analysis workflow of publicly available RNA-sequencing datasets.	STAR Protoc
33907732	Nanotraps for the containment and clearance of SARS-CoV-2.	Matter
33907720	Gene expression analysis of MCF7 cell lines of breast cancer treated with herbal extract of Cissampelos pareira revealed association with viral diseases.	Gene Rep
33907666	"Triazole, imidazole, and thiazole-based compounds as potential agents against coronavirus."	Results Chem
33907665	Indomethacin: Can It Counteract Bradykinin Effects in COVID-19 Patients?	Curr Pharmacol Rep
33907612	"Comparisons of the immunological landscape between COVID-19, influenza, and respiratory syncytial virus patients by clustering analysis."	Comput Struct Biotechnol J
33907537	History of cyclodextrin-based polymers in food and pharmacy: a review.	Environ Chem Lett
33907521	Construction and applications of SARS-CoV-2 pseudoviruses: a mini review.	Int J Biol Sci
33907519	In silico structure-based discovery of a SARS-CoV-2 main protease inhibitor.	Int J Biol Sci
33907518	SARS-CoV-2 main protease suppresses type I interferon production by preventing nuclear translocation of phosphorylated IRF3.	Int J Biol Sci
33907515	Developing effective siRNAs to reduce the expression of key viral genes of COVID-19.	Int J Biol Sci
33907514	The role of CD4(+)FoxP3(+) regulatory T cells in the immunopathogenesis of COVID-19: implications for treatment.	Int J Biol Sci
33907513	Inflammatory stress in SARS-COV-2 associated Acute Kidney Injury.	Int J Biol Sci
33907511	The Genetic Variant of SARS-CoV-2: would It Matter for Controlling the Devastating Pandemic?	Int J Biol Sci
33907508	"mRNA vaccines for COVID-19: what, why and how."	Int J Biol Sci
33907504	Biomolecular interactions with nanoparticles: applications for coronavirus disease 2019.	Curr Opin Colloid Interface Sci
33907373	Identification of selected genes associated with the SARS-CoV-2: a therapeutic approach and disease severity.	Bull Natl Res Cent
33907361	Differences in Interactions Within Viral Replication Complexes of SARS-CoV-2 (COVID-19) and SARS-CoV Coronaviruses Control RNA Replication Ability.	JOM (1989)
33907312	The furin cleavage site in the SARS-CoV-2 spike protein is required for transmission in ferrets.	Nat Microbiol
33907306	A multi-targeting drug design strategy for identifying potent anti-SARS-CoV-2 inhibitors.	Acta Pharmacol Sin
33906967	Noncanonical crRNAs derived from host transcripts enable multiplexable RNA detection by Cas9.	Science
33906927	ColdZyme Maintains Integrity in SARS-CoV-2-Infected Airway Epithelia.	mBio
33906918	Analysis of the Long-Term Impact on Cellular Immunity in COVID-19-Recovered Individuals Reveals a Profound NKT Cell Impairment.	mBio
33906662	"Expression of the SARS-CoV-2 receptorACE2 in human heart is associated with uncontrolled diabetes, obesity, and activation of the renin angiotensin system."	Cardiovasc Diabetol
33906375	Cytokine storm modulation in COVID-19: a proposed role for vitamin D and DPP-4 inhibitor combination therapy (VIDPP-4i).	Immunotherapy
33906227	SARS-CoV-2 Sequence Characteristics of COVID-19 Persistence and Reinfection.	Clin Infect Dis
33906125	Animal models for SARS-CoV-2.	Curr Opin Virol
33906124	Future considerations for the mRNA-lipid nanoparticle vaccine platform.	Curr Opin Virol
33906110	Production in Escherichia coli of recombinant COVID-19 spike protein fragments fused to CRM197.	Biochem Biophys Res Commun
33905951	Functional responsiveness of memory T cells from COVID-19 patients.	Cell Immunol
33905892	SARS-CoV-2 genomic surveillance in Costa Rica: Evidence of a divergent population and an increased detection of a spike T1117I mutation.	Infect Genet Evol
33905891	Spike protein mutational landscape in India during the complete lockdown phase: Could Muller's ratchet be a future game-changer for COVID-19?	Infect Genet Evol
33905739	SARS-CoV-2 infection of primary human lung epithelium for COVID-19 modeling and drug discovery.	Cell Rep
33905505	A Combination of N and S Antigens With IgA and IgG Measurement Strengthens the Accuracy of SARS-CoV-2 Serodiagnostics.	J Infect Dis
33905481	Vaccinated and convalescent donor-derived SARS-CoV-2-specific T cells as adoptive immunotherapy for high-risk COVID-19 patients.	Clin Infect Dis
33905282	Immunobiology and nanotherapeutics of severe acute respiratory syndrome 2 (SARS-CoV-2): a current update.	Infect Dis (Lond)
33904890	SARS-CoV-2-related MIS-C: A key to the viral and genetic causes of Kawasaki disease?	J Exp Med
33904788	Angiotensin Receptor Blockers Are Not Just for Hypertension Anymore.	Physiology (Bethesda)
33904782	Coronavirus Disease 19 and Future Ecological Crises: Hopes from Epigenomics and Unraveling Genome Regulation in Humans and Infectious Agents.	OMICS
33904651	Single-cell analyses reveal SARS-CoV-2 interference with intrinsic immune response in the human gut.	Mol Syst Biol
33904403	Mechanistic theory predicts the effects of temperature and humidity on inactivation of SARS-CoV-2 and other enveloped viruses.	Elife
33904269	Monoclonal antibody therapy in COVID-19.	J Biol Regul Homeost Agents
33904251	Post-adenoviral-based COVID-19 vaccines thrombosis: A proposed mechanism.	J Thromb Haemost
33904240	Targeting SARS-CoV-2 Spike Protein/ACE2 Protein-Protein Interactions: a Computational Study.	Mol Inform
33904225	NeutrobodyPlex-monitoring SARS-CoV-2 neutralizing immune responses using nanobodies.	EMBO Rep
33903964	"Sex hormones, autoimmunity and gender disparity in COVID-19."	Rheumatol Int
33903954	The olfactory nerve is not a likely route to brain infection in COVID-19: a critical review of data from humans and animal models.	Acta Neuropathol
33903779	"Synthesis, X-ray crystal structure, IR and Raman spectroscopic analysis, quantum chemical computational and molecular docking studies on hydrazone-pyridine compound: As an insight into the inhibitor capacity of main protease of SARS-CoV2."	J Mol Struct
33903778	"In search of RdRp and Mpro inhibitors against SARS CoV-2: Molecular docking, molecular dynamic simulations and ADMET analysis."	J Mol Struct
33903777	"New alpha-Hydrazinophosphonic acid: Synthesis, characterization, DFT study and in silico prediction of its potential inhibition of SARS-CoV-2 main protease."	J Mol Struct
33903735	Maternal natural killer cells at the intersection between reproduction and mucosal immunity.	Mucosal Immunol
33903676	Analysis and forecasting of global real time RT-PCR primers and probes for SARS-CoV-2.	Sci Rep
33903660	"Analysis of IgM, IgA, and IgG isotype antibodies Directed against SARS-CoV-2 spike glycoprotein and ORF8 in the course of COVID-19."	Sci Rep
33903171	Dual nature of human ACE2 glycosylation in binding to SARS-CoV-2 spike.	Proc Natl Acad Sci U S A
33903110	Overcoming Culture Restriction for SARS-CoV-2 in Human Cells Facilitates the Screening of Compounds Inhibiting Viral Replication.	Antimicrob Agents Chemother
33903045	Testosterone's Role in COVID-19.	J Sex Med
33902795	Experimental Identification of Immuno- dominant B-cell Epitopes from SARS-CoV-2.	Chimia (Aarau)
33902408	Association of Viruses in the Development of Cardiovascular Diseases.	Curr Pharm Des
33902347	The Effect of SARS-CoV-2 on the Spleen and T Lymphocytes.	Viral Immunol
33902254	"[Plitidepsin, an inhibitor of the cell elongation factor eEF1a, and molnupiravir an analogue of the ribonucleoside cytidine, two new chemical compounds with intense activity against SARS-CoV-2]."	Rev Esp Quimioter
33901557	Identification of Vitamin K3 and its analogues as covalent inhibitors of SARS-CoV-2 3CL(pro).	Int J Biol Macromol
33901540	Will a little change do you good? A putative role of polymorphisms in COVID-19.	Immunol Lett
33901389	"Synthesis, antioxidant, antimicrobial and antiviral docking studies of ethyl 2-(2-(arylidene)hydrazinyl)thiazole-4-carboxylates."	Z Naturforsch C J Biosci
33901295	Functional characterization of organoids derived from irreversibly damaged NASH patient liver.	Hepatology
33901167	Genomic and epidemiological characteristics of SARS-CoV-2 in Africa.	PLoS Negl Trop Dis
33901166	The first few days of a SARS-CoV-2 infection viewed at single-cell resolution.	PLoS Biol
33900819	"Antibody Therapy: From Diphtheria to Cancer, COVID-19, and Beyond."	Monoclon Antib Immunodiagn Immunother
33900725	Comparative Perturbation-Based Modeling of the SARS-CoV-2 Spike Protein Binding with Host Receptor and Neutralizing Antibodies: Structurally Adaptable Allosteric Communication Hotspots Define Spike Sites Targeted by Global Circulating Mutations.	Biochemistry
33900696	Neutrophils and COVID-19: What Is Going On?	Crit Rev Immunol
33900695	COVID-19 and Strategies for Its Therapeutics.	Crit Rev Immunol
33900693	Molecular Insights into Severe Acute Respiratory Syndrome Coronavirus 2 Pathobiology: Dissecting the Interplay between Cellular Innate Immunity and Immune Evasion.	Crit Rev Immunol
33900692	"Immunology of Transplant Patients with SARS-CoV-2 Infection: Transmission, Immune Response, and Therapeutic Strategy."	Crit Rev Immunol
33900691	Viral Proteins under 70 Kilodaltons in Size Prevent the Development of Long-Lasting B-Cell Immune Memory and IgG2a Prevention in COVID-19 Vaccines.	Crit Rev Immunol
33900491	Organoid: a powerful tool to study lung regeneration and disease.	Cell Regen
33900399	Genomic Epidemiology of SARS-CoV-2 Infection During the Initial Pandemic Wave and Association With Disease Severity.	JAMA Netw Open
33900328	N-Glycosylated Ganoderma lucidum immunomodulatory protein improved anti-inflammatory activity via inhibition of the p38 MAPK pathway.	Food Funct
33900318	Inhibition mechanism and hot-spot prediction of nine potential drugs for SARS-CoV-2 M(pro) by large-scale molecular dynamic simulations combined with accurate binding free energy calculations.	Nanoscale
33900279	Editorial: SARS-CoV-2 mRNA Vaccines and the Possible Mechanism of Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT).	Med Sci Monit
33900195	"Novel SARS-CoV-2 Variant Derived from Clade 19B, France."	Emerg Infect Dis
33900193	"Introduction of ORF3a-Q57H SARS-CoV-2 Variant Causing Fourth Epidemic Wave of COVID-19, Hong Kong, China."	Emerg Infect Dis
33900177	"Monitoring SARS-CoV-2 Circulation and Diversity through Community Wastewater Sequencing, the Netherlands and Belgium."	Emerg Infect Dis
33900175	"Use of Genomics to Track Coronavirus Disease Outbreaks, New Zealand."	Emerg Infect Dis
33900165	Susceptibility to SARS-CoV-2 of Cell Lines and Substrates Commonly Used to Diagnose and Isolate Influenza and Other Viruses.	Emerg Infect Dis
33900080	Tuning Proton Transfer Thermodynamics in SARS-CoV-2 Main Protease: Implications for Catalysis and Inhibitor Design.	J Phys Chem Lett
33899752	Mucosal immunity to severe acute respiratory syndrome coronavirus 2 infection.	Curr Opin Infect Dis
33899609	COVID-19: captures iron and generates reactive oxygen species to damage the human immune system.	Autoimmunity
33899542	Manipulation of genes could inhibit SARS-CoV-2 infection that causes COVID-19 pandemics.	Exp Biol Med (Maywood)
33899516	[Cough from a cardiologic perspective].	Ther Umsch
33899033	Asymptomatic and symptomatic SARS-CoV-2 infections elicit polyfunctional antibodies.	Cell Rep Med
33899032	Soluble interleukin-6 receptor in the COVID-19 cytokine storm syndrome.	Cell Rep Med
33898942	Cell-type-resolved quantitative proteomics map of interferon response against SARS-CoV-2.	iScience
33898797	Identification of PBMC-based molecular signature associational with COVID-19 disease severity.	Heliyon
33898733	Immunoinformatics and molecular modeling approach to design universal multi-epitope vaccine for SARS-CoV-2.	Inform Med Unlocked
33898732	"Identification of SARS-CoV-2 origin: Using Ngrams, principal component analysis and Random Forest algorithm."	Inform Med Unlocked
33898662	Statistics and Patterns of Occurrence of Simple Tandem Repeats in SARS-CoV-1 and SARS-CoV-2 Genomic Data.	Data Brief
33898520	Structure-Based Virtual Screening to Identify Novel Potential Compound as an Alternative to Remdesivir to Overcome the RdRp Protein Mutations in SARS-CoV-2.	Front Mol Biosci
33898518	An Overview of Spike Surface Glycoprotein in Severe Acute Respiratory Syndrome-Coronavirus.	Front Mol Biosci
33898484	Engineering Tissue-Informed Biomaterials to Advance Pulmonary Regenerative Medicine.	Front Med (Lausanne)
33898461	COVID-19 During Development: A Matter of Concern.	Front Cell Dev Biol
33897974	"Enzyme kinetic and binding studies identify determinants of specificity for the immunomodulatory enzyme ScpA, a C5a inactivating bacterial protease."	Comput Struct Biotechnol J
33897833	Promising role of curcumin against viral diseases emphasizing COVID-19 management: A review on the mechanistic insights with reference to host-pathogen interaction and immunomodulation.	J Funct Foods
33897804	Inherited and acquired corona of coronavirus in the host: Inspiration from the biomolecular corona of nanoparticles.	Nano Today
33897742	Efficient Transient Expression of Recombinant Proteins Using DNA Viral Vectors in Freshwater Microalgal Species.	Front Plant Sci
33897423	"1,2,3,4,6-Pentagalloyl Glucose, a RBD-ACE2 Binding Inhibitor to Prevent SARS-CoV-2 Infection."	Front Pharmacol
33897410	Impact of COVID-19 Pandemic on Patients With Neurodegenerative Diseases.	Front Aging Neurosci
33897376	"Neurotropic Viruses, Astrocytes, and COVID-19."	Front Cell Neurosci
33897313	Prediction of Epitope based Peptides for Vaccine Development from Complete Proteome of Novel Corona Virus (SARS-COV-2) Using Immunoinformatics.	Int J Pept Res Ther
33897278	The dual role of the immune system in the course of COVID-19. The fatal impact of the aging immune system.	Cent Eur J Immunol
33897081	Analysis of the Genomic Distance Between Bat Coronavirus RaTG13 and SARS-CoV-2 Reveals Multiple Origins of COVID-19.	Acta Math Sci
33896796	Supplementary research on K150del variant of activated protein C.	Aging (Albany NY)
33896688	Durability of Immunity to SARS-CoV-2 and Other Respiratory Viruses.	Trends Microbiol
33896413	Emerging variants of concern in SARS-CoV-2 membrane protein: a highly conserved target with potential pathological and therapeutic implications.	Emerg Microbes Infect
33896392	Combined use of the hepatitis C drugs and amentoflavone could interfere with binding of the spike glycoprotein of SARS-CoV-2 to ACE2: the results of a molecular simulation study.	J Biomol Struct Dyn
33896155	"Antibodies for COVID-19 - which, when and how long?"	J Biol Regul Homeost Agents
33896121	The influence of HLA genotype on the severity of COVID-19 infection.	HLA
33895815	Mutation Rates and Selection on Synonymous Mutations in SARS-CoV-2.	Genome Biol Evol
33895786	An integrative drug repositioning framework discovered a potential therapeutic agent targeting COVID-19.	Signal Transduct Target Ther
33895780	The olfactory route is a potential way for SARS-CoV-2 to invade the central nervous system of rhesus monkeys.	Signal Transduct Target Ther
33895773	RNA-induced liquid phase separation of SARS-CoV-2 nucleocapsid protein facilitates NF-kappaB hyper-activation and inflammation.	Signal Transduct Target Ther
33895478	"Acute and post-acute phase of COVID-19: Analyzing expression patterns of miRNA-29a-3p, 146a-3p, 155-5p, and let-7b-3p in PBMC."	Int Immunopharmacol
33895475	"Potential SARS-CoV-2 vaccines: Concept, progress, and challenges."	Int Immunopharmacol
33895459	Exploring SARS-COV-2 structural proteins to design a multi-epitope vaccine using immunoinformatics approach: An in silico study.	Comput Biol Med
33895457	Identification of potential antiviral compounds against SARS-CoV-2 structural and non structural protein targets: A pharmacoinformatics study of the CAS COVID-19 dataset.	Comput Biol Med
33895357	"SARS-CoV-2 proteins regulate inflammatory, thrombotic and diabetic responses in human arterial fibroblasts."	Clin Immunol
33895337	Temporal proteomic changes induced by nicotine in human cells: A quantitative proteomics approach.	J Proteomics
33895322	Immunogenicity of a new gorilla adenovirus vaccine candidate for COVID-19.	Mol Ther
33895266	N-Terminal Finger Stabilizes the S1 Pocket for the Reversible Feline Drug GC376 in the SARS-CoV-2 M(pro) Dimer.	J Mol Biol
33895135	Inhibition of acid sphingomyelinase by ambroxol prevents SARS-CoV-2 entry into epithelial cells.	J Biol Chem
33895016	RSV genomic diversity and the development of a globally effective RSV intervention.	Vaccine
33894790	The role of co-infections and secondary infections in patients with COVID-19.	Pneumonia (Nathan)
33894687	"ABO blood groups, COVID-19 infection and mortality."	Blood Cells Mol Dis
33894671	Immunohistochemistry patterns of SARS-CoV-2 deaths in forensic autopsies.	Leg Med (Tokyo)
33894564	Phenoxazine nucleoside derivatives with a multiple activity against RNA and DNA viruses.	Eur J Med Chem
33894532	Relevance of carotid bodies in COVID-19: A hypothetical viewpoint.	Auton Neurosci
33894500	Screening of potent phytochemical inhibitors against SARS-CoV-2 protease and its two Asian mutants.	Comput Biol Med
33894421	COVID-19 and thrombotic microangiopathies.	Thromb Res
33894414	In-vitro acetylation of SARS-CoV and SARS-CoV-2 nucleocapsid proteins by human PCAF and GCN5.	Biochem Biophys Res Commun
33894401	"Sponge particulates for biomedical applications: Biofunctionalization, multi-drug shielding, and theranostic applications."	Biomaterials
33894315	Discovery of naturally occurring inhibitors against SARS-CoV-2 3CL(pro) from Ginkgo biloba leaves via large-scale screening.	Fitoterapia
33894278	A cell-based assay to discover inhibitors of SARS-CoV-2 RNA dependent RNA polymerase.	Antiviral Res
33894177	Targeting Runt-Related Transcription Factor 1 Prevents Pulmonary Fibrosis and Reduces Expression of Severe Acute Respiratory Syndrome Coronavirus 2 Host Mediators.	Am J Pathol
33894127	A combination of cross-neutralizing antibodies synergizes to prevent SARS-CoV-2 and SARS-CoV pseudovirus infection.	Cell Host Microbe
33894099	Computational design and modeling of nanobodies toward SARS-CoV-2 receptor binding domain.	Chem Biol Drug Des
33893760	Messenger RNA Vaccines: Beckoning of a New Era in Cancer Immunotherapy.	Oncology (Williston Park)
33893649	Tackling Covid-19 using disordered-to-order transition of residues in the spike protein upon angiotensin-converting enzyme 2 binding.	Proteins
33893632	Increased VWF and Decreased ADAMTS-13 in COVID-19: Creating a Milieu for (Micro)Thrombosis.	Semin Thromb Hemost
33893501	"Introduction, Transmission Dynamics, and Fate of Early Severe Acute Respiratory Syndrome Coronavirus 2 Lineages in Santa Clara County, California."	J Infect Dis
33893388	Structure and function analysis of a potent human neutralizing antibody CA521(FALA) against SARS-CoV-2.	Commun Biol
33893357	A small interfering RNA (siRNA) database for SARS-CoV-2.	Sci Rep
33893295	COVID-19 pathophysiology may be driven by an imbalance in the renin-angiotensin-aldosterone system.	Nat Commun
33893249	Angiotensin-converting Enzyme 2 Specific Cell Subset Identification in Oral Tissues: A Need of the Hour in COVID-19 Research.	J Contemp Dent Pract
33893175	Nanobody cocktails potently neutralize SARS-CoV-2 D614G N501Y variant and protect mice.	Proc Natl Acad Sci U S A
33893170	Human Nasal and Lung Tissues Infected Ex Vivo with SARS-CoV-2 Provide Insights into Differential Tissue-Specific and Virus-Specific Innate Immune Responses in the Upper and Lower Respiratory Tract.	J Virol
33893169	Correlates of Neutralization against SARS-CoV-2 Variants of Concern by Early Pandemic Sera.	J Virol
33893024	SARS-CoV-2: Cross-scale Insights from Ecology and Evolution.	Trends Microbiol
33892639	Online biophysical predictions for SARS-CoV-2 proteins.	BMC Mol Cell Biol
33892621	SARS-CoV-2 in animals: potential for unknown reservoir hosts and public health implications.	Vet Q
33892550	Electrostatic features for nucleocapsid proteins of SARS-CoV and SARS-CoV-2.	Math Biosci Eng
33892507	Progress in aorta and peripheral cardiovascular disease research.	Cardiovasc Res
33892297	In silico approach for identifying natural lead molecules against SARS-COV-2.	J Mol Graph Model
33892139	"Double stranded RNA drives anti-viral innate immune responses, sickness behavior and cognitive dysfunction dependent on dsRNA length, IFNAR1 expression and age."	Brain Behav Immun
33891947	Repression of transcription by the glucocorticoid receptor: A parsimonious model for the genomics era.	J Biol Chem
33891889	Immune dysregulation and autoreactivity correlate with disease severity in SARS-CoV-2-associated multisystem inflammatory syndrome in children.	Immunity
33891615	Angiotensin II receptor blocker or angiotensin-converting enzyme inhibitor use and COVID-19-related outcomes among US Veterans.	PLoS One
33891554	Network-Based Analysis of Fatal Comorbidities of COVID-19 and Potential Therapeutics.	IEEE/ACM Trans Comput Biol Bioinform
33891389	Expedited Approach toward the Rational Design of Noncovalent SARS-CoV-2 Main Protease Inhibitors.	J Med Chem
33891272	Silent hypoxia in COVID-19: pathomechanism and possible management strategy.	Mol Biol Rep
33890572	SARS-CoV-2 requires cholesterol for viral entry and pathological syncytia formation.	Elife
33890550	A novel linker-immunodominant site (LIS) vaccine targeting the SARS-CoV-2 spike protein protects against severe COVID-19 in Syrian hamsters.	Emerg Microbes Infect
33890314	Detection of SARS-CoV-2 in respiratory samples from cats in the UK associated with human-to-cat transmission.	Vet Rec
33890205	In Silico Study of Mutational Stability of SARS-CoV-2 Proteins.	Protein J
33890193	Myocardial Involvement in COVID-19: an Interaction Between Comorbidities and Heart Failure with Preserved Ejection Fraction. A Further Indication of the Role of Inflammation.	Curr Heart Fail Rep
33889923	Microchip-based structure determination of low-molecular weight proteins using cryo-electron microscopy.	Nanoscale
33889801	A REVIEW ON EMERGING PATHOGENESIS OF COVID-19 AND POINTS OF CONCERN FOR RESEARCH COMMUNITIES IN NIGERIA.	Afr J Infect Dis
33889638	"Effect of ACE1 polymorphism rs1799752 on protein levels of ACE2, the SARS-CoV-2 entry receptor, in alveolar lung epithelium."	ERJ Open Res
33889583	First Report on the Latvian SARS-CoV-2 Isolate Genetic Diversity.	Front Med (Lausanne)
33889562	Structural Basis of Potential Inhibitors Targeting SARS-CoV-2 Main Protease.	Front Chem
33889552	IgA Antibodies and IgA Deficiency in SARS-CoV-2 Infection.	Front Cell Infect Microbiol
33889450	Bioinformatic prediction of immunodominant regions in spike protein for early diagnosis of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).	PeerJ
33889134	Base Composition and Host Adaptation of the SARS-CoV-2: Insight From the Codon Usage Perspective.	Front Microbiol
33889082	The Other Side of SARS-CoV-2 Infection: Neurological Sequelae in Patients.	Front Aging Neurosci
33889008	Attenuating the Effects of Novel COVID-19 (SARS-CoV-2) Infection-Induced Cytokine Storm and the Implications.	J Inflamm Res
33888980	Prediction of Anti-COVID 19 Therapeutic Power of Medicinal Moroccan Plants Using Molecular Docking.	Bioinform Biol Insights
33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	Nat Genet
33888738	Nanoparticle composite TPNT1 is effective against SARS-CoV-2 and influenza viruses.	Sci Rep
33888505	Report of SARS-CoV-2 B1.1.7 Lineage in Morocco.	Microbiol Resour Announc
33888467	SARS-CoV-2 can recruit a heme metabolite to evade antibody immunity.	Sci Adv
33888152	Integrative overview of antibodies against SARS-CoV-2 and their possible applications in COVID-19 prophylaxis and treatment.	Microb Cell Fact
33888147	MSC-derived exosomes carrying a cocktail of exogenous interfering RNAs an unprecedented therapy in era of COVID-19 outbreak.	J Transl Med
33887552	"Exploring the utility of extracellular vesicles in ameliorating viral infection-associated inflammation, cytokine storm and tissue damage."	Transl Oncol
33887455	"Cutaneous manifestations associated with anosmia, ageusia and enteritis in SARS-CoV-2 infection - A possible pattern? Observational study and review of the literature."	Int J Infect Dis
33887440	Development of ciclesonide analogues that block SARS-CoV-2 RNA replication.	Bioorg Med Chem Lett
33887436	"Natural killer cells play an important role in virus infection control: Antiviral mechanism, subset expansion and clinical application."	Clin Immunol
33887367	Inferring molecular mechanisms of dexamethasone therapy in severe COVID-19 from existing transcriptomic data.	Gene
33887223	Potent toxic effects of Taroxaz-104 on the replication of SARS-CoV-2 particles.	Chem Biol Interact
33887214	Coronavirus Activates an Altruistic Stem Cell-Mediated Defense Mechanism that Reactivates Dormant Tuberculosis: Implications in Coronavirus Disease 2019 Pandemic.	Am J Pathol
33887205	Increased resistance of SARS-CoV-2 variant P.1 to antibody neutralization.	Cell Host Microbe
33886821	Pathological findings and morphologic correlation of the lungs of autopsied patients with SARS-CoV-2 infection in the Brazilian Amazon using transmission electron microscopy.	Rev Soc Bras Med Trop
33886690	The SARS-CoV-2 and other human coronavirus spike proteins are fine-tuned towards temperature and proteases of the human airways.	PLoS Pathog
33886614	"High-throughput screening of the ReFRAME, Pandemic Box, and COVID Box drug repurposing libraries against SARS-CoV-2 nsp15 endoribonuclease to identify small-molecule inhibitors of viral activity."	PLoS One
33886504	Does taking an angiotensin inhibitor increase the risk for COVID-19? - a systematic review and meta-analysis.	Aging (Albany NY)
33886458	COVID-19 shares clinical features with anti-melanoma differentiation-associated protein 5 positive dermatomyositis and adult Still's disease.	Clin Exp Rheumatol
33886400	"Epidemiology, virology and clinical aspects of hantavirus infections: an overview."	Int J Environ Health Res
33886074	"To Detect and Reject, Parallel Roles for Taste and Immunity."	Curr Nutr Rep
33886062	The complex combination of COVID-19 and diabetes: pleiotropic changes in glucose metabolism.	Endocrine
33886017	Insights into SARS-CoV-2: Medicinal Chemistry Approaches to Combat Its Structural and Functional Biology.	Top Curr Chem (Cham)
33885811	Excessive Matrix Metalloproteinase-1 and Hyperactivation of Endothelial Cells Occurred in COVID-19 Patients and Were Associated With the Severity of COVID-19.	J Infect Dis
33885790	Arena3Dweb: interactive 3D visualization of multilayered networks.	Nucleic Acids Res
33885735	New framework for recombination and adaptive evolution analysis with application to the novel coronavirus SARS-CoV-2.	Brief Bioinform
33885726	Comparative phylogenetic analysis of SARS-CoV-2 spike protein-possibility effect on virus spillover.	Brief Bioinform
33885337	Linkage of Lambda Interferons in Protection Against Severe COVID-19.	J Interferon Cytokine Res
33884644	Profound dysregulation of T cell homeostasis and function in patients with severe COVID-19.	Allergy
33884369	Platypus: an open-access software for integrating lymphocyte single-cell immune repertoires with transcriptomes.	NAR Genom Bioinform
33884270	In Silico Analysis of High-Risk Missense Variants in Human ACE2 Gene and Susceptibility to SARS-CoV-2 Infection.	Biomed Res Int
33883984	"Mutations in the SARS-CoV-2 spike protein modulate the virus affinity to the human ACE2 receptor, an in silico analysis."	EXCLI J
33883951	Binding of the SARS-CoV-2 Spike Protein to the Asialoglycoprotein Receptor on Human Primary Hepatocytes and Immortalized Hepatocyte-Like Cells by Confocal Analysis.	Hepat Med
33883784	Antiviral peptides from aquatic organisms: Functionality and potential inhibitory effect on SARS-CoV-2.	Aquaculture
33883694	The pathogenic role of epithelial and endothelial cells in early-phase COVID-19 pneumonia: victims and partners in crime.	Mod Pathol
33883570	Evidence of a dysregulated vitamin D endocrine system in SARS-CoV-2 infected patient's lung cells.	Sci Rep
33883466	Pandemic analysis of infection and death correlated with genomic open reading frame 10 mutation in severe acute respiratory syndrome coronavirus 2 victims.	J Chin Med Assoc
33883267	Structural basis for backtracking by the SARS-CoV-2 replication-transcription complex.	Proc Natl Acad Sci U S A
33883027	Genetic and non-genetic factors affecting the expression of COVID-19-relevant genes in the large airway epithelium.	Genome Med
33882940	Pathophysiology of skeletal muscle disturbances in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).	J Transl Med
33882805	Potential Candidates against COVID-19 Targeting RNA-Dependent RNA Polymerase: A Comprehensive Review.	Curr Pharm Biotechnol
33882487	Antibody-Dependent Enhancement and the Critical Pattern of COVID-19: Possibilities and Considerations.	Med Princ Pract
33882442	Immunopharmacological perspective on zinc in SARS-CoV-2 infection.	Int Immunopharmacol
33882374	Study of the SARS-CoV-2-specific immune T-cell responses in COVID-19-positive cancer patients.	Eur J Cancer
33882362	Novel RT-ddPCR assays for measuring the levels of subgenomic and genomic SARS-CoV-2 transcripts.	Methods
33882219	Vaccine Breakthrough Infections with SARS-CoV-2 Variants.	N Engl J Med
33882114	Safe and effective two-in-one replicon-and-VLP minispike vaccine for COVID-19: Protection of mice after a single immunization.	PLoS Pathog
33881969	SARS-CoV-2 Entry inhibitors targeting virus-ACE2 or virus-TMPRSS2 interactions.	Curr Med Chem
33881894	Intermolecular Interaction Analyses on SARS-CoV-2 Spike Protein Receptor Binding Domain and Human Angiotensin-Converting Enzyme 2 Receptor-Blocking Antibody/Peptide Using Fragment Molecular Orbital Calculation.	J Phys Chem Lett
33881861	Fast Prediction of Binding Affinities of the SARS-CoV-2 Spike Protein Mutant N501Y (UK Variant) with ACE2 and Miniprotein Drug Candidates.	J Phys Chem B
33881539	Chemistry and biology of ferritin.	Metallomics
33881142	Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers: potential allies in the COVID-19 pandemic instead of a threat?	Clin Sci (Lond)
33880885	Discrimination of COVID-19 from inflammation-induced cytokine storm syndromes by disease-related blood biomarkers.	Arthritis Rheumatol
33880743	Role of pirfenidone in TGF-beta pathways and other inflammatory pathways in acute respiratory syndrome coronavirus 2 (SARS-Cov-2) infection: a theoretical perspective.	Pharmacol Rep
33880537	"ACE2, TMPRSS2 and L-SIGN expression in placentae from HIV-positive pregnancies exposed to antiretroviral therapy-implications for SARS-CoV-2 placental infection."	J Infect Dis
33880524	"In vitro antiviral activity of the anti-HCV drugs daclatasvir and sofosbuvir against SARS-CoV-2, the aetiological agent of COVID-19."	J Antimicrob Chemother
33880519	SARS-CoV-2 ACE2 and TMPRSS2 Receptor Protein Expression Patterns Throughout Gestation.	J Infect Dis
33880454	Uncovering the complexities of biological structures with network-based learning: An application in SARS-CoV-2.	Patterns (N Y)
33880442	Functional autoantibodies against G-protein coupled receptors in patients with persistent Long-COVID-19 symptoms.	J Transl Autoimmun
33880437	Reduced inflammatory responses to SARS-CoV-2 infection in children presenting to hospital with COVID-19 in China.	EClinicalMedicine
33880436	Modeling SARS-CoV-2 infection and its individual differences with ACE2-expressing human iPS cells.	iScience
33880115	"Potential Antioxidative, Anti-inflammatory and Immunomodulatory Effects of Ghrelin, an Endogenous Peptide from the Stomach in SARS-CoV2 Infection."	Int J Pept Res Ther
33879934	"Structurally modified compounds of hydroxychloroquine, remdesivir and tetrahydrocannabinol against main protease of SARS-CoV-2, a possible hope for COVID-19: Docking and molecular dynamics simulation studies."	J Mol Liq
33879930	Synthesis of phosphonate derivatives of 2'-deoxy-2'-fluorotetradialdose d-nucleosides and tetradialdose d-nucleosides.	Tetrahedron
33879890	Single-cell multi-omics analysis of the immune response in COVID-19.	Nat Med
33879858	SARS-CoV-2 spike protein dictates syncytium-mediated lymphocyte elimination.	Cell Death Differ
33879756	Single-cell analysis of angiotensin-converting enzyme II expression in human kidneys and bladders reveals a potential route of 2019 novel coronavirus infection.	Chin Med J (Engl)
33879594	COVID-19 Severity Is Associated with Differential Antibody Fc-Mediated Innate Immune Functions.	mBio
33879592	In Vivo Antigen Expression Regulates CD4 T Cell Differentiation and Vaccine Efficacy against Mycobacterium tuberculosis Infection.	mBio
33879586	Infectious Clones Produce SARS-CoV-2 That Causes Severe Pulmonary Disease in Infected K18-Human ACE2 Mice.	mBio
33879585	Markers of Polyfunctional SARS-CoV-2 Antibodies in Convalescent Plasma.	mBio
33879319	The emerging association between COVID-19 and acute stroke.	Trends Neurosci
33879239	IFN-gamma and TNF-alpha drive a CXCL10+ CCL2+ macrophage phenotype expanded in severe COVID-19 lungs and inflammatory diseases with tissue inflammation.	Genome Med
33879227	"Data mining of coronavirus: SARS-CoV-2, SARS-CoV and MERS-CoV."	BMC Res Notes
33879035	"The in silico mechanism of hVKOR interaction with acetaminophen and its metabolite, as well as N-acetyl cysteine: caution on application in COVID-19 patients."	J Biomol Struct Dyn
33878118	Predicting the animal hosts of coronaviruses from compositional biases of spike protein and whole genome sequences through machine learning.	PLoS Pathog
33877845	Betulonic Acid Derivatives Interfering with Human Coronavirus 229E Replication via the nsp15 Endoribonuclease.	J Med Chem
33877683	Dantrolene repurposed to treat sepsis or septic shock and COVID-19 patients.	Eur Rev Med Pharmacol Sci
33877681	Prediction of potential therapeutic drugs against SARS-CoV-2 by using Connectivity Map based on transcriptome data.	Eur Rev Med Pharmacol Sci
33877547	Trends in Coronavirus Disease 2019 Hospitalization and Prognosis: Gender Effect.	Curr Med Sci
33877545	A Network Pharmacology Study to Uncover the Multiple Molecular Mechanism of the Chinese Patent Medicine Toujiequwen Granules in the Treatment of Corona Virus Disease 2019 (COVID-19).	Curr Med Sci
33877539	"Genomic Evolution and Variation of SARS-CoV-2 in the Early Phase of COVID-19 Pandemic in Guangdong Province, China."	Curr Med Sci
33876849	The SARS-unique domain (SUD) of SARS-CoV and SARS-CoV-2 interacts with human Paip1 to enhance viral RNA translation.	EMBO J
33876719	Hypothesis: AA amyloidosis is a factor causing systemic complications after coronavirus disease.	Prion
33876632	Antibody Affinity Governs the Inhibition of SARS-CoV-2 Spike/ACE2 Binding in Patient Serum.	ACS Infect Dis
33876439	Chronic use of renin-angiotensin-aldosterone system blockers and mortality in COVID-19: A multicenter prospective cohort and literature review.	Fundam Clin Pharmacol
33876282	"Potential ""biopeptidal"" therapeutics for severe respiratory syndrome coronaviruses: a review of antiviral peptides, viral mechanisms, and prospective needs."	Appl Microbiol Biotechnol
33876086	A crystallography-based investigation of weak interactions for drug design against COVID-19.	Phys Chem Chem Phys
33875979	Classical and Counter-regulatory Renin-angiotensin System: potential key roles in COVID-19 pathophysiology.	CJC Open
33875973	Whole genome comparison of Pakistani Corona virus with Chinese and US Strains along with its predictive severity of COVID-19.	Gene Rep
33875909	An Integrated Approach of the Potential Underlying Molecular Mechanistic Paradigms of SARS-CoV-2-Mediated Coagulopathy.	Indian J Clin Biochem
33875719	Global dynamics of SARS-CoV-2 clades and their relation to COVID-19 epidemiology.	Sci Rep
33875658	Immunogenicity and efficacy of mRNA COVID-19 vaccine MRT5500 in preclinical animal models.	NPJ Vaccines
33875625	Multifactorial Traits of SARS-CoV-2 Cell Entry Related to Diverse Host Proteases and Proteins.	Biomol Ther (Seoul)
33875273	Emerging roles of coronavirus in autoimmune diseases.	Arch Med Res
33875227	[Microvascular thrombosis and clinical implications].	Med Clin (Barc)
33875001	Profiling SARS-CoV-2 mutation fingerprints that range from the viral pangenome to individual infection quasispecies.	Genome Med
33874973	"Comparison of host endothelial, epithelial and inflammatory response in ICU patients with and without COVID-19: a prospective observational cohort study."	Crit Care
33874829	The role of IL-6 and IL-6 blockade in COVID-19.	Expert Rev Clin Immunol
33874789	The Neurobiology of Modern Viral Scourges: ZIKV and COVID-19.	Neuroscientist
33874769	A High-Throughput Radioactivity-Based Assay for Screening SARS-CoV-2 nsp10-nsp16 Complex.	SLAS Discov
33873199	Adjuvanting a subunit COVID-19 vaccine to induce protective immunity.	Nature
33873150	The role of carbohydrate antigen 125 in COVID-19.	Med Hypotheses
33872970	A unique view of SARS-CoV-2 through the lens of ORF8 protein.	Comput Biol Med
33872774	Why does SARS-CoV-2 hit in different ways? Host genetic factors can influence the acquisition or the course of COVID-19.	Eur J Med Genet
33872675	Discovery of chebulagic acid and punicalagin as novel allosteric inhibitors of SARS-CoV-2 3CL(pro).	Antiviral Res
33872590	Interleukin-6: obstacles to targeting a complex cytokine in critical illness.	Lancet Respir Med
33872570	Discovery of a AHR pelargonidin agonist that counter-regulates Ace2 expression and attenuates ACE2-SARS-CoV-2 interaction.	Biochem Pharmacol
33872520	"Modeling Immunity In Vitro: Slices, Chips, and Engineered Tissues."	Annu Rev Biomed Eng
33872498	"Design, Synthesis, and Biological Evaluation of Peptidomimetic Aldehydes as Broad-Spectrum Inhibitors against Enterovirus and SARS-CoV-2."	J Med Chem
33872387	Interactions between SARS coronavirus 2 papain-like protease and immune system: A potential drug target for the treatment of COVID-19.	Scand J Immunol
33872261	CE: Multisystem Inflammatory Syndrome in Children: A Review.	Am J Nurs
33872068	COVID-19: A Mitochondrial Perspective.	DNA Cell Biol
33871970	Structural and Functional Characterization of SARS-CoV-2 RBD Domains Produced in Mammalian Cells.	Anal Chem
33870918	Acute Cardiac Injury in Coronavirus Disease 2019 and Other Viral Infections-A Systematic Review and Meta-Analysis.	Crit Care Med
33870851	Serological investigation of asymptomatic cases of SARS-CoV-2 infection reveals weak and declining antibody responses.	Emerg Microbes Infect
33870763	Ischemic Stroke in the Young.	Clin Appl Thromb Hemost
33870746	Label-Free Screening of SARS-CoV-2 NSP14 Exonuclease Activity Using SAMDI Mass Spectrometry.	SLAS Discov
33870434	SARS-CoV-2 Total and Subgenomic RNA Viral Load in Hospitalized Patients.	J Infect Dis
33870242	SARS-CoV-2 colonization of maternal and fetal cells of the human placenta promotes alteration of local renin-angiotensin system.	Med (N Y)
33870241	Mucosal-associated invariant T cell responses differ by sex in COVID-19.	Med (N Y)
33870235	COVID-19 and hyperammonemia: Potential interplay between liver and brain dysfunctions.	Brain Behav Immun Health
33870109	Angiotensin-Converting Enzyme 2 Gene Expression in Breast Tissue.	Eur J Breast Health
33869690	Data on the docking of phytoconstituents of betel plant and matcha green tea on SARS-CoV-2.	Data Brief
33869672	"Molecular docking and ADMET studies of Allium cepa, Azadirachta indica and Xylopia aethiopica isolates as potential anti-viral drugs for Covid-19."	Virusdisease
33869309	"Fibrinolytic Serine Proteases, Therapeutic Serpins and Inflammation: Fire Dancers and Firestorms."	Front Cardiovasc Med
33869283	A Multifunctional Peptide From Bacillus Fermented Soybean for Effective Inhibition of SARS-CoV-2 S1 Receptor Binding Domain and Modulation of Toll Like Receptor 4: A Molecular Docking Study.	Front Mol Biosci
33869282	Perspectives on RNA Vaccine Candidates for COVID-19.	Front Mol Biosci
33869251	The Association Between Alpha-1 Adrenergic Receptor Antagonists and In-Hospital Mortality From COVID-19.	Front Med (Lausanne)
33868970	Virtual screening by targeting proteolytic sites of furin and TMPRSS2 to propose potential compounds obstructing the entry of SARS-CoV-2 virus into human host cells.	J Tradit Complement Med
33868814	Multi-schema computational prediction of the comprehensive SARS-CoV-2 vs. human interactome.	PeerJ
33868743	COVID-19 and mutations a threat level assessment.	Nepal J Epidemiol
33868301	Lung Neutrophilic Recruitment and IL-8/IL-17A Tissue Expression in COVID-19.	Front Immunol
33868294	Influence of Hypoxia on the Epithelial-Pathogen Interactions in the Lung: Implications for Respiratory Disease.	Front Immunol
33868293	MicroLet-7b Regulates Neutrophil Function and Dampens Neutrophilic Inflammation by Suppressing the Canonical TLR4/NF-kappaB Pathway.	Front Immunol
33868239	Genetics Insight for COVID-19 Susceptibility and Severity: A Review.	Front Immunol
33868232	T Cells Plead for Rejuvenation and Amplification; With the Brain's Neurotransmitters and Neuropeptides We Can Make It Happen.	Front Immunol
33868218	"Mink, SARS-CoV-2, and the Human-Animal Interface."	Front Microbiol
33868174	New Roles for Vitamin D Superagonists: From COVID to Cancer.	Front Endocrinol (Lausanne)
33868163	Type 2 Diabetes Mellitus and COVID-19: A Narrative Review.	Front Endocrinol (Lausanne)
33868085	A Translational Perspective of Maternal Immune Activation by SARS-CoV-2 on the Potential Prenatal Origin of Neurodevelopmental Disorders: The Role of the Cholinergic Anti-inflammatory Pathway.	Front Psychol
33868029	Plasma Linoleate Diols Are Potential Biomarkers for Severe COVID-19 Infections.	Front Physiol
33867981	Pathological Findings in COVID-19 as a Tool to Define SARS-CoV-2 Pathogenesis. A Systematic Review.	Front Pharmacol
33867899	In Silico Identification of Multi-target Anti-SARS-CoV-2 Peptides from Quinoa Seed Proteins.	Int J Pept Res Ther
33867898	Brazilian essential oils as source for the discovery of new anti-COVID-19 drug: a review guided by in silico study.	Phytochem Rev
33867892	Possible Potential Effects of Honey and Its Main Components Against Covid-19 Infection.	Dose Response
33867845	SARS-CoV-2-induced Overexpression of miR-4485 Suppresses Osteogenic Differentiation and Impairs Fracture Healing.	Int J Biol Sci
33867805	Prolonged humoral and cellular immunity in COVID-19-recovered patients.	Saudi J Biol Sci
33867777	The binding mechanism of ivermectin and levosalbutamol with spike protein of SARS-CoV-2.	Struct Chem
33867696	Antiviral activity of fermented foods and their probiotics bacteria towards respiratory and alimentary tracts viruses.	Food Control
33867575	Molecular insights of hyaluronic acid-hydroxychloroquine conjugate as a promising drug in targeting SARS-CoV-2 viral proteins.	J Mol Struct
33867526	Germline variants in UNC13D and AP3B1 are enriched in COVID-19 patients experiencing severe cytokine storms.	Eur J Hum Genet
33867348	"In-silico pharmacophoric and molecular docking-based drug discovery against the Main Protease (Mpro) of SARS-CoV-2, a causative agent COVID-19."	Pak J Pharm Sci
33867315	The immune response to SARS-CoV-2 and COVID-19 immunopathology - Current perspectives.	Pulmonology
33867313	Epigenome-wide association study of COVID-19 severity with respiratory failure.	EBioMedicine
33867312	Evidence of the pathogenic HERV-W envelope expression in T lymphocytes in association with the respiratory outcome of COVID-19 patients.	EBioMedicine
33867130	Therapeutic Potential of Targeting Plasminogen Activator Inhibitor-1 in COVID-19.	Trends Pharmacol Sci
33866960	3D U-Net: A voxel-based method in binding site prediction of protein structure.	J Bioinform Comput Biol
33866607	"The good, the bad and the ugly: G-CSF, ageing and neutrophils-Implications for severe COVID-19."	J Leukoc Biol
33866350	Is acupuncture effective in the treatment of COVID-19 related symptoms? Based on bioinformatics/network topology strategy.	Brief Bioinform
33866349	Deep drug-target binding affinity prediction with multiple attention blocks.	Brief Bioinform
33866132	Babaodan controls excessive immune responses and may represent a cytokine-targeted agent suitable for COVID-19 treatment.	Biomed Pharmacother
33866129	Aminoglycosides as potential inhibitors of SARS-CoV-2 main protease: an in silico drug repurposing study on FDA-approved antiviral and anti-infection agents.	J Infect Public Health
33865979	The fight against COVID-19: Striking a balance in the renin-angiotensin system.	Drug Discov Today
33865882	Risk factors for adverse outcomes of COVID-19 patients: Possible basis for diverse responses to the novel coronavirus SARS-CoV-2.	Life Sci
33865880	"Antiviral strategies should focus on stimulating the biosynthesis of heparan sulfates, not their inhibition."	Life Sci
33865879	Therapeutic potential of mesenchymal stem cells in multiple organs affected by COVID-19.	Life Sci
33865266	Dynamic Antibody Response: a Biomarker for COVID-19.	Clin Lab
33864728	Host PDZ-containing proteins targeted by SARS-CoV-2.	FEBS J
33864655	Molecular basis for higher affinity of SARS-CoV-2 spike RBD for human ACE2 receptor.	Proteins
33864621	High-throughput screening identifies established drugs as SARS-CoV-2 PLpro inhibitors.	Protein Cell
33864532	Multi-conformation representation of Mpro identifies promising candidates for drug repurposing against COVID-19.	J Mol Model
33864026	On the origin and evolution of SARS-CoV-2.	Exp Mol Med
33863911	mRNA-based SARS-CoV-2 vaccine candidate CVnCoV induces high levels of virus-neutralising antibodies and mediates protection in rodents.	NPJ Vaccines
33863887	Orally delivered MK-4482 inhibits SARS-CoV-2 replication in the Syrian hamster model.	Nat Commun
33863729	The SARS-CoV-2 Spike variant D614G favors an open conformational state.	Sci Adv
33862474	Novel inhibitors of the main protease enzyme of SARS-CoV-2 identified via molecular dynamics simulation-guided in vitro assay.	Bioorg Chem
33862305	Virtual screening of peptides with high affinity for SARS-CoV-2 main protease.	Comput Biol Med
33862077	Notable sequence homology of the ORF10 protein introspects the architecture of SARS-CoV-2.	Int J Biol Macromol
33862071	Virosome-based nanovaccines; a promising bioinspiration and biomimetic approach for preventing viral diseases: A review.	Int J Biol Macromol
33861802	"Extensive activation, tissue trafficking, turnover and functional impairment of NK cells in COVID-19 patients at disease onset associates with subsequent disease severity."	PLoS Pathog
33861442	Possible Mechanisms and Special Clinical Considerations of Curcumin Supplementation in Patients with COVID-19.	Adv Exp Med Biol
33860983	Mass spectrometry-based proteomic platforms for better understanding of SARS-CoV-2 induced pathogenesis and potential diagnostic approaches.	Proteomics
33860910	The effects of ACE2 expression mediating pharmacotherapy in COVID-19 patients.	Neth Heart J
33860905	Aging versus youth: Endocrine aspects of vulnerability for COVID-19.	Rev Endocr Metab Disord
33860882	Individuals with isolated congenital GH deficiency due to a GHRH receptor gene mutation appear to cope better with SARS-CoV-2 infection than controls.	Endocrine
33860875	Avian influenza A (H7N9) virus: from low pathogenic to highly pathogenic.	Front Med
33860869	Induction of Exaggerated Cytokine Production in Human Peripheral Blood Mononuclear Cells by a Recombinant SARS-CoV-2 Spike Glycoprotein S1 and Its Inhibition by Dexamethasone.	Inflammation
33860730	From nicotine to the cholinergic anti-inflammatory reflex - Can nicotine alleviate the dysregulated inflammation in COVID-19?	J Immunotoxicol
33860605	Polysulfates Block SARS-CoV-2 Uptake through Electrostatic Interactions*.	Angew Chem Int Ed Engl
33860221	COVID-19: Is There a Link between Alcohol Abuse and SARS-CoV-2-Induced Severe Neurological Manifestations?	ACS Pharmacol Transl Sci
33860220	COVID-19: Does SARS-CoV-2 Modulate Acanthamoeba Epigenetics to Enhance Survival and Transmission in the Environment?	ACS Pharmacol Transl Sci
33860219	Toward the Next-Generation COVID-19 Vaccines That Circumvent Antigenic Drift while Defusing Viral Infection.	ACS Pharmacol Transl Sci
33860218	SARS-CoV-2 Glycosylation Suggests That Vaccines Should Have Adopted the S1 Subunit as Antigen.	ACS Pharmacol Transl Sci
33860009	"Molecular optimization, docking, and dynamic simulation profiling of selective aromatic phytochemical ligands in blocking the SARS-CoV-2 S protein attachment to ACE2 receptor: an in silico approach of targeted drug designing."	J Adv Vet Anim Res
33859951	Wuhan to World: The COVID-19 Pandemic.	Front Cell Infect Microbiol
33859687	Diabetes Mellitus and COVID-19: Associations and Possible Mechanisms.	Int J Endocrinol
33859652	Repurposing Ivermectin for COVID-19: Molecular Aspects and Therapeutic Possibilities.	Front Immunol
33859644	Innate and Adaptive Immunity Alterations in Metabolic Associated Fatty Liver Disease and Its Implication in COVID-19 Severity.	Front Immunol
33859566	Role of Cigarette Smoke on Angiotensin-Converting Enzyme-2 Protein Membrane Expression in Bronchial Epithelial Cells Using an Air-Liquid Interface Model.	Front Pharmacol
33859516	Through The Back Door: Expiratory Accumulation of SARS-Cov-2 in the Olfactory Mucosa as Mechanism for CNS Penetration.	Int J Med Sci
33859400	Generation of recombinant hyperimmune globulins from diverse B-cell repertoires.	Nat Biotechnol
33859163	"Multi-platform omics analysis reveals molecular signature for COVID-19 pathogenesis, prognosis and drug target discovery."	Signal Transduct Target Ther
33858945	Distinct antibody and memory B cell responses in SARS-CoV-2 naive and recovered individuals following mRNA vaccination.	Sci Immunol
33858942	Killed whole-genome reduced-bacteria surface-expressed coronavirus fusion peptide vaccines protect against disease in a porcine model.	Proc Natl Acad Sci U S A
33858941	Host barriers to SARS-CoV-2 demonstrated by ferrets in a high-exposure domestic setting.	Proc Natl Acad Sci U S A
33858934	Metatranscriptomic Analysis Reveals SARS-CoV-2 Mutations in Wastewater of the Frankfurt Metropolitan Area in Southern Germany.	Microbiol Resour Announc
33858933	Genome Sequences of Three SARS-CoV-2 ORF7a Deletion Variants Obtained from Patients in Hong Kong.	Microbiol Resour Announc
33858931	"Genome Sequences of Five SARS-CoV-2 Variants from Mumbai, India, Obtained by Nanopore Sequencing."	Microbiol Resour Announc
33858724	Obesity as an adipose tissue dysfunction disease and a risk factor for infections - Covid-19 as a case study.	Eur J Intern Med
33858312	New Trends On Biological Activities And Clinical Studies Of Quinolinic Analogues: A Review.	Curr Drug Targets
33858231	Current Update on Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Development with a Special Emphasis on Gene Therapy Viral Vector Design and Construction for Vaccination.	Hum Gene Ther
33858123	Different therapeutic associations of renin-angiotensin system inhibitors with coronavirus disease 2019 compared with usual pneumonia.	Korean J Intern Med
33857895	Rapid screening for SARS-CoV-2 variants of concern in clinical and environmental samples using nested RT-PCR assays targeting key mutations of the spike protein.	Water Res
33857754	Development of flexible electrochemical impedance spectroscopy-based biosensing platform for rapid screening of SARS-CoV-2 inhibitors.	Biosens Bioelectron
33857718	Endothelial-Mesenchymal Transition in COVID-19 lung lesions.	Pathol Res Pract
33857716	COVID-19 and cancer: Sailing through the tides.	Pathol Res Pract
33857566	Potential mechanisms of anaphylaxis to COVID-19 mRNA vaccines.	J Allergy Clin Immunol
33857435	"Confronting COVID-19-associated cough and the post-COVID syndrome: role of viral neurotropism, neuroinflammation, and neuroimmune responses."	Lancet Respir Med
33857422	SARS-CoV-2 mutations acquired in mink reduce antibody-mediated neutralization.	Cell Rep
33857406	"Genomic characteristics and clinical effect of the emergent SARS-CoV-2 B.1.1.7 lineage in London, UK: a whole-genome sequencing and hospital-based cohort study."	Lancet Infect Dis
33857397	TLR4 as a therapeutic target for respiratory and neurological complications of SARS-CoV-2.	Expert Opin Ther Targets
33857328	Can ketone bodies inactivate coronavirus spike protein? The potential of biocidal agents against SARS-CoV-2.	Bioessays
33857136	Deciphering the introduction and transmission of SARS-CoV-2 in the Colombian Amazon Basin.	PLoS Negl Trop Dis
33856918	COVID-19 and Cardiovascular Disease: From Bench to Bedside.	Circ Res
33856796	Identification and Characterization of Species-Specific Severe Acute Respiratory Syndrome Coronavirus 2 Physicochemical Properties.	J Proteome Res
33856612	A COVID moonshot: assessment of ligand binding to the SARS-CoV-2 main protease by saturation transfer difference NMR spectroscopy.	J Biomol NMR
33856591	"Identification of potential plant-based inhibitor against viral proteases of SARS-CoV-2 through molecular docking, MM-PBSA binding energy calculations and molecular dynamics simulation."	Mol Divers
33856123	Estrogen receptors and their roles in the immune and respiratory systems.	Anat Rec (Hoboken)
33855951	SARS-CoV-2 one year on: evidence for ongoing viral adaptation.	J Gen Virol
33855870	Can cilia provide an entry gateway for SARS-CoV-2 to human ciliated cells?	Physiol Genomics
33855640	Novel transgenic mice with Cre-dependent co-expression of GFP and human ACE2: a safe tool for study of COVID-19 pathogenesis.	Transgenic Res
33855277	Synergistic Inhibition of SARS-CoV-2 Replication Using Disulfiram/Ebselen and Remdesivir.	ACS Pharmacol Transl Sci
33855276	Tissue-Specific Proteomics Analysis of Anti-COVID-19 Nucleoside and Nucleotide Prodrug-Activating Enzymes Provides Insights into the Optimization of Prodrug Design and Pharmacotherapy Strategy.	ACS Pharmacol Transl Sci
33855275	Repurposing Quinoline and Artemisinin Antimalarials as Therapeutics for SARS-CoV-2: Rationale and Implications.	ACS Pharmacol Transl Sci
33855133	"Dataset of AMBER force field parameters of drugs, natural products and steroids for simulations using GROMACS."	Data Brief
33855058	In vitro Assessment of Antiviral Effect of Natural Compounds on Porcine Epidemic Diarrhea Coronavirus.	Front Vet Sci
33855053	Stroke in SARS-CoV-2 Infection: A Pictorial Overview of the Pathoetiology.	Front Cardiovasc Med
33855003	COVID-19 in Children: Respiratory Involvement and Some Differences With the Adults.	Front Pediatr
33854700	Intriguing Antiviral Modified Nucleosides: A Retrospective View into the Future Treatment of COVID-19.	ACS Med Chem Lett
33854516	How to Train Your Dragon: Harnessing Gamma Delta T Cells Antiviral Functions and Trained Immunity in a Pandemic Era.	Front Immunol
33854510	Commensal Microbiome Expands Tgammadelta17 Cells in the Lung and Promotes Particulate Matter-Induced Acute Neutrophilia.	Front Immunol
33854506	Age-Related Dynamics of Lung-Resident Memory CD8(+) T Cells in the Age of COVID-19.	Front Immunol
33854501	Integrin Activation Enables Sensitive Detection of Functional CD4(+) and CD8(+) T Cells: Application to Characterize SARS-CoV-2 Immunity.	Front Immunol
33854432	Angiotensin Receptor Blockers for COVID-19: Pathophysiological and Pharmacological Considerations About Ongoing and Future Prospective Clinical Trials.	Front Pharmacol
33854115	Delta-range coupling between prefrontal cortex and hippocampus supported by respiratory rhythmic input from the olfactory bulb in freely behaving rats.	Sci Rep
33853975	Identification of B.1.346 Lineage of SARS-CoV-2 in Japan: Genomic Evidence of Re-entry of Clade 20C.	Keio J Med
33853972	Potential effects of COVID-19 on reproductive systems and fertility; assisted reproductive technology guidelines and considerations: a review.	Hong Kong Med J
33853970	"Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil."	Science
33853968	Epstein-Barr Virus Lytic Replication Induces ACE2 Expression and Enhances SARS-CoV-2 Pseudotyped Virus Entry in Epithelial Cells.	J Virol
33853928	SARS-CoV-2 genome-wide T cell epitope mapping reveals immunodominance and substantial CD8(+) T cell activation in COVID-19 patients.	Sci Immunol
33853873	"Term Human Placental Trophoblasts Express SARS-CoV-2 Entry Factors ACE2, TMPRSS2, and Furin."	mSphere
33853786	Fragment binding to the Nsp3 macrodomain of SARS-CoV-2 identified through crystallographic screening and computational docking.	Sci Adv
33853691	Temporal landscape of human gut RNA and DNA virome in SARS-CoV-2 infection and severity.	Microbiome
33853637	Dodging COVID-19 infection: low expression and localization of ACE2 and TMPRSS2 in multiple donor-derived lines of human umbilical cord-derived mesenchymal stem cells.	J Transl Med
33853498	Potential Role of Gut Microbiota in Traditional Chinese Medicine against COVID-19.	Am J Chin Med
33853387	Pneumomediastinum in COVID-19 disease: Outcomes and relation to the Macklin effect.	Asian Cardiovasc Thorac Ann
33853355	An Immuno-Cardiac Model for Macrophage-Mediated Inflammation in COVID-19 Hearts.	Circ Res
33852884	Human Pluripotent Stem Cell-Derived Intestinal Organoids Model SARS-CoV-2 Infection Revealing a Common Epithelial Inflammatory Response.	Stem Cell Reports
33852652	Renin-Angiotensin-Aldosterone System Inhibitors in COVID-19: A Review.	Clinics (Sao Paulo)
33852526	Neuropathogenesis of acute coronavirus disease 2019.	Curr Opin Neurol
33851385	Platelet Function in Viral Immunity and SARS-CoV-2 Infection.	Semin Thromb Hemost
33850935	Nicotine upregulates ACE2 expression and increases competence for SARS-CoV-2 in human pneumocytes.	ERJ Open Res
33850607	Dependence of SARS-CoV-2 infection on cholesterol-rich lipid raft and endosomal acidification.	Comput Struct Biotechnol J
33850605	Structural Insights into Plasticity and Discovery of Remdesivir Metabolite GS-441524 Binding in SARS-CoV-2 Macrodomain.	ACS Med Chem Lett
33850424	Virus-receptor interactions of SARS-CoV-2 spikereceptor-binding domain and human neuropilin-1 b1 domain.	Saudi J Biol Sci
33849978	Interferon-Independent Restriction of RNA Virus Entry and Replication by a Class of Damage-Associated Molecular Patterns.	mBio
33849972	SARS-CoV-2 ORF6 Disrupts Bidirectional Nucleocytoplasmic Transport through Interactions with Rae1 and Nup98.	mBio
33849817	Insulin resistance in COVID-19 and diabetes.	Prim Care Diabetes
33849598	Hypoproteinemia predicts disease severity and mortality in COVID-19: a call for action.	Diagn Pathol
33848919	Role of NLRP3 inflammasome in COVID-19 and periodontitis: Possible protective effect of melatonin.	Med Hypotheses
33848890	Essential oils as an effective alternative for the treatment of COVID-19: Molecular interaction analysis of protease (M(pro)) with pharmacokinetics and toxicological properties.	J Infect Public Health
33848775	Pharmacological and clinical application of heparin progress: An essential drug for modern medicine.	Biomed Pharmacother
33848683	Systematizing the genomic order and relatedness in the open reading frames (ORFs) of the coronaviruses.	Infect Genet Evol
33848447	Secreted Extracellular Cyclophilin A is a Novel Mediator of Ventilator Induced Lung Injury.	Am J Respir Crit Care Med
33848207	Male bias in ACE2 basic science research: missed opportunity for discovery in the time of COVID-19.	Am J Physiol Regul Integr Comp Physiol
33848173	Highly Accurate Chip-Based Resequencing of SARS-CoV-2 Clinical Samples.	Langmuir
33847825	The Involvement of MicroRNAs in SARS-CoV-2 Infection Comorbid with HIV-Associated Preeclampsia.	Curr Hypertens Rep
33847407	TRB sequences targeting ORF1a/b are associated with disease severity in hospitalized COVID-19 patients.	J Leukoc Biol
33847382	Potential antiviral activity of isorhamnetin against SARS-CoV-2 spike pseudotyped virus in vitro.	Drug Dev Res
33847347	Bioinformatics and system biology approach to identify the influences of SARS-CoV-2 infections to idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease patients.	Brief Bioinform
33847245	"Pan-coronavirus fusion inhibitors possess potent inhibitory activity against HIV-1, HIV-2, and simian immunodeficiency virus."	Emerg Microbes Infect
33847241	Inhibition of SARS-CoV-2 main protease: a repurposing study that targets the dimer interface of the protein.	J Biomol Struct Dyn
33847226	SARSCoV-2 RBD219-N1C1: A yeast-expressed SARS-CoV-2 recombinant receptor-binding domain candidate vaccine stimulates virus neutralizing antibodies and T-cell immunity in mice.	Hum Vaccin Immunother
33847185	Therapeutic Nuclear Magnetic Resonance affects the core clock mechanism and associated Hypoxia-inducible factor-1.	Chronobiol Int
33847020	Long-COVID syndrome-associated brain fog and chemofog: Luteolin to the rescue.	Biofactors
33846880	Cognitive and behavioral manifestations in SARS-CoV-2 infection: not specific or distinctive features?	Neurol Sci
33846694	Computational prediction of potential siRNA and human miRNA sequences to silence orf1ab associated genes for future therapeutics against SARS-CoV-2.	Inform Med Unlocked
33846686	Lung-selective 25-hydroxycholesterol nanotherapeutics as a suppressor of COVID-19-associated cytokine storm.	Nano Today
33846661	"Construction, petro-collecting/dispersing capacities, antimicrobial activity, and molecular docking study of new cationic surfactant-sulfonamide conjugates."	J Mol Liq
33846658	"Synthesis, antimicrobial activity, density functional modelling and molecular docking with COVID-19 main protease studies of benzoxazole derivative: 2-(p-chloro-benzyl)-5-[3-(4-ethly-1-piperazynl) propionamido]-benzoxazole."	J Mol Struct
33846513	Human ACE2 receptor polymorphisms and altered susceptibility to SARS-CoV-2.	Commun Biol
33846375	A study of differential circRNA and lncRNA expressions in COVID-19-infected peripheral blood.	Sci Rep
33846275	Distinct cellular immune profiles in the airways and blood of critically ill patients with COVID-19.	Thorax
33846272	Shared B cell memory to coronaviruses and other pathogens varies in human age groups and tissues.	Science
33846224	Longitudinal Peripheral Blood Transcriptional Analysis Reveals Molecular Signatures of Disease Progression in COVID-19 Patients.	J Immunol
33845874	Longitudinal assessment of IFN-I activity and immune profile in critically ill COVID-19 patients with acute respiratory distress syndrome.	Crit Care
33845734	The Beneficial Effects of QIAPI 1(R) against Pentavalent Arsenic-Induced Lung Toxicity a Hypothetical Model for SARS CoV2-Induced Lung Toxicity.	Curr Pharm Biotechnol
33845649	The Use of In Silico Tools for the Toxicity Prediction of Potential Inhibitors of SARS-CoV-2.	Altern Lab Anim
33845483	Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV.	Nature
33845430	The role of human C5a as a non-genomic target in corticosteroid therapy for management of severe COVID19.	Comput Biol Chem
33845428	"Is procalcitonin a part of human immunological response to SARS-CoV-2 infection or ""just"" a marker of bacterial coinfection?"	Curr Res Transl Med
33845270	Identification of novel compounds against three targets of SARS CoV-2 coronavirus by combined virtual screening and supervised machine learning.	Comput Biol Med
33845201	COVID-19 and hypertension: Is there a role for dsRNA and activation of Toll-like receptor 3?	Vascul Pharmacol
33845194	The microbiota-mediated dietary and nutritional interventions for COVID-19.	Clin Immunol
33845193	Genetic justification of severe COVID-19 using a rigorous algorithm.	Clin Immunol
33845063	Quantifying the effect of trypsin and elastase on in vitro SARS-CoV infections.	Virus Res
33844770	[Anti-inflammatory therapies for SARS-COV2 infection from a hematological perspective].	Rev Med Chil
33844653	Structure-based phylogeny identifies avoralstat as a TMPRSS2 inhibitor that prevents SARS-CoV-2 infection in mice.	J Clin Invest
33844652	SARS-CoV-2 as a superantigen in multisystem inflammatory syndrome in children.	J Clin Invest
33844613	Antimicrobial peptides and other peptide-like therapeutics as promising candidates to combat SARS-CoV-2.	Expert Rev Anti Infect Ther
33844596	Unraveling the thread of uncontrolled immune response in COVID-19 and STEMI: an emerging need for knowledge sharing.	Am J Physiol Heart Circ Physiol
33844528	Anti-SARS-CoV-2 Activity of Andrographis paniculata Extract and Its Major Component Andrographolide in Human Lung Epithelial Cells and Cytotoxicity Evaluation in Major Organ Cell Representatives.	J Nat Prod
33844527	Exploring the Allosteric Territory of Protein Function.	J Phys Chem B
33844274	Characterization of HIV-1 virus-like particles and determination of Gag stoichiometry for different production platforms.	Biotechnol Bioeng
33844135	Structure-based identification of SARS-CoV-2 main protease inhibitors from anti-viral specific chemical libraries: an exhaustive computational screening approach.	Mol Divers
33843779	"Antibodies: Friends, Foes, or Both? Lessons From COVID-19 for the Rheumatologist."	J Clin Rheumatol
33843572	Pathogenicity and transmissibility of a novel respirovirus isolated from a Malayan pangolin.	J Gen Virol
33843474	Elucidation of the inhibitory activity of ivermectin with host nuclear importin alpha and several SARS-CoV-2 targets.	J Biomol Struct Dyn
33843452	Rigid monoclonal antibodies improve detection of SARS-CoV-2 nucleocapsid protein.	MAbs
33843160	"Safety of protease inhibitors and Arbidol for SARS-CoV-2 pneumonia in Zhejiang Province, China."	J Zhejiang Univ Sci B
33842903	Secondary analysis of transcriptomes of SARS-CoV-2 infection models to characterize COVID-19.	Patterns (N Y)
33842902	Complete map of SARS-CoV-2 RBD mutations that escape the monoclonal antibody LY-CoV555 and its cocktail with LY-CoV016.	Cell Rep Med
33842901	Rapid decline of neutralizing antibodies is associated with decay of IgM in adults recovered from mild COVID-19.	Cell Rep Med
33842900	SARS-CoV-2 protein subunit vaccination of mice and rhesus macaques elicits potent and durable neutralizing antibody responses.	Cell Rep Med
33842899	Boosting nitric oxide in stress and respiratory infection: Potential relevance for asthma and COVID-19.	Brain Behav Immun Health
33842898	The unfolding palette of COVID-19 multisystemic syndrome and its neurological manifestations.	Brain Behav Immun Health
33842877	Conformational Changes of the Receptor Binding Domain of SARS-CoV-2 Spike Protein and Prediction of a B-Cell Antigenic Epitope Using Structural Data.	Front Artif Intell
33842874	Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors in COVID-19: Meta-analysis/Meta-regression Adjusted for Confounding Factors.	CJC Open
33842834	Computational molecular docking and virtual screening revealed promising SARS-CoV-2 drugs.	Precis Clin Med
33842675	Potential combination therapy using twenty phytochemicals from twenty plants to prevent SARS- CoV-2 infection: An in silico Approach.	Virusdisease
33842674	In silico approach to understand the epigenetic mechanism of SARS-CoV-2 and its impact on the environment.	Virusdisease
33842673	"Phytochemicals as potential drug candidates for targeting SARS CoV 2 proteins, an in silico study."	Virusdisease
33842517	"Ross River Virus Immune Evasion Strategies and the Relevance to Post-viral Fatigue, and Myalgic Encephalomyelitis Onset."	Front Med (Lausanne)
33842503	"Anemia in Chronic Kidney Disease: From Pathophysiology and Current Treatments, to Future Agents."	Front Med (Lausanne)
33842446	Towards a Quantitative Single Particle Characterization by Super Resolution Microscopy: From Virus Structures to Antivirals Design.	Front Bioeng Biotechnol
33842191	"Computational screening of FDA approved drugs of fungal origin that may interfere with SARS-CoV-2 spike protein activation, viral RNA replication, and post-translational modification: a multiple target approach."	In Silico Pharmacol
33842190	In search of drugs to alleviate suppression of the host's innate immune responses against SARS-CoV-2 using a molecular modeling approach.	In Silico Pharmacol
33842188	"Binding ability of arginine, citrulline, N-acetyl citrulline and thiocitrulline with SARS COV-2 main protease using molecular docking studies."	Netw Model Anal Health Inform Bioinform
33842072	Neurology and the COVID-19 Pandemic: Gathering Data for an Informed Response.	Neurol Clin Pract
33842018	Reducing SARS-CoV-2 Pathological Protein Activity with Small Molecules.	J Pharm Anal
33841912	Alternate primers for whole-genome SARS-CoV-2 sequencing.	Virus Evol
33841894	Serum levels of ACE2 are higher in patients with obesity and diabetes.	Obes Sci Pract
33841880	Preclinical development of a molecular clamp-stabilised subunit vaccine for severe acute respiratory syndrome coronavirus 2.	Clin Transl Immunology
33841800	Reverse vaccinology approach towards the in-silico multiepitope vaccine development against SARS-CoV-2.	F1000Res
33841751	Identification of multipotent drugs for COVID-19 therapeutics with the evaluation of their SARS-CoV2 inhibitory activity.	Comput Struct Biotechnol J
33841750	Temperature effect on the SARS-CoV-2: A molecular dynamics study of the spike homotrimeric glycoprotein.	Comput Struct Biotechnol J
33841748	AutoVEM: An automated tool to real-time monitor epidemic trends and key mutations in SARS-CoV-2 evolution.	Comput Struct Biotechnol J
33841627	The COVID-19 pandemic and the potential treatment of the novel coronavirus SARS-CoV-2.	Am J Transl Res
33841493	AI Aided Design of Epitope-Based Vaccine for the Induction of Cellular Immune Responses Against SARS-CoV-2.	Front Genet
33841446	Complement Overactivation and Consumption Predicts In-Hospital Mortality in SARS-CoV-2 Infection.	Front Immunol
33841439	Revisiting Pleiotropic Effects of Type I Interferons: Rationale for Its Prophylactic and Therapeutic Use Against SARS-CoV-2.	Front Immunol
33841438	Plasmacytoid Dendritic Cells Depletion and Elevation of IFN-gamma Dependent Chemokines CXCL9 and CXCL10 in Children With Multisystem Inflammatory Syndrome.	Front Immunol
33841435	Neutrophils in COVID-19.	Front Immunol
33841434	COVID-19 and HIV-Associated Immune Reconstitution Inflammatory Syndrome: Emergence of Pathogen-Specific Immune Responses Adding Fuel to the Fire.	Front Immunol
33841418	"Proteomic Characterization, Biodistribution, and Functional Studies of Immune-Therapeutic Exosomes: Implications for Inflammatory Lung Diseases."	Front Immunol
33841395	Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein Based Novel Epitopes Induce Potent Immune Responses in vivo and Inhibit Viral Replication in vitro.	Front Immunol
33841169	Alteration of Diffusion Capacity After SARS-CoV-2 Infection: A Pathophysiological Approach.	Front Physiol
33841165	Identification of Plitidepsin as Potent Inhibitor of SARS-CoV-2-Induced Cytopathic Effect After a Drug Repurposing Screen.	Front Pharmacol
33841038	An in silico approach to target RNA-dependent RNA polymerase of COVID-19 with naturally occurring phytochemicals.	Environ Dev Sustain
33840836	The identification of novel inhibitors of human angiotensin-converting enzyme 2 and main protease of Sars-Cov-2: A combination of in silico methods for treatment of COVID-19.	J Mol Struct
33840835	Rational design of flavonoid based potential inhibitors targeting SARS-CoV 3CL protease for the treatment of COVID-19.	J Mol Struct
33840417	[Epidemiological features and mechanism of coronavirus disease 2019 in children].	Zhongguo Dang Dai Er Ke Za Zhi
33840257	"Surviving the Rookie Virus, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2): The Immunopathology of a SARS-CoV2 Infection."	Cell Transplant
33840201	"Angiotensin II Type 2 Receptor: A Target for Protection Against Hypertension, Metabolic Dysfunction, and Organ Remodeling."	Hypertension
33840006	Milk Peptides as Novel Multi-Targeted Therapeutic Candidates for SARS-CoV2.	Protein J
33839760	Bioinformatics and machine learning approach identifies potential drug targets and pathways in COVID-19.	Brief Bioinform
33839740	SMMPPI: a machine learning-based approach for prediction of modulators of protein-protein interactions and its application for identification of novel inhibitors for RBD:hACE2 interactions in SARS-CoV-2.	Brief Bioinform
33839270	ACoRE: Accurate SARS-CoV-2 genome reconstruction for the characterization of intra-host and inter-host viral diversity in clinical samples and for the evaluation of re-infections.	Genomics
33839230	mRNA-lipid nanoparticle COVID-19 vaccines: Structure and stability.	Int J Pharm
33839165	"Structure-based Design of a Specific, Homogeneous Luminescence Enzyme Reporter Assay for SARS-CoV-2."	J Mol Biol
33838744	Establishment of a reverse genetics system for SARS-CoV-2 using circular polymerase extension reaction.	Cell Rep
33838638	Free SARS-CoV-2 Spike Protein S1 Particles May Play a Role in the Pathogenesis of COVID-19 Infection.	Biochemistry (Mosc)
33838627	Structure and Expression of Large (+)RNA Genomes of Viruses of Higher Eukaryotes.	Biochemistry (Mosc)
33838626	Recombinant SARS-CoV-2 S Protein Binds to Glycans of the Lactosamine Family in vitro.	Biochemistry (Mosc)
33838582	Antiviral zinc oxide nanoparticles mediated by hesperidin and in silico comparison study between antiviral phenolics as anti-SARS-CoV-2.	Colloids Surf B Biointerfaces
33838447	"Comments on the ambiguity of selected surface markers, signaling pathways and omics profiles hampering the identification of myeloid-derived suppressor cells."	Cell Immunol
33838330	The effect of environmental diesel exhaust pollution on SARS-CoV-2 infection: The mechanism of pulmonary ground glass opacity.	Environ Toxicol Pharmacol
33838329	E-cigarette vape and lung ACE2 expression: Implications for coronavirus vulnerability.	Environ Toxicol Pharmacol
33838280	Interferon-induced transmembrane protein-3 genetic variant rs12252 is associated with COVID-19 mortality.	Genomics
33838172	Is SARS-CoV-2 Spike glycoprotein impairing macrophage function via alpha7-nicotinic acetylcholine receptors?	Food Chem Toxicol
33837972	"Coronavirus genomic nsp14-ExoN, structure, role, mechanism, and potential application as a drug target."	J Med Virol
33837893	Investigation of angucycline compounds as potential drug candidates against SARS Cov-2 main protease using docking and molecular dynamic approaches.	Mol Divers
33837760	Letter to the Editor: Significant mutation enrichment in inverted repeat sites of new SARS-CoV-2 strains.	Brief Bioinform
33837596	Capturing Cytokines with Advanced Materials: A Potential Strategy to Tackle COVID-19 Cytokine Storm.	Adv Mater
33837568	Silencing of SARS-CoV-2 with modified siRNA-peptide dendrimer formulation.	Allergy
33837392	Broad Severe Acute Respiratory Syndrome Coronavirus 2 Cell Tropism and Immunopathology in Lung Tissues From Fatal Coronavirus Disease 2019.	J Infect Dis
33837377	Actionable druggable genome-wide Mendelian randomization identifies repurposing opportunities for COVID-19.	Nat Med
33837241	"Spatio-temporal evolution and influencing mechanism of the COVID-19 epidemic in Shandong province, China."	Sci Rep
33837219	IL-33 expression in response to SARS-CoV-2 correlates with seropositivity in COVID-19 convalescent individuals.	Nat Commun
33837212	Lipid nanoparticle encapsulated nucleoside-modified mRNA vaccines elicit polyfunctional HIV-1 antibodies comparable to proteins in nonhuman primates.	NPJ Vaccines
33837182	GCG inhibits SARS-CoV-2 replication by disrupting the liquid phase condensation of its nucleocapsid protein.	Nat Commun
33837054	IL-6 modulation for COVID-19: the right patients at the right time?	J Immunother Cancer
33836538	Comprehensive Review of Cardiovascular Involvement in COVID-19.	AACN Adv Crit Care
33836527	Animal Models of COVID-19. I. Comparative Virology and Disease Pathogenesis.	ILAR J
33836368	Identification of COVID-19 subtypes based on immunogenomic profiling.	Int Immunopharmacol
33836338	"Could SARS-CoV-2 blocking of ACE2 in endothelial cells result in upregulation of CX3CL1, promoting thrombosis in COVID-19 patients?"	Med Hypotheses
33836204	SARS-CoV-2 presented moderately during two episodes of the infection with lack of antibody responses.	Virus Res
33836156	TOP1 inhibition therapy protects against SARS-CoV-2-induced lethal inflammation.	Cell
33836142	Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant.	Immunity
33836016	Mutations derived from horseshoe bat ACE2 orthologs enhance ACE2-Fc neutralization of SARS-CoV-2.	PLoS Pathog
33835998	Genome Scale-Differential Flux Analysis reveals deregulation of lung cell metabolism on SARS-CoV-2 infection.	PLoS Comput Biol
33835812	"Prodrugs of a 1'-CN-4-Aza-7,9-dideazaadenosine C-Nucleoside Leading to the Discovery of Remdesivir (GS-5734) as a Potent Inhibitor of Respiratory Syncytial Virus with Efficacy in the African Green Monkey Model of RSV."	J Med Chem
33835767	"Effects of angiotensin II receptor blocker usage on viral load, antibody dynamics, and transcriptional characteristics among COVID-19 patients with hypertension."	J Zhejiang Univ Sci B
33835765	Structural and physiological changes of the human body upon SARS-CoV-2 infection.	J Zhejiang Univ Sci B
33835761	CRISPR/Cas: a Nobel Prize award-winning precise genome editing technology for gene therapy and crop improvement.	J Zhejiang Univ Sci B
33835735	"Pathomechanism and Management of Stroke in COVID-19: Review of Immunopathogenesis, Coagulopathy, Endothelial Dysfunction, and Downregulation of ACE2."	J Clin Neurol
33835709	SARS-CoV-2 outbreak in Iran: The dynamics of the epidemic and evidence on two independent introductions.	Transbound Emerg Dis
33835528	Multiple clades of SARS-CoV-2 were introduced to Thailand during the first quarter of 2020.	Microbiol Immunol
33835432	A Mechanistic Link Between Selenium and Coronavirus Disease 2019 (COVID-19).	Curr Nutr Rep
33835389	Construction of Non-infectious SARS-CoV-2 Replicons and Their Application in Drug Evaluation.	Virol Sin
33835386	Scientific Hypothesis for Treatment of COVID-19's Lung Lesions by Adjusting ACE/ACE2 Imbalance.	Cardiovasc Toxicol
33835028	Human airway cells prevent SARS-CoV-2 multibasic cleavage site cell culture adaptation.	Elife
33835019	[Involvement of the complement cascade in severe forms of COVID-19].	Med Sci (Paris)
33834772	Insights into SARS-CoV-2's Mutations for Evading Human Antibodies: Sacrifice and Survival.	J Med Chem
33834497	Salivary glands are a target for SARS-CoV-2: a source for saliva contamination.	J Pathol
33834387	MyD88 and beyond: a perspective on MyD88-targeted therapeutic approach for modulation of host immunity.	Immunol Res
33834168	In Vitro-Administered Dexamethasone Suppresses T Cell Function With Reversal by Interleukin-7 in Coronavirus Disease 2019.	Crit Care Explor
33834021	ActiveDriverDB: Interpreting Genetic Variation in Human and Cancer Genomes Using Post-translational Modification Sites and Signaling Networks (2021 Update).	Front Cell Dev Biol
33834012	Comparison of Clinical Features and Outcomes of Medically Attended COVID-19 and Influenza Patients in a Defined Population in the 2020 Respiratory Virus Season.	Front Public Health
33833758	Bovine Coronavirus Immune Milk Against COVID-19.	Front Immunol
33833755	SARS-CoV-2 Proteome-Wide Analysis Revealed Significant Epitope Signatures in COVID-19 Patients.	Front Immunol
33833750	COVID-19-A Theory of Autoimmunity Against ACE-2 Explained.	Front Immunol
33833683	"COVID-19: Famotidine, Histamine, Mast Cells, and Mechanisms."	Front Pharmacol
33833678	Interplay Between Endocrine Disruptors and Immunity: Implications for Diseases of Autoreactive Etiology.	Front Pharmacol
33833673	Neuropsychiatric Symptoms of COVID-19 Explained by SARS-CoV-2 Proteins' Mimicry of Human Protein Interactions.	Front Hum Neurosci
33833618	"Whole-Transcriptome RNA Sequencing Reveals Significant Differentially Expressed mRNAs, miRNAs, and lncRNAs and Related Regulating Biological Pathways in the Peripheral Blood of COVID-19 Patients."	Mediators Inflamm
33833585	SARS-CoV-2 and Human Immunodeficiency Virus: Pathogen Pincer Attack.	HIV AIDS (Auckl)
33833547	Interferon-lambda3 Exacerbates the Inflammatory Response to Microbial Ligands: Implications for SARS-CoV-2 Pathogenesis.	J Inflamm Res
33833543	Association of Early Inflammation with Age and Asymptomatic Disease in COVID-19.	J Inflamm Res
33833542	Anti-Inflammatory and Antiviral Osmotic Polymeric Film to Treat Covid-19 Early-Stage Infection.	J Inflamm Res
33833483	COVID-19 and comorbidities of hepatic diseases in a global perspective.	World J Gastroenterol
33833480	Coronavirus disease-2019 and the intestinal tract: An overview.	World J Gastroenterol
33832850	Pathophysiology of light phenotype SARS-CoV-2 interstitial pneumonia: from histopathological features to clinical presentations.	Pulmonology
33832550	MUC1-C influences cell survival in lung adenocarcinoma Calu-3 cells after SARS-CoV-2 infection.	BMB Rep
33832440	Common low complexity regions for SARS-CoV-2 and human proteomes as potential multidirectional risk factor in vaccine development.	BMC Bioinformatics
33832398	Cytokine storm associated coagulation complications in COVID-19 patients: Pathogenesis and Management.	Expert Rev Anti Infect Ther
33832321	Considerations and perspectives on digestive diseases during the COVID-19 pandemic: a narrative review.	Ann Palliat Med
33832291	Investigation into molecular mechanisms and high-frequency core TCM for pulmonary fibrosis secondary to COVID-19 based on network pharmacology and data mining.	Ann Palliat Med
33831697	Identification of SARS-CoV-2 viral entry inhibitors using machine learning and cell-based pseudotyped particle assay.	Bioorg Med Chem
33831567	Implications of SARS-Cov-2 infection on eNOS and iNOS activity: Consequences for the respiratory and vascular systems.	Nitric Oxide
33831468	In silico analysis of the potential mechanism of a preventive Chinese medicine formula on coronavirus disease 2019.	J Ethnopharmacol
33831450	Antiviral potential of plant polysaccharide nanoparticles actuating non-specific immunity.	Int J Biol Macromol
33831378	The origins of viral infection sleuth.	Cell
33831372	SARS-CoV-2 evolution in an immunocompromised host reveals shared neutralization escape mechanisms.	Cell
33831263	"Endothelial cell, myeloid, and adaptive immune responses in SARS-CoV-2 infection."	FASEB J
33831133	"High-throughput, single-copy sequencing reveals SARS-CoV-2 spike variants coincident with mounting humoral immunity during acute COVID-19."	PLoS Pathog
33831132	A human coronavirus evolves antigenically to escape antibody immunity.	PLoS Pathog
33831079	"Whole genome variation in 27 Mexican indigenous populations, demographic and biomedical insights."	PLoS One
33830976	Angiotensin-converting-enzyme inhibitors and angiotensin II receptor blockers for COVID-19: A living systematic review of randomized clinical trials.	Medwave
33830946	Functional characterization of CD4+ T cell receptors crossreactive for SARS-CoV-2 and endemic coronaviruses.	J Clin Invest
33830908	The green tea catechin epigallocatechin gallate inhibits SARS-CoV-2 infection.	J Gen Virol
33830901	Correlation of humoral immune responses to different SARS-CoV-2 antigens with virus neutralizing antibodies and symptomatic severity in a German COVID-19 cohort.	Emerg Microbes Infect
33830862	Positive aspects of the mRNA platform for SARS-CoV-2 vaccines.	Hum Vaccin Immunother
33830737	Effect of Polymer Hydrophilicity and Molar Mass on the Properties of the Protein in Protein-Polymer Conjugates: The Case of PPEylated Myoglobin.	Biomacromolecules
33830701	"[COVID-19 vaccines: vaccine targets, immunogenicity and allergic reactions]."	Rev Med Suisse
33830530	Association between the HLA genotype and the severity of COVID-19 infection among South Asians.	J Med Virol
33830145	"COVID 19 in Children: Gastrointestinal, Hepatobiliary and Pancreatic Manifestation."	Mymensingh Med J
33830084	A mechanism for matrikine regulation in acute inflammatory lung injury.	JCI Insight
33829974	C-Phycocyanin-derived Phycocyanobilin as a Potential Nutraceutical Approach for Major Neurodegenerative Disorders and COVID-19-induced Damage to the Nervous System.	Curr Neuropharmacol
33829971	COVID-19 and ARDS: Update On Preventive And Therapeutic Venues.	Curr Mol Med
33829849	Hipotesis sobre las conexiones entre COVID-19 severo en ninos y nutricion: una revision narrativa.	Nutr Hosp
33829781	Benchmark of Popular Free Energy Approaches Revealing the Inhibitors Binding to SARS-CoV-2 Mpro.	J Chem Inf Model
33829608	Adenosine triphosphate energy-independently controls protein homeostasis with unique structure and diverse mechanisms.	Protein Sci
33829465	Therapeutic potential of N-acetyl cysteine (NAC) in preventing cytokine storm in COVID-19: review of current evidence.	Eur Rev Med Pharmacol Sci
33829461	Post-COVID pulmonary fibrosis: therapeutic efficacy using with mesenchymal stem cells - How the lung heals.	Eur Rev Med Pharmacol Sci
33829393	Clinical and Pathophysiologic Spectrum of Neuro-COVID.	Mol Neurobiol
33829029	Thymidine Phosphorylase Is Increased in COVID-19 Patients in an Acuity-Dependent Manner.	Front Med (Lausanne)
33828999	Virus-Induced Changes of the Respiratory Tract Environment Promote Secondary Infections With Streptococcus pneumoniae.	Front Cell Infect Microbiol
33828922	Immunoinformatic approach to design a multiepitope vaccine targeting non-mutational hotspot regions of structural and non-structural proteins of the SARS CoV2.	PeerJ
33828641	Gender disparity in COVID-19: Role of sex steroid hormones.	Asian Pac J Trop Med
33828579	Epigenetic Lens to Visualize the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Infection in COVID-19 Pandemic.	Front Genet
33828563	A Rapid and Efficient Screening System for Neutralizing Antibodies and Its Application for SARS-CoV-2.	Front Immunol
33828481	Fever and Antipyretic Supported by Traditional Chinese Medicine: A Multi-Pathway Regulation.	Front Pharmacol
33828231	From bedside to bench: regulation of host factors in SARS-CoV-2 infection.	Exp Mol Med
33828130	Cytotoxic T-lymphocyte elicited vaccine against SARS-CoV-2 employing immunoinformatics framework.	Sci Rep
33827988	ORF10-Cullin-2-ZYG11B complex is not required for SARS-CoV-2 infection.	Proc Natl Acad Sci U S A
33827897	SARS-CoV-2 drives JAK1/2-dependent local complement hyperactivation.	Sci Immunol
33827113	Drugs that inhibit TMEM16 proteins block SARS-CoV-2 spike-induced syncytia.	Nature
33827074	Outcomes of Hospitalized COVID-19 Patients Receiving Renin Angiotensin System Blockers and Calcium Channel Blockers.	Am J Nephrol
33827042	The first SARS-CoV-2 genetic variants of concern (VOC) in Poland: The concept of a comprehensive approach to monitoring and surveillance of emerging variants.	Adv Med Sci
33826681	Temporal dynamics of SARS-CoV-2 mutation accumulation within and across infected hosts.	PLoS Pathog
33826484	Computational exploration of natural peptides targeting ACE2.	J Biomol Struct Dyn
33826483	Identification of doxorubicin as a potential therapeutic against SARS-CoV-2 (COVID-19) protease: a molecular docking and dynamics simulation studies.	J Biomol Struct Dyn
33826068	RNAi Technology and Investigation on Possible Vaccines to Combat SARS-CoV-2 Infection.	Appl Biochem Biotechnol
33826045	Are antiphospholipid antibodies just a common epiphenomenon or are they causative of immune-mediated coagulopathy in COVID-19?	Clin Rheumatol
33825700	Structural biology of coronavirus ion channels.	Acta Crystallogr D Struct Biol
33825619	Protection against reinfection with D614- or G614-SARS-CoV-2 isolates in golden Syrian hamster.	Emerg Microbes Infect
33825201	Drug synergy of combinatory treatment with remdesivir and the repurposed drugs fluoxetine and itraconazole effectively impairs SARS-CoV-2 infection in vitro.	Br J Pharmacol
33825125	CD169/SIGLEC1 is expressed on circulating monocytes in COVID-19 and expression levels are associated with disease severity.	Infection
33825097	"Identifying structural-functional analogue of GRL0617, the only well-established inhibitor for papain-like protease (PLpro) of SARS-CoV2 from the pool of fungal metabolites using docking and molecular dynamics simulation."	Mol Divers
33824998	Obesity and its impact on COVID-19.	J Mol Med (Berl)
33824915	Design and identification of novel annomontine analogues against SARS-CoV-2: An in-silico approach.	Heliyon
33824883	SARS-CoV-2 tracking in Tunisia through next-generation sequencing: lessons for the future.	EuroMediterr J Environ Integr
33824882	Viral reverse engineering using Artificial Intelligence and big data COVID-19 infection with Long Short-term Memory (LSTM).	Environ Technol Innov
33824762	The Effect of Chronic and Inhospital Exposure to Renin-Angiotensin System Inhibitors on the Outcome and Inflammatory State of Coronavirus Disease 2019 Adult Inpatients.	Int J Hypertens
33824725	Genetic variability in COVID-19-related genes in the Brazilian population.	Hum Genome Var
33824495	Influenza virus and SARS-CoV-2: pathogenesis and host responses in the respiratory tract.	Nat Rev Microbiol
33824489	Emerging concepts in the science of vaccine adjuvants.	Nat Rev Drug Discov
33824483	Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19.	Nat Rev Immunol
33824342	T cell assays differentiate clinical and subclinical SARS-CoV-2 infections from cross-reactive antiviral responses.	Nat Commun
33824288	Functional comparison of SARS-CoV-2 with closely related pangolin and bat coronaviruses.	Cell Discov
33824130	"Novel Coronavirus-2019 (2019-nCoV): Perspectives of emergence, prophylaxis and predicted treatment approaches."	Pak J Pharm Sci
33824128	QadirVID-19: A fusion inhibitor against Novel Coronavirus-2019 for specific management of COVID-19.	Pak J Pharm Sci
33824127	Vitamin D is a potential inhibitor of COVID-19: In silico molecular docking to the binding site of SARS-CoV-2 endoribonuclease Nsp15.	Pak J Pharm Sci
33823870	Adhatoda Vasica attenuates inflammatory and hypoxic responses in preclinical mouse models: potential for repurposing in COVID-19-like conditions.	Respir Res
33823769	"Infection, Infectious Agents and Vascular Disease."	Rev Recent Clin Trials
33823594	Morphology and Composition of Immunodiffusion Precipitin Complexes Evaluated via Microscopy and Proteomics.	J Proteome Res
33823371	"Endotheliitis, endothelin, and endothelin receptor blockers in COVID-19."	Med Hypotheses
33823303	A single dose of self-transcribing and replicating RNA-based SARS-CoV-2 vaccine produces protective adaptive immunity in mice.	Mol Ther
33823185	Virtual high throughput screening: Potential inhibitors for SARS-CoV-2 PL(PRO) and 3CL(PRO) proteases.	Eur J Pharmacol
33823179	Evidence that Maackia amurensis seed lectin (MASL) exerts pleiotropic actions on oral squamous cells with potential to inhibit SARS-CoV-2 infection and COVID-19 disease progression.	Exp Cell Res
33823154	A novel anti-human IL-1R7 antibody reduces IL-18-mediated inflammatory signaling.	J Biol Chem
33822878	Choice of assemblers has a critical impact on de novo assembly of SARS-CoV-2 genome and characterizing variants.	Brief Bioinform
33822777	Natural mucosal barriers and COVID-19 in children.	JCI Insight
33822770	SARS-CoV-2 mRNA vaccines induce broad CD4+ T cell responses that recognize SARS-CoV-2 variants and HCoV-NL63.	J Clin Invest
33822639	In silico investigation of the viroporin E as a vaccine target against SARS-CoV-2.	Am J Physiol Lung Cell Mol Physiol
33822495	Chaga Medicinal Mushroom Inonotus obliquus (Agaricomycetes) Terpenoids May Interfere with SARS-CoV-2 Spike Protein Recognition of the Host Cell: A Molecular Docking Study.	Int J Med Mushrooms
33822489	iPSC screening for drug repurposing identifies anti-RNA virus agents modulating host cell susceptibility.	FEBS Open Bio
33822421	"Silibinin as potential tool against SARS-Cov-2: In silico spike receptor-binding domain and main protease molecular docking analysis, and in vitro endothelial protective effects."	Phytother Res
33822324	Neuropathophysiology of coronavirus disease 2019: neuroinflammation and blood brain barrier disruption are critical pathophysiological processes that contribute to the clinical symptoms of SARS-CoV-2 infection.	Inflammopharmacology
33822097	Differential T-Cell Reactivity to Endemic Coronaviruses and SARS-CoV-2 in Community and Health Care Workers.	J Infect Dis
33822045	IgG immune complexes may contribute to neutrophil activation in the course of severe COVID-19.	J Infect Dis
33822042	Pan-selectin inhibitors as potential therapeutics for COVID-19 treatment: in silico screening study.	Glycobiology
33821487	Role of iron and iron-related proteins in mesenchymal stem cells: Cellular and clinical aspects.	J Cell Physiol
33821254	A potent neutralizing nanobody against SARS-CoV-2 with inhaled delivery potential.	MedComm (Beijing)
33821252	Construction of a risk map to understand the vulnerability of various types of cancer patients to COVID-19 infection.	MedComm (Beijing)
33821250	Alterations in T and B cell function persist in convalescent COVID-19 patients.	Med (N Y)
33821222	An overview of basic molecular biology of SARS-CoV-2 and current COVID-19 prevention strategies.	Gene Rep
33821207	Renal Injury by SARS-CoV-2 Infection: A Systematic Review.	Kidney Dis (Basel)
33821096	COVID-19 vs influenza viruses: A cockroach optimized deep neural network classification approach.	Int J Imaging Syst Technol
33820904	Impact of Cardiovascular Diseases on COVID-19: A Systematic Review.	Med Sci Monit
33820835	"The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates."	Sci Transl Med
33820827	Crystal structure of inhibitor-bound human MSPL that can activate high pathogenic avian influenza.	Life Sci Alliance
33820739	Genomic surveillance of Nevada patients revealed prevalence of unique SARS-CoV-2 variants bearing mutations in the RdRp gene.	J Genet Genomics
33820514	The Main Receptors Involved with COVID-19: a Systematic Review and Meta-analysis.	Curr Med Chem
33820462	Circadian clock modulating small molecules repurposing as inhibitors of SARS-CoV-2 M(pro) for pharmacological interventions in COVID-19 pandemic.	Chronobiol Int
33819740	"The contrasting role of nasopharyngeal angiotensin converting enzyme 2 (ACE2) transcription in SARS-CoV-2 infection: A cross-sectional study of people tested for COVID-19 in British Columbia, Canada."	EBioMedicine
33819681	Immunogenicity and antigenicity based T-cell and B-cell epitopes identification from conserved regions of 10664 SARS-CoV-2 genomes.	Infect Genet Evol
33819492	Restoring the endothelial barrier function in the elderly.	Mech Ageing Dev
33819170	Enhanced IL-6 and IL-12B Gene Expression After SARS-CoV-2 Infection in Leprosy Patients May Increase the Risk of Neural Damage.	Am J Trop Med Hyg
33818952	The Rapid Development and Early Success of Covid 19 Vaccines Have Raised Hopes for Accelerating the Cancer Treatment Mechanism.	Arch Razi Inst
33818861	The role of autophagy in controlling SARS-CoV-2 infection: An overview on virophagy-mediated molecular drug targets.	Cell Biol Int
33818474	Phylogenetic classification of the whole-genome sequences of SARS-CoV-2 from India & evolutionary trends.	Indian J Med Res
33818470	Drug repurposing for identification of potential inhibitors against SARS-CoV-2 spike receptor-binding domain: An in silico approach.	Indian J Med Res
33818465	An overview of preclinical animal models for SARS-CoV-2 pathogenicity.	Indian J Med Res
33818464	Cardiovascular manifestations of COVID-19: An evidence-based narrative review.	Indian J Med Res
33818412	"Impact of COVID-19 on the Gut: A Review of the Manifestations, Pathology, Management, and Challenges."	Acta Med Indones
33818026	"A review on the clinical trials of repurposing therapeutic drugs, mechanisms and preventive measures against SARS-CoV-2."	Drug Metab Pers Ther
33818000	Investigating the ACE2 polymorphisms in COVID-19 susceptibility: An in silico analysis.	Mol Genet Genomic Med
33817867	"Phyto-pharmacological perspective of Silymarin: A potential prophylactic or therapeutic agent for COVID-19, based on its promising immunomodulatory, anti-coagulant and anti-viral property."	Phytother Res
33817822	Immunomodulatory and anti-inflammatory potential of crocin in COVID-19 treatment.	J Food Biochem
33817672	Network-based virus-host interaction prediction with application to SARS-CoV-2.	Patterns (N Y)
33817671	"Outside-in induction of the IFITM3 trafficking system by infections, including SARS-CoV-2, in the pathobiology of Alzheimer's disease."	Brain Behav Immun Health
33817557	Repair of programmed DNA lesions in antibody class switch recombination: common and unique features.	Genome Instab Dis
33817451	Current opinion in neurological manifestations of SARS-CoV-2 infection.	Curr Opin Toxicol
33817389	Mink SARS-CoV-2 Infection in Poland - Short Communication.	J Vet Res
33817388	"Prediction of potential inhibitors of SARS-CoV-2 using 3D-QSAR, molecular docking modeling and ADMET properties."	Heliyon
33817352	Repurposing of approved drugs with potential to interact with SARS-CoV-2 receptor.	Biochem Biophys Rep
33817321	Diabetes and COVID-19.	Open Life Sci
33816542	The Looming Effects of Estrogen in Covid-19: A Rocky Rollout.	Front Nutr
33816521	Combination of Angiotensin (1-7) Agonists and Convalescent Plasma as a New Strategy to Overcome Angiotensin Converting Enzyme 2 (ACE2) Inhibition for the Treatment of COVID-19.	Front Med (Lausanne)
33816489	Exploiting Connections for Viral Replication.	Front Cell Dev Biol
33816359	Vitamin D and COVID-19: is there a role?	J Diabetes Metab Disord
33816347	Persistent Bacterial Coinfection of a COVID-19 Patient Caused by a Genetically Adapted Pseudomonas aeruginosa Chronic Colonizer.	Front Cell Infect Microbiol
33816341	The Weight of Obesity in Immunity from Influenza to COVID-19.	Front Cell Infect Microbiol
33816047	"A review of novel coronavirus disease (COVID-19): based on genomic structure, phylogeny, current shreds of evidence, candidate vaccines, and drug repurposing."	3 Biotech
33815890	Global Sex Disparity of COVID-19: A Descriptive Review of Sex Hormones and Consideration for the Potential Therapeutic Use of Hormone Replacement Therapy in Older Adults.	Aging Dis
33815889	An Account of Immune Senescence in the Clinical Pathophysiology of COVID-19 Infection in Aging.	Aging Dis
33815867	"SARS-CoV-2: the ""Uncensored"" Truth about Its Origin and Adipose-Derived Mesenchymal Stem Cells as New Potential Immune-Modulatory Weapon."	Aging Dis
33815808	Computational insights of phytochemical-driven disruption of RNA-dependent RNA polymerase-mediated replication of coronavirus: a strategic treatment plan against coronavirus disease 2019.	New Microbes New Infect
33815798	Hypercoagulability in COVID-19: A review of the potential mechanisms underlying clotting disorders.	SAGE Open Med
33815697	Coagulopathy: Another side effect of coronavirus infection.	J Cardiovasc Thorac Res
33815693	Lung organoid simulations for modelling and predicting the effect of mutations on SARS-CoV-2 infectivity.	Comput Struct Biotechnol J
33815692	COVID-19 co-infection mathematical model as guided through signaling structural framework.	Comput Struct Biotechnol J
33815686	Neuropilins: C-end rule peptides and their association with nociception and COVID-19.	Comput Struct Biotechnol J
33815663	"HIF-1, the Warburg Effect, and Macrophage/Microglia Polarization Potential Role in COVID-19 Pathogenesis."	Oxid Med Cell Longev
33815467	Initial Insights Into the Genetic Epidemiology of SARS-CoV-2 Isolates From Kerala Suggest Local Spread From Limited Introductions.	Front Genet
33815459	Genomic Variations in SARS-CoV-2 Genomes From Gujarat: Underlying Role of Variants in Disease Epidemiology.	Front Genet
33815415	Immunity to SARS-CoV-2: Lessons Learned.	Front Immunol
33815361	Is Ferroptosis a Future Direction in Exploring Cryptococcal Meningitis?	Front Immunol
33815307	Genomic Feature Analysis of Betacoronavirus Provides Insights Into SARS and COVID-19 Pandemics.	Front Microbiol
33815295	The Efficacy and Potential Mechanisms of Metformin in the Treatment of COVID-19 in the Diabetics: A Systematic Review.	Front Endocrinol (Lausanne)
33815126	Repurposing Anti-Malaria Phytomedicine Artemisinin as a COVID-19 Drug.	Front Pharmacol
33814954	Nanoemulsions: The rising star of antiviral therapeutics and nanodelivery system-current status and prospects.	Curr Opin Colloid Interface Sci
33814612	Unmasking of crucial structural fragments for coronavirus protease inhibitors and its implications in COVID-19 drug discovery.	J Mol Struct
33814400	[SUBACUTE THYROIDITIS AND COVID-19 (REVIEW)].	Georgian Med News
33813796	"Characterization of the SARS-CoV-2 E Protein: Sequence, Structure, Viroporin, and Inhibitors."	Protein Sci
33813307	A SARS-CoV-2 -human metalloproteome interaction map.	J Inorg Biochem
33813274	Targeted design of drug binding sites in the main protease of SARS-CoV-2 reveals potential signatures of adaptation.	Biochem Biophys Res Commun
33813272	"ALG-097111, a potent and selective SARS-CoV-2 3-chymotrypsin-like cysteine protease inhibitor exhibits in vivo efficacy in a Syrian Hamster model."	Biochem Biophys Res Commun
33813122	SARS-CoV-2 specific T-cell immunity in COVID-19 convalescent patients and unexposed controls measured by ex vivo ELISpot assay.	Clin Microbiol Infect
33813118	Recommendations for accurate genotyping of SARS-CoV-2 using amplicon-based sequencing of clinical samples.	Clin Microbiol Infect
33813013	Antiviral effect of fufang yinhua jiedu (FFYH) granules against influenza A virus through regulating the inflammatory responses by TLR7/MyD88 signaling pathway.	J Ethnopharmacol
33812944	A novel method for conserved sequence extraction with prospective mutation prediction for SARS-CoV-2 PCR primer design.	J Virol Methods
33812856	Animal models for SARS-Cov2/Covid19 research-A commentary.	Biochem Pharmacol
33812315	Structure-based drug design of an inhibitor of the SARS-CoV-2 (COVID-19) main protease using free software: A tutorial for students and scientists.	Eur J Med Chem
33812037	The role of microRNAs in modulating SARS-CoV-2 infection in human cells: a systematic review.	Infect Genet Evol
33811970	"Effect of ramipril on kidney, lung and heart ACE2 in a diabetic mice model."	Mol Cell Endocrinol
33811957	Traditional Chinese Medicine (TCM) in the treatment of COVID-19 and other viral infections: Efficacies and mechanisms.	Pharmacol Ther
33811811	Drug repurposing screens reveal cell-type-specific entry pathways and FDA-approved drugs active against SARS-Cov-2.	Cell Rep
33811810	"The aging lung: Physiology, disease, and immunity."	Cell
33811809	BET inhibition blocks inflammation-induced cardiac dysfunction and SARS-CoV-2 infection.	Cell
33811680	Downregulation of type III interferons in patients with severe COVID-19.	J Med Virol
33811541	An update: the emerging evidence of complement involvement in COVID-19.	Med Microbiol Immunol
33811468	"Resourcing, annotating, and analysing synthetic peptides of SARS-CoV-2 for immunopeptidomics and other immunological studies."	Proteomics
33811309	Myasthenia gravis at the crossroad of COVID-19: focus on immunological and respiratory interplay.	Acta Neurol Belg
33811212	Genetic variability in COVID-19-related genes in the Brazilian population.	Hum Genome Var
33811184	SARS-CoV-2 induces double-stranded RNA-mediated innate immune responses in respiratory epithelial-derived cells and cardiomyocytes.	Proc Natl Acad Sci U S A
33811162	X-ray screening identifies active site and allosteric inhibitors of SARS-CoV-2 main protease.	Science
33810774	In silico inquest reveals the efficacy of Cannabis in the treatment of post-Covid-19 related neurodegeneration.	J Biomol Struct Dyn
33810568	Synthesis and Characterization of a Minophosphonate Containing Chitosan Polymer Derivatives: Investigations of Cytotoxic Activity and in Silico Study of SARS-CoV-19.	Polymers (Basel)
33810465	Neutralizing Monoclonal Anti-SARS-CoV-2 Antibodies Isolated from Immunized Rabbits Define Novel Vulnerable Spike-Protein Epitope.	Viruses
33810456	B-Cell Memory Responses to Variant Viral Antigens.	Viruses
33810394	Growth Arrest-Specific Factor 6 (GAS6) Is Increased in COVID-19 Patients and Predicts Clinical Outcome.	Biomedicines
33810391	An Overview of Current Knowledge of Deadly CoVs and Their Interface with Innate Immunity.	Viruses
33810287	Lactiplantibacillus plantarum as a Potential Adjuvant and Delivery System for the Development of SARS-CoV-2 Oral Vaccines.	Microorganisms
33810168	"Multiple Early Introductions of SARS-CoV-2 to Cape Town, South Africa."	Viruses
33810129	Antiviral Cyanometabolites-A Review.	Biomolecules
33810026	Potent Neutralization Antibodies Induced by a Recombinant Trimeric Spike Protein Vaccine Candidate Containing PIKA Adjuvant for COVID-19.	Vaccines (Basel)
33810011	Deep Learning for Novel Antimicrobial Peptide Design.	Biomolecules
33810010	Targeting CX3CR1 Suppresses the Fanconi Anemia DNA Repair Pathway and Synergizes with Platinum.	Cancers (Basel)
33809983	"Comparative Investigation of Composition, Antifungal, and Anti-Inflammatory Effects of the Essential Oil from Three Industrial Hemp Varieties from Italian Cultivation."	Antibiotics (Basel)
33809971	"Renin-Angiotensin-Aldosterone System: Friend or Foe-The Matter of Balance. Insight on History, Therapeutic Implications and COVID-19 Interactions."	Int J Mol Sci
33809963	"Medicinal Plants, Phytochemicals, and Herbs to Combat Viral Pathogens Including SARS-CoV-2."	Molecules
33809954	Why Does SARS-CoV-2 Infection Induce Autoantibody Production?	Pathogens
33809949	A Resource for the Network Representation of Cell Perturbations Caused by SARS-CoV-2 Infection.	Genes (Basel)
33809851	The Impact of Angiotensin-Converting Enzyme 2 (ACE2) Expression on the Incidence and Severity of COVID-19 Infection.	Pathogens
33809620	Mechanisms Modified by (-)-Epicatechin and Taxifolin Relevant for the Treatment of Hypertension and Viral Infection: Knowledge from Preclinical Studies.	Antioxidants (Basel)
33809265	"Interacting Proteins, Polymorphisms and the Susceptibility of Animals to SARS-CoV-2."	Animals (Basel)
33809164	LipoParticles: Lipid-Coated PLA Nanoparticles Enhanced In Vitro mRNA Transfection Compared to Liposomes.	Pharmaceutics
33809063	Single-Cell Expression Landscape of SARS-CoV-2 Receptor ACE2 and Host Proteases in Normal and Malignant Lung Tissues from Pulmonary Adenocarcinoma Patients.	Cancers (Basel)
33808998	Thymic Aging May Be Associated with COVID-19 Pathophysiology in the Elderly.	Cells
33808940	Identification of Anti-Severe Acute Respiratory Syndrome-Related Coronavirus 2 (SARS-CoV-2) Oxysterol Derivatives In Vitro.	Int J Mol Sci
33808906	Profiles of Peripheral Immune Cells of Uncomplicated COVID-19 Cases with Distinct Viral RNA Shedding Periods.	Viruses
33808905	Acinetobacter baumannii Antibiotic Resistance Mechanisms.	Pathogens
33808783	Mutations in Animal SARS-CoV-2 Induce Mismatches with the Diagnostic PCR Assays.	Pathogens
33808721	Comprehensive Virtual Screening of the Antiviral Potentialities of Marine Polycyclic Guanidine Alkaloids against SARS-CoV-2 (COVID-19).	Biomolecules
33808687	Phylogenomic Evidence of Reinfection and Persistence of SARS-CoV-2: First Report from Colombia.	Vaccines (Basel)
33808658	"Exaptation of Retroviral Syncytin for Development of Syncytialized Placenta, Its Limited Homology to the SARS-CoV-2 Spike Protein and Arguments against Disturbing Narrative in the Context of COVID-19 Vaccination."	Biology (Basel)
33808640	Modulation of Hemostasis in COVID-19; Blood Platelets May Be Important Pieces in the COVID-19 Puzzle.	Pathogens
33808574	"Dietary and Protective Factors to Halt or Mitigate Progression of Autoimmunity, COVID-19 and Its Associated Metabolic Diseases."	Int J Mol Sci
33808490	The Relationship between COVID-19 and Innate Immunity in Children: A Review.	Children (Basel)
33808275	In Vitro Antiviral Activities of Salinomycin on Porcine Epidemic Diarrhea Virus.	Viruses
33808197	Immunological Aspects Related to Viral Infections in Severe Asthma and the Role of Omalizumab.	Biomedicines
33808054	The Inhibitory Effects of Plant Derivate Polyphenols on the Main Protease of SARS Coronavirus 2 and Their Structure-Activity Relationship.	Molecules
33807988	Targeting the DEAD-Box RNA Helicase eIF4A with Rocaglates-A Pan-Antiviral Strategy for Minimizing the Impact of Future RNA Virus Pandemics.	Microorganisms
33807957	Antibody Response to the BNT162b2 mRNA COVID-19 Vaccine in Subjects with Prior SARS-CoV-2 Infection.	Viruses
33807915	The Role of Immunogenetics in COVID-19.	Int J Mol Sci
33807854	Population-Predicted MHC Class II Epitope Presentation of SARS-CoV-2 Structural Proteins Correlates to the Case Fatality Rates of COVID-19 in Different Countries.	Int J Mol Sci
33807773	SARS-CoV-2 Main Protease Active Site Ligands in the Human Metabolome.	Molecules
33807682	CNBP Binds and Unfolds In Vitro G-Quadruplexes Formed in the SARS-CoV-2 Positive and Negative Genome Strands.	Int J Mol Sci
33807579	"Allergic Reactions to Current Available COVID-19 Vaccinations: Pathophysiology, Causality, and Therapeutic Considerations."	Vaccines (Basel)
33807556	Molecular Analysis of SARS-CoV-2 Genetic Lineages in Jordan: Tracking the Introduction and Spread of COVID-19 UK Variant of Concern at a Country Level.	Pathogens
33807522	Multifaceted Mechanisms of Action of Metformin Which Have Been Unraveled One after Another in the Long History.	Int J Mol Sci
33807516	VLP-Based Vaccines as a Suitable Technology to Target Trypanosomatid Diseases.	Vaccines (Basel)
33807474	Downfalls of Chemical Probes Acting at the Kinase ATP-Site: CK2 as a Case Study.	Molecules
33807248	Potent Antiviral Activity against HSV-1 and SARS-CoV-2 by Antimicrobial Peptoids.	Pharmaceuticals (Basel)
33807095	Blockers of the SARS-CoV-2 3a Channel Identified by Targeted Drug Repurposing.	Viruses
33807059	Light Sheet Microscopy-Assisted 3D Analysis of SARS-CoV-2 Infection in the Respiratory Tract of the Ferret Model.	Viruses
33806967	Bioinformatic Analysis of Genome-Predicted Bat Cathelicidins.	Molecules
33806810	Aging and Interferons: Impacts on Inflammation and Viral Disease Outcomes.	Cells
33806671	SiO2-Ag Composite as a Highly Virucidal Material: A Roadmap that Rapidly Eliminates SARS-CoV-2.	Nanomaterials (Basel)
33806595	Bleeding by Bruton Tyrosine Kinase-Inhibitors: Dependency on Drug Type and Disease.	Cancers (Basel)
33806540	SARS-CoV-2 Infection: Modulator of Pulmonary Embolism Paradigm.	J Clin Med
33806395	The History and Mystery of Alveolar Epithelial Type II Cells: Focus on Their Physiologic and Pathologic Role in Lung.	Int J Mol Sci
33806331	Repurposing of Some Natural Product Isolates as SARS-COV-2 Main Protease Inhibitors via In Vitro Cell Free and Cell-Based Antiviral Assessments and Molecular Modeling Approaches.	Pharmaceuticals (Basel)
33806292	Potential Therapeutic Applications of Hydrogen in Chronic Inflammatory Diseases: Possible Inhibiting Role on Mitochondrial Stress.	Int J Mol Sci
33806290	Arginase 1 (Arg1) as an Up-Regulated Gene in COVID-19 Patients: A Promising Marker in COVID-19 Immunopathy.	J Clin Med
33806274	"Therapeutic Potential of EGCG, a Green Tea Polyphenol, for Treatment of Coronavirus Diseases."	Life (Basel)
33806254	Ribosome-Profiling Reveals Restricted Post Transcriptional Expression of Antiviral Cytokines and Transcription Factors during SARS-CoV-2 Infection.	Int J Mol Sci
33806155	Site-Specific O-Glycosylation Analysis of SARS-CoV-2 Spike Protein Produced in Insect and Human Cells.	Viruses
33805880	Immunogenicity of Varicella-Zoster Virus Glycoprotein E Formulated with Lipid Nanoparticles and Nucleic Immunostimulators in Mice.	Vaccines (Basel)
33805829	Post-Translational Protein Deimination Signatures in Plasma and Plasma EVs of Reindeer (Rangifer tarandus).	Biology (Basel)
33805760	Angiotensin-(1-7)-A Potential Remedy for AKI: Insights Derived from the COVID-19 Pandemic.	J Clin Med
33805739	Placental Immune Responses to Viruses: Molecular and Histo-Pathologic Perspectives.	Int J Mol Sci
33805473	Immunogenicity and Neutralizing Activity Comparison of SARS-CoV-2 Spike Full-Length and Subunit Domain Proteins in Young Adult and Old-Aged Mice.	Vaccines (Basel)
33805458	"Transcriptional and Non-Transcriptional Activation, Posttranslational Modifications, and Antiviral Functions of Interferon Regulatory Factor 3 and Viral Antagonism by the SARS-Coronavirus."	Viruses
33805419	Accelerated Repurposing and Drug Development of Pulmonary Hypertension Therapies for COVID-19 Treatment Using an AI-Integrated Biosimulation Platform.	Molecules
33804991	Medical Application of Substances Derived from Non-Pathogenic Fungi Aspergillus oryzae and A. luchuensis-Containing Koji.	J Fungi (Basel)
33804981	Soluble Spike DNA Vaccine Provides Long-Term Protective Immunity against SARS-CoV-2 in Mice and Nonhuman Primates.	Vaccines (Basel)
33804957	NSP16 2'-O-MTase in Coronavirus Pathogenesis: Possible Prevention and Treatments Strategies.	Viruses
33804769	Exosomes from COVID-19 Patients Carry Tenascin-C and Fibrinogen-beta in Triggering Inflammatory Signals in Cells of Distant Organ.	Int J Mol Sci
33804765	Susceptibility and Severity of Viral Infections in Obesity: Lessons from Influenza to COVID-19. Does Leptin Play a Role?	Int J Mol Sci
33804667	Endogenously Produced SARS-CoV-2 Specific IgG Antibodies May Have a Limited Impact on Clearing Nasal Shedding of Virus during Primary Infection in Humans.	Viruses
33804556	SARS-CoV-2 Variant of Concern 202012/01 Has about Twofold Replicative Advantage and Acquires Concerning Mutations.	Viruses
33804408	C1q Complement/Tumor Necrosis Factor-Associated Proteins in Cardiovascular Disease and COVID-19.	Proteomes
33804294	Differential Effects of Antiseptic Mouth Rinses on SARS-CoV-2 Infectivity In Vitro.	Pathogens
33804129	"Metal-Bound Methisazone; Novel Drugs Targeting Prophylaxis and Treatment of SARS-CoV-2, a Molecular Docking Study."	Int J Mol Sci
33804076	"Blood Levels of Galectin-9, an Immuno-Regulating Molecule, Reflect the Severity for the Acute and Chronic Infectious Diseases."	Biomolecules
33804075	Renal Manifestations of Covid-19: Physiology and Pathophysiology.	J Clin Med
33804069	The Tissue Renin-Angiotensin System and Its Role in the Pathogenesis of Major Human Diseases: Quo Vadis?	Cells
33803988	Metagenomic Snapshots of Viral Components in Guinean Bats.	Microorganisms
33803475	Acute and Post-Acute Neurological Complications of COVID-19.	Neurol Int
33803455	Experimental Inoculation of Young Calves with SARS-CoV-2.	Viruses
33803417	"Synthesis and Antiviral Evaluation of (1,4-Disubstituted-1,2,3-Triazol)-(E)-2-Methyl-but-2-Enyl Nucleoside Phosphonate Prodrugs."	Molecules
33803400	"Structure-Function Analyses of New SARS-CoV-2 Variants B.1.1.7, B.1.351 and B.1.1.28.1: Clinical, Diagnostic, Therapeutic and Public Health Implications."	Viruses
33803295	"Does COVID-19 Vaccination Warrant the Classical Principle ""ofelein i mi vlaptin""?"	Medicina (Kaunas)
33803118	Urgent Need for Field Surveys of Coronaviruses in Southeast Asia to Understand the SARS-CoV-2 Phylogeny and Risk Assessment for Future Outbreaks.	Biomolecules
33802995	COVID-19 and Neurological Impairment: Hypothalamic Circuits and Beyond.	Viruses
33802899	Detection and Genome Sequencing of SARS-CoV-2 in a Domestic Cat with Respiratory Signs in Switzerland.	Viruses
33802860	Is PF-00835231 a Pan-SARS-CoV-2 Mpro Inhibitor? A Comparative Study.	Molecules
33802857	SARS-CoV-2 Infections in Animals: Reservoirs for Reverse Zoonosis and Models for Study.	Viruses
33802761	Therapeutic Role of Tocilizumab in SARS-CoV-2-Induced Cytokine Storm: Rationale and Current Evidence.	Int J Mol Sci
33802729	"SARS-CoV-2 Entry Related Viral and Host Genetic Variations: Implications on COVID-19 Severity, Immune Escape, and Infectivity."	Int J Mol Sci
33802650	In Translation: FcRn across the Therapeutic Spectrum.	Int J Mol Sci
33802569	mRNA-lncRNA Co-Expression Network Analysis Reveals the Role of lncRNAs in Immune Dysfunction during Severe SARS-CoV-2 Infection.	Viruses
33802468	Secondary Metabolites of Plants as Modulators of Endothelium Functions.	Int J Mol Sci
33802310	Immunogenetic Predictors of Severe COVID-19.	Vaccines (Basel)
33802256	Electronic Cigarette Aerosol Is Cytotoxic and Increases ACE2 Expression on Human Airway Epithelial Cells: Implications for SARS-CoV-2 (COVID-19).	J Clin Med
33802215	Interaction of Remdesivir with Clinically Relevant Hepatic Drug Uptake Transporters.	Pharmaceutics
33802042	Association between Viral Infections and Risk of Autistic Disorder: An Overview.	Int J Environ Res Public Health
33801926	"Simultaneous CD8(+) T-Cell Immune Response against SARS-Cov-2 S, M, and N Induced by Endogenously Engineered Extracellular Vesicles in Both Spleen and Lungs."	Vaccines (Basel)
33801921	Severe COVID-19 Infection Associated with Endothelial Dysfunction Induces Multiple Organ Dysfunction: A Review of Therapeutic Interventions.	Biomedicines
33801527	"Link between Viral Infections, Immune System, Inflammation and Diet."	Int J Environ Res Public Health
33801496	miRCOVID-19: Potential Targets of Human miRNAs in SARS-CoV-2 for RNA-Based Drug Discovery.	Noncoding RNA
33801468	What Every Diabetologist Should Know about SARS-CoV-2: State of Knowledge at the Beginning of 2021.	J Clin Med
33801464	SARS-CoV-2 Nucleocapsid Protein Targets RIG-I-Like Receptor Pathways to Inhibit the Induction of Interferon Response.	Cells
33801380	SARS-CoV-2 Infection Is Asymptomatic in Nearly Half of Adults with Robust Anti-Spike Protein Receptor-Binding Domain Antibody Response.	Vaccines (Basel)
33801257	The Mutation Profile of SARS-CoV-2 Is Primarily Shaped by the Host Antiviral Defense.	Viruses
33801151	Identification of Potential SARS-CoV-2 Main Protease and Spike Protein Inhibitors from the Genus Aloe: An In Silico Study for Drug Development.	Molecules
33800954	Interactions of SARS-CoV-2 with the Blood-Brain Barrier.	Int J Mol Sci
33800947	Targeting MMP-Regulation of Inflammation to Increase Metabolic Tolerance to COVID-19 Pathologies: A Hypothesis.	Biomolecules
33800932	The Combination of Bromelain and Acetylcysteine (BromAc) Synergistically Inactivates SARS-CoV-2.	Viruses
33800807	Recovery of Innate Immune Cells and Persisting Alterations in Adaptive Immunity in the Peripheral Blood of Convalescent Plasma Donors at Eight Months Post SARS-CoV-2 Infection.	Microorganisms
33800686	Parkinson's Disease Causative Mutation in Vps35 Disturbs Tetherin Trafficking to Cell Surfaces and Facilitates Virus Spread.	Cells
33800523	Recent Progress in Torovirus Molecular Biology.	Viruses
33800390	Drosophila as a Model for Infectious Diseases.	Int J Mol Sci
33800013	Structure-Based Virtual Screening Identifies Multiple Stable Binding Sites at the RecA Domains of SARS-CoV-2 Helicase Enzyme.	Molecules
33799956	"Updates on Anticoagulation and Laboratory Tools for Therapy Monitoring of Heparin, Vitamin K Antagonists and Direct Oral Anticoagulants."	Biomedicines
33799871	Receptor-Based Pharmacophore Modeling in the Search for Natural Products for COVID-19 M(pro).	Molecules
33799867	Development of an In Vitro Airway Epithelial-Endothelial Cell Culture Model on a Flexible Porous Poly(Trimethylene Carbonate) Membrane Based on Calu-3 Airway Epithelial Cells and Lung Microvascular Endothelial Cells.	Membranes (Basel)
33799854	Renal Morphology in Coronavirus Disease: A Literature Review.	Medicina (Kaunas)
33799853	Role of Mitochondria in Viral Infections.	Life (Basel)
33799583	Oral Symptoms Associated with COVID-19 and Their Pathogenic Mechanisms: A Literature Review.	Dent J (Basel)
33799505	Emerging SARS-CoV-2 Variants and Impact in Global Vaccination Programs against SARS-CoV-2/COVID-19.	Vaccines (Basel)
33799284	COVID-19 and the Risk of Relapse in Multiple Sclerosis Patients: A Fight with No Bystander Effect?	Mult Scler Relat Disord
33799164	Strengthening CoViD-19 therapy via combinations of RAS modulators.	Med Hypotheses
33798836	Rutin and flavone analogs as prospective SARS-CoV-2 main protease inhibitors: In silico drug discovery study.	J Mol Graph Model
33798758	Molecular epidemiology analysis of early variants of SARS-CoV-2 reveals the potential impact of mutations P504L and Y541C (NSP13) in the clinical COVID-19 outcomes.	Infect Genet Evol
33798667	The dawn of mRNA vaccines: The COVID-19 case.	J Control Release
33798491	Infection- and vaccine-induced antibody binding and neutralization of the B.1.351 SARS-CoV-2 variant.	Cell Host Microbe
33798476	Pregnancy alters interleukin-1 beta expression and antiviral antibody responses during severe acute respiratory syndrome coronavirus 2 infection.	Am J Obstet Gynecol
33797868	Inspecting the Mechanism of Fragment Hits Binding on SARS-CoV-2 M(pro) by Using Supervised Molecular Dynamics (SuMD) Simulations.	ChemMedChem
33797663	Novel mutations in NSP-1 and PLPro of SARS-CoV-2 NIB-1 genome mount for effective therapeutics.	J Genet Eng Biotechnol
33797393	"Genetic Evidence and Host Immune Response in Persons Reinfected with SARS-CoV-2, Brazil."	Emerg Infect Dis
33797351	The Role of Obesity in the Immunopathogenesis of COVID-19 Respiratory Disease and Critical Illness.	Am J Respir Cell Mol Biol
33797339	COVID19-inhibitory activity of withanolides involves targeting of the host cell surface receptor ACE2: insights from computational and biochemical assays.	J Biomol Struct Dyn
33797336	In silico characterization of mutations circulating in SARS-CoV-2 structural proteins.	J Biomol Struct Dyn
33797236	Stealth Fluorescence Labeling for Live Microscopy Imaging of mRNA Delivery.	J Am Chem Soc
33797130	Discovery of potent Covid-19 main protease inhibitors using integrated drug-repurposing strategy.	Biotechnol Appl Biochem
33797123	In silico approach of secondary metabolites from Brazilian herbal medicines to search for potential drugs against SARS-CoV-2.	Phytother Res
33796820	A deep learning framework for high-throughput mechanism-driven phenotype compound screening and its application to COVID-19 drug repurposing.	Nat Mach Intell
33796285	Renin-angiotensin system blockade in the COVID-19 pandemic.	Clin Kidney J
33796130	Network Analysis and Transcriptome Profiling Identify Autophagic and Mitochondrial Dysfunctions in SARS-CoV-2 Infection.	Front Genet
33796097	Immune Interaction Map of Human SARS-CoV-2 Target Genes: Implications for Therapeutic Avenues.	Front Immunol
33796068	The Double Edge Sword of Testosterone's Role in the COVID-19 Pandemic.	Front Endocrinol (Lausanne)
33796026	Insight Into the Prospects for RNAi Therapy of Cancer.	Front Pharmacol
33795938	"Corona Viruses: A Review on SARS, MERS and COVID-19."	Microbiol Insights
33795932	The Relevance of Bioinformatics Applications in the Discovery of Vaccine Candidates and Potential Drugs for COVID-19 Treatment.	Bioinform Biol Insights
33795929	"The Functional Classification of ORF8 in SARS-CoV-2 Replication, Immune Evasion, and Viral Pathogenesis Inferred through Phylogenetic Profiling."	Evol Bioinform Online
33795870	Antibody responses to the BNT162b2 mRNA vaccine in individuals previously infected with SARS-CoV-2.	Nat Med
33795830	Pathophysiology of SARS-CoV-2: the Mount Sinai COVID-19 autopsy experience.	Mod Pathol
33795722	Analysis of SARS-CoV-2 genomic epidemiology reveals disease transmission coupled to variant emergence and allelic variation.	Sci Rep
33795718	Molecular dynamics and in silico mutagenesis on the reversible inhibitor-bound SARS-CoV-2 main protease complexes reveal the role of lateral pocket in enhancing the ligand affinity.	Sci Rep
33795692	Systems serology detects functionally distinct coronavirus antibody features in children and elderly.	Nat Commun
33795671	Lead compounds for the development of SARS-CoV-2 3CL protease inhibitors.	Nat Commun
33795584	Therapy with RAS inhibitors during the COVID-19 pandemic.	J Cardiovasc Med (Hagerstown)
33795432	Designed proteins assemble antibodies into modular nanocages.	Science
33795347	"Coding-Complete Genome Sequence of a SARS-CoV-2 Strain Isolated in Gilgit, Pakistan."	Microbiol Resour Announc
33795344	Genome Sequence of a SARS-CoV-2 Strain from a COVID-19 Clinical Sample from the Khagrachari District of Bangladesh.	Microbiol Resour Announc
33795156	Likelihood of amyloid formation in COVID-19-induced ARDS.	Trends Microbiol
33794925	"Gene signature and immune cell profiling by high-dimensional, single-cell analysis in COVID-19 patients, presenting Low T3 syndrome and coexistent hematological malignancies."	J Transl Med
33794655	Endothelial Dysfunction in the Brain: Setting the Stage for Stroke and Other Cerebrovascular Complications of COVID-19.	Stroke
33794653	Acute Viral Illnesses and Ischemic Stroke: Pathophysiological Considerations in the Era of the COVID-19 Pandemic.	Stroke
33794459	Virtual screening of plant-derived compounds against SARS-CoV-2 viral proteins using computational tools.	Sci Total Environ
33794380	"Bacille Calmette-Guerin (BCG) vaccine and potential cross-protection against SARS-CoV-2 infection - Assumptions, knowns, unknowns and need for developing an accurate scientific evidence base."	Int J Infect Dis
33794345	Severe acute respiratory syndrome coronavirus 2 escape mutants and protective immunity from natural infections or immunizations.	Clin Microbiol Infect
33794238	"A review on antiviral and immunomodulatory polysaccharides from Indian medicinal plants, which may be beneficial to COVID-19 infected patients."	Int J Biol Macromol
33794152	Multivalent binding of the partially disordered SARS-CoV-2 nucleocapsid phosphoprotein dimer to RNA.	Biophys J
33794150	SARS-CoV-2 Nsp16 activation mechanism and a cryptic pocket with pan-coronavirus antiviral potential.	Biophys J
33794145	Modular basis for potent SARS-CoV-2 neutralization by a prevalent VH1-2-derived antibody class.	Cell Rep
33794143	SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies.	Cell
33794092	"Protein Footprinting, Conformational Dynamics, and Core Interface-Adjacent Neutralization ""Hotspots"" in the SARS-CoV-2 Spike Protein Receptor Binding Domain/Human ACE2 Interaction."	J Am Soc Mass Spectrom
33793546	Computational epitope map of SARS-CoV-2 spike protein.	PLoS Comput Biol
33793331	"Hypertension, a Moving Target in COVID-19: Current Views and Perspectives."	Circ Res
33793189	Nano-Enabled COVID-19 Vaccines: Meeting the Challenges of Durable Antibody Plus Cellular Immunity and Immune Escape.	ACS Nano
33793103	"[COVID-toes, a cutaneous sign of innate resistance to SARS-CoV-2]."	Rev Med Suisse
33793006	Features of HLA class I expression and its clinical relevance in SARS-CoV-2: What do we know so far?	Rev Med Virol
33792947	Variation in predicted COVID-19 risk among lemurs and lorises.	Am J Primatol
33792889	Mortality in Patients with COVID-19 on Renin Angiotensin System Inhibitor Long-Term Treatment: An Observational Study Showing that Things Are Not Always as They Seem.	Adv Ther
33792836	Piece of the puzzle: Remdesivir disassembles the multimeric SARS-CoV-2 RNA-dependent RNA polymerase complex.	Cell Biochem Biophys
33792762	Toxicology and pharmacology of synthetic organoselenium compounds: an update.	Arch Toxicol
33792750	Sequencing of SARS-CoV-2 genome using different nanopore chemistries.	Appl Microbiol Biotechnol
33792447	The circadian clock gene Bmal1: Role in COVID-19 and periodontitis.	Chronobiol Int
33792313	Role of Hydrogen Bonds in Formation of Co-amorphous Valsartan/Nicotinamide Compositions of High Solubility and Durability with Anti-hypertension and Anti-COVID-19 Potential.	Mol Pharm
33792109	Reduced frequency of T helper 17 and T helper 1 cells and their association with critical coronavirus disease 2019.	APMIS
33791346	Cardiovascular Disease and COVID-19: Insight From Cases With Heart Failure.	Front Cardiovasc Med
33791293	Coronavirus-Induced Host Cubic Membranes and Lipid-Related Antiviral Therapies: A Focus on Bioactive Plasmalogens.	Front Cell Dev Biol
33791232	Perspectives and Challenges in the Fight Against COVID-19: The Role of Genetic Variability.	Front Cell Infect Microbiol
33791231	SARS-CoV-2-Indigenous Microbiota Nexus: Does Gut Microbiota Contribute to Inflammation and Disease Severity in COVID-19?	Front Cell Infect Microbiol
33791156	Screening strategy of TMPRSS2 inhibitors by FRET-based enzymatic activity for TMPRSS2-based cancer and COVID-19 treatment.	Am J Cancer Res
33790994	Severe acute respiratory syndrome coronavirus 2 ORF3a induces the expression of ACE2 in oral and pulmonary epithelial cells and the food supplement Vita Deyun((R)) diminishes this effect.	Exp Ther Med
33790892	"Longitudinal Profiling of Antibody Response in Patients With COVID-19 in a Tertiary Care Hospital in Beijing, China."	Front Immunol
33790874	Emergence of Bat-Related Betacoronaviruses: Hazard and Risks.	Front Microbiol
33790857	Dooming Phagocyte Responses: Inflammatory Effects of Endogenous Oxidized Phospholipids.	Front Endocrinol (Lausanne)
33790587	BCG Vaccine-Induced Trained Immunity and COVID-19: Protective or Bystander?	Infect Drug Resist
33790352	Computational drug repurposing study elucidating simultaneous inhibition of entry and replication of novel corona virus by Grazoprevir.	Sci Rep
33790236	Gender associates with both susceptibility to infection and pathogenesis of SARS-CoV-2 in Syrian hamster.	Signal Transduct Target Ther
33789998	Activation of STING Signaling Pathway Effectively Blocks Human Coronavirus Infection.	J Virol
33789993	The Physiological TMPRSS2 Inhibitor HAI-2 Alleviates SARS-CoV-2 Infection.	J Virol
33789940	Stability of SARS-CoV-2 Spike G614 Variant Surpasses That of the D614 Variant after Cold Storage.	mSphere
33789928	Viral Respiratory Pathogens and Lung Injury.	Clin Microbiol Rev
33789211	SARS-CoV-2 spike protein interactions with amyloidogenic proteins: Potential clues to neurodegeneration.	Biochem Biophys Res Commun
33789145	Nanocurcumin improves Treg cell responses in patients with mild and severe SARS-CoV2.	Life Sci
33789086	The variant gambit: COVID-19's next move.	Cell Host Microbe
33789085	SARS-CoV-2 spike variants exhibit differential infectivity and neutralization resistance to convalescent or post-vaccination sera.	Cell Host Microbe
33789084	Potent SARS-CoV-2 neutralizing antibodies directed against spike N-terminal domain target a single supersite.	Cell Host Microbe
33788668	An overview of Covid-19 pandemic: immunology and pharmacology.	J Immunoassay Immunochem
33788636	A study on non-synonymous mutational patterns in structural proteins of SARS-CoV-2.	Genome
33788271	Antigen-dependent multistep differentiation of T follicular helper cells and its role in SARS-CoV-2 infection and vaccination.	Eur J Immunol
33788265	"The link between microglia and the severity of COVID-19: The ""two-hit"" hypothesis."	J Med Virol
33788264	Increased B-cell activity with consumption of activated monocytes in severe COVID-19 patients.	Eur J Immunol
33788190	"Roles of Genetic Predisposition in the Sex Bias of Pulmonary Pathophysiology, as a Function of Estrogens : Sex Matters in the Prevalence of Lung Diseases."	Adv Exp Med Biol
33788116	Antiviral Drug Ivermectin at Nanomolar Concentrations Inhibits Glycine-Induced Chloride Current in Rat Hippocampal Neurons.	Bull Exp Biol Med
33787911	Association Between Renin-Angiotensin-Aldosterone System Inhibitors and Clinical Outcomes in Patients With COVID-19: A Systematic Review and Meta-analysis.	JAMA Netw Open
33787872	Drugmonizome and Drugmonizome-ML: integration and abstraction of small molecule attributes for drug enrichment analysis and machine learning.	Database (Oxford)
33787730	Dental workers in front-line of COVID-19: an in silico evaluation targeting their prevention.	J Appl Oral Sci
33787678	COVID-19 and Thromboinflammation: Is There a Role for Statins?	Clinics (Sao Paulo)
33787515	The relationship between serum levels of interleukin-2 and IL-8 with circulating microRNA-10b in patients with COVID-19.	Iran J Immunol
33787513	"Does prior immunization with measles, mumps, and rubella vaccines contribute to the antibody response to COVID-19 antigens?"	Iran J Immunol
33787510	The role and delicate balance of Host Immunity in Coronavirus Disease-19.	Iran J Immunol
33787351	CD38 in the age of COVID-19: a medical perspective.	Physiol Rev
33787221	A Clinical-Stage Cysteine Protease Inhibitor blocks SARS-CoV-2 Infection of Human and Monkey Cells.	ACS Chem Biol
33787218	Novel Compounds Targeting Neuropilin Receptor 1 with Potential To Interfere with SARS-CoV-2 Virus Entry.	ACS Chem Neurosci
33787066	An Integrative in silico Drug Repurposing Approach for Identification of Potential Inhibitors of SARS-CoV-2 Main Protease.	Mol Inform
33786919	"Multiple sites on SARS-CoV-2 spike protein are susceptible to proteolysis by cathepsins B, K, L, S, and V."	Protein Sci
33786906	Cholestatic liver injury in COVID-19 is a rare and distinct entity and is associated with increased mortality.	J Intern Med
33786876	Flavonoids as potential phytotherapeutics to combat cytokine storm in SARS-CoV-2.	Phytother Res
33786727	Pharmacoinformatics-based identification of transmembrane protease serine-2 inhibitors from Morus Alba as SARS-CoV-2 cell entry inhibitors.	Mol Divers
33786714	A potential impact of SARS-CoV-2 on pituitary glands and pituitary neuroendocrine tumors.	Endocrine
33786537	Adsorption of SARS-CoV-2 Spike Protein S1 at Oxide Surfaces Studied by High-Speed Atomic Force Microscopy.	Adv Nanobiomed Res
33786534	"News About the Extracellular Vesicles from Mesenchymal Stem Cells: Functions, Therapy and Protection from COVID-19."	J Exp Pathol (Wilmington)
33786450	Severe Acute Respiratory Syndrome-Associated Coronavirus 2 Infection and Organ Dysfunction in the ICU: Opportunities for Translational Research.	Crit Care Explor
33786440	"New Decade, Old Debate: Blocking the Cytokine Pathways in Infection-Induced Cytokine Cascade."	Crit Care Explor
33786418	An in silico analysis of effective siRNAs against COVID-19 by targeting the leader sequence of SARS-CoV-2.	Adv Cell Gene Ther
33786417	"Potential New Treatments for Kawasaki Disease, Its Variations, and Multisystem Inflammatory Syndrome."	SN Compr Clin Med
33786405	Recent advances in carbon nanomaterials for biomedical applications: A review.	Curr Opin Biomed Eng
33786376	Cytosolic delivery of nucleic acids: The case of ionizable lipid nanoparticles.	Bioeng Transl Med
33786375	Potent Noncovalent Inhibitors of the Main Protease of SARS-CoV-2 from Molecular Sculpting of the Drug Perampanel Guided by Free Energy Perturbation Calculations.	ACS Cent Sci
33786369	Drug Repurposing of Itraconazole and Estradiol Benzoate against COVID-19 by Blocking SARS-CoV-2 Spike Protein-Mediated Membrane Fusion.	Adv Ther (Weinh)
33786368	Sulfoglycodendrimer Therapeutics for HIV-1 and SARS-CoV-2.	Adv Ther (Weinh)
33786291	In silico studies of selected multi-drug targeting against 3CLpro and nsp12 RNA-dependent RNA-polymerase proteins of SARS-CoV-2 and SARS-CoV.	Netw Model Anal Health Inform Bioinform
33786199	Recent Advances on Nanomaterials to COVID-19 Management: A Systematic Review on Antiviral/Virucidal Agents and Mechanisms of SARS-CoV-2 Inhibition/Inactivation.	Glob Chall
33786172	Low type I interferon response in COVID-19 patients: Interferon response may be a potential treatment for COVID-19.	Biomed Rep
33785765	SARS-CoV-2 in severe COVID-19 induces a TGF-beta-dominated chronic immune response that does not target itself.	Nat Commun
33785745	Replicating bacterium-vectored vaccine expressing SARS-CoV-2 Membrane and Nucleocapsid proteins protects against severe COVID-19-like disease in hamsters.	NPJ Vaccines
33785729	"Integrated characterization of SARS-CoV-2 genome, microbiome, antibiotic resistance and host response from single throat swabs."	Cell Discov
33785720	Immunodeficiency-associated lymphoproliferative disorders and lymphoid neoplasms in post-COVID-19 pandemic era.	Exp Oncol
33785634	Multidisciplinary Approaches Identify Compounds that Bind to Human ACE2 or SARS-CoV-2 Spike Protein as Candidates to Block SARS-CoV-2-ACE2 Receptor Interactions.	mBio
33785615	Dynamic Dissection of the Endocytosis of Porcine Epidemic Diarrhea Coronavirus Cooperatively Mediated by Clathrin and Caveolae as Visualized by Single-Virus Tracking.	mBio
33785459	Emergence and outcomes of the SARS-CoV-2 'Marseille-4' variant.	Int J Infect Dis
33785249	Therapeutic Potential of Metformin in COVID-19: Reasoning for Its Protective Role.	Trends Microbiol
33785044	Hypothetical COVID-19 protection mechanism: hints from centenarians.	Immun Ageing
33784944	Design and synthesis of novel phe-phe hydroxyethylene derivatives as potential coronavirus main protease inhibitors.	J Biomol Struct Dyn
33784877	Role of Tissue Factor in the Pathogenesis of COVID-19 and the Possible Ways to Inhibit It.	Clin Appl Thromb Hemost
33784499	Antiviral drug screen identifies DNA-damage response inhibitor as potent blocker of SARS-CoV-2 replication.	Cell Rep
33784482	A Recombinant Fragment of Human Surfactant Protein D Binds Spike Protein and Inhibits Infectivity and Replication of SARS-CoV-2 in Clinical Samples.	Am J Respir Cell Mol Biol
33784417	Upregulation of CCR4 in activated CD8(+) T cells indicates enhanced lung homing in patients with severe acute SARS-CoV-2 infection.	Eur J Immunol
33784094	Lead Discovery of SARS-CoV-2 Main Protease Inhibitors through Covalent Docking-Based Virtual Screening.	J Chem Inf Model
33783873	Skin manifestations of the BNT162b2 mRNA COVID-19 vaccine in healthcare workers. 'COVID-arm': a clinical and histological characterization.	J Eur Acad Dermatol Venereol
33783202	3D Heteronuclear Magnetization Transfers for the Establishment of Secondary Structures in SARS-CoV-2-Derived RNAs.	J Am Chem Soc
33783182	Inhibition of Human Coronaviruses by Antimalarial Peroxides.	ACS Infect Dis
33783027	Coronavirus infection: An immunologists' perspective.	Scand J Immunol
33782990	"Comprehensive comparative genomic and microsatellite analysis of SARS, MERS, BAT-SARS, and COVID-19 coronaviruses."	J Med Virol
33782651	Perspectives on plant flavonoid quercetin-based drugs for novel SARS-CoV-2.	Beni Suef Univ J Basic Appl Sci
33782640	The potential of miRNA-based therapeutics in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: A review.	J Pharm Anal
33782449	DNA methylation architecture of the ACE2 gene in nasal cells of children.	Sci Rep
33782412	"Comprehensive transcriptomic analysis of COVID-19 blood, lung, and airway."	Sci Rep
33782395	"The SARS-CoV-2 nucleocapsid protein is dynamic, disordered, and phase separates with RNA."	Nat Commun
33782253	Targeting B cells in multiple sclerosis.	Curr Opin Neurol
33782089	Cutting Edge: Reduced Adenosine-to-Inosine Editing of Endogenous Alu RNAs in Severe COVID-19 Disease.	J Immunol
33781885	BRD4 targeting nanotherapy prevents lipopolysaccharide induced acute respiratory distress syndrome.	Int J Pharm
33781873	Understanding the heart-brain axis response in COVID-19 patients: A suggestive perspective for therapeutic development.	Pharmacol Res
33781871	Antiviral activity of portulaca oleracea L. extracts against porcine epidemic diarrhea virus by partial suppression on myd88/NF-kappab activation in vitro.	Microb Pathog
33781838	Emerging importance of ACE2 in external stratified epithelial tissues.	Mol Cell Endocrinol
33781826	Heparin prevents in vitro glycocalyx shedding induced by plasma from COVID-19 patients.	Life Sci
33781803	Proteomic analysis identifies the RNA helicase DDX3X as a host target against SARS-CoV-2 infection.	Antiviral Res
33781798	Genome-wide analysis of 10664 SARS-CoV-2 genomes to identify virus strains in 73 countries based on single nucleotide polymorphism.	Virus Res
33781385	Early postmortem mapping of SARS-CoV-2 RNA in patients with COVID-19 and the correlation with tissue damage.	Elife
33781287	Precision therapeutic targets for COVID-19.	Virol J
33781188	Protein-ligand Docking Simulations with AutoDock4 Focused on the Main Protease of SARS-CoV-2.	Curr Med Chem
33780970	Escape of SARS-CoV-2 501Y.V2 from neutralization by convalescent plasma.	Nature
33780969	The spatial landscape of lung pathology during COVID-19 progression.	Nature
33780519	"Viral genomic, metagenomic and human transcriptomic characterization and prediction of the clinical forms of COVID-19."	PLoS Pathog
33780434	Disparate temperature-dependent virus-host dynamics for SARS-CoV-2 and SARS-CoV in the human respiratory epithelium.	PLoS Biol
33780352	Differentially expressed immune response genes in COVID-19 patients based on disease severity.	Aging (Albany NY)
33779758	"Isatis indigotica: a review of phytochemistry, pharmacological activities and clinical applications."	J Pharm Pharmacol
33779464	B Cell Response to Vaccination.	Immunol Invest
33779460	SARS-CoV-2 infection: molecular mechanisms of severe outcomes to suggest therapeutics.	Expert Rev Proteomics
33779346	Thymulin and peroxiredoxin 6 have protective effects against streptozotocin-induced type 1 diabetes in mice.	Int J Immunopathol Pharmacol
33778918	Research progress on coronavirus S proteins and their receptors.	Arch Virol
33778795	Phylogenomic analysis of COVID-19 summer and winter outbreaks in Hong Kong: An observational study.	Lancet Reg Health West Pac
33778788	A comprehensive analysis and resource to use CRISPR-Cas13 for broad-spectrum targeting of RNA viruses.	Cell Rep Med
33778787	Spatial mapping of SARS-CoV-2 and H1N1 lung injury identifies differential transcriptional signatures.	Cell Rep Med
33778467	Toward the prevention of coronavirus infection: what role can polymers play?	Mater Today Adv
33778306	Proteomics Analysis of Serum from COVID-19 Patients.	ACS Omega
33778286	Ethyl Pyruvate as a Potential Defense Intervention against Cytokine Storm in COVID-19?	ACS Omega
33778258	"Repurposing the Ebola and Marburg Virus Inhibitors Tilorone, Quinacrine, and Pyronaridine: In Vitro Activity against SARS-CoV-2 and Potential Mechanisms."	ACS Omega
33778182	Comparative analysis of mutational hotspots in the spike protein of SARS-CoV-2 isolates from different geographic origins.	Gene Rep
33778179	Mutational analysis of structural proteins of SARS-CoV-2.	Heliyon
33778129	Computationally approached inhibition potential of Tinospora cordifolia towards COVID-19 targets.	Virusdisease
33778090	Dysregulated Host Response in Severe Acute Respiratory Syndrome Coronavirus 2-Induced Critical Illness.	Open Forum Infect Dis
33778087	Risk of SARS-CoV-2 infection and COVID-19 prognosis with the use of renin-angiotensin-aldosterone system (RAAS) inhibitors: a systematic review.	Futur J Pharm Sci
33777970	Insights on the Structural Variations of the Furin-Like Cleavage Site Found Among the December 2019-July 2020 SARS-CoV-2 Spike Glycoprotein: A Computational Study Linking Viral Evolution and Infection.	Front Med (Lausanne)
33777844	Next-Generation Sequencing Reveals the Progression of COVID-19.	Front Cell Infect Microbiol
33777580	CD26/Dipeptidyl Peptidase IV and Its Multiple Biological Functions.	Cureus
33777333	Specific epitopes form extensive hydrogen-bonding networks to ensure efficient antibody binding of SARS-CoV-2: Implications for advanced antibody design.	Comput Struct Biotechnol J
33777332	SARS-CoV-2 infection and smoking: What is the association? A brief review.	Comput Struct Biotechnol J
33777139	Gut-Lung Axis in COVID-19.	Interdiscip Perspect Infect Dis
33777054	"T Cell Activation, Highly Armed Cytotoxic Cells and a Shift in Monocytes CD300 Receptors Expression Is Characteristic of Patients With Severe COVID-19."	Front Immunol
33777047	Mast Cell and Eosinophil Activation Are Associated With COVID-19 and TLR-Mediated Viral Inflammation: Implications for an Anti-Siglec-8 Antibody.	Front Immunol
33777030	Induction of Potent and Durable Neutralizing Antibodies Against SARS-CoV-2 Using a Receptor Binding Domain-Based Immunogen.	Front Immunol
33777028	Immune Memory in Mild COVID-19 Patients and Unexposed Donors Reveals Persistent T Cell Responses After SARS-CoV-2 Infection.	Front Immunol
33777012	"Increased sCD163 and sCD14 Plasmatic Levels and Depletion of Peripheral Blood Pro-Inflammatory Monocytes, Myeloid and Plasmacytoid Dendritic Cells in Patients With Severe COVID-19 Pneumonia."	Front Immunol
33776785	"The Good Treatment, the Bad Virus, and the Ugly Inflammation: Pathophysiology of Kidney Involvement During COVID-19."	Front Physiol
33776395	"Synthesis, Molecular Docking, In Silico ADME Predictions, and Toxicity Studies of N-Substituted-5-(4-Chloroquinolin-2-yl)-1,3,4-Thiadiazol-2-Amine Derivatives as COVID-19 Inhibitors."	Russ J Bioorg Chem
33776343	Structure-based inhibitor screening of natural products against NSP15 of SARS-CoV-2 revealed thymopentin and oleuropein as potent inhibitors.	J Proteins Proteom
33776210	Docking and in silico toxicity assessment of Arthrospira compounds as potential antiviral agents against SARS-CoV-2.	J Appl Phycol
33776206	Taming of Covid-19: potential and emerging application of mesenchymal stem cells.	Cytotechnology
33776065	In silico studies on stilbenolignan analogues as SARS-CoV-2 Mpro inhibitors.	Chem Phys Lett
33775925	"Diabetes, inflammation, and the adiponectin paradox: Therapeutic targets in SARS-CoV-2."	Drug Discov Today
33775827	In-silico screening for identification of potential inhibitors against SARS-CoV-2 transmembrane serine protease 2 (TMPRSS2).	Eur J Pharm Sci
33775667	Engineered Ultra-High Affinity Synthetic Antibodies for SARS-CoV-2 Neutralization and Detection.	J Mol Biol
33775096	Antimalarial Quinacrine and Chloroquine Lose Their Activity by Decreasing Cationic Amphiphilic Structure with a Slight Decrease in pH.	J Med Chem
33774984	[Features of pathogenesis and COVID-19 course for the elderly and old age.]	Adv Gerontol
33774723	"Understanding and managing anti-MDA 5 dermatomyositis, including potential COVID-19 mimicry."	Rheumatol Int
33774672	SARS-CoV-2 spike protein binding selectively accelerates substrate-specific catalytic activity of ACE2.	J Biochem
33774649	Cathepsin L plays a key role in SARS-CoV-2 infection in humans and humanized mice and is a promising target for new drug development.	Signal Transduct Target Ther
33774628	Animal Hosts and Experimental Models of SARS-CoV-2 Infection.	Chemotherapy
33774551	The development and kinetics of functional antibody-dependent cell-mediated cytotoxicity (ADCC) to SARS-CoV-2 spike protein.	Virology
33774510	Conflicting and ambiguous names of overlapping ORFs in the SARS-CoV-2 genome: A homology-based resolution.	Virology
33774291	Advances on the immunotoxicity of outdoor particulate matter: A focus on physical and chemical properties and respiratory defence mechanisms.	Sci Total Environ
33774195	"Attenuation of 7-ketocholesterol- and 7beta-hydroxycholesterol-induced oxiapoptophagy by nutrients, synthetic molecules and oils: Potential for the prevention of age-related diseases."	Ageing Res Rev
33774179	Activation of classical and alternative complement pathways in the pathogenesis of lung injury in COVID-19.	Clin Immunol
33774178	Molecular characterization of interactions between the D614G variant of SARS-CoV-2 S-protein and neutralizing antibodies: A computational approach.	Infect Genet Evol
33774068	Therapeutic targets in lung tissue remodelling and fibrosis.	Pharmacol Ther
33774023	Dipeptidylpeptidase-4 levels and DPP4 gene polymorphisms in patients with COVID-19. Association with disease and with severity.	Life Sci
33773419	Coronavirus survival on beach sand: Sun vs COVID-19.	Mar Pollut Bull
33773396	Glycyrrhizin prevents SARS-CoV-2 S1 and Orf3a induced high mobility group box 1 (HMGB1) release and inhibits viral replication.	Cytokine
33773105	Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein.	Cell
33772888	COVID-19 as a trigger of acute attacks in people with hereditary angioedema.	Clin Exp Allergy
33772778	A single subcutaneous or intranasal immunization with adenovirus-based SARS-CoV-2 vaccine induces robust humoral and cellular immune responses in mice.	Eur J Immunol
33772767	Peptide microarray-based analysis of antibody responses to SARS-CoV-2 identifies unique epitopes with potential for diagnostic test development.	Eur J Immunol
33772259	Phylogenetic analyses of SARS-CoV-2 B.1.1.7 lineage suggest a single origin followed by multiple exportation events versus convergent evolution.	Clin Infect Dis
33772244	Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies.	Nat Med
33771662	COVID-19 and the liver: an adverse outcome pathway perspective.	Toxicology
33771478	Generation of WAe001-A-58 human embryonic stem cell line with inducible expression of the SARS-CoV-2 nucleocapsid protein.	Stem Cell Res
33771354	A New Chemical Probe Challenges the Broad Cancer Essentiality of CK2.	Trends Pharmacol Sci
33771096	"In silico comparative study of SARS-CoV-2 proteins and antigenic proteins in BCG, OPV, MMR and other vaccines: evidence of a possible putative protective effect."	BMC Bioinformatics
33771058	Neutralization of the eye and skin irritant benzalkonium chloride using UVC radiation.	Cutan Ocul Toxicol
33770833	CYP2D6 and CYP3A4 variants influence the risk and outcome of COVID-19 infection among rheumatoid arthritis patients maintained on hydroxychloroquine.	Drug Metab Pers Ther
33770472	Animal Reservoirs and Hosts for Emerging Alphacoronaviruses and Betacoronaviruses.	Emerg Infect Dis
33770349	"(1)H, (13)C, and (15)N backbone chemical-shift assignments of SARS-CoV-2 non-structural protein 1 (leader protein)."	Biomol NMR Assign
33770191	[Neuromuscular complications of SARS-CoV-2 infections-Part 1: peripheral nerves].	Nervenarzt
33770098	Genomic variation and epidemiology of SARS-CoV-2 importation and early circulation in Israel.	PLoS One
33769912	Analysis of the SARS-CoV-2-host protein interaction network reveals new biology and drug candidates: focus on the spike surface glycoprotein and RNA polymerase.	Expert Opin Drug Discov
33769683	SARS-CoV-2 biology and variants: anticipation of viral evolution and what needs to be done.	Environ Microbiol
33769552	"Dual inhibition of CB1 receptors and iNOS, as a potential novel approach to the pharmacological management of acute and long COVID-19."	Br J Pharmacol
33769313	The microbiome in atopic patients and potential modifications in the context of the severe acute respiratory syndrome coronavirus 2 pandemic.	Curr Opin Allergy Clin Immunol
33769311	IgV somatic mutation of human anti-SARS-CoV-2 monoclonal antibodies governs neutralization and breadth of reactivity.	JCI Insight
33769223	SUMO: a novel target for anti-coronavirus therapy.	Pathog Glob Health
33769143	"Chlorogenic acid, a natural product as potential inhibitor of COVID-19: virtual screening experiment based on network pharmacology and molecular docking."	Nat Prod Res
33768964	The evolutionary dynamics of endemic human coronaviruses.	Virus Evol
33768439	"The Renin-Angiotensin System, Hypertension, and SARS-CoV-2 Infection: a Review."	Curr Hypertens Rep
33768214	Possible Therapeutic Use of Natural Compounds Against COVID-19.	J Cell Signal
33768104	"Clinical, Serological, Whole Genome Sequence Analyses to Confirm SARS-CoV-2 Reinfection in Patients From Mumbai, India."	Front Med (Lausanne)
33768100	D-Limonene Is a Potential Monoterpene to Inhibit PI3K/Akt/IKK-alpha/NF-kappaB p65 Signaling Pathway in Coronavirus Disease 2019 Pulmonary Fibrosis.	Front Med (Lausanne)
33767730	Structural and Drug Screening Analysis of the Non-structural Proteins of Severe Acute Respiratory Syndrome Coronavirus 2 Virus Extracted From Indian Coronavirus Disease 2019 Patients.	Front Genet
33767706	The Case for S2: The Potential Benefits of the S2 Subunit of the SARS-CoV-2 Spike Protein as an Immunogen in Fighting the COVID-19 Pandemic.	Front Immunol
33767689	Polymeric Pathogen-Like Particles-Based Combination Adjuvants Elicit Potent Mucosal T Cell Immunity to Influenza A Virus.	Front Immunol
33767634	Do Cellular Entry Mechanisms of SARS-Cov-2 Affect Myocardial Cells and Contribute to Cardiac Injury in COVID-19 Patients?	Front Physiol
33767626	Anti-IL5 Drugs in COVID-19 Patients: Role of Eosinophils in SARS-CoV-2-Induced Immunopathology.	Front Pharmacol
33767623	The Anti-inflammatory Effect of the Tricyclic Antidepressant Clomipramine and Its High Penetration in the Brain Might Be Useful to Prevent the Psychiatric Consequences of SARS-CoV-2 Infection.	Front Pharmacol
33767619	Plant Products as Inhibitors of Coronavirus 3CL Protease.	Front Pharmacol
33767597	Evaluation and characterization of HSPA5 (GRP78) expression profiles in normal individuals and cancer patients with COVID-19.	Int J Biol Sci
33767445	Bispecific IgG neutralizes SARS-CoV-2 variants and prevents escape in mice.	Nature
33767405	SARS-CoV-2 infection of the oral cavity and saliva.	Nat Med
33767306	In silico investigation of critical binding pattern in SARS-CoV-2 spike protein with angiotensin-converting enzyme 2.	Sci Rep
33767200	The effect of SARS-CoV-2 D614G mutation on BNT162b2 vaccine-elicited neutralization.	NPJ Vaccines
33767183	SARS-CoV-2 infection rewires host cell metabolism and is potentially susceptible to mTORC1 inhibition.	Nat Commun
33767156	Immune memory in convalescent patients with asymptomatic or mild COVID-19.	Cell Discov
33767094	Emerging infectious encephalitides.	Curr Opin Neurol
33767060	Pathogenesis of coronavirus disease 2019-associated kidney injury.	Curr Opin Nephrol Hypertens
33766944	mRNA vaccination boosts cross-variant neutralizing antibodies elicited by SARS-CoV-2 infection.	Science
33766902	Genome Sequences of Three SARS-CoV-2 P.1 Strains Identified from Patients Returning from Brazil to Italy.	Microbiol Resour Announc
33766897	Near-Complete Genome Sequence of a SARS-CoV-2 VOC 202012/01 Strain in Peru.	Microbiol Resour Announc
33766889	Generation of SARS-CoV-2 reporter replicon for high-throughput antiviral screening and testing.	Proc Natl Acad Sci U S A
33766727	"Fibrinolysis Shutdown in COVID-19: Clinical Manifestations, Molecular Mechanisms, and Therapeutic Implications."	J Am Coll Surg
33766711	SARS-CoV-2 variants lacking ORF8 occurred in farmed mink and pangolin.	Gene
33766591	A review on the interaction of nucleoside analogues with SARS-CoV-2 RNA dependent RNA polymerase.	Int J Biol Macromol
33766136	Functional analysis of SARS-CoV-2 proteins in Drosophila identifies Orf6-induced pathogenic effects with Selinexor as an effective treatment.	Cell Biosci
33766124	"Characterization of SARS-CoV-2 proteins reveals Orf6 pathogenicity, subcellular localization, host interactions and attenuation by Selinexor."	Cell Biosci
33766078	"Association of the host genetic factors, hypercholesterolemia and diabetes with mild influenza in an Iranian population."	Virol J
33765919	Vaccinomic approach for novel multi epitopes vaccine against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2).	BMC Immunol
33765614	The potential for Lactoferrin to reduce SARS-CoV-2 induced cytokine storm.	Int Immunopharmacol
33765612	ACE2 correlates with immune infiltrates in colon adenocarcinoma: Implication for COVID-19.	Int Immunopharmacol
33765611	"The contributory role of lymphocyte subsets, pathophysiology of lymphopenia and its implication as prognostic and therapeutic opportunity in COVID-19."	Int Immunopharmacol
33765610	An overview of some potential immunotherapeutic options against COVID-19.	Int Immunopharmacol
33765436	Longitudinal profiling of respiratory and systemic immune responses reveals myeloid cell-driven lung inflammation in severe COVID-19.	Immunity
33765435	Multi-cohort analysis of host immune response identifies conserved protective and detrimental modules associated with severity across viruses.	Immunity
33765414	Sarbecovirus ORF6 proteins hamper induction of interferon signaling.	Cell Rep
33765290	Nervous System Involvement in COVID-19: a Review of the Current Knowledge.	Mol Neurobiol
33765239	"In silico evaluation of potential inhibitory activity of remdesivir, favipiravir, ribavirin and galidesivir active forms on SARS-CoV-2 RNA polymerase."	Mol Divers
33764897	Application of chitosan as a natural disinfectant against porcine epidemic diarrhoea virus.	Acta Vet Hung
33764894	High-dose ACEi might be harmful in COVID-19 patients with serious respiratory distress syndrome by leading to excessive bradykinin receptor activation.	Physiol Int
33764553	Dissemination and evolution of SARS-CoV-2 in the early pandemic phase in South America.	J Med Virol
33764543	Fetal and placental infection with SARS-CoV-2 in early pregnancy.	J Med Virol
33764269	"Isatin-based virtual high throughput screening, molecular docking, DFT, QM/MM, MD and MM-PBSA study of novel inhibitors of SARS-CoV-2 main protease."	J Biomol Struct Dyn
33763936	Review of studies of severe acute respiratory syndrome related coronavirus-2 pathogenesis in human organoid models.	Rev Med Virol
33763494	Hydroxychloroquine Effects on TLR Signalling: Underexposed but Unneglectable in COVID-19.	J Immunol Res
33763088	Germline Genetic Variants of Viral Entry and Innate Immunity May Influence Susceptibility to SARS-CoV-2 Infection: Toward a Polygenic Risk Score for Risk Stratification.	Front Immunol
33763080	Predicting Lyme Disease From Patients' Peripheral Blood Mononuclear Cells Profiled With RNA-Sequencing.	Front Immunol
33763078	The Characterization of Disease Severity Associated IgG Subclasses Response in COVID-19 Patients.	Front Immunol
33763052	Epidemiological Study of Betacoronaviruses in Captive Malayan Pangolins.	Front Microbiol
33762960	Aripiprazole as a Candidate Treatment of COVID-19 Identified Through Genomic Analysis.	Front Pharmacol
33762942	Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on Angiotensin-Converting Enzyme 2 Levels: A Comprehensive Analysis Based on Animal Studies.	Front Pharmacol
33762895	Revealing the mechanism of SARS-CoV-2 spike protein binding with ACE2.	Comput Sci Eng
33762883	Inhalable nanovaccine with biomimetic coronavirus structure to trigger mucosal immunity of respiratory tract against COVID-19.	Chem Eng J
33762818	Potential Anti-Coronavirus Agents and the Pharmacologic Mechanisms.	Drug Des Devel Ther
33762651	Abnormal upregulation of cardiovascular disease biomarker PLA2G7 induced by proinflammatory macrophages in COVID-19 patients.	Sci Rep
33762619	Mining of high throughput screening database reveals AP-1 and autophagy pathways as potential targets for COVID-19 therapeutics.	Sci Rep
33762578	Inhibition of HECT E3 ligases as potential therapy for COVID-19.	Cell Death Dis
33761605	Heme oxygenase-1 inducer hemin does not inhibit SARS-CoV-2 virus infection.	Biomed Pharmacother
33761394	Evaluation of kinetics and thermodynamics of interaction between immobilized SARS-CoV-2 nucleoprotein and specific antibodies by total internal reflection ellipsometry.	J Colloid Interface Sci
33761326	N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2.	Cell
33761319	"Linear epitope landscape of the SARS-CoV-2 Spike protein constructed from 1,051 COVID-19 patients."	Cell Rep
33761041	COVID-19 and myocarditis: a systematic review and overview of current challenges.	Heart Fail Rev
33761008	Diverse SARS-CoV-2 variants preceded the initial COVID-19 outbreak in Croatia.	Arch Virol
33760889	Comparative analysis reveals the species-specific genetic determinants of ACE2 required for SARS-CoV-2 entry.	PLoS Pathog
33760825	Influence of obesity on serum levels of SARS-CoV-2-specific antibodies in COVID-19 patients.	PLoS One
33760807	SARS-CoV-2 variants reveal features critical for replication in primary human cells.	PLoS Biol
33760611	Unveiling the Molecular Structure of Antimalarial Drugs Chloroquine and Hydroxychloroquine in Solution through Analysis of (1)H NMR Chemical Shifts.	J Phys Chem B
33760416	[Obesity and COVID-19 : Mechanisms involved in the collusion of two pandemics].	Rev Med Suisse
33760404	[COVID-19 AND AUTOIMMUNE DISEASES].	Harefuah
33760271	Study on the mechanism of active components of Liupao tea on 3CL(pro) based on HPLC-DAD fingerprint and molecular docking technique.	J Food Biochem
33760045	Membraneless organelles restructured and built by pandemic viruses: HIV-1 and SARS-CoV-2.	J Mol Cell Biol
33759703	A computational study on active constituents of Habb-ul-aas and Tabasheer as inhibitors of SARS-CoV-2 main protease.	J Biomol Struct Dyn
33759690	In silico screening of therapeutic potentials from Strychnos nux-vomica against the dimeric main protease (M(pro)) structure of SARS-CoV-2.	J Biomol Struct Dyn
33759631	Interleukin-6 Antagonists: Lessons From Cytokine Release Syndrome to the Therapeutic Application in Severe COVID-19 Infection.	J Pharm Pract
33759572	Implications of preexisting asthma on COVID-19 pathogenesis.	Am J Physiol Lung Cell Mol Physiol
33759544	Predictive association of ABCB1 C3435T genetic polymorphism with the efficacy or safety of lopinavir and ritonavir in COVID-19 patients.	Pharmacogenomics
33759345	Risk stratification by long non-coding RNAs profiling in COVID-19 patients.	J Cell Mol Med
33759279	"Plant-derived chemicals as potential inhibitors of SARS-CoV-2 main protease (6LU7), a virtual screening study."	Phytother Res
33759236	Melatonin multifaceted pharmacological actions on melatonin receptors converging to abrogate COVID-19.	J Pineal Res
33759207	Monoclonal antibodies capable of binding SARS-CoV-2 spike protein receptor-binding motif specifically prevent GM-CSF induction.	J Leukoc Biol
33758785	Pan-India novel coronavirus SARS-CoV-2 genomics and global diversity analysis in spike protein.	Heliyon
33758772	A molecular docking study of SARS-CoV-2 main protease against phytochemicals of Boerhavia diffusa Linn. for novel COVID-19 drug discovery.	Virusdisease
33758716	Renin-Angiotensin-Aldosterone System Blockers Prior to Hospitalization and Their Association With Clinical Outcomes in Coronavirus Disease 2019 (COVID-19).	Cureus
33758649	Structural determinants driving the binding process between PDZ domain of wild type human PALS1 protein and SLiM sequences of SARS-CoV E proteins.	Comput Struct Biotechnol J
33758621	Impact of chemotherapy on lymphocytes and serological memory in recovered COVID-19 patients with acute leukemia.	J Cancer
33758593	Engineering a self-navigated MnARK nanovaccine for inducing potent protective immunity against novel coronavirus.	Nano Today
33758570	Structure insights of SARS-CoV-2 open state envelope protein and inhibiting through active phytochemical of ayurvedic medicinal plants from Withania somnifera.	Saudi J Biol Sci
33758527	"Coronil, a Tri-Herbal Formulation, Attenuates Spike-Protein-Mediated SARS-CoV-2 Viral Entry into Human Alveolar Epithelial Cells and Pro-Inflammatory Cytokines Production by Inhibiting Spike Protein-ACE-2 Interaction."	J Inflamm Res
33758289	Long-term evolution of the epithelial cell secretome in preclinical 3D models of the human bronchial epithelium.	Sci Rep
33758205	Emergence of novel SARS-CoV-2 variants in the Netherlands.	Sci Rep
33758164	The lncRNA Snhg1-Vps13D vesicle trafficking system promotes memory CD8 T cell establishment via regulating the dual effects of IL-7 signaling.	Signal Transduct Target Ther
33758081	"Molecular Basis for Bordetella pertussis Interference with Complement, Coagulation, Fibrinolytic, and Contact Activation Systems: the Cryo-EM Structure of the Vag8-C1 Inhibitor Complex."	mBio
33758071	Pulmonary vascular proliferation in patients with severe COVID-19: an autopsy study.	Thorax
33758061	Essential requirement for JPT2 in NAADP-evoked Ca(2+) signaling.	Sci Signal
33757938	The SARS-CoV-2 receptor and other key components of the Renin-Angiotensin-Aldosterone System related to COVID-19 are expressed in enterocytes in larval zebrafish.	Biol Open
33757684	Interferon system deficiencies exacerbating severe pandemic virus infections.	Trends Microbiol
33757449	"Human cell-dependent, directional, time-dependent changes in the mono- and oligonucleotide compositions of SARS-CoV-2 genomes."	BMC Microbiol
33757410	Immune dysregulation and system pathology in COVID-19.	Virulence
33757336	COVID-19: Antiviral agents and enzyme inhibitors/receptor blockers in development.	Exp Biol Med (Maywood)
33757279	"Identification and characterization of circRNAs encoded by MERS-CoV, SARS-CoV-1 and SARS-CoV-2."	Brief Bioinform
33757133	Famotidine Repurposing for Novel Corona Virus Disease of 2019: A Systematic Review.	Drug Res (Stuttg)
33756485	Local Angiotensin-Converting Enzyme 2 Gene Expression in Kidney Allografts Is Not Affected by Renin-Angiotensin-Aldosterone Inhibitors.	Kidney Blood Press Res
33756482	Pathophysiological Implication of Vitamin D in Diabetic Kidney Disease.	Kidney Blood Press Res
33756342	A tissue- and gender-specific regulation of the SARS-CoV-2 receptor ACE2 by p53 in pigs.	Biochem Biophys Res Commun
33756225	Landscape of SARS-CoV-2 spike protein-interacting cells in human tissues.	Int Immunopharmacol
33756110	The antigenic anatomy of SARS-CoV-2 receptor binding domain.	Cell
33756061	Non-optimal codon usage preferences of coronaviruses determine their promiscuity for infecting multiple hosts.	FEBS J
33756051	SARS-CoV-2-specific serological and functional T cell immune responses during acute and early COVID-19 convalescence in solid organ transplant patients.	Am J Transplant
33755985	Flight hormones as therapeutic target for novel Coronavirus infectious disease.	Eur Rev Med Pharmacol Sci
33755983	Early combination treatment with existing HIV antivirals: an effective treatment for COVID-19?	Eur Rev Med Pharmacol Sci
33755980	"Gene expression analysis identifies genes associated with SARS-COV-2 receptors, ACE2 and TMPRSS2, in normal human lung tissues."	Eur Rev Med Pharmacol Sci
33755914	Backbone chemical shift spectral assignments of SARS coronavirus-2 non-structural protein nsp9.	Biomol NMR Assign
33755731	Coronavirus Occurrence in the Household Influenza Vaccine Evaluation (HIVE) Cohort of Michigan Households: Reinfection Frequency and Serologic Responses to Seasonal and Severe Acute Respiratory Syndrome Coronaviruses.	J Infect Dis
33755725	Longitudinal Analysis of Human Memory T-Cell Response According to the Severity of Illness up to 8 Months After Severe Acute Respiratory Syndrome Coronavirus 2 Infection.	J Infect Dis
33755704	Whole-genome sequencing of SARS-CoV-2 reveals the detection of G614 variant in Pakistan.	PLoS One
33755450	Direct Observation of Protonation State Modulation in SARS-CoV-2 Main Protease upon Inhibitor Binding with Neutron Crystallography.	J Med Chem
33755226	Cross-immunity and trained immunity in explaining variable COVID-19 mortality-Guidance for future pandemics.	J Med Virol
33755203	ACE2 models of frequently contacted animals provide clues of their SARS-CoV-2 S protein affinity and viral susceptibility.	J Med Virol
33755190	"Higher infectivity of the SARS-CoV-2 new variants is associated with K417N/T, E484K, and N501Y mutants: An insight from structural data."	J Cell Physiol
33754933	Targeting Fc effector function in vaccine design.	Expert Opin Ther Targets
33754931	COVID-19 infection and rheumatoid arthritis: mutual outburst cytokines and remedies.	Curr Med Res Opin
33754623	COVID-19 and male fertility: Taking stock of one year after the outbreak began.	Arch Ital Urol Androl
33754609	Effects of COVID-19 on male sex function and its potential sexual transmission.	Arch Ital Urol Androl
33754149	Human Rhinovirus Infection Blocks Severe Acute Respiratory Syndrome Coronavirus 2 Replication Within the Respiratory Epithelium: Implications for COVID-19 Epidemiology.	J Infect Dis
33754147	A single intranasal dose of chimpanzee adenovirus-vectored vaccine protects against SARS-CoV-2 infection in rhesus macaques.	Cell Rep Med
33754082	The evolutionary history of ACE2 usage within the coronavirus subgenus Sarbecovirus.	Virus Evol
33753982	2D MXenes with antiviral and immunomodulatory properties: A pilot study against SARS-CoV-2.	Nano Today
33753964	Wild Sambucus nigra L. from north-east edge of the species range: A valuable germplasm with inhibitory capacity against SARS-CoV2 S-protein RBD and hACE2 binding in vitro.	Ind Crops Prod
33753950	Binding and drug displacement study of colchicine and bovine serum albumin in presence of azithromycin using multispectroscopic techniques and molecular dynamic simulation.	J Mol Liq
33753947	[COVID-19 in children: SARS-CoV-2-related inflammatory multisystem syndrome mimicking Kawasaki disease].	Bull Acad Natl Med
33753738	SARS-CoV-2 infection induces sustained humoral immune responses in convalescent patients following symptomatic COVID-19.	Nat Commun
33753282	Cerium oxide nanoparticle delivery of microRNA-146a for local treatment of acute lung injury.	Nanomedicine
33753260	SARS-CoV-2 main protease inhibition by compounds isolated from Luffa cylindrica using molecular docking.	Bioorg Med Chem Lett
33753206	Transient plasma cell dyscrasia in COVID-19 patients linked to IL-6 triggering.	Microbes Infect
33753180	Novel indel mutation in the N gene of SARS-CoV-2 clinical samples that were diagnosed positive in a commercial RT-PCR assay.	Virus Res
33753011	Extracellular vesicles: Their emerging roles in the pathogenesis of respiratory diseases.	Respir Investig
33752798	Convalescent COVID-19 patients are susceptible to endothelial dysfunction due to persistent immune activation.	Elife
33752797	Rare variants increase the risk of severe COVID-19.	Elife
33752274	Effects of a DPP-4 Inhibitor and RAS Blockade on Clinical Outcomes of Patients with Diabetes and COVID-19.	Diabetes Metab J
33752217	Variants in ACE2 and TMPRSS2 Genes Are Not Major Determinants of COVID-19 Severity in UK Biobank Subjects.	Hum Hered
33752209	The Impact of Old and Novel Cardiovascular Risk Factors.	Blood Purif
33752085	Can ozone inactivate SARS-CoV-2? A review of mechanisms and performance on viruses.	J Hazard Mater
33751995	"Structural insights on the interaction potential of natural leads against major protein targets of SARS-CoV-2: Molecular modelling, docking and dynamic simulation studies."	Comput Biol Med
33751756	Chitin-lipid interactions and the potential relationship between Demodex and SARS-CoV-2.	Dermatol Ther
33751748	Chemo-Enzymatic Modification of the 5' Cap Maintains Translation and Increases Immunogenic Properties of mRNA.	Angew Chem Int Ed Engl
33751722	Bioinformatic analyses hinted at augmented T helper 17 cell differentiation and cytokine response as the central mechanism of COVID-19-associated Guillain-Barre syndrome.	Cell Prolif
33751699	Variable routes to genomic and host adaptation among coronaviruses.	J Evol Biol
33751396	Islet organoid as a promising model for diabetes.	Protein Cell
33751323	"Sodium-glucose co-transporter 2 inhibitors in COVID-19: meeting at the crossroads between heart, diabetes and infectious diseases."	Int J Clin Pharm
33751241	SARS-CoV-2 infection represents a high risk for the elderly: analysis of pathogenesis.	Arch Virol
33751111	Broad phenotypic alterations and potential dysfunction of lymphocytes in individuals clinically recovered from COVID-19.	J Mol Cell Biol
33750978	"A quantitative model used to compare within-host SARS-CoV-2, MERS-CoV, and SARS-CoV dynamics provides insights into the pathogenesis and treatment of SARS-CoV-2."	PLoS Biol
33750975	DNA vaccine candidate encoding SARS-CoV-2 spike proteins elicited potent humoral and Th1 cell-mediated immune responses in mice.	PLoS One
33750913	Overexpression of angiotensin-converting enzyme 2 by renin-angiotensin system inhibitors. Truth or myth? A systematic review of animal studies.	Hypertens Res
33750821	Cross-linking peptide and repurposed drugs inhibit both entry pathways of SARS-CoV-2.	Nat Commun
33750399	Modelling the association between COVID-19 transmissibility and D614G substitution in SARS-CoV-2 spike protein: using the surveillance data in California as an example.	Theor Biol Med Model
33750071	Cytokine Release Syndrome Biology and Management.	Cancer J
33750020	KnetMiner: a comprehensive approach for supporting evidence-based gene discovery and complex trait analysis across species.	Plant Biotechnol J
33750009	COVID-19: emergence and mutational diversification of SARS-CoV-2.	Microb Biotechnol
33749995	Platelets: 'multiple choice' effectors in the immune response and their implication in COVID-19 thromboinflammatory process.	Int J Lab Hematol
33749993	Integrated intra- and intercellular signaling knowledge for multicellular omics analysis.	Mol Syst Biol
33749986	Identification of mutation resistance coldspots for targeting the SARS-CoV2 main protease.	IUBMB Life
33749932	A small molecule compound berberine as an orally active therapeutic candidate against COVID-19 and SARS: A computational and mechanistic study.	FASEB J
33749902	Resolvin D1 and D2 reduce SARS-CoV-2-induced inflammatory responses in cystic fibrosis macrophages.	FASEB J
33749660	Genomic diversity of SARS-CoV-2 during early introduction into the Baltimore-Washington metropolitan area.	JCI Insight
33749564	"Investigation of structural, treatment and clinical characteristics of COVID-19 along with the challenges caused by its prevalence."	Infect Disord Drug Targets
33749559	"RNA sensors as a mechanism of innate immune evasion among SARS-CoV2, HIV and Nipah viruses."	Curr Protein Pept Sci
33749558	Herbal Medicine in Fighting Against COVID-19: New Battle with an Old Weapon.	Curr Pharm Biotechnol
33749547	"Evaluation of the effects of chlorhexidine and several flavonoids as antiviral purposes on SARS-CoV-2 main protease: molecular docking, molecular dynamics simulation studies."	J Biomol Struct Dyn
33749545	"On the search for COVID-19 therapeutics: identification of potential SARS-CoV-2 main protease inhibitors by virtual screening, pharmacophore modeling and molecular dynamics."	J Biomol Struct Dyn
33749538	Phylogenic analysis of coronavirus genome and molecular studies on potential anti-COVID-19 agents from selected FDA-approved drugs.	J Biomol Struct Dyn
33749528	Repurposing of anticancer phytochemicals for identifying potential fusion inhibitor for SARS-CoV-2 using molecular docking and molecular dynamics (MD) simulations.	J Biomol Struct Dyn
33749496	Cyanobacterial natural products as sources for antiviral drug discovery against COVID-19.	J Biomol Struct Dyn
33748924	Endothelial dysfunction in COVID-19 calls for immediate attention: the emerging roles of the endothelium in inflammation caused by SARS-CoV-2.	Front Med
33748827	Early Insights into COVID-19 in Persons Living with HIV and Cardiovascular Manifestations.	J AIDS HIV Treat
33748822	Lack of Molecular Mimicry between Nonhuman Primates and Infectious Pathogens: The Possible Genetic Bases.	Glob Med Genet
33748818	Potential of CRISPR/Cas13 System in Treatment and Diagnosis of COVID-19.	Glob Med Genet
33748788	Long-term persistence of RBD(+) memory B cells encoding neutralizing antibodies in SARS-CoV-2 infection.	Cell Rep Med
33748697	Common variants at 21q22.3 locus influence MX1 and TMPRSS2 gene expression and susceptibility to severe COVID-19.	iScience
33748696	Learning from HIV-1 to predict the immunogenicity of T cell epitopes in SARS-CoV-2.	iScience
33748632	Neutrophil Elastase and Proteinase 3 Cleavage Sites Are Adjacent to the Polybasic Sequence within the Proteolytic Sensitive Activation Loop of the SARS-CoV-2 Spike Protein.	ACS Omega
33748620	SARS-CoV-2: The Road Less Traveled-From the Respiratory Mucosa to the Brain.	ACS Omega
33748599	Investigating the Internalization and COVID-19 Antiviral Computational Analysis of Optimized Nanoscale Zinc Oxide.	ACS Omega
33748571	SARS-CoV-2 Genome from the Khyber Pakhtunkhwa Province of Pakistan.	ACS Omega
33748539	Night shift schedule alters endogenous regulation of circulating cytokines.	Neurobiol Sleep Circadian Rhythms
33748510	Evaluation of flavonoids as 2019-nCoV cell entry inhibitor through molecular docking and pharmacological analysis.	Heliyon
33748156	Angiotensin-Converting Enzyme (ACE) Inhibitors and Angiotensin Receptor Blockers (ARB) Are Protective Against ICU Admission and Mortality for Patients With COVID-19 Disease.	Front Med (Lausanne)
33748141	Targeting Endosomal Recycling Pathways by Bacterial and Viral Pathogens.	Front Cell Dev Biol
33748041	Distinct Characteristics of COVID-19 Infection in Children.	Front Pediatr
33747756	Innate and adaptive immune responses toward nanomedicines.	Acta Pharm Sin B
33747754	Computational analysis of functional monomers used in molecular imprinting for promising COVID-19 detection.	Comput Theor Chem
33747543	Genomic epidemiology of a densely sampled COVID-19 outbreak in China.	Virus Evol
33747533	Claims and reasons about mild COVID-19 in children.	New Microbes New Infect
33747512	Adaptive immunity to human coronaviruses is widespread but low in magnitude.	Clin Transl Immunology
33747508	RGD-binding integrins and TGF-beta in SARS-CoV-2 infections - novel targets to treat COVID-19 patients?	Clin Transl Immunology
33747397	Elevated P-Selectin in Severe Covid-19: Considerations for Therapeutic Options.	Mediterr J Hematol Infect Dis
33747262	"Game of ""crowning"" season 8: RAS and reproductive hormones in COVID-19 - can we end this viral series?"	Arch Med Sci
33747178	Acidic preconditioning reduces lipopolysaccharide-induced acute lung injury by upregulating the expression of angiotensin-converting enzyme 2.	Exp Ther Med
33746948	Lung Protection vs. Infection Resolution: Interleukin 10 Suspected of Double-Dealing in COVID-19.	Front Immunol
33746914	Global Geographic and Temporal Analysis of SARS-CoV-2 Haplotypes Normalized by COVID-19 Cases During the Pandemic.	Front Microbiol
33746908	Molecular Docking Reveals Ivermectin and Remdesivir as Potential Repurposed Drugs Against SARS-CoV-2.	Front Microbiol
33746897	Physiological and Immunological Causes of the Susceptibility of Chronic Inflammatory Patients to COVID-19 Infection: Focus on Diabetes.	Front Endocrinol (Lausanne)
33746739	Molecular Mechanism of Action of Repurposed Drugs and Traditional Chinese Medicine Used for the Treatment of Patients Infected With COVID-19: A Systematic Scoping Review.	Front Pharmacol
33746667	Coronavirus (SARS-CoV-2) in gastroenterology and its current epidemiological situation: An updated review until January 2021.	EXCLI J
33746666	A review on function and side effects of systemic corticosteroids used in high-grade COVID-19 to prevent cytokine storms.	EXCLI J
33746660	In-Silico Drug Designing of Spike Receptor with Its ACE2 Receptor and Nsp10/Nsp16 MTase Complex Against SARS-CoV-2.	Int J Pept Res Ther
33746604	A network pharmacology based approach for predicting active ingredients and potential mechanism of Lianhuaqingwen capsule in treating COVID-19.	Int J Med Sci
33746581	Systematic elucidation of the mechanism of Jingyin granule in the treatment of Novel Coronavirus (COVID-19) Pneumonia via Network Pharmacology.	Int J Med Sci
33746567	One-step vapor deposition of fluorinated polycationic coating to fabricate antifouling and anti-infective textile against drug-resistant bacteria and viruses.	Chem Eng J
33746538	A comprehensive insight into the role of zinc deficiency in the renin-angiotensin and kinin-kallikrein system dysfunctions in COVID-19 patients.	Saudi J Biol Sci
33746457	Modulation of neutrophil (dys)function by Ayurvedic herbs and its potential influence on SARS-CoV-2 infection.	J Ayurveda Integr Med
33746377	"Silent Hypoxemia Leads to Vicious Cycle of Infection, Coagulopathy and Cytokine Storm in COVID-19: Can Prophylactic Oxygen Therapy Prevent It?"	Indian J Clin Biochem
33746318	"Structural investigations, quantum mechanical studies on proton and metal affinity and biological activity predictions of selpercatinib."	J Mol Liq
33746069	"In silico Nigellidine (N. sativa) bind to viral spike/active-sites of ACE1/2, AT1/2 to prevent COVID-19 induced vaso-tumult/vascular-damage/comorbidity."	Vascul Pharmacol
33746068	A possible role for ST2 as prognostic biomarker for COVID-19.	Vascul Pharmacol
33745980	Improved multidetector asymmetrical-flow field-flow fractionation method for particle sizing and concentration measurements of lipid-based nanocarriers for RNA delivery.	Eur J Pharm Biopharm
33745778	Rapid and reliable hybridoma screening method that is suitable for production of functional structure-recognizing monoclonal antibody.	J Biosci Bioeng
33745440	Harnessing the natural pool of polyketide and non-ribosomal peptide family: A route map towards novel drug development.	Curr Mol Pharmacol
33745431	ACE2 as a key target for treatment of COVID-19 related cardiovascular diseases: current progress and prospect.	Curr Drug Targets
33745423	"Ethnobotany, Pharmacological activities and Bioavailability studies of ""King of Bitter"" (Kalmegh): A Review (2010-2020)."	Comb Chem High Throughput Screen
33745336	Nexus between COVID-19 and periodontal disease.	J Int Med Res
33745077	Status of mannose-binding lectin (MBL) and complement system in COVID-19 patients and therapeutic applications of antiviral plant MBLs.	Mol Cell Biochem
33744846	"TMBIM6, a potential virus target protein identified by integrated multiomics data analysis in SARS-CoV-2-infected host cells."	Aging (Albany NY)
33744490	Coronavirus entry: how we arrived at SARS-CoV-2.	Curr Opin Virol
33744314	SARS-CoV-2 Fusion Peptide has a Greater Membrane Perturbating Effect than SARS-CoV with Highly Specific Dependence on Ca(2).	J Mol Biol
33744048	Assessment of SARS-CoV-2 specific CD4(+) and CD8 (+) T cell responses using MHC class I and II tetramers.	Vaccine
33743891	Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera.	Cell
33743803	Indels in SARS-CoV-2 occur at template-switching hotspots.	BioData Min
33743213	Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity.	Cell
33743212	COVID-19 and the human innate immune system.	Cell
33743211	Discovery and functional interrogation of SARS-CoV-2 RNA-host protein interactions.	Cell
33742451	"Emerging roles of extracellular vesicles in COVID-19, a double-edged sword?"	Immunology
33742096	Functional profiling of COVID-19 respiratory tract microbiomes.	Sci Rep
33742062	Identification of macrophage activation-related biomarkers in obese type 2 diabetes that may be indicative of enhanced respiratory risk in COVID-19.	Sci Rep
33741993	Ad26.COV2.S protects Syrian hamsters against G614 spike variant SARS-CoV-2 and does not enhance respiratory disease.	NPJ Vaccines
33741992	Human endogenous retrovirus-enveloped baculoviral DNA vaccines against MERS-CoV and SARS-CoV2.	NPJ Vaccines
33741972	Exposure to SARS-CoV-2 generates T-cell memory in the absence of a detectable viral infection.	Nat Commun
33741941	Alpha-1 antitrypsin inhibits TMPRSS2 protease activity and SARS-CoV-2 infection.	Nat Commun
33741894	Umbilical cord blood-derived microglia-like cells to model COVID-19 exposure.	Transl Psychiatry
33741691	Melatonin may decrease risk for and aid treatment of COVID-19 and other RNA viral infections.	Open Heart
33741630	Filling in the Gaps in Metformin Biodegradation: a New Enzyme and a Metabolic Pathway for Guanylurea.	Appl Environ Microbiol
33741598	"Single-component, self-assembling, protein nanoparticles presenting the receptor binding domain and stabilized spike as SARS-CoV-2 vaccine candidates."	Sci Adv
33741335	"Sequence Analysis of 20,453 Severe Acute Respiratory Syndrome Coronavirus 2 Genomes from the Houston Metropolitan Area Identifies the Emergence and Widespread Distribution of Multiple Isolates of All Major Variants of Concern."	Am J Pathol
33741318	Level up for culture models - How 3D cell culture models benefit SARS-CoV-2 research.	Biomed J
33740855	"Acute infections, venous thrombosis, and recommended thromboprophylaxis."	Vnitr Lek
33740562	Which species does the virus like most: Binding modes study between SARS-CoV-2 S protein and ACE2 receptor.	J Mol Graph Model
33740455	Antivirals with common targets against highly pathogenic viruses.	Cell
33740387	Lung Epithelial Cell Transcriptional Regulation as a Factor in COVID-19-associated Coagulopathies.	Am J Respir Cell Mol Biol
33740320	Annulate lamellae and intracellular pathogens.	Cell Microbiol
33740184	Possible role of purinergic signaling in COVID-19.	Mol Cell Biochem
33740028	SARS-CoV-2 outbreak in a tri-national urban area is dominated by a B.1 lineage variant linked to a mass gathering event.	PLoS Pathog
33739565	Calcium activity in response to nAChR ligands in murine bone marrow granulocytes with different Gr-1 expression.	Cell Biol Int
33739364	Lasting memories of SARS-CoV-2 infection.	J Exp Med
33739215	Vitamin D and immuno-pathology of COVID-19: many interactions but uncertain therapeutic benefits.	Expert Rev Anti Infect Ther
33739142	SARS-CoV-2 as an inflammatory cardiovascular disease: current knowledge and future challenges.	Future Cardiol
33738989	Mutations in spike protein and allele variations in ACE2 impact targeted therapy strategies against SARS-CoV-2.	Zool Res
33738806	Complement cascade in severe forms of COVID-19: Recent advances in therapy.	Eur J Immunol
33738432	SARS-CoV-2 infection aggravates chronic comorbidities of cardiovascular diseases and diabetes in mice.	Animal Model Exp Med
33738305	Increased blood angiotensin converting enzyme 2 activity in critically ill COVID-19 patients.	ERJ Open Res
33738273	"Anti-Infective, Anti-Inflammatory, and Immunomodulatory Properties of Breast Milk Factors for the Protection of Infants in the Pandemic From COVID-19."	Front Public Health
33738124	SARS-CoV-2 genomic analyses in cancer patients reveal elevated intrahost genetic diversity.	Virus Evol
33738063	Design and Structure-Activity Relationship of a Potent Furin Inhibitor Derived from Influenza Hemagglutinin.	ACS Med Chem Lett
33738043	Angiotensin-converting enzyme 2 connects COVID-19 with cancer and cancer immunotherapy.	World J Gastrointest Oncol
33737994	What Do Influenza and COVID-19 Represent for Patients With Inflammatory Bowel Disease?	Gastroenterology Res
33737961	The Renin-Angiotensin-Aldosterone System and Coronavirus Disease 2019.	Eur Cardiol
33737894	Neuropsychiatric and Cognitive Sequelae of COVID-19.	Front Psychol
33737867	Microglia Fighting for Neurological and Mental Health: On the Central Nervous System Frontline of COVID-19 Pandemic.	Front Cell Neurosci
33737851	Smoking Enigma in Coronavirus Disease 2019: A Tug of War between Predisposition and Possible Way Out.	Tob Use Insights
33737819	Investigation of One Familial Cluster of COVID-19 in Taiwan: Differentiation of Genetic Variation Among Isolates and Implications for Epidemiological Investigation and Surveillance by Genomic Assay.	Infect Drug Resist
33737804	Withanone from Withania somnifera Attenuates SARS-CoV-2 RBD and Host ACE2 Interactions to Rescue Spike Protein Induced Pathologies in Humanized Zebrafish Model.	Drug Des Devel Ther
33737694	Metabolomics analysis reveals a modified amino acid metabolism that correlates with altered oxygen homeostasis in COVID-19 patients.	Sci Rep
33737684	"Proteomic blood profiling in mild, severe and critical COVID-19 patients."	Sci Rep
33737545	Computational evidence for nitro derivatives of quinoline and quinoline N-oxide as low-cost alternative for the treatment of SARS-CoV-2 infection.	Sci Rep
33737523	Prioritizing antiviral drugs against SARS-CoV-2 by integrating viral complete genome sequences and drug chemical structures.	Sci Rep
33737495	SARS-CoV-2 genomics: An Indian perspective on sequencing viral variants.	J Biosci
33737447	Perfect Match Genomic Landscape strategy: Refinement and customization of reference genomes.	Proc Natl Acad Sci U S A
33737349	First Report of a SARS-CoV-2 Genome Sequence with a Spike His69-Val70 Deletion and an Asn439Lys Mutation in Morocco.	Microbiol Resour Announc
33737214	Structural and molecular perspectives of SARS-CoV-2.	Methods
33737154	Global and local mutations in Bangladeshi SARS-CoV-2 genomes.	Virus Res
33737129	Genomic surveillance of SARS-CoV-2 in the Republic of Congo.	Int J Infect Dis
33737124	Epidemiological transcriptomic data supports BCG protection in viral diseases including COVID-19.	Gene
33736953	Phytochemicals against SARS-CoV as potential drug leads.	Biomed J
33736695	Mesenchymal stem/stromal cells as a valuable source for the treatment of immune-mediated disorders.	Stem Cell Res Ther
33735881	SARS-CoV-2 Lineages and Sub-Lineages Circulating Worldwide: A Dynamic Overview.	Chemotherapy
33735872	Analysis of Three Mutations in Italian Strains of SARS-CoV-2: Implications for Pathogenesis.	Chemotherapy
33735608	SARS-CoV-2 501Y.V2 variants lack higher infectivity but do have immune escape.	Cell
33735607	B cell-specific XIST complex enforces X-inactivation and restrains atypical B cells.	Cell
33735271	A comprehensive SARS-CoV-2 genomic analysis identifies potential targets for drug repurposing.	PLoS One
33735262	The association of COVID-19 occurrence and severity with the use of angiotensin converting enzyme inhibitors or angiotensin-II receptor blockers in patients with hypertension.	PLoS One
33735102	Haematopoietic ageing through the lens of single-cell technologies.	Dis Model Mech
33734961	Profile of specific antibodies to the SARS-CoV-2.	J Med Microbiol
33734704	Macrolides May Prevent Severe Acute Respiratory Syndrome Coronavirus 2 Entry into Cells: A Quantitative Structure Activity Relationship Study and Experimental Validation.	J Chem Inf Model
33734675	Membrane Nanoparticles Derived from ACE2-Rich Cells Block SARS-CoV-2 Infection.	ACS Nano
33734656	Infections in Endocrinology: Viruses	Endotext
33734600	Back to basics in COVID-19: Antigens and antibodies-Completing the puzzle.	J Cell Mol Med
33734074	[Vaccination immunology in SARS-CoV-2].	Ugeskr Laeger
33734021	Antiretroviral drug activity and potential for pre-exposure prophylaxis against COVID-19 and HIV infection.	J Biomol Struct Dyn
33734013	Cross-reactive antibody against human coronavirus OC43 spike protein correlates with disease severity in COVID-19 patients: a retrospective study.	Emerg Microbes Infect
33733740	Computational Mutagenesis at the SARS-CoV-2 Spike Protein/Angiotensin-Converting Enzyme 2 Binding Interface: Comparison with Experimental Evidence.	ACS Nano
33733422	"COVID-19: pathogenesis, advances in treatment and vaccine development and environmental impact-an updated review."	Environ Sci Pollut Res Int
33733315	COVID-19 and the clinical course of rheumatic manifestations.	Clin Rheumatol
33733058	Sialylation of host proteins as targetable risk factor for COVID-19 susceptibility and spreading: A hypothesis.	FASEB Bioadv
33732940	"Discovery of Clioquinol and analogues as novel inhibitors of Severe Acute Respiratory Syndrome Coronavirus 2 infection, ACE2 and ACE2 - Spike protein interaction in vitro."	Heliyon
33732720	Interleukin-18 in Inflammatory Kidney Disease.	Front Med (Lausanne)
33732682	Evaluation of Annona muricata Acetogenins as Potential Anti-SARS-CoV-2 Agents Through Computational Approaches.	Front Chem
33732659	Exogenous Coronavirus Interacts With Endogenous Retrotransposon in Human Cells.	Front Cell Infect Microbiol
33732462	Conflicts over calcium and the treatment of COVID-19.	Evol Med Public Health
33732459	Antibodies to neutralising epitopes synergistically block the interaction of the receptor-binding domain of SARS-CoV-2 to ACE 2.	Clin Transl Immunology
33732334	Kidney involvement in coronavirus-associated diseases (Review).	Exp Ther Med
33732293	Anti-infection mechanism of phosphodiesterase-5 inhibitors and their roles in coronavirus disease 2019 (Review).	Exp Ther Med
33732292	Immunoregulatory therapy strategies that target cytokine storms in patients with COVID-19 (Review).	Exp Ther Med
33732261	Association of HLA Class I Genotypes With Severity of Coronavirus Disease-19.	Front Immunol
33732258	A Novel DNA Vaccine Against SARS-CoV-2 Encoding a Chimeric Protein of Its Receptor-Binding Domain (RBD) Fused to the Amino-Terminal Region of Hepatitis B Virus preS1 With a W4P Mutation.	Front Immunol
33732254	"Phenotype, Susceptibility, Autoimmunity, and Immunotherapy Between Kawasaki Disease and Coronavirus Disease-19 Associated Multisystem Inflammatory Syndrome in Children."	Front Immunol
33732251	SARS-CoV-2 Causes a Different Cytokine Response Compared to Other Cytokine Storm-Causing Respiratory Viruses in Severely Ill Patients.	Front Immunol
33732102	The Epidemiological and Mechanistic Understanding of the Neurological Manifestations of COVID-19: A Comprehensive Meta-Analysis and a Network Medicine Observation.	Front Neurosci
33732045	Nano-formulation of herbo-mineral alternative medicine from linga chenduram and evaluation of antiviral efficacy.	Saudi J Biol Sci
33732005	"Integrated Bioinformatic Analysis of SARS-CoV-2 Infection Related Genes ACE2, BSG and TMPRSS2 in Aerodigestive Cancers."	J Inflamm Res
33731853	Structural basis for bivalent binding and inhibition of SARS-CoV-2 infection by human potent neutralizing antibodies.	Cell Res
33731724	A conserved immunogenic and vulnerable site on the coronavirus spike protein delineated by cross-reactive monoclonal antibodies.	Nat Commun
33731300	Genetic modification to design a stable yeast-expressed recombinant SARS-CoV-2 receptor binding domain as a COVID-19 vaccine candidate.	Biochim Biophys Acta Gen Subj
33731271	Intranasal administration of a recombinant RBD vaccine induced protective immunity against SARS-CoV-2 in mouse.	Vaccine
33731252	Physiological implications of COVID-19 in reproduction: angiotensin-converting enzyme 2 a key player.	Reprod Fertil Dev
33730680	A theoretical study on the effects of interdomain flexibility on drug encounter rate for coronavirus nucleocapsid-type proteins.	Biophys Chem
33730676	COVID-19 enters the expanding network of apolipoprotein E4-related pathologies.	Redox Biol
33730597	Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera.	Cell
33730580	Virological and immunological features of SARS-CoV-2-infected children who develop neutralizing antibodies.	Cell Rep
33730572	Translational adaptation of human viruses to the tissues they infect.	Cell Rep
33730355	COVID-19 pandemic: what about the gonads?	Hormones (Athens)
33730325	"(1)H, (13)C and (15)N Backbone chemical shift assignments of the n-terminal and central intrinsically disordered domains of SARS-CoV-2 nucleoprotein."	Biomol NMR Assign
33730053	SARS-CoV-2 viral dynamics in non-human primates.	PLoS Comput Biol
33730024	"Single-cell longitudinal analysis of SARS-CoV-2 infection in human airway epithelium identifies target cells, alterations in gene expression, and cell state changes."	PLoS Biol
33730022	Immuno-informatics design of a multimeric epitope peptide based vaccine targeting SARS-CoV-2 spike glycoprotein.	PLoS One
33730017	Structural analysis of viral ExoN domains reveals polyphyletic hijacking events.	PLoS One
33730015	Gene variants of coagulation related proteins that interact with SARS-CoV-2.	PLoS Comput Biol
33729819	Could boron-containing compounds (BCCs) be effective against SARS-CoV-2 as anti-viral agent?	Bratisl Lek Listy
33729741	SARS-CoV-2-specific Cell-mediated Immunity in Kidney Transplant Recipients Recovered From COVID-19.	Transplantation
33729394	"Immunity, virus evolution, and effectiveness of SARS-CoV-2 vaccines."	Braz J Med Biol Res
33729332	MASPs at the crossroad between the complement and the coagulation cascades - the case for COVID-19.	Genet Mol Biol
33729154	Genomic and healthcare dynamics of nosocomial SARS-CoV-2 transmission.	Elife
33728925	CCR5Delta32 deletion as a protective factor in Czech first-wave COVID-19 subjects.	Physiol Res
33728702	Adoptive transfer of ex vivo expanded SARS-CoV-2-specific cytotoxic lymphocytes: A viable strategy for COVID-19 immunosuppressed patients?	Transpl Infect Dis
33728680	Enhanced binding of the N501Y-mutated SARS-CoV-2 spike protein to the human ACE2 receptor: insights from molecular dynamics simulations.	FEBS Lett
33728416	VERSO: A comprehensive framework for the inference of robust phylogenies and the quantification of intra-host genomic diversity of viral samples.	Patterns (N Y)
33728353	A review on the phytochemical and pharmacological properties of Hyptis suaveolens (L.) Poit.	Futur J Pharm Sci
33728324	Immunoinformatics and Molecular Docking Studies Predicted Potential Multiepitope-Based Peptide Vaccine and Novel Compounds against Novel SARS-CoV-2 through Virtual Screening.	Biomed Res Int
33728295	Regulation of the expression of proinflammatory cytokines induced by SARS-CoV-2.	World J Clin Cases
33728277	Cellular and Humoral Immune Responses in Covid-19 and Immunotherapeutic Approaches.	Immunotargets Ther
33728141	Renin-Angiotensin-Aldosterone System Inhibitors and COVID-19: A Meta-Analysis and Systematic Review.	Cureus
33728103	Single Cell Transcriptomic Re-analysis of Immune Cells in Bronchoalveolar Lavage Fluids Reveals the Correlation of B Cell Characteristics and Disease Severity of Patients with SARS-CoV-2 Infection.	Immune Netw
33728101	Structure of SARS-CoV-2 Spike Glycoprotein for Therapeutic and Preventive Target.	Immune Netw
33728096	SARS-CoV-2 Infection of Airway Epithelial Cells.	Immune Netw
33728095	SARS-CoV-2-Specific T Cell Responses in Patients with COVID-19 and Unexposed Individuals.	Immune Netw
33728094	Understanding the Host Innate Immune Responses against SARS-CoV-2 Infection and COVID-19 Pathogenesis.	Immune Netw
33728049	Characteristics of T-cell responses in COVID-19 patients with prolonged SARS-CoV-2 positivity - a cohort study.	Clin Transl Immunology
33727943	Phytochemicals of Rhus spp. as Potential Inhibitors of the SARS-CoV-2 Main Protease: Molecular Docking and Drug-Likeness Study.	Evid Based Complement Alternat Med
33727782	In silico identification of compounds from Nigella sativa seed oil as potential inhibitors of SARS-CoV-2 targets.	Bull Natl Res Cent
33727770	Interaction between hepatitis B virus and SARS-CoV-2 infections.	World J Gastroenterol
33727703	Clofazimine broadly inhibits coronaviruses including SARS-CoV-2.	Nature
33727702	ISG15-dependent activation of the sensor MDA5 is antagonized by the SARS-CoV-2 papain-like protease to evade host innate immunity.	Nat Microbiol
33727674	Genomic investigation of the coronavirus disease-2019 outbreak in the Republic of Korea.	Sci Rep
33727631	Metabolic dysfunction and immunometabolism in COVID-19 pathophysiology and therapeutics.	Int J Obes (Lond)
33727353	Critical ACE2 Determinants of SARS-CoV-2 and Group 2B Coronavirus Infection and Replication.	mBio
33727347	Mechanism of Viral Glycoprotein Targeting by Membrane-Associated RING-CH Proteins.	mBio
33727331	Deletion of the SARS-CoV-2 Spike Cytoplasmic Tail Increases Infectivity in Pseudovirus Neutralization Assays.	J Virol
33727330	The furin-S2' site in avian coronavirus plays a key role in central nervous system damage progression.	J Virol
33727252	Structural impact on SARS-CoV-2 spike protein by D614G substitution.	Science
33727249	Phylo-geo-network and haplogroup analysis of 611 novel coronavirus (SARS-CoV-2) genomes from India.	Life Sci Alliance
33727169	"Mutations in SARS-CoV-2; Consequences in structure, function, and pathogenicity of the virus."	Microb Pathog
33727051	Development of multi-epitope peptide-based vaccines against SARS-CoV-2.	Biomed J
33727050	A brief review on potential application of mesenchymal stem cell and secretome in combating mortality and morbidity in COVID-19 patients.	Biomed J
33726831	Exploration and validation of related hub gene expression during SARS-CoV-2 infection of human bronchial organoids.	Hum Genomics
33726557	A review: Mechanism of action of antiviral drugs.	Int J Immunopathol Pharmacol
33726544	"COVID-19 hospitalization rates rise exponentially with age, inversely proportional to thymic T-cell production."	J R Soc Interface
33725751	Circular RNA-MicroRNA-MRNA interaction predictions in SARS-CoV-2 infection.	J Integr Bioinform
33725700	Covid-19 Interstitial Pneumonia: Histological and Immunohistochemical Features on Cryobiopsies.	Respiration
33725211	Serologic Cross-Reactivity of SARS-CoV-2 with Endemic and Seasonal Betacoronaviruses.	J Clin Immunol
33725111	Whole genome analysis of more than 10 000 SARS-CoV-2 virus unveils global genetic diversity and target region of NSP6.	Brief Bioinform
33725065	Genetic and structural analyses of ssRNA viruses pave the way for the discovery of novel antiviral pharmacological targets.	Mol Omics
33725024	Variability in digestive and respiratory tract Ace2 expression is associated with the microbiome.	PLoS One
33724953	A sobering addition to the literature on COVID-19 and the brain.	J Clin Invest
33724837	Systemic Perturbations in Amine and Kynurenine Metabolism Associated with Acute SARS-CoV-2 Infection and Inflammatory Cytokine Responses.	J Proteome Res
33724631	Neutralising antibody escape of SARS-CoV-2 spike protein: Risk assessment for antibody-based Covid-19 therapeutics and vaccines.	Rev Med Virol
33724604	"Interindividual immunogenic variants: Susceptibility to coronavirus, respiratory syncytial virus and influenza virus."	Rev Med Virol
33724490	What can cerebrospinal fluid testing and brain autopsies tell us about viral neuroinvasion of SARS-CoV-2.	J Med Virol
33724185	Seroconversion stages COVID19 into distinct pathophysiological states.	Elife
33724070	Development of a High-Throughput Screening Assay to Identify Inhibitors of the SARS-CoV-2 Guanine-N7-Methyltransferase Using RapidFire Mass Spectrometry.	SLAS Discov
33723711	"Cancer vs. SARS-CoV-2 induced inflammation, overlapping functions, and pharmacological targeting."	Inflammopharmacology
33723631	Transmission of SARS-CoV-2 in northern Ghana: insights from whole-genome sequencing.	Arch Virol
33723531	Biomaterial-based immunoengineering to fight COVID-19 and infectious diseases.	Matter
33723528	Th1 skewed immune response of whole virion inactivated SARS CoV 2 vaccine and its safety evaluation.	iScience
33723527	ORF8 contributes to cytokine storm during SARS-CoV-2 infection by activating IL-17 pathway.	iScience
33723524	Virus-inspired surface-nanoengineered antimicrobial liposome: A potential system to simultaneously achieve high activity and selectivity.	Bioact Mater
33723522	ACE2: At the crossroad of COVID-19 and lung cancer.	Gene Rep
33723519	Potency of Mesenchymal Stem Cell and Its Secretome in Treating COVID-19.	Regen Eng Transl Med
33723515	"Computational approach to decipher cellular interactors and drug targets during co-infection of SARS-CoV-2, Dengue, and Chikungunya virus."	Virusdisease
33723514	In vitro characterization of engineered red blood cells as viral traps against HIV-1 and SARS-CoV-2.	Mol Ther Methods Clin Dev
33723501	"Repurposing CFDA-approved drug carrimycin as an antiviral agent against human coronaviruses, including the currently pandemic SARS-CoV-2."	Acta Pharm Sin B
33723416	The first 12 months of COVID-19: a timeline of immunological insights.	Nat Rev Immunol
33723294	SARS-CoV-2-induced humoral immunity through B cell epitope analysis in COVID-19 infected individuals.	Sci Rep
33723270	The serotonin reuptake inhibitor Fluoxetine inhibits SARS-CoV-2 in human lung tissue.	Sci Rep
33723254	SARS-CoV-2 hijacks folate and one-carbon metabolism for viral replication.	Nat Commun
33723251	Plasma IL-6 levels following corticosteroid therapy as an indicator of ICU length of stay in critically ill COVID-19 patients.	Cell Death Discov
33723226	Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2.	Cell Discov
33723219	Unique and complementary suppression of cGAS-STING and RNA sensing- triggered innate immune responses by SARS-CoV-2 proteins.	Signal Transduct Target Ther
33723208	COVID-19 patient transcriptomic and genomic profiling reveals comorbidity interactions with psychiatric disorders.	Transl Psychiatry
33723017	SARS-CoV-2 infection of human iPSC-derived cardiac cells reflects cytopathic features in hearts of patients with COVID-19.	Sci Transl Med
33723016	T cell and antibody kinetics delineate SARS-CoV-2 peptides mediating long-term immune responses in COVID-19 convalescent individuals.	Sci Transl Med
33722935	Subgenomic RNA identification in SARS-CoV-2 genomic sequencing data.	Genome Res
33722770	Low Doses of Radiation Increase the Immunosuppressive Profile of Lung Macrophages During Viral Infection and Pneumonia.	Int J Radiat Oncol Biol Phys
33722710	Resveratrol-mediated attenuation of superantigen-driven acute respiratory distress syndrome is mediated by microbiota in the lungs and gut.	Pharmacol Res
33722593	COVID-19 and IL-6: Why vitamin D (probably) helps but tocilizumab might not.	Eur J Pharmacol
33722535	Dipeptidyl peptidase 4 inhibitors: Applications in innate immunity?	Biochem Pharmacol
33722288	SARS-CoV-2 vaccine ChAdOx1 nCoV-19 infection of human cell lines reveals low levels of viral backbone gene transcription alongside very high levels of SARS-CoV-2 S glycoprotein gene transcription.	Genome Med
33722197	Renin-angiotensin system inhibitors and susceptibility to COVID-19 in patients with hypertension: a propensity score-matched cohort study in primary care.	BMC Infect Dis
33721918	Novel perspectives for SARS-CoV-2 genome browsing.	J Integr Bioinform
33721888	alpha1-Antitrypsin: Key Player or Bystander in Acute Respiratory Distress Syndrome?	Anesthesiology
33721758	"SARS-CoV-2: Insight in genome structure, pathogenesis and viral receptor binding analysis - An updated review."	Int Immunopharmacol
33721736	Deep learning model for virtual screening of novel 3C-like protease enzyme inhibitors against SARS coronavirus diseases.	Comput Biol Med
33721722	Wide-range direct detection of 25-hydroxyvitamin D3 using polyethylene-glycol-free gold nanorod based on LSPR aptasensor.	Biosens Bioelectron
33721239	COVID-19 and the ethnicity link - is there a photochemical link?	Photochem Photobiol Sci
33721144	Longitudinal multi-omics transition associated with fatality in critically ill COVID-19 patients.	Intensive Care Med Exp
33721136	HCl-induced acute lung injury: a study of the curative role of mesenchymal stem/stromal cells and cobalt protoporphyrin.	J Genet Eng Biotechnol
33720905	A majority of uninfected adults show preexisting antibody reactivity against SARS-CoV-2.	JCI Insight
33720900	Is the Frontal Lobe the Primary Target of SARS-CoV-2?	J Alzheimers Dis
33720635	"[BCG, muramylpeptides, trained immunity (part II): a low molecular weight alternative to multicomponent bacterial immunostimulants for prevention of respiratory infections during a pandemic]."	Ter Arkh
33720613	[The role of vitamin D in seasonal acute respiratory viral infections and COVID-19].	Ter Arkh
33720594	"[BCG, muramylpeptides, trained immunity (part I): linkages in the light of the COVID-19 pandemic]."	Ter Arkh
33720009	Genetic association and causal inference converge on hyperglycaemia as a modifiable factor to improve lung function.	Elife
33719855	Potentiality of Moringa oleifera against SARS-CoV-2: identified by a rational computer aided drug design method.	J Biomol Struct Dyn
33719829	COVID-19 and human reproduction: A pandemic that packs a serious punch.	Syst Biol Reprod Med
33719350	A Negative Feedback Model to Explain Regulation of SARS-CoV-2 Replication and Transcription.	Front Genet
33719190	Identification of the absorbed ingredients and metabolites in rats after an intravenous administration of Tanreqing injection using high-performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry.	J Sep Sci
33719175	The impact of obesity on immune response to infection: Plausible mechanisms and outcomes.	Obes Rev
33718934	Membrane remodeling by SARS-CoV-2 - double-enveloped viral replication.	Fac Rev
33718878	Genetic Characteristics and Phylogeny of 969-bp S Gene Sequence of SARS-CoV-2 from Hawai'i Reveals the Worldwide Emerging P681H Mutation.	Hawaii J Health Soc Welf
33718825	"SARS-CoV-2, SARS-CoV-1, and HIV-1 derived ssRNA sequences activate the NLRP3 inflammasome in human macrophages through a non-classical pathway."	iScience
33718777	Biosensing surfaces and therapeutic biomaterials for the central nervous system in COVID-19.	Emergent Mater
33718452	Single-Cell Transcriptome Analysis Decipher New Potential Regulation Mechanism of ACE2 and NPs Signaling Among Heart Failure Patients Infected With SARS-CoV-2.	Front Cardiovasc Med
33718448	Endothelial Cells in Emerging Viral Infections.	Front Cardiovasc Med
33718434	Drug Repurposing Strategy (DRS): Emerging Approach to Identify Potential Therapeutics for Treatment of Novel Coronavirus Infection.	Front Mol Biosci
33718360	"SARS-CoV-2-Specific Memory T Lymphocytes From COVID-19 Convalescent Donors: Identification, Biobanking, and Large-Scale Production for Adoptive Cell Therapy."	Front Cell Dev Biol
33718270	T-Helper Cell Subset Response Is a Determining Factor in COVID-19 Progression.	Front Cell Infect Microbiol
33718121	Complimenting the Complement: Mechanistic Insights and Opportunities for Therapeutics in Hepatocellular Carcinoma.	Front Oncol
33717596	Coagulation disorders and thromboembolic disease in COVID-19: review of current evidence in search of a better approach.	J Thorac Dis
33717195	COVID-19 Impairs Immune Response to Candida albicans.	Front Immunol
33717193	Two Different Antibody-Dependent Enhancement (ADE) Risks for SARS-CoV-2 Antibodies.	Front Immunol
33717181	Microbiota Modulation of the Gut-Lung Axis in COVID-19.	Front Immunol
33717172	CXCL17 Is a Specific Diagnostic Biomarker for Severe Pandemic Influenza A(H1N1) That Predicts Poor Clinical Outcome.	Front Immunol
33717168	Specialized Pro-Resolving Mediators as Potential Regulators of Inflammatory Macrophage Responses in COVID-19.	Front Immunol
33717166	"A Comprehensive Review of Viral Characteristics, Transmission, Pathophysiology, Immune Response, and Management of SARS-CoV-2 and COVID-19 as a Basis for Controlling the Pandemic."	Front Immunol
33717140	Epigenetic Landscapes of Single-Cell Chromatin Accessibility and Transcriptomic Immune Profiles of T Cells in COVID-19 Patients.	Front Immunol
33717077	A Proteome-Wide Immunoinformatics Tool to Accelerate T-Cell Epitope Discovery and Vaccine Design in the Context of Emerging Infectious Diseases: An Ethnicity-Oriented Approach.	Front Immunol
33717074	"In Nasal Mucosal Secretions, Distinct IFN and IgA Responses Are Found in Severe and Mild SARS-CoV-2 Infection."	Front Immunol
33716989	Vitamin D Association With Macrophage-Derived Cytokines in Polycystic Ovary Syndrome: An Enhanced Risk of COVID-19 Infection?	Front Endocrinol (Lausanne)
33716771	Metabolic Alterations in SARS-CoV-2 Infection and Its Implication in Kidney Dysfunction.	Front Physiol
33716752	Discovering Potential RNA Dependent RNA Polymerase Inhibitors as Prospective Drugs Against COVID-19: An in silico Approach.	Front Pharmacol
33716745	The Potential Therapeutic Effect of RNA Interference and Natural Products on COVID-19: A Review of the Coronaviruses Infection.	Front Pharmacol
33716737	"In silico Analyses of Immune System Protein Interactome Network, Single-Cell RNA Sequencing of Human Tissues, and Artificial Neural Networks Reveal Potential Therapeutic Targets for Drug Repurposing Against COVID-19."	Front Pharmacol
33716601	[Role of genetic factors in pneumonia and COVID-19].	Pneumologe (Berl)
33716413	Clinical Characteristics of Paediatric Hyperinflammatory Syndrome in the Era of Corona Virus Disease 2019 (COVID-19).	Indian J Clin Biochem
33716308	Inhibition of interferon-stimulated gene 15 and lysine 48-linked ubiquitin binding to the SARS-CoV-2 papain-like protease by small molecules: In silico studies.	Chem Phys Lett
33716307	"Biological perspective of thiazolide derivatives against Mpro and MTase of SARS-CoV-2: Molecular docking, DFT and MD simulation investigations."	Chem Phys Lett
33716059	Implications of microscale lung damage for COVID-19 pulmonary ventilation dynamics: A narrative review.	Life Sci
33716040	The SARS-CoV-2 Y453F mink variant displays a pronounced increase in ACE-2 affinity but does not challenge antibody neutralization.	J Biol Chem
33715598	A rational design of a multi-epitope vaccine against SARS-CoV-2 which accounts for the glycan shield of the spike glycoprotein.	J Biomol Struct Dyn
33715595	"Black tea bioactives as inhibitors of multiple targets of SARS-CoV-2 (3CLpro, PLpro and RdRp): a virtual screening and molecular dynamic simulation study."	J Biomol Struct Dyn
33715592	"In silico drug designing for COVID-19: an approach of high-throughput virtual screening, molecular, and essential dynamics simulations."	J Biomol Struct Dyn
33715108	Neurological Manifestation of SARS-CoV-2 Induced Inflammation and Possible Therapeutic Strategies Against COVID-19.	Mol Neurobiol
33715015	High dimensional profiling identifies specific immune types along the recovery trajectories of critically ill COVID19 patients.	Cell Mol Life Sci
33715009	Interleukin-6: From arthritis to CAR-T cell therapy and COVID-19.	Int Immunol
33714947	Age cohorts stratified according to age-distributions of COVID-19 morbidity statistics identify uniquely age-dependent CD3(+)CD8(+) T-cell lymphocytopenia in COVID-19 patients without comorbidities on admission.	Aging (Albany NY)
33714753	Development of a SARS-CoV-2 nucleocapsid specific monoclonal antibody.	Virology
33714688	Predicting and Preventing Immune Checkpoint Inhibitor Toxicity: Targeting Cytokines.	Trends Immunol
33714595	"Pernio (Chilblains), SARS-CoV-2, and COVID Toes Unified Through Cutaneous and Systemic Mechanisms."	Mayo Clin Proc
33714279	A hypothesis: Bitter taste receptors as a therapeutic target for the clinical symptoms of SARS-CoV-2.	Pharmazie
33714258	Insight into the emerging role of SARS-CoV-2 nonstructural and accessory proteins in modulation of multiple mechanisms of host innate defense.	Bosn J Basic Med Sci
33714028	Shared genetic etiology between idiopathic pulmonary fibrosis and COVID-19 severity.	EBioMedicine
33713994	Chemodynamic features of nanoparticles: Application to understanding the dynamic life cycle of SARS-CoV-2 in aerosols and aqueous biointerfacial zones.	Adv Colloid Interface Sci
33713961	COVID-19: Why does disease severity vary among individuals?	Respir Med
33713819	The potential significance of high avidity immunoglobulin G (IgG) for protective immunity towards SARS-CoV-2.	Int J Infect Dis
33713816	Coinfection of tuberculosis and COVID-19 limits the ability to in vitro respond to SARS-CoV-2.	Int J Infect Dis
33713772	Structural leitmotif and functional variations of the structural catalytic core in (chymo)trypsin-like serine/cysteine fold proteinases.	Int J Biol Macromol
33713753	"Ivermectin also inhibits the replication of bovine respiratory viruses (BRSV, BPIV-3, BoHV-1, BCoV and BVDV) in vitro."	Virus Res
33713730	Combined in silico and in vitro approaches identified the antipsychotic drug lurasidone and the antiviral drug elbasvir as SARS-CoV2 and HCoV-OC43 inhibitors.	Antiviral Res
33713699	Impaired regulatory T cell control of astroglial overdrive and microglial pruning in schizophrenia.	Neurosci Biobehav Rev
33713620	Soluble ACE2-mediated cell entry of SARS-CoV-2 via interaction with proteins related to the renin-angiotensin system.	Cell
33713619	Time-resolved systems immunology reveals a late juncture linked to fatal COVID-19.	Cell
33713597	The SARS-CoV-2 subgenome landscape and its novel regulatory features.	Mol Cell
33713594	The effect of spike mutations on SARS-CoV-2 neutralization.	Cell Rep
33713492	Drug repositioning to target NSP15 protein on SARS-CoV-2 as possible COVID-19 treatment.	J Comput Chem
33713114	The Missing Expression Level-Evolutionary Rate Anticorrelation in Viruses Does Not Support Protein Function as a Main Constraint on Sequence Evolution.	Genome Biol Evol
33713098	[Anti-inflammatory effects of amantadine and memantine in SARS-CoV-2 infection].	Pol Merkur Lekarski
33712622	Integrated cytokine and metabolite analysis reveals immunometabolic reprogramming in COVID-19 patients with therapeutic implications.	Nat Commun
33712587	"Shotgun transcriptome, spatial omics, and isothermal profiling of SARS-CoV-2 infection reveals unique host responses, viral diversification, and drug interactions."	Nat Commun
33712574	Evidences for lipid involvement in SARS-CoV-2 cytopathogenesis.	Cell Death Dis
33712270	Inpatient Omission of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers Is Associated With Morbidity and Mortality in Coronavirus Disease 2019.	Clin Ther
33712145	Heparan sulfates from bat and human lung and their binding to the spike protein of SARS-CoV-2 virus.	Carbohydr Polym
33712035	Does reactivation of cytomegalovirus contribute to severe COVID-19 disease?	Immun Ageing
33711981	Repurposing novel therapeutic candidate drugs for coronavirus disease-19 based on protein-protein interaction network analysis.	BMC Biotechnol
33711743	Evaluation of potential anti-RNA-dependent RNA polymerase (RdRP) drugs against the newly emerged model of COVID-19 RdRP using computational methods.	Biophys Chem
33711707	The influence of IFITM3 polymorphisms on susceptibility to SARS-CoV-2 infection and severity of COVID-19.	Cytokine
33711560	SARS_CoV2 RBD gene transcription cannot be driven by CMV promoter.	Virology
33711547	Reservoir hosts prediction for COVID-19 by hybrid transfer learning model.	J Biomed Inform
33711361	Mesenchymal stem cells: Biological characteristics and application in disease therapy.	Biochimie
33711336	Emetine suppresses SARS-CoV-2 replication by inhibiting interaction of viral mRNA with eIF4E.	Antiviral Res
33711090	Covalent and non-covalent binding free energy calculations for peptidomimetic inhibitors of SARS-CoV-2 main protease.	Phys Chem Chem Phys
33711082	A novel cell culture system modeling the SARS-CoV-2 life cycle.	PLoS Pathog
33711012	Natural selection in the evolution of SARS-CoV-2 in bats created a generalist virus and highly capable human pathogen.	PLoS Biol
33710758	In the eye of the storm: SARS-CoV-2 infection and replication at the ocular surface?	Stem Cells Transl Med
33710663	COVID-19: Risk Factors Associated with Infectivity and Severity.	Scand J Immunol
33710662	Evidence for CAT gene being functionally involved in the susceptibility of COVID-19.	FASEB J
33710599	ARB-Based Combination Therapy for the Clinical Management of Hypertension and Hypertension-Related Comorbidities: A Spotlight on Their Use in COVID-19 Patients.	High Blood Press Cardiovasc Prev
33710597	Neurological manifestations of COVID-19: with emphasis on Iranian patients.	J Neurovirol
33710424	Neurological and psychiatric presentations associated with COVID-19.	Eur Arch Psychiatry Clin Neurosci
33709981	RNA therapeutics for cardiovascular disease.	Curr Opin Cardiol
33709963	Pattern of genomic variation in SARS-CoV-2 (COVID-19) suggests restricted nonrandom changes: Analysis using Shewhart control charts.	J Biosci
33709675	Therapeutic strategies in patients with coagulopathy and disseminated intravascular coagulation: awareness of the phase-dependent characteristics.	Minerva Med
33709491	Synthetic Homogeneous Glycoforms of the SARS-CoV-2 Spike Receptor-Binding Domain Reveals Different Binding Profiles of Monoclonal Antibodies.	Angew Chem Int Ed Engl
33709461	The envelope protein of SARS-CoV-2 increases intra-Golgi pH and forms a cation channel that is regulated by pH.	J Physiol
33709119	PreDTIs: prediction of drug-target interactions based on multiple feature information using gradient boosting framework with data balancing and feature selection techniques.	Brief Bioinform
33708724	Selected Micronutrients: An Option to Boost Immunity against COVID-19 and Prevent Adverse Pregnancy Outcomes in Pregnant Women: A Narrative Review.	Iran J Public Health
33708444	Suxamethonium-Induced Hyperkalemia: A Short Review of Causes and Recommendations for Clinical Applications.	Crit Care Res Pract
33708401	Crystallographic models of SARS-CoV-2 3CL(pro): in-depth assessment of structure quality and validation.	IUCrJ
33708124	Targeting Neurological Manifestations of Coronaviruses by Candidate Phytochemicals: A Mechanistic Approach.	Front Pharmacol
33708112	Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2.	Front Pharmacol
33708109	Calming the Storm: Natural Immunosuppressants as Adjuvants to Target the Cytokine Storm in COVID-19.	Front Pharmacol
33707958	Renal Involvement in COVID-19: A Review of the Literature.	Infect Drug Resist
33707780	Fibroblastic reticular cell lineage convergence in Peyer's patches governs intestinal immunity.	Nat Immunol
33707532	Preclinical efficacy and safety analysis of gamma-irradiated inactivated SARS-CoV-2 vaccine candidates.	Sci Rep
33707526	Pan-cancer analysis of RNA expression of ANGIOTENSIN-I-CONVERTING ENZYME 2 reveals high variability and possible impact on COVID-19 clinical outcomes.	Sci Rep
33707453	Bat and pangolin coronavirus spike glycoprotein structures provide insights into SARS-CoV-2 evolution.	Nat Commun
33707427	SARS-CoV-2 neutralizing human recombinant antibodies selected from pre-pandemic healthy donors binding at RBD-ACE2 interface.	Nat Commun
33707409	Effect of Calcineurin Inhibitors and Mammalian Target of Rapamycin Inhibitors on the Course of COVID-19 in Kidney Transplant Recipients.	Ann Transplant
33707363	Contributions of human ACE2 and TMPRSS2 in determining host-pathogen interaction of COVID-19.	J Genet
33707329	Coding-Complete Genome Sequences and Mutation Profiles of Nine SARS-CoV-2 Strains Detected from COVID-19 Patients in Bangladesh.	Microbiol Resour Announc
33707325	Coding-Complete Genome Sequence and Phylogenetic Relatedness of a SARS-CoV-2 Strain Detected in March 2020 in Cameroon.	Microbiol Resour Announc
33707314	Interrogation of the cellular immunome of cancer patients with regard to the COVID-19 pandemic.	J Immunother Cancer
33706759	Upregulation of ACE2 and TMPRSS2 by particulate matter and idiopathic pulmonary fibrosis: a potential role in severe COVID-19.	Part Fibre Toxicol
33706683	"Potential inhibitors of angiotensin converting enzyme 2 receptor of COVID-19 by Corchorus olitorius Linn using docking, molecular dynamics, conceptual DFT investigation and pharmacophore mapping."	J Biomol Struct Dyn
33706626	Compounds of plants with activity against SARS-CoV-2 targets.	Expert Rev Clin Pharmacol
33706521	Effect of ambient temperature on respiratory tract cells exposed to SARS-CoV-2 viral mimicking nanospheres-An experimental study.	Biointerphases
33706364	Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies.	Nature
33706207	Characterization of neutralizing versus binding antibodies and memory B cells in COVID-19 recovered individuals from India.	Virology
33706157	SARS-CoV-2 S1 NanoBiT: A nanoluciferase complementation-based biosensor to rapidly probe SARS-CoV-2 receptor recognition.	Biosens Bioelectron
33706082	"Coronavirus disease-19: The multi-level, multi-faceted vasculopathy."	Atherosclerosis
33706067	Why blood group A individuals are at risk whereas blood group O individuals are protected from SARS-CoV-2 (COVID-19) infection: A hypothesis regarding how the virus invades the human body via ABO(H) blood group-determining carbohydrates.	Immunobiology
33705994	A hijack mechanism of Indian SARS-CoV-2 isolates for relapsing contemporary antiviral therapeutics.	Comput Biol Med
33705988	Loss of sarcomeric proteins via upregulation of JAK/STAT signaling underlies interferon-gamma-induced contractile deficit in engineered human myocardium.	Acta Biomater
33705799	Clinical and molecular aspects of veterinary coronaviruses.	Virus Res
33705760	Exploring dynamics and network analysis of spike glycoprotein of SARS-COV-2.	Biophys J
33705729	SARS-CoV-2 variant B.1.1.7 is susceptible to neutralizing antibodies elicited by ancestral spike vaccines.	Cell Host Microbe
33705721	Bacillus Calmette-Guerin Vaccine and Nonspecific Immunity.	Am J Med Sci
33705704	Virus vaccines: proteins prefer prolines.	Cell Host Microbe
33705702	The great escape? SARS-CoV-2 variants evading neutralizing responses.	Cell Host Microbe
33705636	Current community transmission and future perspectives on the COVID-19 process	Turk J Med Sci
33705595	New targets for drug design: importance of nsp14/nsp10 complex formation for the 3'-5' exoribonucleolytic activity on SARS-CoV-2.	FEBS J
33705542	Human cardiosphere-derived stromal cells exposed to SARS-CoV-2 evolve into hyper-inflammatory/pro-fibrotic phenotype and produce infective viral particles depending on the levels of ACE2 receptor expression.	Cardiovasc Res
33705440	Effect of renin-angiotensin-aldosterone system inhibitors on Covid-19 patients in Korea.	PLoS One
33705359	HLA class I-associated expansion of TRBV11-2 T cells in multisystem inflammatory syndrome in children.	J Clin Invest
33705292	COVID-19 and Oxidative Stress.	Biochemistry (Mosc)
33704866	Gap junction-mediated cell-cell interaction between transplanted mesenchymal stem cells and vascular endothelium in stroke.	Stem Cells
33704818	Immunoinformatic analysis of structural and epitope variations in the spike and Orf8 proteins of SARS-CoV-2/B.1.1.7.	J Med Virol
33704348	An analysis of chronic kidney disease as a prognostic factor in pediatric cases of COVID-19.	J Bras Nefrol
33704069	"The Global Landscape of SARS-CoV-2 Genomes, Variants, and Haplotypes in 2019nCoVR."	Genomics Proteomics Bioinformatics
33704068	Longitudinal proteomic profiling of dialysis patients with COVID-19 reveals markers of severity and predictors of death.	Elife
33704002	Role of ACE2 genetic polymorphisms in susceptibility to SARS-CoV-2 among highly exposed but non infected healthcare workers.	Emerg Microbes Infect
33703938	COVID-19: The Heart of the Matter-Pathological Changes and a Proposed Mechanism.	J Cardiovasc Pharmacol Ther
33694125	Colonic Epithelial Angiotensin-Converting Enzyme 2 (ACE2) Expression in Blacks and Whites: Potential Implications for Pathogenesis Covid-19 Racial Disparities.	J Racial Ethn Health Disparities
33693976	Targeted LC-MS/MS platform for the comprehensive determination of peptides in the kallikrein-kinin system.	Anal Bioanal Chem
33693814	De novo 3D models of SARS-CoV-2 RNA elements from consensus experimental secondary structures.	Nucleic Acids Res
33693749	Sex differences in the evolution of neutralizing antibodies to SARS-CoV-2.	J Infect Dis
33693723	What makes (hydroxy)chloroquine ineffective against COVID-19: insights from cell biology.	J Mol Cell Biol
33693506	COVID-19: disease pathways and gene expression changes predict methylprednisolone can improve outcome in severe cases.	Bioinformatics
33693066	Structural analogues of existing anti-viral drugs inhibit SARS-CoV-2 RNA dependent RNA polymerase: A computational hierarchical investigation.	Heliyon
33693030	Circulating Exosomes Are Strongly Involved in SARS-CoV-2 Infection.	Front Mol Biosci
33693014	Understanding COVID-19 in Wuhan From the Perspective of Cold-Dampness: Clinical Evidences and Mechanisms.	Front Med (Lausanne)
33692973	SARS-CoV-2 and the Gastrointestinal Tract in Children.	Front Pediatr
33692906	Unification and extensive diversification of M/Orf3-related ion channel proteins in coronaviruses and other nidoviruses.	Virus Evol
33692801	The Outcome of Critically Ill COVID-19 Patients Is Linked to Thromboinflammation Dominated by the Kallikrein/Kinin System.	Front Immunol
33692788	Reduced Expression of Autophagy Markers and Expansion of Myeloid-Derived Suppressor Cells Correlate With Poor T Cell Response in Severe COVID-19 Patients.	Front Immunol
33692712	Sickness and the Social Brain: Love in the Time of COVID.	Front Psychiatry
33692701	Controversial Roles of the Renin Angiotensin System and Its Modulators During the COVID-19 Pandemic.	Front Physiol
33692695	Drug Repurposing and Polypharmacology to Fight SARS-CoV-2 Through Inhibition of the Main Protease.	Front Pharmacol
33692650	Towards better understanding of the heparin role in NETosis: feasibility of using native mass spectrometry to monitor interactions of neutrophil elastase with heparin oligomers.	Int J Mass Spectrom
33692570	COVID-19 and liver disease: mechanistic and clinical perspectives.	Nat Rev Gastroenterol Hepatol
33692457	Neutralization of SARS-CoV-2 with IgG from COVID-19-convalescent plasma.	Sci Rep
33692390	Antibody isotype diversity against SARS-CoV-2 is associated with differential serum neutralization capacities.	Sci Rep
33692386	Blockade of SARS-CoV-2 spike protein-mediated cell-cell fusion using COVID-19 convalescent plasma.	Sci Rep
33692377	Drug design and repurposing with DockThor-VS web server focusing on SARS-CoV-2 therapeutic targets and their non-synonym variants.	Sci Rep
33692215	"Cryo-EM structure of S-Trimer, a subunit vaccine candidate for COVID-19."	J Virol
33692211	SARS-CoV-2 rapidly adapts in aged BALB/c mice and induces typical pneumonia.	J Virol
33692203	Susceptibility of white-tailed deer (Odocoileus virginianus) to SARS-CoV-2.	J Virol
33692201	Coronavirus-Specific Antibody Cross Reactivity in Rhesus Macaques Following SARS-CoV-2 Vaccination and Infection.	J Virol
33692194	Original Antigenic Sin: the Downside of Immunological Memory and Implications for COVID-19.	mSphere
33692097	Inflammatory profiles across the spectrum of disease reveal a distinct role for GM-CSF in severe COVID-19.	Sci Immunol
33691601	The preclinical inhibitor GS441524 in combination with GC376 efficaciously inhibited the proliferation of SARS-CoV-2 in the mouse respiratory tract.	Emerg Microbes Infect
33691446	The pharmacological mechanism of Huashi Baidu Formula for the treatment of COVID-19 by combined network pharmacology and molecular docking.	Ann Palliat Med
33691249	Fluoxetine as an anti-inflammatory therapy in SARS-CoV-2 infection.	Biomed Pharmacother
33691247	Temporal dynamics of the host molecular responses underlying severe COVID-19 progression and disease resolution.	EBioMedicine
33691216	"Insights into SARS-CoV-2 evolution, potential antivirals, and vaccines."	Virology
33691172	Contribution of STAT3 to the pathogenesis of COVID-19.	Microb Pathog
33691157	Selenium (Se) plays a key role in the biological effects of some viruses: Implications for COVID-19.	Environ Res
33691146	The Organoid Platform: Promises and Challenges as Tools in the Fight against COVID-19.	Stem Cell Reports
33691144	Single-cell RNA sequencing reveals the sustained immune cell dysfunction in the pathogenesis of sepsis secondary to bacterial pneumonia.	Genomics
33691139	Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection.	Cell
33691138	A trans-complementation system for SARS-CoV-2 recapitulates authentic viral replication without virulence.	Cell
33691089	Metabolic programs define dysfunctional immune responses in severe COVID-19 patients.	Cell Rep
33691013	Protein sequence models for prediction and comparative analysis of the SARS-CoV-2 -human interactome.	Pac Symp Biocomput
33691012	Feasibility of the vaccine development for SARS-CoV-2 and other viruses using the shell disorder analysis.	Pac Symp Biocomput
33691011	SARS-CoV-2 Drug Discovery based on Intrinsically Disordered Regions.	Pac Symp Biocomput
33690985	Hemagglutinin Functionalized Liposomal Vaccines Enhance Germinal Center and Follicular Helper T Cell Immunity.	Adv Healthc Mater
33690265	Detection of a SARS-CoV-2 variant of concern in South Africa.	Nature
33690207	A straightforward molecular strategy to retrospectively investigate the spread of SARS-CoV-2 VOC202012/01 B.1.1.7 variant.	J Infect Dev Ctries
33689873	Application of niclosamide and analogs as small molecule inhibitors of Zika virus and SARS-CoV-2 infection.	Bioorg Med Chem Lett
33689803	Neutrophil Extracellular Traps in Inflammatory Bowel Disease: Pathogenic Mechanisms and Clinical Translation.	Cell Mol Gastroenterol Hepatol
33689516	"Molecular mechanisms of Na,K-ATPase dysregulation driving alveolar epithelial barrier failure in severe COVID-19."	Am J Physiol Lung Cell Mol Physiol
33689451	Ribavirin shows antiviral activity against SARS-CoV-2 and downregulates the activity of TMPRSS2 and the expression of ACE2 in vitro.	Can J Physiol Pharmacol
33689397	Plant Metabolites as Antiviral Preparations Against Coronaviruses.	J Med Food
33689357	Theoretical Analysis Reveals the Cost and Benefit of Proofreading in Coronavirus Genome Replication.	J Phys Chem Lett
33689337	"Structure, Dynamics, Receptor Binding, and Antibody Binding of the Fully Glycosylated Full-Length SARS-CoV-2 Spike Protein in a Viral Membrane."	J Chem Theory Comput
33689074	Thermovaccination: Thermoheliox as an Immune Response Stimulant. Kinetics of Antibodies and C-Reactive Protein Synthesis in Coronaviral Infection.	Dokl Biochem Biophys
33689070	Novel Negative Sense Genes in the RNA Genome of Coronaviruses.	Dokl Biochem Biophys
33688867	1'-Ribose cyano substitution allows Remdesivir to effectively inhibit nucleotide addition and proofreading during SARS-CoV-2 viral RNA replication.	Phys Chem Chem Phys
33688631	Urine proteome of COVID-19 patients.	Urine (Amst)
33688586	"In silico analysis of altered expression of long non-coding RNA in SARS-CoV-2 infected cells and their possible regulation by STAT1, STAT3 and interferon regulatory factors."	Heliyon
33688584	The study of antiviral drugs targeting SARS-CoV-2 nucleocapsid and spike proteins through large-scale compound repurposing.	Heliyon
33688459	Immune Responses to SARS-CoV-2 in Solid Organ Transplant Recipients.	Curr Transplant Rep
33688456	Mapping COVID-19 with nuclear imaging: from infection to functional sequelae.	Am J Nucl Med Mol Imaging
33688448	Potential therapeutic and pharmacological strategies for SARS-CoV2.	J Pharm Investig
33688409	Cardiovascular Manifestations of COVID-19.	Heart Views
33688191	New Acaciin-Loaded Self-Assembled Nanofibers as M(Pro) Inhibitors Against BCV as a Surrogate Model for SARS-CoV-2.	Int J Nanomedicine
33688079	Identification of human immune cell subtypes most responsive to IL-1beta-induced inflammatory signaling using mass cytometry.	Sci Signal
33688063	SARS-CoV-2 within-host diversity and transmission.	Science
33688035	One or two injections of MVA-vectored vaccine shields hACE2 transgenic mice from SARS-CoV-2 upper and lower respiratory tract infection.	Proc Natl Acad Sci U S A
33688034	A safe and highly efficacious measles virus-based vaccine expressing SARS-CoV-2 stabilized prefusion spike.	Proc Natl Acad Sci U S A
33687995	Therapeutic Targeting of the Complement System: From Rare Diseases to Pandemics.	Pharmacol Rev
33687893	Exploring Spike Protein as Potential Target of Novel Coronavirus and to Inhibit the Viability utilizing Natural Agents.	Curr Drug Targets
33687881	"The situation of small molecules targeting key proteins to combat SARS-CoV-2: Synthesis, metabolic pathway, mechanism of action, and potential therapeutic applications."	Mini Rev Med Chem
33687847	CoronaPep: An Anti-Coronavirus Peptide Generation Tool.	IEEE/ACM Trans Comput Biol Bioinform
33687511	Phage Display Technique as a Tool for Diagnosis and Antibody Selection for Coronaviruses.	Curr Microbiol
33687143	"Between two storms, vasoactive peptides or bradykinin underlie severity of COVID-19?"	Physiol Rep
33687087	Calcium sensing receptor hyperactivation through viral envelop protein E of SARS CoV2: A novel target for cardio-renal damage in COVID-19 infection.	Drug Dev Res
33687066	Insights into coronavirus immunity taught by the murine coronavirus.	Eur J Immunol
33686980	Coagulopathy in COVID-19.	Lung India
33686748	Nicotinamide pathways as the root cause of sepsis - an evolutionary perspective on macrophage energetic shifts.	FEBS J
33686492	"Association between ABO blood types and coronavirus disease 2019 (COVID-19), genetic associations, and underlying molecular mechanisms: a literature review of 23 studies."	Ann Hematol
33686400	Susceptibility of Midge and Mosquito Vectors to SARS-CoV-2.	J Med Entomol
33686287	Genome-wide CRISPR screening identifies TMEM106B as a proviral host factor for SARS-CoV-2.	Nat Genet
33686154	MRC5 cells engineered to express ACE2 serve as a model system for the discovery of antivirals targeting SARS-CoV-2.	Sci Rep
33686143	The in-vitro effect of famotidine on sars-cov-2 proteases and virus replication.	Sci Rep
33686135	Homotaurine limits the spreading of T cell autoreactivity within the CNS and ameliorates disease in a model of multiple sclerosis.	Sci Rep
33686064	The dichotomous and incomplete adaptive immunity in COVID-19 patients with different disease severity.	Signal Transduct Target Ther
33685917	The PRRA insert at the S1/S2 site modulates cellular tropism of SARS-CoV-2 and ACE2 usage by the closely related Bat RaTG13.	J Virol
33685741	First confirmation of importation and transmission in Spain of the newly identified SARS-CoV-2 B.1.1.7 variant.	Enferm Infecc Microbiol Clin (Engl Ed)
33685621	Lost in deletion: The enigmatic ORF8 protein of SARS-CoV-2.	Biochem Biophys Res Commun
33685461	Endotheliopathy in septic conditions: mechanistic insight into intravascular coagulation.	Crit Care
33685364	An in-silico approach to identify the potential hot spots in SARS-CoV-2 spike RBD to block the interaction with ACE2 receptor.	J Biomol Struct Dyn
33685349	SARS-CoV-2 infection in nonhuman primates alters the composition and functional activity of the gut microbiota.	Gut Microbes
33685335	"In silico identification of novel SARS-COV-2 2'-O-methyltransferase (nsp16) inhibitors: structure-based virtual screening, molecular dynamics simulation and MM-PBSA approaches."	J Enzyme Inhib Med Chem
33685299	"Lactoferrin: an overview of its main functions, immunomodulatory and antimicrobial role, and clinical significance."	Crit Rev Food Sci Nutr
33685230	An immune epigenetic insight to COVID-19 infection.	Epigenomics
33684975	A Comprehensive Review of COVID-19 Associated Neurological Manifestations.	S D Med
33684969	"Intestinal SGLT1 as a therapeutic target in COVID-19-related diabetes: A ""two-edged sword"" hypothesis."	Br J Clin Pharmacol
33684923	Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7.	Nature
33684603	Ensemble-based screening of natural products and FDA-approved drugs identified potent inhibitors of SARS-CoV-2 that work with two distinct mechanisms.	J Mol Graph Model
33684592	COVID-19 and cytokine storm syndrome: are there lessons from macrophage activation syndrome?	Transl Res
33684397	Insilico drug repurposing using FDA approved drugs against Membrane protein of SARS-CoV-2.	J Pharm Sci
33684269	The Present State of Understanding of Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with SARS-CoV-2 Infection - A Comprehensive Review of the Current Literature.	S D Med
33684258	Neutralizing Aptamers Block S/RBD-ACE2 Interactions and Prevent Host Cell Infection.	Angew Chem Int Ed Engl
33684134	A network-informed analysis of SARS-CoV-2 and hemophagocytic lymphohistiocytosis genes' interactions points to Neutrophil extracellular traps as mediators of thrombosis in COVID-19.	PLoS Comput Biol
33683968	In quest of a new therapeutic approach in COVID-19: the endocannabinoid system.	Drug Metab Rev
33683819	Magnetization Transfer to Enhance NOE Cross-Peaks among Labile Protons: Applications to Imino-Imino Sequential Walks in SARS-CoV-2-Derived RNAs.	Angew Chem Int Ed Engl
33683787	A SARS-CoV-2 Spike Binding DNA Aptamer that Inhibits Pseudovirus Infection by an RBD-Independent Mechanism*.	Angew Chem Int Ed Engl
33683658	Isolation and genetic characterization of SARS-CoV-2 from Indian patients in a single family without H/O travel abroad.	Virus Genes
33683626	Divulging the Intricacies of Crosstalk Between NF-Kb and Nrf2-Keap1 Pathway in Neurological Complications of COVID-19.	Mol Neurobiol
33683342	Heterogeneous NLRP3 inflammasome signature in circulating myeloid cells as a biomarker of COVID-19 severity.	Blood Adv
33683337	Tandem high-dose influenza vaccination is associated with more durable serologic immunity in patients with plasma cell dyscrasias.	Blood Adv
33683204	SARS-CoV-2 suppresses anticoagulant and fibrinolytic gene expression in the lung.	Elife
33683136	"A SARS-CoV-2 Peptide Spectral Library Enables Rapid, Sensitive Identification of Virus Peptides in Complex Biological Samples."	J Proteome Res
33682642	"Finding potent inhibitors against SARS-CoV-2 main protease through virtual screening, ADMET, and molecular dynamics simulation studies."	J Biomol Struct Dyn
33682639	"Binding and inhibitory effect of ravidasvir on 3CL(pro) of SARS-CoV-2: a molecular docking, molecular dynamics and MM/PBSA approach."	J Biomol Struct Dyn
33682633	Structural insight into the binding interactions of NTPs and nucleotide analogues to RNA dependent RNA polymerase of SARS-CoV-2.	J Biomol Struct Dyn
33682632	"Structure-based virtual screening, molecular dynamics and binding affinity calculations of some potential phytocompounds against SARS-CoV-2."	J Biomol Struct Dyn
33682606	Flavonoids as potential therapeutics against novel coronavirus disease-2019 (nCOVID-19).	J Biomol Struct Dyn
33682075	"A comparative review of pathogenesis and host innate immunity evasion strategies among the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), severe acute respiratory syndrome coronavirus (SARS-CoV) and the Middle East respiratory syndrome coronavirus (MERS-CoV)."	Arch Microbiol
33681755	The new SARS-CoV-2 strain shows a stronger binding affinity to ACE2 due to N501Y mutant.	Med Drug Discov
33681751	"Latent rheumatic, thyroid and phospholipid autoimmunity in hospitalized patients with COVID-19."	J Transl Autoimmun
33681723	Targeting androgen regulation of TMPRSS2 and ACE2 as a therapeutic strategy to combat COVID-19.	iScience
33681537	SARS-CoV-2 Infects Human Engineered Heart Tissues and Models COVID-19 Myocarditis.	JACC Basic Transl Sci
33681536	What Are the Clinical Implications of the SARS-CoV-2 Variants: 5 Things Every Cardiologist Should Know.	JACC Basic Transl Sci
33681535	Analysis and comparison of genetic variants and mutations of the novel coronavirus SARS-CoV-2.	Gene Rep
33681482	In silico investigation of potential inhibitors to main protease and spike protein of SARS-CoV-2 in propolis.	Biochem Biophys Rep
33681368	The Role of Bacterial and Fungal Human Respiratory Microbiota in COVID-19 Patients.	Biomed Res Int
33681293	Neurological Consequences of SARS-CoV-2 Infection and Concurrence of Treatment-Induced Neuropsychiatric Adverse Events in COVID-19 Patients: Navigating the Uncharted.	Front Mol Biosci
33681266	New Insights Into the Physiopathology of COVID-19: SARS-CoV-2-Associated Gastrointestinal Illness.	Front Med (Lausanne)
33681145	Viroporins vs. Other Pore-Forming Proteins: What Lessons Can We Take?	Front Chem
33680867	COVID-19 Outbreak in Malaysia: Decoding D614G Mutation of SARS-CoV-2 Virus Isolated from an Asymptomatic Case in Pahang.	Mater Today Proc
33680715	Determination of Potential Drug Candidate Molecules of the Hypericum perforatum for COVID-19 Treatment.	Curr Pharmacol Rep
33680575	DisCoVering potential candidates of RNAi-based therapy for COVID-19 using computational methods.	PeerJ
33680474	Severe acute respiratory syndrome coronavirus 2 may exploit human transcription factors involved in retinoic acid and interferon-mediated response: a hypothesis supported by an in silico analysis.	New Microbes New Infect
33680466	Robust correlations across six SARS-CoV-2 serology assays detecting distinct antibody features.	Clin Transl Immunology
33680365	Severe COVID-19 Pneumonia is Associated with Increased Plasma Immunoglobulin G Agonist Autoantibodies Targeting the 5-Hydroxytryptamine 2A Receptor.	Endocrinol Diabetes Metab J
33680061	The Hydroalcoholic Extract of Uncaria tomentosa (Cat's Claw) Inhibits the Infection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) In Vitro.	Evid Based Complement Alternat Med
33679887	SARS-CoV-2 Infection-Induced Promoter Hypomethylation as an Epigenetic Modulator of Heat Shock Protein A1L (HSPA1L) Gene.	Front Genet
33679778	Inflammation and Antiviral Immune Response Associated With Severe Progression of COVID-19.	Front Immunol
33679775	C-Reactive Protein Triggers Cell Death in Ischemic Cells.	Front Immunol
33679760	Cyclic-di-GMP Induces STING-Dependent ILC2 to ILC1 Shift During Innate Type 2 Lung Inflammation.	Front Immunol
33679730	Less Severe Cases of COVID-19 in Sub-Saharan Africa: Could Co-infection or a Recent History of Plasmodium falciparum Infection Be Protective?	Front Immunol
33679725	Serum Amyloid A in Inflammatory Rheumatic Diseases: A Compendious Review of a Renowned Biomarker.	Front Immunol
33679622	Evolutionary Dynamics and Dissemination Pattern of the SARS-CoV-2 Lineage B.1.1.33 During the Early Pandemic Phase in Brazil.	Front Microbiol
33679437	"In vitro and In silico Models to Study SARS-CoV-2 Infection: Integrating Experimental and Computational Tools to Mimic ""COVID-19 Cardiomyocyte""."	Front Physiol
33679428	Pathogenesis of Acute Kidney Injury in Coronavirus Disease 2019.	Front Physiol
33679426	Is There an Effect of Fetal Mesenchymal Stem Cells in the Mother-Fetus Dyad in COVID-19 Pregnancies and Vertical Transmission?	Front Physiol
33679425	COVID-19-Associated Neurological Manifestations: An Emerging Electroencephalographic Literature.	Front Physiol
33679384	Potential Natural Products Against Respiratory Viruses: A Perspective to Develop Anti-COVID-19 Medicines.	Front Pharmacol
33679215	COVID-19 Thrombosis: Bridging the Old and New Concepts.	Malays J Med Sci
33679194	Molecular adaptive evolution of SARS-COV-2 spike protein in Saudi Arabia.	Saudi J Biol Sci
33679150	Comparison of clinically approved molecules on SARS-CoV-2 drug target proteins: a molecular docking study.	Turk J Chem
33679136	The Implications of Zinc Therapy in Combating the COVID-19 Global Pandemic.	J Inflamm Res
33678903	Inhibitory efficacy of RNA virus drugs against SARS-CoV-2 proteins: An extensive study.	J Mol Struct
33678621	Screening potential FDA-approved inhibitors of the SARS-CoV-2 major protease 3CL(pro) through high-throughput virtual screening and molecular dynamics simulation.	Aging (Albany NY)
33678150	Integrated gut virome and bacteriome dynamics in COVID-19 patients.	Gut Microbes
33677923	Best Achievements in Clinical Thyroidology in 2020.	Endocrinol Metab (Seoul)
33677719	The Potential of Developing Pan-Coronaviral Antibodies to Spike Peptides in Convalescent COVID-19 Patients.	Arch Immunol Ther Exp (Warsz)
33677612	Understanding COVID-19 through adverse outcome pathways - 2nd CIAO AOP Design Workshop.	ALTEX
33677567	"Entry, egress and vertical transmission of SARS-CoV-2."	J Mol Cell Biol
33677468	Dynamic blood single-cell immune responses in patients with COVID-19.	Signal Transduct Target Ther
33677394	Human pluripotent stem cell-based organoids and cell platforms for modelling SARS-CoV-2 infection and drug discovery.	Stem Cell Res
33677227	Docking-based virtual screening studies aiming at the covalent inhibition of SARS-CoV-2 M(Pro) by targeting the cysteine 145.	Comput Biol Chem
33677109	The extent of molecular variation in novel SARS-CoV-2 after the six-month global spread.	Infect Genet Evol
33676971	Intestinal Host Response to SARS-CoV-2 Infection and COVID-19 Outcomes in Patients With Gastrointestinal Symptoms.	Gastroenterology
33676968	Antiviral peptides against Coronaviridae family: A review.	Peptides
33676899	Camostat mesylate inhibits SARS-CoV-2 activation by TMPRSS2-related proteases and its metabolite GBPA exerts antiviral activity.	EBioMedicine
33676588	One year of SARS-CoV-2 evolution.	Cell Host Microbe
33676365	Normalization of single-cell RNA-seq counts by log(x + 1)* or log(1 + x).	Bioinformatics
33676232	SARS-CoV-2 variants combining spike mutations and the absence of ORF8 may be more transmissible and require close monitoring.	Biochem Biophys Res Commun
33676141	Coronavirus Infections in the Nervous System of Children: A Scoping Review Making the Case for Long-Term Neurodevelopmental Surveillance.	Pediatr Neurol
33676041	"Molecular designing, crystal structure determination and in silico screening of copper(II) complexes bearing 8-hydroxyquinoline derivatives as anti-COVID-19."	Bioorg Chem
33676010	Impact of I/D polymorphism of angiotensin-converting enzyme 1 (ACE1) gene on the severity of COVID-19 patients.	Infect Genet Evol
33675757	Binding mode of SARS-CoV-2 fusion peptide to human cellular membrane.	Biophys J
33675655	Emergence of a Severe Acute Respiratory Syndrome Coronavirus 2 virus variant with novel genomic architecture in Hong Kong.	Clin Infect Dis
33675510	Exploring naphthyl derivatives as SARS-CoV papain-like protease (PLpro) inhibitors and its implications in COVID-19 drug discovery.	Mol Divers
33675361	The miRNA: a small but powerful RNA for COVID-19.	Brief Bioinform
33675239	Nucleoside-modified messenger RNA COVID-19 vaccine platform.	J Med Virol
33675065	Janus kinase signaling as risk factor and therapeutic target for severe SARS-CoV-2 infection.	Eur J Immunol
33674876	Identifying Primate ACE2 Variants That Confer Resistance to SARS-CoV-2.	Mol Biol Evol
33674802	Structural basis for inhibition of the SARS-CoV-2 RNA polymerase by suramin.	Nat Struct Mol Biol
33674800	Robust SARS-CoV-2-specific T cell immunity is maintained at 6 months following primary infection.	Nat Immunol
33674719	IFN signaling and neutrophil degranulation transcriptional signatures are induced during SARS-CoV-2 infection.	Commun Biol
33674591	Deciphering the state of immune silence in fatal COVID-19 patients.	Nat Commun
33674391	"COVID-19 Drugs Chloroquine and Hydroxychloroquine, but Not Azithromycin and Remdesivir, Block hERG Potassium Channels."	J Pharmacol Exp Ther
33674317	"Longitudinal antibody repertoire in ""mild"" versus ""severe"" COVID-19 patients reveals immune markers associated with disease severity and resolution."	Sci Adv
33674185	SARS-CoV-2 mediated neuroinflammation and the impact of COVID-19 in neurological disorders.	Cytokine Growth Factor Rev
33673697	COVID-19 and Alzheimer's Disease.	Brain Sci
33673634	Effects of Omega-3 Polyunsaturated Fatty Acids and Their Metabolites on Haemostasis-Current Perspectives in Cardiovascular Disease.	Int J Mol Sci
33673614	"In Vitro and In Vivo Models for Studying SARS-CoV-2, the Etiological Agent Responsible for COVID-19 Pandemic."	Viruses
33673529	Demystifying Excess Immune Response in COVID-19 to Reposition an Orphan Drug for Down-Regulation of NF-kappaB: A Systematic Review.	Viruses
33673527	Antiviral and Immunomodulation Effects of Artemisia.	Medicina (Kaunas)
33673459	Upregulation of the Renin-Angiotensin System Pathways and SARS-CoV-2 Infection: The Rationale for the Administration of Zinc-Chelating Agents in COVID-19 Patients.	Cells
33673067	Titers of Neutralizing Antibodies against SARS-CoV-2 Are Independent of Symptoms of Non-Severe COVID-19 in Young Adults.	Viruses
33673048	SARS-CoV-2 mRNA Vaccines: Immunological Mechanism and Beyond.	Vaccines (Basel)
33672890	SARS-CoV-2 RNA Detection with Duplex-Specific Nuclease Signal Amplification.	Micromachines (Basel)
33672766	Thrombocytopenia in Virus Infections.	J Clin Med
33672738	"Innate Receptor Activation Patterns Involving TLR and NLR Synergisms in COVID-19, ALI/ARDS and Sepsis Cytokine Storms: A Review and Model Making Novel Predictions and Therapeutic Suggestions."	Int J Mol Sci
33672721	Establishing an Analogue Based In Silico Pipeline in the Pursuit of Novel Inhibitory Scaffolds against the SARS Coronavirus 2 Papain-Like Protease.	Molecules
33672450	Spike S2 Subunit: The Dark Horse in the Race for Prophylactic and Therapeutic Interventions against SARS-CoV-2.	Vaccines (Basel)
33672333	Resveratrol Inhibits HCoV-229E and SARS-CoV-2 Coronavirus Replication In Vitro.	Viruses
33672163	Therapeutic Intervention of COVID-19 by Natural Products: A Population-Specific Survey Directed Approach.	Molecules
33672054	Structure-Based Identification of Natural Products as SARS-CoV-2 M(pro) Antagonist from Echinacea angustifolia Using Computational Approaches.	Viruses
33671877	Neutralizing Human Antibodies against Severe Acute Respiratory Syndrome Coronavirus 2 Isolated from a Human Synthetic Fab Phage Display Library.	Int J Mol Sci
33671652	Screening and Molecular Modeling Evaluation of Food Peptides to Inhibit Key Targets of COVID-19 Virus.	Biomolecules
33671651	sFasL-The Key to a Riddle: Immune Responses in Aging Lung and Disease.	Int J Mol Sci
33671631	"Genomic Epidemiology of SARS-CoV-2 in Madrid, Spain, during the First Wave of the Pandemic: Fast Spread and Early Dominance by D614G Variants."	Microorganisms
33671334	Targeting the Complement Serine Protease MASP-2 as a Therapeutic Strategy for Coronavirus Infections.	Viruses
33671255	"Multivalent Display of SARS-CoV-2 Spike (RBD Domain) of COVID-19 to Nanomaterial, Protein Ferritin Nanocages."	Biomolecules
33671159	Novel Coronavirus Disease 2019 (COVID-19) and Cytokine Storms for More Effective Treatments from an Inflammatory Pathophysiology.	J Clin Med
33671076	TMPRSS11D and TMPRSS13 Activate the SARS-CoV-2 Spike Protein.	Viruses
33671039	Recent Progress and Opportunities for Nucleic Acid Aptamers.	Life (Basel)
33670942	Emerging Immunotherapies against Novel Molecular Targets in Breast Cancer.	Int J Mol Sci
33670859	Capsid and Genome Modification Strategies to Reduce the Immunogenicity of Adenoviral Vectors.	Int J Mol Sci
33670580	MicroRNAs and Long Non-Coding RNAs as Potential Candidates to Target Specific Motifs of SARS-CoV-2.	Noncoding RNA
33670490	"Mitochondriopathies as a Clue to Systemic Disorders-Analytical Tools and Mitigating Measures in Context of Predictive, Preventive, and Personalized (3P) Medicine."	Int J Mol Sci
33670436	Novel Synthetic Routes to Prepare Biologically Active Quinoxalines and Their Derivatives: A Synthetic Review for the Last Two Decades.	Molecules
33670394	The Impact of SARS-CoV-2 Infection on the Development of Neurodegeneration in Multiple Sclerosis.	Int J Mol Sci
33670363	Berberine and Obatoclax Inhibit SARS-Cov-2 Replication in Primary Human Nasal Epithelial Cells In Vitro.	Viruses
33670304	"Drugs, Metabolites, and Lung Accumulating Small Lysosomotropic Molecules: Multiple Targeting Impedes SARS-CoV-2 Infection and Progress to COVID-19."	Int J Mol Sci
33670189	Polyphosphate Reverses the Toxicity of the Quasi-Enzyme Bleomycin on Alveolar Endothelial Lung Cells In Vitro.	Cancers (Basel)
33670182	VOC 202012/01 Variant Is Effectively Neutralized by Antibodies Produced by Patients Infected before Its Diffusion in Italy.	Viruses
33670023	Rational Design of a Pan-Coronavirus Vaccine Based on Conserved CTL Epitopes.	Viruses
33669990	The Pleiotropic Function of Human Sirtuins as Modulators of Metabolic Pathways and Viral Infections.	Cells
33669922	Single-Molecule FRET Imaging of Virus Spike-Host Interactions.	Viruses
33669738	Computational Selectivity Assessment of Protease Inhibitors against SARS-CoV-2.	Int J Mol Sci
33669720	In Silico Screening of the DrugBank Database to Search for Possible Drugs against SARS-CoV-2.	Molecules
33669408	The Role of Bcl-xL Protein in Viral Infections.	Int J Mol Sci
33669352	Dysfunctional Inflammation in Cystic Fibrosis Airways: From Mechanisms to Novel Therapeutic Approaches.	Int J Mol Sci
33669276	Safety and Outcomes Associated with the Pharmacological Inhibition of the Kinin-Kallikrein System in Severe COVID-19.	Viruses
33669264	Honeysuckle Aqueous Extracts Induced let-7a Suppress EV71 Replication and Pathogenesis In Vitro and In Vivo and Is Predicted to Inhibit SARS-CoV-2.	Viruses
33669167	Phosphodiesterase Inhibitors in Acute Lung Injury: What Are the Perspectives?	Int J Mol Sci
33669141	Liquid Biomolecular Condensates and Viral Lifecycles: Review and Perspectives.	Viruses
33669132	"In Silico, In Vitro and In Cellulo Models for Monitoring SARS-CoV-2 Spike/Human ACE2 Complex, Viral Entry and Cell Fusion."	Viruses
33669011	"How Do Inflammatory Mediators, Immune Response and Air Pollution Contribute to COVID-19 Disease Severity? A Lesson to Learn."	Life (Basel)
33668924	NETosis in Wound Healing: When Enough Is Enough.	Cells
33668756	Characterization of Critical Determinants of ACE2-SARS CoV-2 RBD Interaction.	Int J Mol Sci
33668694	Antiviral Activity of Vacuolar ATPase Blocker Diphyllin against SARS-CoV-2.	Microorganisms
33668613	Therapeutic Antibodies for the Treatment of Respiratory Tract Infections-Current Overview and Perspectives.	Vaccines (Basel)
33668523	Bioactive Alkaloids from Genus Aspergillus: Mechanistic Interpretation of Their Antimicrobial and Potential SARS-CoV-2 Inhibitory Activity Using Molecular Modelling.	Int J Mol Sci
33668514	Characterization and Biomarker Analyses of Post-COVID-19 Complications and Neurological Manifestations.	Cells
33668493	"Obesity, Nutrients and the Immune System in the Era of COVID-19."	Nutrients
33668428	Nucleoside Analogs and Nucleoside Precursors as Drugs in the Fight against SARS-CoV-2 and Other Coronaviruses.	Molecules
33668405	Comparative Transcriptome Profiling of Human and Pig Intestinal Epithelial Cells after Porcine Deltacoronavirus Infection.	Viruses
33668325	Involvement of Oxidative Stress and the Innate Immune System in SARS-CoV-2 Infection.	Diseases
33668085	"EGCG, a Green Tea Catechin, as a Potential Therapeutic Agent for Symptomatic and Asymptomatic SARS-CoV-2 Infection."	Molecules
33668070	Expression of Surfactant Protein D Distinguishes Severe Pandemic Influenza A(H1N1) from Coronavirus Disease 2019.	J Infect Dis
33667900	Discovery of novel inhibitors against main protease (Mpro) of SARS-CoV-2 via virtual screening and biochemical evaluation.	Bioorg Chem
33667722	Different selection dynamics of S and RdRp between SARS-CoV-2 genomes with and without the dominant mutations.	Infect Genet Evol
33667698	CCR5Delta32 mutations do not determine COVID-19 disease course.	Int J Infect Dis
33667651	"Expression of SARS-CoV-2 surface glycoprotein fragment 319-640 in E. coli, and its refolding and purification."	Protein Expr Purif
33667568	Novel RT-ddPCR assays for simultaneous quantification of multiple noncoding and coding regions of SARS-CoV-2 RNA.	J Virol Methods
33667553	The human pandemic coronaviruses on the show: The spike glycoprotein as the main actor in the coronaviruses play.	Int J Biol Macromol
33667466	Co-expression of the SARS-CoV-2 entry receptors ACE2 and TMPRSS2 in healthy human conjunctiva.	Exp Eye Res
33667455	Potential repurposing of the HDAC inhibitor valproic acid for patients with COVID-19.	Eur J Pharmacol
33667349	Extremely potent human monoclonal antibodies from COVID-19 convalescent patients.	Cell
33666950	A comprehensive library of fluorescent constructs of SARS-CoV-2 proteins and their initial characterisation in different cell types.	Biol Cell
33666926	"Nutrition, Immune Function, and Infectious Disease."	Med J (Ft Sam Houst Tex)
33666783	Environmental Determinants of Coronavirus Disease 2019 (COVID-19).	Curr Allergy Asthma Rep
33666220	"Type-2 diabetes, a co-morbidity in Covid-19: does insulin signaling matter?"	Biochem Soc Trans
33666206	SARS-CoV-2 and tissue damage: current insights and biomaterial-based therapeutic strategies.	Biomater Sci
33666147	Lessons learned 1 year after SARS-CoV-2 emergence leading to COVID-19 pandemic.	Emerg Microbes Infect
33666138	Immunization and Drug Metabolizing Enzymes: Focus on Hepatic Cytochrome P450 3A.	Expert Rev Vaccines
33666135	Bispecific VH/Fab antibodies targeting neutralizing and non-neutralizing Spike epitopes demonstrate enhanced potency against SARS-CoV-2.	MAbs
33666082	Ubiquitin-Modified Proteome of SARS-CoV-2-Infected Host Cells Reveals Insights into Virus-Host Interaction and Pathogenesis.	J Proteome Res
33666069	COVID-19: the difference between the nose and the lung.	Monaldi Arch Chest Dis
33665645	The potential of rapalogs to enhance resilience against SARS-CoV-2 infection and reduce the severity of COVID-19.	Lancet Healthy Longev
33665567	A computational framework of host-based drug repositioning for broad-spectrum antivirals against RNA viruses.	iScience
33665210	Right Ventricular Damage in COVID-19: Association Between Myocardial Injury and COVID-19.	Front Cardiovasc Med
33665182	Susceptibility for Some Infectious Diseases in Patients With Diabetes: The Key Role of Glycemia.	Front Public Health
33665043	"Low compositions of human toll-like receptor 7/8-stimulating RNA motifs in the MERS-CoV, SARS-CoV and SARS-CoV-2 genomes imply a substantial ability to evade human innate immunity."	PeerJ
33664866	MERS-CoV and SARS-CoV-2 replication can be inhibited by targeting the interaction between the viral spike protein and the nucleocapsid protein.	Theranostics
33664772	Perspectives About Modulating Host Immune System in Targeting SARS-CoV-2 in India.	Front Genet
33664752	"Carvacrol, a Plant Metabolite Targeting Viral Protease (M(pro)) and ACE2 in Host Cells Can Be a Possible Candidate for COVID-19."	Front Plant Sci
33664674	Sex Differences in the Incidence and Risk Factors of Myocardial Injury in COVID-19 Patients: A Retrospective Cohort Study.	Front Physiol
33664552	Role of endothelial cell receptors in the context of SARS-CoV-2 infection (COVID-19).	Proc (Bayl Univ Med Cent)
33664494	Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies.	Nat Med
33664446	Polyunsaturated omega-3 fatty acids inhibit ACE2-controlled SARS-CoV-2 binding and cellular entry.	Sci Rep
33664395	"COVID-19 engages clinical markers for the management of cancer and cancer-relevant regulators of cell proliferation, death, migration, and immune response."	Sci Rep
33664393	Potential neutralizing antibodies discovered for novel corona virus using machine learning.	Sci Rep
33664170	"COVID-19 pandemic: from origins to outcomes. A comprehensive review of viral pathogenesis, clinical manifestations, diagnostic evaluation, and management."	Infez Med
33664168	COVID-19-associated coagulopathy: a concise review on pathogenesis and clinical implications.	Infez Med
33664151	Identification of a SARS-CoV-2 Lineage B1.1.7 Virus in New York following Return Travel from the United Kingdom.	Microbiol Resour Announc
33664060	SARS-CoV-2 mutations in MHC-I-restricted epitopes evade CD8(+) T cell responses.	Sci Immunol
33663367	Recent Advance in Natural Products with Antiviral Activities.	Mini Rev Med Chem
33663346	Metadynamics-based enhanced sampling protocol for virtual screening: case study for 3CLpro protein for SARS-CoV-2.	J Biomol Struct Dyn
33662873	The age-dependent decline of the extracellular thiol-disulfide balance and its role in SARS-CoV-2 infection.	Redox Biol
33662796	Recombinant ADAMTS13 reduces abnormally up-regulated von Willebrand factor in plasma from patients with severe COVID-19.	Thromb Res
33662683	Targeting multiple conformations of SARS-CoV2 Papain-Like Protease for drug repositioning: An in-silico study.	Comput Biol Med
33662681	Network pharmacology and RNA-sequencing reveal the molecular mechanism of Xuebijing injection on COVID-19-induced cardiac dysfunction.	Comput Biol Med
33662680	Flavonoids against the SARS-CoV-2 induced inflammatory storm.	Biomed Pharmacother
33662593	Synthesis and immunogenicity assessment of a gold nanoparticle conjugate for the delivery of a peptide from SARS-CoV-2.	Nanomedicine
33662570	Spike protein fusion loop controls SARS-CoV-2 fusogenicity and infectivity.	J Struct Biol
33662537	"Design, synthesis and biological evaluation of 2-aminoquinazolin-4(3H)-one derivatives as potential SARS-CoV-2 and MERS-CoV treatments."	Bioorg Med Chem Lett
33662449	SARS-CoV-2 and other coronaviruses negatively influence mitochondrial quality control: beneficial effects of melatonin.	Pharmacol Ther
33662418	SARS-CoV-2: Insights into its structural intricacies and functional aspects for drug and vaccine development.	Int J Biol Macromol
33662015	Genomic characterization and evolution of SARS-CoV-2 of a Canadian population.	PLoS One
33661932	Quercetin/Zinc complex and stem cells: A new drug therapy to ameliorate glycometabolic control and pulmonary dysfunction in diabetes mellitus: Structural characterization and genetic studies.	PLoS One
33661927	Hypoxia-induced inflammation: Profiling the first 24-hour posthypoxic plasma and central nervous system changes.	PLoS One
33661923	Presence of antibody-dependent cellular cytotoxicity (ADCC) against SARS-CoV-2 in COVID-19 plasma.	PLoS One
33661875	Molecular biology of coronaviruses: an overview of virus-host interactions and pathogenesis.	Bol Med Hosp Infant Mex
33661628	Oligomannose N-Glycans 3D Architecture and Its Response to the FcgammaRIIIa Structural Landscape.	J Phys Chem B
33661489	Sustainability of SARS-CoV-2 Induced Humoral Immune Responses in COVID-19 Patients from Hospitalization to Convalescence Over Six Months.	Virol Sin
33661132	Molecular and Cellular Biomarkers of COVID-19 Prognosis: Protocol for the Prospective Cohort TARGET Study.	JMIR Res Protoc
33660945	"Pulmonary, cardiac and renal distribution of ACE2, furin, TMPRSS2 and ADAM17 in rats with heart failure: Potential implication for COVID-19 disease."	J Cell Mol Med
33660619	"Lethal zoonotic coronavirus infections of humans - comparative phylogenetics, epidemiology, transmission, and clinical features of coronavirus disease 2019, The Middle East respiratory syndrome and severe acute respiratory syndrome."	Curr Opin Pulm Med
33660566	Host Defence RNases as Antiviral Agents against Enveloped Single Stranded RNA Viruses.	Virulence
33660398	Dual role for angiotensin-converting enzyme 2 in Severe Acute Respiratory Syndrome Coronavirus 2 infection and cardiac fat.	Obes Rev
33660218	The highly flexible disordered regions of the SARS-CoV-2 nucleocapsid N protein within the 1-248 residue construct: sequence-specific resonance assignments through NMR.	Biomol NMR Assign
33660116	How Does COVID-19 Affect the Neurobiology of Suicide?	Curr Psychiatry Rep
33660020	Repositioning HIV protease inhibitors and nucleos(t)ide RNA polymerase inhibitors for the treatment of SARS-CoV-2 infection and COVID-19.	Eur J Clin Pharmacol
33659858	SARS-CoV-2 and endothelial cell interaction in COVID-19: molecular perspectives.	Vasc Biol
33659771	Bacillus Calmette-Guerin (BCG): the adroit vaccine.	AIMS Microbiol
33659508	Evaluation of the Sequence Variability within the PCR Primer/Probe Target Regions of the SARS-CoV-2 Genome.	Bio Protoc
33659275	Molecular Mechanisms Behind Anti SARS-CoV-2 Action of Lactoferrin.	Front Mol Biosci
33659260	Population Bottlenecks and Intra-host Evolution During Human-to-Human Transmission of SARS-CoV-2.	Front Med (Lausanne)
33659247	Mesenchymal Stromal Cell-Derived Extracellular Vesicles in Lung Diseases: Current Status and Perspectives.	Front Cell Dev Biol
33659220	Nasopharyngeal Microbiome Signature in COVID-19 Positive Patients: Can We Definitively Get a Role to Fusobacterium periodonticum?	Front Cell Infect Microbiol
33659153	Genomic Surveillance of SARS-CoV-2: Distribution of Clades in the Republic of Korea in 2020.	Osong Public Health Res Perspect
33659022	SARS CoV-2 Spike Protein in silico Interaction With ACE2 Receptors From Wild and Domestic Species.	Front Genet
33658931	Phytochemicals: Potential Therapeutic Interventions Against Coronavirus-Associated Lung Injury.	Front Pharmacol
33658751	SARS-CoV-2 and the Eye: A Relationship for a Possible Prognostic Tool in COVID-19 Patients.	Clin Ophthalmol
33658619	"Association of angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers with risk of mortality, severity or SARS-CoV-2 test positivity in COVID-19 patients: meta-analysis."	Sci Rep
33658497	Immunogenicity of prime-boost protein subunit vaccine strategies against SARS-CoV-2 in mice and macaques.	Nat Commun
33658420	THE PECULIARITY OF COVID- 19 GENOME AND THE CORONAVIRUS RNA TRANSLATION PROCESS AS APOTENTIAL TARGET FOR ETIOTROPIC MEDICATIONSWITH ADENINE AND OTHER NUCLEOTIDE ANALOGUES (REVIEW).	Georgian Med News
33658363	"Sialoglycan recognition is a common connection linking acidosis, zinc, and HMGB1 in sepsis."	Proc Natl Acad Sci U S A
33658355	Broad neutralization of H1 and H3 viruses by adjuvanted influenza HA stem vaccines in nonhuman primates.	Sci Transl Med
33658349	Potent Neutralization of SARS-CoV-2 by Hetero-bivalent Alpaca Nanobodies Targeting the Spike Receptor-Binding Domain.	J Virol
33658335	CRISPR immunity: a case study for justified somatic genetic modification?	J Med Ethics
33658332	Functional and genetic analysis of viral receptor ACE2 orthologs reveals a broad potential host range of SARS-CoV-2.	Proc Natl Acad Sci U S A
33658206	Hallmarks of Alpha- and Betacoronavirus non-structural protein 7+8 complexes.	Sci Adv
33657648	Allergenic components of the mRNA-1273 vaccine for COVID-19: Possible involvement of polyethylene glycol and IgG-mediated complement activation.	Allergy
33657459	COVID-19: A methyl-group assault?	Med Hypotheses
33657458	Autism Spectrum Disorder patients may be susceptible to COVID-19 disease due to deficiency in melatonin.	Med Hypotheses
33657424	Robust SARS-CoV-2 infection in nasal turbinates after treatment with systemic neutralizing antibodies.	Cell Host Microbe
33657418	"SARS-CoV-2 Infects Human Pluripotent Stem Cell-Derived Cardiomyocytes, Impairing Electrical and Mechanical Function."	Stem Cell Reports
33657410	COVID-19 immune features revealed by a large-scale single-cell transcriptome atlas.	Cell
33657325	An Active Site Inhibitor Induces Conformational Penalties for ACE2 Recognition by the Spike Protein of SARS-CoV-2.	J Phys Chem B
33657316	Heterogeneity of Glycan Processing on Trimeric SARS-CoV-2 Spike Protein Revealed by Charge Detection Mass Spectrometry.	J Am Chem Soc
33657135	A high-affinity RBD-targeting nanobody improves fusion partner's potency against SARS-CoV-2.	PLoS Pathog
33656738	A Systematic Review of the Assessment of the Presence of SARS-CoV-2 in Human Semen.	Adv Exp Med Biol
33656723	"The Novel Coronavirus and Haemostatic Abnormalities: Pathophysiology, Clinical Manifestations, and Treatment Recommendations."	Adv Exp Med Biol
33656721	COVID-19 and Vulnerable Populations in Sub-Saharan Africa.	Adv Exp Med Biol
33656720	Does SARS-CoV-2 Threaten Male Fertility?	Adv Exp Med Biol
33656719	The Novel Coronavirus and Inflammation.	Adv Exp Med Biol
33656718	The Immune Response and Effectiveness of COVID-19 Therapies.	Adv Exp Med Biol
33656717	COVID-19 Is an Endothelial Disease: Implications of Nitric Oxide.	Adv Exp Med Biol
33656716	Obesity and Risk of COVID-19 Infection and Severity: Available Evidence and Mechanisms.	Adv Exp Med Biol
33656715	Emerging Technologies for the Treatment of COVID-19.	Adv Exp Med Biol
33656713	Relationship Between COVID-19 and Angiotensin-Converting Enzyme 2: A Scoping Review.	Adv Exp Med Biol
33656711	Endothelial Dysfunction as a Primary Consequence of SARS-CoV-2 Infection.	Adv Exp Med Biol
33656515	Immunodominant antibody germlines in COVID-19.	J Exp Med
33656463	Consequences of coronavirus infections for primitive and mature hematopoietic cells: new insights and why it matters.	Curr Opin Hematol
33656293	[COVID-19 and myocardial injury].	Rev Med Suisse
33655850	Diabetes and COVID-19; a review of possible mechanisms.	Curr Pharm Des
33655830	Treatment approaches for COVID-19: A critical review.	Mini Rev Med Chem
33655825	"COVID-19: Epidemiology, Pathology, Diagnosis, Treatment, and Impact."	Curr Pharm Des
33655803	Host Modulation and Treatment of Periodontal Disease.	J Dent Res
33655751	Biostructural Models for the Binding of Nucleoside Analogs to SARS-CoV-2 RNA-Dependent RNA Polymerase.	J Chem Inf Model
33655614	Targeting the Main Protease of SARS-CoV-2: From the Establishment of High Throughput Screening to the Design of Tailored Inhibitors.	Angew Chem Int Ed Engl
33655480	Coronaviruses in humans and animals: the role of bats in viral evolution.	Environ Sci Pollut Res Int
33655087	Mutations and polymorphisms in genes involved in the infections by covid 19: a review.	Gene Rep
33655086	Antiviral and immunomodulatory activity of curcumin: A case for prophylactic therapy for COVID-19.	Heliyon
33655082	Exploring existing drugs: proposing potential compounds in the treatment of COVID-19.	Heliyon
33654512	In-silico nucleotide and protein analyses of S-gene region in selected zoonotic coronaviruses reveal conserved domains and evolutionary emergence with trajectory course of viral entry from SARS-CoV-2 genomic data.	Pan Afr Med J
33654454	Screening of inhibitors against SARS-CoV-2 spike protein and their capability to block the viral entry mechanism: A viroinformatics study.	Saudi J Biol Sci
33654345	"In silico evaluation of the compounds of the ayurvedic drug, AYUSH-64, for the action against the SARS-CoV-2 main protease."	J Ayurveda Integr Med
33654293	Single-cell meta-analysis of SARS-CoV-2 entry genes across tissues and demographics.	Nat Med
33654292	SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma.	Nat Med
33653907	Deep immune profiling of MIS-C demonstrates marked but transient immune activation compared to adult and pediatric COVID-19.	Sci Immunol
33653892	Introduction of Two Prolines and Removal of the Polybasic Cleavage Site Lead to Higher Efficacy of a Recombinant Spike-Based SARS-CoV-2 Vaccine in the Mouse Model.	mBio
33653891	Development of Spike Receptor-Binding Domain Nanoparticles as a Vaccine Candidate against SARS-CoV-2 Infection in Ferrets.	mBio
33653888	Genetically Engineered Live-Attenuated Middle East Respiratory Syndrome Coronavirus Viruses Confer Full Protection against Lethal Infection.	mBio
33653700	Rapid High-Throughput Whole-Genome Sequencing of SARS-CoV-2 by Using One-Step Reverse Transcription-PCR Amplification with an Integrated Microfluidic System and Next-Generation Sequencing.	J Clin Microbiol
33653238	Withdrawal Notice: Identification of the Interaction between Angiotensin-converting Enzyme Residues and Severe Acute Respiratory Syndrome Coronavirus 2	Curr Pharm Des
33653215	The effects of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on ischemic stroke and the possible underlying mechanisms.	Int J Neurosci
33653188	Insights into the possible impact of COVID-19 on the endocrine system.	Arch Physiol Biochem
33652988	SARS-CoV-2 Infection and Disease Modelling Using Stem Cell Technology and Organoids.	Int J Mol Sci
33652894	Repurposing of Sitagliptin- Melittin Optimized Nanoformula against SARS-CoV-2: Antiviral Screening and Molecular Docking Studies.	Pharmaceutics
33652815	SARS-CoV-2 Nonstructural Proteins 1 and 13 Suppress Caspase-1 and the NLRP3 Inflammasome Activation.	Microorganisms
33652692	Propolis in Metabolic Syndrome and Its Associated Chronic Diseases: A Narrative Review.	Antioxidants (Basel)
33652685	Animal Coronaviruses Induced Apoptosis.	Life (Basel)
33652634	The Role of the Host Ubiquitin System in Promoting Replication of Emergent Viruses.	Viruses
33652622	Our Evolving Understanding of ME/CFS.	Medicina (Kaunas)
33652503	Potential mechanisms of action of convalescent plasma in COVID-19.	Diagnosis (Berl)
33652275	Coronavirus and its terrifying inning around the globe: The pharmaceutical cares at the main frontline.	Chemosphere
33651967	beta-glucans: wide-spectrum immune-balancing food-supplement-based enteric (beta-WIFE) vaccine adjuvant approach to COVID-19.	Hum Vaccin Immunother
33651876	Extreme phenotypes approach to investigate host genetics and COVID-19 outcomes.	Genet Mol Biol
33651717	Cell-free DNA maps COVID-19 tissue injury and risk of death and can cause tissue injury.	JCI Insight
33651636	Deregulated miRNA expression is associated with endothelial dysfunction in post-mortem lung biopsies of COVID-19 patients.	Am J Physiol Lung Cell Mol Physiol
33651244	Structural Flexibility of Peripheral Loops and Extended C-terminal Domain of Short Length Substrate Binding Protein from Rhodothermus marinus.	Protein J
33651117	[Neuroimmunology of COVID-19].	Nervenarzt
33651072	Targeting SARS-CoV-2 spike protein by stapled hACE2 peptides.	Chem Commun (Camb)
33650967	Association of Toll-like receptor 7 variants with life-threatening COVID-19 disease in males: findings from a nested case-control study.	Elife
33650490	Genomic epidemiology of COVID-19 in care homes in the east of England.	Elife
33650226	Insights into Sars-CoV-2 vaccination in patients with chronic plaque psoriasis on systemic treatments.	J Eur Acad Dermatol Venereol
33649798	COVID19 and SARSCoV2 host cell entry mediators: Expression profiling of TMRSS4 in health and disease.	Int J Mol Med
33649748	Total predicted MHC-I epitope load is inversely associated with population mortality from SARS-CoV-2.	Cell Rep Med
33649738	Platelet and Endothelial Activation as Potential Mechanisms Behind the Thrombotic Complications of COVID-19 Patients.	JACC Basic Transl Sci
33649734	"Repurposing FDA-approved drugs to fight COVID-19 using in silico methods: Targeting SARS-CoV-2 RdRp enzyme and host cell receptors (ACE2, CD147) through virtual screening and molecular dynamic simulations."	Inform Med Unlocked
33649700	Screening of drug databank against WT and mutant main protease of SARS-CoV-2: Towards finding potential compound for repurposing against COVID-19.	Saudi J Biol Sci
33649547	ACE2 receptor usage reveals variation in susceptibility to SARS-CoV and SARS-CoV-2 infection among bat species.	Nat Ecol Evol
33649539	Lung expression of genes putatively involved in SARS-CoV-2 infection is modulated in cis by germline variants.	Eur J Hum Genet
33649400	Impact of SARS-CoV-2 infection on the recovery of peripheral blood mononuclear cells by density gradient.	Sci Rep
33649323	"S-Trimer, a COVID-19 subunit vaccine candidate, induces protective immunity in nonhuman primates."	Nat Commun
33649297	SARS-CoV-2 engages inflammasome and pyroptosis in human primary monocytes.	Cell Death Discov
33649194	"Genomic characterization of a novel SARS-CoV-2 lineage from Rio de Janeiro, Brazil."	J Virol
33648989	Vascular Normalization to Improve Treatment of COVID-19: Lessons from Treatment of Cancer.	Clin Cancer Res
33648924	Extensive longitudinal immune profiling reveals sustained innate immune activation in COVID-19 patients with unfavorable outcome	Eur Cytokine Netw
33648582	Stem cells and COVID-19: are the human amniotic cells a new hope for therapies against the SARS-CoV-2 virus?	Stem Cell Res Ther
33648564	"Diabetes, obesity, and insulin resistance in COVID-19: molecular interrelationship and therapeutic implications."	Diabetol Metab Syndr
33647885	The networks of m(6)A-SARS-CoV-2 related genes and immune infiltration patterns in idiopathic pulmonary fibrosis.	Aging (Albany NY)
33647824	Title of article: Mucosal-associated invariant T cells in lung diseases.	Int Immunopharmacol
33647767	Shorter androgen receptor polyQ alleles protect against life-threatening COVID-19 disease in European males.	EBioMedicine
33647752	Pinpointing the potential hits for hindering interaction of SARS-CoV-2 S-protein with ACE2 from the pool of antiviral phytochemicals utilizing molecular docking and molecular dynamics (MD) simulations.	J Mol Graph Model
33647606	"Old drug, new Trick? The rationale for the treatment of COVID-19 with activated protein C."	Med Hypotheses
33647447	Facemasks and face recognition: Potential impact on synaptic plasticity.	Neurobiol Dis
33647446	"Latest updates on SARS-CoV-2 genomic characterization, drug, and vaccine development; a comprehensive bioinformatics review."	Microb Pathog
33647320	TAM kinases as regulators of cell death.	Biochim Biophys Acta Mol Cell Res
33647240	Low risk of the TMPRSS2 inhibitor camostat mesylate and its metabolite GBPA to act as perpetrators of drug-drug interactions.	Chem Biol Interact
33647239	Guillain-Barre syndrome.	Lancet
33647228	"Novel Mutation of SARS-CoV-2, Vietnam, July 2020."	Emerg Infect Dis
33647008	Success of prophylactic antiviral therapy for SARS-CoV-2: Predicted critical efficacies and impact of different drug-specific mechanisms of action.	PLoS Comput Biol
33646645	"Covid-19 and oral diseases: Crosstalk, synergy or association?"	Rev Med Virol
33646622	Sex-based differences in severity and mortality in COVID-19.	Rev Med Virol
33646363	[COVID-19 and the central and peripheral nervous system].	Pathologe
33646362	COVID-19 effects on the kidney.	Pathologe
33646361	[Biology and pathology of coronaviruses].	Pathologe
33646265	Highly functional virus-specific cellular immune response in asymptomatic SARS-CoV-2 infection.	J Exp Med
33645977	"Boceprevir, Calpain Inhibitors II and XII, and GC-376 Have Broad-Spectrum Antiviral Activity against Coronaviruses."	ACS Infect Dis
33645763	Repurposing functional inhibitors of acid sphingomyelinase (fiasmas): an opportunity against SARS-CoV-2 infection?	J Clin Pharm Ther
33645489	"A mini review on the pathogenesis, diagnosis and treatment options for COVID-19."	Infect Disord Drug Targets
33645482	Predicted SARS-CoV-2 miRNAs associated with epigenetic viral pathogenesis and the detection of new possible drugs for Covid-19.	Curr Drug Deliv
33645457	Targeting allosteric pockets of SARS-CoV-2 main protease M(pro).	J Biomol Struct Dyn
33645443	A potential peptide inhibitor of SARS-CoV-2 S and human ACE2 complex.	J Biomol Struct Dyn
33645342	Virus-associated ribozymes and nano carriers against COVID-19.	Artif Cells Nanomed Biotechnol
33644594	Novel Development of Predictive Feature Fingerprints to Identify Chemistry-Based Features for the Effective Drug Design of SARS-CoV-2 Target Antagonists and Inhibitors Using Machine Learning.	ACS Omega
33644468	SARS-CoV-2 spike protein S1 subunit induces pro-inflammatory responses via toll-like receptor 4 signaling in murine and human macrophages.	Heliyon
33644261	"SARS-CoV-2: phylogenetic origins, pathogenesis, modes of transmission, and the potential role of nanotechnology."	Virusdisease
33644099	Furin Expression in Patients With Psoriasis-A Patient Cohort Endangered to SARS-COV2?	Front Med (Lausanne)
33644077	Mechanistic and Therapeutic Implications of Extracellular Vesicles as a Potential Link Between Covid-19 and Cardiovascular Disease Manifestations.	Front Cell Dev Biol
33643982	Can ACE2 Receptor Polymorphism Predict Species Susceptibility to SARS-CoV-2?	Front Public Health
33643932	COVID-19: Molecular and Cellular Response.	Front Cell Infect Microbiol
33643929	"Viral Infections, the Microbiome, and Probiotics."	Front Cell Infect Microbiol
33643765	Estimation of drug-likeness properties of GC-MS separated bioactive compounds in rare medicinal Pleione maculata using molecular docking technique and SwissADME in silico tools.	Netw Model Anal Health Inform Bioinform
33643762	Cordifolioside: potent inhibitor against M(pro) of SARS-CoV-2 and immunomodulatory through human TGF-beta and TNF-alpha.	3 Biotech
33643542	The Balance between Two Branches of RAS Can Protect from Severe COVID-19 Course.	Biochem (Mosc) Suppl Ser A Membr Cell Biol
33643375	COVID-DeepPredictor: Recurrent Neural Network to Predict SARS-CoV-2 and Other Pathogenic Viruses.	Front Genet
33643316	The Immunopathology of COVID-19 and the Cannabis Paradigm.	Front Immunol
33643308	Immunomodulatory Effects of Azithromycin Revisited: Potential Applications to COVID-19.	Front Immunol
33643285	VISTA: A Target to Manage the Innate Cytokine Storm.	Front Immunol
33643275	Low Levels of Natural Anti-alpha-N-Acetylgalactosamine (Tn) Antibodies Are Associated With COVID-19.	Front Microbiol
33643227	Early Diffusion of SARS-CoV-2 Infection in the Inner Area of the Italian Sardinia Island.	Front Microbiol
33643083	Impact of SARS-CoV-2 Infection on Cognitive Function: A Systematic Review.	Front Psychiatry
33643063	"SARS-COV-2 and Ocular Surface: From Physiology to Pathology, a Route to Understand Transmission and Disease."	Front Physiol
33643033	Modalities and Mechanisms of Treatment for Coronavirus Disease 2019.	Front Pharmacol
33642896	In silico analysis of quranic and prophetic medicinals plants for the treatment of infectious viral diseases including corona virus.	Saudi J Biol Sci
33642886	Smoking and COVID-19: A Scoping Review.	Tob Use Insights
33642866	Inhibition of ACE2 Expression by Ascorbic Acid Alone and its Combinations with Other Natural Compounds.	Infect Dis (Auckl)
33642829	Digestive system involvement of infections with SARS-CoV-2 and other coronaviruses: Clinical manifestations and potential mechanisms.	World J Gastroenterol
33642821	Current understanding of the impact of COVID-19 on gastrointestinal disease: Challenges and openings.	World J Gastroenterol
33642804	"The emerging SARS-CoV, MERS-CoV, and SARS-CoV-2: An insight into the viruses zoonotic aspects."	Vet World
33641858	"A review: Epidemiology, pathogenesis and prospect in developing vaccines for novel Coronavirus (COVID-19)."	Indian J Tuberc
33641831	BCG vaccination induced protection from COVID-19.	Indian J Tuberc
33641685	Zinc deficiency as a possible risk factor for increased susceptibility and severe progression of Corona Virus Disease 19.	Br J Nutr
33641587	"COVID-19: Immunology, Immunopathogenesis and Potential Therapies."	Int Rev Immunol
33641565	Exposure of human intestinal epithelial cells and primary human hepatocytes to trypsin-like serine protease inhibitors with potential antiviral effect.	J Enzyme Inhib Med Chem
33641023	Structure-activity relationship (SAR) and molecular dynamics study of withaferin-A fragment derivatives as potential therapeutic lead against main protease (M(pro)) of SARS-CoV-2.	J Mol Model
33640999	COVID-19 illness and autoimmune diseases: recent insights.	Inflamm Res
33640537	"Inflammation, immunity and potential target therapy of SARS-COV-2: A total scale analysis review."	Food Chem Toxicol
33640332	Exploring algae and cyanobacteria as a promising natural source of antiviral drug against SARS-CoV-2.	Biomed J
33640032	Ginkgolic acid and anacardic acid are specific covalent inhibitors of SARS-CoV-2 cysteine proteases.	Cell Biosci
33639976	Inhibitors of endosomal acidification suppress SARS-CoV-2 replication and relieve viral pneumonia in hACE2 transgenic mice.	Virol J
33639626	Mechanisms of COVID-19 Entry into the Cell: Potential Therapeutic Approaches Based on Virus Entry Inhibition in COVID-19 Patients with Underlying Diseases.	Iran J Allergy Asthma Immunol
33639344	A new class of alpha-ketoamide derivatives with potent anticancer and anti-SARS-CoV-2 activities.	Eur J Med Chem
33639316	"Multi-targeting approach for nsp3, nsp9, nsp12 and nsp15 proteins of SARS-CoV-2 by Diosmin as illustrated by molecular docking and molecular dynamics simulation methodologies."	Methods
33639276	The role of A-to-I RNA editing in infections by RNA viruses: Possible implications for SARS-CoV-2 infection.	Clin Immunol
33639198	SARS-CoV-2 journey to the brain with a focus on potential role of docosahexaenoic acid bioactive lipid mediators.	Biochimie
33639193	Brief review on repurposed drugs and vaccines for possible treatment of COVID-19.	Eur J Pharmacol
33639176	In-vitro evaluation of the immunomodulatory effects of Baricitinib: Implication for COVID-19 therapy.	J Infect
33639165	Glucosylceramide synthase inhibitors prevent replication of SARS-CoV-2 and influenza virus.	J Biol Chem
33638807	MicroRNA Mimics or Inhibitors as Antiviral Therapeutic Approaches Against COVID-19.	Drugs
33638671	"The Inclusive Review on SARS-CoV-2 Biology, Epidemiology, Diagnosis, and Potential Management Options."	Curr Microbiol
33638553	Interaction effects between angiotensin-converting enzyme inhibitors or angiotensin receptor blockers and steroid or antiviral therapies in COVID-19: A population-based study.	J Med Virol
33638460	Spiking dependence of SARS-CoV-2 pathogenicity on TMPRSS2.	J Med Virol
33638345	A Modelling Framework for Embedding-based Predictions for Compound-Viral Protein Activity.	Bioinformatics
33638018	Stroke and presence of patent foramen ovale in sickle cell disease.	J Thromb Thrombolysis
33637958	SARS-CoV-2 nsp12 attenuates type I interferon production by inhibiting IRF3 nuclear translocation.	Cell Mol Immunol
33637951	"Obesity in COVID-19 era, implications for mechanisms, comorbidities, and prognosis: a review and meta-analysis."	Int J Obes (Lond)
33637950	Increased TLR/MyD88 signaling in patients with obesity: is there a link to COVID-19 disease severity?	Int J Obes (Lond)
33637823	Homologies between SARS-CoV-2 and allergen proteins may direct T cell-mediated heterologous immune responses.	Sci Rep
33637820	Hospitalization and mortality associated with SARS-CoV-2 viral clades in COVID-19.	Sci Rep
33637768	A SARS-CoV-2 cytopathicity dataset generated by high-content screening of a large drug repurposing collection.	Sci Data
33637603	SARS-CoV-2 causes severe epithelial inflammation and barrier dysfunction.	J Virol
33637588	Cyclic gallium-68 labeled peptides for specific detection of human angiotensin-converting enzyme 2.	J Nucl Med
33636719	SARS-CoV-2 spike D614G change enhances replication and transmission.	Nature
33636189	Targeting SARS-CoV-2 Nsp3 macrodomain structure with insights from human poly(ADP-ribose) glycohydrolase (PARG) structures with inhibitors.	Prog Biophys Mol Biol
33636175	Targeting RAGE to prevent SARS-CoV-2-mediated multiple organ failure: Hypotheses and perspectives.	Life Sci
33636127	In vivo structural characterization of the SARS-CoV-2 RNA genome identifies host proteins vulnerable to repurposed drugs.	Cell
33636110	Common Genetic Variation in Humans Impacts In Vitro Susceptibility to SARS-CoV-2 Infection.	Stem Cell Reports
33635931	Inhibition of anti-viral stress granule formation by coronavirus endoribonuclease nsp15 ensures efficient virus replication.	PLoS Pathog
33635919	Breadth and function of antibody response to acute SARS-CoV-2 infection in humans.	PLoS Pathog
33635912	Transmission of SARS-CoV-2 in domestic cats imposes a narrow bottleneck.	PLoS Pathog
33635872	Histone H4 potentiates neutrophil inflammatory responses to influenza A virus: Down-modulation by H4 binding to C-reactive protein and Surfactant protein D.	PLoS One
33635833	Identification of SARS-CoV-2-specific immune alterations in acutely ill patients.	J Clin Invest
33635655	Rapid SARS-CoV-2 Spike Protein Detection by Carbon Nanotube-Based Near-Infrared Nanosensors.	Nano Lett
33635546	"The Interplay Between the Immune System, the Renin-Angiotensin-Aldosterone System (RAAS), and RAAS Inhibitors May Modulate the Outcome of COVID-19: A Systematic Review."	J Clin Pharmacol
33635533	Angiotensin-Converting-Enzyme 2 and Renin-Angiotensin System Inhibitors in COVID-19: An Update.	High Blood Press Cardiovasc Prev
33635335	A neutrophil activation signature predicts critical illness and mortality in COVID-19.	Blood Adv
33635316	Lipidomic alteration of plasma in cured COVID-19 patients using ultra high-performance liquid chromatography with high-resolution mass spectrometry.	Biosci Rep
33634444	Severe SARS-CoV-2 Infection Inhibits Fibrinolysis Leading to Changes in Viscoelastic Properties of Blood Clot: A Descriptive Study of Fibrinolysis in COVID-19.	Thromb Haemost
33634309	A model for pH coupling of the SARS-CoV-2 spike protein open/closed equilibrium.	Brief Bioinform
33634160	Plant-Derived Food Grade Substances (PDFGS) Active Against Respiratory Viruses: A Systematic Review of Non-clinical Studies.	Front Nutr
33634100	Human Dental Pulp Stem Cells Modulate Cytokine Production in vitro by Peripheral Blood Mononuclear Cells From Coronavirus Disease 2019 Patients.	Front Cell Dev Biol
33634060	Immunopathological Changes in SARS-CoV-2 Critical and Non-critical Pneumonia Patients: A Systematic Review to Determine the Cause of Co-infection.	Front Public Health
33633726	Activation of the Cholinergic Anti-Inflammatory Pathway as a Novel Therapeutic Strategy for COVID-19.	Front Immunol
33633588	The Physiological Mechanisms of the Sex-Based Difference in Outcomes of COVID19 Infection.	Front Physiol
33633566	Severe Acute Respiratory Syndrome Coronavirus-2 Induces Cytokine Storm and Inflammation During Coronavirus Disease 19: Perspectives and Possible Therapeutic Approaches.	Front Pharmacol
33633408	A Neanderthal OAS1 isoform protects individuals of European ancestry against COVID-19 susceptibility and severity.	Nat Med
33633229	Structural insights into SARS-CoV-2 spike protein and its natural mutants found in Mexican population.	Sci Rep
33633155	Immunoinformatic based identification of cytotoxic T lymphocyte epitopes from the Indian isolate of SARS-CoV-2.	Sci Rep
33633121	Elevation in viral entry genes and innate immunity compromise underlying increased infectivity and severity of COVID-19 in cancer patients.	Sci Rep
33633106	Historical Insight into Infections and Disorders Associated with Neurological and Psychiatric Sequelae Similar to Long COVID.	Med Sci Monit
33632991	Organoids: A New Model for SARS-CoV-2 Translational Research.	Int J Stem Cells
33632982	Neutrophil Extracellular Traps in Coronavirus Disease-19-Associated Ischemic Stroke: A Novel Avenue in Neuroscience.	Exp Neurobiol
33632868	Genome Sequence of a Minacovirus Strain from a Farmed Mink in The Netherlands.	Microbiol Resour Announc
33632858	Genome Sequence of a SARS-CoV-2 Strain from Bangladesh That Is Nearly Identical to United Kingdom SARS-CoV-2 Variant B.1.1.7.	Microbiol Resour Announc
33632754	Impact of COVID-19 on female fertility: a systematic review and meta-analysis protocol.	BMJ Open
33632561	Pharmacological approach for the reduction of inflammatory and prothrombotic hyperactive state in COVID-19 positive patients by acting on complement cascade.	Hum Immunol
33632296	Interplay between severities of COVID-19 and the gut microbiome: implications of bacterial co-infections?	Gut Pathog
33632295	Comorbidities and inflammation associated with ovarian cancer and its influence on SARS-CoV-2 infection.	J Ovarian Res
33632278	"Virus-like particles: preparation, immunogenicity and their roles as nanovaccines and drug nanocarriers."	J Nanobiotechnology
33632261	mRNA vaccine for cancer immunotherapy.	Mol Cancer
33631936	Antiviral Bafilomycins from a Feces-Inhabiting Streptomyces sp.	J Nat Prod
33631756	Immune Dysfunction in Patients with Chronic Lymphocytic Leukemia and Challenges during COVID-19 Pandemic.	Acta Haematol
33631632	Association between chronic fatigue syndrome and suicidality among survivors of Middle East respiratory syndrome over a 2-year follow-up period.	J Psychiatr Res
33631222	"Pervasive transmission of E484K and emergence of VUI-NP13L with evidence of SARS-CoV-2 co-infection events by two different lineages in Rio Grande do Sul, Brazil."	Virus Res
33631219	"Protection against COVID-19 in African population: Immunology, genetics, and malaria clues for therapeutic targets."	Virus Res
33631204	Ca(2+)-dependent mechanism of membrane insertion and destabilization by the SARS-CoV-2 fusion peptide.	Biophys J
33631123	Neurotropic Effects of SARS-CoV-2 Modeled by the Human Brain Organoids.	Stem Cell Reports
33631122	Revealing Tissue-Specific SARS-CoV-2 Infection and Host Responses using Human Stem Cell-Derived Lung and Cerebral Organoids.	Stem Cell Reports
33631118	"A modified vaccinia Ankara vector-based vaccine protects macaques from SARS-CoV-2 infection, immune pathology, and dysfunction in the lungs."	Immunity
33631104	Remdesivir is a delayed translocation inhibitor of SARS-CoV-2 replication.	Mol Cell
33631096	Seasonal human coronavirus antibodies are boosted upon SARS-CoV-2 infection but not associated with protection.	Cell
33630927	Transcriptomic profiling and genomic mutational analysis of Human coronavirus (HCoV)-229E -infected human cells.	PLoS One
33630831	A plasmid DNA-launched SARS-CoV-2 reverse genetics system and coronavirus toolkit for COVID-19 research.	PLoS Biol
33630760	Long-term microstructure and cerebral blood flow changes in patients recovered from COVID-19 without neurological manifestations.	J Clin Invest
33630167	Cutaneous Manifestations Related to COVID-19 Immune Dysregulation in the Pediatric Age Group.	Curr Allergy Asthma Rep
33629970	COVID-19 - pathogenesis and immunological findings across the clinical manifestation spectrum.	Curr Opin Pulm Med
33629859	Aptamer Conjugated Gold Nanostar-Based Distance-Dependent Nanoparticle Surface Energy Transfer Spectroscopy for Ultrasensitive Detection and Inactivation of Corona Virus.	J Phys Chem Lett
33629345	"Commentary - CRISPR-based techniques: Cas9, Cas13 and their applications in the era of COVID-19."	Eur Rev Med Pharmacol Sci
33629341	Differential expression and immune correlation analysis of COVID-19 receptor ACE2 and TMPRSS2 genes in all normal and tumor tissues.	Eur Rev Med Pharmacol Sci
33629340	"Evaluation of molecular interaction, physicochemical parameters and conserved pattern of SARS-CoV-2 Spike RBD and hACE2: in silico and molecular dynamics approach."	Eur Rev Med Pharmacol Sci
33629339	Predictors of morbidity and mortality in COVID-19.	Eur Rev Med Pharmacol Sci
33629337	Thromboembolic involvement and its possible pathogenesis in COVID-19 mortality: lesson from post-mortem reports.	Eur Rev Med Pharmacol Sci
33629254	"CIGB-258, a peptide derived from human heat-shock protein 60, decreases hyperinflammation in COVID-19 patients."	Cell Stress Chaperones
33629236	A Biochemical Perspective of the Nonstructural Proteins (NSPs) and the Spike Protein of SARS CoV-2.	Protein J
33629195	Does remote ischaemic conditioning reduce inflammation? A focus on innate immunity and cytokine response.	Basic Res Cardiol
33628764	New Insights Into Potential Benefits of Bioactive Compounds of Bee Products on COVID-19: A Review and Assessment of Recent Research.	Front Mol Biosci
33628748	Polyvaccine: joining the links in the cascade of type 1 diabetes.	Clin Exp Vaccine Res
33628442	Human neutralising antibodies elicited by SARS-CoV-2 non-D614G variants offer cross-protection against the SARS-CoV-2 D614G variant.	Clin Transl Immunology
33628371	Oxidative Imbalance as a Crucial Factor in Inflammatory Lung Diseases: Could Antioxidant Treatment Constitute a New Therapeutic Strategy?	Oxid Med Cell Longev
33628162	Insights into the actions of angiotensin-1 receptor (AT1R) inverse agonists: Perspectives and implications in COVID-19 treatment.	EXCLI J
33628091	Role of IL-6 inhibitor in treatment of COVID-19-related cytokine release syndrome.	Int J Med Sci
33627511	Antibody Response against SARS-CoV-2 and Seasonal Coronaviruses in Nonhospitalized COVID-19 Patients.	mSphere
33627397	"Potential differences in cleavage of the S protein and type-1 interferon together control human coronavirus infection, propagation, and neuropathology within the central nervous system."	J Virol
33627390	Effect of an Adenovirus-Vectored Universal Influenza Virus Vaccine on Pulmonary Pathophysiology in a Mouse Model.	J Virol
33626910	Vascular Endothelial Damage in the Pathogenesis of Organ Injury in Severe COVID-19.	Arterioscler Thromb Vasc Biol
33626380	The ORF8 protein of SARS-CoV-2 induced endoplasmic reticulum stress and mediated immune evasion by antagonizing production of interferon beta.	Virus Res
33626333	Human Intestinal Organoids Recapitulate Enteric Infections of Enterovirus and Coronavirus.	Stem Cell Reports
33626315	Epithelial and Endothelial Expressions of ACE2: SARS-CoV-2 Entry Routes.	J Pharm Pharm Sci
33626247	"Demographic, clinical, laboratory, and genetic risk factors associated with COVID-19 severity in adults: A narrative review."	Dent Med Probl
33626084	"Comparative analysis of ACE2 protein expression in rodent, non-human primate, and human respiratory tract at baseline and after injury: A conundrum for COVID-19 pathogenesis."	PLoS One
33626040	Detecting SARS-CoV-2 variants with SNP genotyping.	PLoS One
33625796	SARS-CoV-2 innate effector associations and viral load in early nasopharyngeal infection.	Physiol Rep
33625752	Crystallographic molecular replacement using an in silico-generated search model of SARS-CoV-2 ORF8.	Protein Sci
33625681	Bioinformatics Analysis of SARS-CoV-2 to Approach an Effective Vaccine Candidate Against COVID-19.	Mol Biotechnol
33625513	The Activin/Follistatin Axis Is Severely Deregulated in COVID-19 and Independently Associated With In-Hospital Mortality.	J Infect Dis
33625490	The SARS-CoV-2 induced targeted amino acid profiling in patients at hospitalized and convalescent stage.	Biosci Rep
33625318	"4-acetamido-3-nitrobenzoic acid - structural, quantum chemical studies, ADMET and molecular docking studies of SARS-CoV2."	J Biomol Struct Dyn
33625297	T Helper 17 Response to Severe Acute Respiratory Syndrome Coronavirus 2: A Type of Immune Response with Possible Therapeutic Implications.	Viral Immunol
33624859	"Production of high-quality SARS-CoV-2 antigens: Impact of bioprocess and storage on glycosylation, biophysical attributes, and ELISA serologic tests performance."	Biotechnol Bioeng
33624516	Association of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers With the Risk of Hospitalization and Death in Hypertensive Patients With COVID-19.	J Am Heart Assoc
33624419	Targeting tumour necrosis factor to ameliorate viral pneumonia.	FEBS J
33624382	Innate immune evasion mediated by picornaviral 3C protease: Possible lessons for coronaviral 3C-like protease?	Rev Med Virol
33624358	Suggestions on cleavage embryo and blastocyst vitrification/transfer based on expression profile of ACE2 and TMPRSS2 in current COVID-19 pandemic.	Mol Reprod Dev
33624300	Akt-independent effects of triciribine on ACE2 expression in human lung epithelial cells: Potential benefits in restricting SARS-CoV2 infection.	J Cell Physiol
33624270	A comprehensive review of SARS-CoV-2 genetic mutations and lessons from animal coronavirus recombination in one health perspective.	J Microbiol
33623995	A molecular modelling approach for identifying antiviral selenium-containing heterocyclic compounds that inhibit the main protease of SARS-CoV-2: an in silico investigation.	Brief Bioinform
33623833	Characterizing genomic variants and mutations in SARS-CoV-2 proteins from Indian isolates.	Gene Rep
33623738	Renin-Angiotensin System Implications to COVID-19 Comorbidities.	J Microsc Ultrastruct
33623736	COVID-19 and Phosphodiesterase Enzyme Type 5 Inhibitors.	J Microsc Ultrastruct
33623641	Ultra-large-scale ab initio quantum chemical computation of bio-molecular systems: The case of spike protein of SARS-CoV-2 virus.	Comput Struct Biotechnol J
33623561	"Immunity, parasites, genetics and sex hormones: contributors to mild inflammatory responses in COVID-19?"	Pan Afr Med J
33623170	Identification of high affinity and low molecular alternatives of boceprevir against SARS-CoV-2 main protease: A virtual screening approach.	Chem Phys Lett
33623157	Biological activity-based modeling identifies antiviral leads against SARS-CoV-2.	Nat Biotechnol
33622975	Prolonged evolution of the human B cell response to SARS-CoV-2 infection.	Sci Immunol
33622974	Clonal expansion and activation of tissue-resident memory-like Th17 cells expressing GM-CSF in the lungs of severe COVID-19 patients.	Sci Immunol
33622961	A comparative analysis of SARS-CoV-2 antivirals characterizes 3CL(pro) inhibitor PF-00835231 as a potential new treatment for COVID-19.	J Virol
33622890	Homozygosity for rs17775810 Minor Allele Associated With Reduced Mortality of COVID-19 in the UK Biobank Cohort.	In Vivo
33622855	Identifying Potentially Beneficial Genetic Mutations Associated with Monophyletic Selective Sweep and a Proof-of-Concept Study with Viral Genetic Data.	mSystems
33622851	"Comparative Genomics and Integrated Network Approach Unveiled Undirected Phylogeny Patterns, Co-mutational Hot Spots, Functional Cross Talk, and Regulatory Interactions in SARS-CoV-2."	mSystems
33622601	Dual Nature of Type I Interferons in SARS-CoV-2-Induced Inflammation.	Trends Immunol
33622224	SARS-CoV-2 proteins: Are they useful as targets for COVID-19 drugs and vaccines?	Curr Mol Med
33622218	Severe Acute Respiratory Syndrome Coronavirus Type 2: Insight Into Challenges for Cell Therapy.	Exp Clin Transplant
33621843	Persistent SARS-2 infections contribute to long COVID-19.	Med Hypotheses
33621704	COVID-19 mortality as a fingerprint of biological age.	Ageing Res Rev
33621620	"Stroke increases the expression of ACE2, the SARS-CoV-2 binding receptor, in murine lungs."	Brain Behav Immun
33621589	Effects of statins on myocarditis: A review of underlying molecular mechanisms.	Prog Cardiovasc Dis
33621516	Transport mechanisms of SARS-CoV-E viroporin in calcium solutions: Lipid-dependent Anomalous Mole Fraction Effect and regulation of pore conductance.	Biochim Biophys Acta Biomembr
33621488	Autophagosome maturation stymied by SARS-CoV-2.	Dev Cell
33621484	Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity.	Cell
33621211	Comorbid illnesses are associated with altered adaptive immune responses to SARS-CoV-2.	JCI Insight
33621190	Improving the Understanding of the Immunopathogenesis of Lymphopenia as a Correlate of SARS-CoV-2 Infection Risk and Disease Progression in African Patients: Protocol for a Cross-sectional Study.	JMIR Res Protoc
33621159	The Pathophysiology and Dangers of Silent Hypoxemia in COVID-19 Lung Injury.	Ann Am Thorac Soc
33621130	Perspectives on Targeting IL-6 as a Potential Therapeutic Strategy for COVID-19.	J Interferon Cytokine Res
33620862	COVID (SARS-COV-2) Vaccine	StatPearls
33620776	"A rapid novel strategy for screening of antibody phage libraries for production, purification, and functional characterization of amber stop codons containing single-chain antibody fragments."	Biotechnol Prog
33620066	Lysosome activation in peripheral blood mononuclear cells and prognostic significance of circulating LC3B in COVID-19.	Brief Bioinform
33620031	COVID-19 CG enables SARS-CoV-2 mutation and lineage tracking by locations and dates of interest.	Elife
33619962	Shedding Light on the Inhibitory Mechanisms of SARS-CoV-1/CoV-2 Spike Proteins by ACE2-Designed Peptides.	J Chem Inf Model
33619888	Blue photobiomodulation LED therapy impacts SARS-CoV-2 by limiting its replication in Vero cells.	J Biophotonics
33619758	Tetracycline as an inhibitor to the SARS-CoV-2.	J Cell Biochem
33619460	Covid-19 treatment: Investigation on the phytochemical constituents of Vernonia amygdalina as potential Coronavirus-2 inhibitors.	Comput Toxicol
33619452	"Rare mutations in the accessory proteins ORF6, ORF7b, and ORF10 of the SARS-CoV-2 genomes."	Meta Gene
33619449	An integrated virtual screening of compounds from Carica papaya leaves against multiple protein targets of SARS-Coronavirus-2.	Results Chem
33619447	Efficacy and Safety of New and Emerging Drugs for COVID-19: Favipiravir and Dexamethasone.	Curr Pharmacol Rep
33619443	Supervised machine learning approach to molecular dynamics forecast of SARS-CoV-2 spike glycoproteins at varying temperatures.	MRS Adv
33619413	"The Novel Coronavirus Infection (COVID-19) and Nervous System Involvement: Mechanisms of Neurological Disorders, Clinical Manifestations, and the Organization of Neurological Care."	Neurosci Behav Physiol
33619392	Genome-scale deconvolution of RNA structure ensembles.	Nat Methods
33619344	In silico detection of SARS-CoV-2 specific B-cell epitopes and validation in ELISA for serological diagnosis of COVID-19.	Sci Rep
33619331	Serine 477 plays a crucial role in the interaction of the SARS-CoV-2 spike protein with the human receptor ACE2.	Sci Rep
33619281	Antibody affinity maturation and plasma IgA associate with clinical outcome in hospitalized COVID-19 patients.	Nat Commun
33618979	Cyclin-dependent Kinases as Emerging Targets for Developing Novel Antiviral Therapeutics.	Trends Microbiol
33618765	Intra-host variation and evolutionary dynamics of SARS-CoV-2 populations in COVID-19 patients.	Genome Med
33618668	Identification and functional analysis of the SARS-COV-2 nucleocapsid protein.	BMC Microbiol
33618659	Effects of Cell Proteostasis Network on the Survival of SARS-CoV-2.	Biol Proced Online
33618639	The Association of Respiratory Viruses with Oxidative Stress and Antioxidants. Implications for the COVID-19 Pandemic.	Curr Pharm Des
33618635	Mesenchymal Stem Cell Derived-Exosomes as Effective Factors in Reducing Cytokine Storm Symptoms of COVID-19.	Protein Pept Lett
33618628	Investigation of the inhibitory activity of some dietary bioactive flavonoids against SARS-CoV-2 using molecular dynamics simulations and MM-PBSA calculations.	J Biomol Struct Dyn
33618621	Structural stability predictions and molecular dynamics simulations of RBD and HR1 mutations associated with SARS-CoV-2 spike glycoprotein.	J Biomol Struct Dyn
33618607	COVID-19 and cardiovascular complications: an update from the underlying mechanism to consequences and possible clinical intervention.	Expert Rev Anti Infect Ther
33618530	Potential therapeutic road for targeting the SARS-CoV-2 at throat.	Bratisl Lek Listy
33618158	Protease targeted COVID-19 drug discovery: What we have learned from the past SARS-CoV inhibitors?	Eur J Med Chem
33618008	Characterizing SARS-CoV-2 genome diversity circulating in South American countries: Signatures of potentially emergent lineages?	Int J Infect Dis
33617964	"Saponins: Extraction, bio-medicinal properties and way forward to anti-viral representatives."	Food Chem Toxicol
33617948	In silico identification of available drugs targeting cell surface BiP to disrupt SARS-CoV-2 binding and replication: Drug repurposing approach.	Eur J Pharm Sci
33617879	Selective targeting of the inactive state of hematopoietic cell kinase (Hck) with a stable curcumin derivative.	J Biol Chem
33617818	Impact of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Hypertensive Patients with COVID-19 (COVIDECA Study).	Am J Cardiol
33617712	Angiotensin-converting enzyme 2 and kidney diseases in the era of coronavirus disease 2019.	Korean J Intern Med
33617700	COVID-19 and neurology perspective.	Horm Mol Biol Clin Investig
33617253	Applications of Protein Secondary Structure Algorithms in SARS-CoV-2 Research.	J Proteome Res
33617048	B cell analysis in SARS-CoV-2 versus malaria: Increased frequencies of plasmablasts and atypical memory B cells in COVID-19.	J Leukoc Biol
33616462	Cytokine release syndrome in COVID-19: a major mechanism of morbidity and mortality.	Int Rev Immunol
33616026	Update on SARS-CoV-2 infection in children.	Paediatr Int Child Health
33615998	In silico evaluation of isatin-based derivatives with RNA-dependent RNA polymerase of the novel coronavirus SARS-CoV-2.	J Biomol Struct Dyn
33615982	Platelets and viruses.	Platelets
33615750	Comparison of COVID-19 and influenza characteristics.	J Zhejiang Univ Sci B
33615696	Application of spectral library prediction for parallel reaction monitoring of viral peptides.	Proteomics
33615450	Sub-second heat inactivation of coronavirus using a betacoronavirus model.	Biotechnol Bioeng
33615316	Adsorption of SARS-CoV-2 Spike Protein S1 at Oxide Surfaces Studied by High-Speed Atomic Force Microscopy.	Adv Nanobiomed Res
33615195	Structural insight reveals SARS-CoV-2 ORF7a as an immunomodulating factor for human CD14(+) monocytes.	iScience
33615193	Glycosylation of SARS-CoV-2 Steers Evolutionary Outcomes in the Postvaccination Phase.	ACS Pharmacol Transl Sci
33615192	Docking Prediction of Levodopa in the Receptor Binding Domain of Spike Protein of SARS-CoV-2.	ACS Pharmacol Transl Sci
33615190	"SARS-CoV-2, Hypoxia, and Calcium Signaling: The Consequences and Therapeutic Options."	ACS Pharmacol Transl Sci
33615189	Identification of Novel MicroRNAs as Promising Therapeutics for SARS-CoV-2 by Regulating the EGFR-ADAM17 Axis: An In Silico Analysis.	ACS Pharmacol Transl Sci
33615177	Innate Immunity Plays a Key Role in Controlling Viral Load in COVID-19: Mechanistic Insights from a Whole-Body Infection Dynamics Model.	ACS Pharmacol Transl Sci
33615141	Nanotechnology: an emerging approach to combat COVID-19.	Emergent Mater
33615129	Anti-phospholipid syndrome and COVID-19 thrombosis: connecting the dots.	Rheumatol Adv Pract
33615115	Stapled ACE2 peptidomimetics designed to target the SARS-CoV-2 spike protein do not prevent virus internalization.	Pept Sci (Hoboken)
33615088	A clinical primer for the expected and potential post-COVID-19 syndromes.	Pain Rep
33615042	"A comparative genomics-based study of positive strand RNA viruses emphasizing on SARS-CoV-2 utilizing dinucleotide signature, codon usage and codon context analyses."	Gene Rep
33615041	SARS-CoV-2 spillover transmission due to recombination event.	Gene Rep
33614925	Intra-nasal zinc level relationship to COVID-19 anosmia and type 1 interferon response: A proposal.	Laryngoscope Investig Otolaryngol
33614907	Virus-Free and Live-Cell Visualizing SARS-CoV-2 Cell Entry for Studies of Neutralizing Antibodies and Compound Inhibitors.	Small Methods
33614744	"Why Is COVID-19 More Severe in Patients With Diabetes? The Role of Angiotensin-Converting Enzyme 2, Endothelial Dysfunction and the Immunoinflammatory System."	Front Cardiovasc Med
33614627	Targeting Lipid Rafts as a Strategy Against Coronavirus.	Front Cell Dev Biol
33614597	In silico Exploration of Inhibitors for SARS-CoV-2's Papain-Like Protease.	Front Chem
33614592	In Silico Study of Coumarins and Quinolines Derivatives as Potent Inhibitors of SARS-CoV-2 Main Protease.	Front Chem
33614513	Landscape Profiling Analysis of DPP4 in Malignancies: Therapeutic Implication for Tumor Patients With Coronavirus Disease 2019.	Front Oncol
33614402	Corilagin inhibits SARS-CoV-2 replication by targeting viral RNA-dependent RNA polymerase.	Acta Pharm Sin B
33614158	Tuning intrinsic disorder predictors for virus proteins.	Virus Evol
33614032	High levels of soluble CD25 in COVID-19 severity suggest a divergence between anti-viral and pro-inflammatory T-cell responses.	Clin Transl Immunology
33613871	The paradoxical problem with COVID-19 ocular infection: Moderate clinical manifestation and potential infection risk.	Comput Struct Biotechnol J
33613853	Competitive Immunoassay of SARS-CoV-2 Using Pig Sera-Derived Anti-SARS-CoV-2 Antibodies.	Biochip J
33613787	On the Verge of Life: Distribution of Nucleotide Sequences in Viral RNAs.	Biosemiotics
33613621	"SARS-CoV-2 Genomes From Oklahoma, United States."	Front Genet
33613576	An Immunological Perspective: What Happened to Pregnant Women After Recovering From COVID-19?	Front Immunol
33613574	Parallels in Sepsis and COVID-19 Conditions: Implications for Managing Severe COVID-19.	Front Immunol
33613518	Virus Infections and Host Metabolism-Can We Manage the Interactions?	Front Immunol
33613483	Evolution of Drug-Resistant Mycobacterium tuberculosis Strains and Their Adaptation to the Human Lung Environment.	Front Microbiol
33613280	Chemokine Regulation During Epidemic Coronavirus Infection.	Front Pharmacol
33613275	Neuronal and Cerebrovascular Complications in Coronavirus Disease 2019.	Front Pharmacol
33613009	Aggregation hot spots in the SARS-CoV-2 proteome may constitute potential therapeutic targets for the suppression of the viral replication and multiplication.	J Proteins Proteom
33613002	Trace Elements as Immunoregulators in SARS-CoV-2 and Other Viral Infections.	Indian J Clin Biochem
33612990	Coronavirus-Replikation: Mechanismus und Inhibition durch Remdesivir.	Biospektrum (Heidelb)
33612989	"COR-101, ein menschlicher Antikorper gegen COVID-19."	Biospektrum (Heidelb)
33612988	Den molekularen Wirtszellveranderungen durch SARS-CoV-2 auf der Spur.	Biospektrum (Heidelb)
33612970	Development of a SARS-CoV-2-derived receptor-binding domain-based ACE2 biosensor.	Sens Actuators B Chem
33612899	Rational design of potent anti-COVID-19 main protease drugs: An extensive multi-spectrum in silico approach.	J Mol Liq
33612858	Identification of Nafamostat and VR23 as COVID-19 drug candidates by targeting 3CL(pro) and PL(pro).	J Mol Struct
33612147	Hamster and ferret experimental infection with intranasal low dose of a single strain of SARS-CoV-2.	J Gen Virol
33612076	Identification of the binding interactions of some novel antiviral compounds against Nsp1 protein from SARS-CoV-2 (COVID-19) through high throughput screening.	J Biomol Struct Dyn
33611884	Use of Renin-Angiotensin-Aldosterone System Inhibitors and Severe COVID-19 Outcomes in Patients with Hypertension: A Nationwide Cohort Study.	Diabetes Metab J
33611766	Roux-en-Y Gastric Bypass Downregulates Angiotensin-Converting Enzyme 2 (ACE2) Gene Expression in Subcutaneous White Adipose Tissue: A Putative Protective Mechanism Against Severe COVID-19.	Obes Surg
33611368	Comparison of the binding characteristics of SARS-CoV and SARS-CoV-2 RBDs to ACE2 at different temperatures by MD simulations.	Brief Bioinform
33611340	Identification of biomarkers and pathways for the SARS-CoV-2 infections that make complexities in pulmonary arterial hypertension patients.	Brief Bioinform
33611213	Induction of stress resistance and extension of lifespan in Chaenorhabditis elegans serotonin-receptor knockout strains by withanolide A.	Phytomedicine
33611189	Molecular modeling-guided optimization of acetylcholinesterase reactivators: A proof for reactivation of covalently inhibited targets.	Eur J Med Chem
33611129	Non-standard bioinformatics characterization of SARS-CoV-2.	Comput Biol Med
33610778	SARS-CoV-2 and immune-microbiome interactions: Lessons from respiratory viral infections.	Int J Infect Dis
33610751	The SARS-CoV-2 as an instrumental trigger of autoimmunity.	Autoimmun Rev
33610741	Coronavirus-induced autoimmunity.	Clin Immunol
33610693	Adaptive immune responses to SARS-CoV-2.	Adv Drug Deliv Rev
33610551	Evaluating angiotensin-converting enzyme 2-mediated SARS-CoV-2 entry across species.	J Biol Chem
33610036	SARS-CoV-2 infection and COVID-19 severity in individuals with prior seasonal coronavirus infection.	Diagn Microbiol Infect Dis
33609889	Synthetic and medicinal perspective of quinolines as antiviral agents.	Eur J Med Chem
33609783	Developing new drugs that activate the protective arm of the renin-angiotensin system as a potential treatment for respiratory failure in COVID-19 patients.	Drug Discov Today
33609782	Inflammation control and improvement of cognitive function in COVID-19 infections: is there a role for kynurenine 3-monooxygenase inhibition?	Drug Discov Today
33609730	Thermodynamic evaluation of the impact of DNA mismatches in PCR-type SARS-CoV-2 primers and probes.	Mol Cell Probes
33609650	The pro-inflammatory cytokines in COVID-19 pathogenesis: What goes wrong?	Microb Pathog
33609539	A double edged-sword - The Complement System during SARS-CoV-2 infection.	Life Sci
33609497	Testing of the inhibitory effects of loratadine and desloratadine on SARS-CoV-2 spike pseudotyped virus viropexis.	Chem Biol Interact
33609494	A potential interaction between the SARS-CoV-2 spike protein and nicotinic acetylcholine receptors.	Biophys J
33609410	Repurposing of thalidomide and its derivatives for the treatment of SARS-coV-2 infections: Hints on molecular action.	Br J Clin Pharmacol
33609255	A Review of Persistent Post-COVID Syndrome (PPCS).	Clin Rev Allergy Immunol
33609237	An Algorithm for Gene Fragment Reconstruction.	Interdiscip Sci
33609069	Prostate adenocarcinoma and COVID-19: The possible impacts of TMPRSS2 expressions in susceptibility to SARS-CoV-2.	J Cell Mol Med
33609027	Whole-genome Sequencing of SARS-CoV-2: Using Phylogeny and Structural Modeling to Contextualize Local Viral Evolution.	Mil Med
33608752	Screening and evaluation of anti-SARS-CoV-2 components from Ephedra sinica by ACE2/CMC-HPLC-IT-TOF-MS approach.	Anal Bioanal Chem
33608746	Pharmacological mechanism of immunomodulatory agents for the treatment of severe cases of COVID-19 infection.	Inflamm Res
33608656	COVID-19-from mucosal immunology to IBD patients.	Mucosal Immunol
33608566	Immune transcriptomes of highly exposed SARS-CoV-2 asymptomatic seropositive versus seronegative individuals from the Ischgl community.	Sci Rep
33608565	Flexibility and mobility of SARS-CoV-2-related protein structures.	Sci Rep
33608522	Evolution of immune responses to SARS-CoV-2 in mild-moderate COVID-19.	Nat Commun
33608407	SARS-CoV-2 and SARS-CoV Spike-Mediated Cell-Cell Fusion Differ in Their Requirements for Receptor Expression and Proteolytic Activation.	J Virol
33608189	Type I and III IFN-mediated antiviral actions counteracted by SARS-CoV-2 proteins and host inherited factors.	Cytokine Growth Factor Rev
33607929	N-Acetylcysteine and Hydrogen Sulfide in Coronavirus Disease 2019.	Antioxid Redox Signal
33607766	Novel signaling pathways regulate SARS-CoV and SARS-CoV-2 infectious disease.	Medicine (Baltimore)
33607405	A genetic insight into vitamin D binding protein and COVID-19.	Med Hypotheses
33607290	SARS CoV2 infection _The longevity study perspectives.	Ageing Res Rev
33607284	Variants in ACE2; potential influences on virus infection and COVID-19 severity.	Infect Genet Evol
33607159	"COVID-19, cytokines, inflammation, and spices: How are they related?"	Life Sci
33607132	Underscoring the immense potential of chitosan in fighting a wide spectrum of viruses: A plausible molecule against SARS-CoV-2?	Int J Biol Macromol
33607086	Biomechanical characterization of SARS-CoV-2 spike RBD and human ACE2 protein-protein interaction.	Biophys J
33606962	Experimental Models of SARS-CoV-2 Infection: Possible Platforms to Study COVID-19 Pathogenesis and Potential Treatments.	Annu Rev Pharmacol Toxicol
33606912	Virtual screening FDA approved drugs against multiple targets of SARS-CoV-2.	Clin Transl Sci
33606889	Re(I) Tricarbonyl Complexes as Coordinate Covalent Inhibitors for the SARS-CoV-2 Main Cysteine Protease.	Angew Chem Int Ed Engl
33606828	SARS-CoV-2 genetic diversity in Venezuela: Predominance of D614G variants and analysis of one outbreak.	PLoS One
33606823	Exploring novel and potent cell penetrating peptides in the proteome of SARS-COV-2 using bioinformatics approaches.	PLoS One
33606602	Postexposure Liponucleotide Prophylaxis and Treatment Attenuates Acute Respiratory Distress Syndrome in Influenza-infected Mice.	Am J Respir Cell Mol Biol
33606519	Simultaneous Inhibition of SARS-CoV-2 Entry Pathways by Cyclosporine.	ACS Chem Neurosci
33606395	"Atrial appendage angiotensin-converting enzyme-2, aging and cardiac surgical patients: a platform for understanding aging-related coronavirus disease-2019 vulnerabilities."	Curr Opin Anaesthesiol
33606070	Serum and CSF alpha-synuclein levels do not change in COVID-19 patients with neurological symptoms.	J Neurol
33605848	Advances of Inorganic Materials in the Detection and Therapeutic Uses Against Coronaviruses.	Curr Med Chem
33605822	The Role of the SARS-CoV-2 S-Protein Glycosylation in the Interaction of SARS-CoV-2/ACE2 and Immunological Responses.	Viral Immunol
33605735	Open Science Resources for the Mass Spectrometry-Based Analysis of SARS-CoV-2.	J Proteome Res
33605463	Toward an understanding of regulatory T cells in COVID-19: A systematic review.	J Med Virol
33605423	Susceptibility and Attenuated Transmissibility of SARS-CoV-2 in Domestic Cats.	J Infect Dis
33605421	Comparative Genomics Reveals Early Emergence and Biased Spatiotemporal Distribution of SARS-CoV-2.	Mol Biol Evol
33605367	Neurobiology of COVID-19: how can the virus affect the brain?	Braz J Psychiatry
33605244	"COVID-19: All Facts, No Myth."	Kathmandu Univ Med J (KUMJ)
33605109	The Recombination Potential between SARS-CoV-2 and MERS-CoV from Cross-Species Spill-over Infections.	J Epidemiol Glob Health
33604922	High-throughput detection of antibodies targeting the SARS-CoV-2 Spike in longitudinal convalescent plasma samples.	Transfusion
33604849	Use of Virus-Mimicking Nanoparticles to Investigate Early Infection Events in Upper Airway 3D Models.	Methods Mol Biol
33604809	Role of vitamin D in treating COVID-19-associated coagulopathy: problems and perspectives.	Mol Cell Biochem
33604758	The pulmonary pathology of COVID-19.	Virchows Arch
33604698	Multi-omics highlights ABO plasma protein as a causal risk factor for COVID-19.	Hum Genet
33604359	Microvascular Angiopathic Consequences of COVID-19.	Front Cardiovasc Med
33603870	Multifactorial expression of IL-6 with update on COVID-19 and the therapeutic strategies of its blockade (Review).	Exp Ther Med
33603759	Impaired Cellular Immunity to SARS-CoV-2 in Severe COVID-19 Patients.	Front Immunol
33603755	Legend of the Sentinels: Development of Lung Resident Memory T Cells and Their Roles in Diseases.	Front Immunol
33603116	Coinfection with influenza A virus enhances SARS-CoV-2 infectivity.	Cell Res
33603076	Temporal association between human upper respiratory and gut bacterial microbiomes during the course of COVID-19 in adults.	Commun Biol
33602998	"Molecular features similarities between SARS-CoV-2, SARS, MERS and key human genes could favour the viral infections and trigger collateral effects."	Sci Rep
33602939	The Y chromosome ancestry marker R1b1b2: a surrogate of the SARS-CoV-2 population affinity.	Hum Genome Var
33602937	Interleukin-3 is a predictive marker for severity and outcome during SARS-CoV-2 infections.	Nat Commun
33602867	SARS-CoV-2 M(pro) inhibitors with antiviral activity in a transgenic mouse model.	Science
33602693	SARS-CoV-2 genomic diversity and the implications for qRT-PCR diagnostics and transmission.	Genome Res
33602633	3D culture models to study SARS-CoV-2 infectivity and antiviral candidates: From spheroids to bioprinting.	Biomed J
33602511	Evolutionary and structural analysis elucidates mutations on SARS-CoV2 spike protein with altered human ACE2 binding affinity.	Biochem Biophys Res Commun
33602138	SARS-CoV-2 early infection signature identified potential key infection mechanisms and drug targets.	BMC Genomics
33602083	"Phyto-compounds from a rather poisonous plant, Strychnos nux-vomica, show high potency against SARS-CoV-2 RNA-dependent RNA polymerase."	Curr Mol Med
33602071	Viral Envelope Membrane: A Special Entry Pathway and a Promising Drug Target.	Curr Med Chem
33601392	The COVID-Kidney Controversy: Can SARS-CoV-2 Cause Direct Renal Infection?	Nephron
33601246	Type 2 diabetes mellitus impaired nasal immunity and increased the risk of hyposmia in COVID-19 mild pneumonia patients.	Int Immunopharmacol
33601098	Medical progress: Stem cells as a new therapeutic strategy for COVID-19.	Stem Cell Res
33600934	"Angiotensin-converting enzyme 2, coronavirus disease 2019, and abdominal aortic aneurysms."	J Vasc Surg
33600902	Smell and taste disorders in COVID-19: From pathogenesis to clinical features and outcomes.	Neurosci Lett
33600811	High expression of SARS-CoV-2 entry factors in human conjunctival goblet cells.	Exp Eye Res
33600673	"COVID-19: a review on SARS-CoV-2 origin, epidemiology, virology, clinical manifestations and complications with special emphasis on adverse outcome in Bhopal Gas Tragedy survivor."	Horm Mol Biol Clin Investig
33600624	Intracellular host cell membrane remodelling induced by SARS-CoV-2 infection in vitro.	Biol Cell
33600379	Aging imparts cell-autonomous dysfunction to regulatory T cells during recovery from influenza pneumonia.	JCI Insight
33600302	Difficulties in Differentiating Coronaviruses from Subcellular Structures in Human Tissues by Electron Microscopy.	Emerg Infect Dis
33600286	Dexamethasone and transdehydroandrosterone significantly reduce pulmonary epithelial cell injuries associated with mechanical ventilation.	J Appl Physiol (1985)
33599408	"[Pediatric COVID-19 - Pathophysiology, immune responses, genetic predispositions, hyperinflammatory syndrome]."	Rev Med Suisse
33599180	In silico prediction of SARS-CoV-2 main protease and polymerase inhibitors: 3D-Pharmacophore modelling.	J Biomol Struct Dyn
33597956	Cytokine Storm as a Cellular Response to dsDNA Breaks: A New Proposal.	Front Immunol
33597888	"Potency, Safety, and Pharmacokinetic Profiles of Potential Inhibitors Targeting SARS-CoV-2 Main Protease."	Front Pharmacol
33597826	Current mutatome of SARS-CoV-2 in Turkey reveals mutations of interest.	Turk J Biol
33597532	Dysregulated transcriptional responses to SARS-CoV-2 in the periphery.	Nat Commun
33597531	Innate cell profiles during the acute and convalescent phase of SARS-CoV-2 infection in children.	Nat Commun
33597253	Bepridil is potent against SARS-CoV-2 in vitro.	Proc Natl Acad Sci U S A
33597251	An engineered decoy receptor for SARS-CoV-2 broadly binds protein S sequence variants.	Sci Adv
33597220	Intranasal fusion inhibitory lipopeptide prevents direct-contact SARS-CoV-2 transmission in ferrets.	Science
33597174	Why Are Viruses Spiked?	mSphere
33596787	"Metabolomic profiling of three Araucaria species, and their possible potential role against COVID-19."	J Biomol Struct Dyn
33596407	Major role of IgM in the neutralizing activity of convalescent plasma against SARS-CoV-2.	Cell Rep
33596401	SARS-CoV-2 infection: Understanding the immune system abnormalities to get an adequate diagnosis.	Bosn J Basic Med Sci
33596266	"SARS-CoV-2 tropism, entry, replication, and propagation: Considerations for drug discovery and development."	PLoS Pathog
33596252	The analysis on the human protein domain targets and host-like interacting motifs for the MERS-CoV and SARS-CoV/CoV-2 infers the molecular mimicry of coronavirus.	PLoS One
33596239	High throughput detection and genetic epidemiology of SARS-CoV-2 using COVIDSeq next-generation sequencing.	PLoS One
33596235	Mapping major SARS-CoV-2 drug targets and assessment of druggability using computational fragment screening: Identification of an allosteric small-molecule binding site on the Nsp13 helicase.	PLoS One
33596218	Iota-carrageenan neutralizes SARS-CoV-2 and inhibits viral replication in vitro.	PLoS One
33596198	COVID-19 induces a hyperactive phenotype in circulating platelets.	PLoS Biol
33596158	"l-Cysteine Stimulates the Effect of Vitamin D on Inhibition of Oxidative Stress, IL-8, and MCP-1 Secretion in High Glucose Treated Monocytes."	J Am Coll Nutr
33596123	Adjusting extracellular pH to prevent entry of SARS-CoV-2 into human cells.	Genome
33595922	Detection of the SARS-CoV-2 D614G mutation using engineered Cas12a guide RNA.	Biotechnol J
33595856	Genetic variation analyses indicate conserved SARS-CoV-2-host interaction and varied genetic adaptation in immune response factors in modern human evolution.	Dev Growth Differ
33595761	Association of Antihypertensive Agents with the Risk of In-Hospital Death in Patients with Covid-19.	Cardiovasc Drugs Ther
33595720	Mutant strains of SARS-CoV-2 are more prone to infect obese patient: a review.	Wien Klin Wochenschr
33595589	ACE2 and COVID-19: An anthropological perspective.	Anthropol Anz
33594957	"Synthesis, structural, spectral, antioxidant, bioactivity and molecular docking investigations of a novel triazole derivative."	J Biomol Struct Dyn
33594850	In silico approach: docking study of oxindole derivatives against the main protease of COVID-19 and its comparison with existing therapeutic agents.	J Basic Clin Physiol Pharmacol
33594843	Evidence that Ginkgo Biloba could use in the influenza and coronavirus COVID-19 infections.	J Basic Clin Physiol Pharmacol
33594794	Severe acute respiratory syndrome-coronavirus-2 spike (S) protein based vaccine candidates: State of the art and future prospects.	Rev Med Virol
33594727	Nonstructural protein 7 and 8 complexes of SARS-CoV-2.	Protein Sci
33594342	Identification of potential antivirals against SARS-CoV-2 using virtual screening method.	Inform Med Unlocked
33594223	Respiratory viral co-infections among SARS-CoV-2 cases confirmed by virome capture sequencing.	Sci Rep
33594041	Predicting mammalian hosts in which novel coronaviruses can be generated.	Nat Commun
33593982	The Balance of Neutrophil Extracellular Trap Formation and Nuclease Degradation: an Unknown Role of Bacterial Coinfections in COVID-19 Patients?	mBio
33593941	A genomic region associated with protection against severe COVID-19 is inherited from Neandertals.	Proc Natl Acad Sci U S A
33593923	A systems-based method to repurpose marketed therapeutics for antiviral use: a SARS-CoV-2 case study.	Life Sci Alliance
33593784	Prospective meta-analysis protocol on randomised trials of renin-angiotensin system inhibitors in patients with COVID-19: an initiative of the International Society of Hypertension.	BMJ Open
33593727	The gut microbiome: a missing link in understanding the gastrointestinal manifestations of COVID-19?	Cold Spring Harb Mol Case Stud
33593661	Granulocyte macrophage colony-stimulating factor has come of age: From a vaccine adjuvant to antiviral immunotherapy.	Cytokine Growth Factor Rev
33593483	Scientific and pharmacological rationale for the treatment of cardiac damage caused by COVID-19.	Discov Med
33593376	mRNA vaccine: a potential therapeutic strategy.	Mol Cancer
33593260	Cross talk between COVID-19 and breast cancer.	Curr Cancer Drug Targets
33593248	The Role of Sialylation in Respiratory Viral Infection and Treatment.	Curr Med Chem
33593247	Evidence of protein binding by a nucleopeptide based on a thymine-decorated L-diaminopropanoic acid through CD and in silico studies.	Curr Med Chem
33593209	"Infection, inflammation and intervention: mechanistic modelling of epithelial cells in COVID-19."	J R Soc Interface
33593200	Coronavirus helicases: attractive and unique targets of antiviral drug-development and therapeutic patents.	Expert Opin Ther Pat
33592540	Myeloid-derived suppressor cells (MDSC): When good intentions go awry.	Cell Immunol
33592322	Role of arachidonic cascade in COVID-19 infection: A review.	Prostaglandins Other Lipid Mediat
33592317	Distinguishing SARS-CoV-2 bonafide re-infection from pre-existing minor variant reactivation.	Infect Genet Evol
33592201	Glossary of phytoconstituents: Can these be repurposed against SARS CoV-2? A quick in silico screening of various phytoconstituents from plant Glycyrrhiza glabra with SARS CoV-2 main protease.	Food Chem Toxicol
33592168	Comprehensive mapping of mutations in the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human plasma antibodies.	Cell Host Microbe
33592108	Data science in unveiling COVID-19 pathogenesis and diagnosis: evolutionary origin to drug repurposing.	Brief Bioinform
33592054	Angiotensin-converting enzyme 2 (ACE2) expression increases with age in patients requiring mechanical ventilation.	PLoS One
33591607	Implications of SARS-CoV-2 infection for neurogastroenterology.	Neurogastroenterol Motil
33591423	mRNA-Based Vaccines and Mode of Action.	Curr Top Microbiol Immunol
33591004	von Willebrand Factor Multimer Formation Contributes to Immunothrombosis in Coronavirus Disease 2019.	Crit Care Med
33590976	Oral manifestations of COVID-19: Brief review.	Dent Med Probl
33590968	SARS-CoV-2 infection remodels the host protein thermal stability landscape.	Mol Syst Biol
33590946	Hallmarks of the aging T-cell system.	FEBS J
33590936	Genetic and epigenetic factors associated with increased severity of Covid-19.	Cell Biol Int
33590931	Medicinal plants: Treasure for antiviral drug discovery.	Phytother Res
33590853	In vitro selection of an RNA aptamer yields an interleukin-6/interleukin-6 receptor interaction inhibitor.	Biosci Biotechnol Biochem
33590806	Repurposing drugs and identification of inhibitors of integral proteins (spike protein and main protease) of SARS-CoV-2.	J Biomol Struct Dyn
33590764	De novo design of new chemical entities for SARS-CoV-2 using artificial intelligence.	Future Med Chem
33590398	COVID-19: a new emerging respiratory disease from the neurological perspective.	Environ Sci Pollut Res Int
33589885	Persistence of SARS-CoV-2-specific B and T cell responses in convalescent COVID-19 patients 6-8 months after the infection.	Med (N Y)
33589882	"Antibody titers against SARS-CoV-2 decline, but do not disappear for several months."	EClinicalMedicine
33589845	Are vanadium complexes druggable against the main protease M(pro) of SARS-CoV-2? - A computational approach.	Inorganica Chim Acta
33589829	Potential intestinal infection and faecal-oral transmission of SARS-CoV-2.	Nat Rev Gastroenterol Hepatol
33589825	Humoral signatures of protective and pathological SARS-CoV-2 infection in children.	Nat Med
33589648	Analysis of SARS-CoV-2 mutations in the United States suggests presence of four substrains and novel variants.	Commun Biol
33589636	Discrete SARS-CoV-2 antibody titers track with functional humoral stability.	Nat Commun
33589624	Causal network models of SARS-CoV-2 expression and aging to identify candidates for drug repurposing.	Nat Commun
33588797	Renin-angiotensin system modulators and other risk factors in COVID-19 patients with hypertension: a Korean perspective.	BMC Infect Dis
33588727	Small-molecule antiviral agents in ongoing clinical trials for COVID-19.	Curr Drug Targets
33588719	Trefoil Factor Family (TFF) Peptides and their Different Roles in the Mucosal Innate Immune Defense and More: An Update.	Curr Med Chem
33588349	Epitope mimicry analysis of SARS-COV-2 surface proteins and human lung proteins.	J Mol Graph Model
33588235	"EGCG, a green tea polyphenol, inhibits human coronavirus replication in vitro."	Biochem Biophys Res Commun
33588180	Discovery and structural optimization of 3-O-beta-chacotriosyl oleanane-type triterpenoids as potent entry inhibitors of SARS-CoV-2 virus infections.	Eur J Med Chem
33588098	"Therapeutic approaches to coronavirus infection according to ""One Health"" concept."	Res Vet Sci
33588026	Variant analysis of SARS-CoV-2 genomes in the Middle East.	Microb Pathog
33587745	Roles of host small RNAs in the evolution and host tropism of coronaviruses.	Brief Bioinform
33587321	Oroxylin A is a severe acute respiratory syndrome coronavirus 2-spiked pseudotyped virus blocker obtained from Radix Scutellariae using angiotensin-converting enzyme II/cell membrane chromatography.	Phytother Res
33587268	Making sense of spike D614G in SARS-CoV-2 transmission.	Sci China Life Sci
33587177	"The triumvirate: why hypertension, obesity, and diabetes are risk factors for adverse effects in patients with COVID-19."	Acta Diabetol
33587028	"A comprehensive profile of genomic variations in the SARS-CoV-2 isolates from the state of Telangana, India."	J Gen Virol
33586810	Non-canonical autophagy functions of ATG16L1 in epithelial cells limit lethal infection by influenza A virus.	EMBO J
33586620	"Whole proteome screening and identification of potential epitopes of SARS-CoV-2 for vaccine design-an immunoinformatic, molecular docking and molecular dynamics simulation accelerated robust strategy."	J Biomol Struct Dyn
33586320	Mesenchymal stem cell immunomodulation: In pursuit of controlling COVID-19 related cytokine storm.	Stem Cells
33586288	Neutralizing antibodies targeting the SARS-CoV-2 receptor binding domain isolated from a naive human antibody library.	Protein Sci
33586189	"COVID-19: immunopathology, pathophysiological mechanisms, and treatment options."	J Pathol
33586020	Peripheral Nervous System Manifestations Associated with COVID-19.	Curr Neurol Neurosci Rep
33585889	Global Patterns of Recombination across Human Viruses.	Mol Biol Evol
33585826	"Evaluation of the susceptibility and fatality of lung cancer patients towards the COVID-19 infection: A systemic approach through analyzing the ACE2, CXCL10 and their co-expressed genes."	Curr Res Microb Sci
33585820	Mucosal immune responses in COVID19 - a living review.	Oxf Open Immunol
33585808	An update to monoclonal antibody as therapeutic option against COVID-19.	Biosaf Health
33585805	Quantitative assays reveal cell fusion at minimal levels of SARS-CoV-2 spike protein and fusion from without.	iScience
33585804	Transcriptomic profiling of SARS-CoV-2 infected human cell lines identifies HSP90 as target for COVID-19 therapy.	iScience
33585706	"Can Echinacea be a potential candidate to target immunity, inflammation, and infection - The trinity of coronavirus disease 2019."	Heliyon
33585567	SARS-CoV-2 and Glutamine: SARS-CoV-2 Triggered Pathogenesis via Metabolic Reprograming of Glutamine in Host Cells.	Front Mol Biosci
33585554	SARS-CoV-2 Proteins Exploit Host's Genetic and Epigenetic Mediators for the Annexation of Key Host Signaling Pathways.	Front Mol Biosci
33585520	ACE Gene I/D Polymorphism and Acute Pulmonary Embolism in COVID19 Pneumonia: A Potential Predisposing Role.	Front Med (Lausanne)
33585507	Functional Exhaustion of Type I and II Interferons Production in Severe COVID-19 Patients.	Front Med (Lausanne)
33585502	Structural Comparison of the SARS CoV 2 Spike Protein Relative to Other Human-Infecting Coronaviruses.	Front Med (Lausanne)
33585398	Microsecond MD Simulation and Multiple-Conformation Virtual Screening to Identify Potential Anti-COVID-19 Inhibitors Against SARS-CoV-2 Main Protease.	Front Chem
33585285	"Unraveling the Interconnection Patterns Across Lung Microbiome, Respiratory Diseases, and COVID-19."	Front Cell Infect Microbiol
33585155	Exploring the active constituents of Oroxylum indicum in intervention of novel coronavirus (COVID-19) based on molecular docking method.	Netw Model Anal Health Inform Bioinform
33585152	Screening of JAK-STAT modulators from the antiviral plants of Indian traditional system of medicine with the potential to inhibit 2019 novel coronavirus using network pharmacology.	3 Biotech
33585048	Evolutionary analysis and lineage designation of SARS-CoV-2 genomes.	Sci Bull (Beijing)
33584747	Development of Plant-Produced Recombinant ACE2-Fc Fusion Protein as a Potential Therapeutic Agent Against SARS-CoV-2.	Front Plant Sci
33584733	High Levels of Circulating IL-8 and Soluble IL-2R Are Associated With Prolonged Illness in Patients With Severe COVID-19.	Front Immunol
33584720	Infection Mechanism of SARS-COV-2 and Its Implication on the Nervous System.	Front Immunol
33584719	Cytokine Signature Induced by SARS-CoV-2 Spike Protein in a Mouse Model.	Front Immunol
33584712	Distinct Features and Functions of Systemic and Mucosal Humoral Immunity Among SARS-CoV-2 Convalescent Individuals.	Front Immunol
33584709	Reaction of Human Monoclonal Antibodies to SARS-CoV-2 Proteins With Tissue Antigens: Implications for Autoimmune Diseases.	Front Immunol
33584697	Cannabinoids as Key Regulators of Inflammasome Signaling: A Current Perspective.	Front Immunol
33584679	COVID-19: Imbalanced Immune Responses and Potential Immunotherapies.	Front Immunol
33584668	Induction of SARS-CoV-2 Protein S-Specific CD8+ T Cells in the Lungs of gp96-Ig-S Vaccinated Mice.	Front Immunol
33584662	Complement Activation in Kidneys of Patients With COVID-19.	Front Immunol
33584661	Initiation of Post-Primary Tuberculosis of the Lungs: Exploring the Secret Role of Bone Marrow Derived Stem Cells.	Front Immunol
33584656	"Key Components of Inflammasome and Pyroptosis Pathways Are Deficient in Canines and Felines, Possibly Affecting Their Response to SARS-CoV-2 Infection."	Front Immunol
33584506	"COVID-19 Pathophysiology Predicts That Ischemic Stroke Occurrence Is an Expectation, Not an Exception-A Systematic Review."	Front Neurol
33584343	Pathogenesis of Multiple Organ Injury in COVID-19 and Potential Therapeutic Strategies.	Front Physiol
33584335	The Impact of Polyphenols-Based Diet on the Inflammatory Profile in COVID-19 Elderly and Obese Patients.	Front Physiol
33584306	HIF Prolyl Hydroxylase Inhibitors for COVID-19 Treatment: Pros and Cons.	Front Pharmacol
33584285	Protective Effect of Arbidol Against Pulmonary Fibrosis and Sepsis in Mice.	Front Pharmacol
33584278	Biomarkers of Neurodegeneration and Precision Therapy in Retinal Disease.	Front Pharmacol
33584267	Nasal Delivery of Hesperidin/Chitosan Nanoparticles Suppresses Cytokine Storm Syndrome in a Mouse Model of Acute Lung Injury.	Front Pharmacol
33584265	"Research Advance on Qingfei Paidu Decoction in Prescription Principle, Mechanism Analysis and Clinical Application."	Front Pharmacol
33584070	Liver injury in the era of COVID-19.	World J Gastroenterol
33583971	Neutrophil Extracellular Traps: New Aspects.	Moscow Univ Biol Sci Bull
33583954	"Computational search for drug repurposing to identify potential inhibitors against SARS-COV-2 using Molecular Docking, QTAIM and IQA methods in viral Spike protein - Human ACE2 interface."	J Mol Struct
33583712	Pathophysiology and Imaging Findings of COVID-19 Infection: An Organ-system Based Review.	Acad Radiol
33583576	"Sex- or Gender-specific Differences in the Clinical Presentation, Outcome, and Treatment of SARS-CoV-2."	Clin Ther
33583366	Renin Angiotensin System in Central Nervous System diseases and its interaction with COVID-19.	Curr Med Chem
33583350	Anti-HIV-drug and phyto-flavonoid combination against SARS-CoV-2: a molecular docking-simulation base assessment.	J Biomol Struct Dyn
33583328	In silico identification and validation of natural antiviral compounds as potential inhibitors of SARS-CoV-2 methyltransferase.	J Biomol Struct Dyn
33583326	Structural genetics of circulating variants affecting the SARS-CoV-2 spike/human ACE2 complex.	J Biomol Struct Dyn
33583283	CT visual quantitative evaluation of hypertensive patients with coronavirus disease (COVID-19): Potential influence of angiotensin converting enzyme inhibitors / angiotensin receptor blockers on severity of lung involvement.	Clin Exp Hypertens
33583157	Overview of COVID-19 and neurological complications.	Rev Neurosci
33583045	Network Meta-Analysis on the Mechanisms Underlying Alcohol Augmentation of COVID-19 Pathologies.	Alcohol Clin Exp Res
33583003	Relationship between betacoronaviruses and the endocrine system: a new key to understand the COVID-19 pandemic-A comprehensive review.	J Endocrinol Invest
33582935	"Molecular docking, binding mode analysis, molecular dynamics, and prediction of ADMET/toxicity properties of selective potential antiviral agents against SARS-CoV-2 main protease: an effort toward drug repurposing to combat COVID-19."	Mol Divers
33582654	Neurological involvement in the respiratory manifestations of COVID-19 patients.	Aging (Albany NY)
33582547	Effect of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) on reproductive system.	Stem Cell Res
33582454	"Expression, purification and immunological characterization of recombinant nucleocapsid protein fragment from SARS-CoV-2."	Virology
33582450	Induced dysregulation of ACE2 by SARS-CoV-2 plays a key role in COVID-19 severity.	Biomed Pharmacother
33582369	"Pre-existing T-cell immunity to SARS-CoV-2 in unexposed healthy controls in Ecuador, as detected with a COVID-19 Interferon-Gamma Release Assay."	Int J Infect Dis
33582244	Immunogenicity and crossreactivity of antibodies to the nucleocapsid protein of SARS-CoV-2: utility and limitations in seroprevalence and immunity studies.	Transl Res
33582215	COVID-19 as a worldwide selective event and bitter taste receptor polymorphisms: An ecological correlational study.	Int J Biol Macromol
33581688	Chemical composition and pharmacological mechanism of ephedra-glycyrrhiza drug pair against coronavirus disease 2019 (COVID-19).	Aging (Albany NY)
33581501	Advances in immunotherapy for COVID-19: A comprehensive review.	Int Immunopharmacol
33581339	Compositional Variability and Mutation Spectra of Monophyletic SARS-CoV-2 Clades.	Genomics Proteomics Bioinformatics
33581321	A new horizon for the old antibacterial drug clofoctol.	Drug Discov Today
33581053	Human Erythroid Progenitors Are Directly Infected by SARS-CoV-2: Implications for Emerging Erythropoiesis in Severe COVID-19 Patients.	Stem Cell Reports
33580917	Breastfeeding importance and its therapeutic potential against SARS-CoV-2.	Physiol Rep
33580783	Functional alterations caused by mutations reflect evolutionary trends of SARS-CoV-2.	Brief Bioinform
33580768	[Effects of COVID-19 on the central nervous system].	Zh Nevrol Psikhiatr Im S S Korsakova
33580645	COVID-19 infection and stroke risk.	Rev Neurosci
33580566	"Background to new treatments for COVID-19, including its chronicity, through altering elements of the cytokine storm."	Rev Med Virol
33580518	Three salvianolic acids inhibit 2019-nCoV spike pseudovirus viropexis by binding to both its RBD and receptor ACE2.	J Med Virol
33580259	S-Variant SARS-CoV-2 Lineage B1.1.7 Is Associated With Significantly Higher Viral Load in Samples Tested by TaqPath Polymerase Chain Reaction.	J Infect Dis
33580175	Immunoreactive peptide maps of SARS-CoV-2.	Commun Biol
33580154	Human ACE2 peptide-mimics block SARS-CoV-2 pulmonary cells infection.	Commun Biol
33580132	"Phylogenomics reveals viral sources, transmission, and potential superinfection in early-stage COVID-19 patients in Ontario, Canada."	Sci Rep
33580111	"SARS-CoV-2 genomic surveillance in Rondonia, Brazilian Western Amazon."	Sci Rep
33579792	The effect of the D614G substitution on the structure of the spike glycoprotein of SARS-CoV-2.	Proc Natl Acad Sci U S A
33579725	The Inflammatory Factors Associated with Disease Severity to Predict COVID-19 Progression.	J Immunol
33579701	Insights into neutralizing antibody responses in individuals exposed to SARS-CoV-2 in Chile.	Sci Adv
33578849	Potential Role of Antioxidant and Anti-Inflammatory Therapies to Prevent Severe SARS-Cov-2 Complications.	Antioxidants (Basel)
33578831	"Field-Template, QSAR, Ensemble Molecular Docking, and 3D-RISM Solvation Studies Expose Potential of FDA-Approved Marine Drugs as SARS-CoVID-2 Main Protease Inhibitors."	Molecules
33578665	Serological Test to Determine Exposure to SARS-CoV-2: ELISA Based on the Receptor-Binding Domain of the Spike Protein (S-RBDN318-V510) Expressed in Escherichia coli.	Diagnostics (Basel)
33578631	Molecular Insights into the Thrombotic and Microvascular Injury in Placental Endothelium of Women with Mild or Severe COVID-19.	Cells
33578447	ABO blood group and COVID-19: a review on behalf of the ISBT COVID-19 working group.	Vox Sang
33578295	Age-dependent effects of the recombinant spike protein/SARS-CoV-2 on the M-CSF- and IL-34-differentiated macrophages in vitro.	Biochem Biophys Res Commun
33578036	Nanoluciferase complementation-based bioreporter reveals the importance of N-linked glycosylation of SARS-CoV-2 S for viral entry.	Mol Ther
33578018	The unbalanced p53/SIRT1 axis may impact lymphocyte homeostasis in COVID-19 patients.	Int J Infect Dis
33577820	Potential drug targets of SARS-CoV-2: From genomics to therapeutics.	Int J Biol Macromol
33577760	Leveraging the antiviral type I interferon system as a first line of defense against SARS-CoV-2 pathogenicity.	Immunity
33577445	Phylogenetic pattern of SARS-CoV-2 from COVID-19 patients from Bosnia and Herzegovina: lessons learned to optimize future molecular and epidemiological approaches.	Bosn J Basic Med Sci
33577324	"Kobophenol A Inhibits Binding of Host ACE2 Receptor with Spike RBD Domain of SARS-CoV-2, a Lead Compound for Blocking COVID-19."	J Phys Chem Lett
33577121	Innate Immune Cells and Hypertension: Neutrophils and Neutrophil Extracellular Traps (NETs).	Compr Physiol
33577115	"COVID-19: Current knowledge in clinical features, immunological responses, and vaccine development."	FASEB J
33577069	Pathogenesis of dysgeusia in COVID-19 patients: a scoping review.	Eur Rev Med Pharmacol Sci
33577068	Relationship between COVID-19 and the male reproductive system.	Eur Rev Med Pharmacol Sci
33576611	Predictive Modeling of Virus Inactivation by UV.	Environ Sci Technol
33576532	Improvement of caffeic acid biotransformation into para-hydroxybenzoic acid by Candida albicans CI-24 via gamma irradiation and model-based optimization.	Biotechnol Appl Biochem
33576494	High neutralizing potency of swine glyco-humanized polyclonal antibodies against SARS-CoV-2.	Eur J Immunol
33576464	Severe acute respiratory syndrome coronavirus 2 for physicians: Molecular characteristics and host immunity (Review).	Mol Med Rep
33576441	Determining available strategies for prevention and therapy: Exploring COVID19 from the perspective of ACE2 (Review).	Int J Mol Med
33576237	COVID-19: Are Non-Communicable Diseases Risk Factors for Its Severity?	Am J Health Promot
33576058	Halting SARS-CoV-2: lung organoids step up to the plate.	EMBO J
33575962	P2Y14 Receptor as a Target for Neutrophilia Attenuation in Severe COVID-19 Cases: From Hematopoietic Stem Cell Recruitment and Chemotaxis to Thrombo-inflammation.	Stem Cell Rev Rep
33575961	Results and Prospects of Using Activator of Hematopoietic Stem Cell Differentiation in Complex Therapy for Patients with COVID-19.	Stem Cell Rev Rep
33575887	[Histomorphological patterns of regional lymph nodes in COVID-19 lungs].	Pathologe
33575886	[Systemic consequences and clinical aspects of SARS-CoV-2 infection].	Pathologe
33575657	T cell phenotypes in COVID-19 - a living review.	Oxf Open Immunol
33575497	The Neutralizing Antibody Response against Severe Acute Respiratory Syndrome Coronavirus 2 and the Cytokine/Chemokine Release in Patients with Different Levels of Coronavirus Diseases 2019 Severity: Cytokine Storm Still Persists Despite Viral Disappearance in Critical Patients.	JMA J
33574990	Exploration of sex-specific and age-dependent COVID-19 fatality rate in Bangladesh population.	World J Radiol
33574769	Targeting Endolysosomal Two-Pore Channels to Treat Cardiovascular Disorders in the Novel COronaVIrus Disease 2019.	Front Physiol
33574768	COVID 19-Induced Smell and Taste Impairments: Putative Impact on Physiology.	Front Physiol
33574416	Identification of ebselen and its analogues as potent covalent inhibitors of papain-like protease from SARS-CoV-2.	Sci Rep
33574281	A genome-wide CRISPR screen identifies host factors that regulate SARS-CoV-2 entry.	Nat Commun
33574228	Post-exposure protection of SARS-CoV-2 lethal infected K18-hACE2 transgenic mice by neutralizing human monoclonal antibody.	Nat Commun
33574116	Pathophysiology of acute respiratory syndrome coronavirus 2 infection: a systematic literature review to inform EULAR points to consider.	RMD Open
33574104	"Coding-Complete Genome Sequences of NITMA1086 and NITMA1139, Two SARS-CoV-2 Isolates from Belagavi District, Karnataka State, India, Harboring the D614G Mutation."	Microbiol Resour Announc
33574037	SARS-CoV-2 infection induces protective immunity and limits transmission in Syrian hamsters.	Life Sci Alliance
33573850	The cytokine storm in COVID-19: Further advances in our understanding the role of specific chemokines involved.	Cytokine Growth Factor Rev
33573545	S.A.R.S Covid-19 A Medicinal Chemistry Approach.	Mini Rev Med Chem
33573430	"A Timely Call to Arms: COVID-19, the Circadian Clock, and Critical Care."	J Biol Rhythms
33573324	Research Progress on the Cardiac Injury from ACE2 Targeting in SARS-CoV-2 Infection.	Biomolecules
33573283	"Pseudo-Dipeptide Bearing alpha,alpha-Difluoromethyl Ketone Moiety as Electrophilic Warhead with Activity against Coronaviruses."	Int J Mol Sci
33573221	Potential SARS-CoV-2 Immune Correlates of Protection in Infection and Vaccine Immunization.	Pathogens
33573169	"Micronutrients, Phytochemicals and Mediterranean Diet: A Potential Protective Role against COVID-19 through Modulation of PAF Actions and Metabolism."	Nutrients
33573088	In Silico Study of Polyunsaturated Fatty Acids as Potential SARS-CoV-2 Spike Protein Closed Conformation Stabilizers: Epidemiological and Computational Approaches.	Molecules
33572938	Expression of the SARS-CoV-2 Receptor ACE2 and Proinflammatory Cytokines Induced by the Periodontopathic Bacterium Fusobacterium nucleatum in Human Respiratory Epithelial Cells.	Int J Mol Sci
33572857	"COVID-19: A Review on the Novel Coronavirus Disease Evolution, Transmission, Detection, Control and Prevention."	Viruses
33572760	Mucociliary Respiratory Epithelium Integrity in Molecular Defense and Susceptibility to Pulmonary Viral Infections.	Biology (Basel)
33572734	Nicotinic Acetylcholine Receptor Involvement in Inflammatory Bowel Disease and Interactions with Gut Microbiota.	Int J Environ Res Public Health
33572725	Effect of An 84-bp Deletion of the Receptor-Binding Domain on the ACE2 Binding Affinity of the SARS-CoV-2 Spike Protein: An In Silico Analysis.	Genes (Basel)
33572702	Immune Response to SARS-CoV-2 Infection in Obesity and T2D: Literature Review.	Vaccines (Basel)
33572467	Brilacidin Demonstrates Inhibition of SARS-CoV-2 in Cell Culture.	Viruses
33572452	Synthetic Messenger RNA-Based Vaccines: from Scorn to Hype.	Viruses
33572417	No Evidence for Classic Thrombotic Microangiopathy in COVID-19.	J Clin Med
33572332	Conjugation of Mannans to Enhance the Potency of Liposome Nanoparticles for the Delivery of RNA Vaccines.	Pharmaceutics
33572274	Understanding Viral Infection Mechanisms and Patient Symptoms for the Development of COVID-19 Therapeutics.	Int J Mol Sci
33572190	Molecular Epidemiology Surveillance of SARS-CoV-2: Mutations and Genetic Diversity One Year after Emerging.	Pathogens
33572117	Fluoxetine Can Inhibit SARS-CoV-2 In Vitro.	Microorganisms
33571819	Leflunomide an immunomodulator with antineoplastic and antiviral potentials but drug-induced liver injury: A comprehensive review.	Int Immunopharmacol
33571798	Exploring the efficacy of naturally occurring biflavone based antioxidants towards the inhibition of the SARS-CoV-2 spike glycoprotein mediated membrane fusion.	Virology
33571758	"Antihistamine and cationic amphiphilic drugs, old molecules as new tools against the COVID-19?"	Med Hypotheses
33571745	Immune response scenario and vaccine development for SARS-CoV-2 infection.	Int Immunopharmacol
33571742	COVID-19 and developmental origins of health and disease.	Early Hum Dev
33571544	Dissecting lipid metabolism alterations in SARS-CoV-2.	Prog Lipid Res
33571481	A certain proportion of docosahexaenoic acid tends to revert structural and dynamical effects of cholesterol on lipid membranes.	Biochim Biophys Acta Biomembr
33571429	Maturation and persistence of the anti-SARS-CoV-2 memory B cell response.	Cell
33571304	Multi-clonal SARS-CoV-2 neutralization by antibodies isolated from severe COVID-19 convalescent donors.	PLoS Pathog
33571241	In silico analysis suggests less effective MHC-II presentation of SARS-CoV-2 RBM peptides: Implication for neutralizing antibody responses.	PLoS One
33571169	Antibody responses to endemic coronaviruses modulate COVID-19 convalescent plasma functionality.	J Clin Invest
33571162	Durable SARS-CoV-2 B cell immunity after mild or severe disease.	J Clin Invest
33571146	Clonal dispersion of Acinetobacter baumannii in an intensive care unit designed to patients COVID-19.	J Infect Dev Ctries
33570681	The COVID-19 Pandemic: an Appraisal of its Impact on Human Immunodeficiency Virus Infection and Pre-Eclampsia.	Curr Hypertens Rep
33570492	The allosteric modulation of complement C5 by knob domain peptides.	Elife
33570490	The Spike D614G mutation increases SARS-CoV-2 infection of multiple human cell types.	Elife
33570381	Challenges for Targeting SARS-CoV-2 Proteases as a Therapeutic Strategy for COVID-19.	ACS Infect Dis
33570080	Challenges in estimating virus divergence times in short epidemic timescales with special reference to the evolution of SARS-CoV-2 pandemic.	Genet Mol Biol
33569967	Hepatic injury and COVID-19: pathogenic mechanisms or epiphenomena?	Rev Esp Enferm Dig
33569952	Enhanced Cholesterol-Dependent Hemifusion by Internal Fusion Peptide 1 of SARS Coronavirus-2 Compared to Its N-Terminal Counterpart.	Biochemistry
33569904	Amino acid sensing pathway: A major check point in the pathogenesis of obesity and COVID-19.	Obes Rev
33569701	The impact of immuno-aging on SARS-CoV-2 vaccine development.	Geroscience
33569606	COVID-19 and immunity: quo vadis?	Int Immunol
33569598	Integrated network analysis reveals new genes suggesting COVID-19 chronic effects and treatment.	Brief Bioinform
33569547	Hsp90 inhibition protects the brain microvascular endothelium against oxidative stress.	Brain Disord
33569392	Elucidating the Interactions Between Heparin/Heparan Sulfate and SARS-CoV-2-Related Proteins-An Important Strategy for Developing Novel Therapeutics for the COVID-19 Pandemic.	Front Mol Biosci
33569065	Therapies Targeting Trained Immune Cells in Inflammatory and Autoimmune Diseases.	Front Immunol
33568991	Tissue Distribution of ACE2 Protein in Syrian Golden Hamster (Mesocricetus auratus) and Its Possible Implications in SARS-CoV-2 Related Studies.	Front Pharmacol
33568930	Overview on the Discovery and Development of Anti-Inflammatory Drugs: Should the Focus Be on Synthesis or Degradation of PGE2?	J Inflamm Res
33568759	Genomic mutations and changes in protein secondary structure and solvent accessibility of SARS-CoV-2 (COVID-19 virus).	Sci Rep
33568715	Rapid seroconversion and persistent functional IgG antibodies in severe COVID-19 patients correlates with an IL-12p70 and IL-33 signature.	Sci Rep
33568700	Morphometry of SARS-CoV and SARS-CoV-2 particles in ultrathin plastic sections of infected Vero cell cultures.	Sci Rep
33568512	Porcine Epidemic Diarrhea Virus Infection Induces Caspase-8-Mediated G3BP1 Cleavage and Subverts Stress Granules To Promote Viral Replication.	J Virol
33568452	Molecular Evolution of Human Coronavirus 229E in Hong Kong and a Fatal COVID-19 Case Involving Coinfection with a Novel Human Coronavirus 229E Genogroup.	mSphere
33567843	The history of the emergence and transmission of human coronaviruses.	Onderstepoort J Vet Res
33567746	"SARS-CoV-2: An Update on Genomics, Risk Assessment, Potential Therapeutics and Vaccine Development."	Int J Environ Res Public Health
33567739	ERAP1 and ERAP2 Enzymes: A Protective Shield for RAS against COVID-19?	Int J Mol Sci
33567598	Host Diversity and Potential Transmission Pathways of SARS-CoV-2 at the Human-Animal Interface.	Pathogens
33567580	In Silico Investigation of the New UK (B.1.1.7) and South African (501Y.V2) SARS-CoV-2 Variants with a Focus at the ACE2-Spike RBD Interface.	Int J Mol Sci
33567524	Protein Expression of Angiotensin-Converting Enzyme 2 (ACE2) is Upregulated in Brains with Alzheimer's Disease.	Int J Mol Sci
33567448	mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants.	Nature
33567446	"Potential Interplay between Nrf2, TRPA1, and TRPV1 in Nutrients for the Control of COVID-19."	Int Arch Allergy Immunol
33567255	SARS-CoV-2 ORF9b inhibits RIG-I-MAVS antiviral signaling by interrupting K63-linked ubiquitination of NEMO.	Cell Rep
33567252	COVID-19 immune signatures reveal stable antiviral T cell function despite declining humoral responses.	Immunity
33567179	COVID-19 and pregnancy: are they friends or enemies?	Horm Mol Biol Clin Investig
33566951	Morphology and morphogenesis of SARS-CoV-2 in Vero-E6 cells.	Mem Inst Oswaldo Cruz
33566457	Age-related differences in the immune response could contribute to determine the spectrum of severity of COVID-19.	Immun Inflamm Dis
33566370	A pressor dose of angiotensin II has no influence on the angiotensin-converting enzyme 2 and other molecules associated with SARS-CoV-2 infection in mice.	FASEB J
33566210	"Photosynthetically Controlled Spirulina, but Not Solar Spirulina, Inhibits TNF-alpha Secretion: Potential Implications for COVID-19-Related Cytokine Storm Therapy."	Mar Biotechnol (NY)
33565617	The challenge of avidity determination in SARS-CoV-2 serology.	J Med Virol
33565387	Artificially expanded genetic information systems (AEGISs) as potent inhibitors of the RNA-dependent RNA polymerase of the SARS-CoV-2.	J Biomol Struct Dyn
33565127	Role of the SphK-S1P-S1PRs pathway in invasion of the nervous system by SARS-CoV-2 infection.	Clin Exp Pharmacol Physiol
33564990	Novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2) and Other Coronaviruses: A Genome-wide Comparative Annotation and Analysis.	Mol Cell Biochem
33564978	Single-cell transcriptomes of peripheral blood cells indicate and elucidate severity of COVID-19.	Sci China Life Sci
33564974	There are similarities between rheumatic disease with lung involvement and COVID-19 pneumonia.	Ir J Med Sci
33564749	Integrated immune dynamics define correlates of COVID-19 severity and antibody responses.	Cell Rep Med
33564691	Mutational hotspots and conserved domains of SARS-CoV-2 genome in African population.	Beni Suef Univ J Basic Appl Sci
33564683	"Comparison of Immune Response between SARS, MERS, and COVID-19 Infection, Perspective on Vaccine Design and Development."	Biomed Res Int
33564646	"How Our Neanderthal Genes Affect the COVID-19 Mortality: Iran and Mongolia, Two Countries with the Same SARS-CoV-2 Mutation Cluster but Different Mortality Rates."	J Biomed Phys Eng
33564310	ACE2 Is a Prognostic Biomarker and Associated with Immune Infiltration in Kidney Renal Clear Cell Carcinoma: Implication for COVID-19.	J Oncol
33564281	Unraveled roles of hyaluronan in severe COVID-19.	EXCLI J
33564258	Neopterin: A Promising Candidate Biomarker for Severe COVID-19.	J Inflamm Res
33564221	Structural modeling and analysis of the SARS-CoV-2 cell entry inhibitor camostat bound to the trypsin-like protease TMPRSS2.	Med Chem Res
33564211	Nano-size dependence in the adsorption by the SARS-CoV-2 spike protein over gold colloid.	Colloids Surf A Physicochem Eng Asp
33564093	Tipiracil binds to uridine site and inhibits Nsp15 endoribonuclease NendoU from SARS-CoV-2.	Commun Biol
33564056	Describing variability in pig genes involved in coronavirus infections for a One Health perspective in conservation of animal genetic resources.	Sci Rep
33564039	"Histone deacetylase inhibitors suppress ACE2 and ABO simultaneously, suggesting a preventive potential against COVID-19."	Sci Rep
33563978	Evidence for SARS-CoV-2 related coronaviruses circulating in bats and pangolins in Southeast Asia.	Nat Commun
33563974	Lasting antibody and T cell responses to SARS-CoV-2 in COVID-19 patients three months after infection.	Nat Commun
33563656	The Polybasic Cleavage Site in SARS-CoV-2 Spike Modulates Viral Sensitivity to Type I Interferon and IFITM2.	J Virol
33563543	"Interferons and other cytokines, genetics and beyond in COVID-19 and autoimmunity."	Cytokine Growth Factor Rev
33563320	CoronaHiT: high-throughput sequencing of SARS-CoV-2 genomes.	Genome Med
33563197	The Ineluctable Role of ACE-2 Receptors in SARS COV-2 Infection and Drug Repurposing as a Plausible SARS COV-2 Therapy : A Concise Treatise.	Curr Mol Med
33563186	"COVID-19: Our Current Knowledge of Epidemiology, Pathology, Therapeutic Approaches, and Diagnostic Methods."	Anticancer Agents Med Chem
33563156	Coumarins and Quinolones as Effective Multiple Targeted Agents Versus Covid-19: An in Silico Study.	Med Chem
33563150	Targeting Viral RNA-Dependent RNA Polymerases as an Antiviral Therapy.	Curr Med Chem
33563148	Nucleoside Inhibitors of Coronaviruses.	Curr Med Chem
33562645	"Animal Coronaviruses and SARS-COV-2 in Animals, What Do We Actually Know?"	Life (Basel)
33562472	"Tryptophan Metabolites and Aryl Hydrocarbon Receptor in Severe Acute Respiratory Syndrome, Coronavirus-2 (SARS-CoV-2) Pathophysiology."	Int J Mol Sci
33562321	Population Genomics Insights into the First Wave of COVID-19.	Life (Basel)
33562210	Silence of the Lambs: The Immunological and Molecular Mechanisms of COVID-19 in Children in Comparison with Adults.	Microorganisms
33562203	HIV mRNA Vaccines-Progress and Future Paths.	Vaccines (Basel)
33562193	Viral Infection and Cardiovascular Disease: Implications for the Molecular Basis of COVID-19 Pathogenesis.	Int J Mol Sci
33562141	Localized and Systemic Immune Responses against SARS-CoV-2 Following Mucosal Immunization.	Vaccines (Basel)
33562030	Therapeutic Potential of Resveratrol in COVID-19-Associated Hemostatic Disorders.	Molecules
33561864	SARS-CoV-2 infection is effectively treated and prevented by EIDD-2801.	Nature
33561649	"Repurposing potential of Ayurvedic medicinal plants derived active principles against SARS-CoV-2 associated target proteins revealed by molecular docking, molecular dynamics and MM-PBSA studies."	Biomed Pharmacother
33561624	"The potential use of lactate blockers for the prevention of COVID-19 worst outcome, insights from exercise immunology."	Med Hypotheses
33561300	Aptamer Blocking Strategy Inhibits SARS-CoV-2 Virus Infection.	Angew Chem Int Ed Engl
33560990	In silico prediction of new mutations that can improve the binding abilities between 2019-nCoV coronavirus and human ACE2.	IEEE/ACM Trans Comput Biol Bioinform
33560940	The in vitro antiviral activity of lactoferrin against common human coronaviruses and SARS-CoV-2 is mediated by targeting the heparan sulfate co-receptor.	Emerg Microbes Infect
33560482	Alterations in Phenotypes and Responses of T Cells Within 6 Months of Recovery from COVID-19: A Cohort Study.	Virol Sin
33560456	[COVID-19: effects on the lungs and heart].	Pathologe
33560402	Kinase inhibitors developed for treatment of hematologic malignancies: implications for immune modulation in COVID-19.	Blood Adv
33560365	Differentially conserved amino acid positions may reflect differences in SARS-CoV-2 and SARS-CoV behaviour.	Bioinformatics
33560122	Axial Chiral Binaphthoquinone and Perylenequinones from the Stromata of Hypocrella bambusae Are SARS-CoV-2 Entry Inhibitors.	J Nat Prod
33560054	Renin-angiotensin-system inhibitors and all-cause mortality in patients with COVID-19: a systematic review and meta-analysis of observational studies.	J Hypertens
33559937	Being pregnant in the COVID-19 pandemic: Effects on the placenta in all aspects.	J Med Virol
33559886	Receptors modulation on the ocular surface: A novel insight into the ocular infection and disease transmission of SARS-COV-2.	J Med Virol
33559848	The cytokine storm and thyroid hormone changes in COVID-19.	J Endocrinol Invest
33559368	Epidemiology and evolution of novel deltacoronaviruses in birds in central China.	Transbound Emerg Dis
33559328	Not just a pathogen: The importance of recognizing genetic variability to mitigate a wildlife pandemic.	Mol Ecol Resour
33559270	Soybean-associated endophytic fungi as potential source for anti-COVID-19 metabolites supported by docking analysis.	J Appl Microbiol
33559128	Human antiviral B cell responses: Emerging lessons from hepatitis B and COVID-19.	Immunol Rev
33558864	COVID-19 may affect male fertility but is not sexually transmitted: a systematic review.	F S Rev
33558863	Expression and purification of tag-free SARS-CoV-2 RNA-dependent RNA polymerase in Escherichia coli.	STAR Protoc
33558859	Genetic diversity and genomic epidemiology of SARS-CoV-2 in Morocco.	Biosaf Health
33558857	Proteomic investigation reveals dominant alterations of neutrophil degranulation and mRNA translation pathways in patients with COVID-19.	iScience
33558851	"SUMO pathway, blood coagulation and oxidative stress in SARS-CoV-2 infection."	Biochem Biophys Rep
33558827	Chemokines and chemokine receptors during COVID-19 infection.	Comput Struct Biotechnol J
33558807	Tracing the origins of SARS-COV-2 in coronavirus phylogenies: a review.	Environ Chem Lett
33558800	Photo-catalyzed TiO2 inactivates pathogenic viruses by attacking viral genome.	Chem Eng J
33558797	"Combined docking methods and molecular dynamics to identify effective antiviral 2, 5-diaminobenzophenonederivatives against SARS-CoV-2."	J King Saud Univ Sci
33558789	Role of food nutrients and supplementation in fighting against viral infections and boosting immunity: A review.	Trends Food Sci Technol
33558778	QSAR study of unsymmetrical aromatic disulfides as potent avian SARS-CoV main protease inhibitors using quantum chemical descriptors and statistical methods.	Chemometr Intell Lab Syst
33558724	"Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K and N501Y variants by BNT162b2 vaccine-elicited sera."	Nat Med
33558635	"Potent neutralization of clinical isolates of SARS-CoV-2 D614 and G614 variants by a monomeric, sub-nanomolar affinity nanobody."	Sci Rep
33558541	Distinct mechanisms for TMPRSS2 expression explain organ-specific inhibition of SARS-CoV-2 infection by enzalutamide.	Nat Commun
33558493	SARS-CoV-2 D614G spike mutation increases entry efficiency with enhanced ACE2-binding affinity.	Nat Commun
33558375	T Cell Phenotyping in Individuals Hospitalized with COVID-19.	J Immunol
33558299	"AT-527, a Double Prodrug of a Guanosine Nucleotide Analog, Is a Potent Inhibitor of SARS-CoV-2 In Vitro and a Promising Oral Antiviral for Treatment of COVID-19."	Antimicrob Agents Chemother
33558131	The roles and potential therapeutic implications of C5a in the pathogenesis of COVID-19-associated coagulopathy.	Cytokine Growth Factor Rev
33558040	Shifts in global bat diversity suggest a possible role of climate change in the emergence of SARS-CoV-1 and SARS-CoV-2.	Sci Total Environ
33558003	"Self-Reported Symptoms of COVID-19, Including Symptoms Most Predictive of SARS-CoV-2 Infection, Are Heritable."	Twin Res Hum Genet
33557911	Carboxypeptidase B blocks ex vivo activation of the anaphylatoxin-neutrophil extracellular trap axis in neutrophils from COVID-19 patients.	Crit Care
33557908	SARS-CoV-2 pneumonia-receptor binding and lung immunopathology: a narrative review.	Crit Care
33557330	SARS-CoV-2 Immuno-Pathogenesis and Potential for Diverse Vaccines and Therapies: Opportunities and Challenges.	Infect Dis Rep
33557301	"Biologic Drugs for Rheumatoid Arthritis in the Context of Biosimilars, Genetics, Epigenetics and COVID-19 Treatment."	Cells
33557278	Comparison of Antiviral Activity of Gemcitabine with 2'-Fluoro-2'-Deoxycytidine and Combination Therapy with Remdesivir against SARS-CoV-2.	Int J Mol Sci
33557253	"Predicting Potential SARS-COV-2 Drugs-In Depth Drug Database Screening Using Deep Neural Network Framework SSnet, Classical Virtual Screening and Docking."	Int J Mol Sci
33557213	"Evolution of SARS-CoV-2 Envelope, Membrane, Nucleocapsid, and Spike Structural Proteins from the Beginning of the Pandemic to September 2020: A Global and Regional Approach by Epidemiological Week."	Viruses
33557205	A Transcription Regulatory Sequence in the 5' Untranslated Region of SARS-CoV-2 Is Vital for Virus Replication with an Altered Evolutionary Pattern against Human Inhibitory MicroRNAs.	Cells
33557115	Combining Different Docking Engines and Consensus Strategies to Design and Validate Optimized Virtual Screening Protocols for the SARS-CoV-2 3CL Protease.	Molecules
33557097	In Silico Screening of Natural Products Isolated from Mexican Herbal Medicines against COVID-19.	Biomolecules
33556959	Circulating CD4 T Cells Elicited by Endemic Coronaviruses Display Vast Disparities in Abundance and Functional Potential Linked to Antigen Specificity and Age.	J Infect Dis
33556871	An update review of emerging small-molecule therapeutic options for COVID-19.	Biomed Pharmacother
33556653	The G614 pandemic SARS-CoV-2 variant is not more pathogenic than the original D614 form in adult Syrian hamsters.	Virology
33556646	Interaction of small molecules with the SARS-CoV-2 papain-like protease: In silico studies and in vitro validation of protease activity inhibition using an enzymatic inhibition assay.	J Mol Graph Model
33556628	FN3-based monobodies selective for the receptor binding domain of the SARS-CoV-2 spike protein.	N Biotechnol
33556558	SARS-CoV-2 mutation 614G creates an elastase cleavage site enhancing its spread in high AAT-deficient regions.	Infect Genet Evol
33556408	The Mechanism of SARS-CoV-2 Nucleocapsid Protein Recognition by the Human 14-3-3 Proteins.	J Mol Biol
33556379	Susceptibility of neuroblastoma and glioblastoma cell lines to SARS-CoV-2 infection.	Brain Res
33556247	Transcriptional and Metabolic Control of Memory B Cells and Plasma Cells.	Annu Rev Immunol
33556147	Multimerization- and glycosylation-dependent receptor binding of SARS-CoV-2 spike proteins.	PLoS Pathog
33555988	A novel DNA and protein combination COVID-19 vaccine formulation provides full protection against SARS-CoV-2 in rhesus macaques.	Emerg Microbes Infect
33555895	"Proteo-Genomic Analysis of SARS-CoV-2: A Clinical Landscape of Single-Nucleotide Polymorphisms, COVID-19 Proteome, and Host Responses."	J Proteome Res
33555378	"COVID-19: molecular pathophysiology, genetic evolution and prospective therapeutics-a review."	Arch Microbiol
33555346	The Heterogeneous Landscape and Early Evolution of Pathogen-Associated CpG Dinucleotides in SARS-CoV-2.	Mol Biol Evol
33554856	SARS-CoV-2 S protein:ACE2 interaction reveals novel allosteric targets.	Elife
33554747	Targeting the N-terminal domain of the RNA-binding protein of the SARS-CoV-2 with high affinity natural compounds to abrogate the protein-RNA interaction: a molecular dynamics study.	J Biomol Struct Dyn
33554684	SARS-CoV-2 invasion of the central nervous: a brief review.	Hosp Pract (1995)
33554218	Neuropathology of COVID-19 (neuro-COVID): clinicopathological update.	Free Neuropathol
33554119	Interpretable detection of novel human viruses from genome sequencing data.	NAR Genom Bioinform
33553941	SARSCOVIDB-A New Platform for the Analysis of the Molecular Impact of SARS-CoV-2 Viral Infection.	ACS Omega
33553808	"Bioinformatics analyses of significant genes, related pathways, and candidate diagnostic biomarkers and molecular targets in SARS-CoV-2/COVID-19."	Gene Rep
33553784	The molecular assessment of SARS-CoV-2 Nucleocapsid Phosphoprotein variants among Indian isolates.	Heliyon
33553708	Recent updates in the clinical trials of therapeutic monoclonal antibodies targeting cytokine storm for the management of COVID-19.	Heliyon
33553391	Clinical features and potential mechanism of coronavirus disease 2019-associated liver injury.	World J Clin Cases
33553231	"Dietary Fish, Fish Nutrients, and Immune Function: A Review."	Front Nutr
33553222	Vigilance on New-Onset Atherosclerosis Following SARS-CoV-2 Infection.	Front Med (Lausanne)
33553219	Can GPR4 Be a Potential Therapeutic Target for COVID-19?	Front Med (Lausanne)
33553109	Computational Characterizations of the Interactions Between the Pontacyl Violet 6R and Exoribonuclease as a Potential Drug Target Against SARS-CoV-2.	Front Chem
33552855	Caffeine-Operated Synthetic Modules for Chemogenetic Control of Protein Activities by Life Style.	Adv Sci (Weinh)
33552835	Mechanistic insight into anti-COVID-19 drugs: recent trends and advancements.	3 Biotech
33552834	Structural analysis of COVID-19 spike protein in recognizing the ACE2 receptor of different mammalian species and its susceptibility to viral infection.	3 Biotech
33552630	Peptides-based vaccine against SARS-nCoV-2 antigenic fragmented synthetic epitopes recognized by T cell and beta-cell initiation of specific antibodies to fight the infection.	Biodes Manuf
33552515	Reviewing immunopathology characteristics of SARS-CoV-2 for cancer entwisted with SARS-CoV-2.	SAGE Open Med
33552508	Pattern of circulating SARS-CoV-2-specific antibody-secreting and memory B-cell generation in patients with acute COVID-19.	Clin Transl Immunology
33552444	Current concepts in the development of therapeutics against human and animal coronavirus diseases by targeting NP.	Comput Struct Biotechnol J
33552306	Deep Learning-Based Potential Ligand Prediction Framework for COVID-19 with Drug-Target Interaction Model.	Cognit Comput
33552070	"Living in a Hostile World: Inflammation, New Drug Development, and Coronavirus."	Front Immunol
33552069	Delving Into the Origin of Destructive Inflammation in COVID-19: A Betrayal of Natural Host Defense Peptides?	Front Immunol
33552062	Cytokine Storm in Coronavirus Disease 2019 and Adult-Onset Still's Disease: Similarities and Differences.	Front Immunol
33551947	The Spatial and Cell-Type Distribution of SARS-CoV-2 Receptor ACE2 in the Human and Mouse Brains.	Front Neurol
33551833	CSF3 Is a Potential Drug Target for the Treatment of COVID-19.	Front Physiol
33551831	A Potential Role of the Renin-Angiotensin-System for Disturbances of Respiratory Chemosensitivity in Acute Respiratory Distress Syndrome and Severe Acute Respiratory Syndrome.	Front Physiol
33551727	Novel Targets of SARS-CoV-2 Spike Protein in Human Fetal Brain Development Suggest Early Pregnancy Vulnerability.	Front Neurosci
33551714	Critical roles of TLRs on the polarization of mesenchymal stem cells for cell therapy of viral infections: a notice for COVID-19 treatment.	Comp Clin Path
33551672	The COVID-19 puzzle: a global nightmare.	Environ Dev Sustain
33551661	Computational drug screening against the SARS-CoV-2 Saudi Arabia isolates through a multiple-sequence alignment approach.	Saudi J Biol Sci
33551489	"Magnesium and Vitamin D Deficiency as a Potential Cause of Immune Dysfunction, Cytokine Storm and Disseminated Intravascular Coagulation in covid-19 patients."	Mo Med
33551236	"The need for precision nutrition, genetic variation and resolution in Covid-19 patients."	Mol Aspects Med
33551039	The Influence of Immune Immaturity on Outcome After Virus Infections.	J Allergy Clin Immunol Pract
33550983	COVID-19 and cytokine storm syndrome: can what we know about interleukin-6 in ovarian cancer be applied?	J Ovarian Res
33550970	Coronavirus (COVID -19): Chemical entities of biological interest.	Mini Rev Med Chem
33550966	The Computational Intervention of Macrolide Antibiotics in the Treatment of COVID-19.	Curr Pharm Des
33550892	Microbiota-derived short-chain fatty acids do not interfere with SARS-CoV-2 infection of human colonic samples.	Gut Microbes
33550782	CNS implications of COVID-19: a comprehensive review.	Rev Neurosci
33550780	Neurological involvement of COVID-19: from neuroinvasion and neuroimmune crosstalk to long-term consequences.	Rev Neurosci
33550350	[Homologous modeling and binding ability analysis of Spike protein after point mutation of severe acute respiratory syndrome coronavirus 2 to receptor proteins and potential antiviral drugs].	Beijing Da Xue Xue Bao Yi Xue Ban
33550276	The age pattern of the male-to-female ratio in mortality from COVID-19 mirrors that of cardiovascular disease in the general population.	Aging (Albany NY)
33550179	Advance of structural modification of nucleosides scaffold.	Eur J Med Chem
33550140	Structural insights into SARS-CoV-2 infection and therapeutics development.	Stem Cell Res
33550050	SARS-CoV-2: From the pathogenesis to potential anti-viral treatments.	Biomed Pharmacother
33550034	"Clinically relevant cell culture models and their significance in isolation, pathogenesis, vaccine development, repurposing and screening of new drugs for SARS-CoV-2: a systematic review."	Tissue Cell
33549714	Mutational analysis and assessment of its impact on proteins of SARS-CoV-2 genomes from India.	Gene
33549696	A role for pathogen risk factors and autoimmunity in encephalitis lethargica?	Prog Neuropsychopharmacol Biol Psychiatry
33549591	Health disparities: Intracellular consequences of social determinants of health.	Toxicol Appl Pharmacol
33549572	Genetic conservation of SARS-CoV-2 RNA replication complex in globally circulating isolates and recently emerged variants from humans and minks suggests minimal pre-existing resistance to remdesivir.	Antiviral Res
33548839	Evaluating the effects of cardiometabolic exposures on circulating proteins which may contribute to severe SARS-CoV-2.	EBioMedicine
33548599	Detecting SARS-CoV-2 3CLpro expression and activity using a polyclonal antiserum and a luciferase-based biosensor.	Virology
33548496	"The three frontlines against COVID-19: Brain, Behavior, and Immunity."	Brain Behav Immun
33548481	Pronounce expression of Tim-3 and CD39 but not PD1 defines CD8 T cells in critical Covid-19 patients.	Microb Pathog
33548321	Targeting C-terminal Helical bundle of NCOVID19 Envelope (E) protein.	Int J Biol Macromol
33548314	"Epigallocatechin-3-gallate, an active ingredient of Traditional Chinese Medicines, inhibits the 3CLpro activity of SARS-CoV-2."	Int J Biol Macromol
33548227	How glycobiology can help us treat and beat the COVID-19 pandemic.	J Biol Chem
33548198	Genomic monitoring of SARS-CoV-2 uncovers an Nsp1 deletion variant that modulates type I interferon response.	Cell Host Microbe
33547819	Inflammatory Cytokine Patterns Associated with Neurological Diseases in Coronavirus Disease 2019.	Ann Neurol
33547593	Murine-beta-coronavirus-induced neuropathogenesis sheds light on CNS pathobiology of SARS-CoV2.	J Neurovirol
33547426	Immune cartography of macrophage activation syndrome in the COVID-19 era.	Nat Rev Rheumatol
33547334	An in silico deep learning approach to multi-epitope vaccine design: a SARS-CoV-2 case study.	Sci Rep
33547281	Structure and binding properties of Pangolin-CoV spike glycoprotein inform the evolution of SARS-CoV-2.	Nat Commun
33547084	Nsp1 protein of SARS-CoV-2 disrupts the mRNA export machinery to inhibit host gene expression.	Sci Adv
33547083	A lymph node-targeted Amphiphile vaccine induces potent cellular and humoral immunity to SARS-CoV-2.	Sci Adv
33547029	"Tuberculosis and COVID-19 interaction: A review of biological, clinical and public health effects."	Pulmonology
33546902	Predictive immunogenetic markers in COVID-19.	Hum Immunol
33546870	Immunoinformatics Approach for the Identification and Characterization of T Cell and B Cell Epitopes towards the Peptide-Based Vaccine against SARS-CoV-2.	Arch Med Res
33546734	Management of Renin-Angiotensin-Aldosterone System blockade in patients admitted to hospital with confirmed coronavirus disease (COVID-19) infection (The McGill RAAS-COVID- 19): A structured summary of a study protocol for a randomized controlled trial.	Trials
33546489	Mucosal-Associated Invariant T (MAIT) Cells Are Highly Activated and Functionally Impaired in COVID-19 Patients.	Viruses
33546463	Neurological Sequelae in Patients with COVID-19: A Histopathological Perspective.	Int J Environ Res Public Health
33546347	COVID-19 Vaccination: From Interesting Agent to the Patient.	Vaccines (Basel)
33546185	"Thapsigargin Is a Broad-Spectrum Inhibitor of Major Human Respiratory Viruses: Coronavirus, Respiratory Syncytial Virus and Influenza A Virus."	Viruses
33545711	SARS-CoV-2 evolution during treatment of chronic infection.	Nature
33545635	RNA sequence and ligand binding alter conformational profile of SARS-CoV-2 stem loop II motif.	Biochem Biophys Res Commun
33545556	Potential APOBEC-mediated RNA editing of the genomes of SARS-CoV-2 and other coronaviruses and its impact on their longer term evolution.	Virology
33545161	"Chloroquine: Autophagy inhibitor, antimalarial, bitter taste receptor agonist in fight against COVID-19, a reality check?"	Eur J Pharmacol
33545052	Cross-reactivity of SARS-CoV structural protein antibodies against SARS-CoV-2.	Cell Rep
33544838	Auto-antibodies to type I IFNs can underlie adverse reactions to yellow fever live attenuated vaccine.	J Exp Med
33544733	"Molecular characterization and the mutation pattern of SARS-CoV-2 during first and second wave outbreaks in Hiroshima, Japan."	PLoS One
33544720	SAveRUNNER: A network-based algorithm for drug repurposing and its application to COVID-19.	PLoS Comput Biol
33544528	COVID-19 and nutritional deficiency: a review of existing knowledge.	Horm Mol Biol Clin Investig
33544511	COVID-19 and cardiovascular disease: a review of current knowledge.	Horm Mol Biol Clin Investig
33544398	Epithelial response to IFN-gamma promotes SARS-CoV-2 infection.	EMBO Mol Med
33544324	A Role for Extracellular Vesicles in SARS-CoV-2 Therapeutics and Prevention.	J Neuroimmune Pharmacol
33544293	Clinical outcome of renin-angiotensin-aldosterone system blockers in treatment of hypertensive patients with COVID-19: a systematic review and meta-analysis.	Egypt Heart J
33544010	Short Communication:Evidence of Novel SARS-CoV-2 Variants Circulation in Romania.	AIDS Res Hum Retroviruses
33543899	"Sex, Hormones, Immune Functions, and Susceptibility to Coronavirus Disease 2019 (COVID-19)-Related Morbidity."	Obstet Gynecol
33543652	Immune checkpoint inhibition in COVID-19: risks and benefits.	Expert Opin Biol Ther
33543236	Potential Interaction Between SARS-CoV-2 and Thyroid: A Review.	Endocrinology
33542929	Peripheral Inflammatory Cytokines and Lymphocyte Subset Features of Deceased COVID-19 Patients.	Biomed Res Int
33542917	In silico Screening of Natural Compounds as Potential Inhibitors of SARS-CoV-2 Main Protease and Spike RBD: Targets for COVID-19.	Front Mol Biosci
33542724	SP-A and SP-D: Dual Functioning Immune Molecules With Antiviral and Immunomodulatory Properties.	Front Immunol
33542445	Pharmacogenomics and COVID-19: clinical implications of human genome interactions with repurposed drugs.	Pharmacogenomics J
33542420	Dynamics of binding ability prediction between spike protein and human ACE2 reveals the adaptive strategy of SARS-CoV-2 in humans.	Sci Rep
33542325	DNA-launched RNA replicon vaccines induce potent anti-SARS-CoV-2 immune responses in mice.	Sci Rep
33542252	Sensitive mass spectrometric determination of kinin-kallikrein system peptides in light of COVID-19.	Sci Rep
33542028	Potent and Selective Knockdown of Tyrosine Kinase 2 by Antisense Oligonucleotides.	Immunohorizons
33541739	Differential Expression of Rab5 and Rab7 Small GTPase Proteins in Placental Tissues From Pregnancies Affected by Maternal Coronavirus Disease 2019.	Clin Ther
33540924	A Neutralization Assay Based on Pseudo-Typed Lentivirus with SARS CoV-2 Spike Protein in ACE2-Expressing CRFK Cells.	Pathogens
33540713	The SARS-CoV-2-Inactivating Activity of Hydroxytyrosol-Rich Aqueous Olive Pulp Extract (HIDROX((R))) and Its Use as a Virucidal Cream for Topical Application.	Viruses
33540664	miR-24 Targets the Transmembrane Glycoprotein Neuropilin-1 in Human Brain Microvascular Endothelial Cells.	Noncoding RNA
33540583	Mechanisms of Coronavirus Nsp1-Mediated Control of Host and Viral Gene Expression.	Cells
33540576	Genomic Signatures of SARS-CoV-2 Associated with Patient Mortality.	Viruses
33540487	"An Androsterone-H2 @C60 hybrid: Synthesis, Properties and Molecular Docking Simulations with SARS-Cov-2."	Chempluschem
33540371	"Profiling of the immune repertoire in COVID-19 patients with mild, severe, convalescent, or retesting-positive status."	J Autoimmun
33540085	ABO phenotype and SARS-CoV-2 infection: Is there any correlation?	Infect Genet Evol
33540040	Importance of glutamine 189 flexibility in SARS-CoV-2 main protease: Lesson learned from in silico virtual screening of ChEMBL database and molecular dynamics.	Eur J Pharm Sci
33539890	"FunCoup 5: Functional Association Networks in All Domains of Life, Supporting Directed Links and Tissue-Specificity."	J Mol Biol
33539853	Microarray patches enable the development of skin-targeted vaccines against COVID-19.	Adv Drug Deliv Rev
33539819	SARS-CoV-2 entry inhibitors by dual targeting TMPRSS2 and ACE2: An in silico drug repurposing study.	Eur J Pharmacol
33539765	Zooanthroponotic potential of SARS-CoV-2 and implications of reintroduction into human populations.	Cell Host Microbe
33539638	"A novel allele, HLA-C*15:227, identified when typing COVID-19 patients."	HLA
33539530	Diseasome and comorbidities complexities of SARS-CoV-2 infection with common malignant diseases.	Brief Bioinform
33539484	Three-dimensional chromatin in infectious disease-A role for gene regulation and pathogenicity?	PLoS Pathog
33539316	Renin-angiotensin-aldosterone system peptide profiles in patients with COVID-19.	Eur J Endocrinol
33539214	Rationale for the Role of Heparin and Related GAG Antithrombotics in COVID-19 Infection.	Clin Appl Thromb Hemost
33539188	Secretion of von Willebrand Factor and Suppression of ADAMTS-13 Activity by Markedly High Concentration of Ferritin.	Clin Appl Thromb Hemost
33539089	Recent Developments in the Use of Kinase Inhibitors for Management of Viral Infections.	J Med Chem
33539086	Virus-Like Particles as Positive Controls for COVID-19 RT-LAMP Diagnostic Assays.	Biomacromolecules
33538960	Potential Effects of COVID-19 on Cytochrome P450-Mediated Drug Metabolism and Disposition in Infected Patients.	Eur J Drug Metab Pharmacokinet
33538817	Myeloid cell dynamics correlating with clinical outcomes of severe COVID-19 in Japan.	Int Immunol
33538596	Targeting SARS-CoV-2 M3CLpro by HCV NS3/4a Inhibitors: In Silico Modeling and In Vitro Screening.	J Chem Inf Model
33538586	Persistent Brainstem Dysfunction in Long-COVID: A Hypothesis.	ACS Chem Neurosci
33538189	Dangerous liaisons? The role of inflammation and comorbidities in HIV and SARS-CoV-2 infection.	Expert Rev Clin Immunol
33537958	Systematic Network and Meta-analysis on the Antiviral Mechanisms of Probiotics: A Preventive and Treatment Strategy to Mitigate SARS-CoV-2 Infection.	Probiotics Antimicrob Proteins
33537555	Aging- and gender-related modulation of RAAS: potential implications in COVID-19 disease.	Vasc Biol
33537347	Thrombosis and Coagulopathy in COVID-19: Current Understanding and Implications for Antithrombotic Treatment in Patients Treated With Percutaneous Coronary Intervention.	Front Cardiovasc Med
33537342	Mechanisms of Pulmonary Hypertension in Acute Respiratory Distress Syndrome (ARDS).	Front Mol Biosci
33537341	"Deletion of BST2 Cytoplasmic and Transmembrane N-Terminal Domains Results in SARS-CoV, SARS-CoV-2, and Influenza Virus Production Suppression in a Vero Cell Line."	Front Mol Biosci
33537336	"COVID-19, COPD, and AECOPD: Immunological, Epidemiological, and Clinical Aspects."	Front Med (Lausanne)
33537261	Cross-Immunization Against Respiratory Coronaviruses May Protect Children From SARS-CoV2: More Than a Simple Hypothesis?	Front Pediatr
33537060	"The Dynamic Expression of Potential Mediators of Severe Acute Respiratory Syndrome Coronavirus 2 Cellular Entry in Fetal, Neonatal, and Adult Rhesus Monkeys."	Front Genet
33536639	SARS-CoV-2 infects and replicates in cells of the human endocrine and exocrine pancreas.	Nat Metab
33536629	Treatment of influenza and SARS-CoV-2 infections via mRNA-encoded Cas13a in rodents.	Nat Biotechnol
33536486	Dysregulation of lipid metabolism and pathological inflammation in patients with COVID-19.	Sci Rep
33536425	A single-dose mRNA vaccine provides a long-term protection for hACE2 transgenic mice from SARS-CoV-2.	Nat Commun
33536258	Recurrent deletions in the SARS-CoV-2 spike glycoprotein drive antibody escape.	Science
33536218	A diagnostic host response biosignature for COVID-19 from RNA profiling of nasal swabs and blood.	Sci Adv
33536217	Leveraging systems biology for predicting modulators of inflammation in patients with COVID-19.	Sci Adv
33536081	Genetic variants are identified to increase risk of COVID-19 related mortality from UK Biobank data.	Hum Genomics
33535951	Molecular Elucidation and Therapeutic Targeting for combating COVID19: Current Scenario and Future Prospective.	Curr Mol Med
33535950	Natural substances and semisynthetic derivatives as potential alternative products against SARS-CoV-2.	Mini Rev Med Chem
33535692	IgM and IgG Profiles Reveal Peculiar Features of Humoral Immunity Response to SARS-CoV-2 Infection.	Int J Environ Res Public Health
33535496	Cancer Related Anemia: An Integrated Multitarget Approach and Lifestyle Interventions.	Nutrients
33535459	"Native High-Density Lipoproteins (HDL) with Higher Paraoxonase Exerts a Potent Antiviral Effect against SARS-CoV-2 (COVID-19), While Glycated HDL Lost the Antiviral Activity."	Antioxidants (Basel)
33535388	Targeting NSP16 Methyltransferase for the Broad-Spectrum Clinical Management of Coronaviruses: Managing the Next Pandemic.	Diseases
33535236	Dynamics of Neutralizing Antibody Titers in the Months After Severe Acute Respiratory Syndrome Coronavirus 2 Infection.	J Infect Dis
33535230	jSRC: a flexible and accurate joint learning algorithm for clustering of single-cell RNA-sequencing data.	Brief Bioinform
33535156	Eyes on coronavirus.	Stem Cell Res
33535144	Analogue discovery of safer alternatives to HCQ and CQ drugs for SAR-CoV-2 by computational design.	Comput Biol Med
33535105	Introduction into the Marseille geographical area of a mild SARS-CoV-2 variant originating from sub-Saharan Africa: An investigational study.	Travel Med Infect Dis
33535027	Identification of SARS-CoV-2 spike mutations that attenuate monoclonal and serum antibody neutralization.	Cell Host Microbe
33534923	Innate and adaptive immune responses to SARS-CoV-2 in humans: relevance to acquired immunity and vaccine responses.	Clin Exp Immunol
33534852	"Uncovering potential host proteins and pathways that may interact with eukaryotic short linear motifs in viral proteins of MERS, SARS and SARS2 coronaviruses that infect humans."	PLoS One
33534793	ViralLink: An integrated workflow to investigate the effect of SARS-CoV-2 on intracellular signalling and regulatory pathways.	PLoS Comput Biol
33534765	COVID-19 Infection in the Human Reproductive Tract of Men and Nonpregnant Women.	Am J Trop Med Hyg
33534552	Toolkit for Quickly Generating and Characterizing Molecular Probes Specific for SARS-CoV-2 Nucleocapsid as a Primer for Future Coronavirus Pandemic Preparedness.	ACS Synth Biol
33534399	Immunopathological Roles of Neutrophils in Virus Infection and COVID-19.	Shock
33534131	Potential mechanisms of cerebrovascular diseases in COVID-19 patients.	J Neurovirol
33534108	Repurposing of Tetracyclines for COVID-19 Neurological and Neuropsychiatric Manifestations: A Valid Option to Control SARS-CoV-2-Associated Neuroinflammation?	J Neuroimmune Pharmacol
33533916	SARS-CoV-2 induces human plasmacytoid predendritic cell diversification via UNC93B and IRAK4.	J Exp Med
33533915	Persistent cellular immunity to SARS-CoV-2 infection.	J Exp Med
33533428	Prediction of Single Point Mutations in Human Coronavirus and Their Effects on Binding to 9-O-Acetylated Sialic Acid and Hidroxychloroquine.	Acta Chim Slov
33533409	The male disadvantage in life expectancy: can we close the gender gap?	Int Health
33533405	ACE2 and energy metabolism: the connection between COVID-19 and chronic metabolic disorders.	Clin Sci (Lond)
33533266	Age-associated Ligand-receptor Interactions Imputed from Nasopharyngeal Transcriptomes of COVID-19 Patients.	Immunol Invest
33533219	[The use of viral RNA polymerase inhibitors in combination with a fusion inhibitor in the treatment of patients with COVID-19: hypothesis].	Vopr Virusol
33533208	"[Formation of population gene pools of zoonotic viruses, potentially threatening biosafety]."	Vopr Virusol
33533178	Graphene Sheets with Defined Dual Functionalities for the Strong SARS-CoV-2 Interactions.	Small
33533071	Long non-coding RNAs: Promising new targets in pulmonary fibrosis.	J Gene Med
33533060	Isoelectric point determination by imaged CIEF of commercially available SARS-CoV-2 proteins and the hACE2 receptor.	Electrophoresis
33532909	Computational and Experimental Studies Reveal That Thymoquinone Blocks the Entry of Coronaviruses Into In Vitro Cells.	Infect Dis Ther
33532709	Mutational signatures and heterogeneous host response revealed via large-scale characterization of SARS-CoV-2 genomic diversity.	iScience
33532701	The Vagal Autonomic Pathway of COVID-19 at the Crossroad of Alzheimer's Disease and Aging: A Review of Knowledge.	J Alzheimers Dis Rep
33532671	From genomes to molecular dynamics - A bottom up approach in extrication of SARS CoV-2 main protease inhibitors.	Comput Toxicol
33532652	ACE2 and FURIN variants are potential predictors of SARS-CoV-2 outcome: A time to implement precision medicine against COVID-19.	Heliyon
33532640	Potential compounds from several Indonesian plants to prevent SARS-CoV-2 infection: A mini-review of SARS-CoV-2 therapeutic targets.	Heliyon
33532600	A narrative review of the pathophysiology of COVID-19 infection among cancer patients: Current evidence and research perspectives.	Health Sci Rep
33532517	In silico virtual screening-based study of nutraceuticals predicts the therapeutic potentials of folic acid and its derivatives against COVID-19.	Virusdisease
33532377	COVID-19 reinfection: Linked Possibilities and future outlook.	J Family Med Prim Care
33532126	Prediction of SARS-CoV Interaction with Host Proteins during Lung Aging Reveals a Potential Role for TRIB3 in COVID-19.	Aging Dis
33532123	Low level of Vitamin C and dysregulation of Vitamin C transporter might be involved in the severity of COVID-19 Infection.	Aging Dis
33532071	"Influenza, but not SARS-CoV-2, infection induces a rapid interferon response that wanes with age and diminished tissue-resident memory CD8(+) T cells."	Clin Transl Immunology
33531865	Aurintricarboxylic acid and its metal ion complexes in comparative virtual screening versus Lopinavir and Hydroxychloroquine in fighting COVID-19 pandemic: Synthesis and characterization.	Inorg Chem Commun
33531826	Nucleic Acid-Sensing Pathways During SARS-CoV-2 Infection: Expectations versus Reality.	J Inflamm Res
33531790	Enhanced production of camptothecin by immobilized callus of Ophiorrhiza mungos and a bioinformatic insight into its potential antiviral effect against SARS-CoV-2.	J King Saud Univ Sci
33531712	Outcome of SARS-CoV-2 infection is linked to MAIT cell activation and cytotoxicity.	Nat Immunol
33531709	Sixteen novel lineages of SARS-CoV-2 in South Africa.	Nat Med
33531686	More light on cancer and COVID-19 reciprocal interaction.	Br J Cancer
33531496	Structure of papain-like protease from SARS-CoV-2 and its complexes with non-covalent inhibitors.	Nat Commun
33531264	Dynamic changes in monocytes subsets in COVID-19 patients.	Hum Immunol
33531083	De novo design and bioactivity prediction of SARS-CoV-2 main protease inhibitors using recurrent neural network-based transfer learning.	BMC Chem
33530913	"Cluster analysis of coronavirus sequences using computational sequence descriptors: With applications to SARS, MERS and SARS-CoV-2 (CoVID-19)."	Curr Comput Aided Drug Des
33530831	Pathophysiologic mechanisms of cerebral endotheliopathy and stroke due to Sars-CoV-2.	J Cereb Blood Flow Metab
33530624	COVID-19 and Pediatric Asthma: Clinical and Management Challenges.	Int J Environ Res Public Health
33530554	Mediterranean Diet for the Prevention of Gestational Diabetes in the Covid-19 Era: Implications of Il-6 In Diabesity.	Int J Mol Sci
33530550	The Novel Perspectives Opened by ST2 in the Pandemic: A Review of Its Role in the Diagnosis and Prognosis of Patients with Heart Failure and COVID-19.	Diagnostics (Basel)
33530467	Current Updates on Naturally Occurring Compounds Recognizing SARS-CoV-2 Druggable Targets.	Molecules
33530458	Human iPSC-Based Modeling of Central Nerve System Disorders for Drug Discovery.	Int J Mol Sci
33530371	Viral Evasion of RIG-I-Like Receptor-Mediated Immunity through Dysregulation of Ubiquitination and ISGylation.	Viruses
33530355	One Year of SARS-CoV-2: How Much Has the Virus Changed?	Biology (Basel)
33530099	Altered Blood Cell Traits Underlie a Major Genetic Locus of Severe COVID-19.	J Gerontol A Biol Sci Med Sci
33530091	Neuroinflammation and Brain Development: Possible Risk Factors in COVID-19-Infected Children.	Neuroimmunomodulation
33530084	"Genetic Variation, Diet, Inflammation, and the Risk for COVID-19."	Lifestyle Genom
33529763	High level stable expression of recombinant HIV gp120 in glutamine synthetase gene deficient HEK293T cells.	Protein Expr Purif
33529750	Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): Where will the drugs come from?	Pharmacol Res
33529600	"Diabetes, obesity, metabolism, and SARS-CoV-2 infection: the end of the beginning."	Cell Metab
33529260	Clinical and whole genome characterization of SARS-CoV-2 in India.	PLoS One
33529230	High-level expression of the monomeric SARS-CoV-2 S protein RBD 320-537 in stably transfected CHO cells by the EEF1A1-based plasmid vector.	PLoS One
33529170	Dromedary camels as a natural source of neutralizing nanobodies against SARS-CoV-2.	JCI Insight
33529167	The COVID-19 immune landscape is dynamically and reversibly correlated with disease severity.	J Clin Invest
33528568	The Nexus Between Telomere Length and Lymphocyte Count in Seniors Hospitalized With COVID-19.	J Gerontol A Biol Sci Med Sci
33527774	Lingonberry polyphenols: Potential SARS-CoV-2 inhibitors as nutraceutical tools?	Physiol Rep
33527593	Pathophysiological mechanisms and management of patients with long-time anosmia related to COVID-19.	J Intern Med
33527314	Raloxifene as a treatment option for viral infections.	J Microbiol
33527308	DPP4 Inhibitors and COVID-19-Holy Grail or Another Dead End?	Arch Immunol Ther Exp (Warsz)
33527306	mTOR inhibition: a double-edged sword in patients with COVID-19?	Hum Cell
33527211	COVID-19-associated liver injury: from bedside to bench.	J Gastroenterol
33527157	[COVID-19 effects on the kidney].	Pathologe
33527091	Variations in Orf3a protein of SARS-CoV-2 alter its structure and function.	Biochem Biophys Rep
33527087	A Single Immunization with Spike-Functionalized Ferritin Vaccines Elicits Neutralizing Antibody Responses against SARS-CoV-2 in Mice.	ACS Cent Sci
33527086	"Modeling the Binding Mechanism of Remdesivir, Favilavir, and Ribavirin to SARS-CoV-2 RNA-Dependent RNA Polymerase."	ACS Cent Sci
33527085	De Novo Discovery of High-Affinity Peptide Binders for the SARS-CoV-2 Spike Protein.	ACS Cent Sci
33527083	To stress or not to stress: Brain-behavior-immune interaction may weaken or promote the immune response to SARS-CoV-2.	Neurobiol Stress
33527080	Virtual screening of phytochemical compounds as potential inhibitors against SARS-CoV-2 infection.	Beni Suef Univ J Basic Appl Sci
33527003	Molecular dynamics analysis of phytochemicals from Ageratina adenophora against COVID-19 main protease (M(pro)) and human angiotensin-converting enzyme 2 (ACE2).	Biocatal Agric Biotechnol
33526974	Severe acute respiratory syndrome coronavirus (SARS-CoV)-2 infection induces dysregulation of immunity: in silico gene expression analysis.	Int J Med Sci
33526965	Identification of natural compounds as potent inhibitors of SARS-CoV-2 main protease using combined docking and molecular dynamics simulations.	Saudi J Biol Sci
33526960	Presence of antibodies against SARS-CoV-2 spike protein in bovine whey IgG enriched fraction.	Int Dairy J
33526951	"5-((1H-imidazol-1-yl)methyl)quinolin-8-ol as potential antiviral SARS-CoV-2 candidate: Synthesis, crystal structure, Hirshfeld surface analysis, DFT and molecular docking studies."	J Mol Struct
33526920	Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity.	Nat Rev Immunol
33526776	Piglet immunization with a spike subunit vaccine enhances disease by porcine epidemic diarrhea virus.	NPJ Vaccines
33526596	Structure of the SARS-CoV-2 RNA-dependent RNA polymerase in the presence of favipiravir-RTP.	Proc Natl Acad Sci U S A
33526482	Kinetic Characterization and Inhibitor Screening for the Proteases Leading to Identification of Drugs against SARS-CoV-2.	Antimicrob Agents Chemother
33526471	A Novel Soluble ACE2 Variant with Prolonged Duration of Action Neutralizes SARS-CoV-2 Infection in Human Kidney Organoids.	J Am Soc Nephrol
33526352	"Implications of the Emergence of a New Variant of SARS-CoV-2, VUI-202012/01."	Arch Med Res
33526325	"The interplay between neutrophils, complement, and microthrombi in COVID-19."	Best Pract Res Clin Rheumatol
33526007	Insights of Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV-2) pandemic: a current review.	Biol Proced Online
33526003	"Flavonol morin targets host ACE2, IMP-alpha, PARP-1 and viral proteins of SARS-CoV-2, SARS-CoV and MERS-CoV critical for infection and survival: a computational analysis."	J Biomol Struct Dyn
33525993	Impact of dimerization and N3 binding on molecular dynamics of SARS-CoV and SARS-CoV-2 main proteases.	J Biomol Struct Dyn
33525682	Expression of Endogenous Angiotensin-Converting Enzyme 2 in Human Induced Pluripotent Stem Cell-Derived Retinal Organoids.	Int J Mol Sci
33525632	"The SARS-Coronavirus Infection Cycle: A Survey of Viral Membrane Proteins, Their Functional Interactions and Pathogenesis."	Int J Mol Sci
33525562	Lithium and Therapeutic Targeting of GSK-3.	Cells
33525440	The Central Role of Fibrinolytic Response in COVID-19-A Hematologist's Perspective.	Int J Mol Sci
33525415	Chloroquine and Hydroxychloroquine Interact Differently with ACE2 Domains Reported to Bind with the Coronavirus Spike Protein: Mediation by ACE2 Polymorphism.	Molecules
33525411	Computational Determination of Potential Multiprotein Targeting Natural Compounds for Rational Drug Design Against SARS-COV-2.	Molecules
33525368	The Aging Bowel Dysfunction and Elderly Vulnerability towards COVID-19 Infection.	Life (Basel)
33525252	The role of angiotensin-converting enzyme 2 in COVID-19 induced lung injury.	Acta Biomed
33525240	Hepcidin is a friend rather than a foe in COVID19-induced complications.	Acta Biomed
33525222	"A review of current knowledge on Pollution, Cigarette Smoking and COVID-19 diffusion and their relationship with inflammation."	Acta Biomed
33524996	"Allergische Reaktionen auf COVID-19-Impfungen - Was HNO-Arzte wissen sollten - Teil 1: Allgemeine Aspekte von Allergien auf Impfstoffe, immunologische Grundlagen von Allergien auf Impfstoffe, Immunmechanismen von allergischen und pseudoallergischen Reaktionen; Teil 2: Charakteristiken der mRNA-Impfstoffe BNT162b2 und mRNA-1273 zur Prophylaxe von COVID-19, weitere Impfstoff-Kandidaten und assoziierte Immunphanomene; Teil 3: Praktische Aspekte der Prophylaxe, Diagnostik und Therapie von Allergien auf COVID-19-Impfstoffe."	Laryngorhinootologie
33524990	BNT162b vaccines protect rhesus macaques from SARS-CoV-2.	Nature
33524886	Characterizing the immune responses of those who survived or succumbed to COVID-19: Can immunological signatures predict outcome?	Cytokine
33524881	What do we know about the antibody responses to SARS-CoV-2?	Immunobiology
33524876	COVID-19 convalescent plasma composition and immunological effects in severe patients.	J Autoimmun
33524849	Coronavirus infection induces progressive restructuring of the endoplasmic reticulum involving the formation and degradation of double membrane vesicles.	Virology
33524687	RNA-dependent RNA polymerase (RdRp) inhibitors: The current landscape and repurposing for the COVID-19 pandemic.	Eur J Med Chem
33524589	A global analysis of replacement of genetic variants of SARS-CoV-2 in association with containment capacity and changes in disease severity.	Clin Microbiol Infect
33524563	Inhibitory efficiency of potential drugs against SARS-CoV-2 by blocking human angiotensin converting enzyme-2: Virtual screening and molecular dynamics study.	Microb Pathog
33524396	Potent mouse monoclonal antibodies that block SARS-CoV-2 infection.	J Biol Chem
33524238	Hallmarks and detection techniques of cellular senescence and cellular ageing in immune cells.	Aging Cell
33524237	Cap 1 Messenger RNA Synthesis with Co-transcriptional CleanCap((R)) Analog by In Vitro Transcription.	Curr Protoc
33524188	COVID-19 and Liver Cirrhosis: Focus on the Nonclassical Renin-Angiotensin System and Implications for Therapy.	Hepatology
33524124	Dysregulated Innate and Adaptive Immune Responses Discriminate Disease Severity in COVID-19.	J Infect Dis
33524041	Metabolomic/lipidomic profiling of COVID-19 and individual response to tocilizumab.	PLoS Pathog
33524017	A drug repurposing screen identifies hepatitis C antivirals as inhibitors of the SARS-CoV2 main protease.	PLoS One
33523846	Heteromultivalent topology-matched nanostructures as potent and broad-spectrum influenza A virus inhibitors.	Sci Adv
33523655	Retrained Generic Antibodies Can Recognize SARS-CoV-2.	J Phys Chem Lett
33523654	Remdesivir Metabolite GS-441524 Effectively Inhibits SARS-CoV-2 Infection in Mouse Models.	J Med Chem
33523642	Synthesis and Biopharmaceutical Applications of Sugar-Based Polymers: New Advances and Future Prospects.	ACS Biomater Sci Eng
33523608	"SARS CoV-2 related microvascular damage and symptoms during and after COVID-19: Consequences of capillary transit-time changes, tissue hypoxia and inflammation."	Physiol Rep
33523532	Early humoral defence: Contributing to confining COVID-19 to conducting airways?	Scand J Immunol
33522983	"COVID-19 and male reproductive function: a prospective, longitudinal cohort study."	Reproduction
33522893	COVID-19-associated cytokine storm syndrome and diagnostic principles: an old and new Issue.	Emerg Microbes Infect
33522795	Regeneration Profiles of Olfactory Epithelium after SARS-CoV-2 Infection in Golden Syrian Hamsters.	ACS Chem Neurosci
33522708	"Lumpy skin disease, an emerging transboundary viral disease: A review."	Vet Med Sci
33522422	LARP1 and LARP4: up close with PABP for mRNA 3' poly(A) protection and stabilization.	RNA Biol
33522308	Estrogen and Androgen Receptor Inhibitors: Unexpected Allies in the Fight Against COVID-19.	Cell Transplant
33522164	Comparative genetic analyses of Korean bat coronaviruses with SARS-CoV and the newly emerged SARS-CoV-2.	J Vet Sci
33522107	Sustained cellular immunity in adults recovered from mild COVID-19.	Cytometry A
33521857	Gut microbiota in antiviral strategy from bats to humans: a missing link in COVID-19.	Sci China Life Sci
33521836	"Respiratory infections during lithium and valproate medication: a within-individual prospective study of 50,000 patients with bipolar disorder."	Int J Bipolar Disord
33521783	Stroke in patients infected by the novel coronavirus and its causal mechanisms: A narrative review.	J Am Coll Emerg Physicians Open
33521757	Structural Basis of SARS-CoV-2 Polymerase Inhibition by Favipiravir.	Innovation (N Y)
33521751	SARS-CoV-2 Re-infections: Lessons from Other Coronaviruses.	Med (N Y)
33521747	A booster dose enhances immunogenicity of the COVID-19 vaccine candidate ChAdOx1 nCoV-19 in aged mice.	Med (N Y)
33521697	A distinct innate immune signature marks progression from mild to severe COVID-19.	Cell Rep Med
33521695	Comprehensive analysis of T cell immunodominance and immunoprevalence of SARS-CoV-2 epitopes in COVID-19 cases.	Cell Rep Med
33521692	Neurological involvement in SARS-CoV-2 infection: A clinical systematic review.	Brain Behav Immun Health
33521688	COVID-19 impacts the expression of molecular markers associated with neuropsychiatric disorders.	Brain Behav Immun Health
33521687	"Human eggs, zygotes, and embryos express the receptor angiotensin 1-converting enzyme 2 and transmembrane serine protease 2 protein necessary for severe acute respiratory syndrome coronavirus 2 infection."	F S Sci
33521655	COVID-19 vasculitis and novel vasculitis mimics.	Lancet Rheumatol
33521641	BIN1 rs744373 SNP and COVID-19 mortality.	World Acad Sci J
33521622	"2020 update on human coronaviruses: One health, one world."	Med Nov Technol Devices
33521606	Antiviral activity of sulfated polysaccharides from marine algae and its application in combating COVID-19: Mini review.	Bioresour Technol Rep
33521593	The presentation of SARS-CoV-2 peptides by the common HLA-A( *)02:01 molecule.	iScience
33521390	Antivirals for COVID-19: A critical review.	Clin Epidemiol Glob Health
33521384	Genetic variations among SARS-CoV-2 strains isolated in China.	Gene Rep
33521383	COVID-19: What you need to know.	Gene Rep
33521382	Genome-wide in silico identification and characterization of Simple Sequence Repeats in diverse completed SARS-CoV-2 genomes.	Gene Rep
33521378	Hypoxia-inducible factor (HIF): The link between obesity and COVID-19.	Obes Med
33521335	"The polybasic insert, the RBD of the SARS-CoV-2 spike protein, and the feline coronavirus - evolved or yet to evolve."	Biochem Biophys Rep
33521300	Risk of severe COVID-19 in hypertensive patients treated with renin-angiotensin-aldosterone system inhibitors.	Med Clin (Engl Ed)
33521241	Manipulated bio antimicrobial peptides from probiotic bacteria as proposed drugs for COVID-19 disease.	Inform Med Unlocked
33521210	"Gastrointestinal symptoms, pathophysiology, and treatment in COVID-19."	Genes Dis
33521209	Immune characteristics analysis reveals two key inflammatory factors correlated to the expressions of SARS-CoV-2 S1-specific antibodies.	Genes Dis
33521168	"Narrative review of the immune response against coronavirus: An overview, applicability for SARS-COV-2, and therapeutic implications."	An Pediatr (Engl Ed)
33521163	Comprehensive and systemic optimization for improving the yield of SARS-CoV-2 spike pseudotyped virus.	Mol Ther Methods Clin Dev
33521098	Effect of a fever in viral infections - the 'Goldilocks' phenomenon?	World J Clin Cases
33521076	An Insight Into COVID-19: A 21st Century Disaster and Its Relation to Immunocompetence and Food Antioxidants.	Front Vet Sci
33521069	"Gene Expression Profiling Reveals the Shared and Distinct Transcriptional Signatures in Human Lung Epithelial Cells Infected With SARS-CoV-2, MERS-CoV, or SARS-CoV: Potential Implications in Cardiovascular Complications of COVID-19."	Front Cardiovasc Med
33521067	Generation of SARS-CoV-2 Spike Pseudotyped Virus for Viral Entry and Neutralization Assays: A 1-Week Protocol.	Front Cardiovasc Med
33521016	Susceptibility Factors of Stomach for SARS-CoV-2 and Treatment Implication of Mucosal Protective Agent in COVID-19.	Front Med (Lausanne)
33521006	ACE2 Expression in Kidney and Testis May Cause Kidney and Testis Infection in COVID-19 Patients.	Front Med (Lausanne)
33520952	Evolutionarily Conserved Long Non-coding RNA Regulates Gene Expression in Cytokine Storm During COVID-19.	Front Bioeng Biotechnol
33520943	In silico Analysis Revealed Potential Anti-SARS-CoV-2 Main Protease Activity by the Zonulin Inhibitor Larazotide Acetate.	Front Chem
33520910	Coronavirus Disease (COVID-19): Comprehensive Review of Clinical Presentation.	Front Public Health
33520892	COVID-19: Considerations for Children and Families During the Pandemic.	Front Pediatr
33520685	Mushroom-derived bioactive compounds potentially serve as the inhibitors of SARS-CoV-2 main protease: An in silico approach.	J Tradit Complement Med
33520684	Analyzing the potential therapeutic mechanism of Huashi Baidu Decoction on severe COVID-19 through integrating network pharmacological methods.	J Tradit Complement Med
33520683	Anti-COVID-19 drug candidates: A review on potential biological activities of natural products in the management of new coronavirus infection.	J Tradit Complement Med
33520682	Molecular docking analysis of rutin reveals possible inhibition of SARS-CoV-2 vital proteins.	J Tradit Complement Med
33520676	Spectroscopic investigation on the affinity of SARS-CoV-2 spike protein to gold nano-particles.	Colloid Interface Sci Commun
33520672	FDA recommended potent drugs against COVID-19: Insight through molecular docking.	Mater Today Proc
33520633	"In-silico drug repurposing study: Amprenavir, enalaprilat, and plerixafor, potential drugs for destabilizing the SARS-CoV-2 S-protein-angiotensin-converting enzyme 2 complex."	Results Chem
33520632	Biflavonoid as potential 3-chymotrypsin-like protease (3CLpro) inhibitor of SARS-Coronavirus.	Results Chem
33520590	Training Feedforward Neural Network Using Enhanced Black Hole Algorithm: A Case Study on COVID-19 Related ACE2 Gene Expression Classification.	Arab J Sci Eng
33520580	"Molecular mechanism, diagnosis, and potential treatment for novel coronavirus (COVID-19): a current literature review and perspective."	3 Biotech
33520579	Screening of potent drug inhibitors against SARS-CoV-2 RNA polymerase: an in silico approach.	3 Biotech
33520335	A theoretical exploration of the origin and early evolution of a pandemic.	Sci Bull (Beijing)
33520330	Natural Host-Environmental Media-Human: A New Potential Pathway of COVID-19 Outbreak.	Engineering (Beijing)
33520309	Recovery scenario and immunity in COVID-19 disease: A new strategy to predict the potential of reinfection.	J Adv Res
33520278	"Crystal structure, Hirshfeld surface analysis, DFT and mol-ecular docking investigation of 2-(2-oxo-1,3-oxazolidin-3-yl)ethyl 2-[2-(2-oxo-1,3-oxazolidin-3-yl)eth-oxy]quinoline-4-carboxyl-ate."	Acta Crystallogr E Crystallogr Commun
33520197	In silico prediction of structure and function for a large family of transmembrane proteins that includes human Tmem41b.	F1000Res
33520118	Meta-analysis of transcriptome datasets: An alternative method to study IL-6 regulation in coronavirus disease 2019.	Comput Struct Biotechnol J
33520015	Analysis of the mechanism of Shufeng Jiedu capsule prevention and treatment for COVID-19 by network pharmacology tools.	Eur J Integr Med
33520014	"Two pronged approach for prevention and therapy of COVID-19 (Sars-CoV-2) by a multi-targeted herbal drug, a component of ayurvedic decoction."	Eur J Integr Med
33519990	[Histological pulmonary features due to the Sars-CoV-2].	Rev Francoph Lab
33519902	Detecting the Multiomics Signatures of Factor-Specific Inflammatory Effects on Airway Smooth Muscles.	Front Genet
33519814	Adenosine at the Interphase of Hypoxia and Inflammation in Lung Injury.	Front Immunol
33519802	Does Angiotensin II Peak in Response to SARS-CoV-2?	Front Immunol
33519677	Progress in Research on SARS-CoV-2 Infection Causing Neurological Diseases and Its Infection Mechanism.	Front Neurol
33519526	"Serum Renin Levels Increase With Age in Boys Resulting in Higher Renin Levels in Young Men Compared to Young Women, and Soluble Angiotensin-Converting Enzyme 2 Correlates With Renin and Body Mass Index."	Front Physiol
33519510	SARS-CoV-2 Mediated Endothelial Dysfunction: The Potential Role of Chronic Oxidative Stress.	Front Physiol
33519469	Inhibition of SARS-CoV-2 by Highly Potent Broad-Spectrum Anti-Coronaviral Tylophorine-Based Derivatives.	Front Pharmacol
33519467	3-Hydroxyphthalic Anhydride-Modified Chicken Ovalbumin as a Potential Candidate Inhibits SARS-CoV-2 Infection by Disrupting the Interaction of Spike Protein With Host ACE2 Receptor.	Front Pharmacol
33519463	TLR9 and COVID-19: A Multidisciplinary Theory of a Multifaceted Therapeutic Target.	Front Pharmacol
33519460	Methylene Blue Inhibits the SARS-CoV-2 Spike-ACE2 Protein-Protein Interaction-a Mechanism that can Contribute to its Antiviral Activity Against COVID-19.	Front Pharmacol
33519449	A Review on Plant Bioactive Compounds and Their Modes of Action Against Coronavirus Infection.	Front Pharmacol
33519338	Understanding Obesity: The Role of Adipose Tissue Microenvironment and the Gut Microbiome.	Saudi J Med Med Sci
33519332	[Aging of the lungs and immune system as hellmark in the pathogenesis of idiopathic pulmonary fibrosis and COVID-19].	Pneumologe (Berl)
33519322	Drug repositioning based on similarity constrained probabilistic matrix factorization: COVID-19 as a case study.	Appl Soft Comput
33519291	"Mechanogenomic coupling of lung tissue stiffness, EMT and coronavirus pathogenicity."	Curr Opin Solid State Mater Sci
33519278	Genome composition and genetic characterization of SARS-CoV-2.	Saudi J Biol Sci
33519272	In-silico network-based analysis of drugs used against COVID-19: Human well-being study.	Saudi J Biol Sci
33519271	"Immune system response during viral Infections: Immunomodulators, cytokine storm (CS) and Immunotherapeutics in COVID-19."	Saudi Pharm J
33519225	Cytokine Storm and Mucus Hypersecretion in COVID-19: Review of Mechanisms.	J Inflamm Res
33519207	Letter to the Editor: Microbiota in the Respiratory System-A Possible Explanation to Age and Sex Variability in Susceptibility to SARS-CoV-2.	Microbiol Insights
33519200	Nanomedicine for the SARS-CoV-2: State-of-the-Art and Future Prospects.	Int J Nanomedicine
33519145	Evaluating the potency of Sulawesi propolis compounds as ACE-2 inhibitors through molecular docking for COVID-19 drug discovery preliminary study.	J King Saud Univ Sci
33519134	Pathophysiology of COVID-19 and Host centric approaches of Ayurveda.	J Ayurveda Integr Med
33519087	"Review article: Probiotics, prebiotics and dietary approaches during COVID-19 pandemic."	Trends Food Sci Technol
33519023	Molecular modeling evaluation of the binding effect of five protease inhibitors to COVID-19 main protease.	Chem Phys
33518858	Structure features of peptide-type SARS-CoV main protease inhibitors: Quantitative structure activity relationship study.	Chemometr Intell Lab Syst
33518856	A computational approach for the screening of potential antiviral compounds against SARS-CoV-2 protease: Ionic liquid vs herbal and natural compounds.	J Mol Liq
33518854	"Charge-transfer chemistry of azithromycin, the antibiotic used worldwide to treat the coronavirus disease (COVID-19). Part II: Complexation with several pi-acceptors (PA, CLA, CHL)."	J Mol Liq
33518853	Computational study on peptidomimetic inhibitors against SARS-CoV-2 main protease.	J Mol Liq
33518803	Inhibitory capacity of chloroquine against SARS-COV-2 by effective binding with angiotensin converting enzyme-2 receptor: An insight from molecular docking and MD-simulation studies.	J Mol Struct
33518802	In silico assessment and sonochemical synthesis of 2-alkynyl 3-chloropyrazines as prospective ligands for SARS-CoV-2.	J Mol Struct
33518801	Molecular docking identification for the efficacy of some zinc complexes with chloroquine and hydroxychloroquine against main protease of COVID-19.	J Mol Struct
33518776	Computed optical spectra of SARS-CoV-2 proteins.	Chem Phys Lett
33518775	Identification of potential inhibitors of SARS-CoV-2 main protease from Aloe vera compounds: A molecular docking study.	Chem Phys Lett
33518774	Exploring the new potential antiviral constituents of Moringa oliefera for SARS-COV-2 pathogenesis: An in silico molecular docking and dynamic studies.	Chem Phys Lett
33518628	Inactivation of SARS-CoV-2 by Catechins from Green Tea.	Jpn J Infect Dis
33517789	Study on mechanism of matrine in treatment of COVID-19 combined with liver injury by network pharmacology and molecular docking technology.	Drug Deliv
33517367	Virtual screening and molecular dynamics simulation study of plant-derived compounds to identify potential inhibitors of main protease from SARS-CoV-2.	Brief Bioinform
33517235	High expression of ACE2 in HER2 subtype of breast cancer is a marker of poor prognosis.	Cancer Treat Res Commun
33516970	Human coronaviruses in idiopathic Parkinson's disease: Implications of SARS-CoV-2's modulation of the host's transcriptome.	Infect Genet Evol
33516969	Codon usage analysis of zoonotic coronaviruses reveals lower adaptation to humans by SARS-CoV-2.	Infect Genet Evol
33516820	Edible plant-derived exosomal microRNAs: Exploiting a cross-kingdom regulatory mechanism for targeting SARS-CoV-2.	Toxicol Appl Pharmacol
33516600	Recombinant SARS-CoV-2 RBD with a built in T helper epitope induces strong neutralization antibody response.	Vaccine
33516277	Early induction of functional SARS-CoV-2-specific T cells associates with rapid viral clearance and mild disease in COVID-19 patients.	Cell Rep
33516247	Detection of SARS-CoV-2 from patient fecal samples by whole genome sequencing.	Gut Pathog
33516131	Lysosomal ion channels involved in cellular entry and uncoating of enveloped viruses: Implications for therapeutic strategies against SARS-CoV-2.	Cell Calcium
33515918	"Potential inhibitors interacting in Neuropilin-1 to develop an adjuvant drug against COVID-19, by molecular docking."	Bioorg Med Chem
33515911	The Nucleocapsid protein triggers the main humoral immune response in COVID-19 patients.	Biochem Biophys Res Commun
33515713	Mannose binding lectin gene 2 (rs1800450) missense variant may contribute to development and severity of COVID-19 infection.	Infect Genet Evol
33515606	Dual inhibition of SARS-CoV-2 and human rhinovirus with protease inhibitors in clinical development.	Antiviral Res
33515531	PDE4 inhibition as a therapeutic strategy for improvement of pulmonary dysfunctions in Covid-19 and cigarette smoking.	Biochem Pharmacol
33515320	SARS-CoV-2 vaccines and autoimmune diseases amidst the COVID-19 crisis.	Rheumatol Int
33514944	Engineering SARS-CoV-2 using a reverse genetic system.	Nat Protoc
33514825	SARS-CoV-2 specific antibody and neutralization assays reveal the wide range of the humoral immune response to virus.	Commun Biol
33514629	Neutralization of SARS-CoV-2 lineage B.1.1.7 pseudovirus by BNT162b2 vaccine-elicited human sera.	Science
33514628	SARS-CoV-2 triggers an MDA-5-dependent interferon response which is unable to control replication in lung epithelial cells.	J Virol
33514423	"ACE2 Nascence, trafficking, and SARS-CoV-2 pathogenesis: the saga continues."	Hum Genomics
33514385	Development of multivalent nanobodies blocking SARS-CoV-2 infection by targeting RBD of spike protein.	J Nanobiotechnology
33514319	Horizontal gene transfer and recombination analysis of SARS-CoV-2 genes helps discover its close relatives and shed light on its origin.	BMC Ecol Evol
33513850	"Promising Extracellular Vesicle-Based Vaccines against Viruses, Including SARS-CoV-2."	Biology (Basel)
33513822	"Caged Dexamethasone/Quercetin Nanoparticles, Formed of the Morphogenetic Active Inorganic Polyphosphate, are Strong Inducers of MUC5AC."	Mar Drugs
33513449	Different SARS-CoV-2 haplotypes associate with geographic origin and case fatality rates of COVID-19 patients.	Infect Genet Evol
33513419	Potential effect of Maxing Shigan decoction against coronavirus disease 2019 (COVID-19) revealed by network pharmacology and experimental verification.	J Ethnopharmacol
33513400	Cardiovascular protective properties of oxytocin against COVID-19.	Life Sci
33513380	"Selection, identification, and characterization of SARS-CoV-2 monoclonal antibody resistant mutants."	J Virol Methods
33513337	B cell memory: understanding COVID-19.	Immunity
33513307	Modulating the Barrier Function of Human Alveolar Epithelial (hAELVi) Cell Monolayers as a Model of Inflammation.	Altern Lab Anim
33513210	Baseline T cell immune phenotypes predict virologic and disease control upon SARS-CoV infection in Collaborative Cross mice.	PLoS Pathog
33513050	How IvIg Can Mitigate Covid-19 Disease: A Symmetrical Immune Network Model.	Monoclon Antib Immunodiagn Immunother
33512688	Disentangling conflicting evidence on DPP-4 inhibitors and outcomes of COVID-19: narrative review and meta-analysis.	J Endocrinol Invest
33512650	Strong Binding of Leupeptin with TMPRSS2 Protease May Be an Alternative to Camostat and Nafamostat for SARS-CoV-2 Repurposed Drug: Evaluation from Molecular Docking and Molecular Dynamics Simulations.	Appl Biochem Biotechnol
33512610	Apoptosis induced by SARS-CoV-2: can we target it?	Apoptosis
33512572	The microbiome of bat guano: for what is this knowledge important?	Appl Microbiol Biotechnol
33512495	Rapid Spread of Mutant Alleles in Worldwide SARS-CoV-2 Strains Revealed by Genome-Wide Single Nucleotide Polymorphism and Variation Analysis.	Genome Biol Evol
33512415	Antibody-induced procoagulant platelets in severe COVID-19 infection.	Blood
33512172	Study of Specific Receptor Binding Mode Suggests a Possible Enzymatic Disinfectant for SARS-CoV-2.	Langmuir
33512021	Evolutionary analysis of SARS-CoV-2 spike protein for its different clades.	J Med Virol
33512003	Neurological risks and benefits of cytokine-based treatments in coronavirus disease 2019: from preclinical to clinical evidence.	Br J Pharmacol
33511992	ACE2/Ang-(1-7)/Mas1 axis and the vascular system: vasoprotection to COVID-19-associated vascular disease.	Clin Sci (Lond)
33511840	Detection of SARS-CoV-2 and Its Mutated Variants via CRISPR-Cas13-Based Transcription Amplification.	Anal Chem
33511555	Degradation of SARS-CoV-2 receptor ACE2 by the E3 ubiquitin ligase Skp2 in lung epithelial cells.	Front Med
33511519	Mesenchymal Stem Cell-Derived Extracellular Vesicles Carrying miRNA as a Potential Multi Target Therapy to COVID-19: an In Silico Analysis.	Stem Cell Rev Rep
33511329	Adhesive contact between cylindrical (Ebola) and spherical (SARS-CoV-2) viral particles and a cell membrane.	Mech Soft Mater
33511171	Angiotensin converting enzymes inhibitors or angiotensin receptor blockers should be continued in COVID-19 patients with hypertension.	World J Clin Cases
33511168	COVID-19: An overview and a clinical update.	World J Clin Cases
33511147	Down-Regulation of Colonic ACE2 Expression in Patients With Inflammatory Bowel Disease Responding to Anti-TNF Therapy: Implications for COVID-19.	Front Med (Lausanne)
33511102	Structural Insight Into the SARS-CoV-2 Nucleocapsid Protein C-Terminal Domain Reveals a Novel Recognition Mechanism for Viral Transcriptional Regulatory Sequences.	Front Chem
33510731	SARS-CoV-2 Causes a Systemically Multiple Organs Damages and Dissemination in Hamsters.	Front Microbiol
33510644	"Aging, Immunity, and COVID-19: How Age Influences the Host Immune Response to Coronavirus Infections?"	Front Physiol
33510633	Impact of COVID-19 on Mitochondrial-Based Immunity in Aging and Age-Related Diseases.	Front Aging Neurosci
33510584	Scalable Analysis of Authentic Viral Envelopes on FRONTERA.	Comput Sci Eng
33510385	The m(6)A methylome of SARS-CoV-2 in host cells.	Cell Res
33510359	Meta-analysis of host transcriptional responses to SARS-CoV-2 infection reveals their manifestation in human tumors.	Sci Rep
33510353	Network theoretic analysis of JAK/STAT pathway and extrapolation to drugs and viruses including COVID-19.	Sci Rep
33510275	SARS-CoV-2 infection elicits a rapid neutralizing antibody response that correlates with disease severity.	Sci Rep
33510171	Genomic epidemiology of the early stages of the SARS-CoV-2 outbreak in Russia.	Nat Commun
33510133	A small molecule compound with an indole moiety inhibits the main protease of SARS-CoV-2 and blocks virus replication.	Nat Commun
33509997	"Genome Sequence of a SARS-CoV-2 VUI 202012/01 Strain Identified from a Patient Returning from London, England, to the Apulia Region of Italy."	Microbiol Resour Announc
33509993	Genome Sequences of 10 SARS-CoV-2 Viral Strains Obtained by Nanopore Sequencing of Nasopharyngeal Swabs in Malta.	Microbiol Resour Announc
33509990	Genome Sequencing of a Novel Coronavirus SARS-CoV-2 Isolate from Iraq.	Microbiol Resour Announc
33509749	[Mechanism and material basis of Lianhua Qingwen capsule for improving clinical cure rate of COVID-19: a study based on network pharmacology and molecular docking technology].	Nan Fang Yi Ke Da Xue Xue Bao
33509701	COVID-19 severity in obese patients: Potential mechanisms and molecular targets for clinical intervention.	Obes Res Clin Pract
33509629	The impact of SARS-CoV-2 and COVID-19 on male reproduction and men's health.	Fertil Steril
33509217	Anti-inflammatory potential of Quercetin in COVID-19 treatment.	J Inflamm (Lond)
33509045	"Applying high throughput and comprehensive immunoinformatics approaches to design a trivalent subunit vaccine for induction of immune response against emerging human coronaviruses SARS-CoV, MERS-CoV and SARS-CoV-2."	J Biomol Struct Dyn
33508989	"A systematic review on the recurrence of SARS-CoV-2 virus: frequency, risk factors, and possible explanations."	Infect Dis (Lond)
33508651	ACE2 expression is related to the interferon response in airway epithelial cells but is that functional for SARS-CoV-2 entry?	Cytokine
33508515	Association of clade-G SARS-CoV-2 viruses and age with increased mortality rates across 57 countries and India.	Infect Genet Evol
33508323	Latent periodicity-2 in coronavirus SARS-CoV-2 genome: Evolutionary implications.	J Theor Biol
33508291	SARS-CoV-2 infection: The role of PD-1/PD-L1 and CTLA-4 axis.	Life Sci
33508281	Association of ACE inhibitors and angiotensin type II blockers with ACE2 overexpression in COVID-19 comorbidities: A pathway-based analytical study.	Eur J Pharmacol
33508216	Inflammatory Leptomeningeal Cytokines Mediate COVID-19 Neurologic Symptoms in Cancer Patients.	Cancer Cell
33508197	On Drug-Membrane Permeability of Antivirals for SARS-CoV-2.	J Phys Chem Lett
33508121	Glucocorticoids and the Brain after Critical Illness.	Endocrinology
33507994	Switched and unswitched memory B cells detected during SARS-CoV-2 convalescence correlate with limited symptom duration.	PLoS One
33507952	"Single cell resolution of SARS-CoV-2 tropism, antiviral responses, and susceptibility to therapies in primary human airway epithelium."	PLoS Pathog
33507884	"The Na+, K+-ATPase beta1 subunit regulates epithelial tight junctions via MRCKalpha."	JCI Insight
33507714	COVID-19 impact on reproduction and fertility.	JBRA Assist Reprod
33507556	No association between use of angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers prior to hospital admission and clinical course of COVID-19 in the COvid MEdicaTion (COMET) study.	Br J Clin Pharmacol
33507143	"Targeting novel structural and functional features of coronavirus protease nsp5 (3CL(pro), M(pro)) in the age of COVID-19."	J Gen Virol
33506962	A parsimonious approach for recognizing SARS-CoV-2 and host interactions.	J Med Virol
33506952	Role of Toll-like receptors in the pathogenesis of COVID-19.	J Med Virol
33506945	High expression of ACE2 in the human lung leads to the release of IL6 by suppressing cellular immunity: IL6 plays a key role in COVID-19.	Eur Rev Med Pharmacol Sci
33506944	Does Angiotensin II receptor blockers increase the risk of SARS-CoV-2 infection? A real-life experience.	Eur Rev Med Pharmacol Sci
33506741	Structural similarity-based prediction of host factors associated with SARS-CoV-2 infection and pathogenesis.	J Biomol Struct Dyn
33506652	Cholesterol metabolism pathways - are the intermediates more important than the products?	FEBS J
33506644	Genotype-phenotype correlation identified a novel SARS-CoV-2 variant possibly linked to severe disease.	Transbound Emerg Dis
33506607	siRNA Therapeutics against Respiratory Viral Infections-What Have We Learned for Potential COVID-19 Therapies?	Adv Healthc Mater
33506503	RAAS Blockade and COVID-19: Mechanistic Modeling of Mas and AT1 Receptor Occupancy as Indicators of Pro-Inflammatory and Anti-Inflammatory Balance.	Clin Pharmacol Ther
33506161	Circulating Levels of Calcitonin Gene-Related Peptide Are Lower in COVID-19 Patients.	J Endocr Soc
33506114	Mutational sensitivity of D614G in spike protein of SARS-CoV-2 in Jordan.	Biochem Biophys Rep
33506065	Thymosin Alpha 1 Mitigates Cytokine Storm in Blood Cells From Coronavirus Disease 2019 Patients.	Open Forum Infect Dis
33505977	Identifying Transcriptomic Signatures and Rules for SARS-CoV-2 Infection.	Front Cell Dev Biol
33505872	Antiviral drugs against severe acute respiratory syndrome coronavirus 2 infection triggering the coronavirus disease-19 pandemic.	Tzu Chi Med J
33505806	Identification and molecular characterization of mutations in nucleocapsid phosphoprotein of SARS-CoV-2.	PeerJ
33505639	Spontaneous binding of potential COVID-19 drugs (Camostat and Nafamostat) to human serine protease TMPRSS2.	Comput Struct Biotechnol J
33505425	"Deciphering the Subtype Differentiation History of SARS-CoV-2 Based on a New Breadth-First Searching Optimized Alignment Method Over a Global Data Set of 24,768 Sequences."	Front Genet
33505220	"COVID-19 and Toll-Like Receptor 4 (TLR4): SARS-CoV-2 May Bind and Activate TLR4 to Increase ACE2 Expression, Facilitating Entry and Causing Hyperinflammation."	Mediators Inflamm
33505216	Exploring the Pivotal Immunomodulatory and Anti-Inflammatory Potentials of Glycyrrhizic and Glycyrrhetinic Acids.	Mediators Inflamm
33505149	Lipidome is lipids regulator in gastrointestinal tract and it is a life collar in COVID-19: A review.	World J Gastroenterol
33504944	Elucidating the tunability of binding behavior for the MERS-CoV macro domain with NAD metabolites.	Commun Biol
33504824	Altered high-density lipoprotein composition and functions during severe COVID-19.	Sci Rep
33504779	Cryo-EM structures of the SARS-CoV-2 endoribonuclease Nsp15 reveal insight into nuclease specificity and dynamics.	Nat Commun
33504682	Differential Signaling and Virus Production in Calu-3 Cells and Vero Cells upon SARS-CoV-2 Infection.	Biomol Ther (Seoul)
33504565	Renin-angiotensin system blocker and outcomes of COVID-19: a systematic review and meta-analysis.	Thorax
33504359	"Natural killer cells associated with SARS-CoV-2 viral RNA shedding, antibody response and mortality in COVID-19 patients."	Exp Hematol Oncol
33504332	"When a pandemic and an epidemic collide: COVID-19, gut microbiota, and the double burden of malnutrition."	BMC Med
33504319	Patents Related to Pathogenic Human Coronaviruses.	Recent Pat Biotechnol
33504318	"An Alternative ""Trojan Horse"" Hypothesis for COVID-19: Immune Deficiency of IL-10 and SARS-CoV-2 Biology."	Endocr Metab Immune Disord Drug Targets
33504302	"Pathogenesis of COVID-19, Disease outbreak: A Review."	Curr Pharm Biotechnol
33504301	Phenylbenzopyrone of flavonoids as a potential scaffold to prevent SARS-CoV-2 replication by inhibiting its MPRO main protease.	Curr Pharm Biotechnol
33504092	From Angiotensin II to Cyclic Peptides and Angiotensin Receptor Blockers (ARBs): Perspectives of ARBs in COVID-19 Therapy.	Molecules
33504008	Identification of 37 Heterogeneous Drug Candidates for Treatment of COVID-19 via a Rational Transcriptomics-Based Drug Repurposing Approach.	Pharmaceuticals (Basel)
33503828	The Obesity Paradox Predicts the Second Wave of COVID-19 to Be Severe in Western Countries.	Int J Environ Res Public Health
33503821	Epigenetic Evolution of ACE2 and IL-6 Genes: Non-Canonical Interferon-Stimulated Genes Correlate to COVID-19 Susceptibility in Vertebrates.	Genes (Basel)
33503819	Crystal Structure of SARS-CoV-2 Main Protease in Complex with the Non-Covalent Inhibitor ML188.	Viruses
33503651	De novo design of modular and tunable protein biosensors.	Nature
33503560	"Molecular structure, NBO analysis of the hydrogen-bonded interactions, spectroscopic (FT-IR, FT-Raman), drug likeness and molecular docking of the novel anti COVID-2 molecule (2E)-N-methyl-2-[(4-oxo-4H-chromen-3-yl)methylidene]-hydrazinecarbothioamide (Dimer) - quantum chemical approach."	Spectrochim Acta A Mol Biomol Spectrosc
33503469	Nicotinic cholinergic system and COVID-19: In silico identification of interactions between alpha7 nicotinic acetylcholine receptor and the cryptic epitopes of SARS-Co-V and SARS-CoV-2 Spike glycoproteins.	Food Chem Toxicol
33503446	Multi-organ proteomic landscape of COVID-19 autopsies.	Cell
33503420	The immunodominant and neutralization linear epitopes for SARS-CoV-2.	Cell Rep
33503244	Neutrophils Set Extracellular Traps to Injure Lungs in Coronavirus Disease 2019.	J Infect Dis
33502950	Soluble ACE2 as a potential therapy for COVID-19.	Am J Physiol Cell Physiol
33502877	"Are clarithromycin, azithromycin and their analogues effective in the treatment of COVID19?"	Bratisl Lek Listy
33502593	Viral infections and their relationship to neurological disorders.	Arch Virol
33502471	"Evidence of Severe Acute Respiratory Syndrome Coronavirus 2 Replication and Tropism in the Lungs, Airways, and Vascular Endothelium of Patients With Fatal Coronavirus Disease 2019: An Autopsy Case Series."	J Infect Dis
33501958	Are All Patients with Cancer at Heightened Risk for Severe Coronavirus Disease 2019 (COVID-19)?	Clin Infect Dis
33501887	Every breath you take: Impacts of environmental dust exposure on intestinal barrier function-from the gut-lung axis to COVID-19.	Am J Physiol Gastrointest Liver Physiol
33501730	A deletion in SARS-CoV-2 ORF7 identified in COVID-19 outbreak in Uruguay.	Transbound Emerg Dis
33500788	Synonymous mutations and the molecular evolution of SARS-CoV-2 origins.	Virus Evol
33500787	Possible host-adaptation of SARS-CoV-2 due to improved ACE2 receptor binding in mink.	Virus Evol
33500774	"Reproducibly sampling SARS-CoV-2 genomes across time, geography, and viral diversity."	F1000Res
33500718	Clinical analysis and pluripotent stem cells-based model reveal possible impacts of ACE2 and lung progenitor cells on infants vulnerable to COVID-19.	Theranostics
33500591	Probing CAS database as prospective antiviral agents against SARS-CoV-2 main protease.	J Mol Struct
33500568	Deletion of the NKG2C receptor encoding KLRC2 gene and HLA-E variants are risk factors for severe COVID-19.	Genet Med
33500564	The lung-gut axis during viral respiratory infections: the impact of gut dysbiosis on secondary disease outcomes.	Mucosal Immunol
33500537	A PCR amplicon-based SARS-CoV-2 replicon for antiviral evaluation.	Sci Rep
33500101	Cross-reactive Antibody Response between SARS-CoV-2 and SARS-CoV Infections.	Cell Rep
33500022	"Molecular Docking of Azithromycin, Ritonavir, Lopinavir, Oseltamivir, Ivermectin and Heparin Interacting with Coronavirus Disease 2019 Main and Severe Acute Respiratory Syndrome Coronavirus-2 3C-Like Proteases."	J Nanosci Nanotechnol
33499234	"Interactions of Influenza and SARS-CoV-2 with the Lung Endothelium: Similarities, Differences, and Implications for Therapy."	Viruses
33499228	"ABO Blood Types and COVID-19: Spurious, Anecdotal, or Truly Important Relationships? A Reasoned Review of Available Data."	Viruses
33499042	The MHC Class II Transactivator CIITA: Not (Quite) the Odd-One-Out Anymore among NLR Proteins.	Int J Mol Sci
33498923	Development of a Cell-Based Luciferase Complementation Assay for Identification of SARS-CoV-2 3CL(pro) Inhibitors.	Viruses
33498909	Membrane Microvesicles as Potential Vaccine Candidates.	Int J Mol Sci
33498861	Multi-Organ Involvement in COVID-19: Beyond Pulmonary Manifestations.	J Clin Med
33498725	A Missing Link: Engagements of Dendritic Cells in the Pathogenesis of SARS-CoV-2 Infections.	Int J Mol Sci
33498631	Protective Effects of Lactoferrin against SARS-CoV-2 Infection In Vitro.	Nutrients
33498426	Mechanistic Implications of Biomass-Derived Particulate Matter for Immunity and Immune Disorders.	Toxics
33498225	Biological and Clinical Consequences of Integrin Binding via a Rogue RGD Motif in the SARS CoV-2 Spike Protein.	Viruses
33498183	Can SARS-CoV-2 Virus Use Multiple Receptors to Enter Host Cells?	Int J Mol Sci
33497931	"Increased placental expression of angiotensin-converting enzyme 2, the receptor of SARS-CoV-2, associated with hypoxia in twin anemia-polycythemia sequence (TAPS)."	Placenta
33497837	"SARS-CoV-2 and other human coronaviruses: Mapping of protease recognition sites, antigenic variation of spike protein and their grouping through molecular phylogenetics."	Infect Genet Evol
33497610	Adaptive immunity to SARS-CoV-2 and COVID-19.	Cell
33497607	Repositioning of histamine H1 receptor antagonist: Doxepin inhibits viropexis of SARS-CoV-2 Spike pseudovirus by blocking ACE2.	Eur J Pharmacol
33497434	Identifying anti-coronavirus peptides by incorporating different negative datasets and imbalanced learning strategies.	Brief Bioinform
33497425	Isolating SARS-CoV-2 Strains From Countries in the Same Meridian: Genome Evolutionary Analysis.	JMIR Bioinform Biotech
33497420	Temporal development and neutralising potential of antibodies against SARS-CoV-2 in hospitalised COVID-19 patients: An observational cohort study.	PLoS One
33497392	Generalized linear models provide a measure of virulence for specific mutations in SARS-CoV-2 strains.	PLoS One
33497372	SARS-CoV-2 impact on oral health: A general view.	Bol Med Hosp Infant Mex
33497369	Severe SARS-CoV-2 placenta infection can impact neonatal outcome in the absence of vertical transmission.	J Clin Invest
33497356	Similarities and differences between the immunopathogenesis of COVID-19-related pediatric multisystem inflammatory syndrome and Kawasaki disease.	J Clin Invest
33497110	New Findings on the Pathophysiology of Severe COVID-19 Infections.	Am J Nurs
33497081	COVID-19: Epidemiology and clinical practice implications.	Nurse Pract
33496842	COVID-19 in Children with Asthma.	Lung
33496683	The Novel Coronavirus Enigma: Phylogeny and Analyses of Coevolving Mutations Among the SARS-CoV-2 Viruses Circulating in India.	JMIR Bioinform Biotech
33496650	Protective Immunity and Persistent Lung Sequelae in Domestic Cats after SARS-CoV-2 Infection.	Emerg Infect Dis
33496228	"Early Transmission Dynamics, Spread, and Genomic Characterization of SARS-CoV-2 in Panama."	Emerg Infect Dis
33496147	[Potential therapies for COVID-19 cardiovascular complications using artemisinin and its derivatives intervene based on its cardiovascular protection].	Zhongguo Zhong Yao Za Zhi
33496060	Targeting cyclooxygenase enzyme for the adjuvant COVID-19 therapy.	Drug Dev Res
33495758	Epitope-resolved profiling of the SARS-CoV-2 antibody response identifies cross-reactivity with endemic human coronaviruses.	Cell Rep Med
33495756	Use of machine learning to identify a T cell response to SARS-CoV-2.	Cell Rep Med
33495741	Temporal increase in D614G mutation of SARS-CoV-2 in the Middle East and North Africa.	Heliyon
33495740	Phosphatidylserine is an overlooked mediator of COVID-19 thromboinflammation.	Heliyon
33495727	Polyphenols as promising biologically active substances for preventing SARS-CoV-2: A review with research evidence and underlying mechanisms.	Food Biosci
33495715	SARS-CoV-2 nucleocapsid protein phase separates with G3BPs to disassemble stress granules and facilitate viral production.	Sci Bull (Beijing)
33495714	Binding of the SARS-CoV-2 spike protein to glycans.	Sci Bull (Beijing)
33495713	The Rhinolophus affinis bat ACE2 and multiple animal orthologs are functional receptors for bat coronavirus RaTG13 and SARS-CoV-2.	Sci Bull (Beijing)
33495684	Luteolin and abyssinone II as potential inhibitors of SARS-CoV-2: an in silico molecular modeling approach in battling the COVID-19 outbreak.	Bull Natl Res Cent
33495676	COVID-19 and Gut Microbiota: A Potential Connection.	Indian J Clin Biochem
33495451	The double-sided effects of Mycobacterium Bovis bacillus Calmette-Guerin vaccine.	NPJ Vaccines
33495308	Prospective mapping of viral mutations that escape antibodies used to treat COVID-19.	Science
33495307	Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody.	Science
33495306	Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1A.	Science
33494667	Role of Poly(ADP-ribose) polymerase (PARP1) in viral infection and its implication in SARS-CoV-2 pathogenesis.	Curr Drug Targets
33494631	The Overlap between Genetic Susceptibility to COVID-19 and Skin Diseases.	Immunol Invest
33494530	Delivery of mRNA Vaccine against SARS-CoV-2 Using a Polyglucin:Spermidine Conjugate.	Vaccines (Basel)
33494381	Newcastle Disease Virus-Like Particles Displaying Prefusion-Stabilized SARS-CoV-2 Spikes Elicit Potent Neutralizing Responses.	Vaccines (Basel)
33494244	"Exercise, Immune System, Nutrition, Respiratory and Cardiovascular Diseases during COVID-19: A Complex Combination."	Int J Environ Res Public Health
33494237	COVID-19: Characteristics and Therapeutics.	Cells
33494096	Global absence and targeting of protective immune states in severe COVID-19.	Nature
33494095	Loss of furin cleavage site attenuates SARS-CoV-2 pathogenesis.	Nature
33493983	Mechanisms of thrombosis and cardiovascular complications in COVID-19.	Thromb Res
33493945	Inositol and vitamin D may naturally protect human reproduction and women undergoing assisted reproduction from Covid-19 risk.	J Reprod Immunol
33493922	"An extensive study on the COVID-19 pandemic, an emerging global crisis: Risks, transmission, impacts and mitigation."	J Infect Public Health
33493919	Identification of potential SARS-CoV-2 entry inhibitors by targeting the interface region between the spike RBD and human ACE2.	J Infect Public Health
33493916	Natural biflavonoids as potential therapeutic agents against microbial diseases.	Sci Total Environ
33493866	Ergosterol peroxide exhibits antiviral and immunomodulatory abilities against porcine deltacoronavirus (PDCoV) via suppression of NF-kappaB and p38/MAPK signaling pathways in vitro.	Int Immunopharmacol
33493690	A short discussion about the SARS-CoV-2 mRNA-1273 vaccine.	Int J Infect Dis
33493677	SARS-CoV-2 Mediated Hyperferritinemia and Cardiac Arrest: Preliminary Insights.	Drug Discov Today
33493637	Immunotoxic role of organophosphates: An unseen risk escalating SARS-CoV-2 pathogenicity.	Food Chem Toxicol
33493287	"Monocytes and Macrophages, Targets of Severe Acute Respiratory Syndrome Coronavirus 2: The Clue for Coronavirus Disease 2019 Immunoparalysis."	J Infect Dis
33493263	Kidney injury molecule-1 is a potential receptor for SARS-CoV-2.	J Mol Cell Biol
33493227	"Screening, simulation, and optimization design of small molecule inhibitors of the SARS-CoV-2 spike glycoprotein."	PLoS One
33493185	T cell response to SARS-CoV-2 infection in humans: A systematic review.	PLoS One
33493182	Furin cleavage of SARS-CoV-2 Spike promotes but is not essential for infection and cell-cell fusion.	PLoS Pathog
33492978	Similarities and Dissimilarities of COVID-19 and Other Coronavirus Diseases.	Annu Rev Microbiol
33492566	"Computational assessment of saikosaponins as adjuvant treatment for COVID-19: molecular docking, dynamics, and network pharmacology analysis."	Mol Divers
33492565	Physical exercise effects on the brain during COVID-19 pandemic: links between mental and cardiovascular health.	Neurol Sci
33492492	Molecular docking studies of some selected gallic acid derivatives against five non-structural proteins of novel coronavirus.	J Genet Eng Biotechnol
33492309	Functional monocytic myeloid-derived suppressor cells increase in blood but not airways and predict COVID-19 severity.	J Clin Invest
33492298	"COVID-19 and the Kidneys, Implications and Outcomes."	Iran J Kidney Dis
33491915	Broad-Spectrum Antiviral Agents Based on Multivalent Inhibitors of Viral Infectivity.	Adv Healthc Mater
33491822	A rapid and cost-effective multiplex ARMS-PCR method for the simultaneous genotyping of the circulating SARS-CoV-2 phylogenetic clades.	J Med Virol
33491759	Immune-checkpoint inhibitors from cancer to COVID19: A promising avenue for the treatment of patients with COVID19 (Review).	Int J Oncol
33491580	Immunomodulatory and anti-cytokine therapeutic potential of curcumin and its derivatives for treating COVID-19 - a computational modeling.	J Biomol Struct Dyn
33491579	Molecular basis for the repurposing of histamine H2-receptor antagonist to treat COVID-19.	J Biomol Struct Dyn
33491573	Exploring potential inhibitor of SARS-CoV2 replicase from FDA approved drugs using insilico drug discovery methods.	J Biomol Struct Dyn
33491508	Scutellaria baicalensis extract and baicalein inhibit replication of SARS-CoV-2 and its 3C-like protease in vitro.	J Enzyme Inhib Med Chem
33491070	Noncoding RNAs: modulators and modulatable players during infection-induced stress response.	Brief Funct Genomics
33490902	High-throughput rational design of the remdesivir binding site in the RdRp of SARS-CoV-2: implications for potential resistance.	iScience
33490718	Mutational analysis of SARS-CoV-2 ORF8 during six months of COVID-19 pandemic.	Gene Rep
33490695	"Understanding the implications of SARS-CoV-2 re-infections on immune response milieu, laboratory tests and control measures against COVID-19."	Heliyon
33490659	"Can limonene be a possible candidate for evaluation as an agent or adjuvant against infection, immunity, and inflammation in COVID-19?"	Heliyon
33490198	"A narrative review on the basic and clinical aspects of the novel SARS-CoV-2, the etiologic agent of COVID-19."	Ann Transl Med
33490124	The Strategy of Boosting the Immune System Under the COVID-19 Pandemic.	Front Vet Sci
33490110	Molecular Docking and Molecular Dynamics Aided Virtual Search of OliveNet Directory for Secoiridoids to Combat SARS-CoV-2 Infection and Associated Hyperinflammatory Responses.	Front Mol Biosci
33489899	"COVID-19: High-JAKing of the Inflammatory ""Flight"" by Ruxolitinib to Avoid the Cytokine Storm."	Front Oncol
33489841	"Endocrine Involvement in COVID-19: Mechanisms, Clinical Features, and Implications for Care."	Indian J Endocrinol Metab
33489475	Perspectives: potential therapeutic approach with inhalation of ACE2-derived peptides for SARS-CoV-2 infection.	Am J Clin Exp Immunol
33489438	An unorthodox pathophysiology of severe cases of COVID-19 the weak heme hypothesis.	Am J Blood Res
33489355	Arterial Hypertension as a Risk Comorbidity Associated with COVID-19 Pathology.	Int J Hypertens
33488611	Genetic Dissection of the Regulatory Mechanisms of Ace2 in the Infected Mouse Lung.	Front Immunol
33488597	"HLA, Immune Response, and Susceptibility to COVID-19."	Front Immunol
33488596	Sex Differences in Immunity: Implications for the Development of Novel Vaccines Against Emerging Pathogens.	Front Immunol
33488592	Rapid GMP-Compliant Expansion of SARS-CoV-2-Specific T Cells From Convalescent Donors for Use as an Allogeneic Cell Therapy for COVID-19.	Front Immunol
33488517	"The Adrenal Cortex, an Underestimated Site of SARS-CoV-2 Infection."	Front Endocrinol (Lausanne)
33488318	Could Dermaseptin Analogue be a Competitive Inhibitor for ACE2 Towards Binding with Viral Spike Protein Causing COVID19?: Computational Investigation.	Int J Pept Res Ther
33488314	"Antimicrobial Activity, DFT Calculations, and Molecular Docking of Dialdehyde Cellulose/Graphene Oxide Film Against Covid-19."	J Polym Environ
33488306	The Long Haul of COVID-19 Recovery: Immune Rejuvenation versus Immune Support.	Integr Med (Encinitas)
33488023	Cardiovascular Complications of COVID-19 and Associated Concerns: A Review.	Acta Cardiol Sin
33487892	Extracorporeal membrane oxygenation and lung transplantation.	Indian J Thorac Cardiovasc Surg
33487779	Genomic Study of COVID-19 Corona Virus Excludes Its Origin from Recombination or Characterized Biological Sources and Suggests a Role for HERVS in Its Wide Range Symptoms.	Cytol Genet
33487628	Selective Neuronal Mitochondrial Targeting in SARS-CoV-2 Infection Affects Cognitive Processes to Induce 'Brain Fog' and Results in Behavioral Changes that Favor Viral Survival.	Med Sci Monit
33486690	Hantavirus: The Next Pandemic We Are Waiting For?	Interdiscip Sci
33486674	SARS-COV-2 infection and lung tumor microenvironment.	Mol Biol Rep
33486617	NMR assignments of the macro domain from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).	Biomol NMR Assign
33486489	SARS-CoV-2-Associated T-Cell Responses in the Presence of Humoral Immunodeficiency.	Int Arch Allergy Immunol
33486479	Evidence of SARS-CoV2 Entry Protein ACE2 in the Human Nose and Olfactory Bulb.	Cells Tissues Organs
33486379	A meta-analysis of comorbidities in COVID-19: Which diseases increase the susceptibility of SARS-CoV-2 infection?	Comput Biol Med
33486372	Bioinformatics prediction of B and T cell epitopes within the spike and nucleocapsid proteins of SARS-CoV2.	J Infect Public Health
33486333	"Immunology, immunopathogenesis and immunotherapeutics of COVID-19; an overview."	Int Immunopharmacol
33486212	Impact of virus genetic variability and host immunity for the success of COVID-19 vaccines.	Biomed Pharmacother
33486202	Human endeavor for anti-SARS-CoV-2 pharmacotherapy: A major strategy to fight the pandemic.	Biomed Pharmacother
33486200	The race to treat COVID-19: Potential therapeutic agents for the prevention and treatment of SARS-CoV-2.	Eur J Med Chem
33486116	Drugs acting on the renin-angiotensin system and SARS-CoV-2.	Drug Discov Today
33485971	Dissecting the novel mechanism of reduning injection in treating Coronavirus Disease 2019 (COVID-19) based on network pharmacology and experimental verification.	J Ethnopharmacol
33485957	Associations between COVID-19 and skin conditions identified through epidemiology and genomic studies.	J Allergy Clin Immunol
33485847	Pharmacoinformatics approach based identification of potential Nsp15 endoribonuclease modulators for SARS-CoV-2 inhibition.	Arch Biochem Biophys
33485845	Systemic diseases and the cornea.	Exp Eye Res
33485405	Enhancement versus neutralization by SARS-CoV-2 antibodies from a convalescent donor associates with distinct epitopes on the RBD.	Cell Rep
33485182	The effects of novel coronavirus (SARS-CoV-2) infection on cardiovascular diseases and cardiopulmonary injuries.	Stem Cell Res
33484868	"Epigenetic underpinnings of inflammation: Connecting the dots between pulmonary diseases, lung cancer and COVID-19."	Semin Cancer Biol
33484784	Protein structural heterogeneity: A hypothesis for the basis of proteolytic recognition by the main protease of SARS-CoV and SARS-CoV-2.	Biochimie
33484712	Elucidation of interactions regulating conformational stability and dynamics of SARS-CoV-2 S-protein.	Biophys J
33484708	Chloroquine may induce endothelial injury through lysosomal dysfunction and oxidative stress.	Toxicol Appl Pharmacol
33484606	Green giant-a tiny chloroplast genome with mighty power to produce high-value proteins: history and phylogeny.	Plant Biotechnol J
33484403	"(1)H, (13)C and (15)N chemical shift assignment of the stem-loop 5a from the 5'-UTR of SARS-CoV-2."	Biomol NMR Assign
33484168	Elastase and exacerbation of neutrophil innate immunity are involved in multi-visceral manifestations of COVID-19.	Allergy
33483864	The cardiovascular disorders and prognostic cardiac biomarkers in COVID-19.	Mol Biol Rep
33483858	"Multi-organ damage by covid-19: congestive (cardio-pulmonary) heart failure, and blood-heart barrier leakage."	Mol Cell Biochem
33483791	"A comparative study of human betacoronavirus spike proteins: structure, function and therapeutics."	Arch Virol
33483707	Systematic evaluation of IgG responses to SARS-CoV-2 spike protein-derived peptides for monitoring COVID-19 patients.	Cell Mol Immunol
33483691	Decoding the temporal nature of brain GR activity in the NFkappaB signal transition leading to depressive-like behavior.	Mol Psychiatry
33483492	SARS-CoV-2 induces robust germinal center CD4 T follicular helper cell responses in rhesus macaques.	Nat Commun
33483491	A COVID-19 vaccine candidate using SpyCatcher multimerization of the SARS-CoV-2 spike protein receptor-binding domain induces potent neutralising antibody responses.	Nat Commun
33482337	Interleukin 1alpha: a comprehensive review on the role of IL-1alpha in the pathogenesis and treatment of autoimmune and inflammatory diseases.	Autoimmun Rev
33482326	Transcriptome network analyses in human coronavirus infections suggest a rational use of immunomodulatory drugs for COVID-19 therapy.	Genomics
33482242	A stable platform for the production of virus-like particles pseudotyped with the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) spike protein.	Virus Res
33482149	Biochemical features and mutations of key proteins in SARS-CoV-2 and their impacts on RNA therapeutics.	Biochem Pharmacol
33481950	"Serum Amyloid P inhibits single stranded RNA-induced lung inflammation, lung damage, and cytokine storm in mice."	PLoS One
33481684	Expression of SARS-CoV-2 Host Cell Entry Factors in Immune System Components of Healthy Individuals and Its Relevance for COVID-19 Immunopathology.	Viral Immunol
33481336	Generation of enzymatically competent SARS-CoV-2 decoy receptor ACE2-Fc in glycoengineered Nicotiana benthamiana.	Biotechnol J
33480807	Complement activation and coagulopathy - an ominous duo in COVID19.	Expert Rev Hematol
33480671	Design of SARS-CoV-2 hFc-Conjugated Receptor-Binding Domain mRNA Vaccine Delivered via Lipid Nanoparticles.	ACS Nano
33480287	"Clocks, Viruses, and Immunity: Lessons for the COVID-19 Pandemic."	J Biol Rhythms
33479758	Experimental data using candesartan and captopril indicate no double-edged sword effect in COVID-19.	Clin Sci (Lond)
33479725	"An integrated approach to determine the abundance, mutation rate and phylogeny of the SARS-CoV-2 genome."	Brief Bioinform
33479570	Influence of 4'-Substitution on the Activity of Gemcitabine and Its ProTide Against VZV and SARS-CoV-2.	ACS Med Chem Lett
33479506	High expression of ACE2 and TMPRSS2 and clinical characteristics of COVID-19 in colorectal cancer patients.	NPJ Precis Oncol
33479401	Catechin and curcumin interact with S protein of SARS-CoV2 and ACE2 of human cell membrane: insights from computational studies.	Sci Rep
33479353	Network analysis of Down syndrome and SARS-CoV-2 identifies risk and protective factors for COVID-19.	Sci Rep
33479198	The SARS-CoV-2 nucleocapsid phosphoprotein forms mutually exclusive condensates with RNA and the membrane-associated M protein.	Nat Commun
33479167	Major alterations in the mononuclear phagocyte landscape associated with COVID-19 severity.	Proc Natl Acad Sci U S A
33479166	Dynamic competition between SARS-CoV-2 NSP1 and mRNA on the human ribosome inhibits translation initiation.	Proc Natl Acad Sci U S A
33478949	Severely ill COVID-19 patients display impaired exhaustion features in SARS-CoV-2-reactive CD8(+) T cells.	Sci Immunol
33478794	"Immunoinformatics prediction of overlapping CD8(+) T-cell, IFN-gamma and IL-4 inducer CD4(+) T-cell and linear B-cell epitopes based vaccines against COVID-19 (SARS-CoV-2)."	Vaccine
33478787	Immuno-informatics approach for B-cell and T-cell epitope based peptide vaccine design against novel COVID-19 virus.	Vaccine
33478625	"Two-step strategy for the identification of SARS-CoV-2 variant of concern 202012/01 and other variants with spike deletion H69-V70, France, August to December 2020."	Euro Surveill
33478554	Mechanistic modeling of the SARS-CoV-2 disease map.	BioData Min
33478471	Allergen fragrance molecules: a potential relief for COVID-19.	BMC Complement Med Ther
33478342	In silico evaluation of lapachol derivatives binding to the Nsp9 of SARS-CoV-2.	J Biomol Struct Dyn
33478237	"SARS-CoV-2 (Covid-19): A short update on molecular biochemistry, pathology, diagnosis and therapeutic strategies."	Ann Clin Biochem
33478107	The Immunopathological and Histological Landscape of COVID-19-Mediated Lung Injury.	Int J Mol Sci
33477969	The Positive Allosteric Modulation of alpha7-Nicotinic Cholinergic Receptors by GAT107 Increases Bacterial Lung Clearance in Hyperoxic Mice by Decreasing Oxidative Stress in Macrophages.	Antioxidants (Basel)
33477951	"Structural Mapping of Mutations in Spike, RdRp and Orf3a Genes of SARS-CoV-2 in Influenza Like Illness (ILI) Patients."	Viruses
33477902	Structural Analysis of Neutralizing Epitopes of the SARS-CoV-2 Spike to Guide Therapy and Vaccine Design Strategies.	Viruses
33477901	Diarylureas: Repositioning from Antitumor to Antimicrobials or Multi-Target Agents against New Pandemics.	Antibiotics (Basel)
33477885	"Intra-Host Diversity of SARS-Cov-2 Should Not Be Neglected: Case of the State of Victoria, Australia."	Viruses
33477869	Neuroinvasion and Encephalitis Following Intranasal Inoculation of SARS-CoV-2 in K18-hACE2 Mice.	Viruses
33477787	mRNA-Enhanced Cell Therapy and Cardiovascular Regeneration.	Cells
33477534	"Immune Responses Induced by mRNA Vaccination in Mice, Monkeys and Humans."	Vaccines (Basel)
33477477	SARS-CoV-2 Cellular Infection and Therapeutic Opportunities: Lessons Learned from Ebola Virus.	Membranes (Basel)
33477379	Chimeric Porcine Deltacoronaviruses with Sparrow Coronavirus Spike Protein or the Receptor-Binding Domain Infect Pigs but Lose Virulence and Intestinal Tropism.	Viruses
33477376	"Quinacrine, an Antimalarial Drug with Strong Activity Inhibiting SARS-CoV-2 Viral Replication In Vitro."	Viruses
33477294	COVID-19-The Potential Beneficial Therapeutic Effects of Spironolactone during SARS-CoV-2 Infection.	Pharmaceuticals (Basel)
33477032	ATP biphasically modulates LLPS of SARS-CoV-2 nucleocapsid protein and specifically binds its RNA-binding domain.	Biochem Biophys Res Commun
33476804	Clade GR and clade GH isolates of SARS-CoV-2 in Asia show highest amount of SNPs.	Infect Genet Evol
33476695	The 442th amino acid residue of the spike protein is critical for the adaptation to bat hosts for SARS-related coronaviruses.	Virus Res
33476691	Inhibition of drug-metabolizing enzymes by Qingfei Paidu decoction: Implication of herb-drug interactions in COVID-19 pharmacotherapy.	Food Chem Toxicol
33476648	SARS-CoV-2 infects cells after viral entry via clathrin-mediated endocytosis.	J Biol Chem
33476581	Acute Immune Signatures and Their Legacies in Severe Acute Respiratory Syndrome Coronavirus-2 Infected Cancer Patients.	Cancer Cell
33476549	Compromised SARS-CoV-2-specific placental antibody transfer.	Cell
33476327	SARS-CoV-2 variants with mutations at the S1/S2 cleavage site are generated in vitro during propagation in TMPRSS2-deficient cells.	PLoS Pathog
33476301	Effective virus-neutralizing activities in antisera from the first wave of survivors of severe COVID-19.	JCI Insight
33475934	"(1)H, (13)C and (15)N backbone chemical shift assignments of SARS-CoV-2 nsp3a."	Biomol NMR Assign
33475497	SARS-CoV infection crosstalk with human host cell noncoding-RNA machinery: An in-silico approach.	Biomed Pharmacother
33475441	SARS-CoV-2 RNA-dependent RNA polymerase as a therapeutic target for COVID-19.	Expert Opin Ther Pat
33475167	Targeting SARS-CoV-2 viral proteases as a therapeutic strategy to treat COVID-19.	J Med Virol
33475077	"COVID-19, Angiotensin-Converting Enzyme 2 and Renin-Angiotensin System Inhibition: Implications for Practice."	Curr Hypertens Rev
33475021	In silico study indicates antimalarials as direct inhibitors of SARS-CoV-2-RNA dependent RNA polymerase.	J Biomol Struct Dyn
33475020	"Insight into molecular characteristics of SARS-CoV-2 spike protein following D614G point mutation, a molecular dynamics study."	J Biomol Struct Dyn
33474935	Evaluation of UV-C Decontamination of Clinical Tissue Sections for Spatially Resolved Analysis by Mass Spectrometry Imaging (MSI).	Anal Chem
33474931	"Topography, Spike Dynamics, and Nanomechanics of Individual Native SARS-CoV-2 Virions."	Nano Lett
33473223	"Lessons from the host defences of bats, a unique viral reservoir."	Nature
33473155	Discriminating mild from critical COVID-19 by innate and adaptive immune single-cell profiling of bronchoalveolar lavages.	Cell Res
33473151	Identification of 3-chymotrypsin like protease (3CLPro) inhibitors as potential anti-SARS-CoV-2 agents.	Commun Biol
33473140	Molecular determinants and mechanism for antibody cocktail preventing SARS-CoV-2 escape.	Nat Commun
33473130	The complex structure of GRL0617 and SARS-CoV-2 PLpro reveals a hot spot for antiviral drug discovery.	Nat Commun
33472985	Interplay of Antibody and Cytokine Production Reveals CXCL13 as a Potential Novel Biomarker of Lethal SARS-CoV-2 Infection.	mSphere
33472939	Comparison of Subgenomic and Total RNA in SARS-CoV-2 Challenged Rhesus Macaques.	J Virol
33472904	A Novel Point Mutation in the N Gene of SARS-CoV-2 May Affect the Detection of the Virus by Reverse Transcription-Quantitative PCR.	J Clin Microbiol
33472860	Coronavirus replication-transcription complex: Vital and selective NMPylation of a conserved site in nsp9 by the NiRAN-RdRp subunit.	Proc Natl Acad Sci U S A
33472675	Evaluation of the efficacy and safety of icatibant and C1 esterase/kallikrein inhibitor in severe COVID-19: study protocol for a three-armed randomized controlled trial.	Trials
33472576	Anatomical and Pathological Observation and Analysis of SARS and COVID-19: Microthrombosis Is the Main Cause of Death.	Biol Proced Online
33472369	ACE-2-Derived Biomimetic Peptides for the Inhibition of Spike Protein of SARS-CoV-2.	J Proteome Res
33471859	In silico comparative genomics of SARS-CoV-2 to determine the source and diversity of the pathogen in Bangladesh.	PLoS One
33471720	Considerations for Gut Microbiota and Probiotics in Patients with Diabetes Amidst the Covid-19 Pandemic: A Narrative Review.	Endocr Pract
33471297	Clinical Characteristics and Outcomes of Patients with COVID-19 Infection: The Results of the SARS-RAS Study of the Italian Society of Hypertension.	High Blood Press Cardiovasc Prev
33471060	Cellinker: a platform of ligand-receptor interactions for intercellular communication analysis.	Bioinformatics
33470888	Distribution of the ACE1 D Allele in the Bosnian-Herzegovinian Population and its Possible Role in the Regional Epidemiological Picture of COVID-19.	Genet Test Mol Biomarkers
33470589	Atopic endotypes as a modulating factor for SARS-CoV-2 infection: mechanisms and implications.	Curr Opin Allergy Clin Immunol
33470077	Coronaviruses - a new old menace.	Postepy Biochem
33470076	"Differentiation, emergence and re-emergence of viral pathogens: past, present, future"	Postepy Biochem
33470073	"Towards elucidating the structure, function, and druggability of coronavirus cis-acting RNA motifs"	Postepy Biochem
33469977	"Molecular Simulations suggest Vitamins, Retinoids and Steroids as Ligands of the Free Fatty Acid Pocket of the SARS-CoV-2 Spike Protein*."	Angew Chem Int Ed Engl
33469835	Level of the SARS-CoV-2 receptor ACE2 activity is highly elevated in old-aged patients with aortic stenosis: implications for ACE2 as a biomarker for the severity of COVID-19.	Geroscience
33469663	SARS-CoV-2/human interactome reveals ACE2 locus crosstalk with the immune regulatory network in the host.	Pathog Dis
33469649	Exploring G protein-coupled receptors and yeast surface display strategies for viral detection in baker's yeast: SARS-CoV-2 as a case study.	FEMS Yeast Res
33469529	Nitric Oxide Releasing Hydrogel Nanoparticles Decreases Epithelial Cell Injuries Associated With Airway Reopening.	Front Bioeng Biotechnol
33469527	Elucidating Interactions Between SARS-CoV-2 Trimeric Spike Protein and ACE2 Using Homology Modeling and Molecular Dynamics Simulations.	Front Chem
33469510	"A domain-based vaccine construct against SARS-CoV-2, the causative agent of COVID-19 pandemic: development of self-amplifying mRNA and peptide vaccines."	Bioimpacts
33469465	Single-Cell RNA Sequencing of Tocilizumab-Treated Peripheral Blood Mononuclear Cells as an in vitro Model of Inflammation.	Front Genet
33469197	Maternal endothelial dysfunction in HIV-associated preeclampsia comorbid with COVID-19: a review.	Hypertens Res
33469152	Sex bias of females in survival from cancer and infections. Is X the answer?	Br J Cancer
33469026	"Genomic epidemiology of SARS-CoV-2 reveals multiple lineages and early spread of SARS-CoV-2 infections in Lombardy, Italy."	Nat Commun
33468703	"Stenoparib, an Inhibitor of Cellular Poly(ADP-Ribose) Polymerase, Blocks Replication of the SARS-CoV-2 and HCoV-NL63 Human Coronaviruses In Vitro."	mBio
33468702	SARS-CoV-2 Genomic Variation in Space and Time in Hospitalized Patients in Philadelphia.	mBio
33468697	Atypical Divergence of SARS-CoV-2 Orf8 from Orf7a within the Coronavirus Lineage Suggests Potential Stealthy Viral Strategies in Immune Evasion.	mBio
33468695	SARS-CoV-2 Infection Severity Is Linked to Superior Humoral Immunity against the Spike.	mBio
33468694	Coronaviruses Associated with the Superfamily Musteloidea.	mBio
33468689	At Least Seven Distinct Rotavirus Genotype Constellations in Bats with Evidence of Reassortment and Zoonotic Transmissions.	mBio
33468688	Engineering a Reliable and Convenient SARS-CoV-2 Replicon System for Analysis of Viral RNA Synthesis and Screening of Antiviral Inhibitors.	mBio
33468686	Genome Sequencing of Sewage Detects Regionally Prevalent SARS-CoV-2 Variants.	mBio
33468674	Synthetic protein conjugate vaccines provide protection against Mycobacterium tuberculosis in mice.	Proc Natl Acad Sci U S A
33468620	Ipomoeassin-F inhibits the in vitro biogenesis of the SARS-CoV-2 spike protein and its host cell membrane receptor.	J Cell Sci
33468464	Inhibition of Arenaviruses by Combinations of Orally Available Approved Drugs.	Antimicrob Agents Chemother
33468263	Vitamin A in resistance to and recovery from infection: relevance to SARS-CoV2.	Br J Nutr
33468250	MSC-NTF (NurOwn(R)) exosomes: a novel therapeutic modality in the mouse LPS-induced ARDS model.	Stem Cell Res Ther
33468160	Multienzymes activity of metals and metal oxide nanomaterials: applications from biotechnology to medicine and environmental engineering.	J Nanobiotechnology
33467912	The potential association between PARP14 and SARS-CoV-2 infection (COVID-19).	Future Med Chem
33467896	Inter-proteomic posttranslational modifications of the SARS-CoV-2 and the host proteins A new frontier.	Exp Biol Med (Maywood)
33467732	Intranasal Infection of Ferrets with SARS-CoV-2 as a Model for Asymptomatic Human Infection.	Viruses
33467724	Nucleocapsid and Spike Proteins of the Coronavirus SARS-CoV-2 Induce IL6 in Monocytes and Macrophages-Potential Implications for Cytokine Storm Syndrome.	Vaccines (Basel)
33467642	Mitochondrial Functionality in Inflammatory Pathology-Modulatory Role of Physical Activity.	Life (Basel)
33467522	A Global Review on Short Peptides: Frontiers and Perspectives.	Molecules
33467206	"MicroRNAs for Virus Pathogenicity and Host Responses, Identified in SARS-CoV-2 Genomes, May Play Roles in Viral-Host Co-Evolution in Putative Zoonotic Host Species."	Viruses
33467029	Natural and Nature-Derived Products Targeting Human Coronaviruses.	Molecules
33466921	Domains and Functions of Spike Protein in Sars-Cov-2 in the Context of Vaccine Design.	Viruses
33466743	Cheminformatics-Based Identification of Potential Novel Anti-SARS-CoV-2 Natural Compounds of African Origin.	Molecules
33466734	Cannabis sativa L. as a Natural Drug Meeting the Criteria of a Multitarget Approach to Treatment.	Int J Mol Sci
33466589	Significance of NETs Formation in COVID-19.	Cells
33466585	Severe COVID-19 Lung Infection in Older People and Periodontitis.	J Clin Med
33465472	Therapeutic approaches targeting renin-angiotensin system in sepsis and its complications.	Pharmacol Res
33465451	In silico T cell epitope identification for SARS-CoV-2: Progress and perspectives.	Adv Drug Deliv Rev
33465325	Viral pathogenesis of SARS-CoV-2 infection and male reproductive health.	Open Biol
33465165	Hydroxychloroquine-mediated inhibition of SARS-CoV-2 entry is attenuated by TMPRSS2.	PLoS Pathog
33465158	K18-hACE2 mice develop respiratory disease resembling severe COVID-19.	PLoS Pathog
33465137	The coronavirus proofreading exoribonuclease mediates extensive viral recombination.	PLoS Pathog
33465066	Modeling the structure of the frameshift-stimulatory pseudoknot in SARS-CoV-2 reveals multiple possible conformers.	PLoS Comput Biol
33465050	Fighting the storm: could novel anti-TNFalpha and anti-IL-6 C. sativa cultivars tame cytokine storm in COVID-19?	Aging (Albany NY)
33464917	Proteomic Approaches to Study SARS-CoV-2 Biology and COVID-19 Pathology.	J Proteome Res
33464914	"COVID-19 Transmission, Current Treatment, and Future Therapeutic Strategies."	Mol Pharm
33464829	Rapid Development of SARS-CoV-2 Spike Protein Receptor-Binding Domain Self-Assembled Nanoparticle Vaccine Candidates.	ACS Nano
33464672	Sterilizing Immunity against SARS-CoV-2 Infection in Mice by a Single-Shot and Lipid Amphiphile Imidazoquinoline TLR7/8 Agonist-Adjuvanted Recombinant Spike Protein Vaccine*.	Angew Chem Int Ed Engl
33464639	Role of vitamin D in regulating COVID-19 severity-An immunological perspective.	J Leukoc Biol
33464637	Genome-wide DNA methylation profiling of peripheral blood reveals an epigenetic signature associated with severe COVID-19.	J Leukoc Biol
33464546	SARS-CoV-2: its potential neurological manifestations and plausible mechanism: a review article.	Acta Neurol Belg
33464543	Cell-Based High-Throughput Screening Protocol for Discovering Antiviral Inhibitors Against SARS-COV-2 Main Protease (3CLpro).	Mol Biotechnol
33464535	Evidence of Coronavirus (CoV) Pathogenesis and Emerging Pathogen SARS-CoV-2 in the Nervous System: A Review on Neurological Impairments and Manifestations.	J Mol Neurosci
33464439	"Bats, pangolins, minks and other animals - villains or victims of SARS-CoV-2?"	Vet Res Commun
33464429	Anti-phospholipids antibodies and immune complexes in COVID-19 patients: a putative role in disease course for anti-annexin-V antibodies.	Clin Rheumatol
33464421	Comprehensive analysis of genomic diversity of SARS-CoV-2 in different geographic regions of India: an endeavour to classify Indian SARS-CoV-2 strains on the basis of co-existing mutations.	Arch Virol
33464336	Effect of Discontinuing vs Continuing Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers on Days Alive and Out of the Hospital in Patients Admitted With COVID-19: A Randomized Clinical Trial.	JAMA
33464307	Mapping and role of T cell response in SARS-CoV-2-infected mice.	J Exp Med
33464168	"Androgens, the kidney, and COVID-19: an opportunity for translational research."	Am J Physiol Renal Physiol
33463917	Minireview: The Introduction of COVID-19 and Microvascular Disease-Introduction of COVID-19 and the Relationship between Its Receptor and Diabetic Vascular Complications.	Crit Rev Eukaryot Gene Expr
33463909	17beta-estradiol reduces SARS-CoV-2 infection in vitro.	Physiol Rep
33463525	Evidence for adaptive evolution in the receptor-binding domain of seasonal coronaviruses OC43 and 229e.	Elife
33463480	The Role of Justicia Adhatoda as prophylaxis for COVID-19 - Analysis based on docking study.	Infect Disord Drug Targets
33463470	An Updated Review on Betacoronavirus Viral Entry Inhibitors: Learning from Past Discoveries to Advance COVID-19 Drug Discovery.	Curr Top Med Chem
33463113	Variable Clinical Manifestations of COVID-19: Viral and Human Genomes Talk.	Iran J Allergy Asthma Immunol
33462852	ACE2 in the second act of COVID-19 syndrome: Peptide dysregulation and possible correction with oestrogen.	J Neuroendocrinol
33462776	Purinergic Signaling of ATP in COVID-19 Associated Guillain-Barre Syndrome.	J Neuroimmune Pharmacol
33462706	"Age-associated difference in circulating ACE2, the gateway for SARS-COV-2, in humans: results from the InCHIANTI study."	Geroscience
33462671	The roles of signaling pathways in SARS-CoV-2 infection; lessons learned from SARS-CoV and MERS-CoV.	Arch Virol
33462575	Mass spectrometry reveals potential of beta-lactams as SARS-CoV-2 M(pro) inhibitors.	Chem Commun (Camb)
33462564	"Epidemiology and pathobiology of SARS-CoV-2 (COVID-19) in comparison with SARS, MERS: An updated overview of current knowledge and future perspectives."	Clin Epidemiol Glob Health
33462562	Traditional foods with their constituent's antiviral and immune system modulating properties.	Heliyon
33462384	Regulation of RIG-I-like receptor-mediated signaling: interaction between host and viral factors.	Cell Mol Immunol
33462320	Predicting mammalian species at risk of being infected by SARS-CoV-2 from an ACE2 perspective.	Sci Rep
33461573	"MERS-CoV: epidemiology, molecular dynamics, therapeutics, and future challenges."	Ann Clin Microbiol Antimicrob
33461503	Dynamic changes in lymphocyte subsets and parallel cytokine levels in patients with severe and critical COVID-19.	BMC Infect Dis
33461215	Ligand-based approach for predicting drug targets and for virtual screening against COVID-19.	Brief Bioinform
33461210	Evolution of antibody immunity to SARS-CoV-2.	Nature
33461019	"Multifunctional angiotensin converting enzyme 2, the SARS-CoV-2 entry receptor, and critical appraisal of its role in acute lung injury."	Biomed Pharmacother
33460600	Improving SARS-CoV-2 structures: Peer review by early coordinate release.	Biophys J
33460213	"What coronavirus 3C-like protease tells us: From structure, substrate selectivity, to inhibitor design."	Med Res Rev
33460172	"SARS-CoV-2, the pandemic coronavirus: Molecular and structural insights."	J Basic Microbiol
33459897	Does death from Covid-19 arise from a multi-step process?	Eur J Epidemiol
33459817	Addressing the potential role of curcumin in the prevention of COVID-19 by targeting the Nsp9 replicase protein through molecular docking.	Arch Microbiol
33459706	Broader Insights into Understanding Tumor Necrosis Factor and Neurodegenerative Disease Pathogenesis Infer New Therapeutic Approaches.	J Alzheimers Dis
33459559	The histo-blood group antigens of the host cell may determine the binding of different viruses such as SARS-CoV-2.	Future Microbiol
33459225	Natural Agents Modulating ACE-2: A Review of Compounds with Potential against SARS-CoV-2 Infections.	Curr Pharm Des
33459192	An in silico analysis of Ibuprofen enantiomers in high concentrations of sodium chloride with SARS-CoV-2 main protease.	J Biomol Struct Dyn
33459182	"Identification of 1,2,3-triazole-phthalimide derivatives as potential drugs against COVID-19: a virtual screening, docking and molecular dynamic study."	J Biomol Struct Dyn
33459176	Molecular docking and simulation studies of natural compounds of Vitex negundo L. against papain-like protease (PL(pro)) of SARS CoV-2 (coronavirus) to conquer the pandemic situation in the world.	J Biomol Struct Dyn
33459174	Withanolides from Withania somnifera as an immunity booster and their therapeutic options against COVID-19.	J Biomol Struct Dyn
33458958	Next-Generation Vaccines: Nanoparticle-Mediated DNA and mRNA Delivery.	Adv Healthc Mater
33458832	"World-wide tracking of major SARS-CoV-2 genome haplotypes in sequences of June 1 to November 15, 2020 and discovery of rapid expansion of a new haplotype."	J Med Virol
33458761	Bioinformatics and system biology approach to identify the influences of COVID-19 on cardiovascular and hypertensive comorbidities.	Brief Bioinform
33458747	Serial co-expression analysis of host factors from SARS-CoV viruses highly converges with former high-throughput screenings and proposes key regulators.	Brief Bioinform
33458630	"Cardiovascular Pathophysiology, Epidemiology, and Treatment Considerations of Coronavirus Disease 2019 (COVID-19): A Review."	CJC Open
33458584	"Inflammatory myopathies: update on diagnosis, pathogenesis and therapies, and COVID-19-related implications."	Acta Myol
33458558	Neurobiology of SARS-CoV-2 interactions with the peripheral nervous system: implications for COVID-19 and pain.	Pain Rep
33458462	"Characterization of the SARS-CoV-2 S Protein: Biophysical, Biochemical, Structural, and Antigenic Analysis."	ACS Omega
33458435	In silico validation of potent phytochemical orientin as inhibitor of SARS-CoV-2 spike and host cell receptor GRP78 binding.	Heliyon
33457495	In silico exploration of novel protease inhibitors against coronavirus 2019 (COVID-19).	Inform Med Unlocked
33457429	Compounds of Citrus medica and Zingiber officinale for COVID-19 inhibition: in silico evidence for cues from Ayurveda.	Futur J Pharm Sci
33457322	Meningoencephalitis Associated with SARS-Coronavirus-2.	Transl Med UniSa
33457195	Footprint of the COVID-19 Pandemic in India: A Study of Immune Landscape and Other Factors Shielding Mortality.	Anal Cell Pathol (Amst)
33457176	Factual insights of the allosteric inhibition mechanism of SARS-CoV-2 main protease by quercetin: an in silico analysis.	3 Biotech
33457172	Designing a next generation multi-epitope based peptide vaccine candidate against SARS-CoV-2 using computational approaches.	3 Biotech
33457171	"In silico docking analysis revealed the potential of phytochemicals present in Phyllanthus amarus and Andrographis paniculata, used in Ayurveda medicine in inhibiting SARS-CoV-2."	3 Biotech
33457109	Decoding Covid-19 with the SARS-CoV-2 Genome.	Curr Genet Med Rep
33457042	A large-scale transcriptional study reveals inhibition of COVID-19 related cytokine storm by traditional Chinese medicines.	Sci Bull (Beijing)
33456770	Protease inhibitor GC376 for COVID-19: Lessons learned from feline infectious peritonitis.	Ann Med Surg (Lond)
33456761	"SARS-CoV-2 meta-interactome suggests disease-specific, autoimmune pathophysiologies and therapeutic targets."	F1000Res
33456724	Unraveling the molecular basis of host cell receptor usage in SARS-CoV-2 and other human pathogenic beta-CoVs.	Comput Struct Biotechnol J
33456620	Principal Component Analysis Applications in COVID-19 Genome Sequence Studies.	Cognit Comput
33456522	"Confronting the threat of SARS-CoV-2: Realities, challenges and therapeutic strategies (Review)."	Exp Ther Med
33456304	The neuropathological impact of COVID-19: a review.	Bull Natl Res Cent
33456056	Employing a systematic approach to biobanking and analyzing clinical and genetic data for advancing COVID-19 research.	Eur J Hum Genet
33455862	Altered Cholesterol and Lipid Synthesis Mediates Hyperinflammation in COVID-19.	Trends Endocrinol Metab
33455043	ACE2 expression is elevated in airway epithelial cells from older and male healthy individuals but reduced in asthma.	Respirology
33454715	Structures of SARS-CoV-2 RNA-Binding Proteins and Therapeutic Targets.	Intervirology
33454595	The role of iron in the pathogenesis of COVID-19 and possible treatment with lactoferrin and other iron chelators.	Biomed Pharmacother
33454368	Monocytes and macrophages in COVID-19: Friends and foes.	Life Sci
33454328	Trends and strategies to combat viral infections: A review on FDA approved antiviral drugs.	Int J Biol Macromol
33454213	The Counter Regulatory Axis of the Lung Renin-Angiotensin System in Severe COVID-19: Pathophysiology and Clinical Implications.	Heart Lung Circ
33454058	The inhibitory effects of PGG and EGCG against the SARS-CoV-2 3C-like protease.	Biochem Biophys Res Commun
33453462	Chromosome 3 cluster rs11385942 variant links complement activation with severe COVID-19.	J Autoimmun
33453392	Bisindolylmaleimide IX: A novel anti-SARS-CoV2 agent targeting viral main protease 3CLpro demonstrated by virtual screening pipeline and in-vitro validation assays.	Methods
33453245	The proteomic characteristics of airway mucus from critical ill COVID-19 patients.	Life Sci
33453010	"A narrative review of coronavirus disease 2019 (COVID-19): clinical, epidemiological characteristics, and systemic manifestations."	Intern Emerg Med
33452858	Disease-duration based comparison of subsets of immune cells in SARS CoV-2 infected patients presenting with mild or severe symptoms identifies prognostic markers for severity.	Immun Inflamm Dis
33452809	"Minimal, superficial DNA damage in human skin from filtered far-ultraviolet C."	Br J Dermatol
33452734	Exploring the treatment of COVID-19 with Yinqiao powder based on network pharmacology.	Phytother Res
33452633	The cerebral network of COVID-19-related encephalopathy: a longitudinal voxel-based 18F-FDG-PET study.	Eur J Nucl Med Mol Imaging
33452303	SARS-CoV-2 infection susceptibility influenced by ACE2 genetic polymorphisms: insights from Tehran Cardio-Metabolic Genetic Study.	Sci Rep
33452205	Identification of existing pharmaceuticals and herbal medicines as inhibitors of SARS-CoV-2 infection.	Proc Natl Acad Sci U S A
33452008	At the Crossroads: COVID-19 and Immune-Checkpoint Blockade for Cancer.	Cancer Immunol Res
33451855	Dysregulation of Cell Signaling by SARS-CoV-2.	Trends Microbiol
33451132	Systematic Search for SARS-CoV-2 Main Protease Inhibitors for Drug Repurposing: Ethacrynic Acid as a Potential Drug.	Viruses
33450678	Micronutrients and bioactive substances: Their potential roles in combating COVID-19.	Nutrition
33450669	Incomplete humoral response including neutralizing antibodies in asymptomatic to mild COVID-19 patients in Japan.	Virology
33450625	Host genomics of COVID-19: Evidence point towards Alpha 1 antitrypsin deficiency as a putative risk factor for higher mortality rate.	Med Hypotheses
33450541	Broad-spectrum antivirals of protoporphyrins inhibit the entry of highly pathogenic emerging viruses.	Bioorg Chem
33450483	The papain-like protease of coronaviruses cleaves ULK1 to disrupt host autophagy.	Biochem Biophys Res Commun
33450373	Sequence analysis of Indian SARS-CoV-2 isolates shows a stronger interaction of mutant receptor-binding domain with ACE2.	Int J Infect Dis
33450186	ApoE-Isoform-Dependent SARS-CoV-2 Neurotropism and Cellular Response.	Cell Stem Cell
33449976	rfaRm: An R client-side interface to facilitate the analysis of the Rfam database of RNA families.	PLoS One
33449359	Dynamics and electrostatics define an allosteric druggable site within the receptor-binding domain of SARS-CoV-2 spike protein.	FEBS Lett
33449336	"Infection, atherothrombosis and thromboembolism beyond the COVID-19 disease: what similar in physiopathology and researches."	Aging Clin Exp Res
33449290	SARS-CoV-2 infection and thrombotic complications: a narrative review.	J Thromb Thrombolysis
33449149	"Ultrastructural modifications induced by SARS-CoV-2 in Vero cells: a kinetic analysis of viral factory formation, viral particle morphogenesis and virion release."	Cell Mol Life Sci
33448856	Dynamic Network Modeling of Allosteric Interactions and Communication Pathways in the SARS-CoV-2 Spike Trimer Mutants: Differential Modulation of Conformational Landscapes and Signal Transmission via Cascades of Regulatory Switches.	J Phys Chem B
33448740	The role of mesenchymal stem cells in COVID-19 treatment.	Tuberk Toraks
33448738	COVID-19 and acute kidney injury.	Tuberk Toraks
33448629	Spotlight on COVID-19: from biology to therapy and prevention.	FEBS J
33448317	"Vitamin D, zinc and glutamine: Synergistic action with OncoTherad immunomodulator in interferon signaling and COVID19 (Review)."	Int J Mol Med
33448315	COVID19 and ischemic stroke: Mechanisms of hypercoagulability (Review).	Int J Mol Med
33448184	ADP-ribosylhydrolases: from DNA damage repair to COVID-19.	J Zhejiang Univ Sci B
33448169	"[Mechanism and intervention of mucosal immune regulation based on ""lung and large intestine being interior-exteriorly related"" theory of traditional Chinese medicine]."	Zhejiang Da Xue Xue Bao Yi Xue Ban
33447968	In vitro three-dimensional organotypic culture models of the oral mucosa.	In Vitro Cell Dev Biol Anim
33447763	Cardiovascular medications and regulation of COVID-19 receptors expression.	Int J Cardiol Hypertens
33447433	"Narrative review of the novel coronavirus SARS-CoV-2: update on genomic characteristics, transmissions and animal model."	J Thorac Dis
33447372	Computational screening for potential drug candidates against the SARS-CoV-2 main protease.	F1000Res
33447071	Understanding COVID-19 Pandemic: Molecular Mechanisms and Potential Therapeutic Strategies. An Evidence-Based Review.	J Inflamm Res
33446817	Cannabis compounds exhibit anti-inflammatory activity in vitro in COVID-19-related inflammation in lung epithelial cells and pro-inflammatory activity in macrophages.	Sci Rep
33446655	SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 immunogenicity in baboons and protection in mice.	Nat Commun
33446556	Learning the language of viral evolution and escape.	Science
33446512	Orthogonal immunoassays for IgG antibodies to SARS-CoV-2 antigens reveal that immune response lasts beyond 4 mo post illness onset.	Proc Natl Acad Sci U S A
33446414	[Histopathological features due to the SARS-CoV-2].	Ann Pathol
33446406	Slaying SARS-CoV-2 One (Single-domain) Antibody at a Time.	Trends Microbiol
33446077	Prospecting for Cressa cretica to treat COVID-19 via in silico molecular docking models of the SARS-CoV-2.	J Biomol Struct Dyn
33446058	Bacillus species; a potential source of anti-SARS-CoV-2 main protease inhibitors.	J Biomol Struct Dyn
33445936	Principles and new perspectives in the vaccination against SARS-CoV-2 virus.	Cas Lek Cesk
33445824	Clinical outcomes of COVID-19 following the use of angiotensin-converting enzyme inhibitors or angiotensin-receptor blockers among patients with hypertension in Korea: a nationwide study.	Epidemiol Health
33445810	Cytokines and Chemokines in SARS-CoV-2 Infections-Therapeutic Strategies Targeting Cytokine Storm.	Biomolecules
33445785	The Long-Term Evolutionary History of Gradual Reduction of CpG Dinucleotides in the SARS-CoV-2 Lineage.	Biology (Basel)
33445583	Severe COVID-19 and Sepsis: Immune Pathogenesis and Laboratory Markers.	Microorganisms
33444904	COVID-19 patients may become predisposed to pulmonary arterial hypertension.	Med Hypotheses
33444702	Inhibition of coronavirus infection by a synthetic STING agonist in primary human airway system.	Antiviral Res
33444631	Association analysis framework of genetic and exposure risks for COVID-19 in middle-aged and elderly adults.	Mech Ageing Dev
33444546	Comprehensive in vivo secondary structure of the SARS-CoV-2 genome reveals novel regulatory motifs and mechanisms.	Mol Cell
33444511	Immune response to COVID-19 infection: a double-edged sword.	Immunol Med
33444422	Clinical and radiological findings of adult hospitalized patients with community-acquired pneumonia from SARS-CoV-2 and endemic human coronaviruses.	PLoS One
33444408	Quercetin as a potential treatment for COVID-19-induced acute kidney injury: Based on network pharmacology and molecular docking study.	PLoS One
33444356	Modeling the initial phase of SARS-CoV-2 deposition in the respiratory tract mimicked by the 11C radionuclide.	PLoS One
33444117	Functional pathophysiology of SARS-CoV-2-induced acute lung injury and clinical implications.	J Appl Physiol (1985)
33443932	Vascular activation is a strong predictor of mortality in coronavirus disease 2019 patients on the ICU.	Blood Coagul Fibrinolysis
33443816	The role of SARS-CoV-2 target ACE2 in cardiovascular diseases.	J Cell Mol Med
33443616	Efficacy of synthetic glucocorticoids in COVID-19 endothelites.	Naunyn Schmiedebergs Arch Pharmacol
33443384	What Is a Cytokine Storm and Should It Matter to Me?	J Am Acad Orthop Surg
33443366	Severe COVID-19: Immunosuppression or Hyperinflammation?	Shock
33443248	Synthesis and immunological evaluation of synthetic peptide based anti-SARS-CoV-2 vaccine candidates.	Chem Commun (Camb)
33443121	Manipulation of ACE2 expression in COVID-19.	Open Heart
33443088	Identification of SARS-CoV-2 Nucleocapsid and Spike T-Cell Epitopes for Assessing T-Cell Immunity.	J Virol
33443036	Rapid generation of durable B cell memory to SARS-CoV-2 spike and nucleocapsid proteins in COVID-19 and convalescence.	Sci Immunol
33443016	Cytokine ranking via mutual information algorithm correlates cytokine profiles with presenting disease severity in patients infected with SARS-CoV-2.	Elife
33442728	ACE/ACE2 balance might be instrumental to explain the certain comorbidities leading to severe COVID-19 cases.	Biosci Rep
33442447	Liver injury in COVID-19: The hepatic aspect of the respiratory syndrome - what we know so far.	World J Hepatol
33442386	Repurposing of Biologic and Targeted Synthetic Anti-Rheumatic Drugs in COVID-19 and Hyper-Inflammation: A Comprehensive Review of Available and Emerging Evidence at the Peak of the Pandemic.	Front Pharmacol
33442168	Diabetes and COVID-19: A Review.	J ASEAN Fed Endocr Soc
33442016	Immune determinants of COVID-19 disease presentation and severity.	Nat Med
33441985	Contact residue contributions to interaction energies between SARS-CoV-1 spike proteins and human ACE2 receptors.	Sci Rep
33441564	Ontological modeling and analysis of experimentally or clinically verified drugs against coronavirus infection.	Sci Data
33441437	Cutting Edge: Mouse SARS-CoV-2 Epitope Reveals Infection and Vaccine-Elicited CD8 T Cell Responses.	J Immunol
33441348	Non-steroidal anti-inflammatory drugs dampen the cytokine and antibody response to SARS-CoV-2 infection.	J Virol
33441314	Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): a Systemic Infection.	Clin Microbiol Rev
33441290	[APOBEC3s: history of an antiviral and mutagenic protein family].	Virologie (Montrouge)
33441177	Observations on the use of Bruton's tyrosine kinase inhibitors in SAR-CoV-2 and cancer.	J Hematol Oncol
33441142	On the role of bacterial metalloproteases in COVID-19 associated cytokine storm.	Cell Commun Signal
33441124	Disease severity-specific neutrophil signatures in blood transcriptomes stratify COVID-19 patients.	Genome Med
33441073	Crosstalk Between Covid-19 And Associated Neurological Disorders: A Review.	Curr Neuropharmacol
33440724	The Fatty Acid Lipid Metabolism Nexus in COVID-19.	Viruses
33440681	Viroinformatics-Based Analysis of SARS-CoV-2 Core Proteins for Potential Therapeutic Targets.	Antibodies (Basel)
33440640	SARS-CoV-2 Spike Protein Elicits Cell Signaling in Human Host Cells: Implications for Possible Consequences of COVID-19 Vaccines.	Vaccines (Basel)
33440622	SARS-CoV-2 Epitope Mapping on Microarrays Highlights Strong Immune-Response to N Protein Region.	Vaccines (Basel)
33440306	"An overview of Betacoronaviruses-associated severe respiratory syndromes, focusing on sex-type-specific immune responses."	Int Immunopharmacol
33440148	MDA5 Governs the Innate Immune Response to SARS-CoV-2 in Lung Epithelial Cells.	Cell Rep
33439572	Impact of chronic exposure to 5-alpha reductase inhibitors on the risk of hospitalization for COVID-19: a case-control study in male population from two COVID-19 regional centers of Lombardy (Italy).	Minerva Urol Nefrol
33439437	SARS-CoV-2 Infection in the Central and Peripheral Nervous System-Associated Morbidities and Their Potential Mechanism.	Mol Neurobiol
33439304	G6PD deficiency and severity of COVID19 pneumonia and acute respiratory distress syndrome: tip of the iceberg?	Ann Hematol
33439253	Antivirals that target the host IMPalpha/beta1-virus interface.	Biochem Soc Trans
33439057	COVID-19 and hypogonadism: secondary immune responses rule-over endocrine mechanisms.	Hum Fertil (Camb)
33438525	"Enfuvirtide, an HIV-1 fusion inhibitor peptide, can act as a potent SARS-CoV-2 fusion inhibitor: an in silico drug repurposing study."	J Biomol Struct Dyn
33438250	A comprehensive review of COVID-19 in India: A frequent catch of the information.	Biotechnol Appl Biochem
33437935	Transcriptomic similarities and differences in host response between SARS-CoV-2 and other viral infections.	iScience
33437929	Childhood Multisystem Inflammatory Syndrome: An Emerging Disease with Prominent Cardiovascular Involvement-A Scoping Review.	SN Compr Clin Med
33437888	Clinically distinct COVID-19 cases share notably similar immune response progression: A follow-up analysis.	Heliyon
33437743	COVID-19: Case fatality and ACE2 inhibitors treatment concerns in patients with comorbidities.	Med J Islam Repub Iran
33437350	COVID-19 associated thromboinflammation of renal capillary: potential mechanisms and treatment.	Am J Transl Res
33437230	In-silico analysis of the inhibition of the SARS-CoV-2 main protease by some active compounds from selected African plants.	J Taibah Univ Med Sci
33437221	Similarities and differences between HIV and SARS-CoV-2.	Int J Med Sci
33437145	SARS-CoV-2 and the reproductive system: known and the unknown..!!	Middle East Fertil Soc J
33437144	Anosmia and COVID-19: perspectives on its association and the pathophysiological mechanisms involved.	Egypt J Neurol Psychiatr Neurosurg
33437137	Combination and tricombination therapy to destabilize the structural integrity of COVID-19 by some bioactive compounds with antiviral drugs: insights from molecular docking study.	Struct Chem
33437096	Statins as inhibitors of voltage-gated potassium channels Kv1.3 in cancer cells.	J Mol Struct
33436985	Antiviral activity of lambda-carrageenan against influenza viruses and severe acute respiratory syndrome coronavirus 2.	Sci Rep
33436624	Mechanism of SARS-CoV-2 polymerase stalling by remdesivir.	Nat Commun
33436577	A therapeutic neutralizing antibody targeting receptor binding domain of SARS-CoV-2 spike protein.	Nat Commun
33436573	Capsid-like particles decorated with the SARS-CoV-2 receptor-binding domain elicit strong virus neutralization activity.	Nat Commun
33436526	Structure-guided multivalent nanobodies block SARS-CoV-2 infection and suppress mutational escape.	Science
33436524	Mosaic nanoparticles elicit cross-reactive immune responses to zoonotic coronaviruses in mice.	Science
33436498	Cytoplasmic short linear motifs in ACE2 and integrin beta3 link SARS-CoV-2 host cell receptors to mediators of endocytosis and autophagy.	Sci Signal
33436497	Short linear motif candidates in the cell entry system used by SARS-CoV-2 and their potential therapeutic implications.	Sci Signal
33436436	Do an Altered Gut Microbiota and an Associated Leaky Gut Affect COVID-19 Severity?	mBio
33436320	Importance of hyperglycemia in COVID-19 intensive-care patients: Mechanism and treatment strategy.	Prim Care Diabetes
33435929	"Insights to SARS-CoV-2 life cycle, pathophysiology, and rationalized treatments that target COVID-19 clinical complications."	J Biomed Sci
33435808	Immune memory: an evolutionary perspective.	Hum Vaccin Immunother
33435759	Immunoinformatics-guided designing and in silico analysis of epitope-based polyvalent vaccines against multiple strains of human coronavirus (HCoV).	Expert Rev Vaccines
33435650	Obesity and COVID-19: the ominous duet affecting the renin-angiotensin system.	Minerva Endocrinol (Torino)
33435561	Transcriptomic Analysis of Respiratory Tissue and Cell Line Models to Examine Glycosylation Machinery during SARS-CoV-2 Infection.	Viruses
33435547	The Effects of COVID-19 on Placenta and Pregnancy: What Do We Know So Far?	Diagnostics (Basel)
33435521	Magnesium in Infectious Diseases in Older People.	Nutrients
33435454	Application of CAR-T Cell Therapy beyond Oncology: Autoimmune Diseases and Viral Infections.	Biomedicines
33435351	Comprehensive Meta-Analysis of COVID-19 Global Metabolomics Datasets.	Metabolites
33435315	Probiotic Effects against Virus Infections: New Weapons for an Old War.	Foods
33435273	Interactions of Potential Anti-COVID-19 Compounds with Multispecific ABC and OATP Drug Transporters.	Pharmaceutics
33434935	Macrophage Activation and Cytokine Release Syndrome in COVID-19: Current Updates and Analysis of Repurposed and Investigational Anti-Cytokine Drugs.	Drug Res (Stuttg)
33434886	Evaluating the impact of COVID-19 on male reproduction.	Reproduction
33434272	Network controllability-based algorithm to target personalized driver genes for discovering combinatorial drugs of individual patients.	Nucleic Acids Res
33434163	Evaluating the Impact of COVID-19 on Male Reproduction.	Reproduction
33434105	SARS-CoV-2 may hijack GPCR signaling pathways to dysregulate lung ion and fluid transport.	Am J Physiol Lung Cell Mol Physiol
33434104	Unique inflammatory profile is associated with higher SARS-CoV-2 acute respiratory distress syndrome (ARDS) mortality.	Am J Physiol Regul Integr Comp Physiol
33433784	A Novel Protein Mapping Method for Predicting the Protein Interactions in COVID-19 Disease by Deep Learning.	Interdiscip Sci
33433624	Neuroinvasion of SARS-CoV-2 in human and mouse brain.	J Exp Med
33433587	Nature and dimensions of the systemic hyper-inflammation and its attenuation by convalescent plasma in severe COVID-19.	J Infect Dis
33433350	COVID-19 and inflammatory bowel disease: A pathophysiological assessment.	Biomed Pharmacother
33433137	Pandemic aspect of dexamethasone: Molecular mechanisms and clinical application.	J Chin Med Assoc
33433004	Mutations in SARS-CoV-2 nsp7 and nsp8 proteins and their predicted impact on replication/transcription complex structure.	J Med Virol
33432808	Proteolytic Activation of SARS-CoV-2 Spike at the S1/S2 Boundary: Potential Role of Proteases beyond Furin.	ACS Infect Dis
33432484	Proposed Mechanisms of Targeting COVID-19 by Delivering Mesenchymal Stem Cells and Their Exosomes to Damaged Organs.	Stem Cell Rev Rep
33432321	Bioinformatics resources facilitate understanding and harnessing clinical research of SARS-CoV-2.	Brief Bioinform
33432283	Evaluation of certain medicinal plants compounds as new potential inhibitors of novel corona virus (COVID-19) using molecular docking analysis.	In Silico Pharmacol
33432269	Exploring the effect of ritonavir and TMC-310911 on SARS-CoV-2 and SARS-CoV main proteases: potential from a molecular perspective.	Future Sci OA
33432259	Comparison of the SARS-CoV-2 (2019-nCoV) M protein with its counterparts of SARS-CoV and MERS-CoV species.	J King Saud Univ Sci
33432258	"Quantum chemical studies on molecular structure, AIM, ELF, RDG and antiviral activities of hybrid hydroxychloroquine in the treatment of COVID-19: Molecular docking and DFT calculations."	J King Saud Univ Sci
33432247	A trimeric human angiotensin-converting enzyme 2 as an anti-SARS-CoV-2 agent.	Nat Struct Mol Biol
33432184	A novel ACE2 isoform is expressed in human respiratory epithelia and is upregulated in response to interferons and RNA respiratory virus infection.	Nat Genet
33432170	Modeling human adaptive immune responses with tonsil organoids.	Nat Med
33432067	No evidence for basigin/CD147 as a direct SARS-CoV-2 spike binding receptor.	Sci Rep
33431876	Development and structural basis of a two-MAb cocktail for treating SARS-CoV-2 infections.	Nat Commun
33431856	Antibody neutralization of SARS-CoV-2 through ACE2 receptor mimicry.	Nat Commun
33431842	Stabilizing the closed SARS-CoV-2 spike trimer.	Nat Commun
33431578	Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19.	Gut
33431557	Generation and Characterization of recombinant SARS-CoV-2 expressing reporter genes.	J Virol
33431511	Single-cell RNA sequencing reveals SARS-CoV-2 infection dynamics in lungs of African green monkeys.	Sci Transl Med
33430924	"Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial."	Trials
33430856	Potential impact of individual exposure histories to endemic human coronaviruses on age-dependent severity of COVID-19.	BMC Med
33430748	In silico Prediction and Designing of Potential siRNAs to be Used as Antivirals Against SARS-CoV-2.	Curr Pharm Des
33430745	"COVID -19 infection: Epidemiology, Virology, Clinical Features, Diagnosis and Pharmacological Treatment."	Curr Pharm Des
33430659	Repurposing existing drugs: identification of SARS-CoV-2 3C-like protease inhibitors.	J Enzyme Inhib Med Chem
33430521	Pan-Enterovirus Amplicon-Based High-Throughput Sequencing Detects the Complete Capsid of a EVA71 Genotype C1 Variant via Wastewater-Based Epidemiology in Arizona.	Viruses
33430431	Proposal of the Definition for COVID-19-Associated Coagulopathy.	J Clin Med
33430424	Experimental Models to Study COVID-19 Effect in Stem Cells.	Cells
33430421	Inactivation of Material from SARS-CoV-2-Infected Primary Airway Epithelial Cell Cultures.	Methods Protoc
33430309	Mapping the SARS-CoV-2-Host Protein-Protein Interactome by Affinity Purification Mass Spectrometry and Proximity-Dependent Biotin Labeling: A Rational and Straightforward Route to Discover Host-Directed Anti-SARS-CoV-2 Therapeutics.	Int J Mol Sci
33430299	Bioactive Terpenes and Their Derivatives as Potential SARS-CoV-2 Proteases Inhibitors from Molecular Modeling Studies.	Biomolecules
33430234	Role of CD4+ T Cells in the Control of Viral Infections: Recent Advances and Open Questions.	Int J Mol Sci
33430081	Drug Repurposing: Dipeptidyl Peptidase IV (DPP4) Inhibitors as Potential Agents to Treat SARS-CoV-2 (2019-nCoV) Infection.	Pharmaceuticals (Basel)
33430050	The Impacts of Low Diversity Sequence Data on Phylodynamic Inference during an Emerging Epidemic.	Viruses
33429925	Neutrophil Extracellular Traps and Their Implications in Cardiovascular and Inflammatory Disease.	Int J Mol Sci
33429418	Circuits between infected macrophages and T cells in SARS-CoV-2 pneumonia.	Nature
33429366	Lung adenocarcinoma patients have higher risk of SARS-CoV-2 infection.	Aging (Albany NY)
33429331	"The immune response and immune evasion characteristics in SARS-CoV, MERS-CoV, and SARS-CoV-2: Vaccine design strategies."	Int Immunopharmacol
33428981	CRISPR systems: Novel approaches for detection and combating COVID-19.	Virus Res
33428706	Cardiovascular disease in patients with COVID-19: evidence from cardiovascular pathology to treatment.	Acta Biochim Biophys Sin (Shanghai)
33428634	Full length genomic sanger sequencing and phylogenetic analysis of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Nigeria.	PLoS One
33428609	Detection of Pulmonary Shunts by Transcranial Doppler in Hospitalized Non-mechanically Ventilated Coronavirus Disease-19 Patients.	Rev Invest Clin
33428591	Shorter telomere lengths in patients with severe COVID-19 disease.	Aging (Albany NY)
33428154	Screening druggable targets and predicting therapeutic drugs for COVID-19 via integrated bioinformatics analysis.	Genes Genomics
33428055	Neurological manifestations of coronavirus disease 2019: exploring past to understand present.	Neurol Sci
33428032	"Reviews on Biological Activity, Clinical Trial and Synthesis Progress of Small Molecules for the Treatment of COVID-19."	Top Curr Chem (Cham)
33427749	SARS-CoV-2-specific CD8+ T cell responses in convalescent COVID-19 individuals.	J Clin Invest
33427605	A genetic element in the SARS-CoV-2 genome is shared with multiple insect species.	J Gen Virol
33427588	Predictive medicinal metabolites from Momordica dioica against comorbidity related proteins of SARS-CoV-2 infections.	J Biomol Struct Dyn
33427554	The immune dysregulations in COVID-19: Implications for the management of rheumatic diseases.	Mod Rheumatol
33427404	COVID-19 and male reproduction: Current research and unknown factors.	Andrology
33427377	Advances in Nucleoside and Nucleotide Analogues in Tackling Human Immunodeficiency Virus and Hepatitis Virus Infections.	ChemMedChem
33427370	A systematic review of experimental evidence for antiviral effects of ivermectin and an in silico analysis of ivermectin's possible mode of action against SARS-CoV-2.	Fundam Clin Pharmacol
33427302	Antibody response to SARS-CoV-2 in infected patients with different clinical outcome.	J Med Virol
33427241	Visualization of SARS-CoV-2 using Immuno RNA-Fluorescence In Situ Hybridization.	J Vis Exp
33427208	Dissecting strategies to tune the therapeutic potential of SARS-CoV-2-specific monoclonal antibody CR3022.	JCI Insight
33427102	"ACE2-derived peptides interact with the RBD domain of SARS-CoV-2 spike glycoprotein, disrupting the interaction with the human ACE2 receptor."	J Biomol Struct Dyn
33426894	NMR Spectroscopic Windows on the Systemic Effects of SARS-CoV-2 Infection on Plasma Lipoproteins and Metabolites in Relation to Circulating Cytokines.	J Proteome Res
33426889	"Ifenprodil Stereoisomers: Synthesis, Absolute Configuration, and Correlation with Biological Activity."	J Med Chem
33426872	Role of Multiomics Data to Understand Host-Pathogen Interactions in COVID-19 Pathogenesis.	J Proteome Res
33426683	Potential detrimental role of soluble ACE2 in severe COVID-19 comorbid patients.	Rev Med Virol
33426604	ACE-2-interacting Domain of SARS-CoV-2 (AIDS) Peptide Suppresses Inflammation to Reduce Fever and Protect Lungs and Heart in Mice: Implications for COVID-19 Therapy.	J Neuroimmune Pharmacol
33426593	Challenge of post-COVID era: management of cardiovascular complications in asymptomatic carriers of SARS-CoV-2.	Heart Fail Rev
33426541	Potentials of Interferons and Hydroxychloroquine for the Prophylaxis and Early Treatment of COVID-19.	J Cell Immunol
33426509	A multi-pronged approach targeting SARS-CoV-2 proteins using ultra-large virtual screening.	iScience
33426364	Friend or foe? ACE2 inhibitors and GLP-1R agonists in COVID-19 treatment.	Obes Med
33426096	Cellular and Molecular Immunology Approaches for the Development of Immunotherapies against the New Coronavirus (SARS-CoV-2): Challenges to Near-Future Breakthroughs.	J Immunol Res
33426074	Molecular Insights into the MAPK Cascade during Viral Infection: Potential Crosstalk between HCQ and HCQ Analogues.	Biomed Res Int
33425994	Molecular Docking Studies on the Anti-viral Effects of Compounds From Kabasura Kudineer on SARS-CoV-2 3CL(pro).	Front Mol Biosci
33425965	"Association of Cigarette Smoking, COPD, and Lung Cancer With Expression of SARS-CoV-2 Entry Genes in Human Airway Epithelial Cells."	Front Med (Lausanne)
33425850	Computational Prediction of Potential Inhibitors of the Main Protease of SARS-CoV-2.	Front Chem
33425823	"Multisystem Inflammatory Syndrome in Children (MIS-C), a Post-viral Myocarditis and Systemic Vasculitis-A Critical Review of Its Pathogenesis and Treatment."	Front Pediatr
33425697	The coronavirus disease 2019 main protease inhibitor from Andrographis paniculata (Burm. f) Ness.	J Adv Pharm Technol Res
33425684	Nicotinic cholinergic system and COVID-19: In silico evaluation of nicotinic acetylcholine receptor agonists as potential therapeutic interventions.	Toxicol Rep
33425648	In silico investigation of saponins and tannins as potential inhibitors of SARS-CoV-2 main protease (M(pro)).	In Silico Pharmacol
33425647	Designing a conserved peptide-based subunit vaccine against SARS-CoV-2 using immunoinformatics approach.	In Silico Pharmacol
33425487	ENJ algorithm can construct triple phylogenetic trees.	Mol Ther Nucleic Acids
33425429	Recent Insights into Cellular Crosstalk in Respiratory and Gastrointestinal Mucosal Immune Systems.	Immune Netw
33425427	Potential of Plant Bioactive Compounds as SARS-CoV-2 Main Protease (M(pro)) and Spike (S) Glycoprotein Inhibitors: A Molecular Docking Study.	Scientifica (Cairo)
33425367	"A single nucleotide distinguishes the SARS-CoV-2 in the Wuhan outbreak in December 2019 from that in Beijing-Xinfadi in June 2020, China."	New Microbes New Infect
33425362	"Oral probiotics in coronavirus disease 2019: connecting the gut-lung axis to viral pathogenesis, inflammation, secondary infection and clinical trials."	New Microbes New Infect
33425294	Computational Biology Analysis of COVID-19 Receptor-Binding Domains: A Target Site for Indocyanine Green Through Antimicrobial Photodynamic Therapy.	J Lasers Med Sci
33425248	"Host transcriptomic profiling of COVID-19 patients with mild, moderate, and severe clinical outcomes."	Comput Struct Biotechnol J
33425074	Network pharmacology-based analysis of Zukamu granules for the treatment of COVID-19.	Eur J Integr Med
33424954	Collection of SARS-CoV-2 Virus from the Air of a Clinic Within a University Student Health Care Center and Analyses of the Viral Genomic Sequence.	Aerosol Air Qual Res
33424918	A Comprehensive Analysis of cis-Acting RNA Elements in the SARS-CoV-2 Genome by a Bioinformatics Approach.	Front Genet
33424908	Pilot Production of SARS-CoV-2 Related Proteins in Plants: A Proof of Concept for Rapid Repurposing of Indoor Farms Into Biomanufacturing Facilities.	Front Plant Sci
33424856	HCoV- and SARS-CoV-2 Cross-Reactive T Cells in CVID Patients.	Front Immunol
33424804	Imaging Mass Cytometric Analysis of Postmortem Tissues Reveals Dysregulated Immune Cell and Cytokine Responses in Multiple Organs of COVID-19 Patients.	Front Microbiol
33424784	Comparative Genomic Analyses Reveal a Specific Mutation Pattern Between Human Coronavirus SARS-CoV-2 and Bat-CoV RaTG13.	Front Microbiol
33424586	Autophagy Modulation in Lymphocytes From COVID-19 Patients: New Therapeutic Target in SARS-COV-2 Infection.	Front Pharmacol
33424398	In silico evaluation of flavonoids as effective antiviral agents on the spike glycoprotein of SARS-CoV-2.	Saudi J Biol Sci
33424145	"Review on COVID-19 Etiopathogenesis, Clinical Presentation and Treatment Available with Emphasis on ACE2."	Indian J Clin Biochem
33424125	Polysaccharides obtained from natural edible sources and their role in modulating the immune system: Biologically active potential that can be exploited against COVID-19.	Trends Food Sci Technol
33424034	"Pyrrolo[2,3-b]quinoxalines in attenuating cytokine storm in COVID-19: their sonochemical synthesis and in silico / in vitro assessment."	J Mol Struct
33424013	Discovery of New Fusion Inhibitor Peptides against SARS-CoV-2 by Targeting the Spike S2 Subunit.	Biomol Ther (Seoul)
33423931	Copper in infectious disease: Using both sides of the penny.	Semin Cell Dev Biol
33423577	A High-Throughput RNA Displacement Assay for Screening SARS-CoV-2 nsp10-nsp16 Complex toward Developing Therapeutics for COVID-19.	SLAS Discov
33423554	SARS-CoV-2 protein drug targets landscape: a potential pharmacological insight view for the new drug development.	Expert Rev Clin Pharmacol
33423528	Antihypertensive Drugs and COVID-19 Risk: A Cohort Study of 2 Million Hypertensive Patients.	Hypertension
33423443	[Immunological research of COVID-19 and emerging infectious diseases].	Zhonghua Yi Xue Za Zhi
33423388	Glucagon-like peptide-1 receptor agonists in the era of COVID-19: Friend or foe?	Clin Obes
33423311	Human SARS CoV-2 spike protein mutations.	Proteins
33423172	"(1)H,(13)C and (15)N chemical shift assignments of the SUD domains of SARS-CoV-2 non-structural protein 3c: ""The SUD-M and SUD-C domains""."	Biomol NMR Assign
33423067	Transcriptome analysis of cepharanthine against a SARS-CoV-2-related coronavirus.	Brief Bioinform
33422991	Adjuvanted SARS-CoV-2 spike protein elicits neutralizing antibodies and CD4 T cell responses after a single immunization in mice.	EBioMedicine
33422990	SARS-CoV-2 leads to a small vessel endotheliitis in the heart.	EBioMedicine
33422806	Could COVID-19 anosmia and olfactory dysfunction trigger an increased risk of future dementia in patients with ApoE4?	Med Hypotheses
33422689	Endothelial cells and SARS-CoV-2: An intimate relationship.	Vascul Pharmacol
33422682	Identification of SARS-CoV-2 CTL epitopes for development of a multivalent subunit vaccine for COVID-19.	Infect Genet Evol
33422611	"The rocaglate CR-31-B (-) inhibits SARS-CoV-2 replication at non-cytotoxic, low nanomolar concentrations in vitro and ex vivo."	Antiviral Res
33422520	Expression of SARS-COV-2 cell receptor gene ACE2 is associated with immunosuppression and metabolic reprogramming in lung adenocarcinoma based on bioinformatics analyses of gene expression profiles.	Chem Biol Interact
33422505	Exposure to particulate matter upregulates ACE2 and TMPRSS2 expression in the murine lung.	Environ Res
33422363	"Tackling the COVID-19 ""cytokine storm"" with microRNA mimics directly targeting the 3'UTR of pro-inflammatory mRNAs."	Med Hypotheses
33422265	ORF3a of the COVID-19 virus SARS-CoV-2 blocks HOPS complex-mediated assembly of the SNARE complex required for autolysosome formation.	Dev Cell
33422263	"Continuation versus discontinuation of renin-angiotensin system inhibitors in patients admitted to hospital with COVID-19: a prospective, randomised, open-label trial."	Lancet Respir Med
33421977	Genetic Susceptibility of ACE2 and TMPRSS2 in Six Common Cancers and Possible Impacts on COVID-19.	Cancer Res Treat
33421967	Expression of SARS-CoV-2 entry factors in human oral tissue.	J Anat
33421743	Network analysis and molecular mapping for SARS-CoV-2 to reveal drug targets and repurposing of clinically developed drugs.	Virology
33421691	Looking beyond pulmonary disease in COVID-19: A lesson from patients with cystic fibrosis.	Med Hypotheses
33421690	Platelet hyperactivity in COVID-19: Can the tomato extract Fruitflow(R) be used as an antiplatelet regime?	Med Hypotheses
33421689	Impairment in selenocysteine synthesis as a candidate mechanism of inducible coagulopathy in COVID-19 patients.	Med Hypotheses
33421654	Topological Analysis for Sequence Variability: Case Study on more than 2K SARS-CoV-2 sequences of COVID-19 infected 54 countries in comparison with SARS-CoV-1 and MERS-CoV.	Infect Genet Evol
33421473	"Denovo designing, retro-combinatorial synthesis, and molecular dynamics analysis identify novel antiviral VTRM1.1 against RNA-dependent RNA polymerase of SARS CoV2 virus."	Int J Biol Macromol
33421440	Immune reactivity during COVID-19: Implications for treatment.	Immunol Lett
33421326	First genome sequencing of SARS-CoV-2 recovered from an infected cat and its owner in Latin America.	Transbound Emerg Dis
33421274	Circulating cardiovascular microRNAs in critically ill COVID-19 patients.	Eur J Heart Fail
33421051	Brugada syndrome and reduced right ventricular outflow tract conduction reserve: a final common pathway?	Eur Heart J
33420426	AXL is a candidate receptor for SARS-CoV-2 that promotes infection of pulmonary and bronchial epithelial cells.	Cell Res
33420186	ABBV-744 as a potential inhibitor of SARS-CoV-2 main protease enzyme against COVID-19.	Sci Rep
33420163	Host mitochondrial transcriptome response to SARS-CoV-2 in multiple cell models and clinical samples.	Sci Rep
33420048	Cryo-EM analysis of the HCoV-229E spike glycoprotein reveals dynamic prefusion conformational changes.	Nat Commun
33420022	Host and viral determinants for efficient SARS-CoV-2 infection of the human lung.	Nat Commun
33419885	Influenza virus infection increases ACE2 expression and shedding in human small airway epithelial cells.	Eur Respir J
33419245	Can Coronaviruses Steal Genes from the Host as Evidenced in Western European Hedgehogs by EriCoV Genetic Characterization?	Viruses
33419184	Immunogenicity of Multiple Doses of pDNA Vaccines against SARS-CoV-2.	Pharmaceuticals (Basel)
33418950	Population-Specific ACE2 Single-Nucleotide Polymorphisms Have Limited Impact on SARS-CoV-2 Infectivity In Vitro.	Viruses
33418884	GABAB-Receptor Agonist-Based Immunotherapy for Type 1 Diabetes in NOD Mice.	Biomedicines
33418408	An in-silico evaluation of different bioactive molecules of tea for their inhibition potency against non structural protein-15 of SARS-CoV-2.	Food Chem
33418325	Increased expression of antibiotic-resistance genes in biofilm communities upon exposure to cetyltrimethylammonium bromide (CTAB) and other stress conditions.	Sci Total Environ
33418320	BCG immunomodulation: From the 'hygiene hypothesis' to COVID-19.	Immunobiology
33418248	Could cilostazol be beneficial in COVID-19 treatment? Thinking about phosphodiesterase-3 as a therapeutic target.	Int Immunopharmacol
33418136	iRGD conjugated nimbolide liposomes protect against endotoxin induced acute respiratory distress syndrome.	Nanomedicine
33418085	"MicroPhenoDB Associates Metagenomic Data with Pathogenic Microbes, Microbial Core Genes, and Human Disease Phenotypes."	Genomics Proteomics Bioinformatics
33418027	Differential induction of type I and III interferon genes in the upper respiratory tract of patients with coronavirus disease 2019 (COVID-19).	Virus Res
33417835	D614G Mutation Alters SARS-CoV-2 Spike Conformation and Enhances Protease Cleavage at the S1/S2 Junction.	Cell Rep
33417604	Computational drug repurposing strategy predicted peptide-based drugs that can potentially inhibit the interaction of SARS-CoV-2 spike protein with its target (humanACE2).	PLoS One
33417561	Detection of Phenotype-Related Mutations of COVID-19 via the Whole Genomic Data.	IEEE/ACM Trans Comput Biol Bioinform
33417221	Pathophysiological Clues to How the Emergent SARS-CoV-2 Can Potentially Increase the Susceptibility to Neurodegeneration.	Mol Neurobiol
33416946	Are all cytokine storms the same?	Cancer Immunol Immunother
33416933	Chloroquine/hydroxychloroquine: an inflammasome inhibitor in severe COVID-19?	Naunyn Schmiedebergs Arch Pharmacol
33416848	SARS-CoV-2 3D database: understanding the coronavirus proteome and evaluating possible drug targets.	Brief Bioinform
33416113	Unraveling the roles of vitamin D status and melanin during Covid19 (Review).	Int J Mol Med
33416095	An integrative look at SARSCoV2 (Review).	Int J Mol Med
33416020	Searching for potential drugs against SARS-CoV-2 through virtual screening on several molecular targets.	J Biomol Struct Dyn
33415989	Can natural products stop the SARS-CoV-2 virus? A docking and molecular dynamics study of a natural product database.	Future Med Chem
33415739	Unsupervised cluster analysis of SARS-CoV-2 genomes reflects its geographic progression and identifies distinct genetic subgroups of SARS-CoV-2 virus.	Genet Epidemiol
33415647	Testicular Atrophy and Hypothalamic Pathology in COVID-19: Possibility of the Incidence of Male Infertility and HPG Axis Abnormalities.	Reprod Sci
33415646	Potential Role of Zinc in the COVID-19 Disease Process and its Probable Impact on Reproduction.	Reprod Sci
33415422	Hematologic disorders associated with COVID-19: a review.	Ann Hematol
33415126	SARS CoV-2 Organotropism Associated Pathogenic Relationship of Gut-Brain Axis and Illness.	Front Mol Biosci
33415119	Public Database-Driven Insights Into Aging Stress-Associated Defective Gut Barrier With Low SARS-CoV-2 Receptors.	Front Med (Lausanne)
33415017	Tannic acid suppresses SARS-CoV-2 as a dual inhibitor of the viral main protease and the cellular TMPRSS2 protease.	Am J Cancer Res
33414832	"Human Mesenchymal Stem Cells: The Present Alternative for High-Incidence Diseases, Even SARS-Cov-2."	Stem Cells Int
33414783	Host Genetics at the Intersection of Autoimmunity and COVID-19: A Potential Key for Heterogeneous COVID-19 Severity.	Front Immunol
33414753	"Acute Ischemic Stroke in SARS-CoV, MERS-CoV, SARS-CoV-2: Neurorehabilitation Implications of Inflammation Induced Immunological Responses Affecting Vascular Systems."	Front Neurol
33414726	Physiology of Midkine and Its Potential Pathophysiological Role in COVID-19.	Front Physiol
33414643	Calcio-Herbal Medicine Divya-Swasari-Vati Ameliorates SARS-CoV-2 Spike Protein-Induced Pathological Features and Inflammation in Humanized Zebrafish Model by Moderating IL-6 and TNF-alpha Cytokines.	J Inflamm Res
33414581	Optimizing the in vitro colony-forming assay for more efficient delineation of the interaction between lung epithelial stem cells and their niche.	J Stem Cells Regen Med
33414457	Interleukin-38 ameliorates poly(I:C) induced lung inflammation: therapeutic implications in respiratory viral infections.	Cell Death Dis
33414384	SARS-CoV-2 infection is associated with a pro-thrombotic platelet phenotype.	Cell Death Dis
33414350	"Genomic Sequences and Analysis of Five SARS-CoV-2 Variants Obtained from Patients in Lambayeque, Peru."	Microbiol Resour Announc
33414330	Mutation Profile of SARS-CoV-2 Genome Sequences Originating from Eight Israeli Patient Isolates.	Microbiol Resour Announc
33414329	Genome Sequences of Two GH Clade SARS-CoV-2 Strains Isolated from Patients with COVID-19 in South Korea.	Microbiol Resour Announc
33414160	Insight into vaccine development for Alpha-coronaviruses based on structural and immunological analyses of spike proteins.	J Virol
33414159	COVID-19 vaccine candidates based on modified vaccinia virus Ankara expressing the SARS-CoV-2 spike induce robust T- and B-cell immune responses and full efficacy in mice.	J Virol
33413979	A nidovirus perspective on SARS-CoV-2.	Biochem Biophys Res Commun
33413819	Coronavirus Disease 2019-Associated Coagulopathy.	Mayo Clin Proc
33413740	"Early transmissibility assessment of the N501Y mutant strains of SARS-CoV-2 in the United Kingdom, October to November 2020."	Euro Surveill
33413610	An integrated in silico immuno-genetic analytical platform provides insights into COVID-19 serological and vaccine targets.	Genome Med
33413539	HiDeF: identifying persistent structures in multiscale 'omics data.	Genome Biol
33413449	Higher expression of monocyte chemotactic protein 1 in mild COVID-19 patients might be correlated with inhibition of Type I IFN signaling.	Virol J
33413422	Transcriptome of nasopharyngeal samples from COVID-19 patients and a comparative analysis with other SARS-CoV-2 infection models reveal disparate host responses against SARS-CoV-2.	J Transl Med
33413387	"Sputum ACE2, TMPRSS2 and FURIN gene expression in severe neutrophilic asthma."	Respir Res
33413329	Computational analysis to repurpose drugs for COVID-19 based on transcriptional response of host cells to SARS-CoV-2.	BMC Med Inform Decis Mak
33413085	"H2V: a database of human genes and proteins that respond to SARS-CoV-2, SARS-CoV, and MERS-CoV infection."	BMC Bioinformatics
33413032	Identification of potential SARS-CoV-2 M(pro) inhibitors integrating molecular docking and water thermodynamics.	J Biomol Struct Dyn
33412850	Computational Insight Into the Mechanism of SARS-CoV-2 Membrane Fusion.	J Chem Inf Model
33412808	Environmental pollution and COVID-19: the molecular terms and predominant disease outcomes of their sweetheart agreement.	Epidemiol Prev
33412760	Spike protein D614G and RdRp P323L: the SARS-CoV-2 mutations associated with severity of COVID-19.	Genomics Inform
33412759	Druggability for COVID-19: in silico discovery of potential drug compounds against nucleocapsid (N) protein of SARS-CoV-2.	Genomics Inform
33412501	Polycations and polyanions in SARS-CoV-2 infection.	Med Hypotheses
33412411	Neutralizing antibody-dependent and -independent immune responses against SARS-CoV-2 in cynomolgus macaques.	Virology
33412367	Prospective options of algae-derived nutraceuticals as supplements to combat COVID-19 and human coronavirus diseases.	Nutrition
33412255	Can SARS-CoV-2 infect the central nervous system via the olfactory bulb or the blood-brain barrier?	Brain Behav Immun
33412235	Promising phytochemicals of traditional Indian herbal steam inhalation therapy to combat COVID-19 - An in silico study.	Food Chem Toxicol
33412089	COVID-19-neutralizing antibodies predict disease severity and survival.	Cell
33411935	Early Differences in Cytokine Production by Severity of Coronavirus Disease 2019.	J Infect Dis
33411888	Monte Carlo Simulation of SARS-CoV-2 Radiation-Induced Inactivation for Vaccine Development.	Radiat Res
33411735	"COVID-19, leprosy, and neutrophils."	PLoS Negl Trop Dis
33411143	"COVID-19, rheumatic diseases and immune dysregulation-a perspective."	Clin Rheumatol
33410308	Pitfalls of barcodes in the study of worldwide SARS-CoV-2 variation and phylodynamics.	Zool Res
33410223	A main event and multiple introductions of SARS-CoV-2 initiated the COVID-19 epidemic in Greece.	J Med Virol
33409846	Active vitamin D supplementation and COVID-19 infections: review.	Ir J Med Sci
33409839	Brain Disease Network Analysis to Elucidate the Neurological Manifestations of COVID-19.	Mol Neurobiol
33409413	A SARS-CoV-2 antiviral therapy score card.	Glob Health Med
33409271	"Design, Expression, Purification, and Characterization of a YFP-Tagged 2019-nCoV Spike Receptor-Binding Domain Construct."	Front Bioeng Biotechnol
33409173	Recent discovery and development on SARS-CoV-2: A review of current literature.	J Family Med Prim Care
33408744	Hypertension and Electrolyte Disorders in Patients with COVID-19.	Electrolyte Blood Press
33408715	Akt-Fas to Quell Aberrant T Cell Differentiation and Apoptosis in Covid-19.	Front Immunol
33408342	A longitudinal study of SARS-CoV-2-infected patients reveals a high correlation between neutralizing antibodies and COVID-19 severity.	Cell Mol Immunol
33408195	"COVID-19, immunothrombosis and venous thromboembolism: biological mechanisms."	Thorax
33408181	Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection.	Science
33407800	Identification and characterization of a silent mutation in RNA binding domain of N protein coding gene from SARS-CoV-2.	BMC Res Notes
33407110	Rapid single cell evaluation of human disease and disorder targets using REVEAL: SingleCell.	BMC Genomics
33407005	Critical role of neutralizing antibody for SARS-CoV-2 reinfection and transmission.	Emerg Microbes Infect
33406943	Statins as an adjunctive therapy for COVID-19: the biological and clinical plausibility.	Immunopharmacol Immunotoxicol
33406838	N- and O-Glycosylation of the SARS-CoV-2 Spike Protein.	Anal Chem
33406522	Genetic Variation and Evolution of the 2019 Novel Coronavirus.	Public Health Genomics
33406391	T Cell Memory: Understanding COVID-19.	Immunity
33406224	HISNAPI: a bioinformatic tool for dynamic hot spot analysis in nucleic acid-protein interface with a case study.	Brief Bioinform
33406222	Exploration of natural compounds with anti-SARS-CoV-2 activity via inhibition of SARS-CoV-2 Mpro.	Brief Bioinform
33406218	A comprehensive drug repurposing study for COVID19 treatment: novel putative dihydroorotate dehydrogenase inhibitors show association to serotonin-dopamine receptors.	Brief Bioinform
33406042	"2019nCoVAS: Developing the Web Service for Epidemic Transmission Prediction, Genome Analysis, and Psychological Stress Assessment for 2019-nCoV."	IEEE/ACM Trans Comput Biol Bioinform
33405482	Viral strategies for circumventing p53: the case of severe acute respiratory syndrome coronavirus.	Curr Opin Oncol
33405427	Cytokine-induced liver injury in coronavirus disease-2019 (COVID-19): untangling the knots.	Eur J Gastroenterol Hepatol
33405411	Severe Acute Respiratory Syndrome Coronavirus-2-Associated Acute Kidney Injury: A Narrative Review Focused Upon Pathophysiology.	Crit Care Med
33405340	"QSAR Modeling of SARS-CoV M(pro) Inhibitors Identifies Sufugolix, Cenicriviroc, Proglumetacin, and other Drugs as Candidates for Repurposing against SARS-CoV-2."	Mol Inform
33405098	Is COVID-19 Gender-sensitive?	J Neuroimmune Pharmacol
33404999	The soluble catalytic ectodomain of ACE2 a biomarker of cardiac remodelling: new insights for heart failure and COVID19.	Heart Fail Rev
33404977	Genetic Diversity of SARS-CoV2 and Environmental Settings: Possible Association with Neurological Disorders.	Mol Neurobiol
33404925	Promising Therapy for Heart Failure in Patients with Severe COVID-19: Calming the Cytokine Storm.	Cardiovasc Drugs Ther
33404385	COVID-19 in children: Pathogenesis and current status.	Allergy Asthma Proc
33404363	Kinins and chymase: the forgotten components of the renin-angiotensin system and their implications in COVID-19 disease.	Am J Physiol Lung Cell Mol Physiol
33404263	Existing antiviral options against SARS-CoV-2 replication in COVID-19 patients.	Future Microbiol
33404091	In silico analyses on the comparative sensing of SARS-CoV-2 mRNA by the intracellular TLRs of humans.	J Med Virol
33404078	Leptin correlates with monocytes activation and severe condition in COVID-19 patients.	J Leukoc Biol
33403962	Rapid evolution of our understanding of the pathogenesis of COVID-19: Implications for therapy.	S Afr Med J
33403946	In silico design of multi-epitope-based peptide vaccine against SARS-CoV-2 using its spike protein.	J Biomol Struct Dyn
33403490	Does the Global Outbreak of COVID-19 or Other Viral Diseases Threaten the Stem Cell Reservoir Inside the Body?	Stem Cell Rev Rep
33403489	Human Oocytes Express Both ACE2 and BSG Genes and Corresponding Proteins: Is SARS-CoV-2 Infection Possible?	Stem Cell Rev Rep
33403480	Repurposing of CNS drugs to treat COVID-19 infection: targeting the sigma-1 receptor.	Eur Arch Psychiatry Clin Neurosci
33403186	Human Leukocyte Antigen (HLA) Class I Susceptible Alleles Against COVID-19 Increase Both Infection and Severity Rate.	Cureus
33402708	Cold sensitivity of the SARS-CoV-2 spike ectodomain.	Nat Struct Mol Biol
33402434	In silico dynamics of COVID-19 phenotypes for optimizing clinical management.	Proc Natl Acad Sci U S A
33402318	Complement Factors in COVID-19 Therapeutics and Vaccines.	Trends Immunol
33402024	Computational analysis of dynamic allostery and control in the SARS-CoV-2 main protease.	J R Soc Interface
33401987	"G6PD deficiency, redox homeostasis, and viral infections: implications for SARS-CoV-2 (COVID-19)."	Free Radic Res
33401979	Using in silico modelling and FRET-based assays in the discovery of novel FDA-approved drugs as inhibitors of MERS-CoV helicase.	SAR QSAR Environ Res
33401749	Role of Melatonin on Virus-Induced Neuropathogenesis-A Concomitant Therapeutic Strategy to Understand SARS-CoV-2 Infection.	Antioxidants (Basel)
33401657	The scRNA-seq Expression Profiling of the Receptor ACE2 and the Cellular Protease TMPRSS2 Reveals Human Organs Susceptible to SARS-CoV-2 Infection.	Int J Environ Res Public Health
33401632	Coagulative Disorders in Critically Ill COVID-19 Patients with Acute Distress Respiratory Syndrome: A Critical Review.	J Clin Med
33401565	SARS-CoV-2 Entry Genes Expression in Relation with Interferon Response in Cystic Fibrosis Patients.	Microorganisms
33401333	Coronavirus disease 2019 and the revival of passive immunization: Antibody therapy for inhibiting severe acute respiratory syndrome coronavirus 2 and preventing host cell infection: IUPHAR review: 31.	Br J Pharmacol
33401287	Unveiling Long COVID-19 Disease.	AIDS Rev
33401173	A novel screening strategy of anti-SARS-CoV-2 drugs via blocking interaction between Spike RBD and ACE2.	Environ Int
33401171	The JANUS of chronic inflammatory and autoimmune diseases onset during COVID-19 - A systematic review of the literature.	J Autoimmun
33401144	Entropy-driven electrochemiluminescence ultra-sensitive detection strategy of NF-kappaB p50 as the regulator of cytokine storm.	Biosens Bioelectron
33401106	COVID-19 and chronic fatigue syndrome: Is the worst yet to come?	Med Hypotheses
33401036	B cell depletion and signs of sepsis-acquired immunodeficiency in bone marrow and spleen of COVID-19 deceased.	Int J Infect Dis
33400957	Self-assembled mRNA vaccines.	Adv Drug Deliv Rev
33400927	Using bioinformatic protein sequence similarity to investigate if SARS CoV-2 infection could cause an ocular autoimmune inflammatory reactions?	Exp Eye Res
33400393	Overview of antiviral drug candidates targeting coronaviral 3C-like main proteases.	FEBS J
33400387	In vitro characterisation of SARS-CoV-2 and susceptibility of domestic ferrets (Mustela putorius furo).	Transbound Emerg Dis
33400131	European context of the diversity and phylogenetic position of SARS-CoV-2 sequences from Polish COVID-19 patients.	J Appl Genet
33400086	"COVID-19: inflammatory responses, structure-based drug design and potential therapeutics."	Mol Divers
33400085	First structure-activity relationship analysis of SARS-CoV-2 virus main protease (Mpro) inhibitors: an endeavor on COVID-19 drug discovery.	Mol Divers
33399879	Production of ORF8 protein from SARS-CoV-2 using an inducible virus-mediated expression system in suspension-cultured tobacco BY-2 cells.	Plant Cell Rep
33399851	Angiotensin-converting enzyme 2 and COVID-19 in cardiorenal diseases.	Clin Sci (Lond)
33399743	[Gastrointestinal and hepatic manifestations of COVID-19 in children].	Rev Chil Pediatr
33399535	Longitudinal high-throughput TCR repertoire profiling reveals the dynamics of T-cell memory formation after mild COVID-19 infection.	Elife
33399353	Pulmonary pathology of COVID-19: a review of autopsy studies.	Curr Opin Pulm Med
33399270	The chronic neuropsychiatric sequelae of COVID-19: The need for a prospective study of viral impact on brain functioning.	Alzheimers Dement
33399033	"Characterization of SARS-CoV-2 ORF6 deletion variants detected in a nosocomial cluster during routine genomic surveillance, Lyon, France."	Emerg Microbes Infect
33399028	The interplay between emerging human coronavirus infections and autophagy.	Emerg Microbes Infect
33398692	Overview of COVID-19 inflammatory pathogenesis from the therapeutic perspective.	Arch Pharm Res
33398691	Role of specialized pro-resolving lipid mediators and their receptors in virus infection: a promising therapeutic strategy for SARS-CoV-2 cytokine storm.	Arch Pharm Res
33398633	Identification of novel inhibitors of angiotensin-converting enzyme 2 (ACE-2) receptor from Urtica dioica to combat coronavirus disease 2019 (COVID-19).	Mol Divers
33398362	Renin-Angiotensin-Aldosterone System (RAAS) Inhibitors and Coronavirus Disease 2019 (COVID-19).	South Med J
33398250	Structure-Based Virtual Screening and Biochemical Validation to Discover a Potential Inhibitor of the SARS-CoV-2 Main Protease.	ACS Omega
33398248	"Computationally predicted SARS-COV-2 encoded microRNAs target NFKB, JAK/STAT and TGFB signaling pathways."	Gene Rep
33398242	Potential therapeutic approaches of microRNAs for COVID-19: Challenges and opportunities.	J Oral Biol Craniofac Res
33398234	Computational design of SARS-CoV-2 spike glycoproteins to increase immunogenicity by T cell epitope engineering.	Comput Struct Biotechnol J
33398233	Novel coronavirus disease (COVID-19) pandemic: A recent mini review.	Comput Struct Biotechnol J
33398129	Human stem cell models to study host-virus interactions in the central nervous system.	Nat Rev Immunol
33398055	Dose-dependent response to infection with SARS-CoV-2 in the ferret model and evidence of protective immunity.	Nat Commun
33398010	Epicutaneous immunization with modified vaccinia Ankara viral vectors generates superior T cell immunity against a respiratory viral challenge.	NPJ Vaccines
33397975	The aging transcriptome and cellular landscape of the human lung in relation to SARS-CoV-2.	Nat Commun
33397841	A Southeast Asian Perspective on the COVID-19 Pandemic: Hemoglobin E (HbE)-Trait Confers Resistance Against COVID-19.	Med Sci Monit Basic Res
33397718	ADP-ribose and analogues bound to the deMARylating macrodomain from the bat coronavirus HKU4.	Proc Natl Acad Sci U S A
33397677	Stereotypic neutralizing VH antibodies against SARS-CoV-2 spike protein receptor binding domain in patients with COVID-19 and healthy individuals.	Sci Transl Med
33397514	Mediators of SARS-CoV-2 entry are preferentially enriched in cardiomyocytes.	Hereditas
33397223	Virtual screening of curcumin and its analogs against the spike surface glycoprotein of SARS-CoV-2 and SARS-CoV.	J Biomol Struct Dyn
33397209	Molecular mechanism of inhibition of COVID-19 main protease by beta-adrenoceptor agonists and adenosine deaminase inhibitors using in silico methods.	J Biomol Struct Dyn
33396837	Strong Correlation between the Case Fatality Rate of COVID-19 and the rs6598045 Single Nucleotide Polymorphism (SNP) of the Interferon-Induced Transmembrane Protein 3 (IFITM3) Gene at the Population-Level.	Genes (Basel)
33396801	"Computational Analysis of SARS-CoV-2 and SARS-Like Coronavirus Diversity in Human, Bat and Pangolin Populations."	Viruses
33396605	SARS-CoV-2 Nucleocapsid Protein Interacts with RIG-I and Represses RIG-Mediated IFN-beta Production.	Viruses
33396594	PSGL-1 Inhibits the Incorporation of SARS-CoV and SARS-CoV-2 Spike Glycoproteins into Pseudovirions and Impairs Pseudovirus Attachment and Infectivity.	Viruses
33396592	The Interactions of Nintedanib and Oral Anticoagulants-Molecular Mechanisms and Clinical Implications.	Int J Mol Sci
33396584	"Markers Associated with COVID-19 Susceptibility, Resistance, and Severity."	Viruses
33396557	Unpacking Pandora From Its Box: Deciphering the Molecular Basis of the SARS-CoV-2 Coronavirus.	Int J Mol Sci
33396343	Lead SARS-CoV-2 Candidate Vaccines: Expectations from Phase III Trials and Recommendations Post-Vaccine Approval.	Viruses
33396184	The Two-Way Switch Role of ACE2 in the Treatment of Novel Coronavirus Pneumonia and Underlying Comorbidities.	Molecules
33395782	"New onset diabetes, type 1 diabetes and COVID-19."	Diabetes Metab Syndr
33395484	"Tropism of SARS-CoV-2, SARS-CoV and influenza virus in canine tissue explants."	J Infect Dis
33395482	SARS-CoV-2 encephalitis is a cytokine release syndrome: evidences from cerebrospinal fluid analyses.	Clin Infect Dis
33395426	The role of Neuropilin-1 in COVID-19.	PLoS Pathog
33395363	Epigenetic mechanisms influencing COVID-19.	Genome
33395259	"Antiviral Activity of 7-Substituted 7-Deazapurine Ribonucleosides, Monophosphate Prodrugs, and Triphoshates against Emerging RNA Viruses."	ACS Infect Dis
33395101	COVID-19 and neurocognitive disorders.	Curr Opin Psychiatry
33395080	Cardiovascular implications and complications of the coronavirus disease-2019 pandemic: a world upside down.	Curr Opin Cardiol
33395057	Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers and the Risk of SARS-CoV-2 Infection or Hospitalization With COVID-19 Disease: A Systematic Review and Meta-Analysis.	Am J Ther
33395036	Angiotensin-converting enzyme 2: from a vasoactive peptide to the gatekeeper of a global pandemic.	Curr Opin Nephrol Hypertens
33394891	Type 2 Immunity and Age Modify Gene Expression of Coronavirus-induced Disease 2019 Receptors in Eosinophilic Gastrointestinal Disorders.	J Pediatr Gastroenterol Nutr
33394568	Illuminating the immunopathology of SARS-CoV-2.	Cytometry B Clin Cytom
33394351	Human Monoclonal Antibodies: On the Menu of Targeted Therapeutics Against COVID-19.	Virol Sin
33394134	NF-kappaB signalling as a pharmacological target in COVID-19: potential roles for IKKbeta inhibitors.	Naunyn Schmiedebergs Arch Pharmacol
33394058	"[Cardiovascular diseases and COVID-19 : Pathophysiology, complications and treatment]."	Herz
33393898	COVID-19: An Update on Pathogenesis and Treatment.	Curr Pharm Des
33393462	SARS-CoV-2 entry into human airway organoids is serine protease-mediated and facilitated by the multibasic cleavage site.	Elife
33393420	"Neurological and Neuropsychological Changes Associated with SARS-CoV-2 Infection: New Observations, New Mechanisms."	Neuroscientist
33393319	Neurological symptoms in COVID-19 patients.	Bratisl Lek Listy
33393161	"Recent advancements in glycoproteomic studies: Glycopeptide enrichment and derivatization, characterization of glycosylation in SARS CoV2, and interacting glycoproteins."	Mass Spectrom Rev
33393116	Therapeutic targets and potential agents for the treatment of COVID-19.	Med Res Rev
33392924	Backbone chemical shift assignments for the SARS-CoV-2 non-structural protein Nsp9: intermediate (ms - mus) dynamics in the C-terminal helix at the dimer interface.	Biomol NMR Assign
33392612	Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Codon Usage and Replicative Fitness.	Glob Med Genet
33392409	Atlas of ACE2 gene expression reveals novel insights into transmission of SARS-CoV-2.	Heliyon
33392263	The Leukotriene Receptor Antagonist Montelukast as a Potential COVID-19 Therapeutic.	Front Mol Biosci
33392262	"Structural Characterization of SARS-CoV-2: Where We Are, and Where We Need to Be."	Front Mol Biosci
33392261	Identification of Potential Inhibitors of 3CL Protease of SARS-CoV-2 From ZINC Database by Molecular Docking-Based Virtual Screening.	Front Mol Biosci
33392257	Surveying the Side-Chain Network Approach to Protein Structure and Dynamics: The SARS-CoV-2 Spike Protein as an Illustrative Case.	Front Mol Biosci
33392206	Extracellular RNA as a Versatile DAMP and Alarm Signal That Influences Leukocyte Recruitment in Inflammation and Infection.	Front Cell Dev Biol
33392133	"Interplay Between Air Travel, Genome Integrity, and COVID-19 Risk vis-a-vis Flight Crew."	Front Public Health
33391880	"Full-length genome characterization and phylogenetic analysis of SARS-CoV-2 virus strains from Yogyakarta and Central Java, Indonesia."	PeerJ
33391794	"ACE inhibition and cardiometabolic risk factors, lung ACE2 and TMPRSS2 gene expression, and plasma ACE2 levels: a Mendelian randomization study."	R Soc Open Sci
33391730	'The long tail of Covid-19' - The detection of a prolonged inflammatory response after a SARS-CoV-2 infection in asymptomatic and mildly affected patients.	F1000Res
33391636	Extracellular vesicles containing ACE2 efficiently prevent infection by SARS-CoV-2 Spike protein-containing virus.	J Extracell Vesicles
33391634	Exploiting cheminformatic and machine learning to navigate the available chemical space of potential small molecule inhibitors of SARS-CoV-2.	Comput Struct Biotechnol J
33391633	Computational modelling supports that dengue virus envelope antibodies can bind to SARS-CoV-2 receptor binding sites: Is pre-exposure to dengue virus protective against COVID-19 severity?	Comput Struct Biotechnol J
33391623	Manganese nanodepot augments host immune response against coronavirus.	Nano Res
33391502	COVID-19 and Cancer Comorbidity: Therapeutic Opportunities and Challenges.	Theranostics
33391497	Rapid design and development of CRISPR-Cas13a targeting SARS-CoV-2 spike protein.	Theranostics
33391477	Immunopathogenesis and treatment of cytokine storm in COVID-19.	Theranostics
33391285	A Potent SARS-CoV-2 Neutralizing Human Monoclonal Antibody That Reduces Viral Burden and Disease Severity in Syrian Hamsters.	Front Immunol
33391280	"Different Innate and Adaptive Immune Responses to SARS-CoV-2 Infection of Asymptomatic, Mild, and Severe Cases."	Front Immunol
33391255	Class I HLA Allele Predicted Restricted Antigenic Coverages for Spike and Nucleocapsid Proteins Are Associated With Deaths Related to COVID-19.	Front Immunol
33391014	COVID-19-Associated Hyper-Fibrinolysis: Mechanism and Implementations.	Front Physiol
33390952	"Potential Simultaneous Inhibitors of Angiotensin-Converting Enzyme 2 and Transmembrane Protease, Serine 2."	Front Pharmacol
33390836	SARS-CoV-2 variants evolved during the early stage of the pandemic and effects of mutations on adaptation in Wuhan populations.	Int J Biol Sci
33390833	A Multiple-Hit Hypothesis Involving Reactive Oxygen Species and Myeloperoxidase Explains Clinical Deterioration and Fatality in COVID-19.	Int J Biol Sci
33390830	ACE2 Correlated With Immune Infiltration Serves As A Novel Prognostic Biomarker In Clear Cell Renal Cell Carcinoma: Implication For COVID-19.	Int J Biol Sci
33390810	DCs-based therapies: potential strategies in severe SARS-CoV-2 infection.	Int J Med Sci
33390800	Perspective Adjunctive Therapies for COVID-19: Beyond Antiviral Therapy.	Int J Med Sci
33390762	Exogenous pulmonary surfactant: A review focused on adjunctive therapy for severe acute respiratory syndrome coronavirus 2 including SP-A and SP-D as added clinical marker.	Curr Opin Colloid Interface Sci
33390681	"Computational investigations of three main drugs and their comparison with synthesized compounds as potent inhibitors of SARS-CoV-2 main protease (M(pro)): DFT, QSAR, molecular docking, and in silico toxicity analysis."	J King Saud Univ Sci
33390634	"Excited-state electronic properties, structural studies, noncovalent interactions, and inhibition of the novel severe acute respiratory syndrome coronavirus 2 proteins in Ripretinib by first-principle simulations."	J Mol Liq
33390613	"Synthesis of novel indolo[3,2-c]isoquinoline derivatives bearing pyrimidine, piperazine rings and their biological evaluation and docking studies against COVID-19 virus main protease."	J Mol Struct
33390561	Does coronaviruses induce neurodegenerative diseases? A systematic review on the neurotropism and neuroinvasion of SARS-CoV-2.	Drug Discov Ther
33390458	Cell Atlases as Roadmaps in Health and Disease.	Keio J Med
33390183	Obesity and COVID-19: what makes obese host so vulnerable?	Immun Ageing
33390179	Alu retrotransposons and COVID-19 susceptibility and morbidity.	Hum Genomics
33389884	Immune Computation and COVID-19 Mortality: A Rationale for IVIg.	Crit Rev Immunol
33389724	SARS-CoV-2 therapeutics: how far do we stand from a remedy?	Pharmacol Rep
33389560	CoViTris2020 and ChloViD2020: a striking new hope in COVID-19 therapy.	Mol Divers
33389548	"(1)H, (15)N and (13)C resonance assignments of the N-terminal domain of the nucleocapsid protein from the endemic human coronavirus HKU1."	Biomol NMR Assign
33389441	"The anti-HCV, Sofosbuvir, versus the anti-EBOV Remdesivir against SARS-CoV-2 RNA dependent RNA polymerase in silico."	Mol Divers
33389440	Designing of peptide aptamer targeting the receptor-binding domain of spike protein of SARS-CoV-2: an in silico study.	Mol Divers
33389262	COVID-19: angiotensin-converting enzyme 2 (ACE2) expression and tissue susceptibility to SARS-CoV-2 infection.	Eur J Clin Microbiol Infect Dis
33389257	"Culture of SARS-CoV-2 in a panel of laboratory cell lines, permissivity, and differences in growth profile."	Eur J Clin Microbiol Infect Dis
33388749	"Distinct disease severity between children and older adults with COVID-19: Impacts of ACE2 expression, distribution, and lung progenitor cells."	Clin Infect Dis
33388272	Dynamics of severe acute respiratory syndrome coronavirus 2 genome variants in the feces during convalescence.	J Genet Genomics
33388129	Remdesivir: From Ebola to COVID-19.	Biochem Biophys Res Commun
33388094	Induction of alarmin S100A8/A9 mediates activation of aberrant neutrophils in the pathogenesis of COVID-19.	Cell Host Microbe
33388027	Propedia: a database for protein-peptide identification based on a hybrid clustering algorithm.	BMC Bioinformatics
33388025	Covid-19 In Man: A Very Dangerous Affair.	Endocr Metab Immune Disord Drug Targets
33388022	Diabetes Mellitus and SARS-CoV-2 Infection: Pathophysiologic Mechanisms and Implications in Management.	Curr Diabetes Rev
33388014	Use of Natural Compounds as a Potential Therapeutic Agent Against COVID-19.	Curr Pharm Des
33387941	Acute kidney injury due to COVID-19 and the circadian rhythm.	Med Hypotheses
33387885	In silico study of the potential interactions of 4'-acetamidechalcones with protein targets in SARS-CoV-2.	Biochem Biophys Res Commun
33387788	Dexamethasone inhibits SARS-CoV-2 spike pseudotyped virus viropexis by binding to ACE2.	Virology
33387787	Programmed -1 Ribosomal Frameshifting in coronaviruses: A therapeutic target.	Virology
33387629	Inhibition of the replication of SARS-CoV-2 in human cells by the FDA-approved drug chlorpromazine.	Int J Antimicrob Agents
33387467	Unraveling the mechanism of arbidol binding and inhibition of SARS-CoV-2: Insights from atomistic simulations.	Eur J Pharmacol
33387249	In Silico Evaluation of Prospective Anti-COVID-19 Drug Candidates as Potential SARS-CoV-2 Main Protease Inhibitors.	Protein J
33387210	Von Willebrand factor with increased binding capacity is associated with reduced platelet aggregation but enhanced agglutination in COVID-19 patients: another COVID-19 paradox?	J Thromb Thrombolysis
33387156	"SARS-CoV-2-Induced ARDS Associates with MDSC Expansion, Lymphocyte Dysfunction, and Arginine Shortage."	J Clin Immunol
33386849	Population Dynamics and Structural Effects at Short and Long Range Support the Hypothesis of the Selective Advantage of the G614 SARS-CoV-2 Spike Variant.	Mol Biol Evol
33386773	SARS-CoV-2 nucleocapsid protein intranasal inoculation induces local and systemic T cell responses in mice.	J Med Virol
33386398	"SARS-CoV-2 Receptor ACE2 Gene Is Associated with Hypertension and Severity of COVID 19: Interaction with Sex, Obesity, and Smoking."	Am J Hypertens
33386081	"Network machine learning maps phytochemically rich ""Hyperfoods"" to fight COVID-19."	Hum Genomics
33386025	Identifying the natural polyphenol catechin as a multi-targeted agent against SARS-CoV-2 for the plausible therapy of COVID-19: an integrated computational approach.	Brief Bioinform
33385879	"Phenylmethimazole is a candidate drug for the treatment of severe forms of coronavirus disease 2019 (COVID-19) as well as other virus-induced ""cytokines storm""."	Med Hypotheses
33385878	The plausible mechanisms of tramadol for treatment of COVID-19.	Med Hypotheses
33385714	Genome-wide analysis of Indian SARS-CoV-2 genomes to identify T-cell and B-cell epitopes from conserved regions based on immunogenicity and antigenicity.	Int Immunopharmacol
33385461	"Development of new vaccine target against SARS-CoV2 using envelope (E) protein: An evolutionary, molecular modeling and docking based study."	Int J Biol Macromol
33385419	Plasma renin activity has a complex prognostic role in patients with acute coronary syndromes.	Int J Cardiol
33385178	Induced Pluripotent Stem Cell Derived Human Lung Organoids to Map and Treat the SARS-CoV2 Infections In Vitro.	Adv Exp Med Biol
33384909	Mutational spectra of SARS-CoV-2 isolated from animals.	PeerJ
33384691	Deep Sequencing of B Cell Receptor Repertoires From COVID-19 Patients Reveals Strong Convergent Immune Signatures.	Front Immunol
33384690	Sharing CD4+ T Cell Loss: When COVID-19 and HIV Collide on Immune System.	Front Immunol
33384436	Deposition distribution of the new coronavirus (SARS-CoV-2) in the human airways upon exposure to cough-generated droplets and aerosol particles.	Sci Rep
33384338	Human species D adenovirus hexon capsid protein mediates cell entry through a direct interaction with CD46.	Proc Natl Acad Sci U S A
33384142	Comprehensive analysis of COVID-19 during pregnancy.	Biochem Biophys Res Commun
33383826	Broadly Active Antiviral Compounds Disturb Zika Virus Progeny Release Rescuing Virus-Induced Toxicity in Brain Organoids.	Viruses
33383825	Discovery of a Bradykinin B2 Partial Agonist Profile of Raloxifene in a Drug Repurposing Campaign.	Int J Mol Sci
33383528	Identification and computational analysis of mutations in SARS-CoV-2.	Comput Biol Med
33383524	Ethnicity and the relationship between covid-19 and the herpes simplex viruses.	Med Hypotheses
33383190	Structural insights of key enzymes into therapeutic intervention against SARS-CoV-2.	J Struct Biol
33383142	Comprehensive analysis of TCR repertoire in COVID-19 using single cell sequencing.	Genomics
33383045	A bird eye view on cystic fibrosis: An underestimated multifaceted chronic disorder.	Life Sci
33382973	Neurological Manifestations of COVID-19 Feature T Cell Exhaustion and Dedifferentiated Monocytes in Cerebrospinal Fluid.	Immunity
33382968	Genome-Scale Identification of SARS-CoV-2 and Pan-coronavirus Host Factor Networks.	Cell
33382966	Molecular and cellular mechanisms of liver dysfunction in COVID-19.	Discov Med
33382930	Mega doses of retinol: A possible immunomodulation in Covid-19 illness in resource-limited settings.	Rev Med Virol
33382919	Thrombotic thrombocytopenic purpura (TTP) response following COVID-19 infection: Implications for the ADAMTS-13-von Willebrand factor axis.	J Thromb Haemost
33382687	SARS-CoV-2 infection induces mixed M1/M2 phenotype in circulating monocytes and alterations in both dendritic cell and monocyte subsets.	PLoS One
33382685	A novel virtual screening procedure identifies Pralatrexate as inhibitor of SARS-CoV-2 RdRp and it reduces viral replication in vitro.	PLoS Comput Biol
33382450	Cardiovascular aspects of COVID-19.	Swiss Med Wkly
33382348	"MicroRNAs and SARS-CoV-2 life cycle, pathogenesis, and mutations: biomarkers or therapeutic agents?"	Cell Cycle
33382023	Fisetin 8-C-glucoside as entry inhibitor in SARS CoV-2 infection: molecular modelling study.	J Biomol Struct Dyn
33382021	Virtual repurposing of ursodeoxycholate and chenodeoxycholate as lead candidates against SARS-Cov2-Envelope protein: A molecular dynamics investigation.	J Biomol Struct Dyn
33381913	Peripheral inflammation and blood-brain barrier disruption: effects and mechanisms.	CNS Neurosci Ther
33381848	FBA reveals guanylate kinase as a potential target for antiviral therapies against SARS-CoV-2.	Bioinformatics
33381809	Improving gene network inference with graph wavelets and making insights about ageing-associated regulatory changes in lungs.	Brief Bioinform
33381519	Potential Mechanisms for Traditional Chinese Medicine in Treating Airway Mucus Hypersecretion Associated With Coronavirus Disease 2019.	Front Mol Biosci
33381492	Host DDX Helicases as Possible SARS-CoV-2 Proviral Factors: A Structural Overview of Their Hijacking Through Multiple Viral Proteins.	Front Chem
33381482	COVID-19 Pneumonia in Children: From Etiology to Management.	Front Pediatr
33381464	"What Can Cellular Redox, Iron, and Reactive Oxygen Species Suggest About the Mechanisms and Potential Therapy of COVID-19?"	Front Cell Infect Microbiol
33381273	SARS-CoV-2 and Other Respiratory Viruses: What Does Oxidative Stress Have to Do with It?	Oxid Med Cell Longev
33381197	Screening for a Potential Therapeutic Agent from the Herbal Formula in the 4(th) Edition of the Chinese National Guidelines for the Initial-Stage Management of COVID-19 via Molecular Docking.	Evid Based Complement Alternat Med
33381049	A New Crystal Form of the SARS-CoV-2 Receptor Binding Domain: CR3022 Complex-An Ideal Target for In-Crystal Fragment Screening of the ACE2 Binding Site Surface.	Front Pharmacol
33380608	Interplay of COVID-19 and physiological dysfunctions.	Chin J Physiol
33380494	Coronavirus Receptors as Immune Modulators.	J Immunol
33380405	[Progress in source tracking of SARS-CoV-2].	Nan Fang Yi Ke Da Xue Xue Bao
33380375	Phytopharmaceuticals mediated Furin and TMPRSS2 receptor blocking: can it be a potential therapeutic option for Covid-19?	Phytomedicine
33380345	Cognitive impact of COVID-19: looking beyond the short term.	Alzheimers Res Ther
33380340	ACE2: the molecular doorway to SARS-CoV-2.	Cell Biosci
33380328	Design of a companion bioinformatic tool to detect the emergence and geographical distribution of SARS-CoV-2 Spike protein genetic variants.	J Transl Med
33379366	Nicotine Changes Airway Epithelial Phenotype and May Increase the SARS-COV-2 Infection Severity.	Molecules
33379162	Is Gut Microbiota Dysbiosis a Predictor of Increased Susceptibility to Poor Outcome of COVID-19 Patients? An Update.	Microorganisms
33378966	Potential effects of SARS-CoV-2 on the gastrointestinal tract and liver.	Biomed Pharmacother
33378565	Therapeutic approaches against coronaviruses acute respiratory syndrome.	Pharmacol Res Perspect
33378321	"A Review of Pathophysiology, Clinical Features, and Management Options of COVID-19 Associated Coagulopathy."	Shock
33378062	Risk factors of COVID-19 mortality: a systematic review of current literature and lessons from recent retracted articles.	Eur Rev Med Pharmacol Sci
33378056	Nervous system complications of COVID-19 with a focus on stroke.	Eur Rev Med Pharmacol Sci
33377937	SARS-CoV-2 infection and the antiviral innate immune response.	J Mol Cell Biol
33377928	The development of neutralizing antibodies against SARS-CoV-2 and their common features.	J Mol Cell Biol
33377359	The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.	J Biol Regul Homeost Agents
33377319	Omega 3 Fatty Acids and COVID-19: A Comprehensive Review.	Infect Chemother
33377145	Evolutionary and codon usage preference insights into spike glycoprotein of SARS-CoV-2.	Brief Bioinform
33377122	Hydroxychloroquine Inhibits the Trained Innate Immune Response to Interferons.	Cell Rep Med
33377107	Glycomics-informed glycoproteomic analysis of site-specific glycosylation for SARS-CoV-2 spike protein.	STAR Protoc
33377103	A protocol for displaying viral envelope glycoproteins on the surface of vesicular stomatitis viruses.	STAR Protoc
33377063	Sensitization of Non-permissive Laboratory Mice to SARS-CoV-2 with a Replication-Deficient Adenovirus Expressing Human ACE2.	STAR Protoc
33376956	Cell-mediated immunity to SARS-CoV-2.	Pediatr Investig
33376955	Type I interferon: From innate response to treatment for COVID-19.	Pediatr Investig
33376953	Severe acute respiratory syndrome coronavirus 2-induced multisystem inflammatory syndrome in children.	Pediatr Investig
33376910	Enhanced Affinity for 3-Amino-Chromane-Derived sigma1 Receptor Ligands.	ACS Omega
33376694	Lung Pathology in COVID-19: A Systematic Review.	Int J Appl Basic Med Res
33376594	Severe SARS-CoV-2 patients develop a higher specific T-cell response.	Clin Transl Immunology
33376242	In-depth blood proteome profiling analysis revealed distinct functional characteristics of plasma proteins between severe and non-severe COVID-19 patients.	Sci Rep
33376043	"Lycorine, a non-nucleoside RNA dependent RNA polymerase inhibitor, as potential treatment for emerging coronavirus infections."	Phytomedicine
33375876	Progress in understanding COVID-19: insights from the omics approach.	Crit Rev Clin Lab Sci
33375692	Nutraceutical Strategies for Suppressing NLRP3 Inflammasome Activation: Pertinence to the Management of COVID-19 and Beyond.	Nutrients
33375675	Peripheral Blood Immune Profiling of Convalescent Plasma Donors Reveals Alterations in Specific Immune Subpopulations Even at 2 Months Post SARS-CoV-2 Infection.	Viruses
33375616	"Structural Variability, Expression Profile, and Pharmacogenetic Properties of TMPRSS2 Gene as a Potential Target for COVID-19 Therapy."	Genes (Basel)
33375460	A Computational Approach to Explore the Interaction of Semisynthetic Nitrogenous Heterocyclic Compounds with the SARS-CoV-2 Main Protease.	Biomolecules
33375410	The PIKfyve Inhibitor Apilimod: A Double-Edged Sword against COVID-19.	Cells
33375371	Endothelium Infection and Dysregulation by SARS-CoV-2: Evidence and Caveats in COVID-19.	Viruses
33375282	Sterols and Triterpenes: Antiviral Potential Supported by In-Silico Analysis.	Plants (Basel)
33375175	C-type Lectin CD209L/L-SIGN and CD209/DC-SIGN: Cell Adhesion Molecules Turned to Pathogen Recognition Receptors.	Biology (Basel)
33374824	Structure and Hierarchy of SARS-CoV-2 Infection Dynamics Models Revealed by Reaction Network Analysis.	Viruses
33374797	Multiple Recombination Events and Strong Purifying Selection at the Origin of SARS-CoV-2 Spike Glycoprotein Increased Correlated Dynamic Movements.	Int J Mol Sci
33374759	"COVID-19: A Global Challenge with Old History, Epidemiology and Progress So Far."	Molecules
33374748	Road Map to Understanding SARS-CoV-2 Clinico-Immunopathology and COVID-19 Disease Severity.	Pathogens
33374717	Drug Repurposing Approach against Novel Coronavirus Disease (COVID-19) through Virtual Screening Targeting SARS-CoV-2 Main Protease.	Biology (Basel)
33374593	Current Status and Future Prospects of Perinatal Stem Cells.	Genes (Basel)
33374514	Fluoroquinolone Antibiotics Exhibit Low Antiviral Activity against SARS-CoV-2 and MERS-CoV.	Viruses
33374416	Impact of Genetic Variability in ACE2 Expression on the Evolutionary Dynamics of SARS-CoV-2 Spike D614G Mutation.	Genes (Basel)
33374407	PASylated Thymosin alpha1: A Long-Acting Immunostimulatory Peptide for Applications in Oncology and Virology.	Int J Mol Sci
33374387	Blocking Effect of Demethylzeylasteral on the Interaction between Human ACE2 Protein and SARS-CoV-2 RBD Protein Discovered Using SPR Technology.	Molecules
33374356	Pharmacotherapy in COVID 19: Potential Impact of Targeting the Complement System.	Biomedicines
33374214	Quercetin as a Natural Therapeutic Candidate for the Treatment of Influenza Virus.	Biomolecules
33374168	Do Animals Play a Role in the Transmission of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2)? A Commentary.	Animals (Basel)
33374149	Fucoidan and Lung Function: Value in Viral Infection.	Mar Drugs
33373718	Conus venom fractions inhibit the adhesion of Plasmodium falciparum erythrocyte membrane protein 1 domains to the host vascular receptors.	J Proteomics
33373693	Spike glycoproteins: Their significance for corona viruses and receptor binding activities for pathogenesis and viral survival.	Microb Pathog
33373681	"COVID-19, ferrosenescence and neurodegeneration, a mini-review."	Prog Neuropsychopharmacol Biol Psychiatry
33373644	Pathophysiology and pharmacological management of pulmonary and cardiovascular features of COVID-19.	J Mol Cell Cardiol
33373502	Mucin signature as a potential tool to predict susceptibility to COVID-19.	Physiol Rep
33373194	Uncovering Flexible Active Site Conformations of SARS-CoV-2 3CL Proteases through Protease Pharmacophore Clusters and COVID-19 Drug Repurposing.	ACS Nano
33372854	SARS-CoV-2 proteases PLpro and 3CLpro cleave IRF3 and critical modulators of inflammatory pathways (NLRP12 and TAB1): implications for disease presentation across species.	Emerg Microbes Infect
33372806	Alkaloids and flavonoids from African phytochemicals as potential inhibitors of SARS-Cov-2 RNA-dependent RNA polymerase: an in silico perspective.	Antivir Chem Chemother
33372782	Novel Sigma 1 Receptor Antagonists as Potential Therapeutics for Pain Management.	J Med Chem
33372574	In silico analysis of phytochemicals as potential inhibitors of proteases involved in SARS-CoV-2 infection.	J Biomol Struct Dyn
33372567	"A review on favipiravir: the properties, function, and usefulness to treat COVID-19."	Expert Rev Anti Infect Ther
33372384	"Susceptibility of turkeys, chickens and chicken embryos to SARS-CoV-2."	Transbound Emerg Dis
33372280	Immunomodulatory effects of nanocurcumin on Th17 cell responses in mild and severe COVID-19 patients.	J Cell Physiol
33372199	SARS-CoV-2 Proteome Microarray for Mapping COVID-19 Antibody Interactions at Amino Acid Resolution.	ACS Cent Sci
33372198	Conservation analysis of SARS-CoV-2 spike suggests complicated viral adaptation history from bat to human.	Evol Med Public Health
33372181	In silico discovery of antigenic proteins and epitopes of SARS-CoV-2 for the development of a vaccine or a diagnostic approach for COVID-19.	Sci Rep
33372179	Neonatal hyperoxia enhances age-dependent expression of SARS-CoV-2 receptors in mice.	Sci Rep
33372174	Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) membrane (M) protein inhibits type I and III interferon production by targeting RIG-I/MDA-5 signaling.	Signal Transduct Target Ther
33372171	SARS-Cov-2 infection in transplant-related biology: Where do we stand?	Ann Transplant
33371901	The immune system view of the coronavirus SARS-CoV-2.	Biol Direct
33371892	Statistical power in COVID-19 case-control host genomic study design.	Genome Med
33371835	ACE2 as a potential target for management of novel coronavirus (nCoV- 2019).	Curr Drug Discov Technol
33371832	The potential mechanism of N-acetylcysteine in treating COVID-19.	Curr Pharm Biotechnol
33371830	The Fight against Human Viruses: How NMR Can Help?	Curr Med Chem
33371275	Harnessing Cellular Immunity for Vaccination against Respiratory Viruses.	Vaccines (Basel)
33371200	The RNA Architecture of the SARS-CoV-2 3'-Untranslated Region.	Viruses
33370781	"Surface texture limits transfer of S. aureus, T4 bacteriophage, influenza B virus and human coronavirus."	PLoS One
33370597	Repurposing of renin inhibitors as SARS-COV-2 main protease inhibitors: A computational study.	Virology
33370311	ACE2 polymorphisms as potential players in COVID-19 outcome.	PLoS One
33369768	Remdesivir potently inhibits carboxylesterase-2 through covalent modifications: signifying strong drug-drug interactions.	Fundam Clin Pharmacol
33369281	Might proton pump or sodium-hydrogen exchanger inhibitors be of value to ameliorate SARs-CoV-2 pathophysiology?	Physiol Rep
33369210	Targeting host cell proteases as a potential treatment strategy to limit the spread of SARS-CoV-2 in the respiratory tract.	Pharmacol Res Perspect
33368788	Classical and alternative receptors for SARS-CoV-2 therapeutic strategy.	Rev Med Virol
33368679	Spatial and temporal roles of SARS-CoV PL(pro) -A snapshot.	FASEB J
33368386	Dynamic tracking of variant frequencies depicts the evolution of mutation sites amongst SARS-CoV-2 genomes from India.	J Med Virol
33368245	Effects of cigarette smoking on SARS-CoV-2 receptor ACE2 expression in the respiratory epithelium(dagger).	J Pathol
33368089	Heparin Inhibits Cellular Invasion by SARS-CoV-2: Structural Dependence of the Interaction of the Spike S1 Receptor-Binding Domain with Heparin.	Thromb Haemost
33368058	Therapeutic Approach Against 2019-nCoV by Inhibition of the ACE-2 receptor.	Drug Res (Stuttg)
33368021	COVID-19 coagulopathy: is it disseminated intravascular coagulation?	Intern Emerg Med
33367897	Role of Immunoglobulin M and A Antibodies in the Neutralization of Severe Acute Respiratory Syndrome Coronavirus 2.	J Infect Dis
33367731	Fostamatinib Inhibits Neutrophils Extracellular Traps Induced by COVID-19 Patient Plasma: A Potential Therapeutic.	J Infect Dis
33367597	Structure and regulation of coronavirus genomes: state-of-the-art and novel insights from SARS-CoV-2 studies.	Biochem Soc Trans
33365386	Is COVID-19 Fatality Rate Associated with Malaria Endemicity?	Discoveries (Craiova)
33365326	"Zinc, Vitamin D and Vitamin C: Perspectives for COVID-19 With a Focus on Physical Tissue Barrier Integrity."	Front Nutr
33365070	"Current directions, conceptions and viewpoints on 2019-nCoV (Review)."	Exp Ther Med
33364961	"PB28, the Sigma-1 and Sigma-2 Receptors Modulator With Potent Anti-SARS-CoV-2 Activity: A Review About Its Pharmacological Properties and Structure Affinity Relationships."	Front Pharmacol
33364957	Repurposing Sigma-1 Receptor Ligands for COVID-19 Therapy?	Front Pharmacol
33364944	Computational Studies of Hydroxychloroquine and Chloroquine Metabolites as Possible Candidates for Coronavirus (COVID-19) Treatment.	Front Pharmacol
33364877	The Association between Chronic Use of Renin-Angiotensin-Aldosterone System Blockers and in-Hospital Adverse Events among COVID-19 Patients with Hypertension.	Sisli Etfal Hastan Tip Bul
33364539	Biologically active compounds from marine organisms in the strategies for combating coronaviruses.	AIMS Microbiol
33364503	Identifying epitopes for cluster of differentiation and design of new peptides inhibitors against human SARS-CoV-2 spike RBD by an in-silico approach.	Heliyon
33364494	Bioinformatic evaluation of the potential animal models for studying SARS-Cov-2.	Heliyon
33364445	"Analysis of non-structural proteins, NSPs of SARS-CoV-2 as targets for computational drug designing."	Biochem Biophys Rep
33364247	Molecular Mechanisms Lead to Sex-Specific COVID-19 Prognosis and Targeted Therapies.	Front Med (Lausanne)
33364229	Identification of Small Molecule Inhibitors of the Deubiquitinating Activity of the SARS-CoV-2 Papain-Like Protease: in silico Molecular Docking Studies and in vitro Enzymatic Activity Assay.	Front Chem
33364201	Cathepsin L in COVID-19: From Pharmacological Evidences to Genetics.	Front Cell Infect Microbiol
33363733	"Trained immunity as a novel approach against COVID-19 with a focus on Bacillus Calmette-Guerin vaccine: mechanisms, challenges and perspectives."	Clin Transl Immunology
33363705	A recent origin of Orf3a from M protein across the coronavirus lineage arising by sharp divergence.	Comput Struct Biotechnol J
33363658	HOW GENETICISTS CONTRIBUTE TO UNDERSTANDING OF COVID-19 DISEASE PATHOGENICITY.	Acta Endocrinol (Buchar)
33363552	Metabolic Engineering Strategies of Industrial Hemp (Cannabis sativa L.): A Brief Review of the Advances and Challenges.	Front Plant Sci
33363465	MicroRNAs Bioinformatics Analyses Identifying HDAC Pathway as a Putative Target for Existing Anti-COVID-19 Therapeutics.	Front Pharmacol
33363420	"COVID-19 Pandemic: A Compressive Review on Gender, Herd Immunity, and Physiological Mechanisms."	Risk Manag Healthc Policy
33363416	An Up-to-Date Overview of Therapeutic Agents for the Treatment of COVID-19 Disease.	Clin Pharmacol
33363393	"COVID-19 and Obesity: Epidemiology, Pathogenesis and Treatment."	Diabetes Metab Syndr Obes
33363283	Life-Threatening COVID-19: Defective Interferons Unleash Excessive Inflammation.	Med (N Y)
33363254	Natural Products Database Screening for the Discovery of Naturally Occurring SARS-Cov-2 Spike Glycoprotein Blockers.	ChemistrySelect
33363251	Computational and network pharmacology analysis of bioflavonoids as possible natural antiviral compounds in COVID-19.	Inform Med Unlocked
33363234	An Overview of SARS-CoV-2 and Animal Infection.	Front Vet Sci
33363221	The Role of MSC Therapy in Attenuating the Damaging Effects of the Cytokine Storm Induced by COVID-19 on the Heart and Cardiovascular System.	Front Cardiovasc Med
33363209	A Potential Peptide From Soy Cheese Produced Using Lactobacillus delbrueckii WS4 for Effective Inhibition of SARS-CoV-2 Main Protease and S1 Glycoprotein.	Front Mol Biosci
33363207	Spike Proteins of SARS-CoV and SARS-CoV-2 Utilize Different Mechanisms to Bind With Human ACE2.	Front Mol Biosci
33363183	ACE2 and Furin Expressions in Oral Epithelial Cells Possibly Facilitate COVID-19 Infection via Respiratory and Fecal-Oral Routes.	Front Med (Lausanne)
33363165	Severe Acute Respiratory Syndrome Coronavirus 2-Induced Neurological Complications.	Front Cell Dev Biol
33363088	Bee Venom-A Potential Complementary Medicine Candidate for SARS-CoV-2 Infections.	Front Public Health
33362999	Thymosin alpha 1: A comprehensive review of the literature.	World J Virol
33362783	Treatment of Rare Inflammatory Kidney Diseases: Drugs Targeting the Terminal Complement Pathway.	Front Immunol
33362782	NF-kappaB Pathway as a Potential Target for Treatment of Critical Stage COVID-19 Patients.	Front Immunol
33362779	Dynamic SARS-CoV-2-Specific Immunity in Critically Ill Patients With Hypertension.	Front Immunol
33362771	A Network-Based Analysis Reveals the Mechanism Underlying Vitamin D in Suppressing Cytokine Storm and Virus in SARS-CoV-2 Infection.	Front Immunol
33362759	Will SARS-CoV-2 Infection Elicit Long-Lasting Protective or Sterilising Immunity? Implications for Vaccine Strategies (2020).	Front Immunol
33362758	SARS-CoV-2: Immune Response Elicited by Infection and Development of Vaccines and Treatments.	Front Immunol
33362757	Early Phases of COVID-19 Are Characterized by a Reduction in Lymphocyte Populations and the Presence of Atypical Monocytes.	Front Immunol
33362713	Activation of Melanocortin Receptors as a Potential Strategy to Reduce Local and Systemic Reactions Induced by Respiratory Viruses.	Front Endocrinol (Lausanne)
33362695	SARS-CoV-2 Is Not Detected in the Cerebrospinal Fluid of Encephalopathic COVID-19 Patients.	Front Neurol
33362575	Pathophysiology of SARS-CoV-2 in Lung of Diabetic Patients.	Front Physiol
33362565	Alpha-1 Antitrypsin for COVID-19 Treatment: Dual Role in Antiviral Infection and Anti-Inflammation.	Front Pharmacol
33362557	Nutraceutical Targeting of Inflammation-Modulating microRNAs in Severe Forms of COVID-19: A Novel Approach to Prevent the Cytokine Storm.	Front Pharmacol
33362545	"Prognostic Genetic Markers for Thrombosis in COVID-19 Patients: A Focused Analysis on D-Dimer, Homocysteine and Thromboembolism."	Front Pharmacol
33362542	SARS-CoV-2 Spike-Heat Shock Protein A5 (GRP78) Recognition may be Related to the Immersed Human Coronaviruses.	Front Pharmacol
33362291	Unraveling the origin of interactions of hydroxychloroquine with the receptor-binding domain of SARS-CoV-2 in aqueous medium.	Chem Phys Lett
33361824	Hypertension delays viral clearance and exacerbates airway hyperinflammation in patients with COVID-19.	Nat Biotechnol
33361777	Artificial intelligence predicts the immunogenic landscape of SARS-CoV-2 leading to universal blueprints for vaccine designs.	Sci Rep
33361764	Endothelial activation and dysfunction in COVID-19: from basic mechanisms to potential therapeutic approaches.	Signal Transduct Target Ther
33361761	Longitudinal transcriptome analyses show robust T cell immunity during recovery from COVID-19.	Signal Transduct Target Ther
33361716	ACE2 role in SARS-CoV-2 infectivity and Covid-19 severity.	Malays J Pathol
33361715	Severe acute respiratory syndrome-Coronavirus-2 infection: A review of the clinical-pathological correlations of Coronavirus disease-19 in children.	Malays J Pathol
33361522	"Immunometabolism at the cornerstone of inflammaging, immunosenescence, and autoimmunity in COVID-19."	Aging (Albany NY)
33361429	Coronavirus Endoribonuclease Ensures Efficient Viral Replication and Prevents Protein Kinase R Activation.	J Virol
33361386	Biological Significance of Anti-SARS-CoV-2 Antibodies: Lessons Learned From Progressive Multifocal Leukoencephalopathy.	Neurol Neuroimmunol Neuroinflamm
33361342	The Importance and Challenges of Identifying SARS-CoV-2 Reinfections.	J Clin Microbiol
33361333	"Structure of SARS-CoV-2 ORF8, a rapidly evolving immune evasion protein."	Proc Natl Acad Sci U S A
33361332	DeepTracer for fast de novo cryo-EM protein structure modeling and special studies on CoV-related complexes.	Proc Natl Acad Sci U S A
33361161	Discordant neutralizing antibody and T cell responses in asymptomatic and mild SARS-CoV-2 infection.	Sci Immunol
33361116	Afucosylated IgG characterizes enveloped viral responses and correlates with COVID-19 severity.	Science
33361110	Profiling of immune dysfunction in COVID-19 patients allows early prediction of disease progression.	Life Sci Alliance
33361013	Cytokine release syndrome: inhibition of pro-inflammatory cytokines as a solution for reducing COVID-19 mortality.	Eur Cytokine Netw
33360831	A computational drug repurposing approach in identifying the cephalosporin antibiotic and anti-hepatitis C drug derivatives for COVID-19 treatment.	Comput Biol Med
33360731	Endothelial cell damage is the central part of COVID-19 and a mouse model induced by injection of the S1 subunit of the spike protein.	Ann Diagn Pathol
33360674	Takotsubo Syndrome and COVID-19: Associations and Implications.	Curr Probl Cardiol
33360543	Overexpression of SARS-CoV-2 protein ORF6 dislocates RAE1 and NUP98 from the nuclear pore complex.	Biochem Biophys Res Commun
33360484	"Neuropathological explanation of minimal COVID-19 infection rate in newborns, infants and children - a mystery so far. New insight into the role of Substance P."	J Neurol Sci
33360293	Hydroxychloroquine can potentially interfere with immune function in COVID-19 patients: Mechanisms and insights.	Redox Biol
33360025	Cytokine storm induced by SARS-CoV-2 infection: The spectrum of its neurological manifestations.	Cytokine
33359834	The Molecular Mechanism of Domain Swapping of the C-Terminal Domain of the SARS-Coronavirus Main Protease.	Biophys J
33359807	SARS-Cov-2 ORF3a: Mutability and function.	Int J Biol Macromol
33359760	Effects of vitamin D on macrophages and myeloid-derived suppressor cells (MDSCs) hyperinflammatory response in the lungs of COVID-19 patients.	Cell Immunol
33359419	Obesity - A Risk Factor for Psoriasis and COVID-19.	Actas Dermosifiliogr
33359380	High frequency of cerebrospinal fluid autoantibodies in COVID-19 patients with neurological symptoms.	Brain Behav Immun
33359190	Tmprss2 specific miRNAs as promising regulators for SARS-CoV-2 entry checkpoint.	Virus Res
33359141	COVID-19 vaccines: The status and perspectives in delivery points of view.	Adv Drug Deliv Rev
33359061	Molecular epidemiology of COVID-19 in Oman: A molecular and surveillance study for the early transmission of COVID-19 in the country.	Int J Infect Dis
33358977	Lipid-based vaccine nanoparticles for induction of humoral immune responses against HIV-1 and SARS-CoV-2.	J Control Release
33358906	Targeting inflammatory cytokine storm to fight against COVID-19 associated severe complications.	Life Sci
33358868	Strategies to DAMPen COVID-19-mediated lung and systemic inflammation and vascular injury.	Transl Res
33358827	A protein folding robot driven by a self-taught agent.	Biosystems
33358567	Biological functions of MAIT cells in tissues.	Mol Immunol
33358501	Relationship Between Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and the Etiology of Acute Kidney Injury (AKI).	Am J Med Sci
33357843	Comprehensive Landscape of Heparin Therapy for COVID-19.	Carbohydr Polym
33357725	Traditional Chinese medicine network pharmacology study on exploring the mechanism of Xuebijing Injection in the treatment of coronavirus disease 2019.	Chin J Nat Med
33357513	Host genetic effects in pneumonia.	Am J Hum Genet
33357464	Functional interrogation of a SARS-CoV-2 host protein interactome identifies unique and shared coronavirus host factors.	Cell Host Microbe
33357418	Intranasal vaccination with a lentiviral vector protects against SARS-CoV-2 in preclinical animal models.	Cell Host Microbe
33357411	Cell-Type-Specific Immune Dysregulation in Severely Ill COVID-19 Patients.	Cell Rep
33357409	The persistence of interleukin-6 is regulated by a blood buffer system derived from dendritic cells.	Immunity
33357233	Potentially adaptive SARS-CoV-2 mutations discovered with novel spatiotemporal and explainable AI models.	Genome Biol
33357215	Phosphatidylserine inside out: a possible underlying mechanism in the inflammation and coagulation abnormalities of COVID-19.	Cell Commun Signal
33357192	In silico studies reveal antiviral effects of traditional Indian spices on COVID-19.	Curr Pharm Des
33357102	Naturally Occurring Animal Coronaviruses as Models for Studying Highly Pathogenic Human Coronaviral Disease.	Vet Pathol
33357073	"Dual inhibition of SARS-CoV-2 spike and main protease through a repurposed drug, rutin."	J Biomol Struct Dyn
33357040	Prediction of potential inhibitors against SARS-CoV-2 endoribonuclease: RNA immunity sensing.	J Biomol Struct Dyn
33357038	Design and in silico study of the novel coumarin derivatives against SARS-CoV-2 main enzymes.	J Biomol Struct Dyn
33356922	Small molecule stabilization of non-native protein-protein interactions of SARS-CoV-2 N protein as a mechanism of action against COVID-19.	J Biomol Struct Dyn
33356621	On the molecular structure of Remdesivir for the treatment of Covid-19.	Comput Methods Biomech Biomed Engin
33356606	"Association of ACEI/ARB, inflammatory cytokines, and antiviral drugs with liver dysfunction in patients with hypertension and COVID-19."	Clin Exp Hypertens
33356523	Xerostomia and Taste Alterations in COVID-19.	Ear Nose Throat J
33356231	Tenofovir-Amino Acid Conjugates Act as Polymerase Substrates-Implications for Avoiding Cellular Phosphorylation in the Discovery of Nucleotide Analogues.	J Med Chem
33356169	Rationally Designed ACE2-Derived Peptides Inhibit SARS-CoV-2.	Bioconjug Chem
33356134	Biomaterials-Based Opportunities to Engineer the Pulmonary Host Immune Response in COVID-19.	ACS Biomater Sci Eng
33356052	"COVID 19 - Possible interrelations with respiratory comorbidities caused by occupational exposure to various hazardous bioaerosols. Part I. Occurrence, epidemiology and presumed origin of the pandemic."	Ann Agric Environ Med
33355886	Antibody response and therapy in COVID-19 patients: what can be learned for vaccine development?	Sci China Life Sci
33355798	Research Status of SARS-CoV-2 on Cardiovascular System Injury in Children.	Braz J Cardiovasc Surg
33355542	The role of biomaterials and three dimensional (3D) in vitro tissue models in fighting against COVID-19.	Biomater Sci
33355522	Healing after COVID-19: are survivors at risk for pulmonary fibrosis?	Am J Physiol Lung Cell Mol Physiol
33355186	Is COVID-19-Induced Platelet Activation a Cause of Concern for Patients with Cancer?	Cancer Res
33355054	Pericytes Within A Pulmonary Neurovascular Unit in Coronavirus Disease 2019 Elicited Pathological Changes.	Curr Neurovasc Res
33355053	"Repurposed Antiviral Drugs for the Treatment of COVID-19: Syntheses, Mechanism of Infection and Clinical Trials."	Mini Rev Med Chem
33355050	"A Clinical Review of COVID-19; Pathogenesis, Diagnosis, and Management."	Curr Pharm Des
33354975	Zoonotic origins and animal hosts of coronaviruses causing human disease pandemics: A review.	Onderstepoort J Vet Res
33354848	Polyphenols are potential nutritional adjuvants for targeting COVID-19.	Phytother Res
33354650	Host-Viral Interactions Revealed among Shared Transcriptomics Signatures of ARDS and Thrombosis: A Clue into COVID-19 Pathogenesis.	TH Open
33353972	High affinity nanobodies block SARS-CoV-2 spike receptor binding domain interaction with human angiotensin converting enzyme.	Sci Rep
33353955	Phylogenetic supertree reveals detailed evolution of SARS-CoV-2.	Sci Rep
33353499	Structure and dynamics of membrane protein in SARS-CoV-2.	J Biomol Struct Dyn
33353101	SARS-CoV-2 Spike Alterations Enhance Pseudoparticle Titers and Replication-Competent VSV-SARS-CoV-2 Virus.	Viruses
33352869	Effect of COVID-19 on Lungs: Focusing on Prospective Malignant Phenotypes.	Cancers (Basel)
33352703	SARS-Cov-2 Interactome with Human Ghost Proteome: A Neglected World Encompassing a Wealth of Biological Data.	Microorganisms
33352699	Vascular Endothelial Glycocalyx Damage in COVID-19.	Int J Mol Sci
33352565	"Spices to Control COVID-19 Symptoms: Yes, but Not Only...."	Int Arch Allergy Immunol
33352531	Sex-dependent immune response and lethality of COVID-19.	Stem Cell Res
33352458	Identification of FDA approved drugs and nucleoside analogues as potential SARS-CoV-2 A1pp domain inhibitor: An in silico study.	Comput Biol Med
33352298	COVID-19 in patients with systemic lupus erythematosus: lessons learned from the inflammatory disease.	Transl Res
33352263	Type 2 diabetes and viral infection; cause and effect of disease.	Diabetes Res Clin Pract
33352046	Natural Products with Potential to Treat RNA Virus Pathogens Including SARS-CoV-2.	J Nat Prod
33351863	Designing of a next generation multiepitope based vaccine (MEV) against SARS-COV-2: Immunoinformatics and in silico approaches.	PLoS One
33351847	Coronavirus genomes carry the signatures of their habitats.	PLoS One
33351828	Multi-resolution visualization and analysis of biomolecular networks through hierarchical community detection and web-based graphical tools.	PLoS One
33351354	[The role of HLA genes: from autoimmune diseases to COVID-19].	Probl Endokrinol (Mosk)
33350913	"Territorywide Study of Early Coronavirus Disease Outbreak, Hong Kong, China."	Emerg Infect Dis
33350580	Biochemical study on the protective effect of curcumin on acetaminophen and gamma-irradiation induced hepatic toxicity in rats.	Environ Toxicol
33350432	Sex differences in immune responses to SARS-CoV-2 in patients with COVID-19.	Biosci Rep
33350309	Structure-Based Screening to Discover New Inhibitors for Papain-like Proteinase of SARS-CoV-2: An In Silico Study.	J Proteome Res
33350283	"SARS-CoV-2/COVID-19, Lymphatic vessels, lymph, and lymphology."	Lymphology
33350096	"SARS-CoV-2 effects on the renin-angiotensin-aldosterone system, therapeutic implications."	Acta Physiol (Oxf)
33350032	Ferritin as a Platform for Creating Antiviral Mosaic Nanocages: Prospects for Treating COVID-19.	Chembiochem
33350010	A Ligand Selection Strategy Identifies Chemical Probes Targeting the Proteases of SARS-CoV-2.	Angew Chem Int Ed Engl
33349849	The effect of angiotensin-converting enzyme levels on COVID-19 susceptibility and severity: a Mendelian randomization study.	Int J Epidemiol
33349812	Spiky nanostructures for virus inhibition and infection prevention.	Smart Mater Med
33349797	Intradermal delivery of receptor-binding domain of SARS-CoV-2 spike protein with dissolvable microneedles to induce humoral and cellular responses in mice.	Bioeng Transl Med
33349792	Essential interpretations of bioinformatics in COVID-19 pandemic.	Meta Gene
33349665	The SARS-CoV-2 RNA-protein interactome in infected human cells.	Nat Microbiol
33349633	Calcium channel blocker amlodipine besylate therapy is associated with reduced case fatality rate of COVID-19 patients with hypertension.	Cell Discov
33349263	Beneficial effect of Indigo Naturalis on acute lung injury induced by influenza A virus.	Chin Med
33349165	"SARS-CoV-2 infection in farmed minks, associated zoonotic concerns, and importance of the One Health approach during the ongoing COVID-19 pandemic."	Vet Q
33349108	Search for SARS-CoV-2 RNA in platelets from COVID-19 patients.	Platelets
33348746	"Monitoring Viral Entry in Real-Time Using a Luciferase Recombinant Vesicular Stomatitis Virus Producing SARS-CoV-2, EBOV, LASV, CHIKV, and VSV Glycoproteins."	Viruses
33348699	"Extracellular Vesicles: Roles in Human Viral Infections, Immune-Diagnostic, and Therapeutic Applications."	Pathogens
33348607	A Newcastle Disease Virus (NDV) Expressing a Membrane-Anchored Spike as a Cost-Effective Inactivated SARS-CoV-2 Vaccine.	Vaccines (Basel)
33348462	Action of Dipeptidyl Peptidase-4 Inhibitors on SARS-CoV-2 Main Protease.	ChemMedChem
33348379	The impact of structural bioinformatics tools and resources on SARS-CoV-2 research and therapeutic strategies.	Brief Bioinform
33348368	A review on viral data sources and search systems for perspective mitigation of COVID-19.	Brief Bioinform
33348292	Interferon-inducer antivirals: Potential candidates to combat COVID-19.	Int Immunopharmacol
33348007	The role of renin-angiotensin system activated phagocytes in the SARS-CoV-2 coronavirus infection.	J Vasc Surg
33347989	Different mutations in SARS-CoV-2 associate with severe and mild outcome.	Int J Antimicrob Agents
33347987	The role of NO in COVID-19 and potential therapeutic strategies.	Free Radic Biol Med
33347881	Effects of Intestinal Fungi and Viruses on Immune Responses and Inflammatory Bowel Diseases.	Gastroenterology
33347649	Usage of peptidases by SARS-CoV-2 and several human coronaviruses as receptors: A mysterious story.	Biotechnol Appl Biochem
33347622	Comparative insight into the genomic landscape of SARS-CoV-2 and identification of mutations associated with the origin of infection and diversity.	J Med Virol
33347610	Silent hypoxaemia in COVID-19 patients.	J Physiol
33347477	"Positive association of angiotensin II receptor blockers, not angiotensin-converting enzyme inhibitors, with an increased vulnerability to SARS-CoV-2 infection in patients hospitalized for suspected COVID-19 pneumonia."	PLoS One
33347439	"A modular framework for multiscale, multicellular, spatiotemporal modeling of acute primary viral infection and immune response in epithelial tissues and its application to drug therapy timing and effectiveness."	PLoS Comput Biol
33347434	The SARS-CoV-2 Spike protein has a broad tropism for mammalian ACE2 proteins.	PLoS Biol
33347311	Overview of Targets and Potential Drugs of SARS-CoV-2 According to the Viral Replication.	J Proteome Res
33346959	[Male fertility in the context of COVID-19: Concern and considerations].	Zhonghua Nan Ke Xue
33346958	[Novel coronavirus induces testicular injury: Analysis of causes and follow-up monitoring].	Zhonghua Nan Ke Xue
33346955	[Novel coronavirus and male reproductive health].	Zhonghua Nan Ke Xue
33346851	"Potential roles of mitochondrial cofactors in the adjuvant mitigation of proinflammatory acute infections, as in the case of sepsis and COVID-19 pneumonia."	Inflamm Res
33346830	CorGAT: a tool for the functional annotation of SARS-CoV-2 genomes.	Bioinformatics
33346828	The COVID-19 Ontology.	Bioinformatics
33346633	The SARS-CoV-2 Cytopathic Effect Is Blocked by Lysosome Alkalizing Small Molecules.	ACS Infect Dis
33346454	[Novel coronavirus infection COVID-19: extrapulmonary manifestations].	Ter Arkh
33346100	Recognition of plausible therapeutic agents to combat COVID-19: An omics data based combined approach.	Gene
33345626	The cardiovascular aspect of COVID-19.	Ann Med
33345622	Increased expression of hypoxia-induced factor 1alpha mRNA and its related genes in myeloid blood cells from critically ill COVID-19 patients.	Ann Med
33345195	Outcomes Associated with the Use of Renin-Angiotensin-Aldosterone System Blockade in Hospitalized Patients with SARS-CoV-2 Infection.	Kidney360
33344919	MR1-Restricted T Cells with MAIT-like Characteristics Are Functionally Conserved in the Pteropid Bat Pteropus alecto.	iScience
33344913	Docking Prediction of Amantadine in the Receptor Binding Domain of Spike Protein of SARS-CoV-2.	ACS Pharmacol Transl Sci
33344912	Defusing SARS-CoV-2: Emergency Brakes in a Vaccine Failure Scenario.	ACS Pharmacol Transl Sci
33344794	Prospective role of thyroid disorders in monitoring COVID-19 pandemic.	Heliyon
33344790	Investigation on penetration of saffron components through lipid bilayer bound to spike protein of SARS-CoV-2 using steered molecular dynamics simulation.	Heliyon
33344582	Understanding the immunopathogenesis of COVID-19: Its implication for therapeutic strategy.	World J Clin Cases
33344513	Pandemic Perspective: Commonalities Between COVID-19 and Cardio-Oncology.	Front Cardiovasc Med
33344509	Recent Progress in the Drug Development Targeting SARS-CoV-2 Main Protease as Treatment for COVID-19.	Front Mol Biosci
33344479	Body Localization of ACE-2: On the Trail of the Keyhole of SARS-CoV-2.	Front Med (Lausanne)
33344044	No impact of cancer and plague-relevant FPR1 polymorphisms on COVID-19.	Oncoimmunology
33343897	Innate lymphoid cell composition associates with COVID-19 disease severity.	Clin Transl Immunology
33343834	Temperature dependence of the SARS-CoV-2 affinity to human ACE2 determines COVID-19 progression and clinical outcome.	Comput Struct Biotechnol J
33343740	[COVID-19 and kidney involvement].	Nephrologe
33343709	COVID-19 and cerebrovascular diseases: a comprehensive overview.	Ther Adv Neurol Disord
33343585	B Cell Subsets as Severity-Associated Signatures in COVID-19 Patients.	Front Immunol
33343584	"Insights Into Immunothrombosis: The Interplay Among Neutrophil Extracellular Trap, von Willebrand Factor, and ADAMTS13."	Front Immunol
33343579	Human Leukocyte Antigen Complex and Other Immunogenetic and Clinical Factors Influence Susceptibility or Protection to SARS-CoV-2 Infection and Severity of the Disease Course. The Sardinian Experience.	Front Immunol
33343486	Complications and Pathophysiology of COVID-19 in the Nervous System.	Front Neurol
33343395	Novel Mechanical Strain Characterization of Ventilated ex vivo Porcine and Murine Lung using Digital Image Correlation.	Front Physiol
33343386	COVID-19: A Challenge to Physiology of Aging.	Front Physiol
33343349	Perspectives in Peptide-Based Vaccination Strategies for Syndrome Coronavirus 2 Pandemic.	Front Pharmacol
33343232	COVID-19 and Neutrophils: The Relationship between Hyperinflammation and Neutrophil Extracellular Traps.	Mediators Inflamm
33342753	"Renin-angiotensin system blockers and susceptibility to COVID-19: an international, open science, cohort analysis."	Lancet Digit Health
33342421	Possible therapeutic interventions in COVID-19 induced ARDS by cotinine as an ACE-2 promoter and AT-1R blocker.	Infect Disord Drug Targets
33342088	Molecularly imprinted spongy columns for Angiotensin(II) recognition from human serum.	Biotechnol Prog
33341900	SARS-CoV-2 hot-spot mutations are significantly enriched within inverted repeats and CpG island loci.	Brief Bioinform
33341894	Potential benefits of dietary seaweeds as protection against COVID-19.	Nutr Rev
33341869	Inferring microenvironmental regulation of gene expression from single-cell RNA sequencing data using scMLnet with an application to COVID-19.	Brief Bioinform
33341814	Hyperinflammation and Immune Response Generation in COVID-19.	Neuroimmunomodulation
33341650	"Diverse chemical space of indoleamine-2,3-dioxygenase 1 (Ido1) inhibitors."	Eur J Med Chem
33341604	Neutralizing antibodies targeting SARS-CoV-2 spike protein.	Stem Cell Res
33341233	The broad spectrum host-directed agent ivermectin as an antiviral for SARS-CoV-2 ?	Biochem Biophys Res Commun
33341210	Paraviral eruptions in the era of COVID-19: Do some skin manifestations point to a natural resistance to SARS-CoV-2?	Clin Dermatol
33341209	Systemic steroids and risk of fecal-oral shedding and increased transmission of SARS-CoV-2 in pemphigus cases.	Clin Dermatol
33340798	Furin cleavage sites naturally occur in coronaviruses.	Stem Cell Res
33340765	In vitro display evolution of IL-6R-binding unnatural peptides ribosomally initiated and cyclized with m-(chloromethyl)benzoic acid.	Biochem Biophys Res Commun
33340640	Cerebral vasculitis of medium-sized vessels as a possible mechanism of brain damage in COVID-19 patients.	J Neuroradiol
33340637	Infectious bronchitis virus: Identification of Gallus gallus APN high-affinity ligands with antiviral effects.	Antiviral Res
33340543	Force-dependent stimulation of RNA unwinding by SARS-CoV-2 nsp13 helicase.	Biophys J
33340519	Subtle Influence of ACE2 Glycan Processing on SARS-CoV-2 Recognition.	J Mol Biol
33340417	"SARS-CoV-2 candidate vaccines - composition, mechanisms of action and stages of clinical development."	Allergy
33340273	Cortisol level dysregulation and its prevalence-Is it nature's alarm clock?	Physiol Rep
33340034	"Responses to acute infection with SARS-CoV-2 in the lungs of rhesus macaques, baboons and marmosets."	Nat Microbiol
33340022	Viral targets for vaccines against COVID-19.	Nat Rev Immunol
33339864	Dynamic data-driven meta-analysis for prioritisation of host genes implicated in COVID-19.	Sci Rep
33339432	Functional Complexes of Angiotensin-Converting Enzyme 2 and Renin-Angiotensin System Receptors: Expression in Adult but Not Fetal Lung Tissue.	Int J Mol Sci
33339153	Investigation of Genetic Variations of IL6 and IL6R as Potential Prognostic and Pharmacogenetics Biomarkers: Implications for COVID-19 and Neuroinflammatory Disorders.	Life (Basel)
33339096	Bioactivity Potential of Marine Natural Products from Scleractinia-Associated Microbes and In Silico Anti-SARS-COV-2 Evaluation.	Mar Drugs
33338955	"Downregulation of microRNA-146a in diabetes, obesity and hypertension may contribute to severe COVID-19."	Med Hypotheses
33338916	"A nuclear factor kappa B reporter cell line used to evaluate ex vivo the net inflammatory effect of plasma samples from patients with rheumatoid arthritis, psoriasis, or COVID-19."	Cytokine
33338751	Myricetin: A review of the most recent research.	Biomed Pharmacother
33338639	"Ethnic and age-specific acute lung injury/acute respiratory distress syndrome risk associated with angiotensin-converting enzyme insertion/deletion polymorphisms, implications for COVID-19: A meta-analysis."	Infect Genet Evol
33338635	COVID-19 and thrombosis: From bench to bedside.	Trends Cardiovasc Med
33338422	A Crisp(r) New Perspective on SARS-CoV-2 Biology.	Cell
33338421	TMEM41B Is a Pan-flavivirus Host Factor.	Cell
33338412	"PD-1-Expressing SARS-CoV-2-Specific CD8(+) T Cells Are Not Exhausted, but Functional in Patients with COVID-19."	Immunity
33338400	RBM-MHC: A Semi-Supervised Machine-Learning Method for Sample-Specific Prediction of Antigen Presentation by HLA-I Alleles.	Cell Syst
33338197	Reinfection with SARS-CoV-2: Implications for Vaccines.	Clin Infect Dis
33337934	Antagonism of Type I Interferon by Severe Acute Respiratory Syndrome Coronavirus 2.	J Interferon Cytokine Res
33337932	Role of Host Immune and Inflammatory Responses in COVID-19 Cases with Underlying Primary Immunodeficiency: A Review.	J Interferon Cytokine Res
33337873	A Nanomechanical Study on Deciphering the Stickiness of SARS-CoV-2 on Inanimate Surfaces.	ACS Appl Mater Interfaces
33337480	"IL-6 in inflammation, autoimmunity and cancer."	Int Immunol
33337478	"Renin-angiotensin system blockers, risk of SARS-CoV-2 infection and outcomes fromCoViD-19: systematic review and meta-analysis."	Eur Heart J Cardiovasc Pharmacother
33336824	The renin-angiotensin system in COVID-19: Why ACE2 targeting by coronaviruses produces higher mortality in elderly hypertensive patients?	Bioessays
33336811	Respiratory syndrome coronavirus-2 response: Microbiota as lactobacilli could make the difference.	J Med Virol
33336781	Molecular pathways triggered by COVID-19 in different organs: ACE2 receptor-expressing cells under attack? A review.	Eur Rev Med Pharmacol Sci
33336773	Cytokine storms caused by novel coronavirus 2019 and treatment for cardiac injury.	Eur Rev Med Pharmacol Sci
33336769	Could glutathione depletion be the Trojan horse of COVID-19 mortality?	Eur Rev Med Pharmacol Sci
33336412	"microRNA-146a and -155, upregulated by periodontitis and type 2 diabetes in oral fluids, are predicted to regulate SARS-CoV-2 oral receptor genes."	J Periodontol
33336018	Evaluation of COVID-19 based on ACE2 expression in normal and cancer patients.	Open Med (Wars)
33335956	Novel SARS-CoV-2 outbreak and COVID19 disease; a systemic review on the global pandemic.	Genes Dis
33335812	"Repurposing FDA-approved phytomedicines, natural products, antivirals and cell protectives against SARS-CoV-2 (COVID-19) RNA-dependent RNA polymerase."	PeerJ
33335743	Emerging phylogenetic structure of the SARS-CoV-2 pandemic.	Virus Evol
33335737	Evolutionary medical insights into the SARS-CoV-2 pandemic.	Evol Med Public Health
33335532	Lymphocyte Changes in Severe COVID-19: Delayed Over-Activation of STING?	Front Immunol
33335527	Impact of Diabetes in Patients Diagnosed With COVID-19.	Front Immunol
33335518	COVID-19: The Emerging Immunopathological Determinants for Recovery or Death.	Front Microbiol
33335323	T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial.	Nat Med
33335206	"Biochemical and biophysical characterization of the main protease, 3-chymotrypsin-like protease (3CLpro) from the novel coronavirus SARS-CoV 2."	Sci Rep
33335073	Cross-species recognition of SARS-CoV-2 to bat ACE2.	Proc Natl Acad Sci U S A
33334896	"Two SARS-CoV-2 Genome Sequences of Isolates from Rural U.S. Patients Harboring the D614G Mutation, Obtained Using Nanopore Sequencing."	Microbiol Resour Announc
33334394	The impact of obesity on the cellular and molecular pathophysiology of COVID-19.	S Afr Med J
33334050	SARS-CoV-2 and Viral Sepsis: Immune Dysfunction and Implications in Kidney Failure.	J Clin Med
33333996	Antimicrobial and Amyloidogenic Activity of Peptides. Can Antimicrobial Peptides Be Used against SARS-CoV-2?	Int J Mol Sci
33333995	"Viral Pandemics of the Last Four Decades: Pathophysiology, Health Impacts and Perspectives."	Int J Environ Res Public Health
33333742	Identification of Host Cellular Protein Substrates of SARS-COV-2 Main Protease.	Int J Mol Sci
33333559	Gene expression profiling of SARS-CoV-2 infections reveal distinct primary lung cell and systemic immune infection responses that identify pathways relevant in COVID-19 disease.	Brief Bioinform
33333472	Statins and PCSK9 inhibitors: What is their role in coronavirus disease 2019?	Med Hypotheses
33333424	"Effect of nelfinavir stereoisomers on coronavirus main protease: Molecular docking, molecular dynamics simulation and MM/GBSA study."	J Mol Graph Model
33333256	"Influenza infection, SARS, MERS and COVID-19: Cytokine storm - The common denominator and the lessons to be learned."	Clin Immunol
33333024	Genetic Screens Identify Host Factors for SARS-CoV-2 and Common Cold Coronaviruses.	Cell
33332890	COVID-19 and autoimmune diseases.	Curr Opin Rheumatol
33332737	Does COVID-19 contribute to development of neurological disease?	Immun Inflamm Dis
33332663	Peculiar immunophenotypic signature in MIS-C-affected children.	Pediatr Allergy Immunol
33332624	Liver Disease and Coronavirus Disease 2019: From Pathogenesis to Clinical Care.	Hepatology
33332472	Genomic epidemiology reveals multiple introductions and spread of SARS-CoV-2 in the Indian state of Karnataka.	PLoS One
33332358	Recombination events are concentrated in the spike protein region of Betacoronaviruses.	PLoS Genet
33331927	SARS-CoV-2-specific T cells are rapidly expanded for therapeutic use and target conserved regions of the membrane protein.	Blood
33331810	Understanding the outcomes of COVID-19 - does the current model of an acute respiratory infection really fit?	J Gen Virol
33331657	Apoptosis-induced T-cell lymphopenia is related to COVID-19 severity.	J Med Virol
33331649	Dysregulation of the mevalonate pathway during SARS-CoV-2 infection: An in silico study.	J Med Virol
33331574	Comparative evaluation of memory T cells in COVID-19 patients and the predictive role of CD4+CD8+ double positive T lymphocytes as a new marker.	Rev Assoc Med Bras (1992)
33331360	A novel STING agonist for cancer immunotherapy and a SARS-CoV-2 vaccine adjuvant.	Chem Commun (Camb)
33331243	Comparative molecular dynamics study of the receptor-binding domains in SARS-CoV-2 and SARS-CoV and the effects of mutations on the binding affinity.	J Biomol Struct Dyn
33330852	Unfolded protein response in the COVID-19 context.	Aging Health Res
33330844	Clinically Approved Antiviral Drug in an Orally Administrable Nanoparticle for COVID-19.	ACS Pharmacol Transl Sci
33330843	Targeting ACE2-RBD Interaction as a Platform for COVID-19 Therapeutics: Development and Drug-Repurposing Screen of an AlphaLISA Proximity Assay.	ACS Pharmacol Transl Sci
33330841	"Ebselen, Disulfiram, Carmofur, PX-12, Tideglusib, and Shikonin Are Nonspecific Promiscuous SARS-CoV-2 Main Protease Inhibitors."	ACS Pharmacol Transl Sci
33330839	Identifying SARS-CoV-2 Entry Inhibitors through Drug Repurposing Screens of SARS-S and MERS-S Pseudotyped Particles.	ACS Pharmacol Transl Sci
33330838	Probing the Dynamic Structure-Function and Structure-Free Energy Relationships of the Coronavirus Main Protease with Biodynamics Theory.	ACS Pharmacol Transl Sci
33330766	Emergence of SARS-CoV-2 and its outlook.	Glob Health Med
33330645	The Genetic Dissection of Ace2 Expression Variation in the Heart of Murine Genetic Reference Population.	Front Cardiovasc Med
33330626	Computational Investigation of Structural Dynamics of SARS-CoV-2 Methyltransferase-Stimulatory Factor Heterodimer nsp16/nsp10 Bound to the Cofactor SAM.	Front Mol Biosci
33330620	Renal Carcinoma Is Associated With Increased Risk of Coronavirus Infections.	Front Mol Biosci
33330597	The Impact of Obesity and Lifestyle on the Immune System and Susceptibility to Infections Such as COVID-19.	Front Nutr
33330557	Impact of SARS-CoV-2 on Male Reproductive Health: A Review of the Literature on Male Reproductive Involvement in COVID-19.	Front Med (Lausanne)
33330542	The Lebanese COVID-19 Cohort; A Challenge for the ABO Blood Group System.	Front Med (Lausanne)
33330498	Mesenchymal Stem Cells (MSCs) as a Potential Therapeutic Strategy in COVID-19 Patients: Literature Research.	Front Cell Dev Biol
33330376	Screening of Natural Products Targeting SARS-CoV-2-ACE2 Receptor Interface - A MixMD Based HTVS Pipeline.	Front Chem
33330288	COVID-19 in Children: A Review and Parallels to Other Hyperinflammatory Syndromes.	Front Pediatr
33329730	Whole Genome Identification of Potential G-Quadruplexes and Analysis of the G-Quadruplex Binding Domain for SARS-CoV-2.	Front Genet
33329667	Docking Characterization and in vitro Inhibitory Activity of Flavan-3-ols and Dimeric Proanthocyanidins Against the Main Protease Activity of SARS-Cov-2.	Front Plant Sci
33329653	Monoclonal Antibodies B38 and H4 Produced in Nicotiana benthamiana Neutralize SARS-CoV-2 in vitro.	Front Plant Sci
33329607	Mucosal Immunity in COVID-19: A Neglected but Critical Aspect of SARS-CoV-2 Infection.	Front Immunol
33329603	Type I Interferon (IFN)-Regulated Activation of Canonical and Non-Canonical Signaling Pathways.	Front Immunol
33329592	Lessons Learned Comparing Immune System Alterations of Bacterial Sepsis and SARS-CoV-2 Sepsis.	Front Immunol
33329589	CD71(+) Erythroid Cells in Human Neonates Exhibit Immunosuppressive Properties and Compromise Immune Response Against Systemic Infection in Neonatal Mice.	Front Immunol
33329533	Controlling Cytokine Storm Is Vital in COVID-19.	Front Immunol
33329480	Analysis of Indian SARS-CoV-2 Genomes Reveals Prevalence of D614G Mutation in Spike Protein Predicting an Increase in Interaction With TMPRSS2 and Virus Infectivity.	Front Microbiol
33329064	Modulation of Autophagy by SARS-CoV-2: A Potential Threat for Cardiovascular System.	Front Physiol
33329052	Biological Context Linking Hypertension and Higher Risk for COVID-19 Severity.	Front Physiol
33328777	"COVID-19, Antiphospholipid Antibodies, and Catastrophic Antiphospholipid Syndrome: A Possible Association?"	Clin Med Insights Arthritis Musculoskelet Disord
33328624	The S1 protein of SARS-CoV-2 crosses the blood-brain barrier in mice.	Nat Neurosci
33328588	Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology.	Mol Psychiatry
33328475	A single dose of recombinant VSV-G-spike vaccine provides protection against SARS-CoV-2 challenge.	Nat Commun
33328453	Genetic architecture of host proteins involved in SARS-CoV-2 infection.	Nat Commun
33328281	Relevance of the Bruton Tyrosine Kinase as a Target for COVID-19 Therapy.	Mol Cancer Res
33328008	[A review on the role of angiotensin-converting enzyme 2 in children with coronavirus disease 2019].	Zhongguo Dang Dai Er Ke Za Zhi
33327991	Postmortem Stability of SARS-CoV-2 in Nasopharyngeal Mucosa.	Emerg Infect Dis
33327924	An Updated Review on COVID-19.	Infect Disord Drug Targets
33327918	Recent Developments of Quinoline Derivatives and their Potential Biological Activities.	Curr Org Synth
33327904	Emergence and Reemergence of Human Coronaviruses: Spike Protein as the Potential Molecular Switch and Pharmaceutical Target.	Curr Pharm Des
33327866	Structure of the multiple functional domains from coronavirus nonstructural protein 3.	Emerg Microbes Infect
33327744	"Journey to a Receptor for Advanced Glycation End Products Connection in Severe Acute Respiratory Syndrome Coronavirus 2 Infection: With Stops Along the Way in the Lung, Heart, Blood Vessels, and Adipose Tissue."	Arterioscler Thromb Vasc Biol
33327700	COVID-19 and haemodynamic failure: a point of view on mechanisms and treatment.	Anaesthesiol Intensive Ther
33327623	Genetic and Acquired Heterotopic Ossification: A Translational Tale of Mice and Men.	Biomedicines
33327566	Genomic Epidemiology of the First Wave of SARS-CoV-2 in Italy.	Viruses
33327522	Morphogenetic (Mucin Expression) as Well as Potential Anti-Corona Viral Activity of the Marine Secondary Metabolite Polyphosphate on A549 Cells.	Mar Drugs
33327507	HCoV-NL63 and SARS-CoV-2 Share Recognized Epitopes by the Humoral Response in Sera of People Collected Pre- and during CoV-2 Pandemic.	Microorganisms
33327170	Investigating ion transport inside the pentameric ion channel encoded in COVID-19 E protein.	Phys Rev E
33326977	IFIT Proteins Are Involved in CXCL10 Expression in Human Glomerular Endothelial Cells Treated with a Toll-Like Receptor 3 Agonist.	Kidney Blood Press Res
33326874	Covid-19 and blood groups: ABO antibody levels may also matter.	Int J Infect Dis
33326798	An ACE2 Microbody Containing a Single Immunoglobulin Fc Domain Is a Potent Inhibitor of SARS-CoV-2.	Cell Rep
33326767	SARS-CoV-2 Epitopes Are Recognized by a Public and Diverse Repertoire of Human T Cell Receptors.	Immunity
33326604	Von Willebrand factor propeptide in severe coronavirus disease 2019 (COVID-19): evidence of acute and sustained endothelial cell activation.	Br J Haematol
33326500	mRNA induced expression of human angiotensin-converting enzyme 2 in mice for the study of the adaptive immune response to severe acute respiratory syndrome coronavirus 2.	PLoS Pathog
33326472	Lipid droplets fuel SARS-CoV-2 replication and production of inflammatory mediators.	PLoS Pathog
33326313	The H(+)-ATPase (V-ATPase): from proton pump to signaling complex in health and disease.	Am J Physiol Cell Physiol
33326239	Supercomputer-Based Ensemble Docking Drug Discovery Pipeline with Application to Covid-19.	J Chem Inf Model
33325821	"The Perspective of Coronavirus Disease Outbreak: Epidemiology, Transmission, and Possible Treatment."	Vector Borne Zoonotic Dis
33325750	Genomic analysis of SARS-CoV-2 reveals local viral evolution in Ghana.	Exp Biol Med (Maywood)
33325715	Peptide Correlation Analysis (PeCorA) Reveals Differential Proteoform Regulation.	J Proteome Res
33325143	T and B cell Epitope analysis of SARS-CoV-2 S protein based on immunoinformatics and experimental research.	J Cell Mol Med
33324769	Recent updates on COVID-19: A holistic review.	Heliyon
33324574	"SARS-CoV-2: Structure, Biology, and Structure-Based Therapeutics Development."	Front Cell Infect Microbiol
33324572	Gut Microbiota Status in COVID-19: An Unrecognized Player?	Front Cell Infect Microbiol
33324471	Identification of 14 Known Drugs as Inhibitors of the Main Protease of SARS-CoV-2.	ACS Med Chem Lett
33324414	Negative Clinical Evolution in COVID-19 Patients Is Frequently Accompanied With an Increased Proportion of Undifferentiated Th Cells and a Strong Underrepresentation of the Th1 Subset.	Front Immunol
33324374	Comparative Transcriptome Analysis Reveals the Intensive Early Stage Responses of Host Cells to SARS-CoV-2 Infection.	Front Microbiol
33324224	Role of Endolysosomes in Severe Acute Respiratory Syndrome Coronavirus-2 Infection and Coronavirus Disease 2019 Pathogenesis: Implications for Potential Treatments.	Front Pharmacol
33324223	Possible Role of Adenosine in COVID-19 Pathogenesis and Therapeutic Opportunities.	Front Pharmacol
33324213	Deciphering the Pharmacological Mechanisms of Ma Xing Shi Gan Decoction against COVID-19 through Integrating Network Pharmacology and Experimental Exploration.	Front Pharmacol
33324210	Targeting Macrophages as a Therapeutic Option in Coronavirus Disease 2019.	Front Pharmacol
33323800	Gene Expression of Angiotensin-Converting Enzyme 2 Receptor in Skin and the Implications for COVID-19.	Adv Skin Wound Care
33323111	Coagulation abnormalities in SARS-CoV-2 infection: overexpression tissue factor.	Thromb J
33322988	Impact of renin-angiotensin system inhibitors use on mortality in severe COVID-19 patients with hypertension: a retrospective observational study.	J Int Med Res
33322797	IgA2 Antibodies against SARS-CoV-2 Correlate with NET Formation and Fatal Outcome in Severely Diseased COVID-19 Patients.	Cells
33322757	Can Natural Polyphenols Help in Reducing Cytokine Storm in COVID-19 Patients?	Molecules
33322733	Challenges and Opportunities from Targeting Inflammatory Responses to SARS-CoV-2 Infection: A Narrative Review.	J Clin Med
33322584	The Microbiota/Host Immune System Interaction in the Nose to Protect from COVID-19.	Life (Basel)
33322557	Picomolar SARS-CoV-2 Neutralization Using Multi-Arm PEG Nanobody Constructs.	Biomolecules
33322535	Transcriptional Profiling of Immune and Inflammatory Responses in the Context of SARS-CoV-2 Fungal Superinfection in a Human Airway Epithelial Model.	Microorganisms
33322366	Pathology of Coronavirus Infections: A Review of Lesions in Animals in the One-Health Perspective.	Animals (Basel)
33322198	Possible Transmission Flow of SARS-CoV-2 Based on ACE2 Features.	Molecules
33322168	Taming the Autophagy as a Strategy for Treating COVID-19.	Cells
33322160	Dysregulated Interferon Response Underlying Severe COVID-19.	Viruses
33322052	A Computer-Aided Drug Design Approach to Predict Marine Drug-Like Leads for SARS-CoV-2 Main Protease Inhibition.	Mar Drugs
33322045	Novel Broad-Spectrum Antiviral Inhibitors Targeting Host Factors Essential for Replication of Pathogenic RNA Viruses.	Viruses
33321862	Molecular Docking Study on Several Benzoic Acid Derivatives against SARS-CoV-2.	Molecules
33321254	The role of extracellular DNA in COVID-19: Clues from inflamm-aging.	Ageing Res Rev
33321203	A computational approach to design potential siRNA molecules as a prospective tool for silencing nucleocapsid phosphoprotein and surface glycoprotein gene of SARS-CoV-2.	Genomics
33321075	Predicted Cellular Immunity Population Coverage Gaps for SARS-CoV-2 Subunit Vaccines and Their Augmentation by Compact Peptide Sets.	Cell Syst
33320670	Proton-Coupled Conformational Activation of SARS Coronavirus Main Proteases and Opportunity for Designing Small-Molecule Broad-Spectrum Targeted Covalent Inhibitors.	J Am Chem Soc
33320635	Bioengineered in Vitro Tissue Models to Study SARS-CoV-2 Pathogenesis and Therapeutic Validation.	ACS Biomater Sci Eng
33320454	COVID-19 and obesity: the meeting of two pandemics.	Arch Endocrinol Metab
33320447	Evidence and implications of pre-existing humoral cross-reactive immunity to SARS-CoV-2.	Immun Inflamm Dis
33320321	Human Bocavirus as a Possible Contributor to Respiratory Disease in the Georgian Military Population.	J Spec Oper Med
33320086	Neutralizing SARS-CoV-2.	Elife
33319649	Anti-SARS-CoV-2 neutralizing monoclonal antibodies: clinical pipeline.	MAbs
33319212	Dual targeting of 3CL(pro) and PL(pro) of SARS-CoV-2: A novel structure-based design approach to treat COVID-19.	Curr Res Struct Biol
33319167	Structural characterization of nonstructural protein 1 from SARS-CoV-2.	iScience
33319166	Transcriptional response modules characterize IL-1beta and IL-6 activity in COVID-19.	iScience
33319124	Mutational insights into the envelope protein of SARS-CoV-2.	Gene Rep
33318880	Protoporphyrin IX and verteporfin potently inhibit SARS-CoV-2 infection in vitro and in a mouse model expressing human ACE2.	Sci Bull (Beijing)
33318860	Extensive genetic diversity and host range of rodent-borne coronaviruses.	Virus Evol
33318859	Evaluation of NGS-based approaches for SARS-CoV-2 whole genome characterisation.	Virus Evol
33318797	Identification of similar epitopes between severe acute respiratory syndrome coronavirus-2 and Bacillus Calmette-Guerin: potential for cross-reactive adaptive immunity.	Clin Transl Immunology
33318594	Development of immunohistochemistry and in situ hybridisation for the detection of SARS-CoV and SARS-CoV-2 in formalin-fixed paraffin-embedded specimens.	Sci Rep
33318562	Minimal system for assembly of SARS-CoV-2 virus like particles.	Sci Rep
33318519	Gene expression network analysis provides potential targets against SARS-CoV-2.	Sci Rep
33317745	The nervous system-A new territory being explored of SARS-CoV-2.	J Clin Neurosci
33317695	Autophagy in T cells from aged donors is maintained by spermidine and correlates with function and vaccine responses.	Elife
33317643	Renal complications in coronavirus disease 2019: a systematic review.	Inflamm Regen
33317538	Viruses belonging to Anelloviridae or Circoviridae as a possible cause of chronic fatigue.	J Transl Med
33317409	"Multitarget in silico studies of Ocimum menthiifolium, family Lamiaceae against SARS-CoV-2 supported by molecular dynamics simulation."	J Biomol Struct Dyn
33316996	Ensemble Docking Coupled to Linear Interaction Energy Calculations for Identification of Coronavirus Main Protease (3CL(pro)) Non-Covalent Small-Molecule Inhibitors.	Molecules
33316947	Multiple Introductions Followed by Ongoing Community Spread of SARS-CoV-2 at One of the Largest Metropolitan Areas of Northeast Brazil.	Viruses
33316266	Repurposing of histone deacetylase inhibitors: A promising strategy to combat pulmonary fibrosis promoted by TGF-beta signalling in COVID-19 survivors.	Life Sci
33316234	Identification of Distinct Immunophenotypes in Critically Ill Coronavirus Disease 2019 Patients.	Chest
33316227	Thermovaccination - thermoheliox as a stimulator of the immune response. Kinetics of the synthesis of antibodies and C-reactive protein in coronavirus infection.	Chem Biol Interact
33316067	Phylogenetic Analysis of SARS-CoV-2 Data Is Difficult.	Mol Biol Evol
33316043	A Phylodynamic Workflow to Rapidly Gain Insights into the Dispersal History and Dynamics of SARS-CoV-2 Lineages.	Mol Biol Evol
33316002	Combination of C21 and ARBs with rhACE2 as a therapeutic protocol: A new promising approach for treating ARDS in patients with coronavirus infection.	Med J Islam Repub Iran
33315943	Female reproductive tract has low concentration of SARS-CoV2 receptors.	PLoS One
33315853	Integrated Bioinformatics Analysis Reveals Key Candidate Genes and Cytokine Pathways Involved in COVID-19 After Rhinovirus Infection in Asthma Patients.	Med Sci Monit
33315291	Does inflammation link stress to poor COVID-19 outcome?	Stress Health
33314794	Computational drug repurposing study of the RNA binding domain of SARS-CoV-2 nucleocapsid protein with antiviral agents.	Biotechnol Prog
33314219	mTOR inhibition in COVID-19: A commentary and review of efficacy in RNA viruses.	J Med Virol
33314076	Can the hyperthermia-mediated heat shock factor/heat shock protein 70 pathway dampen the cytokine storm during SARS-CoV-2 infection?	Br J Pharmacol
33314068	NLR in eXile: Emerging roles of NLRX1 in immunity and human disease.	Immunology
33314005	Host metabolism dysregulation and cell tropism identification in human airway and alveolar organoids upon SARS-CoV-2 infection.	Protein Cell
33313438	HMGB1 as a potential biomarker and therapeutic target for severe COVID-19.	Heliyon
33313418	Integrative vectors for regulated expression of SARS-CoV-2 proteins implicated in RNA metabolism.	Wellcome Open Res
33313362	Chasing COVID-19 through SARS-CoV-2 spike glycoprotein.	Virusdisease
33313306	Pathophysiology and potential future therapeutic targets using preclinical models of COVID-19.	ERJ Open Res
33313148	A bioinformatics analysis on the potential role of ACE2 in cardiac impairment of patients with coronavirus disease 2019.	Ann Transl Med
33312949	Single-Cell Sequencing of Glioblastoma Reveals Central Nervous System Susceptibility to SARS-CoV-2.	Front Oncol
33312899	Kidney injury in COVID-19.	World J Nephrol
33312565	Rapid detection of SARS-CoV-2-specific memory T-cell immunity in recovered COVID-19 cases.	Clin Transl Immunology
33312454	L1000 connectivity map interrogation identifies candidate drugs for repurposing as SARS-CoV-2 antiviral therapies.	Comput Struct Biotechnol J
33312453	Transcriptomic signatures and repurposing drugs for COVID-19 patients: findings of bioinformatics analyses.	Comput Struct Biotechnol J
33312449	Potential implications of SARS-CoV-2 oral infection in the host microbiota.	J Oral Microbiol
33312255	Clinical and Pathogenic Correlations Between SARS-CoV-2 Infection and Hemolytic Uremic Syndrome in Children.	Maedica (Bucur)
33312229	Histopathology features of the lung in COVID-19 patients.	Diagn Histopathol (Oxf)
33312199	Metabolic Perturbations and Severe COVID-19 Disease: Implication of Molecular Pathways.	Int J Endocrinol
33312178	MAFB and MAF Transcription Factors as Macrophage Checkpoints for COVID-19 Severity.	Front Immunol
33312128	Coronavirus Disease-19 Infection: Implications on Male Fertility and Reproduction.	Front Physiol
33312066	Pharmacogenomics landscape of COVID-19 therapy response in Serbian population and comparison with worldwide populations.	J Med Biochem
33312009	A Systematic Review of the Cardiovascular Manifestations and Outcomes in the Setting of Coronavirus-19 Disease.	Clin Med Insights Cardiol
33311634	Structural and functional comparison of SARS-CoV-2-spike receptor binding domain produced in Pichia pastoris and mammalian cells.	Sci Rep
33311543	The kinetics of humoral response and its relationship with the disease severity in COVID-19.	Commun Biol
33311501	Genomic epidemiology reveals transmission patterns and dynamics of SARS-CoV-2 in Aotearoa New Zealand.	Nat Commun
33311429	Does Virus-Receptor Interplay Influence Human Coronaviruses Infection Outcome?	Med Sci Monit
33310900	Targeting transcriptional regulation of SARS-CoV-2 entry factors ACE2 and TMPRSS2.	Proc Natl Acad Sci U S A
33310888	Spike glycoprotein and host cell determinants of SARS-CoV-2 entry and cytopathic effects.	J Virol
33310781	Recombinant ACE2 Expression Is Required for SARS-CoV-2 To Infect Primary Human Endothelial Cells and Induce Inflammatory and Procoagulative Responses.	mBio
33310780	Stapled Peptides Based on Human Angiotensin-Converting Enzyme 2 (ACE2) Potently Inhibit SARS-CoV-2 Infection In Vitro.	mBio
33310765	Presentations and mechanisms of CNS disorders related to COVID-19.	Neurol Neuroimmunol Neuroinflamm
33310740	Lung and Kidney ACE2 and TMPRSS2 in Renin-Angiotensin System Blocker-Treated Comorbid Diabetic Mice Mimicking Host Factors That Have Been Linked to Severe COVID-19.	Diabetes
33310664	Persistence of SARS-CoV-2-specific antibodies in COVID-19 patients.	Int Immunopharmacol
33310480	Cell membrane chromatography for the analysis of the interaction between chloroquine and hydroxychloroquine with ACE2 receptors.	J Chromatogr B Analyt Technol Biomed Life Sci
33310156	The evolving obesity challenge: targeting the vagus nerve and the inflammatory reflex in the response.	Pharmacol Ther
33310152	Metformin in acute respiratory distress syndrome: An opinion.	Exp Gerontol
33310043	Screened antipsychotic drugs inhibit SARS-CoV-2 binding with ACE2 in vitro.	Life Sci
33310028	Dynamic anti-spike protein antibody profiles in COVID-19 patients.	Int J Infect Dis
33310017	The ACE2-binding Interface of SARS-CoV-2 Spike Inherently Deflects Immune Recognition.	J Mol Biol
33309661	Ritonavir may inhibit exoribonuclease activity of nsp14 from the SARS-CoV-2 virus and potentiate the activity of chain terminating drugs.	Int J Biol Macromol
33309533	Potential SARS-CoV-2 main protease inhibitors.	Drug Discov Today
33309398	"SARS-CoV-2: what it is, how it acts, and how it manifests in imaging studies."	Radiologia (Engl Ed)
33309308	Integrated Bioinformatics Analysis for the Screening of Associated Pathways and Therapeutic Drugs in Coronavirus Disease 2019.	Arch Med Res
33309272	Identification of antiviral antihistamines for COVID-19 repurposing.	Biochem Biophys Res Commun
33309251	Is the oral cavity a reservoir for prolonged SARS-CoV-2 shedding?	Med Hypotheses
33309104	Using Genetics To Dissect SARS-CoV-2 Infection.	Trends Genet
33308936	Alveolar epithelial cell type II as main target of SARS-CoV-2 virus and COVID-19 development via NF-Kb pathway deregulation: A physio-pathological theory.	Med Hypotheses
33308506	Coronavirus Disease 2019 and Hypertension: The Role of Angiotensin-Converting Enzyme 2 and the Renin-Angiotensin System.	Adv Chronic Kidney Dis
33308501	Pathophysiology and Pathology of Acute Kidney Injury in Patients With COVID-19.	Adv Chronic Kidney Dis
33308225	Identification of biological correlates associated with respiratory failure in COVID-19.	BMC Med Genomics
33308150	Identification of CD8(+) T cell epitopes through proteasome cleavage site predictions.	BMC Bioinformatics
33308117	Chloroquine Analogs: An Overview of Natural and Synthetic Quinolines as Broad Spectrum Antiviral Agents.	Curr Pharm Des
33307964	Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers Use and COVID-19 Infection Among 824 650 Patients With Hypertension From a US Integrated Healthcare System.	J Am Heart Assoc
33307651	Possible consequences of Covid-19 on the nervous system.	Neuro Endocrinol Lett
33307546	Genetic mechanisms of critical illness in COVID-19.	Nature
33307513	COVID-19 and cancer: From basic mechanisms to vaccine development using nanotechnology.	Int Immunopharmacol
33307107	Decreased serum levels of the inflammaging marker miR-146a are associated with clinical non-response to tocilizumab in COVID-19 patients.	Mech Ageing Dev
33307078	Pathological findings in the postmortem liver of patients with coronavirus disease 2019 (COVID-19).	Hum Pathol
33307034	The Gastrointestinal Tract Is an Alternative Route for SARS-CoV-2 Infection in a Nonhuman Primate Model.	Gastroenterology
33306986	Using Cardiovascular Cells from Human Pluripotent Stem Cells for COVID-19 Research: Why the Heart Fails.	Stem Cell Reports
33306985	D614G Spike Mutation Increases SARS CoV-2 Susceptibility to Neutralization.	Cell Host Microbe
33306746	Disentangling the dynamical underpinnings of differences in SARS-CoV-2 pathology using within-host ecological models.	PLoS Pathog
33306471	High-Throughput Screening and Quantum Mechanics for Identifying Potent Inhibitors Against Mac1 Domain of SARS-CoV-2 Nsp3.	IEEE/ACM Trans Comput Biol Bioinform
33306459	SARS-CoV-2 genomic characterization and clinical manifestation of the COVID-19 outbreak in Uruguay.	Emerg Microbes Infect
33306409	Ravaging SARS-CoV-2: rudimentary diagnosis and puzzling immunological responses.	Curr Med Res Opin
33306377	Candidate Binding Sites for Allosteric Inhibition of the SARS-CoV-2 Main Protease from the Analysis of Large-Scale Molecular Dynamics Simulations.	J Phys Chem Lett
33306235	SARS-CoV-2 infection as a trigger of autoimmune response.	Clin Transl Sci
33306162	Transcriptional profiling of leukocytes in critically ill COVID19 patients: implications for interferon response and coagulation.	Intensive Care Med Exp
33306138	[Endotheliitis in COVID-19].	Pathologe
33305988	Anisotine and amarogentin as promising inhibitory candidates against SARS-CoV-2 proteins: a computational investigation.	J Biomol Struct Dyn
33305919	Insights on Kawasaki disease and multisystem inflammatory syndrome: relationship with COVID-19 infection.	Minerva Pediatr (Torino)
33305832	Thermal inactivation of COVID-19 specimens improves RNA quality and quantity.	J Cell Physiol
33305790	"ACE2, a multifunctional protein - from cardiovascular regulation to COVID-19."	Clin Sci (Lond)
33305712	COVID-19 Severity: Lung-Heart Interplay.	Curr Cardiol Rev
33305659	Clinical stage molecule PT150 is a modulator of glucocorticoid and androgen receptors with antiviral activity against SARS-CoV-2.	Cell Cycle
33305655	"Coronavirus disease 2019 (COVID-19), human erythrocytes and the PKC-alpha/-beta inhibitor chelerythrine -possible therapeutic implication."	Cell Cycle
33305456	"COVID-19: Virology, biology and novel laboratory diagnosis."	J Gene Med
33305306	Structural assessment of SARS-CoV2 accessory protein ORF7a predicts LFA-1 and Mac-1 binding potential.	Biosci Rep
33305304	Structure-aided ACEI-capped remdesivir-loaded novel PLGA nanoparticles: toward a computational simulation design for anti-SARS-CoV-2 therapy.	Phys Chem Chem Phys
33304884	Repurposing Known Drugs as Covalent and Non-covalent Inhibitors of the SARS-CoV-2 Papain-Like Protease.	Front Chem
33304657	Evolutionary dynamics and geographic dispersal of beta coronaviruses in African bats.	PeerJ
33304473	COVID-19 therapy with mesenchymal stromal cells (MSC) and convalescent plasma must consider exosome involvement: Do the exosomes in convalescent plasma antagonize the weak immune antibodies?	J Extracell Vesicles
33304309	Impact of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in the Nervous System: Implications of COVID-19 in Neurodegeneration.	Front Neurol
33304284	How Does SARS-CoV-2 Affect the Central Nervous System? A Working Hypothesis.	Front Psychiatry
33304243	Neuropathobiology of COVID-19: The Role for Glia.	Front Cell Neurosci
33303849	Genomic recombination events may reveal the evolution of coronavirus and the origin of SARS-CoV-2.	Sci Rep
33303686	Phylogenetic analysis of SARS-CoV-2 in Boston highlights the impact of superspreading events.	Science
33303345	How does SARS-CoV-2 targets the elderly patients? A review on potential mechanisms increasing disease severity.	Eur J Intern Med
33303323	The application of DNA polymerases and Cas9 as representative of DNA-modifying enzymes group in DNA sensor design (review).	Biosens Bioelectron
33303307	Could changes in the airborne pollutant particulate matter acting as a viral vector have exerted selective pressure to cause COVID-19 evolution?	Med Hypotheses
33303218	COVID-19 and diabetes: A bidirectional relationship.	Clin Investig Arterioscler
33303190	The biogenesis of SARS-CoV-2 spike glycoprotein: multiple targets for host-directed antiviral therapy.	Biochem Biophys Res Commun
33302853	Silybin B and Cianidanol Inhibit M pro and Spike Protein of SARS-CoV-2: Evidence from in Silico Molecular Docking Studies.	Curr Pharm Des
33302852	Natural Products Homoharringtonine and Emetine Alkaloids for SARSCoV-2 Treatment Options.	Curr Pharm Des
33302737	Protease-activated receptor 1 as a potential therapeutic target for COVID-19.	Exp Biol Med (Maywood)
33302501	"Comprehensive Structural and Molecular Comparison of Spike Proteins of SARS-CoV-2, SARS-CoV and MERS-CoV, and Their Interactions with ACE2."	Cells
33302366	Mechanisms of Dysregulated Humoral and Cellular Immunity by SARS-CoV-2.	Pathogens
33302344	Inhibition of SARS-CoV-2 Entry into Host Cells Using Small Molecules.	Pharmaceuticals (Basel)
33302292	iDMer: an integrative and mechanism-driven response system for identifying compound interventions for sudden virus outbreak.	Brief Bioinform
33302163	A molecular docking study of EGCG and theaflavin digallate with the druggable targets of SARS-CoV-2.	Comput Biol Med
33302033	The deregulated immune reaction and cytokines release storm (CRS) in COVID-19 disease.	Int Immunopharmacol
33301988	Covid-19 pathogenesis in prostatic cancer and TMPRSS2-ERG regulatory genetic pathway.	Infect Genet Evol
33301987	Host range projection of SARS-CoV-2: South Asia perspective.	Infect Genet Evol
33301953	Next-generation computational tools and resources for coronavirus research: From detection to vaccine discovery.	Comput Biol Med
33301863	COVID-19-related myocarditis and cholinergic anti-inflammatory pathways.	Hellenic J Cardiol
33301853	"Rapid, high-yield production of full-length SARS-CoV-2 spike ectodomain by transient gene expression in CHO cells."	J Biotechnol
33301717	FRETing over SARS-CoV-2: Conformational Dynamics of the Spike Glycoprotein.	Cell Host Microbe
33301685	COVID-19: The Effect of Host Genetic Variations on Host-Virus Interactions.	J Proteome Res
33301543	The SARS-CoV-2 ORF10 is not essential in vitro or in vivo in humans.	PLoS Pathog
33301503	CD8 T cell epitope generation toward the continually mutating SARS-CoV-2 spike protein in genetically diverse human population: Implications for disease control and prevention.	PLoS One
33301474	"The transcriptomic profiling of SARS-CoV-2 compared to SARS, MERS, EBOV, and H1N1."	PLoS One
33301441	"Retinoic acid improves baseline barrier function and attenuates TNF-alpha-induced barrier leak in human bronchial epithelial cell culture model, 16HBE 14o."	PLoS One
33300454	Biflavonoids from Rhus succedanea as probable natural inhibitors against SARS-CoV-2: a molecular docking and molecular dynamics approach.	J Biomol Struct Dyn
33300356	Vitamin D may protect against multiple organ damage caused by COVID-19.	Bratisl Lek Listy
33300152	Cellular mechanisms underlying neurological/neuropsychiatric manifestations of COVID-19.	J Med Virol
33300137	Immunohistochemical expression of angiotensin-converting enzyme 2 in minor salivary glands during SARS-CoV-2 infection.	J Med Virol
33300133	Understanding the pathophysiological changes via untargeted metabolomics in COVID-19 patients.	J Med Virol
33299899	Potential Therapeutic Role of Purinergic Receptors in Cardiovascular Disease Mediated by SARS-CoV-2.	J Immunol Res
33299872	Phylogenomics Analysis of SARS-CoV2 Genomes Reveals Distinct Selection Pressure on Different Viral Strains.	Biomed Res Int
33299610	"SARS-CoV-2, Early Entry Events."	J Pathog
33299552	A proposed molecular mechanism for pathogenesis of severe RNA-viral pulmonary infections.	F1000Res
33299503	An Immunoinformatics Study to Predict Epitopes in the Envelope Protein of SARS-CoV-2.	Can J Infect Dis Med Microbiol
33299463	Insights from the Perspective of Traditional Chinese Medicine to Elucidate Association of Lily Disease and Yin Deficiency and Internal Heat of Depression.	Evid Based Complement Alternat Med
33299126	COVID-19 and graft-versus-host disease: a tale of two diseases (and why age matters).	Lab Invest
33298935	Analytical validity of nanopore sequencing for rapid SARS-CoV-2 genome analysis.	Nat Commun
33298930	Temporal and spatial heterogeneity of host response to SARS-CoV-2 pulmonary infection.	Nat Commun
33298900	Heparan sulfate assists SARS-CoV-2 in cell entry and can be targeted by approved drugs in vitro.	Cell Discov
33298875	Initial whole-genome sequencing and analysis of the host genetic contribution to COVID-19 severity and susceptibility.	Cell Discov
33298872	Patient-derived SARS-CoV-2 mutations impact viral replication dynamics and infectivity in vitro and with clinical implications in vivo.	Cell Discov
33298615	A Highly Specific Assay for the Detection of SARS-CoV-2-Reactive CD4(+) and CD8(+) T Cells in COVID-19 Patients.	J Immunol
33298508	Ischemic stroke in COVID-19-positive patients: an overview of SARS-CoV-2 and thrombotic mechanisms for the neurointerventionalist.	J Neurointerv Surg
33297920	Coronavirus Disease 2019: Virology and Drug Targets.	Infect Disord Drug Targets
33297909	"The role of Interleukin-6 in the pathogenesis, prognosis and treatment of severe COVID-19."	Curr Med Chem
33297848	"In vitro antimicrobial, physicochemical, pharmacokinetics and molecular docking studies of benzoyl uridine esters against SARS-CoV-2 main protease."	J Biomol Struct Dyn
33297724	Targeting viral genome synthesis as broad-spectrum approach against RNA virus infections.	Antivir Chem Chemother
33297540	Mechanistic Aspects and Therapeutic Potential of Quercetin against COVID-19-Associated Acute Kidney Injury.	Molecules
33297444	"Lectin Protein as a Promising Component to Functionalize Micelles, Liposomes and Lipid NPs against Coronavirus."	Biomedicines
33297431	Novel Molecular Evidence Related to COVID-19 in Patients with Diabetes Mellitus.	J Clin Med
33296701	Functional SARS-CoV-2-Specific Immune Memory Persists after Mild COVID-19.	Cell
33296687	"Longitudinal Multi-omics Analyses Identify Responses of Megakaryocytes, Erythroid Cells, and Plasmablasts as Hallmarks of Severe COVID-19."	Immunity
33296686	Low-Avidity CD4(+) T Cell Responses to SARS-CoV-2 in Unexposed Individuals and Humans with Severe COVID-19.	Immunity
33296685	SARS-CoV-2 mRNA Vaccines Foster Potent Antigen-Specific Germinal Center Responses Associated with Neutralizing Antibody Generation.	Immunity
33296619	Targeting ACE2 for COVID-19 Therapy: Opportunities and Challenges.	Am J Respir Cell Mol Biol
33296558	A mechanism-based pharmacokinetic model of remdesivir leveraging interspecies scaling to simulate COVID-19 treatment in humans.	CPT Pharmacometrics Syst Pharmacol
33296169	Recent Insights into Emerging Coronavirus: SARS-CoV-2.	ACS Infect Dis
33296106	"COVID-19, microthromboses, inflammation, and platelet activating factor."	Biofactors
33296096	"Expression of ACE2, TMPRSS2, and Furin in Mouse Ear Tissue, and the Implications for SARS-CoV-2 Infection."	Laryngoscope
33295922	Understanding the relationship between viral infections and trace elements from a metallomics perspective: implications for COVID-19.	Metallomics
33295829	Exploring the possible use of saponin adjuvants in COVID-19 vaccine.	Hum Vaccin Immunother
33295677	Prediction of putative epitope-based vaccine against all corona virus strains for the Chinese population: Approach toward development of vaccine.	Microbiol Immunol
33295606	SARS-CoV-2 spike protein binds to bacterial lipopolysaccharide and boosts proinflammatory activity.	J Mol Cell Biol
33295605	Assessing Uncertainty in the Rooting of the SARS-CoV-2 Phylogeny.	Mol Biol Evol
33295584	A glance upon Epigenetic and COVID-19.	An Acad Bras Cienc
33295347	Tracing the driving forces responsible for the remarkable infectivity of 2019-nCoV: 1. Receptor binding domain in its bound and unbound states.	Phys Chem Chem Phys
33295324	"COVID-19, Your Pet and Other Animals: Are You at Risk?"	MEDICC Rev
33295321	SARS-CoV-2 Transmission Channels: A Review of the Literature.	MEDICC Rev
33295095	"Experimental challenge of a North American bat species, big brown bat (Eptesicus fuscus), with SARS-CoV-2."	Transbound Emerg Dis
33294858	A High-Content Screen for Mucin-1-Reducing Compounds Identifies Fostamatinib as a Candidate for Rapid Repurposing for Acute Lung Injury.	Cell Rep Med
33294769	Identification of a SARS-like bat coronavirus that shares structural features with the spike glycoprotein receptor-binding domain of SARS-CoV-2.	Access Microbiol
33294728	Comprehensive in silico identification of impacts of ACE2 SNPs on COVID-19 susceptibility in different populations.	Gene Rep
33294721	"Molecular docking, molecular dynamics, and in vitro studies reveal the potential of angiotensin II receptor blockers to inhibit the COVID-19 main protease."	Heliyon
33294461	The Impact of Diabetes Mellitus in COVID-19: A Mechanistic Review of Molecular Interactions.	J Diabetes Res
33294307	Are losartan and imatinib effective against SARS-CoV2 pathogenesis? A pathophysiologic-based in silico study.	In Silico Pharmacol
33294226	From Radiological Manifestations to Pulmonary Pathogenesis of COVID-19: A Bench to Bedside Review.	Radiol Res Pract
33294034	Coronavirus Disease 2019 and Cardiac Arrhythmias.	Eur Cardiol
33293837	Targeting Polyamine Metabolism for Control of Human Viral Diseases.	Infect Drug Resist
33293664	Older adults lack SARS CoV-2 cross-reactive T lymphocytes directed to human coronaviruses OC43 and NL63.	Sci Rep
33293627	"SARS-CoV-2 receptor ACE2 is co-expressed with genes related to transmembrane serine proteases, viral entry, immunity and cellular stress."	Sci Rep
33293527	A cross-talk between epithelium and endothelium mediates human alveolar-capillary injury during SARS-CoV-2 infection.	Cell Death Dis
33293514	"A blood transcriptome-based analysis of disease progression, immune regulation, and symptoms in coronavirus-infected patients."	Cell Death Discov
33293316	"Study protocol for a multicentre, prospective cohort study of the association of angiotensin II type 1 receptor blockers on outcomes of coronavirus infection."	BMJ Open
33293279	SARS-CoV-2 infection and adverse outcomes in users of ACE inhibitors and angiotensin-receptor blockers: a nationwide case-control and cohort analysis.	Thorax
33293238	SARS-CoV-2: Targeted managements and vaccine development.	Cytokine Growth Factor Rev
33292846	Autonomic balance determines the severity of COVID-19 courses.	Bioelectron Med
33292691	Nrf2-interacting nutrients and COVID-19: time for research to develop adaptation strategies.	Clin Transl Allergy
33292385	Exploring active ingredients and function mechanisms of Ephedra-bitter almond for prevention and treatment of Corona virus disease 2019 (COVID-19) based on network pharmacology.	BioData Min
33292333	SARS-CoV-2 and mitochondrial health: implications of lifestyle and ageing.	Immun Ageing
33292147	Evaluation of the Binding Affinity of Anti-Viral Drugs against Main Protease of SARS-CoV-2 through a Molecular Docking Study.	Infect Disord Drug Targets
33292135	Docking Paradigm in Drug Design.	Curr Top Med Chem
33292134	An Updated Review on SARS-CoV-2 Main Proteinase (M(Pro)): Protein Structure and Small-Molecule Inhibitors.	Curr Top Med Chem
33292131	Expression and Clinical Significance of SARS-CoV-2 Human Targets in Neoplastic and Non-Neoplastic Lung Tissues.	Curr Cancer Drug Targets
33292107	Metabolism and Interactions of Chloroquine and Hydroxychloroquine with Human Cytochrome P450 Enzymes and Drug Transporters.	Curr Drug Metab
33292085	Depicting the inhibitory potential of polyphenols from Isatis indigotica root against the main protease of SARS CoV-2 using computational approaches.	J Biomol Struct Dyn
33292056	Sensing the interactions between carbohydrate-binding agents and N-linked glycans of SARS-CoV-2 spike glycoprotein using molecular docking and simulation studies.	J Biomol Struct Dyn
33291769	"Interrelated Mechanism by Which the Methide Quinone Celastrol, Obtained from the Roots of Tripterygium wilfordii, Inhibits Main Protease 3CL(pro) of COVID-19 and Acts as Superoxide Radical Scavenger."	Int J Mol Sci
33291713	Early Humoral Response Correlates with Disease Severity and Outcomes in COVID-19 Patients.	Viruses
33291642	FDA-Approved Drugs with Potent In Vitro Antiviral Activity against Severe Acute Respiratory Syndrome Coronavirus 2.	Pharmaceuticals (Basel)
33291560	Anti-Viral Potential and Modulation of Nrf2 by Curcumin: Pharmacological Implications.	Antioxidants (Basel)
33291455	"IMU-838, a Developmental DHODH Inhibitor in Phase II for Autoimmune Disease, Shows Anti-SARS-CoV-2 and Broad-Spectrum Antiviral Efficacy In Vitro."	Viruses
33291346	The Contribution of Endothelial Dysfunction in Systemic Injury Subsequent to SARS-Cov-2 Infection.	Int J Mol Sci
33291299	Multiple SARS-CoV-2 Introductions Shaped the Early Outbreak in Central Eastern Europe: Comparing Hungarian Data to a Worldwide Sequence Data-Matrix.	Viruses
33290972	In silico screening of potential anti-COVID-19 bioactive natural constituents from food sources by molecular docking.	Nutrition
33290963	Neutrophils and COVID-19: The road so far.	Int Immunopharmacol
33290786	Genomic and evolutionary comparison between SARS-CoV-2 and other human coronaviruses.	J Virol Methods
33290767	Assessment of antiviral potencies of cannabinoids against SARS-CoV-2 using computational and in vitro approaches.	Int J Biol Macromol
33290746	Genomic RNA Elements Drive Phase Separation of the SARS-CoV-2 Nucleocapsid.	Mol Cell
33290743	MINERVA: A Facile Strategy for SARS-CoV-2 Whole-Genome Deep Sequencing of Clinical Samples.	Mol Cell
33290594	Outcome of patients hospitalized for Covid-19 and exposure to angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers in France: Results of the ACECoV study.	Fundam Clin Pharmacol
33290571	COVID-19 Vaccines: A Primer for Clinicians.	Pediatr Ann
33290476	Role of different tautomers in the base-pairing abilities of some of the vital antiviral drugs used against COVID-19.	Phys Chem Chem Phys
33290397	Targeting TMPRSS2 and Cathepsin B/L together may be synergistic against SARS-CoV-2 infection.	PLoS Comput Biol
33290288	Eye Diseases Direct Interest to Complement Pathway and Macrophages as Regulators of Inflammation in COVID-19.	Asia Pac J Ophthalmol (Phila)
33290272	Battle for supremacy: nucleic acid interactions between viruses and cells.	J Clin Invest
33290144	Identification of SARS-CoV-2 Proteins Binding Human mRNAs As a Novel Signature Predicting Overall Survival in Hepatocellular Carcinoma.	DNA Cell Biol
33289868	Can SARS-CoV-2 infect the eye? An overview of the receptor status in ocular tissue.	Ophthalmologe
33289808	Asymptomatic SARS-CoV-2 infection: is it all about being refractile to innate immune sensing of viral spare-parts?-Clues from exotic animal reservoirs.	Pathog Dis
33289787	COVID-19 stokes inflammasomes.	J Exp Med
33289456	Virtual screening of phytoconstituents from miracle herb nigella sativa targeting nucleocapsid protein and papain-like protease of SARS-CoV-2 for COVID-19 treatment.	J Biomol Struct Dyn
33289334	Repurposing potential of FDA-approved and investigational drugs for COVID-19 targeting SARS-CoV-2 spike and main protease and validation by machine learning algorithm.	Chem Biol Drug Des
33289321	Tracing the path of inhaled nitric oxide: Biological consequences of protein nitrosylation.	Pediatr Pulmonol
33289233	Alimentary system is directly attacked by SARS-COV-2 and further prevents immune dysregulation caused by COVID-19.	Int J Clin Pract
33289207	Antigenic variation of SARS-CoV-2 in response to immune pressure.	Mol Ecol
33289192	Dysregulation of the immune response in coronavirus disease 2019.	Cell Biol Int
33289169	Neutrophils mediate Th17 promotion in COVID-19 patients.	J Leukoc Biol
33289122	Hidden in plain sight: The effects of BCG vaccination in the COVID-19 pandemic.	J Med Virol
33289002	Enhancement of the IFN-beta-induced host signature informs repurposed drugs for COVID-19.	Heliyon
33288836	Baculovirus-free insect cell expression system for high yield antibody and antigen production.	Sci Rep
33288662	IgA dominates the early neutralizing antibody response to SARS-CoV-2.	Sci Transl Med
33288661	Enhanced SARS-CoV-2 neutralization by dimeric IgA.	Sci Transl Med
33288645	Defining the features and duration of antibody responses to SARS-CoV-2 infection associated with disease severity and outcome.	Sci Immunol
33288200	The main protease and RNA-dependent RNA polymerase are two prime targets for SARS-CoV-2.	Biochem Biophys Res Commun
33287945	A comprehensive review of histopathological findings of infections induced by COVID-19.	Cell Mol Biol (Noisy-le-grand)
33287717	"Molecular epidemiology of SARS-CoV-2 clusters caused by asymptomatic cases in Anhui Province, China."	BMC Infect Dis
33287462	Vitamin C and Cardiovascular Disease: An Update.	Antioxidants (Basel)
33287311	"Geranii Herba as a Potential Inhibitor of SARS-CoV-2 Main 3CL(pro), Spike RBD, and Regulation of Unfolded Protein Response: An In Silico Approach."	Antibiotics (Basel)
33287245	Persistent Detection and Infectious Potential of SARS-CoV-2 Virus in Clinical Specimens from COVID-19 Patients.	Viruses
33287144	Targeting the RdRp of Emerging RNA Viruses: The Structure-Based Drug Design Challenge.	Molecules
33285567	Design of an epitope-based peptide vaccine against the SARS-CoV-2: a vaccine-informatics approach.	Brief Bioinform
33285566	Key residues influencing binding affinities of 2019-nCoV with ACE2 in different species.	Brief Bioinform
33285430	An insight into the interaction between alpha-ketoamide- based inhibitor and coronavirus main protease: A detailed in silico study.	Biophys Chem
33284956	ACE2: from protection of liver disease to propagation of COVID-19.	Clin Sci (Lond)
33284859	SARS-CoV-2 spike protein promotes IL-6 trans-signaling by activation of angiotensin II receptor signaling in epithelial cells.	PLoS Pathog
33284849	Infection of human Nasal Epithelial Cells with SARS-CoV-2 and a 382-nt deletion isolate lacking ORF8 reveals similar viral kinetics and host transcriptional profiles.	PLoS Pathog
33284827	Alignment of virus-host protein-protein interaction networks by integer linear programming: SARS-CoV-2.	PLoS One
33284795	In silico mutagenesis of human ACE2 with S protein and translational efficiency explain SARS-CoV-2 infectivity in different species.	PLoS Comput Biol
33284413	Endotoxemia and circulating bacteriome in severe COVID-19 patients.	Intensive Care Med Exp
33284134	Metabolic reprogramming and epigenetic changes of vital organs in SARS-CoV-2-induced systemic toxicity.	JCI Insight
33284049	The receptor for advanced glycation end product (RAGE) pathway in COVID-19.	Biomarkers
33283984	A Quick Route to Multiple Highly Potent SARS-CoV-2 Main Protease Inhibitors*.	ChemMedChem
33283765	Novel therapeutic approaches toward Hantaan virus and its clinical features' similarity with COVID-19.	Indian J Pharmacol
33283618	Differences in RAAS/vitamin D linked to genetics and socioeconomic factors could explain the higher mortality rate in African Americans with COVID-19.	Ther Adv Cardiovasc Dis
33283602	"Angiotensin-converting enzyme 2, the complement system, the kallikrein-kinin system, type-2 diabetes, interleukin-6, and their interactions regarding the complex COVID-19 pathophysiological crossroads."	J Renin Angiotensin Aldosterone Syst
33283287	An organoid-derived bronchioalveolar model for SARS-CoV-2 infection of human alveolar type II-like cells.	EMBO J
33283188	"The Intersection between COVID-19, the Gene Family of ACE2 and Alzheimer's Disease."	Neurosci Insights
33283177	Remdesivir Is Effective in Combating COVID-19 because It Is a Better Substrate than ATP for the Viral RNA-Dependent RNA Polymerase.	iScience
33283104	SSSCPreds: Deep Neural Network-Based Software for the Prediction of Conformational Variability and Application to SARS-CoV-2.	ACS Omega
33283062	Proteins from SARS-CoV-2 reduce T cell proliferation: A mirror image of sepsis.	Heliyon
33283030	Selection of animal models for COVID-19 research.	Virusdisease
33282890	"Clinical Characteristics, Diagnosis, and Treatment of Major Coronavirus Outbreaks."	Front Med (Lausanne)
33282694	Animal coronaviruses and coronavirus disease 2019: Lesson for One Health approach.	Open Vet J
33282690	SARS-CoV-2 effects in the genitourinary system and prospects of sex hormone therapy.	Asian J Urol
33282445	SARS-CoV-2 induced intestinal responses with a biomimetic human gut-on-chip.	Sci Bull (Beijing)
33282419	Micro-RNAs in the regulation of immune response against SARS CoV-2 and other viral infections.	J Adv Res
33282201	Pulmonary vasodilators: beyond the bounds of pulmonary arterial hypertension therapy in COVID-19.	Pulm Circ
33282193	Circulating markers of angiogenesis and endotheliopathy in COVID-19.	Pulm Circ
33282147	ACE2 partially dictates the host range and tropism of SARS-CoV-2.	Comput Struct Biotechnol J
33282075	Coronavirus Disease 2019 (COVID-19) set to increase burden of atherosclerotic cardiovascular disease in Kenya.	Pan Afr Med J
33281941	The gut microbiome: an under-recognised contributor to the COVID-19 pandemic?	Therap Adv Gastroenterol
33281876	Identification of Potential Key Agents for Targeting RNA-Dependent RNA Polymerase of SARS-CoV-2 by Integrated Analysis and Virtual Drug Screening.	Front Genet
33281824	Development of Patient-Derived Human Monoclonal Antibodies Against Nucleocapsid Protein of Severe Acute Respiratory Syndrome Coronavirus 2 for Coronavirus Disease 2019 Diagnosis.	Front Immunol
33281748	SARS-CoV-2 Receptor Angiotensin I-Converting Enzyme Type 2 (ACE2) Is Expressed in Human Pancreatic beta-Cells and in the Human Pancreas Microvasculature.	Front Endocrinol (Lausanne)
33281479	Exploring human-animal host interactions and emergence of COVID-19: Evolutionary and ecological dynamics.	Saudi J Biol Sci
33281478	The potential of Paritaprevir and Emetine as inhibitors of SARS-CoV-2 RdRp.	Saudi J Biol Sci
33281325	Pathophysiological Mechanisms and Neurological Manifestations in COVID-19.	Indian J Crit Care Med
33281323	Mechanisms of Hypoxia in COVID-19 Patients: A Pathophysiologic Reflection.	Indian J Crit Care Med
33281252	Modeling and simulations of CoViD-19 molecular mechanism induced by cytokines storm during SARS-CoV2 infection.	J Mol Liq
33281125	Cardiovascular manifestations of COVID-19: An evidence-based narrative review.	Indian J Med Res
33281063	Combining Antivirals and Immunomodulators to Fight COVID-19.	Trends Immunol
33280254	Little to no expression of angiotensin-converting enzyme-2 on most human peripheral blood immune cells but highly expressed on tissue macrophages.	Cytometry A
33280062	Determinants of soluble angiotensin-converting enzyme 2 concentrations in adult patients with complex congenital heart disease.	Clin Res Cardiol
33280009	"Association of Neutrophil Activation, More Than Platelet Activation, With Thrombotic Complications in Coronavirus Disease 2019."	J Infect Dis
33279989	"Next generation sequencing of SARS-CoV-2 genomes: challenges, applications and opportunities."	Brief Bioinform
33279857	Prophylactic intranasal administration of a TLR2/6 agonist reduces upper respiratory tract viral shedding in a SARS-CoV-2 challenge ferret model.	EBioMedicine
33279630	Lesions in the lungs of fatal corona virus disease Covid-19.	Ann Anat
33278734	SARS-CoV-2 replicates in respiratory ex vivo organ cultures of domestic ruminant species.	Vet Microbiol
33278618	Higher pharyngeal epithelial gene expression of angiotensin-converting Enzyme-2 in patients with upper respiratory infection.	Int J Infect Dis
33278517	The interplay between inflammatory pathways and COVID-19: A critical review on pathogenesis and therapeutic options.	Microb Pathog
33278516	ACE2 and TMPRSS2 polymorphisms in various diseases with special reference to its impact on COVID-19 disease.	Microb Pathog
33278462	2-Pyridone natural products as inhibitors of SARS-CoV-2 main protease.	Chem Biol Interact
33278358	Baricitinib treatment resolves lower-airway macrophage inflammation and neutrophil recruitment in SARS-CoV-2-infected rhesus macaques.	Cell
33278357	"Synergism of TNF-alpha and IFN-gamma Triggers Inflammatory Cell Death, Tissue Damage, and Mortality in SARS-CoV-2 Infection and Cytokine Shock Syndromes."	Cell
33278189	Is Spironolactone the Preferred Renin-Angiotensin-Aldosterone Inhibitor for Protection Against COVID-19?	J Cardiovasc Pharmacol
33278160	Hidden in plain sight: sex and gender in global pandemics.	Curr Opin HIV AIDS
33277988	Severe Acute Respiratory Syndrome Coronavirus 2-Induced Immune Activation and Death of Monocyte-Derived Human Macrophages and Dendritic Cells.	J Infect Dis
33277640	"Host genetics and infectious disease: new tools, insights and translational opportunities."	Nat Rev Genet
33277638	Untuned antiviral immunity in COVID-19 revealed by temporal type I/III interferon patterns and flu comparison.	Nat Immunol
33277466	CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells.	Signal Transduct Target Ther
33277453	"Angiotensin Converting Enzyme Inhibitors, A Risk Factor of Poor Outcome in Diabetic Patients with COVID-19 Infection."	Iran J Kidney Dis
33277388	"Cutting Edge: Severe SARS-CoV-2 Infection in Humans Is Defined by a Shift in the Serum Lipidome, Resulting in Dysregulation of Eicosanoid Immune Mediators."	J Immunol
33277373	B careful: Humoral responses and COVID-19 severity.	Sci Immunol
33277323	Conformational dynamics of SARS-CoV-2 trimeric spike glycoprotein in complex with receptor ACE2 revealed by cryo-EM.	Sci Adv
33277181	T Cells: Warriors of SARS-CoV-2 Infection.	Trends Immunol
33277150	Potential roles of micronutrient deficiency and immune system dysfunction in the coronavirus disease 2019 (COVID-19) pandemic.	Nutrition
33277106	Can chloroquine/hydroxychloroquine prove efficient in cancer cachexia? A hypothesis in the era of COVID-19.	Med Hypotheses
33276953	Molecular docking of potential SARS-CoV-2 papain-like protease inhibitors.	Biochem Biophys Res Commun
33276951	Dual ELISA using SARS-CoV-2 nucleocapsid protein produced in E. coli and CHO cells reveals epitope masking by N-glycosylation.	Biochem Biophys Res Commun
33276369	Correlates of protection against SARS-CoV-2 in rhesus macaques.	Nature
33276356	[The Challenges of Vaccine Development Against Betacoronaviruses: Antibody Dependent Enhancement and Sendai Virus as a Possible Vaccine Vector].	Mol Biol (Mosk)
33276297	DBCOVP: A database of coronavirus virulent glycoproteins.	Comput Biol Med
33276282	Effect of SARS-CoV-2 coinfection was not apparent on the dynamics of chronic hepatitis B infection.	Virology
33276271	Techniques assisting peptide vaccine and peptidomimetic design. Sidechain exposure in the SARS-CoV-2 spike glycoprotein.	Comput Biol Med
33275999	"A comprehensive guide to the pharmacologic regulation of angiotensin converting enzyme 2 (ACE2), the SARS-CoV-2 entry receptor."	Pharmacol Ther
33275961	Drug designing against NSP15 of SARS-COV2 via high throughput computational screening and structural dynamics approach.	Eur J Pharmacol
33275900	Evaluating the Effects of SARS-CoV-2 Spike Mutation D614G on Transmissibility and Pathogenicity.	Cell
33275899	Modeling Multi-organ Infection by SARS-CoV-2 Using Stem Cell Technology.	Cell Stem Cell
33275896	Nanoparticle Vaccines Based on the Receptor Binding Domain (RBD) and Heptad Repeat (HR) of SARS-CoV-2 Elicit Robust Protective Immune Responses.	Immunity
33275640	A natural mutation between SARS-CoV-2 and SARS-CoV determines neutralization by a cross-reactive antibody.	PLoS Pathog
33275540	"SARS-CoV-2, ACE2 expression, and systemic organ invasion."	Physiol Genomics
33275517	"Sex differences in COVID-19: candidate pathways, genetics of ACE2, and sex hormones."	Am J Physiol Heart Circ Physiol
33275493	Multiscale Feedback Loops in SARS-CoV-2 Viral Evolution.	J Comput Biol
33275483	"Retracted: A Study of Potential SARS-CoV-2 Antiviral Drugs and Preliminary Research of Their Molecular Mechanism, Based on Anti-SARS-CoV Drug Screening and Molecular Dynamics Simulation."	J Comput Biol
33275432	Water-Repellent TiO2-Organic Dye-Based Air Filters for Efficient Visible-Light-Activated Photochemical Inactivation against Bioaerosols.	Nano Lett
33275410	One-Enzyme Reverse Transcription qPCR Using Taq DNA Polymerase.	Biochemistry
33275404	Deleterious Outcomes in Long-Hauler COVID-19: The Effects of SARS-CoV-2 on the CNS in Chronic COVID Syndrome.	ACS Chem Neurosci
33275129	Human induced pluripotent stem cells as a tool for disease modeling and drug screening for COVID-19.	Genet Mol Biol
33274949	"Deciphering the Molecular Details of the Lipoxin Formation Mechanism in the 5(S),15(S)-DiHpETE Biosynthetic Pathway Catalyzed by Reticulocyte 15-Lipoxygenase-1."	J Phys Chem B
33274945	Computational Insights into the Conformational Accessibility and Binding Strength of SARS-CoV-2 Spike Protein to Human Angiotensin-Converting Enzyme 2.	J Phys Chem Lett
33274614	"Origin, evolution and global spread of SARS-CoV-2."	C R Biol
33274348	"CovMulNet19, Integrating Proteins, Diseases, Drugs, and Symptoms: A Network Medicine Approach to COVID-19."	Netw Syst Med
33274259	"Association of COVID-19 and other viral infections with interstitial lung diseases, pulmonary fibrosis, and pulmonary hypertension: A narrative review."	Can J Respir Ther
33274246	Multiepitope Subunit Vaccine Design against COVID-19 Based on the Spike Protein of SARS-CoV-2: An In Silico Analysis.	J Immunol Res
33274196	Prognostic Significance of COVID-19 Receptor ACE2 and Recommendation for Antihypertensive Drug in Renal Cell Carcinoma.	Biomed Res Int
33274180	An Experimental Model for Peri-conceptual COVID-19 Pregnancy Loss and Proposed Interventions to Optimize Outcomes.	Int J Mol Cell Med
33274176	Therapeutic Potential of Mesenchymal Stem Cells and Their Secretome in the Treatment of SARS-CoV-2-Induced Acute Respiratory Distress Syndrome.	Anal Cell Pathol (Amst)
33273962	Randomness for Nucleotide Sequences of SARS-CoV-2 and Its Related Subfamilies.	Comput Math Methods Med
33273723	Evolutionary and structural analysis of SARS-CoV-2 specific evasion of host immunity.	Genes Immun
33273695	Primidone blocks RIPK1-driven cell death and inflammation.	Cell Death Differ
33273140	"First COVID-19 molecular docking with a chalcone-based compound: synthesis, single-crystal structure and Hirshfeld surface analysis study."	Acta Crystallogr C Struct Chem
33272571	Structural stability of SARS-CoV-2 virus like particles degrades with temperature.	Biochem Biophys Res Commun
33272568	Evolutionary and structural analysis elucidates mutations on SARS-CoV2 spike protein with altered human ACE2 binding affinity.	Biochem Biophys Res Commun
33272291	The dysregulated innate immune response in severe COVID-19 pneumonia that could drive poorer outcome.	J Transl Med
33272178	Therapeutic Measures for the Novel Coronavirus: A Review of Current Status and Future Perspective.	Curr Mol Med
33272175	Molecular characterization of SARS-CoV-2.	Curr Mol Med
33271925	Establishment of Murine Hybridoma Cells Producing Antibodies against Spike Protein of SARS-CoV-2.	Int J Mol Sci
33271804	Transcriptional Differences for COVID-19 Disease Map Genes between Males and Females Indicate a Different Basal Immunophenotype Relevant to the Disease.	Genes (Basel)
33271780	Covid-19-Associated Pulmonary Aspergillosis: The Other Side of the Coin.	Vaccines (Basel)
33271762	Non-Coding RNAs and SARS-Related Coronaviruses.	Viruses
33271751	Identification of Persuasive Antiviral Natural Compounds for COVID-19 by Targeting Endoribonuclease NSP15: A Structural-Bioinformatics Approach.	Molecules
33271682	Neuropsychiatric manifestations of COVID-19 and possible pathogenic mechanisms: Insights from other coronaviruses.	Asian J Psychiatr
33271226	Effects of nitrite and far-red light on coagulation.	Nitric Oxide
33271151	Investigation of beta-lactoglobulin derived bioactive peptides against SARS-CoV-2 (COVID-19): In silico analysis.	Eur J Pharmacol
33271067	Cryo-EM Structures of SARS-CoV-2 Spike without and with ACE2 Reveal a pH-Dependent Switch to Mediate Endosomal Positioning of Receptor-Binding Domains.	Cell Host Microbe
33271063	The Roborovski Dwarf Hamster Is A Highly Susceptible Model for a Rapid and Fatal Course of SARS-CoV-2 Infection.	Cell Rep
33270927	Opposing activities of IFITM proteins in SARS-CoV-2 infection.	EMBO J
33270726	Principal component analysis of coronaviruses reveals their diversity and seasonal and pandemic potential.	PLoS One
33270653	Insights on cross-species transmission of SARS-CoV-2 from structural modeling.	PLoS Comput Biol
33270594	BIOCHEMICAL ASPECTS OF SYMPTOMATIC TREATMENT IN PATIENTS WITH COVID-19 (REVIEW).	Georgian Med News
33270413	Non-Receptor-Mediated Lipid Membrane Permeabilization by the SARS-CoV-2 Spike Protein S1 Subunit.	ACS Appl Mater Interfaces
33270351	Pathways to Severe COVID-19 for People with Obesity.	Obesity (Silver Spring)
33270159	"(1)H, (13)C, and (15)N backbone chemical shift assignments of the C-terminal dimerization domain of SARS-CoV-2 nucleocapsid protein."	Biomol NMR Assign
33270134	Absence of SARS-CoV-2 neutralizing activity in pre-pandemic sera from individuals with recent seasonal coronavirus infection.	Clin Infect Dis
33270111	GENCODE 2021.	Nucleic Acids Res
33270024	Therapeutic targeting of interleukin-6 for the treatment of COVID-19.	Eur Cytokine Netw
33269932	Molecular Dynamics Reveals Complex Compensatory Effects of Ionic Strength on the Severe Acute Respiratory Syndrome Coronavirus 2 Spike/Human Angiotensin-Converting Enzyme 2 Interaction.	J Phys Chem Lett
33269805	How SARS-CoV-2 (COVID-19) spreads within infected hosts - what we know so far.	Emerg Top Life Sci
33269412	The human coronaviruses (HCoVs) and the molecular mechanisms of SARS-CoV-2 infection.	J Mol Med (Berl)
33269102	"COVID-19 in Elderly Adults: Clinical Features, Molecular Mechanisms, and Proposed Strategies."	Aging Dis
33269094	Innate and Adaptive Immunity in Aging and Longevity: The Foundation of Resilience.	Aging Dis
33269092	COVID-19 and Acute Sarcopenia.	Aging Dis
33268588	Research progress in nervous system damage caused by SARS-CoV-2.	Zhong Nan Da Xue Xue Bao Yi Xue Ban
33268587	Progress in the study on COVID-19-related renal injury.	Zhong Nan Da Xue Xue Bao Yi Xue Ban
33268522	Identification of HLA-A*02:01-restricted candidate epitopes derived from the non-structural polyprotein 1a of SARS-CoV-2 that may be natural targets of CD8(+) T cell recognition in vivo.	J Virol
33268519	The global and local distribution of RNA structure throughout the SARS-CoV-2 genome.	J Virol
33268501	The viral protein NSP1 acts as a ribosome gatekeeper for shutting down host translation and fostering SARS-CoV-2 translation.	RNA
33268377	Priming of SARS-CoV-2 S protein by several membrane-bound serine proteinases could explain enhanced viral infectivity and systemic COVID-19 infection.	J Biol Chem
33267999	COVID-19: A double threat to takotsubo cardiomyopathy and spontaneous coronary artery dissection?	Med Hypotheses
33267767	Covid-19: Urgent Call to Action.	Antiinflamm Antiallergy Agents Med Chem
33267713	"COMPARE Analysis, a Bioinformatic Approach to Accelerate Drug Repurposing against Covid-19 and Other Emerging Epidemics."	SLAS Discov
33267662	Circulating Markers of Neutrophil Extracellular Traps Are of Prognostic Value in Patients With COVID-19.	Arterioscler Thromb Vasc Biol
33267656	Patients With COVID-19 Have Elevated Levels of Circulating Extracellular Vesicle Tissue Factor Activity That Is Associated With Severity and Mortality-Brief Report.	Arterioscler Thromb Vasc Biol
33266135	Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: Triggering a Lethal Fight to Keep Control of the Ten-Eleven Translocase (TET)-Associated DNA Demethylation?	Pathogens
33265982	Modeling the Molecular Impact of SARS-CoV-2 Infection on the Renin-Angiotensin System.	Viruses
33265927	SARS-CoV-2 Inhibition by Sulfonated Compounds.	Microorganisms
33264669	"The dynamic association between COVID-19 and chronic disorders: An updated insight into prevalence, mechanisms and therapeutic modalities."	Infect Genet Evol
33264668	Scrutinizing the SARS-CoV-2 protein information for designing an effective vaccine encompassing both the T-cell and B-cell epitopes.	Infect Genet Evol
33264497	The structural basis of accelerated host cell entry by SARS-CoV-2dagger.	FEBS J
33264436	Spheroids and organoids as humanized 3D scaffold-free engineered tissues for SARS-CoV-2 viral infection and drug screening.	Artif Organs
33264412	ACE2 in the renin-angiotensin system.	Clin Sci (Lond)
33264393	Translational control of coronaviruses.	Nucleic Acids Res
33264373	Structural basis of RNA recognition by the SARS-CoV-2 nucleocapsid phosphoprotein.	PLoS Pathog
33264345	In silico immune infiltration profiling combined with functional enrichment analysis reveals a potential role for naive B cells as a trigger for severe immune responses in the lungs of COVID-19 patients.	PLoS One
33264073	Lymphocyte Subset Alteration and Monocyte CD4 Expression Reduction in Patients with Severe COVID-19.	Viral Immunol
33264025	Remdesivir Strongly Binds to Both RNA-Dependent RNA Polymerase and Main Protease of SARS-CoV-2: Evidence from Molecular Simulations.	J Phys Chem B
33263756	Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) Antibody Responses in Children With Multisystem Inflammatory Syndrome in Children (MIS-C) and Mild and Severe Coronavirus Disease 2019 (COVID-19).	J Pediatric Infect Dis Soc
33263691	In silico analysis of mismatches in RT-qPCR assays of 177 SARS-CoV-2 sequences from Brazil.	Rev Soc Bras Med Trop
33263384	Comparative Multiplexed Interactomics of SARS-CoV-2 and Homologous Coronavirus Nonstructural Proteins Identifies Unique and Shared Host-Cell Dependencies.	ACS Infect Dis
33263093	Gene expression profiling of corona virus microarray datasets to identify crucial targets in COVID-19 patients.	Gene Rep
33263073	Decoding information on COVID-19: Ontological approach towards design possible therapeutics.	Inform Med Unlocked
33262993	Dynamics of CD4 T Cell and Antibody Responses in COVID-19 Patients With Different Disease Severity.	Front Med (Lausanne)
33262955	A Testimony of the Surgent SARS-CoV-2 in the Immunological Panorama of the Human Host.	Front Cell Infect Microbiol
33262895	Genomic characterization of SARS-CoV-2 in Egypt.	J Adv Res
33262894	New Consensus pattern in Spike CoV-2: potential implications in coagulation process and cell-cell fusion.	Cell Death Discov
33262810	Interleukin-6 signaling blockade treatment for cytokine release syndrome in COVID-19 (Review).	Exp Ther Med
33262797	A Novel Coronavirus Disease (COVID-19): a Review of Host Cell Signaling Pathways.	Tanaffos
33262747	Current and Future Direct-Acting Antivirals Against COVID-19.	Front Microbiol
33262663	Antiviral Effects of Oleandrin.	J Exp Pharmacol
33262453	Dalbavancin binds ACE2 to block its interaction with SARS-CoV-2 spike protein and is effective in inhibiting SARS-CoV-2 infection in animal models.	Cell Res
33262452	Rational development of a human antibody cocktail that deploys multiple functions to confer Pan-SARS-CoVs protection.	Cell Res
33262359	"Targeting the coronavirus SARS-CoV-2: computational insights into the mechanism of action of the protease inhibitors lopinavir, ritonavir and nelfinavir."	Sci Rep
33262177	Why is COVID-19 less severe in children? A review of the proposed mechanisms underlying the age-related difference in severity of SARS-CoV-2 infections.	Arch Dis Child
33262017	Understanding COVID - 19 pandemic - A comprehensive Ayurvedic perspective.	J Ayurveda Integr Med
33261847	"Synthesis, molecular docking, and in silico ADME/Tox profiling studies of new 1-aryl-5-(3-azidopropyl)indol-4-ones: Potential inhibitors of SARS CoV-2 main protease."	Bioorg Chem
33261718	"Intrafamilial Exposure to SARS-CoV-2 Associated with Cellular Immune Response without Seroconversion, France."	Emerg Infect Dis
33261606	SARS coronavirus 2: from genome to infectome.	Respir Res
33261583	Specific dynamic variations in the peripheral blood lymphocyte subsets in COVID-19 and severe influenza A patients: a retrospective observational study.	BMC Infect Dis
33260592	Carnosine to Combat Novel Coronavirus (nCoV): Molecular Docking and Modeling to Cocrystallized Host Angiotensin-Converting Enzyme 2 (ACE2) and Viral Spike Protein.	Molecules
33260370	Repositioning of Ligands That Target the Spike Glycoprotein as Potential Drugs for SARS-CoV-2 in an In Silico Study.	Molecules
33260195	A single-dose live-attenuated YF17D-vectored SARS-CoV-2 vaccine candidate.	Nature
33260103	Mechanistic insight on the remdesivir binding to RNA-Dependent RNA polymerase (RdRp) of SARS-cov-2.	Comput Biol Med
33260035	"Determining crucial genes associated with COVID-19 based on COPD Findings(sextile,sextilesextile)."	Comput Biol Med
33260034	"Comparative transcriptome analysis of SARS-CoV, MERS-CoV, and SARS-CoV-2 to identify potential pathways for drug repurposing."	Comput Biol Med
33259924	"Scope of adjuvant therapy using roflumilast, a PDE-4 inhibitor against COVID-19."	Pulm Pharmacol Ther
33259879	Evolution and genetic diversity of SARS-CoV-2 in Africa using whole genome sequences.	Int J Infect Dis
33259846	Mendelian randomization analysis identified genes pleiotropically associated with the risk and prognosis of COVID-19.	J Infect
33259815	Cutaneous Manifestations in Patients With COVID-19: Clinical Characteristics and Possible Pathophysiologic Mechanisms.	Actas Dermosifiliogr (Engl Ed)
33259812	Actionable Cytopathogenic Host Responses of Human Alveolar Type 2 Cells to SARS-CoV-2.	Mol Cell
33259809	The Short- and Long-Range RNA-RNA Interactome of SARS-CoV-2.	Mol Cell
33259798	Direct Exposure to SARS-CoV-2 and Cigarette Smoke Increases Infection Severity and Alters the Stem Cell-Derived Airway Repair Response.	Cell Stem Cell
33259788	Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody Recognition.	Cell Host Microbe
33259596	Effect of Bruton tyrosine kinase inhibitor on efficacy of adjuvanted recombinant hepatitis B and zoster vaccines.	Blood
33259031	"Beta- and Novel Delta-Coronaviruses Are Identified from Wild Animals in the Qinghai-Tibetan Plateau, China."	Virol Sin
33258925	A pocket guide on how to structure SARS-CoV-2 drugs and therapies.	Biochem Soc Trans
33258903	The zoonotic potential of bat-borne coronaviruses.	Emerg Top Life Sci
33258165	Viral nucleoprotein antibodies activate TRIM21 and induce T cell immunity.	EMBO J
33257936	"Effect of D614G Spike Variant on Immunoglobulin G, M, or A Spike Seroassay Performance."	J Infect Dis
33257876	Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19.	Nat Neurosci
33257775	Depletion of circulating IgM memory B cells predicts unfavourable outcome in COVID-19.	Sci Rep
33257774	Investigation of COVID-19 comorbidities reveals genes and pathways coincident with the SARS-CoV-2 viral disease.	Sci Rep
33257760	Conserved interactions required for inhibition of the main protease of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).	Sci Rep
33257716	Immunoinformatic design of a COVID-19 subunit vaccine using entire structural immunogenic epitopes of SARS-CoV-2.	Sci Rep
33257686	Development of a multi-antigenic SARS-CoV-2 vaccine candidate using a synthetic poxvirus platform.	Nat Commun
33257679	Lethality of SARS-CoV-2 infection in K18 human angiotensin-converting enzyme 2 transgenic mice.	Nat Commun
33257624	Involvement of the exocrine pancreas during COVID-19 infection and possible pathogenetic hypothesis: a concise review.	Infez Med
33257622	Viral dynamics in the Upper Respiratory Tract (URT) of SARS-CoV-2.	Infez Med
33257540	A highly immunogenic and effective measles virus-based Th1-biased COVID-19 vaccine.	Proc Natl Acad Sci U S A
33257477	A Versatile Reporter System To Monitor Virus-Infected Cells and Its Application to Dengue Virus and SARS-CoV-2.	J Virol
33257107	Biomolecular endotype factors involved in COVID-19 airway infectivity: A systematic review.	Auris Nasus Larynx
33257090	COVID-19's toll on the elderly and those with diabetes mellitus - Is vitamin B12 deficiency an accomplice?	Med Hypotheses
33256890	IgG Seroconversion and Pathophysiology in Severe Acute Respiratory Syndrome Coronavirus 2 Infection.	Emerg Infect Dis
33256833	Detection of viral RNA fragments in human iPSC cardiomyocytes following treatment with extracellular vesicles from SARS-CoV-2 coding sequence overexpressing lung epithelial cells.	Stem Cell Res Ther
33256807	Pervasive generation of non-canonical subgenomic RNAs by SARS-CoV-2.	Genome Med
33256749	LMWF5A suppresses cytokine release by modulating select inflammatory transcription factor activity in stimulated PBMC.	J Transl Med
33256484	Recent efforts in drug discovery on vascular inflammation and consequent atherosclerosis.	Expert Opin Drug Discov
33256355	Impact of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on in-hospital mortality in COVID-19 patients: a systematic review and meta-analysis.	Singapore Med J
33256227	Identification of an Antiviral Compound from the Pandemic Response Box that Efficiently Inhibits SARS-CoV-2 Infection In Vitro.	Microorganisms
33256111	Could Naturally Occurring Coronaviral Diseases in Animals Serve as Models for COVID-19? A Review Focusing on the Bovine Model.	Pathogens
33255989	"Comparing and Contrasting MERS, SARS-CoV, and SARS-CoV-2: Prevention, Transmission, Management, and Vaccine Development."	Pathogens
33255977	Characterization of Structural and Energetic Differences between Conformations of the SARS-CoV-2 Spike Protein.	Materials (Basel)
33255849	In Silico Discovery of Antimicrobial Peptides as an Alternative to Control SARS-CoV-2.	Molecules
33255615	"The Absence of Yellow Fever in Asia: History, Hypotheses, Vector Dispersal, Possibility of YF in Asia, and Other Enigmas."	Viruses
33255326	Novel Small-Molecule Scaffolds as Candidates against the SARS Coronavirus 2 Main Protease: A Fragment-Guided in Silico Approach.	Molecules
33255253	Alkaloids: Therapeutic Potential against Human Coronaviruses.	Molecules
33254614	Environmental impacts on the transmission and evolution of COVID-19 combing the knowledge of pathogenic respiratory coronaviruses.	Environ Pollut
33254590	Smart polymeric eye gear: A possible preventive measure against ocular transmission of COVID-19.	Med Hypotheses
33254589	Role of testosterone in COVID-19 patients - A double-edged sword?	Med Hypotheses
33254586	Fabry disease patients have an increased risk of stroke in the COVID-19 ERA. A hypothesis.	Med Hypotheses
33254584	"A hypothesis for examining dihydroxyacetone, the active component in sunless tanning products, as a topical prophylactic against SARS-COV-2 transmission."	Med Hypotheses
33254579	Host - virus - drug interactions as determinants of COVID-19's phenotypes: A data-driven hypothesis.	Med Hypotheses
33254575	"Relevance of SARS-CoV-2 related factors ACE2 and TMPRSS2 expressions in gastrointestinal tissue with pathogenesis of digestive symptoms, diabetes-associated mortality, and disease recurrence in COVID-19 patients."	Med Hypotheses
33254571	The viral protein fragment theory of COVID-19 pathogenesis.	Med Hypotheses
33254568	Distinguishing between typical Kawasaki disease and multisystem inflammatory syndrome in children (MIS-C) associated with SARS-CoV-2.	Med Hypotheses
33254564	Role of inositol to improve surfactant functions and reduce IL-6 levels: A potential adjuvant strategy for SARS-CoV-2 pneumonia?	Med Hypotheses
33254555	COVID-19: Endogenous Retinoic Acid Theory and Retinoic Acid Depletion Syndrome.	Med Hypotheses
33254553	A role of glycation and methylation for SARS-CoV-2 infection in diabetes?	Med Hypotheses
33254550	SARS-CoV-2 and miRNA-like inhibition power.	Med Hypotheses
33254549	"Premises among SARS-CoV-2, dysbiosis and diarrhea: Walking through the ACE2/mTOR/autophagy route."	Med Hypotheses
33254548	Heme oxygenase-1 (HO-1) cytoprotective pathway: A potential treatment strategy against coronavirus disease 2019 (COVID-19)-induced cytokine storm syndrome.	Med Hypotheses
33254544	Second wave of Covid-19 is determined by immune mechanism.	Med Hypotheses
33254541	Life-threatening course in coronavirus disease 2019 (COVID-19): Is there a link to methylenetetrahydrofolic acid reductase (MTHFR) polymorphism and hyperhomocysteinemia?	Med Hypotheses
33254538	COVID-19 and the renin-angiotensin system (RAS): A spark that sets the forest alight?	Med Hypotheses
33254534	Red blood cell exchange for SARS-CoV-2: A Gemini of therapeutic opportunities.	Med Hypotheses
33254527	COVID-19 and ethnicity: Does reduced responsiveness to glucocorticoids explain the more aggressive nature of disease among minorities?	Med Hypotheses
33254525	Vitamin K epoxide reductase complex subunit 1 (VKORC1) gene polymorphism as determinant of differences in Covid-19-related disease severity.	Med Hypotheses
33254519	SARS-CoV-2-mediated encephalitis: Role of AT2R receptors in the blood-brain barrier.	Med Hypotheses
33254518	SARS-CoV-2 dysregulation of PTBP1 and YWHAE/Z gene expression: A primer of neurodegeneration.	Med Hypotheses
33254516	COVID 19 mortality: Probable role of microbiome to explain disparity.	Med Hypotheses
33254515	Repurposing prolactin as a promising immunomodulator for the treatment of COVID-19: Are common Antiemetics the wonder drug to fight coronavirus?	Med Hypotheses
33254513	COVID-19: Can the symptomatic SARS-CoV-2 infection affect the homeostasis of the gut-brain-microbiota axis?	Med Hypotheses
33254510	Could imiquimod (Aldara 5% cream) or other TLR7 agonists be used in the treatment of COVID-19?	Med Hypotheses
33254506	A potential therapeutic combination for treatment of COVID-19: Synergistic effect of DPP4 and RAAS suppression.	Med Hypotheses
33254502	The AI-discovered aetiology of COVID-19 and rationale of the irinotecan+ etoposide combination therapy for critically ill COVID-19 patients.	Med Hypotheses
33254500	Bone biology and COVID-19 infection: Is ACE2 a potential influence factor?	Med Hypotheses
33254494	"Common determinants of severe Covid-19 infection are explicable by SARS-CoV-2 secreted glycoprotein interaction with the CD33-related Siglecs, Siglec-3 and Siglec-5/14."	Med Hypotheses
33254487	Factors related to asymptomatic or severe COVID-19 infection.	Med Hypotheses
33254484	Methylene blue may have a role in the treatment of COVID-19.	Med Hypotheses
33254482	The influence of ABO blood groups on COVID-19 susceptibility and severity: A molecular hypothesis based on carbohydrate-carbohydrate interactions.	Med Hypotheses
33254479	Are graphene and graphene-derived products capable of preventing COVID-19 infection?	Med Hypotheses
33254432	Targeting the SARS-CoV2 nucleocapsid protein for potential therapeutics using immuno-informatics and structure-based drug discovery techniques.	Biomed Pharmacother
33254234	"Key genetic elements, single and in clusters, underlying geographically dependent SARS-CoV-2 genetic adaptation and their impact on binding affinity for drugs and immune control."	J Antimicrob Chemother
33254013	Potential molecular targets of nonstructural proteins for the development of antiviral drugs against SARS-CoV-2 infection.	Biomed Pharmacother
33253796	The potential involvement of JAK-STAT signaling pathway in the COVID-19 infection assisted by ACE2.	Gene
33253764	Exploring the magic bullets to identify Achilles' heel in SARS-CoV-2: Delving deeper into the sea of possible therapeutic options in Covid-19 disease: An update.	Food Chem Toxicol
33253762	Gamma-oryzanol as a potential modulator of oxidative stress and inflammation via PPAR-y in adipose tissue: a hypothetical therapeutic for cytokine storm in COVID-19?	Mol Cell Endocrinol
33253698	"Comparative analyses of SARS-CoV-2 binding (IgG, IgM, IgA) and neutralizing antibodies from human serum samples."	J Immunol Methods
33253656	One year update on the COVID-19 pandemic: Where are we now?	Acta Trop
33253634	A multiscale coarse-grained model of the SARS-CoV-2 virion.	Biophys J
33253633	Thermal inactivation scaling applied for SARS-CoV-2.	Biophys J
33253295	Ifit2 deficiency restricts microglial activation and leukocyte migration following murine coronavirus (m-CoV) CNS infection.	PLoS Pathog
33253226	SARS-CoV-2 lineage B.6 was the major contributor to early pandemic transmission in Malaysia.	PLoS Negl Trop Dis
33253058	"A Gapless, Unambiguous RNA Metagenome-Assembled Genome Sequence of a Unique SARS-CoV-2 Variant Encoding Spike S813I and ORF1a A859V Substitutions."	OMICS
33252301	Nanomedicinal delivery of stimulator of interferon genes agonists: recent advances in virus vaccination.	Nanomedicine (Lond)
33252294	The severe acute respiratory syndrome due to coronavirus 2 (SARS-CoV-2) infection and the climacteric woman.	Climacteric
33252031	Identification of naphthyridine and quinoline derivatives as potential Nsp16-Nsp10 inhibitors: a pharmacoinformatics study.	J Biomol Struct Dyn
33252008	Design of a multi-epitope-based vaccine targeting M-protein of SARS-CoV2: an immunoinformatics approach.	J Biomol Struct Dyn
33251983	Synthetic flavonoids as potential antiviral agents against SARS-CoV-2 main protease.	J Biomol Struct Dyn
33251975	"Combination of QSAR, molecular docking, molecular dynamic simulation and MM-PBSA: analogues of lopinavir and favipiravir as potential drug candidates against COVID-19."	J Biomol Struct Dyn
33251972	Evaluation of traditional ayurvedic Kadha for prevention and management of the novel Coronavirus (SARS-CoV-2) using in silico approach.	J Biomol Struct Dyn
33251966	Defining the Syrian hamster as a highly susceptible preclinical model for SARS-CoV-2 infection.	Emerg Microbes Infect
33251943	Computational guided identification of novel potent inhibitors of N-terminal domain of nucleocapsid protein of severe acute respiratory syndrome coronavirus 2.	J Biomol Struct Dyn
33251800	A Novel Angiotensin Converting Enzyme 2 (ACE2) Activating Peptide: A Reflection of 10 Years of Research on a Small Peptide Ile-Arg-Trp (IRW).	J Agric Food Chem
33251605	Deregulated cellular circuits driving immunoglobulins and complement consumption associate with the severity of COVID-19 patients.	Eur J Immunol
33251580	Higher ACE2 expression levels in epicardial cells than subcutaneous stromal cells from patients with cardiovascular disease: Diabetes and obesity as possible enhancer.	Eur J Clin Invest
33251489	SARS-CoV-2 Receptors and Entry Genes Are Expressed in the Human Olfactory Neuroepithelium and Brain.	iScience
33251412	Chemocentric Informatics Analysis: Dexamethasone Versus Combination Therapy for COVID-19.	ACS Omega
33251389	Screening marine algae metabolites as high-affinity inhibitors of SARS-CoV-2 main protease (3CLpro): an in silico analysis to identify novel drug candidates to combat COVID-19 pandemic.	Appl Biol Chem
33251388	High affinity of host human microRNAs to SARS-CoV-2 genome: An in silico analysis.	Noncoding RNA Res
33251371	Structure-based drug designing of naphthalene based SARS-CoV PLpro inhibitors for the treatment of COVID-19.	Heliyon
33251326	Plausible mechanisms explaining the role of cucurbitacins as potential therapeutic drugs against coronavirus 2019.	Inform Med Unlocked
33251267	A Mini-Review on Cell Cycle Regulation of Coronavirus Infection.	Front Vet Sci
33251185	Supporting SARS-CoV-2 Papain-Like Protease Drug Discovery: In silico Methods and Benchmarking.	Front Chem
33251083	Identification of potential mRNA panels for severe acute respiratory syndrome coronavirus 2 (COVID-19) diagnosis and treatment using microarray dataset and bioinformatics methods.	3 Biotech
33251031	"Role of mitochondria, oxidative stress and the response to antioxidants in myalgic encephalomyelitis/chronic fatigue syndrome: A possible approach to SARS-CoV-2 'long-haulers'?"	Chronic Dis Transl Med
33251029	SARS-CoV-2 infection: can ferroptosis be a potential treatment target for multiple organ involvement?	Cell Death Discov
33250972	SARS-CoV2 infectivity is potentially modulated by host redox status.	Comput Struct Biotechnol J
33250893	Potential CD8+ T Cell Cross-Reactivity Against SARS-CoV-2 Conferred by Other Coronavirus Strains.	Front Immunol
33250777	A Scientific Rationale for Using Cystic Fibrosis Transmembrane Conductance Regulator Therapeutics in COVID-19 Patients.	Front Physiol
33250716	Harnessing the Neural Stem Cell Secretome for Regenerative Neuroimmunology.	Front Cell Neurosci
33250660	Thermal and hydrodynamic properties of coronavirus at various temperature and pressure via molecular dynamics approach.	J Therm Anal Calorim
33250638	COVID-19 pandemic: Mechanistic approaches and gender vulnerabilities.	Saudi Pharm J
33250631	A brief review of the neurological manifestations of the coronavirus disease.	Egypt J Neurol Psychiatr Neurosurg
33250601	Network pharmacology of AYUSH recommended immune-boosting medicinal plants against COVID-19.	J Ayurveda Integr Med
33250494	"Isolation of Human Coronaviruses OC43, HKU1, NL63, and 229E in Yamagata, Japan, Using Primary Human Airway Epithelium Cells Cultured by Employing an Air-Liquid Interface Culture."	Jpn J Infect Dis
33249673	Specialized proresolving mediators in infection and lung injury.	Biofactors
33249605	Intracerebral endotheliitis and microbleeds are neuropathological features of COVID-19.	Neuropathol Appl Neurobiol
33249471	Serum Protein Profiling Reveals a Specific Upregulation of the Immunomodulatory Protein Progranulin in Coronavirus Disease 2019.	J Infect Dis
33249452	New Horizons: Does Mineralocorticoid Receptor Activation by Cortisol Cause ATP Release and COVID-19 Complications?	J Clin Endocrinol Metab
33249335	Maternal immune responses and obstetrical outcomes of pregnant women with COVID-19 and possible health risks of offspring.	J Reprod Immunol
33249285	Hypoxic preconditioning - A nonpharmacological approach in COVID-19 prevention.	Int J Infect Dis
33249281	A traditional Chinese medicine formula NRICM101 to target COVID-19 through multiple pathways: A bedside-to-bench study.	Biomed Pharmacother
33249264	Coevolutionary forces shaping the fitness of SARS-CoV-2 spike glycoprotein against human receptor ACE2.	Infect Genet Evol
33249233	SARS-COV-2 (Covid-19) and male fertility: Where are we?	Reprod Toxicol
33249199	DPP-4 inhibition and COVID-19: From initial concerns to recent expectations.	Diabetes Metab
33249093	Antiviral drugs targeting endosomal membrane proteins inhibit distant animal and human pathogenic viruses.	Antiviral Res
33249077	"Flavonols as potential antiviral drugs targeting SARS-CoV-2 proteases (3CL(pro) and PL(pro)), spike protein, RNA-dependent RNA polymerase (RdRp) and angiotensin-converting enzyme II receptor (ACE2)."	Eur J Pharmacol
33249060	The DHODH inhibitor PTC299 arrests SARS-CoV-2 replication and suppresses induction of inflammatory cytokines.	Virus Res
33248817	A Shift Towards an Immature Myeloid Profile in Peripheral Blood of Critically Ill COVID-19 Patients.	Arch Med Res
33248422	RAC1 nitration at Y(32) IS involved in the endothelial barrier disruption associated with lipopolysaccharide-mediated acute lung injury.	Redox Biol
33248385	Severe COVID-19: A multifaceted viral vasculopathy syndrome.	Ann Diagn Pathol
33248226	Improved production of SARS-CoV-2 spike receptor-binding domain (RBD) for serology assays.	Protein Expr Purif
33248195	Ionophore antibiotic X-206 is a potent inhibitor of SARS-CoV-2 infection in vitro.	Antiviral Res
33248159	What can we learn from brain autopsies in COVID-19?	Neurosci Lett
33248129	From examining the relationship between (corona)viral adhesins and galectins to glyco-perspectives.	Biophys J
33248025	Phosphoregulation of Phase Separation by the SARS-CoV-2 N Protein Suggests a Biophysical Basis for its Dual Functions.	Mol Cell
33247469	Coronaviruses in children: A review of potential mechanisms of childhood protection.	Acta Paediatr
33247152	Dynamic changes in anti-SARS-CoV-2 antibodies during SARS-CoV-2 infection and recovery from COVID-19.	Nat Commun
33247138	"Cellular events of acute, resolving or progressive COVID-19 in SARS-CoV-2 infected non-human primates."	Nat Commun
33247109	RBD-Fc-based COVID-19 vaccine candidate induces highly potent SARS-CoV-2 neutralizing antibody response.	Signal Transduct Target Ther
33247108	Nucleocapsid protein of SARS-CoV-2 phase separates into RNA-rich polymerase-containing condensates.	Nat Commun
33247099	SARS-CoV-2 genomic and subgenomic RNAs in diagnostic samples are not an indicator of active replication.	Nat Commun
33246770	An inter-correlated cytokine network identified at the center of cytokine storm predicted COVID-19 prognosis.	Cytokine
33246736	Antibody-guided structure-based vaccines.	Semin Immunol
33246692	More that ACE2? NRP1 may play a central role in the underlying pathophysiological mechanism of olfactory dysfunction in COVID-19 and its association with enhanced survival.	Med Hypotheses
33246479	Can COVID-19 pandemic boost the epidemic of neurodegenerative diseases?	Biol Direct
33246398	Exploring nature's bounty: identification of Withania somnifera as a promising source of therapeutic agents against COVID-19 by virtual screening and in silico evaluation.	J Biomol Struct Dyn
33246394	Multiple epitope-based vaccine prediction against SARS-CoV-2 spike glycoprotein.	J Biomol Struct Dyn
33246378	Protease inhibitors targeting the main protease and papain-like protease of coronaviruses.	Expert Opin Ther Pat
33246355	A bioinformatic approach to investigating cytokine genes and their receptor variants in relation to COVID-19 progression.	Int J Immunogenet
33246294	Pulmonary pathology of ARDS in COVID-19: A pathological review for clinicians.	Respir Med
33246269	Pathology of TB/COVID-19 Co-Infection: The phantom menace.	Tuberculosis (Edinb)
33246009	Visceral fat is associated to the severity of COVID-19.	Metabolism
33245961	Structural insights into SARS-CoV-2 proteins.	J Mol Biol
33245898	"COVID-19 vaccine: A recent update in pipeline vaccines, their design and development strategies."	Eur J Pharmacol
33245895	"Human Inborn Errors of Immunity (HIEI): predominantly antibody deficiencies (PADs): if you suspect it, you can detect it."	J Pediatr (Rio J)
33245857	Integrative Imaging Reveals SARS-CoV-2-Induced Reshaping of Subcellular Morphologies.	Cell Host Microbe
33245774	"PAGER-CoV: a comprehensive collection of pathways, annotated gene-lists and gene signatures for coronavirus disease studies."	Nucleic Acids Res
33245761	MoonProt 3.0: an update of the moonlighting proteins database.	Nucleic Acids Res
33245731	"MEK inhibitors reduce cellular expression of ACE2, pERK, pRb while stimulating NK-mediated cytotoxicity and attenuating inflammatory cytokines relevant to SARS-CoV-2 infection."	Oncotarget
33245701	Immune Competence and Minimizing Susceptibility to COVID-19 and Other Immune System Threats.	Altern Ther Health Med
33245474	N-Glycan Modification in Covid-19 Pathophysiology: In vitro Structural Changes with Limited Functional Effects.	J Clin Immunol
33245471	"Expression and co-expression analyses of TMPRSS2, a key element in COVID-19."	Eur J Clin Microbiol Infect Dis
33245459	Molecular docking and simulation investigation: effect of beta-sesquiphellandrene with ionic integration on SARS-CoV2 and SFTS viruses.	J Genet Eng Biotechnol
33245005	JAK-STAT Pathway Inhibition and their Implications in COVID-19 Therapy.	Postgrad Med
33244974	"Viral Infection-Induced Gut Dysbiosis, Neuroinflammation, and alpha-Synuclein Aggregation: Updates and Perspectives on COVID-19 and Neurodegenerative Disorders."	ACS Chem Neurosci
33244856	"Novel coronavirus disease (COVID-19) update on epidemiology, pathogenicity, clinical course and treatments."	Int J Clin Pract
33244830	Predicting cryptic ligand binding sites based on normal modes guided conformational sampling.	Proteins
33244583	Novel SARS-CoV-2 encoded small RNAs in the passage to humans.	Bioinformatics
33244382	"Significant changes of CD4, FOXP3, CD25, and IL6 expression level in Iranian COVID-19 patients."	Gastroenterol Hepatol Bed Bench
33244381	Investigating the human protein-host protein interactome of SARS-CoV-2 infection in the small intestine.	Gastroenterol Hepatol Bed Bench
33244380	Introducing APOA1 as a key protein in COVID-19 infection: a bioinformatics approach.	Gastroenterol Hepatol Bed Bench
33244378	Computation screening and molecular docking of FDA approved viral protease inhibitors as a potential drug against COVID-19.	Gastroenterol Hepatol Bed Bench
33244377	Coronavirus disease 2019 (COVID-19) and pediatric gastroenterology.	Gastroenterol Hepatol Bed Bench
33244376	Coronaviruses and gastrointestinal symptoms: an old liaison for the new SARS-CoV-2.	Gastroenterol Hepatol Bed Bench
33244196	"Origin and genomic characteristics of SARS-CoV-2 and its interaction with angiotensin converting enzyme type 2 receptors, focusing on the gastrointestinal tract."	World J Gastroenterol
33244168	HDL-scavenger receptor B type 1 facilitates SARS-CoV-2 entry.	Nat Metab
33244161	"The central role of the nasal microenvironment in the transmission, modulation, and clinical progression of SARS-CoV-2 infection."	Mucosal Immunol
33243994	SARS-CoV-2 spike-protein D614G mutation increases virion spike density and infectivity.	Nat Commun
33243941	Characteristics of viral specimens collected from asymptomatic and fatal cases of COVID-19.	J Biomed Res
33243842	Endothelial eNAMPT amplifies pre-clinical acute lung injury: efficacy of an eNAMPT-neutralising monoclonal antibody.	Eur Respir J
33243665	Same pollution sources for climate change might be hyperactivating the NLRP3 inflammasome and exacerbating neuroinflammation and SARS mortality.	Med Hypotheses
33243541	The role of respiratory droplet physicochemistry in limiting and promoting the airborne transmission of human coronaviruses: A critical review.	Environ Pollut
33243253	Analysis of the efficacy of HIV protease inhibitors against SARS-CoV-2's main protease.	Virol J
33243230	Dual and mutual interaction between microbiota and viral infections: a possible treat for COVID-19.	Microb Cell Fact
33243116	"Can Host Cell Proteins Like ACE2, ADAM17, TMPRSS2, Androgen Receptor be the Efficient Targets in SARS-CoV-2 Infection?"	Curr Drug Targets
33243086	Assessing COVID-19 susceptibility through analysis of the genetic and epigenetic diversity of ACE2-mediated SARS-CoV-2 entry.	Pharmacogenomics
33242917	Association of Salivary Content Alteration and Early Ageusia Symptoms in COVID-19 Infections: A Systematic Review.	Eur J Dent
33242856	SEX DISPARITIES IN COVID-19 SEVERITY AND OUTCOME: ARE MEN WEAKER OR WOMEN STRONGER?	Neuroendocrinology
33242791	A safety consideration of mesenchymal stem cell therapy on COVID-19.	Stem Cell Res
33242646	Structural and functional insights into non-structural proteins of coronaviruses.	Microb Pathog
33242581	The phylogenetic relationship within SARS-CoV-2s: An expanding basal clade.	Mol Phylogenet Evol
33242394	Cross-Neutralization of a SARS-CoV-2 Antibody to a Functionally Conserved Site Is Mediated by Avidity.	Immunity
33242391	Real-Time Conformational Dynamics of SARS-CoV-2 Spikes on Virus Particles.	Cell Host Microbe
33242368	Identification of key signaling pathways induced by SARS-CoV2 that underlie thrombosis and vascular injury in COVID-19 patients.	J Leukoc Biol
33242255	An integrative analysis identifying transcriptional features and key genes involved in COVID-19.	Epigenomics
33241871	Translation of Mycobacterium Survival Strategy to Develop a Lipo-peptide based Fusion Inhibitor*.	Angew Chem Int Ed Engl
33241838	"Spontaneous, solvent-free entrapment of siRNA within lipid nanoparticles."	Nanoscale
33241658	Anti-coronavirus disease 2019 (COVID-19) targets and mechanisms of puerarin.	J Cell Mol Med
33241508	Impact of COVID-19 on the thyroid gland: an update.	Rev Endocr Metab Disord
33240967	Bovine Interferon Lambda Is a Potent Antiviral Against SARS-CoV-2 Infection in vitro.	Front Vet Sci
33240937	Molecular Basis of Cardiac and Vascular Injuries Associated With COVID-19.	Front Cardiovasc Med
33240881	"Recent Advances in Pathophysiology, Drug Development and Future Perspectives of SARS-CoV-2."	Front Cell Dev Biol
33240681	The frequency of combined IFITM3 haplotype involving the reference alleles of both rs12252 and rs34481144 is in line with COVID-19 standardized mortality ratio of ethnic groups in England.	PeerJ
33240326	The Secretive Liaison of Particulate Matter and SARS-CoV-2. A Hypothesis and Theory Investigation.	Front Genet
33240265	Immunomodulation for Severe COVID-19 Pneumonia: The State of the Art.	Front Immunol
33240216	A Suggested Role of Human Growth Hormone in Control of the COVID-19 Pandemic.	Front Endocrinol (Lausanne)
33240098	SARS-CoV-2 Aiming for the Heart: A Multicenter Italian Perspective About Cardiovascular Issues in COVID-19.	Front Physiol
33240092	Use of Cannabinoids to Treat Acute Respiratory Distress Syndrome and Cytokine Storm Associated with Coronavirus Disease-2019.	Front Pharmacol
33239694	In silico studies evidenced the role of structurally diverse plant secondary metabolites in reducing SARS-CoV-2 pathogenesis.	Sci Rep
33239683	Longitudinal proteomic profiling reveals increased early inflammation and sustained apoptosis proteins in severe COVID-19.	Sci Rep
33239633	No evidence for increased transmissibility from recurrent mutations in SARS-CoV-2.	Nat Commun
33239605	Convalescent Memory T Cell Immunity in Individuals with Mild or Asymptomatic SARS-CoV-2 Infection May Result from an Evolutionarily Adapted Immune Response to Coronavirus and the 'Common Cold'.	Med Sci Monit
33239458	Gammacoronavirus Avian Infectious Bronchitis Virus and Alphacoronavirus Porcine Epidemic Diarrhea Virus Exploit a Cell-Survival Strategy via Upregulation of cFOS to Promote Viral Replication.	J Virol
33239457	The Human Adenovirus Type 2 Transcriptome: An Amazing Complexity of Alternatively Spliced mRNAs.	J Virol
33239446	Cholesterol 25-hydroxylase suppresses SARS-CoV-2 replication by blocking membrane fusion.	Proc Natl Acad Sci U S A
33239366	Conserved Genomic Terminals of SARS-CoV-2 as Coevolving Functional Elements and Potential Therapeutic Targets.	mSphere
33239293	Regeneration of the pulmonary vascular endothelium after viral pneumonia requires COUP-TF2.	Sci Adv
33239231	Hypothesis: Alpha-1-antitrypsin is a promising treatment option for COVID-19.	Med Hypotheses
33239166	Development of a nano-luciferase based assay to measure the binding of SARS-CoV-2 spike receptor binding domain to ACE-2.	Biochem Biophys Res Commun
33238910	The potential role of serum angiotensin-converting enzyme in coronavirus disease 2019.	BMC Infect Dis
33238863	Storm at the Time of Corona: A Glimpse at the Current Understanding and Therapeutic Opportunities of the SARS-CoV-2 Cytokine Storm.	Curr Pharm Des
33238596	Soluble Receptor for Advanced Glycation End Products and Its Forms in COVID-19 Patients with and without Diabetes Mellitus: A Pilot Study on Their Role as Disease Biomarkers.	J Clin Med
33238570	The Potential Role of Osteopontin and Furin in Worsening Disease Outcomes in COVID-19 Patients with Pre-Existing Diabetes.	Cells
33238451	Drawing Comparisons between SARS-CoV-2 and the Animal Coronaviruses.	Microorganisms
33238290	Progenitor identification and SARS-CoV-2 infection in human distal lung organoids.	Nature
33237815	"Angiotensin-converting enzyme 2 and COVID-19: patients, comorbidities, and therapies."	Am J Physiol Lung Cell Mol Physiol
33237727	Biomimetic Virus-Like Particles as Severe Acute Respiratory Syndrome Coronavirus 2 Diagnostic Tools.	ACS Nano
33237619	Molecular investigation of adequate sources of mesenchymal stem cells for cell therapy of COVID-19-associated organ failure.	Stem Cells Transl Med
33237528	Thymalin: Activation of Differentiation of Human Hematopoietic Stem Cells.	Bull Exp Biol Med
33237286	UniProt: the universal protein knowledgebase in 2021.	Nucleic Acids Res
33237152	Molecular mechanisms and pharmacological interventions in the replication cycle of human coronaviruses.	Genet Mol Biol
33237151	Host-shift as the cause of emerging infectious diseases: Experimental approaches using Drosophila-virus interactions.	Genet Mol Biol
33236920	COVID-19 endocrinopathy with hindsight from SARS.	Am J Physiol Endocrinol Metab
33236896	"Airborne Transmission of COVID-19: Aerosol Dispersion, Lung Deposition, and Virus-Receptor Interactions."	ACS Nano
33236692	Covid-19 and leptospirosis: Cytokine storm and the use of steroids.	Trop Doct
33236629	Specificity Enhancement of Deoxyribonucleic Acid Polymerization for Sensitive Nucleic Acid Detection.	Anal Chem
33236586	"Ferritin and Severe COVID-19, from Clinical Observations to Pathogenic Implications and Therapeutic Perspectives."	Isr Med Assoc J
33236484	Proteomics in the COVID-19 Battlefield: First Semester Check-Up.	Proteomics
33236433	SARS-CoV-2 infection and neonates: a review of evidence and unresolved questions.	Pediatr Allergy Immunol
33236427	Immunological basis of virus-host interaction in COVID-19.	Pediatr Allergy Immunol
33236418	HMGB1: A pleiotropic activity.	Pediatr Allergy Immunol
33236375	Review of COVID-19 and male genital tract.	Andrologia
33236284	Inflammasomes and Childhood Autoimmune Diseases: A Review of Current Knowledge.	Clin Rev Allergy Immunol
33236176	Computational guided identification of a citrus flavonoid as potential inhibitor of SARS-CoV-2 main protease.	Mol Divers
33236142	Zinc and SARSCoV2: A molecular modeling study of Zn interactions with RNAdependent RNApolymerase and 3Clike proteinase enzymes.	Int J Mol Med
33236131	Approaches towards fighting the COVID19 pandemic (Review).	Int J Mol Med
33236001	Minireview of progress in the structural study of SARS-CoV-2 proteins.	Curr Res Microb Sci
33235892	Effects of Recent Use of Renin-Angiotensin System Inhibitors on Mortality of Patients With Coronavirus Disease 2019.	Open Forum Infect Dis
33235813	Temporal signal and the phylodynamic threshold of SARS-CoV-2.	Virus Evol
33235797	Old friends meet a new foe: A potential role for immune-priming parasites in mitigating COVID-19 morbidity and mortality.	Evol Med Public Health
33235690	"Immunopathology, host-virus genome interactions, and effective vaccine development in SARS-CoV-2."	Comput Struct Biotechnol J
33235538	Plasma-activated water: An alternative disinfectant for S protein inactivation to prevent SARS-CoV-2 infection.	Chem Eng J
33235385	Establishment of an African green monkey model for COVID-19 and protection against re-infection.	Nat Immunol
33235258	Identification and validation of 174 COVID-19 vaccine candidate epitopes reveals low performance of common epitope prediction tools.	Sci Rep
33234728	Expression profiles revealed potential kidney injury caused by SARS-CoV-2: a systematic analysis of ACE2 and clinical lessons learned from this discovery.	Aging (Albany NY)
33234691	Kallikrein 13 serves as a priming protease during infection by the human coronavirus HKU1.	Sci Signal
33234678	Inhibiting the reproduction of SARS-CoV-2 through perturbations in human lung cell metabolic network.	Life Sci Alliance
33234675	Structure of Nonstructural Protein 1 from SARS-CoV-2.	J Virol
33234322	Experimental study of Forsythoside A on prevention and treatment of avian infectious bronchitis.	Res Vet Sci
33234268	Emerging paradigms of viral diseases and paramount role of natural resources as antiviral agents.	Sci Total Environ
33234239	Host-directed editing of the SARS-CoV-2 genome.	Biochem Biophys Res Commun
33233817	Immune-Modulating Drug MP1032 with SARS-CoV-2 Antiviral Activity In Vitro: A potential Multi-Target Approach for Prevention and Early Intervention Treatment of COVID-19.	Int J Mol Sci
33233780	Population Difference in Allele Frequency of HLA-C*05 and Its Correlation with COVID-19 Mortality.	Viruses
33233748	Biomimetic Nanoparticles Potentiate the Anti-Inflammatory Properties of Dexamethasone and Reduce the Cytokine Storm Syndrome: An Additional Weapon against COVID-19?	Nanomaterials (Basel)
33233715	Endothelial Damage in Acute Respiratory Distress Syndrome.	Int J Mol Sci
33233560	Food Ingredients and Active Compounds against the Coronavirus Disease (COVID-19) Pandemic: A Comprehensive Review.	Foods
33233531	Immunogenetic Association Underlying Severe COVID-19.	Vaccines (Basel)
33233425	ACE2 Interaction Networks in COVID-19: A Physiological Framework for Prediction of Outcome in Patients with Cardiovascular Risk Factors.	J Clin Med
33233333	"Possible Correlations between Atherosclerosis, Acute Coronary Syndromes and COVID-19."	J Clin Med
33232965	Skin Manifestations Associated with COVID-19: Current Knowledge and Future Perspectives.	Dermatology
33232870	Newcastle disease virus (NDV) expressing the spike protein of SARS-CoV-2 as a live virus vaccine candidate.	EBioMedicine
33232865	SARS-CoV-2 attachment to host cells is possibly mediated via RGD-integrin interaction in a calcium-dependent manner and suggests pulmonary EDTA chelation therapy as a novel treatment for COVID 19.	Immunobiology
33232783	Putative roles of vitamin D in modulating immune response and immunopathology associated with COVID-19.	Virus Res
33232769	SARS-CoV-2 spike protein-mediated cell signaling in lung vascular cells.	Vascul Pharmacol
33232691	Cryo-EM Structure of an Extended SARS-CoV-2 Replication and Transcription Complex Reveals an Intermediate State in Cap Synthesis.	Cell
33232663	Androgen Signaling Regulates SARS-CoV-2 Receptor Levels and Is Associated with Severe COVID-19 Symptoms in Men.	Cell Stem Cell
33232578	The tyrosine kinase inhibitor nilotinib inhibits SARS-CoV-2 in vitro.	Basic Clin Pharmacol Toxicol
33232303	An immune-based biomarker signature is associated with mortality in COVID-19 patients.	JCI Insight
33232272	Influence of aging on deterioration of patients with COVID-19.	Aging (Albany NY)
33232205	Biochemical and antigenic characterization of the structural proteins and their post-translational modifications in purified SARS-CoV-2 virions of an inactivated vaccine candidate.	Emerg Microbes Infect
33232192	A comprehensive review on the antiviral activities of chalcones.	J Drug Target
33231780	SARS-CoV-2: a new dimension to our understanding of coronaviruses.	Int Microbiol
33231770	Down's syndrome and COVID-19: risk or protection factor against infection? A molecular and genetic approach.	Neurol Sci
33231642	Mouse Genome Database (MGD): Knowledgebase for mouse-human comparative biology.	Nucleic Acids Res
33231620	"ACE2, angiotensin 1-7 and skeletal muscle: review in the era of COVID-19."	Clin Sci (Lond)
33231615	Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients.	J Exp Med
33231598	The biomaterial polyphosphate blocks stoichiometric binding of the SARS-CoV-2 S-protein to the cellular ACE2 receptor.	Biomater Sci
33231569	"Genomic, epigenomic, and immune subtype analysis of CTSL/B and SARS-CoV-2 receptor ACE2 in pan-cancer."	Aging (Albany NY)
33231487	"Association of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Blockers With Severity of COVID-19: A Multicenter, Prospective Study."	J Cardiovasc Pharmacol Ther
33231439	Synthesis of Palladium(II) Complexes via Michael Addition: Antiproliferative Effects through ROS-Mediated Mitochondrial Apoptosis and Docking with SARS-CoV-2.	Inorg Chem
33231324	Prefusion spike protein stabilization through computational mutagenesis.	Proteins
33231299	Effects of renin-angiotensin-aldosterone system inhibitors on disease severity and mortality in patients with COVID-19: A meta-analysis.	J Med Virol
33231155	Catechin Derivatives as Inhibitor of COVID-19 Main Protease (Mpro): Molecular Docking studies unveils an opportunity against CORONA.	Comb Chem High Throughput Screen
33230947	Thromboinflammation in COVID-19: Can alpha2 -macroglobulin help to control the fire?	J Thromb Haemost
33230904	The ADAMTS13-von Willebrand factor axis in COVID-19 patients.	J Thromb Haemost
33230589	Brain solutions for hearing problems during the COVID-19 pandemic and the misery of wearing a mask.	Eur Arch Otorhinolaryngol
33230497	"Nutrition, immunity and COVID-19."	BMJ Nutr Prev Health
33230487	Protein-ligand binding interactions of imidazolium salts with SARS CoV-2.	Heliyon
33230417	SARS-CoV-2 and Plasmodium falciparum common immunodominant regions may explain low COVID-19 incidence in the malaria-endemic belt.	New Microbes New Infect
33230386	Molecular targets and system biology approaches for drug repurposing against SARS-CoV-2.	Bull Natl Res Cent
33230349	Advances in developing small molecule SARS 3CL(pro) inhibitors as potential remedy for corona virus infection.	Tetrahedron
33230180	"Virtual screening of anti-HIV1 compounds against SARS-CoV-2: machine learning modeling, chemoinformatics and molecular dynamics simulation based analysis."	Sci Rep
33230174	Targeted intracellular degradation of SARS-CoV-2 via computationally optimized peptide fusions.	Commun Biol
33229976	Coronavirus 2019: clinical and neuropathological aspects.	Curr Opin Rheumatol
33229949	COVID-19 antibody development fueled by HIV-1 broadly neutralizing antibody research.	Curr Opin HIV AIDS
33229732	Peptidylarginine deiminases and extracellular vesicles: prospective drug targets and biomarkers in central nervous system diseases and repair.	Neural Regen Res
33229462	Genomic epidemiology of superspreading events in Austria reveals mutational dynamics and transmission properties of SARS-CoV-2.	Sci Transl Med
33229438	"The SARS-CoV-2 envelope and membrane proteins modulate maturation and retention of the spike protein, allowing assembly of virus-like particles."	J Biol Chem
33229429	Off-Target In Vitro Profiling Demonstrates that Remdesivir Is a Highly Selective Antiviral Agent.	Antimicrob Agents Chemother
33229187	Sex and COVID-19: A Protective Role for Reproductive Steroids.	Trends Endocrinol Metab
33228481	Molecular dynamics simulation perception study of the binding affinity performance for main protease of SARS-CoV-2.	J Biomol Struct Dyn
33228475	"Computational gene expression profiling in the exploration of biomarkers, non-coding functional RNAs and drug perturbagens for COVID-19."	J Biomol Struct Dyn
33228447	Coronavirus Disease 2019-Associated Thrombosis and Coagulopathy: Review of the Pathophysiological Characteristics and Implications for Antithrombotic Management.	J Am Heart Assoc
33228423	Association of TNF-alpha G-308 a Promoter Polymorphism with the Course and Outcome of COVID-19 Patients.	Immunol Invest
33228225	Cardiovascular Manifestations of COVID-19 Infection.	Cells
33228163	Molluscan Compounds Provide Drug Leads for the Treatment and Prevention of Respiratory Disease.	Mar Drugs
33227700	Decoding the silent walk of COVID-19: Halting its spread using old bullets.	Biomed Pharmacother
33227636	"No credible evidence for links between 2D:4D and COVID-19 outcomes: A probabilistic perspective on digit ratio, ACE variants, and national case fatalities."	Early Hum Dev
33227435	Physiological resiliency in diving mammals: Insights on hypoxia protection using the Krogh principle to understand COVID-19 symptoms.	Comp Biochem Physiol A Mol Integr Physiol
33227343	"Genomic surveillance of SARS-CoV-2 in Thailand reveals mixed imported populations, a local lineage expansion and a virus with truncated ORF7a."	Virus Res
33227287	A comprehensive review on potential therapeutics interventions for COVID-19.	Eur J Pharmacol
33227285	A review on possible mechanistic insights of Nitazoxanide for repurposing in COVID-19.	Eur J Pharmacol
33226885	"An update on COVID-19: SARS-CoV-2 life cycle, immunopathology, and BCG vaccination."	Prep Biochem Biotechnol
33226815	Theoretical Design of Functionalized Gold Nanoparticles as Antiviral Agents against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).	J Phys Chem Lett
33226581	Probiotics-Derived Peptides and Their Immunomodulatory Molecules Can Play a Preventive Role Against Viral Diseases Including COVID-19.	Probiotics Antimicrob Proteins
33226337	Differential impact of BTK active site inhibitors on the conformational state of full-length BTK.	Elife
33226303	"Targeting SARS-CoV-2 main protease: structure based virtual screening, in silico ADMET studies and molecular dynamics simulation for identification of potential inhibitors."	J Biomol Struct Dyn
33226078	COVID-19 and cardiovascular diseases.	J Mol Cell Biol
33225958	"Evaluation on the use of Nanopore sequencing for direct characterization of coronaviruses from respiratory specimens, and a study on emerging missense mutations in partial RdRP gene of SARS-CoV-2."	Virol J
33225870	In silico screening predicts common cold drug Dextromethorphan along with Prednisolone and Dexamethasone can be effective against novel Coronavirus disease (COVID-19).	J Biomol Struct Dyn
33225826	Cordycepin: a bioactive metabolite of Cordyceps militaris and polyadenylation inhibitor with therapeutic potential against COVID-19.	J Biomol Struct Dyn
33225414	"(1)H,(13)C and (15)N chemical shift assignments of the SUD domains of SARS-CoV-2 non-structural protein 3c: ""the N-terminal domain-SUD-N""."	Biomol NMR Assign
33225251	COVID-19 and stroke: A review.	Brain Hemorrhages
33225219	Targeting arachidonic acid-related metabolites in COVID-19 patients: potential use of drug-loaded nanoparticles.	Emergent Mater
33225084	Designing spike protein (S-Protein) based multi-epitope peptide vaccine against SARS COVID-19 by immunoinformatics.	Heliyon
33225036	Patients with SARS-CoV-2 and HBV co-infection are at risk of greater liver injury.	Genes Dis
33224993	COVID-19 pandemic crisis-a complete outline of SARS-CoV-2.	Futur J Pharm Sci
33224734	Therapeutic potential of miRNAs targeting SARS-CoV-2 host cell receptor ACE2.	Meta Gene
33224599	Cardiovascular risk and complications associated with COVID-19.	Am J Cardiovasc Dis
33224575	Cardiovascular risk in COVID-19 infection.	Am J Cardiovasc Dis
33224529	"Acute Ischemic Stroke in COVID-19: Putative Mechanisms, Clinical Characteristics, and Management."	Neurol Res Int
33224380	Metabolic Syndrome and COVID-19.	Cardiol Res
33224265	A comprehensive review about SARS-CoV-2.	Future Virol
33224264	Perversely expressed long noncoding RNAs can alter host response and viral proliferation in SARS-CoV-2 infection.	Future Virol
33224256	Investigation of the Potential Mechanism Governing the Effect of the Shen Zhu San on COVID-19 by Network Pharmacology.	Evid Based Complement Alternat Med
33224040	Dual Substance Use of Electronic Cigarettes and Alcohol.	Front Physiol
33223766	Molecular interaction analysis of Sulawesi propolis compounds with SARS-CoV-2 main protease as preliminary study for COVID-19 drug discovery.	J King Saud Univ Sci
33223566	Synthesis of potentially new schiff bases of N-substituted-2-quinolonylacetohydrazides as anti-COVID-19 agents.	J Mol Struct
33223560	An in-silico study on selected organosulfur compounds as potential drugs for SARS-CoV-2 infection via binding multiple drug targets.	Chem Phys Lett
33223326	Endocrine disrupting chemicals and COVID-19 relationships: A computational systems biology approach.	Environ Int
33223324	Blood clots in COVID-19 patients: Simplifying the curious mystery.	Med Hypotheses
33222412	Association between renin-angiotensin-aldosterone system inhibitor use and COVID-19 hospitalization and death: a 1.4 million patient nationwide registry analysis.	Eur J Heart Fail
33222314	PCSK9 inhibitors for COVID-19: an opportunity to enhance the antiviral action of interferon in patients with hypercholesterolaemia.	J Intern Med
33222020	Renin-angiotensin system inhibitors and mortality in patients with COVID-19.	Infection
33221922	The UCSC Genome Browser database: 2021 update.	Nucleic Acids Res
33221759	In search of preventive strategies: novel high-CBD Cannabis sativa extracts modulate ACE2 expression in COVID-19 gateway tissues.	Aging (Albany NY)
33221625	The bioenergetics of COVID-19 immunopathology and the therapeutic potential of biophysical radiances.	J Photochem Photobiol B
33221483	The role of the lectin pathway of the complement system in SARS-CoV-2 lung injury.	Transl Res
33221318	An overview of viruses discovered over the last decades and drug development for the current pandemic.	Eur J Pharmacol
33221169	The emerging role of microRNAs in the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.	Int Immunopharmacol
33221134	Dendritic cell vaccine immunotherapy; the beginning of the end of cancer and COVID-19. A hypothesis.	Med Hypotheses
33221129	Magnesium and inflammation: Advances and perspectives.	Semin Cell Dev Biol
33221119	"Genetic analysis of SARS-CoV-2 isolates collected from Bangladesh: Insights into the origin, mutational spectrum and possible pathomechanism."	Comput Biol Chem
33220925	T-cell dysregulation in COVID-19.	Biochem Biophys Res Commun
33220921	Functional importance of the D614G mutation in the SARS-CoV-2 spike protein.	Biochem Biophys Res Commun
33220791	The Human Leukocyte Antigen Class II Immunopeptidome of the SARS-CoV-2 Spike Glycoprotein.	Cell Rep
33220366	COVID-19 and psychosis risk: Real or delusional concern?	Neurosci Lett
33220345	Essential functional molecules associated with SARS-CoV-2 infection: Potential therapeutic targets for COVID-19.	Gene
33219837	"Severe COVID-19, multisystem inflammatory syndrome in children, and Kawasaki disease: immunological mechanisms, clinical manifestations and management."	Rheumatol Int
33219827	Critical illness-associated cerebral microbleeds for patients with severe COVID-19: etiologic hypotheses.	J Neurol
33219803	Lack of Susceptibility to SARS-CoV-2 and MERS-CoV in Poultry.	Emerg Infect Dis
33219796	"Detection and Characterization of Bat Sarbecovirus Phylogenetically Related to SARS-CoV-2, Japan."	Emerg Infect Dis
33219681	Evidence of Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection After Recovery from Mild Coronavirus Disease 2019.	Clin Infect Dis
33219646	"Genomic Epidemiology of Severe Acute Respiratory Syndrome Coronavirus 2, Colombia."	Emerg Infect Dis
33219414	"(1)H, (13)C, and (15)N backbone and side chain chemical shift assignments of the SARS-CoV-2 non-structural protein 7."	Biomol NMR Assign
33219294	Adverse impact of renin-angiotensin system blockade on the clinical course in hospitalized patients with severe COVID-19: a retrospective cohort study.	Sci Rep
33219167	HTCC as a Polymeric Inhibitor of SARS-CoV-2 and MERS-CoV.	J Virol
33219050	Interferon therapy for COVID-19 and emerging infections: Prospects and concerns.	Cleve Clin J Med
33218357	"The dark side of the spoon - glucose, ketones and COVID-19: a possible role for ketogenic diet?"	J Transl Med
33218025	A Novel Purification Procedure for Active Recombinant Human DPP4 and the Inability of DPP4 to Bind SARS-CoV-2.	Molecules
33218024	Target-Centered Drug Repurposing Predictions of Human Angiotensin-Converting Enzyme 2 (ACE2) and Transmembrane Protease Serine Subtype 2 (TMPRSS2) Interacting Approved Drugs for Coronavirus Disease 2019 (COVID-19) Treatment through a Drug-Target Interaction Deep Learning Model.	Viruses
33217916	COVID-19 Infection Detection and Prevention by SARS-CoV-2 Active Antigens: A Synthetic Vaccine Approach.	Vaccines (Basel)
33217763	Severe acute respiratory syndrome coronavirus 2 infection reaches the human nervous system: How?	J Neurosci Res
33217661	Evaluation of acridinedione analogs as potential SARS-CoV-2 main protease inhibitors and their comparison with repurposed anti-viral drugs.	Comput Biol Med
33217430	A bacterial artificial chromosome (BAC)-vectored noninfectious replicon of SARS-CoV-2.	Antiviral Res
33217329	Native Mass Spectrometry-Based Screening for Optimal Sample Preparation in Single-Particle Cryo-EM.	Structure
33217246	Tissue-Specific Immunopathology in Fatal COVID-19.	Am J Respir Crit Care Med
33217190	Mechanisms of a Sustained Anti-inflammatory Drug Response in Alveolar Macrophages Unraveled with Mathematical Modeling.	CPT Pharmacometrics Syst Pharmacol
33217169	A Prototype QSP Model of the Immune Response to SARS-CoV-2 for Community Development.	CPT Pharmacometrics Syst Pharmacol
33217134	Vascular neutrophilic inflammation and immunothrombosis distinguish severe COVID-19 from influenza pneumonia.	J Thromb Haemost
33217098	Rhinovirus and asthma: Challenges and opportunities.	Rev Med Virol
33217033	Comparison of infection risks and clinical outcomes in patients with and without SARS-CoV-2 lung infection under renin-angiotensin-aldosterone system blockade: Systematic review and meta-analysis.	Br J Clin Pharmacol
33216893	"DPL: a comprehensive database on sequences, structures, sources and functions of peptide ligands."	Database (Oxford)
33216851	Coinfection by Severe Acute Respiratory Syndrome Coronavirus 2 and Influenza A(H1N1)pdm09 Virus Enhances the Severity of Pneumonia in Golden Syrian Hamsters.	Clin Infect Dis
33216735	SARS-CoV-2 B cell receptor signatures in at-risk populations.	J Clin Invest
33216734	Does common cold coronavirus infection protect against severe SARS-CoV-2 disease?	J Clin Invest
33216381	Designing therapeutic strategies to combat severe acute respiratory syndrome coronavirus-2 disease: COVID-19.	Drug Dev Res
33216184	Risk for COVID-19 infection in patients with tobacco smoke-associated cancers of the upper and lower airway.	Eur Arch Otorhinolaryngol
33215965	An innovative method for the selection of inhibitors of the viral spike-glycoprotein of the SARS-CoV.	J Bioinform Comput Biol
33215884	Decreased GLUT1/NHE1 RNA expression in whole blood predicts disease severity in patients with COVID-19.	ESC Heart Fail
33215503	Saliva NMR-Based Metabolomics in the War Against COVID-19.	Anal Chem
33215463	Diabetes and COVID-19: a major challenge in pandemic period?	Eur Rev Med Pharmacol Sci
33215159	Potential Role of Oral Rinses Targeting the Viral Lipid Envelope in SARS-CoV-2 Infection.	Function (Oxf)
33215042	Activity of phytochemical constituents of Curcuma longa (turmeric) and Andrographis paniculata against coronavirus (COVID-19): an in silico approach.	Futur J Pharm Sci
33214943	Neuroinvasion and Viral Reservoir in COVID-19.	Cureus
33214719	Leukocyte trafficking to the lungs and beyond: lessons from influenza for COVID-19.	Nat Rev Immunol
33214651	Thrombocytopathy and endotheliopathy: crucial contributors to COVID-19 thromboinflammation.	Nat Rev Cardiol
33214224	SARS-CoV-2 viral budding and entry can be modeled using BSL-2 level virus-like particles.	J Biol Chem
33214057	A Potential Role of Interleukin 10 in COVID-19 Pathogenesis.	Trends Immunol
33213997	COVID-19 inflammation results in urine cytokine elevation and causes COVID-19 associated cystitis (CAC).	Med Hypotheses
33213829	Therapeutic modalities and novel approaches in regenerative medicine for COVID-19.	Int J Antimicrob Agents
33213324	Coronavirus Disease -2019 (COVID-19) in 2020: A Perspective Study of a Global Pandemic.	Curr Pharm Des
33213323	"COVID-19 and Domestic Animals: Exploring the Species Barrier Crossing, Zoonotic and Reverse Zoonotic Transmission of SARS-CoV-2."	Curr Pharm Des
33213322	Natural Products: A Rich Source of Antiviral Drug Lead Candidates for the Management of COVID-19.	Curr Pharm Des
33213294	Virtual screening and molecular simulation study of natural products database for lead identification of novel coronavirus main protease inhibitors.	J Biomol Struct Dyn
33213082	Candidate Gene Markers Associated with Fecal Shedding of the Feline Enteric Coronavirus (FECV).	Pathogens
33212316	SARS-CoV-2 and nervous system: From pathogenesis to clinical manifestation.	J Neuroimmunol
33212200	An updated and comprehensive review of the antiviral potential of essential oils and their chemical constituents with special focus on their mechanism of action against various influenza and coronaviruses.	Microb Pathog
33211854	"RCSB Protein Data Bank: powerful new tools for exploring 3D structures of biological macromolecules for basic and applied research and education in fundamental biology, biomedicine, biotechnology, bioengineering and energy sciences."	Nucleic Acids Res
33211596	"Intravenous sulforhodamine B reduces alveolar surface tension, improves oxygenation, and reduces ventilation injury in a respiratory distress model."	J Appl Physiol (1985)
33211438	"[Severe COVID-19, a new complication to be added to numerous comorbidities associated to obesity]."	Rev Med Liege
33211435	[COVID-19 and asthma].	Rev Med Liege
33211434	[Renin-angiotensin-aldosterone system : brief history and questions related to the COVID-19 pandemic].	Rev Med Liege
33211433	[Neuropsychiatric complications of COVID-19].	Rev Med Liege
33211431	[Kidney injury in COVID-19].	Rev Med Liege
33211389	Multiple potential targets of opioids in the treatment of acute respiratory distress syndrome from COVID-19.	J Cell Mol Med
33211371	Direct inhibitory effect on viral entry of influenza A and SARS-CoV-2 viruses by azithromycin.	Cell Prolif
33211088	"Antibody potency, effector function, and combinations in protection and therapy for SARS-CoV-2 infection in vivo."	J Exp Med
33211087	Evaluation of the Incidence and Potential Mechanisms of Tracheal Complications in Patients With COVID-19.	JAMA Otolaryngol Head Neck Surg
33210953	Potential inhibitors of SARS-CoV-2: recent advances.	J Drug Target
33210927	Hydration-Induced Disorder Lowers the Energy Barriers for Methyl Rotation in Drug Molecules.	J Phys Chem Lett
33210826	The potential effects of clinical antidiabetic agents on SARS-CoV-2.	J Diabetes
33210729	Distinct expression of SARS-CoV-2 receptor ACE2 correlates with endotypes of chronic rhinosinusitis with nasal polyps.	Allergy
33210709	Correcting the imbalanced protective RAS in COVID-19 with angiotensin AT2-receptor agonists.	Clin Sci (Lond)
33210707	Host factors involved in influenza virus infection.	Emerg Top Life Sci
33210623	COVID-19: Current Understanding of Pathophysiology.	J Nepal Health Res Counc
33210622	Gender Disaggregation in COVID-19 and Increased Male Susceptibility.	J Nepal Health Res Counc
33210561	Structure-based identification of potential SARS-CoV-2 main protease inhibitors.	J Biomol Struct Dyn
33210552	A mini-review on the effects of COVID-19 on younger individuals.	Exp Biol Med (Maywood)
33210477	"Evolutionary study of COVID-19, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as an emerging coronavirus: Phylogenetic analysis and literature review."	Vet Med Sci
33210447	Potential of algal metabolites for the development of broad-spectrum antiviral therapeutics: Possible implications in COVID-19 therapy.	Phytother Res
33210357	"ACE inhibitors, angiotensin receptor blockers and endothelial injury in COVID-19."	J Intern Med
33210300	Why are ACE2 binding coronavirus strains SARS-CoV/SARS-CoV-2 wild and NL63 mild?	Proteins
33209992	"nSARS-Cov-2, pulmonary edema and thrombosis: possible molecular insights using miRNA-gene circuits in regulatory networks."	ExRNA
33209791	Coronavirus and Its effect on the respiratory system: Is there any association between pneumonia and immune cells.	J Family Med Prim Care
33209754	COVID 19 and diabetes: An endocrinologist's perspective.	J Family Med Prim Care
33209300	Increased IL-10-producing regulatory T cells are characteristic of severe cases of COVID-19.	Clin Transl Immunology
33208929	Macrophage expression and prognostic significance of the long pentraxin PTX3 in COVID-19.	Nat Immunol
33208827	Development of CpG-adjuvanted stable prefusion SARS-CoV-2 spike antigen as a subunit vaccine against COVID-19.	Sci Rep
33208793	SARS-CoV-2 structure and replication characterized by in situ cryo-electron tomography.	Nat Commun
33208736	Architecture of a SARS-CoV-2 mini replication and transcription complex.	Nat Commun
33208735	Crystallographic structure of wild-type SARS-CoV-2 main protease acyl-enzyme intermediate with physiological C-terminal autoprocessing site.	Nat Commun
33208493	Cerebral microhaemorrhage in COVID-19: a critical illness related phenomenon?	Stroke Vasc Neurol
33208459	Systematic Examination of Antigen-Specific Recall T Cell Responses to SARS-CoV-2 versus Influenza Virus Reveals a Distinct Inflammatory Profile.	J Immunol
33208380	The known unknowns of T cell immunity to COVID-19.	Sci Immunol
33208167	Garlic (Allium sativum L.): a potential unique therapeutic food rich in organosulfur and flavonoid compounds to fight with COVID-19.	Nutr J
33208074	Inhibition of S-protein RBD and hACE2 Interaction for Control of SARSCoV- 2 Infection (COVID-19).	Mini Rev Med Chem
33208052	Endothelialitis plays a central role in the pathophysiology of severe COVID-19 and its cardiovascular complications.	Acta Cardiol
33208020	CETSA MS Profiling for a Comparative Assessment of FDA-Approved Antivirals Repurposed for COVID-19 Therapy Identifies TRIP13 as a Remdesivir Off-Target.	SLAS Discov
33208006	"Nervous system involvement in SARS-coronavirus infection: a review on lessons learned from the previous outbreaks, ongoing pandemic and what to expect in the future."	Int J Neurosci
33207802	Recombination and Positive Selection Differentially Shaped the Diversity of Betacoronavirus Subgenera.	Viruses
33207753	"Mini-Review on the Roles of Vitamin C, Vitamin D, and Selenium in the Immune System against COVID-19."	Molecules
33207699	Large-Scale Plasma Analysis Revealed New Mechanisms and Molecules Associated with the Host Response to SARS-CoV-2.	Int J Mol Sci
33207583	Antibody Responses to SARS-CoV-2 Antigens in Humans and Animals.	Vaccines (Basel)
33207533	"Computational Analysis of Targeting SARS-CoV-2, Viral Entry Proteins ACE2 and TMPRSS2, and Interferon Genes by Host MicroRNAs."	Genes (Basel)
33207245	SARS-CoV-2 Cell Entry Factors ACE2 and TMPRSS2 Are Expressed in the Microvasculature and Ducts of Human Pancreas but Are Not Enriched in beta Cells.	Cell Metab
33207244	Expression of SARS-CoV-2 Entry Factors in the Pancreas of Normal Organ Donors and Individuals with COVID-19.	Cell Metab
33207208	JAK1 Inhibition Blocks Lethal Immune Hypersensitivity in a Mouse Model of Down Syndrome.	Cell Rep
33207184	Compromised Humoral Functional Evolution Tracks with SARS-CoV-2 Mortality.	Cell
33207070	"Global SNP analysis of 11,183 SARS-CoV-2 strains reveals high genetic diversity."	Transbound Emerg Dis
33206959	The IMEx coronavirus interactome: an evolving map of Coronaviridae-host molecular interactions.	Database (Oxford)
33206767	COVID-19 and Liver Damage: Narrative Review and Proposed Clinical Protocol for Critically ill Pediatric Patients.	Clinics (Sao Paulo)
33206736	Myoglobin molecule charging in electrolyte solutions.	Phys Chem Chem Phys
33206719	Clinical and molecular characterization of COVID-19 hospitalized patients.	PLoS One
33206688	EGYVIR: An immunomodulatory herbal extract with potent antiviral activity against SARS-CoV-2.	PLoS One
33206635	Stability of SARS-CoV-2 phylogenies.	PLoS Genet
33206434	Severe acute respiratory syndrome coronavirus-2 natural animal reservoirs and experimental models: systematic review.	Rev Med Virol
33206207	Histamine receptors and COVID-19.	Inflamm Res
33206176	Hypertension and renin-angiotensin system blockers are not associated with expression of angiotensin-converting enzyme 2 (ACE2) in the kidney.	Eur Heart J
33205948	"Detection, Mapping, and Proteotyping of SARS-CoV-2 Coronavirus with High Resolution Mass Spectrometry."	ACS Infect Dis
33205830	Coronapp: A web application to annotate and monitor SARS-CoV-2 mutations.	J Med Virol
33205807	"Investigation of CD26, a potential SARS-CoV-2 receptor, as a biomarker of age and pathology."	Biosci Rep
33205709	Loss of orf3b in the circulating SARS-CoV-2 strains.	Emerg Microbes Infect
33205654	Exploring the Mechanism of Covalent Inhibition: Simulating the Binding Free Energy of alpha-Ketoamide Inhibitors of the Main Protease of SARS-CoV-2.	Biochemistry
33205496	Pharmacogenomics of genetic polymorphism within the genes responsible for SARS-CoV-2 susceptibility and the drug-metabolising genes used in treatment.	Rev Med Virol
33205351	Multidimensional Proteomic Approach of Endothelial Progenitors Demonstrate Expression of KDR Restricted to CD19 Cells.	Stem Cell Rev Rep
33205194	"The SARS-CoV-2 receptor, angiotensin-converting enzyme 2, is required for human endometrial stromal cell decidualizationdagger."	Biol Reprod
33205039	The combination of bromelain and curcumin as an immune-boosting nutraceutical in the prevention of severe COVID-19.	Metabol Open
33205008	Innate and Adaptive Immunity of Murine Neural Stem Cell-Derived piRNA Exosomes/Microvesicles against Pseudotyped SARS-CoV-2 and HIV-Based Lentivirus.	iScience
33204713	Potential Roles of the Renin-Angiotensin System in the Pathogenesis and Treatment of COVID-19.	Biomed Res Int
33204411	Targeting SARS-CoV-2 RNA-dependent RNA polymerase: An in silico drug repurposing for COVID-19.	F1000Res
33204385	Lymphocyte subsets in haematological patients with COVID-19: Multicentre prospective study.	Transl Oncol
33204369	"Infections of the lung: a predictive, preventive and personalized perspective through the lens of evolution, the emergence of SARS-CoV-2 and its pathogenesis."	EPMA J
33204339	Virus-induced p38 MAPK activation facilitates viral infection.	Theranostics
33204291	Network Pharmacology Analysis to Identify Phytochemicals in Traditional Chinese Medicines That May Regulate ACE2 for the Treatment of COVID-19.	Evid Based Complement Alternat Med
33204097	Cardiovascular Considerations in COVID19: A Comprehensive Review.	Ther Clin Risk Manag
33203926	High-content screening of Thai medicinal plants reveals Boesenbergia rotunda extract and its component Panduratin A as anti-SARS-CoV-2 agents.	Sci Rep
33203890	Upper airway gene expression reveals suppressed immune responses to SARS-CoV-2 compared with other respiratory viruses.	Nat Commun
33203860	STAT2 signaling restricts viral dissemination but drives severe pneumonia in SARS-CoV-2 infected hamsters.	Nat Commun
33203833	Immune suppression in the early stage of COVID-19 disease.	Nat Commun
33203821	Repurposing Screens of FDA-Approved Drugs Identify 29 Inhibitors of SARS-CoV-2.	J Microbiol Biotechnol
33203811	Potential SARS-CoV-2 protease M(pro) inhibitors: repurposing FDA-approved drugs.	Phys Biol
33203793	Cell differentiation and aging accompanied by depletion of the ACE2 protein.	Aging (Albany NY)
33203681	"Global analysis of more than 50,000 SARS-CoV-2 genomes reveals epistasis between eight viral genes."	Proc Natl Acad Sci U S A
33203679	"Targeting the renin-angiotensin signaling pathway in COVID-19: Unanswered questions, opportunities, and challenges."	Proc Natl Acad Sci U S A
33203513	An enlightening role for cytokine storm in coronavirus infection.	Clin Immunol
33203214	Polymer microarrays rapidly identify competitive adsorbents of virus-like particles.	Biointerphases
33203141	The Rationale for Angiotensin Receptor Neprilysin Inhibitors in a Multi-Targeted Therapeutic Approach to COVID-19.	Int J Mol Sci
33203131	Placental Pathology of COVID-19 with and without Fetal and Neonatal Infection: Trophoblast Necrosis and Chronic Histiocytic Intervillositis as Risk Factors for Transplacental Transmission of SARS-CoV-2.	Viruses
33202960	"An Immediate and Long-Term Complication of COVID-19 May Be Type 2 Diabetes Mellitus: The Central Role of beta-Cell Dysfunction, Apoptosis and Exploration of Possible Mechanisms."	Cells
33202948	Diesel Particulate Matter 2.5 Induces Epithelial-to-Mesenchymal Transition and Upregulation of SARS-CoV-2 Receptor during Human Pluripotent Stem Cell-Derived Alveolar Organoid Development.	Int J Environ Res Public Health
33202670	Vitamin D3 as Potential Treatment Adjuncts for COVID-19.	Nutrients
33202598	The Pivotal Role of Adipocyte-Na K peptide in Reversing Systemic Inflammation in Obesity and COVID-19 in the Development of Heart Failure.	Antioxidants (Basel)
33202215	"Furin Protease: From SARS CoV-2 to Anthrax, Diabetes, and Hypertension."	Perm J
33202203	"NETosis: Molecular Mechanisms, Role in Physiology and Pathology."	Biochemistry (Mosc)
33202195	Cytokine Storm May Not Be the Chief Culprit for the Deterioration of COVID-19.	Viral Immunol
33202171	Viral macrodomains: a structural and evolutionary assessment of the pharmacological potential.	Open Biol
33202092	Genetic insight into COVID-19 related liver injury: A note on MBOAT7.	Liver Int
33202023	Carbapenemase-producing Enterobacterales causing secondary infections during the COVID-19 crisis at a New York City hospital.	J Antimicrob Chemother
33201937	A Pathophysiological Model for COVID-19: Critical Importance of Transepithelial Sodium Transport upon Airway Infection.	Function (Oxf)
33201914	"Genetic diversity of SARS-CoV-2 and clinical, epidemiological characteristics of COVID-19 patients in Hanoi, Vietnam."	PLoS One
33201699	Triterpenoid-Mediated Inhibition of Virus-Host Interaction: Is Now the Time for Discovering Viral Entry/Release Inhibitors from Nature?	J Med Chem
33201386	"Molecular docking studies, molecular dynamics and ADME/tox reveal therapeutic potentials of STOCK1N-69160 against papain-like protease of SARS-CoV-2."	Mol Divers
33201341	ceRNA analysis of SARS-CoV-2.	Arch Virol
33201001	Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers and Mortality Among COVID-19 Patients: A Systematic Review and Meta-Analysis.	Am J Ther
33200935	Computational Design of 25-mer Peptide Binders of SARS-CoV-2.	J Phys Chem B
33200842	The genetic structure of SARS-CoV-2 does not rule out a laboratory origin: SARS-COV-2 chimeric structure and furin cleavage site might be the result of genetic manipulation.	Bioessays
33200826	SARS-CoV-2 nucleocapsid protein phase-separates with RNA and with human hnRNPs.	EMBO J
33200786	Endothelial pulsatile shear stress is a backstop for COVID-19.	Emerg Top Life Sci
33200717	Pharmacological inhibition of MMP3 as a potential therapeutic option for COVID-19 associated acute respiratory distress syndrome.	Infect Disord Drug Targets
33200697	Natural Compounds as Inhibitors of SARS-CoV-2 Main Protease (3CLpro): A Molecular Docking and Simulation Approach to Combat COVID-19.	Curr Pharm Des
33200683	Computational investigation of binding of chloroquinone and hydroxychloroquinone against PLPro of SARS-CoV-2.	J Biomol Struct Dyn
33200681	"Determination of potential inhibitors based on isatin derivatives against SARS-CoV-2 main protease (m(pro)): a molecular docking, molecular dynamics and structure-activity relationship studies."	J Biomol Struct Dyn
33200680	In silico screening and molecular dynamics of phytochemicals from Indian cuisine against SARS-CoV-2 M(Pro).	J Biomol Struct Dyn
33200678	Computational investigation for identification of potential phytochemicals and antiviral drugs as potential inhibitors for RNA-dependent RNA polymerase of COVID-19.	J Biomol Struct Dyn
33200673	Inhibitory potential of repurposed drugs against the SARS-CoV-2 main protease: a computational-aided approach.	J Biomol Struct Dyn
33200417	The other side of COVID-19 pandemic: Effects on male fertility.	J Med Virol
33200379	Computational study of pomegranate peel extract polyphenols as potential inhibitors of SARS-CoV-2 virus internalization.	Mol Cell Biochem
33200284	Modelling the structural and reactivity landscapes of tucatinib with special reference to its wavefunction-dependent properties and screening for potential antiviral activity.	J Mol Model
33200104	Can the coronavirus infection penetrates the brain resulting in sudden anosmia followed by severe neurological disorders?	eNeurologicalSci
33200089	A multiple peptides vaccine against COVID-19 designed from the nucleocapsid phosphoprotein (N) and Spike Glycoprotein (S) via the immunoinformatics approach.	Inform Med Unlocked
33200088	Engineering a novel subunit vaccine against SARS-CoV-2 by exploring immunoinformatics approach.	Inform Med Unlocked
33200085	"Combinatorial therapeutic trial plans for COVID-19 treatment armed up with antiviral, antiparasitic, cell-entry inhibitor, and immune-boosters."	Virusdisease
33200084	Structure-guided discovery approach identifies potential lead compounds targeting M(pro) of SARS-CoV-2.	Virusdisease
33200082	Enhanced expression of immune checkpoint receptors during SARS-CoV-2 viral infection.	Mol Ther Methods Clin Dev
33200080	A Distinct Phylogenetic Cluster of Indian Severe Acute Respiratory Syndrome Coronavirus 2 Isolates.	Open Forum Infect Dis
33200028	Mutations in the SARS-CoV-2 spike RBD are responsible for stronger ACE2 binding and poor anti-SARS-CoV mAbs cross-neutralization.	Comput Struct Biotechnol J
33200027	In silico and in vitro studies reveal complement system drives coagulation cascade in SARS-CoV-2 pathogenesis.	Comput Struct Biotechnol J
33200026	Chinese herbal compounds against SARS-CoV-2: Puerarin and quercetin impair the binding of viral S-protein to ACE2 receptor.	Comput Struct Biotechnol J
33200006	[COVID-19 pneumonia].	Gastroenterologe
33199981	The potential antiviral effect of major royal jelly protein2 and its isoform X1 against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Insight on their sialidase activity and molecular docking.	J Funct Foods
33199970	Genetic analysis of the 2019 coronavirus pandemic with from real-time reverse transcriptase polymerase chain reaction.	Saudi J Biol Sci
33199969	Synthesis of novel coumarin analogues: Investigation of molecular docking interaction of SARS-CoV-2 proteins with natural and synthetic coumarin analogues and their pharmacokinetics studies.	Saudi J Biol Sci
33199930	A computational study to disclose potential drugs and vaccine ensemble for COVID-19 conundrum.	J Mol Liq
33199926	[Proinflammatory cytokines and cardio-vascular risk: From myocardial infarction tocytokine storm of COVID-19].	Bull Acad Natl Med
33199883	Eliciting B cell immunity against infectious diseases using nanovaccines.	Nat Nanotechnol
33199863	Spike-specific circulating T follicular helper cell and cross-neutralizing antibody responses in COVID-19-convalescent individuals.	Nat Microbiol
33199671	Expression Analyses of MicroRNAs in Hamster Lung Tissues Infected by SARS-CoV-2.	Mol Cells
33199208	Severe acute respiratory syndrome coronavirus 2 and renin-angiotensin system blockers: A review and pooled analysis.	Arch Cardiovasc Dis
33199023	"History of the COVID-19 pandemic: Origin, explosion, worldwide spreading."	Biochem Biophys Res Commun
33199022	"The D614G mutations in the SARS-CoV-2 spike protein: Implications for viral infectivity, disease severity and vaccine design."	Biochem Biophys Res Commun
33199021	Evolution patterns of SARS-CoV-2: Snapshot on its genome variants.	Biochem Biophys Res Commun
33198855	"[Analysis of pathogenesis, syndrome differentiation and treatment of asymptomatic infectors of coronavirus disease 2019 based on the theory of ""pathogen hiding in the pleurodiaphragmatic interspace""]."	Zhonghua Wei Zhong Bing Ji Jiu Yi Xue
33198594	Immunodominant regions prediction of nucleocapsid protein for SARS-CoV-2 early diagnosis: a bioinformatics and immunoinformatics study.	Pathog Glob Health
33198412	Emerging Neurological and Psychobiological Aspects of COVID-19 Infection.	Brain Sci
33198287	"SARS-CoV-2 Proteins Induce IFNG in Th1 Lymphocytes Generated from CD4+ Cells from Healthy, Unexposed Polish Donors."	Vaccines (Basel)
33197881	Role of angiotensin-converting enzyme 2 in neurodegenerative diseases during the COVID-19 pandemic.	Aging (Albany NY)
33197855	Connecting the dots on vertical transmission of SARS-CoV-2 using protein-protein interaction network analysis - Potential roles of placental ACE2 and ENDOU.	Placenta
33197765	SARS-CoV-2 microbiome dysbiosis linked disorders and possible probiotics role.	Biomed Pharmacother
33197762	"Early use of non-steroidal anti-inflammatory drugs in COVID-19 might reverse pathogenesis, prevent complications and improve clinical outcomes."	Biomed Pharmacother
33197472	Angiotensin converting enzyme genotypes and mortality from COVID-19: An ecological study.	J Infect
33197260	Correlation Between Early Plasma Interleukin 37 Responses With Low Inflammatory Cytokine Levels and Benign Clinical Outcomes in Severe Acute Respiratory Syndrome Coronavirus 2 Infection.	J Infect Dis
33197212	The treatment of SARS-CoV2 with antivirals and mitigation of the cytokine storm syndrome: the role of gene expression.	Genome
33197204	COVID-19-Associated Nonocclusive Fibrin Microthrombi in the Heart.	Circulation
33196989	"Covid-19, heat shock proteins, and autoimmune bullous diseases: a potential link deserving further attention."	Cell Stress Chaperones
33196830	GenBank.	Nucleic Acids Res
33196292	COVID-19 and Sepsis Are Associated With Different Abnormalities in Plasma Procoagulant and Fibrinolytic Activity.	Arterioscler Thromb Vasc Biol
33196159	COVID-19 and Body Iron: A Survey on Phenomenological and Genetic Correlations.	ACS Chem Neurosci
33196058	Possible protective role of 17beta-estradiol against COVID-19.	J Allergy Infect Dis
33196035	"SARS-CoV-2: A critical review of its history, pathogenesis, transmission, diagnosis and treatment."	Biosaf Health
33195997	Applying Immune Instincts and Maternal Intelligence from Comparative Microbiology to COVID-19.	SN Compr Clin Med
33195828	Binding of the small-molecule kinase inhibitor ruxolitinib to membranes does not disturb membrane integrity.	Biochem Biophys Rep
33195813	Human coronaviruses: ophthalmic manifestations.	BMJ Open Ophthalmol
33195627	Natural Infection by SARS-CoV-2 in Companion Animals: A Review of Case Reports and Current Evidence of Their Role in the Epidemiology of COVID-19.	Front Vet Sci
33195610	Coronavirus Infection of the Central Nervous System: Animal Models in the Time of COVID-19.	Front Vet Sci
33195600	"The Coronaviruses of Animals and Birds: Their Zoonosis, Vaccines, and Models for SARS-CoV and SARS-CoV2."	Front Vet Sci
33195487	Vascular Manifestations of COVID-19 - Thromboembolism and Microvascular Dysfunction.	Front Cardiovasc Med
33195477	Small Resistance Artery Disease and ACE2 in Hypertension: A New Paradigm in the Context of COVID-19.	Front Cardiovasc Med
33195436	ACE2 in the Era of SARS-CoV-2: Controversies and Novel Perspectives.	Front Mol Biosci
33195427	Investigation of the Effect of Temperature on the Structure of SARS-CoV-2 Spike Protein by Molecular Dynamics Simulations.	Front Mol Biosci
33195415	Systematic Analysis of Coronavirus Disease 2019 (COVID-19) Receptor ACE2 in Malignant Tumors: Pan-Cancer Analysis.	Front Mol Biosci
33195414	Identifying Pathways and Networks Associated With the SARS-CoV-2 Cell Receptor ACE2 Based on Gene Expression Profiles in Normal and SARS-CoV-2-Infected Human Tissues.	Front Mol Biosci
33195402	Determine the Potential Epitope Based Peptide Vaccine Against Novel SARS-CoV-2 Targeting Structural Proteins Using Immunoinformatics Approaches.	Front Mol Biosci
33195401	SARS-CoV-2 Virion Stabilization by Zn Binding.	Front Mol Biosci
33195400	COVID-19: Targeting Proteases in Viral Invasion and Host Immune Response.	Front Mol Biosci
33195397	Drug Weaponry to Fight Against SARS-CoV-2.	Front Mol Biosci
33195352	"Prevalence, Mechanisms, and Implications of Gastrointestinal Symptoms in COVID-19."	Front Med (Lausanne)
33195336	Centrality of G6PD in COVID-19: The Biochemical Rationale and Clinical Implications.	Front Med (Lausanne)
33195331	The Pursuit of COVID-19 Biomarkers: Putting the Spotlight on ACE2 and TMPRSS2 Regulatory Sequences.	Front Med (Lausanne)
33195212	The Landscape of Coronavirus Disease 2019 (COVID-19) and Integrated Analysis SARS-CoV-2 Receptors and Potential Inhibitors in Lung Adenocarcinoma Patients.	Front Cell Dev Biol
33195080	"Identification of a New Potential SARS-COV-2 RNA-Dependent RNA Polymerase Inhibitor via Combining Fragment-Based Drug Design, Docking, Molecular Dynamics, and MM-PBSA Calculations."	Front Chem
33195060	Hijacking SARS-CoV-2/ACE2 Receptor Interaction by Natural and Semi-synthetic Steroidal Agents Acting on Functional Pockets on the Receptor Binding Domain.	Front Chem
33194993	Childhood Immunization and COVID-19: An Early Narrative Review.	Front Public Health
33194988	Lethal Pneumonia Cases in Mojiang Miners (2012) and the Mineshaft Could Provide Important Clues to the Origin of SARS-CoV-2.	Front Public Health
33194826	miR-1207-5p Can Contribute to Dysregulation of Inflammatory Response in COVID-19 via Targeting SARS-CoV-2 RNA.	Front Cell Infect Microbiol
33194802	Innate Immunity and Influenza A Virus Pathogenesis: Lessons for COVID-19.	Front Cell Infect Microbiol
33194800	Systems Biology Approaches for Therapeutics Development Against COVID-19.	Front Cell Infect Microbiol
33194755	COVID-19-Induced Modifications in the Tumor Microenvironment: Do They Affect Cancer Reawakening and Metastatic Relapse?	Front Oncol
33194671	Coronavirus Disease 2019: A Brief Review of the Clinical Manifestations and Pathogenesis to the Novel Management Approaches and Treatments.	Front Oncol
33194423	Non-SARS-CoV-2 genome sequences identified in clinical samples from COVID-19 infected patients: Evidence for co-infections.	PeerJ
33194341	Excessive G-U transversions in novel allele variants in SARS-CoV-2 genomes.	PeerJ
33194329	"Epitope-based chimeric peptide vaccine design against S, M and E proteins of SARS-CoV-2, the etiologic agent of COVID-19 pandemic: an in silico approach."	PeerJ
33194122	Gastrointestinal pathophysiology of SARS-CoV2 - a literature review.	J Community Hosp Intern Med Perspect
33193695	Identifying Effective Antiviral Drugs Against SARS-CoV-2 by Drug Repositioning Through Virus-Drug Association Prediction.	Front Genet
33193689	TMPRSS2 Correlated With Immune Infiltration Serves as a Prognostic Biomarker in Prostatic Adenocarcinoma: Implication for the COVID-2019.	Front Genet
33193684	Predicting the Animal Susceptibility and Therapeutic Drugs to SARS-CoV-2 Based on Spike Glycoprotein Combined With ACE2.	Front Genet
33193683	Characterization of Chloroplast Genomes From Two Salvia Medicinal Plants and Gene Transfer Among Their Mitochondrial and Chloroplast Genomes.	Front Genet
33193639	Underlying Mechanisms and Candidate Drugs for COVID-19 Based on the Connectivity Map Database.	Front Genet
33193454	CoVaccine HT Adjuvant Potentiates Robust Immune Responses to Recombinant SARS-CoV-2 Spike S1 Immunization.	Front Immunol
33193427	Tea Bioactive Modulate Innate Immunity: In Perception to COVID-19 Pandemic.	Front Immunol
33193418	COVID-19 and Systemic Lupus Erythematosus: Focus on Immune Response and Therapeutics.	Front Immunol
33193414	Immunoinformatic Analysis of SARS-CoV-2 Nucleocapsid Protein and Identification of COVID-19 Vaccine Targets.	Front Immunol
33193407	The Influence of the Lectin Pathway of Complement Activation on Infections of the Respiratory System.	Front Immunol
33193390	"SOCS, Intrinsic Virulence Factors, and Treatment of COVID-19."	Front Immunol
33193385	Perspective: Reducing SARS-CoV2 Infectivity and Its Associated Immunopathology.	Front Immunol
33193384	"Heightened Circulating Interferon-Inducible Chemokines, and Activated Pro-Cytolytic Th1-Cell Phenotype Features Covid-19 Aggravation in the Second Week of Illness."	Front Immunol
33193377	I mmunosenescence and Inflammaging: Risk Factors of Severe COVID-19 in Older People.	Front Immunol
33193350	Immune Mechanisms in Cardiovascular Diseases Associated With Viral Infection.	Front Immunol
33193349	NLRP3 Inflammasome: The Stormy Link Between Obesity and COVID-19.	Front Immunol
33193337	COVID-19 as an Immune Complex Hypersensitivity in Antigen Excess Conditions: Theoretical Pathogenetic Process and Suggestions for Potential Therapeutic Interventions.	Front Immunol
33193331	A 21st Century Evil: Immunopathology and New Therapies of COVID-19.	Front Immunol
33193156	G-Quadruplexes Are Present in Human Coronaviruses Including SARS-CoV-2.	Front Microbiol
33193132	"Positive Selection of ORF1ab, ORF3a, and ORF8 Genes Drives the Early Evolutionary Trends of SARS-CoV-2 During the 2020 COVID-19 Pandemic."	Front Microbiol
33193115	Emerging Molecular Prospective of SARS-CoV-2: Feasible Nanotechnology Based Detection and Inhibition.	Front Microbiol
33193019	"COVID-19 Associated Ischemic Stroke and Hemorrhagic Stroke: Incidence, Potential Pathological Mechanism, and Management."	Front Neurol
33193009	"Loss of Olfactory Function-Early Indicator for Covid-19, Other Viral Infections and Neurodegenerative Disorders."	Front Neurol
33192602	Beta-Adrenergic Receptor Stimulation Modulates the Cellular Proarrhythmic Effects of Chloroquine and Azithromycin.	Front Physiol
33192207	Designing of Nucleocapsid Protein Based Novel Multi-epitope Vaccine Against SARS-COV-2 Using Immunoinformatics Approach.	Int J Pept Res Ther
33191989	"Pneumolysis and ""Silent Hypoxemia"" in COVID-19."	Indian J Clin Biochem
33191884	Do genetic factors predispose people to COVID-19: A review article.	Curr Mol Med
33191813	Dendritic cells in COVID-19 immunopathogenesis: insights for a possible role in determining disease outcome.	Int Rev Immunol
33191600	Renin-angiotensin system inhibition and risk of infection and mortality in COVID-19: a systematic review and meta-analysis.	Intern Med J
33191474	Mechanisms of COVID-19-induced heart failure: a short review.	Heart Fail Rev
33191206	Repurposing existing drugs for the treatment of COVID-19/SARS-CoV-2 infection: A review describing drug mechanisms of action.	Biochem Pharmacol
33191178	Chicken Egg Yolk Antibodies (IgYs) block the binding of multiple SARS-CoV-2 spike protein variants to human ACE2.	Int Immunopharmacol
33191083	Protease targeted COVID-19 drug discovery and its challenges: Insight into viral main protease (Mpro) and papain-like protease (PLpro) inhibitors.	Bioorg Med Chem
33191068	"Network pharmacology, molecular docking integrated surface plasmon resonance technology reveals the mechanism of Toujie Quwen Granules against coronavirus disease 2019 pneumonia."	Phytomedicine
33190827	T cell immunity to SARS-CoV-2 following natural infection and vaccination.	Biochem Biophys Res Commun
33190685	The Mystery of MIS-C Post-SARS-CoV-2 Infection.	Trends Microbiol
33190493	Revealing the Inhibition Mechanism of RNA-Dependent RNA Polymerase (RdRp) of SARS-CoV-2 by Remdesivir and Nucleotide Analogues: A Molecular Dynamics Simulation Study.	J Phys Chem B
33190346	Pathophysiological mechanisms of liver injury in COVID-19.	Liver Int
33190306	Gastrointestinal and renal complications in SARS-CoV-2-infected patients: Role of immune system.	Scand J Immunol
33190302	"Coronavirus disease 2019 (COVID-19): An overview of the immunopathology, serological diagnosis and management."	Scand J Immunol
33190277	"CB2 receptor-selective agonists as candidates for targeting infection, inflammation, and immunity in SARS-CoV-2 infections."	Drug Dev Res
33190150	Bioinformatic analysis of SMN1-ACE/ACE2 interactions hinted at a potential protective effect of spinal muscular atrophy against COVID-19-induced lung injury.	Brief Bioinform
33190011	Culinary spice bioactives as potential therapeutics against SARS-CoV-2: Computational investigation.	Comput Biol Med
33189887	Major reduction of NKT cells in patients with severe COVID-19 pneumonia.	Clin Immunol
33189832	The key role of Warburg effect in SARS-CoV-2 replication and associated inflammatory response.	Biochimie
33189817	The nucleocapsid protein of zoonotic betacoronaviruses is an attractive target for antiviral drug discovery.	Life Sci
33189776	Repurposed drugs and nutraceuticals targeting envelope protein: A possible therapeutic strategy against COVID-19.	Genomics
33189768	Peptide and peptide-based inhibitors of SARS-CoV-2 entry.	Adv Drug Deliv Rev
33189680	The flexibility of ACE2 in the context of SARS-CoV-2 infection.	Biophys J
33189582	"Ivermectin: An Anthelmintic, an Insecticide, and Much More."	Trends Parasitol
33189453	SARS-CoV 2; Possible alternative virus receptors and pathophysiological determinants.	Med Hypotheses
33189452	Could a family history of type 2 diabetes be a risk factor to the endothelial damage in the patient with COVID-19?	Med Hypotheses
33188794	"Treating exuberant, non-resolving inflammation in the lung; Implications for acute respiratory distress syndrome and COVID-19."	Pharmacol Ther
33188728	Nonstructural Protein 1 of SARS-CoV-2 Is a Potent Pathogenicity Factor Redirecting Host Protein Synthesis Machinery toward Viral RNA.	Mol Cell
33188579	Human mesenchymal stromal cells do not express ACE2 and TMPRSS2 and are not permissive to SARS-CoV-2 infection.	Stem Cells Transl Med
33188364	COVID-19 and diabetes mellitus: from pathophysiology to clinical management.	Nat Rev Endocrinol
33188207	Characterization of neutralizing antibody with prophylactic and therapeutic efficacy against SARS-CoV-2 in rhesus monkeys.	Nat Commun
33187979	Distinct inflammatory profiles distinguish COVID-19 from influenza with limited contributions from cytokine storm.	Sci Adv
33187978	JAK inhibition reduces SARS-CoV-2 liver infectivity and modulates inflammatory responses to reduce morbidity and mortality.	Sci Adv
33187644	Humoral immune responses and neutralizing antibodies against SARS-CoV-2; implications in pathogenesis and protective immunity.	Biochem Biophys Res Commun
33187633	Cardiac Involvement of COVID-19: A Comprehensive Review.	Am J Med Sci
33187280	Clinical Features and Pathogenic Mechanisms of Gastrointestinal Injury in COVID-19.	J Clin Med
33187255	Significance of Simple Steatosis: An Update on the Clinical and Molecular Evidence.	Cells
33187101	Exposome and Immunity Training: How Pathogen Exposure Order Influences Innate Immune Cell Lineage Commitment and Function.	Int J Mol Sci
33187074	Spike Glycoprotein-Mediated Entry of SARS Coronaviruses.	Viruses
33187040	Coronavirus Disease-19 (COVID-19) and Heart Failure: Current Perspective.	J Assoc Physicians India
33186866	"Human Coronaviruses SARS-CoV, MERS-CoV, and SARS-CoV-2 in Children."	J Pediatr Nurs
33186810	A clade of SARS-CoV-2 viruses associated with lower viral loads in patient upper airways.	EBioMedicine
33186795	Kefir: A protective dietary supplementation against viral infection.	Biomed Pharmacother
33186749	Drug Inhibition of SARS-CoV-2 Replication in Human Pluripotent Stem Cell-Derived Intestinal Organoids.	Cell Mol Gastroenterol Hepatol
33186710	Lessons From the 1918 Flu Pandemic: A Novel Etiologic Subtype of ADHD?	J Am Acad Child Adolesc Psychiatry
33186704	"CCR5 inhibition in critical COVID-19 patients decreases inflammatory cytokines, increases CD8 T-cells, and decreases SARS-CoV2 RNA in plasma by day 14."	Int J Infect Dis
33186585	PolarProtDb: A Database of Transmembrane and Secreted Proteins showing Apical-Basal Polarity.	J Mol Biol
33186542	COVID-19-Induced ARDS Is Associated with Decreased Frequency of Activated Memory/Effector T Cells Expressing CD11a(+).	Mol Ther
33186327	Determinants of healing among patients with coronavirus disease 2019: the results of the SARS-RAS study of the Italian Society of Hypertension.	J Hypertens
33186231	Structural basis of severe acute respiratory syndrome coronavirus 2 infection.	Curr Opin HIV AIDS
33186230	Molecular epidemiology in the HIV and SARS-CoV-2 pandemics.	Curr Opin HIV AIDS
33186228	Adaptation of advanced clinical virology assays from HIV-1 to SARS-CoV-2.	Curr Opin HIV AIDS
33186186	"Coronavirus disease 2019 and asthma, allergic rhinitis: molecular mechanisms and host-environmental interactions."	Curr Opin Allergy Clin Immunol
33186179	Cross-sectional Imaging Manifestations of Extrapulmonary Involvement in COVID-19 Disease.	J Comput Assist Tomogr
33186121	Comparative analysis of SARS-CoV-2 and its receptor ACE2 with evolutionarily related coronaviruses.	Aging (Albany NY)
33186086	Complicating Infections Associated with Common Endemic Human Respiratory Coronaviruses.	Health Secur
33186044	Targeting SARS-CoV-2 Proteases and Polymerase for COVID-19 Treatment: State of the Art and Future Opportunities.	J Med Chem
33186016	PRIMoRDiA: A Software to Explore Reactivity and Electronic Structure in Large Biomolecules.	J Chem Inf Model
33185982	Interferon-stimulated gene products as regulators of central carbon metabolism.	FEBS J
33185926	SARS-CoV-2-mediated immune system activation and potential application in immunotherapy.	Med Res Rev
33185828	Potential approaches to combat COVID-19: a mini-review.	Mol Biol Rep
33185784	"Comparison of Binding Site of Remdesivir and Its Metabolites with NSP12-NSP7-NSP8, and NSP3 of SARS CoV-2 Virus and Alternative Potential Drugs for COVID-19 Treatment."	Protein J
33185582	COVID-19 in age-related neurodegenerative diseases: is there a role for vitamin D3 as a possible therapeutic strategy?	Rev Neurosci
33185497	Harnessing the non-specific immunogenic effects of available vaccines to combat COVID-19.	Hum Vaccin Immunother
33184809	Therapeutic Approach against 2019-nCoV by Inhibition of ACE-2 Receptor.	Drug Res (Stuttg)
33184722	Identification of saquinavir as a potent inhibitor of dimeric SARS-CoV2 main protease through MM/GBSA.	J Mol Model
33184600	Peptide modelling and screening against human ACE2 and spike glycoprotein RBD of SARS-CoV-2.	In Silico Pharmacol
33184509	Characterization of pre-existing and induced SARS-CoV-2-specific CD8(+) T cells.	Nat Med
33184506	The emerging role of neutrophil extracellular traps in severe acute respiratory syndrome coronavirus 2 (COVID-19).	Sci Rep
33184504	Molecular targeting of vulnerable RNA sequences in SARS CoV-2: identifying clinical feasibility.	Gene Ther
33184476	Genetic influences on viral-induced cytokine responses in the lung.	Mucosal Immunol
33184246	Identification of a repurposed drug as an inhibitor of Spike protein of human coronavirus SARS-CoV-2 by computational methods.	J Biosci
33184236	SARS-CoV-2 D614G variant exhibits efficient replication ex vivo and transmission in vivo.	Science
33184176	"The SKI complex is a broad-spectrum, host-directed antiviral drug target for coronaviruses, influenza, and filoviruses."	Proc Natl Acad Sci U S A
33184173	Analysis of genomic distributions of SARS-CoV-2 reveals a dominant strain type with strong allelic associations.	Proc Natl Acad Sci U S A
33184103	Defensive Properties of Mucin Glycoproteins during Respiratory Infections-Relevance for SARS-CoV-2.	mBio
33183974	"COVID-19 susceptibility in pregnancy: Immune/inflammatory considerations, the role of placental ACE-2 and research considerations."	Reprod Biol
33183854	Periodontal pocket and COVID-19: Could there be a possible link?	Med Hypotheses
33183383	Obesity and the increased risk for COVID-19: mechanisms and nutritional management.	Nutr Res Rev
33183207	COVID-19 and Comorbidities: Is Inflammation the Underlying Condition in Children? A Narrative Review.	Curr Pediatr Rev
33183205	Recent Advances in the Discovery of Potent Proteases Inhibitors Targeting the SARS Coronaviruses.	Curr Top Med Chem
33183203	"Nicotinamide: Oversight of Metabolic Dysfunction Through SIRT1, mTOR, and Clock Genes."	Curr Neurovasc Res
33183178	"Identification of natural inhibitors against prime targets of SARS-CoV-2 using molecular docking, molecular dynamics simulation and MM-PBSA approaches."	J Biomol Struct Dyn
33183004	High-Throughput Screening of an FDA-Approved Drug Library Identifies Inhibitors against Arenaviruses and SARS-CoV-2.	ACS Infect Dis
33182802	Cell Clearing Systems as Targets of Polyphenols in Viral Infections: Potential Implications for COVID-19 Pathogenesis.	Antioxidants (Basel)
33182653	SARS-CoV-2 Infection and Cardioncology: From Cardiometabolic Risk Factors to Outcomes in Cancer Patients.	Cancers (Basel)
33182546	SARS-CoV-2 Vaccines: Inactivation by Gamma Irradiation for T and B Cell Immunity.	Pathogens
33182350	Anti-Inflammatory Effects of Amantadine and Memantine: Possible Therapeutics for the Treatment of Covid-19?	J Pers Med
33182073	Understanding the complexities of SARS-CoV2 infection and its immunology: A road to immune-based therapeutics.	Int Immunopharmacol
33182059	Correlation between premorbid IL-6 levels and COVID-19 mortality: Potential role for Vitamin D.	Int Immunopharmacol
33181590	Inflammatory Response and Phenotyping in Severe Acute Respiratory Infection From the Middle East Respiratory Syndrome Coronavirus and Other Etiologies.	Crit Care Med
33181437	Neutralizing monoclonal antibody fails to recognize porcine epidemic diarrhea virus with two regions deleted in spike protein.	Vet Microbiol
33181329	Analysis of the potential impact of genomic variants in global SARS-CoV-2 genomes on molecular diagnostic assays.	Int J Infect Dis
33181319	Necrostatin-1 and necroptosis inhibition: Pathophysiology and therapeutic implications.	Pharmacol Res
33181224	Molecular docking simulation reveals ACE2 polymorphisms that may increase the affinity of ACE2 with the SARS-CoV-2 Spike protein.	Biochimie
33181158	From angiotensin-converting enzyme 2 disruption to thromboinflammatory microvascular disease: A paradigm drawn from COVID-19.	Int J Cardiol
33181144	Russelioside B; A pregnane glycoside for treatment of gastric ulcer via modulation of heat shock protein-70 and vascular endothelial growth factor.	Steroids
33181114	In silico analysis of selected alkaloids against main protease (M(pro)) of SARS-CoV-2.	Chem Biol Interact
33181057	"Type I IFNs: A Blessing in Disguise or Partner in Crime in MERS-CoV-, SARS-CoV-, and SARS-CoV-2-Induced Pathology and Potential Use of Type I IFNs in Synergism with IFN-gamma as a Novel Antiviral Approach Against COVID-19."	Viral Immunol
33180935	Immunological Assessment of Pediatric Multisystem Inflammatory Syndrome Related to Coronavirus Disease 2019.	J Pediatric Infect Dis Soc
33180882	Virulence and pathogenesis of SARS-CoV-2 infection in rhesus macaques: A nonhuman primate model of COVID-19 progression.	PLoS Pathog
33180746	Age-determined expression of priming protease TMPRSS2 and localization of SARS-CoV-2 in lung epithelium.	J Clin Invest
33180562	Pulmonary Endothelial Dysfunction and Thrombotic Complications in Patients with COVID-19.	Am J Respir Cell Mol Biol
33180463	COVID-19 in the Developing World: Is the Immune Response to alpha-Gal an Overlooked Factor Mitigating the Severity of Infection?	ACS Infect Dis
33179934	Decoding Asymptomatic COVID-19 Infection and Transmission.	J Phys Chem Lett
33179911	Quercetin and Its Metabolites Inhibit Recombinant Human Angiotensin-Converting Enzyme 2 (ACE2) Activity.	J Agric Food Chem
33179852	Human soluble ACE2 improves the effect of remdesivir in SARS-CoV-2 infection.	EMBO Mol Med
33179785	Vascular obliteration because of endothelial and myointimal growth in COVID-19 patients.	Int J Dermatol
33179586	Reprofiling of approved drugs against SARS-CoV-2 main protease: an in-silico study.	J Biomol Struct Dyn
33179568	In-silico drug repurposing for targeting SARS-CoV-2 main protease (M(pro)).	J Biomol Struct Dyn
33179566	Human coronavirus dependency on host heat shock protein 90 reveals an antiviral target.	Emerg Microbes Infect
33179437	Association of HLA-B22 serotype with SARS-CoV-2 susceptibility in Hong Kong Chinese patients.	HLA
33179220	Sex differences in COVID-19: the role of androgens in disease severity and progression.	Endocrine
33179020	A Novel Link between Early Life Allergen Exposure and Neuroimmune Development in Children.	J Clin Exp Immunol
33178900	SARS-CoV-2 cell receptor gene ACE2 -mediated immunomodulation in breast cancer subtypes.	Biochem Biophys Rep
33178779	Comprehensive review on the prevailing COVID-19 therapeutics and the potential of repurposing SARS-CoV-1 candidate drugs to target SARS-CoV-2 as a fast-track treatment and prevention option.	Ann Transl Med
33178392	Mesenchymal stem cells as living anti-inflammatory therapy for COVID-19 related acute respiratory distress syndrome.	World J Stem Cells
33178221	T-Cell Hyperactivation and Paralysis in Severe COVID-19 Infection Revealed by Single-Cell Analysis.	Front Immunol
33178220	Potential Cross-Reactive Immunity to SARS-CoV-2 From Common Human Pathogens and Vaccines.	Front Immunol
33178207	A Longitudinal Study of Immune Cells in Severe COVID-19 Patients.	Front Immunol
33178193	Is Cross-Reactive Immunity Triggering COVID-19 Immunopathogenesis?	Front Immunol
33178176	Differential Expression of Viral Transcripts From Single-Cell RNA Sequencing of Moderate and Severe COVID-19 Patients and Its Implications for Case Severity.	Front Microbiol
33178164	"Antimicrobial Peptides: Classification, Design, Application and Research Progress in Multiple Fields."	Front Microbiol
33178109	Revisiting the Immune Balance Theory: A Neurological Insight Into the Epidemic of COVID-19 and Its Alike.	Front Neurol
33178033	Physical Exercise and the Renin Angiotensin System: Prospects in the COVID-19.	Front Physiol
33178016	"COVID-19 Outbreak: Pathogenesis, Current Therapies, and Potentials for Future Management."	Front Pharmacol
33177848	Multiple Expression Assessments of ACE2 and TMPRSS2 SARS-CoV-2 Entry Molecules in the Urinary Tract and Their Associations with Clinical Manifestations of COVID-19.	Infect Drug Resist
33177698	Structure and drug binding of the SARS-CoV-2 envelope protein transmembrane domain in lipid bilayers.	Nat Struct Mol Biol
33177594	"SARS-CoV-2 receptor is co-expressed with elements of the kinin-kallikrein, renin-angiotensin and coagulation systems in alveolar cells."	Sci Rep
33177504	Immune responses to SARS-CoV-2 in three children of parents with symptomatic COVID-19.	Nat Commun
33177481	Long-Term Respiratory and Neurological Sequelae of COVID-19.	Med Sci Monit
33177276	Aspiration of periodontopathic bacteria due to poor oral hygiene potentially contributes to the aggravation of COVID-19.	J Oral Sci
33177213	A Genome Epidemiological Study of SARS-CoV-2 Introduction into Japan.	mSphere
33176880	"Pharmacophore modelling of vanillin derivatives, favipiravir, chloroquine, hydroxychloroquine, monolaurin and tetrodotoxin as M(Pro) inhibitors of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)."	BMC Res Notes
33176644	Are Hsp90 inhibitors good candidates against Covid-19?	Curr Protein Pept Sci
33176643	Computational Evidences of Phytochemical Mediated Disruption of PLpro Driven Replication of SARS-CoV-2: A Therapeutic Approach against COVID-19.	Curr Pharm Biotechnol
33176395	"Camostat mesylate against SARS-CoV-2 and COVID-19-Rationale, dosing and safety."	Basic Clin Pharmacol Toxicol
33176367	Favipiravir and COVID-19: A Simplified Summary.	Drug Res (Stuttg)
33176202	High prevalence of pre-existing serological cross-reactivity against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) in sub-Saharan Africa.	Int J Infect Dis
33175635	Neurological manifestations of coronavirus infections: role of angiotensin-converting enzyme 2 in COVID-19.	Int J Neurosci
33175614	"COVID-19 coronavirus vaccine T cell epitope prediction analysis based on distributions of HLA class I loci (HLA-A, -B, -C) across global populations."	Hum Vaccin Immunother
33175551	Identifying the Zoonotic Origin of SARS-CoV-2 by Modeling the Binding Affinity between the Spike Receptor-Binding Domain and Host ACE2.	J Proteome Res
33175425	COVID-19 lessons from the dish: Dissecting CNS manifestations through brain organoids.	EMBO J
33175403	Characterising and managing paediatric SARSCoV-2 infection: Learning about the virus in a global classroom.	Acta Paediatr
33175236	"Molecular basis for drug repurposing to study the interface of the S protein in SARS-CoV-2 and human ACE2 through docking, characterization, and molecular dynamics for natural drug candidates."	J Mol Model
33175170	"Database Resources of the National Genomics Data Center, China National Center for Bioinformation in 2021."	Nucleic Acids Res
33175089	COVID-KOP: integrating emerging COVID-19 data with the ROBOKOP database.	Bioinformatics
33174922	Renal changes in COVID-19 infection.	Rev Assoc Med Bras (1992)
33174669	Computational Hot-Spot Analysis of the SARS-CoV-2 Receptor Binding Domain/ACE2 Complex*.	Chembiochem
33174637	Why does COVID-19 pathology have several clinical forms?	Bioessays
33174605	"OMA orthology in 2021: website overhaul, conserved isoforms, ancestral gene order and more."	Nucleic Acids Res
33174599	A Descriptive and Quantitative Immunohistochemical Study Demonstrating a Spectrum of Platelet Recruitment Patterns Across Pulmonary Infections Including COVID-19.	Am J Clin Pathol
33174592	Composition of the immunoglobulin G glycome associates with the severity of COVID-19.	Glycobiology
33174576	Context contribution to the intermolecular recognition of human ACE2-derived peptides by SARS-CoV-2 spike protein: implications for improving the peptide affinity but not altering the peptide specificity by optimizing indirect readout.	Mol Omics
33174447	"In well-differentiated primary human bronchial epithelial cells, TGF-beta1 and TGF-beta2 induce expression of furin."	Am J Physiol Lung Cell Mol Physiol
33174446	Dysregulation of endocytic machinery and ACE2 in small airways of smokers and COPD patients can augment their susceptibility to SARS-CoV-2 (COVID-19) infections.	Am J Physiol Lung Cell Mol Physiol
33174418	Epitope-Based Potential Vaccine Candidate for Humoral and Cell-Mediated Immunity to Combat Severe Acute Respiratory Syndrome Coronavirus 2 Pandemic.	J Phys Chem Lett
33174415	Interactive Molecular Dynamics in Virtual Reality Is an Effective Tool for Flexible Substrate and Inhibitor Docking to the SARS-CoV-2 Main Protease.	J Chem Inf Model
33174406	Contextualizing cardiac dysfunction in critically ill patients with COVID-19.	Minerva Anestesiol
33173966	Hematological changes in patients with COVID19 (Review).	Mol Med Rep
33173860	Coronavirus in human diseases: Mechanisms and advances in clinical treatment.	MedComm (Beijing)
33173846	Adaptive Evolution of Peptide Inhibitors for Mutating SARS-CoV-2.	Adv Theory Simul
33173837	New putative animal reservoirs of SARS-CoV-2 in Italian fauna: A bioinformatic approach.	Heliyon
33173781	Computational Study of the Ion and Water Permeation and Transport Mechanisms of the SARS-CoV-2 Pentameric E Protein Channel.	Front Mol Biosci
33173755	"Quantum mechanical, spectroscopic and docking studies of (2E)-1-(4-aminophenyl)-3-(4-benzyloxyphenyl)-prop-2-en-1-one Chalcone derivative by density functional theory - A prospective respiratory drug."	Mater Today Proc
33173719	Biomimetic Human Disease Model of SARS-CoV-2 Induced Lung Injury and Immune Responses on Organ Chip System.	Adv Sci (Weinh)
33173718	Bioinspired DNase-I-Coated Melanin-Like Nanospheres for Modulation of Infection-Associated NETosis Dysregulation.	Adv Sci (Weinh)
33173643	Smoking Doubles the Mortality Risk in COVID-19: A Meta-Analysis of Recent Reports and Potential Mechanisms.	Cureus
33173592	A Hydrophobic-Interaction-Based Mechanism Triggers Docking between the SARS-CoV-2 Spike and Angiotensin-Converting Enzyme 2.	Glob Chall
33173539	Identification of Novel SARS-CoV-2 Drug Targets by Host MicroRNAs and Transcription Factors Co-regulatory Interaction Network Analysis.	Front Genet
33173452	"Determining the relationship between SARS-CoV-2 infection, dopamine, and COVID-19 complications."	J Taibah Univ Med Sci
33173434	Herbal plants coordinate COVID-19 in multiple dimensions - An insight analysis for clinically applied remedies.	Int J Med Sci
33173252	"Titanium (IV) complexes of some tetra-dentate symmetrical bis-Schiff bases of 1,6-hexanediamine: Synthesis, characterization, and in silico prediction of potential inhibitor against coronavirus (SARS-CoV-2)."	Appl Organomet Chem
33173250	Towards a novel peptide vaccine for Middle East respiratory syndrome coronavirus and its possible use against pandemic COVID-19.	J Mol Liq
33173052	Lung transcriptome of a COVID-19 patient and systems biology predictions suggest impaired surfactant production which may be druggable by surfactant therapy.	Sci Rep
33173010	Effective Inhibition of SARS-CoV-2 Entry by Heparin and Enoxaparin Derivatives.	J Virol
33172935	Transmission of SARS-CoV-2 on mink farms between humans and mink and back to humans.	Science
33172748	Cardiovascular Manifestations and Mechanisms in Patients with COVID-19.	Trends Endocrinol Metab
33172372	Tinocordiside from Tinospora cordifolia (Giloy) May Curb SARS-CoV-2 Contagion by Disrupting the Electrostatic Interactions between Host ACE2 and Viral S-Protein Receptor Binding Domain.	Comb Chem High Throughput Screen
33172369	"In-silico analysis of angiotensin converting enzyme 2 (ACE2) of livestock, pet and poultry animals to determine its susceptibility to SARS-CoV- 2 infection."	Comb Chem High Throughput Screen
33172366	The PentaFOLD 3.0 Algorithm for the Selection of Stable Elements of Secondary Structure to be Included in Vaccine Peptides.	Protein Pept Lett
33172188	Intestinal Barrier Function in Health and Disease-Any role of SARS-CoV-2?	Microorganisms
33172092	"Drugs Repurposing Using QSAR, Docking and Molecular Dynamics for Possible Inhibitors of the SARS-CoV-2 M(pro) Protease."	Molecules
33172013	Dangerous Pathogens as a Potential Problem for Public Health.	Medicina (Kaunas)
33172012	Fragment Library of Natural Products and Compound Databases for Drug Discovery.	Biomolecules
33171852	Cardiovascular Active Peptides of Marine Origin with ACE Inhibitory Activities: Potential Role as Anti-Hypertensive Drugs and in Prevention of SARS-CoV-2 Infection.	Int J Mol Sci
33171736	Cell Biology of Viral Infections.	Cells
33171544	Food-derived antioxidants and COVID-19.	J Food Biochem
33171276	Age-related mitochondrial dysfunction as a key factor in COVID-19 disease.	Exp Gerontol
33171111	"Acute Respiratory Distress in Aged, SARS-CoV-2-Infected African Green Monkeys but Not Rhesus Macaques."	Am J Pathol
33171100	Multi-Omics Resolves a Sharp Disease-State Shift between Mild and Moderate COVID-19.	Cell
33171099	Quick COVID-19 Healers Sustain Anti-SARS-CoV-2 Antibody Production.	Cell
33170924	Serological antibody testing in the COVID-19 pandemic: their molecular basis and applications.	Biochem Soc Trans
33170902	Large scale genomic analysis of 3067 SARS-CoV-2 genomes reveals a clonal geo-distribution and a rich genetic variations of hotspots mutations.	PLoS One
33170884	"Static all-atom energetic mappings of the SARS-Cov-2 spike protein and dynamic stability analysis of ""Up"" versus ""Down"" protomer states."	PLoS One
33170521	Step toward repurposing drug discovery for COVID-19 therapeutics through in silico approach.	Drug Dev Res
33170448	"Trace Element Zinc, a Nature's Gift to Fight Unprecedented Global Pandemic COVID-19."	Biol Trace Elem Res
33170317	ACE2: The Major Cell Entry Receptor for SARS-CoV-2.	Lung
33170176	A pilot study on the preventative potential of alpha-cyclodextrin and hydroxytyrosol against SARS-CoV-2 transmission.	Acta Biomed
33170174	Natural compounds as inhibitors of SARS-CoV-2 endocytosis: A promising approach against COVID-19.	Acta Biomed
33169644	Countermeasure and therapeutic: A(1-7) to treat acute respiratory distress syndrome due to COVID-19 infection.	J Renin Angiotensin Aldosterone Syst
33169562	[Overview of novel coronavirus infection and replication].	Sheng Wu Gong Cheng Xue Bao
33169410	Can BCG vaccine protect against COVID-19 via trained immunity and tolerogenesis?	Bioessays
33169132	Network Pharmacology and bioinformatics analyses identify intersection genes of niacin and COVID-19 as potential therapeutic targets.	Brief Bioinform
33169110	Impact of Gastrointestinal Symptoms in COVID-19: a Molecular Approach.	SN Compr Clin Med
33169107	Synergy of melanin and vitamin-D may play a fundamental role in preventing SARS-CoV-2 infections and halt COVID-19 by inactivating furin protease.	Transl Med Commun
33169063	SARS-CoV-2 associated COVID-19 in geriatric population: A brief narrative review.	Saudi J Biol Sci
33169062	Coagulopathies in novel coronavirus (SARS-CoV-2) pandemic: Emerging evidence for hematologists.	Saudi J Biol Sci
33169060	Pain related viral infections: a literature review.	Egypt J Neurol Psychiatr Neurosurg
33169014	Proinflammatory IgG Fc structures in patients with severe COVID-19.	Nat Immunol
33168795	Age-related gene expression alterations by SARS-CoV-2 infection contribute to poor prognosis in elderly.	J Genet
33168521	Comparison of detection rate of 16 sampling methods for respiratory viruses: a Bayesian network meta-analysis of clinical data and systematic review.	BMJ Glob Health
33168456	"Raltegravir, Indinavir, Tipranavir, Dolutegravir, and Etravirine against main protease and RNA-dependent RNA polymerase of SARS-CoV-2: A molecular docking and drug repurposing approach."	J Infect Public Health
33168188	"Obesity alters Ace2 and Tmprss2 expression in lung, trachea, and esophagus in a sex-dependent manner: Implications for COVID-19."	Biochem Biophys Res Commun
33167900	"Kinetic changes in virology, specific antibody response and imaging during the clinical course of COVID-19: a descriptive study."	BMC Infect Dis
33167852	SARS-CoV-2 and interferon blockade.	Mol Med
33167846	An overview on COVID-19 pandemic: from discovery to treatment.	Infect Disord Drug Targets
33167752	"Potential Influence of Olfactory, Gustatory, and Pharyngolaryngeal Sensory Dysfunctions on Swallowing Physiology in COVID-19."	Otolaryngol Head Neck Surg
33167401	Antibody-Based Immunotherapeutic Strategies for COVID-19.	Pathogens
33167313	SARS-CoV-2 Infection in Cancer Patients: Effects on Disease Outcomes and Patient Prognosis.	Cancers (Basel)
33167083	Immunoprotective potential of Ayurvedic herb Kalmegh (Andrographis paniculata) against respiratory viral infections - LC-MS/MS and network pharmacology analysis.	Phytochem Anal
33167030	Secondary structure determination of conserved SARS-CoV-2 RNA elements by NMR spectroscopy.	Nucleic Acids Res
33166999	Genome-wide mapping of SARS-CoV-2 RNA structures identifies therapeutically-relevant elements.	Nucleic Acids Res
33166988	COVID-19 treatments and pathogenesis including anosmia in K18-hACE2 mice.	Nature
33166692	LPD-12: a promising lipopeptide to control COVID-19.	Int J Antimicrob Agents
33166683	Development of a PCR-RFLP method for detection of D614G mutation in SARS-CoV-2.	Infect Genet Evol
33166657	Clinically Suspected Myocarditis in the Course of Severe Acute Respiratory Syndrome Novel Coronavirus-2 Infection: Fact or Fiction?	J Card Fail
33166565	Deletion in the C-terminal region of the envelope glycoprotein in some of the Indian SARS-CoV-2 genome.	Virus Res
33166547	A fluorescence-based high throughput-screening assay for the SARS-CoV RNA synthesis complex.	J Virol Methods
33166093	Can immunological manipulation defeat SARS-CoV-2? Why G-CSF induced neutrophil expansion is worth a clinical trial: G-CSF treatment against COVID-19.	Bioessays
33166035	The role of senescent T cells in immunopathology.	Aging Cell
33165417	Network pharmacology-based study of the molecular mechanisms of Qixuekang in treating COVID-19 during the recovery period.	Int J Clin Exp Pathol
33165008	The single-cell landscape of immunological responses of CD4+ T cells in HIV versus severe acute respiratory syndrome coronavirus 2.	Curr Opin HIV AIDS
33164997	Inflammatory endotypes of CRSwNP and responses to COVID-19.	Curr Opin Allergy Clin Immunol
33164796	Identification of a dominant CD8(+) CTL epitope in the SARS-associated coronavirus 2 spike protein.	Vaccine
33164753	Single-cell multiomic profiling of human lungs reveals cell-type-specific and age-dynamic control of SARS-CoV2 host genes.	Elife
33164751	ACE2: Evidence of role as entry receptor for SARS-CoV-2 and implications in comorbidities.	Elife
33164664	Multi-epitope vaccine against SARS-CoV-2 applying immunoinformatics and molecular dynamics simulation approaches.	J Biomol Struct Dyn
33164606	COVID-19 during Pregnancy and Postpartum.	J Diet Suppl
33164601	COVID-19 during Pregnancy and Postpartum.	J Diet Suppl
33164550	Individuating Possibly Repurposable Drugs and Drug Targets for COVID-19 Treatment Through Hypothesis-Driven Systems Medicine Using CoVex.	Assay Drug Dev Technol
33164538	Glucose-6-phosphate dehydrogenase deficiency enhances Covid-19 infection in elderly people.	Bratisl Lek Listy
33164536	Is mitochondrial bioenergetics and coenzyme Q10 the target of a virus causing COVID-19?	Bratisl Lek Listy
33164230	Insights into disparities observed with COVID-19.	J Intern Med
33164048	Inhibition of SARS-CoV-2 in Vero cell cultures by peptide-conjugated morpholino oligomers.	J Antimicrob Chemother
33163980	Pharmacological Inhibition of Acid Sphingomyelinase Prevents Uptake of SARS-CoV-2 by Epithelial Cells.	Cell Rep Med
33163958	Comparative Analysis of Nanomechanical Features of Coronavirus Spike Proteins and Correlation with Lethality and Infection Rate.	Matter
33163695	Genomic exploration light on multiple origin with potential parsimony-informative sites of the severe acute respiratory syndrome coronavirus 2 in Bangladesh.	Gene Rep
33163683	Aptamer BC 007 - Efficient binder of spreading-crucial SARS-CoV-2 proteins.	Heliyon
33163249	The Progression of SARS Coronavirus 2 (SARS-CoV2): Mutation in the Receptor Binding Domain of Spike Gene.	Immune Netw
33163105	[Sars-CoV-2 genomic and phylodynamic analyses].	Rev Francoph Lab
33163102	[Human coronaviruses].	Rev Francoph Lab
33163005	"The Neat Dance of COVID-19: NEAT1, DANCR, and Co-Modulated Cholinergic RNAs Link to Inflammation."	Front Immunol
33162899	Pathophysiology of Cardiovascular Complications in COVID-19.	Front Physiol
33162891	Vulnerabilities of the SARS-CoV-2 Virus to Proteotoxicity-Opportunity for Repurposed Chemotherapy of COVID-19 Infection.	Front Pharmacol
33162887	Targeting Neutrophils to Treat Acute Respiratory Distress Syndrome in Coronavirus Disease.	Front Pharmacol
33162728	Coronavirus rotational diffusivity.	Phys Fluids (1994)
33162723	Stability analysis in COVID-19 within-host model with immune response.	Commun Nonlinear Sci Numer Simul
33162722	A comprehensive overview of proteomics approach for COVID 19: new perspectives in target therapy strategies.	J Proteins Proteom
33162382	The novel zoonotic Coronavirus disease 2019 (COVID-19) pandemic: Health perspective on the outbreak.	J Healthc Qual Res
33161843	Flow-Mediated Susceptibility and Molecular Response of Cerebral Endothelia to SARS-CoV-2 Infection.	Stroke
33161818	The Circadian Clock and Viral Infections.	J Biol Rhythms
33161739	How the zoonotic origins of SARS-CoV-2 ensure its survival as a human disease.	Br J Community Nurs
33161559	Nanoconjugates-Based Stem Cell Therapy for the Management of COVID-19.	Stem Cell Rev Rep
33161557	Recent advances in therapeutic applications of neutralizing antibodies for virus infections: an overview.	Immunol Res
33161318	Endothelial dysfunction in COVID-19: Current findings and therapeutic implications.	Atherosclerosis
33161277	COVID-19 update: The race to therapeutic development.	Drug Resist Updat
33161087	Trends of mutation accumulation across global SARS-CoV-2 genomes: Implications for the evolution of the novel coronavirus.	Genomics
33160965	"Altered Intestinal ACE2 Levels Are Associated With Inflammation, Severe Disease, and Response to Anti-Cytokine Therapy in Inflammatory Bowel Disease."	Gastroenterology
33160938	Computational drug re-purposing targeting the spike glycoprotein of SARS-CoV-2 as an effective strategy to neutralize COVID-19.	Eur J Pharmacol
33160751	Role of Systemic and Nasal Glucocorticoid Treatment in the Regulation of the Inflammatory Response in Patients with SARS-Cov-2 Infection.	Arch Med Res
33160446	Elicitation of Potent Neutralizing Antibody Responses by Designed Protein Nanoparticle Vaccines for SARS-CoV-2.	Cell
33160363	COVID-19: Is there a role for immunonutrition in obese patient?	J Transl Med
33160064	Arginine depletion as a therapeutic approach for patients with COVID-19.	Int J Infect Dis
33160024	Discovery of cyclic sulfonamide derivatives as potent inhibitors of SARS-CoV-2.	Bioorg Med Chem Lett
33159981	"Bis(monoacylglycero)phosphate, an important actor in the host endocytic machinery hijacked by SARS-CoV-2 and related viruses."	Biochimie
33159807	"(1)H, (13)C, and (15)N backbone chemical shift assignments of coronavirus-2 non-structural protein Nsp10."	Biomol NMR Assign
33159646	The Role and Therapeutic Potential of NF-kappa-B Pathway in Severe COVID-19 Patients.	Inflammopharmacology
33159417	Humanized COVID-19 decoy antibody effectively blocks viral entry and prevents SARS-CoV-2 infection.	EMBO Mol Med
33159391	A pharmacology-based comprehensive review on medicinal plants and phytoactive constituents possibly effective in the management of COVID-19.	Phytother Res
33159236	Dermatological aspects of SARS-CoV-2 infection: mechanisms and manifestations.	Arch Dermatol Res
33159154	Mucus production stimulated by IFN-AhR signaling triggers hypoxia of COVID-19.	Cell Res
33159040	Age-severity matched cytokine profiling reveals specific signatures in Covid-19 patients.	Cell Death Dis
33159009	Preexisting and de novo humoral immunity to SARS-CoV-2 in humans.	Science
33158999	Long-Term Modeling of SARS-CoV-2 Infection of In Vitro Cultured Polarized Human Airway Epithelium.	mBio
33158975	Tissue-resident CD8(+) T cells drive age-associated chronic lung sequelae after viral pneumonia.	Sci Immunol
33158944	The SARS-CoV-2 Conserved Macrodomain Is a Mono-ADP-Ribosylhydrolase.	J Virol
33158912	Structure and inhibition of the SARS-CoV-2 main protease reveal strategy for developing dual inhibitors against M(pro) and cathepsin L.	Sci Adv
33158808	"Persistence of viral RNA, pneumocyte syncytia and thrombosis are hallmarks of advanced COVID-19 pathology."	EBioMedicine
33158732	Investigating the Concept and Origin of Viruses.	Trends Microbiol
33158717	"Shufeng Jiedu, a promising herbal therapy for moderate COVID-19:Antiviral and anti-inflammatory properties, pathways of bioactive compounds, and a clinical real-world pragmatic study."	Phytomedicine
33158276	"Coevolution, Dynamics and Allostery Conspire in Shaping Cooperative Binding and Signal Transmission of the SARS-CoV-2 Spike Protein with Human Angiotensin-Converting Enzyme 2."	Int J Mol Sci
33158234	"COVID-19 Pandemic: Epidemiology, Etiology, Conventional and Non-Conventional Therapies."	Int J Environ Res Public Health
33158147	Rapid High-Yield Production of Functional SARS-CoV-2 Receptor Binding Domain by Viral and Non-Viral Transient Expression for Pre-Clinical Evaluation.	Vaccines (Basel)
33158051	Threading the Pieces Together: Integrative Perspective on SARS-CoV-2.	Pathogens
33157558	COVID-19 and Cardiovascular Comorbidities.	Exp Clin Endocrinol Diabetes
33157320	Does eNOS derived nitric oxide protect the young from severe COVID-19 complications?	Ageing Res Rev
33157300	SARS-CoV-2 spread across the Colombian-Venezuelan border.	Infect Genet Evol
33157278	"Cholesterol, lipoproteins, and COVID-19: Basic concepts and clinical applications."	Biochim Biophys Acta Mol Cell Biol Lipids
33157216	Immunopathological similarities between COVID-19 and influenza: Investigating the consequences of Co-infection.	Microb Pathog
33157038	beta-Coronaviruses Use Lysosomes for Egress Instead of the Biosynthetic Secretory Pathway.	Cell
33156843	A network medicine approach to investigation and population-based validation of disease manifestations and drug repurposing for COVID-19.	PLoS Biol
33156486	"Long-Term Existence of SARS-CoV-2 in COVID-19 Patients: Host Immunity, Viral Virulence, and Transmissibility."	Virol Sin
33156333	The InterPro protein families and domains database: 20 years on.	Nucleic Acids Res
33156097	Improving Hepatitis B Virus Vaccination Responses in Inflammatory Bowel Disease: Does Greater Dose and Greater Frequency Lead to Greater Protection?	Am J Gastroenterol
33155902	Current Landscape of Natural Products against Coronaviruses: Perspectives in COVID-19 Treatment and Anti-viral Mechanism.	Curr Pharm Des
33155887	A Computational Approach for Identifying Potential Phytochemicals Against Non-structural Protein 1 (Nsp1) of SARS-CoV-2.	Comb Chem High Throughput Screen
33155531	Identification and characterization of novel RdRp and Nsp15 inhibitors for SARS-COV2 using computational approach.	J Biomol Struct Dyn
33155525	How could we forget immunometabolism in SARS-CoV2 infection or COVID-19?	Int Rev Immunol
33155524	"Computationally validated SARS-CoV-2 CTL and HTL Multi-Patch vaccines, designed by reverse epitomics approach, show potential to cover large ethnically distributed human population worldwide."	J Biomol Struct Dyn
33155515	"Saporin, a Polynucleotide-Adenosine Nucleosidase, May Be an Efficacious Therapeutic Agent for SARS-CoV-2 Infection."	SLAS Discov
33155280	Enhanced expression of angiotensin-converting enzyme 2 in psoriatic skin and its upregulation in keratinocytes by interferon-gamma: implication of inflammatory milieu in skin tropism of SARS-CoV-2.	Br J Dermatol
33154981	The Structure of the Membrane Protein of SARS-CoV-2 Resembles the Sugar Transporter SemiSWEET.	Pathog Immun
33154753	Elevated Exhaustion Levels of NK and CD8(+) T Cells as Indicators for Progression and Prognosis of COVID-19 Disease.	Front Immunol
33154751	Coronavirus Proteins as Ion Channels: Current and Potential Research.	Front Immunol
33154590	Distinct antibody responses to SARS-CoV-2 in children and adults across the COVID-19 clinical spectrum.	Nat Immunol
33154514	Effective screening of SARS-CoV-2 neutralizing antibodies in patient serum using lentivirus particles pseudotyped with SARS-CoV-2 spike glycoprotein.	Sci Rep
33154404	Searching for target-specific and multi-targeting organics for Covid-19 in the Drugbank database with a double scoring approach.	Sci Rep
33154233	Paediatric COVID-19 and the GUT.	Indian J Med Microbiol
33154232	Convalescent plasma - Is it useful for treating SARS Co-V2 infection?	Indian J Med Microbiol
33154165	"Design of a highly thermotolerant, immunogenic SARS-CoV-2 spike fragment."	J Biol Chem
33154144	Renin-angiotensin-aldosterone system inhibitors and the risk of mortality in patients with hypertension hospitalised for COVID-19: systematic review and meta-analysis.	Open Heart
33154108	Versatile and multivalent nanobodies efficiently neutralize SARS-CoV-2.	Science
33154107	De novo design of potent and resilient hACE2 decoys to neutralize SARS-CoV-2.	Science
33154106	An ultrapotent synthetic nanobody neutralizes SARS-CoV-2 by stabilizing inactive Spike.	Science
33153991	COVID-19 and COPD: a narrative review of the basic science and clinical outcomes.	Eur Respir Rev
33153921	Potential Influence of Helminth Molecules on COVID-19 Pathology.	Trends Parasitol
33153908	"Coronaviruses: Innate Immunity, Inflammasome Activation, Inflammatory Cell Death, and Cytokines."	Trends Immunol
33153403	Highlights in the fight against COVID-19: does autophagy play a role in SARS-CoV-2 infection?	Autophagy
33153216	Novel Evidence of Acute Kidney Injury in COVID-19.	J Clin Med
33153161	"Erythrocyte, Platelet, Serum Ferritin, and P-Selectin Pathophysiology Implicated in Severe Hypercoagulation and Vascular Complications in COVID-19."	Int J Mol Sci
33153096	"COVID-19 Vaccines Currently under Preclinical and Clinical Studies, and Associated Antiviral Immune Response."	Vaccines (Basel)
33152916	Male predisposition to severe COVID-19: Review of evidence and potential therapeutic prospects.	Biomed Pharmacother
33152616	"Molecular screening of antimalarial, antiviral, anti-inflammatory and HIV protease inhibitors against spike glycoprotein of coronavirus."	J Mol Graph Model
33152464	"Artepillin C: A comprehensive review of its chemistry, bioavailability, and pharmacological properties."	Fitoterapia
33152446	Prenatal exposure to viral infection and neuropsychiatric disorders in offspring: A review of the literature and recommendations for the COVID-19 pandemic.	Brain Behav Immun
33152343	Detection of Viral Infections by Innate Immunity.	Biochem Pharmacol
33152262	Malleability of the SARS-CoV-2 3CL M(pro) Active-Site Cavity Facilitates Binding of Clinical Antivirals.	Structure
33152254	The wide spectrum of Kawasaki-like disease associated with SARS-CoV-2 infection.	Expert Rev Clin Immunol
33152198	"Isolation and characterization of an early SARS-CoV-2 isolate from the 2020 epidemic in Medellin, Colombia"	Biomedica
33152019	"Variant analysis of 1,040 SARS-CoV-2 genomes."	PLoS One
33151738	Universal anti-influenza vaccines based on viral HA2 and M2e antigens.	Acta Virol
33151461	Neutrophil extracellular traps and thrombosis in COVID-19.	J Thromb Thrombolysis
33151168	Sitagliptin: a potential drug for the treatment of COVID-19?	Acta Pharm
33151166	"Identification of potential COVID-19 main protease inhibitors using structure-based pharmacophore approach, molecular docking and repurposing studies."	Acta Pharm
33151142	Lysine 164 is critical for SARS-CoV-2 Nsp1 inhibition of host gene expression.	J Gen Virol
33151090	Mitochondrial metabolic manipulation by SARS-CoV-2 in peripheral blood mononuclear cells of patients with COVID-19.	Am J Physiol Cell Physiol
33151050	Histopathology and Ultrastructural Findings of Fatal COVID-19 Infections on Testis.	World J Mens Health
33151049	Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-Associated Urogenital Disease: A Current Update.	World J Mens Health
33150973	Kidney involvement in COVID-19 and its treatments.	J Med Virol
33150961	SARS-CoV-2 and inflammatory responses: From mechanisms to the potential therapeutic use of intravenous immunoglobulin.	J Med Virol
33150860	"Traditional medicinal plants against replication, maturation and transmission targets of SARS-CoV-2: computational investigation."	J Biomol Struct Dyn
33150855	SARS-CoV-2 M(pro) inhibitors: identification of anti-SARS-CoV-2 M(pro) compounds from FDA approved drugs.	J Biomol Struct Dyn
33150674	Acute kidney injury associated with COVID-19-Cumulative evidence and rationale supporting against direct kidney injury (infection).	Nephrology (Carlton)
33149733	The Inflammasome in Times of COVID-19.	Front Immunol
33149655	Coagulation Disorders in COVID-19: Role of Toll-like Receptors.	J Inflamm Res
33149633	Exploring Diversity of COVID19 Based on Substitution Distance.	Infect Drug Resist
33149560	Targeting the GRP78-Dependant SARS-CoV-2 Cell Entry by Peptides and Small Molecules.	Bioinform Biol Insights
33149541	New Pathways of Mutational Change in SARS-CoV-2 Proteomes Involve Regions of Intrinsic Disorder Important for Virus Replication and Release.	Evol Bioinform Online
33149224	Epitope similarity cannot explain the pre-formed T cell immunity towards structural SARS-CoV-2 proteins.	Sci Rep
33149112	"Selection, biophysical and structural analysis of synthetic nanobodies that effectively neutralize SARS-CoV-2."	Nat Commun
33148714	SARS-CoV-2 Cysteine-like Protease Antibodies Can Be Detected in Serum and Saliva of COVID-19-Seropositive Individuals.	J Immunol
33148469	Update of takotsubo syndrome in the era of COVID-19.	J Cardiol
33148439	Cognitive disorders associated with hospitalization of COVID-19: Results from an observational cohort study.	Brain Behav Immun
33148390	[Progress on role of cytokine storm in exacerbation of coronavirus disease 2019 (COVID-19): Review].	Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi
33148151	Insights from Pharmaceutical Biotechnology into Phenolic Biopharmaceuticals against COVID-19.	Curr Pharm Biotechnol
33147968	In Silico Antibody Mutagenesis for Optimizing Its Binding to Spike Protein of Severe Acute Respiratory Syndrome Coronavirus 2.	J Phys Chem Lett
33147964	COVID-19: Oxidative Preconditioning as a Potential Therapeutic Approach.	ACS Chem Neurosci
33147871	New Insights in Laboratory Testing for COVID-19 Patients: Looking for the Role and Predictive Value of Human epididymis secretory protein 4 (HE4) and the Innate Immunity of the Oral Cavity and Respiratory Tract.	Microorganisms
33147850	Application of Humanized Zebrafish Model in the Suppression of SARS-CoV-2 Spike Protein Induced Pathology by Tri-Herbal Medicine Coronil via Cytokine Modulation.	Molecules
33147840	First Phylogenetic Analysis of Malian SARS-CoV-2 Sequences Provides Molecular Insights into the Genomic Diversity of the Sahel Region.	Viruses
33147821	Epitope-Based Immunoinformatics Approach on Nucleocapsid Protein of Severe Acute Respiratory Syndrome-Coronavirus-2.	Molecules
33147723	Therapeutic Potential of Ursonic Acid: Comparison with Ursolic Acid.	Biomolecules
33147627	Computational strategies to combat COVID-19: useful tools to accelerate SARS-CoV-2 and coronavirus research.	Brief Bioinform
33147503	Host sphingolipids: Perspective immune adjuvant for controlling SARS-CoV-2 infection for managing COVID-19 disease.	Prostaglandins Other Lipid Mediat
33147451	HSV-1 and Zika Virus but Not SARS-CoV-2 Replicate in the Human Cornea and Are Restricted by Corneal Type III Interferon.	Cell Rep
33147445	Identification of Required Host Factors for SARS-CoV-2 Infection in Human Cells.	Cell
33147444	Genome-wide CRISPR Screens Reveal Host Factors Critical for SARS-CoV-2 Infection.	Cell
33147321	An unconventional view of COVID-19 T cell immunity.	J Exp Med
33147113	Protective Potentials of Type III Interferons in COVID-19 Patients: Lessons from Differential Properties of Type I- and III Interferons.	Viral Immunol
33147014	Seeding Brain Protein Aggregation by SARS-CoV-2 as a Possible Long-Term Complication of COVID-19 Infection.	ACS Chem Neurosci
33146673	Network pharmacology for the identification of phytochemicals in traditional Chinese medicine for COVID-19 that may regulate interleukin-6.	Biosci Rep
33146564	High-dimensional single-cell analysis reveals the immune characteristics of COVID-19.	Am J Physiol Lung Cell Mol Physiol
33146561	Coronavirus disease 2019: investigational therapies in the prevention and treatment of hyperinflammation.	Expert Rev Clin Immunol
33146390	Characterizing Transcriptional Regulatory Sequences in Coronaviruses and Their Role in Recombination.	Mol Biol Evol
33146371	"ACE2 and ACE: structure-based insights into mechanism, regulation and receptor recognition by SARS-CoV."	Clin Sci (Lond)
33146070	Pathway enrichment analysis of virus-host interactome and prioritization of novel compounds targeting the spike glycoprotein receptor binding domain-human angiotensin-converting enzyme 2 interface to combat SARS-CoV-2.	J Biomol Struct Dyn
33145962	"Dynamics of NK, CD8 and Tfh cell mediated the production of cytokines and antiviral antibodies in Chinese patients with moderate COVID-19."	J Cell Mol Med
33145867	Immunology of COVID-19.	Environ Microbiol
33145472	SARS-CoV-2 (COVID-19) and the Endocrine System.	J Endocr Soc
33145296	Analysis of 2019-nCoV receptor ACE2 expression in different tissues and its significance study.	Ann Transl Med
33145103	Renin-Angiotensin System Inhibitors in COVID-19: Current Concepts.	Int J Hypertens
33145015	Bioinformatic study to discover natural molecules with activity against COVID-19.	F1000Res
33144890	[The virology of SARS-CoV-2].	Gastroenterologe
33144786	Neurological Involvement in COVID-19 Patients: A Narrative Review.	J Neurosci Rural Pract
33144490	"Classical Drug Digitoxin Inhibits Influenza Cytokine Storm, With Implications for Covid-19 Therapy."	In Vivo
33144323	Adaptation of influenza viruses to human airway receptors.	J Biol Chem
33144321	Changes in SARS-CoV-2 Spike versus Nucleoprotein Antibody Responses Impact the Estimates of Infections in Population-Based Seroprevalence Studies.	J Virol
33144203	Intra-host non-synonymous diversity at a neutralizing antibody epitope of SARS-CoV-2 spike protein N-terminal domain.	Clin Microbiol Infect
33143815	COVID-19 in children: Pathogenesis and current status.	Allergy Asthma Proc
33143619	Rediscovery of caffeine: an excellent drug for improving patient outcomes while fighting WARS.	Curr Med Chem
33143614	Cardiovascular Manifestations of COVID-19.	Curr Cardiol Rev
33143552	"Identification of natural inhibitors against Mpro of SARS-CoV-2 by molecular docking, molecular dynamics simulation, and MM/PBSA methods."	J Biomol Struct Dyn
33143379	The Role of Molecular Chaperones in Virus Infection and Implications for Understanding and Treating COVID-19.	J Clin Med
33143371	Cardiovascular Disease and SARS-CoV-2: the Role of Host Immune Response Versus Direct Viral Injury.	Int J Mol Sci
33143316	Aprotinin Inhibits SARS-CoV-2 Replication.	Cells
33143053	miR-98 Regulates TMPRSS2 Expression in Human Endothelial Cells: Key Implications for COVID-19.	Biomedicines
33142989	Osmotic Adaptation by Na(+)-Dependent Transporters and ACE2: Correlation with Hemostatic Crisis in COVID-19.	Biomedicines
33142844	Hyperthrombotic Milieu in COVID-19 Patients.	Cells
33142819	COVID-19 and Parkinson's Disease: Shared Inflammatory Pathways Under Oxidative Stress.	Brain Sci
33142770	In Vitro Antiviral Activity of Doxycycline against SARS-CoV-2.	Molecules
33142431	A perspective on potential target proteins of COVID-19: Comparison with SARS-CoV for designing new small molecules.	Bioorg Chem
33142370	An overview of the gut side of the SARS-CoV-2 infection.	Intest Res
33142113	Three-Dimensional Human Alveolar Stem Cell Culture Models Reveal Infection Response to SARS-CoV-2.	Cell Stem Cell
33141814	HIV and SARS-CoV-2: points to consider to face this new pandemic.	Medwave
33141807	HLA and AB0 Polymorphisms May Influence SARS-CoV-2 Infection and COVID-19 Severity.	Transplantation
33141358	A comprehensive review on promising anti-viral therapeutic candidates identified against main protease from SARS-CoV-2 through various computational methods.	J Genet Eng Biotechnol
33141332	What is the significance of the conjunctiva as a potential transmission route for SARS-CoV-2 infections?	Ophthalmologe
33141018	"COVID-19: Cytokine storm modulation/blockade with oral polyvalent immunoglobulins (PVIG, KMP01D): A potential and safe therapeutic agent (Primum nil nocere)."	Int J Clin Pharmacol Ther
33140943	[Smell impairment in COVID-19 patients: mechanisms and clinical significance].	Vestn Otorinolaringol
33140889	Network pharmacology and molecular docking analyses on Lianhua Qingwen capsule indicate Akt1 is a potential target to treat and prevent COVID-19.	Cell Prolif
33140861	Blood molecular markers associated with COVID-19 immunopathology and multi-organ damage.	EMBO J
33140827	ACE2 and gut amino acid transport.	Clin Sci (Lond)
33140777	Structure-based lead optimization of herbal medicine rutin for inhibiting SARS-CoV-2's main protease.	Phys Chem Chem Phys
33140706	Targeting the initiation and termination codons of SARS-CoV-2 spike protein as possible therapy against COVID-19: the role of novel harpagide 5-O-beta-D-glucopyranoside from Clerodendrum volubile P Beauv. (Labiatae).	J Biomol Struct Dyn
33140703	Targeting SARS-CoV-2 nucleocapsid oligomerization: Insights from molecular docking and molecular dynamics simulations.	J Biomol Struct Dyn
33140695	Computer aided identification of potential SARS CoV-2 main protease inhibitors from diterpenoids and biflavonoids of Torreya nucifera leaves.	J Biomol Struct Dyn
33140690	DFT and docking studies of designed conjugates of noscapines & repurposing drugs: promising inhibitors of main protease of SARS-CoV-2 and falcipan-2.	J Biomol Struct Dyn
33140636	Toward COVID-19 Therapeutics: A Viewpoint from the Nonprotein Amino Acid Based Synthetic Peptide Design Approach.	ACS Chem Neurosci
33140243	Abrupt Deterioration of COVID-19 Patients and Spreading of SARS COV-2 Virions in the Lungs.	Ann Biomed Eng
33140034	Beyond Shielding: The Roles of Glycans in the SARS-CoV-2 Spike Protein.	ACS Cent Sci
33140033	Targeting the SARS-CoV-2 RNA Genome with Small Molecule Binders and Ribonuclease Targeting Chimera (RIBOTAC) Degraders.	ACS Cent Sci
33139972	Nano-targeting lessons from the SARS-CoV-2.	Nano Today
33139969	Hypoxia: A key feature of COVID-19 launching activation of HIF-1 and cytokine storm.	J Inflamm (Lond)
33139905	Low serum neutralizing anti-SARS-CoV-2 S antibody levels in mildly affected COVID-19 convalescent patients revealed by two different detection methods.	Cell Mol Immunol
33139704	Full genome viral sequences inform patterns of SARS-CoV-2 spread into and within Israel.	Nat Commun
33139693	COVID-19-associated gastrointestinal and liver injury: clinical features and potential mechanisms.	Signal Transduct Target Ther
33139569	Rapid identification of a human antibody with high prophylactic and therapeutic efficacy in three animal models of SARS-CoV-2 infection.	Proc Natl Acad Sci U S A
33139422	A Multiplex Microsphere IgG Assay for SARS-CoV-2 Using ACE2-Mediated Inhibition as a Surrogate for Neutralization.	J Clin Microbiol
33139139	NVX-CoV2373 vaccine protects cynomolgus macaque upper and lower airways against SARS-CoV-2 challenge.	Vaccine
33139116	Complement activation and endothelial perturbation parallel COVID-19 severity and activity.	J Autoimmun
33138947	Covid-19 and vit-d: Disease mortality negatively correlates with sunlight exposure.	Spat Spatiotemporal Epidemiol
33138839	CXCL10 could drive longer duration of mechanical ventilation during COVID-19 ARDS.	Crit Care
33138699	Emerging of composition variations of SARS-CoV-2 spike protein and human ACE2 contribute to the level of infection: in silico approaches.	J Biomol Struct Dyn
33138262	"COVID-19: Look to the Future, Learn from the Past."	Viruses
33138197	Antiviral and Immunomodulatory Effects of Phytochemicals from Honey against COVID-19: Potential Mechanisms of Action and Future Directions.	Molecules
33138195	Single-Cell Transcriptome Analysis Highlights a Role for Neutrophils and Inflammatory Macrophages in the Pathogenesis of Severe COVID-19.	Cells
33138181	Emerging Mechanisms of Pulmonary Vasoconstriction in SARS-CoV-2-Induced Acute Respiratory Distress Syndrome (ARDS) and Potential Therapeutic Targets.	Int J Mol Sci
33138151	"Man-Specific, GalNAc/T/Tn-Specific and Neu5Ac-Specific Seaweed Lectins as Glycan Probes for the SARS-CoV-2 (COVID-19) Coronavirus."	Mar Drugs
33137894	"Molecular Insights into Human Transmembrane Protease Serine-2 (TMPS2) Inhibitors against SARS-CoV2: Homology Modelling, Molecular Dynamics, and Docking Studies."	Molecules
33137892	"Phylogeography of 27,000 SARS-CoV-2 Genomes: Europe as the Major Source of the COVID-19 Pandemic."	Microorganisms
33137851	"Is there a link between vitamin D status, SARS-CoV-2 infection risk and COVID-19 severity?"	Cell Biochem Funct
33137690	Interaction of small molecules with the SARS-CoV-2 main protease in silico and in vitro validation of potential lead compounds using an enzyme-linked immunosorbent assay.	Comput Biol Chem
33137649	Evaluation of mechanisms of action of re-purposed drugs for treatment of COVID-19.	Cell Immunol
33137615	COVID-19 and Major Organ Thromboembolism: Manifestations in Neurovascular and Cardiovascular Systems.	J Stroke Cerebrovasc Dis
33137510	"Aging in COVID-19: Vulnerability, immunity and intervention."	Ageing Res Rev
33137344	Human coronavirus spike protein-host receptor recognition.	Prog Biophys Mol Biol
33137330	Functional and druggability analysis of the SARS-CoV-2 proteome.	Eur J Pharmacol
33137182	ADPriboDB 2.0: an updated database of ADP-ribosylated proteins.	Nucleic Acids Res
33137165	The role of cysteine peptidases in coronavirus cell entry and replication: The therapeutic potential of cathepsin inhibitors.	PLoS Pathog
33136724	COVID-19: gastrointestinal symptoms from the view of gut-lung axis.	Eur J Gastroenterol Hepatol
33136473	"A Web-Based Platform on Coronavirus Disease-19 to Maintain Predicted Diagnostic, Drug, and Vaccine Candidates."	Monoclon Antib Immunodiagn Immunother
33136080	Why individuals with cerebral palsy are at higher risk for respiratory complications from COVID-19.	J Pediatr Rehabil Med
33135884	"Structure of the SARS-CoV-2 Nsp1/5'-Untranslated Region Complex and Implications for Potential Therapeutic Targets, a Vaccine, and Virulence."	J Phys Chem Lett
33135725	"ACE2, the kidney and the emergence of COVID-19 two decades after ACE2 discovery."	Clin Sci (Lond)
33135607	Exploring the Potential Mechanism of Shufeng Jiedu Capsule for Treating COVID-19 by Comprehensive Network Pharmacological Approaches and Molecular Docking Validation.	Comb Chem High Throughput Screen
33135345	The noncoding and coding transcriptional landscape of the peripheral immune response in patients with COVID-19.	Clin Transl Med
33135263	5-alpha-reductase inhibitors are associated with reduced frequency of COVID-19 symptoms in males with androgenetic alopecia.	J Eur Acad Dermatol Venereol
33135055	Comprehensive characterization of N- and O- glycosylation of SARS-CoV-2 human receptor angiotensin converting enzyme 2.	Glycobiology
33134952	Spectrum of Vascular Involvement in Coronavirus Disease 2019 Pneumonia-Findings on CT Perfusion.	Crit Care Explor
33134901	Impaired spermatogenesis in COVID-19 patients.	EClinicalMedicine
33134888	"SARS-CoV-2 Targets by the pscRNA Profiling of ACE2, TMPRSS2 and Furin Proteases."	iScience
33134887	Robust and Specific Secretory IgA Against SARS-CoV-2 Detected in Human Milk.	iScience
33134847	COVID-19 and Hematology-What Do We Know So Far?	SN Compr Clin Med
33134697	Quantitative Structure-Activity Relationship Machine Learning Models and their Applications for Identifying Viral 3CLpro- and RdRp-Targeting Compounds as Potential Therapeutics for COVID-19 and Related Viral Infections.	ACS Omega
33134398	Generation of Chicken IgY against SARS-COV-2 Spike Protein and Epitope Mapping.	J Immunol Res
33134395	Implications of COVID-19 Pandemic on Evolution of Diabetes in Malaria-Endemic African Region.	J Diabetes Res
33134318	ssRNA Virus and Host Lipid Rearrangements: Is There a Role for Lipid Droplets in SARS-CoV-2 Infection?	Front Mol Biosci
33134310	Discovery of Potential Flavonoid Inhibitors Against COVID-19 3CL Proteinase Based on Virtual Screening Strategy.	Front Mol Biosci
33134238	Health Disparities in COVID-19: Addressing the Role of Social Determinants of Health in Immune System Dysfunction to Turn the Tide.	Front Public Health
33134226	Why Do Some Reports Claim that the Number of COVID-19 Hospitalized Smokers is Smaller than Expected?	J Biomed Phys Eng
33133611	Coronavirus disease 2019: scientific overview of the global pandemic.	New Microbes New Infect
33133492	Systemic effects of the hormonal treatment of male hypogonadism with preliminary indications for the management of COVID-19 patients.	Ther Adv Endocrinol Metab
33133166	Host Genetic Variants Potentially Associated With SARS-CoV-2: A Multi-Population Analysis.	Front Genet
33133145	Analysis of the Spectrum of ACE2 Variation Suggests a Possible Influence of Rare and Common Variants on Susceptibility to COVID-19 and Severity of Outcome.	Front Genet
33133090	Targeting Lipid Rafts-A Potential Therapy for COVID-19.	Front Immunol
33133083	Immune Correlates of COVID-19 Control.	Front Immunol
33133055	"SARS-CoV-2 nsp1: Bioinformatics, Potential Structural and Functional Features, and Implications for Drug/Vaccine Designs."	Front Microbiol
33133042	Genomic Modeling as an Approach to Identify Surrogates for Use in Experimental Validation of SARS-CoV-2 and HuNoV Inactivation by UV-C Treatment.	Front Microbiol
33133024	Covid-19 and Diabetes: A Complex Bidirectional Relationship.	Front Endocrinol (Lausanne)
33132913	Fei Yan No. 1 as a Combined Treatment for COVID-19: An Efficacy and Potential Mechanistic Study.	Front Pharmacol
33132795	[The virology of SARS-CoV-2].	Pneumologe (Berl)
33132779	Leading From Darkness to Light: Understanding Chronic Disease and Coronavirus: An Integrative Perspective.	Integr Med (Encinitas)
33132747	First principle study of silver nanoparticle interactions with antimalarial drugs extracted from Artemisia annua plant.	J Nanopart Res
33132617	The COVID-19: Current understanding.	Vet World
33132205	Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses.	Drug Resist Updat
33132153	The effect of environmental pollution on immune evasion checkpoints of SARS-CoV-2.	Environ Toxicol Pharmacol
33132111	Overlapping host pathways between SARS-CoV-2 and its potential copathogens: An in silico analysis.	Infect Genet Evol
33132005	Mechanisms of SARS-CoV-2 Transmission and Pathogenesis.	Trends Immunol
33131922	PET Imaging as a Tool for Assessing COVID-19 Brain Changes.	Trends Neurosci
33131800	Virus isolation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) for diagnostic and research purposes.	Pathology
33131721	"Screening Malaria-box compounds to identify potential inhibitors against SARS-CoV-2 M(pro), using molecular docking and dynamics simulation studies."	Eur J Pharmacol
33131637	Gordian Knot: Gastrointestinal lesions caused by three highly pathogenic coronaviruses from SARS-CoV and MERS-CoV to SARS-CoV-2.	Eur J Pharmacol
33131530	Multi-omics-based identification of SARS-CoV-2 infection biology and candidate drugs against COVID-19.	Comput Biol Med
33131453	Massive dissemination of a SARS-CoV-2 Spike Y839 variant in Portugal.	Emerg Microbes Infect
33131430	An in-silico analysis of ivermectin interaction with potential SARS-CoV-2 targets and host nuclear importin alpha.	J Biomol Struct Dyn
33130659	[COVID-19: TOPICAL ISSUES OF CLINIC ACTIVITIES DURING A PANDEMIC].	Georgian Med News
33130519	"Host-pathogen interaction in COVID-19: Pathogenesis, potential therapeutics and vaccination strategies."	Immunobiology
33130382	A natural food preservative peptide nisin can interact with the SARS-CoV-2 spike protein receptor human ACE2.	Virology
33130319	Long-acting nanoparticulate DNase-1 for effective suppression of SARS-CoV-2-mediated neutrophil activities and cytokine storm.	Biomaterials
33130280	Unravelling high-affinity binding compounds towards transmembrane protease serine 2 enzyme in treating SARS-CoV-2 infection using molecular modelling and docking studies.	Eur J Pharmacol
33130279	In silico identification of strong binders of the SARS-CoV-2 receptor-binding domain.	Eur J Pharmacol
33130103	"The Role of Angiotensin Converting Enzyme 2 in Modulating Gut Microbiota, Intestinal Inflammation, and Coronavirus Infection."	Gastroenterology
33130005	A connectivity map-based drug repurposing study and integrative analysis of transcriptomic profiling of SARS-CoV-2 infection.	Infect Genet Evol
33129966	Could SARS-CoV-2-induced lung injury be attenuated by vitamin D?	Int J Infect Dis
33129880	"Is highly expressed ACE 2 in pregnant women ""a curse"" in times of COVID-19 pandemic?"	Life Sci
33129692	CGRP Receptor Antagonism in COVID-19: Potential Cardiopulmonary Adverse Effects.	Trends Mol Med
33129512	[Pharmacokinetic changes related to acute infection. Examples from the SARS-CoV-2 pandemic].	Therapie
33129373	Orthogonal SARS-CoV-2 Serological Assays Enable Surveillance of Low-Prevalence Communities and Reveal Durable Humoral Immunity.	Immunity
33129318	Noncoding RNAs implication in cardiovascular diseases in the COVID-19 era.	J Transl Med
33129099	"Nano-curcumin therapy, a promising method in modulating inflammatory cytokines in COVID-19 patients."	Int Immunopharmacol
33129009	Ac2-26 mimetic peptide of annexin A1 to treat severe COVID-19: A hypothesis.	Med Hypotheses
33128895	Human Lung Stem Cell-Based Alveolospheres Provide Insights into SARS-CoV-2-Mediated Interferon Responses and Pneumocyte Dysfunction.	Cell Stem Cell
33128877	Unbiased Screens Show CD8(+) T Cells of COVID-19 Patients Recognize Shared Epitopes in SARS-CoV-2 that Largely Reside outside the Spike Protein.	Immunity
33128875	Plasma Proteomics Identify Biomarkers and Pathogenesis of COVID-19.	Immunity
33128861	Animal models for SARS-CoV-2 research: A comprehensive literature review.	Transbound Emerg Dis
33128792	Immunological imprint of COVID-19 on human peripheral blood leukocyte populations.	Allergy
33128388	Production of trimeric SARS-CoV-2 spike protein by CHO cells for serological COVID-19 testing.	Biotechnol Bioeng
33128369	Analysis of Humoral Immune Responses in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection.	J Infect Dis
33128245	Photoinactivation of the Coronavirus Surrogate phi6 by Visible Light.	Photochem Photobiol
33127911	Genomic surveillance of COVID-19 cases in Beijing.	Nat Commun
33127906	SARS-CoV-2 viral load is associated with increased disease severity and mortality.	Nat Commun
33127862	Molecular Architecture of Early Dissemination and Massive Second Wave of the SARS-CoV-2 Virus in a Major Metropolitan Area.	mBio
33127861	Pervasive RNA Secondary Structure in the Genomes of SARS-CoV-2 and Other Coronaviruses.	mBio
33127745	A Founder Effect Led Early SARS-CoV-2 Transmission in Spain.	J Virol
33127503	Cerebrospinal fluid findings in neurological diseases associated with COVID-19 and insights into mechanisms of disease development.	Int J Infect Dis
33126915	COVID-19: a potential driver of immune-mediated breast cancer recurrence?	Breast Cancer Res
33126860	The alpha7 nicotinic acetylcholine receptor agonist GTS-21 improves bacterial clearance in mice by restoring hyperoxia-compromised macrophage function.	Mol Med
33126723	Similar Clinical Course and Significance of Circulating Innate and Adaptive Immune Cell Counts in STEMI and COVID-19.	J Clin Med
33126657	Renin-Angiotensin System: An Important Player in the Pathogenesis of Acute Respiratory Distress Syndrome.	Int J Mol Sci
33126565	Outcomes of COVID-19 Hospitalized Patients Previously Treated with Renin-Angiotensin System Inhibitors.	J Clin Med
33126244	Compositional diversity and evolutionary pattern of coronavirus accessory proteins.	Brief Bioinform
33126128	In silico identification of Tretinoin as a SARS-CoV-2 envelope (E) protein ion channel inhibitor.	Comput Biol Med
33126048	Potential SARS-CoV-2 interactions with proteins involved in trophoblast functions - An in-silico study.	Placenta
33125977	Changes in physiology and immune system during pregnancy and coronavirus infection: A review.	Eur J Obstet Gynecol Reprod Biol
33125711	Unfractionated heparin inhibits live wild type SARS-CoV-2 cell infectivity at therapeutically relevant concentrations.	Br J Pharmacol
33125580	Profile of SARS-CoV-2.	Wien Klin Wochenschr
33125439	On the whereabouts of SARS-CoV-2 in the human body: A systematic review.	PLoS Pathog
33125431	Kidney ACE2 expression: Implications for chronic kidney disease.	PLoS One
33125421	Modeling the load of SARS-CoV-2 virus in human expelled particles during coughing and speaking.	PLoS One
33125298	Role of vitamin D in pathogenesis and severity of COVID-19 infection.	Arch Physiol Biochem
33125078	Pfam: The protein families database in 2021.	Nucleic Acids Res
33125064	A Path toward SARS-CoV-2 Attenuation: Metabolic Pressure on CTP Synthesis Rules the Virus Evolution.	Genome Biol Evol
33124941	Inflammation and thrombosis in COVID-19 pathophysiology: proteinase-activated and purinergic receptors as drivers and candidate therapeutic targets.	Physiol Rev
33124920	Cardiology and COVID-19: do we have sufficient information?	Future Cardiol
33124786	Nucleotide analogues as inhibitors of SARS-CoV Polymerase.	Pharmacol Res Perspect
33124544	"Factors of Severity in Patients with COVID-19: Cytokine/Chemokine Concentrations, Viral Load, and Antibody Responses."	Am J Trop Med Hyg
33124193	Transcriptomic analysis reveals novel mechanisms of SARS-CoV-2 infection in human lung cells.	Immun Inflamm Dis
33124149	The effects of aging on host resistance and disease tolerance to SARS-CoV-2 infection.	FEBS J
33124044	Are Migraine Patients at Increased Risk for Symptomatic Coronavirus Disease 2019 Due to Shared Comorbidities?	Headache
33124029	"Immunoinflammatory, Thrombohaemostatic, and Cardiovascular Mechanisms in COVID-19."	Thromb Haemost
33123616	The role of nicotinic receptors in SARS-CoV-2 receptor ACE2 expression in intestinal epithelia.	Bioelectron Med
33123533	Designing a Network Proximity-Based Drug Repurposing Strategy for COVID-19.	Front Cell Dev Biol
33123498	Within-Host Diversity of SARS-CoV-2 in COVID-19 Patients With Variable Disease Severities.	Front Cell Infect Microbiol
33123364	Temporal changes in complement activation in haemodialysis patients with COVID-19 as a predictor of disease progression.	Clin Kidney J
33123353	Complement and protection from tissue injury in COVID-19.	Clin Kidney J
33123171	"Clinical, Serological, and Histopathological Similarities Between Severe COVID-19 and Acute Exacerbation of Connective Tissue Disease-Associated Interstitial Lung Disease (CTD-ILD)."	Front Immunol
33123167	Pro- and Anti-Inflammatory Responses in Severe COVID-19-Induced Acute Respiratory Distress Syndrome-An Observational Pilot Study.	Front Immunol
33123154	Increased Plasma Heparanase Activity in COVID-19 Patients.	Front Immunol
33123152	Immunesenescence: A Predisposing Risk Factor for the Development of COVID-19?	Front Immunol
33123087	From Influenza Virus to Novel Corona Virus (SARS-CoV-2)-The Contribution of Obesity.	Front Endocrinol (Lausanne)
33123031	"ACE2, COVID-19 Infection, Inflammation, and Coagulopathy: Missing Pieces in the Puzzle."	Front Physiol
33122999	Histological Evidence for the Enteric Nervous System and the Choroid Plexus as Alternative Routes of Neuroinvasion by SARS-CoV2.	Front Neuroanat
33122784	IL-4/IL-13 remodeling pathway of COVID-19 lung injury.	Sci Rep
33122473	Identification of therapeutic drugs against COVID-19 through computational investigation on drug repurposing and structural modification.	J Biomed Res
33122196	High affinity binding of SARS-CoV-2 spike protein enhances ACE2 carboxypeptidase activity.	J Biol Chem
33122172	Repurposing Nucleoside Analogs for Human Coronaviruses.	Antimicrob Agents Chemother
33122171	Development of a Simple In Vitro Assay To Identify and Evaluate Nucleotide Analogs against SARS-CoV-2 RNA-Dependent RNA Polymerase.	Antimicrob Agents Chemother
33121927	The comprehensive study on the therapeutic effects of baicalein for the treatment of COVID-19 in vivo and in vitro.	Biochem Pharmacol
33121920	Race to arsenal COVID-19 therapeutics: Current alarming status and future directions.	Chem Biol Interact
33121513	Prediction and evolution of B cell epitopes of surface protein in SARS-CoV-2.	Virol J
33121413	COVID-19 and Autoimmune Diseases: A Systematic Review of Reported Cases.	Curr Rheumatol Rev
33121412	The Perfect Storm: A Rheumatologist's Point of View on COVID-19 Infection.	Curr Rheumatol Rev
33121282	Potential of Ficus microcarpa metabolites against SARS-CoV-2 main protease supported by docking studies.	Nat Prod Res
33121220	Relating angiotensin-converting enzyme inhibitors or angiotensin receptor blockers with incidence or mortality of COVID-19.	ESC Heart Fail
33120941	COVID-19-Associated Neurological Disorders: The Potential Route of CNS Invasion and Blood-Brain Relevance.	Cells
33120898	"Alteration, Reduction and Taste Loss: Main Causes and Potential Implications on Dietary Habits."	Nutrients
33120555	Dynamics of SARS-CoV-2 infection model with two modes of transmission and immune response.	Math Biosci Eng
33120281	Statins and SARS-CoV-2 disease: Current concepts and possible benefits.	Diabetes Metab Syndr
33120236	Innate and adaptive immune responses against coronavirus.	Biomed Pharmacother
33119712	"SARS-CoV-2 RNA shedding in recovered COVID-19 cases and the presence of antibodies against SARS-CoV-2 in recovered COVID-19 cases and close contacts, Thailand, April-June 2020."	PLoS One
33119657	SARS-CoV-2 transmission routes from genetic data: A Danish case study	PLoS One
33119547	Sustained cellular immune dysregulation in individuals recovering from SARS-CoV-2 infection.	J Clin Invest
33119313	Molecular Basis of SARS-CoV-2 Infection and Rational Design of Potential Antiviral Agents: Modeling and Simulation Approaches.	J Proteome Res
33119257	Profiling SARS-CoV-2 Main Protease (M(PRO)) Binding to Repurposed Drugs Using Molecular Dynamics Simulations in Classical and Neural Network-Trained Force Fields.	ACS Comb Sci
33119251	Can Neurotropic Free-Living Amoeba Serve as a Model to Study SARS-CoV-2 Pathogenesis?	ACS Chem Neurosci
33119197	Is there a role for the ACE2 receptor in SARS-CoV-2 interactions with platelets?	J Thromb Haemost
33119046	ER functions are exploited by viruses to support distinct stages of their life cycle.	Biochem Soc Trans
33118859	A SARS-CoV-2 variant with the 12-bp deletion at E gene.	Emerg Microbes Infect
33118741	COVID-19 - Endothelial Axis and Coronary Artery Bypass Graft Patency: a Target for Therapeutic Intervention?	Braz J Cardiovasc Surg
33118480	Uncaria tomentosa (cat's claw): a promising herbal medicine against SARS-CoV-2/ACE-2 junction and SARS-CoV-2 spike protein based on molecular modeling.	J Biomol Struct Dyn
33118361	Pancreatic injury in COVID-19: pathogenesis and challenges.	Rev Esp Enferm Dig
33118327	Biophysical analysis of SARS-CoV-2 transmission and theranostic development via N protein computational characterization.	Biotechnol Prog
33118022	Molecular diversity of coronavirus host cell entry receptors.	FEMS Microbiol Rev
33117437	"Testosterone in COVID-19 - Foe, Friend or Fatal Victim?"	Eur Endocrinol
33117408	The Role of Type I Interferons in the Pathogenesis and Treatment of COVID-19.	Front Immunol
33117402	Can Beta-2-Adrenergic Pathway Be a New Target to Combat SARS-CoV-2 Hyperinflammatory Syndrome?-Lessons Learned From Cancer.	Front Immunol
33117392	Longitudinal Analysis of T and B Cell Receptor Repertoire Transcripts Reveal Dynamic Immune Response in COVID-19 Patients.	Front Immunol
33117379	ACE2/ADAM17/TMPRSS2 Interplay May Be the Main Risk Factor for COVID-19.	Front Immunol
33117378	"The SARS-CoV-2 Spike Glycoprotein Biosynthesis, Structure, Function, and Antigenicity: Implications for the Design of Spike-Based Vaccine Immunogens."	Front Immunol
33117359	"Immune-Boosting, Antioxidant and Anti-inflammatory Food Supplements Targeting Pathogenesis of COVID-19."	Front Immunol
33117175	Paracetamol-Induced Glutathione Consumption: Is There a Link With Severe COVID-19 Illness?	Front Pharmacol
33117174	COVID-19 Genetic and Environmental Risk Factors: A Look at the Evidence.	Front Pharmacol
33116752	Cytokine Response in SARS-CoV-2 Infection in the Elderly.	J Inflamm Res
33116747	Inflammatory Cytokine: IL-17A Signaling Pathway in Patients Present with COVID-19 and Current Treatment Strategy.	J Inflamm Res
33116692	Role of Renin-Angiotensin System in Acute Lung Injury Caused by Viral Infection.	Infect Drug Resist
33116543	The Current Recommended Drugs and Strategies for the Treatment of Coronavirus Disease (COVID-19).	Ther Clin Risk Manag
33116397	Glycopeptides as Potential Interventions for COVID-19.	Biologics
33116300	Coronavirus biology and replication: implications for SARS-CoV-2.	Nat Rev Microbiol
33116299	Identification of SARS-CoV-2 inhibitors using lung and colonic organoids.	Nature
33116249	Identification of SARS-CoV-2 entry inhibitors among already approved drugs.	Acta Pharmacol Sin
33116139	ACE2 localizes to the respiratory cilia and is not increased by ACE inhibitors or ARBs.	Nat Commun
33116089	Molecular Detection of Human Coronavirus from North Central Part of Bangladesh Depending on ORF1ab and N Gene.	Mymensingh Med J
33116043	Stabilizing mast cells by commonly used drugs: a novel therapeutic target to relieve post-COVID syndrome?	Drug Discov Ther
33116037	Is amiloride a promising cardiovascular medication to persist in the COVID-19 crisis?	Drug Discov Ther
33115920	Robust neutralizing antibodies to SARS-CoV-2 infection persist for months.	Science
33115882	The beneficial and pathogenic roles of complement in COVID-19.	Cleve Clin J Med
33115677	"HIV/SARS-CoV-2 co-infection: T cell profile, cytokine dynamics and role of exhausted lymphocytes."	Int J Infect Dis
33115667	Membrane heist: Coronavirus host membrane remodeling during replication.	Biochimie
33115641	Don't sugar coat the COVID (only the vasculature).	Biomed J
33115584	Possible Potential Outcomes from COVID-19 Complications on Testes: Lesson from SARS Infection.	J Coll Physicians Surg Pak
33115235	Hydroxychloroquine Exhibits a Strong Complex Interaction with DNA: Unraveling the Mechanism of Action.	J Phys Chem Lett
33114742	Antibody Binding to SARS-CoV-2 S Glycoprotein Correlates with but Does Not Predict Neutralization.	Viruses
33114676	"Interleukin-6: Molecule in the Intersection of Cancer, Ageing and COVID-19."	Int J Mol Sci
33114495	"Covid-19: Fat, Obesity, Inflammation, Ethnicity, and Sex Differences."	Pathogens
33114370	A Proline-Based Tectons and Supramolecular Synthons for Drug Design 2.0: A Case Study of ACEI.	Pharmaceuticals (Basel)
33114359	SARS-CoV-2/Renin-Angiotensin System: Deciphering the Clues for a Couple with Potentially Harmful Effects on Skeletal Muscle.	Int J Mol Sci
33114356	New Insights on the Mobility of Viral and Host Non-Coding RNAs Reveal Extracellular Vesicles as Intriguing Candidate Antiviral Targets.	Pathogens
33114322	Evolution of Transmissible Gastroenteritis Virus (TGEV): A Codon Usage Perspective.	Int J Mol Sci
33114247	The Cell Tropism of Porcine Respiratory Coronavirus for Airway Epithelial Cells Is Determined by the Expression of Porcine Aminopeptidase N.	Viruses
33113474	The Interferon-induced transmembrane protein 3 gene (IFITM3) rs12252 C variant is associated with COVID-19.	Cytokine
33113418	Potential of natural astaxanthin in alleviating the risk of cytokine storm in COVID-19.	Biomed Pharmacother
33113348	SARS-CoV-2 Infects the Brain Choroid Plexus and Disrupts the Blood-CSF Barrier in Human Brain Organoids.	Cell Stem Cell
33113345	High-Density Amplicon Sequencing Identifies Community Spread and Ongoing Evolution of SARS-CoV-2 in the Southern United States.	Cell Rep
33113222	T cell immunobiology and cytokine storm of COVID-19.	Scand J Immunol
33113212	"COVID-19, varying genetic resistance to viral disease and immune tolerance checkpoints."	Immunol Cell Biol
33112930	Common childhood vaccines do not elicit a cross-reactive antibody response against SARS-CoV-2.	PLoS One
33112891	"Bioinformatic characterization of angiotensin-converting enzyme 2, the entry receptor for SARS-CoV-2."	PLoS One
33112694	A Comprehensive Review of Neurologic Manifestations of COVID-19 and Management of Pre-existing Neurologic Disorders in Children.	J Child Neurol
33112638	"Literature review on virus and host response proteins in COVID-19: pathobiology, management, diagnosis and treatment."	Acta Virol
33112637	Mechanisms and potential therapeutic targets of hyperinflammatory responses in SARS-CoV-2.	Acta Virol
33112236	Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants.	Elife
33112187	Angiotensin-converting enzyme 2 expression in COPD and IPF fibroblasts: the forgotten cell in COVID-19.	Am J Physiol Lung Cell Mol Physiol
33112147	Critical Sequence Hotspots for Binding of Novel Coronavirus to Angiotensin Converter Enzyme as Evaluated by Molecular Simulations.	J Phys Chem B
33112126	Targeting Crucial Host Factors of SARS-CoV-2.	ACS Infect Dis
33112036	SARS-CoV-2 evades immune detection in alveolar macrophages.	EMBO Rep
33111751	SARS-CoV-2 isolation from the first reported patients in Brazil and establishment of a coordinated task network.	Mem Inst Oswaldo Cruz
33111624	Deciphering underlying mechanism of Sars-CoV-2 infection in humans and revealing the therapeutic potential of bioactive constituents from Nigella sativa to combat COVID19: in-silico study.	J Biomol Struct Dyn
33111622	In silico analysis of the interactions of certain flavonoids with the receptor-binding domain of 2019 novel coronavirus and cellular proteases and their pharmacokinetic properties.	J Biomol Struct Dyn
33111618	Binding mechanism and structural insights into the identified protein target of COVID-19 and importin-alpha with in-vitro effective drug ivermectin.	J Biomol Struct Dyn
33111578	Pathogenesis guided therapeutic management of COVID-19: an immunological perspective.	Int Rev Immunol
33111431	N-Terminomics for the Identification of In Vitro Substrates and Cleavage Site Specificity of the SARS-CoV-2 Main Protease.	Proteomics
33111375	SARS-CoV-2 RBD Neutralizing Antibody Induction is Enhanced by Particulate Vaccination.	Adv Mater
33111059	Histopathologic Findings of Coronavirus in Lung: A Mini-Review.	Clin Pathol
33110936	Hematologic parameters in coronavirus infection (COVID-19) and their clinical implications.	Discoveries (Craiova)
33110916	Exploring Host Genetic Polymorphisms Involved in SARS-CoV Infection Outcomes: Implications for Personalized Medicine in COVID-19.	Int J Genomics
33110775	A review on exploring evidence-based approach to harnessing the immune system in times of corona virus pandemic: Best of modern and traditional Indian system of medicine.	J Family Med Prim Care
33110761	Vaccine- and natural infection-induced mechanisms that could modulate vaccine safety.	Toxicol Rep
33110678	Mutations Observed in the SARS-CoV-2 Spike Glycoprotein and Their Effects in the Interaction of Virus with ACE-2 Receptor.	Medeni Med J
33110386	"Computational selection of flavonoid compounds as inhibitors against SARS-CoV-2 main protease, RNA-dependent RNA polymerase and spike proteins: A molecular docking study."	Saudi J Biol Sci
33110251	SARS-CoV-2 membrane glycoprotein M antagonizes the MAVS-mediated innate antiviral response.	Cell Mol Immunol
33110240	"Hypoxia, HIF-1alpha, and COVID-19: from pathogenic factors to potential therapeutic targets."	Acta Pharmacol Sin
33110195	Comparative ACE2 variation and primate COVID-19 risk.	Commun Biol
33110074	Early expansion of myeloid-derived suppressor cells inhibits SARS-CoV-2 specific T-cell response and may predict fatal COVID-19 outcome.	Cell Death Dis
33110068	Structural basis for potent neutralization of SARS-CoV-2 and role of antibody affinity maturation.	Nat Commun
33109839	Brainstem Dysfunction in SARS-COV-2 Infection can be a Potential Cause of Respiratory Distress.	Neurol India
33109794	Covid 19 and its cardiovascular effects.	Ann Card Anaesth
33109704	Antibody Binding Epitope Mapping (AbMap) of Hundred Antibodies in a Single Run.	Mol Cell Proteomics
33109497	"Computational studies reveal mechanism by which quinone derivatives can inhibit SARS-CoV-2. Study of embelin and two therapeutic compounds of interest, methyl prednisolone and dexamethasone."	J Infect Public Health
33109270	"Molecular detection of drug resistant polymorphisms in Plasmodium falciparum isolates from Southwest, Nigeria."	BMC Res Notes
33109057	Molecular Docking Studies of Bioactive Nicotiflorin against 6W63 Novel Coronavirus 2019 (COVID-19).	Comb Chem High Throughput Screen
33109039	The Binding of Remdesivir to SARS-CoV-2 RNA-Dependent RNA Polymerase May Pave The Way Towards the Design of Potential Drugs for COVID-19 Treatment.	Curr Pharm Biotechnol
33109028	Natural Products in Mitigation of SARS CoV Infections.	Curr Med Chem
33109027	Recent Advances Towards Drug Design Targeting the Protease of 2019 Novel Coronavirus (2019-nCoV).	Curr Med Chem
33108902	ACE2 and TMPRSS2 Potential Involvement in Genetic Susceptibility to SARS-COV-2 in Cancer Patients.	Cell Transplant
33108833	Potential mechanisms of SARS-CoV-2 action on male gonadal function and fertility: Current status and future prospects.	Andrologia
33108655	Development and Expression of Subunit Vaccines Against Viruses in Plants.	Methods Mol Biol
33108354	Inflammatory syndromes associated with SARS-CoV-2 infection: dysregulation of the immune response across the age spectrum.	J Clin Invest
33108121	[Biochemical and statistical lessons from the evolution of the SARS-CoV-2 virus: paths for novel antiviral warfare].	C R Biol
33107812	Secondary metabolites from spice and herbs as potential multitarget inhibitors of SARS-CoV-2 proteins.	J Biomol Struct Dyn
33107685	Severe Acute Respiratory Syndrome Coronavirus-2 Spike Protein Nanogel as a Pro-Antigen Strategy with Enhanced Protective Immune Responses.	Small
33107641	Discharge may not be the end of treatment: Pay attention to pulmonary fibrosis caused by severe COVID-19.	J Med Virol
33107304	Molecular Dynamics Reveals a DNA-Induced Dynamic Switch Triggering Activation of CRISPR-Cas12a.	J Chem Inf Model
33106987	Role of Oxidative Stress on SARS-CoV (SARS) and SARS-CoV-2 (COVID-19) Infection: A Review.	Protein J
33106832	[Structure of SARS-CoV-2 and treatment of COVID-19].	Sheng Li Xue Bao
33106783	Pediatric Inflammatory Multisystem Syndrome Temporally Associated with SARS-CoV-2: a New Challenge amid the Pandemic.	SN Compr Clin Med
33106757	Probing infectious disease by single-cell RNA sequencing: Progresses and perspectives.	Comput Struct Biotechnol J
33106741	"Discovery of small molecule PLpro inhibitor against COVID-19 using structure-based virtual screening, molecular dynamics simulation, and molecular mechanics/Generalized Born surface area (MM/GBSA) calculation."	Struct Chem
33106680	Genetically modified mouse models to help fight COVID-19.	Nat Protoc
33106671	Spike mutation D614G alters SARS-CoV-2 fitness.	Nature
33106569	The global population of SARS-CoV-2 is composed of six major subtypes.	Sci Rep
33106140	Mechanistic Insights to the Binding of Antibody CR3022 Against RBD from SARS-CoV and HCoV-19/SARS-CoV-2: A Computational Study.	Comb Chem High Throughput Screen
33106053	Biochemical and immunological aspects of COVID-19 infection and therapeutical intervention of oral low dose cytokine therapy: a systematic review.	Immunopharmacol Immunotoxicol
33105999	Computer simulations of the interaction between SARS-CoV-2 spike glycoprotein and different surfaces.	Biointerphases
33105869	The SARS-CoV-2 Spike Glycoprotein as a Drug and Vaccine Target: Structural Insights into Its Complexes with ACE2 and Antibodies.	Cells
33105830	Probiotics in Treatment of Viral Respiratory Infections and Neuroinflammatory Disorders.	Molecules
33105809	Intensive Care Unit-Acquired Weakness: Not just Another Muscle Atrophying Condition.	Int J Mol Sci
33105694	Bioactive Natural Antivirals: An Updated Review of the Available Plants and Isolated Molecules.	Molecules
33105685	Viewpoint: Origin of SARS-CoV-2.	Viruses
33105275	Obesity and immune status in children.	Curr Opin Pediatr
33104993	A comparative phylogenomic analysis of SARS-CoV-2 strains reported from non-human mammalian species and environmental samples.	Mol Biol Rep
33104520	Single-cell expression profiles of ACE2 and TMPRSS2 reveals potential vertical transmission and fetus infection of SARS-CoV-2.	Aging (Albany NY)
33104327	COSMO-RS-Based Descriptors for the Machine Learning-Enabled Screening of Nucleotide Analogue Drugs against SARS-CoV-2.	J Phys Chem Lett
33104300	"COVID-19: a user's guide, status of the art and an original proposal to terminate viral recurrence."	Minerva Med
33104167	SARS-CoV-2 specific T-cells Are Rapidly Expanded for Therapeutic Use and Target Conserved Regions of Membrane Protein.	Blood
33104057	Prolonged adaptive immune activation in COVID-19: implications for maintenance of long-term immunity?	J Clin Invest
33103998	Inhibition of SARS-CoV-2 viral entry upon blocking N- and O-glycan elaboration.	Elife
33103907	Evidence of Structural Protein Damage and Membrane Lipid Remodeling in Red Blood Cells from COVID-19 Patients.	J Proteome Res
33103616	"Natural phyto, compounds as possible noncovalent inhibitors against SARS-CoV2 protease: computational approach."	J Biomol Struct Dyn
33103586	High-throughput virtual screening of drug databanks for potential inhibitors of SARS-CoV-2 spike glycoprotein.	J Biomol Struct Dyn
33103512	The probiotic Bifidobacterium in the management of Coronavirus: A theoretical basis.	Int J Immunopathol Pharmacol
33103435	Computational Identification of Human Biological Processes and Protein Sequence Motifs Putatively Targeted by SARS-CoV-2 Proteins Using Protein-Protein Interaction Networks.	J Proteome Res
33103387	[PHYSIOLOGICAL GENDER DIFFERENCES AND THEIR EFFECT ON COVID-19 CAUSED MORBIDITY].	Harefuah
33103220	Supervised molecular dynamics for exploring the druggability of the SARS-CoV-2 spike protein.	J Comput Aided Mol Des
33103132	Interference between rhinovirus and influenza A virus: a clinical data analysis and experimental infection study.	Lancet Microbe
33103107	Protein-driven mechanism of multiorgan damage in COVID-19.	Med Drug Discov
33102987	Xanthene based hybrid analogues to inhibit protease of novel corona Virus: Molecular docking and ADMET studies.	Comput Toxicol
33102950	"The Integrin Binding Peptide, ATN-161, as a Novel Therapy for SARS-CoV-2 Infection."	JACC Basic Transl Sci
33102688	In silico identification of drug candidates against COVID-19.	Inform Med Unlocked
33102628	"SARS-CoV, MERS-CoV, and 2019-nCoV viruses: an overview of origin, evolution, and genetic variations."	Virusdisease
33102591	Sequence Analysis and Structure Prediction of SARS-CoV-2 Accessory Proteins 9b and ORF14: Evolutionary Analysis Indicates Close Relatedness to Bat Coronavirus.	Biomed Res Int
33102585	"Phytochemicals from Selective Plants Have Promising Potential against SARS-CoV-2: Investigation and Corroboration through Molecular Docking, MD Simulations, and Quantum Computations."	Biomed Res Int
33102545	"COVID-19 in Human, Animal, and Environment: A Review."	Front Vet Sci
33102489	Mesenchymal Stem Cells and Their Extracellular Vesicles: A Potential Game Changer for the COVID-19 Crisis.	Front Cell Dev Biol
33102261	Macrophages in diabetes mellitus (DM) and COVID-19: do they trigger DM?	J Diabetes Metab Disord
33101829	In silico analysis of ACE2 orthologues to predict animal host range with high susceptibility to SARS-CoV-2.	3 Biotech
33101705	The differential immune responses to COVID-19 in peripheral and lung revealed by single-cell RNA sequencing.	Cell Discov
33101694	Biochemical parameters and pathogenesis of SARS-CoV-2 infection in vital organs: COVID-19 outbreak in Iran.	New Microbes New Infect
33101604	Side chain similarity comparisons for integrated drug repositioning and potential toxicity assessments in epidemic response scenarios: The case for COVID-19.	Comput Struct Biotechnol J
33101484	COVID-19 and diabetes mellitus: Unraveling the hypotheses that worsen the prognosis (Review).	Exp Ther Med
33101402	On the modeling of the interaction between tumor growth and the immune system using some new fractional and fractional-fractal operators.	Adv Differ Equ
33101387	Genetic Association of ACE2 rs2285666 Polymorphism With COVID-19 Spatial Distribution in India.	Front Genet
33101356	Infectivity and Progression of COVID-19 Based on Selected Host Candidate Gene Variants.	Front Genet
33101314	"Inflammation, Thrombosis, and Destruction: The Three-Headed Cerberus of Trauma- and SARS-CoV-2-Induced ARDS."	Front Immunol
33101306	Covid-19: Perspectives on Innate Immune Evasion.	Front Immunol
33101294	Innate Immune Responses to Acute Viral Infection During Pregnancy.	Front Immunol
33101291	Perspective: The Potential Effects of Naringenin in COVID-19.	Front Immunol
33101264	Genetic Spectrum and Distinct Evolution Patterns of SARS-CoV-2.	Front Microbiol
33101254	The Potential Intermediate Hosts for SARS-CoV-2.	Front Microbiol
33101246	"Animal Models for COVID-19: More to the Picture Than ACE2, Rodents, Ferrets, and Non-human Primates. A Case for Porcine Respiratory Coronavirus and the Obese Ossabaw Pig."	Front Microbiol
33101244	Rapid Genomic Characterization of SARS-CoV-2 by Direct Amplicon-Based Sequencing Through Comparison of MinION and Illumina iSeq100(TM) System.	Front Microbiol
33101215	Stabilizing Cellular Barriers: Raising the Shields Against COVID-19.	Front Endocrinol (Lausanne)
33101175	SAMHD1 as the Potential Link Between SARS-CoV-2 Infection and Neurological Complications.	Front Neurol
33101066	Angiotensin Converting Enzyme 2 (ACE2) in Pregnancy: Preeclampsia and Small for Gestational Age.	Front Physiol
33101023	Anti-SARS-CoV Natural Products With the Potential to Inhibit SARS-CoV-2 (COVID-19).	Front Pharmacol
33100642	Respiratory and cardiovascular effects of COVID-19 infection and their management.	J Anaesthesiol Clin Pharmacol
33100613	Molecular docking analysis of selected phytochemicals against SARS-CoV-2 M(pro) receptor.	Vegetos
33100380	Identification of alkaloids from Justicia adhatoda as potent SARS CoV-2 main protease inhibitors: An in silico perspective.	J Mol Struct
33100379	DFT investigation of atazanavir as potential inhibitor for 2019-nCoV coronavirus M protease.	J Mol Struct
33100378	"Synthesis, anti-bacterial evaluation, DFT study and molecular docking as a potential 3-chymotrypsin-like protease (3CLpro) of SARS-CoV-2 inhibitors of a novel Schiff bases."	J Mol Struct
33100352	Change of Antigenic Determinants of SARS-CoV-2 Virus S-Protein as a Possible Cause of Antibody-Dependent Enhancement of Virus Infection and Cytokine Storm.	Biophysics (Oxf)
33100351	Dinitrosyl Iron Complexes with Thiol-Containing Ligands Can Suppress Viral Infections as Donors of the Nitrosonium Cation (Hypothesis).	Biophysics (Oxf)
33100290	An overview of potential therapeutic agents to treat COVID-19.	Biosci Trends
33100211	Novel Coronavirus SARS-CoV-2 (COVID-19) and Pregnancy: A hypothetical view.	Endocr Metab Immune Disord Drug Targets
33100195	COVID-19 Vaccines in Clinical Trials and their Mode of Action for Immunity against the Virus.	Curr Pharm Des
33100032	Exploring RdRp-remdesivir interactions to screen RdRp inhibitors for the management of novel coronavirus 2019-nCoV.	SAR QSAR Environ Res
33099990	Are Patients with Asthma and Chronic Obstructive Pulmonary Disease Preferred Targets of COVID-19?	Tuberc Respir Dis (Seoul)
33099897	Severe acute respiratory syndrome coronavirus-2 infection and the gut-liver axis.	J Dig Dis
33099890	"COVID-19: A Case for Inhibiting NLRP3 Inflammasome, Suppression of Inflammation with Curcumin?"	Basic Clin Pharmacol Toxicol
33099545	Understanding Severe Acute Respiratory Syndrome Coronavirus 2 Replication to Design Efficient Drug Combination Therapies.	Intervirology
33099241	A novel rapid detection for SARS-CoV-2 spike 1 antigens using human angiotensin converting enzyme 2 (ACE2).	Biosens Bioelectron
33099199	"Exploring the intrinsic dynamics of SARS-CoV-2, SARS-CoV and MERS-CoV spike glycoprotein through normal mode analysis using anisotropic network model."	J Mol Graph Model
33098839	System biological investigations of hydroxychloroquine and azithromycin targets and their implications in QT interval prolongation.	Chem Biol Interact
33098835	Translating bioactive peptides for COVID-19 therapy.	Eur J Pharmacol
33098588	Neuroprotective effects of flavone luteolin in neuroinflammation and neurotrauma.	Biofactors
33098476	An Overview of the Crystallized Structures of the SARS-CoV-2.	Protein J
33098397	COVID-19 Mediated by Basigin Can Affect Male and Female Fertility.	Int J Fertil Steril
33098359	Proteomic characteristics of bronchoalveolar lavage fluid in critical COVID-19 patients.	FEBS J
33098357	"Stem cell therapy for COVID-19, ARDS and pulmonary fibrosis."	Cell Prolif
33098230	Genetic insight into COVID-19-related liver injury.	Liver Int
33098147	Neuroinvasive potential of SARS-CoV2 with neuroradiological and neuropathological findings: is the brain a target or a victim?	APMIS
33097791	A platform incorporating trimeric antigens into self-assembling nanoparticles reveals SARS-CoV-2-spike nanoparticles to elicit substantially higher neutralizing responses than spike alone.	Sci Rep
33097660	SARS-CoV-2 Orf6 hijacks Nup98 to block STAT nuclear import and antagonize interferon signaling.	Proc Natl Acad Sci U S A
33097186	ACE2 contributes to the maintenance of mouse epithelial barrier function.	Biochem Biophys Res Commun
33097184	Leveraging coronavirus binding to gangliosides for innovative vaccine and therapeutic strategies against COVID-19.	Biochem Biophys Res Commun
33097094	Identification of AAV serotypes for lung gene therapy in human embryonic stem cell-derived lung organoids.	Stem Cell Res Ther
33096825	Extracellular Vesicles in the Pathogenesis of Viral Infections in Humans.	Viruses
33096722	Why Does COVID-19 Affect Patients with Spinal Cord Injury Milder? A Case-Control Study: Results from Two Observational Cohorts.	J Pers Med
33096114	Preventing the development of severe COVID-19 by modifying immunothrombosis.	Life Sci
33096082	Structure-altering mutations of the SARS-CoV-2 frameshifting RNA element.	Biophys J
33096026	Large-Scale Multi-omic Analysis of COVID-19 Severity.	Cell Syst
33096020	Imbalance of Regulatory and Cytotoxic SARS-CoV-2-Reactive CD4(+) T Cells in COVID-19.	Cell
33095583	Utility of Proteomics in Emerging and Re-Emerging Infectious Diseases Caused by RNA Viruses.	J Proteome Res
33095513	The use of renin-angiotensin-aldosterone system (RAAS) inhibitors is associated with a lower risk of mortality in hypertensive COVID-19 patients: A systematic review and meta-analysis.	J Med Virol
33095459	Chronic COVID syndrome: Need for an appropriate medical terminology for long-COVID and COVID long-haulers.	J Med Virol
33095454	Evolutionary dynamics of SARS-CoV-2 nucleocapsid protein and its consequences.	J Med Virol
33095007	Antiviral Peptides as Promising Therapeutics against SARS-CoV-2.	J Phys Chem B
33094998	Flexible Synthetic Carbohydrate Receptors as Inhibitors of Viral Attachment.	Biochemistry
33094891	Discovery of novel pyrazole derivatives as a potent anti-inflammatory agent in RAW264.7 cells via inhibition of NF-kB for possible benefit against SARS-CoV-2.	J Biochem Mol Toxicol
33094705	Caffeine and caffeine-containing pharmaceuticals as promising inhibitors for 3-chymotrypsin-like protease of SARS-CoV-2.	J Biomol Struct Dyn
33094701	Potential therapeutic use of corticosteroids as SARS CoV-2 main protease inhibitors: a computational study.	J Biomol Struct Dyn
33094680	A multi-stage virtual screening of FDA-approved drugs reveals potential inhibitors of SARS-CoV-2 main protease.	J Biomol Struct Dyn
33094537	Single-cell analysis identified lung progenitor cells in COVID-19 patients.	Cell Prolif
33094446	Zinc and COVID-19: Basis of Current Clinical Trials.	Biol Trace Elem Res
33094324	Exploring lectin-glycan interactions to combat COVID-19: Lessons acquired from other enveloped viruses.	Glycobiology
33094291	Luminespib counteracts the Kifunensine-induced lung endothelial barrier dysfunction.	Curr Res Toxicol
33093945	Electrolyte Disturbances in SARS-CoV-2 Infection.	F1000Res
33093684	SARS-CoV-2 M(pro) inhibitors and activity-based probes for patient-sample imaging.	Nat Chem Biol
33093202	Engineered ACE2 receptor traps potently neutralize SARS-CoV-2.	Proc Natl Acad Sci U S A
33093069	Sequencing identifies multiple early introductions of SARS-CoV-2 to the New York City region.	Genome Res
33093050	Coding-Complete Genome Sequences of 23 SARS-CoV-2 Samples from the Philippines.	Microbiol Resour Announc
33092925	Identification of tuna protein-derived peptides as potent SARS-CoV-2 inhibitors via molecular docking and molecular dynamic simulation.	Food Chem
33092787	Biodiversity loss and COVID-19 pandemic: The role of bats in the origin and the spreading of the disease.	Biochem Biophys Res Commun
33092738	Coronavirus and Cardiometabolic Syndrome: JACC Focus Seminar.	J Am Coll Cardiol
33092737	"Coronavirus and Cardiovascular Disease, Myocardial Injury, and Arrhythmia: JACC Focus Seminar."	J Am Coll Cardiol
33092736	"Coronavirus Historical Perspective, Disease Mechanisms, and Clinical Outcomes: JACC Focus Seminar."	J Am Coll Cardiol
33092637	Human genetic factors associated with susceptibility to SARS-CoV-2 infection and COVID-19 disease severity.	Hum Genomics
33092458	"Similarities between the effect of SARS-CoV-2 and HCV on the cellular level, and the possible role of ion channels in COVID19 progression: a review of potential targets for diagnosis and treatment."	Channels (Austin)
33092124	Are Viral Vectors Any Good for RNAi Antiviral Therapy?	Viruses
33092045	"Detailed Molecular Interactions of Favipiravir with SARS-CoV-2, SARS-CoV, MERS-CoV, and Influenza Virus Polymerases In Silico."	Microorganisms
33091758	The role of androgens in COVID-19.	Diabetes Metab Syndr
33091672	"Nano-sized formazan analogues: Synthesis, structure elucidation, antimicrobial activity and docking study for COVID-19."	Bioorg Chem
33091590	"Molecular characterization, pathogen-host interaction pathway and in silico approaches for vaccine design against COVID-19."	J Chem Neuroanat
33091582	Inhibition of N-linked Glycosylation by Tunicamycin May Contribute to The Treatment of SARS-CoV-2.	Microb Pathog
33091573	Heme oxygenase-1 modulation: A potential therapeutic target for COVID-19 and associated complications.	Free Radic Biol Med
33091548	Variant analysis of the first Lebanese SARS-CoV-2 isolates.	Genomics
33091416	Neurotropism of SARS-CoV-2 and its neuropathological alterations: Similarities with other coronaviruses.	Neurosci Biobehav Rev
33091382	Structure-Based Design with Tag-Based Purification and In-Process Biotinylation Enable Streamlined Development of SARS-CoV-2 Spike Molecular Probes.	Cell Rep
33091154	Vaccine design based on 16 epitopes of SARS-CoV-2 spike protein.	J Med Virol
33091066	Time-lapse sentinel surveillance of SARS-CoV-2 spread in India.	PLoS One
33090793	Targeting Proteases for Treating COVID-19.	J Proteome Res
33090785	Virtual Double-System Single-Box: A Nonequilibrium Alchemical Technique for Absolute Binding Free Energy Calculations: Application to Ligands of the SARS-CoV-2 Main Protease.	J Chem Theory Comput
33090696	Sex differences in antiviral immunity in SARS-CoV-2 infection: Mitochondria and mitomiR come into view.	Acta Physiol (Oxf)
33090621	Anti-inflammatory effects of cordycepin: A review.	Phytother Res
33090532	Susceptibility of livestock and companion animals to COVID-19.	J Med Virol
33090515	Extrapulmonary manifestations of severe acute respiratory syndrome coronavirus-2 infection.	J Med Virol
33090512	Effects of SARS-CoV-2 mutations on protein structures and intraviral protein-protein interactions.	J Med Virol
33090493	Mutations in membrane-fusion subunit of spike glycoprotein play crucial role in the recent outbreak of COVID-19.	J Med Virol
33090438	Impact of COVID-19 on the cerebrovascular system and the prevention of RBC lysis.	Eur Rev Med Pharmacol Sci
33090434	Could dantrolene be explored as a repurposed drug to treat COVID-19 patients by restoring intracellular calcium homeostasis?	Eur Rev Med Pharmacol Sci
33090359	Hordatines as a Potential Inhibitor of COVID-19 Main Protease and RNA Polymerase: An In-Silico Approach.	Nat Prod Bioprospect
33089730	Screening of phytochemicals as potent inhibitor of 3-chymotrypsin and papain-like proteases of SARS-CoV2: an in silico approach to combat COVID-19.	J Biomol Struct Dyn
33089728	"Prevention of SARS-CoV-2 cell entry: insight from in silico interaction of drug-like alkaloids with spike glycoprotein, human ACE2, and TMPRSS2."	J Biomol Struct Dyn
33089717	Antiviral Activity of Reagents in Mouth Rinses against SARS-CoV-2.	J Dent Res
33089707	Potential neurological manifestations of COVID-19: a narrative review.	Postgrad Med
33089452	"Human Hematopoietic Stem, Progenitor, and Immune Cells Respond Ex Vivo to SARS-CoV-2 Spike Protein."	Stem Cell Rev Rep
33088822	SARS-CoV-2 Bound Human Serum Albumin and Systemic Septic Shock.	Front Cardiovasc Med
33088807	Prognostic and Immunological Value of Angiotensin-Converting Enzyme 2 in Pan-Cancer.	Front Mol Biosci
33088671	Targeting complement cascade: an alternative strategy for COVID-19.	3 Biotech
33088633	Positive selection within the genomes of SARS-CoV-2 and other Coronaviruses independent of impact on protein function.	PeerJ
33087721	Antibody-mediated disruption of the SARS-CoV-2 spike glycoprotein.	Nat Commun
33087299	Understanding the role of neutrophils in acute respiratory distress syndrome.	Biomed J
33087172	The epigenetic implication in coronavirus infection and therapy.	Clin Epigenetics
33086932	The bumpy road to achieve herd immunity in COVID-19.	J Immunoassay Immunochem
33086867	Exploring the Role of Endothelial Cell Resilience in Cardiovascular Health and Disease.	Arterioscler Thromb Vasc Biol
33086697	"Effects of Coronavirus Persistence on the Genome Structure and Subsequent Gene Expression, Pathogenicity and Adaptation Capability."	Cells
33086222	Identification of Immunohistochemical Reagents for In Situ Protein Expression Analysis of Coronavirus-associated Changes in Human Tissues.	Appl Immunohistochem Mol Morphol
33086122	Mechanistic insights into dimethyl cardamonin-mediated pharmacological effects: A double control of the AMPK-HMGB1 signaling axis.	Life Sci
33086029	Renin-angiotensin system at the interface of COVID-19 infection.	Eur J Pharmacol
33086021	"Epigenetic regulation of ACE2, the receptor of the SARS-CoV-2 virus(1)."	Genome
33085654	Age-related susceptibility to coronavirus infections: role of impaired and dysregulated host immunity.	J Clin Invest
33085541	Mutation profile of over 4500 SARS-CoV-2 isolations reveals prevalent cytosine-to-uridine deamination on viral RNAs.	Future Microbiol
33085491	Thermodynamics of the Interaction between the Spike Protein of Severe Acute Respiratory Syndrome Coronavirus-2 and the Receptor of Human Angiotensin-Converting Enzyme 2. Effects of Possible Ligands.	J Phys Chem Lett
33085084	SARS-CoV-2-specific virulence factors in COVID-19.	J Med Virol
33084959	Micronutrients and bioactive compounds in the immunological pathways related to SARS-CoV-2 (adults and elderly).	Eur J Nutr
33084879	Double trouble: combined cardiovascular effects of particulate matter exposure and coronavirus disease 2019.	Cardiovasc Res
33084624	Immune Responses During Human Coronavirus Infection: Suggestions for Future Studies.	Niger J Physiol Sci
33084512	Targeting the 3CLpro and RdRp of SARS-CoV-2 with phytochemicals from medicinal plants of the Andean Region: molecular docking and molecular dynamics simulations.	J Biomol Struct Dyn
33084449	Deep mutagenesis in the study of COVID-19: a technical overview for the proteomics community.	Expert Rev Proteomics
33084340	The COVID-19 Pandemic from a Human Genetic Perspective.	J Proteome Res
33084150	Why Does the Novel Coronavirus Spike Protein Interact so Strongly with the Human ACE2? A Thermodynamic Answer.	Chembiochem
33084001	"The Cross-Talk between Age, Hypertension and Inflammation in COVID-19 Patients: Therapeutic Targets."	Drugs Aging
33083934	Update on cerebrovascular manifestations of COVID-19.	Neurol Sci
33083914	Coronavirus: proteomics analysis of chicken kidney tissue infected with variant 2 (IS-1494)-like avian infectious bronchitis virus.	Arch Virol
33083826	Associations Between Genetically Predicted Protein Levels and COVID-19 Severity.	J Infect Dis
33083782	Converging pathways in pulmonary fibrosis and Covid-19 - The fibrotic link to disease severity.	Respir Med X
33083695	"Neurological Complications of SARS-CoV, MERS-CoV, and COVID-19."	SN Compr Clin Med
33083627	Computer-aided drug design against spike glycoprotein of SARS-CoV-2 to aid COVID-19 treatment.	Heliyon
33083517	Leaving no stone unturned: Allosteric targeting of SARS-CoV-2 spike protein at putative druggable sites disrupts human angiotensin-converting enzyme interactions at the receptor binding domain.	Inform Med Unlocked
33083500	2019-nCoV: a worldwide concern and facts.	Virusdisease
33083436	Does inflammation help during COVID-19?	ERJ Open Res
33083387	Role of monoclonal antibody drugs in the treatment of COVID-19.	World J Clin Cases
33083157	Mutations of SARS-CoV-2 nsp14 exhibit strong association with increased genome-wide mutation load.	PeerJ
33083031	Experimental and in silico evidence suggests vaccines are unlikely to be affected by D614G mutation in SARS-CoV-2 spike protein.	NPJ Vaccines
33083026	Ad26 vector-based COVID-19 vaccine encoding a prefusion-stabilized SARS-CoV-2 Spike immunogen induces potent humoral and cellular immune responses.	NPJ Vaccines
33082935	Immunopathology of galectin-3: an increasingly promising target in COVID-19.	F1000Res
33082858	Examining the effector mechanisms of Xuebijing injection on COVID-19 based on network pharmacology.	BioData Min
33082849	"Cancer progression in COVID-19: integrating the roles of renin angiotensin aldosterone system, angiopoietin-2, heat shock protein-27 and epithelial mesenchymal transition."	Ecancermedicalscience
33082714	Coagulopathy associated with COVID-19 - Perspectives & Preventive strategies using a biological response modifier Glucan.	Thromb J
33082620	Insights into the Immunopathophysiology of Severe COVID-19 in Metabolic Disorders.	Ann Natl Acad Med Sci
33082599	"Chloroquine and hydroxychloroquine inhibitors for COVID-19 sialic acid cellular receptor: Structure, hirshfeld atomic charge analysis and solvent effect."	J Mol Struct
33082574	Bi-paratopic and multivalent VH domains block ACE2 binding and neutralize SARS-CoV-2.	Nat Chem Biol
33082473	Development of humanized tri-specific nanobodies with potent neutralization for SARS-CoV-2.	Sci Rep
33082451	Point mutation bias in SARS-CoV-2 variants results in increased ability to stimulate inflammatory responses.	Sci Rep
33082405	Multiple early introductions of SARS-CoV-2 into a global travel hub in the Middle East.	Sci Rep
33082395	Expression of SARS-CoV-2 entry factors in lung epithelial stem cells and its potential implications for COVID-19.	Sci Rep
33082295	Structural analysis of full-length SARS-CoV-2 spike protein from an advanced vaccine candidate.	Science
33082294	Neuropilin-1 is a host factor for SARS-CoV-2 infection.	Science
33082293	Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity.	Science
33082267	Dysregulation of Angiotensin Converting Enzyme 2 Expression and Function in Comorbid Disease Conditions Possibly Contributes to Coronavirus Infectious Disease 2019 Complication Severity.	Mol Pharmacol
33082264	Accurate Diagnosis of COVID-19 by a Novel Immunogenic Secreted SARS-CoV-2 orf8 Protein.	mBio
33082259	Inhibition of Coronavirus Entry In Vitro and Ex Vivo by a Lipid-Conjugated Peptide Derived from the SARS-CoV-2 Spike Glycoprotein HRC Domain.	mBio
33082228	Transcriptional and proteomic insights into the host response in fatal COVID-19 cases.	Proc Natl Acad Sci U S A
33082024	Sexual Dimorphism of Coronavirus 19 Morbidity and Lethality.	Trends Endocrinol Metab
33082015	Exploring the out of sight antigens of SARS-CoV-2 to design a candidate multi-epitope vaccine by utilizing immunoinformatics approaches.	Vaccine
33081928	Origin of new emergent Coronavirus and Candida fungal diseases-Terrestrial or cosmic?	Adv Genet
33081907	[Possibility of mesenchymal stem cell transplantation in the treatment of coronavirus disease 2019].	Zhonghua Wei Zhong Bing Ji Jiu Yi Xue
33081906	[Research progress of coagulation dysfunction in coronavirus disease 2019].	Zhonghua Wei Zhong Bing Ji Jiu Yi Xue
33081905	[Metformin: one of the possible options to reduce the mortality of severe coronavirus disease 2019?]	Zhonghua Wei Zhong Bing Ji Jiu Yi Xue
33081856	Nutrigenetics of antioxidant enzymes and micronutrient needs in the context of viral infections.	Nutr Res Rev
33081670	Downregulation of Membrane-bound Angiotensin Converting Enzyme 2 (ACE2) Receptor has a Pivotal Role in COVID-19 Immunopathology.	Curr Drug Targets
33081458	[Clinical and pathogenetic aspects of nervous system impairments in COVID-19].	Zh Nevrol Psikhiatr Im S S Korsakova
33081421	Expression Pattern of the SARS-CoV-2 Entry Genes ACE2 and TMPRSS2 in the Respiratory Tract.	Viruses
33081023	"Design, Synthesis and In Vitro Experimental Validation of Novel TRPV4 Antagonists Inspired by Labdane Diterpenes."	Mar Drugs
33080984	Identification and Tracking of Antiviral Drug Combinations.	Viruses
33080900	In silico Investigation on the Inhibiting Role of Nicotine/Caffeine by Blocking the S Protein of SARS-CoV-2 Versus ACE2 Receptor.	Microorganisms
33080715	"A systematic review of etiology, epidemiology, clinical manifestations, image findings, and medication of 2019 Corona Virus Disease-19 in Wuhan, China."	Medicine (Baltimore)
33080459	The triggering of post-COVID-19 autoimmunity phenomena could be associated with both transient immunosuppression and an inappropriate form of immune reconstitution in susceptible individuals.	Med Hypotheses
33080435	The role of Interleukin-4 in COVID-19 associated male infertility - A hypothesis.	J Reprod Immunol
33080339	Alcohol use disorder: A pre-existing condition for COVID-19?	Alcohol
33080267	Designed variants of ACE2-Fc that decouple anti-SARS-CoV-2 activities from unwanted cardiovascular effects.	Int J Biol Macromol
33080218	"SARS-CoV-2 Disrupts Splicing, Translation, and Protein Trafficking to Suppress Host Defenses."	Cell
33080068	Cell-mediated and humoral adaptive immune responses to SARS-CoV-2 are lower in asymptomatic than symptomatic COVID-19 patients.	Eur J Immunol
33079950	Proteins associated with neutrophil degranulation are upregulated in nasopharyngeal swabs from SARS-CoV-2 patients.	PLoS One
33079314	Using Chou's 5-steps rule to study pharmacophore-based virtual screening of SARS-CoV-2 Mpro inhibitors.	Mol Divers
33079210	Inflammasome formation in the lungs of patients with fatal COVID-19.	Inflamm Res
33078675	Potential therapeutic effect of turmeric contents against SARS-CoV-2 compared with experimental COVID-19 therapies: in silico study.	J Biomol Struct Dyn
33078623	Hypothesis: Sex-Related Differences in ACE2 Activity May Contribute to Higher Mortality in Men Versus Women With COVID-19.	J Cardiovasc Pharmacol Ther
33078545	Altered bioenergetics and mitochondrial dysfunction of monocytes in patients with COVID-19 pneumonia.	EMBO Mol Med
33078484	Atrial fibrillation in COVID-19: A review of possible mechanisms.	FASEB J
33078408	Mechanisms of COVID-19-induced cardiovascular disease: Is sepsis or exosome the missing link?	J Cell Physiol
33078369	Neurobiochemical Cross-talk Between COVID-19 and Alzheimer's Disease.	Mol Neurobiol
33078096	Molecular Docking and ADMET Study of Bioactive Compounds of Glycyrrhiza glabra Against Main Protease of SARS-CoV2.	Mater Today Proc
33078035	Modeling of the adsorption of a protein-fragment on kaolinite with potential antiviral activity.	Appl Clay Sci
33078028	Is a healthy microbiome responsible for lower mortality in COVID-19?	Biologia (Bratisl)
33077917	"Immunity, endothelial injury and complement-induced coagulopathy in COVID-19."	Nat Rev Nephrol
33077916	Interferons and viruses induce a novel truncated ACE2 isoform and not the full-length SARS-CoV-2 receptor.	Nat Genet
33077915	Tissue-specific and interferon-inducible expression of nonfunctional ACE2 through endogenous retroelement co-option.	Nat Genet
33077899	Rapid production of SARS-CoV-2 receptor binding domain (RBD) and spike specific monoclonal antibody CR3022 in Nicotiana benthamiana.	Sci Rep
33077837	Finding disease modules for cancer and COVID-19 in gene co-expression networks with the Core&Peel method.	Sci Rep
33077836	Molecular docking study of potential phytochemicals and their effects on the complex of SARS-CoV2 spike protein and human ACE2.	Sci Rep
33077821	"Rational approach toward COVID-19 main protease inhibitors via molecular docking, molecular dynamics simulation and free energy calculation."	Sci Rep
33077685	Site-specific N-glycosylation Characterization of Recombinant SARS-CoV-2 Spike Proteins.	Mol Cell Proteomics
33077488	Gamut of cardiac manifestations and complications of COVID-19: a contemporary review.	J Investig Med
33077403	Could Oral Phosphodiesterase 5 Inhibitors Have a Potential Adjuvant Role in Combating COVID-19 Infection?	Sex Med Rev
33077340	Sex-biased Immune Responses Following SARS-CoV-2 Infection.	Trends Microbiol
33076729	Immune system changes during COVID-19 recovery play key role in determining disease severity.	Int J Immunopathol Pharmacol
33076559	Products of Oxidative Guanine Damage Form Base Pairs with Guanine.	Int J Mol Sci
33076493	"SARS-CoV-2 Viral Load, IFNlambda Polymorphisms and the Course of COVID-19: An Observational Study."	J Clin Med
33075714	Toll-like receptors in sepsis-associated cytokine storm and their endogenous negative regulators as future immunomodulatory targets.	Int Immunopharmacol
33075532	Higher binding affinity of furin for SARS-CoV-2 spike (S) protein D614G mutant could be associated with higher SARS-CoV-2 infectivity.	Int J Infect Dis
33075530	COVID toes: where do we stand with the current evidence?	Int J Infect Dis
33075136	Impaired natural killer cell counts and cytolytic activity in patients with severe COVID-19.	Blood Adv
33074732	COVID-19 and Hypercoagulability: A Review.	Clin Appl Thromb Hemost
33074266	The cognitive consequences of the COVID-19 epidemic: collateral damage?	Brain Commun
33074241	Antivirals Against SARS-CoV2: Relevance to the Treatment of Alzheimer's Disease.	J Alzheimers Dis
33074111	Structural and molecular basis of the interaction mechanism of selected drugs towards multiple targets of SARS-CoV-2 by molecular docking and dynamic simulation studies- deciphering the scope of repurposed drugs.	Comput Biol Med
33073969	An Overview on the Common Laboratory Parameter Alterations and their Related Molecular Pathways in Screening for COVID-19 Patients.	Clin Lab
33073946	"Covid-19 Pandemic: Through the Lens of Science, a Painstaking Review."	Clin Lab
33073910	Detection of SARS-CoV-2 in saliva and characterization of oral symptoms in COVID-19 patients.	Cell Prolif
33073716	A computational and bioinformatic analysis of ACE2: an elucidation of its dual role in COVID-19 pathology and finding its associated partners as potential therapeutic targets.	J Biomol Struct Dyn
33073712	Structural basis for the inhibition of SARS-CoV2 main protease by Indian medicinal plant-derived antiviral compounds.	J Biomol Struct Dyn
33073699	Antiviral activity of traditional medicinal plants from Ayurveda against SARS-CoV-2 infection.	J Biomol Struct Dyn
33073694	Comparison of transgenic and adenovirus hACE2 mouse models for SARS-CoV-2 infection.	Emerg Microbes Infect
33073571	Gold/Silver Hybrid Nanoparticles with Enduring Inhibition of Coronavirus Multiplication through Multisite Mechanisms.	Bioconjug Chem
33073555	SARS-CoV-2-related lung pathology: macroscopic and histologic features and their clinical implications.	Panminerva Med
33073512	Obesity and COVID-19: A jigsaw puzzle with still missing pieces.	Clin Obes
33073359	Divergent SARS-CoV-2-specific T- and B-cell responses in severe but not mild COVID-19 patients.	Eur J Immunol
33073355	Pathogenesis-directed therapy of 2019 novel coronavirus disease.	J Med Virol
33073244	Imperfect storm: is interleukin-33 the Achilles heel of COVID-19?	Lancet Rheumatol
33073203	Helminths and COVID-19 Co-Infections: A Neglected Critical Challenge.	ACS Pharmacol Transl Sci
33073200	Heme/Hemeoxygenase-1 System Is a Potential Therapeutic Intervention for COVID-19 Patients with Severe Complications.	ACS Pharmacol Transl Sci
33073199	Achilles' Heel of SARS-CoV-2 Structure.	ACS Pharmacol Transl Sci
33073198	Therapeutically Targeted Destabilization of the Quaternary Structure of the Spike Protein in the Dominant G614 Strain of SARS-CoV-2.	ACS Pharmacol Transl Sci
33073197	Can SARS-CoV-2 Accumulate Mutations in the S-Protein to Increase Pathogenicity?	ACS Pharmacol Transl Sci
33073073	"Time to get ill: the intersection of viral infections, sex, and the X chromosome."	Curr Opin Physiol
33073072	The role of inflammation in hypertension: novel concepts.	Curr Opin Physiol
33073064	Cardiorenal Tissues Express SARS-CoV-2 Entry Genes and Basigin (BSG/CD147) Increases With Age in Endothelial Cells.	JACC Basic Transl Sci
33072893	Identification of novel mutations in the methyltransferase complex (Nsp10-Nsp16) of SARS-CoV-2.	Biochem Biophys Rep
33072849	Understand variability of COVID-19 through population and tissue variations in expression of SARS-CoV-2 host genes.	Inform Med Unlocked
33072702	"Epidemiological and Genomic Analysis of SARS-CoV-2 in 10 Patients From a Mid-Sized City Outside of Hubei, China in the Early Phase of the COVID-19 Outbreak."	Front Public Health
33072699	Geographical Distribution of Genetic Variants and Lineages of SARS-CoV-2 in Chile.	Front Public Health
33072500	Angiotensin-converting enzyme 2 (ACE2): SARS-CoV-2 receptor and RAS modulator.	Acta Pharm Sin B
33072499	Identifying potential anti-COVID-19 pharmacological components of traditional Chinese medicine Lianhuaqingwen capsule based on human exposure and ACE2 biochromatography screening.	Acta Pharm Sin B
33072409	The role of death domain proteins in host response upon SARS-CoV-2 infection: modulation of programmed cell death and translational applications.	Cell Death Discov
33072338	Development of a novel platform of virus-like particle (VLP)-based vaccine against COVID-19 by exposing epitopes: an immunoinformatics approach.	New Microbes New Infect
33072323	"Kinetics and isotype assessment of antibodies targeting the spike protein receptor-binding domain of severe acute respiratory syndrome-coronavirus-2 in COVID-19 patients as a function of age, biological sex and disease severity."	Clin Transl Immunology
33072240	Enhancing innate immunity against virus in times of COVID-19: Trying to untangle facts from fictions.	World Allergy Organ J
33072222	Structure-Based Design of Novel Peptidomimetics Targeting the SARS-CoV-2 Spike Protein.	Cell Mol Bioeng
33072191	MiR-146a rs2910164 G > C polymorphism modulates Notch-1/IL-6 signaling during infection: a possible risk factor for Crohn's disease.	Gut Pathog
33072190	Systematic analyses on the potential immune and anti-inflammatory mechanisms of Shufeng Jiedu Capsule against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-caused pneumonia.	J Funct Foods
33072117	Familial Mediterranean Fever and COVID-19: Friends or Foes?	Front Immunol
33072103	Immunopathogenesis of COVID-19: Summary and Possible Interventions.	Front Immunol
33072099	Increased Serum Levels of sCD14 and sCD163 Indicate a Preponderant Role for Monocytes in COVID-19 Immunopathology.	Front Immunol
33072098	The Dynamics of the Ferret Immune Response During H7N9 Influenza Virus Infection.	Front Immunol
33072097	COVID-19: In the Eye of the Cytokine Storm.	Front Immunol
33072093	Strategies for Targeting SARS CoV-2: Small Molecule Inhibitors-The Current Status.	Front Immunol
33072032	Small Non-coding RNAs: Do They Encode Answers for Controlling SARS-CoV-2 in the Future?	Front Microbiol
33072018	Translation-Associated Mutational U-Pressure in the First ORF of SARS-CoV-2 and Other Coronaviruses.	Front Microbiol
33071996	Proteomics Insights Into the Molecular Basis of SARS-CoV-2 Infection: What We Can Learn From the Human Olfactory Axis.	Front Microbiol
33071815	Regulation of Angiotensin- Converting Enzyme 2 in Obesity: Implications for COVID-19.	Front Physiol
33071786	Anti-IL-6 Versus Anti-IL-6R Blocking Antibodies to Treat Acute Ebola Infection in BALB/c Mice: Potential Implications for Treating Cytokine Release Syndrome.	Front Pharmacol
33071777	"Lian Hua Qing Wen Capsules, a Potent Epithelial Protector in Acute Lung Injury Model, Block Proapoptotic Communication Between Macrophages, and Alveolar Epithelial Cells."	Front Pharmacol
33071468	Seizure and COVID-19: Association and review of potential mechanism.	Neurol Psychiatry Brain Res
33071354	Fenoterol and dobutamine as SARS-CoV-2 main protease inhibitors: A virtual screening study.	J Mol Struct
33071353	"Synthesis, spectroscopy, crystal structure, TGA/DTA study, DFT and molecular docking investigations of (E)-4-(4-methylbenzyl)-6-styrylpyridazin-3(2H)-one."	J Mol Struct
33071352	"Anti-COVID-19 terpenoid from marine sources: A docking, admet and molecular dynamics study."	J Mol Struct
33071142	WITHDRAWN: Can Traditional Chinese Medicine provide insights into controlling the COVID-19 pandemic: Serpentinization-induced lithospheric long-wavelength magnetic anomalies in Proterozoic bedrocks in a weakened geomagnetic field mediate the aberrant transformation of biogenic molecules in COVID-19 via magnetic catalysis.	Sci Total Environ
33071044	Type I IFN-dependent antibody response at the basis of sex dimorphism in the outcome of COVID-19.	Cytokine Growth Factor Rev
33071005	COVID-19 vaccine and boosted immunity: Nothing ad interim to do?	Vaccine
33071000	Bacillus Calmette-Guerin (BCG) vaccine generates immunoregulatory cells in the cervical lymph nodes in guinea pigs injected intra dermally.	Vaccine
33070902	"How SARS-Cov-2 can involve the central nervous system. A systematic analysis of literature of the department of human neurosciences of Sapienza University, Italy."	J Clin Neurosci
33070544	Cardiovascular system and COVID-19: manifestations and therapeutics.	Rev Cardiovasc Med
33070543	SARS-CoV-2 infection in patients with diabetes mellitus and hypertension: a systematic review.	Rev Cardiovasc Med
33070542	Current targets and drug candidates for prevention and treatment of SARS-CoV-2 (COVID-19) infection.	Rev Cardiovasc Med
33070539	Vitamin D deficiency in association with endothelial dysfunction: Implications for patients with COVID-19.	Rev Cardiovasc Med
33070537	Endothelial dysfunction contributes to COVID-19-associated vascular inflammation and coagulopathy.	Rev Cardiovasc Med
33070389	"The BioGRID database: A comprehensive biomedical resource of curated protein, genetic, and chemical interactions."	Protein Sci
33070314	High prevalence of cryofibrinogenemia in patients with chilblains during the COVID-19 outbreak.	Int J Dermatol
33069829	Clustering and classification of virus sequence through music communication protocol and wavelet transform.	Genomics
33069815	The role of dysregulated immune responses in COVID-19 pathogenesis.	Virus Res
33069705	Assessing the consequences of environmental exposures on the expression of the human receptor and proteases involved in SARS-CoV-2 cell-entry.	Environ Res
33069672	ADMET profile and virtual screening of plant and microbial natural metabolites as SARS-CoV-2 S1 glycoprotein receptor binding domain and main protease inhibitors.	Eur J Pharmacol
33069383	[SARS-COV-2 myocarditis. An update].	Ann Cardiol Angeiol (Paris)
33069360	Recognition of the SARS-CoV-2 receptor binding domain by neutralizing antibodies.	Biochem Biophys Res Commun
33069201	"BCG vaccine, a ray of hope in treating Severe Acute Respiratory Syndrome (SARS)."	Infect Disord Drug Targets
33069124	"MEDT study of the 1,3-DC reaction of diazomethane with Psilostachyin and investigation about the interactions of some pyrazoline derivatives with protease (M(pro)) of nCoV-2."	J Mol Graph Model
33069094	Pro resolving inflammatory effects of the lipid mediators of omega 3 fatty acids and its implication in SARS COVID-19.	Med Hypotheses
33069093	NCAM protein and SARS-COV-2 surface proteins: In-silico hypothetical evidence for the immunopathogenesis of Guillain-Barre syndrome.	Med Hypotheses
33068865	Recent findings on the Coronavirus disease 2019 (COVID-19); immunopathogenesis and immunotherapeutics.	Int Immunopharmacol
33068723	COVID-19 - A vascular disease.	Trends Cardiovasc Med
33068588	Perspectives on mechanistic implications of ROS inducers for targeting viral infections.	Eur J Pharmacol
33068560	Inhaled corticosteroids downregulate the SARS-CoV-2 receptor ACE2 in COPD through suppression of type I interferon.	J Allergy Clin Immunol
33068416	Structural analysis of SARS-CoV-2 genome and predictions of the human interactome.	Nucleic Acids Res
33068412	RASP: an atlas of transcriptome-wide RNA secondary structure probing data.	Nucleic Acids Res
33068260	"A Crowned Killer's Resume: Genome, Structure, Receptors, and Origin of SARS-CoV-2."	Virol Sin
33067719	Effect of Ergothioneine on 7-Ketocholesterol-Induced Endothelial Injury.	Neuromolecular Med
33067518	Quantifying the adhesive strength between the SARS-CoV-2 S-proteins and human receptor and its effect in therapeutics.	Sci Rep
33067472	Whole blood immunophenotyping uncovers immature neutrophil-to-VD2 T-cell ratio as an early marker for severe COVID-19.	Nat Commun
33067384	SARS-CoV-2 Is Restricted by Zinc Finger Antiviral Protein despite Preadaptation to the Low-CpG Environment in Humans.	mBio
33067272	Identification of a Polymorphism in the N Gene of SARS-CoV-2 That Adversely Impacts Detection by Reverse Transcription-PCR.	J Clin Microbiol
33067239	Activity profiling and crystal structures of inhibitor-bound SARS-CoV-2 papain-like protease: A framework for anti-COVID-19 drug design.	Sci Adv
33066821	COVID-19 and iron dysregulation: distant sequence similarity between hepcidin and the novel coronavirus spike glycoprotein.	Biol Direct
33066701	Amplicon-Based Detection and Sequencing of SARS-CoV-2 in Nasopharyngeal Swabs from Patients With COVID-19 and Identification of Deletions in the Viral Genome That Encode Proteins Involved in Interferon Antagonism.	Viruses
33066495	"Is There a Link between Bisphenol A (BPA), a Key Endocrine Disruptor, and the Risk for SARS-CoV-2 Infection and Severe COVID-19?"	J Clin Med
33066442	The Inhibition of NLRP3 Inflammasome and IL-6 Production by Hibiscus noldeae Baker f. Derived Constituents Provides a Link to Its Anti-Inflammatory Therapeutic Potentials.	Molecules
33066278	High-Throughput Screening for Inhibitors of the SARS-CoV-2 Protease Using a FRET-Biosensor.	Molecules
33065601	Asthma and severe acute respiratory syndrome coronavirus 2019: current evidence and knowledge gaps.	Curr Opin Pulm Med
33065600	Revisiting matrix metalloproteinase 12: its role in pathophysiology of asthma and related pulmonary diseases.	Curr Opin Pulm Med
33065551	CD45: a critical regulator in immune cells to predict severe and non-severe COVID-19 patients.	Aging (Albany NY)
33065388	In silico drug discovery of major metabolites from spices as SARS-CoV-2 main protease inhibitors.	Comput Biol Med
33065278	Coronavirus Disease 2019 (SARS-CoV-2) and polycystic ovarian disease: Is there a higher risk for these women?	J Steroid Biochem Mol Biol
33065213	Hyperbolic rules of the cooperative organization of eukaryotic and prokaryotic genomes.	Biosystems
33065209	The role of kallikrein-kinin and renin-angiotensin systems in COVID-19 infection.	Peptides
33065163	Metabolic impact of weight loss induced reduction of adipose ACE-2 - Potential implication in COVID-19 infections?	Metabolism
33065092	Pharmacological insight into potential therapeutic agents for the deadly Covid-19 pandemic.	Eur J Pharmacol
33065046	Basal-like Progenitor Cells: A Review of Dysplastic Alveolar Regeneration and Remodeling in Lung Repair.	Stem Cell Reports
33065034	SARS-CoV-2 immunity: review and applications to phase 3 vaccine candidates.	Lancet
33065030	Vascular Disease and Thrombosis in SARS-CoV-2-Infected Rhesus Macaques.	Cell
33064856	Increased odds ratio for COVID-19 in patients with recurrent aphthous stomatitis.	J Oral Pathol Med
33064832	Commonalities Between COVID-19 and Radiation Injury.	Radiat Res
33064690	Considerations on the use of antihypertensive blockers of the renin-angiotensin system in adults and children in the face of the COVID-19 pandemic.	Bol Med Hosp Infant Mex
33064680	SARS-CoV-2 and influenza: a comparative overview and treatment implications.	Bol Med Hosp Infant Mex
33064671	SARS-CoV-2-specific antibody rearrangements in prepandemic immune repertoires of risk cohorts and patients with COVID-19.	J Clin Invest
33064630	Evidence and speculations: vaccines and therapeutic options for COVID-19 pandemic.	Hum Vaccin Immunother
33064620	The role of the thymus in COVID-19 disease severity: implications for antibody treatment and immunization.	Hum Vaccin Immunother
33064571	Review of COVID-19 Antibody Therapies.	Annu Rev Biophys
33064451	Comprehensive Analysis of the Glycan Complement of SARS-CoV-2 Spike Proteins Using Signature Ions-Triggered Electron-Transfer/Higher-Energy Collisional Dissociation (EThcD) Mass Spectrometry.	Anal Chem
33064288	SARS-CoV-2 mediated lung inflammatory responses in host: targeting the cytokine storm for therapeutic interventions.	Mol Cell Biochem
33064267	Neurological Involvements of SARS-CoV2 Infection.	Mol Neurobiol
33064147	"Unraveling the Role of ACE2, the Binding Receptor for SARS-CoV-2, in Inflammatory Bowel Disease."	Inflamm Bowel Dis
33064080	COVID-19 and cardiovascular disease: characteristic features in older patients.	Geriatr Psychol Neuropsychiatr Vieil
33063823	Twenty years of progress in angiotensin converting enzyme 2 and its link to SARS-CoV-2 disease.	Clin Sci (Lond)
33063792	Molecular determinants of vascular transport of dexamethasone in COVID-19 therapy.	IUCrJ
33063791	Continuous flexibility analysis of SARS-CoV-2 spike prefusion structures.	IUCrJ
33063790	Room-temperature X-ray crystallography reveals the oxidation and reactivity of cysteine residues in SARS-CoV-2 3CL M(pro): insights into enzyme mechanism and drug design.	IUCrJ
33063674	Role of Genetic Variants and Gene Expression in the Susceptibility and Severity of COVID-19.	Ann Lab Med
33063628	From COVID-19 to clot: the involvement of the complement system.	J Biomol Struct Dyn
33063271	Ciprofloxacin and moxifloxacin could interact with SARS-CoV-2 protease: preliminary in silico analysis.	Pharmacol Rep
33063256	"Coagulopathy, endothelial dysfunction, thrombotic microangiopathy and complement activation: potential role of complement system inhibition in COVID-19."	J Thromb Thrombolysis
33063092	Immunotherapy of COVID-19 with poly (ADP-ribose) polymerase inhibitors: starting with nicotinamide.	Biosci Rep
33063089	Higher mortality of COVID-19 in males: sex differences in immune response and cardiovascular comorbidities.	Cardiovasc Res
33062955	Dipeptidyl Peptidase-4: A Potential Therapeutic Target in Diabetic Kidney Disease with SARS-CoV-2 Infection.	ACS Pharmacol Transl Sci
33062954	Can Papain-like Protease Inhibitors Halt SARS-CoV-2 Replication?	ACS Pharmacol Transl Sci
33062953	Identification of SARS-CoV-2 3CL Protease Inhibitors by a Quantitative High-Throughput Screening.	ACS Pharmacol Transl Sci
33062952	An Enzymatic TMPRSS2 Assay for Assessment of Clinical Candidates and Discovery of Inhibitors as Potential Treatment of COVID-19.	ACS Pharmacol Transl Sci
33062950	Potential Therapeutic Agents and Associated Bioassay Data for COVID-19 and Related Human Coronavirus Infections.	ACS Pharmacol Transl Sci
33062720	Elucidating the Pivotal Immunomodulatory and Anti-Inflammatory Potentials of Chloroquine and Hydroxychloroquine.	J Immunol Res
33062712	Clinical Features of COVID-19 Patients with Diabetes and Secondary Hyperglycemia.	J Diabetes Res
33062618	Immunoglobulin G2 Antibody as a Potential Target for COVID-19 Vaccine.	Immunotargets Ther
33062588	"Sex, Sleep, Steroids, and Lifestyle: Unraveling the Coronavirus Disease 2019 Conundrum."	J Transl Int Med
33062480	Overview of the Pathogenesis and Treatment of SARS-CoV-2 for Clinicians: A Comprehensive Literature Review.	Cureus
33062414	Computational perspectives revealed prospective vaccine candidates from five structural proteins of novel SARS corona virus 2019 (SARS-CoV-2).	PeerJ
33062077	Immunopathogenesis of SARS-CoV-2-induced pneumonia: lessons from influenza virus infection.	Inflamm Regen
33062058	How to boost the immune defence prior to respiratory virus infections with the special focus on coronavirus infections.	Gut Pathog
33061814	"Comprehensive analysis of two potential novel SARS-CoV-2 entries, TMPRSS2 and IFITM3, in healthy individuals and cancer patients."	Int J Biol Sci
33061805	"Update of the current knowledge on genetics, evolution, immunopathogenesis, and transmission for coronavirus disease 19 (COVID-19)."	Int J Biol Sci
33061744	"Clinical Profile of Covid-19 in Children, Review of Existing Literatures."	Pediatric Health Med Ther
33061507	Increased Metabolic Burden Among Blacks: A Putative Mechanism for Disparate COVID-19 Outcomes.	Diabetes Metab Syndr Obes
33061471	Drugs for Multiple Sclerosis Activate Natural Killer Cells: Do They Protect Against COVID-19 Infection?	Infect Drug Resist
33061464	Dynamic Interplay Between Microbiota and Mucosal Immunity in Early Shaping of Asthma and its Implication for the COVID-19 Pandemic.	J Asthma Allergy
33061288	The Role of the Ocular Tissue in SARS-CoV-2 Transmission.	Clin Ophthalmol
33061265	Unfolding COVID-19: Lessons-in-Learning in Ophthalmology.	Clin Ophthalmol
33060875	Coronavirus Disease 2019: Latest Data on Neuroinvasive Potential.	Iran J Med Sci
33060840	Unique immunological profile in patients with COVID-19.	Cell Mol Immunol
33060796	Rapid genomic characterization of SARS-CoV-2 viruses from clinical specimens using nanopore sequencing.	Sci Rep
33060595	A nanoluciferase SARS-CoV-2 for rapid neutralization testing and screening of anti-infective drugs for COVID-19.	Nat Commun
33060566	Pathological features of COVID-19-associated lung injury: a preliminary proteomics report based on clinical samples.	Signal Transduct Target Ther
33060311	The Effect of HLA-B27 on Susceptibility and Severity of COVID-19.	J Rheumatol
33060199	Unusual zwitterionic catalytic site of SARS-CoV-2 main protease revealed by neutron crystallography.	J Biol Chem
33060197	Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms.	Science
33059811	[Association of age distribution with the expression of angiotensin-converting enzyme 2 in lung tissues in severe acute respiratory syndrome coronavirus 2 infection: reflections from the study of RAS pathway expression in mice].	Zhongguo Dang Dai Er Ke Za Zhi
33059719	"A painful lesson from the COVID-19 pandemic: the need for broad-spectrum, host-directed antivirals."	J Transl Med
33059711	Harnessing the immune system to overcome cytokine storm and reduce viral load in COVID-19: a review of the phases of illness and therapeutic agents.	Virol J
33059225	Is a COVID-19 vaccine developed by nature already at work?	Med Hypotheses
33059040	Benign Evolution of SARS-Cov2 Infections in Children With Inflammatory Bowel Disease: Results From Two International Databases.	Clin Gastroenterol Hepatol
33058970	Papain-like cysteine proteinase zone (PCP-zone) and PCP structural catalytic core (PCP-SCC) of enzymes with cysteine proteinase fold.	Int J Biol Macromol
33058948	Docked severe acute respiratory syndrome coronavirus 2 proteins within the cutaneous and subcutaneous microvasculature and their role in the pathogenesis of severe coronavirus disease 2019.	Hum Pathol
33058776	Genetics of COVID-19.	J Pediatr (Rio J)
33058760	The Architecture of Inactivated SARS-CoV-2 with Postfusion Spikes Revealed by Cryo-EM and Cryo-ET.	Structure
33058755	A Therapeutic Non-self-reactive SARS-CoV-2 Antibody Protects from Lung Pathology in a COVID-19 Hamster Model.	Cell
33058753	Cellular Immunity in COVID-19 Convalescents with PCR-Confirmed Infection but with Undetectable SARS-CoV-2-Specific IgG.	Emerg Infect Dis
33058425	Cannabidiol (CBD) modulation of apelin in acute respiratory distress syndrome.	J Cell Mol Med
33057966	Potential neuroinvasive and neurotrophic properties of SARS-CoV-2 in pediatric patients: comparison of SARS-CoV-2 with non-segmented RNA viruses.	J Neurovirol
33057955	The upshot of Polyphenolic compounds on immunity amid COVID-19 pandemic and other emerging communicable diseases: An appraisal.	Nat Prod Bioprospect
33057452	Potential bioactive glycosylated flavonoids as SARS-CoV-2 main protease inhibitors: A molecular docking and simulation studies.	PLoS One
33057358	"Design of novel multiepitope constructs-based peptide vaccine against the structural S, N and M proteins of human COVID-19 using immunoinformatics analysis."	PLoS One
33057007	ACE2 mouse models: a toolbox for cardiovascular and pulmonary research.	Nat Commun
33055537	"An Autopsy Review: ""COVID Toes""."	Am J Dermatopathol
33055417	What are protective antibody responses to pandemic SARS-CoV-2?	J Clin Invest
33055254	The Inhaled Steroid Ciclesonide Blocks SARS-CoV-2 RNA Replication by Targeting the Viral Replication-Transcription Complex in Cultured Cells.	J Virol
33055229	Immunopathogenesis of Coronavirus-Induced Acute Respiratory Distress Syndrome (ARDS): Potential Infection-Associated Hemophagocytic Lymphohistiocytosis.	Clin Microbiol Rev
33055034	Modeling in the Time of COVID-19: Statistical and Rule-based Mesoscale Models.	IEEE Trans Vis Comput Graph
33054904	Micro-fusion inhibition tests: quantifying antibody neutralization of virus-mediated cell-cell fusion.	J Gen Virol
33054860	Coronaviruses and gastrointestinal diseases.	Mil Med Res
33054759	Alveolar cells under mechanical stressed niche: critical contributors to pulmonary fibrosis.	Mol Med
33054673	Large and Small Cerebral Vessel Involvement in Severe COVID-19: Detailed Clinical Workup of a Case Series.	Stroke
33054436	Chemical composition and pharmacological mechanism of shenfu decoction in the treatment of novel coronavirus pneumonia (COVID-19).	Drug Dev Ind Pharm
33054210	Discovery of Ketone-Based Covalent Inhibitors of Coronavirus 3CL Proteases for the Potential Therapeutic Treatment of COVID-19.	J Med Chem
33054129	No evidence of hemoglobin damage by SARS-CoV-2 infection.	Haematologica
33054027	[Anatomical pathology of novel coronavirus (COVID-19) infection. First impressions].	Arkh Patol
33053830	Docking and QSAR of Aminothioureas at the SARS-CoV-2 S-Protein-Human ACE2 Receptor Interface.	Molecules
33053430	The SARS-CoV-2 spike protein alters barrier function in 2D static and 3D microfluidic in-vitro models of the human blood-brain barrier.	Neurobiol Dis
33053371	A Sweep of Earth's Virome Reveals Host-Guided Viral Protein Structural Mimicry and Points to Determinants of Human Disease.	Cell Syst
33052822	Update on Neurological Manifestations of SARS-CoV-2.	West J Emerg Med
33052685	Discovery of COVID-19 Inhibitors Targeting the SARS-CoV-2 Nsp13 Helicase.	J Phys Chem Lett
33052573	Neurological manifestations and comorbidity associated with COVID-19: an overview.	Neurol Sci
33052496	"Angiogenesis, hereditary hemorrhagic telangiectasia and COVID-19."	Angiogenesis
33052326	SARS-CoV-2 morbidity and mortality in racial/ethnic minority populations: A window into the stress related inflammatory basis of health disparities?	Brain Behav Immun Health
33052325	Spike protein-based epitopes predicted against SARS-CoV-2 through literature mining.	Med Nov Technol Devices
33052313	Chloroquine and hydroxychloroquine for combating COVID-19: Investigating efficacy and hypothesizing new formulations using Bio/chemoinformatics tools.	Inform Med Unlocked
33052312	Virus database annotations assist in tracing information on patients infected with emerging pathogens.	Inform Med Unlocked
33052306	Comparative docking studies to understand the binding affinity of nicotine with soluble ACE2 (sACE2)-SARS-CoV-2 complex over sACE2.	Toxicol Rep
33052254	Why PB28 Could Be a Covid 2019 Game Changer?	ACS Med Chem Lett
33052202	Exploring the role of triazole functionalized heteroatom co-doped carbon quantum dots against human coronaviruses.	Nano Today
33052144	Identification of potential inhibitors of SARS-CoV-2 papain-like protease from tropane alkaloids from Schizanthus porrigens: A molecular docking study.	Chem Phys Lett
33052054	Platelets Promote Thromboinflammation in SARS-CoV-2 Pneumonia.	Arterioscler Thromb Vasc Biol
33051876	Syncytia formation by SARS-CoV-2-infected cells.	EMBO J
33051841	Air pollution particulate matter as a potential carrier of SARS-CoV-2 to the nervous system and/or neurological symptom enhancer: arguments in favor.	Environ Sci Pollut Res Int
33051393	[Important and Unresolved Aspects of Neuropathologic Analyses of COVID-19 Individuals].	Brain Nerve
33051390	[The Peripheral Neuropathy and Myopathy Associated with Severe Acute Respiratory Syndrome-Correlated New Coronavirus (SARS-Cov-2)].	Brain Nerve
33051389	[COVID-19-related Cerebrovascular Disease and Vasculitis].	Brain Nerve
33051388	[Neurological Manifestations of COVID-19: Meningoencephalitis and Encephalopathy].	Brain Nerve
33051386	[Neuromuscular Manifestations and Pathogenesis of COVID-19].	Brain Nerve
33051368	From People to Panthera: Natural SARS-CoV-2 Infection in Tigers and Lions at the Bronx Zoo.	mBio
33051297	Identify potent SARS-CoV-2 main protease inhibitors via accelerated free energy perturbation-based virtual screening of existing drugs.	Proc Natl Acad Sci U S A
33051211	Coronavirus infection and PARP expression dysregulate the NAD metabolome: An actionable component of innate immunity.	J Biol Chem
33051104	A Cytokine Circus with a Viral Ringleader: SARS-CoV-2-Associated Cytokine Storm Syndromes.	Trends Mol Med
33050860	COVID-19 and Renal Diseases: An Update.	Curr Drug Targets
33050737	Hyperoxia and modulation of pulmonary vascular and immune responses in COVID-19.	Am J Physiol Lung Cell Mol Physiol
33050511	Impact of Microbiota: A Paradigm for Evolving Herd Immunity against Viral Diseases.	Viruses
33050463	"Genomic Diversity and Hotspot Mutations in 30,983 SARS-CoV-2 Genomes: Moving Toward a Universal Vaccine for the ""Confined Virus""?"	Pathogens
33050459	May Mangafodipir or Other SOD Mimetics Contribute to Better Care in COVID-19 Patients?	Antioxidants (Basel)
33050376	Structural Features and PF4 Functions that Occur in Heparin-Induced Thrombocytopenia (HIT) Complicated by COVID-19.	Antibodies (Basel)
33050360	Protease Inhibitory Effect of Natural Polyphenolic Compounds on SARS-CoV-2: An In Silico Study.	Molecules
33050291	Superimposition of Viral Protein Structures: A Means to Decipher the Phylogenies of Viruses.	Viruses
33050264	Tracking SARS-CoV-2 in Sewage: Evidence of Changes in Virus Variant Predominance during COVID-19 Pandemic.	Viruses
33050053	Evolutionary Analysis of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reveals Genomic Divergence with Implications for Universal Vaccine Efficacy.	Vaccines (Basel)
33050019	COVID-19-Associated Candidiasis (CAC): An Underestimated Complication in the Absence of Immunological Predispositions?	J Fungi (Basel)
33049937	Towards Accurate Genotype-Phenotype Correlations in the CYP2D6 Gene.	J Pers Med
33049751	The Impact of COVID-19 Disease on Platelets and Coagulation.	Pathobiology
33049737	Pentoxifylline: A Drug with Antiviral and Anti-Inflammatory Effects to Be Considered in the Treatment of Coronavirus Disease 2019.	Med Princ Pract
33049594	Viral replication of SARS-CoV-2 could be self-limitative - The role of the renin-angiotensin system on COVID-19 pathophysiology.	Med Hypotheses
33049583	GB-2 inhibits ACE2 and TMPRSS2 expression: In vivo and in vitro studies.	Biomed Pharmacother
33049387	Non-synonymous mutations of SARS-CoV-2 leads epitope loss and segregates its variants.	Microbes Infect
33049279	Mesenchymal stem cell immunomodulation and regeneration therapeutics as an ameliorative approach for COVID-19 pandemics.	Life Sci
33049069	"Analysis of SARS-CoV-2 mutations in Mexico, Belize, and isolated regions of Guatemala and its implication in the diagnosis."	J Med Virol
33049061	Co-Expression of Mitochondrial Genes and ACE2 in Cornea Involved in COVID-19.	Invest Ophthalmol Vis Sci
33048778	"Insights into the COVID-19 pandemic: Origin, pathogenesis, diagnosis, and therapeutic interventions."	Front Biosci (Elite Ed)
33048448	Generation of Recombinant SARS-CoV-2 Using a Bacterial Artificial Chromosome.	Curr Protoc Microbiol
33048220	An overview of viral infections of the nervous system in the immunosuppressed.	J Neurol
33047883	Association between HLA gene polymorphisms and mortality of COVID-19: An in silico analysis.	Immun Inflamm Dis
33047822	Imposed mutational meltdown as an antiviral strategy.	Evolution
33047740	Cholesterol-modifying drugs in COVID-19.	Oxf Open Immunol
33047658	Cysteine focused covalent inhibitors against the main protease of SARS-CoV-2.	J Biomol Struct Dyn
33047412	Revisiting pharmacological potentials of Nigella sativa seed: A promising option for COVID-19 prevention and cure.	Phytother Res
33047161	What chances do children have against COVID-19? Is the answer hidden within the thymus?	Eur J Pediatr
33047062	Designing of cytotoxic and helper T cell epitope map provides insights into the highly contagious nature of the pandemic novel coronavirus SARS-CoV-2.	R Soc Open Sci
33047045	Targeting the glycan of receptor binding domain with jacalin as a novel approach to develop a treatment against COVID-19.	R Soc Open Sci
33046850	Myocarditis and inflammatory cardiomyopathy: current evidence and future directions.	Nat Rev Cardiol
33046764	"Drug binding dynamics of the dimeric SARS-CoV-2 main protease, determined by molecular dynamics simulation."	Sci Rep
33046696	Type 2 and interferon inflammation regulate SARS-CoV-2 entry factor expression in the airway epithelium.	Nat Commun
33046695	Analysis of SARS-CoV-2 vertical transmission during pregnancy.	Nat Commun
33046644	Swine acute diarrhea syndrome coronavirus replication in primary human cells reveals potential susceptibility to infection.	Proc Natl Acad Sci U S A
33046529	Sensitive Recovery of Complete SARS-CoV-2 Genomes from Clinical Samples by Use of Swift Biosciences' SARS-CoV-2 Multiplex Amplicon Sequencing Panel.	J Clin Microbiol
33046268	Puzzling out the COVID-19: Therapy targeting HLA-G and HLA-E.	Hum Immunol
33045858	Cationic drugs and COVID-19.	Int J Immunopathol Pharmacol
33045777	Role of neutrophil chemoattractant CXCL5 in SARS-CoV-2 infection-induced lung inflammatory innate immune response in an in vivo hACE2 transfection mouse model.	Zool Res
33045727	GESS: a database of global evaluation of SARS-CoV-2/hCoV-19 sequences.	Nucleic Acids Res
33045721	ViruSurf: an integrated database to investigate viral sequences.	Nucleic Acids Res
33045718	SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies.	Nature
33045426	Susceptibility of the obese population to COVID-19.	Int J Infect Dis
33045350	Azithromycin and ambroxol as potential pharmacotherapy for SARS-CoV-2.	Int J Antimicrob Agents
33045068	COVID-Align: accurate online alignment of hCoV-19 genomes using a profile HMM.	Bioinformatics
33043967	"Serum ACE2, Angiotensin II, and Aldosterone Levels Are Unchanged in Patients With COVID-19."	Am J Hypertens
33043784	High-Throughput Screening for Drugs That Inhibit Papain-Like Protease in SARS-CoV-2.	SLAS Discov
33043289	Structures and dynamics of the novel S1/S2 protease cleavage site loop of the SARS-CoV-2 spike glycoprotein.	J Struct Biol X
33043283	SARS-CoV-2 Infection Dysregulates the Metabolomic and Lipidomic Profiles of Serum.	iScience
33043282	Furin: A Potential Therapeutic Target for COVID-19.	iScience
33043272	Redesigning COVID-19 Care With Network Medicine and Machine Learning.	Mayo Clin Proc Innov Qual Outcomes
33043253	Assessing the SARS-CoV-2 threat to wildlife: Potential risk to a broad range of mammals.	Perspect Ecol Conserv
33043252	Kawasaki Disease and Multisystem Inflammatory Syndrome in Children with COVID-19.	SN Compr Clin Med
33043235	The Potential Role of Coagulation Factor Xa in the Pathophysiology of COVID-19: A Role for Anticoagulants as Multimodal Therapeutic Agents.	TH Open
33043232	Thrombo-inflammation response to Tocilizumab in COVID-19.	Res Pract Thromb Haemost
33043128	A Cyclodextrin-Stabilized Spermine-Tagged Drug Triplex that Targets Theophylline to the Lungs Selectively in Respiratory Emergency.	Adv Ther (Weinh)
33043110	Exploration of surface glycoprotein to design multi-epitope vaccine for the prevention of Covid-19.	Inform Med Unlocked
33043050	Alteration in angiotensin-converting enzyme 2 by PM1 during the development of emphysema in rats.	ERJ Open Res
33043048	Angiotensin-converting enzyme 2 expression is not induced by the renin-angiotensin system in the lung.	ERJ Open Res
33043037	Moderate Fever Cycles as a Potential Mechanism to Protect the Respiratory System in COVID-19 Patients.	Front Med (Lausanne)
33042994	Insights on SARS-CoV-2 Molecular Interactions With the Renin-Angiotensin System.	Front Cell Dev Biol
33042956	Seasonality of Respiratory Viral Infections: Will COVID-19 Follow Suit?	Front Public Health
33042918	Pediatric Inflammatory Multisystem Syndrome Temporally Related With SARS-CoV-2: Immunological Similarities With Acute Rheumatic Fever and Toxic Shock Syndrome.	Front Pediatr
33042442	Transcription factor-mediated signaling pathways' contribution to the pathology of acute lung injury and acute respiratory distress syndrome.	Am J Transl Res
33042335	2019-nCoV may create complications in colon cancer patients with ACE2 expression.	Int J Clin Exp Pathol
33042157	Mast Cells in Alveolar Septa of COVID-19 Patients: A Pathogenic Pathway That May Link Interstitial Edema to Immunothrombosis.	Front Immunol
33042151	Blocking of the High-Affinity Interaction-Synapse Between SARS-CoV-2 Spike and Human ACE2 Proteins Likely Requires Multiple High-Affinity Antibodies: An Immune Perspective.	Front Immunol
33042116	COVID-19: Infection or Autoimmunity.	Front Immunol
33042101	Viruses That Can and Cannot Coexist With Humans and the Future of SARS-CoV-2.	Front Microbiol
33042039	"Flexible, Functional, and Familiar: Characteristics of SARS-CoV-2 Spike Protein Evolution."	Front Microbiol
33042029	"Obesity, Diabetes and COVID-19: An Infectious Disease Spreading From the East Collides With the Consequences of an Unhealthy Western Lifestyle."	Front Endocrinol (Lausanne)
33041989	Neuromuscular Complications With SARS-COV-2 Infection: A Review.	Front Neurol
33041985	The Potential Role of SARS-COV-2 in the Pathogenesis of Parkinson's Disease.	Front Neurol
33041830	Pathophysiology and Potential Therapeutic Candidates for COVID-19: A Poorly Understood Arena.	Front Pharmacol
33041827	Systems Pharmacology and Verification of ShenFuHuang Formula in Zebrafish Model Reveal Multi-Scale Treatment Strategy for Septic Syndrome in COVID-19.	Front Pharmacol
33041797	In Silico Prediction of Molecular Targets of Astragaloside IV for Alleviation of COVID-19 Hyperinflammation by Systems Network Pharmacology and Bioinformatic Gene Expression Analysis.	Front Pharmacol
33041736	"Glycosylation, ligand binding sites and antigenic variations between membrane glycoprotein of COVID-19 and related coronaviruses."	Vacunas
33041700	Reflections on the COVID-19 Pandemic.	Integr Med (Encinitas)
33041634	Characterization of SARS-CoV-2 dynamics in the host.	Annu Rev Control
33041626	Brief communication: Immunohistochemical detection of ACE2 in human salivary gland.	Oral Sci Int
33041543	"The Good, The Bad and The Ugly: A Mathematical Model Investigates the Differing Outcomes Among CoVID-19 Patients."	J Indian Inst Sci
33041507	Association between selective IgA deficiency and COVID-19.	J Clin Biochem Nutr
33041407	Promising terpenes as SARS-CoV-2 spike receptor-binding domain (RBD) attachment inhibitors to the human ACE2 receptor: Integrated computational approach.	J Mol Liq
33041371	Screening of potential drug from Azadirachta Indica (Neem) extracts for SARS-CoV-2: An insight from molecular docking and MD-simulation studies.	J Mol Struct
33041350	"Neuroprotective immunity by essential nutrient ""Choline"" for the prevention of SARS CoV2 infections: An in silico study by molecular dynamics approach."	Chem Phys Lett
33041212	Structural Basis of SARS-CoV-2 and SARS-CoV Antibody Interactions.	Trends Immunol
33041173	Glycyrrhizic acid exerts inhibitory activity against the spike protein of SARS-CoV-2.	Phytomedicine
33040727	Transcription Factor Nrf2 as a Potential Therapeutic Target for Prevention of Cytokine Storm in COVID-19 Patients.	Biochemistry (Mosc)
33040198	SARS-CoV-2 has the advantage of competing the iMet-tRNAs with human hosts to allow efficient translation.	Mol Genet Genomics
33039950	Dysimmunity and inflammatory storm: Watch out for bone lesions in COVID-19 infection.	Med Hypotheses
33039660	"Role of astroglial toll-like receptors (TLRs) in central nervous system infections, injury and neurodegenerative diseases."	Brain Behav Immun
33039603	Immunoinformatics approach to understand molecular interaction between multi-epitopic regions of SARS-CoV-2 spike-protein with TLR4/MD-2 complex.	Infect Genet Evol
33039544	Anti-inflammatory drugs and the renin-angiotensin-aldosterone system: Current knowledge and potential effects on early SARS-CoV-2 infection.	Virus Res
33039415	The intracellular renin-angiotensin system: Friend or foe. Some light from the dopaminergic neurons.	Prog Neurobiol
33039392	Reduced severe acute respiratory syndrome coronavirus 2 entry factors and enhanced innate immune gene expression in the nasal epithelium of pregnant rats.	Am J Obstet Gynecol
33039209	Yeast-expressed SARS-CoV recombinant receptor-binding domain (RBD219-N1) formulated with aluminum hydroxide induces protective immunity and reduces immune enhancement.	Vaccine
33039147	High-resolution structure and biophysical characterization of the nucleocapsid phosphoprotein dimerization domain from the Covid-19 severe acute respiratory syndrome coronavirus 2.	Biochem Biophys Res Commun
33038939	Cytokine Storms in Cancer and COVID-19.	Cancer Cell
33038909	Targeted Delivery of CRISPR/Cas13 as a Promising Therapeutic Approach to Treat SARS-CoV-2.	Curr Pharm Biotechnol
33038863	Association of immune checkpoint inhibitors with respiratory infections: A review.	Cancer Treat Rev
33038834	"Polyunsaturated fatty acid biosynthesis pathway and genetics. implications for interindividual variability in prothrombotic, inflammatory conditions such as COVID-19(,, bigstar, bigstar bigstar)."	Prostaglandins Leukot Essent Fatty Acids
33038530	"The potential link between inherited G6PD deficiency, oxidative stress, and vitamin D deficiency and the racial inequities in mortality associated with COVID-19."	Free Radic Biol Med
33038452	Molecular mechanisms of the novel coronavirus SARS-CoV-2 and potential anti-COVID19 pharmacological targets since the outbreak of the pandemic.	Food Chem Toxicol
33038433	"COVID-19: Discovery, diagnostics and drug development."	J Hepatol
33038424	SARS-CoV-2 receptor networks in diabetic and COVID-19-associated kidney disease.	Kidney Int
33038418	Targeting pivotal inflammatory pathways in COVID-19: A mechanistic review.	Eur J Pharmacol
33038254	Complement Activation in the Disease Course of Coronavirus Disease 2019 and Its Effects on Clinical Outcomes.	J Infect Dis
33038021	Association of renin-angiotensin-aldosterone system inhibitors with mortality and testing positive of COVID-19: Meta-analysis.	J Med Virol
33037564	Potential Inhibitors for SARS-CoV-2 and Functional Food Components as Nutritional Supplement for COVID-19: A Review.	Plant Foods Hum Nutr
33037400	A compromised specific humoral immune response against the SARS-CoV-2 receptor-binding domain is related to viral persistence and periodic shedding in the gastrointestinal tract.	Cell Mol Immunol
33037393	An aberrant STAT pathway is central to COVID-19.	Cell Death Differ
33037310	The sequence at Spike S1/S2 site enables cleavage by furin and phospho-regulation in SARS-CoV2 but not in SARS-CoV1 or MERS-CoV.	Sci Rep
33037188	SARS-CoV-2 triggers inflammatory responses and cell death through caspase-8 activation.	Signal Transduct Target Ther
33037066	REGN-COV2 antibodies prevent and treat SARS-CoV-2 infection in rhesus macaques and hamsters.	Science
33036961	Cross-reactive neutralization of SARS-CoV-2 by serum antibodies from recovered SARS patients and immunized animals.	Sci Adv
33036956	Machine learning techniques for sequence-based prediction of viral-host interactions between SARS-CoV-2 and human proteins.	Biomed J
33036853	SARS-CoV-2 infection and its association with thrombosis and ischemic stroke: a review.	Am J Emerg Med
33036646	Evaluation of a genetic risk score for severity of COVID-19 using human chromosomal-scale length variation.	Hum Genomics
33036548	Molecular modeling study of tectoquinone and acteoside from Tectona grandis linn: a new SARS-CoV-2 main protease inhibitor against COVID-19.	J Biomol Struct Dyn
33036546	Role of angiotensin-converting enzyme 2 and pericytes in cardiac complications of COVID-19 infection.	Am J Physiol Heart Circ Physiol
33036293	"Clean Grinding Technique: A Facile Synthesis and In Silico Antiviral Activity of Hydrazones, Pyrazoles, and Pyrazines Bearing Thiazole Moiety against SARS-CoV-2 Main Protease (M(pro))."	Molecules
33036230	Crystal Structure of Non-Structural Protein 10 from Severe Acute Respiratory Syndrome Coronavirus-2.	Int J Mol Sci
33036202	Host Receptors of Influenza Viruses and Coronaviruses-Molecular Mechanisms of Recognition.	Vaccines (Basel)
33036180	Tissue Proteases and Immune Responses: Influencing Factors of COVID-19 Severity and Mortality.	Pathogens
33035675	First COVID-19 case in Zambia - Comparative phylogenomic analyses of SARS-CoV-2 detected in African countries.	Int J Infect Dis
33035643	Emergence and molecular mechanisms of SARS-CoV-2 and HIV to target host cells and potential therapeutics.	Infect Genet Evol
33035589	Involvement of the nervous system in COVID-19: The bell should toll in the brain.	Life Sci
33035581	Can endolysosomal deacidification and inhibition of autophagy prevent severe COVID-19?	Life Sci
33035434	Extracellular vesicles: new players in regulating vascular barrier function.	Am J Physiol Heart Circ Physiol
33035337	DockCoV2: a drug database against SARS-CoV-2.	Nucleic Acids Res
33034798	Whole genome sequencing and phylogenetic classification of Tunisian SARS-CoV-2 strains from patients of the Military Hospital in Tunis.	Virus Genes
33034780	Drug screening and development from the affinity of S protein of new coronavirus with ACE2.	Eur J Clin Microbiol Infect Dis
33034443	Antimicrobial Nanomaterials and Coatings: Current Mechanisms and Future Perspectives to Control the Spread of Viruses Including SARS-CoV-2.	ACS Nano
33034398	A role for quercetin in coronavirus disease 2019 (COVID-19).	Phytother Res
33034338	Computer-aided prediction and design of IL-6 inducing peptides: IL-6 plays a crucial role in COVID-19.	Brief Bioinform
33034169	Urticaria and coronavirus infection: a lesson from SARS-CoV-2 pandemic.	Eur Ann Allergy Clin Immunol
33034151	Potential zoonotic sources of SARS-CoV-2 infections.	Transbound Emerg Dis
33034084	Predicting susceptibility for SARS-CoV-2 infection in domestic and wildlife animals using ACE2 protein sequence homology.	Zoo Biol
33034007	Combining fragment docking with graph theory to improve ligand docking for homology model structures.	J Comput Aided Mol Des
33033963	Effect of different human tissue processing techniques on SARS-CoV-2 inactivation-review.	Cell Tissue Bank
33033851	Immune reconstitution and clinical recovery following anti-CD28 antibody (TGN1412)-induced cytokine storm.	Cancer Immunol Immunother
33033717	Prepare for the Future: Dissecting the Spike to Seek Broadly Neutralizing Antibodies and Universal Vaccine for Pandemic Coronaviruses.	Front Mol Biosci
33033561	Perspectives on mesenchymal stem/progenitor cells and their derivates as potential therapies for lung damage caused by COVID-19.	World J Stem Cells
33033346	The specific metabolome profiling of patients infected by SARS-COV-2 supports the key role of tryptophan-nicotinamide pathway and cytosine metabolism.	Sci Rep
33033344	Hot spot profiles of SARS-CoV-2 and human ACE2 receptor protein protein interaction obtained by density functional tight binding fragment molecular orbital method.	Sci Rep
33033248	Two distinct immunopathological profiles in autopsy lungs of COVID-19.	Nat Commun
33033172	Persistence and decay of human antibody responses to the receptor binding domain of SARS-CoV-2 spike protein in COVID-19 patients.	Sci Immunol
33033170	The Role of Smoking and Nicotine in the Transmission and Pathogenesis of COVID-19.	J Pharmacol Exp Ther
33033152	Cellular senescence: friend or foe to respiratory viral infections?	Eur Respir J
33032965	Endothelial glycocalyx damage as a systemic inflammatory microvascular endotheliopathy in COVID-19.	Biomed J
33032673	Mechanisms linking the human gut microbiome to prophylactic and treatment strategies for COVID-19.	Br J Nutr
33032174	COVID-19 in children: Could pertussis vaccine play the protective role?	Med Hypotheses
33032170	SARS-CoV-2 cell entry receptor ACE2 mediated endothelial dysfunction leads to vascular thrombosis in COVID-19 patients.	Med Hypotheses
33032060	Could Sars-Cov2 affect MS progression?	Mult Scler Relat Disord
33031856	Can N-3 polyunsaturated fatty acids be considered a potential adjuvant therapy for COVID-19-associated cardiovascular complications?	Pharmacol Ther
33031791	Rapamycin as a potential repurpose drug candidate for the treatment of COVID-19.	Chem Biol Interact
33031765	Mining the Antibody Repertoire for Solutions to SARS-CoV-2.	Cell Host Microbe
33031744	A Mouse-Adapted SARS-CoV-2 Induces Acute Lung Injury and Mortality in Standard Laboratory Mice.	Cell
33031602	Angiotensin-converting enzyme 2: A protective factor in regulating disease virulence of SARS-COV-2.	IUBMB Life
33031368	Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers During the COVID-19 Pandemic: A Modeling Analysis.	PLoS Comput Biol
33031088	Can the novel coronavirus be transmitted via RNAs without protein capsids?	J Infect Dev Ctries
33031080	"Could ""trained immunity"" be induced by live attenuated vaccines protect against COVID-19? Review of available evidence."	J Infect Dev Ctries
33031017	"Blood flow, capillary transit times, and tissue oxygenation: the centennial of capillary recruitment."	J Appl Physiol (1985)
33030464	What is holding back the development of antiviral metallodrugs? A literature overview and implications for SARS-CoV-2 therapeutics and future viral outbreaks.	Dalton Trans
33030333	Covert Pathways to the Cranial Cavity: Could These Be Potential Routes of SARS-CoV-2 to the Brain?	ACS Chem Neurosci
33030105	Molecular dynamics analysis predicts ritonavir and naloxegol strongly block the SARS-CoV-2 spike protein-hACE2 binding.	J Biomol Struct Dyn
33030102	Finding potent inhibitors for COVID-19 main protease (M(pro)): an in silico approach using SARS-CoV-3CL protease inhibitors for combating CORONA.	J Biomol Struct Dyn
33030073	The benefits of Vitamin D in the COVID-19 pandemic: biochemical and immunological mechanisms.	Arch Physiol Biochem
33029768	An Assessment on Impact of COVID-19 Infection in a Gender Specific Manner.	Stem Cell Rev Rep
33029758	Inflammation Triggered by SARS-CoV-2 and ACE2 Augment Drives Multiple Organ Failure of Severe COVID-19: Molecular Mechanisms and Implications.	Inflammation
33029696	Role of ACE2 receptor and the landscape of treatment options from convalescent plasma therapy to the drug repurposing in COVID-19.	Mol Cell Biochem
33029570	Molecular docking between human TMPRSS2 and SARS-CoV-2 spike protein: conformation and intermolecular interactions.	AIMS Microbiol
33029559	Rapid and inexpensive whole-genome sequencing of SARS-CoV-2 using 1200 bp tiled amplicons and Oxford Nanopore Rapid Barcoding.	Biol Methods Protoc
33029513	Alkaloids from Cryptolepis sanguinolenta as Potential Inhibitors of SARS-CoV-2 Viral Proteins: An In Silico Study.	Biomed Res Int
33029383	Intra-genome variability in the dinucleotide composition of SARS-CoV-2.	Virus Evol
33029269	Could Estrogen Protect Women From COVID-19?	J Clin Med Res
33029165	Investigating Potential Inhibitory Effect of Uncaria tomentosa (Cat's Claw) against the Main Protease 3CL(pro) of SARS-CoV-2 by Molecular Modeling.	Evid Based Complement Alternat Med
33029105	"Cytokine Storm in COVID-19 Patients, Its Impact on Organs and Potential Treatment by QTY Code-Designed Detergent-Free Chemokine Receptors."	Mediators Inflamm
33029094	Investigating the mechanism of ShuFeng JieDu capsule for the treatment of novel Coronavirus pneumonia (COVID-19) based on network pharmacology.	Int J Med Sci
33028979	Extrafollicular B cell responses correlate with neutralizing antibodies and morbidity in COVID-19.	Nat Immunol
33028965	Metallodrug ranitidine bismuth citrate suppresses SARS-CoV-2 replication and relieves virus-associated pneumonia in Syrian hamsters.	Nat Microbiol
33028810	Crystallographic and electrophilic fragment screening of the SARS-CoV-2 main protease.	Nat Commun
33028676	Remdesivir targets a structurally analogous region of the Ebola virus and SARS-CoV-2 polymerases.	Proc Natl Acad Sci U S A
33027617	An Alternative Binding Mode of IGHV3-53 Antibodies to the SARS-CoV-2 Receptor Binding Domain.	Cell Rep
33027600	A Canadian perspective on severe acute respiratory syndrome coronavirus 2 infection and treatment: how prevalent underlying inflammatory disease contributes to pathogenesis.	Biochem Cell Biol
33027420	"COVID-19: molecular targets, drug repurposing and new avenues for drug discovery."	Mem Inst Oswaldo Cruz
33027419	Flavonoid glycosides and their putative human metabolites as potential inhibitors of the SARS-CoV-2 main protease (Mpro) and RNA-dependent RNA polymerase (RdRp).	Mem Inst Oswaldo Cruz
33027418	"Current evidence of neurological features, diagnosis, and neuropathogenesis associated with COVID-19."	Rev Soc Bras Med Trop
33027185	COVID-19 in children: current evidence and key questions.	Curr Opin Infect Dis
33026922	Urogenital System Damaging Manifestations of 3 Human Infected Coronaviruses.	J Urol
33026669	Minimized glycemic fluctuation decreases the risk of severe illness and death in patients with COVID-19.	J Med Virol
33026649	Suppression of SARS-CoV-2 infection in ex-vivo human lung tissues by targeting class III phosphoinositide 3-kinase.	J Med Virol
33026453	Analysis of Genomic Characteristics and Transmission Routes of Patients With Confirmed SARS-CoV-2 in Southern California During the Early Stage of the US COVID-19 Pandemic.	JAMA Netw Open
33025993	"Discovery of potent inhibitors for SARS-CoV-2's main protease by ligand-based/structure-based virtual screening, MD simulations, and binding energy calculations."	Phys Chem Chem Phys
33025751	"Anatomical Investigation and GC/MS Analysis of 'Coco de Mer', Lodoicea maldivica (Arecaceae)."	Chem Biodivers
33025652	Using genetics to understand the role of antihypertensive drugs modulating angiotensin-converting enzyme in immune function and inflammation.	Br J Clin Pharmacol
33025599	Integrated network pharmacology and molecular docking strategy to explore the mechanism of medicinal and edible Astragali Radix-Atractylodis Macrocephalae Rhizoma acting on pneumonia via immunomodulation.	J Food Biochem
33025553	Detection of SARS-COV-2 receptor ACE-2 mRNA in thyroid cells: a clue for COVID-19-related subacute thyroiditis.	J Endocrinol Invest
33025529	Mechanisms by Which SARS-CoV-2 May Impact Male Fertility.	Reprod Sci
33025261	A Systems Biology Workflow for Drug and Vaccine Repurposing: Identifying Small-Molecule BCG Mimics to Reduce or Prevent COVID-19 Mortality.	Pharm Res
33025199	Identification of novel mutations in SARS-COV-2 isolates from Turkey.	Arch Virol
33025046	ACE2 expression in allergic airway disease may decrease the risk and severity of COVID-19.	Eur Arch Otorhinolaryngol
33025029	Effects of SARS-CoV-2 and its functional receptor ACE2 on the cardiovascular system.	Herz
33024988	Network-based identification genetic effect of SARS-CoV-2 infections to Idiopathic pulmonary fibrosis (IPF) patients.	Brief Bioinform
33024851	Expression profiles of the SARS-CoV-2 host invasion genes in nasopharyngeal and oropharyngeal swabs of COVID-19 patients.	Heliyon
33024578	Benchmarking evolutionary tinkering underlying human-viral molecular mimicry shows multiple host pulmonary-arterial peptides mimicked by SARS-CoV-2.	Cell Death Discov
33024515	Immunological aspects of COVID-19: What do we know?	World J Biol Chem
33024460	Cardiac arrhythmias in patients with COVID-19.	J Arrhythm
33024307	Characteristics of SARS-CoV-2 and COVID-19.	Nat Rev Microbiol
33024281	Cross-reactive memory T cells and herd immunity to SARS-CoV-2.	Nat Rev Immunol
33024223	Sofosbuvir terminated RNA is more resistant to SARS-CoV-2 proofreader than RNA terminated by Remdesivir.	Sci Rep
33024144	Molecular epidemiology of the first wave of severe acute respiratory syndrome coronavirus 2 infection in Thailand in 2020.	Sci Rep
33024017	Decoy nanoparticles protect against COVID-19 by concurrently adsorbing viruses and inflammatory cytokines.	Proc Natl Acad Sci U S A
33024003	"Expression of ACE2, the SARS-CoV-2 Receptor, in Lung Tissue of Patients With Type 2 Diabetes."	Diabetes
33023856	The Complement C5a-C5aR1 GPCR Axis in COVID-19 Therapeutics.	Trends Immunol
33023827	Intestinal permeability changes with bacterial translocation as key events modulating systemic host immune response to SARS-CoV-2: A working hypothesis.	Dig Liver Dis
33023681	Vitamin K metabolism as the potential missing link between lung damage and thromboembolism in Coronavirus disease 2019.	Br J Nutr
33023602	Does cystic fibrosis constitute an advantage in COVID-19 infection?	Ital J Pediatr
33023459	"Covid-19, SARS -CoV-2, Origin, transmission and treatment aspects, a brief review."	Infect Disord Drug Targets
33023438	miRNAs in SARS-CoV 2: A Spoke in the Wheel of Pathogenesis.	Curr Pharm Des
33023417	In silico exploration of small-molecule alpha-helix mimetics as inhibitors of SARS-COV-2 attachment to ACE2.	J Biomol Struct Dyn
33023358	Making a case for using gammadelta T cells against SARS-CoV-2.	Crit Rev Microbiol
33023356	Antecedent Administration of Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Antagonists and Survival After Hospitalization for COVID-19 Syndrome.	J Am Heart Assoc
33023332	Attenuation of acute and chronic inflammation using compounds derived from plants.	Exp Biol Med (Maywood)
33023287	"COVID-19 and Multisystem Inflammatory Syndrome, or is it Mast Cell Activation Syndrome?"	J Biol Regul Homeost Agents
33022950	Cold-Adapted Live Attenuated SARS-Cov-2 Vaccine Completely Protects Human ACE2 Transgenic Mice from SARS-Cov-2 Infection.	Vaccines (Basel)
33022818	Covid-19 and kidney injury: Pathophysiology and molecular mechanisms.	Rev Med Virol
33022790	Clotting disorder in severe acute respiratory syndrome coronavirus 2.	Rev Med Virol
33022781	"SARS-CoV-2 infection, COVID-19 pathogenesis, and exposure to air pollution: What is the connection?"	Ann N Y Acad Sci
33022712	Targeting acute kidney injury in COVID-19.	Nephrol Dial Transplant
33022569	Prediction of potential inhibitors of the dimeric SARS-CoV2 main proteinase through the MM/GBSA approach.	J Mol Graph Model
33022567	"1,2,4 triazolo[1,5-a] pyrimidin-7-ones as novel SARS-CoV-2 Main protease inhibitors: In silico screening and molecular dynamics simulation of potential COVID-19 drug candidates."	Biophys Chem
33022271	Can selective serotonin reuptake inhibitors have a neuroprotective effect during COVID-19?	Eur J Pharmacol
33022076	Immunobiology and immunotherapy of COVID-19: A clinically updated overview.	J Cell Physiol
33022015	Biochemical screening for SARS-CoV-2 main protease inhibitors.	PLoS One
33021596	Serum Responses of Children With Kawasaki Disease Against Severe Acute Respiratory Syndrome Coronavirus 2 Proteins.	Pediatr Infect Dis J
33021506	COVID-19 and myeloid cells: complex interplay correlates with lung severity.	J Clin Invest
33020742	Novel hybrid antiviral VTRRT-13V2.1 against SARS-CoV2 main protease: retro-combinatorial synthesis and molecular dynamics analysis.	Heliyon
33020722	Broad host range of SARS-CoV-2 and the molecular basis for SARS-CoV-2 binding to cat ACE2.	Cell Discov
33020707	Structural insight into the recognition of S-adenosyl-L-homocysteine and sinefungin in SARS-CoV-2 Nsp16/Nsp10 RNA cap 2'-O-Methyltransferase.	Comput Struct Biotechnol J
33020692	In-host Mathematical Modelling of COVID-19 in Humans.	Annu Rev Control
33020502	SARS-CoV-2 spike protein predicted to form complexes with host receptor protein orthologues from a broad range of mammals.	Sci Rep
33020343	The Management of Cytokine Storm in COVID-19.	Acta Med Indones
33019935	COVID-19: A Great Mime or a Trigger Event of Autoimmune Manifestations?	Curr Rheumatol Rev
33019920	COVID-19 Related Coagulopathy: What is Known Up to Now.	Curr Med Chem
33019628	Persistence of Anti-SARS-CoV-2 Antibodies in Non-Hospitalized COVID-19 Convalescent Health Care Workers.	J Clin Med
33019592	Gut Microbiota Dysbiosis-Immune Hyperresponse-Inflammation Triad in Coronavirus Disease 2019 (COVID-19): Impact of Pharmacological and Nutraceutical Approaches.	Microorganisms
33019591	"The Mitochondrial Outer Membrane Protein Tom70-Mediator in Protein Traffic, Membrane Contact Sites and Innate Immunity."	Int J Mol Sci
33017914	Alpha-lipoic acid may protect patients with diabetes against COVID-19 infection.	Med Hypotheses
33017912	A new approach for COVID-19 treatment by micro-RNA.	Med Hypotheses
33017910	Defensin 5 for prevention of SARS-CoV-2 invasion and Covid-19 disease.	Med Hypotheses
33017909	Could aquaporin modulators be employed as prospective drugs for COVID-19 related pulmonary comorbidity?	Med Hypotheses
33017906	Exercise as medicine for COVID-19: On PPAR with emerging pharmacotherapy.	Med Hypotheses
33017874	"Computational analysis of SARS-CoV-2, SARS-CoV, and MERS-CoV genome using MEGA."	Genomics Inform
33017479	Headache in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Narrative Review.	Headache
33017386	"Origin, structural characteristics, prevention measures, diagnosis and potential drugs to prevent and COVID-19."	Medwave
33017280	COVID-19: Between Past and Present.	Viral Immunol
33017071	Angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker treatment and haemodynamic factors are associated with increased cardiac mRNA expression of angiotensin-converting enzyme 2 in patients with cardiovascular disease.	Eur J Heart Fail
33017040	Durability of neutralizing antibodies and T-cell response post SARS-CoV-2 infection.	Front Med
33017003	VIRTUS: a pipeline for comprehensive virus analysis from conventional RNA-seq data.	Bioinformatics
33016678	[SARS-CoV-2 (COVID-19) as a predictor of neuroinflammation and neurodegeneration: potential therapy strategies].	Zh Nevrol Psikhiatr Im S S Korsakova
33016666	Quercetin Phytosome(R) as a potential candidate for managing COVID-19.	Minerva Gastroenterol (Torino)
33016237	"Structural analysis, virtual screening and molecular simulation to identify potential inhibitors targeting 2'-O-ribose methyltransferase of SARS-CoV-2 coronavirus."	J Biomol Struct Dyn
33016156	Hypothesis: The electrical properties of coronavirus.	Electromagn Biol Med
33016027	Coronavirus-19 (SARS-CoV-2) induces acute severe lung inflammation via IL-1 causing cytokine storm in COVID-19: a promising inhibitory strategy.	J Biol Regul Homeost Agents
33015938	A comparative analysis of remdesivir and other repurposed antivirals against SARS-CoV-2.	EMBO Mol Med
33015868	Predicting susceptibility to SARS-CoV-2 infection based on structural differences in ACE2 across species.	FASEB J
33015836	"Identification, protein antiglycation, antioxidant, antiproliferative, and molecular docking of novel bioactive peptides produced from hydrolysis of Lens culinaris."	J Food Biochem
33015820	The therapeutic potential of targeting ACE2 in COVID-19.	Eur Rev Med Pharmacol Sci
33015650	Cross-Sectional Evaluation of Humoral Responses against SARS-CoV-2 Spike.	Cell Rep Med
33015628	Computational Evaluation of the Inhibition Efficacies of HIV Antivirals on SARS-CoV-2 (COVID-19) Protease and Identification of 3D Pharmacophore and Hit Compounds.	Adv Pharmacol Pharm Sci
33015593	Mitochondria: In the Cross Fire of SARS-CoV-2 and Immunity.	iScience
33015591	PPARgamma Cistrome Repression during Activation of Lung Monocyte-Macrophages in Severe COVID-19.	iScience
33015553	The SARS-CoV-2 Outbreak: an Epidemiological and Clinical Perspective.	SN Compr Clin Med
33015552	The Neurological Complexities and Prognosis of COVID-19.	SN Compr Clin Med
33015550	"SARS-CoV-2, an Underestimated Pathogen of the Nervous System."	SN Compr Clin Med
33015428	Biosurfactants and anti-inflammatory activity: A potential new approach towards COVID-19.	Curr Opin Environ Sci Health
33015411	Identification of twenty-five mutations in surface glycoprotein (Spike) of SARS-CoV-2 among Indian isolates and their impact on protein dynamics.	Gene Rep
33015402	Characterization of local SARS-CoV-2 isolates and pathogenicity in IFNAR(-/-) mice.	Heliyon
33015130	Selenium and RNA Virus Interactions: Potential Implications for SARS-CoV-2 Infection (COVID-19).	Front Nutr
33014983	A Basic Review of the Preliminary Evidence That COVID-19 Risk and Severity Is Increased in Vitamin D Deficiency.	Front Public Health
33014780	Tyrosine Kinase Inhibitors Play an Antiviral Action in Patients Affected by Chronic Myeloid Leukemia: A Possible Model Supporting Their Use in the Fight Against SARS-CoV-2.	Front Oncol
33014631	Systematic Review of Ocular Involvement of SARS-CoV-2 in Coronavirus Disease 2019.	Curr Ophthalmol Rep
33014532	"Research progress on Mesenchymal Stem Cells (MSCs), Adipose-Derived Mesenchymal Stem Cells (AD-MSCs), Drugs, and Vaccines in Inhibiting COVID-19 Disease."	Aging Dis
33014317	"Effective Anti-SARS-CoV-2 RNA Dependent RNA Polymerase Drugs Based on Docking Methods: The Case of Milbemycin, Ivermectin, and Baloxavir Marboxil."	Avicenna J Med Biotechnol
33014275	COVID-19: Proposing a Ketone-Based Metabolic Therapy as a Treatment to Blunt the Cytokine Storm.	Oxid Med Cell Longev
33014208	How COVID-19 induces cytokine storm with high mortality.	Inflamm Regen
33014130	Possible mechanisms of action of clarithromycin and its clinical application as a repurposing drug for treating multiple myeloma.	Ecancermedicalscience
33013930	Neurological Damage by Coronaviruses: A Catastrophe in the Queue!	Front Immunol
33013929	Variations in SARS-CoV-2 Spike Protein Cell Epitopes and Glycosylation Profiles During Global Transmission Course of COVID-19.	Front Immunol
33013925	"Comparative Review of SARS-CoV-2, SARS-CoV, MERS-CoV, and Influenza A Respiratory Viruses."	Front Immunol
33013872	Excessive Neutrophils and Neutrophil Extracellular Traps in COVID-19.	Front Immunol
33013871	"Mitigating Coronavirus Induced Dysfunctional Immunity for At-Risk Populations in COVID-19: Trained Immunity, BCG and ""New Old Friends""."	Front Immunol
33013857	Identification of Novel Candidate Epitopes on SARS-CoV-2 Proteins for South America: A Review of HLA Frequencies by Country.	Front Immunol
33013809	"Comprehensive Genome Analysis of 6,000 USA SARS-CoV-2 Isolates Reveals Haplotype Signatures and Localized Transmission Patterns by State and by Country."	Front Microbiol
33013759	Is There a Link Between the Pathogenic Human Coronavirus Envelope Protein and Immunopathology? A Review of the Literature.	Front Microbiol
33013700	Artificial Light at Night (ALAN): A Potential Anthropogenic Component for the COVID-19 and HCoVs Outbreak.	Front Endocrinol (Lausanne)
33013675	Neurological Aspects of SARS-CoV-2 Infection: Mechanisms and Manifestations.	Front Neurol
33013637	COVID-19-Related Anosmia: The Olfactory Pathway Hypothesis and Early Intervention.	Front Neurol
33013423	"Age-Dependent Assessment of Genes Involved in Cellular Senescence, Telomere, and Mitochondrial Pathways in Human Lung Tissue of Smokers, COPD, and IPF: Associations With SARS-CoV-2 COVID-19 ACE2-TMPRSS2-Furin-DPP4 Axis."	Front Pharmacol
33013413	A Review of the Pharmacological Properties of Psoralen.	Front Pharmacol
33013395	Research Progress on Main Symptoms of Novel Coronavirus Pneumonia Improved by Traditional Chinese Medicine.	Front Pharmacol
33013062	COVID 19 and Acute Kidney Injury.	Indian J Nephrol
33013059	"Epidemiology, Genomic Structure, the Molecular Mechanism of Injury, Diagnosis and Clinical Manifestations of Coronavirus Infection: An Overview."	Indian J Nephrol
33012988	Understanding the role of milk in regulating human homeostasis in the context of the COVID-19 global pandemic.	Trends Food Sci Technol
33012891	COVID-19 and the Heart.	Colomb Med (Cali)
33012699	Valinomycin as a potential antiviral agent against coronaviruses: A review.	Biomed J
33012349	COVID-19 and Sex Differences: Mechanisms and Biomarkers.	Mayo Clin Proc
33012213	Searching for effective antiviral small molecules against influenza A virus: A patent review.	Expert Opin Ther Pat
33012091	SARS-CoV-2 outbreak investigation in a German meat processing plant.	EMBO Mol Med
33011993	Antiviral therapies: advances and perspectives.	Fundam Clin Pharmacol
33011887	COVID-19 and multiorgan failure: A narrative review on potential mechanisms.	J Mol Histol
33011745	Predicting the response of the dental pulp to SARS-CoV2 infection: a transcriptome-wide effect cross-analysis.	Genes Immun
33011520	Molecular and serological characterization of SARS-CoV-2 infection among COVID-19 patients.	Virology
33011363	Novel cyclohexanone compound as a potential ligand against SARS-CoV-2 main-protease.	Microb Pathog
33011361	Porcine epidemic diarrhea virus: Molecular mechanisms of attenuation and vaccines.	Microb Pathog
33011274	Control of systemic inflammation through early nitric oxide supplementation with nitric oxide releasing nanoparticles.	Free Radic Biol Med
33011243	New putative insights into neprilysin (NEP)-dependent pharmacotherapeutic role of roflumilast in treating COVID-19.	Eur J Pharmacol
33010978	Enhanced elicitation of potent neutralizing antibodies by the SARS-CoV-2 spike receptor binding domain Fc fusion protein in mice.	Vaccine
33010822	Human Pluripotent Stem Cell-Derived Neural Cells and Brain Organoids Reveal SARS-CoV-2 Neurotropism Predominates in Choroid Plexus Epithelium.	Cell Stem Cell
33010815	Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity.	Cell
33010669	"The novel coronavirus Disease-2019 (COVID-19): Mechanism of action, detection and recent therapeutic strategies."	Virology
33010584	How does the COVID-19 cause seizure and epilepsy in patients? The potential mechanisms.	Mult Scler Relat Disord
33010495	SARS-CoV-2 Induces a More Robust Innate Immune Response and Replicates Less Efficiently Than SARS-CoV in the Human Intestines: An Ex Vivo Study With Implications on Pathogenesis of COVID-19.	Cell Mol Gastroenterol Hepatol
33009914	A database resource and online analysis tools for coronaviruses on a historical and global scale.	Database (Oxford)
33009829	The antibody response to the glycan alpha-Gal correlates with COVID-19 disease symptoms.	J Med Virol
33009727	Are cystic fibrosis mutation carriers a potentially highly vulnerable group to COVID-19?	J Cell Mol Med
33009401	SARS-CoV2-mediated suppression of NRF2-signaling reveals potent antiviral and anti-inflammatory activity of 4-octyl-itaconate and dimethyl fumarate.	Nat Commun
33009246	SARS-CoV-2 spike protein co-opts VEGF-A/neuropilin-1 receptor signaling to induce analgesia.	Pain
33009240	A review of severe acute respiratory syndrome coronavirus 2 infection in the reproductive system.	J Chin Med Assoc
33008960	Review on therapeutic targets for COVID-19: insights from cytokine storm.	Postgrad Med J
33008869	Role of GILZ in the Kidney and the Cardiovascular System: Relevance to Cardiorenal Complications of COVID-19.	J Pharmacol Exp Ther
33008777	In silico molecular docking: Evaluation of coumarin based derivatives against SARS-CoV-2.	J Infect Public Health
33008593	"The expression of SARS-CoV-2 receptor ACE2 and CD147, and protease TMPRSS2 in human and mouse brain cells and mouse brain tissues."	Biochem Biophys Res Commun
33008363	Real-time audio and visual display of the Coronavirus genome.	BMC Bioinformatics
33007742	Role of heterocyclic compounds in SARS and SARS CoV-2 pandemic.	Bioorg Chem
33007575	An in-silico evaluation of COVID-19 main protease with clinically approved drugs.	J Mol Graph Model
33007557	Druggable targets from coronaviruses for designing new antiviral drugs.	Bioorg Med Chem
33007504	Mitigation of the replication of SARS-CoV-2 by nitric oxide in vitro.	Redox Biol
33007476	SARS Coronavirus-2 variant tracing within the first Coronavirus Disease 19 clusters in northern Germany.	Clin Microbiol Infect
33007455	COX2 inhibition in the treatment of COVID-19: Review of literature to propose repositioning of celecoxib for randomized controlled studies.	Int J Infect Dis
33007416	Natural product derived phytochemicals in managing acute lung injury by multiple mechanisms.	Pharmacol Res
33007400	COVID-19 in clinical practice: A narrative synthesis.	Med Mal Infect
33007398	Genetics and genomics of SARS-CoV-2: A review of the literature with the special focus on genetic diversity and SARS-CoV-2 genome detection.	Genomics
33007369	"Cytokine storm, not only in COVID-19 patients. Mini-review."	Immunol Lett
33007342	Zoonotic evolution and implications of microbiome in viral transmission and infection.	Virus Res
33007239	Furin Inhibitors Block SARS-CoV-2 Spike Protein Cleavage to Suppress Virus Production and Cytopathic Effects.	Cell Rep
33006981	Similarity between mutation spectra in hypermutated genomes of rubella virus and in SARS-CoV-2 genomes accumulated during the COVID-19 pandemic.	PLoS One
33006953	Testis and blood-testis barrier in Covid-19 infestation: role of angiotensin-converting enzyme 2 in male infertility.	J Basic Clin Physiol Pharmacol
33006900	Molecular Simulations and Network Modeling Reveal an Allosteric Signaling in the SARS-CoV-2 Spike Proteins.	J Proteome Res
33006605	Systemic effects of missense mutations on SARS-CoV-2 spike glycoprotein stability and receptor-binding affinity.	Brief Bioinform
33006576	Room-temperature neutron and X-ray data collection of 3CL M(pro) from SARS-CoV-2.	Acta Crystallogr F Struct Biol Commun
33006442	Influence of blood pressure control and application of renin-angiotensin-aldosterone system inhibitors on the outcomes in COVID-19 patients with hypertension.	J Clin Hypertens (Greenwich)
33006300	SARS-CoV-2 samples may escape detection because of a single point mutation in the N gene.	Euro Surveill
33006287	A Novel Strategy for the Development of Vaccines for SARS-CoV-2 (COVID-19) and Other Viruses Using AI and Viral Shell Disorder.	J Proteome Res
33006233	COVID-19 is an emergent disease of aging.	Aging Cell
33005986	Molecular characterization of canine coronaviruses: an enteric and pantropic approach.	Arch Virol
33005531	The Role of Sex in the Risk of Mortality From COVID-19 Amongst Adult Patients: A Systematic Review.	Cureus
33005486	"Genomic diversity and evolution, diagnosis, prevention, and therapeutics of the pandemic COVID-19 disease."	PeerJ
33005212	In silico identification of conserved cis-acting RNA elements in the SARS-CoV-2 genome.	Future Virol
33004978	Designing a multi-epitope peptide based vaccine against SARS-CoV-2.	Sci Rep
33004529	Targeting coagulation activation in severe COVID-19 pneumonia: lessons from bacterial pneumonia and sepsis.	Eur Respir Rev
33004527	The integrated stress response in pulmonary disease.	Eur Respir Rev
33004323	COVID-19 and the kidney.	Cleve Clin J Med
33003988	Susceptibility of swine cells and domestic pigs to SARS-CoV-2.	Emerg Microbes Infect
33003648	Effective Immune Functions of Micronutrients against SARS-CoV-2.	Nutrients
33003587	Interaction of Human ACE2 to Membrane-Bound SARS-CoV-1 and SARS-CoV-2 S Glycoproteins.	Viruses
33003552	Oxidative Stress and Inflammation in COVID-19-Associated Sepsis: The Potential Role of Anti-Oxidant Therapy in Avoiding Disease Progression.	Antioxidants (Basel)
33003471	Disharmonic Inflammatory Signatures in COVID-19: Augmented Neutrophils' but Impaired Monocytes' and Dendritic Cells' Responsiveness.	Cells
33003465	Performance of Targeted Library Preparation Solutions for SARS-CoV-2 Whole Genome Analysis.	Diagnostics (Basel)
33003377	Targeting the SphK-S1P-SIPR Pathway as a Potential Therapeutic Approach for COVID-19.	Int J Mol Sci
33003197	"A computational toolset for rapid identification of SARS-CoV-2, other viruses and microorganisms from sequencing data."	Brief Bioinform
33003119	A brief discussion of the benefit and mechanism of vitamin D supplementation on coronavirus disease 2019.	Curr Opin Clin Nutr Metab Care
33002827	Rhamnocitrin extracted from Nervilia fordii inhibited vascular endothelial activation via miR-185/STIM-1/SOCE/NFATc3.	Phytomedicine
33002653	Does intestinal dysbiosis contribute to an aberrant inflammatory response to severe acute respiratory syndrome coronavirus 2 in frail patients?	Nutrition
33002515	Secukinumab lowers expression of ACE2 in affected skin of patients with psoriasis.	J Allergy Clin Immunol
33002409	Microbial cell-free DNA in plasma of patients with sepsis: a potential diagnostic methodology.	Discov Med
33002209	"Evidence of central nervous system infection and neuroinvasive routes, as well as neurological involvement, in the lethality of SARS-CoV-2 infection."	J Med Virol
33002109	COVID-19 and diabetes: the contributions of hyperglycemia.	J Mol Cell Biol
33002032	In-silico design of a potential inhibitor of SARS-CoV-2 S protein.	PLoS One
33001920	Light and corona: guided-wave readout for coronavirus spike protein-host-receptor binding.	Opt Lett
33001856	"COVID-19 during pregnancy: an overview of maternal characteristics, clinical symptoms, maternal and neonatal outcomes of 10,996 cases described in 15 countries."	J Perinat Med
33001783	"Multisystem Imaging Manifestations of COVID-19, Part 1: Viral Pathogenesis and Pulmonary and Vascular System Complications."	Radiographics
33001090	Concanavalin A targeting N-linked glycans in spike proteins influence viral interactions.	Dalton Trans
33001051	Inflammation and thrombosis in patients with COVID-19: A prothrombotic and inflammatory disease caused by SARS coronavirus-2.	Anatol J Cardiol
33001029	Dynamically evolving novel overlapping gene as a factor in the SARS-CoV-2 pandemic.	Elife
33000610	Covid-19 and cardiac involvement in childhood: state of the art.	J Biol Regul Homeost Agents
33000221	Neuropilin1 as a new potential SARSCoV2 infection mediator implicated in the neurologic features and central nervous system involvement of COVID19.	Mol Med Rep
33000143	Dynamics of neutralizing antibody titers in the months after SARS-CoV-2 infection.	J Infect Dis
33000129	An ace model for SARS-CoV-2 infection.	J Exp Med
32999768	Potential COVID-19 papain-like protease PL(pro) inhibitors: repurposing FDA-approved drugs.	PeerJ
32999467	SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition.	Nat Immunol
32999356	Ultrastructural analysis of SARS-CoV-2 interactions with the host cell via high resolution scanning electron microscopy.	Sci Rep
32999292	Enhancement of trans-cleavage activity of Cas12a with engineered crRNA enables amplified nucleic acid detection.	Nat Commun
32999036	Single-Cell RNA Sequencing Reveals the Diversity of the Immunological Landscape following Central Nervous System Infection by a Murine Coronavirus.	J Virol
32998763	Neurological consequences of COVID-19: what have we learned and where do we go from here?	J Neuroinflammation
32998618	The inhibitory effect of some natural bioactive compounds against SARS-CoV-2 main protease: insights from molecular docking analysis and molecular dynamic simulation.	J Environ Sci Health A Tox Hazard Subst Environ Eng
32998607	Renin-Angiotensin System Blockers and Adverse Outcomes of Influenza and Pneumonia: A Danish Cohort Study.	J Am Heart Assoc
32998512	"Neurological, neuropsychiatric and neurodevelopmental complications of COVID-19."	Aust N Z J Psychiatry
32998451	"Renin Angiotensin System, COVID-19 and Male Fertility: Any Risk for Conceiving?"	Microorganisms
32998369	Role of Vitamin K-Dependent Factors Protein S and GAS6 and TAM Receptors in SARS-CoV-2 Infection and COVID-19-Associated Immunothrombosis.	Cells
32998368	"Papain-Like Proteases as Coronaviral Drug Targets: Current Inhibitors, Opportunities, and Limitations."	Pharmaceuticals (Basel)
32998157	COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses.	Nature
32998156	The major genetic risk factor for severe COVID-19 is inherited from Neanderthals.	Nature
32997887	Teachings from COVID-19 and aging-An oxidative process.	J Cosmet Dermatol
32997808	Advances and recent developments in asthma in 2020.	Allergy
32997660	IL6-mediated HCoV-host interactome regulatory network and GO/Pathway enrichment analysis.	PLoS Comput Biol
32997649	Recent endemic coronavirus infection is associated with less-severe COVID-19.	J Clin Invest
32997488	Chemosensory Dysfunction in COVID-19: Integration of Genetic and Epidemiological Data Points to D614G Spike Protein Variant as a Contributing Factor.	ACS Chem Neurosci
32997001	"Genomic and phylogenetic characterisation of an imported case of SARS-CoV-2 in Amazonas State, Brazil."	Mem Inst Oswaldo Cruz
32996784	Sex steroids skew ACE2 expression in human airway: a contributing factor to sex differences in COVID-19?	Am J Physiol Lung Cell Mol Physiol
32996197	Arenaria kansuensis attenuates pulmonary fibrosis in mice via the activation of Nrf2 pathway and the inhibition of NF-kB/TGF-beta1/Smad2/3 pathway.	Phytother Res
32996011	"Identification of potential inhibitors of coronavirus hemagglutinin-esterase using molecular docking, molecular dynamics simulation and binding free energy calculation."	Mol Divers
32995920	2020 update on the renin-angiotensin-aldosterone system in pediatric kidney disease and its interactions with coronavirus.	Pediatr Nephrol
32995758	"ReScan, a Multiplex Diagnostic Pipeline, Pans Human Sera for SARS-CoV-2 Antigens."	Cell Rep Med
32995660	Single cell sequencing unraveling genetic basis of severe COVID19 in obesity.	Obes Med
32995557	Integrated genomic view of SARS-CoV-2 in India.	Wellcome Open Res
32995321	Post-transplant immunosuppression and COVID-19: From a double whammy to a mixed blessing.	World J Transplant
32994757	Possible pharmaceutical applications can be developed from naturally occurring phenanthroindolizidine and phenanthroquinolizidine alkaloids.	Phytochem Rev
32994698	Unraveling the Possible Routes of SARS-COV-2 Invasion into the Central Nervous System.	Curr Treat Options Neurol
32994678	Comparative molecular docking analysis of the SARS CoV-2 Spike glycoprotein with the human ACE-2 receptors and thrombin.	Bioinformation
32994673	CoViD-19 Susceptibility.	Bioinformation
32994418	Susceptibility of tree shrew to SARS-CoV-2 infection.	Sci Rep
32994390	"[Origin of SARS-CoV-2 theories, keys and unknowns of an emerged disease.]"	Rev Esp Salud Publica
32994364	Viral epitope profiling of COVID-19 patients reveals cross-reactivity and correlates of severity.	Science
32994343	"Experimental infection of domestic dogs and cats with SARS-CoV-2: Pathogenesis, transmission, and response to reexposure in cats."	Proc Natl Acad Sci U S A
32994342	Coronavirus hemagglutinin-esterase and spike proteins coevolve for functional balance and optimal virion avidity.	Proc Natl Acad Sci U S A
32994211	High-resolution structures of the SARS-CoV-2 2'-O-methyltransferase reveal strategies for structure-based inhibitor design.	Sci Signal
32993656	"Expression of SARS-CoV-2 entry receptors in the respiratory tract of healthy individuals, smokers and asthmatics."	Respir Res
32993497	The role of host defences in Covid 19 and treatments thereof.	Mol Med
32993405	The Mechanical Autophagy as a Part of Cellular Immunity; Facts and Features in Treating the Medical Disorders.	Immunol Invest
32993321	Insult to Injury-Potential Contribution of Coronavirus Disease-19 to Neuroinflammation and the Development of HIV-Associated Neurocognitive Disorders.	AIDS Res Hum Retroviruses
32993173	Potential Anti-SARS-CoV-2 Therapeutics That Target the Post-Entry Stages of the Viral Life Cycle: A Comprehensive Review.	Viruses
32993146	Chemically Diverse and Biologically Active Secondary Metabolites from Marine Phylum chlorophyta.	Mar Drugs
32993136	Network Controllability-Based Prioritization of Candidates for SARS-CoV-2 Drug Repositioning.	Viruses
32993015	Role of SARS-CoV-2 in Altering the RNA-Binding Protein and miRNA-Directed Post-Transcriptional Regulatory Networks in Humans.	Int J Mol Sci
32992875	Targeting Host Defense System and Rescuing Compromised Mitochondria to Increase Tolerance against Pathogens by Melatonin May Impact Outcome of Deadly Virus Infection Pertinent to COVID-19.	Molecules
32992843	Sex and SP-A2 Dependent NAD(H) Redox Alterations in Mouse Alveolar Macrophages in Response to Ozone Exposure: Potential Implications for COVID-19.	Antioxidants (Basel)
32992810	Endothelial Cell Contributions to COVID-19.	Pathogens
32992777	Interaction of Hydroxychloroquine with Pharmacokinetically Important Drug Transporters.	Pharmaceutics
32992775	Glutathione Supplementation as an Adjunctive Therapy in COVID-19.	Antioxidants (Basel)
32992731	Impact of Comorbidities on SARS-CoV-2 Viral Entry-Related Genes.	J Pers Med
32992681	Identification of Novel Hypothalamic MicroRNAs as Promising Therapeutics for SARS-CoV-2 by Regulating ACE2 and TMPRSS2 Expression: An In Silico Analysis.	Brain Sci
32992592	Host Immune Response Driving SARS-CoV-2 Evolution.	Viruses
32992409	SARS-COV-2 (COVID-19): Cellular and biochemical properties and pharmacological insights into new therapeutic developments.	Cell Biochem Funct
32992291	Porcine deltacoronavirus nucleocapsid protein species-specifically suppressed IRF7-induced type I interferon production via ubiquitin-proteasomal degradation pathway.	Vet Microbiol
32992282	Selenium and selenoproteins in viral infection with potential relevance to COVID-19.	Redox Biol
32992245	COVID-19 therapy: What weapons do we bring into battle?	Bioorg Med Chem
32992235	Where are we with understanding of COVID-19?	Adv Biol Regul
32992048	RAAS inhibitors are not associated with mortality in COVID-19 patients: Findings from an observational multicenter study in Italy and a meta-analysis of 19 studies.	Vascul Pharmacol
32991900	Novel insights into the treatment of SARS-CoV-2 infection: An overview of current clinical trials.	Int J Biol Macromol
32991879	Pharmacological agents to therapeutic treatment of cardiac injury caused by Covid-19.	Life Sci
32991844	Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology.	Cell
32991843	Mapping Systemic Inflammation and Antibody Responses in Multisystem Inflammatory Syndrome in Children (MIS-C).	Cell
32991842	Structural and Functional Analysis of the D614G SARS-CoV-2 Spike Protein Variant.	Cell
32991819	Lung Expression of Human Angiotensin-Converting Enzyme 2 Sensitizes the Mouse to SARS-CoV-2 Infection.	Am J Respir Cell Mol Biol
32991738	Overexpression of the SARS-CoV-2 receptor ACE2 is induced by cigarette smoke in bronchial and alveolar epithelia.	J Pathol
32991329	COVID-19 survival associates with the immunoglobulin response to the SARS-CoV-2 spike receptor binding domain.	J Clin Invest
32991323	"SARS-CoV-2, immunosenescence and inflammaging: partners in the COVID-19 crime."	Aging (Albany NY)
32991251	The COVID-19 pandemic: a global health crisis.	Physiol Genomics
32991231	Neutralizing antibody response elicited by SARS-CoV-2 receptor-binding domain.	Hum Vaccin Immunother
32991014	"The cytokine storm-An appropriate, over-reactive response to SARS-CoV-2 or the wrong immune pathway?"	Scand J Immunol
32990980	The possible double-edged sword effects of vitamin D on COVID-19: A hypothesis.	Cell Biol Int
32990925	Multiple Neuroinvasive Pathways in COVID-19.	Mol Neurobiol
32990479	Diagnosis of SARS-CoV-2 infection in the setting of the cytokine release syndrome.	Expert Rev Mol Diagn
32990448	COVID-19 in children: Heterogeneity within the disease and hypothetical pathogenesis.	Asian Pac J Allergy Immunol
32990314	Discovery and characterization of ACE2 - a 20-year journey of surprises from vasopeptidase to COVID-19.	Clin Sci (Lond)
32990278	Antibody responses in COVID-19 patients.	J Biomed Res
32990161	Establishment of replication-competent vesicular stomatitis virus-based recombinant viruses suitable for SARS-CoV-2 entry and neutralization assays.	Emerg Microbes Infect
32990100	The increasing importance of the novel Coronavirus.	Hosp Pract (1995)
32989935	COVID-19 Patients Upregulate Toll-like Receptor 4-mediated Inflammatory Signaling That Mimics Bacterial Sepsis.	J Korean Med Sci
32989429	SARS-CoV-2 Infection Boosts MX1 Antiviral Effector in COVID-19 Patients.	iScience
32989174	MAIT cell activation and dynamics associated with COVID-19 disease severity.	Sci Immunol
32989130	Superantigenic character of an insert unique to SARS-CoV-2 spike supported by skewed TCR repertoire in patients with hyperinflammation.	Proc Natl Acad Sci U S A
32989044	Physiologic RNA targets and refined sequence specificity of coronavirus EndoU.	RNA
32988772	Antibodies at work in the time of severe acute respiratory syndrome coronavirus 2.	Cytotherapy
32988758	COVID 19 and liver: An A-Z literature review.	Dig Liver Dis
32988728	Is Toll-like receptor 4 involved in the severity of COVID-19 pathology in patients with cardiometabolic comorbidities?	Cytokine Growth Factor Rev
32988645	[HLA genetic polymorphisms and prognosis of patients with COVID-19].	Med Intensiva (Engl Ed)
32987852	"SARS-CoV-2: From Structure to Pathology, Host Immune Response and Therapeutic Management."	Microorganisms
32987828	"The Impacts of Antivirals on the Coronavirus Genome Structure and Subsequent Pathogenicity, Virus Fitness and Antiviral Design."	Biomedicines
32987794	"Possible Cross-Reactivity between SARS-CoV-2 Proteins, CRM197 and Proteins in Pneumococcal Vaccines May Protect Against Symptomatic SARS-CoV-2 Disease and Death."	Vaccines (Basel)
32987757	Peptides: Prospects for Use in the Treatment of COVID-19.	Molecules
32987701	Mitochondrial Glutathione: Recent Insights and Role in Disease.	Antioxidants (Basel)
32987502	The within-host viral kinetics of SARS-CoV-2.	Math Biosci Eng
32987103	Design of novel viral attachment inhibitors of the spike glycoprotein (S) of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) through virtual screening and dynamics.	Int J Antimicrob Agents
32987060	Mechanisms and treatments of myocardial injury in patients with corona virus disease 2019.	Life Sci
32987038	"Neprilysin expression and functions in development, ageing and disease."	Mech Ageing Dev
32987033	Transcription-based drug repurposing for COVID-19.	Virus Res
32986928	Pathophysiology of coronavirus disease 2019 for wound care professionals.	Int Wound J
32986926	Binding of SARS-CoV-2 to Cell Receptors: A Tale of Molecular Evolution.	Chembiochem
32986832	Biased Mutation and Selection in RNA Viruses.	Mol Biol Evol
32986250	A bioinformatic prediction of antigen presentation from SARS-CoV-2 spike protein revealed a theoretical correlation of HLA-DRB1*01 with COVID-19 fatality in Mexican population: An ecological approach.	J Med Virol
32986016	Neurological manifestations in COVID-19 and its possible mechanism.	Aging (Albany NY)
32985653	"The iminosugars celgosivir, castanospermine and UV-4 inhibit SARS-CoV-2 replication."	Glycobiology
32985528	Modeling lung perfusion abnormalities to explain early COVID-19 hypoxemia.	Nat Commun
32985513	Structural and functional modelling of SARS-CoV-2 entry in animal models.	Sci Rep
32985211	Potential therapeutic effects of Resveratrol against SARS-CoV-2.	Acta Virol
32985209	Genomic characterization and phylogenetic evolution of the SARS-CoV-2.	Acta Virol
32985202	SARS-CoV-2: Zoonotic origin of pandemic coronavirus.	Acta Virol
32985201	SARS-CoV-2 and COVID-19: How much do we know?	Acta Virol
32985199	Immunotherapy approaches on innate immunity for SARS-Cov-2.	Acta Virol
32985113	Feline infectious peritonitis (FIP) and coronavirus disease 19 (COVID-19): Are they similar?	Transbound Emerg Dis
32985017	Natural products for COVID-19 prevention and treatment regarding to previous coronavirus infections and novel studies.	Phytother Res
32984999	Virtual screening for functional foods against the main protease of SARS-CoV-2.	J Food Biochem
32984987	Superiority of cilostazol among antiplatelet FDA-approved drugs against COVID 19 M(pro) and spike protein: Drug repurposing approach.	Drug Dev Res
32984892	Angiotensin-converting enzyme 2 (ACE2) levels in relation to risk factors for COVID-19 in two large cohorts of patients with atrial fibrillation.	Eur Heart J
32984856	Programming Multifaceted Pulmonary T Cell Immunity by Combination Adjuvants.	Cell Rep Med
32984855	Oral SARS-CoV-2 Inoculation Establishes Subclinical Respiratory Infection with Virus Shedding in Golden Syrian Hamsters.	Cell Rep Med
32984832	In Silico Modeling of Coronavirus Disease 2019 Acute Respiratory Distress Syndrome: Pathophysiologic Insights and Potential Management Implications.	Crit Care Explor
32984768	SARS-CoV-2-Related Kidney Injury: Current Concern and Challenges.	SN Compr Clin Med
32984764	Immune Thrombocytopenia Secondary to COVID-19: a Systematic Review.	SN Compr Clin Med
32984664	Identification of Geographic Specific SARS-Cov-2 Mutations by Random Forest Classification and Variable Selection Methods.	Stat Appl
32984641	Gut microbiome dysbiosis and endotoxemia - Additional pathophysiological explanation for increased COVID-19 severity in obesity.	Obes Med
32984621	Animal Coronaviruses in the Light of COVID-19.	J Vet Res
32984620	Nucleic acid-based therapy for coronavirus disease 2019.	Heliyon
32984567	A SARS-CoV-2 host infection model network based on genomic human Transcription Factors (TFs) depletion.	Heliyon
32984566	Selective pressure on SARS-CoV-2 protein coding genes and glycosylation site prediction.	Heliyon
32984543	Identifying pathophysiological bases of disease in COVID-19.	Transl Med Commun
32984489	Thermodynamic equilibrium dose-response models for MERS-CoV infection reveal a potential protective role of human lung mucus but not for SARS-CoV-2.	Microb Risk Anal
32984400	Understanding Selenium and Glutathione as Antiviral Factors in COVID-19: Does the Viral M(pro) Protease Target Host Selenoproteins and Glutathione Synthesis?	Front Nutr
32984339	Repurposing Fragile X Drugs to Inhibit SARS-CoV-2 Viral Reproduction.	Front Cell Dev Biol
32984253	Importance of Dietary Changes During the Coronavirus Pandemic: How to Upgrade Your Immune Response.	Front Public Health
32983927	COVID-19 and Tuberculosis.	J Transl Int Med
32983652	Potential role of cellular miRNAs in coronavirus-host interplay.	PeerJ
32983542	What could explain the late emergence of COVID-19 in Africa?	New Microbes New Infect
32983400	Computational biophysical characterization of the SARS-CoV-2 spike protein binding with the ACE2 receptor and implications for infectivity.	Comput Struct Biotechnol J
32983399	An immersive journey to the molecular structure of SARS-CoV-2: Virtual reality in COVID-19.	Comput Struct Biotechnol J
32983347	Emerging Neurology of COVID-19.	Neurohospitalist
32983259	Therapeutic mechanism of Toujie Quwen granules in COVID-19 based on network pharmacology.	BioData Min
32983181	Experimental Models for the Study of Central Nervous System Infection by SARS-CoV-2.	Front Immunol
32983176	What's Sex Got to Do With COVID-19? Gender-Based Differences in the Host Immune Response to Coronaviruses.	Front Immunol
32983174	Re-analysis of Single Cell Transcriptome Reveals That the NR3C1-CXCL8-Neutrophil Axis Determines the Severity of COVID-19.	Front Immunol
32983172	"Cytokine Storm in COVID-19: ""When You Come Out of the Storm, You Won't Be the Same Person Who Walked in""."	Front Immunol
32983152	The Immune Response and Immunopathology of COVID-19.	Front Immunol
32983141	Obesity-Driven Deficiencies of Specialized Pro-resolving Mediators May Drive Adverse Outcomes During SARS-CoV-2 Infection.	Front Immunol
32983106	Analysis of Co-inhibitory Receptor Expression in COVID-19 Infection Compared to Acute Plasmodium falciparum Malaria: LAG-3 and TIM-3 Correlate With T Cell Activation and Course of Disease.	Front Immunol
32983097	"A Systematic, Unbiased Mapping of CD8(+) and CD4(+) T Cell Epitopes in Yellow Fever Vaccinees."	Front Immunol
32983065	Development of HiBiT-Tagged Recombinant Infectious Bronchitis Coronavirus for Efficient in vitro and in vivo Viral Quantification.	Front Microbiol
32983025	Toward Understanding Molecular Bases for Biological Diversification of Human Coronaviruses: Present Status and Future Perspectives.	Front Microbiol
32983015	Picking up a Fight: Fine Tuning Mitochondrial Innate Immune Defenses Against RNA Viruses.	Front Microbiol
32982760	Mitochondria Targeted Viral Replication and Survival Strategies-Prospective on SARS-CoV-2.	Front Pharmacol
32982720	"SARS-CoV-2 Treatment Approaches: Numerous Options, No Certainty for a Versatile Virus."	Front Pharmacol
32982622	Air pollution by NO2 and PM2.5 explains COVID-19 infection severity by overexpression of angiotensin-converting enzyme 2 in respiratory cells: a review.	Environ Chem Lett
32982616	Flavonoids: A complementary approach to conventional therapy of COVID-19?	Phytochem Rev
32982366	Role of IFN and Complements System: Innate Immunity in SARS-CoV-2.	J Inflamm Res
32982349	"COVID's Razor: RAS Imbalance, the Common Denominator Across Disparate, Unexpected Aspects of COVID-19."	Diabetes Metab Syndr Obes
32981925	Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes Platform to Study SARS-CoV-2 Related Myocardial Injury.	Circ J
32981754	Bioactive Lipids in COVID-19-Further Evidence.	Arch Med Res
32981683	Machine learning methods accurately predict host specificity of coronaviruses based on spike sequences alone.	Biochem Biophys Res Commun
32981462	"The COVID-19 Effect on the Immune System and Mitochondrial Dynamics in Diabetes, Obesity, and Dementia."	Neuroscientist
32981461	"Pharmacophore based virtual screening, molecular docking, molecular dynamics and MM-GBSA approach for identification of prospective SARS-CoV-2 inhibitor from natural product databases."	J Biomol Struct Dyn
32981460	Discovery of Drug-Like Ligands for the Mac1 Domain of SARS-CoV-2 Nsp3.	SLAS Discov
32981399	COVID-19 Infection: Concise Review Based on the Immunological Perspective.	Immunol Invest
32981369	"Severe Acute Respiratory Syndrome Coronavirus 2, COVID-19, and the Renin-Angiotensin System: Pressing Needs and Best Research Practices."	Hypertension
32981365	Clinical and Proteomic Correlates of Plasma ACE2 (Angiotensin-Converting Enzyme 2) in Human Heart Failure.	Hypertension
32981130	Covid-19.bioreproducibility.org: A web resource for SARS-CoV-2-related structural models.	Protein Sci
32981112	Hunting coronavirus by transmission electron microscopy - a guide to SARS-CoV-2-associated ultrastructural pathology in COVID-19 tissues.	Histopathology
32981023	A Review on the Neurological Manifestations of COVID-19 Infection: a Mechanistic View.	Mol Neurobiol
32980554	NOD2-dependent BCG-induced trained immunity: A way to regulate innate responses to SARS-CoV2?	Int J Infect Dis
32980515	Identification of a novel orally bioavailable NLRP3 inflammasome inhibitor.	Bioorg Med Chem Lett
32980462	Evolutionary artificial intelligence based peptide discoveries for effective Covid-19 therapeutics.	Biochim Biophys Acta Mol Basis Dis
32980424	Coronavirus disease 2019 in patients with inborn errors of immunity: An international study.	J Allergy Clin Immunol
32980406	Evaluation of the potency of FDA-approved drugs on wild type and mutant SARS-CoV-2 helicase (Nsp13).	Int J Biol Macromol
32980345	Intestinal Inflammation Modulates the Expression of ACE2 and TMPRSS2 and Potentially Overlaps With the Pathogenesis of SARS-CoV-2-related Disease.	Gastroenterology
32980319	Extrapulmonary manifestations of COVID-19 in children: a comprehensive review and pathophysiological considerations.	J Pediatr (Rio J)
32979942	Molecular Architecture of the SARS-CoV-2 Virus.	Cell
32979941	Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19.	Cell
32979938	Evasion of Type I Interferon by SARS-CoV-2.	Cell Rep
32979900	The assessment of the serum levels of TWEAK and prostaglandin F2alpha in COVID - 19	Turk J Med Sci
32979815	Identification of novel human USP2 inhibitor and its putative role in treatment of COVID-19 by inhibiting SARS-CoV-2 papain-like (PLpro) protease.	Comput Biol Chem
32979742	COVID-2019 - A comprehensive pathology insight.	Pathol Res Pract
32979477	Signal hotspot mutations in SARS-CoV-2 genomes evolve as the virus spreads and actively replicates in different parts of the world.	Virus Res
32979476	Current approaches for target-specific drug discovery using natural compounds against SARS-CoV-2 infection.	Virus Res
32979436	The structure-activity relationship of the interactions of SARS-CoV-2 spike glycoproteins with glucuronomannan and sulfated galactofucan from Saccharina japonica.	Int J Biol Macromol
32979405	Concentration of infectious SARS-CoV-2 by polyethylene glycol precipitation.	J Virol Methods
32979398	SARS-CoV-2 pathophysiology and its clinical implications: An integrative overview of the pharmacotherapeutic management of COVID-19.	Food Chem Toxicol
32979360	Mesenchymal stem cell therapies for COVID-19: Current status and mechanism of action.	Life Sci
32979316	SARS-CoV-2 Infection of Pluripotent Stem Cell-Derived Human Lung Alveolar Type 2 Cells Elicits a Rapid Epithelial-Intrinsic Inflammatory Response.	Cell Stem Cell
32978971	Innate immunity during SARS-CoV-2: evasion strategies and activation trigger hypoxia and vascular damage.	Clin Exp Immunol
32978729	Neurological Complications Associated with the Blood-Brain Barrier Damage Induced by the Inflammatory Response During SARS-CoV-2 Infection.	Mol Neurobiol
32978651	Why COVID-19 is less frequent and severe in children: a narrative review.	World J Pediatr
32978337	"COVID-19: Current understanding of its Pathophysiology, Clinical presentation and Treatment."	Postgrad Med J
32978313	Rescue of SARS-CoV-2 from a Single Bacterial Artificial Chromosome.	mBio
32978311	S Protein-Reactive IgG and Memory B Cell Production after Human SARS-CoV-2 Infection Includes Broad Reactivity to the S2 Subunit.	mBio
32978291	"Anti-SARS-CoV-2 antibodies in the CSF, blood-brain barrier dysfunction, and neurological outcome: Studies in 8 stuporous and comatose patients."	Neurol Neuroimmunol Neuroinflamm
32978255	Presence of hyaluronan in lung alveoli in severe Covid-19: An opening for new treatment options?	J Biol Chem
32978039	"Systems pharmacological study illustrates the immune regulation, anti-infection, anti-inflammation, and multi-organ protection mechanism of Qing-Fei-Pai-Du decoction in the treatment of COVID-19."	Phytomedicine
32977949	Andrographolide and its fluorescent derivative inhibit the main proteases of 2019-nCoV and SARS-CoV through covalent linkage.	Biochem Biophys Res Commun
32977547	"Potential of Cell-Free Supernatant from Lactobacillus plantarum NIBR97, Including Novel Bacteriocins, as a Natural Alternative to Chemical Disinfectants."	Pharmaceuticals (Basel)
32977525	The Application of Porphyrins and Their Analogues for Inactivation of Viruses.	Molecules
32977355	Androgen receptor genetic variant predicts COVID-19 disease severity: a prospective longitudinal study of hospitalized COVID-19 male patients.	J Eur Acad Dermatol Venereol
32977101	Syncope at SARS-CoV-2 onset.	Auton Neurosci
32976799	"COVID-19 Makes B Cells Forget, but T Cells Remember."	Cell
32976665	Elevated markers of gut leakage and inflammasome activation in COVID-19 patients with cardiac involvement.	J Intern Med
32976572	"COVID-19 Knowledge Graph: a computable, multi-modal, cause-and-effect knowledge model of COVID-19 pathophysiology."	Bioinformatics
32976117	Are T cells helpful for COVID-19: the relationship between response and risk.	J Clin Invest
32975865	Expression of ACE2 in airways: Implication for COVID-19 risk and disease management in patients with chronic inflammatory respiratory diseases.	Clin Exp Allergy
32975856	Evolution of SARS-CoV-2 genome from December 2019 to late March 2020: Emerged haplotypes and informative Tag nucleotide variations.	J Med Virol
32975565	Coronavirus Disease 2019 (COVID-19) and Nutritional Status: The Missing Link?	Adv Nutr
32975484	Targeting the endolysosomal host-SARS-CoV-2 interface by clinically licensed functional inhibitors of acid sphingomyelinase (FIASMA) including the antidepressant fluoxetine.	Emerg Microbes Infect
32975374	Naturally activated adaptive immunity in COVID-19 patients.	J Cell Mol Med
32975064	Quantitative Proteomic Analysis of the Expression of SARS-CoV-2 Receptors in the Gut of Patients with Chronic Enterocolitis.	Yonsei Med J
32974373	"Exploring the Demographics and Clinical Characteristics Related to the Expression of Angiotensin-Converting Enzyme 2, a Receptor of SARS-CoV-2."	Front Med (Lausanne)
32974353	SARS-CoV-2 Codon Usage Bias Downregulates Host Expressed Genes With Similar Codon Usage.	Front Cell Dev Biol
32974340	Single-Cell RNA-seq Identifies Cell Subsets in Human Placenta That Highly Expresses Factors Driving Pathogenesis of SARS-CoV-2.	Front Cell Dev Biol
32974224	"Unraveling the Epidemiology, Geographical Distribution, and Genomic Evolution of Potentially Lethal Coronaviruses (SARS, MERS, and SARS CoV-2)."	Front Cell Infect Microbiol
32974030	"Lions, tigers and kittens too: ACE2 and susceptibility to COVID-19."	Evol Med Public Health
32974019	Neurological manifestations in COVID-19: A narrative review.	SAGE Open Med
32973879	Single Cell RNA-seq Data Analysis Reveals the Potential Risk of SARS-CoV-2 Infection Among Different Respiratory System Conditions.	Front Genet
32973818	PI3Kdelta Inhibition as a Potential Therapeutic Target in COVID-19.	Front Immunol
32973815	"Hyperinflammation and Fibrosis in Severe COVID-19 Patients: Galectin-3, a Target Molecule to Consider."	Front Immunol
32973814	Immunomodulatory and Antiviral Activity of Metformin and Its Potential Implications in Treating Coronavirus Disease 2019 and Lung Injury.	Front Immunol
32973803	Innate Immune Responses to Highly Pathogenic Coronaviruses and Other Significant Respiratory Viral Infections.	Front Immunol
32973730	The Strengths of Scanning Electron Microscopy in Deciphering SARS-CoV-2 Infectious Cycle.	Front Microbiol
32973697	Probiotics at War Against Viruses: What Is Missing From the Picture?	Front Microbiol
32973655	Respiratory Syndrome Coronavirus Infections: Possible Mechanisms of Neurological Implications-A Systematic Review.	Front Neurol
32973590	COVID-19 Neurological Manifestations and Underlying Mechanisms: A Scoping Review.	Front Psychiatry
32973534	"Research Progress of Genetic Structure, Pathogenic Mechanism, Clinical Characteristics, and Potential Treatments of Coronavirus Disease 2019."	Front Pharmacol
32973527	Harnessing Memory NK Cell to Protect Against COVID-19.	Front Pharmacol
32973505	"Repurposing Drugs, Ongoing Vaccine, and New Therapeutic Development Initiatives Against COVID-19."	Front Pharmacol
32973504	The C-C Chemokine Receptor Type 4 Is an Immunomodulatory Target of Hydroxychloroquine.	Front Pharmacol
32973171	Sequence analysis of SARS-CoV-2 genome reveals features important for vaccine design.	Sci Rep
32972996	Autoantibodies against type I IFNs in patients with life-threatening COVID-19.	Science
32972995	Inborn errors of type I IFN immunity in patients with life-threatening COVID-19.	Science
32972994	Ultrapotent human antibodies protect against SARS-CoV-2 challenge via multiple mechanisms.	Science
32972948	Whole-Genome Sequence of SARS-CoV-2 Isolate Siena-1/2020.	Microbiol Resour Announc
32972934	Coding-Complete Genome Sequences of Three SARS-CoV-2 Strains from Bangladesh.	Microbiol Resour Announc
32972810	COVID-19 and Microvascular Disease: Pathophysiology of SARS-CoV-2 Infection With Focus on the Renin-Angiotensin System.	Heart Lung Circ
32972561	Arrhythmias and COVID-19: A Review.	JACC Clin Electrophysiol
32972339	Targeting Host Cell Proteases to Prevent SARS-CoV-2 Invasion.	Curr Drug Targets
32972338	Antibiotic Potentiation of Natural Products: A Promising Target to Fight Pathogenic Bacteria.	Curr Drug Targets
32972196	Clinical evidences on the antiviral properties of macrolide antibiotics in the COVID-19 era and beyond.	Antivir Chem Chemother
32972153	Ingavirin might be a promising agent to combat Severe Acute Respiratory Coronavirus 2 (SARS-CoV-2).	Ceska Slov Farm
32972126	MicroCLOTS pathophysiology in COVID 19.	Korean J Intern Med
32971954	The Epidemiological Signature of Pathogen Populations That Vary in the Relationship between Free-Living Parasite Survival and Virulence.	Viruses
32971906	Imaging Diagnostics and Pathology in SARS-CoV-2-Related Diseases.	Int J Mol Sci
32971895	Identification of a Membrane Binding Peptide in the Envelope Protein of MHV Coronavirus.	Viruses
32971526	Cells of the adult human heart.	Nature
32971472	Heterogeneous expression of the SARS-Coronavirus-2 receptor ACE2 in the human respiratory tract.	EBioMedicine
32971150	"Incidence of COVID-19 infection and prevalence of diabetes, obesity and hypertension according to altitude in Peruvian population."	Diabetes Res Clin Pract
32971147	"The emergence of COVID-19 as a global pandemic: Understanding the epidemiology, immune response and potential therapeutic targets of SARS-CoV-2."	Biochimie
32971122	Deciphering the SSR incidences across viral members of Coronaviridae family.	Chem Biol Interact
32971109	Elevated plasma sTIM-3 levels in patients with severe COVID-19.	J Allergy Clin Immunol
32971105	Cardiac inflammation in COVID-19: Lessons from heart failure.	Life Sci
32971089	Integrative transcriptomics analysis of lung epithelial cells and identification of repurposable drug candidates for COVID-19.	Eur J Pharmacol
32970990	Structurally Resolved SARS-CoV-2 Antibody Shows High Efficacy in Severely Infected Hamsters and Provides a Potent Cocktail Pairing Strategy.	Cell
32970989	SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2.	Cell
32970974	Exosomes: Applications in Respiratory Infectious Diseases and Prospects for Coronavirus Disease 2019 (COVID-19).	J Biomed Nanotechnol
32970935	Coronaviruses in wild birds - A potential and suitable vector for global distribution.	Vet Med Sci
32970861	Viral infection and smell loss: The case of COVID-19.	J Neurochem
32970479	No Relevant Analogy Between COVID-19 and Acute Mountain Sickness.	High Alt Med Biol
32970391	An investigation into the molecular basis of cancer comorbidities in coronavirus infection.	FEBS Open Bio
32970329	Genomic and proteomic mutation landscapes of SARS-CoV-2.	J Med Virol
32969768	Robust and persistent SARS-CoV-2 infection in the human intestinal brush border expressing cells.	Emerg Microbes Infect
32969524	The natural way forward: Molecular dynamics simulation analysis of phytochemicals from Indian medicinal plants as potential inhibitors of SARS-CoV-2 targets.	Phytother Res
32969367	A Retrospective Study from 2 Centers in China on the Effects of Continued Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Patients with Hypertension and COVID-19.	Med Sci Monit
32969333	Repurposing of the approved small molecule drugs in order to inhibit SARS-CoV-2 S protein and human ACE2 interaction through virtual screening approaches.	J Biomol Struct Dyn
32969125	Azithromycin in viral infections.	Rev Med Virol
32969123	Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its effect on gametogenesis and early pregnancy.	Am J Reprod Immunol
32968798	Unveiling COVID-19-associated organ-specific cell types and cell-specific pathway cascade.	Brief Bioinform
32968643	Research advances in myocardial injury caused by COVID-19.	Cardiovasc Diagn Ther
32967965	Template-dependent inhibition of coronavirus RNA-dependent RNA polymerase by remdesivir reveals a second mechanism of action.	J Biol Chem
32967937	COVID-19 can affect the heart.	Science
32967859	The pulmonary pathology of COVID-19.	Cleve Clin J Med
32967703	"TMPRSS2, a SARS-CoV-2 internalization protease is downregulated in head and neck cancer patients."	J Exp Clin Cancer Res
32967693	A persistently replicating SARS-CoV-2 variant derived from an asymptomatic individual.	J Transl Med
32967329	Implications of Oxidative Stress and Potential Role of Mitochondrial Dysfunction in COVID-19: Therapeutic Effects of Vitamin D.	Antioxidants (Basel)
32967280	Molecular Features of Non-Selective Small Molecule Antagonists of the Bradykinin Receptors.	Pharmaceuticals (Basel)
32967229	Immune Checkpoints in Viral Infections.	Viruses
32967179	Plants-Derived Biomolecules as Potent Antiviral Phytomedicines: New Insights on Ethnobotanical Evidences against Coronaviruses.	Plants (Basel)
32967165	"Oxidative Stress, Proton Fluxes, and Chloroquine/Hydroxychloroquine Treatment for COVID-19."	Antioxidants (Basel)
32967126	Immune Modulatory Effects of Vitamin D on Viral Infections.	Nutrients
32967116	Recognition of Potential COVID-19 Drug Treatments through the Study of Existing Protein-Drug and Protein-Protein Structures: An Analysis of Kinetically Active Residues.	Biomolecules
32966970	"Endocrine aspects of ACE2 regulation: RAAS, steroid hormones and SARS-CoV-2."	J Endocrinol
32966857	Mutations on COVID-19 diagnostic targets.	Genomics
32966814	AR12 (OSU-03012) suppresses GRP78 expression and inhibits SARS-CoV-2 replication.	Biochem Pharmacol
32966801	Activation of the SARS-CoV-2 Receptor Ace2 through JAK/STAT-Dependent Enhancers during Pregnancy.	Cell Rep
32966765	The Immunology of Multisystem Inflammatory Syndrome in Children with COVID-19.	Cell
32966646	Phylogenetic analysis of SARS-CoV-2 in the first few months since its emergence.	J Med Virol
32966582	SARS-CoV-2 infects and induces cytotoxic effects in human cardiomyocytes.	Cardiovasc Res
32966484	Inhibitory activities of marine sulfated polysaccharides against SARS-CoV-2.	Food Funct
32966269	Healthy donor T cell responses to common cold coronaviruses and SARS-CoV-2.	J Clin Invest
32966040	Targeting Polyamines Inhibits Coronavirus Infection by Reducing Cellular Attachment and Entry.	ACS Infect Dis
32966032	Example of Steady-State Electric-Current Modeling of a Complicated Cellular Topology with Boundary Element Fast Multipole Method	Brain and Human Body Modeling 2020: Computational Human Models Presented at EMBC 2019 and the BRAIN Initiative(R) 2019 Meeting
32965736	"SARS-CoV-2 and the possible connection to ERs, ACE2, and RAGE: Focus on susceptibility factors."	FASEB J
32965717	SARS-CoV-2 infection in India bucks the trend: Trained innate immunity?	Am J Hum Biol
32965677	N-terminally truncated nucleocapsid protein of SARS-CoV-2 as a better serological marker than whole nucleocapsid protein in evaluating the immunogenicity of inactivated SARS-CoV-2.	J Med Virol
32965660	The Perfect Storm: COVID-19 Health Disparities in US Blacks.	J Racial Ethn Health Disparities
32965508	Insights into the biased activity of dextromethorphan and haloperidol towards SARS-CoV-2 NSP6: in silico binding mechanistic analysis.	J Mol Med (Berl)
32965173	Secondary structure of the SARS-CoV-2 5'-UTR.	RNA Biol
32965078	Severe acute respiratory syndrome-coronavirus-2: Current advances in therapeutic targets and drug development.	Rev Med Virol
32965016	Advances in SARS-CoV-2: a systematic review.	Eur Rev Med Pharmacol Sci
32965011	An association between exposure to Middle East Respiratory Syndrome (MERS) and mortality rate of Coronavirus Disease 2019 (COVID-19).	Eur Rev Med Pharmacol Sci
32965010	SARS-CoV-2 infection: NLRP3 inflammasome as plausible target to prevent cardiopulmonary complications?	Eur Rev Med Pharmacol Sci
32964827	Design and in-silico screening of Peptide Nucleic Acid (PNA) inspired novel pronucleotide scaffolds targeting COVID-19.	Curr Comput Aided Drug Des
32964805	Repurposing drugs for treatment of SARS-CoV-2 infection: computational design insights into mechanisms of action.	J Biomol Struct Dyn
32964802	Identification of destabilizing SNPs in SARS-CoV2-ACE2 protein and spike glycoprotein: implications for virus entry mechanisms.	J Biomol Struct Dyn
32964796	Coronavirus interactions with the cellular autophagy machinery.	Autophagy
32964684	The overlooked chamber in coronavirus disease 2019.	ESC Heart Fail
32964551	Aframomum melegueta secondary metabolites exhibit polypharmacology against SARS-CoV-2 drug targets: in vitro validation of furin inhibition.	Phytother Res
32964419	Neuroinvasion of SARS-CoV-2 may play a role in the breakdown of the respiratory center of the brain.	J Med Virol
32964056	Attenuated Subcomponent Vaccine Design Targeting the SARS-CoV-2 Nucleocapsid Phosphoprotein RNA Binding Domain: In Silico Analysis.	J Immunol Res
32963884	Computer-Aided Analysis of Multiple SARS-CoV-2 Therapeutic Targets: Identification of Potent Molecules from African Medicinal Plants.	Scientifica (Cairo)
32963703	Hydrogen: A Novel Option in Human Disease Treatment.	Oxid Med Cell Longev
32963564	Tea Polyphenols EGCG and Theaflavin Inhibit the Activity of SARS-CoV-2 3CL-Protease In Vitro.	Evid Based Complement Alternat Med
32963540	Possible Role for Bacteriophages in the Treatment of SARS-CoV-2 Infection.	Int J Microbiol
32963441	Systemic Involvement of Novel Coronavirus (COVID-19): A Review of Literature.	Indian J Crit Care Med
32963413	"Synthesis, characterization and computational study on potential inhibitory action of novel azo imidazole derivatives against COVID-19 main protease (M(pro): 6LU7)."	J Mol Struct
32963239	Consensus transcriptional regulatory networks of coronavirus-infected human cells.	Sci Data
32963228	Receptor-binding domain-specific human neutralizing monoclonal antibodies against SARS-CoV and SARS-CoV-2.	Signal Transduct Target Ther
32963099	In Silico Structure-Based Repositioning of Approved Drugs for Spike Glycoprotein S2 Domain Fusion Peptide of SARS-CoV-2: Rationale from Molecular Dynamics and Binding Free Energy Calculations.	mSystems
32962867	Targeting SARS-CoV-2 Main Protease: A Computational Drug Repurposing Study.	Arch Med Res
32962761	Severe COVID-19: what have we learned with the immunopathogenesis?	Adv Rheumatol
32962623	The Role of Tocilizumab in Cytokine Storm and Improving Outcomes in COVID-19.	Recent Pat Antiinfect Drug Discov
32962613	"Progress in Studies on Structural and Remedial Aspects of Newly Born Coronavirus, SARS-CoV-2."	Curr Top Med Chem
32962355	Assessment of proton-coupled conformational dynamics of SARS and MERS coronavirus papain-like proteases: Implication for designing broad-spectrum antiviral inhibitors.	J Chem Phys
32962156	A Putative Prophylactic Solution for COVID-19: Development of Novel Multiepitope Vaccine Candidate against SARS-COV-2 by Comprehensive Immunoinformatic and Molecular Modelling Approach.	Biology (Basel)
32961897	Induction of the Antiviral Immune Response and Its Circumvention by Coronaviruses.	Viruses
32961440	Do free radical NETwork and oxidative stress disparities in African Americans enhance their vulnerability to SARS-CoV-2 infection and COVID-19 severity?	Redox Biol
32961333	Complement C3 vs C5 inhibition in severe COVID-19: Early clinical findings reveal differential biological efficacy.	Clin Immunol
32961274	Vaccines for COVID-19: perspectives from nucleic acid vaccines to BCG as delivery vector system.	Microbes Infect
32961082	Perspectives on development of vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).	Hum Vaccin Immunother
32961074	Cytokine storm and COVID-19: a chronicle of pro-inflammatory cytokines.	Open Biol
32960504	Coronavirus: A possible cause of reduced male fertility.	Andrology
32960480	Ethnic differences in alpha-1 antitrypsin deficiency allele frequencies may partially explain national differences in COVID-19 fatality rates.	FASEB J
32960473	Differential microRNA expression in the peripheral blood from human patients with COVID-19.	J Clin Lab Anal
32960167	[Adaptive immunity against SARS-CoV-2].	Med Sci (Paris)
32960159	"The potential role of procyanidin as a therapeutic agent against SARS-CoV-2: a text mining, molecular docking and molecular dynamics simulation approach."	J Biomol Struct Dyn
32960072	"COVID-19 and Respiratory System Disorders: Current Knowledge, Future Clinical and Translational Research Questions."	Arterioscler Thromb Vasc Biol
32960061	Theoretical Insights into the Anti-SARS-CoV-2 Activity of Chloroquine and Its Analogs and In Silico Screening of Main Protease Inhibitors.	J Proteome Res
32959951	Coronavirus disease-19 and cardiovascular disease: A risk factor or a risk marker?	Rev Med Virol
32959913	"A pharmacological framework for integrating treating the host, drug repurposing and the damage response framework in COVID-19."	Br J Clin Pharmacol
32959892	"Quantitative proteomics reveals a broad-spectrum antiviral property of ivermectin, benefiting for COVID-19 treatment."	J Cell Physiol
32959144	SARS-CoV-2 host receptors ACE2 and CD147 (BSG) are present on human oocytes and blastocysts.	J Assist Reprod Genet
32959007	An overview of COVID-19 with an emphasis on computational approach for its preventive intervention.	3 Biotech
32958687	Immune Response Resetting as a Novel Strategy to Overcome SARS-CoV-2-Induced Cytokine Storm.	J Immunol
32958614	Immune responses to SARS-CoV-2 infection in hospitalized pediatric and adult patients.	Sci Transl Med
32958580	Free fatty acid binding pocket in the locked structure of SARS-CoV-2 spike protein.	Science
32958250	Potent antiviral effect of silver nanoparticles on SARS-CoV-2.	Biochem Biophys Res Commun
32957905	Immuno-Informatics Quest against COVID-19/SARS-COV-2: Determining Putative T-Cell Epitopes for Vaccine Prediction.	Infect Disord Drug Targets
32957894	Understanding the Role of Corona Virus based on Current Scientific Evidence - A Review with Emerging Importance in Pandemic.	Recent Pat Antiinfect Drug Discov
32957889	Identification of Main Protease of Coronavirus SARS-CoV-2 (Mpro)Inhibitors from Melissa officinalis.	Curr Drug Discov Technol
32957884	Quercetin and its relative therapeutic potential against COVID-19: A retrospective review and prospective overview.	Curr Mol Med
32957797	Putative COVID- 19 Induction of Reward Deficiency Syndrome (RDS) and Associated Behavioral Addictions with Potential Concomitant Dopamine Depletion: Is COVID-19 Social Distancing a Double Edged Sword?	Subst Use Misuse
32957788	Techniques and Strategies for Potential Protein Target Discovery and Active Pharmaceutical Molecule Screening in a Pandemic.	J Proteome Res
32957548	Complex Immunometabolic Profiling Reveals the Activation of Cellular Immunity and Biliary Lesions in Patients with Severe COVID-19.	J Clin Med
32957545	Nutritional Therapy to Modulate Tryptophan Metabolism and Aryl Hydrocarbon-Receptor Signaling Activation in Human Diseases.	Nutrients
32957467	Host Diversity and Origin of Zoonoses: The Ancient and the New.	Animals (Basel)
32957454	Novel Binding Mechanisms of Fusion Broad Range Anti-Infective Protein Ricin A Chain Mutant-Pokeweed Antiviral Protein 1 (RTAM-PAP1) against SARS-CoV-2 Key Proteins in Silico.	Toxins (Basel)
32957112	COVID-19 and Extracellular Vesicles: An Intriguing Interplay.	Kidney Blood Press Res
32956927	Does a younger host make the virus weaker? Presenting a new hypothesis.	Diabetes Metab Syndr
32956843	Angiotensin-converting enzyme 2 (ACE2): COVID 19 gate way to multiple organ failure syndromes.	Respir Physiol Neurobiol
32956664	Assessment of effective imidazole derivatives against SARS-CoV-2 main protease through computational approach.	Life Sci
32956644	A review of medications used to control and improve the signs and symptoms of COVID-19 patients.	Eur J Pharmacol
32956643	Role of proteolytic enzymes in the COVID-19 infection and promising therapeutic approaches.	Biochem Pharmacol
32956495	"Dexamethasone, pro-resolving lipid mediators and resolution of inflammation in COVID-19."	Allergy
32955906	Coronaviruses as the emerging threats for human health: should we be prepared for the future outbreaks of new coronaviruses?	Bratisl Lek Listy
32955901	How do arbidol and its analogs inhibit the SARS-CoV-2?	Bratisl Lek Listy
32955770	Cellular senescence as a potential mediator of COVID-19 severity in the elderly.	Aging Cell
32955375	"Gastrointestinal coronavirus disease 2019: epidemiology, clinical features, pathogenesis, prevention, and management."	Expert Rev Gastroenterol Hepatol
32955126	"COVID-19, nausea, and vomiting."	J Gastroenterol Hepatol
32954998	The Emergence of Human Pathogenic Coronaviruses: Lectins as Antivirals for SARS-CoV-2.	Curr Pharm Des
32954984	In silico modeling for quick prediction of inhibitory activity against 3CL(pro) enzyme in SARS CoV diseases.	J Biomol Struct Dyn
32954666	Comprehensive annotations of the mutational spectra of SARS-CoV-2 spike protein: a fast and accurate pipeline.	Transbound Emerg Dis
32954047	Genetic characterization of structural and open reading Fram-8 proteins of SARS-CoV-2 isolates from different countries.	Gene Rep
32954038	"Thermodynamic insight into viral infections 2: empirical formulas, molecular compositions and thermodynamic properties of SARS, MERS and SARS-CoV-2 (COVID-19) viruses."	Heliyon
32953947	SARS-CoV-2 infection: physiological and environmental gift factors at high altitude.	Virusdisease
32953841	Autoimmunity as the comet tail of COVID-19 pandemic.	World J Clin Cases
32953249	Similarity Studies of Corona Viruses through Chaos Game Representation.	Comput Mol Biosci
32953201	Pulmonary embolism in patients with coronavirus disease-2019 (COVID-19) pneumonia: a narrative review.	Ann Intensive Care
32952870	Mechanisms and consequences of COVID-19 associated liver injury: What can we affirm?	World J Hepatol
32952855	Mesenchymal stromal cells as potential immunomodulatory players in severe acute respiratory distress syndrome induced by SARS-CoV-2 infection.	World J Stem Cells
32952832	"The pandemic COVID-19: a tale of viremia, cellular oxidation and immune dysfunction."	Pan Afr Med J
32952690	Possible Nutritional Interventions in COVID 19.	Maedica (Bucur)
32952595	Ramatroban as a Novel Immunotherapy for COVID-19.	J Mol Genet Med
32951577	Carbohydrate-Binding Agents: Potential of Repurposing for COVID-19 Therapy.	Curr Protein Pept Sci
32950986	Switching Host Metabolism as an Approach to Dampen SARS-CoV-2 Infection.	Ann Nutr Metab
32950975	When Therapeutic IgA Antibodies Might Come of Age.	Pharmacology
32950735	Linking ACE2 and angiotensin II to pulmonary immunovascular dysregulation in SARS-CoV-2 infection.	Int J Infect Dis
32950697	Substitutions in Spike and Nucleocapsid proteins of SARS-CoV-2 circulating in South America.	Infect Genet Evol
32950529	Prediction of potential inhibitors for RNA-dependent RNA polymerase of SARS-CoV-2 using comprehensive drug repurposing and molecular docking approach.	Int J Biol Macromol
32950466	Thyroid disorders and SARS-CoV-2 infection: From pathophysiological mechanism to patient management.	Ann Endocrinol (Paris)
32950067	"Human Mesenchymal Stromal Cells Are Resistant to SARS-CoV-2 Infection under Steady-State, Inflammatory Conditions and in the Presence of SARS-CoV-2-Infected Cells."	Stem Cell Reports
32949888	"Network pharmacology analysis of the therapeutic mechanisms of the traditional Chinese herbal formula Lian Hua Qing Wen in Corona virus disease 2019 (COVID-19), gives fundamental support to the clinical use of LHQW."	Phytomedicine
32949606	"Antiviral activity of chlorpromazine, fluphenazine, perphenazine, prochlorperazine, and thioridazine towards RNA-viruses. A review."	Eur J Pharmacol
32949594	"The conundrum of human immune system ""senescence""."	Mech Ageing Dev
32949526	Taming the cytokine storm: repurposing montelukast for the attenuation and prophylaxis of severe COVID-19 symptoms.	Drug Discov Today
32949380	Impact of Treatment with Renin-Angiotensin System Inhibitors on Clinical Outcomes in Hypertensive Patients Hospitalized with COVID-19.	High Blood Press Cardiovasc Prev
32949308	"Clinical characteristics of moderate and severe cases with COVID-19 in Wuhan, China: a retrospective study."	Clin Exp Med
32949179	STAT3 isoforms differentially affect ACE2 expression: A potential target for COVID-19 therapy.	J Cell Mol Med
32948978	"Transthyretin Amyloidosis: Update on the Clinical Spectrum, Pathogenesis, and Disease-Modifying Therapies."	Neurol Ther
32948855	Sensitive fluorescence detection of SARS-CoV-2 RNA in clinical samples via one-pot isothermal ligation and transcription.	Nat Biomed Eng
32948688	Impaired Cytotoxic CD8(+) T Cell Response in Elderly COVID-19 Patients.	mBio
32948512	Antibody-like proteins that capture and neutralize SARS-CoV-2.	Sci Adv
32948484	Opinions on the current pandemic of COVID-19: Use functional food to boost our immune functions.	J Infect Public Health
32948440	Glycogen synthase kinase-3: A putative target to combat severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic.	Cytokine Growth Factor Rev
32948420	Caffeic acid derivatives (CAFDs) as inhibitors of SARS-CoV-2: CAFDs-based functional foods as a potential alternative approach to combat COVID-19.	Phytomedicine
32948252	The role of mesenchymal stromal cells in immune modulation of COVID-19: focus on cytokine storm.	Stem Cell Res Ther
32948238	Sex differences in severity and mortality from COVID-19: are males more vulnerable?	Biol Sex Differ
32948116	Identification of potential inhibitors of SARS-CoV-2 main protease and spike receptor from 10 important spices through structure-based virtual screening and molecular dynamic study.	J Biomol Struct Dyn
32948103	A computational approach to drug repurposing against SARS-CoV-2 RNA dependent RNA polymerase (RdRp).	J Biomol Struct Dyn
32948003	Lessons from Bacillus Calmette-Guerin: Harnessing Trained Immunity for Vaccine Development.	Cells
32947927	Cardiovascular Complications Associated with COVID-19 and Potential Therapeutic~Strategies.	Int J Mol Sci
32947803	COVID-19-Induced Thrombosis in Patients without Gastrointestinal Symptoms and Elevated Fecal Calprotectin: Hypothesis Regarding Mechanism of Intestinal Damage Associated with COVID-19.	Trop Med Infect Dis
32947478	Thrombotic Complications of COVID-19 Infection: A Review.	Cardiol Rev
32947193	Dyspneic and non-dyspneic (silent) hypoxemia in COVID-19: Possible neurological mechanism.	Clin Neurol Neurosurg
32947136	Druggable targets of SARS-CoV-2 and treatment opportunities for COVID-19.	Bioorg Chem
32946915	SARS-CoV-2 and coagulation disorders in different organs.	Life Sci
32946807	A Single-Cell RNA Expression Map of Human Coronavirus Entry Factors.	Cell Rep
32946692	Structural Insights into the Binding Modes of Viral RNA-Dependent RNA Polymerases Using a Function-Site Interaction Fingerprint Method for RNA Virus Drug Discovery.	J Proteome Res
32946664	SARS-CoV-2 infection of Chinese hamsters (Cricetulus griseus) reproduces COVID-19 pneumonia in a well-established small animal model.	Transbound Emerg Dis
32946531	The association between ABO blood group and SARS-CoV-2 infection: A meta-analysis.	PLoS One
32946527	Disentangling primer interactions improves SARS-CoV-2 genome sequencing by multiplex tiling PCR.	PLoS One
32946517	Exploring links between vitamin D deficiency and COVID-19.	PLoS Pathog
32946292	SARS-CoV-2 Targeting the Retina: Host-virus Interaction and Possible Mechanisms of Viral Tropism.	Ocul Immunol Inflamm
32946224	"Structural, Biophysical, and Biochemical Elucidation of the SARS-CoV-2 Nonstructural Protein 3 Macro Domain."	ACS Infect Dis
32946149	Covid-19 and dengue: Double punches for dengue-endemic countries in Asia.	Rev Med Virol
32946131	"Investigation of immune cells on elimination of pulmonary-Infected COVID-19 and important role of innate immunity, phagocytes."	Rev Med Virol
32945643	SeXX and COVID-19: tussle between the two.	Monaldi Arch Chest Dis
32945352	Transcriptomic analysis of COVID19 lungs and bronchoalveolar lavage fluid samples reveals predominant B cell activation responses to infection.	Int J Mol Med
32945216	Angiotensin converting enzyme inhibitors and angiotensin II receptor blockers and outcomes in patients with COVID-19: a systematic review and meta-analysis.	Expert Rev Cardiovasc Ther
32945158	Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19.	J Biol Regul Homeost Agents
32945111	Defibrotide in the COVID-19 coagulopathy: What is the timing?	J Thromb Haemost
32945081	COVID-19 patients exhibit reduced procoagulant platelet responses.	J Thromb Haemost
32944968	Cholesterol 25-Hydroxylase inhibits SARS-CoV-2 and other coronaviruses by depleting membrane cholesterol.	EMBO J
32944935	Single-cell RNA sequencing analysis of SARS-CoV-2 entry receptors in human organoids.	J Cell Physiol
32944929	COVID-19 and seizures: Is there a link?	Epilepsia
32944295	Impact of glycan cloud on the B-cell epitope prediction of SARS-CoV-2 Spike protein.	NPJ Vaccines
32944091	The Coronavirus Disease 2019 Outbreak Highlights the Importance of Sex-sensitive Medicine.	Eur Cardiol
32943888	Design an Efficient Multi-Epitope Peptide Vaccine Candidate Against SARS-CoV-2: An in silico Analysis.	Infect Drug Resist
32943637	"A systematic review of antibody mediated immunity to coronaviruses: kinetics, correlates of protection, and association with severity."	Nat Commun
32943628	Rapid incorporation of Favipiravir by the fast and permissive viral RNA polymerase complex results in SARS-CoV-2 lethal mutagenesis.	Nat Commun
32943587	Impact of Circulating SARS-CoV-2 Mutant G614 on the COVID-19 Pandemic.	Iran J Kidney Dis
32943538	Systemic complement activation is associated with respiratory failure in COVID-19 hospitalized patients.	Proc Natl Acad Sci U S A
32943497	Longitudinal immune profiling reveals key myeloid signatures associated with COVID-19.	Sci Immunol
32943474	COVID-19 and the heart: what we have learnt so far.	Postgrad Med J
32943302	Identification of phytochemicals as potential therapeutic agents that binds to Nsp15 protein target of coronavirus (SARS-CoV-2) that are capable of inhibiting virus replication.	Phytomedicine
32943233	Endothelial injury and thrombotic microangiopathy in COVID-19: Treatment with the lectin-pathway inhibitor narsoplimab.	Immunobiology
32943188	"RNA-dependent RNA polymerase: Structure, mechanism, and drug discovery for COVID-19."	Biochem Biophys Res Commun
32942955	"Understanding the dynamics of COVID-19; implications for therapeutic intervention, vaccine development and movement control."	Br J Biomed Sci
32942748	SARS-CoV-2 Infection: A Role for S1P/S1P Receptor Signaling in the Nervous System?	Int J Mol Sci
32942671	Ivermectin as a Broad-Spectrum Host-Directed Antiviral: The Real Deal?	Cells
32942296	Potential inhibitors for the novel coronavirus (SARS-CoV-2).	Brief Bioinform
32942285	Receptor binding and priming of the spike protein of SARS-CoV-2 for membrane fusion.	Nature
32942152	Candesartan could ameliorate the COVID-19 cytokine storm.	Biomed Pharmacother
32942131	Induction of ketosis as a potential therapeutic option to limit hyperglycemia and prevent cytokine storm in COVID-19.	Nutrition
32941803	High Potency of a Bivalent Human VH Domain in SARS-CoV-2 Animal Models.	Cell
32941797	Shining Light on the COVID-19 Pandemic: A Vitamin D Receptor Checkpoint in Defense of Unregulated Wound Healing.	Cell Metab
32941788	SARS-CoV-2 ORF3b Is a Potent Interferon Antagonist Whose Activity Is Increased by a Naturally Occurring Elongation Variant.	Cell Rep
32941787	Human B Cell Clonal Expansion and Convergent Antibody Responses to SARS-CoV-2.	Cell Host Microbe
32941783	The inhibitory effect of a coronavirus spike protein fragment with ACE2.	Biophys J
32941612	Potential Pathogenicity Determinants Identified from Structural Proteomics of SARS-CoV and SARS-CoV-2.	Mol Biol Evol
32941419	Genetic grouping of SARS-CoV-2 coronavirus sequences using informative subtype markers for pandemic spread visualization.	PLoS Comput Biol
32941186	"Obesity, vitamin D deficiency and old age a serious combination with respect to coronavirus disease-2019 severity and outcome."	Curr Opin Clin Nutr Metab Care
32940950	Effects of Exercise on ACE2.	Obesity (Silver Spring)
32940922	Expression of ACE2 and TMPRSS2 Proteins in the Upper and Lower Aerodigestive Tracts of Rats: Implications on COVID 19 Infections.	Laryngoscope
32940906	Digging metagenomic data of pangolins revealed SARS-CoV-2 related viruses and other significant viruses.	J Med Virol
32940573	Molecular Basis of Pathogenesis of Coronaviruses: A Comparative Genomics Approach to Planetary Health to Prevent Zoonotic Outbreaks in the 21st Century.	OMICS
32940572	Short- and potential long-term adverse health outcomes of COVID-19: a rapid review.	Emerg Microbes Infect
32940201	Extrapulmonary Clinical Manifestations in COVID-19 Patients.	Am J Trop Med Hyg
32940187	Tocilizumab in SARS-CoV-2 Patients with the Syndrome of Cytokine Storm: A Narrative Review.	Rev Recent Clin Trials
32940180	The Use of Cyclodextrin or its Complexes as a Potential Treatment Against the 2019 Novel Coronavirus: A Mini-Review.	Curr Drug Deliv
32940134	A dynamic simulation study of FDA drug from zinc database against COVID-19 main protease receptor.	J Biomol Struct Dyn
32939952	Targeting RNA G-Quadruplex in SARS-CoV-2: A Promising Therapeutic Target for COVID-19?	Angew Chem Int Ed Engl
32939324	Immune responses during COVID-19 infection.	Oncoimmunology
32939273	Crystal structures of SARS-CoV-2 ADP-ribose phosphatase: from the apo form to ligand complexes.	IUCrJ
32939266	Thromboembolic disease in COVID-19 patients: A brief narrative review.	J Intensive Care
32939238	Hypothesis of COVID-19 Therapy with Sildenafil.	Int J Prev Med
32939236	Salivary extracellular vesicles inhibit Zika virus but not SARS-CoV-2 infection.	J Extracell Vesicles
32939188	CRISPR-Based Diagnosis of Infectious and Noninfectious Diseases.	Biol Proced Online
32938937	Structural models of human ACE2 variants with SARS-CoV-2 Spike protein for structure-based drug design.	Sci Data
32938911	Cryo-EM structure of coronavirus-HKU1 haemagglutinin esterase reveals architectural changes arising from prolonged circulation in humans.	Nat Commun
32938769	The Enzymatic Activity of the nsp14 Exoribonuclease Is Critical for Replication of MERS-CoV and SARS-CoV-2.	J Virol
32938761	Type I Interferon Susceptibility Distinguishes SARS-CoV-2 from SARS-CoV.	J Virol
32938758	"Relationships between hyperinsulinaemia, magnesium, vitamin D, thrombosis and COVID-19: rationale for clinical management."	Open Heart
32938731	COVID-19 and Diabetes: A Collision and Collusion of Two Diseases.	Diabetes
32938700	Competitive SARS-CoV-2 Serology Reveals Most Antibodies Targeting the Spike Receptor-Binding Domain Compete for ACE2 Binding.	mSphere
32938504	Reverse vaccinology assisted designing of multiepitope-based subunit vaccine against SARS-CoV-2.	Infect Dis Poverty
32938313	In silico investigation of spice molecules as potent inhibitor of SARS-CoV-2.	J Biomol Struct Dyn
32938299	Platelets Can Associate with SARS-Cov-2 RNA and Are Hyperactivated in COVID-19.	Circ Res
32937949	Neurological Complications of COVID-19 and Possible Neuroinvasion Pathways: A Systematic Review.	Int J Environ Res Public Health
32937868	Spatio-Temporal Mutational Profile Appearances of Swedish SARS-CoV-2 during the Early Pandemic.	Viruses
32937615	High levels of SARS-CoV-2-specific T cells with restricted functionality in severe courses of COVID-19.	JCI Insight
32937591	Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia.	Sci Adv
32937441	Emergence of SARS-CoV-2 through recombination and strong purifying selection.	Sci Adv
32937193	Quasi-species nature and differential gene expression of severe acute respiratory syndrome coronavirus 2 and phylogenetic analysis of a novel Iranian strain.	Infect Genet Evol
32937008	Randomized elimination and prolongation of ACE inhibitors and ARBs in coronavirus 2019 (REPLACE COVID) Trial Protocol.	J Clin Hypertens (Greenwich)
32936832	Most frequent South Asian haplotypes of ACE2 share identity by descent with East Eurasian populations.	PLoS One
32936826	Isolation and characterization of severe acute respiratory syndrome coronavirus 2 in Turkey.	PLoS One
32936732	Leveraging on the genomics and immunopathology of SARS-CoV-2 for vaccines development: prospects and challenges.	Hum Vaccin Immunother
32936693	Men and COVID-19: A Pathophysiologic Review.	Am J Mens Health
32936531	"SARS-CoV-2 multifaceted interaction with the human host. Part II: Innate immunity response, immunopathology, and epigenetics."	IUBMB Life
32936465	Research progress and challenges to coronavirus vaccine development.	J Med Virol
32936429	Gender susceptibility to COVID-19: a review of the putative role of sex hormones and X chromosome.	J Endocrinol Invest
32936048	Molecular basis of the potential interaction of SARS-CoV-2 spike protein to CD147 in COVID-19 associated-lymphopenia.	J Biomol Struct Dyn
32935928	Crosstalk between coronavirus disease 2019 and cardiovascular disease and its treatment.	ESC Heart Fail
32935873	Invited Review: The spectrum of neuropathology in COVID-19.	Neuropathol Appl Neurobiol
32935831	Identification of the RNase-binding site of SARS-CoV-2 RNA for anchor primer-PCR detection of viral loading in 306 COVID-19 patients.	Brief Bioinform
32935536	[Immunity against SARS-CoV-2: walking to the vaccination].	Rev Esp Quimioter
32935498	"Phylogeography of SARS-CoV-2 pandemic in Spain: a story of multiple introductions, micro-geographic stratification, founder effects, and super-spreaders."	Zool Res
32935333	T-cell responses and therapies against SARS-CoV-2 infection.	Immunology
32935064	Chloroquine to fight COVID-19: A consideration of mechanisms and adverse effects?	Heliyon
32934824	Molecular neuro-biological and systemic health benefits of achieving dopamine homeostasis in the face of a catastrophic pandemic (COVID- 19): A mechanistic exploration.	J Syst Integr Neurosci
32934806	Prediction of repurposed drugs for treating lung injury in COVID-19.	F1000Res
32934770	Structural Impact of Mutation D614G in SARS-CoV-2 Spike Protein: Enhanced Infectivity and Therapeutic Opportunity.	ACS Med Chem Lett
32934769	Striking Similarities between CDRs in Some mAbs That Neutralize COVID-19.	ACS Med Chem Lett
32934758	Tuberculosis and COVID-19: Lessons from the Past Viral Outbreaks and Possible Future Outcomes.	Can Respir J
32934757	Expression of ACE2 and a viral virulence-regulating factor CCN family member 1 in human iPSC-derived neural cells: implications for COVID-19-related CNS disorders.	Inflamm Regen
32934084	A Potent Postentry Restriction to Primate Lentiviruses in a Yinpterochiropteran Bat.	mBio
32933536	Pathophysiology and treatment strategies for COVID-19.	J Transl Med
32933522	Correlation of the two most frequent HLA haplotypes in the Italian population to the differential regional incidence of Covid-19.	J Transl Med
32933378	Targeting SARS-CoV-2 Nsp12/Nsp8 interaction interface with approved and investigational drugs: an in silico structure-based approach.	J Biomol Struct Dyn
32933166	"Host Synthesized Carbohydrate Antigens on Viral Glycoproteins as ""Achilles' Heel"" of Viruses Contributing to Anti-Viral Immune Protection."	Int J Mol Sci
32933150	"Coronavirus Infections in Companion Animals: Virology, Epidemiology, Clinical and Pathologic Features."	Viruses
32933047	Why COVID-19 Transmission Is More Efficient and Aggressive Than Viral Transmission in Previous Coronavirus Epidemics?	Biomolecules
32933031	"Neutrophil Extracellular Traps and By-Products Play a Key Role in COVID-19: Pathogenesis, Risk Factors, and Therapy."	J Clin Med
32932954	COVID-19 and Thyroid: Progress and Prospects.	Int J Environ Res Public Health
32932571	[Progress in research of specific antibody dynamic characteristics in patients with COVID-19].	Zhonghua Liu Xing Bing Xue Za Zhi
32931783	"Curcumin, a traditional spice component, can hold the promise against COVID-19?"	Eur J Pharmacol
32931734	A Single-Dose Intranasal ChAd Vaccine Protects Upper and Lower Respiratory Tracts against SARS-CoV-2.	Cell
32931703	Sequence Characterization and Molecular Modeling of Clinically Relevant Variants of the SARS-CoV-2 Main Protease.	Biochemistry
32931622	COVID-19 and hepatic involvement: The liver as a main actor of the pandemic novel.	Scand J Immunol
32931441	"CoV-Seq, a New Tool for SARS-CoV-2 Genome Analysis and Visualization: Development and Usability Study."	J Med Internet Res
32931291	Generation of SARS-CoV-2 S1 Spike Glycoprotein Putative Antigenic Epitopes in Vitro by Intracellular Aminopeptidases.	J Proteome Res
32931058	The younger the milder clinical course of COVID-19: Even in newborns?	Pediatr Allergy Immunol
32930523	Pharmacological hypothesis: TPC2 antagonist tetrandrine as a potential therapeutic agent for COVID-19.	Pharmacol Res Perspect
32930481	Structure-Activity Relationships of Benzamides and Isoindolines Designed as SARS-CoV Protease Inhibitors Effective against SARS-CoV-2.	ChemMedChem
32930458	Regulatory CD4(+) and CD8(+) T cells are negatively correlated with CD4(+) /CD8(+) T cell ratios in patients acutely infected with SARS-CoV-2.	J Leukoc Biol
32930456	"Cytokine release syndrome in COVID-19: Innate immune, vascular, and platelet pathogenic factors differ in severity of disease and sex."	J Leukoc Biol
32930394	Pathological post-mortem findings in lungs infected with SARS-CoV-2.	J Pathol
32930095	Obesity and diabetes as comorbidities for COVID-19: Underlying mechanisms and the role of viral-bacterial interactions.	Elife
32930058	Naltrexone a potential therapeutic candidate for COVID-19.	J Biomol Struct Dyn
32930052	SARS-CoV-2 neutralizing antibody responses are more robust in patients with severe disease.	Emerg Microbes Infect
32929876	The Longitudinal Immune Response to Coronavirus Disease 2019: Chasing the Cytokine Storm.	Arthritis Rheumatol
32929412	A systematic review on COVID-19 pandemic with special emphasis on curative potentials of Nigeria based medicinal plants.	Heliyon
32929317	What are the drugs having potential against COVID-19?	Med Chem Res
32929302	The New Coronavirus COVID-19 Infection.	Mol Gen Microbiol Virol
32929291	Structural dynamics of COVID-19 main protease.	J Mol Struct
32929268	Seasonal coronavirus protective immunity is short-lasting.	Nat Med
32929138	Analysis of the SARS-CoV-2 spike protein glycan shield reveals implications for immune recognition.	Sci Rep
32929007	Microglia depletion exacerbates demyelination and impairs remyelination in a neurotropic coronavirus infection.	Proc Natl Acad Sci U S A
32929000	"RNA Drugs and RNA Targets for Small Molecules: Principles, Progress, and Challenges."	Pharmacol Rev
32928903	Gastrointestinal implications in COVID-19.	J Investig Med
32928868	Currently prescribed drugs in the UK that could upregulate or downregulate ACE2 in COVID-19 disease: a systematic review.	BMJ Open
32928234	Characterization of codon usage pattern in SARS-CoV-2.	Virol J
32928086	In silico modeling of small molecule carboxamides as inhibitors of SARS-CoV 3CL protease: An approach towards combating COVID-19.	Comb Chem High Throughput Screen
32927621	Mass Spectrometry and Structural Biology Techniques in the Studies on the Coronavirus-Receptor Interaction.	Molecules
32927129	"Is oseltamivir suitable for fighting against COVID-19: In silico assessment, in vitro and retrospective study."	Bioorg Chem
32927009	Molecular phylogeny and missense mutations at envelope proteins across coronaviruses.	Genomics
32926931	Subclinical elevated B-type Natriuretic Peptide (BNP) indicates endothelial dysfunction contributing to hypoxia susceptibility in healthy individuals.	Life Sci
32926920	New insights on possible vaccine development against SARS-CoV-2.	Life Sci
32926918	COVID-19 associated complications and potential therapeutic targets.	Eur J Pharmacol
32926917	Should ACE2 be given a chance in COVID-19 therapeutics: A semi-systematic review of strategies enhancing ACE2.	Eur J Pharmacol
32926779	Supramolecular Mechanism of Viral Envelope Disruption by Molecular Tweezers.	J Am Chem Soc
32926453	"Methotrexate inhibits SARS-CoV-2 virus replication ""in vitro""."	J Med Virol
32926425	Th17 and Treg cells function in SARS-CoV2 patients compared with healthy controls.	J Cell Physiol
32926272	Impact of COVID-19 on the Cardiovascular System: A Review of Available Reports.	Cardiovasc Drugs Ther
32926254	"Synthesis of 3,3'-methylenebis(4-hydroxyquinolin-2(1H)-ones) of prospective anti-COVID-19 drugs."	Mol Divers
32926098	SARS-CoV-2-triggered neutrophil extracellular traps mediate COVID-19 pathology.	J Exp Med
32926097	"Neutrophil extracellular traps infiltrate the lung airway, interstitial, and vascular compartments in severe COVID-19."	J Exp Med
32925166	Complement and coagulation: key triggers of COVID-19-induced multiorgan pathology.	J Clin Invest
32924827	Potential protease inhibitors and their combinations to block SARS-CoV-2.	J Biomol Struct Dyn
32924825	Computational insight of dexamethasone against potential targets of SARS-CoV-2.	J Biomol Struct Dyn
32924567	COVID-19 Infection: Viral Macro- and Micro-Vascular Coagulopathy and Thromboembolism/Prophylactic and Therapeutic Management.	J Cardiovasc Pharmacol Ther
32924089	Kawasaki Disease: an Update.	Curr Rheumatol Rep
32924062	Origin-independent analysis links SARS-CoV-2 local genomes with COVID-19 incidence and mortality.	Brief Bioinform
32923747	Potential role of ACE2-related microRNAs in COVID-19-associated nephropathy.	Noncoding RNA Res
32923731	An immunoinformatics study on the spike protein of SARS-CoV-2 revealing potential epitopes as vaccine candidates.	Heliyon
32923679	"C-C chemokine receptor type 5 links COVID-19, rheumatoid arthritis, and Hydroxychloroquine: in silico analysis."	Transl Med Commun
32923657	Cannabidiol Modulates Cytokine Storm in Acute Respiratory Distress Syndrome Induced by Simulated Viral Infection Using Synthetic RNA.	Cannabis Cannabinoid Res
32923629	Viruses harness YxxO motif to interact with host AP2M1 for replication: A vulnerable broad-spectrum antiviral target.	Sci Adv
32923381	Geometric architecture of viruses.	World J Virol
32923158	Repurposing CD8(+) T cell immunity against SARS-CoV-2 for cancer immunotherapy: a positive aspect of the COVID-19 pandemic?	Oncoimmunology
32923004	Potential treatment with Chinese and Western medicine targeting NSP14 of SARS-CoV-2.	J Pharm Anal
32922804	Preliminary report of in vitro and in vivo effectiveness of dornase alfa on SARS-CoV-2 infection.	New Microbes New Infect
32922564	Coronavirus: a shift in focus away from IFN response and towards other inflammatory targets.	J Cell Commun Signal
32922517	Dexamethasone in the era of COVID-19: friend or foe? An essay on the effects of dexamethasone and the potential risks of its inadvertent use in patients with diabetes.	Diabetol Metab Syndr
32922406	"The Comparative Immunological Characteristics of SARS-CoV, MERS-CoV, and SARS-CoV-2 Coronavirus Infections."	Front Immunol
32922301	Pathways in the Pathophysiology of Coronavirus 19 Lung Disease Accessible to Prevention and Treatment.	Front Physiol
32922297	COVID-19 Usurps Host Regulatory Networks.	Front Pharmacol
32922174	COVID-19: Rational discovery of the therapeutic potential of Melatonin as a SARS-CoV-2 main Protease Inhibitor.	Int J Med Sci
32921981	A Review on Novel Drug Targets and Future Directions for COVID-19 Treatment.	Biologics
32921830	Rheumatological aspects of pathogenesis and treatment of COVID-19 infection.	Reumatologia
32921819	The Challenges of Vaccine Development against Betacoronaviruses: Antibody Dependent Enhancement and Sendai Virus as a Possible Vaccine Vector.	Mol Biol
32921750	"Iron overload and Hepcidin overexpression could play a key role in COVID infection, and may explain vulnerability in elderly, diabetics, and obese patients."	Acta Biomed
32921745	Novel Coronavirus (SARS-CoV-2) resistance in African populations: A cause worth exploring.	Acta Biomed
32921729	Sars-CoV-2 infection in patients with cystic fibrosis. An overview.	Acta Biomed
32921728	"The ""perfect"" storm: Current evidence on pediatric inflammatory multisystem disease during SARS-CoV-2 pandemic."	Acta Biomed
32921726	"Coronavirus infections in children: from SARS and MERS to COVID-19, a narrative review of epidemiological and clinical features."	Acta Biomed
32921715	Cardiovascular system is at higher risk of affecting by COVID-19.	Acta Biomed
32921517	Beyond Infection: Integrating Competence into Reservoir Host Prediction.	Trends Ecol Evol
32921279	Highly conserved binding region of ACE2 as a receptor for SARS-CoV-2 between humans and mammals.	Vet Q
32921216	"COVID-19 and cardiac injury: clinical manifestations, biomarkers, mechanisms, diagnosis, treatment, and follow up."	Expert Rev Anti Infect Ther
32920757	Role of melatonin in the treatment of COVID-19; as an adjuvant through cluster differentiation 147 (CD147).	Mol Biol Rep
32920756	Intussusceptive angiogenesis in Covid-19: hypothesis on the significance and focus on the possible role of FGF2.	Mol Biol Rep
32920752	COVID-19 and its Therapeutics: Special Emphasis on Mesenchymal Stem Cells Based Therapy.	Stem Cell Rev Rep
32920514	The role of Interleukin 6 inhibitors in therapy of severe COVID-19.	Biomed Pharmacother
32920511	Can a metabolism-targeted therapeutic intervention successfully subjugate SARS-COV-2? A scientific rational.	Biomed Pharmacother
32920291	Chloroquine and hydroxychloroquine as ACE2 blockers to inhibit viropexis of 2019-nCoV Spike pseudotyped virus.	Phytomedicine
32920239	"Targeting the SARS-CoV-2 main protease using FDA-approved Isavuconazonium, a P2-P3 alpha-ketoamide derivative and Pentagastrin: An in-silico drug discovery approach."	J Mol Graph Model
32920235	Covid-19 hyperinflammation and post-Covid-19 illness may be rooted in mast cell activation syndrome.	Int J Infect Dis
32920233	Antibody-dependent enhancement of coronavirus.	Int J Infect Dis
32920210	On the genetics and immunopathogenesis of COVID-19.	Clin Immunol
32920170	May omega-3 fatty acid dietary supplementation help reduce severe complications in Covid-19 patients?	Biochimie
32920121	SARS-CoV-2 transcriptome analysis and molecular cataloguing of immunodominant epitopes for multi-epitope based vaccine design.	Genomics
32920092	Characterization of the cytokine storm reflects hyperinflammatory endothelial dysfunction in COVID-19.	J Allergy Clin Immunol
32920049	Anti-Frameshifting Ligand Active against SARS Coronavirus-2 Is Resistant to Natural Mutations of the Frameshift-Stimulatory Pseudoknot.	J Mol Biol
32920000	Safety assessment of drug combinations used in COVID-19 treatment: in silico toxicogenomic data-mining approach.	Toxicol Appl Pharmacol
32919977	Immunopathology of Hyperinflammation in COVID-19.	Am J Pathol
32919938	Macrophage responses associated with COVID-19: A pharmacological perspective.	Eur J Pharmacol
32919067	A graph-based approach identifies dynamic H-bond communication networks in spike protein S of SARS-CoV-2.	J Struct Biol
32918944	SARS-CoV-2 host tropism: An in silico analysis of the main cellular factors.	Virus Res
32918943	The role of host genetics in susceptibility to severe viral infections in humans and insights into host genetics of severe COVID-19: A systematic review.	Virus Res
32918855	"SARS-CoV-2 multifaceted interaction with human host. Part I: What we have learnt and done so far, and the still unknown realities."	IUBMB Life
32918747	Ultrastructure of cell trafficking pathways and coronavirus: how to recognise the wolf amongst the sheep.	J Pathol
32918656	Lopinavir-Ritonavir in SARS-CoV-2 Infection and Drug-Drug Interactions with Cardioactive Medications.	Cardiovasc Drugs Ther
32918567	"The coagulopathy, endotheliopathy, and vasculitis of COVID-19."	Inflamm Res
32918506	Vitamin D binding protein polymorphism and COVID-19.	J Med Virol
32918236	An online repository of solvation thermodynamic and structural maps of SARS-CoV-2 targets.	J Comput Aided Mol Des
32918209	Mortality and Disease Severity Among COVID-19 Patients Receiving Renin-Angiotensin System Inhibitors: A Systematic Review and Meta-analysis.	Am J Cardiovasc Drugs
32918208	Potential Therapeutic Roles for Direct Factor Xa Inhibitors in Coronavirus Infections.	Am J Cardiovasc Drugs
32917884	Molecular interaction and inhibition of SARS-CoV-2 binding to the ACE2 receptor.	Nat Commun
32917722	Sphingosine prevents binding of SARS-CoV-2 spike to its cellular receptor ACE2.	J Biol Chem
32917717	Molecular characterization of ebselen binding activity to SARS-CoV-2 main protease.	Sci Adv
32917504	"Overexpression of the Severe Acute Respiratory Syndrome Coronavirus-2 Receptor, Angiotensin-Converting Enzyme 2, in Diabetic Kidney Disease: Implications for Kidney Injury in Novel Coronavirus Disease 2019."	Can J Diabetes
32917283	Analysis of ACE2 genetic variants in 131 Italian SARS-CoV-2-positive patients.	Hum Genomics
32917282	"Genetic variants of the human host influencing the coronavirus-associated phenotypes (SARS, MERS and COVID-19): rapid systematic review and field synopsis."	Hum Genomics
32916958	Coronavirus Antiviral Research Database (CoV-RDB): An Online Database Designed to Facilitate Comparisons between Candidate Anti-Coronavirus Compounds.	Viruses
32916925	Factors Associated with Increased Morbidity and Mortality of Obese and Overweight COVID-19 Patients.	Biology (Basel)
32916821	Smoking and COVID-19: Adding Fuel to the Flame.	Int J Mol Sci
32916812	Immune Response to COVID-19: Can We Benefit from the SARS-CoV and MERS-CoV Pandemic Experience?	Pathogens
32916568	Advances in understanding the initiation of HIV-1 reverse transcription.	Curr Opin Struct Biol
32916377	"Silico analysis of interaction between full-length SARS-CoV2 S protein with human Ace2 receptor: Modelling, docking, MD simulation."	Biophys Chem
32916371	"Venous thrombosis epidemiology, pathophysiology, and anticoagulant therapies and trials in severe acute respiratory syndrome coronavirus 2 infection."	J Vasc Surg Venous Lymphat Disord
32916311	Bioactive pyrrole-based compounds with target selectivity.	Eur J Med Chem
32916258	Identification of angiotensin-converting enzyme 2 (ACE2) protein as the potential biomarker in SARS-CoV-2 infection-related lung cancer using computational analyses.	Genomics
32916246	Immune response in COVID-19: What do we currently know?	Microb Pathog
32916218	"Cardiac arrest and drug-related cardiac toxicity in the Covid-19 era. Epidemiology, pathophysiology and management."	Food Chem Toxicol
32916095	Estimating the Binding of Sars-CoV-2 Peptides to HLA Class I in Human Subpopulations Using Artificial Neural Networks.	Cell Syst
32915959	Intestinal Receptor of SARS-CoV-2 in Inflamed IBD Tissue Seems Downregulated by HNF4A in Ileum and Upregulated by Interferon Regulating Factors in Colon.	J Crohns Colitis
32915650	A Systematic Review of the Neuropathologic Findings of Post-Viral Olfactory Dysfunction: Implications and Novel Insight for the COVID-19 Pandemic.	Am J Rhinol Allergy
32915649	Potential mechanism underlying the effect of matrine on COVID-19 patients revealed through network pharmacological approaches and molecular docking analysis.	Arch Physiol Biochem
32915505	Structural Characterization of N-Linked Glycans in the Receptor Binding Domain of the SARS-CoV-2 Spike Protein and their Interactions with Human Lectins.	Angew Chem Int Ed Engl
32915473	Gold Metallodrugs to Target Coronavirus Proteins: Inhibitory Effects on the Spike-ACE2 Interaction and on PLpro Protease Activity by Auranofin and Gold Organometallics*.	Chemistry
32915100	Coronavirus disease 2019 (COVID-19) in domestic animals and wildlife: advances and prospects in the development of animal models for vaccine and therapeutic research.	Hum Vaccin Immunother
32914699	Anosmia in COVID-19: Underlying Mechanisms and Assessment of an Olfactory Route to Brain Infection.	Neuroscientist
32914690	Synthesis of exfoliated multilayer graphene and its putative interactions with SARS-CoV-2 virus investigated through computational studies.	J Biomol Struct Dyn
32914674	Can intravenous oxytocin infusion counteract hyperinflammation in COVID-19 infected patients?	World J Biol Psychiatry
32914439	Structures of the SARS-CoV-2 nucleocapsid and their perspectives for drug design.	EMBO J
32914167	Comparative host-pathogen protein-protein interaction analysis of recent coronavirus outbreaks and important host targets identification.	Brief Bioinform
32913847	Liver in the limelight in the corona (COVID-19) time.	World J Clin Cases
32913581	"Unlocking COVID therapeutic targets: A structure-based rationale against SARS-CoV-2, SARS-CoV and MERS-CoV Spike."	Comput Struct Biotechnol J
32913364	"A comprehensive, longitudinal analysis of humoral responses specific to four recombinant antigens of SARS-CoV-2 in severe and non-severe COVID-19 patients."	PLoS Pathog
32913304	Single-cell transcriptomic atlas of primate cardiopulmonary aging.	Cell Res
32913273	Humanized single domain antibodies neutralize SARS-CoV-2 by targeting the spike receptor binding domain.	Nat Commun
32913137	Heparin-binding Peptides as Novel Therapies to Stop SARS-CoV-2 Cellular Entry and Infection.	Mol Pharmacol
32913053	Suboptimal SARS-CoV-2-specific CD8(+) T cell response associated with the prominent HLA-A*02:01 phenotype.	Proc Natl Acad Sci U S A
32913009	"Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2."	mBio
32913008	Vimentin as a target for the treatment of COVID-19.	BMJ Open Respir Res
32912711	COVID-19 and diabetes; Possible role of polymorphism and rise of telemedicine.	Prim Care Diabetes
32912355	Vitamin D deficiency in schizophrenia implications for COVID-19 infection.	Ir J Psychol Med
32912226	The potential role of microvascular pathology in the neurological manifestations of coronavirus infection.	Fluids Barriers CNS
32912123	Emerging Novel Coronavirus is a Global Threat: Insight in the Biology of COVID-19 and its Hijacking Process of Hosts' Cell.	Curr Pharm Des
32911874	Infection of Brain Organoids and 2D Cortical Neurons with SARS-CoV-2 Pseudovirus.	Viruses
32911757	Polyphenols vs. Coronaviruses: How Far Has Research Moved Forward?	Molecules
32911691	Dendritic Cells and SARS-CoV-2 Infection: Still an Unclarified Connection.	Cells
32911560	COVID-19 and Sodium-Glucose Cotransporter 2 Inhibitors: No Fear to Attempt?	Exp Clin Endocrinol Diabetes
32911432	Site mapping and small molecule blind docking reveal a possible target site on the SARS-CoV-2 main protease dimer interface.	Comput Biol Chem
32910955	Structural-based virtual screening and in vitro assays for small molecules inhibiting the feline coronavirus 3CL protease as a surrogate platform for coronaviruses.	Antiviral Res
32910820	Immune asynchrony in COVID-19 pathogenesis and potential immunotherapies.	J Exp Med
32910704	New normal: two aspects of adipose tissue in COVID-19-treat and threat?	Expert Opin Biol Ther
32910469	Expansion of plasmablasts and loss of memory B cells in peripheral blood from COVID-19 patients with pneumonia.	Eur J Immunol
32910461	The dynamics of immune response in COVID-19 patients with different illness severity.	J Med Virol
32910458	Apoptosis and immunophenotyping of peripheral blood lymphocytes in Iranian COVID-19 patients: Clinical and laboratory characteristics.	J Med Virol
32910347	Comparative Antiviral Efficacy of Viral Protease Inhibitors against the Novel SARS-CoV-2 In Vitro.	Virol Sin
32910274	Renin-Angiotensin System Inhibitors and COVID-19: a Systematic Review and Meta-Analysis. Evidence for Significant Geographical Disparities.	Curr Hypertens Rep
32909961	"Clinical course and risk factors for recurrence of positive SARS-CoV-2 RNA: a retrospective cohort study from Wuhan, China."	Aging (Albany NY)
32909925	Exploring structural dynamics of the MERS-CoV receptor DPP4 and mutant DPP4 receptors.	J Biomol Struct Dyn
32909898	The Role of Phosphodiesterase-5 Inhibitors in COVID-19: An Exploration of Literature From Similar Pathologies.	J Intensive Care Med
32909703	Could Mustelids spur COVID-19 into a panzootic?	Vet Ital
32909528	Virtual screening of approved clinic drugs with main protease (3CL(pro)) reveals potential inhibitory effects on SARS-CoV-2.	J Biomol Struct Dyn
32909060	Anosmia: an evolution of our understanding of its importance in COVID-19 and what questions remain to be answered.	Eur Arch Otorhinolaryngol
32908574	A Model for SARS-CoV-2 Infection with Treatment.	Comput Math Methods Med
32908316	SARS-CoV-2 Nsp1 binds the ribosomal mRNA channel to inhibit translation.	Nat Struct Mol Biol
32908214	Antibody-dependent enhancement and SARS-CoV-2 vaccines and therapies.	Nat Microbiol
32908073	Management of Atrial Fibrillation in COVID-19 Pandemic.	Circ J
32908071	Association of ACE2 receptor and ACEIs/ARBs with disease severity in COVID-19.	Drug Discov Ther
32907861	De novo design of picomolar SARS-CoV-2 miniprotein inhibitors.	Science
32907757	Amplifying immunogenicity of prospective Covid-19 vaccines by glycoengineering the coronavirus glycan-shield to present alpha-gal epitopes.	Vaccine
32907637	COVID-19: an update and cardiac involvement.	J Cardiothorac Surg
32907596	"In vitro virucidal activity of Echinaforce(R), an Echinacea purpurea preparation, against coronaviruses, including common cold coronavirus 229E and SARS-CoV-2."	Virol J
32907512	SARS-CoV M(pro) inhibitory activity of aromatic disulfide compounds: QSAR model.	J Biomol Struct Dyn
32907334	Repurposing of FDA-Approved Toremifene to Treat COVID-19 by Blocking the Spike Glycoprotein and NSP14 of SARS-CoV-2.	J Proteome Res
32906733	The New Coronavirus (SARS-CoV-2): A Comprehensive Review on Immunity and the Application of Bioinformatics and Molecular Modeling to the Discovery of Potential Anti-SARS-CoV-2 Agents.	Molecules
32906143	The coding capacity of SARS-CoV-2.	Nature
32905897	"Understanding COVID-19: A hypothesis regarding digit ratio (2D:4D), ACE I/D polymorphism, oxygen metabolism and national case fatality rates."	Early Hum Dev
32905851	SARS-CoV-2 infections in children and young people.	Clin Immunol
32905794	"The inorganic polymer, polyphosphate, blocks binding of SARS-CoV-2 spike protein to ACE2 receptor at physiological concentrations."	Biochem Pharmacol
32905698	Sapphire-Based Clustering.	J Chem Theory Comput
32905655	"Susceptibility to COVID-19 in populations with health disparities: Posited involvement of mitochondrial disorder, socioeconomic stress, and pollutants."	J Biochem Mol Toxicol
32905551	The Association of Renin-Angiotensin-Aldosterone System Inhibitors With Outcomes Among a Predominantly Ethnic Minority Patient Population Hospitalized With COVID-19: The Bronx Experience.	Cureus
32905500	Effect of COVID-19 on the Organs.	Cureus
32905393	Structural basis of SARS-CoV-2 main protease inhibition by a broad-spectrum anti-coronaviral drug.	Am J Cancer Res
32905208	Hypoxia response and acute lung and kidney injury: possible implications for therapy of COVID-19.	Clin Kidney J
32905186	A brief outline of respiratory viral disease outbreaks: 1889-till date on the public health perspectives.	Virusdisease
32905022	The SARS-CoV-2 host cell receptor ACE2 correlates positively with immunotherapy response and is a potential protective factor for cancer progression.	Comput Struct Biotechnol J
32905015	Current approaches used in treating COVID-19 from a molecular mechanisms and immune response perspective.	Saudi Pharm J
32904969	"COVID-19 associated atrial fibrillation: Incidence, putative mechanisms and potential clinical implications."	Int J Cardiol Heart Vasc
32904944	"Vitamin D and immune regulation: antibacterial, antiviral, anti-inflammatory."	JBMR Plus
32904892	Bone Metabolism in SARS-CoV-2 Disease: Possible Osteoimmunology and Gender Implications.	Clin Rev Bone Miner Metab
32904785	"Integrate structural analysis, isoform diversity, and interferon-inductive propensity of ACE2 to predict SARS-CoV2 susceptibility in vertebrates."	Heliyon
32904757	Potential Applications of Microfluidics to Acute Kidney Injury Associated with Viral Infection.	Cell Mol Bioeng
32904707	Nanomedicine strategies to target coronavirus.	Nano Today
32904687	Temporal Detection and Phylogenetic Assessment of SARS-CoV-2 in Municipal Wastewater.	Cell Rep Med
32904625	Exploration of inhibitory action of Azo imidazole derivatives against COVID-19 main protease (M(pro)): A computational study.	J Mol Struct
32904601	Mass Spectrometry Analysis of Newly Emerging Coronavirus HCoV-19 Spike Protein and Human ACE2 Reveals Camouflaging Glycans and Unique Post-Translational Modifications.	Engineering (Beijing)
32904587	Extracellular Vesicle-Related Thrombosis in Viral Infection.	Int J Gen Med
32904468	"Robust T Cell Response Toward Spike, Membrane, and Nucleocapsid SARS-CoV-2 Proteins Is Not Associated with Recovery in Critical COVID-19 Patients."	Cell Rep Med
32904401	BioAider: An efficient tool for viral genome analysis and its application in tracing SARS-CoV-2 transmission.	Sustain Cities Soc
32903864	Preliminary Exploration of the Cause of Liver Disorders During Early Stages in COVID-19 Patients.	Front Med (Lausanne)
32903561	ACE2 Expression in the Cat and the Tiger Gastrointestinal Tracts.	Front Vet Sci
32903492	Pulmonary and Extra-Pulmonary Clinical Manifestations of COVID-19.	Front Med (Lausanne)
32903391	Neurological Manifestations of Severe SARS-CoV-2 Infection: Potential Mechanisms and Implications of Individualized Mechanical Ventilation Settings.	Front Neurol
32903321	Localization of Cell Receptor-Related Genes of SARS-CoV-2 in the Kidney through Single-Cell Transcriptome Analysis.	Kidney Dis (Basel)
32903279	Can data from paediatric cohorts solve the COVID-19 puzzle?	PLoS Pathog
32903266	Identification of immunodominant linear epitopes from SARS-CoV-2 patient plasma.	PLoS One
32903131	Systematic review of the antiviral properties of TRIM56: a potential therapeutic intervention for COVID-19.	Expert Rev Clin Immunol
32903111	Immune response and blood-brain barrier dysfunction during viral neuroinvasion.	Innate Immun
32903043	Human coronaviruses 229E and OC43 replicate and induce distinct antiviral responses in differentiated primary human bronchial epithelial cells.	Am J Physiol Lung Cell Mol Physiol
32903031	Heterogeneous groups of alveolar type II cells in lung homeostasis and repair.	Am J Physiol Cell Physiol
32902889	The emerging SARS-CoV-2 papain-like protease: Its relationship with recent coronavirus epidemics.	J Med Virol
32902818	A geroscience perspective on immune resilience and infectious diseases: a potential case for metformin.	Geroscience
32902374	Analysis of partial sequences of the RNA-dependent RNA polymerase gene as a tool for genus and subgenus classification of coronaviruses.	J Gen Virol
32902372	Predicting the recombination potential of severe acute respiratory syndrome coronavirus 2 and Middle East respiratory syndrome coronavirus.	J Gen Virol
32902367	Acute respiratory distress syndrome (ARDS) caused by the novel coronavirus disease (COVID-19): a practical comprehensive literature review.	Expert Rev Respir Med
32902005	Glycyrrhizin: An old weapon against a novel coronavirus.	Phytother Res
32901940	ACE2: Its potential role and regulation in severe acute respiratory syndrome and COVID-19.	J Cell Physiol
32901936	Targeted therapy strategies against SARS-CoV-2 cell entry mechanisms: A systematic review of in vitro and in vivo studies.	J Cell Physiol
32901762	SARS-CoV-2 infections with emphasis on pediatric patients: a narrative review.	Rev Inst Med Trop Sao Paulo
32901615	Coagulation disorders in SARS-CoV-2 infection.	Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub
32901582	Fusion Protein Targeted Antiviral Peptides: Fragment-Based Drug Design (FBDD) Guided Rational Design of Dipeptides Against SARS-CoV-2.	Curr Protein Pept Sci
32901577	"Ribonucleocapsid assembly/packaging signals in the genomes of the coronaviruses SARS-CoV and SARS-CoV-2: detection, comparison and implications for therapeutic targeting."	J Biomol Struct Dyn
32901559	In search of a vaccine against COVID-19: implications for nursing practice.	Br J Nurs
32901433	Ethnic Prevalence of Angiotensin-Converting Enzyme Deletion (D) Polymorphism and COVID-19 Risk: Rationale for Use of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers.	J Racial Ethn Health Disparities
32901413	A Review on the Serum Electrolytes and Trace Elements Role in the Pathophysiology of COVID-19.	Biol Trace Elem Res
32901204	Analyzing COVID-19 virus based on enhanced fragmented biological Local Aligner using improved Ions Motion Optimization algorithm.	Appl Soft Comput
32901196	"SARS-CoV-2 in environmental perspective: Occurrence, persistence, surveillance, inactivation and challenges."	Chem Eng J
32901177	[COVID-19 infection-update].	Gefasschirurgie
32900822	Disruption of Adaptive Immunity Enhances Disease in SARS-CoV-2-Infected Syrian Hamsters.	J Virol
32900008	COVID-19 and Kidney Injury.	R I Med J (2013)
32899833	Cardiovascular Damage in COVID-19: Therapeutic Approaches Targeting the Renin-Angiotensin-Aldosterone System.	Int J Mol Sci
32899480	Attenuated Influenza Virions Expressing the SARS-CoV-2 Receptor-Binding Domain Induce Neutralizing Antibodies in Mice.	Viruses
32899439	Genetic Hypothesis and Pharmacogenetics Side of Renin-Angiotensin-System in COVID-19.	Genes (Basel)
32899381	"State of the Art Review of Cell Therapy in the Treatment of Lung Disease, and the Potential for Aerosol Delivery."	Int J Mol Sci
32899231	The HMOX1 Pathway as a Promising Target for the Treatment and Prevention of SARS-CoV-2 of 2019 (COVID-19).	Int J Mol Sci
32899010	The relationship between hyperglycemia and the infection of COVID-19 in diabetic patients: A protocol for systematic review and meta-analysis.	Medicine (Baltimore)
32898764	A new generation of vaccines based on alphavirus self-amplifying RNA.	Curr Opin Virol
32898469	SARS-CoV-2 envelope protein topology in eukaryotic membranes.	Open Biol
32898238	Sustained Responses of Neutralizing Antibodies Against Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Recovered Patients and Their Therapeutic Applicability.	Clin Infect Dis
32898168	"In vivo antiviral host transcriptional response to SARS-CoV-2 by viral load, sex, and age."	PLoS Biol
32897811	Infection as a Stroke Risk Factor and Determinant of Outcome After Stroke.	Stroke
32897518	Effects of Antimalarial Drugs on Neuroinflammation-Potential Use for Treatment of COVID-19-Related Neurologic Complications.	Mol Neurobiol
32897211	[Mechanism of Qingfei Paidu decoction for treatment of COVID-19: analysis based on network pharmacology and molecular docking technology].	Nan Fang Yi Ke Da Xue Xue Bao
32897178	"Molecular docking, validation, dynamics simulations, and pharmacokinetic prediction of natural compounds against the SARS-CoV-2 main-protease."	J Biomol Struct Dyn
32897177	SARS-CoV-2 spike produced in insect cells elicits high neutralization titres in non-human primates.	Emerg Microbes Infect
32897173	Drug similarity and structure-based screening of medicinal compounds to target macrodomain-I from SARS-CoV-2 to rescue the host immune system: a molecular dynamics study.	J Biomol Struct Dyn
32897138	Screening of plant-based natural compounds as a potential COVID-19 main protease inhibitor: an in silico docking and molecular dynamics simulation approach.	J Biomol Struct Dyn
32897080	METATRYP v 2.0: Metaproteomic Least Common Ancestor Analysis for Taxonomic Inference Using Specialized Sequence Assemblies-Standalone Software and Web Servers for Marine Microorganisms and Coronaviruses.	J Proteome Res
32897023	[Influence of COVID-19 on male fertility. What is already known?]	Urologiia
32896576	"Virions and respiratory droplets in air: Diffusion, drift, and contact with the epithelium."	Biosystems
32896566	Evaluation of SARS-CoV-2 3C-like protease inhibitors using self-assembled monolayer desorption ionization mass spectrometry.	Antiviral Res
32896310	The role of IL-6 and other mediators in the cytokine storm associated with SARS-CoV-2 infection.	J Allergy Clin Immunol
32896226	"In-silico screening of plant-derived antivirals against main protease, 3CL(pro) and endoribonuclease, NSP15 proteins of SARS-CoV-2."	J Biomol Struct Dyn
32896192	Immunothrombosis and thromboinflammation in host defense and disease.	Platelets
32895985	Discordant anti-SARS-CoV-2 spike protein and RNA staining in cutaneous perniotic lesions suggests endothelial deposition of cleaved spike protein.	J Cutan Pathol
32895900	Mesenchymal Stromal Cells in Viral Infections: Implications for COVID-19.	Stem Cell Rev Rep
32895779	Coronavirus: a shift in focus away from IFN response and towards other inflammatory targets.	J Cell Commun Signal
32895643	Genomic characterization of SARS-CoV-2 identified in a reemerging COVID-19 outbreak in Beijing's Xinfadi market in 2020.	Biosaf Health
32895641	Integrative Network Biology Framework Elucidates Molecular Mechanisms of SARS-CoV-2 Pathogenesis.	iScience
32895640	COVID-19 and Multiple Sclerosis: Predisposition and Precautions in Treatment.	SN Compr Clin Med
32895623	Crystal structure of SARS-CoV-2 papain-like protease.	Acta Pharm Sin B
32895615	"Newly Emerging Human Coronaviruses: Animal Models and Vaccine Research for SARS, MERS, and COVID-19."	Immune Netw
32895447	Quantitative proteomic analysis of the tizoxanide effect in vero cells.	Sci Rep
32895172	[A systematic pharmacological investigation of pharmacologically active ingredients in Toujie Quwen granules for treatment of COVID-19].	Nan Fang Yi Ke Da Xue Xue Bao
32894672	Protective Role of Glutathione against Peroxynitrite-Mediated DNA Damage During Acute Inflammation.	Chem Res Toxicol
32894568	Three critical clinicobiological phases of the human SARS-associated coronavirus infections.	Eur Rev Med Pharmacol Sci
32893735	Robust neutralization assay based on SARS-CoV-2 S-protein-bearing vesicular stomatitis virus (VSV) pseudovirus and ACE2-overexpressing BHK21 cells.	Emerg Microbes Infect
32893632	In Silico Drug Repurposing for SARS-CoV-2 Main Proteinase and Spike Proteins.	J Proteome Res
32893565	[Investigation of modulating effect of Qingfei Paidu Decoction on host metabolism and gut microbiome in rats].	Zhongguo Zhong Yao Za Zhi
32893295	Where Did SARS-CoV-2 Come From?	Mol Biol Evol
32892755	"Obesity, COVID-19 and innate immunometabolism."	Br J Nutr
32892687	Platelets and renal failure in the SARS-CoV-2 syndrome.	Platelets
32892615	The vascular side of COVID-19 disease. Position paper of the International Union of Angiology.	Int Angiol
32892403	Oromucosal immunomodulation as clinical spectrum mitigating factor in SARS-CoV-2 infection.	Scand J Immunol
32891874	Improved binding of SARS-CoV-2 Envelope protein to tight junction-associated PALS1 could play a key role in COVID-19 pathogenesis.	Microbes Infect
32891697	Treatments in Covid-19 patients with pre-existing metabolic dysfunction-associated fatty liver disease: A potential threat for drug-induced liver injury?	Biochimie
32891636	MicroRNAs targeting the SARS-CoV-2 entry receptor ACE2 in cardiomyocytes.	J Mol Cell Cardiol
32890979	Quantitative phylogenomic evidence reveals a spatially structured SARS-CoV-2 diversity.	Virology
32890967	Propolis and its potential against SARS-CoV-2 infection mechanisms and COVID-19 disease: Running title: Propolis against SARS-CoV-2 infection and COVID-19.	Biomed Pharmacother
32890913	Phillyrin (KD-1) exerts anti-viral and anti-inflammatory activities against novel coronavirus (SARS-CoV-2) and human coronavirus 229E (HCoV-229E) by suppressing the nuclear factor kappa B (NF-kappaB) signaling pathway.	Phytomedicine
32890763	Evolutionary dynamics of the SARS-CoV-2 ORF8 accessory gene.	Infect Genet Evol
32890396	CoV3D: a database of high resolution coronavirus protein structures.	Nucleic Acids Res
32890338	Hypercoagulability and coronavirus disease 2019-associated hypoxemic respiratory failure: Mechanisms and emerging management paradigms.	J Trauma Acute Care Surg
32890309	"COVID-19 Associated Hypercoagulability: Manifestations, Mechanisms, and Management."	Shock
32889638	Coronaviruses and stress: from cellular to global.	Cell Stress Chaperones
32889094	Inferring the genetic variability in Indian SARS-CoV-2 genomes using consensus of multiple sequence alignment techniques.	Infect Genet Evol
32889088	Current state of vaccine development and targeted therapies for COVID-19: impact of basic science discoveries.	Cardiovasc Pathol
32889022	Peptides to combat viral infectious diseases.	Peptides
32888871	From SARS to COVID-19: What lessons have we learned?	J Infect Public Health
32888767	Conserved HLA binding peptides from five non-structural proteins of SARS-CoV-2-An in silico glance.	Hum Immunol
32888706	"SARS-CoV-2 in children: spectrum of disease, transmission and immunopathological underpinnings."	Pathology
32888287	Coronaviruses and Endocrine System: a Systematic Review on Evidences and Shadows.	Endocr Metab Immune Disord Drug Targets
32888278	"The Impetus of COVID -19 in Multiple Organ Affliction apart from Res-piratory Infection: Pathogenesis, Diagnostic Measures and Current Treatment Strategy."	Infect Disord Drug Targets
32888056	GC usage of SARS-CoV-2 genes might adapt to the environment of human lung expressed genes.	Mol Genet Genomics
32887977	Broad and strong memory CD4(+) and CD8(+) T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19.	Nat Immunol
32887884	Both Boceprevir and GC376 efficaciously inhibit SARS-CoV-2 by targeting its main protease.	Nat Commun
32887876	An alpaca nanobody neutralizes SARS-CoV-2 by blocking receptor interaction.	Nat Commun
32887790	Cell and animal models of SARS-CoV-2 pathogenesis and immunity.	Dis Model Mech
32887754	Antibody Responses to SARS-CoV-2: Let's Stick to Known Knowns.	J Immunol
32887735	An Early Pandemic Analysis of SARS-CoV-2 Population Structure and Dynamics in Arizona.	mBio
32887634	SARS-CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19.	J Hematol Oncol
32887532	Inhibitors of type II transmembrane serine proteases in the treatment of diseases of the respiratory tract - A review of patent literature.	Expert Opin Ther Pat
32887260	Rationale for the Use of Radiation-Activated Mesenchymal Stromal/Stem Cells in Acute Respiratory Distress Syndrome.	Cells
32886936	Direct or Collateral Liver Damage in SARS-CoV-2-Infected Patients.	Semin Liver Dis
32886840	Overcoming Symmetry Mismatch in Vaccine Nanoassembly through Spontaneous Amidation.	Angew Chem Int Ed Engl
32886791	Site-specific characterization of SARS-CoV-2 spike glycoprotein receptor-binding domain.	Glycobiology
32886755	Phenotypical and functional alteration of unconventional T cells in severe COVID-19 patients.	J Exp Med
32886331	"COVID-19 outbreak: history, mechanism, transmission, structural studies and therapeutics."	Infection
32886002	COVID-19 and hypertension: is the HSP60 culprit for the severe course and worse outcome?	Am J Physiol Heart Circ Physiol
32885971	The Answer Lies in the Energy: How Simple Atomistic Molecular Dynamics Simulations May Hold the Key to Epitope Prediction on the Fully Glycosylated SARS-CoV-2 Spike Protein.	J Phys Chem Lett
32885825	Specialized pro-resolving mediator network: an update on production and actions.	Essays Biochem
32885740	Identification of promising antiviral drug candidates against non-structural protein 15 (NSP15) from SARS-CoV-2: an in silico assisted drug-repurposing study.	J Biomol Struct Dyn
32885345	The potential similarities of COVID-19 and autoimmune disease pathogenesis and therapeutic options: new insights approach.	Clin Rheumatol
32885275	Molecular mechanisms involved in the positive effects of physical activity on coping with COVID-19.	Eur J Appl Physiol
32885147	A Pathophysiological Perspective on the SARS-CoV-2 Coagulopathy.	Hemasphere
32885037	COVID-19 and possible links with Parkinson's disease and parkinsonism: from bench to bedside.	NPJ Parkinsons Dis
32884871	COVID-19 and Hyperinflammatory Syndrome in Children: Kawasaki Disease with Macrophage Activation Syndrome in Disguise?	Cureus
32884218	COVID-19 pandemic: Pathophysiology and manifestations from the gastrointestinal tract.	World J Gastroenterol
32884216	Mutations in SARS-CoV-2 Leading to Antigenic Variations in Spike Protein: A Challenge in Vaccine Development.	J Lab Physicians
32884213	Predicted peptide patterns from the SARS-CoV-2 proteome for MS-MS based diagnosis.	Bioinformation
32884153	Ad26 vaccine protects against SARS-CoV-2 severe clinical disease in hamsters.	Nat Med
32883951	COVID-19-activated SREBP2 disturbs cholesterol biosynthesis and leads to cytokine storm.	Signal Transduct Target Ther
32883935	Genomic evolution of severe acute respiratory syndrome Coronavirus 2 in India and vaccine impact.	Indian J Med Microbiol
32883878	Reduced development of COVID-19 in children reveals molecular checkpoints gating pathogenesis illuminating potential therapeutics.	Proc Natl Acad Sci U S A
32883529	"Coronavirus 2019, Microthromboses, and Platelet Activating Factor."	Clin Ther
32883368	A protein interaction map identifies existing drugs targeting SARS-CoV-2.	BMC Pharmacol Toxicol
32883116	Future perspective: biologic agents in patients with severe COVID-19.	Immunopharmacol Immunotoxicol
32883081	A Chain Only as Strong as Its Weakest Link: An Up-to-Date Literature Review on the Bidirectional Interaction of Pulmonary Fibrosis and COVID-19.	J Proteome Res
32883010	Potential of Ocular Transmission of SARS-CoV-2: A Review.	Vision (Basel)
32883007	Natural Killer Cell Dysfunction and Its Role in COVID-19.	Int J Mol Sci
32882868	Natural Flavonoids as Potential Angiotensin-Converting Enzyme 2 Inhibitors for Anti-SARS-CoV-2.	Molecules
32882823	Computational and Transcriptome Analyses Revealed Preferential Induction of Chemotaxis and Lipid Synthesis by SARS-CoV-2.	Biology (Basel)
32882706	"COVID-19 is, in the end, an endothelial disease."	Eur Heart J
32882432	Genome based evolutionary lineage of SARS-CoV-2 towards the development of novel chimeric vaccine.	Infect Genet Evol
32882331	"Angiotensin-converting enzymes (ACE, ACE2) gene variants and COVID-19 outcome."	Gene
32882182	Effects of COVID-19 on the Nervous System.	Cell
32882061	Hyperferritinemia in patients with COVID-19: An opportunity for iron chelation?	Artif Organs
32881980	Possibility for reverse zoonotic transmission of SARS-CoV-2 to free-ranging wildlife: A case study of bats.	PLoS Pathog
32881907	Comparative genome analysis of novel coronavirus (SARS-CoV-2) from different geographical locations and the effect of mutations on major target proteins: An in silico insight.	PLoS One
32881661	Discovery of Some Antiviral Natural products to fight against Novel Corona Virus (SARS-CoV-2) using Insilico approach.	Comb Chem High Throughput Screen
32881659	Targeting Natural Products for the Treatment of COVID-19 - An Updated Review.	Curr Pharm Des
32881656	Targeting COVID-19 in Parkinson's Patients: Drugs Repurposed.	Curr Med Chem
32881654	Renin Angiotensin System (RAS) and Immune System Profile in Specific Subgroups with COVID-19.	Curr Med Chem
32881628	"Current perspective on diagnosis, epidemiological assessment, prevention strategies, and potential therapeutic interventions for severe acute respiratory infections caused by 2019 novel coronavirus (SARS-CoV-2)."	Hum Vaccin Immunother
32881285	Modulation of endothelial organelle size as an antithrombotic strategy.	J Thromb Haemost
32881064	"Beyond dexamethasone, emerging immuno-thrombotic therapies for COVID-19."	Br J Clin Pharmacol
32881062	Hypothesis: The potential therapeutic role of nicorandil in COVID-19.	Clin Exp Pharmacol Physiol
32881059	A novel concept for treatment and vaccination against Covid-19 with an inhaled chitosan-coated DNA vaccine encoding a secreted spike protein portion.	Clin Exp Pharmacol Physiol
32881026	Fox3(+) CD25(+) CD4(+) T-regulatory cells may transform the nCoV's final destiny to CNS!	J Med Virol
32880995	Questions concerning the proximal origin of SARS-CoV-2.	J Med Virol
32880990	"Coronavirus disease 2019 is associated with low circulating plasma levels of angiotensin 1 and angiotensin 1,7."	J Med Virol
32880961	Harnessing co-operative immune augmentation by contact allergens to enhance the efficacy of viral vaccines.	Contact Dermatitis
32880957	Variation and multilevel selection of SARS-CoV-2.	Evolution
32880939	"Telomere length, epidemiology and pathogenesis of severe COVID-19."	Eur J Clin Invest
32880929	Molecular dynamics study with mutation shows that N-terminal domain structural re-orientation in Niemann-Pick type C1 is required for proper alignment of cholesterol transport.	J Neurochem
32880920	Transcriptomic analyses suggest that mucopolysaccharidosis patients may be less susceptible to COVID-19.	FEBS Lett
32880873	Studying the neuropsychological sequelae of SARS-CoV-2: lessons learned from 35 years of neuroHIV research.	J Neurovirol
32880786	"Ocular tropism of coronavirus (CoVs): a comparison of the interaction between the animal-to-human transmitted coronaviruses (SARS-CoV-1, SARS-CoV-2, MERS-CoV, CoV-229E, NL63, OC43, HKU1) and the eye."	Int Ophthalmol
32880739	Hypertension and Age-Related Cognitive Impairment: Common Risk Factors and a Role for Precision Aging.	Curr Hypertens Rep
32880654	The Collision of Meta-Inflammation and SARS-CoV-2 Pandemic Infection.	Endocrinology
32880441	Correlation between CNS Tuberculosis and the COVID-19 Pandemic: The Neurological and Therapeutic Insights.	ACS Chem Neurosci
32879801	"A comparison of COVID-19, SARS and MERS."	PeerJ
32879797	Mutation density changes in SARS-CoV-2 are related to the pandemic stage but to a lesser extent in the dominant strain with mutations in spike and RdRp.	PeerJ
32879591	COVID-19 and liver injury: where do we stand?	Ann Gastroenterol
32879484	Biosynthesis of medicinal tropane alkaloids in yeast.	Nature
32879306	Ocular conjunctival inoculation of SARS-CoV-2 can cause mild COVID-19 in rhesus macaques.	Nat Commun
32879112	Potential pathogenesis of severe acute respiratory syndrome coronavirus 2.	Zhong Nan Da Xue Xue Bao Yi Xue Ban
32878977	Mapping genome variation of SARS-CoV-2 worldwide highlights the impact of COVID-19 super-spreaders.	Genome Res
32878932	A Simplified Quantitative Real-Time PCR Assay for Monitoring SARS-CoV-2 Growth in Cell Culture.	mSphere
32878931	Evolution of Early SARS-CoV-2 and Cross-Coronavirus Immunity.	mSphere
32878912	Expansion of SARS-CoV-2-Specific Antibody-Secreting Cells and Generation of Neutralizing Antibodies in Hospitalized COVID-19 Patients.	J Immunol
32878881	"De novo design, retrosynthetic analysis and combinatorial synthesis of a hybrid antiviral (VTAR-01) to inhibit the interaction of SARS-CoV2 spike glycoprotein with human angiotensin-converting enzyme 2."	Biol Open
32878641	SARS-CoV-2/COVID-19 and advances in developing potential therapeutics and vaccines to counter this emerging pandemic.	Ann Clin Microbiol Antimicrob
32878546	Systemic innate and adaptive immune responses to SARS-CoV-2 as it relates to other coronaviruses.	Hum Vaccin Immunother
32878480	Elevated FiO2 increases SARS-CoV-2 co-receptor expression in respiratory tract epithelium.	Am J Physiol Lung Cell Mol Physiol
32878468	Severe Acute Respiratory Syndrome Coronavirus 2 Impact on the Central Nervous System: Are Astrocytes and Microglia Main Players or Merely Bystanders?	ASN Neuro
32878290	Lipidomics Issues on Human Positive ssRNA Virus Infection: An Update.	Metabolites
32877948	The Potential Therapeutic Role of Proton Pump Inhibitors in COVID-19: Hypotheses Based on Existing Evidences.	Drug Res (Stuttg)
32877828	Immunotherapeutic approaches to curtail COVID-19.	Int Immunopharmacol
32877699	Loss of Bcl-6-Expressing T Follicular Helper Cells and Germinal Centers in COVID-19.	Cell
32877642	Growth Factor Receptor Signaling Inhibition Prevents SARS-CoV-2 Replication.	Mol Cell
32877502	Direct activation of the alternative complement pathway by SARS-CoV-2 spike proteins is blocked by factor D inhibition.	Blood
32877500	Position Paper of the Department of Hypertension of the Brazilian Society of Nephrology: Use of renin-angiotensin system blockers during the course of Covid-19 infection.	J Bras Nefrol
32876900	Neurological injuries in COVID-19 patients: direct viral invasion or a bystander injury after infection of epithelial/endothelial cells.	J Neurovirol
32876803	Opioid and neuroHIV Comorbidity - Current and Future Perspectives.	J Neuroimmune Pharmacol
32876633	[Impact of COVID-19 on liver disease and the public health in Peru].	Rev Gastroenterol Peru
32876538	"Pharmacoinformatics and hypothetical studies on allicin, curcumin, and gingerol as potential candidates against COVID-19-associated proteases."	J Biomol Struct Dyn
32876341	SARS-CoV-2 targets neurons of 3D human brain organoids.	EMBO J
32876223	COVID-19: respuesta inmune y perspectivas terapeuticas.	Rev Peru Med Exp Salud Publica
32875950	Proposing a fungal metabolite-flaviolin as a potential inhibitor of 3CL(pro) of novel coronavirus SARS-CoV-2 identified using docking and molecular dynamics.	J Biomol Struct Dyn
32875925	Active-site Molecular docking of Nigellidine with nucleocapsid- NSP2-MPro of COVID-19 and to human IL1R-IL6R and strong antioxidant role of Nigella-sativa in experimental rats.	J Drug Target
32875809	Potential use of noncoding RNAs and innovative therapeutic strategies to target the 5'UTR of SARS-CoV-2.	Epigenomics
32875709	Leveraging mRNA Sequences and Nanoparticles to Deliver SARS-CoV-2 Antigens In Vivo.	Adv Mater
32875598	Lymphopenia an important immunological abnormality in patients with COVID-19: Possible mechanisms.	Scand J Immunol
32875490	"Renin-angiotensin-system inhibition in the context of corona virus disease-19: experimental evidence, observational studies, and clinical implications."	Heart Fail Rev
32875286	"What are the roles of antibodies versus a durable, high quality T-cell response in protective immunity against SARS-CoV-2?"	Vaccine X
32875166	In silico structure modelling of SARS-CoV-2 Nsp13 helicase and Nsp14 and repurposing of FDA approved antiviral drugs as dual inhibitors.	Gene Rep
32875060	Angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers and the risk of COVID-19 infection or severe disease: Systematic review and meta-analysis.	Int J Cardiol Heart Vasc
32874745	Cardiovascular Considerations in Coronavirus Disease 2019 with a Special Focus on Arrhythmia.	J Innov Card Rhythm Manag
32874702	Discovery of human coronaviruses pan-papain-like protease inhibitors using computational approaches.	J Pharm Anal
32874447	Neurological symptoms due to Coronavirus disease 2019.	Neurol Int
32873808	Tracking the COVID-19 pandemic in Australia using genomics.	Nat Commun
32873700	Gene of the month: TMPRSS2 (transmembrane serine protease 2).	J Clin Pathol
32873611	Low Baseline Pulmonary Levels of Cytotoxic Lymphocytes as a Predisposing Risk Factor for Severe COVID-19.	mSystems
32873192	No small matter: a perspective on nanotechnology-enabled solutions to fight COVID-19.	Nanomedicine (Lond)
32873185	"Repurposing simeprevir, calpain inhibitor IV and a cathepsin F inhibitor against SARS-CoV-2 and insights into their interactions with M(pro)."	J Biomol Struct Dyn
32873176	"Potential inhibitors of SARS-cov-2 RNA dependent RNA polymerase protein: molecular docking, molecular dynamics simulations and MM-PBSA analyses."	J Biomol Struct Dyn
32873147	Angiotensin converting enzyme inhibitors do not increase the risk of poor outcomes in COVID-19 disease. A multi-centre observational study.	Scott Med J
32872802	Fractional diffusion on the human proteome as an alternative to the multi-organ damage of SARS-CoV-2.	Chaos
32872736	Update on association between exposure to renin-angiotensin-aldosterone system inhibitors and coronavirus disease 2019 in South Korea.	Korean J Intern Med
32872731	Effects of renin-angiotensin system blockers on the risk and outcomes of severe acute respiratory syndrome coronavirus 2 infection in patients with hypertension.	Korean J Intern Med
32872641	Implications for SARS-CoV-2 Vaccine Design: Fusion of Spike Glycoprotein Transmembrane Domain to Receptor-Binding Domain Induces Trimerization.	Membranes (Basel)
32872395	The Natural-Mineral-Based Novel Nanomaterial IFMC Increases Intravascular Nitric Oxide without Its Intake: Implications for COVID-19 and beyond.	Nanomaterials (Basel)
32872332	"Delta9-Tetrahydrocannabinol Prevents Mortality from Acute Respiratory Distress Syndrome through the Induction of Apoptosis in Immune Cells, Leading to Cytokine Storm Suppression."	Int J Mol Sci
32872217	Biochemical and Computational Approach of Selected Phytocompounds from Tinospora crispa in the Management of COVID-19.	Molecules
32871847	"Raloxifene and Bazedoxifene Could Be Promising Candidates for Preventing the COVID-19 Related Cytokine Storm, ARDS and Mortality."	In Vivo
32871846	Ivermectin Docks to the SARS-CoV-2 Spike Receptor-binding Domain Attached to ACE2.	In Vivo
32871607	Mannose-Binding Lectin is Associated with Thrombosis and Coagulopathy in Critically Ill COVID-19 Patients.	Thromb Haemost
32871306	COVID-19 and cardiovascular consequences: Is the endothelial dysfunction the hardest challenge?	Thromb Res
32871219	An investigation of rhinovirus infection on cellular uptake of poly (glycerol-adipate) nanoparticles.	Int J Pharm
32871007	SARS2020: an integrated platform for identification of novel coronavirus by a consensus sequence-function model.	Bioinformatics
32870815	Immune pathogenesis of COVID-19-related multisystem inflammatory syndrome in children.	J Clin Invest
32870735	Vitamin D in Prevention and Treatment of COVID-19: Current Perspective and Future Prospects.	J Am Coll Nutr
32870563	Catalytic Asymmetric Synthesis of the anti-COVID-19 Drug Remdesivir.	Angew Chem Int Ed Engl
32870529	Quantitative and qualitative alterations of circulating myeloid cells and plasmacytoid DC in SARS-CoV-2 infection.	Immunology
32870435	Potential of Plant Proteins Digested In Silico by Gastrointestinal Enzymes as Nutritional Supplement for COVID-19 Patients.	Plant Foods Hum Nutr
32870433	Thrombin Inhibition by Argatroban: Potential Therapeutic Benefits in COVID-19.	Cardiovasc Drugs Ther
32870373	Why do SARS-CoV-2 NSPs rush to the ER?	J Neurol
32870351	Future perspective: high-throughput construction of new ultrasensitive cytokine and virion liquid chips for high-throughput screening (HTS) of anti-inflammatory drugs or clinical diagnosis and treatment of inflammatory diseases.	Anal Bioanal Chem
32870054	Ocular Symptoms of SARS-CoV-2: Indication of Possible Ocular Transmission or Viral Shedding.	Ocul Immunol Inflamm
32869939	SARS-CoV-2 and its relationship with the genitourinary tract: Implications for male reproductive health in the context of COVID-19 pandemic.	Andrology
32869854	Using serpins cysteine protease cross-specificity to possibly trap SARS-CoV-2 Mpro with reactive center loop chimera.	Clin Sci (Lond)
32869699	Designing an efficient multi-epitope vaccine displaying interactions with diverse HLA molecules for an efficient humoral and cellular immune response to prevent COVID-19 infection.	Expert Rev Vaccines
32869673	Renin-Angiotensin-Aldosterone System Inhibitors and Risks of Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Systematic Review and Meta-Analysis.	Hypertension
32869585	[Discussion on the effect pathways of preventing and treating coronavirus disease 2019 by acupuncture and moxibustion from the regulation of immune inflammatory response].	Zhongguo Zhen Jiu
32869377	Skin manifestations in COVID-19 provide a clue for disease's pathophysiology understanding.	J Eur Acad Dermatol Venereol
32869376	Possible routes of SARS-CoV-2 invasion in brain: In context of neurological symptoms in COVID-19 patients.	J Neurosci Res
32869342	Neutrophil calprotectin identifies severe pulmonary disease in COVID-19.	J Leukoc Biol
32869183	Understanding the Immunologic Characteristics of Neurologic Manifestations of SARS-CoV-2 and Potential Immunological Mechanisms.	Mol Neurobiol
32869005	A drug screening toolkit based on the -1 ribosomal frameshifting of SARS-CoV-2.	Heliyon
32868983	Potential clinical drugs as covalent inhibitors of the priming proteases of the spike protein of SARS-CoV-2.	Comput Struct Biotechnol J
32868957	Ultrasound assisted synthesis of 3-alkynyl substituted 2-chloroquinoxaline derivatives: Their in silico assessment as potential ligands for N-protein of SARS-CoV-2.	Tetrahedron Lett
32868909	New insights into the cell- and tissue-specificity of glucocorticoid actions.	Cell Mol Immunol
32868447	A SARS-CoV-2 vaccine candidate would likely match all currently circulating variants.	Proc Natl Acad Sci U S A
32868115	"Coagulation dysfunction in COVID-19: The interplay between inflammation, viral infection and the coagulation system."	Blood Rev
32867854	Emerging of a SARS-CoV-2 viral strain with a deletion in nsp1.	J Transl Med
32867666	COVID-19: Pathophysiology; Mechanism of Transmission and Possible Molecular Drug Target for Management.	Curr Mol Pharmacol
32867652	Feasibility of Mesenchymal Stem Cell Therapy for COVID-19: A Mini Review.	Curr Gene Ther
32867645	Neutralization of SARS-CoV-2 Spike Protein via Natural Compounds: A Multilayered High Throughput Virtual Screening Approach.	Curr Pharm Des
32867617	Human Induced Pluripotent Stem Cell-Derived Lung Epithelial System for SARS-CoV-2 Infection Modeling and Its Potential in Drug Repurposing.	Stem Cells Dev
32867349	Design and Evaluation of Anti-SARS-Coronavirus Agents Based on Molecular Interactions with the Viral Protease.	Molecules
32867310	The Role of NLRP3 Inflammasome in the Pathogenesis of Traumatic Brain Injury.	Int J Mol Sci
32867305	COVID-19 and Genetic Variants of Protein Involved in the SARS-CoV-2 Entry into the Host Cells.	Genes (Basel)
32867244	Aryl Hydrocarbon Receptor Role in Co-Ordinating SARS-CoV-2 Entry and Symptomatology: Linking Cytotoxicity Changes in COVID-19 and Cancers; Modulation by Racial Discrimination Stress.	Biology (Basel)
32867137	Cardiovascular System in COVID-19: Simply a Viewer or a Leading Actor?	Life (Basel)
32867123	Using All-Atom Potentials to Refine RNA Structure Predictions of SARS-CoV-2 Stem Loops.	Int J Mol Sci
32867008	Potential interactions of SARS-CoV-2 with human cell receptors in the skin: Understanding the enigma for a lower frequency of skin lesions compared to other tissues.	Exp Dermatol
32866898	ADE and hyperinflammation in SARS-CoV2 infection- comparison with dengue hemorrhagic fever and feline infectious peritonitis.	Cytokine
32866803	"Quantum chemical insight into molecular structure, NBO analysis of the hydrogen-bonded interactions, spectroscopic (FT-IR, FT-Raman), drug likeness and molecular docking of the novel anti COVID-19 molecule 2-[(4,6-diaminopyrimidin-2-yl)sulfanyl]-N-(4-fluorophenyl)acetamide - dimer."	Spectrochim Acta A Mol Biomol Spectrosc
32866780	Virtual screening and molecular dynamics study of approved drugs as inhibitors of spike protein S1 domain and ACE2 interaction in SARS-CoV-2.	J Mol Graph Model
32866645	"Interferon gamma, TGF-beta1 and RANTES expression in upper airway samples from SARS-CoV-2 infected patients."	Clin Immunol
32866640	Comprehensive evolution and molecular characteristics of a large number of SARS-CoV-2 genomes reveal its epidemic trends.	Int J Infect Dis
32866574	Arterial Thrombosis in Coronavirus Disease 2019 Patients: A Rapid Systematic Review.	Ann Vasc Surg
32866536	Association of vitamin D with the modulation of the disease severity in COVID-19.	Virus Res
32866534	Scaffold morphing of arbidol (umifenovir) in search of multi-targeting therapy halting the interaction of SARS-CoV-2 with ACE2 and other proteases involved in COVID-19.	Virus Res
32866437	Immune response in SARS-CoV-2 infection: the role of interferons type I and type III.	Braz J Infect Dis
32866323	Chilblains and COVID-19: further evidence against a causal association.	J Eur Acad Dermatol Venereol
32865757	Cytokine storm in aged people with CoV-2: possible role of vitamins as therapy or preventive strategy.	Aging Clin Exp Res
32865603	[COVID-19: epidemiology and clinical facts].	Radiologe
32865490	The Pathology of Severe COVID-19-Related Lung Damage.	Dtsch Arztebl Int
32865137	Surfactant replacement might help recovery of low-compliance lung in severe COVID-19 pneumonia.	Ther Adv Respir Dis
32864982	Interaction Between Coronavirus S-Protein and Human ACE2: Hints for Exploring Efficient Therapeutic Targets to Treat COVID-19.	Angiology
32864934	Cardiovascular involvement in COVID-19: not to be missed.	Braz J Cardiovasc Surg
32864865	The phenotypic changes of gammadelta T cells in COVID-19 patients.	J Cell Mol Med
32864784	Angiotensin-converting enzyme as a new immunologic target for the new SARS-CoV-2.	Immunol Cell Biol
32864605	Development and effectiveness of pseudotyped SARS-CoV-2 system as determined by neutralizing efficiency and entry inhibition test in vitro.	Biosaf Health
32864575	Managing the COVID-19 Pandemic: Research Strategies Based on the Evolutionary and Molecular Characteristics of Coronaviruses.	SN Compr Clin Med
32864572	"Treatment Options Available for COVID-19 and an Analysis on Possible Role of Combination of rhACE2, Angiotensin (1-7) and Angiotensin (1-9) as Effective Therapeutic Measure."	SN Compr Clin Med
32864545	The Resilient Child: Sex-Steroid Hormones and COVID-19 Incidence in Pediatric Patients.	J Endocr Soc
32864402	"Dataset of mutational analysis, miRNAs targeting SARS-CoV-2 genes and host gene expression in SARS-CoV and SARS-CoV-2 infections."	Data Brief
32864374	Coronavirus epitope prediction from highly conserved region of spike protein.	Clin Exp Vaccine Res
32864299	Hydroxychloroquine in COVID-19: Potential Mechanism of Action Against SARS-CoV-2.	Curr Pharmacol Rep
32864262	A Review of Postmortem Findings in Patients With COVID-19.	Cureus
32864162	Pharmacogenomics of COVID-19 therapies.	NPJ Genom Med
32864128	Systematic analysis of disease-specific immunological signatures in patients with febrile illness from Saudi Arabia.	Clin Transl Immunology
32863965	Emerging evidence of myocardial injury in COVID-19: A path through the smoke.	Theranostics
32863947	Nanomedicine therapies modulating Macrophage Dysfunction: a potential strategy to attenuate Cytokine Storms in severe infections.	Theranostics
32863490	"Structural and physico-chemical evaluation of melatonin and its solution-state excited properties, with emphasis on its binding with novel coronavirus proteins."	J Mol Liq
32863430	Molecular dynamics simulation of docking structures of SARS-CoV-2 main protease and HIV protease inhibitors.	J Mol Struct
32863223	"Expression profiling meta-analysis of ACE2 and TMPRSS2, the putative anti-inflammatory receptor and priming protease of SARS-CoV-2 in human cells, and identification of putative modulators."	Redox Biol
32863157	Renin-angiotensin system blockers and severe acute respiratory syndrome coronavirus 2.	Arch Cardiovasc Dis
32863134	Modeling Potential Autophagy Pathways in COVID-19 and Sarcoidosis.	Trends Immunol
32863070	BCG vaccine may generate cross-reactive T cells against SARS-CoV-2: In silico analyses and a hypothesis.	Vaccine
32863034	A Perspective on Erythropoietin as a Potential Adjuvant Therapy for Acute Lung Injury/Acute Respiratory Distress Syndrome in Patients with COVID-19.	Arch Med Res
32862840	Synergistic antiviral effect of hydroxychloroquine and azithromycin in combination against SARS-CoV-2: What molecular dynamics studies of virus-host interactions reveal.	Int J Antimicrob Agents
32862512	Epicardial Fat Inflammation in Severe COVID-19.	Obesity (Silver Spring)
32862236	Entry Inhibitors: Efficient Means to Block Viral Infection.	J Membr Biol
32862101	Novel Selenium-based compounds with therapeutic potential for SOD1-linked amyotrophic lateral sclerosis.	EBioMedicine
32862058	Consistent localization of SARS-CoV-2 spike glycoprotein and ACE2 over TMPRSS2 predominance in placental villi of 15 COVID-19 positive maternal-fetal dyads.	Placenta
32861974	Molecular modelling investigation for drugs and nutraceuticals against protease of SARS-CoV-2.	J Mol Graph Model
32861965	"Insights into antiviral mechanisms of remdesivir, lopinavir/ritonavir and chloroquine/hydroxychloroquine affecting the new SARS-CoV-2."	Biomed Pharmacother
32861856	Age-Related Differences in Immunological Responses to SARS-CoV-2.	J Allergy Clin Immunol Pract
32861838	Peripheral blood CD4+ cell counts but not CD3+ and CD8+ cell counts are reduced in SARS-CoV-2 infection.	J Affect Disord
32861744	The multifaceted role of plasminogen in inflammation.	Cell Signal
32861340	Targeting TMPRSS2 in SARS-CoV-2 Infection.	Mayo Clin Proc
32861199	Monocyte activation in systemic Covid-19 infection: Assay and rationale.	EBioMedicine
32861070	"ACE2, TMPRSS2 distribution and extrapulmonary organ injury in patients with COVID-19."	Biomed Pharmacother
32860686	"The past, present and future of RNA respiratory viruses: influenza and coronaviruses."	Pathog Dis
32860252	Neutrophil elastase inhibitor (sivelestat) may be a promising therapeutic option for management of acute lung injury/acute respiratory distress syndrome or disseminated intravascular coagulation in COVID-19.	J Clin Pharm Ther
32859121	SARS-CoV-2 Spike 1 Protein Controls Natural Killer Cell Activation via the HLA-E/NKG2A Pathway.	Cells
32859053	Nano-Vesicle (Mis)Communication in Senescence-Related Pathologies.	Cells
32859008	Optimization Rules for SARS-CoV-2 M(pro) Antivirals: Ensemble Docking and Exploration of the Coronavirus Protease Active Site.	Viruses
32858978	Compartmentalized Replication of SARS-Cov-2 in Upper vs. Lower Respiratory Tract Assessed by Whole Genome Quasispecies Analysis.	Microorganisms
32858958	Prediction and Analysis of SARS-CoV-2-Targeting MicroRNA in Human Lung Epithelium.	Genes (Basel)
32858940	Could Mesenchymal Stem Cell-Derived Exosomes Be a Therapeutic Option for Critically Ill COVID-19 Patients?	J Clin Med
32858874	Implication of Aging Related Chronic Neuroinflammation on COVID-19 Pandemic.	J Pers Med
32858623	Coronavirus disease 2019 and cardiovascular implications.	J Cardiovasc Med (Hagerstown)
32858292	Particulate matter and SARS-CoV-2: A possible model of COVID-19 transmission.	Sci Total Environ
32858233	"A survey of genetic variants in SARS-CoV-2 interacting domains of ACE2, TMPRSS2 and TLR3/7/8 across populations."	Infect Genet Evol
32858232	Chemokine receptor gene polymorphisms and COVID-19: Could knowledge gained from HIV/AIDS be important?	Infect Genet Evol
32858226	"SARS-CoV-2 another kind of liver aggressor, how does it do that?"	Ann Hepatol
32857878	Thrombosis in COVID-19.	Am J Hematol
32857808	SNPs or RNA modifications? Concerns on mutation-based evolutionary studies of SARS-CoV-2.	PLoS One
32857671	Coronavirus Disease-2019 Treatment Strategies Targeting Interleukin-6 Signaling and Herbal Medicine.	OMICS
32857620	Azithromycin Downregulates Gene Expression of IL-1beta and Pathways Involving TMPRSS2 and TMPRSS11D Required by SARS-CoV-2.	Am J Respir Cell Mol Biol
32856728	Management of SARS-CoV-2 pneumonia.	J Med Virol
32856707	Viral dynamics and immune correlates of COVID-19 disease severity.	Clin Infect Dis
32856339	Vitamin D and Covid-19: From potential therapeutic effects to unanswered questions.	Rev Med Virol
32855781	COVID-19 and Central Nervous System: Entry Routes And.	Basic Clin Neurosci
32855764	Natural Antioxidants: A Review of Studies on Human and Animal Coronavirus.	Oxid Med Cell Longev
32855413	Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replication.	Nat Commun
32855401	A panel of human neutralizing mAbs targeting SARS-CoV-2 spike at multiple epitopes.	Nat Commun
32855259	"Four SARS-CoV-2 Genome Sequences from Late April in Stockholm, Sweden, Reveal a Rare Mutation in the Spike Protein."	Microbiol Resour Announc
32855215	MHC class II transactivator CIITA induces cell resistance to Ebola virus and SARS-like coronaviruses.	Science
32855182	Characteristics of Large-Vessel Occlusion Associated with COVID-19 and Ischemic Stroke.	AJNR Am J Neuroradiol
32854985	Promising role for mesenchymal stromal cells in coronavirus infectious disease-19 (COVID-19)-related severe acute respiratory syndrome?	Blood Rev
32854762	The receptor binding domain of SARS-CoV-2 spike protein is the result of an ancestral recombination between the bat-CoV RaTG13 and the pangolin-CoV MP789.	BMC Res Notes
32854742	Kawasaki disease epidemic: pitfalls.	Ital J Pediatr
32854739	From SARS and MERS to COVID-19: a brief summary and comparison of severe acute respiratory infections caused by three highly pathogenic human coronaviruses.	Respir Res
32854725	Characterization of accessory genes in coronavirus genomes.	Virol J
32854433	Coronaviruses: Is Sialic Acid a Gate to the Eye of Cytokine Storm? From the Entry to the Effects.	Cells
32854430	Targeting the sAC-Dependent cAMP Pool to Prevent SARS-Cov-2 Infection.	Cells
32854247	"The Importance of Redox Status in the Frame of Lifestyle Approaches and the Genetics of the Lung Innate Immune Molecules, SP-A1 and SP-A2, on Differential Outcomes of COVID-19 Infection."	Antioxidants (Basel)
32854147	Can a gluten-free diet be partly protective for COVID-19 infection?	APMIS
32854108	A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures.	Nature
32853989	Beneficial non-anticoagulant mechanisms underlying heparin treatment of COVID-19 patients.	EBioMedicine
32853823	Intrinsic disorder perspective of an interplay between the renin-angiotensin-aldosterone system and SARS-CoV-2.	Infect Genet Evol
32853604	Screening and evaluation of approved drugs as inhibitors of main protease of SARS-CoV-2.	Int J Biol Macromol
32853599	COVID-19 patients display distinct SARS-CoV-2 specific T-cell responses according to disease severity.	J Infect
32853546	Coronavirus RNA Proofreading: Molecular Basis and Therapeutic Targeting.	Mol Cell
32853545	Implications of Sex Differences in Immunity for SARS-CoV-2 Pathogenesis and Design of Therapeutic Interventions.	Immunity
32853537	"Expression of severe acute respiratory syndrome coronavirus 2 cell entry genes, angiotensin-converting enzyme 2 and transmembrane protease serine 2, in the placenta across gestation and at the maternal-fetal interface in pregnancies complicated by preterm birth or preeclampsia."	Am J Obstet Gynecol
32853525	Impact of Early Pandemic Stage Mutations on Molecular Dynamics of SARS-CoV-2 M(pro).	J Chem Inf Model
32853469	"Nicotinamide adenine dinucleotide: Biosynthesis, consumption and therapeutic role in cardiac diseases."	Acta Physiol (Oxf)
32853340	HLA predictions from the bronchoalveolar lavage fluid and blood samples of eight COVID-19 patients at the pandemic onset.	Bioinformatics
32853319	"[Pathogenic, clinical and diagnostic characteristics of the SARS-CoV-2 pandemic]."	Rev Chilena Infectol
32853024	Immune Modulation to Improve Survival of Viral Pneumonia in Mice.	Am J Respir Cell Mol Biol
32852721	"Renin-Angiotensin-Aldosterone System Inhibitors and Risk of Death in Patients Hospitalised with COVID-19: A Retrospective Italian Cohort Study of 43,000 Patients."	Drug Saf
32852642	Endothelial Dysfunction in COVID-19: Lessons Learned from Coronaviruses.	Curr Hypertens Rep
32852624	Is Sex a Determinant of COVID-19 Infection? Truth or Myth?	Curr Hypertens Rep
32852580	COVID-19: dealing with a potential risk factor for chronic neurological disorders.	J Neurol
32852539	Reduced vitamin K status as a potentially modifiable risk factor of severe COVID-19.	Clin Infect Dis
32852058	The recent outbreaks of human coronaviruses: A medicinal chemistry perspective.	Med Res Rev
32851919	"Targeting COVID-19 (SARS-CoV-2) main protease through active phytochemicals of ayurvedic medicinal plants - Withania somnifera (Ashwagandha), Tinospora cordifolia (Giloy) and Ocimum sanctum (Tulsi) - a molecular docking study."	J Biomol Struct Dyn
32851912	In silico screening of hundred phytocompounds of ten medicinal plants as potential inhibitors of nucleocapsid phosphoprotein of COVID-19: an approach to prevent virus assembly.	J Biomol Struct Dyn
32851910	Insights into the structural and dynamical changes of spike glycoprotein mutations associated with SARS-CoV-2 host receptor binding.	J Biomol Struct Dyn
32851877	"Pathogenesis, clinical manifestations and complications of coronavirus disease 2019 (COVID-19)."	Future Microbiol
32851855	Interaction of SARS-CoV-2 and Other Coronavirus With ACE (Angiotensin-Converting Enzyme)-2 as Their Main Receptor: Therapeutic Implications.	Hypertension
32851697	Single-cell RNA expression profiling of SARS-CoV-2-related ACE2 and TMPRSS2 in human trophectoderm and placenta.	Ultrasound Obstet Gynecol
32851183	Epithelial cell-specific loss of function of Miz1 causes a spontaneous COPD-like phenotype and up-regulates Ace2 expression in mice.	Sci Adv
32850989	Renin-Angiotensin System and Coronavirus Disease 2019: A Narrative Review.	Front Cardiovasc Med
32850978	Combination Therapy Using Inhalable GapmeR and Recombinant ACE2 for COVID-19.	Front Mol Biosci
32850977	"Molecular Pathogenesis, Immunopathogenesis and Novel Therapeutic Strategy Against COVID-19."	Front Mol Biosci
32850973	A Multi-Targeting Approach to Fight SARS-CoV-2 Attachment.	Front Mol Biosci
32850963	Insights Into Dynamics of Inhibitor and Ubiquitin-Like Protein Binding in SARS-CoV-2 Papain-Like Protease.	Front Mol Biosci
32850927	Coronavirus Disease-2019 Conundrum: RAS Blockade and Geriatric-Associated Neuropsychiatric Disorders.	Front Med (Lausanne)
32850890	Single Virus Targeting Multiple Organs: What We Know and Where We Are Heading?	Front Med (Lausanne)
32850752	Prospects for RNAi Therapy of COVID-19.	Front Bioeng Biotechnol
32850726	Construction of SARS-CoV-2 Virus-Like Particles by Mammalian Expression System.	Front Bioeng Biotechnol
32850607	Racial and Gender-Based Differences in COVID-19.	Front Public Health
32850602	COVID-19: A Multidisciplinary Review.	Front Public Health
32850564	Potential Effect of COVID-19 on Maternal and Infant Outcome: Lesson From SARS.	Front Pediatr
32850499	Functional Pangenome Analysis Shows Key Features of E Protein Are Preserved in SARS and SARS-CoV-2.	Front Cell Infect Microbiol
32849833	The Enigma of Low COVID-19 Fatality Rate in India.	Front Genet
32849666	Understanding the Pathophysiology of COVID-19: Could the Contact System Be the Key?	Front Immunol
32849656	Crosstalk Between Platelets and Microbial Pathogens.	Front Immunol
32849654	Overview of Immune Response During SARS-CoV-2 Infection: Lessons From the Past.	Front Immunol
32849643	Contriving Multi-Epitope Subunit of Vaccine for COVID-19: Immunoinformatics Approaches.	Front Immunol
32849623	Remodeling of the Immune Response With Aging: Immunosenescence and Its Potential Impact on COVID-19 Immune Response.	Front Immunol
32849449	CoronaVR: A Computational Resource and Analysis of Epitopes and Therapeutics for Severe Acute Respiratory Syndrome Coronavirus-2.	Front Microbiol
32849438	Oral Microbiome and SARS-CoV-2: Beware of Lung Co-infection.	Front Microbiol
32849425	Coronavirus Interplay With Lipid Rafts and Autophagy Unveils Promising Therapeutic Targets.	Front Microbiol
32849415	"Sequencing the Genome of Indian Flying Fox, Natural Reservoir of Nipah Virus, Using Hybrid Assembly and Conservative Secondary Scaffolding."	Front Microbiol
32849309	Hypercoagulopathy and Adipose Tissue Exacerbated Inflammation May Explain Higher Mortality in COVID-19 Patients With Obesity.	Front Endocrinol (Lausanne)
32848893	The Enigma of Endothelium in COVID-19.	Front Physiol
32848802	A Novel Strategy to Mitigate the Hyperinflammatory Response to COVID-19 by Targeting Leukotrienes.	Front Pharmacol
32848790	Medicinal Plants as Sources of Active Molecules Against COVID-19.	Front Pharmacol
32848788	"DPP-4 Inhibitors in the Prevention/Treatment of Pulmonary Fibrosis, Heart and Kidney Injury Caused by COVID-19-A Therapeutic Approach of Choice in Type 2 Diabetic Patients?"	Front Pharmacol
32848776	Cellular and Molecular Pathways of COVID-19 and Potential Points of Therapeutic Intervention.	Front Pharmacol
32848769	DPP4 and ACE2 in Diabetes and COVID-19: Therapeutic Targets for Cardiovascular Complications?	Front Pharmacol
32848621	SARS-CoV-2 Dissemination Through Peripheral Nerves Explains Multiple Organ Injury.	Front Cell Neurosci
32848431	COVID-19 (Coronavirus Disease 2019): A New Coronavirus Disease.	Infect Drug Resist
32848272	"Increased Incidence, Morbidity, and Mortality in Human Coronavirus NL63 Associated with ACE Inhibitor Therapy and Implication in SARS-CoV-2 (COVID-19)."	Mo Med
32848162	Dynamics of the ACE2-SARS-CoV-2/SARS-CoV spike protein interface reveal unique mechanisms.	Sci Rep
32847856	SARS-CoV-2 and Three Related Coronaviruses Utilize Multiple ACE2 Orthologs and Are Potently Blocked by an Improved ACE2-Ig.	J Virol
32847819	"Cytokine storm release syndrome and the prospects for immunotherapy with COVID-19, part 4: The role of JAK inhibition."	Cleve Clin J Med
32847594	"The importance of vitamin d metabolism as a potential prophylactic, immunoregulatory and neuroprotective treatment for COVID-19."	J Transl Med
32847471	Vascular underpinning of COVID-19.	Open Biol
32847369	Extending the identification of structural features responsible for anti-SARS-CoV activity of peptide-type compounds using QSAR modelling.	SAR QSAR Environ Res
32847034	"Autophagy Augmentation to Alleviate Immune Response Dysfunction, and Resolve Respiratory and COVID-19 Exacerbations."	Cells
32847031	A New ERAP2/Iso3 Isoform Expression Is Triggered by Different Microbial Stimuli in Human Cells. Could It Play a Role in the Modulation of SARS-CoV-2 Infection?	Cells
32847008	Biosensing Cytokine IL-6: A Comparative Analysis of Natural and Synthetic Receptors.	Biosensors (Basel)
32846644	Imiquimod - A toll like receptor 7 agonist - Is an ideal option for management of COVID 19.	Environ Res
32846427	Sex differences in immune responses that underlie COVID-19 disease outcomes.	Nature
32846329	Drug repurposing of anti-infective clinical drugs: Discovery of two potential anti-cytokine storm agents.	Biomed Pharmacother
32846196	Prospect of SARS-CoV-2 spike protein: Potential role in vaccine and therapeutic development.	Virus Res
32846165	Attaching clinical significance to COVID-19-associated diarrhea.	Life Sci
32846088	Protein Surface Printer for Exploring Protein Domains.	J Chem Inf Model
32845937	Friends or foes? The knowns and unknowns of natural killer cell biology in COVID-19 and other coronaviruses in July 2020.	PLoS Pathog
32845733	Role of antibody-dependent enhancement (ADE) in the virulence of SARS-CoV-2 and its mitigation strategies for the development of vaccines and immunotherapies to counter COVID-19.	Hum Vaccin Immunother
32845720	Rho GTPases and the emerging role of tunneling nanotubes in physiology and disease.	Am J Physiol Cell Physiol
32845609	Central Nervous System Targets and Routes for SARS-CoV-2: Current Views and New Hypotheses.	ACS Chem Neurosci
32845580	Individuals with obesity and COVID-19: A global perspective on the epidemiology and biological relationships.	Obes Rev
32845122	Quantum Dot-Conjugated SARS-CoV-2 Spike Pseudo-Virions Enable Tracking of Angiotensin Converting Enzyme 2 Binding and Endocytosis.	ACS Nano
32845033	"Mechanism and inhibition of the papain-like protease, PLpro, of SARS-CoV-2."	EMBO J
32844987	Hemostatic abnormalities in COVID-19: A guided review.	An Acad Bras Cienc
32844713	Functional mapping of B-cell linear epitopes of SARS-CoV-2 in COVID-19 convalescent population.	Emerg Microbes Infect
32844538	Alpha-1-antitrypsin: A possible host protective factor against Covid-19.	Rev Med Virol
32844337	Angiotensin-converting enzyme 2: a double-edged sword in COVID-19 patients with an increased risk of heart failure.	Heart Fail Rev
32844302	The Interplay Between Coagulation and Inflammation Pathways in COVID-19-Associated Respiratory Failure: A Narrative Review.	Pulm Ther
32844126	Leptin levels in SARS-CoV-2 infection related respiratory failure: A cross-sectional study and a pathophysiological framework on the role of fat tissue.	Heliyon
32844125	"Integrative analyses of SARS-CoV-2 genomes from different geographical locations reveal unique features potentially consequential to host-virus interaction, pathogenesis and clues for novel therapies."	Heliyon
32844124	ACE2 coding variants in different populations and their potential impact on SARS-CoV-2 binding affinity.	Biochem Biophys Rep
32843733	Lung innervation in the eye of a cytokine storm: neuroimmune interactions and COVID-19.	Nat Rev Neurol
32843695	Immunoinformatic identification of B cell and T cell epitopes in the SARS-CoV-2 proteome.	Sci Rep
32843628	A broad-spectrum virus- and host-targeting peptide against respiratory viruses including influenza virus and SARS-CoV-2.	Nat Commun
32843626	Origin and cross-species transmission of bat coronaviruses in China.	Nat Commun
32843534	"Development of a Fluorescence-Based, High-Throughput SARS-CoV-2 3CL(pro) Reporter Assay."	J Virol
32843118	"Nutritional status, diet and viral respiratory infections: perspectives for severe acute respiratory syndrome coronavirus 2."	Br J Nutr
32842818	"Understanding the epidemiology, pathophysiology, diagnosis and management of SARS-CoV-2."	J Int Med Res
32842817	COVID-19 and renin-angiotensin system modulators: what do we know so far?	Expert Rev Cardiovasc Ther
32842606	In Silico Identification of Potential Natural Product Inhibitors of Human Proteases Key to SARS-CoV-2 Infection.	Molecules
32842509	Drug Repurposing for Candidate SARS-CoV-2 Main Protease Inhibitors by a Novel In Silico Method.	Molecules
32842491	Viral Vectors Applied for RNAi-Based Antiviral Therapy.	Viruses
32841948	"Clinical Characteristics of Patients with Severe Pneumonia Caused by the SARS-CoV-2 in Wuhan, China."	Respiration
32841689	A genetic barcode of SARS-CoV-2 for monitoring global distribution of different clades during the COVID-19 pandemic.	Int J Infect Dis
32841659	GRP78 targeting: Hitting two birds with a stone.	Life Sci
32841640	Viroinformatics approach to explore the inhibitory mechanism of existing drugs repurposed to fight against COVID-19.	Eur J Pharmacol
32841639	Food proteins are a potential resource for mining cathepsin L inhibitory drugs to combat SARS-CoV-2.	Eur J Pharmacol
32841605	Virus-Receptor Interactions of Glycosylated SARS-CoV-2 Spike and Human ACE2 Receptor.	Cell Host Microbe
32841599	Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding.	Cell
32841579	Cytokines and COVID-19: friends or foes?	Hum Vaccin Immunother
32841477	Allosteric Inhibition of the SARS-CoV-2 Main Protease: Insights from Mass Spectrometry Based Assays*.	Angew Chem Int Ed Engl
32841329	Underlying Vulnerabilities to the Cytokine Storm and Adverse COVID-19 Outcomes in the Aging Immune System.	J Gerontol A Biol Sci Med Sci
32841215	Human angiotensin-converting enzyme 2 transgenic mice infected with SARS-CoV-2 develop severe and fatal respiratory disease.	JCI Insight
32841212	Peripheral CD4+ T cell subsets and antibody response in COVID-19 convalescent individuals.	J Clin Invest
32840758	SARS-CoV-2 Infectivity and Neurological Targets in the Brain.	Cell Mol Neurobiol
32840686	Guillain-Barre syndrome spectrum associated with COVID-19: an up-to-date systematic review of 73 cases.	J Neurol
32840608	COVID-19 re-infection by a phylogenetically distinct SARS-coronavirus-2 strain confirmed by whole genome sequencing.	Clin Infect Dis
32840560	"Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), a newly emerged pathogen: an overview."	Pathog Dis
32840387	"Synthesis of N,N'-bis(1,5-dimethyl-2-phenyl-1,2-dihydro-3-oxopyrazol-4-yl) sebacamide that ameliorate osteoarthritis symptoms and improve bone marrow matrix structure and cartilage alterations induced by monoiodoacetate in the rat model: ""Suggested potent anti-inflammatory agent against COVID-19""."	Hum Exp Toxicol
32840378	Alkamides and Piperamides as Potential Antivirals against the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).	J Phys Chem Lett
32840109	iPSCs-Derived Platform: A Feasible Tool for Probing the Neurotropism of SARS-CoV-2.	ACS Chem Neurosci
32840072	[The mechanism and treatment strategies of SARS-CoV-2 mediated inflammatory response].	Sheng Wu Yi Xue Gong Cheng Xue Za Zhi
32839951	Neurological manifestations of COVID-19: available evidences and a new paradigm.	J Neurovirol
32839763	"SARS-CoV-2-Specific T Cells Exhibit Phenotypic Features of Helper Function, Lack of Terminal Differentiation, and High Proliferation Potential."	Cell Rep Med
32839745	"miRNA target prediction might explain the reduced transmission of SARS-CoV-2 in Jordan, Middle East."	Noncoding RNA Res
32839726	COVID-19 and the kidney: A matter of concern.	Curr Med Res Pract
32839635	Identification of potential SARS-CoV-2 inhibitors from South African medicinal plant extracts using molecular modelling approaches.	S Afr J Bot
32839634	Investigating the potential antiviral activity drugs against SARS-CoV-2 by molecular docking simulation.	J Mol Liq
32839612	SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function.	Nat Immunol
32839585	Lifting the mask on neurological manifestations of COVID-19.	Nat Rev Neurol
32839534	"Association between renin-angiotensin-aldosterone system inhibitor treatment, neutrophil-lymphocyte ratio, D-Dimer and clinical severity of COVID-19 in hospitalized patients: a multicenter, observational study."	J Hum Hypertens
32839380	Impact of COVID-19 on Alzheimer's Disease Risk: Viewpoint for Research Action.	Healthcare (Basel)
32838713	The Antiviral and Antimalarial Drug Repurposing in Quest of Chemotherapeutics to Combat COVID-19 Utilizing Structure-Based Molecular Docking.	Comb Chem High Throughput Screen
32838660	Structure-based drug repurposing for targeting Nsp9 replicase and spike proteins of severe acute respiratory syndrome coronavirus 2.	J Biomol Struct Dyn
32838557	Is periodontal disease a risk factor for developing severe Covid-19 infection? The potential role of Galectin-3.	Exp Biol Med (Maywood)
32838499	[Effects of angiotensin converting enzyme inhibitor/angiotensin receptor blocker on clinical characteristics of coronavirus disease 2019 patients with hypertension].	Zhonghua Nei Ke Za Zhi
32838472	Coagulopathy and Thrombosis as a Result of Severe COVID-19 Infection: A Microvascular Focus.	Thromb Haemost
32838397	Regulatory T cells: A potential weapon to combat COVID-19?	MedComm (Beijing)
32838362	Virus-Host Interactome and Proteomic Survey Reveal Potential Virulence Factors Influencing SARS-CoV-2 Pathogenesis.	Med (N Y)
32838361	Investigating Ketone Bodies as Immunometabolic Countermeasures against Respiratory Viral Infections.	Med (N Y)
32838359	When Two Pandemics Meet: Why Is Obesity Associated with Increased COVID-19 Mortality?	Med (N Y)
32838346	"SARS-CoV-2 in fruit bats, ferrets, pigs, and chickens: an experimental transmission study."	Lancet Microbe
32838342	Systems-Level Immunomonitoring from Acute to Recovery Phase of Severe COVID-19.	Cell Rep Med
32838339	Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and glial cells: Insights and perspectives.	Brain Behav Immun Health
32838301	Employing bioactive compounds derived from Ipomoea obscura (L.) to evaluate potential inhibitor for SARS-CoV-2 main protease and ACE2 protein.	Food Front
32838282	Molecular targets for COVID-19 drug development: Enlightening Nigerians about the pandemic and future treatment.	Biosaf Health
32838280	"Renin-Angiotensin System overactivation in polycystic ovary syndrome, a risk for SARS-CoV-2 infection?"	Metabol Open
32838215	An Impaired Natriuretic Peptide Hormone System May Play a Role in COVID-19 Severity in Vulnerable Populations.	FASEB Bioadv
32838213	Rapid production of clinical-grade SARS-CoV-2 specific T cells.	Adv Cell Gene Ther
32838198	Lung Barrier Function in COVID-19?	SN Compr Clin Med
32838196	Systematic Review: Safety of Intravesical Therapy for Bladder Cancer in the Era of COVID-19.	SN Compr Clin Med
32838195	Protective Effects of CVD and DM Medications in SARS-CoV-2 Infection.	SN Compr Clin Med
32838188	Arrhythmia in COVID-19.	SN Compr Clin Med
32838173	Coronavirus Disease 2019 (COVID-19) as a Multi-Systemic Disease and its Impact in Low- and Middle-Income Countries (LMICs).	SN Compr Clin Med
32838164	"Involvement of Spike Protein, Furin, and ACE2 in SARS-CoV-2-Related Cardiovascular Complications."	SN Compr Clin Med
32838152	"COVID-19 Infection and Haematological Involvement: a Review of Epidemiology, Pathophysiology and Prognosis of Full Blood Count Findings."	SN Compr Clin Med
32838151	Novel Coronavirus (nCoV): a Bitter Old Enemy in a New Avatar.	SN Compr Clin Med
32838148	The Association of Cardiovascular Diseases and Diabetes Mellitus with COVID-19 (SARS-CoV-2) and Their Possible Mechanisms.	SN Compr Clin Med
32838145	Conjunctivitis as a Sentinel of SARS-CoV-2 Infection: a Need of Revision for Mild Symptoms.	SN Compr Clin Med
32838074	Dynamic Regulation of SARS-Cov-2 Binding and Cell Entry Mechanisms in Remodeled Human Ventricular Myocardium.	JACC Basic Transl Sci
32838054	Subcellular hot spots of GPCR signaling promote vascular inflammation.	Curr Opin Endocr Metab Res
32838048	Vitamin D in COVID - 19: Dousing the fire or averting the storm? - A perspective from the Asia-Pacific.	Osteoporos Sarcopenia
32838020	SARS-CoV-2-human protein-protein interaction network.	Inform Med Unlocked
32837985	Development of cell-based pseudovirus entry assay to identify potential viral entry inhibitors and neutralizing antibodies against SARS-CoV-2.	Genes Dis
32837983	"Coronavirus disease 2019 (COVID-19): cytokine storms, hyper-inflammatory phenotypes, and acute respiratory distress syndrome."	Genes Dis
32837981	Amino acid variation analysis of surface spike glycoprotein at 614 in SARS-CoV-2 strains.	Genes Dis
32837957	A brief analysis and hypotheses about the risk of COVID-19 for people with type 1 and type 2 diabetes mellitus.	J Diabetes Metab Disord
32837954	Drug repurposing using computational methods to identify therapeutic options for COVID-19.	J Diabetes Metab Disord
32837913	Male genital damage in COVID-19 patients: Are available data relevant?	Asian J Urol
32837894	The effect of Echinacea spp. on the prevention or treatment of COVID-19 and other respiratory tract infections in humans: A rapid review.	Adv Integr Med
32837872	Natural products as LSD1 inhibitors for cancer therapy.	Acta Pharm Sin B
32837855	"COVID-19 Pandemic: from Molecular Biology, Pathogenesis, Detection, and Treatment to Global Societal Impact."	Curr Pharmacol Rep
32837848	Coronavirus in Continuous Flux: From SARS-CoV to SARS-CoV-2.	Adv Sci (Weinh)
32837764	"2019 novel-coronavirus: Cardiovascular insights about risk factors, myocardial injury, therapy and clinical implications."	Chronic Dis Transl Med
32837756	Is SARS-CoV-2 (COVID-19) postviral olfactory dysfunction (PVOD) different from other PVOD?	World J Otorhinolaryngol Head Neck Surg
32837754	SARS-CoV-2 Entry Factors: ACE2 and TMPRSS2 Are Expressed in Peri-Implantation Embryos and the Maternal-Fetal Interface.	Engineering (Beijing)
32837728	Exploring the causes of mild COVID-19 involvement in pediatric patients.	New Microbes New Infect
32837710	Structural insights into the mechanism of RNA recognition by the N-terminal RNA-binding domain of the SARS-CoV-2 nucleocapsid phosphoprotein.	Comput Struct Biotechnol J
32837585	Significant Unresolved Questions and Opportunities for Bioengineering in Understanding and Treating COVID-19 Disease Progression.	Cell Mol Bioeng
32837584	Animal Models to Study Emerging Technologies Against SARS-CoV-2.	Cell Mol Bioeng
32837583	The Impact of COVID-19 on Cancer Risk and Treatment.	Cell Mol Bioeng
32837538	Potential compound from herbal food of Rhizoma Polygonati for treatment of COVID-19 analyzed by network pharmacology: Viral and cancer signaling mechanisms.	J Funct Foods
32837536	"SARS-CoV-2, an evolutionary perspective of interaction with human ACE2 reveals undiscovered amino acids necessary for complex stability."	Evol Appl
32837527	Additional diagnostic testing of the 2019 novel coronavirus (SARS-CoV-2).	Mol Cell Toxicol
32837521	The novel coronavirus 2019-nCoV: Its evolution and transmission into humans causing global COVID-19 pandemic.	Int J Environ Sci Technol (Tehran)
32837505	Implications of SARS-CoV-2 genetic diversity and mutations on pathogenicity of the COVID-19 and biomedical interventions.	J Taibah Univ Med Sci
32837219	In silico screening of FDA approved drugs reveals ergotamine and dihydroergotamine as potential coronavirus main protease enzyme inhibitors.	Saudi J Biol Sci
32837217	Potential mechanisms of Chinese Herbal Medicine that implicated in the treatment of COVID-19 related renal injury.	Saudi Pharm J
32837213	[Neurological complications of COVID-19].	Prat Anesth Reanim
32837211	[Cardiac complications in critically ill COVID-19 patients].	Prat Anesth Reanim
32837207	[Acute renal failure during COVID-19 epidemic].	Prat Anesth Reanim
32837189	Review of evidence on using ACEi and ARBs in patients with hypertension and COVID-19.	Drugs Ther Perspect
32837137	Genomics insights of SARS-CoV-2 (COVID-19) into target-based drug discovery.	Med Chem Res
32837119	Repurposing metocurine as main protease inhibitor to develop novel antiviral therapy for COVID-19.	Struct Chem
32837118	Destabilizing the structural integrity of COVID-19 by caulerpin and its derivatives along with some antiviral drugs: An in silico approaches for a combination therapy.	Struct Chem
32837113	Structure-based virtual screening of phytochemicals and repurposing of FDA approved antiviral drugs unravels lead molecules as potential inhibitors of coronavirus 3C-like protease enzyme.	J King Saud Univ Sci
32837101	Immunity Against COVID-19: Potential Role of Ayush Kwath.	J Ayurveda Integr Med
32837036	"The Pathophysiology, Diagnosis and Treatment of Corona Virus Disease 2019 (COVID-19)."	Indian J Clin Biochem
32837031	Obesity and COVID-19: A Fatal Alliance.	Indian J Clin Biochem
32836826	Antiviral potential of garlic (Allium sativum) and its organosulfur compounds: A systematic update of pre-clinical and clinical data.	Trends Food Sci Technol
32836811	Computational analysis of the SARS-CoV-2 and other viruses based on the Kolmogorov's complexity and Shannon's information theories.	Nonlinear Dyn
32836709	Evaluating the potential of different inhibitors on RNA-dependent RNA polymerase of severe acute respiratory syndrome coronavirus 2: A molecular modeling approach.	Med J Armed Forces India
32836691	Emerging zoonotic diseases originating in mammals: a systematic review of effects of anthropogenic land-use change.	Mamm Rev
32835775	Identification B and T-Cell epitopes and functional exposed amino acids of S protein as a potential vaccine candidate against SARS-CoV-2/COVID-19.	Microb Pathog
32835759	Association of obesity and its genetic predisposition with the risk of severe COVID-19: Analysis of population-based cohort data.	Metabolism
32835700	"Variability in genes related to SARS-CoV-2 entry into host cells (ACE2, TMPRSS2, TMPRSS11A, ELANE, and CTSL) and its potential use in association studies."	Life Sci
32835666	Sex differences underlying preexisting cardiovascular disease and cardiovascular injury in COVID-19.	J Mol Cell Cardiol
32835632	"In silico validation of coumarin derivatives as potential inhibitors against Main Protease, NSP10/NSP16-Methyltransferase, Phosphatase and Endoribonuclease of SARS CoV-2."	J Biomol Struct Dyn
32835412	An Integrated Multi-Function Heterogeneous Biochemical Circuit for High-Resolution Electrochemistry-Based Genetic Analysis.	Angew Chem Int Ed Engl
32835326	"Comparative tropism, replication kinetics, and cell damage profiling of SARS-CoV-2 and SARS-CoV with implications for clinical manifestations, transmissibility, and laboratory studies of COVID-19: an observational study."	Lancet Microbe
32835306	Characterization and Treatment of SARS-CoV-2 in Nasal and Bronchial Human Airway Epithelia.	Cell Rep Med
32835305	Human iPSC-Derived Cardiomyocytes Are Susceptible to SARS-CoV-2 Infection.	Cell Rep Med
32835303	Rapid Generation of Neutralizing Antibody Responses in COVID-19 Patients.	Cell Rep Med
32835302	Identification of SARS-CoV-2 Vaccine Epitopes Predicted to Induce Long-Term Population-Scale Immunity.	Cell Rep Med
32835295	Cerebrovascular disease in COVID-19: Is there a higher risk of stroke?	Brain Behav Immun Health
32835247	Immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia.	Lancet Rheumatol
32835214	Time-series analyses of directional sequence changes in SARS-CoV-2 genomes and an efficient search method for candidates for advantageous mutations for growth in human cells.	Gene X
32835213	Cyclophilin A and CD147: novel therapeutic targets for the treatment of COVID-19.	Med Drug Discov
32835160	The interaction between the endocannabinoid system and the renin angiotensin system and its potential implication for COVID-19 infection.	J Cannabis Res
32835135	Lung microbiome and coronavirus disease 2019 (COVID-19): Possible link and implications.	Hum Microb J
32835133	Phylogenomic proximity and comparative proteomic analysis of SARS-CoV-2.	Gene Rep
32835132	"mTOR inhibition and p53 activation, microRNAs: The possible therapy against pandemic COVID-19."	Gene Rep
32835126	Association of high level gene expression of ACE2 in adipose tissue with mortality of COVID-19 infection in obese patients.	Obes Med
32835124	A multicenter consensus: A role of furin in the endothelial tropism in obese patients with COVID-19 infection.	Obes Med
32835122	Molecular biology of coronaviruses: current knowledge.	Heliyon
32835090	In Silico Identification of Potential Inhibitors of ADP-Ribose Phosphatase of SARS-CoV-2 nsP3 by Combining E-Pharmacophore- and Receptor-Based Virtual Screening of Database.	ChemistrySelect
32835089	"COVID-19: Emergence of Infectious Diseases, Nanotechnology Aspects, Challenges, and Future Perspectives."	ChemistrySelect
32835083	Predicted therapeutic targets for COVID-19 disease by inhibiting SARS-CoV-2 and its related receptors.	Inform Med Unlocked
32835079	A SARS-CoV-2 vaccine candidate: In-silico cloning and validation.	Inform Med Unlocked
32835078	Structure-based drug designing towards the identification of potential anti-viral for COVID-19 by targeting endoribonuclease NSP15.	Inform Med Unlocked
32835074	Identification and classification of differentially expressed genes reveal potential molecular signature associated with SARS-CoV-2 infection in lung adenocarcinomal cells.	Inform Med Unlocked
32835040	RCOVID19: Recurrence-based SARS-CoV-2 features using chaos game representation.	Data Brief
32835005	Methods for making multiple alignment of genomic sequences for severe acute respiratory syndrome coronavirus 2.	Meta Gene
32834947	Bioactive natural compounds against human coronaviruses: a review and perspective.	Acta Pharm Sin B
32834922	Molecular docking suggests repurposing of brincidofovir as a potential drug targeting SARS-CoV-2 ACE2 receptor and main protease.	Netw Model Anal Health Inform Bioinform
32834902	"COVID-19: pathophysiology, diagnosis, complications and investigational therapeutics."	New Microbes New Infect
32834893	Does hereditary angioedema make COVID-19 worse?	World Allergy Organ J
32834892	Macrophage activation syndrome and COVID-19.	Inflamm Regen
32834891	Genome evolution of SARS-CoV-2 and its virological characteristics.	Inflamm Regen
32834792	Renin-Angiotensin-Aldosterone Inhibitors and COVID-19.	J Nurse Pract
32834698	Exploration on the feasibility of moxibustion in prevention and treatment of COVID-19 from the perspective of modern medical mechanism.	World J Acupunct Moxibustion
32834306	[SARS-CoV-2 pandemic and assisted reproduction].	Clin Invest Ginecol Obstet
32834259	Immunoinformatics characterization of SARS-CoV-2 spike glycoprotein for prioritization of epitope based multivalent peptide vaccine.	J Mol Liq
32834241	Compressed fluids and phytochemical profiling tools to obtain and characterize antiviral and anti-inflammatory compounds from natural sources.	Trends Analyt Chem
32834115	Chemical-informatics approach to COVID-19 drug discovery: Exploration of important fragments and data mining based prediction of some hits from natural origins as main protease (Mpro) inhibitors.	J Mol Struct
32834114	"Crystal structure, chemical reactivity, kinetic and thermodynamic studies of new ligand derived from 4-hydroxycoumarin: Interaction with SARS-CoV-2."	J Mol Struct
32834113	Inhibition of SARS-CoV-2 main protease 3CL(pro) by means of alpha-ketoamide and pyridone-containing pharmaceuticals using in silico molecular docking.	J Mol Struct
32834111	Computational evaluation of major components from plant essential oils as potent inhibitors of SARS-CoV-2 spike protein.	J Mol Struct
32834110	"Azafluorene derivatives as inhibitors of SARS CoV-2 RdRp: Synthesis, physicochemical, quantum chemical, modeling and molecular docking analysis."	J Mol Struct
32834108	Inhibitory activity of hydroxychloroquine on COVID-19 main protease: An insight from MD-simulation studies.	J Mol Struct
32833775	Systemic Complications of COVID-19.	Crit Care Nurs Q
32833774	COVID-19 and the Cardiovascular System.	Crit Care Nurs Q
32833770	"COVID-19: Epidemiology, Pathophysiology, Transmission, Symptoms."	Crit Care Nurs Q
32833687	SARS-CoV-2-specific T cell responses and correlations with COVID-19 patient predisposition.	J Clin Invest
32833435	Computational Alanine Scanning and Structural Analysis of the SARS-CoV-2 Spike Protein/Angiotensin-Converting Enzyme 2 Complex.	ACS Nano
32833367	[SARS-CoV-2 and sodium transport: a diabolical strategy].	Rev Med Suisse
32833213	Proximity Labeling for the Identification of Coronavirus-Host Protein Interactions.	Methods Mol Biol
32833204	Whole-Genome Sequencing Protocols for IBV and Other Coronaviruses Using High-Throughput Sequencing.	Methods Mol Biol
32833200	Coronaviruses: An Updated Overview of Their Replication and Pathogenesis.	Methods Mol Biol
32833058	Various Facets of Pathogenic Lipids in Infectious Diseases: Exploring Virulent Lipid-Host Interactome and Their Druggability.	J Membr Biol
32832913	Role for Anti-Cytokine Therapies in Severe Coronavirus Disease 2019.	Crit Care Explor
32832877	Polymonoclonal (Not Polyclonal) Antibodies Derived from Convalescent Human B Cell Hybridomas Might Be a Better Therapeutic Option than Single Target Monoclonal Antibodies.	ACS Pharmacol Transl Sci
32832263	Anti-COVID-19 multi-epitope vaccine designs employing global viral genome sequences.	PeerJ
32832038	ACE2 enhance viral infection or viral infection aggravate the underlying diseases.	Comput Struct Biotechnol J
32831932	Amphotericin B as antiviral drug: Possible efficacy against COVID-19.	Ann Thorac Med
32831523	Molecular docking analysis of Withaferin A from Withania somnifera with the Glucose regulated protein 78 (GRP78) receptor and the SARS-CoV-2 main protease.	Bioinformation
32831522	Molecular docking analysis of N-substituted Oseltamivir derivatives with the SARS-CoV-2 main protease.	Bioinformation
32831521	Putative Natural History of CoViD-19.	Bioinformation
32831518	Towards the design of epitope candidates for Coronavirus 2.	Bioinformation
32831327	Role of SARS-CoV-2 neurotropism and neuroinvasion in COVID-19 patients disease severity.	Gac Med Mex
32831326	The big challenge of SARS-CoV-2 latency: testes as reservoir.	Gac Med Mex
32831324	Cutaneous susceptibility to SARS-CoV-2 infection according to the expression of viral entry factors in the skin.	Gac Med Mex
32831104	Investigation of the genetic variation in ACE2 on the structural recognition by the novel coronavirus (SARS-CoV-2).	J Transl Med
32830930	"Emergence, Transmission, and Potential Therapeutic Targets for the COVID-19 Pandemic Associated with the SARS-CoV-2."	Cell Physiol Biochem
32830527	Immunomodulation and Regeneration Properties of Dental Pulp Stem Cells: A Potential Therapy to Treat Coronavirus Disease 2019.	Cell Transplant
32830452	BANDeltaIT: B'-Factor Analysis for Drug Design and Structural Biology.	Mol Inform
32830286	"Effect of Renin-Angiotensin-Aldosterone System Inhibitors in Patients with COVID-19: a Systematic Review and Meta-analysis of 28,872 Patients."	Curr Atheroscler Rep
32829962	The looming storm: Blood and cytokines in COVID-19.	Blood Rev
32829961	"Understanding the andromeda strain - The role of cytokine release, coagulopathy and antithrombin III in SARS-CoV2 critical illness."	Blood Rev
32829936	Fruitful Neutralizing Antibody Pipeline Brings Hope To Defeat SARS-Cov-2.	Trends Pharmacol Sci
32829915	Inhibition of porcine epidemic diarrhea virus (PEDV) replication by A77 1726 through targeting JAK and Src tyrosine kinases.	Virology
32829876	Mutations in the phosphorylation sites of SARS-CoV-2 encoded nucleocapsid protein and structure model of sequestration by protein 14-3-3.	Biochem Biophys Res Commun
32829257	"Viral, host and environmental factors that favor anthropozoonotic spillover of coronaviruses: An opinionated review, focusing on SARS-CoV, MERS-CoV and SARS-CoV-2."	Sci Total Environ
32829256	Laser irradiated phenothiazines: New potential treatment for COVID-19 explored by molecular docking.	J Photochem Photobiol B
32829149	Structural analysis of experimental drugs binding to the SARS-CoV-2 target TMPRSS2.	J Mol Graph Model
32829048	Bats in ecosystems and their Wide spectrum of viral infectious potential threats: SARS-CoV-2 and other emerging viruses.	Int J Infect Dis
32828990	The use of knowledge management tools in viroinformatics. Example study of a highly conserved sequence motif in Nsp3 of SARS-CoV-2 as a therapeutic target.	Comput Biol Med
32828550	Host Polymorphisms May Impact SARS-CoV-2 Infectivity.	Trends Genet
32828489	Epigenetic susceptibility to severe respiratory viral infections and its therapeutic implications: a narrative review.	Br J Anaesth
32828312	Establishment and validation of a drug-target microarray for SARS-CoV-2.	Biochem Biophys Res Commun
32828269	SARS-CoV-2 E protein is a potential ion channel that can be inhibited by Gliclazide and Memantine.	Biochem Biophys Res Commun
32828084	Conformational transition of SARS-CoV-2 spike glycoprotein between its closed and open states.	J Chem Phys
32828069	Immunoinformatics-guided design of an epitope-based vaccine against severe acute respiratory syndrome coronavirus 2 spike glycoprotein.	Comput Biol Med
32828027	COVID-19 and the central nervous system.	Clin Neurol Neurosurg
32827661	Emerging strategies on in silico drug development against COVID-19: challenges and opportunities.	Eur J Pharm Sci
32827582	COVID-19 and cancer: A guide with suggested COVID-19 rule-out criteria to support clinical decision-making.	Biochim Biophys Acta Rev Cancer
32826974	Altered immune cell differentiation in the lungs of patients with critical COVID-19.	Nat Rev Immunol
32826914	A cross-reactive human IgA monoclonal antibody blocks SARS-CoV-2 spike-ACE2 interaction.	Nat Commun
32826754	ACE2 and SCARF expression in human dorsal root ganglion nociceptors: implications for SARS-CoV-2 virus neurological effects.	Pain
32826753	Clinical significance of angiotensin-converting enzyme 2 receptors for severe acute respiratory syndrome coronavirus 2 (COVID-19) on peripheral small-fiber sensory neurons is unknown today.	Pain
32826720	COVID-19 and Orchi-epididymitis.	Pediatr Infect Dis J
32826650	Immunohistochemical Study of SARS-CoV-2 Viral Entry Factors in the Cornea and Ocular Surface.	Cornea
32826431	Sepsis and Coronavirus Disease 2019: Common Features and Anti-Inflammatory Therapeutic Approaches.	Crit Care Med
32826388	COVID-19: a probable role of the anticoagulant Protein S in managing COVID-19-associated coagulopathy.	Aging (Albany NY)
32826343	Natural killer cell immunotypes related to COVID-19 disease severity.	Sci Immunol
32826334	Broad host range of SARS-CoV-2 predicted by comparative and structural analysis of ACE2 in vertebrates.	Proc Natl Acad Sci U S A
32826331	IL-6 trans-signaling induces plasminogen activator inhibitor-1 from vascular endothelial cells in cytokine release syndrome.	Proc Natl Acad Sci U S A
32826281	Neonatal and Children's Immune System and COVID-19: Biased Immune Tolerance versus Resistance Strategy.	J Immunol
32826162	Testicular pain as an unusual presentation of COVID-19: a brief review of SARS-CoV-2 and the testis.	Reprod Biomed Online
32825963	Pathologic features of COVID-19: A concise review.	Pathol Res Pract
32825954	Can COVID 2019 induce a specific cardiovascular damage or it exacerbates pre-existing cardiovascular diseases?	Pathol Res Pract
32825737	Antiviral Potential of Nanoparticles-Can Nanoparticles Fight Against Coronaviruses?	Nanomaterials (Basel)
32825713	Caveolae and Lipid Rafts in Endothelium: Valuable Organelles for Multiple Functions.	Biomolecules
32825469	Existence of SARS-CoV-2 Entry Molecules in the Oral Cavity.	Int J Mol Sci
32825438	SARS-CoV-2 ORF8 and SARS-CoV ORF8ab: Genomic Divergence and Functional Convergence.	Pathogens
32825327	Melatonin's Impact on Antioxidative and Anti-Inflammatory Reprogramming in Homeostasis and Disease.	Biomolecules
32825305	Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Exhibits High Predicted Binding Affinity to ACE2 from Lagomorphs (Rabbits and Pikas).	Animals (Basel)
32825182	Ischemic Stroke among the Symptoms Caused by the COVID-19 Infection.	J Clin Med
32825063	The Sialoside-Binding Pocket of SARS-CoV-2 Spike Glycoprotein Structurally Resembles MERS-CoV.	Viruses
32825011	Can Bioactive Lipid Arachidonic Acid Prevent and Ameliorate COVID-19?	Medicina (Kaunas)
32824985	"4,4'-Diaminodiphenyl Sulfone (DDS) as an Inflammasome Competitor."	Int J Mol Sci
32824830	ACE2 Protein Landscape in the Head and Neck Region: The Conundrum of SARS-CoV-2 Infection.	Biology (Basel)
32824753	Deciphering SARS-CoV-2 Virologic and Immunologic Features.	Int J Mol Sci
32824639	Progress in Developing Inhibitors of SARS-CoV-2 3C-Like Protease.	Microorganisms
32824573	Whole Genome Sequencing of SARS-CoV-2: Adapting Illumina Protocols for Quick and Accurate Outbreak Investigation during a Pandemic.	Genes (Basel)
32824454	Putative SARS-CoV-2 M(pro) Inhibitors from an In-House Library of Natural and Nature-Inspired Products: A Virtual Screening and Molecular Docking Study.	Molecules
32824272	"A Comparison of Whole Genome Sequencing of SARS-CoV-2 Using Amplicon-Based Sequencing, Random Hexamers, and Bait Capture."	Viruses
32824072	New Anti SARS-Cov-2 Targets for Quinoline Derivatives Chloroquine and Hydroxychloroquine.	Int J Mol Sci
32823907	Molecular Epidemiology Analysis of SARS-CoV-2 Strains Circulating in Romania during the First Months of the Pandemic.	Life (Basel)
32823901	Understanding COVID-19: From Origin to Potential Therapeutics.	Int J Environ Res Public Health
32823591	Nicotinic Cholinergic System and COVID-19: In Silico Identification of an Interaction between SARS-CoV-2 and Nicotinic Receptors with Potential Therapeutic Targeting Implications.	Int J Mol Sci
32823540	The Interrelation of Neurological and Psychological Symptoms of COVID-19: Risks and Remedies.	J Clin Med
32823497	Hesperidin and SARS-CoV-2: New Light on the Healthy Function of Citrus Fruits.	Antioxidants (Basel)
32823144	The host targeting effect of chloroquine in malaria.	Curr Opin Immunol
32822911	A combinational approach to restore cytokine balance and to inhibit virus growth may promote patient recovery in severe COVID-19 cases.	Cytokine
32822795	"Skin is a potential host of SARS-CoV-2: A clinical, single-cell transcriptome-profiling and histologic study."	J Am Acad Dermatol
32822775	Tocilizumab improves oxidative stress and endothelial glycocalyx: A mechanism that may explain the effects of biological treatment on COVID-19.	Food Chem Toxicol
32822756	Missense mutations in SARS-CoV2 genomes from Indian patients.	Genomics
32822628	COVID-19 and selective vulnerability to Parkinson's disease.	Lancet Neurol
32822564	Effects of a major deletion in the SARS-CoV-2 genome on the severity of infection and the inflammatory response: an observational cohort study.	Lancet
32822426	"COVID-19 pandemic: Insights into structure, function, and hACE2 receptor recognition by SARS-CoV-2."	PLoS Pathog
32822073	Comparing the binding properties of peptides mimicking the Envelope protein of SARS-CoV and SARS-CoV-2 to the PDZ domain of the tight junction-associated PALS1 protein.	Protein Sci
32822061	Longitudinal Characteristics of T Cell Responses in Asymptomatic SARS-CoV-2 Infection.	Virol Sin
32821885	Potential Role of Peptide-Based Antiviral Therapy Against SARS-CoV-2 Infection.	ACS Pharmacol Transl Sci
32821884	The Potential of Antimicrobial Peptides as an Antiviral Therapy against COVID-19.	ACS Pharmacol Transl Sci
32821883	SARS-CoV-2 Receptor ACE2 Is Enriched in a Subpopulation of Mouse Tongue Epithelial Cells in Nongustatory Papillae but Not in Taste Buds or Embryonic Oral Epithelium.	ACS Pharmacol Transl Sci
32821757	"ACE2 as Drug Target of COVID-19 Virus Treatment, Simplified Updated Review."	Rep Biochem Mol Biol
32821661	"Susceptibility to SARS, MERS, and COVID-19 from animal health perspective."	Open Vet J
32821086	A Review on Remdesivir: A Possible Promising Agent for the Treatment of COVID-19.	Drug Des Devel Ther
32821033	"SARS-CoV-2 growth, furin-cleavage-site adaptation and neutralization using serum from acutely infected hospitalized COVID-19 patients."	J Gen Virol
32820884	Neurological symptoms as a clinical manifestation of coronavirus disease 2019: implications for internists.	Pol Arch Intern Med
32820801	Unpuzzling COVID-19: tissue-related signaling pathways associated with SARS-CoV-2 infection and transmission.	Clin Sci (Lond)
32820248	Animal and translational models of SARS-CoV-2 infection and COVID-19.	Mucosal Immunol
32820236	"Renin-angiotensin system inhibitors and the severity of coronavirus disease 2019 in Kanagawa, Japan: a retrospective cohort study."	Hypertens Res
32820179	Evolutionary and structural analyses of SARS-CoV-2 D614G spike protein mutation now documented worldwide.	Sci Rep
32820005	"GRL-0920, an Indole Chloropyridinyl Ester, Completely Blocks SARS-CoV-2 Infection."	mBio
32819683	Angiotensin Converting Enzyme Inhibitor and Angiotensin II Receptor Blocker Use Among Outpatients Diagnosed With COVID-19.	Am J Cardiol
32819226	Lead Finding from Selected Flavonoids with Antiviral (SARS-CoV-2) Potentials Against COVID-19: An In-silico Evaluation.	Comb Chem High Throughput Screen
32818905	"ACE2, Metformin, and COVID-19."	iScience
32818852	SARS-CoV-2 exhibits intra-host genomic plasticity and low-frequency polymorphic quasispecies.	J Clin Virol
32818817	Host-membrane interacting interface of the SARS coronavirus envelope protein: Immense functional potential of C-terminal domain.	Biophys Chem
32818801	"SARS-CoV2 vertical transmission with adverse effects on the newborn revealed through integrated immunohistochemical, electron microscopy and molecular analyses of Placenta."	EBioMedicine
32818576	The immunomodulatory effects of probiotics on respiratory viral infections: A hint for COVID-19 treatment?	Microb Pathog
32818486	"Genes encoding ACE2, TMPRSS2 and related proteins mediating SARS-CoV-2 viral entry are upregulated with age in human cardiomyocytes."	J Mol Cell Cardiol
32818439	SARS-CoV-2 renal tropism associates with acute kidney injury.	Lancet
32818434	COVID-19 and multisystem inflammatory syndrome in children and adolescents.	Lancet Infect Dis
32818261	Structural basis of SARS-CoV-2 spike protein induced by ACE2.	Bioinformatics
32818075	Digestive symptoms of COVID-19 and expression of ACE2 in digestive tract organs.	Cell Death Discov
32817804	No evidence for distinct types in the evolution of SARS-CoV-2.	Virus Evol
32817460	Levels of the TNF-Related Cytokine LIGHT Increase in Hospitalized COVID-19 Patients with Cytokine Release Syndrome and ARDS.	mSphere
32817270	In situ structural analysis of SARS-CoV-2 spike reveals flexibility mediated by three hinges.	Science
32817223	Cryo-electron Microscopy Structure of the Swine Acute Diarrhea Syndrome Coronavirus Spike Glycoprotein Provides Insights into Evolution of Unique Coronavirus Spike Proteins.	J Virol
32817004	Elevated ACE-2 expression in the olfactory neuroepithelium: implications for anosmia and upper respiratory SARS-CoV-2 entry and replication.	Eur Respir J
32816822	Anticipating and managing coagulopathy and thrombotic manifestations of severe COVID-19.	CMAJ
32816392	"Monocytopenia, monocyte morphological anomalies and hyperinflammation characterise severe COVID-19 in type 2 diabetes."	EMBO Mol Med
32816316	Geographical reconstruction of the SARS-CoV-2 outbreak in Lombardy (Italy) during the early phase.	J Med Virol
32816230	ACE2 & TMPRSS2 Expressions in Head & Neck Tissues: A Systematic Review.	Head Neck Pathol
32816107	Diabetes mellitus and SARS-CoV-2-related mortality: the impact of acute hyperglycemic crises and some further considerations.	Acta Diabetol
32815796	Antitussive noscapine and antiviral drug conjugates as arsenal against COVID-19: a comprehensive chemoinformatics analysis.	J Biomol Struct Dyn
32815593	Beta-Adrenergic Blockers as a Potential Treatment for COVID-19 Patients.	Bioessays
32815481	"Molecular docking and simulation studies on SARS-CoV-2 M(pro) reveals Mitoxantrone, Leucovorin, Birinapant, and Dynasore as potent drugs against COVID-19."	J Biomol Struct Dyn
32815406	Exploring the SARS-CoV-2 structural proteins for multi-epitope vaccine development: an in-silico approach.	Expert Rev Vaccines
32814926	[Coagulopathy and thrombosis: similarities and differences among pathogenic coronaviruses].	An Sist Sanit Navar
32814791	Genome-wide analysis of SARS-CoV-2 virus strains circulating worldwide implicates heterogeneity.	Sci Rep
32814760	Comparison of nonhuman primates identified the suitable model for COVID-19.	Signal Transduct Target Ther
32814759	On-target versus off-target effects of drugs inhibiting the replication of SARS-CoV-2.	Cell Death Dis
32814446	COVID-19: fighting the invisible enemy with microRNAs.	Expert Rev Anti Infect Ther
32814369	Male Fertility and the COVID-19 Pandemic: Systematic Review of the Literature.	World J Mens Health
32814065	The Role of Host Genetic Factors in Coronavirus Susceptibility: Review of Animal and Systematic Review of Human Literature.	Am J Hum Genet
32813845	Pulmonary embolism in patients with COVID-19 and its treatment based on low-molecular-weight heparin.	Sao Paulo Med J
32813238	Cross-Talk Between Key Players in Patients with COVID-19 and Ischemic Stroke: A Review on Neurobiological Insight of the Pandemic.	Mol Neurobiol
32813065	Role of probiotics to combat viral infections with emphasis on COVID-19.	Appl Microbiol Biotechnol
32812956	Dynamical properties of enzyme-substrate complexes disclose substrate specificity of the SARS-CoV-2 main protease as characterized by the electron density descriptors.	Phys Chem Chem Phys
32812788	World Sepsis Day: a global agenda to target a leading cause of morbidity and mortality.	Am J Physiol Lung Cell Mol Physiol
32812645	"Obesity, inflammation and COVID-19."	Swiss Med Wkly
32812340	Vitamin B12 may inhibit RNA-dependent-RNA polymerase activity of nsp12 from the SARS-CoV-2 virus.	IUBMB Life
32812049	Circulating Endothelial Cells as a Marker of Endothelial Injury in Severe COVID -19.	J Infect Dis
32812012	Peripheral immunophenotypes in children with multisystem inflammatory syndrome associated with SARS-CoV-2 infection.	Nat Med
32811977	25-Hydroxycholesterol is a potent SARS-CoV-2 inhibitor.	Cell Res
32811550	Preventing the clinical manifestations and disease progression of coronavirus disease using clinically proven protease inhibitors.	Crit Care
32811514	Intranasal exposure of African green monkeys to SARS-CoV-2 results in acute phase pneumonia with shedding and lung injury still present in the early convalescence phase.	Virol J
32811513	The current landscape of coronavirus-host protein-protein interactions.	J Transl Med
32811367	An in-silico evaluation of dietary components for structural inhibition of SARS-Cov-2 main protease.	J Biomol Struct Dyn
32811354	Vitamin D can be effective on the prevention of COVID-19 complications: A narrative review on molecular aspects.	Int J Vitam Nutr Res
32811230	COVID-19 in pregnancy: possible mechanisms not to be discounted.	J Matern Fetal Neonatal Med
32810972	[Effect of COVID-19 on the blood system and its mechanism].	Zhonghua Xue Ye Xue Za Zhi
32810867	The Cellular basis of loss of smell in 2019-nCoV-infected individuals.	Brief Bioinform
32810751	The development of Coronavirus 3C-Like protease (3CL(pro)) inhibitors from 2010 to 2020.	Eur J Med Chem
32810602	Possible role of HLA class-I genotype in SARS-CoV-2 infection and progression: A pilot study in a cohort of Covid-19 Spanish patients.	Clin Immunol
32810597	Identification of Transcription Factors Regulating SARS-CoV-2 Entry Genes in the Intestine.	Cell Mol Gastroenterol Hepatol
32810438	Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell Compartment.	Cell
32809969	Baricitinib restrains the immune dysregulation in patients with severe COVID-19.	J Clin Invest
32809918	Oxytocin's anti-inflammatory and proimmune functions in COVID-19: a transcriptomic signature-based approach.	Physiol Genomics
32809116	Interplay of COVID-19 and cardiovascular diseases in Africa: an observational snapshot.	Clin Res Cardiol
32808462	Mesenchymal stromal cells for sepsis and septic shock: Lessons for treatment of COVID-19.	Stem Cells Transl Med
32808185	Effect of common medications on the expression of SARS-CoV-2 entry receptors in liver tissue.	Arch Toxicol
32808094	Immuno-epidemiology and pathophysiology of coronavirus disease 2019 (COVID-19).	J Mol Med (Berl)
32807944	ORF8 and ORF3b antibodies are accurate serological markers of early and late SARS-CoV-2 infection.	Nat Immunol
32807895	An integrated drug repurposing strategy for the rapid identification of potential SARS-CoV-2 viral inhibitors.	Sci Rep
32807635	Pre-existing diabetes is worse for SARS-CoV-2 infection; an endothelial perspective.	Nutr Metab Cardiovasc Dis
32807512	Gastrointestinal and Hepatic Manifestations of COVID-19: Evolving Recognition and Need for Increased Understanding in Vulnerable Populations.	J Natl Med Assoc
32807298	"Obstructive sleep apnea, renin-angiotensin system, and COVID-19: possible interactions."	J Clin Sleep Med
32807075	Does activation of the protective Renin-Angiotensin System have therapeutic potential in COVID-19?	Mol Med
32807047	Potential Leads from Liquorice Against SARS-CoV-2 Main Protease using Molecular Docking Simulation Studies.	Comb Chem High Throughput Screen
32807019	Renin-angiotensin system antagonists are associated with lower mortality in hypertensive patients with COVID-19.	Scott Med J
32807002	Mortality and Pre-Hospitalization use of Renin-Angiotensin System Inhibitors in Hypertensive COVID-19 Patients.	J Am Heart Assoc
32806722	Obesity and COVID-19: Molecular Mechanisms Linking Both Pandemics.	Int J Mol Sci
32806708	Of Mice and Men: The Coronavirus MHV and Mouse Models as a Translational Approach to Understand SARS-CoV-2.	Viruses
32806657	COVID-19 Is a Multifaceted Challenging Pandemic Which Needs Urgent Public Health Interventions.	Microorganisms
32806067	Enhanced Binding of SARS-CoV-2 Spike Protein to Receptor by Distal Polybasic Cleavage Sites.	ACS Nano
32805774	"RNA-dependent RNA polymerase, RdRP, a promising therapeutic target for cancer and potentially COVID-19."	Cancer Sci
32805734	Structures and distributions of SARS-CoV-2 spike proteins on intact virions.	Nature
32805728	Revealing the targets and mechanisms of vitamin A in the treatment of COVID-19.	Aging (Albany NY)
32805515	Strong homology between SARS-CoV-2 envelope protein and a Mycobacterium sp. antigen allows rapid diagnosis of Mycobacterial infections and may provide specific anti-SARS-CoV-2 immunity via the BCG vaccine.	Ann Diagn Pathol
32805314	Unravelling host-pathogen interactions: ceRNA network in SARS-CoV-2 infection (COVID-19).	Gene
32805303	"Various interferon (IFN)-inducible transmembrane (IFITM) proteins for COVID-19, is there a role for the combination of mycophenolic acid and interferon?"	Biochimie
32805256	The potential effectiveness of acetazolamide in the prevention of acute kidney injury in COVID-19: A hypothesis.	Eur J Pharmacol
32805023	Mechanistic insights into SARS-CoV-2 epidemic via revealing the features of SARS-CoV-2 coding proteins and host responses upon its infection.	Bioinformatics
32805021	CoV-AbDab: the coronavirus antibody database.	Bioinformatics
32804930	Helminth coinfection and COVID-19: An alternate hypothesis.	PLoS Negl Trop Dis
32804730	Patients taking angiotensin-converting enzyme inhibitors/angiotensin II type I receptor blockers: higher risks of severe acute respiratory syndrome coronavirus 2 infection but milder clinical manifestations?	Chin Med J (Engl)
32804597	"Based on Principles and Insights of COVID-19 Epidemiology, Genome Sequencing, and Pathogenesis: Retrospective Analysis of Sinigrin and Prolixin(RX) (Fluphenazine) Provides Off-Label Drug Candidates."	SLAS Discov
32804426	Possible Role of ABCB1 in Lysosomal Accumulation of Azithromycin in COVID-19 Therapy.	Clin Pharmacol Ther
32804015	A novel biparatopic hybrid antibody-ACE2 fusion that blocks SARS-CoV-2 infection: implications for therapy.	MAbs
32803688	The application of direct viral cytopathic hypothesis to design drug trials in the battle against COVID-19.	Daru
32803496	"(1)H, (13)C, and (15)N backbone chemical shift assignments of the apo and the ADP-ribose bound forms of the macrodomain of SARS-CoV-2 non-structural protein 3b."	Biomol NMR Assign
32803146	Possible molecular and paracrine involvement underlying the pathogenesis of COVID-19 cardiovascular complications.	Cardiovasc Endocrinol Metab
32803145	Is it infection or rather vascular inflammation? Game-changer insights and recommendations from patterns of multi-organ involvement and affected subgroups in COVID-19.	Cardiovasc Endocrinol Metab
32803143	Obese communities among the best predictors of COVID-19-related deaths.	Cardiovasc Endocrinol Metab
32802995	Changing epidemiology of SARS-CoV in the context of COVID-19 pandemic.	J Prev Med Hyg
32802982	"Virtual screening, molecular docking studies and DFT calculations of FDA approved compounds similar to the non-nucleoside reverse transcriptase inhibitor (NNRTI) efavirenz."	Heliyon
32802981	Searching potential antiviral candidates for the treatment of the 2019 novel coronavirus based on DFT calculations and molecular docking.	Heliyon
32802902	Genome-wide computational prediction of miRNAs in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) revealed target genes involved in pulmonary vasculature and antiviral innate immunity.	Mol Biol Res Commun
32802896	The Application of Single-Cell RNA Sequencing in Vaccinology.	J Immunol Res
32802325	Cardiovascular involvement during COVID-19 and clinical implications in elderly patients. A review.	Ann Med Surg (Lond)
32802318	Potential chimeric peptides to block the SARS-CoV-2 spike receptor-binding domain.	F1000Res
32802142	"COVID-19: age, Interleukin-6, C-reactive protein, and lymphocytes as key clues from a multicentre retrospective study."	Immun Ageing
32802131	Network Pharmacology Integrated Molecular Docking Reveals the Mechanism of Anisodamine Hydrobromide Injection against Novel Coronavirus Pneumonia.	Evid Based Complement Alternat Med
32801801	Effect of SARS-CoV-2 Infection on the Microbial Composition of Upper Airway.	Infect Drug Resist
32801787	Role of Monocytes/Macrophages in Covid-19 Pathogenesis: Implications for Therapy.	Infect Drug Resist
32801356	A COVID-19 mRNA vaccine encoding SARS-CoV-2 virus-like particles induces a strong antiviral-like immune response in mice.	Cell Res
32801052	"Derivatization and combination therapy of current COVID-19 therapeutic agents: a review of mechanistic pathways, adverse effects, and binding sites."	Drug Discov Today
32800504	"Severe Acute Respiratory Syndrome Coronavirus (SARS, SARS CoV)."	Dis Mon
32800450	Are people with uncontrolled diabetes mellitus at high risk of reinfections with COVID-19?	Prim Care Diabetes
32799894	Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19) - anatomic pathology perspective on current knowledge.	Diagn Pathol
32799761	"In silico molecular investigations of pyridine N-Oxide compounds as potential inhibitors of SARS-CoV-2: 3D QSAR, molecular docking modeling, and ADMET screening."	J Biomol Struct Dyn
32799433	Animal coronaviruses and SARS-CoV-2.	Transbound Emerg Dis
32799423	Effect of Common Medications on the Expression of SARS-CoV-2 Entry Receptors in Kidney Tissue.	Clin Transl Sci
32798789	Potent inhibitors of SARS-CoV-2 3C-like protease derived from N-substituted isatin compounds.	Eur J Med Chem
32798769	"From SARS to SARS-CoV-2, insights on structure, pathogenicity and immunity aspects of pandemic human coronaviruses."	Infect Genet Evol
32798445	Replication-Competent Vesicular Stomatitis Virus Vaccine Vector Protects against SARS-CoV-2-Mediated Pathogenesis in Mice.	Cell Host Microbe
32798373	Molecular Docking and Virtual Screening Based Prediction of Drugs for COVID-19.	Comb Chem High Throughput Screen
32798347	"Beyond Fever, Cough and Dyspnea: The Neurology of COVID-19."	J Assoc Physicians India
32798244	"Protein expression of angiotensin-converting enzyme 2, a SARS-CoV-2-specific receptor, in fetal and placental tissues throughout gestation: new insight for perinatal counseling."	Ultrasound Obstet Gynecol
32798222	Plasma From Recovered COVID-19 Patients Inhibits Spike Protein Binding to ACE2 in a Microsphere-Based Inhibition Assay.	J Infect Dis
32798019	Therapeutic options of TCM for organ injuries associated with COVID-19 and the underlying mechanism.	Phytomedicine
32797762	The role of the allergist/immunologist in the COVID-19 pandemic: A Janus-faced presentation.	Allergy Asthma Proc
32797732	Virtual Boot Camp: COVID-19 evolution and structural biology.	Biochem Mol Biol Educ
32797724	The potential involvement of P2X7 receptor in COVID-19 pathogenesis: A new therapeutic target?	Scand J Immunol
32797326	"A narrative review of the potential pharmacological influence and safety of ibuprofen on coronavirus disease 19 (COVID-19), ACE2, and the immune system: a dichotomy of expectation and reality."	Inflammopharmacology
32797103	Footprint of the host restriction factors APOBEC3 on the genome of human viruses.	PLoS Pathog
32796814	Adaptive immune responses to SARS-CoV-2 infection in severe versus mild individuals.	Signal Transduct Target Ther
32796683	Small Molecule Inhibitors in the Treatment of Rheumatoid Arthritis and Beyond: Latest Updates and Potential Strategy for Fighting COVID-19.	Cells
32796155	Heterogeneous antibodies against SARS-CoV-2 spike receptor binding domain and nucleocapsid with implications for COVID-19 immunity.	JCI Insight
32795835	Is there a role for insulin-like growth factor inhibition in the treatment of COVID-19-related adult respiratory distress syndrome?	Med Hypotheses
32795834	IL-17A and TNF-alpha as potential biomarkers for acute respiratory distress syndrome and mortality in patients with obesity and COVID-19.	Med Hypotheses
32795833	SARS-CoV-2 infection and impact on female genital tract: An untested hypothesis.	Med Hypotheses
32795832	Mitochondrial-targeted ubiquinone: A potential treatment for COVID-19.	Med Hypotheses
32795831	Apparent difference in fatalities between Central Europe and East Asia due to SARS-COV-2 and COVID-19: Four hypotheses for possible explanation.	Med Hypotheses
32795830	Autoimmunity to ACE2 as a possible cause of tissue inflammation in Covid-19.	Med Hypotheses
32795359	Potential therapeutic application of mesenchymal stem cell-derived exosomes in SARS-CoV-2 pneumonia.	Stem Cell Res Ther
32795148	"Protein reliability analysis and virtual screening of natural inhibitors for SARS-CoV-2 main protease (M(pro)) through docking, molecular mechanic & dynamic, and ADMET profiling."	J Biomol Struct Dyn
32795093	Genetic Associations With Plasma Angiotensin Converting Enzyme 2 Concentration: Potential Relevance to COVID-19 Risk.	Circulation
32795091	Myocyte-Specific Upregulation of ACE2 in Cardiovascular Disease: Implications for SARS-CoV-2-Mediated Myocarditis.	Circulation
32794723	Biological Rationale for the Repurposing of BCG Vaccine against SARS-CoV-2.	J Proteome Res
32794348	Mismatch between circulating cytokines and spontaneous cytokine production by leukocytes in hyperinflammatory COVID-19.	J Leukoc Biol
32794346	Receptor utilization of angiotensin-converting enzyme 2 (ACE2) indicates a narrower host range of SARS-CoV-2 than that of SARS-CoV.	Transbound Emerg Dis
32794180	IL-18 and infections: Is there a role for targeted therapies?	J Cell Physiol
32793246	Mechanisms Underlying Potential Therapeutic Approaches for COVID-19.	Front Immunol
32793244	COVID-19: Underlying Adipokine Storm and Angiotensin 1-7 Umbrella.	Front Immunol
32793223	The Effects of Type 2 Diabetes Mellitus on Organ Metabolism and the Immune System.	Front Immunol
32793182	Geographic and Genomic Distribution of SARS-CoV-2 Mutations.	Front Microbiol
32793181	Quinolines-Based SARS-CoV-2 3CLpro and RdRp Inhibitors and Spike-RBD-ACE2 Inhibitor for Drug-Repurposing Against COVID-19: An in silico Analysis.	Front Microbiol
32793108	"The Consequences of Coronavirus-Induced Cytokine Storm Are Associated With Neurological Diseases, Which May Be Preventable."	Front Neurol
32792942	"Evidence for the Effectiveness of Remdesivir (GS-5734), a Nucleoside-Analog Antiviral Drug in the Inhibition of I K(M) or I K(DR) and in the Stimulation of I MEP."	Front Pharmacol
32792851	Immune Response and COVID-19: A mirror image of Sepsis.	Int J Biol Sci
32792611	Vitamin D deficiency in African Americans is associated with a high risk of severe disease and mortality by SARS-CoV-2.	J Hum Hypertens
32792288	Hyperinflammation and the utility of immunomodulatory medications in children with COVID-19.	Paediatr Respir Rev
32792043	COVID-19 Compared to Other Pandemic Diseases.	Rambam Maimonides Med J
32791978	Sequence-based prediction of SARS-CoV-2 vaccine targets using a mass spectrometry-based bioinformatics predictor identifies immunogenic T cell epitopes.	Genome Med
32791568	Vascular endothelial injury exacerbates coronavirus disease 2019: The role of endothelial glycocalyx protection.	Microcirculation
32791504	Association of Coronavirus Disease 2019 and Stroke: A Rising Concern.	Neuroepidemiology
32791497	"Obesity and COVID-19: A Perspective from the European Association for the Study of Obesity on Immunological Perturbations, Therapeutic Challenges, and Opportunities in Obesity."	Obes Facts
32791240	Repurposing of SARS-CoV nucleocapsid protein specific nuclease resistant RNA aptamer for therapeutics against SARS-CoV-2.	Infect Genet Evol
32791213	Dexamethasone: A boon for critically ill COVID-19 patients?	Travel Med Infect Dis
32791137	ACE deletion allele is associated with susceptibility to SARS-CoV-2 infection and mortality rate: An epidemiological study in the Asian population.	Clin Chim Acta
32791036	Acute SARS-CoV-2 Infection Impairs Dendritic Cell and T Cell Responses.	Immunity
32790936	Nicotine and the nicotinic cholinergic system in COVID-19.	FEBS J
32790406	Does SARS-CoV-2 Bind to Human ACE2 More Strongly Than Does SARS-CoV?	J Phys Chem B
32790379	Interdiction of Protein Folding for Therapeutic Drug Development in SARS CoV-2.	J Phys Chem B
32790362	Shell Disorder Analysis Suggests That Pangolins Offered a Window for a Silent Spread of an Attenuated SARS-CoV-2 Precursor among Humans.	J Proteome Res
32790309	COVID-19: Nanomedicine Uncovers Blood-Clot Mystery.	J Proteome Res
32790205	Impact of COVID-19 and other viruses on reproductive health.	Andrologia
32790021	"COVID-19, ketoacidosis and new-onset diabetes: Are there possible cause and effect relationships among them?"	Diabetes Obes Metab
32789839	"Cardiovascular disease during the COVID-19 pandemic: Think ahead, protect hearts, reduce mortality."	Cardiol J
32789802	Fighting the War Against COVID-19 via Cell-Based Regenerative Medicine: Lessons Learned from 1918 Spanish Flu and Other Previous Pandemics.	Stem Cell Rev Rep
32789663	Interleukin-6 Blocking vs. JAK-STAT Inhibition for Prevention of Lung Injury in Patients with COVID-19.	Infect Dis Ther
32789582	Computational analysis of complement inhibitor compstatin using molecular dynamics.	J Mol Model
32788852	Anti-inflammatory Properties of Stingless Bee Honey May Reduce the Severity of Pulmonary Manifestations in COVID-19 Infections.	Malays J Med Sci
32788834	The renin angiotensin aldosterone system and COVID-19.	Saudi Pharm J
32788748	Single-cell landscape of immunological responses in patients with COVID-19.	Nat Immunol
32788708	The type I interferon response in COVID-19: implications for treatment.	Nat Rev Immunol
32788586	Potentially modifiable factors to reduce severity of COVID-19 in type 2 diabetes.	Nutr Diabetes
32788344	Serum Protein Profiling Reveals a Landscape of Inflammation and Immune Signaling in Early-stage COVID-19 Infection.	Mol Cell Proteomics
32788324	SARS-CoV-2 on the ocular surface: is it truly a novel transmission route?	Br J Ophthalmol
32788312	SARS-CoV-2 and the pandemic of COVID-19.	Postgrad Med J
32788292	Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans.	Science
32788194	Optimized Pseudotyping Conditions for the SARS-COV-2 Spike Glycoprotein.	J Virol
32788164	Is there a smoker's paradox in COVID-19?	BMJ Evid Based Med
32788101	"The hypercoagulable state in COVID-19: Incidence, pathophysiology, and management."	Thromb Res
32788071	Comprehensive review of coronavirus disease 2019 (COVID-19).	Biomed J
32787748	"Pentoxifylline and Oxypurinol: Potential Drugs to Prevent the ""Cytokine Release (Storm) Syndrome"" Caused by SARS-CoV-2?"	Curr Pharm Des
32787684	Ligand and structure-based virtual screening applied to the SARS-CoV-2 main protease: an in silico repurposing study.	Future Med Chem
32787337	Repurposing Low-Molecular-Weight Drugs against the Main Protease of Severe Acute Respiratory Syndrome Coronavirus 2.	J Phys Chem Lett
32787330	Dynamic Asymmetry Exposes 2019-nCoV Prefusion Spike.	J Phys Chem Lett
32787328	Screening of Therapeutic Agents for COVID-19 Using Machine Learning and Ensemble Docking Studies.	J Phys Chem Lett
32787225	Structure of Furin Protease Binding to SARS-CoV-2 Spike Glycoprotein and Implications for Potential Targets and Virulence.	J Phys Chem Lett
32786890	Interaction of Drug Candidates with Various SARS-CoV-2 Receptors: An in Silico Study to Combat COVID-19.	J Proteome Res
32786709	Computational Prediction of Mutational Effects on SARS-CoV-2 Binding by Relative Free Energy Calculations.	J Chem Inf Model
32786695	Systemic In Silico Screening in Drug Discovery for Coronavirus Disease (COVID-19) with an Online Interactive Web Server.	J Chem Inf Model
32786692	"Studying the Effects of ACE2 Mutations on the Stability, Dynamics, and Dissociation Process of SARS-CoV-2 S1/hACE2 Complexes."	J Proteome Res
32786685	Molecular Binding Mechanism and Pharmacology Comparative Analysis of Noscapine for Repurposing against SARS-CoV-2 Protease.	J Proteome Res
32786511	Fast Rescoring Protocols to Improve the Performance of Structure-Based Virtual Screening Performed on Protein-Protein Interfaces.	J Chem Inf Model
32786452	Advanced Analysis of Biosensor Data for SARS-CoV-2 RBD and ACE2 Interactions.	Anal Chem
32786343	Fragile Endothelium and Brain Dysregulated Neurochemical Activity in COVID-19.	ACS Chem Neurosci
32786329	Homo sapiens versus SARS-CoV-2.	ACS Chem Neurosci
32786309	Taste and Smell Disorders in COVID-19 Patients: Role of Interleukin-6.	ACS Chem Neurosci
32786258	Chemical Probes for Blocking of Influenza A M2 Wild-type and S31N Channels.	ACS Chem Biol
32786014	Might SARS-CoV-2 Have Arisen via Serial Passage through an Animal Host or Cell Culture?: A potential explanation for much of the novel coronavirus' distinctive genome.	Bioessays
32785948	How close is SARS-CoV-2 to canine and feline coronaviruses?	J Small Anim Pract
32785920	Thrombosis and Hemostasis Issues in Cancer Patients with COVID-19.	Semin Thromb Hemost
32785687	Crippling life support for SARS-CoV-2 and other viruses through synthetic lethality.	J Cell Biol
32785274	Structural insight into the role of novel SARS-CoV-2 E protein: A potential target for vaccine development and other therapeutic strategies.	PLoS One
32785209	Molecular epidemiology of SARS-CoV-2: a review of current data on genetic variability of the virus.	Pol Arch Intern Med
32784899	SARS-CoV-2 Entry Inhibitors: Small Molecules and Peptides Targeting Virus or Host Cells.	Int J Mol Sci
32784826	Preliminary Post-Mortem COVID-19 Evidence of Endothelial Injury and Factor VIII Hyperexpression.	Diagnostics (Basel)
32784802	Expression Profile of SARS-CoV-2 Host Receptors in Human Pancreatic Islets Revealed Upregulation of ACE2 in Diabetic Donors.	Biology (Basel)
32784543	"Are the Clinical Presentations (Phenotypes) of Gitelman's and Bartter's Syndromes Gene Mutations Driven by Their Effects on Intracellular pH, Their ""pH"" Enotype?"	Int J Mol Sci
32784463	The Antiaging Effect of Active Fractions and Ent-11alpha-Hydroxy-15-Oxo-Kaur-16-En-19-Oic Acid Isolated from Adenostemma lavenia (L.) O. Kuntze at the Cellular Level.	Antioxidants (Basel)
32784290	COVID-19 severity associates with pulmonary redistribution of CD1c+ DCs and inflammatory transitional and nonclassical monocytes.	J Clin Invest
32784125	Natural killer cell responses to emerging viruses of zoonotic origin.	Curr Opin Virol
32783921	Single-Cell Sequencing of Peripheral Mononuclear Cells Reveals Distinct Immune Response Landscapes of COVID-19 and Influenza Patients.	Immunity
32783919	A Single Immunization with Nucleoside-Modified mRNA Vaccines Elicits Strong Cellular and Humoral Immune Responses against SARS-CoV-2 in Mice.	Immunity
32783916	Structural Basis for Helicase-Polymerase Coupling in the SARS-CoV-2 Replication-Transcription Complex.	Cell
32783758	ACE2 (Angiotensin-Converting Enzyme 2) in Cardiopulmonary Diseases: Ramifications for the Control of SARS-CoV-2.	Hypertension
32783700	"Product of natural evolution (SARS, MERS, and SARS-CoV-2); deadly diseases, from SARS to SARS-CoV-2."	Hum Vaccin Immunother
32783643	Host-directed therapies: a potential solution to combat COVID-19.	Expert Opin Biol Ther
32783619	Role of the renin-angiotensin system in the development of severe COVID-19 in hypertensive patients.	Am J Physiol Lung Cell Mol Physiol
32783615	First contact: the role of respiratory cilia in host-pathogen interactions in the airways.	Am J Physiol Lung Cell Mol Physiol
32783611	Physiology in Perspective: A Key Role of Physiology in Understanding COVID-19.	Physiology (Bethesda)
32783610	Pathophysiology of COVID-19: Mechanisms Underlying Disease Severity and Progression.	Physiology (Bethesda)
32783352	Antiviral Activity of Nanomaterials against Coronaviruses.	Macromol Biosci
32783247	Tannins inhibit SARS-CoV-2 through binding with catalytic dyad residues of 3CL(pro) : An in silico approach with 19 structural different hydrolysable tannins.	J Food Biochem
32783196	Anti-inflammatory and antiviral roles of hydrogen sulfide: Rationale for considering H2 S donors in COVID-19 therapy.	Br J Pharmacol
32783136	SARS-CoV-2 and the next generations: which impact on reproductive tissues?	J Assist Reprod Genet
32782358	The role of IgG Fc receptors in antibody-dependent enhancement.	Nat Rev Immunol
32782353	Antibody response to SARS-CoV-2 - sustained after all?	Nat Rev Immunol
32781796	Arginine and Endothelial Function.	Biomedicines
32781672	SARS-CoV-2 Consensus-Sequence and Matching Overlapping Peptides Design for COVID19 Immune Studies and Vaccine Development.	Vaccines (Basel)
32781617	"Tomorrow Never Dies: Recent Advances in Diagnosis, Treatment, and Prevention Modalities against Coronavirus (COVID-19) amid Controversies."	Diseases
32781614	Second Update for Anaesthetists on Clinical Features of COVID-19 Patients and Relevant Management.	J Clin Med
32781571	"Investigating Virological, Immunological, and Pathological Avenues to Identify Potential Targets for Developing COVID-19 Treatment and Prevention Strategies."	Vaccines (Basel)
32780783	Global cataloguing of variations in untranslated regions of viral genome and prediction of key host RNA binding protein-microRNA interactions modulating genome stability in SARS-CoV-2.	PLoS One
32780415	COVID-19 Susceptibility in chronic obstructive pulmonary disease.	Eur J Clin Invest
32780299	Mesenchymal stem cells and exosome therapy for COVID-19: current status and future perspective.	Hum Cell
32780273	Pharmacokinetic Basis of the Hydroxychloroquine Response in COVID-19: Implications for Therapy and Prevention.	Eur J Drug Metab Pharmacokinet
32780218	A human circulating immune cell landscape in aging and COVID-19.	Protein Cell
32780149	Advances in research on ACE2 as a receptor for 2019-nCoV.	Cell Mol Life Sci
32779891	Sympathetic activation: a potential link between comorbidities and COVID-19.	FEBS J
32779839	Morbidity and Mortality From COVID-19 Are Not Increased Among Children or Patients With Autoimmune Rheumatic Disease-Possible Immunologic Rationale: Comment on the Article by Henderson et al.	Arthritis Rheumatol
32779813	"Rugosic acid A, derived from Rosa rugosa Thunb., is novel inhibitory agent for NF-kappaB and IL-6/STAT3 axis in acute lung injury model."	Phytother Res
32779810	COVID-19 in pregnancy: Placental and neonatal involvement.	Am J Reprod Immunol
32779790	Obesity as a contributor to immunopathology in pregnant and non-pregnant adults with COVID-19.	Am J Reprod Immunol
32779784	Mutational spectra of SARS-CoV-2 orf1ab polyprotein and signature mutations in the United States of America.	J Med Virol
32779780	Atomistic simulation reveals structural mechanisms underlying D614G spike glycoprotein-enhanced fitness in SARS-COV-2.	J Comput Chem
32779774	Incidence of SARS-CoV-2 infection in inflammatory bowel disease.	J Gastroenterol Hepatol
32779743	Assessment of severity of acute pancreatitis in a Sars-CoV-2 pandemia.	Br J Surg
32779537	Vitamin K deficiency and covid-19.	Scand J Clin Lab Invest
32779445	Profiling of Initial Available SARS-CoV-2 Sequences from Iranian Related COVID-19 Patients.	Cell J
32779341	Understanding immunopathological fallout of human coronavirus infections including COVID-19: Will they cross the path of rheumatologists?	Int J Rheum Dis
32779326	Drugs against SARS-CoV-2: What do we know about their mode of action?	Rev Med Virol
32779305	High affinity interaction of Solanum tuberosum and Brassica juncea residue smoke water compounds with proteins involved in coronavirus infection.	Phytother Res
32779213	COVID-19 and Vitamin D: A lesson from the skin.	Exp Dermatol
32779119	Proton Pump Inhibitors are Risk Factors for Viral Infections: Even for COVID-19?	Clin Drug Investig
32779091	Hypothesized mechanisms explaining poor prognosis in type 2 diabetes patients with COVID-19: a review.	Endocrine
32778962	Repurposing of Kinase Inhibitors for Treatment of COVID-19.	Pharm Res
32778874	Pathogenetic profiling of COVID-19 and SARS-like viruses.	Brief Bioinform
32778421	The outbreak of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): A review of the current global status.	J Infect Public Health
32778178	Coronavirus in cat flea: findings and questions regarding COVID-19.	Parasit Vectors
32778136	A physiological approach to understand the role of respiratory effort in the progression of lung injury in SARS-CoV-2 infection.	Crit Care
32778033	Angiotensin-converting Enzyme 2 roles in the Pathogenesis of COVID-19.	Curr Hypertens Rev
32777758	What every Intensivist should know about COVID-19 associated acute kidney injury.	J Crit Care
32777726	Graphene biosensors for bacterial and viral pathogens.	Biosens Bioelectron
32777300	"Anti-HCV and anti-malaria agent, potential candidates to repurpose for coronavirus infection: Virtual screening, molecular docking, and molecular dynamics simulation study."	Life Sci
32777054	Vascular inflammation and endothelial injury in SARS-CoV-2 infection: The overlooked regulatory cascades implicated by the ACE2 gene cluster.	QJM
32777042	The ApoE Locus and COVID-19: Are We Going Where We Have Been?	J Gerontol A Biol Sci Med Sci
32776905	Anosmia: a missing link in the neuroimmunology of coronavirus disease 2019 (COVID-19).	Rev Neurosci
32776617	COVID-19 as a Blood Clotting Disorder Masquerading as a Respiratory Illness: A Cerebrovascular Perspective and Therapeutic Implications for Stroke Thrombectomy.	J Neuroimaging
32776538	COVID-19 related immune hemolysis and thrombocytopenia.	J Med Virol
32776522	An analysis of SARS-CoV-2 cell entry genes identifies the intestine and colorectal cancer as susceptible tissues.	Br J Surg
32776354	The hidden role of NLRP3 inflammasome in obesity-related COVID-19 exacerbations: Lessons for drug repurposing.	Br J Pharmacol
32776022	Structural Basis for Designing Multiepitope Vaccines Against COVID-19 Infection: In Silico Vaccine Design and Validation.	JMIR Bioinform Biotech
32775582	Dataset for homologous proteins in Drosophila melanogaster for SARS-CoV-2/human interactome.	Data Brief
32774232	Focus on Characteristics of COVID-19 with the Special Reference to the Impact of COVID-19 on the Urogenital System.	Curr Urol
32774178	A comprehensive review of COVID-19 characteristics.	Biol Proced Online
32774170	A gendered magnifying glass on COVID-19.	Clin Mol Allergy
32773989	Repurposing of known anti-virals as potential inhibitors for SARS-CoV-2 main protease using molecular docking analysis.	Bioinformation
32773986	Towards Neuro-CoViD-19.	Bioinformation
32773926	Cardiovascular comorbidities and complications associated with coronavirus disease 2019.	Med J Armed Forces India
32773643	Genomic variance of Open Reading Frames (ORFs) and Spike protein in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).	J Chin Med Assoc
32773420	Transcriptome & viral growth analysis of SARS-CoV-2-infected Vero CCL-81 cells.	Indian J Med Res
32773332	Viruses and viral epidemics in the metabolic theory of evolution.	Eur Ann Otorhinolaryngol Head Neck Dis
32773261	SARS-CoV 2 and the pathobiology of the respiratory control mechanisms in the brainstem.	J Formos Med Assoc
32773257	Potential influence of Nagella sativa (Black cumin) in reinforcing immune system: A hope to decelerate the COVID-19 pandemic.	Phytomedicine
32773102	"Devilishly radical NETwork in COVID-19: Oxidative stress, neutrophil extracellular traps (NETs), and T cell suppression."	Adv Biol Regul
32773101	Where are we with understanding of COVID-19?	Adv Biol Regul
32773100	NK cells: A double edge sword against SARS-CoV-2.	Adv Biol Regul
32773086	Giovanni Di Guardo: Animal Models and Pathogenetic Insights to Covid-19.	J Comp Pathol
32773024	[Tracing the origins of SARS-COV-2 in coronavirus phylogenies].	Med Sci (Paris)
32772895	Structural insight to hydroxychloroquine-3C-like proteinase complexation from SARS-CoV-2: inhibitor modelling study through molecular docking and MD-simulation study.	J Biomol Struct Dyn
32772892	In silico designing of multi-epitope vaccine construct against human coronavirus infections.	J Biomol Struct Dyn
32772513	Delayed severe cytokine storm and immune cell infiltration in SARS-CoV-2-infected aged Chinese rhesus macaques.	Zool Res
32772478	Androgen sensitivity in COVID-19 and antiandrogens: Prospective data are still needed.	Dermatol Ther
32772343	"Low temperature bacterial expression of the neutral amino acid transporters SLC1A5 (ASCT2), and SLC6A19 (B0AT1)."	Mol Biol Rep
32772313	Anthraquinone Derivatives as an Immune Booster and their Therapeutic Option Against COVID-19.	Nat Prod Bioprospect
32772307	Coronavirus Disease 2019 (COVID-19) and Its Neuroinvasive Capacity: Is It Time for Melatonin?	Cell Mol Neurobiol
32772159	Pulmonary arterial thrombosis as an important complication of COVID-19 pulmonary disease: letter to the editor.	Virchows Arch
32771962	An in-silico approach to study the possible interactions of miRNA between human and SARS-CoV2.	Comput Biol Chem
32771941	Environmental pollutant exposure can exacerbate COVID-19 neurologic symptoms.	Med Hypotheses
32771797	Potential treatment methods targeting 2019-nCoV infection.	Eur J Med Chem
32771700	Functional prediction and comparative population analysis of variants in genes for proteases and innate immunity related to SARS-CoV-2 infection.	Infect Genet Evol
32771682	SARS-CoV-2 and ACE2: The biology and clinical data settling the ARB and ACEI controversy.	EBioMedicine
32771640	Increased Complement Receptor-3 levels in monocytes and granulocytes distinguish COVID-19 patients with pneumonia from those with mild symptoms.	Int J Infect Dis
32771622	Global multi-omics and systems pharmacological strategy unravel the multi-targeted therapeutic potential of natural bioactive molecules against COVID-19: An in silico approach.	Genomics
32771430	Analysis of codon usage of severe acute respiratory syndrome corona virus 2 (SARS-CoV-2) and its adaptability in dog.	Virus Res
32771409	Pathogenesis of SARS-CoV-2 induced cardiac injury from the perspective of the virus.	J Mol Cell Cardiol
32771304	Modeling the viral dynamics of SARS-CoV-2 infection.	Math Biosci
32771236	SARS-CoV2 coronavirus: so far polite with children. Debatable immunological and non-immunological evidence.	Allergol Immunopathol (Madr)
32770858	"Updated information on new coronavirus disease 2019 occurrence, drugs, and prediction of a potential receptor."	J Biochem Mol Toxicol
32770768	The role of DBP gene polymorphisms in the prevalence of new coronavirus disease 2019 infection and mortality rate.	J Med Virol
32770758	"Gender differences in the battle against COVID-19: Impact of genetics, comorbidities, inflammation and lifestyle on differences in outcomes."	Int J Clin Pract
32770582	Elucidating the microscopic and computational techniques to study the structure and pathology of SARS-CoVs.	Microsc Res Tech
32770567	Epigallocatechin gallate and theaflavin gallate interaction in SARS-CoV-2 spike-protein central channel with reference to the hydroxychloroquine interaction: Bioinformatics and molecular docking study.	Drug Dev Res
32770540	Trusting a gut feeling: the potential of a newly refined human intestinal enteroid model to evaluate viral-host interactions.	J Physiol
32770392	"(1)H, (13)C, and (15)N backbone chemical shift assignments of the nucleic acid-binding domain of SARS-CoV-2 non-structural protein 3e."	Biomol NMR Assign
32770235	Cerebrospinal fluid features in SARS-CoV-2 RT-PCR positive patients.	Clin Infect Dis
32769760	The Controversy of Renin-Angiotensin-System Blocker Facilitation Versus Countering COVID-19 Infection.	J Cardiovasc Pharmacol
32769685	"Immunity, inflammation and the vasculature in the COVID-19 era."	J Hypertens
32769503	Risk and prognosis of COVID-19 in patients treated with renin-angiotensin-aldosterone inhibitors.	Eur J Anaesthesiol
32769398	Shedding Light on COVID-19: ADAM17 the Missing Link?	Am J Ther
32769050	Repurposing approved drugs as potential inhibitors of 3CL-protease of SARS-CoV-2: Virtual screening and structure based drug design.	Comput Biol Chem
32768974	Outbreak of COVID-19: An emerging global pandemic threat.	Biomed Pharmacother
32768893	The possible immunoregulatory and anti-inflammatory effects of selective serotonin reuptake inhibitors in coronavirus disease patients.	Med Hypotheses
32768882	Targeting SARS-CoV2 Spike Protein Receptor Binding Domain by Therapeutic Antibodies.	Biomed Pharmacother
32768772	Chloroquine kills hair cells in zebrafish lateral line and murine cochlear cultures: Implications for ototoxicity.	Hear Res
32768697	Vitamin D3 and K2 and their potential contribution to reducing the COVID-19 mortality rate.	Int J Infect Dis
32768580	Structural analysis of ACE2 variant N720D demonstrates a higher binding affinity to TMPRSS2.	Life Sci
32768565	COVID-19: Time to exonerate the pangolin from the transmission of SARS-CoV-2 to humans.	Infect Genet Evol
32768503	In silico pharmacokinetic and molecular docking studies of natural flavonoids and synthetic indole chalcones against essential proteins of SARS-CoV-2.	Eur J Pharmacol
32768490	Melatonin potentials against viral infections including COVID-19: Current evidence and new findings.	Virus Res
32768223	Coronaviruses in cats and other companion animals: Where does SARS-CoV-2/COVID-19 fit?	Vet Microbiol
32767940	Withdrawal Notice: Recent Discovery for Inhibitors Targeting in SARS-CoV-2 and Developed anti-NCP	Mini Rev Med Chem
32767936	Possible Targets and Therapies of SARS-CoV-2 Infection.	Mini Rev Med Chem
32767929	Theoretical Study of the Molecular Mechanism of Maxingyigan Decoction Against COVID-19: Network Pharmacology-based Strategy.	Comb Chem High Throughput Screen
32767925	Direct Targets and Subsequent Pathways for Molecular Hydrogen to Exert Multiple Functions: Focusing on Interventions in Radical Reactions.	Curr Pharm Des
32767823	Use of inhibitors of the renin-angiotensin system in hypertensive patients and COVID-19 severity: A systematic review and meta-analysis.	J Clin Pharm Ther
32767801	Renin-angiotensin II-aldosterone axis in SARS-CoV-2-associated xerostomia.	Oral Dis
32767684	Comparative analysis of antiviral efficacy of FDA-approved drugs against SARS-CoV-2 in human lung cells.	J Med Virol
32767348	Inhibitory effects of Vitamin D on inflammation and IL-6 release. A further support for COVID-19 management?	Eur Rev Med Pharmacol Sci
32767317	Speculative clues on Myasthenia gravis and COVID-19.	Eur Rev Med Pharmacol Sci
32767193	ACE polymorphism and COVID-19 outcome.	Endocrine
32767095	"Coronavirus (Covid-19) sepsis: revisiting mitochondrial dysfunction in pathogenesis, aging, inflammation, and mortality."	Inflamm Res
32766805	Brave New Lungs: Aging in the Shadow of COVID-19.	J Gerontol B Psychol Sci Soc Sci
32766418	SARS-CoV-2-associated Takotsubo is not necessarily triggered by the infection.	Int J Cardiol Heart Vasc
32766284	Covid-19 Kills More Men Than Women: An Overview of Possible Reasons.	Front Cardiovasc Med
32766256	Preventing Mortality in COVID-19 Patients: Which Cytokine to Target in a Raging Storm?	Front Cell Dev Biol
32765942	Age-induced NLRP3 Inflammasome Over-activation Increases Lethality of SARS-CoV-2 Pneumonia in Elderly Patients.	Aging Dis
32765941	Bioactive Lipids as Mediators of the Beneficial Action(s) of Mesenchymal Stem Cells in COVID-19.	Aging Dis
32765940	Decreased Naive T-cell Production Leading to Cytokine Storm as Cause of Increased COVID-19 Severity with Comorbidities.	Aging Dis
32765939	COVID-19 and Senotherapeutics: Any Role for the Naturally-occurring Dipeptide Carnosine?	Aging Dis
32765938	"Potential Using of Fat-derived Stromal Cells in the Treatment of Active Disease, and also, in Both Pre- and Post-Periods in COVID-19."	Aging Dis
32765844	In silico screening of known small molecules to bind ACE2 specific RBD on Spike glycoprotein of SARS-CoV-2 for repurposing against COVID-19.	F1000Res
32765822	Genus-specific pattern of intrinsically disordered central regions in the nucleocapsid protein of coronaviruses.	Comput Struct Biotechnol J
32765596	Natural Polymorphisms Are Present in the Furin Cleavage Site of the SARS-CoV-2 Spike Glycoprotein.	Front Genet
32765592	"Epigenetic Regulator miRNA Pattern Differences Among SARS-CoV, SARS-CoV-2, and SARS-CoV-2 World-Wide Isolates Delineated the Mystery Behind the Epic Pathogenicity and Distinct Clinical Characteristics of Pandemic COVID-19."	Front Genet
32765482	Therapeutic Strategies Against COVID-19 and Structural Characterization of SARS-CoV-2: A Review.	Front Microbiol
32765279	Selective Estrogen Receptor Modulators in COVID-19: A Possible Therapeutic Option?	Front Pharmacol
32765270	The Folate Concentration and/or Folic Acid Metabolites in Plasma as Factor for COVID-19 Infection.	Front Pharmacol
32765013	Molecular Basis for Pathogenicity of Human Coronaviruses.	Infect Drug Resist
32764907	COVID-19: The Influence of ACE Genotype and ACE-I and ARBs on the Course of SARS-CoV-2 Infection in Elderly Patients.	Clin Interv Aging
32764693	Morphogenesis and cytopathic effect of SARS-CoV-2 infection in human airway epithelial cells.	Nat Commun
32764665	Single-cell analysis of two severe COVID-19 patients reveals a monocyte-associated and tocilizumab-responding cytokine storm.	Nat Commun
32764519	"Phosphate Derivatives of 3-Carboxyacylbetulin: SynThesis, In Vitro Anti-HIV and Molecular Docking Study."	Biomolecules
32764506	"Wide Diversity of Coronaviruses in Frugivorous and Insectivorous Bat Species: A Pilot Study in Guinea, West Africa."	Viruses
32764454	SARS-CoV-2 Infection and Lung Cancer: Potential Therapeutic Modalities.	Cancers (Basel)
32764417	The Global Emergency of Novel Coronavirus (SARS-CoV-2): An Update of the Current Status and Forecasting.	Int J Environ Res Public Health
32764275	Postulated Adjuvant Therapeutic Strategies for COVID-19.	J Pers Med
32764148	Inhibition of PIKfyve kinase prevents infection by Zaire ebolavirus and SARS-CoV-2.	Proc Natl Acad Sci U S A
32764120	Nuclear Imaging of Bacterial Infection: The State of the Art and Future Directions.	J Nucl Med
32764118	Oestrogen-mediated upregulation of the Mas receptor contributes to sex differences in acute lung injury and lung vascular barrier regulation.	Eur Respir J
32763970	Impaired NLRP3 inflammasome activation/pyroptosis leads to robust inflammatory cell death via caspase-8/RIPK3 during coronavirus infection.	J Biol Chem
32763951	"A Comprehensive, Flexible Collection of SARS-CoV-2 Coding Regions."	G3 (Bethesda)
32763945	"Genome Sequences of Six SARS-CoV-2 Strains Isolated in Morocco, Obtained Using Oxford Nanopore MinION Technology."	Microbiol Resour Announc
32763915	A molecular pore spans the double membrane of the coronavirus replication organelle.	Science
32763662	A putative role for the tobacco mosaic virus in smokers' resistance to COVID-19.	Med Hypotheses
32763661	Why do children seem to be more protected against COVID-19? A hypothesis.	Med Hypotheses
32763660	Ankaferd hemostat (ABS) as a potential mucosal topical agent for the management of COVID-19 syndrome based on its PAR-1 inhibitory effect and oestrogen content.	Med Hypotheses
32763657	Possible mechanisms responsible for acute coronary events in COVID-19.	Med Hypotheses
32763421	Editoral commentary: Cardiac involvement in SARS-CoV-2-associated inflammatory syndromes.	Trends Cardiovasc Med
32763356	Formation of lamellar body-like structure may be an initiator of didecyldimethylammonium chloride-induced toxic response.	Toxicol Appl Pharmacol
32763344	Susceptibility of SARS-CoV-2 to UV irradiation.	Am J Infect Control
32763313	Remdesivir triphosphate can efficiently inhibit the RNA-dependent RNA polymerase from various flaviviruses.	Antiviral Res
32763302	Coronavirus diseases 2019: Current biological situation and potential therapeutic perspective.	Eur J Pharmacol
32763298	Molecular effects and retinopathy induced by hydroxychloroquine during SARS-CoV-2 therapy: Role of CYP450 isoforms and epigenetic modulations.	Eur J Pharmacol
32763128	"The eye: ""An organ that must not be forgotten in coronavirus disease 2019 (COVID-2019) pandemic""."	J Optom
32762891	"Relation Among Right Ventricular Dysfunction, Lung Damage, and Mortality in Patients With COVID-19."	JACC Cardiovasc Imaging
32762876	Lung ACE2 and ADAM17 in pulmonary arterial hypertension: Implications for COVID-19?	J Heart Lung Transplant
32762609	A Novel Hypothesis for Original Antigenic Sin in the Severe Disease of SARS-CoV-2 Infection.	Monoclon Antib Immunodiagn Immunother
32762581	Immunotherapy for SARS-CoV-2: potential opportunities.	Expert Opin Biol Ther
32762561	Diabetes and COVID-19 risk: an miRNA perspective.	Am J Physiol Heart Circ Physiol
32762537	"In silico virtual screening, characterization, docking and molecular dynamics studies of crucial SARS-CoV-2 proteins."	J Biomol Struct Dyn
32762511	In silico investigation of phytoconstituents from Indian medicinal herb 'Tinospora cordifolia (giloy)' against SARS-CoV-2 (COVID-19) by molecular dynamics approach.	J Biomol Struct Dyn
32762443	Endothelial Dysfunction and Thrombosis in Patients With COVID-19-Brief Report.	Arterioscler Thromb Vasc Biol
32762417	"Effect of mutation on structure, function and dynamics of receptor binding domain of human SARS-CoV-2 with host cell receptor ACE2: a molecular dynamics simulations study."	J Biomol Struct Dyn
32762411	Identification of polyphenols from Broussonetia papyrifera as SARS CoV-2 main protease inhibitors using in silico docking and molecular dynamics simulation approaches.	J Biomol Struct Dyn
32762349	COVID-19 and Diabetes: What Should We Expect?	J Diabetes Sci Technol
32762250	Viral Infections of the Upper Airway in the Setting of COVID-19: A Primer for Rhinologists.	Am J Rhinol Allergy
32762171	[Comparative analysis of structural characteristics and epitopes in S proteins between SARS-CoV-2 and SARS-CoV].	Zhejiang Da Xue Xue Bao Yi Xue Ban
32762165	[Replication and transmission mechanisms of highly pathogenic human coronavirus].	Zhejiang Da Xue Xue Bao Yi Xue Ban
32762158	[Coagulation dysfunction in COVID-19].	Zhejiang Da Xue Xue Bao Yi Xue Ban
32762135	Cabbage and fermented vegetables: From death rate heterogeneity in countries to candidates for mitigation strategies of severe COVID-19.	Allergy
32762099	"The relationship between human coronaviruses, asthma and allergy-An unresolved dilemma."	Clin Exp Allergy
32762081	Is the COVID-19 thrombotic catastrophe complement-connected?	J Thromb Haemost
32761914	"Infectious/parainfectious, nonvascular, nonhypoxic central nervous system disease in 48 COVID-19 patients."	J Med Virol
32761908	The arrival and spread of SARS-CoV-2 in Colombia.	J Med Virol
32761894	COVID-19 and immunological regulations - from basic and translational aspects to clinical implications.	J Dtsch Dermatol Ges
32761647	Snake venom-derived bradykinin-potentiating peptides: A promising therapy for COVID-19?	Drug Dev Res
32761524	Is hypoxemia explained by intracardiac or intrapulmonary shunt in COVID-19-related acute respiratory distress syndrome?	Ann Intensive Care
32761523	Potential treatment of COVID-19 by inhibitors of human dihydroorotate dehydrogenase.	Protein Cell
32761452	Sex differences in COVID-19 mortality: opportunity to develop HSP27 (HSPB1) immunotherapy to treat hyper-inflammation?	Cell Stress Chaperones
32761221	COVID-19 and the Coombs test.	Blood
32760915	Glucocorticoids save lives in COVID-19 patients.	Int J Biol Sci
32760740	"COVID-19, State of the Adult and Pediatric Heart: From Myocardial Injury to Cardiac Effect of Potential Therapeutic Intervention."	Front Cardiovasc Med
32760409	Could the Induction of Trained Immunity by beta-Glucan Serve as a Defense Against COVID-19?	Front Immunol
32760408	Prevention of Severe Coronavirus Disease 2019 Outcomes by Reducing Low-Grade Inflammation in High-Risk Categories.	Front Immunol
32760407	High-Dose Intravenous Immunoglobulins in the Treatment of Severe Acute Viral Pneumonia: The Known Mechanisms and Clinical Effects.	Front Immunol
32760352	COVID-19 and Diabetes: The Importance of Controlling RAGE.	Front Endocrinol (Lausanne)
32760213	Bioinformatic Analysis of Correlation between Immune Infiltration and COVID-19 in Cancer Patients.	Int J Biol Sci
32760206	Glucocorticoids improve severe or critical COVID-19 by activating ACE2 and reducing IL-6 levels.	Int J Biol Sci
32759995	Genetic variability in the expression of the SARS-CoV-2 host cell entry factors across populations.	Genes Immun
32759966	A novel receptor-binding domain (RBD)-based mRNA vaccine against SARS-CoV-2.	Cell Res
32759839	Is the Host Viral Response and the Immunogenicity of Vaccines Altered in Pregnancy?	Antibodies (Basel)
32759719	COVID-19 and Obesity: Dangerous Liaisons.	J Clin Med
32759645	COVID-19 and the Kidney: From Epidemiology to Clinical Practice.	J Clin Med
32759577	Role of cytotoxic T lymphocytes and interferon-gamma in coronavirus infection: Lessons from murine coronavirus infections in mice.	J Vet Med Sci
32759504	Complement and tissue factor-enriched neutrophil extracellular traps are key drivers in COVID-19 immunothrombosis.	J Clin Invest
32759312	Immunoinformatic approach to assess SARS-CoV-2 protein S epitopes recognised by the most frequent MHC-I alleles in the Brazilian population.	J Clin Pathol
32759311	Molecules in pathogenesis: angiotensin converting enzyme 2 (ACE2).	J Clin Pathol
32759267	"Atazanavir, Alone or in Combination with Ritonavir, Inhibits SARS-CoV-2 Replication and Proinflammatory Cytokine Production."	Antimicrob Agents Chemother
32759260	Similarities and differences between severe COVID-19 pneumonia and anti-MDA-5-positive dermatomyositis-associated rapidly progressive interstitial lung diseases: a challenge for the future.	Ann Rheum Dis
32759017	The importance of cell-mediated immunity in COVID-19 - An opinion.	Med Hypotheses
32759016	Estrogen shields women from COVID-19 complications by reducing ER stress.	Med Hypotheses
32759008	Fenofibrate increases the amount of sulfatide which seems beneficial against Covid-19.	Med Hypotheses
32759007	Prostaglandin D2 as a mediator of lymphopenia and a therapeutic target in COVID-19 disease.	Med Hypotheses
32759006	Low Incidence and Mortality from SARS-CoV-2 in Southern Europe. Proposal of a hypothesis for Arthropod borne Herd immunity.	Med Hypotheses
32758906	Are night shift workers at an increased risk for COVID-19?	Med Hypotheses
32758904	N-acetycysteine: A potential therapeutic agent in COVID-19 infection.	Med Hypotheses
32758903	"Mevalonate pathway, selenoproteins, redox balance, immune system, Covid-19: Reasoning about connections."	Med Hypotheses
32758901	Acute respiratory distress syndrome from Covid-19: A perfect storm from free radicals? Proposal for a new treatment.	Med Hypotheses
32758897	"Ibuprofen, a traditional drug that may impact the course of COVID-19 new effective formulation in nebulizable solution."	Med Hypotheses
32758895	Biofabrication: An interesting tool to create in vitro model for COVID-19 drug targets.	Med Hypotheses
32758889	Rethinking interleukin-6 blockade for treatment of COVID-19.	Med Hypotheses
32758887	Cross-immunity between respiratory coronaviruses may limit COVID-19 fatalities.	Med Hypotheses
32758884	"COVID-19: NAD(+) deficiency may predispose the aged, obese and type2 diabetics to mortality through its effect on SIRT1 activity."	Med Hypotheses
32758881	SARS-CoV-2 and the sympathetic immune response: Dampening inflammation with antihypertensive drugs (Clonidine and Propranolol).	Med Hypotheses
32758877	Cytochrome P450-mediated drug interactions in COVID-19 patients: Current findings and possible mechanisms.	Med Hypotheses
32758876	Unique fibrinogen-binding motifs in the nucleocapsid phosphoprotein of SARS CoV-2: Potential implications in host-pathogen interactions.	Med Hypotheses
32758875	Understanding Covid and the associated post-infectious hyper-inflammatory state (PIMS-TS) in children.	Med Hypotheses
32758873	Why the lower reported prevalence of asthma in patients diagnosed with COVID-19 validates repurposing EDTA solutions to prevent and manage treat COVID-19 disease.	Med Hypotheses
32758871	COVID-19 as a viral functional ACE2 deficiency disorder with ACE2 related multi-organ disease.	Med Hypotheses
32758869	Can COVID-19 induce glioma tumorogenesis through binding cell receptors?	Med Hypotheses
32758675	Immunoinformatic construction of an adenovirus-based modular vaccine platform and its application in the design of a SARS-CoV-2 vaccine.	Infect Genet Evol
32758625	Role of comorbidities like diabetes on severe acute respiratory syndrome coronavirus-2: A review.	Life Sci
32758569	In silico molecular docking analysis for repurposing therapeutics against multiple proteins from SARS-CoV-2.	Eur J Pharmacol
32758306	Selenium and viral infection: are there lessons for COVID-19?	Br J Nutr
32758273	Management of epigenomic networks entailed in coronavirus infections and COVID-19.	Clin Epigenetics
32757470	ACE2 isoform diversity predicts the host susceptibility of SARS-CoV-2.	Transbound Emerg Dis
32757420	Smoking and COVID-19: Similar bronchial ACE2 and TMPRSS2 expression and higher TMPRSS4 expression in current versus never smokers.	Drug Dev Res
32757366	Is pregnancy an immunological contributor to severe or controlled COVID-19 disease?	Am J Reprod Immunol
32757352	The Enzyme-Free Release of Nucleotides from Phosphoramidates Depends Strongly on the Amino Acid.	Angew Chem Int Ed Engl
32757347	Are patients with chronic rhinosinusitis with nasal polyps at a decreased risk of COVID-19 infection?	Int Forum Allergy Rhinol
32757246	"Association of angiotensin converting enzyme inhibitors and angiotensin II receptor blockers with risk of COVID-19, inflammation level, severity, and death in patients with COVID-19: A rapid systematic review and meta-analysis."	Clin Cardiol
32756996	Unique Clusters of Severe Acute Respiratory Syndrome Coronavirus 2 Causing a Large Coronavirus Disease 2019 Outbreak in Hong Kong.	Clin Infect Dis
32756685	Intra- and intermolecular atomic-scale interactions in the receptor binding domain of SARS-CoV-2 spike protein: implication for ACE2 receptor binding.	Phys Chem Chem Phys
32756614	Discovery of sandwich type COVID-19 nucleocapsid protein DNA aptamers.	Chem Commun (Camb)
32756606	Development and simulation of fully glycosylated molecular models of ACE2-Fc fusion proteins and their interaction with the SARS-CoV-2 spike protein binding domain.	PLoS One
32756549	SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness.	Nature
32756480	COVID-19: The Immune Responses and Clinical Therapy Candidates.	Int J Mol Sci
32756323	Gut Microbiota and Liver Interaction through Immune System Cross-Talk: A Comprehensive Review at the Time of the SARS-CoV-2 Pandemic.	J Clin Med
32755992	MECHANISMS IN ENDOCRINOLOGY: Vitamin D and COVID-19.	Eur J Endocrinol
32755724	Placental barrier against COVID-19.	Placenta
32755598	A Carbohydrate-Binding Protein from the Edible Lablab Beans Effectively Blocks the Infections of Influenza Viruses and SARS-CoV-2.	Cell Rep
32755569	Structure of the Pandemic.	Structure
32755537	[Neurological damage linked to coronaviruses : SARS-CoV-2 and other human coronaviruses].	Med Sci (Paris)
32755466	Human Cardiac Mesenchymal Stem Cells Remodel in Disease and Can Regulate Arrhythmia Substrates.	Circ Arrhythm Electrophysiol
32755425	"Coronavirus disease 2019-Historical context, virology, pathogenesis, immunotherapy, and vaccine development."	Hum Vaccin Immunother
32755395	MDM2-Mediated Ubiquitination of Angiotensin-Converting Enzyme 2 Contributes to the Development of Pulmonary Arterial Hypertension.	Circulation
32755325	The potential role of the carotid body in COVID-19.	Am J Physiol Lung Cell Mol Physiol
32755321	Demystifying pulmonary fibrosis.	Am J Physiol Lung Cell Mol Physiol
32755307	SARS-CoV-2 may regulate cellular responses through depletion of specific host miRNAs.	Am J Physiol Lung Cell Mol Physiol
32755302	Can phytotherapy with polyphenols serve as a powerful approach for the prevention and therapy tool of novel coronavirus disease 2019 (COVID-19)?	Am J Physiol Endocrinol Metab
32755094	Coronavirus disease 2019 in critically ill patients: can we re-program the immune system? A primer for Intensivists.	Minerva Anestesiol
32754974	"Review: An insight into coronaviruses: Challenges, security and scope."	Rev Med Virol
32754955	"Astaxanthin, COVID-19 and immune response: Focus on oxidative stress, apoptosis and autophagy."	Phytother Res
32754890	Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2.	Protein Cell
32754823	Human molecular chaperones share with SARS-CoV-2 antigenic epitopes potentially capable of eliciting autoimmunity against endothelial cells: possible role of molecular mimicry in COVID-19.	Cell Stress Chaperones
32754651	SARS-CoV-2 RNA Dependent RNA polymerase (RdRp) - A drug repurposing study.	Heliyon
32754599	nCOVID-19 Pandemic: From Molecular Pathogenesis to Potential Investigational Therapeutics.	Front Cell Dev Biol
32754437	The Current Clinically Relevant Findings on COVID-19 Pandemic.	Anesth Pain Med
32754254	Olfactory and Taste Disorders in Patients with SARS-CoV-2 Infection.	Int Arch Otorhinolaryngol
32754224	Potential mechanism prediction of Cold-Damp Plague Formula against COVID-19 via network pharmacology analysis and molecular docking.	Chin Med
32754165	A Hypothesis for the Possible Role of Zinc in the Immunological Pathways Related to COVID-19 Infection.	Front Immunol
32754164	The Potential Impact of Zinc Supplementation on COVID-19 Pathogenesis.	Front Immunol
32754163	Cytokine Storm in COVID-19: The Current Evidence and Treatment Strategies.	Front Immunol
32754162	The Potential Effect of Novel Coronavirus SARS-CoV-2 on NK Cells; A Perspective on Potential Therapeutic Interventions.	Front Immunol
32754161	Identification of SARS-CoV-2 Cell Entry Inhibitors by Drug Repurposing Using in silico Structure-Based Virtual Screening Approach.	Front Immunol
32754160	Designing Multi-Epitope Vaccines to Combat Emerging Coronavirus Disease 2019 (COVID-19) by Employing Immuno-Informatics Approach.	Front Immunol
32754159	"Cytokine Storm in COVID-19-Immunopathological Mechanisms, Clinical Considerations, and Therapeutic Approaches: The REPROGRAM Consortium Position Paper."	Front Immunol
32754134	An Optimized Metagenomic Approach for Virome Detection of Clinical Pharyngeal Samples With Respiratory Infection.	Front Microbiol
32754056	SARS-CoV-2 Molecular Network Structure.	Front Physiol
32754041	Pathological Aspects of COVID-19 as a Conformational Disease and the Use of Pharmacological Chaperones as a Potential Therapeutic Strategy.	Front Pharmacol
32754004	Expansion of Single Cell Transcriptomics Data of SARS-CoV Infection in Human Bronchial Epithelial Cells to COVID-19.	Biol Proced Online
32753842	"Plasmapheresis, Anti-ACE2 and Anti-FcgammaRII Monoclonal Antibodies: A Possible Treatment for Severe Cases of COVID-19."	Drug Des Devel Ther
32753756	SARS-CoV-2 infects human neural progenitor cells and brain organoids.	Cell Res
32753755	Structure-guided covalent stabilization of coronavirus spike glycoprotein trimers in the closed conformation.	Nat Struct Mol Biol
32753739	COVAN is the new HIVAN: the re-emergence of collapsing glomerulopathy with COVID-19.	Nat Rev Nephrol
32753646	In vitro screening of a FDA approved chemical library reveals potential inhibitors of SARS-CoV-2 replication.	Sci Rep
32753554	Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans.	Science
32753553	Engineering human ACE2 to optimize binding to the spike protein of SARS coronavirus 2.	Science
32753517	"Cytokine storm release syndrome and the prospects for immunotherapy with COVID-19, part 3: The role of GM-CSF."	Cleve Clin J Med
32753457	Computed Tomography Highlights Increased Visceral Adiposity Associated With Critical Illness in COVID-19.	Diabetes Care
32753456	Increased Hepatic ACE2 Expression in NAFL and Diabetes-A Risk for COVID-19 Patients?	Diabetes Care
32753423	Transient monoarthritis and psoriatic skin lesions following COVID-19.	Ann Rheum Dis
32753148	SARS-CoV-2 Infection and COVID-19 During Pregnancy: A Multidisciplinary Review.	Mayo Clin Proc
32753145	Sex Hormones and Novel Corona Virus Infectious Disease (COVID-19).	Mayo Clin Proc
32753048	Comparison of clinical laboratory tests between bacterial sepsis and SARS-CoV-2-associated viral sepsis.	Mil Med Res
32753027	Role of key point Mutations in Receptor Binding Domain of SARS-CoV-2 Spike Glycoprotein.	Infect Disord Drug Targets
32752951	"Molecular docking, molecular dynamics simulations and reactivity, studies on approved drugs library targeting ACE2 and SARS-CoV-2 binding with ACE2."	J Biomol Struct Dyn
32752947	"Predictive modeling by deep learning, virtual screening and molecular dynamics study of natural compounds against SARS-CoV-2 main protease."	J Biomol Struct Dyn
32752944	Current status and strategic possibilities on potential use of combinational drug therapy against COVID-19 caused by SARS-CoV-2.	J Biomol Struct Dyn
32752938	In silico identification of widely used and well-tolerated drugs as potential SARS-CoV-2 3C-like protease and viral RNA-dependent RNA polymerase inhibitors for direct use in clinical trials.	J Biomol Struct Dyn
32752936	Acute respiratory distress syndrome: a life threatening associated complication of SARS-CoV-2 infection inducing COVID-19.	J Biomol Struct Dyn
32752270	Viral Ubiquitin and Ubiquitin-Like Deconjugases-Swiss Army Knives for Infection.	Biomolecules
32752138	"Tobacco, but Not Nicotine and Flavor-Less Electronic Cigarettes, Induces ACE2 and Immune Dysregulation."	Int J Mol Sci
32752129	Effect of Coronavirus Disease 2019 in Pulmonary Circulation. The Particular Scenario of Precapillary Pulmonary Hypertension.	Diagnostics (Basel)
32751841	SARS-CoV-2 and the Nervous System: From Clinical Features to Molecular Mechanisms.	Int J Mol Sci
32751741	COVID-19-Related Coagulopathy-Is Transferrin a Missing Link?	Diagnostics (Basel)
32751194	Newcastle Disease Virus as a Vaccine Vector for SARS-CoV-2.	Pathogens
32750889	"AGTR2, One Possible Novel Key Gene for the Entry of SARS-CoV-2 Into Human Cells."	IEEE/ACM Trans Comput Biol Bioinform
32750451	Metformin and COVID-19: From cellular mechanisms to reduced mortality.	Diabetes Metab
32750438	The immune system as a target for therapy of SARS-CoV-2: A systematic review of the current immunotherapies for COVID-19.	Life Sci
32750366	"An overview of the pathogenic mechanisms involved in severe cases of COVID-19 infection, and the proposal of salicyl-carnosine as a potential drug for its treatment."	Eur J Pharmacol
32750338	On the evolutionary epidemiology of SARS-CoV-2.	Curr Biol
32750333	Complex Autoinflammatory Syndrome Unveils Fundamental Principles of JAK1 Kinase Transcriptional and Biochemical Function.	Immunity
32750256	Expression of SARS-CoV-2 receptor ACE2 and the protease TMPRSS2 suggests susceptibility of the human embryo in the first trimester.	Open Biol
32750190	Review on the coronavirus disease (COVID-19) pandemic: Its outbreak and current status.	Int J Clin Pract
32750187	Insights on 3D Structures of Potential Drug-targeting Proteins of SARS-CoV-2: Application of Cavity Search and Molecular Docking.	Mol Inform
32750141	Mouse model of SARS-CoV-2 reveals inflammatory role of type I interferon signaling.	J Exp Med
32750108	"Endothelial dysfunction in COVID-19: a position paper of the ESC Working Group for Atherosclerosis and Vascular Biology, and the ESC Council of Basic Cardiovascular Science."	Cardiovasc Res
32749914	Resolution of coronavirus disease 2019 (COVID-19).	Expert Rev Anti Infect Ther
32749868	Does Vaping Increase Susceptibility to COVID-19?	Am J Respir Crit Care Med
32749708	Can aldosterone increase interleukin-6 levels in Covid-19 pneumonia?	J Med Virol
32749702	Targeting human TLRs to combat COVID-19: A solution?	J Med Virol
32749662	SARS-CoV-2 nucleocapsid and Nsp3 binding: an in silico study.	Arch Microbiol
32749644	ACE2 and SARS-CoV-2 Infection: Might GLP-1 Receptor Agonists Play a Role?	Diabetes Ther
32749592	Mouse-adapted SARS-CoV-2 replicates efficiently in the upper and lower respiratory tract of BALB/c and C57BL/6J mice.	Protein Cell
32749531	Immune cell puzzle COVID-19: how do SARS-CoV infections contribute to psychiatric diseases?	Eur Arch Psychiatry Clin Neurosci
32749472	"Suppressed anti-inflammatory heat shock response in high-risk COVID-19 patients: lessons from basic research (inclusive bats), light on conceivable therapies."	Clin Sci (Lond)
32749243	Effects of SARS-CoV-2 on the cardiovascular system: More issues to be addressed.	Anatol J Cardiol
32749095	"MAIT Cells in COVID-19: Heroes, Villains, or Both?"	Crit Rev Immunol
32749094	Novel Coronavirus SARS-CoV-2 Target and Disable Natural Killer Cells: Core Immune Effectors for Fighting the Disease.	Crit Rev Immunol
32748969	Evaluation of medicinal herbs as a potential therapeutic option against SARS-CoV-2 targeting its main protease.	Phytother Res
32748812	Evidence-Based Considerations Exploring Relations between SARS-CoV-2 Pandemic and Air Pollution: Involvement of PM2.5-Mediated Up-Regulation of the Viral Receptor ACE-2.	Int J Environ Res Public Health
32748740	Discovery of Potent SARS-CoV-2 Inhibitors from Approved Antiviral Drugs via Docking and Virtual Screening.	Comb Chem High Throughput Screen
32748634	Renin-Angiotensin System Blockade and Mortality in Patients With Hypertension and COVID-19 Infection.	J Cardiovasc Pharmacol Ther
32748336	Current Overview on Hypercoagulability in COVID-19.	Am J Cardiovasc Drugs
32748331	Physiological Relevance of Angiotensin Converting Enzyme 2 As a Metabolic Linker and Therapeutic Implication of Mesenchymal Stem Cells in COVID-19 and Hypertension.	Stem Cell Rev Rep
32748131	Patterns of Gustatory Recovery in Patients Affected by the COVID-19 Outbreak.	Virol Sin
32748128	COVID-19: The crucial role of blood coagulation and fibrinolysis.	Intern Emerg Med
32748124	Endo-Lysosomal Cation Channels and Infectious Diseases.	Rev Physiol Biochem Pharmacol
32748035	Nanotechnology-based antiviral therapeutics.	Drug Deliv Transl Res
32747830	Immune complement and coagulation dysfunction in adverse outcomes of SARS-CoV-2 infection.	Nat Med
32747721	Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19.	Acta Pharmacol Sin
32747425	3C-like protease inhibitors block coronavirus replication in vitro and improve survival in MERS-CoV-infected mice.	Sci Transl Med
32747391	Pathogenesis of COVID-19-induced ARDS: implications for an ageing population.	Eur Respir J
32747165	The concern about ACE/ARB and COVID-19: Time to hold your horses!	J Am Pharm Assoc (2003)
32747157	A cytokine super cyclone in COVID-19 patients with risk factors: the therapeutic potential of BCG immunization.	Cytokine Growth Factor Rev
32747012	"The effects of renin-angiotensin system inhibitors (RASI) in coronavirus disease (COVID-19) with hypertension: A retrospective, single-center trial."	Med Clin (Barc)
32746922	A consideration of publication-derived immune-related associations in Coronavirus and related lung damaging diseases.	J Transl Med
32746720	Deciphering the protein motion of S1 subunit in SARS-CoV-2 spike glycoprotein through integrated computational methods.	J Biomol Struct Dyn
32746637	Flavonoids with inhibitory activity against SARS-CoV-2 3CLpro.	J Enzyme Inhib Med Chem
32746481	Coronavirus Disease-2019 (COVID-19): An Updated Review.	Drug Res (Stuttg)
32745993	Vascular occlusion by neutrophil extracellular traps in COVID-19.	EBioMedicine
32745925	Polyacylated anthocyanins constructively network with catalytic dyad residues of 3CL(pro) of 2019-nCoV than monomeric anthocyanins: A structural-relationship activity study with 10 anthocyanins using in-silico approaches.	J Mol Graph Model
32745829	Orientation of immobilized antigens on common surfaces by a simple computational model: Exposition of SARS-CoV-2 Spike protein RBD epitopes.	Biophys Chem
32745811	Genetic comparison among various coronavirus strains for the identification of potential vaccine targets of SARS-CoV2.	Infect Genet Evol
32745670	New disease old vaccine: Is recombinant BCG vaccine an answer for COVID-19?	Cell Immunol
32745616	"Team sport, power, and combat athletes are at high genetic risk for coronavirus disease-2019 severity."	J Sport Health Sci
32745604	Angiotensin-converting enzyme 2 (ACE2) receptor and SARS-CoV-2: Potential therapeutic targeting.	Eur J Pharmacol
32745548	Structural stability of SARS-CoV-2 3CLpro and identification of quercetin as an inhibitor by experimental screening.	Int J Biol Macromol
32745502	Probing antiviral drugs against SARS-CoV-2 through virus-drug association prediction based on the KATZ method.	Genomics
32745298	Transcriptomics reveal immune downregulation of newts overwhelmed by chytrid co-infection.	Mol Ecol
32745172	Transient Lymphopenia and Interstitial Pneumonia With Endotheliitis in SARS-CoV-2-Infected Macaques.	J Infect Dis
32744884	"Letter to the Editor: COVID-19, Mitochondria, and Interferon."	J Interferon Cytokine Res
32744716	SARS-CoV-2 vs. SARS-CoV-1 management: antibiotics and inflammasome modulators potential.	Eur Rev Med Pharmacol Sci
32744711	Molecular modelling of the antiviral action of Resveratrol derivatives against the activity of two novel SARS CoV-2 and 2019-nCoV receptors.	Eur Rev Med Pharmacol Sci
32744709	From SARS-CoV to SARS-CoV2: a potential guide to better understanding of pathophysiology of the disease and potential therapeutic modality.	Eur Rev Med Pharmacol Sci
32744564	Covid-19 and the Renin Angiotensin System: Implications for the Older Adults.	J Nutr Health Aging
32744561	"COVID-19, Virology and Geroscience: A Perspective."	J Nutr Health Aging
32744465	"Emerging Human Coronavirus Infections (SARS, MERS, and COVID-19): Where They Are Leading Us."	Int Rev Immunol
32744436	Single-cell RNA sequencing analysis of human kidney reveals the presence of ACE2 receptor: A potential pathway of COVID-19 infection.	Mol Genet Genomic Med
32744052	IL-1 induces throboxane-A2 (TxA2) in COVID-19 causing inflammation and micro-thrombi: inhibitory effect of the IL-1 receptor antagonist (IL-1Ra).	J Biol Regul Homeost Agents
32743884	"Blood myeloperoxidase-DNA, a biomarker of early response to SARS-CoV-2 infection?"	Allergy
32743793	COVID-19 and diabetes mellitus: how one pandemic worsens the other.	Rev Endocr Metab Disord
32743639	Application of Bayesian phylogenetic inference modelling for evolutionary genetic analysis and dynamic changes in 2019-nCoV.	Brief Bioinform
32743211	Prediction of Small Molecule Inhibitors Targeting the Severe Acute Respiratory Syndrome Coronavirus-2 RNA-dependent RNA Polymerase.	ACS Omega
32743022	Targeting the cholinergic anti-inflammatory pathway with vagus nerve stimulation in patients with Covid-19?	Bioelectron Med
32742978	Acute Kidney Injury in the 2019 Novel Coronavirus Disease.	Kidney Dis (Basel)
32742855	Is COVID-19 Similar in Pregnant and Non-Pregnant Women?	Cureus
32742818	RdRp mutations are associated with SARS-CoV-2 genome evolution.	PeerJ
32742815	"Understanding genomic diversity, pan-genome, and evolution of SARS-CoV-2."	PeerJ
32742654	Associations of viral ribonucleic acid (RNA) shedding patterns with clinical illness and immune responses in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection.	Clin Transl Immunology
32742618	Why Children are Less Likely to Contract COVID-19 Infection than Adults?	Int J Prev Med
32742617	COVID-19 Solution.	Int J Prev Med
32742564	Stem cell therapy for COVID-19 and other respiratory diseases: Global trends of clinical trials.	World J Stem Cells
32742475	Expression of the SAR2-Cov-2 receptor ACE2 reveals the susceptibility of COVID-19 in non-small cell lung cancer.	J Cancer
32742308	Smoking and Angiotensin-converting Enzyme Inhibitor/Angiotensin Receptor Blocker Cessation to Limit Coronavirus Disease 2019.	Eur Cardiol
32742035	Variant analysis of SARS-CoV-2 genomes.	Bull World Health Organ
32741461	Endometrial susceptibility to SARS CoV-2: explained by gene expression across the menstrual cycle?	Fertil Steril
32741372	Bioinformatics analysis of epitope-based vaccine design against the novel SARS-CoV-2.	Infect Dis Poverty
32741322	Identification of promising drug candidates against NSP16 of SARS-CoV-2 through computational drug repurposing study.	J Biomol Struct Dyn
32741313	Identification of potential drug candidates to combat COVID-19: a structural study using the main protease (mpro) of SARS-CoV-2.	J Biomol Struct Dyn
32741312	Anthocyanin derivatives as potent inhibitors of SARS-CoV-2 main protease: An in-silico perspective of therapeutic targets against COVID-19 pandemic.	J Biomol Struct Dyn
32741259	"Identification of potential anti-TMPRSS2 natural products through homology modelling, virtual screening and molecular dynamics simulation studies."	J Biomol Struct Dyn
32740825	In Silico Screening of Potential Spike Glycoprotein Inhibitors of SARS-CoV-2 with Drug Repurposing Strategy.	Chin J Integr Med
32740495	Focus on clinical practice: angiotensin-converting enzyme 2 and corona virus disease 2019: pathophysiology and clinical implications.	J Cardiovasc Med (Hagerstown)
32740406	Baseline use of angiotensin-converting enzyme inhibitor/AT1 blocker and outcomes in hospitalized coronavirus disease 2019 African-American patients.	J Hypertens
32740341	Thrombosis and Coagulopathy in COVID-19 Patients Requiring Extracorporeal Membrane Oxygenation.	ASAIO J
32739908	"COVID-19, neutrophil extracellular traps and vascular complications in obstetric practice."	J Perinat Med
32739645	What immunological and hormonal protective factors lower the risk of COVID-19 related deaths in pregnant women?	J Reprod Immunol
32739642	Prioritizing potential ACE2 inhibitors in the COVID-19 pandemic: Insights from a molecular mechanics-assisted structure-based virtual screening experiment.	J Mol Graph Model
32739606	Sars-CoV-2 in pregnancy: Why is it better than expected?	Eur J Obstet Gynecol Reprod Biol
32739507	From Mutation Signature to Molecular Mechanism in the RNA World: A Case of SARS-CoV-2.	Genomics Proteomics Bioinformatics
32739501	On the plausibility of late neuropsychiatric manifestations associated with the COVID-19 pandemic.	J Neurol Sci
32739486	Characterising differential antibody response is integral to future SARS-CoV-2 serostudies.	J Infect
32739476	Repurposing of host-based therapeutic agents for the treatment of coronavirus disease 2019 (COVID-19): a link between antiviral and anticancer mechanisms?	Int J Antimicrob Agents
32739471	The pathophysiology of SARS-CoV-2: A suggested model and therapeutic approach.	Life Sci
32739404	The chemokine receptor antagonist cenicriviroc inhibits the replication of SARS-CoV-2 in vitro.	Antiviral Res
32739174	Approaches and advances in the development of potential therapeutic targets and antiviral agents for the management of SARS-CoV-2 infection.	Eur J Pharmacol
32739050	Applying (or Not?) CAR-T Neurotoxicity Experience to COVID-19 Delirium and Agitation.	Psychosomatics
32738988	The SARS-CoV-2 main protease as drug target.	Bioorg Med Chem Lett
32738628	In silico ADMET and molecular docking study on searching potential inhibitors from limonoids and triterpenoids for COVID-19.	Comput Biol Med
32738617	ACE2 Co-evolutionary Pattern Suggests Targets for Pharmaceutical Intervention in the COVID-19 Pandemic.	iScience
32738360	Computational guided drug repurposing for targeting 2'-O-ribose methyltransferase of SARS-CoV-2.	Life Sci
32738306	"In silico study of azithromycin, chloroquine and hydroxychloroquine and their potential mechanisms of action against SARS-CoV-2 infection."	Int J Antimicrob Agents
32738257	Systematic review of the role of renin-angiotensin system inhibitors in late studies on Covid-19: A new challenge overcome?	Int J Cardiol
32738255	An enzyme-based immunodetection assay to quantify SARS-CoV-2 infection.	Antiviral Res
32738193	A Replication-Competent Vesicular Stomatitis Virus for Studies of SARS-CoV-2 Spike-Mediated Cell Entry and Its Inhibition.	Cell Host Microbe
32738184	Tumor markers as an entry for SARS-CoV-2 infection?	FEBS J
32737861	Coronaviruses and the central nervous system.	J Neurovirol
32737833	Differences and similarities between SARS-CoV and SARS-CoV-2: spike receptor-binding domain recognition and host cell infection with support of cellular serine proteases.	Infection
32737681	Identification of potential Mpro inhibitors for the treatment of COVID-19 by using systematic virtual screening approach.	Mol Divers
32737584	A palindromic RNA sequence as a common breakpoint contributor to copy-choice recombination in SARS-COV-2.	Arch Virol
32737579	The African-American population with a low allele frequency of SNP rs1990760 (T allele) in IFIH1 predicts less IFN-beta expression and potential vulnerability to COVID-19 infection.	Immunogenetics
32737471	Anti-SARS-CoV-2 activities in vitro of Shuanghuanglian preparations and bioactive ingredients.	Acta Pharmacol Sin
32737467	"A thermostable, closed SARS-CoV-2 spike protein trimer."	Nat Struct Mol Biol
32737466	Structural basis for the neutralization of SARS-CoV-2 by an antibody from a convalescent patient.	Nat Struct Mol Biol
32737462	IgGs drive COVID-19 myeloid hyperinflammation.	Nat Rev Immunol
32737423	Hypertension and related diseases in the era of COVID-19: a report from the Japanese Society of Hypertension Task Force on COVID-19.	Hypertens Res
32737124	Risk of severe COVID-19 disease with ACE inhibitors and angiotensin receptor blockers: cohort study including 8.3 million people.	Heart
32737031	Cellular immune responses to covid-19.	BMJ
32736924	[Usefulness of chest ultrasound in a neonatal infection due to SARS-CoV-2].	An Pediatr (Barc)
32736906	COVID-19 and cardiovascular diseases.	J Cardiol
32736881	"Going viral: A brief history of Chilblain-like skin lesions (""COVID toes"") amidst the COVID-19 pandemic."	Semin Oncol
32736832	Can a Combination of AT1R Antagonist and Vitamin D Treat the Lung Complication of COVID-19?	Am J Med Sci
32736592	muLTi-Arm Therapeutic study in pre-ICu patients admitted with Covid-19-Experimental drugs and mechanisms (TACTIC-E): A structured summary of a study protocol for a randomized controlled trial.	Trials
32736573	ACEI/ARB therapy in COVID-19: the double-edged sword of ACE2 and SARS-CoV-2 viral docking.	Crit Care
32736569	A modular framework for the development of targeted Covid-19 blood transcript profiling panels.	J Transl Med
32736307	The four horsemen of a viral Apocalypse: The pathogenesis of SARS-CoV-2 infection (COVID-19).	EBioMedicine
32736274	Structural stability of the SARS-CoV-2 main protease: Can metal ions affect function?	J Inorg Biochem
32735992	Design of an engineered ACE2 as a novel therapeutics against COVID-19.	J Theor Biol
32735900	Topoisomerase III-beta is required for efficient replication of positive-sense RNA viruses.	Antiviral Res
32735892	Network perturbation analysis in human bronchial epithelial cells following SARS-CoV2 infection.	Exp Cell Res
32735889	Angiotensin-Converting Enzyme Gene Polymorphism and Severe Lung Injury in Patients with Coronavirus Disease 2019.	Am J Pathol
32735883	Molecular profiling of immune cell-enriched Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) interacting protein USP13.	Life Sci
32735849	Neutralizing Antibody and Soluble ACE2 Inhibition of a Replication-Competent VSV-SARS-CoV-2 and a Clinical Isolate of SARS-CoV-2.	Cell Host Microbe
32735799	Roles of flavonoids against coronavirus infection.	Chem Biol Interact
32735768	Anti-Inflammatory Properties of Drugs Used to Control COVID-19 and their Effects on the Renin-Angiotensin System and Angiotensin-Converting Enzyme-2.	J Pharm Pharm Sci
32735721	Update on the COVID-19-associated inflammatory syndrome in children and adolescents; paediatric inflammatory multisystem syndrome-temporally associated with SARS-CoV-2.	J Paediatr Child Health
32735689	Dihydroorotate dehydrogenase inhibitors in SARS-CoV-2 infection.	Eur J Clin Invest
32735332	Targetable Biological Mechanisms Implicated in Emergent Psychiatric Conditions Associated With SARS-CoV-2 Infection.	JAMA Psychiatry
32735131	COVID-19-Associated Coagulopathy: An Exacerbated Immunothrombosis Response.	Clin Appl Thromb Hemost
32734864	"[The endocrine and metabolic link between COVID-19, diabetes and obesity]."	Ugeskr Laeger
32734828	"Tackling COVID-19: identification of potential main protease inhibitors via structural analysis, virtual screening, molecular docking and MM-PBSA calculations."	J Biomol Struct Dyn
32734714	Innate immune evasion by SARS-CoV-2: Comparison with SARS-CoV.	Rev Med Virol
32734595	Antibodies in serum of convalescent patients following mild COVID-19 do not always prevent virus-receptor binding.	Allergy
32734518	Classification of the present pharmaceutical agents based on the possible effective mechanism on the COVID-19 infection.	Daru
32734175	SARS-CoV-2 and human reproduction: An open question.	EClinicalMedicine
32733978	How to Boost our Immune System Against Coronavirus Infection?	Arch Bone Jt Surg
32733837	A Perspective on Emerging Therapeutic Interventions for COVID-19.	Front Public Health
32733785	Characterization of changes in global gene expression in the hearts and kidneys of transgenic mice overexpressing human angiotensin-converting enzyme 2.	Lab Anim Res
32733765	SARS-CoV-2: A Piece of Bad News.	Medeni Med J
32733490	"Pregnancy, Viral Infection, and COVID-19."	Front Immunol
32733487	Role of Immune Dysregulation in Increased Mortality Among a Specific Subset of COVID-19 Patients and Immune-Enhancement Strategies for Combatting Through Nutritional Supplements.	Front Immunol
32733480	Viral Evasion of the Complement System and Its Importance for Vaccines and Therapeutics.	Front Immunol
32733448	Role of Autophagy in Lung Inflammation.	Front Immunol
32733388	Working Hypothesis for Glucose Metabolism and SARS-CoV-2 Replication: Interplay Between the Hexosamine Pathway and Interferon RF5 Triggering Hyperinflammation. Role of BCG Vaccine?	Front Endocrinol (Lausanne)
32733001	Activation and evasion of type I interferon responses by SARS-CoV-2.	Nat Commun
32732951	NK cells in COVID-19: protectors or opponents?	Nat Rev Immunol
32732586	"Histopathologic and Autopsy Findings in Patients Diagnosed With Coronavirus Disease 2019 (COVID-19): What We Know So Far Based on Correlation With Clinical, Morphologic and Pathobiological Aspects."	Adv Anat Pathol
32732269	COVID-19 and Involvement of the Corpus Callosum: Potential Effect of the Cytokine Storm?	AJNR Am J Neuroradiol
32732237	Genome Sequences of SARS-CoV-2 Strains Detected in Hong Kong.	Microbiol Resour Announc
32732236	Reports of Coding-Complete Genome Sequences of Five 2019 Novel Coronavirus (SARS-CoV-2) Strains Isolated in Bangladesh.	Microbiol Resour Announc
32732235	"SARS-CoV-2 Genome Sequence from Morocco, Obtained Using Ion AmpliSeq Technology."	Microbiol Resour Announc
32732086	Propofol and sedation in patients with coronavirus disease.	Am J Emerg Med
32731958	COVID-19: a complex multisystem disorder.	Br J Anaesth
32731932	Myocardial Injury in COVID-19 Patients: The Beginning or the End?	J Am Coll Cardiol
32731461	Vaccine Design from the Ensemble of Surface Glycoprotein Epitopes of SARS-CoV-2: An Immunoinformatics Approach.	Vaccines (Basel)
32731361	Computational Studies of SARS-CoV-2 3CLpro: Insights from MD Simulations.	Int J Mol Sci
32731360	The Roles of GRKs in Hemostasis and Thrombosis.	Int J Mol Sci
32731331	"The Antiviral Properties of Cyclosporine. Focus on Coronavirus, Hepatitis C Virus, Influenza Virus, and Human Immunodeficiency Virus Infections."	Biology (Basel)
32731308	"June 2020 at a glance: focus on COVID-19, quality of life and comorbidities."	Eur J Heart Fail
32731282	[COVID-19: A neurological point-of-view].	Dtsch Med Wochenschr
32731281	[COVID-19: The Perspective Of Nephrology].	Dtsch Med Wochenschr
32731280	[COVID-19: a cardiological point-of-view].	Dtsch Med Wochenschr
32731278	[COVID-19: Questions and answers from infectiology].	Dtsch Med Wochenschr
32731277	[COVID-19 from the Perspective of Haematology and Haemostaseology].	Dtsch Med Wochenschr
32730844	Structure-based drug repositioning over the human TMPRSS2 protease domain: search for chemical probes able to repress SARS-CoV-2 Spike protein cleavages.	Eur J Pharm Sci
32730807	The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity.	Cell
32730733	Differential Tropism of SARS-CoV and SARS-CoV-2 in Bat Cells.	Emerg Infect Dis
32730589	Persistent minimal sequences of SARS-CoV-2.	Bioinformatics
32730568	"Estradiol, Progesterone, Immunomodulation, and COVID-19 Outcomes."	Endocrinology
32730555	Association of Cardiac Infection With SARS-CoV-2 in Confirmed COVID-19 Autopsy Cases.	JAMA Cardiol
32730512	"[Renin Angiotensin Axis, Angiotensin Converting Enzyme 2 and Coronavirus]."	Rev Chil Pediatr
32730205	"A comparative overview of COVID-19, MERS and SARS: Review article."	Int J Surg
32730095	COVID-19: a wreak havoc across the globe.	Arch Physiol Biochem
32729732	COVID-19 and gastrointestinal symptoms: the dust has not settled yet.	Expert Rev Gastroenterol Hepatol
32729640	Probing 3CL protease: Rationally designed chemical moieties for COVID-19.	Drug Dev Res
32729633	COVID-19 retinal microangiopathy as an in vivo biomarker of systemic vascular disease?	J Intern Med
32729463	Neuropathogenesis of SARS-CoV-2 infection.	Elife
32729392	Antiviral potential of some novel structural analogs of standard drugs repurposed for the treatment of COVID-19.	J Biomol Struct Dyn
32729367	Coronavirus disease - COVID-19: new perceptives towards epidemic to pandemic.	J Drug Target
32729248	In vitro and in vivo identification of clinically approved drugs that modify ACE2 expression.	Mol Syst Biol
32729180	Molecular Insights into Small-Molecule Drug Discovery for SARS-CoV-2.	Angew Chem Int Ed Engl
32729064	COVID-19: A Concern for Cardiovascular Disease Patients.	Cardiovasc Toxicol
32729001	SARS-CoV-2 and Guillain-Barre syndrome: molecular mimicry with human heat shock proteins as potential pathogenic mechanism.	Cell Stress Chaperones
32728817	[COVID-19 pneumonia].	Internist (Berl)
32728733	No higher risk of respiratory symptoms in Italian rheumatological patients under IL-6R-inhibitor therapy in SARS-CoV-2 pandemic.	Rheumatology (Oxford)
32728654	The Impact of SARS-Cov-2 Virus Infection on the Endocrine System.	J Endocr Soc
32728222	T cell responses in patients with COVID-19.	Nat Rev Immunol
32728221	Tissue damage from neutrophil-induced oxidative stress in COVID-19.	Nat Rev Immunol
32728199	SARS-CoV-2 Orf9b suppresses type I interferon responses by targeting TOM70.	Cell Mol Immunol
32728083	Nanotechnology-based disinfectants and sensors for SARS-CoV-2.	Nat Nanotechnol
32728018	Crystal structure of SARS-CoV-2 nsp10/nsp16 2'-O-methylase and its implication on antiviral drug design.	Signal Transduct Target Ther
32727884	SARS-CoV-2 seroprevalence among parturient women in Philadelphia.	Sci Immunol
32727876	Characterization of Self-Processing Activities and Substrate Specificities of Porcine Torovirus 3C-Like Protease.	J Virol
32727845	Identification of an anti-SARS-CoV-2 receptor-binding domain-directed human monoclonal antibody from a naive semisynthetic library.	J Biol Chem
32727701	Attenuated Novel SARS Coronavirus 2 Infection in an Allogeneic Hematopoietic Stem Cell Transplant Patient on Ruxolitinib.	Clin Lymphoma Myeloma Leuk
32727485	SARS-CoV-2: characteristics and current advances in research.	Virol J
32727177	[Clinical characteristics and outcome of 64 patients with severe COVID-19].	Zhonghua Jie He He Hu Xi Za Zhi
32727176	[Analysis of clinical characteristics of 49 cases of COVID-19].	Zhonghua Jie He He Hu Xi Za Zhi
32727175	[Clinical characteristics and death risk factors of severe COVID-19].	Zhonghua Jie He He Hu Xi Za Zhi
32727145	Phosphodiesterase Inhibitors: Could They Be Beneficial for the Treatment of COVID-19?	Int J Mol Sci
32726803	Papain-like protease regulates SARS-CoV-2 viral spread and innate immunity.	Nature
32726802	A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity.	Nature
32726801	SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19.	Nature
32726800	Association of COVID-19 inflammation with activation of the C5a-C5aR1 axis.	Nature
32726783	JAK/STAT Pathway Inhibition May Be a Promising Therapy for COVID-19-Related Hyperinflammation in Hematologic Patients.	Acta Haematol
32726474	SARS-CoV-2 receptor ACE2 protein expression in serum is significantly associated with age.	Allergy
32726448	Interferon-Induced Transmembrane Protein 3 Related to Coronavirus Disease 2019.	J Infect Dis
32726446	Plasmodium falciparum Infection May Protect a Population from Severe Acute Respiratory Syndrome Coronavirus 2 Infection.	J Infect Dis
32726355	Interplay between SARS-CoV-2 and the type I interferon response.	PLoS Pathog
32726325	Integrative analysis of miRNA and mRNA sequencing data reveals potential regulatory mechanisms of ACE2 and TMPRSS2.	PLoS One
32726217	Progress in Treatment of Myocardial Injury in Patients with 2019-nCoV: A Chinese Experience.	Heart Surg Forum
32726140	Severe Acute Respiratory Syndrome Coronavirus 2 and Coronavirus Disease 2019: A Clinical Overview and Primer.	Biopreserv Biobank
32726128	Sex-derived attributes contributing to SARS-CoV-2 mortality.	Am J Physiol Endocrinol Metab
32726008	[Analysis of potential role of Chinese classic prescriptions in treatment of COVID-19 based on TCMATCOV platform].	Zhongguo Zhong Yao Za Zhi
32726007	[Study on therapeutic effect of Chaiyin Particles on combining disease with syndrome of human coronavirus pneumonia with pestilence attacking lung syndrome based on regulation of immune function].	Zhongguo Zhong Yao Za Zhi
32725927	The ACE2-deficient mouse: A model for a cytokine storm-driven inflammation.	FASEB J
32725795	Bats and humans during the SARS-CoV-2 outbreak: The case of bat-coronaviruses from Mexico.	Transbound Emerg Dis
32725790	Synergy Between Cytokines and Risk Factors in the Cytokine Storm of COVID-19: Does Ongoing Use of Cytokine Inhibitors Have a Protective Effect?	Arthritis Rheumatol
32725610	A Liaison between Sudden Sensorineural Hearing Loss and SARS-CoV-2 Infection.	Thromb Haemost
32725545	Coronaviruses: a challenge of today and a call for extended human postmortem brain analyses.	J Neural Transm (Vienna)
32725480	Prediction of the Receptorome for the Human-Infecting Virome.	Virol Sin
32725449	"Neuroinvasion, neurotropic, and neuroinflammatory events of SARS-CoV-2: understanding the neurological manifestations in COVID-19 patients."	Neurol Sci
32725405	Letter to the editor: Possible role of topical povidone iodine in case of accidental ocular exposure to SARS-CoV-2.	Graefes Arch Clin Exp Ophthalmol
32725381	"Interaction of HSPA5 (Grp78, BIP) with negatively charged phospholipid membranes via oligomerization involving the N-terminal end domain."	Cell Stress Chaperones
32725207	"COVID-19 and Hypercoagulability: Potential Impact on Management with Oral Contraceptives, Estrogen Therapy and Pregnancy."	Endocrinology
32725137	Role of the early secretory pathway in SARS-CoV-2 infection.	J Cell Biol
32725080	"Past, present, and future of COVID-19: a review."	Braz J Med Biol Res
32725017	Quantitative determination of mechanical stability in the novel coronavirus spike protein.	Nanoscale
32724831	"COVID-19 cardiovascular epidemiology, cellular pathogenesis, clinical manifestations and management."	Int J Cardiol Heart Vasc
32724306	Heightened ACE Activity and Unfavorable Consequences in COVID-19 Diabetic Subjects.	Int J Endocrinol
32724296	Neutrophil Extracellular Traps (NETs) and Damage-Associated Molecular Patterns (DAMPs): Two Potential Targets for COVID-19 Treatment.	Mediators Inflamm
32724171	Evolutionary origins of the SARS-CoV-2 sarbecovirus lineage responsible for the COVID-19 pandemic.	Nat Microbiol
32723824	Haplotype networks of SARS-CoV-2 infections in the Diamond Princess cruise ship outbreak.	Proc Natl Acad Sci U S A
32723797	Comparative Genomic Analysis of Rapidly Evolving SARS-CoV-2 Reveals Mosaic Pattern of Phylogeographical Distribution.	mSystems
32723457	Silent Hypoxia in COVID-19: What is Old is New Again!	J Coll Physicians Surg Pak
32723443	"COVID-19 and Kidney Disease: Update on Epidemiology, Clinical Manifestations, Pathophysiology and Management."	J Coll Physicians Surg Pak
32723442	A Systematic Analysis of Studies on Corona Virus Disease 19 (COVID-19) from Viral Emergence to Treatment.	J Coll Physicians Surg Pak
32723427	Evaluation of K18-hACE2 Mice as a Model of SARS-CoV-2 Infection.	Am J Trop Med Hyg
32723359	Characterisation of the transcriptome and proteome of SARS-CoV-2 reveals a cell passage induced in-frame deletion of the furin-like cleavage site from the spike glycoprotein.	Genome Med
32723327	The pathophysiology of 'happy' hypoxemia in COVID-19.	Respir Res
32723229	Could Targeting HMGB1 be Useful for the Clinical Management of COVID-19 Infection?	Comb Chem High Throughput Screen
32722979	"Endothelial activation and dysfunction in metabolic syndrome, type 2 diabetes and coronavirus disease 2019."	J Int Med Res
32722946	Pathogenesis and treatment of idiopathic and rheumatoid arthritis-related interstitial pneumonia. The possible lesson from COVID-19 pneumonia.	Expert Rev Clin Immunol
32722908	Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates.	N Engl J Med
32722864	In silico Drug Repurposing for COVID-19: Targeting SARS-CoV-2 Proteins through Docking and Consensus Ranking.	Mol Inform
32722596	Immune Pathogenesis of COVID-19 Intoxication: Storm or Silence?	Pharmaceuticals (Basel)
32722574	In Silico Insights into the SARS CoV-2 Main Protease Suggest NADH Endogenous Defences in the Control of the Pandemic Coronavirus Infection.	Viruses
32722449	A Message from the Human Placenta: Structural and Immunomodulatory Defense against SARS-CoV-2.	Cells
32722343	Molecular Tracing of SARS-CoV-2 in Italy in the First Three Months of the Epidemic.	Viruses
32722164	Flavonoids Activation of the Transcription Factor Nrf2 as a Hypothesis Approach for the Prevention and Modulation of SARS-CoV-2 Infection Severity.	Antioxidants (Basel)
32721814	The war against the SARS-CoV2 infection: Is it better to fight or mitigate it?	Med Hypotheses
32721813	'The Double-Edged Sword' - An hypothesis for Covid-19-induced salivary biomarkers.	Med Hypotheses
32721809	Kawasaki-like disease in children with COVID-19: A hypothesis.	Med Hypotheses
32721808	Prior infection with intestinal coronaviruses moderates symptom severity and mortality in patients with COVID-19: A hypothesis and preliminary evidence.	Med Hypotheses
32721806	"Spironolactone may provide protection from SARS-CoV-2: Targeting androgens, angiotensin converting enzyme 2 (ACE2), and renin-angiotensin-aldosterone system (RAAS)."	Med Hypotheses
32721805	"Inflammation: A bridge between diabetes and COVID-19, and possible management with sitagliptin."	Med Hypotheses
32721804	Recombinant protein targeting and opsonizing spike glycoprotein for enhancing SARS-CoV-2 phagocytosis.	Med Hypotheses
32721799	SARS-CoV-2 infection pathogenesis is related to oxidative stress as a response to aggression.	Med Hypotheses
32721795	Does COVID-19 cause permanent damage to olfactory and gustatory function?	Med Hypotheses
32721790	Mechanistic insights of host cell fusion of SARS-CoV-1 and SARS-CoV-2 from atomic resolution structure and membrane dynamics.	Biophys Chem
32721534	Adsorptive granulocyte and monocyte apheresis: A potentially relevant therapeutic option for COVID-19.	Int J Infect Dis
32721529	Isolation and phylogenetic analysis of SARS-CoV-2 variants collected in Russia during the COVID-19 outbreak.	Int J Infect Dis
32721252	Eosinophil-Derived Neurotoxin and Respiratory Tract Infection and Inflammation: Implications for COVID-19 Management.	J Interferon Cytokine Res
32721181	Immunometabolic Status of COVID-19 Cancer Patients.	Physiol Rev
32721082	A Computational Approach to Identify Potential Novel Inhibitors against the Coronavirus SARS-CoV-2.	Mol Inform
32720978	The Thrilling Journey of SARS-CoV-2 into the Intestine: From Pathogenesis to Future Clinical Implications.	Inflamm Bowel Dis
32720890	Multiple novel non-canonically transcribed sub-genomic mRNAs produced by avian coronavirus infectious bronchitis virus.	J Gen Virol
32720605	In silico Study to Evaluate the Antiviral Activity of Novel Structures against 3C-like Protease of Novel Coronavirus (COVID-19) and SARS-CoV.	Med Chem
32720578	"Identification of some novel oxazine substituted 9-anilinoacridines as SARS-CoV-2 inhibitors for COVID-19 by molecular docking, free energy calculation and molecular dynamics studies."	J Biomol Struct Dyn
32720577	Plant-derived natural polyphenols as potential antiviral drugs against SARS-CoV-2 via RNA-dependent RNA polymerase (RdRp) inhibition: an in-silico analysis.	J Biomol Struct Dyn
32720571	"Investigating the binding affinity, interaction, and structure-activity-relationship of 76 prescription antiviral drugs targeting RdRp and Mpro of SARS-CoV-2."	J Biomol Struct Dyn
32720486	A nicotinic hypothesis for Covid-19 with preventive and therapeutic implications.	C R Biol
32720461	An overview of the immune mechanisms of viral myocarditis.	Rev Med Virol
32720082	Heart failure and COVID-19.	Heart Fail Rev
32720031	"The kidney, COVID-19, and the chemokine network: an intriguing trio."	Int Urol Nephrol
32719819	Analysis of ACE2 Gene-Encoded Proteins Across Mammalian Species.	Front Vet Sci
32719799	Current Findings Regarding Natural Components With Potential Anti-2019-nCoV Activity.	Front Cell Dev Biol
32719758	Kidney Replacement Therapy in COVID-19 Induced Kidney Failure and Septic Shock: A Pediatric Continuous Renal Replacement Therapy [PCRRT] Position on Emergency Preparedness With Resource Allocation.	Front Pediatr
32719737	Modified Bhramari Pranayama in Covid 19 Infection.	Indian J Otolaryngol Head Neck Surg
32719687	Cell-Mediated Immune Responses to COVID-19 Infection.	Front Immunol
32719686	"Establishing a Unified COVID-19 ""Immunome"": Integrating Coronavirus Pathogenesis and Host Immunopathology."	Front Immunol
32719685	Targeting GM-CSF in COVID-19 Pneumonia: Rationale and Strategies.	Front Immunol
32719684	COVID-19 Coronavirus Vaccine Design Using Reverse Vaccinology and Machine Learning.	Front Immunol
32719673	"In-Depth Bioinformatic Analyses of Nidovirales Including Human SARS-CoV-2, SARS-CoV, MERS-CoV Viruses Suggest Important Roles of Non-canonical Nucleic Acid Structures in Their Lifecycles."	Front Microbiol
32719672	Severe Acute Respiratory Syndrome Coronavirus 2: From Gene Structure to Pathogenic Mechanisms and Potential Therapy.	Front Microbiol
32719619	"While We Wait for a Vaccine Against SARS-CoV-2, Why Not Think About Available Drugs?"	Front Physiol
32719454	Identification of key interactions between SARS-CoV-2 main protease and inhibitor drug candidates.	Sci Rep
32719447	Covid-19 and the cardiovascular system: a comprehensive review.	J Hum Hypertens
32719054	"Sacubitril, valsartan and SARS-CoV-2."	BMJ Evid Based Med
32718953	COVID-19 in Children with Nephrotic Syndrome on Anti-CD20 Chronic Immunosuppression.	Clin J Am Soc Nephrol
32718895	Immune response in COVID-19: A review.	J Infect Public Health
32718858	COVID-19 and cardiovascular comorbidities: An update.	Rev Port Cardiol (Engl Ed)
32718670	Vitamin D high doses supplementation could represent a promising alternative to prevent or treat COVID-19 infection.	Clin Investig Arterioscler
32718300	In Silico Identification of a Potent Arsenic Based Approved Drug Darinaparsin against SARS-CoV-2: Inhibitor of RNA Dependent RNA polymerase (RdRp) and Essential Proteases.	Infect Disord Drug Targets
32718282	Alpha-MSH Targeted Liposomal Nanoparticle for Imaging in Inflammatory Bowel Disease (IBD).	Curr Pharm Des
32718086	Interleukin-6 in Rheumatoid Arthritis.	Int J Mol Sci
32718076	Hyponatremia in Infectious Diseases-A Literature Review.	Int J Environ Res Public Health
32718020	"Potential Anti-COVID-19 Therapeutics that Block the Early Stage of the Viral Life Cycle: Structures, Mechanisms, and Clinical Trials."	Int J Mol Sci
32717854	Immunogenic SARS-CoV-2 Epitopes: In Silico Study Towards Better Understanding of COVID-19 Disease-Paving the Way for Vaccine Development.	Vaccines (Basel)
32717807	HLA-B*44 and C*01 Prevalence Correlates with Covid19 Spreading across Italy.	Int J Mol Sci
32717794	"Enzymatic Protein Biopolymers as a Tool to Synthetize Eukaryotic Messenger Ribonucleic Acid (mRNA) with Uses in Vaccination, Immunotherapy and Nanotechnology."	Polymers (Basel)
32717743	Longitudinal analyses reveal immunological misfiring in severe COVID-19.	Nature
32717568	FDA approved drugs with pharmacotherapeutic potential for SARS-CoV-2 (COVID-19) therapy.	Drug Resist Updat
32717416	Evolution of viral quasispecies during SARS-CoV-2 infection.	Clin Microbiol Infect
32717399	Purinergic signaling in infectious diseases of the central nervous system.	Brain Behav Immun
32717346	Identification of high-affinity inhibitors of SARS-CoV-2 main protease: Towards the development of effective COVID-19 therapy.	Virus Res
32717345	Immunological co-ordination between gut and lungs in SARS-CoV-2 infection.	Virus Res
32717321	Genomics approaches to synthesize plant-based biomolecules for therapeutic applications to combat SARS-CoV-2.	Genomics
32717282	The Lord of the NanoRings: Cyclodextrins and the battle against SARS-CoV-2.	Int J Pharm
32717182	Lessons for COVID-19 Immunity from Other Coronavirus Infections.	Immunity
32717117	Peptidyl Acyloxymethyl Ketones as Activity-Based Probes for the Main Protease of SARS-CoV-2*.	Chembiochem
32717055	Diagnosing Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Related Multisystem Inflammatory Syndrome in Children (MIS-C): Focus on the Gastrointestinal Tract and the Myocardium.	Clin Infect Dis
32717049	Cytoskeleton-a crucial key in host cell for coronavirus infection.	J Mol Cell Biol
32716836	Immunotherapy for ANCA-associated vasculitis during the COVID-19 pandemic.	Eur J Rheumatol
32716648	The Novel Insight of SARS-CoV-2 Molecular Biology and Pathogenesis and Therapeutic Options.	DNA Cell Biol
32716553	Distinct effects of asthma and COPD comorbidity on disease expression and outcome in patients with COVID-19.	Allergy
32715956	"Virtual screening, ADMET prediction and dynamics simulation of potential compounds targeting the main protease of SARS-CoV-2."	J Biomol Struct Dyn
32715661	Hypothesis: Pentoxifylline is a potential cytokine modulator therapeutic in COVID-19 patients.	Pharmacol Res Perspect
32715628	Can ACE2 expression explain SARS-CoV-2 infection of the respiratory epithelia in COVID-19?	Mol Syst Biol
32715618	The protein expression profile of ACE2 in human tissues.	Mol Syst Biol
32715524	COVID-19-Associated Encephalopathy and Cytokine-Mediated Neuroinflammation.	Ann Neurol
32715310	SARS-CoV-2 Whole Genome Amplification and Sequencing for Effective Population-Based Surveillance and Control of Viral Transmission.	Clin Chem
32715280	Neurologic and Immunologic Complications of COVID-19: Potential Long-Term Risk Factors for Alzheimer's Disease.	J Alzheimers Dis Rep
32715080	Association between COVID-19 and cardiovascular disease.	Int J Cardiol Heart Vasc
32714938	Physical Exercise Potentials Against Viral Diseases Like COVID-19 in the Elderly.	Front Med (Lausanne)
32714936	Aging and Coronavirus: Exploring Complementary Therapies to Avoid Inflammatory Overload.	Front Med (Lausanne)
32714688	Gastrointestinal Manifestations in COVID-19 Infection and Its Practical Applications.	Cureus
32714563	Sulfated polysaccharides effectively inhibit SARS-CoV-2 in vitro.	Cell Discov
32714386	"COVID-19 and Inflammatory Bowel Diseases: Risk Assessment, Shared Molecular Pathways, and Therapeutic Challenges."	Gastroenterol Res Pract
32714336	Overview: Systemic Inflammatory Response Derived From Lung Injury Caused by SARS-CoV-2 Infection Explains Severe Outcomes in COVID-19.	Front Immunol
32714335	Beyond Anti-viral Effects of Chloroquine/Hydroxychloroquine.	Front Immunol
32714193	Turning the Tide: Natural Products and Natural-Product-Inspired Chemicals as Potential Counters to SARS-CoV-2 Infection.	Front Pharmacol
32713863	Computational search for potential COVID-19 drugs from FDAapproved drugs and small molecules of natural origin identifies several anti-virals and plant products.	J Biosci
32713862	RNAi suppressor: The hidden weapon of SARS-CoV.	J Biosci
32713810	Oral cancer and ACE2 receptor of SARS-CoV-2.	Oral Oncol
32713380	Re-Detectable Positive RT-PCR Test Results in Recovered COVID-19 Patients: The Potential Role of ACE2.	Disaster Med Public Health Prep
32713282	COVID-19: a novel menace for the practice of nephrology and how to manage it with minor devastation?	Ren Fail
32713161	The potential effects of DPP-4 inhibitors on cardiovascular system in COVID-19 patients.	J Cell Mol Med
32713127	"What the physicians should know about mast cells, dendritic cells, urticaria, and omalizumab during COVID-19 or asymptomatic infections due to SARS-CoV-2?"	Dermatol Ther
32712910	"Understanding COVID-19 via comparative analysis of dark proteomes of SARS-CoV-2, human SARS and bat SARS-like coronaviruses."	Cell Mol Life Sci
32712702	COVID-19 pneumonia: relationship between inflammation assessed by whole-body FDG PET/CT and short-term clinical outcome.	Eur J Nucl Med Mol Imaging
32712639	COVID-19: Critical Role of Angiotensin 1-7 in ACE2 Modulation.	Ann Acad Med Singap
32712629	COVID-19: immunopathogenesis and Immunotherapeutics.	Signal Transduct Target Ther
32712394	"Lessons From COVID-19, ACE2, and Intestinal Inflammation: Could a Virus Trigger Chronic Intestinal Inflammation?"	Clin Gastroenterol Hepatol
32712315	Decoding the proteome of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) for cell-penetrating peptides involved in pathogenesis or applicable as drug delivery vectors.	Infect Genet Evol
32712300	"The interaction of RAAS inhibitors with COVID-19: Current progress, perspective and future."	Life Sci
32712124	Delineating clinical characteristics and comorbidities among 206 COVID-19 deceased patients in India: Emerging significance of renin angiotensin system derangement.	Diabetes Res Clin Pract
32712106	Molecular pathogenesis of secondary bacterial infection associated to viral infections including SARS-CoV-2.	J Infect Public Health
32712049	COVID-19 infection and thrombosis.	Clin Chim Acta
32711925	Can Activation of NRF2 Be a Strategy against COVID-19?	Trends Pharmacol Sci
32711735	Reverse genetic systems: Rational design of coronavirus live attenuated vaccines with immune sequelae.	Adv Virus Res
32711596	"Interactions Between Remdesivir, Ribavirin, Favipiravir, Galidesivir, Hydroxychloroquine and Chloroquine with Fragment Molecular of the COVID-19 Main Protease with Inhibitor N3 Complex (PDB ID:6LU7) Using Molecular Docking."	J Nanosci Nanotechnol
32711254	Linear B-cell epitopes in the spike and nucleocapsid proteins as markers of SARS-CoV-2 exposure and disease severity.	EBioMedicine
32711111	Drugs targeting various stages of the SARS-CoV-2 life cycle: Exploring promising drugs for the treatment of Covid-19.	Cell Signal
32710986	Mutations Strengthened SARS-CoV-2 Infectivity.	J Mol Biol
32710969	Approaching coronavirus disease 2019: Mechanisms of action of repurposed drugs with potential activity against SARS-CoV-2.	Biochem Pharmacol
32710733	Impact of COVID-19 on Nephrology Patients: A Mechanistic Outlook for Pathogenesis of Acute Kidney Injury.	Altern Ther Health Med
32710693	Insight into the pediatric and adult dichotomy of COVID-19: Age-related differences in the immune response to SARS-CoV-2 infection.	Pediatr Pulmonol
32710674	"Use of distinct anti-hypertensive drugs and risk for COVID-19 among hypertensive people: A population-based cohort study in Southern Catalonia, Spain."	J Clin Hypertens (Greenwich)
32710652	Children and COVID-19: Microbiological and immunological insights.	Pediatr Pulmonol
32710575	Angiotensin converting enzyme 2 at the interface between renin-angiotensin system inhibition and coronavirus disease 2019.	J Physiol
32710571	Clinical molecular genetics evaluation in women with reproductive failures.	Am J Reprod Immunol
32710255	Lipoprotein(a) and Its Potential Association with Thrombosis and Inflammation in COVID-19: a Testable Hypothesis.	Curr Atheroscler Rep
32710111	Vitamin D and COVID-19: Lessons from Spaceflight Analogs.	J Nutr
32709978	Crosstalk between COVID-19 and prostate cancer.	Prostate Cancer Prostatic Dis
32709909	Patients with immune-mediated inflammatory diseases receiving cytokine inhibitors have low prevalence of SARS-CoV-2 seroconversion.	Nat Commun
32709887	Structural analysis of the SARS-CoV-2 methyltransferase complex involved in RNA cap creation bound to sinefungin.	Nat Commun
32709886	Structural basis of RNA cap modification by SARS-CoV-2.	Nat Commun
32709193	Lung Injury in COVID-19-An Emerging Hypothesis.	ACS Chem Neurosci
32709055	Polymorphism and Selection Pressure of SARS-CoV-2 Vaccine and Diagnostic Antigens: Implications for Immune Evasion and Serologic Diagnostic Performance.	Pathogens
32708840	Genetic Diversity Among SARS-CoV2 Strains in South America may Impact Performance of Molecular Detection.	Pathogens
32708755	The Yin and Yang of ACE/ACE2 Pathways: The Rationale for the Use of Renin-Angiotensin System Inhibitors in COVID-19 Patients.	Cells
32708578	The Role of Glutathione in Protecting against the Severe Inflammatory Response Triggered by COVID-19.	Antioxidants (Basel)
32708525	From Anti-SARS-CoV-2 Immune Responses to COVID-19 via Molecular Mimicry.	Antibodies (Basel)
32708430	Genetic Polymorphisms Complicate COVID-19 Therapy: Pivotal Role of HO-1 in Cytokine Storm.	Antioxidants (Basel)
32708322	Protective Effect of Epigallocatechin-3-Gallate (EGCG) in Diseases with Uncontrolled Immune Activation: Could Such a Scenario Be Helpful to Counteract COVID-19?	Int J Mol Sci
32708319	Computational Analysis of the Global Effects of Ly6E in the Immune Response to Coronavirus Infection Using Gene Networks.	Genes (Basel)
32708196	A Comprehensive Mapping of the Druggable Cavities within the SARS-CoV-2 Therapeutically Relevant Proteins by Combining Pocket and Docking Searches as Implemented in Pockets 2.0.	Int J Mol Sci
32708112	"COVID-19: A Review on Diagnosis, Treatment, and Prophylaxis."	Int J Mol Sci
32707945	Minireview Exploring the Biological Cycle of Vitamin B3 and Its Influence on Oxidative Stress: Further Molecular and Clinical Aspects.	Molecules
32707842	Defining the CD39/CD73 Axis in SARS-CoV-2 Infection: The CD73(-) Phenotype Identifies Polyfunctional Cytotoxic Lymphocytes.	Cells
32707833	COVID-19: Mechanisms of Vaccination and Immunity.	Vaccines (Basel)
32707768	Two Examples of RNA Aptamers with Antiviral Activity. Are Aptamers the Wished Antiviral Drugs?	Pharmaceuticals (Basel)
32707576	Endothelial barrier integrity in COVID-19-dependent hyperinflammation: does the protective facet of platelet function matter?	Cardiovasc Res
32707573	Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing.	Nature
32707537	Hazards of the Cytokine Storm and Cytokine-Targeted Therapy in Patients With COVID-19: Review.	J Med Internet Res
32707445	Lack of antibody-mediated cross-protection between SARS-CoV-2 and SARS-CoV infections.	EBioMedicine
32707288	Deciphering the co-adaptation of codon usage between respiratory coronaviruses and their human host uncovers candidate therapeutics for COVID-19.	Infect Genet Evol
32707230	Differential immune activation profile of SARS-CoV-2 and SARS-CoV infection in human lung and intestinal cells: Implications for treatment with IFN-beta and IFN inducer.	J Infect
32706783	"In silico identification of potential inhibitors of key SARS-CoV-2 3CL hydrolase (Mpro) via molecular docking, MMGBSA predictive binding energy calculations, and molecular dynamics simulation."	PLoS One
32706609	Inducible Epithelial Resistance against Coronavirus Pneumonia in Mice.	Am J Respir Cell Mol Biol
32706411	Coinfection of other respiratory pathogens and HIV in COVID-19 patients: Is there a pattern?	J Med Virol
32706407	SARS-CoV-2 infection causes pulmonary shunt by vasodilatation.	J Med Virol
32706364	Molecular Underpinnings of Severe Coronavirus Disease 2019.	JAMA
32706096	Editorial - Coronavirus disease 2019 and people living with HIV: clinical considerations.	Eur Rev Med Pharmacol Sci
32706090	CXCL10 an important chemokine associated with cytokine storm in COVID-19 infected patients.	Eur Rev Med Pharmacol Sci
32706089	"Potential usefulness of pentoxifylline, a non-specific phosphodiesterase inhibitor with anti-inflammatory, anti-thrombotic, antioxidant, and anti-fibrogenic properties, in the treatment of SARS-CoV-2."	Eur Rev Med Pharmacol Sci
32706088	Understanding and implementing alternative solutions to address the COVID-19 pandemic in the sense of public health emergencies.	Eur Rev Med Pharmacol Sci
32705962	Molecular docking and dynamics study of natural compound for potential inhibition of main protease of SARS-CoV-2.	J Biomol Struct Dyn
32705953	Identification of a potential SARS-CoV2 inhibitor via molecular dynamics simulations and amino acid decomposition analysis.	J Biomol Struct Dyn
32705952	In-Silico approach for identification of effective and stable inhibitors for COVID-19 main protease (M(pro)) from flavonoid based phytochemical constituents of Calendula officinalis.	J Biomol Struct Dyn
32705942	Computational drug repurposing for the identification of SARS-CoV-2 main protease inhibitors.	J Biomol Struct Dyn
32705906	MAFLD in COVID-19 patients: an insidious enemy.	Expert Rev Gastroenterol Hepatol
32705690	Benzothiazoles as potential antiviral agents.	J Pharm Pharmacol
32705585	Associations between hypovitaminosis D and COVID-19: a narrative review.	Aging Clin Exp Res
32705411	Mechanism of higher risk for COVID-19 in diabetes: a mask to lift.	Endocrine
32705298	[The virology of SARS-CoV-2].	Internist (Berl)
32705281	Coexpression of peripheral olfactory receptors with SARSCoV2 infection mediators: Potential implications beyond loss of smell as a COVID19 symptom.	Int J Mol Med
32704455	Small molecule therapeutics for COVID-19: repurposing of inhaled furosemide.	PeerJ
32704352	"Recruiting the innate immune system with GM-CSF to fight viral diseases, including West Nile Virus encephalitis and COVID-19."	F1000Res
32704169	A SARS-CoV-2 surrogate virus neutralization test based on antibody-mediated blockage of ACE2-spike protein-protein interaction.	Nat Biotechnol
32704094	LY6E impairs coronavirus fusion and confers immune control of viral disease.	Nat Microbiol
32704018	Human SARS-CoV-2 has evolved to reduce CG dinucleotide in its open reading frames.	Sci Rep
32703911	Can Dietary Fatty Acids Affect the COVID-19 Infection Outcome in Vulnerable Populations?	mBio
32703908	Structural basis for neutralization of SARS-CoV-2 and SARS-CoV by a potent therapeutic antibody.	Science
32703906	Structure-based design of prefusion-stabilized SARS-CoV-2 spikes.	Science
32703890	Answer to August 2020 Photo Quiz.	J Clin Microbiol
32703818	TMPRSS2 and furin are both essential for proteolytic activation of SARS-CoV-2 in human airway cells.	Life Sci Alliance
32703719	Dysgeusia in COVID-19: Possible Mechanisms and Implications.	Oral Surg Oral Med Oral Pathol Oral Radiol
32703535	Coagulopathy and Plausible Benefits of Anticoagulation Among COVID-19 Patients.	Curr Probl Cardiol
32703421	Genetic variants that influence SARS-CoV-2 receptor TMPRSS2 expression among population cohorts from multiple continents.	Biochem Biophys Res Commun
32703420	Efficient production of recombinant SARS-CoV-2 spike protein using the baculovirus-silkworm system.	Biochem Biophys Res Commun
32703419	Proteasome activator PA28gamma-dependent degradation of coronavirus disease (COVID-19) nucleocapsid protein.	Biochem Biophys Res Commun
32703328	"The rationale for a multi-step therapeutic approach based on antivirals, drugs and nutrients with immunomodulatory activity in patients with coronavirus-SARS2-induced disease of different severities."	Br J Nutr
32702997	IL-6 (Interleukin 6) Blockade and Heart Rate Corrected QT Interval Prolongation in COVID-19.	Circ Arrhythm Electrophysiol
32702590	"Intermolecular interaction among Remdesivir, RNA and RNA-dependent RNA polymerase of SARS-CoV-2 analyzed by fragment molecular orbital calculation."	J Mol Graph Model
32702272	Geographic components of SARS-CoV-2 expansion: a hypothesis.	J Appl Physiol (1985)
32702098	Continued In-Hospital Angiotensin-Converting Enzyme Inhibitor and Angiotensin II Receptor Blocker Use in Hypertensive COVID-19 Patients Is Associated With Positive Clinical Outcome.	J Infect Dis
32701511	Distinct clinical and immunological features of SARS-CoV-2-induced multisystem inflammatory syndrome in children.	J Clin Invest
32701362	Update Alert 2: Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults.	Ann Intern Med
32701249	COVID-19-like symptoms observed in Chinese tree shrews infected with SARS-CoV-2.	Zool Res
32701194	Emergence of European and North American mutant variants of SARS-CoV-2 in South-East Asia.	Transbound Emerg Dis
32700813	Disseminated intravascular coagulation: A devastating systemic disorder of special concern with COVID-19.	Dermatol Ther
32700795	Targeting SARS-CoV-2 RBD Interface: a Supervised Computational Data-Driven Approach to Identify Potential Modulators.	ChemMedChem
32700671	Monoclonal antibodies for the S2 subunit of spike of SARS-CoV-1 cross-react with the newly-emerged SARS-CoV-2.	Euro Surveill
32700604	"Itolizumab, an anti-CD6 monoclonal antibody, as a potential treatment for COVID-19 complications."	Expert Opin Biol Ther
32700580	Pharmacotherapy in COVID-19 patients: a review of ACE2-raising drugs and their clinical safety.	J Drug Target
32700513	Clock genes may drive seasonal variation in SARS-CoV-2 infectivity: are we due for a second wave of COVID-19 in the fall?	J Biol Regul Homeost Agents
32700510	Characteristics of SARS-CoV-2 and potential pharmacological treatment	Postepy Biochem
32700247	Cepharanthine: a review of the antiviral potential of a Japanese-approved alopecia drug in COVID-19.	Pharmacol Rep
32700055	"The extended autonomic system, dyshomeostasis, and COVID-19."	Clin Auton Res
32700024	COVID-19-associated vasculitis and vasculopathy.	J Thromb Thrombolysis
32699972	"Mild Cytokine Elevation, Moderate CD4(+) T Cell Response and Abundant Antibody Production in Children with COVID-19."	Virol Sin
32699894	Atrial fibrillation in the COVID-19 era: simple bystander or marker of increased risk?	Eur Heart J
32699874	Rocaglamide and silvestrol: a long story from anti-tumor to anti-coronavirus compounds.	Nat Prod Rep
32699357	COVID-19 management in light of the circadian clock.	Nat Rev Mol Cell Biol
32699345	SARS-CoV-2 genomic variations associated with mortality rate of COVID-19.	J Hum Genet
32699321	Controlling the SARS-CoV-2 spike glycoprotein conformation.	Nat Struct Mol Biol
32699160	"COVID-19: Complement, Coagulation, and Collateral Damage."	J Immunol
32699095	Evolutionary Arms Race between Virus and Host Drives Genetic Diversity in Bat Severe Acute Respiratory Syndrome-Related Coronavirus Spike Genes.	J Virol
32699094	Type I and Type III Interferons Restrict SARS-CoV-2 Infection of Human Airway Epithelial Cultures.	J Virol
32699064	Viral subversion of nonsense-mediated mRNA decay.	RNA
32699026	"Respiratory viral sepsis: epidemiology, pathophysiology, diagnosis and treatment."	Eur Respir Rev
32698898	Mesenchymal stem cells: current clinical progress in ARDS and COVID-19.	Stem Cell Res Ther
32698853	Nebulised heparin as a treatment for COVID-19: scientific rationale and a call for randomised evidence.	Crit Care
32698840	"Plasma levels of soluble ACE2are associated with sex, Metabolic Syndrome, and its biomarkers in a large cohort, pointing to a possible mechanism for increased severity in COVID-19."	Crit Care
32698693	Dual inhibitors of SARS-CoV-2 proteases: pharmacophore and molecular dynamics based drug repositioning and phytochemical leads.	J Biomol Struct Dyn
32698689	Targeting SARS-CoV-2 spike protein of COVID-19 with naturally occurring phytochemicals: an in silico study for drug development.	J Biomol Struct Dyn
32698626	"Anti-COVID drugs: repurposing existing drugs or search for new complex entities, strategies and perspectives."	Future Med Chem
32698494	Self-Amplifying RNA Viruses as RNA Vaccines.	Int J Mol Sci
32698441	Age-Dependent Progression of SARS-CoV-2 Infection in Syrian Hamsters.	Viruses
32698440	Tiotropium is Predicted to be a Promising Drug for COVID-19 Through Transcriptome-Based Comprehensive Molecular Pathway Analysis.	Viruses
32698423	"Identification and Analysis of Unstructured, Linear B-Cell Epitopes in SARS-CoV-2 Virion Proteins for Vaccine Development."	Vaccines (Basel)
32698378	"COVID-19: Pain Management in Patients with SARS-CoV-2 Infection-Molecular Mechanisms, Challenges, and Perspectives."	Brain Sci
32698249	Sex-related differences in COVID-19 lethality.	Br J Pharmacol
32698238	COVID-19 and hydatidiform mole.	Am J Reprod Immunol
32698192	Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike.	Nature
32698190	Chloroquine does not inhibit infection of human lung cells with SARS-CoV-2.	Nature
32697970	Making Sense of Mutation: What D614G Means for the COVID-19 Pandemic Remains Unclear.	Cell
32697968	Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus.	Cell
32697943	Elevated Glucose Levels Favor SARS-CoV-2 Infection and Monocyte Response through a HIF-1alpha/Glycolysis-Dependent Axis.	Cell Metab
32697854	Interferon: The invisible link in the physiopathology of COVID-19 and BCGitis?	Scand J Immunol
32697835	"Potential Influence of Menstrual Status and Sex Hormones on Female Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Cross-sectional Multicenter Study in Wuhan, China."	Clin Infect Dis
32697817	Role of lncRNA Morrbid in PTPN11(Shp2)E76K-driven juvenile myelomonocytic leukemia.	Blood Adv
32697367	Are superantigens the cause of cytokine storm and viral sepsis in severe COVID-19? Observations and hypothesis.	Scand J Immunol
32697344	COVID-19 and olfactory dysfunction: A possible associative approach towards neurodegenerative diseases.	J Cell Physiol
32696772	Repurposing drugs against the main protease of SARS-CoV-2: mechanism-based insights supported by available laboratory and clinical data.	Mol Omics
32696759	[Discussion and prospect of infusion of NK cells in the treatment of SARS-CoV-2 infection].	Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi
32696720	Antimalarial-agent artemisinin and derivatives portray more potent binding to Lys353 and Lys31-binding hotspots of SARS-CoV-2 spike protein than hydroxychloroquine: potential repurposing of artenimol for COVID-19.	J Biomol Struct Dyn
32696718	Comparative molecular investigation of the potential inhibitors against SARS-CoV-2 main protease: a molecular docking study.	J Biomol Struct Dyn
32696637	COVID-19: could sex and age be a risk factor?	Minerva Med
32696489	Cytokine storm syndrome in coronavirus disease 2019: A narrative review.	J Intern Med
32696312	Facing acute neuromuscular diseases during COVID-19 pandemic: focus on Guillain-Barre syndrome.	Acta Neurol Belg
32696264	"The Natural History, Pathobiology, and Clinical Manifestations of SARS-CoV-2 Infections."	J Neuroimmune Pharmacol
32696234	Inhibition of SARS-CoV-2 entry through the ACE2/TMPRSS2 pathway: a promising approach for uncovering early COVID-19 drug therapies.	Eur J Clin Pharmacol
32696004	Consideration of Severe Coronavirus Disease 2019 As Viral Sepsis and Potential Use of Immune Checkpoint Inhibitors.	Crit Care Explor
32696001	Less Can Be More When Targeting Interleukin-6-Mediated Cytokine Release Syndrome in Coronavirus Disease 2019.	Crit Care Explor
32695833	Protective Immunity against SARS Subunit Vaccine Candidates Based on Spike Protein: Lessons for Coronavirus Vaccine Development.	J Immunol Res
32695405	COVID-19 and cryo-EM.	IUCrJ
32695331	Targeting complement in severe coronavirus disease 2019 to address microthrombosis.	Clin Kidney J
32695320	A brand-new cardiorenal syndrome in the COVID-19 setting.	Clin Kidney J
32695123	GSK-3 Inhibition as a Therapeutic Approach Against SARs CoV2: Dual Benefit of Inhibiting Viral Replication While Potentiating the Immune Response.	Front Immunol
32695122	Deciphering the Role of Host Genetics in Susceptibility to Severe COVID-19.	Front Immunol
32695025	Regulatory Cross Talk Between SARS-CoV-2 Receptor Binding and Replication Machinery in the Human Host.	Front Physiol
32694793	A metabolic handbook for the COVID-19 pandemic.	Nat Metab
32694292	ACE2: A Linkage for the Interplay Between COVID-19 and Decompensated Cirrhosis.	Am J Gastroenterol
32694201	Distinct conformational states of SARS-CoV-2 spike protein.	Science
32694143	Discovery and Genomic Characterization of a 382-Nucleotide Deletion in ORF7b and ORF8 during the Early Evolution of SARS-CoV-2.	mBio
32694127	COVID-19 and the Gut Microbiome: More than a Gut Feeling.	mSystems
32693711	Coronavirus Disease 2019: Coronaviruses and Kidney Injury.	J Urol
32693294	Flavaglines as natural products targeting eIF4A and prohibitins: From traditional Chinese medicine to antiviral activity against coronaviruses.	Eur J Med Chem
32693241	Emerging role of IL-6 and NLRP3 inflammasome as potential therapeutic targets to combat COVID-19: Role of lncRNAs in cytokine storm modulation.	Life Sci
32693122	"A molecular docking study revealed that synthetic peptides induced conformational changes in the structure of SARS-CoV-2 spike glycoprotein, disrupting the interaction with human ACE2 receptor."	Int J Biol Macromol
32692903	The Potential Benefit of Telmisartan to Protect Overweight Patients with COPD from the Acquisition of COVID-19.	Obesity (Silver Spring)
32692894	Multifactorial pathogenesis of COVID-19-related coagulopathy: Can defibrotide have a role in the early phases of coagulation disorders?	J Thromb Haemost
32692801	"COVID-19 Docking Server: a meta server for docking small molecules, peptides and antibodies against potential targets of COVID-19."	Bioinformatics
32692647	A novel antiviral formulation inhibits a range of enveloped viruses.	J Gen Virol
32692465	"COVID-19, cilia, and smell."	FEBS J
32692408	"Third-trimester placentas of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-positive women: histomorphology, including viral immunohistochemistry and in-situ hybridization."	Histopathology
32692346	Direct Observation of Repeated Infections With Endemic Coronaviruses.	J Infect Dis
32692306	"Virtual screening, molecular dynamics and structure-activity relationship studies to identify potent approved drugs for Covid-19 treatment."	J Biomol Struct Dyn
32692185	"Nucleotide Analogues as Inhibitors of SARS-CoV-2 Polymerase, a Key Drug Target for COVID-19."	J Proteome Res
32692176	Lung Protection by Cathepsin C Inhibition: A New Hope for COVID-19 and ARDS?	J Med Chem
32691890	"ACE2, TMPRSS2, and Furin variants and SARS-CoV-2 infection in Madrid, Spain."	J Med Virol
32691875	SARS-CoV-2 S1 is superior to the RBD as a COVID-19 subunit vaccine antigen.	J Med Virol
32691697	Natural derivatives with dual binding potential against SARS-CoV-2 main protease and human ACE2 possess low oral bioavailability: a brief computational analysis.	J Biomol Struct Dyn
32691695	Dysregulation in Akt/mTOR/HIF-1 signaling identified by proteo-transcriptomics of SARS-CoV-2 infected cells.	Emerg Microbes Infect
32691680	Cyanobacterial metabolites as promising drug leads against the M(pro) and PL(pro) of SARS-CoV-2: an in silico analysis.	J Biomol Struct Dyn
32691391	Chromosome X riddle in SARS-CoV-2 (COVID-19) - related lung pathology.	Pathol Oncol Res
32691370	SARS-CoV-2 Entry Receptor ACE2 Is Expressed on Very Small CD45(-) Precursors of Hematopoietic and Endothelial Cells and in Response to Virus Spike Protein Activates the Nlrp3 Inflammasome.	Stem Cell Rev Rep
32691334	COVID-19 and Hartnup disease: an affair of intestinal amino acid malabsorption.	Eat Weight Disord
32691074	A putative AOP for pneumonia related to COVID-19.	Arch Toxicol
32691039	ACE2 down-regulation may contribute to the increased thrombotic risk in COVID-19.	Eur Heart J
32691011	Structure-based drug designing and immunoinformatics approach for SARS-CoV-2.	Sci Adv
32691005	The antiviral and coronavirus-host protein pathways inhibiting properties of herbs and natural compounds - Additional weapons in the fight against the COVID-19 pandemic?	J Tradit Complement Med
32690985	Coronavirus infection (SARS-CoV-2) in obesity and diabetes comorbidities: is heat shock response determinant for the disease complications?	Diabetol Metab Syndr
32690910	COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives.	Nat Rev Cardiol
32690850	Mechanisms of Stroke in COVID-19.	Cerebrovasc Dis
32690628	An Alphavirus-derived replicon RNA vaccine induces SARS-CoV-2 neutralizing antibody and T cell responses in mice and nonhuman primates.	Sci Transl Med
32690600	Depicting SARS-CoV-2 faecal viral activity in association with gut microbiota composition in patients with COVID-19.	Gut
32690547	A Recurrent Mutation at Position 26340 of SARS-CoV-2 Is Associated with Failure of the E Gene Quantitative Reverse Transcription-PCR Utilized in a Commercial Dual-Target Diagnostic Assay.	J Clin Microbiol
32690544	Genetic variations in the human severe acute respiratory syndrome coronavirus receptor ACE2 and serine protease TMPRSS2.	J Clin Pathol
32690096	"Biological, clinical and epidemiological features of COVID-19, SARS and MERS and AutoDock simulation of ACE2."	Infect Dis Poverty
32690029	Issues for the management of people with diabetes and COVID-19 in ICU.	Cardiovasc Diabetol
32689852	Immune Responses to the Novel Coronavirus-2: Friend or Foe?	Immunol Invest
32689643	Coronavirus Disease 2019 and Stroke: Clinical Manifestations and Pathophysiological Insights.	J Stroke Cerebrovasc Dis
32688380	Should atrial fibrillation be considered a cardiovascular risk factor for a worse prognosis in COVID-19 patients?	Eur Heart J
32688185	Platelets to surrogate lung inflammation in COVID-19 patients.	Med Hypotheses
32688146	The peripheral blood immune cell profile in a teriflunomide-treated multiple sclerosis patient with COVID-19 pneumonia.	J Neuroimmunol
32688139	PARP-inhibitors in a non-oncological indication as COVID-19: Are we aware about its potential role as anti-thrombotic drugs? The discussion is open.	Biomed Pharmacother
32688067	Body temperature and host species preferences of SARS-CoV-2.	Clin Microbiol Infect
32687925	What Is the Incidence of COVID-19 in Patients With IBD in Western Countries?	Gastroenterology
32687918	"Contribution of monocytes and macrophages to the local tissue inflammation and cytokine storm in COVID-19: Lessons from SARS and MERS, and potential therapeutic interventions."	Life Sci
32687917	"An updated insight into the molecular pathogenesis, secondary complications and potential therapeutics of COVID-19 pandemic."	Life Sci
32687861	Phylogenetic and phylodynamic analyses of SARS-CoV-2.	Virus Res
32687852	"Using ""old"" medications to fight new COVID-19: Re-purposing with a purpose."	J Mol Cell Cardiol
32687806	Potential factors linked to high COVID-19 death rates in British minority ethnic groups.	Lancet Infect Dis
32687793	COVID-19 in people with diabetes: understanding the reasons for worse outcomes.	Lancet Diabetes Endocrinol
32687681	Neuropathogenic human coronaviruses: A review.	Rev Med Virol
32687609	Viruses and asthma: the role of common respiratory viruses in asthma and its potential meaning for SARS-CoV-2.	Immunology
32687562	Should Coronavirus Disease 2019-Associated Inflammatory Syndromes in Children Affect Social Reintegration?	JAMA Pediatr
32687484	Severe immunosuppression and not a cytokine storm characterizes COVID-19 infections.	JCI Insight
32687449	Viral Coagulopathy in Patients With COVID-19: Treatment and Care.	Clin Appl Thromb Hemost
32687406	Inhibiting fusion with cellular membrane system: therapeutic options to prevent severe acute respiratory syndrome coronavirus-2 infection.	Am J Physiol Cell Physiol
32687345	Structure-Based Virtual Screening to Discover Potential Lead Molecules for the SARS-CoV-2 Main Protease.	J Chem Inf Model
32687274	Influence of inhibitors of the renin-angiotensin system on risk of acute respiratory distress syndrome in Danish hospitalized COVID-19 patients.	J Hypertens
32687176	"Evidence for Strong Mutation Bias toward, and Selection against, U Content in SARS-CoV-2: Implications for Vaccine Design."	Mol Biol Evol
32686993	"Network analysis, sequence and structure dynamics of key proteins of coronavirus and human host, and molecular docking of selected phytochemicals of nine medicinal plants."	J Biomol Struct Dyn
32686937	SARS-CoV-2-Encoded Proteome and Human Genetics: From Interaction-Based to Ribosomal Biology Impact on Disease and Risk Processes.	J Proteome Res
32686851	Pick Up Your Probes: A Call for Clinically Oriented Point-of-Care Ultrasound Research in COVID-19.	J Ultrasound Med
32686754	Antibody responses to SARS-CoV-2 short-lived.	Nat Rev Immunol
32686753	Virus dissociated from inflammation in fatal COVID-19.	Nat Rev Immunol
32686577	Epigenetic mechanisms regulating COVID-19 infection.	Epigenetics
32686527	Could a specific ACE2 activator drug improve the clinical outcome of SARS-CoV-2? A potential pharmacological insight.	Expert Rev Clin Pharmacol
32686248	Novel coronavirus SARS-CoV-2 (Covid-19) dynamics inside the human body.	Rev Med Virol
32685972	FoldRec-C2C: protein fold recognition by combining cluster-to-cluster model and protein similarity network.	Brief Bioinform
32685886	Antiviral anticoagulation.	Res Pract Thromb Haemost
32685883	Thrombosis and coagulopathy in COVID-19: An illustrated review.	Res Pract Thromb Haemost
32685881	Potential role of platelets in COVID-19: Implications for thrombosis.	Res Pract Thromb Haemost
32685484	Identification of COVID-19 Infection-Related Human Genes Based on a Random Walk Model in a Virus-Human Protein Interaction Network.	Biomed Res Int
32685291	Identification of novel mutations in RNA-dependent RNA polymerases of SARS-CoV-2 and their implications on its protein structure.	PeerJ
32685191	The angiotensin-converting enzyme 2 (ACE2) receptor in the prevention and treatment of COVID-19 are distinctly different paradigms.	Clin Hypertens
32684816	Anti-inflammatory Properties of Stingless Bee Honey May Reduce the Severity of Pulmonary Manifestations in COVID-19 Infections?	Malays J Med Sci
32684497	Vaccines based on virus-like nano-particles for use against Middle East Respiratory Syndrome (MERS) coronavirus.	Vaccine
32684207	[Exploration on the therapeutic mechanisms and safety of blood components of convalescents without erythrocytes on severe acute respiratory syndrome and coronavirus disease 2019].	Zhonghua Wei Zhong Bing Ji Jiu Yi Xue
32684166	Withaferin A: a potential therapeutic agent against COVID-19 infection.	J Ovarian Res
32684114	In-silico drug repurposing and molecular dynamics puzzled out potential SARS-CoV-2 main protease inhibitors.	J Biomol Struct Dyn
32684109	Targeting virus-host interaction by novel pyrimidine derivative: an in silico approach towards discovery of potential drug against COVID-19.	J Biomol Struct Dyn
32684080	"COVID-19, Mast Cells, Cytokine Storm, Psychological Stress, and Neuroinflammation."	Neuroscientist
32683890	What HIV in the Brain Can Teach Us About SARS-CoV-2 Neurological Complications?	AIDS Res Hum Retroviruses
32683753	Pathogenesis and management of myocardial injury in coronavirus disease 2019.	Eur J Heart Fail
32683455	Thrombocytopenia in COVID-19: pathophysiology matters.	Ann Hematol
32683439	"Protein-sol pKa: prediction of electrostatic frustration, with application to coronaviruses."	Bioinformatics
32683333	COVID-19-associated coagulopathy.	Diagnosis (Berl)
32683296	Immune and bioinformatics identification of T cell and B cell epitopes in the protein structure of SARS-CoV-2: A systematic review.	Int Immunopharmacol
32683222	The immunomodulatory effects of exercise against COVID-19.	Med Hypotheses
32683221	Immuno-pathogenesis of nCOVID-19 and a possible host-directed therapy including anti-inflammatory and anti-viral prostaglandin (PG J2) for effective treatment and reduction in the death toll.	Med Hypotheses
32683039	ACE2 imbalance as a key player for the poor outcomes in COVID-19 patients with age-related comorbidities - Role of gut microbiota dysbiosis.	Ageing Res Rev
32682788	"Virology, pathogenesis, diagnosis and in-line treatment of COVID-19."	Eur J Pharmacol
32682765	Lipotoxicity and Cytokine Storm in Severe Acute Pancreatitis and COVID-19.	Gastroenterology
32682575	Targeting Cytokine Storm to Manage Patients with COVID-19: A Mini-Review.	Arch Med Res
32682454	SARS-CoV-2: Should We Be Concerned about the Nervous System?	Am J Trop Med Hyg
32682440	Blocking IL-1 to prevent respiratory failure in COVID-19.	Crit Care
32682363	Covid-19 infection and the host genetic predisposition: does it exist?	Physiol Res
32682081	Fish oil and COVID-19 thromboses.	J Vasc Surg Venous Lymphat Disord
32681986	"Harnessing nitric oxide for preventing, limiting and treating the severe pulmonary consequences of COVID-19."	Nitric Oxide
32681935	SARS-CoV-2 and the cardiovascular system.	Clin Chim Acta
32681845	Coagulopathy in COVID-19: Focus on vascular thrombotic events.	J Mol Cell Cardiol
32681716	Why does COVID-19 kill more elderly men than women? Is there a role for testosterone?	Andrology
32681673	Are the salivary glands the key players in spreading COVID-19 asymptomatic infection in dental practice?	J Med Virol
32681650	SARS-CoV-2 replicating in nonprimate mammalian cells probably have critical advantages for COVID-19 vaccines due to anti-Gal antibodies: A minireview and proposals.	J Med Virol
32681630	The COVID-19 Pandemic: Is It A Wolf Consuming Fertility?	Int J Fertil Steril
32681497	COVID-19 as part of the hyperferritinemic syndromes: the role of iron depletion therapy.	Immunol Res
32681447	Coronaviruses in cattle.	Trop Anim Health Prod
32681297	Pulmonary immune responses against SARS-CoV-2 infection: harmful or not?	Intensive Care Med
32681121	ACE2 gene variants may underlie interindividual variability and susceptibility to COVID-19 in the Italian population.	Eur J Hum Genet
32681106	Cryo-EM analysis of the post-fusion structure of the SARS-CoV spike glycoprotein.	Nat Commun
32680957	SARS-CoV-2 as a Factor to Disbalance the Renin-Angiotensin System: A Suspect in the Case of Exacerbated IL-6 Production.	J Immunol
32680954	"SARS-CoV-2 T cell immunity: Specificity, function, durability, and role in protection."	Sci Immunol
32680924	Oncology-Inspired Treatment Options for COVID-19.	J Nucl Med
32680882	Structural basis for translational shutdown and immune evasion by the Nsp1 protein of SARS-CoV-2.	Science
32680695	Diarrhoea and the COVID-19 pandemic.	Arab J Gastroenterol
32680625	Glucose-6-Phosphate Dehydrogenase Deficiency and COVID-19 Infection.	Mayo Clin Proc
32679784	Immunologic Effects of Vitamin D on Human Health and Disease.	Nutrients
32679775	Deamidated Human Triosephosphate Isomerase is a Promising Druggable Target.	Biomolecules
32679621	Increased CD95 (Fas) and PD-1 expression in peripheral blood T lymphocytes in COVID-19 patients.	Br J Haematol
32679620	Biotin Functionalized Self-Assembled Peptide Nanofiber as an Adjuvant for Immunomodulatory Response.	Biotechnol J
32679596	Obesity and COVID-19: A Virchow's Triad for the 21st Century.	Thromb Haemost
32679589	Supplementation with vitamin D in the COVID-19 pandemic?	Nutr Rev
32679426	The <<moonlighting protein>> able to explain the Th1 immune lockdown in severe COVID-19.	Med Hypotheses
32679425	The hypothesis that SARS-CoV-2 affects male reproductive ability by regulating autophagy.	Med Hypotheses
32679424	Natural protection of ocular surface from viral infections - A hypothesis.	Med Hypotheses
32679422	Is it possible to use Proton Pump Inhibitors in COVID-19 treatment and prophylaxis?	Med Hypotheses
32679367	WITHDRAWN: Selenium - associated gene signatures within the SARS-CoV-2 - host genomic interaction interface.	Free Radic Biol Med
32679185	Correlation between renin-angiotensin system and Severe Acute Respiratory Syndrome Coronavirus 2 infection: What do we know?	Eur J Pharmacol
32679175	Regional differences in use of immune-modulating catechins should be investigated regarding COVID-19.	Brain Behav Immun
32679150	Matrix metallopeptidase 9 as a host protein target of chloroquine and melatonin for immunoregulation in COVID-19: A network-based meta-analysis.	Life Sci
32679148	The bio-mission of interleukin-6 in the pathogenesis of COVID-19: A brief look at potential therapeutic tactics.	Life Sci
32679087	COVID-19: from rapid genome sequencing to fast decisions.	Lancet Infect Dis
32679006	Drug repurposing studies targeting SARS-CoV-2: an ensemble docking approach on drug target 3C-like protease (3CL(pro)).	J Biomol Struct Dyn
32678978	The Utility of Native MS for Understanding the Mechanism of Action of Repurposed Therapeutics in COVID-19: Heparin as a Disruptor of the SARS-CoV-2 Interaction with Its Host Cell Receptor.	Anal Chem
32678975	SARS-CoV2 and pregnancy: An invisible enemy?	Am J Reprod Immunol
32678950	Single-cell oxygen saturation imaging shows that gas exchange by red blood cells is not impaired in COVID-19 patients.	Br J Haematol
32678695	Neutralizing and cross-reacting antibodies: implications for immunotherapy and SARS-CoV-2 vaccine development.	Hum Vaccin Immunother
32678588	SARS-CoV-2 Main Protease: A Molecular Dynamics Study.	J Chem Inf Model
32678542	"[Novel coronavirus infection (COVID-19) and nervous system involvement: pathogenesis, clinical manifestations, organization of neurological care]."	Zh Nevrol Psikhiatr Im S S Korsakova
32678533	Pulmonary Vascular Pathology in Covid-19.	N Engl J Med
32678532	Pulmonary Vascular Pathology in Covid-19.	N Engl J Med
32678531	Pulmonary Vascular Pathology in Covid-19.	N Engl J Med
32678432	Blocking inflammation on the way: Rationale for CXCR2 antagonists for the treatment of COVID-19.	J Exp Med
32678431	"Neutrophils and COVID-19: Nots, NETs, and knots."	J Exp Med
32678428	Platelet activation and platelet-monocyte aggregate formation trigger tissue factor expression in patients with severe COVID-19.	Blood
32678356	Rapid SARS-CoV-2 whole-genome sequencing and analysis for informed public health decision-making in the Netherlands.	Nat Med
32678072	"Detection and Genetic Characterization of Community-Based SARS-CoV-2 Infections - New York City, March 2020."	MMWR Morb Mortal Wkly Rep
32677763	Lessons from SARS and MERS remind us of the possible therapeutic effects of implementing a siRNA strategy to target COVID-19: Shoot the messenger!	J Cell Mol Med
32677545	Approach to the mechanism of action of hydroxychloroquine on SARS-CoV-2: a molecular docking study.	J Biomol Struct Dyn
32677533	Designing a multi-epitope vaccine against SARS-CoV-2: an immunoinformatics approach.	J Biomol Struct Dyn
32677478	"Coronavirus 2019 Disease (COVID-19), Systemic Inflammation, and Cardiovascular Disease."	J Am Heart Assoc
32676883	COVID-19: the role of excessive cytokine release and potential ACE2 down-regulation in promoting hypercoagulable state associated with severe illness.	J Thromb Thrombolysis
32676824	Respiratory mechanics and gas exchanges in the early course of COVID-19 ARDS: a hypothesis-generating study.	Ann Intensive Care
32676542	"Insights into Potential Mechanisms of Injury and Treatment Targets in COVID-19, SARS-Cov-2 Infection."	Int J Clin Res Trials
32676080	"Small Intestinal Immunopathology Plays a ""Big"" Role in Lethal Cytokine Release Syndrome, and Its Modulation by Interferon-gamma, IL-17A, and a Janus Kinase Inhibitor."	Front Immunol
32676039	COVID-19 Sepsis and Microcirculation Dysfunction.	Front Physiol
32675364	Aging immunity may exacerbate COVID-19.	Science
32675312	"ACE2 and TMPRSS2 expression by clinical, HLA, immune, and microbial correlates across 34 human cancers and matched normal tissues: implications for SARS-CoV-2 COVID-19."	J Immunother Cancer
32675285	"Intracellular autoactivation of TMPRSS11A, an airway epithelial transmembrane serine protease."	J Biol Chem
32675207	"Increased expression of ACE2, the SARS-CoV-2 entry receptor, in alveolar and bronchial epithelium of smokers and COPD subjects."	Eur Respir J
32675206	Gene expression and in situ protein profiling of candidate SARS-CoV-2 receptors in human airway epithelial cells and lung tissue.	Eur Respir J
32674791	"Renin-Angiotensin System Blockade in COVID-19: Good, Bad, or Indifferent?"	J Am Coll Cardiol
32674732	Ligand and Structure-based Virtual Screening of Lamiaceae Diterpenes with Potential Activity against a Novel Coronavirus (2019-nCoV).	Curr Top Med Chem
32674673	COVID-19 and Vitamin D deficiency; the two pandemics. Are they correlated?	Int J Vitam Nutr Res
32674515	Validation of Variant Assembly Using HAPHPIPE with Next-Generation Sequence Data from Viruses.	Viruses
32674481	Immunomodulatory Effects of Hydroxychloroquine and Chloroquine in Viral Infections and Their Potential Application in Retinal Gene Therapy.	Int J Mol Sci
32674356	Kurarinone Inhibits HCoV-OC43 Infection by Impairing the Virus-Induced Autophagic Flux in MRC-5 Human Lung Cells.	J Clin Med
32673940	EMMPRIN/BASIGIN as a biological modulator of oral cancer and COVID-19 interaction: Novel propositions.	Med Hypotheses
32673650	"commentary: COVID-19 and Obesity: Exploring Biologic Vulnerabilities, Structural Disparities, and Weight Stigma."	Metabolism
32673567	Longitudinal Isolation of Potent Near-Germline SARS-CoV-2-Neutralizing Antibodies from COVID-19 Patients.	Cell
32673562	RNA-GPS Predicts SARS-CoV-2 RNA Residency to Host Mitochondria and Nucleolus.	Cell Syst
32673509	Effects of Renin-Angiotensin Inhibition on ACE2 (Angiotensin-Converting Enzyme 2) and TMPRSS2 (Transmembrane Protease Serine 2) Expression: Insights Into COVID-19.	Hypertension
32673476	Anosmia in COVID-19: A Bumpy Road to Establishing a Cellular Mechanism.	ACS Chem Neurosci
32673355	Ultraviolet A light effectively reduces bacteria and viruses including coronavirus.	PLoS One
32673162	The interaction between SARS-CoV-2 and ACE2 may have consequences for skeletal muscle viral susceptibility and myopathies.	J Appl Physiol (1985)
32672843	Encephalitic syndrome and anosmia in COVID-19: Do these clinical presentations really reflect SARS-CoV-2 neurotropism? A theory based on the review of 25 COVID-19 cases.	J Med Virol
32672804	Olfactory Loss of Function as a Possible Symptom of COVID-19.	JAMA Otolaryngol Head Neck Surg
32672790	Excess Soluble fms-like Tyrosine Kinase 1 Correlates With Endothelial Dysfunction and Organ Failure in Critically Ill Coronavirus Disease 2019 Patients.	Clin Infect Dis
32672787	Olfactory Loss of Function as a Possible Symptom of COVID-19.	JAMA Otolaryngol Head Neck Surg
32672528	"Computer-aided screening for potential TMPRSS2 inhibitors: a combination of pharmacophore modeling, molecular docking and molecular dynamics simulation approaches."	J Biomol Struct Dyn
32672403	microRNAs as new possible actors in gender disparities of Covid-19 pandemic.	Acta Physiol (Oxf)
32672061	Evidence supporting the use of peptides and peptidomimetics as potential SARS-CoV-2 (COVID-19) therapeutics.	Future Med Chem
32671966	Why the elderly appear to be more severely affected by COVID-19: The potential role of immunosenescence and CMV.	Rev Med Virol
32671936	Factors leading to high morbidity and mortality of COVID-19 in patients with type 2 diabetes.	J Diabetes
32671831	COVID-19 vaccine-readiness for anti-CD20-depleting therapy in autoimmune diseases.	Clin Exp Immunol
32671793	Single-cell analysis reveals bronchoalveolar epithelial dysfunction in COVID-19 patients.	Protein Cell
32671688	"Current Status of Multiple Drug Molecules, and Vaccines: An Update in SARS-CoV-2 Therapeutics."	Mol Neurobiol
32671650	SARS-CoV-2/COVID-19: a primer for cardiologists.	Neth Heart J
32671455	Coagulopathy and thromboembolic events in patients with SARS-CoV-2 infection: pathogenesis and management strategies.	Ann Hematol
32671399	Outcomes of renin-angiotensin-aldosterone system blockers in patients with COVID-19: a systematic review and meta-analysis.	Eur Heart J Cardiovasc Pharmacother
32671115	The Pathogenesis of Coronavirus Disease 2019 (COVID-19): Evaluation and Prevention.	J Immunol Res
32670925	Novel coronavirus: A capsule review for primary care and acute care physicians.	J Family Med Prim Care
32670924	Coronavirus: An emergency for healthcare professionals.	J Family Med Prim Care
32670694	SARS-CoV-2 (COVID 19) Infection in Hypertensive Patients and in Patients With Cardiac Disease.	Cureus
32670618	Coronavirus Disease 2019: Where are we and Where are we Going? Intersections Between Coronavirus Disease 2019 and the Heart.	Card Fail Rev
32670592	Mild SARS-CoV-2 infections in children might be based on evolutionary biology and linked with host reactive oxidative stress and antioxidant capabilities.	New Microbes New Infect
32670526	Pidotimod in Paucisymptomatic SARS-CoV2 Infected Patients.	Mediterr J Hematol Infect Dis
32670475	Cardiovascular Implications of COVID-19 Infections.	Methodist Debakey Cardiovasc J
32670298	Immune and Metabolic Signatures of COVID-19 Revealed by Transcriptomics Data Reuse.	Front Immunol
32670297	Severe COVID-19: NLRP3 Inflammasome Dysregulated.	Front Immunol
32670259	MicroGMT: A Mutation Tracker for SARS-CoV-2 and Other Microbial Genome Sequences.	Front Microbiol
32670091	The Modulation of Mucosal Antiviral Immunity by Immunobiotics: Could They Offer Any Benefit in the SARS-CoV-2 Pandemic?	Front Physiol
32669955	"A comprehensive investigation of the mRNA and protein level of ACE2, the putative receptor of SARS-CoV-2, in human tissues and blood cells."	Int J Med Sci
32669705	The bright and dark sides of protein conformational switches and the unifying forces of infections.	Commun Biol
32669681	A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology.	Nat Microbiol
32669467	Clinical Characteristics and Immune Injury Mechanisms in 71 Patients with COVID-19.	mSphere
32669391	SARS-CoV-2 Infections and ACE2: Clinical Outcomes Linked With Increased Morbidity and Mortality in Individuals With Diabetes.	Diabetes
32669390	"Aging, Male Sex, Obesity, and Metabolic Inflammation Create the Perfect Storm for COVID-19."	Diabetes
32669323	Kidney and Lung ACE2 Expression after an ACE Inhibitor or an Ang II Receptor Blocker: Implications for COVID-19.	J Am Soc Nephrol
32669297	Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications.	Science
32669287	Comprehensive mapping of immune perturbations associated with severe COVID-19.	Sci Immunol
32669265	Discovery of M Protease Inhibitors Encoded by SARS-CoV-2.	Antimicrob Agents Chemother
32669221	"From H1N1 to 2019-nCoV, what do we learn?"	Chin J Traumatol
32668969	Potential Targets for Treatment of Coronavirus Disease 2019 (COVID-19): A Review of Qing-Fei-Pai-Du-Tang and Its Major Herbs.	Am J Chin Med
32668870	RETRACTED: 5G Technology and induction of coronavirus in skin cells.	J Biol Regul Homeost Agents
32668701	High Throughput Virtual Screening to Discover Inhibitors of the Main Protease of the Coronavirus SARS-CoV-2.	Molecules
32668692	Mutational Frequencies of SARS-CoV-2 Genome during the Beginning Months of the Outbreak in USA.	Pathogens
32668462	COVID-19: An Immunopathologic Assault.	AACN Adv Crit Care
32668444	"SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls."	Nature
32668443	Potently neutralizing and protective human antibodies against SARS-CoV-2.	Nature
32668216	Remdesivir Inhibits SARS-CoV-2 in Human Lung Cells and Chimeric SARS-CoV Expressing the SARS-CoV-2 RNA Polymerase in Mice.	Cell Rep
32668215	Human-IgG-Neutralizing Monoclonal Antibodies Block the SARS-CoV-2 Infection.	Cell Rep
32668194	Next-Generation Sequencing of T and B Cell Receptor Repertoires from COVID-19 Patients Showed Signatures Associated with Severity of Disease.	Immunity
32668165	SARS-CoV-2 (COVID-19) and cystic fibrosis.	Am J Physiol Lung Cell Mol Physiol
32668062	Severe acute respiratory syndrome coronavirus 2 may be an underappreciated pathogen of the central nervous system.	Eur J Neurol
32667973	Severe Acute Respiratory Syndrome Coronavirus 2 Infects and Damages the Mature and Immature Olfactory Sensory Neurons of Hamsters.	Clin Infect Dis
32667280	"A putative new SARS-CoV protein, 3c, encoded in an ORF overlapping ORF3a."	J Gen Virol
32666910	"Computational investigation of potential inhibitors of novel coronavirus 2019 through structure-based virtual screening, molecular dynamics and density functional theory studies."	J Biomol Struct Dyn
32666683	COVID-19 and chronic obstructive pulmonary disease: therapeutic potential of blocking SARS-CoV2 adhesion factors.	Intern Med J
32666636	Clinical outcomes of coronavirus disease 2019 (COVID-19) in cancer patients with prior exposure to immune checkpoint inhibitors.	Cancer Commun (Lond)
32666588	"COVID-19, liver transplant, and immunosuppression: Allies or foes?"	Transpl Infect Dis
32666513	Spectrum of Headaches Associated With SARS-CoV-2 Infection: Study of Healthcare Professionals.	Headache
32666177	"The SARS-CoV-2 receptor, ACE-2, is expressed on many different cell types: implications for ACE-inhibitor- and angiotensin II receptor blocker-based antihypertensive therapies-reply."	Intern Emerg Med
32666137	Autoimmune and rheumatic musculoskeletal diseases as a consequence of SARS-CoV-2 infection and its treatment.	Rheumatol Int
32665963	Characteristics of the Coronavirus Disease 2019 and related Therapeutic Options.	Mol Ther Methods Clin Dev
32665962	The Two Faces of ACE2: The Role of ACE2 Receptor and Its Polymorphisms in Hypertension and COVID-19.	Mol Ther Methods Clin Dev
32665808	Exploiting Existing Molecular Scaffolds for Long-Term COVID Treatment.	ACS Med Chem Lett
32665786	Lessons learned from the mechanisms of posttraumatic inflammation extrapolated to the inflammatory response in COVID-19: a review.	Patient Saf Surg
32665783	Current strategies against COVID-19.	Chin Med
32665542	Exploring the SARS-CoV-2 virus-host-drug interactome for drug repurposing.	Nat Commun
32665047	The Dysfunction is in the Details: Neurovascular Changes in COVID-19.	Can J Neurol Sci
32664991	"Relationship of chest CT score with clinical characteristics of 108 patients hospitalized with COVID-19 in Wuhan, China."	Respir Res
32664949	SARS-CoV-2 induces transcriptional signatures in human lung epithelial cells that promote lung fibrosis.	Respir Res
32664879	New insights into genetic susceptibility of COVID-19: an ACE2 and TMPRSS2 polymorphism analysis.	BMC Med
32664708	COVID-19 in children: reasons for uneventful clinical course.	Clin Exp Pediatr
32664570	Polymorphic Forms of Valinomycin Investigated by NMR Crystallography.	Int J Mol Sci
32664543	Lactoferrin as Protective Natural Barrier of Respiratory and Intestinal Mucosa against Coronavirus Infection and Inflammation.	Int J Mol Sci
32664217	"Effects of Airborne Nanoparticles on the Nervous System: Amyloid Protein Aggregation, Neurodegeneration and Neurodegenerative Diseases."	Nanomaterials (Basel)
32663742	COVID-19 infection can cause chemotherapy resistance development in patients with breast cancer and tamoxifen may cause susceptibility to COVID-19 infection.	Med Hypotheses
32663741	Prospective vaccination of COVID-19 using shRNA-plasmid-LDH nanoconjugate.	Med Hypotheses
32663708	"Reckoning a fungal metabolite, Pyranonigrin A as a potential Main protease (M(pro)) inhibitor of novel SARS-CoV-2 virus identified using docking and molecular dynamics simulation."	Biophys Chem
32663617	Population Genetics of SARS-CoV-2: Disentangling Effects of Sampling Bias and Infection Clusters.	Genomics Proteomics Bioinformatics
32663575	"Tackling the cytokine storm in COVID-19, challenges and hopes."	Life Sci
32663409	"Single-Cell RNA Expression Profiling of ACE2, the Receptor of SARS-CoV-2."	Am J Respir Crit Care Med
32663364	COVID-19-associated coagulopathy-Hypothesis: Are children protected due to enhanced thrombin inhibition by higher alpha2 -Macroglobulin macroglobulin (alpha2-M)?	J Thromb Haemost
32663362	"ACE2, the Receptor that Enables Infection by SARS-CoV-2: Biochemistry, Structure, Allostery and Evaluation of the Potential Development of ACE2 Modulators."	ChemMedChem
32663349	Management of crash and burn patients with SARS-CoV-2 associated ARDS.	J Card Surg
32663051	An immunotherapeutic method for COVID-19 patients: a soluble ACE2-Anti-CD16 VHH to block SARS-CoV-2 Spike protein.	Hum Vaccin Immunother
32662982	Calcium Channel Blockers: A Possible Potential Therapeutic Strategy for the Treatment of Alzheimer's Dementia Patients with SARS-CoV-2 Infection.	ACS Chem Neurosci
32662981	"Can the Environmental Phagocyte Acanthamoeba Be a Useful Model to Study SARS-CoV-2 Pathogenicity, Infectivity, and Evasion of Cellular Immune Defenses?"	ACS Chem Neurosci
32662949	Modulation of the acute defence reaction by eplerenone prevents cardiac disease progression in viral myocarditis.	ESC Heart Fail
32662915	Computer modeling of a potential agent against SARS-Cov-2 (COVID-19) protease.	Proteins
32662814	Integrative pharmacological mechanism of vitamin C combined with glycyrrhizic acid against COVID-19: findings of bioinformatics analyses.	Brief Bioinform
32662421	Does the human placenta express the canonical cell entry mediators for SARS-CoV-2?	Elife
32662416	SARS-COV-2 in Ophthalmology: Current Evidence and Standards for Clinical Practice.	Acta Med Port
32662333	Computational discovery of small drug-like compounds as potential inhibitors of SARS-CoV-2 main protease.	J Biomol Struct Dyn
32662203	Hypothetical targets and plausible drugs of coronavirus infection caused by SARS-CoV-2.	Transbound Emerg Dis
32662161	"Covid-19, ACE2 and the kidney."	Acta Physiol (Oxf)
32662111	COVID-19 and Treg/Th17 imbalance: Potential relationship to pregnancy outcomes.	Am J Reprod Immunol
32662099	Therapeutic dilemma in the repression of severe acute respiratory syndrome coronavirus-2 proteome.	Drug Dev Res
32661881	Diabetes and Novel Coronavirus Infection: Implications for Treatment.	Diabetes Ther
32661859	"Can Vitamins, as Epigenetic Modifiers, Enhance Immunity in COVID-19 Patients with Non-communicable Disease?"	Curr Nutr Rep
32661794	Neurological Involvement in COVID-19 and Potential Mechanisms: A Review.	Neurocrit Care
32661586	COVID-19 and purinergic signaling: the need for investigation.	Purinergic Signal
32661494	Computational View toward the Inhibition of SARS-CoV-2 Spike Glycoprotein and the 3CL Protease.	Computation (Basel)
32661423	Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2.	Nat Struct Mol Biol
32661393	Humoral and circulating follicular helper T cell responses in recovered patients with COVID-19.	Nat Med
32661375	Immune-mediated approaches against COVID-19.	Nat Nanotechnol
32661235	"Stress proteins: the biological functions in virus infection, present and challenges for target-based antiviral drug development."	Signal Transduct Target Ther
32661206	Assessment of risk conferred by coding and regulatory variations of TMPRSS2 and CD26 in susceptibility to SARS-CoV-2 infection in human.	J Genet
32661197	The molecular virology of coronaviruses.	J Biol Chem
32661141	Metabolic Syndrome and Viral Pathogenesis: Lessons from Influenza and Coronaviruses.	J Virol
32661140	The SARS-CoV-2 N Protein Is a Good Component in a Vaccine.	J Virol
32661139	Broad and Differential Animal Angiotensin-Converting Enzyme 2 Receptor Usage by SARS-CoV-2.	J Virol
32661059	Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients.	Science
32661058	Structural basis of a shared antibody response to SARS-CoV-2.	Science
32660959	Is FURIN gene expression in salivary glands related to SARS-CoV-2 infectivity through saliva?	J Clin Pathol
32660890	Are sex discordant outcomes in COVID-19 related to sex hormones?	Semin Oncol
32660697	"[SARS-CoV-2 infection: implications for sexual and reproductive health. A position statement of the Asociacion Espanola de Andrologia, Medicina Sexual y Reproductiva (ASESA)]."	Rev Int Androl
32660650	Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19.	Crit Care
32660402	NPC1 as a Modulator of Disease Severity and Viral Entry of SARSCoV- 2.	Curr Mol Med
32660307	RNA-Dependent RNA Polymerase as a Target for COVID-19 Drug Discovery.	SLAS Discov
32660186	[Extra-pulmonary clinical manifestations of novel coronavirus pneumonia].	Zhonghua Gan Zang Bing Za Zhi
32660185	[Research progress on the clinical features and mechanisms of COVID-19 combined with liver injury].	Zhonghua Gan Zang Bing Za Zhi
32660065	"COVID-19, Renin-Angiotensin System and Endothelial Dysfunction."	Cells
32659783	A perspective on potential antibody-dependent enhancement of SARS-CoV-2.	Nature
32659638	From encephalitis lethargica to COVID-19: Is there another epidemic ahead?	Clin Neurol Neurosurg
32659620	Cytologic and molecular correlates of SARS-CoV-2 infection of the nasopharynx.	Ann Diagn Pathol
32659373	Long-term infection of SARS-CoV-2 changed the body's immune status.	Clin Immunol
32659347	Genome-wide analysis of Indian SARS-CoV-2 genomes for the identification of genetic mutation and SNP.	Infect Genet Evol
32659292	Immunoglobulin fragment F(ab')2 against RBD potently neutralizes SARS-CoV-2 in vitro.	Antiviral Res
32659267	"Intermittent fasting, a possible priming tool for host defense against SARS-CoV-2 infection: Crosstalk among calorie restriction, autophagy and immune response."	Immunol Lett
32659199	COVID-19 Pulmonary and Olfactory Dysfunctions: Is the Chemokine CXCL10 the Common Denominator?	Neuroscientist
32659175	Can Vitamin D and L-Cysteine Co-Supplementation Reduce 25(OH)-Vitamin D Deficiency and the Mortality Associated with COVID-19 in African Americans?	J Am Coll Nutr
32659106	Is the Reason of Increased D-Dimer Levels in COVID-19 Because of ACE-2-Induced Apoptosis in Endothelium?	Clin Appl Thromb Hemost
32658964	Viral CpG Deficiency Provides No Evidence That Dogs Were Intermediate Hosts for SARS-CoV-2.	Mol Biol Evol
32658736	Bioinformatics studies on a function of the SARS-CoV-2 spike glycoprotein as the binding of host sialic acid glycans.	Comput Biol Med
32658735	Identification of potential inhibitors of three key enzymes of SARS-CoV2 using computational approach.	Comput Biol Med
32658609	Hospitalized COVID-19 Patients and Venous Thromboembolism: A Perfect Storm.	Circulation
32658591	The pivotal role of TMPRSS2 in coronavirus disease 2019 and prostate cancer.	Future Oncol
32658489	Michael Acceptors Tuned by the Pivotal Aromaticity of Histidine to Block COVID-19 Activity.	J Phys Chem Lett
32658389	The renin-angiotensin-aldosterone system: Role in pathogenesis and potential therapeutic target in COVID-19.	Pharmacol Res Perspect
32658359	"SARS-CoV-2, COVID-19, skin and immunology - What do we know so far?"	Allergy
32658335	The role of host genetics in the immune response to SARS-CoV-2 and COVID-19 susceptibility and severity.	Immunol Rev
32657817	Sarcopenia and COVID-19: A Manifold Insight on Hypertension and the Renin Angiotensin System.	Am J Phys Med Rehabil
32657643	Identification of potential drugs against SARS-CoV-2 non-structural protein 1 (nsp1).	J Biomol Struct Dyn
32657586	Proteomics and Informatics for Understanding Phases and Identifying Biomarkers in COVID-19 Disease.	J Proteome Res
32657484	Angiotensin-converting enzyme 2 as a versatile player in the management of coronavirus disease 2019.	J Diabetes Investig
32657473	"TWIRLS, a knowledge-mining technology, suggests a possible mechanism for the pathological changes in the human host after coronavirus infection via ACE2."	Drug Dev Res
32657207	Opioid Use Disorder and COVID-19: Biological Plausibility for Worsened Outcomes.	Subst Use Misuse
32656939	Lessons from dermatology about inflammatory responses in Covid-19.	Rev Med Virol
32656827	"Letter: ACE2, Rho kinase inhibition and the potential role of vitamin D against COVID-19."	Aliment Pharmacol Ther
32656668	SARS-CoV-2 will constantly sweep its tracks: a vaccine containing CpG motifs in 'lasso' for the multi-faced virus.	Inflamm Res
32656452	Impact of Thiol-Disulfide Balance on the Binding of Covid-19 Spike Protein with Angiotensin-Converting Enzyme 2 Receptor.	ACS Omega
32656314	COVID-19-A theory of autoimmunity to ACE-2.	MOJ Immunol
32656311	Structure-based drug designing for potential antiviral activity of selected natural products from Ayurveda against SARS-CoV-2 spike glycoprotein and its cellular receptor.	Virusdisease
32656307	Decoding the global outbreak of COVID-19: the nature is behind the scene.	Virusdisease
32655856	In the eye of the storm: the right ventricle in COVID-19.	Pulm Circ
32655584	"Nanobodies: Prospects of Expanding the Gamut of Neutralizing Antibodies Against the Novel Coronavirus, SARS-CoV-2."	Front Immunol
32655582	Targeting the NLRP3 Inflammasome in Severe COVID-19.	Front Immunol
32655581	Flattening the COVID-19 Curve With Natural Killer Cell Based Immunotherapies.	Front Immunol
32655580	Human Sialome and Coronavirus Disease-2019 (COVID-19) Pandemic: An Understated Correlation?	Front Immunol
32655579	Intoxication With Endogenous Angiotensin II: A COVID-19 Hypothesis.	Front Immunol
32655578	Three Decades of Interferon-beta in Multiple Sclerosis: Can We Repurpose This Information for the Management of SARS-CoV2 Infection?	Front Immunol
32655577	Targeting the Immune System for Pulmonary Inflammation and Cardiovascular Complications in COVID-19 Patients.	Front Immunol
32655490	Coronaviruses and Central Nervous System Manifestations.	Front Neurol
32654557	Association Between Renin-Angiotensin-Aldosterone System Inhibitors and COVID-19 Infection in South Korea.	Hypertension
32654555	Clinical Features of COVID-19 in Patients With Essential Hypertension and the Impacts of Renin-angiotensin-aldosterone System Inhibitors on the Prognosis of COVID-19 Patients.	Hypertension
32654378	SARS-CoV-2: An immunogenetics call to arms.	Int J Immunogenet
32654359	Liver histopathology in severe COVID 19 respiratory failure is suggestive of vascular alterations.	Liver Int
32654357	Low rate of COVID-19 pneumonia in kidney transplant recipients-A battle between infection and immune response?	Transpl Infect Dis
32654350	Decrease of Non-Classical and Intermediate Monocyte Subsets in Severe Acute SARS-CoV-2 Infection.	Cytometry A
32654296	"A tale of (glycogen synthase kinase) three: Lithium, the kidney and coronavirus disease 19."	Bipolar Disord
32654267	"The recent challenges of highly contagious COVID-19, causing respiratory infections: Symptoms, diagnosis, transmission, possible vaccines, animal models, and immunotherapy."	Chem Biol Drug Des
32654247	Architecture and self-assembly of the SARS-CoV-2 nucleocapsid protein.	Protein Sci
32653981	"COVID-19, coagulopathy and venous thromboembolism: more questions than answers."	Intern Emerg Med
32653765	Immunosenescence exacerbates the COVID-19.	Arch Gerontol Geriatr
32653646	SARS-CoV and SARS-CoV-2 main protease residue interaction networks change when bound to inhibitor N3.	J Struct Biol
32653566	Understanding the Complex Relationship Between Androgens and SARS-CoV2.	Urology
32653530	Good or bad: Application of RAAS inhibitors in COVID-19 patients with cardiovascular comorbidities.	Pharmacol Ther
32653522	The dual impact of ACE2 in COVID-19 and ironical actions in geriatrics and pediatrics with possible therapeutic solutions.	Life Sci
32653520	Computational insights into tetracyclines as inhibitors against SARS-CoV-2 M(pro) via combinatorial molecular simulation calculations.	Life Sci
32653518	"Gaining insights on immune responses to the novel coronavirus, COVID-19 and therapeutic challenges."	Life Sci
32653483	CCR5 Delta32 minorallele is associated with susceptibility to SARS-CoV-2 infection and death: An epidemiological investigation.	Clin Chim Acta
32653469	Thromboinflammation in COVID-19 acute lung injury.	Paediatr Respir Rev
32653452	Characterization of heparin and severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) spike glycoprotein binding interactions.	Antiviral Res
32653425	Does androgen deprivation therapy protect against severe complications from COVID-19?	Ann Oncol
32652915	"In Silico Investigation of the SARS CoV2 Protease with Thymoquinone, the Major Constituent of Nigella Sativa."	Curr Drug Discov Technol
32652766	The link between vitamin D and COVID-19: distinguishing facts from fiction.	J Intern Med
32652722	Coronary artery bypass grafting surgery versus percutaneous coronary intervention: What is the clinical decision framework amid COVID-19 era?	J Card Surg
32652428	Coronavirus disease 2019 (COVID 19) and Malaria: Have anti glycoprotein antibodies a role?	Med Hypotheses
32652139	Update on neurological manifestations of COVID-19.	Life Sci
32652001	Endocrine Significance of SARS-CoV-2's Reliance on ACE2.	Endocrinology
32651900	SARS-CoV-2 and Male Infertility: Possible Multifaceted Pathology.	Reprod Sci
32651761	"Infectivity, virulence, pathogenicity, host-pathogen interactions of SARS and SARS-CoV-2 in experimental animals: a systematic review."	Vet Res Commun
32651741	Gene expression pattern differences in primary human pulmonary epithelial cells infected with MERS-CoV or SARS-CoV-2.	Arch Virol
32651581	Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein.	Nat Med
32651579	Extrapulmonary manifestations of COVID-19.	Nat Med
32651570	CRISPRing for host genes regulating SARS-CoV-2.	Nat Rev Immunol
32651569	SARS-CoV-2 on the neural battleground.	Nat Rev Immunol
32651568	T cell renaissance in COVID-19.	Nat Rev Immunol
32651218	A Case for Targeting Th17 Cells and IL-17A in SARS-CoV-2 Infections.	J Immunol
32651212	Immunophenotyping of COVID-19 and influenza highlights the role of type I interferons in development of severe COVID-19.	Sci Immunol
32651113	Recombinant SARS-CoV-2 spike S1-Fc fusion protein induced high levels of neutralizing responses in nonhuman primates.	Vaccine
32651085	[Is the immune hyporesponsiveness of uremic patients a protective factor for severe COVID-19 pneumonia?]	Nefrologia (Engl Ed)
32651067	[Risk of severe COVID-19 in hypertensive patients treated with renin-angiotensin-aldosterone system inhibitors].	Med Clin (Barc)
32651020	COVID-19: Regulatory Landscape of Medicinal and Medical Device Products for Human Use.	Clin Ther
32650788	Energetics and IC50 based epitope screening in SARS CoV-2 (COVID 19) spike protein by immunoinformatic analysis implicating for a suitable vaccine development.	J Transl Med
32650275	Reappearance of effector T cells is associated with recovery from COVID-19.	EBioMedicine
32650197	Harnessing adenosine A2A receptors as a strategy for suppressing the lung inflammation and thrombotic complications of COVID-19: Potential of pentoxifylline and dipyridamole.	Med Hypotheses
32650004	Eicosanoids: The Overlooked Storm in Coronavirus Disease 2019 (COVID-19)?	Am J Pathol
32649962	High prevalence for obesity in severe COVID-19: Possible links and perspectives towards patient stratification.	Biochimie
32649921	SARS-CoV-2 infection in conjunctival tissue.	Lancet Respir Med
32649880	Need for Speed: From Human SARS-CoV-2 Samples to Protective and Efficacious Antibodies in Weeks.	Cell
32649864	Potential Causes and Consequences of Gastrointestinal Disorders during a SARS-CoV-2 Infection.	Cell Rep
32649840	Liver injury in severe COVID-19 infection: current insights and challenges.	Expert Rev Gastroenterol Hepatol
32649739	Natural Transmission of Bat-like Severe Acute Respiratory Syndrome Coronavirus 2 Without Proline-Arginine-Arginine-Alanine Variants in Coronavirus Disease 2019 Patients.	Clin Infect Dis
32649367	Potential Immunotherapeutic Targets for Hypoxia Due to COVI-Flu.	Shock
32649272	Combating COVID-19 and Building Immune Resilience: A Potential Role for Magnesium Nutrition?	J Am Coll Nutr
32649264	RadioGraphics Update: Venous Thrombosis and Hypercoagulability in the Abdomen and Pelvis-Findings in COVID-19.	Radiographics
32649217	Rhinovirus Infections in Individuals with Asthma Increase ACE2 Expression and Cytokine Pathways Implicated in COVID-19.	Am J Respir Crit Care Med
32649023	COVID-19 and human spermatozoa-Potential risks for infertility and sexual transmission?	Andrology
32648939	Optic nerve analysis in COVID-19 patients.	J Med Virol
32648935	SGLT2 inhibition and COVID-19: The road not taken.	Eur J Clin Invest
32648548	"[Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Should we target the virus, the cell or the disease?]."	Virologie (Montrouge)
32648313	Immunopathology and immunotherapeutic strategies in severe acute respiratory syndrome coronavirus 2 infection.	Rev Med Virol
32648027	Immunologic Features in Coronavirus Disease 2019: Functional Exhaustion of T Cells and Cytokine Storm.	J Clin Immunol
32647884	Emergent Viral Infections of the CNS.	J Neuropathol Exp Neurol
32647360	"Obesity, the most common comorbidity in SARS-CoV-2: is leptin the link?"	Int J Obes (Lond)
32647358	Revealing COVID-19 transmission in Australia by SARS-CoV-2 genome sequencing and agent-based modeling.	Nat Med
32647346	SARS-CoV-2 and bat RaTG13 spike glycoprotein structures inform on virus evolution and furin-cleavage effects.	Nat Struct Mol Biol
32647131	Self-amplifying RNA SARS-CoV-2 lipid nanoparticle vaccine candidate induces high neutralizing antibody titers in mice.	Nat Commun
32647027	Interleukin-6 receptor blockade with subcutaneous tocilizumab in severe COVID-19 pneumonia and hyperinflammation: a case-control study.	Ann Rheum Dis
32646911	Coding-Complete Genome Sequences of Two SARS-CoV-2 Isolates from Early Manifestations of COVID-19 in Israel.	Microbiol Resour Announc
32646908	Coding-Complete Genome Sequence of SARS-CoV-2 Isolate from Bangladesh by Sanger Sequencing.	Microbiol Resour Announc
32646523	Adrenomedullin in COVID-19 induced endotheliitis.	Crit Care
32646487	Evolving geographic diversity in SARS-CoV2 and in silico analysis of replicating enzyme 3CL(pro) targeting repurposed drug candidates.	J Transl Med
32646459	Molecular mechanisms of sex bias differences in COVID-19 mortality.	Crit Care
32646049	"Mutation Patterns of Human SARS-CoV-2 and Bat RaTG13 Coronavirus Genomes Are Strongly Biased Towards C>U Transitions, Indicating Rapid Evolution in Their Hosts."	Genes (Basel)
32646047	Protein Coding and Long Noncoding RNA (lncRNA) Transcriptional Landscape in SARS-CoV-2 Infected Bronchial Epithelial Cells Highlight a Role for Interferon and Inflammatory Response.	Genes (Basel)
32645974	"SARS-CoV-2, ACE2, and Hydroxychloroquine: Cardiovascular Complications, Therapeutics, and Clinical Readouts in the Current Settings."	Pathogens
32645951	Implications of SARS-CoV-2 Mutations for Genomic RNA Structure and Host microRNA Targeting.	Int J Mol Sci
32645725	Fibrinolysis Resistance: A Potential Mechanism Underlying COVID-19 Coagulopathy.	Thromb Haemost
32645661	Is the presence of lung injury in COVID-19 an independent risk factor for secondary lung cancer?	Med Hypotheses
32645659	Epithelial cilia is the first line of defence against Coronavirus; addressing the observed age-gradient in the COVID-19 infection.	Med Hypotheses
32645632	"Baricitinib, a drug with potential effect to prevent SARS-COV-2 from entering target cells and control cytokine storm induced by COVID-19."	Int Immunopharmacol
32645523	Comparative genomic signature representations of the emerging COVID-19 coronavirus and other coronaviruses: High identity and possible recombination between Bat and Pangolin coronaviruses.	Genomics
32645344	Structural features of coronavirus SARS-CoV-2 spike protein: Targets for vaccination.	Life Sci
32645326	Structures of Human Antibodies Bound to SARS-CoV-2 Spike Reveal Common Epitopes and Recurrent Features of Antibodies.	Cell
32645325	The Global Phosphorylation Landscape of SARS-CoV-2 Infection.	Cell
32645320	The Course of COVID-19 in Inflammatory Bowel Disease: Protective Role of TNF Antagonists.	Gastroenterology
32645228	Angiotensin II receptors: Impact for COVID-19 severity.	Dermatol Ther
32645207	Basic immunology may lead to translational therapeutic rationale: SARS-CoV-2 and rheumatic diseases.	Eur J Clin Invest
32645205	"COVID-19 comorbidities, associated procoagulant extracellular vesicles and venous thromboembolisms: a possible link with ethnicity?"	Br J Haematol
32645153	Inhibitors of the renin-angiotensin-aldosterone system and COVID-19 in critically ill elderly patients.	Eur Heart J Cardiovasc Pharmacother
32644266	Immune responses and pathogenesis in persistently PCR-positive patients with SARS-CoV-2 infection.	J Med Virol
32644208	"Erythropoietin-induced hemoglobin subunit beta may stimulate innate immune RNA virus pattern recognition, suppress reactive oxygen species, reduce ACE2 viral doorway opening, and neutrophil extracellular traps against COVID-19."	J Med Virol
32643968	Does SARS-CoV-2 infection cause sperm DNA fragmentation? Possible link with oxidative stress.	Eur J Contracept Reprod Health Care
32643874	COVID-19 and hypertension-evidence and practical management: Guidance from the HOPE Asia Network.	J Clin Hypertens (Greenwich)
32643798	Tackling COVID-19 infection through complement-targeted immunotherapy.	Br J Pharmacol
32643651	Angiotensin-converting enzyme inhibitors and angiotensin receptor blocker in coronavirus disease 2019: Safe and possibly beneficial.	Lung India
32643603	"Generation of a Broadly Useful Model for COVID-19 Pathogenesis, Vaccination, and Treatment."	Cell
32643599	"Introductions and early spread of SARS-CoV-2 in France, 24 January to 23 March 2020."	Euro Surveill
32643596	A review on histotechnology practices in COVID-19 pathology investigations.	J Histotechnol
32643586	On the potential role of exosomes in the COVID-19 reinfection/reactivation opportunity.	J Biomol Struct Dyn
32643552	Identification of bioactive molecule from Withania somnifera (Ashwagandha) as SARS-CoV-2 main protease inhibitor.	J Biomol Struct Dyn
32643550	Potential of NO donor furoxan as SARS-CoV-2 main protease (M(pro)) inhibitors: in silico analysis.	J Biomol Struct Dyn
32643529	Natural-like products as potential SARS-CoV-2 M(pro) inhibitors: in-silico drug discovery.	J Biomol Struct Dyn
32643448	Network pharmacology and molecular docking analysis on molecular targets and mechanisms of Huashi Baidu formula in the treatment of COVID-19.	Drug Dev Ind Pharm
32643416	SARS-CoV-2 Receptor ACE2 (Angiotensin-Converting Enzyme 2) Is Upregulated in Colonic Organoids From Hypertensive Rats.	Hypertension
32643410	Bioactive compounds from marine resources against novel corona virus (2019-nCoV): in silico study for corona viral drug.	Nat Prod Res
32643351	Successful sequencing of the first SARS-CoV-2 genomes from Croatian patients.	Croat Med J
32643158	Excavating SARS-coronavirus 2 genome for epitope-based subunit vaccine synthesis using immunoinformatics approach.	J Cell Physiol
32643141	Ion channel inhibition against COVID-19: A novel target for clinical investigation.	Cardiol J
32642842	Pulmonary pathology and COVID-19: lessons from autopsy. The experience of European Pulmonary Pathologists.	Virchows Arch
32642770	Proteome-wide data analysis reveals tissue-specific network associated with SARS-CoV-2 infection.	J Mol Cell Biol
32642354	Do COVID-19 and SARS Gene Complexities and Variations Help Overcome the Knowledge Gap?	Cureus
32642225	"Addressing the ""What do we have to lose? Just give the drug"" rationale: making the case for clinical trials and against off-label use in COVID-19."	J Thorac Dis
32642005	SARS-CoV-2 pandemic and research gaps: Understanding SARS-CoV-2 interaction with the ACE2 receptor and implications for therapy.	Theranostics
32641873	"Inflammation, Immunity and Immunogenetics in COVID-19: A Narrative Review."	Indian J Clin Biochem
32641750	Sex differences in SARS-CoV-2 infection rates and the potential link to prostate cancer.	Commun Biol
32641705	Single cell transcriptome revealed SARS-CoV-2 entry genes enriched in colon tissues and associated with coronavirus infection and cytokine production.	Signal Transduct Target Ther
32641700	Immunological and inflammatory profiles in mild and severe cases of COVID-19.	Nat Commun
32641511	Discovery of potent thrombin inhibitors from a protease-focused DNA-encoded chemical library.	Proc Natl Acad Sci U S A
32641486	Genomic Analysis of Early SARS-CoV-2 Variants Introduced in Mexico.	J Virol
32641482	"LY6E Restricts Entry of Human Coronaviruses, Including Currently Pandemic SARS-CoV-2."	J Virol
32641481	Serpentoviruses: More than Respiratory Pathogens.	J Virol
32641214	SARS-CoV-2 infection risk assessment in the endometrium: viral infection-related gene expression across the menstrual cycle.	Fertil Steril
32641037	"Caspase1/11 signaling affects muscle regeneration and recovery following ischemia, and can be modulated by chloroquine."	Mol Med
32640747	"Immunopathology of SARS-CoV-2 Infection: Immune Cells and Mediators, Prognostic Factors, and Immune-Therapeutic Implications."	Int J Mol Sci
32640723	Cancer Patients Have a Higher Risk Regarding COVID-19 - and Vice Versa?	Pharmaceuticals (Basel)
32640525	Molecular Aspects of COVID-19 Differential Pathogenesis.	Pathogens
32640487	BTK/ITK dual inhibitors: Modulating immunopathology and lymphopenia for COVID-19 therapy.	J Leukoc Biol
32640417	Neuroinvasive potential of a primary respiratory pathogen SARS- CoV2: Summarizing the evidences.	Diabetes Metab Syndr
32640416	COVID-19 and ethnicity: A novel pathophysiological role for inflammation.	Diabetes Metab Syndr
32640381	"Identification of potential inhibitors against SARS-CoV-2 by targeting proteins responsible for envelope formation and virion assembly using docking based virtual screening, and pharmacokinetics approaches."	Infect Genet Evol
32640331	Analysis of the intricate effects of polyunsaturated fatty acids and polyphenols on inflammatory pathways in health and disease.	Food Chem Toxicol
32640274	SARS-CoV2 envelope protein: non-synonymous mutations and its consequences.	Genomics
32640245	The World Goes Bats: Living Longer and Tolerating Viruses.	Cell Metab
32640192	COVID-19 and the Chemical Senses: Supporting Players Take Center Stage.	Neuron
32640179	Current therapies under investigation for COVID-19: potential COVID-19 treatments.	Can J Physiol Pharmacol
32640172	Poly(ADP-Ribose) Polymerase Inhibition in Acute Lung Injury. A Reemerging Concept.	Am J Respir Cell Mol Biol
32640169	Potential impact of SARS-CoV-2 infection on the thymus.	Can J Microbiol
32640120	Generation of Complete Multi-Cell Type Lung Organoids From Human Embryonic and Patient-Specific Induced Pluripotent Stem Cells for Infectious Disease Modeling and Therapeutics Validation.	Curr Protoc Stem Cell Biol
32639940	Possible Protective Effect of Renin-Angiotensin System Inhibitors in COVID-19 Induced Acute Kidney Injury.	J Am Soc Nephrol
32639866	Disequilibrium between the classic renin-angiotensin system and its opposing arm in SARS-CoV-2-related lung injury.	Am J Physiol Lung Cell Mol Physiol
32639848	The mechanism and treatment of gastrointestinal symptoms in patients with COVID-19.	Am J Physiol Gastrointest Liver Physiol
32639742	The Potential of Various Nanotechnologies for Coronavirus Diagnosis/Treatment Highlighted through a Literature Analysis.	Bioconjug Chem
32639679	COVID-19 is Associated with an Unusual Pattern of Brain Microbleeds in Critically Ill Patients.	J Neuroimaging
32639523	Coronavirus Disease 2019 (COVID-19) and Cardiac Injury.	JAMA Cardiol
32639511	Association of Clonal Hematopoiesis of Indeterminate Potential With Inflammatory Gene Expression in Patients With Severe Degenerative Aortic Valve Stenosis or Chronic Postischemic Heart Failure.	JAMA Cardiol
32639510	Coronavirus Disease 2019 (COVID-19) and Cardiac Injury.	JAMA Cardiol
32639418	COVID-19: an emergent cause of liver injury?	Eur J Gastroenterol Hepatol
32639183	The Inter-alpha-Trypsin Inhibitor Family: Versatile Molecules in Biology and Pathology.	J Histochem Cytochem
32639084	Systematic profiling of ACE2 expression in diverse physiological and pathological conditions for COVID-19/SARS-CoV-2.	J Cell Mol Med
32639055	"Elevated interleukin-6, interleukin-10 and neutrophil : lymphocyte ratio as identifiers of severe coronavirus disease 2019."	Immunology
32639031	Proteinase-activated receptor 1: A target for repurposing in the treatment of COVID-19?	Br J Pharmacol
32638966	Immunological aspects of coronavirus disease during pregnancy: an integrative review.	Rev Assoc Med Bras (1992)
32638677	Opinion paper: Severe Acute Respiratory Syndrome Coronavirus 2 and domestic animals: what relation?	Animal
32638509	The interface between coronaviruses and host cell RNA biology: Novel potential insights for future therapeutic intervention.	Wiley Interdiscip Rev RNA
32638221	Transmission of SARS-CoV-2: an update of current literature.	Eur J Clin Microbiol Infect Dis
32638151	A viral infection explanation for Kawasaki disease in general and for COVID-19 virus-related Kawasaki disease symptoms.	Inflammopharmacology
32638135	Are patients with multiple sclerosis (MS) at higher risk of COVID-19 infection?	Neurol Sci
32638018	Single-cell analysis of SARS-CoV-2 receptor ACE2 and spike protein priming expression of proteases in the human heart.	Cardiovasc Res
32637365	"Participation of the IL-10RB Related Cytokines, IL-22 and IFN-lambda in Defense of the Airway Mucosal Barrier."	Front Cell Infect Microbiol
32637095	"Haematological manifestations, mechanisms of thrombosis and anti-coagulation in COVID-19 disease: A review."	Ann Med Surg (Lond)
32636763	The Potential Beneficial Effect of EPA and DHA Supplementation Managing Cytokine Storm in Coronavirus Disease.	Front Physiol
32636762	Activation of Ang-(1-7)/Mas Receptor Is a Possible Strategy to Treat Coronavirus (SARS-CoV-2) Infection.	Front Physiol
32636755	Potential Benefits of Tryptophan Metabolism to the Efficacy of Tocilizumab in COVID-19.	Front Pharmacol
32636479	Pre-existing immunity to SARS-CoV-2: the knowns and unknowns.	Nat Rev Immunol
32636475	SARS-CoV-2-specific T cells without antibodies.	Nat Rev Immunol
32636454	Infection with novel coronavirus (SARS-CoV-2) causes pneumonia in Rhesus macaques.	Cell Res
32636240	BCG vaccine and COVID-19: implications for infection prophylaxis and cancer immunotherapy.	J Immunother Cancer
32636055	The potential of JAK/STAT pathway inhibition by ruxolitinib in the treatment of COVID-19.	Cytokine Growth Factor Rev
32636031	NSAIDs may increase the risk of thrombosis and acute renal failure in patients with COVID-19 infection.	Therapie
32636018	Angiotensin Converting Enzyme 2 May Mediate Disease Severity In COVID-19.	Am J Cardiol
32635935	Analysis of SARS-CoV-2 RNA-dependent RNA polymerase as a potential therapeutic drug target using a computational approach.	J Transl Med
32635753	Pathology and pathogenicity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).	Exp Biol Med (Maywood)
32635752	Role of inflammatory markers in corona virus disease (COVID-19) patients: A review.	Exp Biol Med (Maywood)
32635697	Mechanisms of Stroke in Coronavirus Disease 2019.	J Stroke
32635598	Canonical and Noncanonical Autophagy as Potential Targets for COVID-19.	Cells
32635302	Atherosclerosis as Pathogenetic Substrate for Sars-Cov2 Cytokine Storm.	J Clin Med
32635289	ACE2 as a Therapeutic Target for COVID-19; its Role in Infectious Processes and Regulation by Modulators of the RAAS System.	J Clin Med
32635188	Analysis of ACE2 Genetic Variability among Populations Highlights a Possible Link with COVID-19-Related Neurological Complications.	Genes (Basel)
32635180	Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design.	Vaccines (Basel)
32634734	Hypoxemia in COVID-19 patients: An hypothesis.	Med Hypotheses
32634733	Factors involved in low susceptibility to COVID-19: An adaptation of high altitude inhabitants.	Med Hypotheses
32634129	Kinetics of viral load and antibody response in relation to COVID-19 severity.	J Clin Invest
32634126	SARS-CoV-2 viral load and antibody responses: the case for convalescent plasma therapy.	J Clin Invest
32634079	The Role of Chloroquine and Hydroxychloroquine in Immune Regulation and Diseases.	Curr Pharm Des
32633849	COVID-19 and HIV co-infection an emerging consensus.	J Med Virol
32633831	RNA-dependent RNA polymerase of SARS-CoV-2 as a therapeutic target.	J Med Virol
32633815	"An update on the origin of SARS-CoV-2: Despite closest identity, bat (RaTG13) and pangolin derived coronaviruses varied in the critical binding site and O-linked glycan residues."	J Med Virol
32633733	Interaction of hydroxychloroquine with SARS-CoV2 functional proteins using all-atoms non-equilibrium alchemical simulations.	Chem Commun (Camb)
32633728	Pathophysiology of SARS-CoV-2 infection in patients with intracerebral hemorrhage.	Aging (Albany NY)
32633718	A mechanistic model and therapeutic interventions for COVID-19 involving a RAS-mediated bradykinin storm.	Elife
32633433	"Nucleotide-Bearing Benzylidene-Tetrahydroxanthylium Near-IR Fluorophore for Sensing DNA Replication, Secondary Structures and Interactions."	Chemistry
32633334	"The hemagglutinin-esterase gene in human coronaviruses SARS-CoV-2, HKU1 and OC43."	Eur Rev Med Pharmacol Sci
32633327	"SARS, MERS and COVID-19: clinical manifestations and organ-system complications: a mini review."	Pathog Dis
32633236	COVID-19 - more than respiratory disease: a gastroenterologist's perspective.	J Physiol Pharmacol
32633235	Renin-angiotensin system inhibitors in management of hypertension during the COVID-19 pandemic.	J Physiol Pharmacol
32632717	In Silico Screening of Potential Chinese Herbal Medicine Against COVID-19 by Targeting SARS-CoV-2 3CLpro and Angiotensin Converting Enzyme II Using Molecular Docking.	Chin J Integr Med
32632558	Anti-coagulation for COVID-19 treatment: both anti-thrombotic and anti-inflammatory?	J Thromb Thrombolysis
32632359	"Reactive oxygen species as an initiator of toxic innate immune responses in retort to SARS-CoV-2 in an ageing population, consider N-acetylcysteine as early therapeutic intervention."	Toxicol Rep
32632085	"Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia."	Nat Commun
32631841	JAK inhibitors in COVID-19: the need for vigilance regarding increased inherent thrombotic risk.	Eur Respir J
32631687	"[SARS-CoV-2, COVID-19 and the eye: An update on published data]."	J Fr Ophtalmol
32631657	Molecular chronicles of cytokine burst in patients with coronavirus disease 2019 (COVID-19) with cardiovascular diseases.	J Thorac Cardiovasc Surg
32631071	COVID-19-associated Acute Respiratory Distress Syndrome Clarified: A Vascular Endotype?	Am J Respir Crit Care Med
32630746	SARS-CoV-2: Repurposed Drugs and Novel Therapeutic Approaches-Insights into Chemical Structure-Biological Activity and Toxicological Screening.	J Clin Med
32630514	Preliminary Virtual Screening Studies to Identify GRP78 Inhibitors Which May Interfere with SARS-CoV-2 Infection.	Pharmaceuticals (Basel)
32630212	"Multi-System Inflammatory Syndrome in Children (MIS-C) Following SARS-CoV-2 Infection: Review of Clinical Presentation, Hypothetical Pathogenesis, and Proposed Management."	Children (Basel)
32630064	Vimentin as a Multifaceted Player and Potential Therapeutic Target in Viral Infections.	Int J Mol Sci
32629995	Putative Roles for Peptidylarginine Deiminases in COVID-19.	Int J Mol Sci
32629960	Evidence for SARS-CoV-2 Infection of Animal Hosts.	Pathogens
32629875	Vasculopathy and Coagulopathy Associated with SARS-CoV-2 Infection.	Cells
32629817	"Influence of Herbal Medicines on HMGB1 Release, SARS-CoV-2 Viral Attachment, Acute Respiratory Failure, and Sepsis. A Literature Review."	Int J Mol Sci
32629804	Repurposing Therapeutics for Potential Treatment of SARS-CoV-2: A Review.	Viruses
32629518	Inflammatory Cell Infiltration of Adrenals in COVID-19.	Horm Metab Res
32629280	COVID19 inhibitors: A prospective therapeutics.	Bioorg Chem
32629204	A hypothesis on the role of the human immune system in covid-19.	Med Hypotheses
32629042	Massive transient damage of the olfactory epithelium associated with infection of sustentacular cells by SARS-CoV-2 in golden Syrian hamsters.	Brain Behav Immun
32628976	SARS-CoV-2 infections and COVID-19 mortalities strongly correlate with ACE1 I/D genotype.	Gene
32628969	Potential neurological effects of severe COVID-19 infection.	Neurosci Res
32628899	Coronaviruses and Integrin alphavbeta3: Does Thyroid Hormone Modify the Relationship?	Endocr Res
32628591	Elucidating the Pivotal Role of Immune Players in the Management of COVID-19: Focus on Mesenchymal Stem Cells and Inflammation.	Curr Stem Cell Res Ther
32628368	Opioid Use Disorder Treatment and Potential Interactions With Novel COVID-19 Medications: A Clinical Perspective.	Prim Care Companion CNS Disord
32628143	Emerging mechanisms for the new coronavirus-related myocardial injury and ischemia: A review of the literature.	Anatol J Cardiol
32628137	Association between chronic ACE inhibitor exposure and decreased odds of severe disease in patients with COVID-19.	Anatol J Cardiol
32628135	Renin-angiotensin system inhibition in COVID-19 patients: Friend or foe?	Anatol J Cardiol
32627759	An Overview of the Genetic Variations of the SARS-CoV-2 Genomes Isolated in Southeast Asian Countries.	J Microbiol Biotechnol
32627758	Progress and Challenges in the Development of COVID-19 Vaccines and Current Understanding of SARS-CoV-2- Specific Immune Responses.	J Microbiol Biotechnol
32627715	Screening of phytochemical compounds of Tinospora cordifolia for their inhibitory activity on SARS-CoV-2: an in silico study.	J Biomol Struct Dyn
32627689	"Possibility of HIV-1 protease inhibitors-clinical trial drugs as repurposed drugs for SARS-CoV-2 main protease: a molecular docking, molecular dynamics and binding free energy simulation study."	J Biomol Struct Dyn
32627622	"Thrombotic microangiopathy, DIC-syndrome and COVID-19: link with pregnancy prothrombotic state."	J Matern Fetal Neonatal Med
32627524	Considerations around the SARS-CoV-2 Spike Protein with Particular Attention to COVID-19 Brain Infection and Neurological Symptoms.	ACS Chem Neurosci
32627515	Dysregulation of the immune system as a driver of the critical course of novel coronavirus disease 2019.	Pol Arch Intern Med
32627330	COVID-19 and arterial hypertension: Hypothesis or evidence?	J Clin Hypertens (Greenwich)
32627299	"Diabetes, obesity and COVID-19: A complex interplay."	Diabetes Obes Metab
32627237	Pills to think about in allergic rhinitis children during COVID-19 era.	Acta Paediatr
32627226	Potential role of IL-17 blocking agents in the treatment of severe COVID-19?	Br J Clin Pharmacol
32627126	COVID-19: Are we dealing with a multisystem vasculopathy in disguise of a viral infection?	J Thromb Thrombolysis
32627059	SARS-CoV-2 receptor ACE2 gene expression in small intestine correlates with age.	Amino Acids
32626922	A dissection of SARSCoV2 with clinical implications (Review).	Int J Mol Med
32626733	Effect of Thymoquinone on Acute Kidney Injury Induced by Sepsis in BALB/c Mice.	Biomed Res Int
32626721	ACE/ACE2 Ratio: A Key Also in 2019 Coronavirus Disease (Covid-19)?	Front Med (Lausanne)
32626626	Role of the Backbenchers of the Renin-Angiotensin System ACE2 and AT2 Receptors in COVID-19: Lessons From SARS.	Cureus
32626559	Does the novel coronavirus 2019 like heart more than the other family members of coronaviruses?	J Cardiovasc Thorac Res
32626554	Nicotine and smoking in the COVID-19 era.	J Cardiovasc Thorac Res
32625165	Potential of SARS-CoV-2 to Cause CNS Infection: Biologic Fundamental and Clinical Experience.	Front Neurol
32624360	SARS-CoV-2 host diversity: An update of natural infections and experimental evidence.	J Microbiol Immunol Infect
32624257	Molecular mechanisms and epidemiology of COVID-19 from an allergist's perspective.	J Allergy Clin Immunol
32624189	A Meta-analysis of the Relationship Between Renin-Angiotensin-Aldosterone System Inhibitors and COVID-19.	Am J Cardiol
32623831	A role for human leucocyte antigens in the susceptibility to SARS-Cov-2 infection observed in transplant patients.	Int J Immunogenet
32623546	Expression of ACE2 in Human Neurons Supports the Neuro-Invasive Potential of COVID-19 Virus.	Cell Mol Neurobiol
32623480	Protein structure analysis of the interactions between SARS-CoV-2 spike protein and the human ACE2 receptor: from conformational changes to novel neutralizing antibodies.	Cell Mol Life Sci
32623451	ApoE e4e4 Genotype and Mortality With COVID-19 in UK Biobank.	J Gerontol A Biol Sci Med Sci
32623357	Virtual screening of approved drugs as potential SARS-CoV-2 main protease inhibitors.	Comput Biol Chem
32623351	Identification of multiple large deletions in ORF7a resulting in in-frame gene fusions in clinical SARS-CoV-2 isolates.	J Clin Virol
32623267	"Clinical, molecular, and epidemiological characterization of the SARS-CoV-2 virus and the Coronavirus Disease 2019 (COVID-19), a comprehensive literature review."	Diagn Microbiol Infect Dis
32623038	Diabetes and COVID-19: Global and regional perspectives.	Diabetes Res Clin Pract
32622895	New insights in COVID-19-associated chilblains: A comparative study with chilblain lupus erythematosus.	J Am Acad Dermatol
32622797	Co-infection of MERS-CoV and SARS-CoV-2 in the same host: A silent threat.	J Infect Public Health
32622449	Obesity and Outcomes in COVID-19: When an Epidemic and Pandemic Collide.	Mayo Clin Proc
32622411	Coronavirus disease-19 and fertility: viral host entry protein expression in male and female reproductive tissues.	Fertil Steril
32622243	Delving deep into the structural aspects of a furin cleavage site inserted into the spike protein of SARS-CoV-2: A structural biophysical perspective.	Biophys Chem
32622086	Neurobiology of coronaviruses: Potential relevance for COVID-19.	Neurobiol Dis
32622082	"Ancestral origin, antigenic resemblance and epidemiological insights of novel coronavirus (SARS-CoV-2): Global burden and Bangladesh perspective."	Infect Genet Evol
32622045	Integrated approaches to reveal mechanisms by which RNA viruses reprogram the cellular environment.	Methods
32621841	Epitope-based peptide vaccines predicted against novel coronavirus disease caused by SARS-CoV-2.	Virus Res
32621779	Angiotensin-(1-7) and Obesity: Role in Cardiorespiratory Fitness and COVID-19 Implications.	Obesity (Silver Spring)
32621718	Shape-based Machine Learning Models for the Potential Novel COVID-19 Protease Inhibitors Assisted by Molecular Dynamics Simulation.	Curr Top Med Chem
32621304	"COVID-19 and asthma, the good or the bad?"	Allergy
32621206	A brief review of liver injury in patients with Corona Virus Disease-19 during the pandemic.	Indian J Gastroenterol
32621202	Use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in context of COVID-19 outbreak: a retrospective analysis.	Front Med
32621057	The use of SARS-CoV-2-related coronaviruses from bats and pangolins to polarize mutations in SARS-Cov-2.	Sci China Life Sci
32621017	SARS-COV-2 and eye immunity: the lesson was learned but we are not done yet. Brainstorming on possible pathophysiology inspired by ocular models.	Int Ophthalmol
32620562	Finding Camel-ot: A Holy Grail against pandemic SARS-CoV-2?	Sci Immunol
32620513	Is pregnancy a risk factor of COVID-19?	Eur J Obstet Gynecol Reprod Biol
32620366	"COVID-19 and the male susceptibility: the role of ACE2, TMPRSS2 and the androgen receptor."	Prog Urol
32620231	Potential underlying mechanisms of cerebral venous thrombosis associated with COVID-19.	J Neuroradiol
32619819	S2 subunit of SARS-nCoV-2 interacts with tumor suppressor protein p53 and BRCA: an in silico study.	Transl Oncol
32619728	A focused review on the genital and sexual affection of COVID-19 patients.	J Gynecol Obstet Hum Reprod
32619698	Elevation of ACE2 as a SARS-CoV-2 entry receptor gene expression in Alzheimer's disease.	J Infect
32619669	Virtual screening based on molecular docking of possible inhibitors of Covid-19 main protease.	Microb Pathog
32619549	Ultra-High-Throughput Clinical Proteomics Reveals Classifiers of COVID-19 Infection.	Cell Syst
32619523	Diabetes and COVID 19 in South-East Asia.	Diabetes Res Clin Pract
32619412	Endothelial cells orchestrate COVID-19 coagulopathy.	Lancet Haematol
32619390	Shotgun proteomics analysis of SARS-CoV-2-infected cells and how it can optimize whole viral particle antigen production for vaccines.	Emerg Microbes Infect
32619162	Bacterial protein azurin and derived peptides as potential anti-SARS-CoV-2 agents: insights from molecular docking and molecular dynamics simulations.	J Biomol Struct Dyn
32619134	Epitope based peptide vaccine against SARS-COV2: an immune-informatics approach.	J Biomol Struct Dyn
32619104	COVID-19 May Predispose to Thrombosis by Affecting Both Vascular Endothelium and Platelets.	Clin Appl Thromb Hemost
32618648	COVID-19 and the Digestive System.	Am J Gastroenterol
32618498	Preceding infection and risk of stroke: An old concept revived by the COVID-19 pandemic.	Int J Stroke
32618198	Incretin-Based Therapies Role in COVID-19 Era: Evolving Insights.	J Cardiovasc Pharmacol Ther
32617987	"Microstructure, pathophysiology, and potential therapeutics of COVID-19: A comprehensive review."	J Med Virol
32617855	Phylogenetic Analysis and Structural Perspectives of RNA-Dependent RNA-Polymerase Inhibition from SARs-CoV-2 with Natural Products.	Interdiscip Sci
32617527	Whole Genome Analysis and Targeted Drug Discovery Using Computational Methods and High Throughput Screening Tools for Emerged Novel Coronavirus (2019-nCoV).	J Pharm Drug Res
32617313	COVID-19: unravelling the clinical progression of nature's virtually perfect biological weapon.	Ann Transl Med
32617121	Myocardial and Microvascular Injury Due to Coronavirus Disease 2019.	Eur Cardiol
32616763	A candidate multi-epitope vaccine against SARS-CoV-2.	Sci Rep
32616709	Mapping the T cell response to COVID-19.	Signal Transduct Target Ther
32616673	Primary exposure to SARS-CoV-2 protects against reinfection in rhesus macaques.	Science
32616647	Complete Genome Sequence of a 2019 Novel Coronavirus (SARS-CoV-2) Strain Causing a COVID-19 Case in Morocco.	Microbiol Resour Announc
32616644	Genome Sequencing of a Severe Acute Respiratory Syndrome Coronavirus 2 Isolate Obtained from a South African Patient with Coronavirus Disease 2019.	Microbiol Resour Announc
32616611	Renin-Angiotensin System Overactivation in Type 2 Diabetes: A Risk for SARS-CoV-2 Infection?	Diabetes Care
32616594	Cyclophilin inhibitors restrict Middle East respiratory syndrome coronavirus via interferon-lambda in vitro and in mice.	Eur Respir J
32616514	Pathogenesis of COVID-19 from the Perspective of the Damage-Response Framework.	mBio
32615377	The use of renin angiotensin system inhibitor on mortality in patients with coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis.	Diabetes Metab Syndr
32615317	Gene signatures of SARS-CoV/SARS-CoV-2-infected ferret lungs in short- and long-term models.	Infect Genet Evol
32615316	"Characterizations of SARS-CoV-2 mutational profile, spike protein stability and viral transmission."	Infect Genet Evol
32615280	High prevalence of COVID-19-associated diabetic ketoacidosis in UK secondary care.	Diabetes Res Clin Pract
32615182	Melatonin is a potential adjuvant to improve clinical outcomes in individuals with obesity and diabetes with coexistence of Covid-19.	Eur J Pharmacol
32615154	Androgen deprivation and SARS-CoV-2 in men with prostate cancer.	Ann Oncol
32614767	"Main Routes of Entry and Genomic Diversity of SARS-CoV-2, Uganda."	Emerg Infect Dis
32614717	"Letter by Weir Regarding Article, ""Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System: Celebrating the 20th Anniversary of the Discovery of ACE2""."	Circ Res
32614684	Review of the SARS-CoV-2 in Wuhan and Analysis as Well as Prediction of Therapeutic Drugs.	Viral Immunol
32614178	Pulmonary Edema in COVID19-A Neural Hypothesis.	ACS Chem Neurosci
32614086	Insights into pathogenesis of fatal COVID-19 pneumonia from histopathology with immunohistochemical and viral RNA studies.	Histopathology
32613971	Construction and immunogenic studies of a mFc fusion receptor binding domain (RBD) of spike protein as a subunit vaccine against SARS-CoV-2 infection.	Chem Commun (Camb)
32613937	SARS-CoV-2 does not replicate in embryonated hen's eggs or in MDCK cell lines.	Euro Surveill
32613681	"Perspective: Vitamin D deficiency and COVID-19 severity - plausibly linked by latitude, ethnicity, impacts on cytokines, ACE2 and thrombosis."	J Intern Med
32613308	"Characteristics of laboratory indexes in COVID-19 patients with non-severe symptoms in Hefei City, China: diagnostic value in organ injuries."	Eur J Clin Microbiol Infect Dis
32613257	[Basic principles of replication and immunology of SARS-CoV-2].	Ophthalmologe
32612617	The COVID-19 Cytokine Storm; What We Know So Far.	Front Immunol
32612616	Potential Treatments for COVID-19 Related Cytokine Storm - Beyond Corticosteroids.	Front Immunol
32612615	"Immune Response, Inflammation, and the Clinical Spectrum of COVID-19."	Front Immunol
32612515	Neuromechanisms of SARS-CoV-2: A Review.	Front Neuroanat
32612430	Unclear Issues Regarding COVID-19.	Eurasian J Med
32612199	Mining of epitopes on spike protein of SARS-CoV-2 from COVID-19 patients.	Cell Res
32612152	Identification of druggable inhibitory immune checkpoints on Natural Killer cells in COVID-19.	Cell Mol Immunol
32611687	On the use of immune checkpoint inhibitors in patients with viral infections including COVID-19.	J Immunother Cancer
32611676	Treatment with ACE inhibitors or ARBs and risk of severe/lethal COVID-19: a meta-analysis.	Heart
32611670	"Angiotensin-converting Enzyme 2, a SARS-CoV-2 Receptor, Is Upregulated by Interleukin 6 through STAT3 Signaling in Synovial Tissues."	J Rheumatol
32611537	Assessing the application of a pseudovirus system for emerging SARS-CoV-2 and re-emerging avian influenza virus H5 subtypes in vaccine development.	Biomed J
32611518	COVID-19: Role of neutrophil extracellular traps in acute lung injury.	Respir Investig
32611485	"Molecular Alterations Prompted by SARS-CoV-2 Infection: Induction of Hyaluronan, Glycosaminoglycan and Mucopolysaccharide Metabolism."	Arch Med Res
32611313	Identification of a druggable binding pocket in the spike protein reveals a key site for existing drugs potentially capable of combating Covid-19 infectivity.	BMC Mol Cell Biol
32611305	Overview of Covid-19 Regarding the Cardiovascular Situation in the Light of Current Reports.	Cardiovasc Hematol Disord Drug Targets
32611087	Topological analysis of SARS CoV-2 main protease.	Chaos
32610587	Does SARS-CoV-2 Trigger Stress-InducedAutoimmunity by Molecular Mimicry? A Hypothesis.	J Clin Med
32610501	The Effect of Natural Feline Coronavirus Infection on the Host Immune Response: A Whole-Transcriptome Analysis of the Mesenteric Lymph Nodes in Cats with and without Feline Infectious Peritonitis.	Pathogens
32610445	Microbial Natural Products as Potential Inhibitors of SARS-CoV-2 Main Protease (M(pro)).	Microorganisms
32610096	Omics-Driven Systems Interrogation of Metabolic Dysregulation in COVID-19 Pathogenesis.	Cell Metab
32610079	Cytokine Storms: Understanding COVID-19.	Immunity
32610043	Critical Role of Type III Interferon in Controlling SARS-CoV-2 Infection in Human Intestinal Epithelial Cells.	Cell Rep
32610037	"Rapid, Sensitive, Full-Genome Sequencing of Severe Acute Respiratory Syndrome Coronavirus 2."	Emerg Infect Dis
32609874	ABO phenotype and death in critically ill patients with COVID-19.	Br J Haematol
32609845	Influenza-induced thrombocytopenia is dependent on the subtype and sialoglycan receptor and increases with virus pathogenicity.	Blood Adv
32608999	"COVID-19 Severity Correlates with Weaker T-Cell Immunity, Hypercytokinemia, and Lung Epithelium Injury."	Am J Respir Crit Care Med
32608380	Clinical and Histopathological Features and Potential Pathological Mechanisms of Skin Lesions in COVID-19: Review of the Literature.	Dermatopathology (Basel)
32608329	In silico analysis and identification of promising hits against 2019 novel coronavirus 3C-like main protease enzyme.	J Biomol Struct Dyn
32608159	"COVID-19: A collision of complement, coagulation and inflammatory pathways."	J Thromb Haemost
32608016	Is susceptibility to severe COVID-19 disease an inborn error of metabolism?	J Inherit Metab Dis
32607866	"A Comprehensive Review of Animal Models for Coronaviruses: SARS-CoV-2, SARS-CoV, and MERS-CoV."	Virol Sin
32607684	The evolution of pulmonary pathology in fatal COVID-19 disease: an autopsy study with clinical correlation.	Virchows Arch
32607467	Pathological Role of Angiotensin II in Severe COVID-19.	TH Open
32607393	Molecular Aspects of Co-morbidities in COVID-19 Infection.	Arch Bone Jt Surg
32607314	Assessing Immune Response to SARS-CoV-2 Infection.	Immunotargets Ther
32606886	Hypercytokinemia and Pathogen-Host Interaction in COVID-19.	J Inflamm Res
32606823	Potential Role of Nrf2 Activators with Dual Antiviral and Anti-Inflammatory Properties in the Management of Viral Pneumonia.	Infect Drug Resist
32606565	Coronaviruses' sugar shields as vaccine candidates.	Curr Trends Immunol
32606420	The value of targeting recombination as a strategy against coronavirus diseases.	Heredity (Edinb)
32606379	The network effect: studying COVID-19 pathology with the Human Cell Atlas.	Nat Rev Mol Cell Biol
32606347	"Distinct stem/progenitor cells proliferate to regenerate the trachea, intrapulmonary airways and alveoli in COVID-19 patients."	Cell Res
32606248	Genomic discovery of an evolutionarily programmed modality for small-molecule targeting of an intractable protein surface.	Proc Natl Acad Sci U S A
32605661	Multiple approaches for massively parallel sequencing of SARS-CoV-2 genomes directly from clinical samples.	Genome Med
32605374	Cytokine Storm in COVID19: A Neural Hypothesis.	ACS Chem Neurosci
32605306	Saxifraga spinulosa-Derived Components Rapidly Inactivate Multiple Viruses Including SARS-CoV-2.	Viruses
32605278	Exploring Sodium Glucose Co-Transporter-2 (SGLT2) Inhibitors for Organ Protection in COVID-19.	J Clin Med
32605194	Coronavirus Disease Pandemic (COVID-19): Challenges and a Global Perspective.	Pathogens
32605182	Pulmonary Toxicity and Inflammatory Response of E-Cigarette Vape Cartridges Containing Medium-Chain Triglycerides Oil and Vitamin E Acetate: Implications in the Pathogenesis of EVALI.	Toxics
32605149	Bioactive Indolyl Diketopiperazines from the Marine Derived Endophytic Aspergillus versicolor DY180635.	Mar Drugs
32604825	"Lessons from SARS-CoV-2 Pandemic: Evolution, Disease Dynamics and Future."	Biology (Basel)
32604797	Data and Text Mining Help Identify Key Proteins Involved in the Molecular Mechanisms Shared by SARS-CoV-2 and HIV-1.	Molecules
32604730	SARS-CoV-2 Evolutionary Adaptation toward Host Entry and Recognition of Receptor O-Acetyl Sialylation in Virus-Host Interaction.	Int J Mol Sci
32604724	Betacoronavirus Genomes: How Genomic Information has been Used to Deal with Past Outbreaks and the COVID-19 Pandemic.	Int J Mol Sci
32604407	Immune modulation in COVID-19: Strategic considerations for personalized therapeutic intervention.	Clin Infect Dis
32604246	Disease of the Year: COVID-19 and Its Neuro-ophthalmic Complications.	J Neuroophthalmol
32604223	Therapeutic Potential of B-1a Cells in COVID-19.	Shock
32603829	SARS-CoV-2 pathophysiology and assessment of coronaviruses in CNS diseases with a focus on therapeutic targets.	Biochim Biophys Acta Mol Basis Dis
32603772	Targeting inflammation and cytokine storm in COVID-19.	Pharmacol Res
32603768	COVID-19 as triggering co-factor for cortical cerebral venous thrombosis?	J Neuroradiol
32603679	Calcineurin inhibitors revisited: A new paradigm for COVID-19?	Braz J Infect Dis
32603509	Sex and gender differences in the outcome of patients with COVID-19.	J Med Virol
32603424	Metabolic Syndrome and COVID 19: Endocrine-Immune-Vascular Interactions Shapes Clinical Course.	Endocrinology
32602956	The many mechanisms of action of Chloroquine: to use or not to use (in COVID-19) that is the question.	Br J Pharmacol
32602883	"Is a ""Cytokine Storm"" Relevant to COVID-19?"	JAMA Intern Med
32602823	Bat SARS-Like WIV1 coronavirus uses the ACE2 of multiple animal species as receptor and evades IFITM3 restriction via TMPRSS2 activation of membrane fusion.	Emerg Microbes Infect
32602627	Angiotensin-converting enzyme 2: The old door for new severe acute respiratory syndrome coronavirus 2 infection.	Rev Med Virol
32602331	How does COVID-19 affect the brain?	Tidsskr Nor Laegeforen
32602074	Structure-based screening of novel lichen compounds against SARS Coronavirus main protease (Mpro) as potentials inhibitors of COVID-19.	Mol Divers
32602046	Long Term Culture of Human Kidney Proximal Tubule Epithelial Cells Maintains Lineage Functions and Serves as an Ex vivo Model for Coronavirus Associated Kidney Injury.	Virol Sin
32602045	SARS-CoV-2 Does Not Replicate in Aedes Mosquito Cells nor Present in Field-Caught Mosquitoes from Wuhan.	Virol Sin
32601923	A contemporary review on pathogenesis and immunity of COVID-19 infection.	Mol Biol Rep
32601839	Novel phosphatidylinositol 4-kinases III beta (PI4KIIIbeta) inhibitors discovered by virtual screening using free energy models.	J Comput Aided Mol Des
32601254	Renin-angiotensin-aldosterone system inhibitors to treat COVID-19?	CMAJ
32601125	Potential role of endothelial cell surface ectopic redox complexes in COVID-19 disease pathogenesis.	Clin Med (Lond)
32601001	Severe Acute Respiratory Syndrome Coronavirus-2 Cardiovascular Complications: Implications for Cardiothoracic Anesthesiology.	J Cardiothorac Vasc Anesth
32600978	Inflammatory Response in Relation to COVID-19 and Other Prothrombotic Phenotypes.	Reumatol Clin (Engl Ed)
32600868	Glucose-6-Phosphate Dehydrogenase Deficiency: An Actionable Risk Factor for Patients with COVID-19?	Arch Med Res
32600476	An Insight into the Sex Differences in COVID-19 Patients: What are the Possible Causes?	Prehosp Disaster Med
32600410	Boning up: amino-bisphophonates as immunostimulants and endosomal disruptors of dendritic cell in SARS-CoV-2 infection.	J Transl Med
32600316	The cholinergic anti-inflammatory pathway alleviates acute lung injury.	Mol Med
32600125	Targeting the gut-lung microbiota axis by means of a high-fibre diet and probiotics may have anti-inflammatory effects in COVID-19 infection.	Ther Adv Respir Dis
32600045	Computing the Effects of SARS-CoV-2 on Respiration Regulatory Mechanisms in COVID-19.	ACS Chem Neurosci
32599963	Class A G Protein-Coupled Receptor Antagonist Famotidine as a Therapeutic Alternative Against SARS-CoV2: An In Silico Analysis.	Biomolecules
32599823	Host-Pathogen Responses to Pandemic Influenza H1N1pdm09 in a Human Respiratory Airway Model.	Viruses
32599375	Which type of cancer patients are more susceptible to the SARS-COX-2: Evidence from a meta-analysis and bioinformatics analysis.	Crit Rev Oncol Hematol
32599304	"SARS-CoV, MERS-CoV and SARS-CoV-2 infections in pregnancy and fetal development."	J Gynecol Obstet Hum Reprod
32599258	"COVID-19 and the cardiovascular system: A review of current data, summary of best practices, outline of controversies, and illustrative case reports."	Am Heart J
32599245	Targeting hub genes and pathways of innate immune response in COVID-19: A network biology perspective.	Int J Biol Macromol
32599161	Preterm birth: Potential risk factor for greater COVID-19 severity?	Respir Physiol Neurobiol
32598985	Potential therapeutic use of ebselen for COVID-19 and other respiratory viral infections.	Free Radic Biol Med
32598305	Do genetic polymorphisms in angiotensin converting enzyme 2 (ACE2) gene play a role in coronavirus disease 2019 (COVID-19)?	Clin Chem Lab Med
32597954	Neutrophil extracellular traps contribute to immunothrombosis in COVID-19 acute respiratory distress syndrome.	Blood
32597948	Predicting human microbe-drug associations via graph convolutional network with conditional random field.	Bioinformatics
32597823	"AhR and IDO1 in pathogenesis of Covid-19 and the ""Systemic AhR Activation Syndrome:"" a translational review and therapeutic perspectives."	Restor Neurol Neurosci
32597792	Reversing immunosenescence for prevention of COVID-19.	Aging (Albany NY)
32597513	New intriguing possibility for prevention of coronavirus pneumonitis: Natural purified polyphenols.	Oral Dis
32597503	Melatonin restores neutrophil functions and prevents apoptosis amid dysfunctional glutathione redox system.	J Pineal Res
32597377	The role of angiotensin-converting enzyme 2 in the pathogenesis of COVID-19: the villain or the hero?	Acta Clin Belg
32597315	"Repurposing of FDA-approved antivirals, antibiotics, anthelmintics, antioxidants, and cell protectives against SARS-CoV-2 papain-like protease."	J Biomol Struct Dyn
32597276	Pathophysiology of the COVID-19 - entry to the CNS through the nose.	Acta Otolaryngol
32596474	Evidence for host-dependent RNA editing in the transcriptome of SARS-CoV-2.	Sci Adv
32596428	Data stream dataset of SARS-CoV-2 genome.	Data Brief
32596365	Changes of Laboratory Cardiac Markers and Mechanisms of Cardiac Injury in Coronavirus Disease 2019.	Biomed Res Int
32596311	Sars-CoV-2 Envelope and Membrane Proteins: Structural Differences Linked to Virus Characteristics?	Biomed Res Int
32596244	The Inhibitory Effect of Curcumin on Virus-Induced Cytokine Storm and Its Potential Use in the Associated Severe Pneumonia.	Front Cell Dev Biol
32596170	SARS-CoV-2 Pathogenesis: Imbalance in the Renin-Angiotensin System Favors Lung Fibrosis.	Front Cell Infect Microbiol
32596078	Emerging Pharmaceutical Treatments of Novel COVID-19: A Review.	Cureus
32595958	"Analyses of spike protein from first deposited sequences of SARS-CoV2 from West Bengal, India."	F1000Res
32595955	Expected immune recognition of COVID-19 virus by memory from earlier infections with common coronaviruses in a large part of the world population.	F1000Res
32595947	The COVID-19 pandemic: catching up with the cataclysm.	F1000Res
32595654	Interferon-Induced Transmembrane Protein (IFITM3) Is Upregulated Explicitly in SARS-CoV-2 Infected Lung Epithelial Cells.	Front Immunol
32595653	Cytokine Release Syndrome (CRS) and Nicotine in COVID-19 Patients: Trying to Calm the Storm.	Front Immunol
32595613	Remdesivir (GS-5734) Impedes Enterovirus Replication Through Viral RNA Synthesis Inhibition.	Front Microbiol
32595513	New Strategy for COVID-19: An Evolutionary Role for RGD Motif in SARS-CoV-2 and Potential Inhibitors for Virus Infection.	Front Pharmacol
32595362	"Mesenchymal stem cell derived extracellular vesicles: promising immunomodulators against autoimmune, autoinflammatory disorders and SARS-CoV-2 infection."	Turk J Biol
32595360	"Interaction of certain monoterpenoid hydrocarbons with the receptor binding domain of 2019 novel coronavirus (2019-nCoV), transmembrane serine protease 2 (TMPRSS2), cathepsin B, and cathepsin L (CatB/L) and their pharmacokinetic properties."	Turk J Biol
32595357	SARS-CoV-2 neutralizing antibody development strategies.	Turk J Biol
32595356	SARS-CoV-2 isolation and propagation from Turkish COVID-19 patients.	Turk J Biol
32595355	Virtual drug repurposing study against SARS-CoV-2 TMPRSS2 target.	Turk J Biol
32595354	Identification of the nucleotide substitutions in 62 SARS-CoV-2 sequences from Turkey.	Turk J Biol
32595353	Integration of transcriptomic profile of SARS-CoV-2 infected normal human bronchial epithelial cells with metabolic and protein-protein interaction networks.	Turk J Biol
32595352	An updated analysis of variations in SARS-CoV-2 genome.	Turk J Biol
32595351	Phylogenetic analysis of SARS-CoV-2 genomes in Turkey.	Turk J Biol
32595278	NeoCoV Is Closer to MERS-CoV than SARS-CoV.	Infect Dis (Auckl)
32595169	Coronavirus disease-19 and its hematological manifestations.	Blood Res
32595085	"Covid-19 and cardiovascular risk: Susceptibility to infection to SARS-CoV-2, severity and prognosis of Covid-19 and blockade of the renin-angiotensin-aldosterone system. An evidence-based viewpoint."	Nutr Metab Cardiovasc Dis
32594820	Potential protective and therapeutic role of immune checkpoint inhibitors against viral infections and COVID-19.	Immunotherapy
32594778	The cytokine storm of COVID-19: a spotlight on prevention and protection.	Expert Opin Ther Targets
32594644	The ACE2 expression in Sertoli cells and germ cells may cause male reproductive disorder after SARS-CoV-2 infection.	J Cell Mol Med
32594572	COVID-19 and cutaneous manifestations: a systematic review.	J Eur Acad Dermatol Venereol
32594472	"[Hypertension, RAAS blockade and risk in COVID-19 patients]."	Lakartidningen
32594342	Flow Cytometry Identifies Risk Factors and Dynamic Changes in Patients with COVID-19.	J Clin Immunol
32594322	Antiviral activity of berberine.	Arch Virol
32594204	The added value of pirfenidone to fight inflammation and fibrotic state induced by SARS-CoV-2 : Anti-inflammatory and anti-fibrotic therapy could solve the lung complications of the infection?	Eur J Clin Pharmacol
32593832	Why is SARS-CoV-2 infection more severe in obese men? The gut lymphatics - Lung axis hypothesis.	Med Hypotheses
32593831	Plausible role of combination of Chlorpromazine hydrochloride and Teicoplanin against COVID-19.	Med Hypotheses
32593830	COVID-19 cytokine storm and novel truth.	Med Hypotheses
32593743	Children and SARS-CoV-2 infection: innocent bystanders...until proven otherwise.	Clin Microbiol Infect
32593740	Irisin modulates genes associated with severe coronavirus disease (COVID-19) outcome in human subcutaneous adipocytes cell culture.	Mol Cell Endocrinol
32593648	Covid-19 in children: A brief overview after three months experience.	Paediatr Respir Rev
32593613	Testing of natural products in clinical trials targeting the SARS-CoV-2 (Covid-19) viral spike protein-angiotensin converting enzyme-2 (ACE2) interaction.	Biochem Pharmacol
32593567	COVID-19 and Clostridioides difficile infection (CDI): Possible implications for elderly patients.	Anaerobe
32593497	Fibrinolysis Shutdown and Thrombosis in Severe COVID-19.	J Am Coll Surg
32593491	Molecular pharmacology of ciclesonide against SARS-CoV-2.	J Allergy Clin Immunol
32593418	A review of cardiac manifestations and predictors of outcome in patients with COVID - 19.	Heart Lung
32592996	"Crystal Structure of the SARS-CoV-2 Non-structural Protein 9, Nsp9."	iScience
32592968	"Letter to the Editor: ""Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Traumatic Cervical Acute Spinal Cord Injury: An Appraisal""."	World Neurosurg
32592919	Endothelial dysfunction in Coronavirus disease 2019 (COVID-19): Gender and age influences.	Med Hypotheses
32592868	Direct SARS-CoV-2 infection of the heart potentiates the cardiovascular sequelae of COVID-19.	Drug Discov Today
32592845	Comparative analysis of protein synthesis rate in COVID-19 with other human coronaviruses.	Infect Genet Evol
32592841	A proposed mechanism for the possible therapeutic potential of Metformin in COVID-19.	Diabetes Res Clin Pract
32592839	Retinal outcomes of COVID-19: Possible role of CD147 and cytokine storm in infected patients with diabetes mellitus.	Diabetes Res Clin Pract
32592817	Antiviral mechanisms of candidate chemical medicines and traditional Chinese medicines for SARS-CoV-2 infection.	Virus Res
32592752	"Identifying phenotypes of COVID-19, defining their pathogenesis, and targeting treatments could improve outcomes."	Respir Physiol Neurobiol
32592501	The cytokine storm and COVID-19.	J Med Virol
32592394	A role for selenium-dependent GPX1 in SARS-CoV-2 virulence.	Am J Clin Nutr
32592145	Identification of a Potential Peptide Inhibitor of SARS-CoV-2 Targeting its Entry into the Host Cells.	Drugs R D
32592113	Potential role of incretins in diabetes and COVID-19 infection: a hypothesis worth exploring.	Intern Emerg Med
32592104	COVID-19 and neurologic manifestations: a still missing link and a call for neurologists.	Neurol Sci
32592085	Could urinary ACE2 protein level help identify individuals susceptible to SARS-CoV-2 infection and complication?	Sci China Life Sci
32592038	Molecular evolution and phylogenetic analysis of SARS-CoV-2 and hosts ACE2 protein suggest Malayan pangolin as intermediary host.	Braz J Microbiol
32591908	Relationship Between ACE2 and Other Components of the Renin-Angiotensin System.	Curr Hypertens Rep
32591839	Infectability of human BrainSphere neurons suggests neurotropism of SARS-CoV-2	ALTEX
32591762	COVID-19 severity correlates with airway epithelium-immune cell interactions identified by single-cell analysis.	Nat Biotechnol
32591496	"Door to the cell for COVID-19 opened, leading way to therapies."	Signal Transduct Target Ther
32591408	Phenotype and kinetics of SARS-CoV-2-specific T cells in COVID-19 patients with acute respiratory distress syndrome.	Sci Immunol
32591393	A Potently Neutralizing Antibody Protects Mice against SARS-CoV-2 Infection.	J Immunol
32591283	[COVID-19 and its relationship with hypertension and cardiovascular disease].	Hipertens Riesgo Vasc
32591269	Vitamin D and Coronavirus.	Geriatr Nurs
32591003	Application of CRISPR/Cas9 to human-induced pluripotent stem cells: from gene editing to drug discovery.	Hum Genomics
32590326	Pulmonary surfactant itself must be a strong defender against SARS-CoV-2.	Med Hypotheses
32590324	Targeting adenosinergic pathway and adenosine A2A receptor signaling for the treatment of COVID-19: A hypothesis.	Med Hypotheses
32590321	Endothelial progenitor cells and mesenchymal stem cells to overcome vascular deterioration and cytokine storm in critical patients with COVID-19.	Med Hypotheses
32590235	TB infection and BCG vaccination: are we protected from COVID-19?	Public Health
32590117	Nitric oxide dosed in short bursts at high concentrations may protect against Covid 19.	Nitric Oxide
32590062	Out of the frying pan and into the fire? Due diligence warranted for ADE in COVID-19.	Microbes Infect
32589897	"The ORF6, ORF8 and nucleocapsid proteins of SARS-CoV-2 inhibit type I interferon signaling pathway."	Virus Res
32589756	"Impaired glucose metabolism in patients with diabetes, prediabetes, and obesity is associated with severe COVID-19."	J Med Virol
32589736	What to Expect from Antibody Assays of SARS-CoV-2?	J Appl Lab Med
32589459	Ocular Surface Expression of SARS-CoV-2 Receptors.	Ocul Immunol Inflamm
32589264	COVID-19 and non-alcoholic fatty liver disease: Two intersecting pandemics.	Eur J Clin Invest
32588938	Serum amyloid A protein has been undervalued as a biomarker of COVID-19.	Diabetes Metab Res Rev
32588674	"COVID-19 pneumonia and immune-related pneumonitis: critical issues on differential diagnosis, potential interactions, and management."	Expert Opin Biol Ther
32588590	Coronaviruses fusion with the membrane and entry to the host cell.	Ann Agric Environ Med
32588565	Updates of Cardiovascular Manifestations in COVID-19: Korean Experience to Broaden Worldwide Perspectives.	Korean Circ J
32588535	The protective rather than prothrombotic fibrinogen in COVID-19 and other inflammatory states.	J Thromb Haemost
32588530	RNA to the rescue: RNA is one of the most promising targets for drug development given its wide variety of uses.	EMBO Rep
32588493	COVID-19-Associated dyslipidemia: Implications for mechanism of impaired resolution and novel therapeutic approaches.	FASEB J
32588453	Covid-19 and thymoquinone: Connecting the dots.	Phytother Res
32588163	Auxiliary role of mesenchymal stem cells as regenerative medicine soldiers to attenuate inflammatory processes of severe acute respiratory infections caused by COVID-19.	Cell Tissue Bank
32588061	Entangling COVID-19 associated thrombosis into a secondary antiphospholipid antibody syndrome: Diagnostic and therapeutic perspectives (Review).	Int J Mol Med
32587923	Novel coronavirus pandemic: A global health threat.	Turk J Emerg Med
32587806	A potential role for Galectin-3 inhibitors in the treatment of COVID-19.	PeerJ
32587367	Potential contribution of increased soluble IL-2R to lymphopenia in COVID-19 patients.	Cell Mol Immunol
32587094	SARS-CoV-2 (COVID-19) structural and evolutionary dynamicome: Insights into functional evolution and human genomics.	J Biol Chem
32587093	Inhibition of SARS-CoV-2 by type I and type III interferons.	J Biol Chem
32586885	"Epidemic and pandemic viral infections: impact on tuberculosis and the lung: A consensus by the World Association for Infectious Diseases and Immunological Disorders (WAidid), Global Tuberculosis Network (GTN), and members of the European Society of Clinical Microbiology and Infectious Diseases Study Group for Mycobacterial Infections (ESGMYC)."	Eur Respir J
32586872	"Genome Sequence of SARS-CoV-2 Isolate Cali-01, from Colombia, Obtained Using Oxford Nanopore MinION Sequencing."	Microbiol Resour Announc
32586675	"The potential sudden shift in clinical research and epidemiology of cardiovascular diseases, caused by COVID-19."	Arch Cardiovasc Dis
32586628	[Obesity as a risk factor in COVID-19: Possible mechanisms and implications].	Aten Primaria
32586380	Advanced bioinformatics rapidly identifies existing therapeutics for patients with coronavirus disease-2019 (COVID-19).	J Transl Med
32585913	SARS-CoV-2: An Update on Potential Antivirals in Light of SARS-CoV Antiviral Drug Discoveries.	Vaccines (Basel)
32585364	"Diabetes, infection risk and COVID-19."	Mol Metab
32585295	Inhibition of cytokine signaling by ruxolitinib and implications for COVID-19 treatment.	Clin Immunol
32585135	Neutralization of SARS-CoV-2 by Destruction of the Prefusion Spike.	Cell Host Microbe
32584762	[Rationales for using JAK 1/2 inhibitors in severely afflicted patients with COVID-19 pneumonia].	Ugeskr Laeger
32584593	Update Alert: Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults.	Ann Intern Med
32584474	A brief review of interplay between vitamin D and angiotensin-converting enzyme 2: Implications for a potential treatment for COVID-19.	Rev Med Virol
32584441	"Immunology of COVID-19: Mechanisms, clinical outcome, diagnostics, and perspectives-A report of the European Academy of Allergy and Clinical Immunology (EAACI)."	Allergy
32584421	"Combined IL-6 and JAK/STAT inhibition therapy in COVID-19-related sHLH, potential game changer."	Br J Haematol
32584416	Amelioration of COVID-19-related cytokine storm syndrome: parallels to chimeric antigen receptor-T cell cytokine release syndrome.	Br J Haematol
32584324	OLFACTORY DISORDERS IN SARS-COV-2 INFECTION: CONSIDERATIONS IN AGING.	Rev Invest Clin
32584323	MEXICAN HUMAN LEUKOCYTE ANTIGEN ALLELES MIGHT PREDICT CLINICAL OUTCOME IN SARS-COV-2 INFECTED PATIENTS.	Rev Invest Clin
32584199	Human and novel coronavirus infections in children: a review.	Paediatr Int Child Health
32583729	Immunoinformatics study to search epitopes of spike glycoprotein from SARS-CoV-2 as potential vaccine.	J Biomol Struct Dyn
32583553	Do pregnant women have protective immunity against COVID-19?	BJOG
32583434	"Neurological, Cognitive, and Behavioral Disorders during COVID-19: The Nitric Oxide Track."	J Am Geriatr Soc
32583353	What about COVID-19 and arachidonic acid pathway?	Eur J Clin Pharmacol
32583231	Age-related decline of de novo T cell responsiveness as a cause of COVID-19 severity.	Geroscience
32583086	"COVID-19-driven endothelial damage: complement, HIF-1, and ABL2 are potential pathways of damage and targets for cure."	Ann Hematol
32583042	[Can SARS-CoV-2 infect the eye?-An overview of the receptor status in ocular tissue].	Ophthalmologe
32582936	Elevated Expression of Serum Endothelial Cell Adhesion Molecules in COVID-19 Patients.	J Infect Dis
32582786	Analysis of Possible Intermediate Hosts of the New Coronavirus SARS-CoV-2.	Front Vet Sci
32582766	Does Early Childhood Vaccination Protect Against COVID-19?	Front Mol Biosci
32582719	Recent Understandings Toward Coronavirus Disease 2019 (COVID-19): From Bench to Bedside.	Front Cell Dev Biol
32582703	Dissecting the Niche for Alveolar Type II Cells With Alveolar Organoids.	Front Cell Dev Biol
32582576	Could Sex/Gender Differences in ACE2 Expression in the Lungs Contribute to the Large Gender Disparity in the Morbidity and Mortality of Patients Infected With the SARS-CoV-2 Virus?	Front Cell Infect Microbiol
32582574	"ACE2, Much More Than Just a Receptor for SARS-COV-2."	Front Cell Infect Microbiol
32582400	Steps towards COVID-19 suppression.	Inflamm Regen
32582339	Variation of 2019 novel coronavirus complete genomes recorded in the 1(st) month of outbreak: Implication for mutation.	J Res Med Sci
32582303	"Neutrophils, Crucial, or Harmful Immune Cells Involved in Coronavirus Infection: A Bioinformatics Study."	Front Genet
32582302	Lack of Association Between Genetic Variants at ACE2 and TMPRSS2 Genes Involved in SARS-CoV-2 Infection and Human Quantitative Phenotypes.	Front Genet
32582222	The Lung Macrophage in SARS-CoV-2 Infection: A Friend or a Foe?	Front Immunol
32582221	Could Coronavirus Disease 2019 (COVID-19) Render Natural Immunity to Re-infections? A Spotlight on the Therapeutic Pipeline.	Front Immunol
32582200	Antibody Dependent Enhancement Due to Original Antigenic Sin and the Development of SARS.	Front Immunol
32582137	Biosurfactants: A Covid-19 Perspective.	Front Microbiol
32582136	SARS-CoV-2 Genome Analysis of Japanese Travelers in Nile River Cruise.	Front Microbiol
32582134	Main Clinical Features of COVID-19 and Potential Prognostic and Therapeutic Value of the Microbiota in SARS-CoV-2 Infections.	Front Microbiol
32581854	Disentangling the Hypothesis of Host Dysosmia and SARS-CoV-2: The Bait Symptom That Hides Neglected Neurophysiological Routes.	Front Physiol
32581816	Neutrophilia and NETopathy as Key Pathologic Drivers of Progressive Lung Impairment in Patients With COVID-19.	Front Pharmacol
32581799	Molecular Insights Into SARS COV-2 Interaction With Cardiovascular Disease: Role of RAAS and MAPK Signaling.	Front Pharmacol
32581256	Recombinant human ACE2: potential therapeutics of SARS-CoV-2 infection and its complication.	Acta Pharmacol Sin
32581217	Structural plasticity of SARS-CoV-2 3CL M(pro) active site cavity revealed by room temperature X-ray crystallography.	Nat Commun
32581194	Targeting lymphocyte Kv1.3-channels to suppress cytokine storm in severe COVID-19: Can it be a novel therapeutic strategy?	Drug Discov Ther
32581081	Rampant C-->U Hypermutation in the Genomes of SARS-CoV-2 and Other Coronaviruses: Causes and Consequences for Their Short- and Long-Term Evolutionary Trajectories.	mSphere
32581077	COVID-19 Hyperinflammation: What about Neutrophils?	mSphere
32581017	Morphoproteomics and Etiopathogenic Features of Pulmonary COVID-19 with Therapeutic Implications: A Case Study.	Ann Clin Lab Sci
32580969	Coronavirus Disease 2019-COVID-19.	Clin Microbiol Rev
32580895	Targeting JAK-STAT Signaling to Control Cytokine Release Syndrome in COVID-19.	Trends Pharmacol Sci
32580440	Air Pollution and Covid-19: The Role of Particulate Matter in the Spread and Increase of Covid-19's Morbidity and Mortality.	Int J Environ Res Public Health
32580258	2019 Novel Coronavirus Pandemic: What Do We Know?	S D Med
32579957	SARS-CoV-2 and cardiovascular complications: From molecular mechanisms to pharmaceutical management.	Biochem Pharmacol
32579952	Hyperferritinemia in critically ill COVID-19 patients - Is ferritin the product of inflammation or a pathogenic mediator?	Clin Chim Acta
32579907	Paromomycin: A potential dual targeted drug effectively inhibits both spike (S1) and main protease of COVID-19.	Int J Infect Dis
32579880	A Human Pluripotent Stem Cell-based Platform to Study SARS-CoV-2 Tropism and Model Virus Infection in Human Cells and Organoids.	Cell Stem Cell
32579874	Prolonged Infectivity of SARS-CoV-2 in Fomites.	Emerg Infect Dis
32579707	Clinical Pharmacology Considerations for Developing Small-Molecule Treatments for COVID-19.	J Clin Pharmacol
32579597	"Predictors of severe or lethal COVID-19, including Angiotensin Converting Enzyme inhibitors and Angiotensin II Receptor Blockers, in a sample of infected Italian citizens."	PLoS One
32579477	Platelets and Immunity: Going Viral.	Arterioscler Thromb Vasc Biol
32579268	SARS-CoV-2-reactive interferon-gamma-producing CD8+ T cells in patients hospitalized with coronavirus disease 2019.	J Med Virol
32579258	Antiviral activities of mycophenolic acid and IMD-0354 against SARS-CoV-2.	Microbiol Immunol
32579254	SARS-CoV-2 and SARS-CoV: Virtual screening of potential inhibitors targeting RNA-dependent RNA polymerase activity (NSP12).	J Med Virol
32579244	Clinical and biological data on the use of hydroxychloroquine against SARS-CoV-2 could support the role of the NLRP3 inflammasome in the pathogenesis of respiratory disease.	J Med Virol
32579100	"Insights into SARS-CoV-2, the Coronavirus Underlying COVID-19: Recent Genomic Data and the Development of Reverse Genetics Systems."	J Gen Virol
32579065	Binding insight of clinically oriented drug famotidine with the identified potential target of SARS-CoV-2.	J Biomol Struct Dyn
32579064	In-silico investigation of phytochemicals from Asparagus racemosus as plausible antiviral agent in COVID-19.	J Biomol Struct Dyn
32579061	Pharmacoinformatics and molecular dynamics simulation studies reveal potential covalent and FDA-approved inhibitors of SARS-CoV-2 main protease 3CL(pro).	J Biomol Struct Dyn
32579059	"Screening of Chloroquine, Hydroxychloroquine and its derivatives for their binding affinity to multiple SARS-CoV-2 protein drug targets."	J Biomol Struct Dyn
32579049	Photobiomodulation: Shining Light on COVID-19.	Photobiomodul Photomed Laser Surg
32579033	SARS-CoV-2-induced Acute Respiratory Distress Syndrome: Pulmonary Mechanics and Gas-Exchange Abnormalities.	Ann Am Thorac Soc
32579012	COVID-19. Immunothrombosis and the gastrointestinal tract.	Rev Esp Enferm Dig
32578982	Molecular Basis for ADP-Ribose Binding to the Mac1 Domain of SARS-CoV-2 nsp3.	Biochemistry
32578486	"Autophagy/virophagy: a ""disposal strategy"" to combat COVID-19."	Autophagy
32578354	Obesity and COVID-19: The mTOR pathway as a possible culprit.	Obes Rev
32578263	Could SARS-CoV-2 affect male fertility?	Andrologia
32578167	COVID-19 Pandemic: Cardiovascular Complications and Future Implications.	Am J Cardiovasc Drugs
32578073	Elderly at time of COronaVIrus disease 2019 (COVID-19): possible role of immunosenescence and malnutrition.	Geroscience
32578011	Consideration on TMPRSS2 and the risk of COVID-19 infection in Cushing's syndrome.	Endocrine
32577830	Is the oral cavity relevant in SARS-CoV-2 pandemic?	Clin Oral Investig
32577762	Men more vulnerable to COVID-19: explained by ACE2 on the X chromosome?	Eur Heart J
32577716	ACE2 is on the X chromosome: could this explain COVID-19 gender differences?	Eur Heart J
32577236	Preventing SARS-CoV-2 infection by blocking a tissue serine protease.	Ther Adv Infect Dis
32577218	COVID-19 and the pulmonary vasculature.	Pulm Circ
32577056	The Nrf2 Activator (DMF) and Covid-19: Is there a Possible Role?	Med Arch
32576928	DREAM-in-CDM Approach and Identification of a New Generation of Anti-inflammatory Drugs Targeting mPGES-1.	Sci Rep
32576678	Upregulation of CD47 Is a Host Checkpoint Response to Pathogen Recognition.	mBio
32576611	Nervous system: subclinical target of SARS-CoV-2 infection.	J Neurol Neurosurg Psychiatry
32576394	Geographical Overlap Between Alpha-1 Antitrypsin Deficiency and COVID-19 Infection in Italy: Casual or Causal?	Arch Bronconeumol (Engl Ed)
32576386	Deciphering the TCR Repertoire to Solve the COVID-19 Mystery.	Trends Pharmacol Sci
32576357	"[2019 Novel coronavirus, renin-angiotension system imbalance and coronavirus disease 2019]."	Zhonghua Wei Zhong Bing Ji Jiu Yi Xue
32576345	[Clinical characteristics and CT imaging features of patients with different clinical types of coronavirus disease 2019].	Zhonghua Wei Zhong Bing Ji Jiu Yi Xue
32576343	[Study on traditional Chinese medicine common syndrome characteristic of coronavirus disease 2019 based on latent structure combined with system clustering analysis].	Zhonghua Wei Zhong Bing Ji Jiu Yi Xue
32575554	Targeting the Heme-Heme Oxygenase System to Prevent Severe Complications Following COVID-19 Infections.	Antioxidants (Basel)
32575476	"Geranium and Lemon Essential Oils and Their Active Compounds Downregulate Angiotensin-Converting Enzyme 2 (ACE2), a SARS-CoV-2 Spike Receptor-Binding Domain, in Epithelial Cells."	Plants (Basel)
32575076	Re-analysis of SARS-CoV-2-infected host cell proteomics time-course data by impact pathway analysis and network analysis: a potential link with inflammatory response.	Aging (Albany NY)
32575050	Good things come in threes (and sometimes fours): Update on renin-angiotensin-aldosterone system inhibitors and COVID-19.	CMAJ
32575019	Pirfenidone: A novel hypothetical treatment for COVID-19.	Med Hypotheses
32575004	May Parkinson's disease be a protective factor against CNS involvement by SARS-CoV2?	Parkinsonism Relat Disord
32574958	Targeting innate immunity by blocking CD14: Novel approach to control inflammation and organ dysfunction in COVID-19 illness.	EBioMedicine
32574840	Persistent Viral Presence Determines the Clinical Course of the Disease in COVID-19.	J Allergy Clin Immunol Pract
32574709	COVID-19 pneumonia: CD8(+) T and NK cells are decreased in number but compensatory increased in cytotoxic potential.	Clin Immunol
32574708	Mitochondria and microbiota dysfunction in COVID-19 pathogenesis.	Mitochondrion
32574699	Discovering small-molecule therapeutics against SARS-CoV-2.	Drug Discov Today
32574578	Is the increased risk for MAFLD patients to develop severe COVID-19 linked to perturbation of the gut-liver axis?	J Hepatol
32574572	Letter to the editor: Immunomodulation by phosphodiesterase-4 inhibitor in COVID-19 patients.	Metabolism
32574379	"A sugar-coated strategy to treat a rare neurologic disease provides a blueprint for a decoy glycan therapeutic and a potential vaccine for CoViD-19: An Editorial Highlight for ""Selective inhibition of anti-MAG IgM autoantibody binding to myelin by an antigen specific glycopolymer""on page 486."	J Neurochem
32574336	"The Lung, the Heart, the Novel Coronavirus, and the Renin-Angiotensin System; The Need for Clinical Trials."	Front Med (Lausanne)
32574331	May Polyphenols Have a Role Against Coronavirus Infection? An Overview of in vitro Evidence.	Front Med (Lausanne)
32574320	Doxycycline: From Ocular Rosacea to COVID-19 Anosmia. New Insight Into the Coronavirus Outbreak.	Front Med (Lausanne)
32574317	Can Stem Cells Beat COVID-19: Advancing Stem Cells and Extracellular Vesicles Toward Mainstream Medicine for Lung Injuries Associated With SARS-CoV-2 Infections.	Front Bioeng Biotechnol
32574288	Coronavirus and Obesity: Could Insulin Resistance Mediate the Severity of Covid-19 Infection?	Front Public Health
32574286	Coronavirus Disease 2019 (COVID-19) in Neonates and Children From China: A Review.	Front Pediatr
32574283	Methylation Pathways and SARS-CoV-2 Lung Infiltration and Cell Membrane-Virus Fusion Are Both Subject to Epigenetics.	Front Cell Infect Microbiol
32574273	Symptomatic Protective Action of Glycyrrhizin (Licorice) in COVID-19 Infection?	Front Immunol
32574272	Innate Immune Signaling and Proteolytic Pathways in the Resolution or Exacerbation of SARS-CoV-2 in Covid-19: Key Therapeutic Targets?	Front Immunol
32574271	"The Biology of Lactoferrin, an Iron-Binding Protein That Can Help Defend Against Viruses and Bacteria."	Front Immunol
32574270	Coronavirus Disease (Covid-19): What Are We Learning in a Country With High Mortality Rate?	Front Immunol
32574269	Could SARS-CoV-2-Induced Hyperinflammation Magnify the Severity of Coronavirus Disease (CoViD-19) Leading to Acute Respiratory Distress Syndrome?	Front Immunol
32574268	Fighting the Host Reaction to SARS-COv-2 in Critically Ill Patients: The Possible Contribution of Off-Label Drugs.	Front Immunol
32574265	Lessons Learned to Date on COVID-19 Hyperinflammatory Syndrome: Considerations for Interventions to Mitigate SARS-CoV-2 Viral Infection and Detrimental Hyperinflammation.	Front Immunol
32574264	"Severe COVID-19, Another Piece in the Puzzle of the Hyperferritinemic Syndrome. An Immunomodulatory Perspective to Alleviate the Storm."	Front Immunol
32574261	Humoral Immune Responses in COVID-19 Patients: A Window on the State of the Art.	Front Immunol
32574260	"Highlight of Immune Pathogenic Response and Hematopathologic Effect in SARS-CoV, MERS-CoV, and SARS-Cov-2 Infection."	Front Immunol
32574259	Novel Coronavirus-Induced NLRP3 Inflammasome Activation: A Potential Drug Target in the Treatment of COVID-19.	Front Immunol
32574258	Could BCG Vaccination Induce Protective Trained Immunity for SARS-CoV-2?	Front Immunol
32574256	"Pangolins Lack IFIH1/MDA5, a Cytoplasmic RNA Sensor That Initiates Innate Immune Defense Upon Coronavirus Infection."	Front Immunol
32574238	An Open Question: Is It Rational to Inhibit the mTor-Dependent Pathway as COVID-19 Therapy?	Front Pharmacol
32574196	ACE2 and TMPRSS2 variation in savanna monkeys (Chlorocebus spp.): Potential risk for zoonotic/anthroponotic transmission of SARS-CoV-2 and a potential model for functional studies.	PLoS One
32574109	Structural Basis of SARS-CoV-2- and SARS-CoV-Receptor Binding and Small-Molecule Blockers as Potential Therapeutics.	Annu Rev Pharmacol Toxicol
32574107	Kawasaki-like diseases and thrombotic coagulopathy in COVID-19: delayed over-activation of the STING pathway?	Emerg Microbes Infect
32573950	COVID-19: From pathogenesis models to the first drug trials.	Microb Biotechnol
32573788	Elucidation of cellular targets and exploitation of the receptor-binding domain of SARS-CoV-2 for vaccine and monoclonal antibody synthesis.	J Med Virol
32573711	Platelet gene expression and function in patients with COVID-19.	Blood
32573433	Antibodies to SARS-CoV-2 and their potential for therapeutic passive immunization.	Elife
32573355	Targeting SARS-COV-2 non-structural protein 16: a virtual drug repurposing study.	J Biomol Struct Dyn
32573351	Ethnomedicines of Indian origin for combating COVID-19 infection by hampering the viral replication: using structure-based drug discovery approach.	J Biomol Struct Dyn
32572552	[What is the importance of the conjunctiva as a potential transmission pathway for SARS-CoV-2 infections?]	Ophthalmologe
32572532	Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion.	Intensive Care Med
32572383	Evaluation of the Inhibitory Activities of COVID-19 of Melaleuca cajuputi Oil Using Docking Simulation.	ChemistrySelect
32572334	"Application of System Biology to Explore the Association of Neprilysin, Angiotensin-Converting Enzyme 2 (ACE2), and Carbonic Anhydrase (CA) in Pathogenesis of SARS-CoV-2."	Biol Proced Online
32572247	Sex differences in immune responses in COVID-19.	Nat Rev Immunol
32572246	Preclinical data from SARS-CoV-2 mRNA vaccine.	Nat Rev Immunol
32572245	Roles for eosinophils and basophils in COVID-19?	Nat Rev Immunol
32572194	Myocardial injury in patients with COVID-19.	Nat Rev Cardiol
32572155	A systematic review of pathological findings in COVID-19: a pathophysiological timeline and possible mechanisms of disease progression.	Mod Pathol
32571951	Oligodendrocytes that survive acute coronavirus infection induce prolonged inflammatory responses in the CNS.	Proc Natl Acad Sci U S A
32571934	Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development.	Proc Natl Acad Sci U S A
32571880	Structural and functional conservation of the programmed -1 ribosomal frameshift signal of SARS coronavirus 2 (SARS-CoV-2).	J Biol Chem
32571838	A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2.	Science
32571797	Identification of Common Deletions in the Spike Protein of Severe Acute Respiratory Syndrome Coronavirus 2.	J Virol
32571582	"COVID-19, a viral endocrinological disease?"	Eur J Intern Med
32571182	Molecular Targets in the Chemotherapy of Coronavirus Infection.	Biochemistry (Mosc)
32571168	"Drug repurposing against SARS-CoV-2 using E-pharmacophore based virtual screening, molecular docking and molecular dynamics with main protease as the target."	J Biomol Struct Dyn
32570882	Cholesterol in Relation to COVID-19: Should We Care about It?	J Clin Med
32570850	Microbiota Modulating Nutritional Approaches to Countering the Effects of Viral Respiratory Infections Including SARS-CoV-2 through Promoting Metabolic and Immune Fitness with Probiotics and Plant Bioactives.	Microorganisms
32570174	SARS-CoV-2 infection and stem cells: Interaction and intervention.	Stem Cell Res
32570166	A hypothesis about the role of fetal hemoglobin in COVID-19.	Med Hypotheses
32570163	Occult SARS-CoV-2 infection; a possible hypothesis for viral relapse.	Med Hypotheses
32569879	Is COVID-19 associated thrombosis caused by overactivation of the complement cascade? A literature review.	Thromb Res
32569833	Exportin 1 inhibition as antiviral therapy.	Drug Discov Today
32569819	Network pharmacological approach for elucidating the mechanisms of traditional Chinese medicine in treating COVID-19 patients.	Pharmacol Res
32569708	COVID-19: Review on latest available drugs and therapies against SARS-CoV-2. Coagulation and inflammation cross-talking.	Virus Res
32569607	Lymphopenia during the COVID-19 infection: What it shows and what can be learned.	Immunol Lett
32569491	Is the use of ACE inb/ARBs associated with higher in-hospital mortality in Covid-19 pneumonia patients?	Clin Exp Hypertens
32569293	Biological sex impacts COVID-19 outcomes.	PLoS Pathog
32568687	"COVID-19 Coronavirus spike protein analysis for synthetic vaccines, a peptidomimetic antagonist, and therapeutic drugs, and analysis of a proposed achilles' heel conserved region to minimize probability of escape mutations and drug resistance."	Comput Biol Med
32568620	Remdesivir (GS-5734) as a therapeutic option of 2019-nCOV main protease - in silico approach.	J Biomol Struct Dyn
32568618	"Chemical-informatics approach to COVID-19 drug discovery: Monte Carlo based QSAR, virtual screening and molecular docking study of some in-house molecules as papain-like protease (PLpro) inhibitors."	J Biomol Struct Dyn
32568613	Evaluation of green tea polyphenols as novel corona virus (SARS CoV-2) main protease (Mpro) inhibitors - an in silico docking and molecular dynamics simulation study.	J Biomol Struct Dyn
32568187	COVID-19 and the endothelium.	Clin Hemorheol Microcirc
32568186	The compelling arguments for the need of microvascular investigation in COVID-19 critical patients.	Clin Hemorheol Microcirc
32568058	"Detection and Characterization of New Coronavirus in Bottlenose Dolphin, United States, 2019."	Emerg Infect Dis
32568027	"SARS-coronavirus-2 replication in Vero E6 cells: replication kinetics, rapid adaptation and cytopathology."	J Gen Virol
32568013	Virtual screening and dynamics of potential inhibitors targeting RNA binding domain of nucleocapsid phosphoprotein from SARS-CoV-2.	J Biomol Struct Dyn
32568012	Sars-cov-2 host entry and replication inhibitors from Indian ginseng: an in-silico approach.	J Biomol Struct Dyn
32567995	Promising inhibitors of main protease of novel corona virus to prevent the spread of COVID-19 using docking and molecular dynamics simulation.	J Biomol Struct Dyn
32567989	In silico identification of potential inhibitors from Cinnamon against main protease and spike glycoprotein of SARS CoV-2.	J Biomol Struct Dyn
32567979	Structure-based virtual screening and molecular dynamics simulation of SARS-CoV-2 Guanine-N7 methyltransferase (nsp14) for identifying antiviral inhibitors against COVID-19.	J Biomol Struct Dyn
32567972	Autophagy and SARS-CoV-2 infection: Apossible smart targeting of the autophagy pathway.	Virulence
32567823	Beyond the lung involvement in COVID-19 patients. A review.	Minerva Med
32567501	Constituents of buriti oil (Mauritia flexuosa L.) like inhibitors of the SARS-Coronavirus main peptidase: an investigation by docking and molecular dynamics.	J Biomol Struct Dyn
32567487	"nCOV-19 peptides mass fingerprinting identification, binding, and blocking of inhibitors flavonoids and anthraquinone of Moringa oleifera and hydroxychloroquine."	J Biomol Struct Dyn
32567404	Multiple organ dysfunction in SARS-CoV-2: MODS-CoV-2.	Expert Rev Respir Med
32567171	The renin-angiotensin-aldosterone system as a link between obesity and coronavirus disease 2019 severity.	Obes Rev
32566896	Perspectives on the development of neutralizing antibodies against SARS-CoV-2.	Antib Ther
32566803	"Novel SARS-CoV-2/COVID-19: Origin, pathogenesis, genes and genetic variations, immune responses and phylogenetic analysis."	Gene Rep
32566425	"Novel COVID-19: A Comprehensive Review of Transmission, Manifestation, and Pathogenesis."	Cureus
32566234	Phyloevolutionary analysis of SARS-CoV-2 in Nigeria.	New Microbes New Infect
32565763	"[The SARS-CoV-2, a new pandemic zoonosis that threatens the world]."	Vacunas
32565626	Time series prediction of COVID-19 by mutation rate analysis using recurrent neural network-based LSTM model.	Chaos Solitons Fractals
32565603	Update on the target structures of SARS-CoV-2: A systematic review.	Indian J Pharmacol
32565512	Exploration and correlation analysis of changes in Krebs von den Lungen-6 levels in COVID-19 patients with different types in China.	Biosci Trends
32565362	Comparative analysis of SARS-CoV-2 receptor ACE2 expression in multiple solid tumors and matched non-diseased tissues.	Infect Genet Evol
32565254	Activation of the renin-angiotensin-aldosterone system is associated with Acute Kidney Injury in COVID-19.	Anaesth Crit Care Pain Med
32565232	"Guidance on diagnosis, prevention and treatment of thromboembolic complications in COVID-19: a position paper of the Brazilian Society of Thrombosis and Hemostasis and the Thrombosis and Hemostasis Committee of the Brazilian Association of Hematology, Hemotherapy and Cellular Therapy."	Hematol Transfus Cell Ther
32565195	Cardiac effects and toxicity of chloroquine: a short update.	Int J Antimicrob Agents
32565134	The influence of interferon-lambda on restricting Middle East Respiratory Syndrome Coronavirus replication in the respiratory epithelium.	Antiviral Res
32565126	Targeting the SARS-CoV-2 spike glycoprotein prefusion conformation: virtual screening and molecular dynamics simulations applied to the identification of potential fusion inhibitors.	Virus Res
32564981	Possible protective role of contact Lens against SARS COV 2.	J Fr Ophtalmol
32564908	COVID-19 - Does This Disease Kill Due to Imbalance of the Renin Angiotensin System (RAS) Caused by Genetic and Gender Differences in the Response to Viral ACE 2 Attack?	Heart Lung Circ
32564694	Sex-Specific Modulation of Blood Pressure and the Renin-Angiotensin System by ACE (Angiotensin-Converting Enzyme) 2.	Hypertension
32564623	Tackling SARS-CoV-2: proposed targets and repurposed drugs.	Future Med Chem
32564476	SARS-CoV-2 and oral ulcers: A causative agent or a predisposing factor?	Oral Dis
32564416	Altered taste in patients with COVID-19: The potential role of salivary glands.	Oral Dis
32564289	"The SARS-CoV-2 receptor, ACE-2, is expressed on many different cell types: implications for ACE-inhibitor- and angiotensin II receptor blocker-based cardiovascular therapies: comment."	Intern Emerg Med
32564072	Impact of Smoking Status on Disease Severity and Mortality of Hospitalized Patients With COVID-19 Infection: A Systematic Review and Meta-analysis.	Nicotine Tob Res
32564071	"More Than Smell-COVID-19 Is Associated With Severe Impairment of Smell, Taste, and Chemesthesis."	Chem Senses
32564046	Coronavirus SARS-Cov-2 and arterial hypertension - facts and myths.	Pol Merkur Lekarski
32564017	The Role of Genetic Sex and Mitochondria in Response to COVID-19 Infection.	Int Arch Allergy Immunol
32563999	"Origin, transmission, diagnosis and management of coronavirus disease 2019 (COVID-19)."	Postgrad Med J
32563970	Deceiving SARS-CoV-2 molecular-tropism clues - A combinational contemporary strategy.	Med Hypotheses
32563849	Surviving the storm: Dealing with COVID-19.	Cell Immunol
32563813	Synthesis of adenine dinucleosides SAM analogs as specific inhibitors of SARS-CoV nsp14 RNA cap guanine-N7-methyltransferase.	Eur J Med Chem
32563685	Contemporary and Future Concepts on Hypertension in African Americans: COVID-19 and Beyond.	J Natl Med Assoc
32563630	Consider Adjunctive Ketamine in Mechanically Ventilated Coronavirus Disease-2019 Patients.	J Cardiothorac Vasc Anesth
32563554	Should we unstress SARS-CoV-2 infected cells?	Cytokine Growth Factor Rev
32563553	COVID-19 infection may increase the risk of parkinsonism - Remember the Spanish flu?	Cytokine Growth Factor Rev
32563494	The neurological insights of the emerging coronaviruses.	J Clin Neurosci
32563282	Prognosis of patients with sickle cell disease and COVID-19: a French experience.	Lancet Haematol
32563234	"Smell and taste dysfunction in patients with SARS-CoV-2 infection: A review of epidemiology, pathogenesis, prognosis, and treatment options."	Asian Pac J Allergy Immunol
32563194	Serum Cytokine and Chemokine Profile in Relation to the Severity of Coronavirus Disease 2019 in China.	J Infect Dis
32563187	Attenuated Interferon and Proinflammatory Response in SARS-CoV-2-Infected Human Dendritic Cells Is Associated With Viral Antagonism of STAT1 Phosphorylation.	J Infect Dis
32562948	Commercial exchanges instead of air pollution as possible origin of COVID-19 initial diffusion phase in Italy: More efforts are necessary to address interdisciplinary research.	Environ Res
32562915	A new pharmacological approach based on remdesivir aerosolized administration on SARS-CoV-2 pulmonary inflammation: A possible and rational therapeutic application.	Med Hypotheses
32562913	Increased susceptibility of SARS-CoV2 infection on oral cancer patients; cause and effects: An hypothesis.	Med Hypotheses
32562911	Hypothesis for the management and treatment of the COVID-19-induced acute respiratory distress syndrome and lung injury using mesenchymal stem cell-derived exosomes.	Med Hypotheses
32562843	COVID-19 and pneumonia: a role for the uPA/uPAR system.	Drug Discov Today
32562826	Therapeutic potential of resveratrol against emerging respiratory viral infections.	Pharmacol Ther
32562764	Dual function of sialic acid in gastrointestinal SARS-CoV-2 infection.	Environ Toxicol Pharmacol
32562746	Tackle the free radicals damage in COVID-19.	Nitric Oxide
32562705	A library of nucleotide analogues terminate RNA synthesis catalyzed by polymerases of coronaviruses that cause SARS and COVID-19.	Antiviral Res
32562701	Apelin-potential therapy for COVID-19?	J Mol Cell Cardiol
32562550	COVID-19: Some clinical questions after the first 4 months.	Eur J Clin Invest
32562483	Adjunct Immunotherapies for the Management of Severely Ill COVID-19 Patients.	Cell Rep Med
32562316	A proposed role for the SARS-CoV-2 nucleocapsid protein in the formation and regulation of biomolecular condensates.	FASEB J
32562276	Statins: Could an old friend help in the fight against COVID-19?	Br J Pharmacol
32562214	"Neurological manifestations of COVID-19, SARS and MERS."	Acta Neurol Belg
32562199	Isolation and Growth Characteristics of SARS-CoV-2 in Vero Cell.	Virol Sin
32561979	Synergistic antiviral effects against SARS-CoV-2 by plant-based molecules.	Plant Cell Rep
32561913	COVID-19 and the Renin-Angiotensin-Aldosterone System.	Clin Infect Dis
32561857	Coronavirus replication factories.	Nat Rev Microbiol
32561706	"Temporal profiling of plasma cytokines, chemokines and growth factors from mild, severe and fatal COVID-19 patients."	Signal Transduct Target Ther
32561465	"Coagulopathy, thromboembolic complications, and the use of heparin in COVID-19 pneumonia."	J Vasc Surg Venous Lymphat Disord
32561291	Endoplasmic reticulum as a potential therapeutic target for covid-19 infection management?	Eur J Pharmacol
32561274	In silico prediction of potential inhibitors for the main protease of SARS-CoV-2 using molecular docking and dynamics simulation based drug-repurposing.	J Infect Public Health
32561270	Analysis of a SARS-CoV-2-Infected Individual Reveals Development of Potent Neutralizing Antibodies with Limited Somatic Mutation.	Immunity
32561269	Acute limb ischemia in COVID-19 patients: Could aortic floating thrombus be the source of embolic complications?	J Vasc Surg
32561129	Perspective on oral exfoliative cytology and COVID-19.	Oral Oncol
32560765	Cardiac involvement of COVID-19: Looking forward to novel discoveries and clinically valuable evidence.	Int J Cardiol
32560459	Role of Changes in State of Bound Water and Tissue Stiffness in Development of Age-Related Diseases.	Polymers (Basel)
32560306	Ambient Air Pollution Increases the Risk of Cerebrovascular and Neuropsychiatric Disorders through Induction of Inflammation and Oxidative Stress.	Int J Mol Sci
32560203	Quinoxaline Derivatives as Antiviral Agents: A Systematic Review.	Molecules
32559419	Therapeutic blockade of granulocyte macrophage colony-stimulating factor in COVID-19-associated hyperinflammation: challenges and opportunities.	Lancet Respir Med
32559343	Rationale for targeting complement in COVID-19.	EMBO Mol Med
32559324	Unraveling the mystery of Covid-19 cytokine storm: From skin to organ systems.	Dermatol Ther
32559285	Interferon-beta-1a Inhibition of Severe Acute Respiratory Syndrome-Coronavirus 2 In Vitro When Administered After Virus Infection.	J Infect Dis
32559180	"COVID-19 infection alters kynurenine and fatty acid metabolism, correlating with IL-6 levels and renal status."	JCI Insight
32559081	Developing a Fully Glycosylated Full-Length SARS-CoV-2 Spike Protein Model in a Viral Membrane.	J Phys Chem B
32558957	Subversion of host stress granules by coronaviruses: Potential roles of pi-rich disordered domains of viral nucleocapsids.	J Med Virol
32558946	Distinct infection process of SARS-CoV-2 in human bronchial epithelial cell lines.	J Med Virol
32558905	Renin-Angiotensin-Aldosterone Inhibitors and Susceptibility to and Severity of COVID-19.	JAMA
32558877	Association of Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use With COVID-19 Diagnosis and Mortality.	JAMA
32558697	COVID-19 and the liver: overview.	Eur J Gastroenterol Hepatol
32558696	"Covid-19 infection, liver injury and prognosis: a suggestion."	Eur J Gastroenterol Hepatol
32558641	"[Coronavirus, emerging viruses]."	Med Sci (Paris)
32558639	"Isolation, Sequence, Infectivity, and Replication Kinetics of Severe Acute Respiratory Syndrome Coronavirus 2."	Emerg Infect Dis
32558620	COVID-19-associated coagulopathy: An exploration of mechanisms.	Vasc Med
32558485	Genomewide Association Study of Severe Covid-19 with Respiratory Failure.	N Engl J Med
32558474	Amplifying RNA Vaccine Development.	N Engl J Med
32558435	Rationale for Evaluating PDE4 Inhibition for Mitigating against Severe Inflammation in COVID-19 Pneumonia and Beyond.	Isr Med Assoc J
32558308	Genetic variability of human angiotensin-converting enzyme 2 (hACE2) among various ethnic populations.	Mol Genet Genomic Med
32558172	SARS-CoV-2 as possible inducer of viral reactivations.	Dermatol Ther
32558150	Individual variation of the SARS-CoV-2 receptor ACE2 gene expression and regulation.	Aging Cell
32558055	SARS CoV-2 aggravates cellular metabolism mediated complications in COVID-19 infection.	Dermatol Ther
32557955	Targeting the interleukin-17 pathway to prevent acute respiratory distress syndrome associated with SARS-CoV-2 infection.	Respirology
32557557	Harnessing inflammation resolving-based therapeutic agents to treat pulmonary viral infections: What can the future offer to COVID-19?	Br J Pharmacol
32557405	Recognition of Natural Products as Potential Inhibitors of COVID-19 Main Protease (Mpro): In-Silico Evidences.	Nat Prod Bioprospect
32557332	COVID-19 and the elderly: insights into pathogenesis and clinical decision-making.	Aging Clin Exp Res
32557271	Possible role of vitamin D in Covid-19 infection in pediatric population.	J Endocrinol Invest
32557270	Conditionally Reprogrammed Human Normal Airway Epithelial Cells at ALI: A Physiological Model for Emerging Viruses.	Virol Sin
32557214	"Potential Role of Anti-interleukin (IL)-6 Drugs in the Treatment of COVID-19: Rationale, Clinical Evidence and Risks."	BioDrugs
32557011	A Double-Edged Sword-Cardiovascular Concerns of Potential Anti-COVID-19 Drugs.	Cardiovasc Drugs Ther
32556942	Severe COVID-19 and aging: are monocytes the key?	Geroscience
32556599	Full genome sequence of the first SARS-CoV-2 detected in Mexico.	Arch Virol
32556101	The renin-angiotensin system: An integrated view of lung disease and coagulopathy in COVID-19 and therapeutic implications.	J Exp Med
32556089	Anosmia in COVID-19: Mechanisms and Significance.	Chem Senses
32555983	Severity of COVID-19 and diabetes mellitus: there is still a lot to be learned.	Arch Endocrinol Metab
32555974	Fighting COVID-19.	Braz J Biol
32555563	[Coagulopathy in COVID-19: pathophysiology].	G Ital Cardiol (Rome)
32555547	Severe COVID-19 in the young and healthy: monogenic inborn errors of immunity?	Nat Rev Immunol
32555424	Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections.	Nat Med
32555413	A new normal for hypertension medicine with coronavirus disease-2019 (COVID-19): proposal from the president of the Japanese Society of Hypertension.	Hypertens Res
32555321	The ORF3a protein of SARS-CoV-2 induces apoptosis in cells.	Cell Mol Immunol
32555182	Cryo-EM structures of HKU2 and SADS-CoV spike glycoproteins provide insights into coronavirus evolution.	Nat Commun
32555145	Targeting the entry step of SARS-CoV-2: a promising therapeutic approach.	Signal Transduct Target Ther
32554953	Can mesenchymal stem cell therapy be the interim management of COVID-19?	Drug Discov Ther
32554923	The complement system in COVID-19: friend and foe?	JCI Insight
32554697	Inactivating Three Interferon Antagonists Attenuates Pathogenesis of an Enteric Coronavirus.	J Virol
32554538	Endothelial cell dysfunction: a major player in SARS-CoV-2 infection (COVID-19)?	Eur Respir J
32554535	Potential role of memantine in the prevention and treatment of COVID-19: its antagonism of nicotinic acetylcholine receptors and beyond.	Eur Respir J
32554532	Thrombosis and COVID-19 pneumonia: the clot thickens!	Eur Respir J
32554478	Locus CauMT1 Provides a Higher-Resolution Alternative to Ribosomal Gene Sequencing for Initial Candida auris Genotyping.	J Clin Microbiol
32554340	The COVID-19 pandemic: is there a role for magnesium? Hypotheses and perspectives.	Magnes Res
32554251	"Protection against COVID-19 injury by qingfei paidu decoction via anti-viral, anti-inflammatory activity and metabolic programming."	Biomed Pharmacother
32554149	Aminoglycosides can be a better choice over macrolides in COVID-19 regimen: Plausible mechanism for repurposing strategy.	Med Hypotheses
32553928	"Potential inhibitors of the interaction between ACE2 and SARS-CoV-2 (RBD), to develop a drug."	Life Sci
32553760	TNFalpha-Antagonist Use and Mucosal Inflammation Are Associated with Increased Intestinal Expression of SARS-CoV-2 Host Protease TMPRSS2 in Patients with Inflammatory Bowel Disease.	Gastroenterology
32553757	Aminosalicylates and COVID-19: Facts or Coincidences?	Gastroenterology
32553716	Multisystem Inflammatory Syndrome in Children (MIS-C) with COVID-19: Insights from simultaneous familial Kawasaki Disease cases.	Int J Infect Dis
32553588	Very low reporting rate of connective tissue diseases among coronavirus disease 2019 (Covid-19) patients and the renin-angiotensin system - An overlooked association?	Eur J Intern Med
32553545	In Vitro and Animal Models for SARS-CoV-2 research.	Trends Pharmacol Sci
32553503	Drugs acting on renin angiotensin system and use in ill patients with COVID-19.	Therapie
32553273	A SARS-CoV-2 Infection Model in Mice Demonstrates Protection by Neutralizing Antibodies.	Cell
32553163	Modulation of Extracellular ISG15 Signaling by Pathogens and Viral Effector Proteins.	Cell Rep
32552865	The unique characteristics of COVID-19 coagulopathy.	Crit Care
32552811	E-cigarette-induced pulmonary inflammation and dysregulated repair are mediated by nAChR alpha7 receptor: role of nAChR alpha7 in SARS-CoV-2 Covid-19 ACE2 receptor regulation.	Respir Res
32552642	Facts and Myths: Efficacies of Repurposing Chloroquine and Hydroxychloroquine for the Treatment of COVID-19.	Curr Drug Targets
32552595	Natural compounds from Clerodendrum spp. as possible therapeutic candidates against SARS-CoV-2: An in silico investigation.	J Biomol Struct Dyn
32552534	"Identification of a novel dual-target scaffold for 3CLpro and RdRp proteins of SARS-CoV-2 using 3D-similarity search, molecular docking, molecular dynamics and ADMET evaluation."	J Biomol Struct Dyn
32552462	Identification of bioactive compounds from Glycyrrhiza glabra as possible inhibitor of SARS-CoV-2 spike glycoprotein and non-structural protein-15: a pharmacoinformatics study.	J Biomol Struct Dyn
32552361	Combined drug repurposing and virtual screening strategies with molecular dynamics simulation identified potent inhibitors for SARS-CoV-2 main protease (3CLpro).	J Biomol Struct Dyn
32552307	A rationale for blocking thromboinflammation in COVID-19 with Btk inhibitors.	Platelets
32551880	Involvement of Cisgender and Transgender Individuals in Studies on the Impact of Hormonal Therapy on COVID-19.	AIDS Patient Care STDS
32551862	Novel insights on the pulmonary vascular consequences of COVID-19.	Am J Physiol Lung Cell Mol Physiol
32551855	Effects of Gene-Eden-VIR and Novirin on SARS-CoV: Implications for COVID-19.	J Evid Based Integr Med
32551795	Coronaviruses.	Acta Virol
32551792	Coronavirus disease 2019: A new severe acute respiratory syndrome from Wuhan in China.	Acta Virol
32551679	Cellular Nanosponges Inhibit SARS-CoV-2 Infectivity.	Nano Lett
32551652	Critical Differences between the Binding Features of the Spike Proteins of SARS-CoV-2 and SARS-CoV.	J Phys Chem B
32551648	The Discovery of a Putative Allosteric Site in the SARS-CoV-2 Spike Protein Using an Integrated Structural/Dynamic Approach.	J Proteome Res
32551639	"Discovery of New Hydroxyethylamine Analogs against 3CL(pro) Protein Target of SARS-CoV-2: Molecular Docking, Molecular Dynamics Simulation, and Structure-Activity Relationship Studies."	J Chem Inf Model
32551560	Discovery of Aptamers Targeting the Receptor-Binding Domain of the SARS-CoV-2 Spike Glycoprotein.	Anal Chem
32551464	Dexamethasone for COVID-19? Not so fast.	J Biol Regul Homeost Agents
32551456	Use of Spironolactone in SARS-CoV-2 ARDS Patients.	Turk J Anaesthesiol Reanim
32550783	Coronavirus Disease 2019 (COVID-19) From the Point of View of Neurologists: Observation of Neurological Findings and Symptoms During the Combat Against a Pandemic.	Noro Psikiyatr Ars
32550259	Coronavirus disease 2019 and cardiovascular system: A narrative review.	Int J Cardiol Heart Vasc
32550069	Anticoagulation Options for Coronavirus Disease 2019 (COVID-19)-Induced Coagulopathy.	Cureus
32550040	Role and mechanism of angiotensin-converting enzyme 2 in acute lung injury in coronavirus disease 2019.	Chronic Dis Transl Med
32549229	Endotheliitis and Endothelial Dysfunction in Patients with COVID-19: Its Role in Thrombosis and Adverse Outcomes.	J Clin Med
32549200	A Putative Role of de-Mono-ADP-Ribosylation of STAT1 by the SARS-CoV-2 Nsp3 Protein in the Cytokine Storm Syndrome of COVID-19.	Viruses
32549125	Do sex-specific immunobiological factors and differences in angiotensin converting enzyme 2 (ACE2) expression explain increased severity and mortality of COVID-19 in males?	Diagnosis (Berl)
32549071	The SARS-CoV-2 Coronavirus and the COVID-19 Outbreak.	Int Braz J Urol
32548750	"The ""Three Italy"" of the COVID-19 epidemic and the possible involvement of SARS-CoV-2 in triggering complications other than pneumonia."	J Neurovirol
32548551	COVID-19 hypothesis: Activated protein C for therapy of virus-induced pathologic thromboinflammation.	Res Pract Thromb Haemost
32548259	Squalene-based multidrug nanoparticles for improved mitigation of uncontrolled inflammation in rodents.	Sci Adv
32547908	Ultraviolet irradiation doses for coronavirus inactivation - review and analysis of coronavirus photoinactivation studies.	GMS Hyg Infect Control
32547891	Computational analysis of microRNA-mediated interactions in SARS-CoV-2 infection.	PeerJ
32547890	Contributions of Latin American researchers in the understanding of the novel coronavirus outbreak: a literature review.	PeerJ
32547788	Off-label therapy targeting pathogenic inflammation in COVID-19.	Cell Death Discov
32547717	Management of hypertension in COVID-19.	World J Cardiol
32547694	Blocking Coronavirus 19 Infection via the SARS-CoV-2 Spike Protein: Initial Steps.	ACS Med Chem Lett
32547693	A Role for Metal-Based Drugs in Fighting COVID-19 Infection? The Case of Auranofin.	ACS Med Chem Lett
32547039	Influence of COVID-19 on Cerebrovascular Disease and its Possible Mechanism.	Neuropsychiatr Dis Treat
32546853	Understanding SARS-CoV-2-related multisystem inflammatory syndrome in children.	Nat Rev Immunol
32546835	Immune checkpoint blockade: releasing the breaks or a protective barrier to COVID-19 severe acute respiratory syndrome?	Br J Cancer
32546764	Immunity-and-matrix-regulatory cells derived from human embryonic stem cells safely and effectively treat mouse lung injury and fibrosis.	Cell Res
32546188	The vascular endothelium: the cornerstone of organ dysfunction in severe SARS-CoV-2 infection.	Crit Care
32546047	Ig-like ACE2 protein therapeutics: A revival in development during the COVID-19 pandemic.	MAbs
32546018	The broad-spectrum antiviral recommendations for drug discovery against COVID-19.	Drug Metab Rev
32545799	Potential Antiviral Options against SARS-CoV-2 Infection.	Viruses
32545714	Reaction Cycles of Halogen Species in the Immune Defense: Implications for Human Health and Diseases and the Pathology and Treatment of COVID-19.	Cells
32545518	Nrf2 Activator PB125((R)) as a Potential Therapeutic Agent against COVID-19.	Antioxidants (Basel)
32545271	Relative Abundance of SARS-CoV-2 Entry Genes in the Enterocytes of the Lower Gastrointestinal Tract.	Genes (Basel)
32545268	Potential of Flavonoid-Inspired Phytomedicines against COVID-19.	Molecules
32544884	De novo design of protein peptides to block association of the SARS-CoV-2 spike protein with human ACE2.	Aging (Albany NY)
32544615	The role of extracellular vesicles in COVID-19 virus infection.	Infect Genet Evol
32544611	Development of child immunity in the context of COVID-19 pandemic.	Clin Immunol
32544566	"ACE2 and TMPRSS2 are expressed on the human ocular surface, suggesting susceptibility to SARS-CoV-2 infection."	Ocul Surf
32544563	COVID-19 cytokine storm: The anger of inflammation.	Cytokine
32544437	Pangolins Harbor SARS-CoV-2-Related Coronaviruses.	Trends Microbiol
32544429	"Insights into SARS-CoV-2 genome, structure, evolution, pathogenesis and therapies: Structural genomics approach."	Biochim Biophys Acta Mol Basis Dis
32544372	Potent neutralization of SARS-CoV-2 by human antibody heavy-chain variable domains isolated from a large library with a new stable scaffold.	MAbs
32544259	Is herpes zoster being an indicator for COVID 19 infection?	Dermatol Ther
32544216	COVID-19 and Crosstalk With the Hallmarks of Aging.	J Gerontol A Biol Sci Med Sci
32544024	An in silico approach for identification of novel inhibitors as potential therapeutics targeting COVID-19 main protease.	J Biomol Struct Dyn
32543978	Computational investigation on Andrographis paniculata phytochemicals to evaluate their potency against SARS-CoV-2 in comparison to known antiviral compounds in drug trials.	J Biomol Struct Dyn
32543892	"Development of a simple, interpretable and easily transferable QSAR model for quick screening antiviral databases in search of novel 3C-like protease (3CLpro) enzyme inhibitors against SARS-CoV diseases."	SAR QSAR Environ Res
32543740	Dysregulation of the immune response affects the outcome of critical COVID-19 patients.	J Med Virol
32543705	Evolutionary relationships and sequence-structure determinants in human SARS coronavirus-2 spike proteins for host receptor recognition.	Proteins
32543703	"SARS-CoV2 may evade innate immune response, causing uncontrolled neutrophil extracellular traps formation and multi-organ failure."	Clin Sci (Lond)
32543691	Genetic Analysis Tracks SARS-CoV-2 Mutations in Human Hosts.	JAMA
32543353	SARS-CoV-2 genomic surveillance in Taiwan revealed novel ORF8-deletion mutant and clade possibly associated with infections in Middle East.	Emerg Microbes Infect
32543348	Virus strain from a mild COVID-19 patient in Hangzhou represents a new trend in SARS-CoV-2 evolution potentially related to Furin cleavage site.	Emerg Microbes Infect
32543296	Psoriasis and risk of the COVID-19: is there a role for angiotensin converting enzyme (ACE)?	J Dermatolog Treat
32542964	Treatment of COVID 19-Repurposing drugs commonly used in dermatology.	Dermatol Ther
32542883	COVID-19 and maternal pre-eclampsia: A synopsis.	Scand J Immunol
32542802	COVID-19: The heart of the issue.	J Card Surg
32542735	An updated review of the association of host genetic factors with susceptibility and resistance to COVID-19.	J Cell Physiol
32542716	Effective coronavirus reduction by various production steps during the manufacture of plasma-derived medicinal products.	Transfusion
32542429	Worldwide ACE (I/D) polymorphism may affect COVID-19 recovery rate: an ecological meta-regression.	Endocrine
32542396	Decoy ACE2-expressing extracellular vesicles that competitively bind SARS-CoV-2 as a possible COVID-19 therapy.	Clin Sci (Lond)
32542337	A systematic review and meta-analysis to evaluate the clinical outcomes in COVID-19 patients on angiotensin-converting enzyme inhibitors or angiotensin receptor blockers.	Eur Heart J Cardiovasc Pharmacother
32542210	The contact activation system as a potential therapeutic target in patients with COVID-19.	Res Pract Thromb Haemost
32541908	Modeling SARS-CoV-2 infection in mice.	Lab Anim (NY)
32541865	"Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease."	Cell Res
32541836	Systemically comparing host immunity between survived and deceased COVID-19 patients.	Cell Mol Immunol
32541255	Revisiting the Protein C Pathway: An Opportunity for Adjunctive Intervention in COVID-19?	Anesth Analg
32541247	"Hypotension, Systemic Inflammatory Response Syndrome, and COVID-19: A Clinical Conundrum."	Anesth Analg
32540904	Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies.	Science
32540903	Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model.	Science
32540901	Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail.	Science
32540900	Broad neutralization of SARS-related viruses by human monoclonal antibodies.	Science
32540792	Eosinophil Response Against Classical and Emerging Respiratory Viruses: COVID-19.	J Investig Allergol Clin Immunol
32540737	Use of pioglitazone in people with type 2 diabetes mellitus with coronavirus disease 2019 (COVID-19): Boon or bane?	Diabetes Metab Syndr
32540605	Activated macrophages are the main inflammatory cell in COVID-19 interstitial pneumonia infiltrates. Is it possible to show their metabolic activity and thus the grade of inflammatory burden with (18)F-Fluorocholine PET/CT?	Med Hypotheses
32540603	Repositioning of pentoxifylline as an immunomodulator and regulator of the renin-angiotensin system in the treatment of COVID-19.	Med Hypotheses
32540495	Molecular conservation and differential mutation on ORF3a gene in Indian SARS-CoV2 genomes.	Genomics
32540458	Elevated nucleoprotein-induced interferon-gamma release in COVID-19 patients detected in a SARS-CoV-2 enzyme-linked immunosorbent spot assay.	J Infect
32540428	Eltrombopag is a potential target for drug intervention in SARS-CoV-2 spike protein.	Infect Genet Evol
32540326	Letter to the Editor: CoVid-19 and type 1 diabetes: Every cloud has a silver lining. Searching the reason of a lower aggressiveness of the CoronaVirus disease in type 1 diabetes.	Diabetes Res Clin Pract
32540268	COVID-19 and Kidney Disease: Molecular Determinants and Clinical Implications in Renal Cancer.	Eur Urol Focus
32539627	Lung under attack by COVID-19-induced cytokine storm: pathogenic mechanisms and therapeutic implications.	Ther Adv Respir Dis
32539537	Why COVID-19 Silent Hypoxemia Is Baffling to Physicians.	Am J Respir Crit Care Med
32539378	Inhibitors of SARS-CoV-2 Entry: Current and Future Opportunities.	J Med Chem
32539372	Fragment Molecular Orbital Based Interaction Analyses on COVID-19 Main Protease - Inhibitor N3 Complex (PDB ID: 6LU7).	J Chem Inf Model
32538857	Neurobiology of COVID-19.	J Alzheimers Dis
32538855	Potential Novel Role of COVID-19 in Alzheimer's Disease and Preventative Mitigation Strategies.	J Alzheimers Dis
32538775	"Combating sars-cov-2 through lipoxins, proteasome, caveolin and nuclear factor-kappab pathways in non-pregnant and pregnant populations."	Cell Mol Biol (Noisy-le-grand)
32538738	Molecular simulation of SARS-CoV-2 spike protein binding to pangolin ACE2 or human ACE2 natural variants reveals altered susceptibility to infection.	J Gen Virol
32538276	Repurposing cefuroxime for treatment of COVID-19: a scoping review of in silico studies.	J Biomol Struct Dyn
32537960	A Pathophysiological Perspective on COVID-19's Lethal Complication: From Viremia to Hypersensitivity Pneumonitis-like Immune Dysregulation.	Infect Chemother
32537610	Inhibition of metalloproteinases in therapy for severe lung injury due to COVID-19.	Med Drug Discov
32537482	Screening and druggability analysis of some plant metabolites against SARS-CoV-2: An integrative computational approach.	Inform Med Unlocked
32537481	EML webinar overview: Simulation-assisted discovery of membrane targeting nanomedicine.	Extreme Mech Lett
32537478	"Airways Expression of SARS-CoV-2 Receptor, ACE2, and TMPRSS2 Is Lower in Children Than Adults and Increases with Smoking and COPD."	Mol Ther Methods Clin Dev
32537248	Mechanisms of Myocardial Injury in Coronavirus Disease 2019.	Card Fail Rev
32537129	"Rethinking COVID-19 'pneumonia' - is this primarily a vaso-occlusive disease, and can early anticoagulation save the ventilator famine?"	Pulm Circ
32536978	Dilated Cardiomyopathy Risk in Patients with Coronavirus Disease 2019: How to Identify and Characterise it Early?	Eur Cardiol
32536965	Mechanism of Dayuanyin in the treatment of coronavirus disease 2019 based on network pharmacology and molecular docking.	Chin Med
32536670	"Uric Acid Elevation by Favipiravir, an Antiviral Drug."	Tohoku J Exp Med
32536632	Potential for jaktinib hydrochloride to treat cytokine storms in patients with COVID-19.	Biosci Trends
32536564	IL-15 immunotherapy is a viable strategy for COVID-19.	Cytokine Growth Factor Rev
32536457	Should We Try SARS-CoV-2 Helicase Inhibitors for COVID-19 Therapy?	Arch Med Res
32536226	Ten challenging questions about SARS-CoV-2 and COVID-19.	Expert Rev Respir Med
32536162	Role of RNA Guanine Quadruplexes in Favoring the Dimerization of SARS Unique Domain in Coronaviruses.	J Phys Chem Lett
32535979	The red half-moon nail sign: a novel manifestation of coronavirus infection.	J Eur Acad Dermatol Venereol
32535955	A compendium answering 150 questions on COVID-19 and SARS-CoV-2.	Allergy
32535752	Cardiovascular Implications and Therapeutic Considerations in COVID-19 Infection.	Cardiol Ther
32535732	IL-6 Inhibitors in the Treatment of Serious COVID-19: A Promising Therapy?	Pharmaceut Med
32535705	Is Hypertension a Real Risk Factor for Poor Prognosis in the COVID-19 Pandemic?	Curr Hypertens Rep
32535456	Natural RNA dependent RNA polymerase inhibitors: Molecular docking studies of some biologically active alkaloids of Argemone mexicana.	Med Hypotheses
32535232	Mechanisms involved in the development of thrombocytopenia in patients with COVID-19.	Thromb Res
32535231	Putative Mechanisms of Diarrhea in COVID-19.	Clin Gastroenterol Hepatol
32535228	Structural analysis of the putative SARS-CoV-2 primase complex.	J Struct Biol
32535155	The stress-inducible molecular chaperone GRP78 as potential therapeutic target for coronavirus infection.	J Infect
32535148	Low risk for SARS-CoV2 symptomatic infection and early complications in paediatric patients during the ongoing CoVID19 epidemics in Lombardy.	Clin Microbiol Infect
32535095	Molecular mimicry may explain multi-organ damage in COVID-19.	Autoimmun Rev
32535093	Covid-19 and autoimmunity.	Autoimmun Rev
32535080	"Virtual screening, ADME/Tox predictions and the drug repurposing concept for future use of old drugs against the COVID-19."	Life Sci
32535078	Vaccination strategies to combat novel corona virus SARS-CoV-2.	Life Sci
32535032	Vitamin D receptor stimulation to reduce acute respiratory distress syndrome (ARDS) in patients with coronavirus SARS-CoV-2 infections: Revised Ms SBMB 2020_166.	J Steroid Biochem Mol Biol
32534947	COVID-19: Do not be phobic from fever.	J Infect Public Health
32534944	Influence of NAD+ as an ageing-related immunomodulator on COVID 19 infection: A hypothesis.	J Infect Public Health
32534867	Sequence homology between human PARP14 and the SARS-CoV-2 ADP ribose 1'-phosphatase.	Immunol Lett
32534506	Bradykinin as a Probable Aspect in SARS-Cov-2 Scenarios: Is Bradykinin Sneaking out of Our Sight?	Iran J Allergy Asthma Immunol
32534505	"Sitagliptin Repositioning in SARS-CoV-2: Effects on ACE-2, CD-26, and Inflammatory Cytokine Storms in the Lung."	Iran J Allergy Asthma Immunol
32534467	Cytokine storm and leukocyte changes in mild versus severe SARS-CoV-2 infection: Review of 3939 COVID-19 patients in China and emerging pathogenesis and therapy concepts.	J Leukoc Biol
32534451	Microdose lithium reduces cellular senescence in human astrocytes - a potential pharmacotherapy for COVID-19?	Aging (Albany NY)
32534341	Could the decrease in the endothelial nitric oxide (NO) production and NO bioavailability be the crucial cause of COVID-19 related deaths?	Med Hypotheses
32534340	The intriguing commonality of NETosis between COVID-19 & Periodontal disease.	Med Hypotheses
32534337	Diacerein: A potential multi-target therapeutic drug for COVID-19.	Med Hypotheses
32534336	COVID-19 & Periodontitis: The cytokine connection.	Med Hypotheses
32534328	COVID-19 and thrombotic complications: Pulmonary thrombosis rather than embolism?	Thromb Res
32534226	Monoclonal antibody as a potential anti-COVID-19.	Biomed Pharmacother
32534187	Potential of coronavirus 3C-like protease inhibitors for the development of new anti-SARS-CoV-2 drugs: Insights from structures of protease and inhibitors.	Int J Antimicrob Agents
32534109	Involvement of cardiovascular system as the critical point in coronavirus disease 2019 (COVID-19) prognosis and recovery.	Hellenic J Cardiol
32534022	Coronavirus disease 2019 and allergen immunotherapy: Theoretical benefits invite to adjustments in practice recommendations.	Ann Allergy Asthma Immunol
32534021	The absence of coronavirus in expressed prostatic secretion in COVID-19 patients in Wuhan city.	Reprod Toxicol
32533990	Is metformin ahead in the race as a repurposed host-directed therapy for patients with diabetes and COVID-19?	Diabetes Res Clin Pract
32533988	COVID19 in South Asians/Asian Indians: Heterogeneity of data and implications for pathophysiology and research.	Diabetes Res Clin Pract
32533838	The pathological autopsy of coronavirus disease 2019 (COVID-2019) in China: a review.	Pathog Dis
32533756	Physiological advantages of children against COVID-19.	Acta Paediatr
32533292	Targeting the immunology of coronavirus disease-19: synchronization creates symphony.	Rheumatol Int
32533263	Intracellular ABCB1 as a Possible Mechanism to Explain the Synergistic Effect of Hydroxychloroquine-Azithromycin Combination in COVID-19 Therapy.	AAPS J
32533111	A versatile mouse model of COVID-19.	Nat Rev Immunol
32533110	SARS-CoV-2 has a sweet tooth.	Nat Rev Immunol
32533071	Ivermectin: a systematic review from antiviral effects to COVID-19 complementary regimen.	J Antibiot (Tokyo)
32533062	Overview of lethal human coronaviruses.	Signal Transduct Target Ther
32532959	The role of furin cleavage site in SARS-CoV-2 spike protein-mediated membrane fusion in the presence or absence of trypsin.	Signal Transduct Target Ther
32532933	"Emerging coronaviruses: first SARS, second MERS and third SARS-CoV-2: epidemiological updates of COVID-19."	Infez Med
32532805	Thrombotic complications of COVID-19 may reflect an upregulation of endothelial tissue factor expression that is contingent on activation of endosomal NADPH oxidase.	Open Heart
32532758	Hypothesis to explain the severe form of COVID-19 in Northern Italy.	BMJ Glob Health
32532524	SARS-CoV-2-A Tough Opponent for the Immune System.	Arch Med Res
32532449	Part I. SARS-CoV-2 triggered 'PANIC' attack in severe COVID-19.	J Neurol Sci
32532094	The Anticoagulant Nafamostat Potently Inhibits SARS-CoV-2 S Protein-Mediated Fusion in a Cell Fusion Assay System and Viral Infection In Vitro in a Cell-Type-Dependent Manner.	Viruses
32532085	Broad-Spectrum Host-Based Antivirals Targeting the Interferon and Lipogenesis Pathways as Potential Treatment Options for the Pandemic Coronavirus Disease 2019 (COVID-19).	Viruses
32531935	Chronic Inflammation in the Context of Everyday Life: Dietary Changes as Mitigating Factors.	Int J Environ Res Public Health
32531539	"Intra-abdominal hypertension as a trigger of ""gut failure"" in SARS-CoV-2 infection: Effect of open abdomen (OA) and negative pressure therapy (NPT) on respiratory and gastrointestinal (GI) function."	Med Hypotheses
32531538	Is hesperidin essential for prophylaxis and treatment of COVID-19 Infection?	Med Hypotheses
32531537	RAGE receptor: May be a potential inflammatory mediator for SARS-COV-2 infection?	Med Hypotheses
32531372	Expression of SARS-CoV-2 receptor ACE2 and coincident host response signature varies by asthma inflammatory phenotype.	J Allergy Clin Immunol
32531256	Cytokine storm induced by SARS-CoV-2.	Clin Chim Acta
32531235	Role of the GTNGTKR motif in the N-terminal receptor-binding domain of the SARS-CoV-2 spike protein.	Virus Res
32531208	Structural and Biochemical Characterization of the nsp12-nsp7-nsp8 Core Polymerase Complex from SARS-CoV-2.	Cell Rep
32531174	New Insights for the Pathogenesis of COVID-19-Related Dysgeusia.	J Dent Res
32531085	C1 esterase inhibitor and the contact system in COVID-19.	Br J Haematol
32531040	Association between renin-angiotensin system inhibitors and COVID-19 complications.	Eur Heart J Cardiovasc Pharmacother
32531002	Pancreatic involvement in SARS-CoV-2: case report and living review.	J Gastrointestin Liver Dis
32530870	Rapid Review: Nonsteroidal Anti-inflammatory Agents and Aminosalicylates in COVID-19 Infections.	J Clin Gastroenterol
32530714	Cigarette Smoking and COVID-19: A Complex Interaction.	Am J Respir Crit Care Med
32530597	Happy Hypoxemia in COVID-19-A Neural Hypothesis.	ACS Chem Neurosci
32530438	New (re)purpose for an old drug: purinergic modulation may extinguish the COVID-19 thromboinflammatory firestorm.	JCI Insight
32530389	SARS-CoV-2 infection of the nervous system: A review of the literature on neurological involvement in novel coronavirus disease-(COVID-19).	Bosn J Basic Med Sci
32530284	"Decoding SARS-CoV-2 Transmission and Evolution and Ramifications for COVID-19 Diagnosis, Vaccine, and Medicine."	J Chem Inf Model
32530282	Computational Determination of Potential Inhibitors of SARS-CoV-2 Main Protease.	J Chem Inf Model
32529952	"SARS-CoV-2 nsp13, nsp14, nsp15 and orf6 function as potent interferon antagonists."	Emerg Microbes Infect
32529866	Covid-19: a comprehensive review of a formidable foe and the road ahead.	Expert Rev Respir Med
32529795	Detection of viral SARS-CoV-2 genomes and histopathological changes in endomyocardial biopsies.	ESC Heart Fail
32529643	Mechanisms and evidence of vertical transmission of infections in pregnancy including SARS-CoV-2s.	Prenat Diagn
32529575	Clinical manifestations and evidence of neurological involvement in 2019 novel coronavirus SARS-CoV-2: a systematic review and meta-analysis.	J Neurol
32529545	Natural Products as Potential Leads Against Coronaviruses: Could They be Encouraging Structural Models Against SARS-CoV-2?	Nat Prod Bioprospect
32529517	"Venous Thromboembolism in COVID-19: Towards an Ideal Approach to Thromboprophylaxis, Screening, and Treatment."	Curr Cardiol Rep
32529477	"The possible pathophysiology mechanism of cytokine storm in elderly adults with COVID-19 infection: the contribution of ""inflame-aging""."	Inflamm Res
32529462	May the Central Nervous System Be Fogged by the Cytokine Storm in COVID-19?: an Appraisal.	J Neuroimmune Pharmacol
32529218	Statin therapy in COVID-19 infection: much more than a single pathway.	Eur Heart J Cardiovasc Pharmacother
32529116	Chemistry and Biology of SARS-CoV-2.	Chem
32529041	Comparisons of Staphylococcus aureus infection and other outcomes between users of angiotensin-converting-enzyme inhibitors and angiotensin II receptor blockers: lessons for COVID-19 from a nationwide cohort study.	Wellcome Open Res
32528815	Genome-Wide Identification and Characterization of Point Mutations in the SARS-CoV-2 Genome.	Osong Public Health Res Perspect
32528725	"Single-copy sensitive, field-deployable, and simultaneous dual-gene detection of SARS-CoV-2 RNA via modified RT-RPA."	Cell Discov
32528233	SARS-CoV-2 COVID-19 susceptibility and lung inflammatory storm by smoking and vaping.	J Inflamm (Lond)
32528138	COVID-19 and the liver-related deaths to come.	Nat Rev Gastroenterol Hepatol
32528136	Considering how biological sex impacts immune responses and COVID-19 outcomes.	Nat Rev Immunol
32528128	"Bat-borne virus diversity, spillover and emergence."	Nat Rev Microbiol
32527987	Potential mechanisms of hemorrhagic stroke in elderly COVID-19 patients.	Aging (Albany NY)
32527928	Type I and III interferons disrupt lung epithelial repair during recovery from viral infection.	Science
32527925	Type III interferons disrupt the lung epithelial barrier upon viral recognition.	Science
32527802	The receptor binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients.	Sci Immunol
32527780	Complete Genome Sequence of a Novel Coronavirus (SARS-CoV-2) Isolate from Bangladesh.	Microbiol Resour Announc
32527763	Should interferons take front stage as an essential MS disease-modifying therapy in the era of coronavirus disease 2019?	Neurol Neuroimmunol Neuroinflamm
32527756	Endocrine changes in SARS-CoV-2 patients and lessons from SARS-CoV.	Postgrad Med J
32527713	In Silico computational screening of Kabasura Kudineer - Official Siddha Formulation and JACOM against SARS-CoV-2 spike protein.	J Ayurveda Integr Med
32527699	[The RAAS and SARS-CoV-2: A riddle to solve].	Hipertens Riesgo Vasc
32527617	Tracking the Genomic Footprints of SARS-CoV-2 Transmission.	Trends Genet
32527570	SARS-CoV-2 in upper and lower airway samples of a laryngectomized patient: New insights and many lessons.	Oral Oncol
32527073	Cerebrovascular events in COVID-19 patients.	Monaldi Arch Chest Dis
32526960	Immunoinformatics and Structural Analysis for Identification of Immunodominant Epitopes in SARS-CoV-2 as Potential Vaccine Targets.	Vaccines (Basel)
32526937	Analysis of the Hosts and Transmission Paths of SARS-CoV-2 in the COVID-19 Outbreak.	Genes (Basel)
32526773	Impaired Breakdown of Bradykinin and Its Metabolites as a Possible Cause for Pulmonary Edema in COVID-19 Infection.	Semin Thromb Hemost
32526763	COVID-19 Experience in Hemodialysis Patients: A Cue for Therapeutic Heparin-Based Strategies?	Nephron
32526511	A potential role for cyclophosphamide in the mitigation of acute respiratory distress syndrome among patients with SARS-CoV-2.	Med Hypotheses
32526509	Could MEFV mutation carriage status have a protective role for COVID-19 pandemic?	Med Hypotheses
32526483	COVID 19 and brain crosstalks.	Clin Neurol Neurosurg
32526370	What is the potential function of microRNAs as biomarkers and therapeutic targets in COVID-19?	Infect Genet Evol
32526282	Computational modelling of flavivirus dynamics: The ins and outs.	Methods
32526273	A plea for the pathogenic role of immune complexes in severe Covid-19.	Clin Immunol
32526208	Structural Basis for RNA Replication by the SARS-CoV-2 Polymerase.	Cell
32526206	SARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in the Respiratory Tract.	Cell
32526191	Pathologists in pursuit of the COVID-19 culprit.	Lancet Infect Dis
32526061	Targeting the NO-cGMP-PDE5 pathway in COVID-19 infection. The DEDALO project.	Andrology
32526060	What did we learn from the previous coronavirus epidemics and what can we do better: a neuroinfectiological point of view.	Eur J Neurol
32526012	ACE2 Expression Is Increased in the Lungs of Patients With Comorbidities Associated With Severe COVID-19.	J Infect Dis
32525813	Renin-angiotensin system and SARS-CoV-2 interaction: underlying mechanisms and potential clinical implications.	Gen Physiol Biophys
32525765	Genetic cluster analysis of SARS-CoV-2 and the identification of those responsible for the major outbreaks in various countries.	Emerg Microbes Infect
32525657	Proinflammatory Cytokines in the Olfactory Mucosa Result in COVID-19 Induced Anosmia.	ACS Chem Neurosci
32525650	Targeting SARS-CoV-2: Novel Source of Antiviral Compound(s) against COVID-19?	ACS Chem Neurosci
32525644	Three Hypotheses About Children COVID19.	Pediatr Infect Dis J
32525600	"Genetic gateways to COVID-19 infection: Implications for risk, severity, and outcomes."	FASEB J
32525575	The possible impairment of respiratory-related neural loops may be associated with the silent pneumonia induced by SARS-CoV-2.	J Med Virol
32525565	Elevated expression of ACE2 in tumor-adjacent normal tissues of cancer patients.	Int J Cancer
32525548	"Assessment of Hypokalemia and Clinical Characteristics in Patients With Coronavirus Disease 2019 in Wenzhou, China."	JAMA Netw Open
32525005	"Effective block by pirfenidone, an antifibrotic pyridone compound (5-methyl-1-phenylpyridin-2[H-1]-one), on hyperpolarization-activated cation current: An additional but distinctive target."	Eur J Pharmacol
32524946	"Genetic structure of SARS-CoV-2 reflects clonal superspreading and multiple independent introduction events, North-Rhine Westphalia, Germany, February and March 2020."	Euro Surveill
32524843	Focus on the 2019 novel coronavirus (SARS-CoV-2).	Future Microbiol
32524732	Worse progression of COVID-19 in men: Is testosterone a key factor?	Andrology
32524333	COVID 19: a clue from innate immunity.	Immunol Res
32523779	"Transmission and evolutionary dynamics of human coronavirus OC43 strains in coastal Kenya investigated by partial spike sequence analysis, 2015-16."	Virus Evol
32523145	"COVID-19 and the renin, angiotensin, aldosterone system. A complex relationship."	Arch Cardiol Mex
32523141	Coronavirus infection in patients with diabetes.	Arch Cardiol Mex
32523133	SARS-CoV-2 downregulation of ACE2 and pleiotropic effects of ACEIs/ARBs.	Hypertens Res
32523109	Molecular structure analyses suggest strategies to therapeutically target SARS-CoV-2.	Nat Commun
32522874	Genomic determinants of pathogenicity in SARS-CoV-2 and other human coronaviruses.	Proc Natl Acad Sci U S A
32522846	ACE2 and COVID-19 and the resulting ARDS.	Postgrad Med J
32522830	Comparative Pathogenesis of Bovine and Porcine Respiratory Coronaviruses in the Animal Host Species and SARS-CoV-2 in Humans.	J Clin Microbiol
32522674	Widely available lysosome targeting agents should be considered as potential therapy for COVID-19.	Int J Antimicrob Agents
32522666	How nicotine can inhibit cytokine storm in the lungs and prevent or lessen the severity of COVID-19 infection?	Immunol Lett
32522617	Outbreak of SARS-CoV2: Pathogenesis of infection and cardiovascular involvement.	Hellenic J Cardiol
32522462	Association of asthma and its genetic predisposition with the risk of severe COVID-19.	J Allergy Clin Immunol
32522400	"Letter to the Editor on ""Bonafe M, Prattichizzo F, Giuliani A, Storci G, Sabbatinelli J, Olivieri F. Inflamm-aging: Why older men are the most susceptible to SARS-CoV-2 complicated outcomes. Cytokine Growth Factor Rev""."	Cytokine Growth Factor Rev
32522207	COVID-19: viral-host interactome analyzed by network based-approach model to study pathogenesis of SARS-CoV-2 infection.	J Transl Med
32522067	"Autophagy as an emerging target for COVID-19: lessons from an old friend, chloroquine."	Autophagy
32521619	Redox-Modulating Agents in the Treatment of Viral Infections.	Int J Mol Sci
32521503	The continuum of SARS-CoV-2's neurotropism and the potential for immune-mediated neuronal injury.	Seizure
32521376	SARS-CoV-2 (Covid-19): Interferon-epsilon may be responsible of decreased mortality in females.	J Reprod Immunol
32521159	Structural Basis of the Potential Binding Mechanism of Remdesivir to SARS-CoV-2 RNA-Dependent RNA Polymerase.	J Phys Chem B
32521068	COVID-19 is milder in children possibly due to cross-immunity.	Acta Paediatr
32520981	ACE2 diversity in placental mammals reveals the evolutionary strategy of SARS-CoV-2.	Genet Mol Biol
32520031	In silico evaluation of marine fish proteins as nutritional supplements for COVID-19 patients.	Food Funct
32519895	Is targeting Akt a viable option to treat advanced-stage COVID-19 patients?	Am J Physiol Lung Cell Mol Physiol
32519892	Consideration of Pannexin 1 channels in COVID-19 pathology and treatment.	Am J Physiol Lung Cell Mol Physiol
32519842	Toward Nanotechnology-Enabled Approaches against the COVID-19 Pandemic.	ACS Nano
32519779	"Circulating levels of IL-2, IL-4, TNF-alpha, IFN-gamma, and C-reactive protein are not associated with severity of COVID-19 symptoms."	J Med Virol
32519753	The potential of cannabidiol in the COVID-19 pandemic.	Br J Pharmacol
32519505	COVID-19: a major cause of cachexia and sarcopenia?	J Cachexia Sarcopenia Muscle
32519352	The Possible Protective Role of alpha-Synuclein Against Severe Acute Respiratory Syndrome Coronavirus 2 Infections in Patients With Parkinson's Disease.	Mov Disord
32519164	Potential role for tissue factor in the pathogenesis of hypercoagulability associated with in COVID-19.	J Thromb Thrombolysis
32518941	Identification of 22 N-glycosites on spike glycoprotein of SARS-CoV-2 and accessible surface glycopeptide motifs: Implications for vaccination and antibody therapeutics.	Glycobiology
32518817	"Synthesis, Spectroscopic Characterizations of Novel Norcantharimides, Their ADME Properties and Docking Studies Against COVID-19 M(pr) degrees ."	ChemistrySelect
32518419	The Janus kinase 1/2 inhibitor ruxolitinib in COVID-19 with severe systemic hyperinflammation.	Leukemia
32518172	Guillain-Barre syndrome: The first documented COVID-19-triggered autoimmune neurologic disease: More to come with myositis in the offing.	Neurol Neuroimmunol Neuroinflamm
32518072	Culture-Based Virus Isolation To Evaluate Potential Infectivity of Clinical Specimens Tested for COVID-19.	J Clin Microbiol
32517505	C3 polymorphisms represent an important immunological confounder on the spread and outcome of COVID-19.	Eur J Prev Cardiol
32517353	Silibinin and SARS-CoV-2: Dual Targeting of Host Cytokine Storm and Virus Replication Machinery for Clinical Management of COVID-19 Patients.	J Clin Med
32517266	"Propagation, Inactivation, and Safety Testing of SARS-CoV-2."	Viruses
32516733	B-cell engineering: A promising approach towards vaccine development for COVID-19.	Med Hypotheses
32516655	Pulmonary delivery of nanostructured lipid carriers for effective repurposing of salinomycin as an antiviral agent.	Med Hypotheses
32516571	Pathogenesis of SARS-CoV-2 in Transgenic Mice Expressing Human Angiotensin-Converting Enzyme 2.	Cell
32516444	Immunological environment shifts during pregnancy may affect the risk of developing severe complications in COVID-19 patients.	Am J Reprod Immunol
32515982	H2S as a potential defense against COVID-19?	Am J Physiol Cell Physiol
32515974	Spiky Nanostructures with Geometry-matching Topography for Virus Inhibition.	Nano Lett
32515699	"[The Agreed Experts' Position of the Eurasian Association of Therapists on Some new Mechanisms of COVID-19 Pathways: Focus on Hemostasis, Hemotransfusion Issues and Blood gas Exchange]."	Kardiologiia
32515561	"[Source of the COVID-19 pandemic: ecology and genetics of coronaviruses (Betacoronavirus: Coronaviridae) SARS-CoV, SARS-CoV-2 (subgenus Sarbecovirus), and MERS-CoV (subgenus Merbecovirus).]"	Vopr Virusol
32515376	The genetic landscape of COVID-19: A South Asian perspective.	J Pak Med Assoc
32515374	The Microbiology of Coronaviruses.	J Pak Med Assoc
32515358	Mutations in SARS-CoV-2 viral RNA identified in Eastern India: Possible implications for the ongoing outbreak in India and impact on viral structure and host susceptibility.	J Biosci
32515168	Clonal haematopoiesis and COVID-19: A possible deadly liaison.	Int J Immunogenet
32514935	Renin-angiotensin system inhibition in COVID-19 patients.	Neth Heart J
32514902	"Systemic steroids in patients with COVID-19: pros and contras, an endocrinological point of view."	J Endocrinol Invest
32514817	"Immune Responses to SARS-CoV, MERS-CoV and SARS-CoV-2."	Adv Exp Med Biol
32514592	Severe COVID-19 is associated with deep and sustained multifaceted cellular immunosuppression.	Intensive Care Med
32514174	A single-cell atlas of the peripheral immune response in patients with severe COVID-19.	Nat Med
32514047	Expansion of myeloid-derived suppressor cells in patients with severe coronavirus disease (COVID-19).	Cell Death Differ
32514035	Dissecting antibody-mediated protection against SARS-CoV-2.	Nat Rev Immunol
32513867	Antibody signature induced by SARS-CoV-2 spike protein immunogens in rabbits.	Sci Transl Med
32513865	Genomic surveillance reveals multiple introductions of SARS-CoV-2 into Northern California.	Science
32513850	Early Insights into Immune Responses during COVID-19.	J Immunol
32513797	Suramin Inhibits SARS-CoV-2 Infection in Cell Culture by Interfering with Early Steps of the Replication Cycle.	Antimicrob Agents Chemother
32513613	COVID-19 and the ABO blood group connection.	Transfus Apher Sci
32513566	SARS-CoV-2 infection: The role of cytokines in COVID-19 disease.	Cytokine Growth Factor Rev
32513532	Altered COVID-19 receptor ACE2 expression in a higher risk group for cerebrovascular disease and ischemic stroke.	Biochem Biophys Res Commun
32513514	The biological characteristics of SARS-CoV-2 spike protein Pro330-Leu650.	Vaccine
32513242	Blocking mineralocorticoid receptor with spironolactone may have a wide range of therapeutic actions in severe COVID-19 disease.	Crit Care
32513225	Neutrophil Elastase Inhibitors: A potential prophylactic treatment option for SARS-CoV-2-induced respiratory complications?	Crit Care
32513070	Selenium supplementation can relieve the clinical complications of COVID-19 and other similar viral infections.	Int J Vitam Nutr Res
32512950	"From Wuhan to COVID-19 Pandemic: An Up-to-Date Review of Its Pathogenesis, Potential Therapeutics, and Recent Advances."	Microorganisms
32512929	The Prediction of miRNAs in SARS-CoV-2 Genomes: hsa-miR Databases Identify 7 Key miRs Linked to Host Responses and Virus Pathogenicity-Related KEGG Pathways Significant for Comorbidities.	Viruses
32512702	COVID-19 Immunopathology and the Central Nervous System: Implication for Multiple Sclerosis and Other Autoimmune Diseases with Associated Demyelination.	Brain Sci
32512673	"COVID-19: pathogenesis, genetic polymorphism, clinical features and laboratory findings"	Turk J Med Sci
32512589	"Coronavirus Disease 2019 Coagulopathy: Disseminated Intravascular Coagulation and Thrombotic Microangiopathy-Either, Neither, or Both."	Semin Thromb Hemost
32512530	Neuropsychiatric aspects of COVID-19 pandemic: A selective review.	Asian J Psychiatr
32512493	The effects of allium sativum on immunity within the scope of COVID-19 infection.	Med Hypotheses
32512491	COVID-19-related complications and decompression illness share main features.: Could the SARS-CoV2-related complications rely on blood foaming?	Med Hypotheses
32512490	Potential role of zinc supplementation in prophylaxis and treatment of COVID-19.	Med Hypotheses
32512386	Proteolytic Cleavage of the SARS-CoV-2 Spike Protein and the Role of the Novel S1/S2 Site.	iScience
32512383	Mitigating Coronavirus-Induced Acute Respiratory Distress Syndrome by Radiotherapy.	iScience
32512362	"Assessing the relationship between surface levels of PM2.5 and PM10 particulate matter impact on COVID-19 in Milan, Italy."	Sci Total Environ
32512290	Expression of angiotensin-converting enzyme 2 and proteases in COVID-19 patients: A potential role of cellular FURIN in the pathogenesis of SARS-CoV-2.	Med Hypotheses
32512289	Neutralizing antibodies mediate virus-immune pathology of COVID-19.	Med Hypotheses
32512089	Corona virus versus existence of human on the earth: A computational and biophysical approach.	Int J Biol Macromol
32511912	COVID-19: Drug Targets and Potential Treatments.	J Med Chem
32511751	SARS-CoV-2: What is known and what there is to know-Focus on coagulation and lipids.	Eur J Clin Invest
32511678	Use of RAAS Inhibitors and Risk of Clinical Deterioration in COVID-19: Results From an Italian Cohort of 133 Hypertensives.	Am J Hypertens
32511667	SARS-CoV-2-Related Inflammatory Multisystem Syndrome in Children: Different or Shared Etiology and Pathophysiology as Kawasaki Disease?	JAMA
32511245	A unifying structural and functional model of the coronavirus replication organelle: Tracking down RNA synthesis.	PLoS Biol
32510978	Overcoming Barriers: The Endothelium As a Linchpin of Coronavirus Disease 2019 Pathogenesis?	Arterioscler Thromb Vasc Biol
32510973	Decoding SARS-CoV-2 hijacking of host mitochondria in COVID-19 pathogenesis.	Am J Physiol Cell Physiol
32510901	SARS-COV-2 and Male Reproductive Health.	JBRA Assist Reprod
32510799	Application of plasmapheresis for Covid-19 patients.	Ther Apher Dial
32510598	Single-cell RNA analysis on ACE2 expression provides insights into SARS-CoV-2 potential entry into the bloodstream and heart injury.	J Cell Physiol
32510562	Long-term and herd immunity against SARS-CoV-2: implications from current and past knowledge.	Pathog Dis
32510261	Is there any possible link between COVID-19 and human infertility?	J Matern Fetal Neonatal Med
32510142	alpha-glucosidase inhibitors as host-directed antiviral agents with potential for the treatment of COVID-19.	Biochem Soc Trans
32510005	COVID-19 target: A specific target for novel coronavirus detection.	Gene Rep
32509819	Coronavirus disease 2019: implications for liver transplantation.	Hepatobiliary Surg Nutr
32509818	SARS-CoV-2 and liver damage: a possible pathogenetic link.	Hepatobiliary Surg Nutr
32509472	Insights on early mutational events in SARS-CoV-2 virus reveal founder effects across geographical regions.	PeerJ
32509310	Severe acute respiratory syndrome coronavirus 2: virus mutations in specific European populations.	New Microbes New Infect
32509257	"SARS-CoV-2, ""common cold"" coronaviruses' cross-reactivity and ""herd immunity"": The razor of Ockham (1285-1347)?"	Infect Dis Rep
32508311	COVID-19 and androgen-targeted therapy for prostate cancer patients.	Endocr Relat Cancer
32508078	SARS-CoV-2 infection in pregnant women: are there long-term effects in offspring's brain development?	Minerva Ginecol
32507883	Covid-19: the renin-angiotensin system imbalance hypothesis.	Clin Sci (Lond)
32507608	Hepatic consequences of COVID-19 infection. Lapping or biting?	Eur J Intern Med
32507577	COVID-19 and Cerebral Hemorrhage: Proposed Mechanisms.	J Neuroradiol
32507543	Spiking Pandemic Potential: Structural and Immunological Aspects of SARS-CoV-2.	Trends Microbiol
32507520	[COVID-19: Pathogenesis of a multi-faceted disease].	Rev Med Interne
32507410	"The influenza virus, SARS-CoV-2, and the airways: Clarification for the otorhinolaryngologist."	Eur Ann Otorhinolaryngol Head Neck Dis
32507368	"SARS-COV-2 associated acute pancreatitis: Cause, consequence or epiphenomenon?"	Pancreatology
32507105	The origin and underlying driving forces of the SARS-CoV-2 outbreak.	J Biomed Sci
32506937	Why Do People With Diabetes Have a High Risk for Severe COVID-19 Disease?-A Dental Hypothesis and Possible Prevention Strategy.	J Diabetes Sci Technol
32506775	Back to the basics: Propolis and COVID-19.	Dermatol Ther
32506743	No current evidence supporting risk of using Ibuprofen in patients with COVID-19.	Int J Clin Pract
32506725	"Dengue Fever, COVID-19 (SARS-CoV-2), and Antibody-Dependent Enhancement (ADE): A Perspective."	Cytometry A
32506640	Viral infections and their relationship with catastrophic antiphospholipid syndrome: a possible pathogenic mechanism of severe COVID-19 thrombotic complications.	J Intern Med
32506549	COVID-19: A Global Threat to the Nervous System.	Ann Neurol
32506536	Emerging viral mutants in Australia suggest RNA recombination event in the SARS-CoV-2 genome.	Med J Aust
32506509	Clinical characteristics of COVID-19 patients combined with allergy.	Allergy
32506222	COVID-19: Impact of and on Diabetes.	Diabetes Ther
32506195	Dipeptidyl peptidase-4 (DPP4) inhibition in COVID-19.	Acta Diabetol
32506067	Covid-19 and Exercise-Induced Immunomodulation.	Neuroimmunomodulation
32505980	Relationship between COVID-19 and obesity.	Diabetes Metab Syndr
32505911	Antibiotic consumption may be linked to exaggeration of COVID-19.	Med Hypotheses
32505910	Novel therapeutic targets for SARS-CoV-2-induced acute lung injury: Targeting a potential IL-1beta/neutrophil extracellular traps feedback loop.	Med Hypotheses
32505821	Analysis of the molecular mechanism of Pudilan (PDL) treatment for COVID-19 by network pharmacology tools.	Biomed Pharmacother
32505779	Could antiphospholipid antibodies contribute to coagulopathy in COVID-19?	J Am Acad Dermatol
32505692	Molecular analysis of several in-house rRT-PCR protocols for SARS-CoV-2 detection in the context of genetic variability of the virus in Colombia.	Infect Genet Evol
32505551	Oral submucous fibrosis and COVID-19: Perspective on comorbidity.	Oral Oncol
32505432	Does COVID-19 cause axonal GBS?	J Clin Neurosci
32505431	Neuroimmune correlates of the nervous system involvement of COVID-19: A commentary.	J Clin Neurosci
32505227	Immunology of COVID-19: Current State of the Science.	Immunity
32505073	Oral cancer and periodontal disease increase the risk of COVID 19? A mechanism mediated through furin and cathepsin overexpression.	Med Hypotheses
32505072	COVID-19 and picotechnology: Potential opportunities.	Med Hypotheses
32505071	SARS-CoV-2 and prostatitis: Dangerous relationship for male sexual and reproductive health.	Med Hypotheses
32505070	"Nebulized Lidocaine in COVID-19, An Hypothesis."	Med Hypotheses
32505067	Could autism spectrum disorders be a risk factor for COVID-19?	Med Hypotheses
32505066	COVID-19: Loss of bridging between innate and adaptive immunity?	Med Hypotheses
32504927	Periodontal pockets: A potential reservoir for SARS-CoV-2?	Med Hypotheses
32504925	What would Sergio Ferreira say to your physician in this war against COVID-19: How about kallikrein/kinin system?	Med Hypotheses
32504923	N-Acetylcysteine: A potential therapeutic agent for SARS-CoV-2.	Med Hypotheses
32504802	Optimizing high-yield production of SARS-CoV-2 soluble spike trimers for serology assays.	Protein Expr Purif
32504757	Protective role of ACE2 and its downregulation in SARS-CoV-2 infection leading to Macrophage Activation Syndrome: Therapeutic implications.	Life Sci
32504751	A novel role of nifuroxazide in attenuation of sepsis-associated acute lung and myocardial injuries; role of TLR4/NLPR3/IL-1beta signaling interruption.	Life Sci
32504450	Dysfunctional Coagulation in COVID-19: From Cell to Bedside.	Adv Ther
32504061	SARS-CoV-2 cross-reactivity in healthy donors.	Nat Rev Immunol
32504060	Immune evasion via SARS-CoV-2 ORF8 protein?	Nat Rev Immunol
32504059	Many paths to COVID-19 lymphocyte dysfunction.	Nat Rev Immunol
32504046	Implications of antibody-dependent enhancement of infection for SARS-CoV-2 countermeasures.	Nat Biotechnol
32503918	Enhanced receptor binding of SARS-CoV-2 through networks of hydrogen-bonding and hydrophobic interactions.	Proc Natl Acad Sci U S A
32503877	Inhibition of Bruton tyrosine kinase in patients with severe COVID-19.	Sci Immunol
32503822	Human Gene Sequences in SARS-CoV-2 and Other Viruses.	In Vivo
32503821	SARS-CoV-2 orf1b Gene Sequence in the NTNG1 Gene on Human Chromosome 1.	In Vivo
32503816	Oral Methioninase for Covid-19 Methionine-restriction Therapy.	In Vivo
32503815	Role of Interleukin-6 in Lung Complications in Patients With COVID-19: Therapeutic Implications.	In Vivo
32503680	Elevation of plasma angiotensin II level is a potential pathogenesis for the critically ill COVID-19 patients.	Crit Care
32503352	Genomic Sequencing and Analysis of Eight Camel-Derived Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Isolates in Saudi Arabia.	Viruses
32502901	Ribosomal proteins as a possible tool for blocking SARS-COV 2 virus replication for a potential prospective treatment.	Med Hypotheses
32502882	Continuing versus suspending angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: Impact on adverse outcomes in hospitalized patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)--The BRACE CORONA Trial.	Am Heart J
32502733	Exploring the genomic and proteomic variations of SARS-CoV-2 spike glycoprotein: A computational biology approach.	Infect Genet Evol
32502659	Potential role of statins in COVID-19.	Int J Infect Dis
32502616	"Co-expression of SARS-CoV-2 entry genes in the superficial adult human conjunctival, limbal and corneal epithelium suggests an additional route of entry via the ocular surface."	Ocul Surf
32502542	The immune system and COVID-19: Friend or foe?	Life Sci
32502296	SARS-CoV-2 as a Potential Trigger of Neurodegenerative Diseases.	Mov Disord
32502247	Inverse Association Between Chronic Hepatitis B Infection and Coronavirus Disease 2019 (COVID-19): Immune Exhaustion or Coincidence?	Clin Infect Dis
32502097	"Angiotensin-converting enzyme inhibitors, angiotensin II type 1 receptor blockers and risk of COVID 19: information from Bartter's and Gitelman's syndromes patients."	J Hypertens
32501810	ACE2 and TMPRSS2 variants and expression as candidates to sex and country differences in COVID-19 severity in Italy.	Aging (Albany NY)
32501731	Cholesterol: A new game player accelerating vasculopathy caused by SARS-CoV-2?	Am J Physiol Endocrinol Metab
32501607	Selective C-reactive protein apheresis for Covid-19 patients suffering from organ damage.	Ther Apher Dial
32501535	Identification of nsp1 gene as the target of SARS-CoV-2 real-time RT-PCR using nanopore whole-genome sequencing.	J Med Virol
32501480	Continuation versus discontinuation of ACE inhibitors or angiotensin II receptor blockers in COVID-19: effects on blood pressure control and mortality.	Eur Heart J Cardiovasc Pharmacother
32501455	Down Syndrome and COVID-19: A Perfect Storm?	Cell Rep Med
32501427	Potential pathophysiological mechanisms leading to increased COVID-19 susceptibility and severity in obesity.	Obes Med
32501423	Developing an ultra-efficient microsatellite discoverer to find structural differences between SARS-CoV-1 and Covid-19.	Inform Med Unlocked
32501397	The ancient and the new: is there an interaction between cytomegalovirus and SARS-CoV-2 infection?	Immun Ageing
32501218	Factors preventing materno-fetal transmission of SARS-CoV-2.	Placenta
32501190	ACE2 and COVID-19: using antihypertensive medications and pharmacogenetic considerations.	Pharmacogenomics
32500944	First detection and genome sequencing of SARS-CoV-2 in an infected cat in France.	Transbound Emerg Dis
32500928	COVID-19 breakthroughs: separating fact from fiction.	FEBS J
32500793	"Repurposing Nimesulide, a Potent Inhibitor of the B0AT1 Subunit of the SARS-CoV-2 Receptor, as a Therapeutic Adjuvant of COVID-19."	SLAS Discov
32500504	SARS-Coronavirus-2 Nsp13 Possesses NTPase and RNA Helicase Activities That Can Be Inhibited by Bismuth Salts.	Virol Sin
32499988	Protective Adaptive Immunity Against Severe Acute Respiratory Syndrome Coronaviruses 2 (SARS-CoV-2) and Implications for Vaccines.	Cureus
32499983	A Comprehensive Review of Severe Acute Respiratory Syndrome Coronavirus 2.	Cureus
32499922	ACE2 expression and sex disparity in COVID-19.	Cell Death Discov
32499909	Is diet partly responsible for differences in COVID-19 death rates between and within countries?	Clin Transl Allergy
32499548	Autoimmune and inflammatory diseases following COVID-19.	Nat Rev Rheumatol
32499358	Complete Genome Sequence of a SARS-CoV-2 Strain Isolated in Northern Germany.	Microbiol Resour Announc
32499314	Involvement of interleukin 6 in SARS-CoV-2 infection: siltuximab as a therapeutic option against COVID-19.	Eur J Hosp Pharm
32499236	"COVID-19 pandemic and troponin: indirect myocardial injury, myocardial inflammation or myocarditis?"	Heart
32499172	Active smoking and severity of coronavirus disease 2019 (COVID-19): Differences in measurement of variables could cause errors in the results.	Eur J Intern Med
32499154	Covid-19 Pandemic and Current Medical Interventions.	Arch Med Res
32499129	Immunotherapies for COVID-19: Restoring the immunity could be the priority.	Anaesth Crit Care Pain Med
32498973	Current evidence on pancreatic involvement in SARS-CoV-2 infection.	Pancreatology
32498762	Coronavirus Disease 2019: Clinical Review.	Acta Med Port
32498696	COVID-19 preclinical models: human angiotensin-converting enzyme 2 transgenic mice.	Hum Genomics
32498686	"Immunologic aspects of characteristics, diagnosis, and treatment of coronavirus disease 2019 (COVID-19)."	J Biomed Sci
32498581	Relationship between pregnancy and coronavirus: what we know.	J Matern Fetal Neonatal Med
32498503	COVID-19: a review.	Monaldi Arch Chest Dis
32497811	Iron: Innocent bystander or vicious culprit in COVID-19 pathogenesis?	Int J Infect Dis
32497778	A pharmacological interactome between COVID-19 patient samples and human sensory neurons reveals potential drivers of neurogenic pulmonary dysfunction.	Brain Behav Immun
32497632	"Potential therapeutic targets for combating SARS-CoV-2: Drug repurposing, clinical trials and recent advancements."	Life Sci
32497535	Commentary: Phosphodiesterase 4 inhibitors as potential adjunct treatment targeting the cytokine storm in COVID-19.	Metabolism
32497522	Respiratory Virus Infections: Understanding COVID-19.	Immunity
32497334	A missing link between SARS-CoV-2 and the eye?: ACE2 expression on the ocular surface.	J Med Virol
32497323	Increasing host cellular receptor-angiotensin-converting enzyme 2 expression by coronavirus may facilitate 2019-nCoV (or SARS-CoV-2) infection.	J Med Virol
32497298	Pancreatic injury in the course of coronavirus disease 2019: A not-so-rare occurrence.	J Med Virol
32497297	Gendered effects on inflammation reaction and outcome of COVID-19 patients in Wuhan.	J Med Virol
32497257	A lesson from a saboteur: High-MW kininogen impact in coronavirus-induced disease 2019.	Br J Pharmacol
32496715	"[Etiology of epidemic outbreaks COVID-19 on Wuhan, Hubei province, Chinese People Republic associated with 2019-nCoV (Nidovirales, Coronaviridae, Coronavirinae, Betacoronavirus, Subgenus Sarbecovirus): lessons of SARS-CoV outbreak.]"	Vopr Virusol
32496587	"Distribution of ACE2, CD147, CD26, and other SARS-CoV-2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID-19 risk factors."	Allergy
32496364	Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Patients With Coronavirus Disease 2019: Friend or Foe?	Cardiol Rev
32496247	Genome analysis of SARS-CoV-2 isolates occurring in India: Present scenario.	Indian J Public Health
32495940	Probiotics and COVID-19: is there any link?	Lett Appl Microbiol
32495923	COVID-19: a conundrum to decipher.	Eur Rev Med Pharmacol Sci
32495849	Gender differences in COVID-19 infection. The estrogen effect on upper and lower airways. Can it help to figure out a treatment?	Eur Rev Med Pharmacol Sci
32495654	Targeting SARS-CoV-2 using polycomb inhibitors as antiviral agents.	Epigenomics
32495577	[Mechanism of Xuanfei Baidu Tang in treatment of COVID-19 based on network pharmacology].	Zhongguo Zhong Yao Za Zhi
32495576	[Visual analysis of coronavirus disease 2019 (COVID-19) studies based on bibliometrics].	Zhongguo Zhong Yao Za Zhi
32495372	Terminal complement inhibition dampens the inflammation during COVID-19.	Br J Haematol
32495299	COVID-19: is there a link between the course of infection and pharmacological agents in diabetes?	J Endocrinol Invest
32495027	Hematological findings in coronavirus disease 2019: indications of progression of disease.	Ann Hematol
32493814	Inflammasomes and Pyroptosis as Therapeutic Targets for COVID-19.	J Immunol
32493812	Role of Aging and the Immune Response to Respiratory Viral Infections: Potential Implications for COVID-19.	J Immunol
32493627	Structural Proteins in Severe Acute Respiratory Syndrome Coronavirus-2.	Arch Med Res
32493626	S1 Subunit and Host Proteases as Potential Therapeutic Avenues for the Treatment of COVID-19.	Arch Med Res
32493597	Stroke as a complication and prognostic factor of COVID-19.	Neurologia (Engl Ed)
32493574	COVID-19 and treatment guided by biochemical and molecular diagnostic tests to reduce myocardial damage and cardiotoxicity.	Rev Esp Cardiol (Engl Ed)
32493510	SARS-CoV-2 SPIKE PROTEIN: an optimal immunological target for vaccines.	J Transl Med
32493070	Comparative Impacts of ACE (Angiotensin-Converting Enzyme) Inhibitors Versus Angiotensin II Receptor Blockers on the Risk of COVID-19 Mortality.	Hypertension
32493030	Thoughts on the alveolar phase of COVID-19.	Am J Physiol Lung Cell Mol Physiol
32492695	Does the newly observed inflammatory syndrome in children demonstrate a link between uncontrolled neutrophil extracellular traps formation and COVID-19?	Pediatr Res
32492562	The association between obesity and poor outcome after COVID-19 indicates a potential therapeutic role for montelukast.	Med Hypotheses
32492443	Right-to-Left Interatrial Shunt in COVID-19 Patients With Pulmonary Embolism: Reply.	Ann Thorac Surg
32492406	Proteomic and Metabolomic Characterization of COVID-19 Patient Sera.	Cell
32492292	Two hits to the renin-angiotensin system may play a key role in severe COVID-19.	Kaohsiung J Med Sci
32492210	Tocilizumab administration in patients with SARS-CoV-2 infection: Subcutaneous injection vs intravenous infusion.	J Med Virol
32492209	Determining host factors contributing to disease severity in a family cluster of 29 hospitalized SARS-CoV-2 patients: Could genetic factors be relevant in the clinical course of COVID-19?	J Med Virol
32492206	Understanding the possible origin and genotyping of the first Bangladeshi SARS-CoV-2 strain.	J Med Virol
32492203	Structural variations and expression profiles of the SARS-CoV-2 host invasion genes in lung cancer.	J Med Virol
32492196	High-coverage SARS-CoV-2 genome sequences acquired by target capture sequencing.	J Med Virol
32492195	Functional prediction and frequency of coding variants in human ACE2 at binding sites with SARS-CoV-2 spike protein on different populations.	J Med Virol
32492193	Potential neuroinvasive pathways of SARS-CoV-2: Deciphering the spectrum of neurological deficit seen in coronavirus disease-2019 (COVID-19).	J Med Virol
32492183	Evidence for mutations in SARS-CoV-2 Italian isolates potentially affecting virus transmission.	J Med Virol
32491949	Understanding the age divide in COVID-19: why are children overwhelmingly spared?	Am J Physiol Lung Cell Mol Physiol
32491829	"SARS-CoV-2, More than a Respiratory Virus: Its Potential Role in Neuropathogenesis."	ACS Chem Neurosci
32491212	Circulating endothelial cells in COVID-19.	Am J Hematol
32491073	The Effect of Coronavirus Disease 2019 on Cardiovascular Diseases.	Arq Bras Cardiol
32490931	"17beta-Estradiol, a potential ally to alleviate SARS-CoV-2 infection."	Clinics (Sao Paulo)
32490889	Coagulation modifiers targeting SARS-CoV-2 main protease Mpro for COVID-19 treatment: an in silico approach.	Mem Inst Oswaldo Cruz
32490733	Interleukin 6 polymorphisms as an indicator of COVID-19 severity in humans.	J Biomol Struct Dyn
32490731	Targeting SARS-CoV-2 receptors as a means for reducing infectivity and improving antiviral and immune response: an algorithm-based method for overcoming resistance to antiviral agents.	Emerg Microbes Infect
32490726	Thromboinflammatory response in SARS-CoV-2 sepsis.	Med Leg J
32490715	In vitro analysis of the renin-angiotensin system and inflammatory gene transcripts in human bronchial epithelial cells after infection with severe acute respiratory syndrome coronavirus.	J Renin Angiotensin Aldosterone Syst
32489698	COVID-19 Virulence in Aged Patients Might Be Impacted by the Host Cellular MicroRNAs Abundance/Profile.	Aging Dis
32489695	COVID-19 in India: Are Biological and Environmental Factors Helping to Stem the Incidence and Severity?	Aging Dis
32489653	Interrelationship Between Coronavirus Infection and Liver Disease.	Clin Liver Dis (Hoboken)
32489508	Simultaneous Treatment of COVID-19 With Serine Protease Inhibitor Camostat and/or Cathepsin L Inhibitor?	J Clin Med Res
32489026	[Intervention mechanism of Qingwen Baidu Yin on cytokine storm based on network pharmacology].	Zhongguo Zhong Yao Za Zhi
32489025	[Exploration on scientific connotation of TCM syndromes and recommended prescriptions against COVID-19 based on TCMTP V2.0].	Zhongguo Zhong Yao Za Zhi
32488956	Can concomitant use of zinc and curcumin with other immunity-boosting nutraceuticals be the arsenal against COVID-19?	Phytother Res
32488861	Applied Clinical Pharmacology in a Crisis: Interleukin-6 Axis Blockade and COVID-19.	Clin Pharmacol Ther
32488837	Possible long-term endocrine-metabolic complications in COVID-19: lesson from the SARS model.	Endocrine
32488616	Coronavirus surveillance of wildlife in the Lao People's Democratic Republic detects viral RNA in rodents.	Arch Virol
32488522	Risk of neuropsychiatric disorders in offspring of COVID-19-infected pregnant women and nutritional intervention.	Eur Arch Psychiatry Clin Neurosci
32488360	Androgenic hormones and the excess male mortality observed in COVID-19 patients: new convergent data.	World J Urol
32488318	Are the cutaneous manifestations during or due to SARS-CoV-2 infection/COVID-19 frequent or not? Revision of possible pathophysiologic mechanisms.	Inflamm Res
32488201	Blood clots and TAM receptor signalling in COVID-19 pathogenesis.	Nat Rev Immunol
32487877	"Editorial: Challenges and Insights amidst the Covid-19 pandemic: Nutrition, the immune system and disease risk."	Curr Opin Clin Nutr Metab Care
32487869	COVID-19 and myocardial injury: is there a role for interleukin-1 inhibition?	J Cardiovasc Med (Hagerstown)
32487714	Cranial neuropathies and COVID-19: Neurotropism and autoimmunity.	Neurology
32487159	Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): a review.	Mol Cancer
32486609	What are we talking about when we talk of steroid in COVID-19?	Minerva Anestesiol
32486488	Nicotinamide Riboside-The Current State of Research and Therapeutic Uses.	Nutrients
32486283	Reporter Replicons for Antiviral Drug Discovery against Positive Single-Stranded RNA Viruses.	Viruses
32486229	Investigation of Some Antiviral N-Heterocycles as COVID 19 Drug: Molecular Docking and DFT Calculations.	Int J Mol Sci
32486196	Cerebrovascular and Neurological Dysfunction under the Threat of COVID-19: Is There a Comorbid Role for Smoking and Vaping?	Int J Mol Sci
32486188	SARS-CoV-2 Infection and the Liver.	Pathogens
32485970	"A Review on SARS-CoV-2 Virology, Pathophysiology, Animal Models, and Anti-Viral Interventions."	Pathogens
32485894	In Silico Evaluation of the Effectivity of Approved Protease Inhibitors against the Main Protease of the Novel SARS-CoV-2 Virus.	Molecules
32485858	Javamide-II Inhibits IL-6 without Significant Impact on TNF-alpha and IL-1beta in Macrophage-Like Cells.	Biomedicines
32485652	Interaction of the prototypical alpha-ketoamide inhibitor with the SARS-CoV-2 main protease active site in silico: Molecular dynamic simulations highlight the stability of the ligand-protein complex.	Comput Biol Chem
32485332	SARS-CoV-2 Molecular and Phylogenetic analysis in COVID-19 patients: A preliminary report from Iran.	Infect Genet Evol
32485315	Diabetes and severity of COVID-19: What is the link?	Med Hypotheses
32485314	Persistent SARS-CoV-2 infection and the risk for cancer.	Med Hypotheses
32485251	A recombinant Lactobacillus plantarum strain expressing the spike protein of SARS-CoV-2.	Int J Biol Macromol
32485205	The endosomal lipid bis(monoacylglycero) phosphate as a potential key player in the mechanism of action of chloroquine against SARS-COV-2 and other enveloped viruses hijacking the endocytic pathway.	Biochimie
32485164	A Mouse Model of SARS-CoV-2 Infection and Pathogenesis.	Cell Host Microbe
32485101	Vascular Endothelial Growth Factor (VEGF) as a Vital Target for Brain Inflammation during the COVID-19 Outbreak.	ACS Chem Neurosci
32485082	Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers are not associated with severe COVID-19 infection in a multi-site UK acute hospital trust.	Eur J Heart Fail
32484966	Using the prone position could help to combat the development of fast hypoxia in some patients with COVID-19.	Acta Paediatr
32484232	[Covid-19 - radiologic and histologic features].	Lakartidningen
32484220	Discovery of G-quadruplex-forming sequences in SARS-CoV-2.	Brief Bioinform
32484155	Malaria and Parasitic Neglected Tropical Diseases: Potential Syndemics with COVID-19?	Am J Trop Med Hyg
32483934	Overview: The history and pediatric perspectives of severe acute respiratory syndromes: Novel or just like SARS.	Pediatr Pulmonol
32483687	The neurological manifestations of COVID-19: a review article.	Neurol Sci
32483490	The role of selectivity of the SARS-CoV-2 virus for human genetic profiles in susceptibility and resistance to COVID-19.	New Microbes New Infect
32483314	COVID-19: organoids go viral.	Nat Rev Mol Cell Biol
32483300	"SARS-CoV-2 infection and overactivation of Nlrp3 inflammasome as a trigger of cytokine ""storm"" and risk factor for damage of hematopoietic stem cells."	Leukemia
32483236	Two linear epitopes on the SARS-CoV-2 spike protein that elicit neutralising antibodies in COVID-19 patients.	Nat Commun
32482926	SARS-CoV-2: the emergence of a viral pathogen causing havoc on human existence.	J Genet
32482915	Expression of Receptors for SARS-CoV-2 in the Gut of Patients with Inflammatory Bowel Disease.	Gut Liver
32482591	Swine enteric alphacoronavirus (swine acute diarrhea syndrome coronavirus): An update three years after its discovery.	Virus Res
32482538	[Proposal for the use of anakinra in acute respiratory distress secondary to COVID-19].	Reumatol Clin (Engl Ed)
32482373	Tocilizumab: A Therapeutic Option for the Treatment of Cytokine Storm Syndrome in COVID-19.	Arch Med Res
32482250	"Prior and novel coronaviruses, Coronavirus Disease 2019 (COVID-19), and human reproduction: what is known?"	Fertil Steril
32482249	No evidence of severe acute respiratory syndrome-coronavirus 2 in semen of males recovering from coronavirus disease 2019.	Fertil Steril
32481719	The Role of MicroRNA in the Airway Surface Liquid Homeostasis.	Int J Mol Sci
32481690	Broad-Spectrum Coronavirus Fusion Inhibitors to Combat COVID-19 and Other Emerging Coronavirus Diseases.	Int J Mol Sci
32480248	Is there enough evidence to discontinue the renin-angiotensin system inhibitors in patients with COVID-19?	Med Hypotheses
32480226	"Effects of host genetic variations on response to, susceptibility and severity of respiratory infections."	Biomed Pharmacother
32479986	Type 3 hypersensitivity in COVID-19 vasculitis.	Clin Immunol
32479985	Selective CD8 cell reduction by SARS-CoV-2 is associated with a worse prognosis and systemic inflammation in COVID-19 patients.	Clin Immunol
32479856	SARS-CoV-2 entry in host cells-multiple targets for treatment and prevention.	Biochimie
32479816	"An update on SARS-CoV-2/COVID-19 with particular reference to its clinical pathology, pathogenesis, immunopathology and mitigation strategies."	Travel Med Infect Dis
32479746	Host-Viral Infection Maps Reveal Signatures of Severe COVID-19 Patients.	Cell
32479648	Is asthma protective against COVID-19?	Allergy
32479159	"Related molecular mechanisms of COVID-19, hypertension, and diabetes."	Am J Physiol Endocrinol Metab
32479133	TMPRSS2 and ACE2 Coexpression in SARS-CoV-2 Salivary Glands Infection.	J Dent Res
32478897	Conditional cell reprogramming for modeling host-virus interactions and human viral diseases.	J Med Virol
32478706	Severe COVID-19 Cases: Is Respiratory Distress Partially Explained by Central Nervous System Involvement?	MEDICC Rev
32478567	Can an Old Ally Defeat a New Enemy?	Circulation
32478523	Comparing the Binding Interactions in the Receptor Binding Domains of SARS-CoV-2 and SARS-CoV.	J Phys Chem Lett
32478289	The origin of SARS-CoV-2 in Istanbul: Sequencing findings from the epicenter of the pandemic in Turkey.	North Clin Istanb
32477373	Implications of COVID-19 Outbreak on Immune Therapies in Multiple Sclerosis Patients-Lessons Learned From SARS and MERS.	Front Immunol
32476796	Gastrointestinal and hepatic manifestations of COVID-19: A comprehensive review.	World J Gastroenterol
32476594	"Virtual screening, ADME/T, and binding free energy analysis of anti-viral, anti-protease, and anti-infectious compounds against NSP10/NSP16 methyltransferase and main protease of SARS CoV-2."	J Recept Signal Transduct Res
32476576	Identification of potential natural inhibitors of SARS-CoV2 main protease by molecular docking and simulation studies.	J Biomol Struct Dyn
32476574	"Virtual screening-driven drug discovery of SARS-CoV2 enzyme inhibitors targeting viral attachment, replication, post-translational modification and host immunity evasion infection mechanisms."	J Biomol Struct Dyn
32476472	COVID-19: ACE2centric Infective Disease?	Hypertension
32476380	"SARS-CoV-2, which induces COVID-19, causes kawasaki-like disease in children: role of pro-inflammatory and anti-inflammatory cytokines."	J Biol Regul Homeost Agents
32475759	IL-6: Relevance for immunopathology of SARS-CoV-2.	Cytokine Growth Factor Rev
32475223	Antiviral effects of probiotic metabolites on COVID-19.	J Biomol Struct Dyn
32475144	"COVID-19-A Novel Zoonotic Disease: A Review of the Disease, the Virus, and Public Health Measures."	Asia Pac J Public Health
32475052	Binding affinities of 438 HLA proteins to complete proteomes of seven pandemic viruses and distributions of strongest and weakest HLA peptide binders in populations worldwide.	HLA
32475006	"Coronaviridae-Old friends, new enemy!"	Oral Dis
32475001	COVID-19 and ectodermal dysplasias. Recommendations are necessary.	Dermatol Ther
32474885	Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment.	Clin Rheumatol
32474587	Olfactory and Gustatory Symptoms in European COVID-19 Cohorts.	Clin Infect Dis
32474554	Mapping the genomic landscape & diversity of COVID-19 based on >3950 clinical isolates of SARS-CoV-2: Likely origin & transmission dynamics of isolates sequenced in India.	Indian J Med Res
32474553	Analysis of RNA sequences of 3636 SARS-CoV-2 collected from 55 countries reveals selective sweep of one virus type.	Indian J Med Res
32474399	Infectivity of human coronavirus in the brain.	EBioMedicine
32474389	Oral saliva and COVID-19.	Oral Oncol
32474381	Is anosmia the price to pay in an immune-induced scorched-earth policy against COVID-19?	Med Hypotheses
32474093	COVID-19 and SARS-Cov-2 Infection: Pathophysiology and Clinical Effects on the Nervous System.	World Neurosurg
32473977	Unfolding SARS-CoV-2 viral genome to understand its gene expression regulation.	Infect Genet Evol
32473976	"SARS-CoV-2 and COVID-19: A genetic, epidemiological, and evolutionary perspective."	Infect Genet Evol
32473600	Mechanism of baricitinib supports artificial intelligence-predicted testing in COVID-19 patients.	EMBO Mol Med
32473509	Zinc Iodide in combination with Dimethyl Sulfoxide for treatment of SARS-CoV-2 and other viral infections.	Med Hypotheses
32473354	Racial disparity in Covid-19 mortality rates - A plausible explanation.	Clin Immunol
32473352	Understanding the B and T cell epitopes of spike protein of severe acute respiratory syndrome coronavirus-2: A computational way to predict the immunogens.	Infect Genet Evol
32473311	Angiotensin receptor blockers for the treatment of COVID-19 and its comorbidities.	Pharmacol Res
32473193	Single cell RNA sequencing analysis did not predict hepatocyte infection by SARS-CoV-2.	J Hepatol
32473127	Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals.	Cell
32473125	Increased cardiovascular mortality in African Americans with COVID-19.	Lancet Respir Med
32473124	Pulmonary and cardiac pathology in African American patients with COVID-19: an autopsy series from New Orleans.	Lancet Respir Med
32473082	Long-term surveillance of bat coronaviruses in Korea: Diversity and distribution pattern.	Transbound Emerg Dis
32472991	"2019 novel coronavirus: what is currently known, cardiovascular implications and management."	Minerva Cardioangiol
32472989	"Relationship between angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers and SARS-CoV-2 infection: where are we?"	Minerva Cardioangiol
32472948	Speeding tumor genotyping during the SARS-CoV-2 outbreak through liquid biopsy.	Cancer
32472779	Food protein-derived antihypertensive peptides in the COVID-19 pandemic: friends of foes?	J Hypertens
32472763	Comparative analysis of Coronaviridae nucleocapsid and surface glycoprotein sequences.	Front Biosci (Landmark Ed)
32472706	"The long-standing history of Corynebacterium parvum, immunity, and viruses."	J Med Virol
32472662	COVID-19 and diabetes: Is there enough evidence?	J Clin Hypertens (Greenwich)
32472655	Cytokine storm in COVID-19 and parthenolide: Preclinical evidence.	Phytother Res
32472588	Increased sFLT-1/PlGF ratio in COVID-19: A novel link to angiotensin II-mediated endothelial dysfunction.	Am J Hematol
32471856	Introductions and early spread of SARS-CoV-2 in the New York City area.	Science
32471829	Novel Immunoglobulin Domain Proteins Provide Insights into Evolution and Pathogenesis of SARS-CoV-2-Related Viruses.	mBio
32471334	Particulate multivalent presentation of the receptor binding domain induces protective immune responses against MERS-CoV.	Emerg Microbes Infect
32471272	Cannabinoid Receptor Type 2: A Possible Target in SARS-CoV-2 (CoV-19) Infection?	Int J Mol Sci
32471205	Prediction of Novel Inhibitors of the Main Protease (M-pro) of SARS-CoV-2 through Consensus Docking and Drug Reposition.	Int J Mol Sci
32471171	Excess Ascorbate is a Chemical Stress Agent against Proteins and Cells.	Pharmaceuticals (Basel)
32471115	The Network of Angiotensin Receptors in Breast Cancer.	Cells
32471056	The Potency of an Anti-MERS Coronavirus Subunit Vaccine Depends on a Unique Combinatorial Adjuvant Formulation.	Vaccines (Basel)
32470948	Why does COVID-19 disproportionately affect older people?	Aging (Albany NY)
32470851	"Role of oxidized LDL-induced ""trained macrophages"" in the pathogenesis of COVID-19 and benefits of pioglitazone: A hypothesis."	Diabetes Metab Syndr
32470789	Survival of COVID-19 patients requires precise immune regulation: The hypothetical immunoprotective role of nicotinic agonists.	Med Hypotheses
32470577	High throughput virtual screening reveals SARS-CoV-2 multi-target binding natural compounds to lead instant therapy for COVID-19 treatment.	Int J Biol Macromol
32470547	Targeting Neprilysin (NEP) pathways: A potential new hope to defeat COVID-19 ghost.	Biochem Pharmacol
32470470	Cathepsin L-selective inhibitors: A potentially promising treatment for COVID-19 patients.	Pharmacol Ther
32470408	The neurological impact of COVID-19.	Lancet Neurol
32470223	COVID-19: Structural predictions of viral success.	Int J Clin Pract
32470174	"Higher prevalence of asymptomatic or mild COVID-19 in children, claims and clues."	J Med Virol
32470173	The novel coronavirus SARS-CoV-2: From a zoonotic infection to coronavirus disease 2019.	J Med Virol
32469504	Heralding Healthcare Professionals: Recognition of Neurological Deficits in COVID-19.	ACS Chem Neurosci
32469437	A Comprehensive Updated Review on SARS-CoV-2 and COVID-19.	J Clin Pharmacol
32469387	Neuropathogenesis and Neurologic Manifestations of the Coronaviruses in the Age of Coronavirus Disease 2019: A Review.	JAMA Neurol
32469301	Potential RNA-dependent RNA polymerase inhibitors as prospective therapeutics against SARS-CoV-2.	J Med Microbiol
32469279	Withanone and Withaferin-A are predicted to interact with transmembrane protease serine 2 (TMPRSS2) and block entry of SARS-CoV-2 into cells.	J Biomol Struct Dyn
32469265	Docking study of chloroquine and hydroxychloroquine interaction with RNA binding domain of nucleocapsid phospho-protein - an in silico insight into the comparative efficacy of repurposing antiviral drugs.	J Biomol Struct Dyn
32469258	Detection of SARS-CoV-2 in Human Retinal Biopsies of Deceased COVID-19 Patients.	Ocul Immunol Inflamm
32469255	SARS-CoV-2 perturbs the renin-angiotensin system and energy metabolism.	Am J Physiol Endocrinol Metab
32469251	The gendered impact of coronavirus disease (COVID-19): do estrogens play a role?	Eur J Contracept Reprod Health Care
32469225	COVID-19 and the immune system.	Physiol Res
32469114	An update on ACE2 amplification and its therapeutic potential.	Acta Physiol (Oxf)
32468851	Facing SARS-CoV-2 outbreak in immunotherapy era.	Future Oncol
32468512	COVID-19 may affect the endocrine pancreas by activating Na(+)/H(+) exchanger 2 and increasing lactate levels.	J Endocrinol Invest
32468411	COVID-19 and Asthma: Reflection During the Pandemic.	Clin Rev Allergy Immunol
32468253	Does gallium-citrate have yet another story to tell? Lessons relevant to the COVID-19 era.	Eur J Nucl Med Mol Imaging
32468151	The unleashing of the immune system in COVID-19 and sepsis: the calm before the storm?	Inflamm Res
32468148	Editorial: Archives of Virology's 80th anniversary symposium-6 months later.	Arch Virol
32468052	Pancancer analysis of transmembrane protease serine 2 and cathepsin L that mediate cellular SARSCoV2 infection leading to COVID-19.	Int J Oncol
32467616	More bricks in the wall against SARS-CoV-2 infection: involvement of gamma9delta2 T cells.	Cell Mol Immunol
32467603	Resistance of children to Covid-19. How?	Mucosal Immunol
32467561	Immune response in COVID-19: addressing a pharmacological challenge by targeting pathways triggered by SARS-CoV-2.	Signal Transduct Target Ther
32467492	COVID-19 Guide for the Rehabilitation Clinician: A Review of Nonpulmonary Manifestations and Complications.	Am J Phys Med Rehabil
32467454	COVID-19 and Kawasaki Disease: An Etiology or Coincidental Infection?	Pediatr Infect Dis J
32467423	Potential Mechanisms of Cardiac Injury and Common Pathways of Inflammation in Patients With COVID-19.	Crit Pathw Cardiol
32467284	Coding-Complete Genome Sequences of Two SARS-CoV-2 Isolates from Egypt.	Microbiol Resour Announc
32467283	Complete Genome Sequence of SARS-CoV-2 in a Tiger from a U.S. Zoological Collection.	Microbiol Resour Announc
32467020	Acute inflammation and pathogenesis of SARS-CoV-2 infection: Cannabidiol as a potential anti-inflammatory treatment?	Cytokine Growth Factor Rev
32466994	Potential risks of SARS-CoV-2 infection on reproductive health.	Reprod Biomed Online
32466598	Metabolic Impacts of Confinement during the COVID-19 Pandemic Due to Modified Diet and Physical Activity Habits.	Nutrients
32466577	"Early Phylogenetic Diversification of SARS-CoV-2: Determination of Variants and the Effect on Epidemiology, Immunology, and Diagnostics."	J Clin Med
32466289	Cellular Metabolic Profiling of CrFK Cells Infected with Feline Infectious Peritonitis Virus Using Phenotype Microarrays.	Pathogens
32464652	Epicardial adipose tissue: fuel for COVID-19-induced cardiac injury?	Eur Heart J
32464642	Myocardial injury in severe COVID-19 infection.	Eur Heart J
32464641	Does epicardial fat contribute to COVID-19 myocardial inflammation?	Eur Heart J
32464637	The mechanistic overview of SARS-CoV-2 using angiotensin-converting enzyme 2 to enter the cell for replication: possible treatment options related to the renin-angiotensin system.	Eur Heart J Cardiovasc Pharmacother
32464584	The underpinning biology relating to multiple sclerosis disease modifying treatments during the COVID-19 pandemic.	Mult Scler Relat Disord
32464496	Genetic variation in SARS-CoV-2 may explain variable severity of COVID-19.	Med Hypotheses
32464494	Homocysteine as a potential predictor of cardiovascular risk in patients with COVID-19.	Med Hypotheses
32464493	Hypoxia inducible factor-1 protects against COVID-19: A hypothesis.	Med Hypotheses
32464491	Selenium supplementation in the prevention of coronavirus infections (COVID-19).	Med Hypotheses
32464367	The neurology of COVID-19 revisited: A proposal from the Environmental Neurology Specialty Group of the World Federation of Neurology to implement international neurological registries.	J Neurol Sci
32464327	COVID-19 and Kawasaki disease in children.	Pharmacol Res
32464271	Could the D614G substitution in the SARS-CoV-2 spike (S) protein be associated with higher COVID-19 mortality?	Int J Infect Dis
32464098	The Innate Immune System: Fighting on the Front Lines or Fanning the Flames of COVID-19?	Cell Host Microbe
32464097	"Type I and Type III Interferons - Induction, Signaling, Evasion, and Application to Combat COVID-19."	Cell Host Microbe
32464083	P-selectin blockade in COVID-19-related ARDS.	Am J Physiol Lung Cell Mol Physiol
32463803	Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent.	J Clin Invest
32463794	Metformin and SARS-CoV-2: mechanistic lessons on air pollution to weather the cytokine/thrombotic storm in COVID-19.	Aging (Albany NY)
32463562	Possible Role of Adipose Tissue and the Endocannabinoid System in Coronavirus Disease 2019 Pathogenesis: Can Rimonabant Return?	Obesity (Silver Spring)
32463434	Metatranscriptomic Characterization of Coronavirus Disease 2019 Identified a Host Transcriptional Classifier Associated With Immune Signaling.	Clin Infect Dis
32463395	The involvement of the central nervous system in patients with COVID-19.	Rev Neurosci
32463365	Knowledge synthesis of 100 million biomedical documents augments the deep expression profiling of coronavirus receptors.	Elife
32463239	Is the Rigidity of SARS-CoV-2 Spike Receptor-Binding Motif the Hallmark for Its Enhanced Infectivity? Insights from All-Atom Simulations.	J Phys Chem Lett
32463078	Decreased myocardial infarction admissions during COVID times: what can we learn?	Cardiovasc Res
32463026	A Novel Vaccine Employing Non-Replicating Rabies Virus Expressing Chimeric SARS-CoV-2 Spike Protein Domains: Functional Inhibition of Viral/Nicotinic Acetylcholine Receptor Complexes.	Med Sci Monit
32463005	The COVID-19 Pandemic: A Challenge for the Cardiovascular Health.	Curr Cardiol Rev
32462996	"Molecular docking, simulation and MM-PBSA studies of nigella sativa compounds: a computational quest to identify potential natural antiviral for COVID-19 treatment."	J Biomol Struct Dyn
32462988	A computational prediction of SARS-CoV-2 structural protein inhibitors from Azadirachta indica (Neem).	J Biomol Struct Dyn
32462970	Identification of potential inhibitors of SARS-COV-2 endoribonuclease (EndoU) from FDA approved drugs: a drug repurposing approach to find therapeutics for COVID-19.	J Biomol Struct Dyn
32462858	Oxygen-ozone therapy as adjuvant in the current emergency in SARS-COV-2 infection: a clinical study.	J Biol Regul Homeost Agents
32462841	[Obesity and risk of severe COVID-19].	Rev Med Suisse
32462744	Shortlisting SARS-CoV-2 Peptides for Targeted Studies from Experimental Data-Dependent Acquisition Tandem Mass Spectrometry Data.	Proteomics
32462717	COVID-19: Consider IL-6 receptor antagonist for the therapy of cytokine storm syndrome in SARS-CoV-2 infected patients.	J Med Virol
32462705	"Clinical features, isolation, and complete genome sequence of severe acute respiratory syndrome coronavirus 2 from the first two patients in Vietnam."	J Med Virol
32462701	Animal models of mechanisms of SARS-CoV-2 infection and COVID-19 pathology.	Br J Pharmacol
32462695	"Coinfection with SARS-CoV-2 and other respiratory pathogens in patients with COVID-19 in Guangzhou, China."	J Med Virol
32462689	Features of enteric disease from human coronaviruses: Implications for COVID-19.	J Med Virol
32462316	"SARS-CoV-2 infection, male fertility and sperm cryopreservation: a position statement of the Italian Society of Andrology and Sexual Medicine (SIAMS) (Societa Italiana di Andrologia e Medicina della Sessualita)."	J Endocrinol Invest
32462282	"Ivermectin, antiviral properties and COVID-19: a possible new mechanism of action."	Naunyn Schmiedebergs Arch Pharmacol
32462267	Coronavirus Disease 2019 (COVID-19) and its implications for cardiovascular care: expert document from the German Cardiac Society and the World Heart Federation.	Clin Res Cardiol
32461703	Mechanobiology predicts raft formations triggered by ligand-receptor activity across the cell membrane.	J Mech Phys Solids
32461672	Kawasaki disease linked to COVID-19 in children.	Nat Rev Immunol
32461671	Innate T cells in COVID-19: friend or foe?	Nat Rev Immunol
32461612	Vulnerabilities in coronavirus glycan shields despite extensive glycosylation.	Nat Commun
32461321	Porcine Epidemic Diarrhea Virus Deficient in RNA Cap Guanine-N-7 Methylation Is Attenuated and Induces Higher Type I and III Interferon Responses.	J Virol
32461230	SARS-CoV-2 pandemic: clinical picture of COVID-19 and implications for research.	Thorax
32461198	"COVID-19, hypertension and cardiovascular diseases: Should we change the therapy?"	Pharmacol Res
32461193	Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases.	Clin Immunol
32461141	The case of complement activation in COVID-19 multiorgan impact.	Kidney Int
32460973	Age-related difference in the rate of coronavirus disease 2019 mortality in women versus men.	Am J Obstet Gynecol
32460632	Viral Infections in Burns.	Surg Infect (Larchmt)
32460624	The amount of cytokine-release defines different shades of Sars-Cov2 infection.	Exp Biol Med (Maywood)
32460534	C3 and ACE1 polymorphisms are more important confounders in the spread and outcome of COVID-19 in comparison with ABO polymorphism.	Eur J Prev Cardiol
32460415	Dysphagia in COVID-19 -multilevel damage to the swallowing network?	Eur J Neurol
32460208	Sodium chromo-glycate and palmitoylethanolamide: A possible strategy to treat mast cell-induced lung inflammation in COVID-19.	Med Hypotheses
32460144	Altered cytokine levels and immune responses in patients with SARS-CoV-2 infection and related conditions.	Cytokine
32459984	"SARS-CoV-2 Phylogenetic Analysis, Lazio Region, Italy, February-March 2020."	Emerg Infect Dis
32459663	"COVID-19, microangiopathy, hemostatic activation, and complement."	J Clin Invest
32459574	"The world is waiting, use sequential analysis and get us the evidence-based treatment we need for COVID-19."	Libyan J Med
32459524	Obesity and COVID-19: immune and metabolic derangement as a possible link to adverse clinical outcomes.	Am J Physiol Endocrinol Metab
32459372	COVID-19 and renin-angiotensin system inhibition: role of angiotensin converting enzyme 2 (ACE2) - Is there any scientific evidence for controversy?	J Intern Med
32459144	Discovery of alliin as a putative inhibitor of the main protease of SARS-CoV-2 by molecular docking.	Biotechniques
32459123	Mechanistic inferences from clinical reports of SARS-CoV-2.	Infect Dis (Lond)
32459003	A role for retinoids in the treatment of COVID-19?	Clin Exp Pharmacol Physiol
32458823	[Coronavirus Covid-19 infection and breastfeeding: an exploratory review].	Rev Esp Salud Publica
32458804	The immune system of children: the key to understanding SARS-CoV-2 susceptibility?	Lancet Child Adolesc Health
32458694	Decreased Mortality of COVID-19 With Renin-Angiotensin-Aldosterone System Inhibitors Therapy in Patients With Hypertension: A Meta-Analysis.	Hypertension
32458561	Lymphopenia in COVID-19: Therapeutic opportunities.	Cell Biol Int
32458475	Ratcheting down the virulence of SARS-CoV-2 in the COVID-19 pandemic.	J Med Virol
32458400	Implications for Neuromodulation Therapy to Control Inflammation and Related Organ Dysfunction in COVID-19.	J Cardiovasc Transl Res
32458383	On barring the vascular gateway against severe COVID-19 disease.	Cell Stress Chaperones
32458242	Can COVID-19 cause myalgia with a completely different mechanism? A hypothesis.	Clin Rheumatol
32458206	Potential new treatment strategies for COVID-19: is there a role for bromhexine as add-on therapy?	Intern Emerg Med
32458193	Understanding the neurotropic characteristics of SARS-CoV-2: from neurological manifestations of COVID-19 to potential neurotropic mechanisms.	J Neurol
32457811	The lethal sex gap: COVID-19.	Immun Ageing
32457522	Dysregulation of type I interferon responses in COVID-19.	Nat Rev Immunol
32457038	Potential COVID-19 therapeutics from a rare disease: weaponizing lipid dysregulation to combat viral infectivity.	J Lipid Res
32456648	Two consecutive myocardial tissue insults for inpatients with COVID-19.	Crit Care
32456461	Clinical sequelae of the novel coronavirus: does COVID-19 infection predispose patients to cancer?	Future Oncol
32456409	"A theory on SARS-COV-2 susceptibility: reduced TLR7-activity as a mechanistic link between men, obese and elderly."	J Biol Regul Homeost Agents
32456368	[Therapy of coronavirus disease 2019 induced acute respiratory distress syndrome is different from traditional acute respiratory distress syndrome].	Zhonghua Shao Shang Za Zhi
32456011	"The Role of Extracellular Vesicles as Allies of HIV, HCV and SARS Viruses."	Viruses
32455942	Potential Therapeutic Targeting of Coronavirus Spike Glycoprotein Priming.	Molecules
32455629	"Tripartite Combination of Candidate Pandemic Mitigation Agents: Vitamin D, Quercetin, and Estradiol Manifest Properties of Medicinal Agents for Targeted Mitigation of the COVID-19 Pandemic Defined by Genomics-Guided Tracing of SARS-CoV-2 Targets in Human Cells."	Biomedicines
32455539	Smoking-Mediated Upregulation of the Androgen Pathway Leads to Increased SARS-CoV-2 Susceptibility.	Int J Mol Sci
32455534	Potential Inhibitors for Novel Coronavirus Protease Identified by Virtual Screening of 606 Million Compounds.	Int J Mol Sci
32455515	[Clinical feature changes of a COVID-19 patient from mild to critical condition and cardiopulmonary pathological results].	Zhonghua Xin Xue Guan Bing Za Zhi
32455089	A Review of Neurological Complications of COVID-19.	Cureus
32454513	Human neutralizing antibodies elicited by SARS-CoV-2 infection.	Nature
32454512	A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2.	Nature
32454510	Potential Immunoregulatory and Antiviral/SARS-CoV-2 Activities of Nitric Oxide.	Med Sci Monit
32454408	COVID-19 as a STING disorder with delayed over-secretion of interferon-beta.	EBioMedicine
32454157	Crosstalk between endoplasmic reticulum stress and anti-viral activities: A novel therapeutic target for COVID-19.	Life Sci
32454103	Type I astrocytes and microglia induce a cytokine response in an encephalitic murine coronavirus infection.	Exp Mol Pathol
32454092	Microvascular thrombosis: experimental and clinical implications.	Transl Res
32454066	High Expression of ACE2 on Keratinocytes Reveals Skin as a Potential Target for SARS-CoV-2.	J Invest Dermatol
32453863	COVID-19 and ABO blood group: another viewpoint.	Br J Haematol
32453861	Is molecular mimicry the culprit in the autoimmune haemolytic anaemia affecting patients with COVID-19?	Br J Haematol
32453494	SARS-CoV-2 presence in seminal fluid: Myth or reality.	Andrology
32453251	Extracorporeal Hemoadsorption: An Option for COVID-19-Associated Cytokine Storm Syndrome.	Shock
32452979	Pediatric Crohn Disease and Multisystem Inflammatory Syndrome in Children (MIS-C) and COVID-19 Treated With Infliximab.	J Pediatr Gastroenterol Nutr
32452762	SARS-CoV-2 strategically mimics proteolytic activation of human ENaC.	Elife
32452757	Vascular injury and COVID-19-related mortality: What lies below the tip of the iceberg?	Clin Nephrol
32452670	Immunity-Boosting Spices and the Novel Coronavirus.	ACS Chem Neurosci
32452644	Caution in the management of SARS-CoV-2 infection in males.	Andrology
32452539	"COVID-19 under spotlight: A close look at the origin, transmission, diagnosis, and treatment of the 2019-nCoV disease."	J Cell Physiol
32452417	New insights into the evolutionary features of viral overlapping genes by discriminant analysis.	Virology
32452282	Fragment tailoring strategy to design novel chemical entities as potential binders of novel corona virus main protease.	J Biomol Struct Dyn
32451923	The G-Quadruplex/Helicase World as a Potential Antiviral Approach Against COVID-19.	Drugs
32451913	"Obesity and COVID-19: ACE 2, the Missing Tile."	Obes Surg
32451881	A DNA Aptamer Based Method for Detection of SARS-CoV-2 Nucleocapsid Protein.	Virol Sin
32451846	Does SARS-CoV-2 infection cause chronic neurological complications?	Geroscience
32451547	APOE e4 Genotype Predicts Severe COVID-19 in the UK Biobank Community Cohort.	J Gerontol A Biol Sci Med Sci
32451533	Molecular Detection of SARS-CoV-2 Infection in FFPE Samples and Histopathologic Findings in Fatal SARS-CoV-2 Cases.	Am J Clin Pathol
32451352	SARS-CoV-2: Viral Mechanisms and Possible Therapeutic Targets - What to Learn from Rheumatologists.	J Rheumatol
32451317	The contribution of diabetic micro-angiopathy to adverse outcomes in COVID-19.	Diabetes Res Clin Pract
32451271	Coronavirus Disease-2019 (COVID-19) and Cardiovascular Complications.	J Cardiothorac Vasc Anesth
32451080	A possible strategy to fight COVID-19: Interfering with spike glycoprotein trimerization.	Biochem Biophys Res Commun
32450787	Liver injury in COVID-19: The current evidence.	United European Gastroenterol J
32450774	"A call to research: the relationship between SARS-2-CoV, ACE 2 and antihypertensives."	Pathog Glob Health
32450631	[The analysis of clinical characteristics of 34 novel coronavirus pneumonia cases in Ningxia Hui autonomous region].	Zhonghua Jie He He Hu Xi Za Zhi
32450346	Biochemical indicators of coronavirus disease 2019 exacerbation and the clinical implications.	Pharmacol Res
32450334	"The interplay of hypertension, ACE-2 and SARS-CoV-2: Emerging data as the ""Ariadne's thread"" for the ""labyrinth"" of COVID-19."	Hellenic J Cardiol
32450197	Extra-respiratory manifestations of COVID-19.	Int J Antimicrob Agents
32450171	Coronaviruses pandemics: Can neutralizing antibodies help?	Life Sci
32450166	Unravelling lead antiviral phytochemicals for the inhibition of SARS-CoV-2 M(pro) enzyme through in silico approach.	Life Sci
32450165	"Coronaviruses pathogenesis, comorbidities and multi-organ damage - A review."	Life Sci
32450087	"ACE2, TMPRSS2, and furin gene expression in the airways of people with asthma-implications for COVID-19."	J Allergy Clin Immunol
32449939	SARS-CoV-2 spike glycoprotein-binding proteins expressed by upper respiratory tract bacteria may prevent severe viral infection.	FEBS Lett
32449171	COVID-19: are neutralizing antibodies neutralizing enough?	Transfusion
32448818	Protease Inhibitors: Candidate Drugs to Inhibit Severe Acute Respiratory Syndrome Coronavirus 2 Replication.	Tohoku J Exp Med
32448674	Ischaemic stroke and SARS-CoV-2 infection: A causal or incidental association?	Neurologia (Engl Ed)
32448635	COVID-19 during pregnancy: Potential risk for neurodevelopmental disorders in neonates?	Eur J Obstet Gynecol Reprod Biol
32448590	Marked Up-Regulation of ACE2 in Hearts of Patients With Obstructive Hypertrophic Cardiomyopathy: Implications for SARS-CoV-2-Mediated COVID-19.	Mayo Clin Proc
32448490	"Mysterious Virus: A Review on Behavior and Treatment Approaches of the Novel Coronavirus, 2019-nCoV."	Arch Med Res
32448098	Structural and simulation analysis of hotspot residues interactions of SARS-CoV 2 with human ACE2 receptor.	J Biomol Struct Dyn
32448085	Repurposing approved drugs as inhibitors of SARS-CoV-2 S-protein from molecular modeling and virtual screening.	J Biomol Struct Dyn
32448041	Covid-19 induced superimposed bacterial infection.	J Biomol Struct Dyn
32448039	In-silico strategies for probing chloroquine based inhibitors against SARS-CoV-2.	J Biomol Struct Dyn
32448034	Identification of phytochemical inhibitors against main protease of COVID-19 using molecular modeling approaches.	J Biomol Struct Dyn
32447934	[Clinical and coagulation characteristics in 7 patients with critical COVID-2019 pneumonia and acro-ischemia].	Zhonghua Xue Ye Xue Za Zhi
32447820	Coronavirus disease (COVID-19): An updated review based on current knowledge and existing literature for dermatologists.	Dermatol Ther
32447736	Lack of Efficacy of SGLT2-i in Severe Pneumonia Related to Novel Coronavirus (nCoV) Infection: No Little Help from Our Friends.	Diabetes Ther
32447630	COVID-19 and the nervous system.	J Neurovirol
32447571	"The Proteins of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS CoV-2 or n-COV19), the Cause of COVID-19."	Protein J
32447232	COVID-19: beta-thalassemia subjects immunised?	Med Hypotheses
32447057	Caution is needed on the effect of altitude on the pathogenesis of SAR-CoV-2 virus.	Respir Physiol Neurobiol
32447007	"Severe air pollution links to higher mortality in COVID-19 patients: The ""double-hit"" hypothesis."	J Infect
32446902	Immunoinformatic analysis of the SARS-CoV-2 envelope protein as a strategy to assess cross-protection against COVID-19.	Microbes Infect
32446866	The eye as the discrete but defensible portal of coronavirus infection.	Ocul Surf
32446778	The cytokine storm in COVID-19: An overview of the involvement of the chemokine/chemokine-receptor system.	Cytokine Growth Factor Rev
32446559	Stability of RNA sequences derived from the coronavirus genome in human cells.	Biochem Biophys Res Commun
32446313	Organoids of human airways to study infectivity and cytopathy of SARS-CoV-2.	Lancet Respir Med
32446267	What solid organ transplant healthcare providers should know about renin-angiotensin-aldosterone system inhibitors and COVID-19.	Clin Transplant
32445956	Review on the potential action mechanisms of Chinese medicines in treating Coronavirus Disease 2019 (COVID-19).	Pharmacol Res
32445924	Overwhelming mutations or SNPs of SARS-CoV-2: A point of caution.	Gene
32445872	Sodium status and kidney involvement during COVID-19 infection.	Virus Res
32445671	Can Ticagrelor be used to prevent sepsis-induced coagulopathy in COVID-19?	Clin Immunol
32445403	SARS-CoV-2 infection-induced immune responses: Friends or foes?	Scand J Immunol
32445249	How did we get here? Short history of COVID-19 and other coronavirus-related epidemics.	Head Neck
32444771	Insight into the relationship between obesity-induced low-level chronic inflammation and COVID-19 infection.	Int J Obes (Lond)
32444693	RAAS inhibitors do not increase the risk of COVID-19.	Nat Rev Cardiol
32444466	The Landscape of Human Cancer Proteins Targeted by SARS-CoV-2.	Cancer Discov
32444414	Antibodies against immunogenic epitopes with high sequence identity to SARS-CoV-2 in patients with autoimmune dermatomyositis.	Ann Rheum Dis
32444400	COVID-19 and the nicotinic cholinergic system.	Eur Respir J
32444269	Immunotherapies for COVID-19: lessons learned from sepsis.	Lancet Respir Med
32443911	Proteasome Inhibitors as a Possible Therapy for SARS-CoV-2.	Int J Mol Sci
32443810	"A Structural View of SARS-CoV-2 RNA Replication Machinery: RNA Synthesis, Proofreading and Final Capping."	Cells
32442557	Lack of type 1 diabetes involvement in SARS-COV-2 population: Only a particular coincidence?	Diabetes Res Clin Pract
32442555	Type 1 diabetes triggered by covid-19 pandemic: A potential outbreak?	Diabetes Res Clin Pract
32442437	The proteasome as a druggable target with multiple therapeutic potentialities: Cutting and non-cutting edges.	Pharmacol Ther
32442317	The case for chronotherapy in Covid-19-induced acute respiratory distress syndrome.	Br J Pharmacol
32442315	Alternative splicing of ACE2 possibly generates variants that may limit the entry of SARS-CoV-2: a potential therapeutic approach using SSOs.	Clin Sci (Lond)
32442294	Therapy With Agents Acting on the Renin-Angiotensin System and Risk of Severe Acute Respiratory Syndrome Coronavirus 2 Infection.	Clin Infect Dis
32442287	Thymosin Alpha 1 Reduces the Mortality of Severe Coronavirus Disease 2019 by Restoration of Lymphocytopenia and Reversion of Exhausted T Cells.	Clin Infect Dis
32442285	Association of Renin-angiotensin-aldosterone System Inhibitors With Coronavirus Disease 2019 (COVID-19)- Related Outcomes in Korea: A Nationwide Population-based Cohort Study.	Clin Infect Dis
32442259	Renin-Angiotensin-Aldosterone System Inhibitors Impact on COVID-19 Mortality: What's Next for ACE2?	Clin Infect Dis
32442210	The hallmarks of COVID-19 disease.	PLoS Pathog
32442105	The FDA-approved gold drug auranofin inhibits novel coronavirus (SARS-COV-2) replication and attenuates inflammation in human cells.	Virology
32441816	Systematic analysis of ACE2 and TMPRSS2 expression in salivary glands reveals underlying transmission mechanism caused by SARS-CoV-2.	J Med Virol
32441805	Severe Acute Lung Injury Related to COVID-19 Infection: A Review and the Possible Role for Escin.	J Clin Pharmacol
32441783	A rationale for targeting the P2X7 receptor in Coronavirus disease 19.	Br J Pharmacol
32441764	Repositioning PARP inhibitors for SARS-CoV-2 infection(COVID-19); a new multi-pronged therapy for acute respiratory distress syndrome?	Br J Pharmacol
32441299	Glecaprevir and Maraviroc are high-affinity inhibitors of SARS-CoV-2 main protease: possible implication in COVID-19 therapy.	Biosci Rep
32441223	COVID-19 and obesity: links and risks.	Expert Rev Endocrinol Metab
32441063	"Coronavirus disease 2019 (COVID-19): angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers and cardiovascular disease."	Med J Aust
32440692	Temporal Correlation Between Neurological and Gastrointestinal Symptoms of SARS-CoV-2.	Inflamm Bowel Dis
32439915	Downregulation of ACE2 induces overstimulation of the renin-angiotensin system in COVID-19: should we block the renin-angiotensin system?	Hypertens Res
32439870	COVID-19: the vasculature unleashed.	Nat Rev Immunol
32439309	"[Narrative review of the immune response against coronavirus: An overview, applicability for SARS-COV-2, and therapeutic implications]."	An Pediatr (Engl Ed)
32439289	Active smoking and COVID-19: a double-edged sword.	Eur J Intern Med
32439198	Probable Molecular Mechanism of Remdesivir for the Treatment of COVID-19: Need to Know More.	Arch Med Res
32439197	COVID-19 and Multiorgan Response.	Curr Probl Cardiol
32438687	The COVID-19 Pandemic during the Time of the Diabetes Pandemic: Likely Fraternal Twins?	Pathogens
32438620	COVID-19: The Inflammation Link and the Role of Nutrition in Potential Mitigation.	Nutrients
32438473	Prevention and treatment of COVID-19 disease by controlled modulation of innate immunity.	Eur J Immunol
32438449	The dilemma of renin-angiotensin system inhibitors in coronavirus disease 2019 (COVID-19): insights into lung fluid handling and gas exchange in heart failure patients.	Eur J Heart Fail
32438383	Inhaled modified angiotensin converting enzyme 2 (ACE2) as a decoy to mitigate SARS-CoV-2 infection.	N Z Med J
32438371	Structure of replicating SARS-CoV-2 polymerase.	Nature
32437961	Coagulation changes and thromboembolic risk in COVID-19 obstetric patients.	Anaesth Crit Care Pain Med
32437891	"COVID-19, an opportunity to reevaluate the correlation between long-term effects of anthropogenic pollutants on viral epidemic/pandemic events and prevalence."	Food Chem Toxicol
32437797	The current understanding and potential therapeutic options to combat COVID-19.	Life Sci
32437766	Multivesicular bodies mimicking SARS-CoV-2 in patients without COVID-19.	Kidney Int
32437749	Human Intestinal Defensin 5 Inhibits SARS-CoV-2 Invasion by Cloaking ACE2.	Gastroenterology
32437659	Trained Immunity: a Tool for Reducing Susceptibility to and the Severity of SARS-CoV-2 Infection.	Cell
32437628	"COVID-19, Asthma, and Inhaled Corticosteroids: Another Beneficial Effect of Inhaled Corticosteroids?"	Am J Respir Crit Care Med
32437622	Complement Activation during Critical Illness: Current Findings and an Outlook in the Era of COVID-19.	Am J Respir Crit Care Med
32437596	"Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19."	N Engl J Med
32437586	Understanding the COVID-19 coagulopathy spectrum.	Anaesthesia
32437478	Harnessing the natural anti-glycan immune response to limit the transmission of enveloped viruses such as SARS-CoV-2.	PLoS Pathog
32437316	"Pathology and Pathogenesis of SARS-CoV-2 Associated with Fatal Coronavirus Disease, United States."	Emerg Infect Dis
32437244	Let's talk about sex in the context of COVID-19.	J Appl Physiol (1985)
32437232	Virus-induced genetics revealed by multidimensional precision medicine transcriptional workflow applicable to COVID-19.	Physiol Genomics
32437018	TMPRSS2: Potential Biomarker for COVID-19 Outcomes.	J Clin Pharmacol
32437002	Is the brain a reservoir organ for SARS-CoV2?	J Med Virol
32436995	"The potential of memantine and related adamantanes such as amantadine, to reduce the neurotoxic effects of COVID-19, including ARDS and to reduce viral replication through lysosomal effects."	J Med Virol
32436829	Triazavirin - Potential inhibitor for 2019-nCoV Coronavirus M protease: A DFT study.	Curr Mol Med
32436629	"High COVID-19 virus replication rates, the creation of antigen-antibody immune complexes and indirect haemagglutination resulting in thrombosis."	Transbound Emerg Dis
32436571	Associations of Early COVID-19 Cases in San Francisco With Domestic and International Travel.	Clin Infect Dis
32436460	TNFalpha inhibitor may be effective for severe COVID-19: learning from toxic epidermal necrolysis.	Ther Adv Respir Dis
32436403	Evidence That Renin-Angiotensin System Inhibitors Should Not Be Discontinued Due to the COVID-19 Pandemic.	Hypertension
32436229	Could COVID-19 have an impact on male fertility?	Andrologia
32435852	Gustatory dysfunctions in COVID-19 patients: possible involvement of taste renin-angiotensin system (RAS).	Eur Arch Otorhinolaryngol
32435607	Potential Role of ACE2 in Coronavirus Disease 2019 (COVID-19) Prevention and Management.	J Transl Int Med
32435059	A suspicious role of interferon in the pathogenesis of SARS-CoV-2 by enhancing expression of ACE2.	Signal Transduct Target Ther
32434946	SARS-CoV-2 infection protects against rechallenge in rhesus macaques.	Science
32434888	Replication of Severe Acute Respiratory Syndrome Coronavirus 2 in Human Respiratory Epithelium.	J Virol
32434816	Severe COVID-19 and related hyperferritinaemia: more than an innocent bystander?	Ann Rheum Dis
32434788	"COVID-19 and lung cancer: risks, mechanisms and treatment interactions."	J Immunother Cancer
32434431	"Cardiovascular disease, heart failure and COVID-19."	J Renin Angiotensin Aldosterone Syst
32434211	Viral and host factors related to the clinical outcome of COVID-19.	Nature
32434133	"The emerging spectrum of cardiopulmonary pathology of the coronavirus disease 2019 (COVID-19): Report of 3 autopsies from Houston, Texas, and review of autopsy findings from other United States cities."	Cardiovasc Pathol
32434058	"A chronicle of SARS-CoV-2: Part-I - Epidemiology, diagnosis, prognosis, transmission and treatment."	Sci Total Environ
32433946	Herd Immunity: Understanding COVID-19.	Immunity
32433742	Extended ORF8 Gene Region Is Valuable in the Epidemiological Investigation of Severe Acute Respiratory Syndrome-Similar Coronavirus.	J Infect Dis
32433641	Potential differential effects of renin-angiotensin system inhibitors on SARS-CoV-2 infection and lung injury in COVID-19.	Hypertens Res
32433465	Immunogenicity of a DNA vaccine candidate for COVID-19.	Nat Commun
32433345	The pharmacological development of direct acting agents for emerging needed therapy against severe acute respiratory syndrome coronavirus-2.	J Chin Med Assoc
32433344	Judicious use of sodium-glucose cotransporter 2 inhibitors in patients with diabetes on coronavirus-19 pandemic.	J Chin Med Assoc
32433259	Why is COVID-19 virus so deadly for cancer patients?	Eur J Cancer Prev
32432977	"Gemcitabine, lycorine and oxysophoridine inhibit novel coronavirus (SARS-CoV-2) in cell culture."	Emerg Microbes Infect
32432918	Estrogen regulates the expression of SARS-CoV-2 receptor ACE2 in differentiated airway epithelial cells.	Am J Physiol Lung Cell Mol Physiol
32432723	Renin-angiotensin system and SARS-CoV-2 infection: there is a before and after.	Eur Heart J
32432704	Renin-angiotensin-aldosterone system dysregulation and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.	Eur Heart J
32432681	Nasal ACE2 Levels and COVID-19 in Children.	JAMA
32432483	Expression of the SARS-CoV-2 ACE2 Receptor in the Human Airway Epithelium.	Am J Respir Crit Care Med
32432433	Severity of COVID-19: The importance of being hypertensive.	Monaldi Arch Chest Dis
32431949	Multivariate analyses of codon usage of SARS-CoV-2 and other betacoronaviruses.	Virus Evol
32431818	Visualizing an unseen enemy; mobilizing structural biology to counter COVID-19.	IUCrJ
32431755	"The novel immunomodulatory biologic LMWF5A for pharmacological attenuation of the ""cytokine storm"" in COVID-19 patients: a hypothesis."	Patient Saf Surg
32431217	Withanone and caffeic acid phenethyl ester are predicted to interact with main protease (M(pro)) of SARS-CoV-2 and inhibit its activity.	J Biomol Struct Dyn
32430996	Potential effects of curcumin in the treatment of COVID-19 infection.	Phytother Res
32430651	"The SARS-CoV-2 receptor, ACE-2, is expressed on many different cell types: implications for ACE-inhibitor- and angiotensin II receptor blocker-based cardiovascular therapies."	Intern Emerg Med
32430627	COVID-19-associated cardiovascular morbidity in older adults: a position paper from the Italian Society of Cardiovascular Researches.	Geroscience
32430459	"Exploring Diseases/Traits and Blood Proteins Causally Related to Expression of ACE2, the Putative Receptor of SARS-CoV-2: A Mendelian Randomization Analysis Highlights Tentative Relevance of Diabetes-Related Traits."	Diabetes Care
32430432	The liaison between respiratory failure and high blood pressure: evidence from COVID-19 patients.	Eur Respir J
32430431	"Smoking, ACE-2 and COVID-19: ongoing controversies."	Eur Respir J
32430427	COVID-19 and vaping: risk for increased susceptibility to SARS-CoV-2 infection?	Eur Respir J
32430402	Could severe COVID-19 be considered a complementopathy?	Lupus Sci Med
32430287	Rho kinase inhibitors for SARS-CoV-2 induced acute respiratory distress syndrome: Support from Bartter's and Gitelman's syndrome patients.	Pharmacol Res
32430286	The possible mechanisms of action of 4-aminoquinolines (chloroquine/hydroxychloroquine) against Sars-Cov-2 infection (COVID-19): A role for iron homeostasis?	Pharmacol Res
32430279	Gut microbiota and Covid-19- possible link and implications.	Virus Res
32430094	The dynamics of humoral immune responses following SARS-CoV-2 infection and the potential for reinfection.	J Gen Virol
32430049	Letter to the editor: The role of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in developing a COVID-19 comorbidity-based host risk score.	Crit Care
32429572	The Role of Lipid Metabolism in COVID-19 Virus Infection and as a Drug Target.	Int J Mol Sci
32429235	AMPK and the Need to Breathe and Feed: What's the Matter with Oxygen?	Int J Mol Sci
32429099	Deubiquitinating Enzymes in Coronaviruses and Possible Therapeutic Opportunities for COVID-19.	Int J Mol Sci
32428921	Acute Kidney Injury in COVID-19 Pandemic.	Nephron
32428864	Angiotensin converting enzyme-2 as therapeutic target in COVID-19.	Diabetes Metab Syndr
32428835	Advances in the relationship between coronavirus infection and cardiovascular diseases.	Biomed Pharmacother
32428811	Exercise as medicine for COVID-19: An ACE in the hole?	Med Hypotheses
32428809	Cytokine Storm: Is it the only major death factor in COVID-19 patients? Coagulation role.	Med Hypotheses
32428392	Characterization and Noncovalent Inhibition of the Deubiquitinase and deISGylase Activity of SARS-CoV-2 Papain-Like Protease.	ACS Infect Dis
32428380	Increased ACE2 Expression in Bronchial Epithelium of COPD Patients who are Overweight.	Obesity (Silver Spring)
32428379	Understanding SARS-CoV-2 endocytosis for COVID-19 drug repurposing.	FEBS J
32428113	"Susceptibility of the Elderly to SARS-CoV-2 Infection: ACE-2 Overexpression, Shedding, and Antibody-dependent Enhancement (ADE)."	Clinics (Sao Paulo)
32428111	Why is SARS-CoV-2 infection milder among children?	Clinics (Sao Paulo)
32427809	Inflammatory and Coagulative Considerations for the Management of Orthopaedic Trauma Patients With COVID-19: A Review of the Current Evidence and Our Surgical Experience.	J Orthop Trauma
32427582	Clinical and pathological investigation of patients with severe COVID-19.	JCI Insight
32427468	Autonomic Brain Centers and Pathophysiology of COVID-19.	ACS Chem Neurosci
32427430	Renin-Angiotensin-Aldosterone System Inhibitors in Covid-19.	N Engl J Med
32427429	Renin-Angiotensin-Aldosterone System Inhibitors in Covid-19.	N Engl J Med
32427428	Renin-Angiotensin-Aldosterone System Inhibitors in Covid-19.	N Engl J Med
32427393	Telomeres and COVID-19.	FASEB J
32427288	ACE2 receptor expression in testes: implications in coronavirus disease 2019 pathogenesisdagger.	Biol Reprod
32426999	"Gnotobiotic Rats Reveal That Gut Microbiota Regulates Colonic mRNA of Ace2, the Receptor for SARS-CoV-2 Infectivity."	Hypertension
32426751	The Clinical Presentation and Immunology of Viral Pneumonia and Implications for Management of Coronavirus Disease 2019.	Crit Care Explor
32426749	Neurologic Manifestations of Severe Respiratory Viral Contagions.	Crit Care Explor
32426388	Computation screening of narcissoside a glycosyloxyflavone for potential novel coronavirus 2019 (COVID-19) inhibitor.	Biomed J
32426374	Cardiovascular Impairment in COVID-19: Learning From Current Options for Cardiovascular Anti-Inflammatory Therapy.	Front Cardiovasc Med
32426212	Cross-reactive Antibody Response between SARS-CoV-2 and SARS-CoV Infections.	Cell Rep
32426068	"Letter to the Editor Regarding ""Neurological Impact of Coronavirus Disease (COVID-19): Practical Considerations for the Neuroscience Community""."	World Neurosurg
32426002	[Therapeutic options for the management of severe Covid-19: A rheumatology perspective].	Reumatol Clin (Engl Ed)
32425955	Potential SARS-CoV-2 Preimmune IgM Epitopes.	Front Immunol
32425950	Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19).	Front Immunol
32425712	Evidence Supporting a Phased Immuno-physiological Approach to COVID-19 From Prevention Through Recovery.	Integr Med (Encinitas)
32425701	Cigarette Smoke Exposure and Inflammatory Signaling Increase the Expression of the SARS-CoV-2 Receptor ACE2 in the Respiratory Tract.	Dev Cell
32425663	Evidence and possible mechanisms of rare maternal-fetal transmission of SARS-CoV-2.	J Clin Virol
32425659	Investigating the genomic landscape of novel coronavirus (2019-nCoV) to identify non-synonymous mutations for use in diagnosis and drug design.	J Clin Virol
32425651	Current Scenario of COVID-19 in Pediatric Age Group and Physiology of Immune and Thymus response.	Saudi J Biol Sci
32425649	"Clinical characteristics and co-infections of 354 hospitalized patients with COVID-19 in Wuhan, China: a retrospective cohort study."	Microbes Infect
32425491	"[Pandemic COVID-19, the new health emergency of international concern: A review]."	Semergen
32425479	MRI Evaluation of the Olfactory Clefts in Patients with SARS-CoV-2 Infection Revealed an Unexpected Mechanism for Olfactory Function Loss.	Acad Radiol
32425432	Renin-Angiotensin System Inhibitors and COVID-19: Potential Therapeutics Rather Than Perpetrators.	Acta Cardiol Sin
32425360	"Systemic endothelial dysfunction: A common pathway for COVID-19, cardiovascular and metabolic diseases."	Nutr Metab Cardiovasc Dis
32425325	Intra-arterial thrombosis associated with COVID-19.	J Vasc Surg
32425307	Mesenchymal stem cells-bridge catalyst between innate and adaptive immunity in COVID 19.	Med Hypotheses
32425304	Reflection on lower rates of COVID-19 in children: Does childhood immunizations offer unexpected protection?	Med Hypotheses
32425303	Bioactive compounds with possible inhibitory activity of Angiotensin-Converting Enzyme-II; a gate to manage and prevent COVID-19.	Med Hypotheses
32425294	Weathering the COVID-19 storm: Lessons from hematologic cytokine syndromes.	Blood Rev
32425270	Potent Neutralizing Antibodies against SARS-CoV-2 Identified by High-Throughput Single-Cell Sequencing of Convalescent Patients' B Cells.	Cell
32425249	Diabetes and COVID-19.	Therapie
32425236	Acute pulmonary embolism: An unseen villain in COVID-19.	Indian Heart J
32425226	The Time Sequences of Respiratory and Rectal Viral Shedding in Patients With Coronavirus Disease 2019.	Gastroenterology
32425224	[Solving one of the pieces of the puzzle: COVID-19 and type 2 diabetes].	Rev Clin Esp (Barc)
32425013	COVID-19 and coagulative axis: review of emerging aspects in a novel disease.	Monaldi Arch Chest Dis
32425000	An overview of COVID-19.	J Zhejiang Univ Sci B
32424954	The hypothetical role of phosphatidic acid in subverting ER membranes during SARS-CoV infection.	Traffic
32424945	Distribution of HLA allele frequencies in 82 Chinese individuals with coronavirus disease-2019 (COVID-19).	HLA
32424634	Antagonizing the renin-angiotensin-aldosterone system in the era of COVID-19.	Intern Emerg Med
32424503	Potential neurological impact of coronaviruses: implications for the novel SARS-CoV-2.	Neurol Sci
32424481	Stages or phenotypes? A critical look at COVID-19 pathophysiology.	Intensive Care Med
32424327	Coronavirus disease 2019 (SARS-CoV-2) and colonization of ocular tissues and secretions: a systematic review.	Eye (Lond)
32423917	COVID-19 as an Acute Inflammatory Disease.	J Immunol
32423664	A close-up on COVID-19 and cardiovascular diseases.	Nutr Metab Cardiovasc Dis
32423554	Coronavirus disease 2019 and the cardiovascular system: Impacts and implications.	Indian Heart J
32423553	Angiotensin converting enzyme: A review on expression profile and its association with human disorders with special focus on SARS-CoV-2 infection.	Vascul Pharmacol
32423250	Effect of coronavirus infection on the human heart: A scoping review.	Eur J Prev Cardiol
32423095	"The Expression and Polymorphism of Entry Machinery for COVID-19 in Human: Juxtaposing Population Groups, Gender, and Different Tissues."	Int J Environ Res Public Health
32423094	"COVID-19 and Individual Genetic Susceptibility/Receptivity: Role of ACE1/ACE2 Genes, Immunity, Inflammation and Coagulation. Might the Double X-chromosome in Females Be Protective against SARS-CoV-2 Compared to the Single X-Chromosome in Males?"	Int J Mol Sci
32422996	Highly Conserved Homotrimer Cavity Formed by the SARS-CoV-2 Spike Glycoprotein: A Novel Binding Site.	J Clin Med
32422932	Detection of Recombinant Rousettus Bat Coronavirus GCCDC1 in Lesser Dawn Bats (Eonycteris spelaea) in Singapore.	Viruses
32422894	A Novel Synonymous Mutation of SARS-CoV-2: Is This Possible to Affect Their Antigenicity and Immunogenicity?	Vaccines (Basel)
32422645	Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody.	Nature
32422545	Neurological manifestations of COVID-19 and other coronavirus infections: A systematic review.	Clin Neurol Neurosurg
32422375	Do superspreaders generate new superspreaders? A hypothesis to explain the propagation pattern of COVID-19.	Int J Infect Dis
32422320	p38 MAPK inhibition: A promising therapeutic approach for COVID-19.	J Mol Cell Cardiol
32422305	Lungs as target of COVID-19 infection: Protective common molecular mechanisms of vitamin D and melatonin as a new potential synergistic treatment.	Life Sci
32422280	Two important controversial risk factors in SARS-CoV-2 infection: Obesity and smoking.	Environ Toxicol Pharmacol
32422208	"Associations Between Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blocker Use, Gastrointestinal Symptoms, and Mortality Among Patients With COVID-19."	Gastroenterology
32422146	Type 2 inflammation modulates ACE2 and TMPRSS2 in airway epithelial cells.	J Allergy Clin Immunol
32422144	Perforin and resistance to SARS coronavirus 2.	J Allergy Clin Immunol
32422077	COVID-19 and Angiotensin-Converting Enzyme Inhibitor/Angiotensin-Receptor Blocker Therapy.	Ann Intern Med
32421546	Correlation analysis of the severity and clinical prognosis of 32 cases of patients with COVID-19.	Respir Med
32421539	Coronavirus Disease 2019-related dyspnea cases difficult to interpret using chest computed tomography.	Respir Med
32421367	Is there an impact of the COVID-19 pandemic on male fertility? The ACE2 connection.	Am J Physiol Endocrinol Metab
32421281	Is there relationship between SARS-CoV-2 and the complement C3 and C4?	Turk J Med Sci
32421102	Exploring the active compounds of traditional Mongolian medicine in intervention of novel coronavirus (COVID-19) based on molecular docking method.	J Funct Foods
32421092	SARS-CoV-2 and COVID-19: Is interleukin-6 (IL-6) the 'culprit lesion' of ARDS onset? What is there besides Tocilizumab? SGP130Fc.	Cytokine X
32420944	The impact of MicroRNAs (miRNAs) on the genotype of coronaviruses.	Acta Biomed
32420938	What happens to people's lungs when they get coronavirus disease 2019?	Acta Biomed
32420934	Tobacco smoking and COVID-19 pandemic: old and new issues. A summary of the evidence from the scientific literature.	Acta Biomed
32420884	[COVID-19 and cardiovascular diseases: viewpoint for older patients].	Geriatr Psychol Neuropsychiatr Vieil
32420674	Three months of COVID-19: A systematic review and meta-analysis.	Rev Med Virol
32420615	Dynamic relationship between D-dimer and COVID-19 severity.	Br J Haematol
32420587	COVID-19 as a cardiovascular disease: the potential role of chronic endothelial dysfunction.	Cardiovasc Res
32420049	Combating COVID-19 with mesenchymal stem cell therapy.	Biotechnol Rep (Amst)
32419926	"Use of the informational spectrum methodology for rapid biological analysis of the novel coronavirus 2019-nCoV: prediction of potential receptor, natural reservoir, tropism and therapeutic/vaccine target."	F1000Res
32419854	Coronavirus in pregnancy. What we know so far?	Maedica (Bucur)
32419838	Knowledge-based repositioning of the anti-HCV direct antiviral agent Sofosbuvir as SARS-CoV-2 treatment.	Infect Agent Cancer
32419753	COVID 19: Neuromuscular Manifestations.	Ann Indian Acad Neurol
32419646	Design of multi-epitope vaccine candidate against SARS-CoV-2: a in-silico study.	J Biomol Struct Dyn
32419053	"Development and characterization of 20 polymorphic microsatellite markers for the white-bellied pangolin Phataginus tricuspis (Mammalia, Pholidota)."	Mol Biol Rep
32418885	Commentary: Could iron chelators prove to be useful as an adjunct to COVID-19 Treatment Regimens?	Metabolism
32418793	An effective CTL peptide vaccine for Ebola Zaire Based on Survivors' CD8+ targeting of a particular nucleocapsid protein epitope with potential implications for COVID-19 vaccine design.	Vaccine
32418715	"COVID-19: Pathogenesis, cytokine storm and therapeutic potential of interferons."	Cytokine Growth Factor Rev
32418663	"Cold Plasma, a New Hope in the Field of Virus Inactivation."	Trends Biotechnol
32418620	"Expression of ACE2, the SARS-CoV-2 Receptor, and TMPRSS2 in Prostate Epithelial Cells."	Eur Urol
32418549	Epidemiology of Coronavirus Disease 2019 (COVID-19) Caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).	Disaster Med Public Health Prep
32418532	Counter-regulatory 'Renin-Angiotensin' System-based Candidate Drugs to Treat COVID-19 Diseases in SARS-CoV-2-infected Patients.	Infect Disord Drug Targets
32418327	Ligand-centered assessment of SARS-CoV-2 drug target models in the Protein Data Bank.	FEBS J
32418199	"Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19)."	J Pathol
32418055	COVID-19 virus may have neuroinvasive potential and cause neurological complications: a perspective review.	J Neurovirol
32417802	The changing landscape of SARS-CoV-2: Implications for the maternal-infant dyad.	J Neonatal Perinatal Med
32417709	Mechanism of inflammatory response in associated comorbidities in COVID-19.	Diabetes Metab Syndr
32417379	Unique Patterns of Cardiovascular Involvement in Coronavirus Disease-2019.	J Card Fail
32417310	"Characterization of eight novel full-length genomes of SARS-CoV-2 among imported COVID-19 cases from abroad in Yunnan, China."	J Infect
32417124	"COVID-19, SARS and MERS: A neurological perspective."	J Clin Neurosci
32416961	Biochemical characterization of SARS-CoV-2 nucleocapsid protein.	Biochem Biophys Res Commun
32416786	"Hypertension, renin-angiotensin-aldosterone system inhibition, and COVID-19."	Lancet
32416679	Novel Drugs Targeting the SARS-CoV-2/COVID-19 Machinery.	Curr Top Med Chem
32416535	Spillover of SARS-CoV-2 into novel wild hosts in North America: A conceptual model for perpetuation of the pathogen.	Sci Total Environ
32416414	Genetic predisposition models to COVID-19 infection.	Med Hypotheses
32416413	Covid-19 management with inflammation resolving mediators? Perspectives and potential.	Med Hypotheses
32416412	"Free DNA, a reason for severe COVID-19 infection?"	Med Hypotheses
32416411	COVID-19 and autism.	Med Hypotheses
32416410	Is it fair to hope that patients with Type 1 Diabetes (autoimmune) may be spared by the infection of Covid-19?	Med Hypotheses
32416259	On the interactions of the receptor-binding domain of SARS-CoV-1 and SARS-CoV-2 spike proteins with monoclonal antibodies and the receptor ACE2.	Virus Res
32416074	A Novel Bat Coronavirus Closely Related to SARS-CoV-2 Contains Natural Insertions at the S1/S2 Cleavage Site of the Spike Protein.	Curr Biol
32416070	Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19.	Cell
32416028	Neurological manifestations and neuro-invasive mechanisms of the severe acute respiratory syndrome coronavirus type 2.	Eur J Neurol
32415992	Emerging cardiological issues during the COVID-19 pandemic.	Eur J Clin Invest
32415836	"Response to ""COVID-19 and ACEI/ARB: Not Associated?"""	Am J Hypertens
32415832	COVID-19 and ACEI/ARB: Not Associated?	Am J Hypertens
32415494	COVID-19 pandemic and therapy with ibuprofen or renin-angiotensin system blockers: no need for interruptions or changes in ongoing chronic treatments.	Naunyn Schmiedebergs Arch Pharmacol
32415481	2019-Novel Coronavirus-Related Acute Cardiac Injury Cannot Be Ignored.	Curr Atheroscler Rep
32415314	Understanding pathophysiology of hemostasis disorders in critically ill patients with COVID-19.	Intensive Care Med
32415260	Key residues of the receptor binding motif in the spike protein of SARS-CoV-2 that interact with ACE2 and neutralizing antibodies.	Cell Mol Immunol
32414711	The renin-angiotensin system - a therapeutic target in COVID-19?	Clin Med (Lond)
32414646	"ACE2 receptor polymorphism: Susceptibility to SARS-CoV-2, hypertension, multi-organ failure, and COVID-19 disease outcome."	J Microbiol Immunol Infect
32414233	Coronavirus disease 2019 outbreak: liver disease a prognostic tool?	Panminerva Med
32413821	A review of modern technologies for tackling COVID-19 pandemic.	Diabetes Metab Syndr
32413712	Contamination and infection: What the coronavirus pandemic could reveal about the evolutionary origins of obsessive-compulsive disorder.	Psychiatry Res
32413701	The role of ACEIs/ARBs in COVID-19: Friend or foe?	Med Hypotheses
32413619	beta-Glucan extracts from the same edible shiitake mushroom Lentinus edodes produce differential in-vitro immunomodulatory and pulmonary cytoprotective effects - Implications for coronavirus disease (COVID-19) immunotherapies.	Sci Total Environ
32413374	Development of passive immunity against SARS-CoV-2 for management of immunodeficient patients-a perspective.	J Allergy Clin Immunol
32413354	"Age, Inflammation, and Disease Location Are Critical Determinants of Intestinal Expression of SARS-CoV-2 Receptor ACE2 and TMPRSS2 in Inflammatory Bowel Disease."	Gastroenterology
32413319	SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues.	Cell
32413300	SnapShot: COVID-19.	Cell
32413276	Identification of Human Single-Domain Antibodies against SARS-CoV-2.	Cell Host Microbe
32412919	Gender and Age Differences Reveal Risk Patterns in COVID-19 Outbreak.	Altern Ther Health Med
32412918	"COVID-19: A Worldwide, Zoonotic, Pandemic Outbreak."	Altern Ther Health Med
32412679	Novel coronavirus disease 2019 (COVID-19) and neurodegenerative disorders.	Dermatol Ther
32412544	In silico fight against novel coronavirus by finding chromone derivatives as inhibitor of coronavirus main proteases enzyme.	Struct Chem
32412415	A Snapshot of SARS-CoV-2 Genome Availability up to April 2020 and its Implications: Data Analysis.	JMIR Public Health Surveill
32412405	Understanding the cytokine storm during COVID-19: Contribution of preexisting chronic inflammation.	Eur J Rheumatol
32412400	COVID-19 and Kawasaki syndrome: should we really be surprised?	Cardiol Young
32412303	Is the kidney a target of SARS-CoV-2?	Am J Physiol Renal Physiol
32412158	Indomethacin and resveratrol as potential treatment adjuncts for SARS-CoV-2/COVID-19.	Int J Clin Pract
32412156	COVID-19 and heart failure: from infection to inflammation and angiotensin II stimulation. Searching for evidence from a new disease.	Eur J Heart Fail
32412125	Androgen sensitivity gateway to COVID-19 disease severity.	Drug Dev Res
32412101	COVID-19 is a Real Headache!	Headache
32411576	SARS-CoV-2 receptor ACE2 gene expression and RAAS inhibitors.	Lancet Respir Med
32410761	"Cardiac valves: Another ""Disaster-hit area"" of COVID-19 patients?"	Heart Lung
32410735	"Interaction of the spike protein RBD from SARS-CoV-2 with ACE2: Similarity with SARS-CoV, hot-spot analysis and effect of the receptor polymorphism."	Biochem Biophys Res Commun
32410690	Age and sex differences in soluble ACE2 may give insights for COVID-19.	Crit Care
32410504	Marine natural compounds as potents inhibitors against the main protease of SARS-CoV-2-a molecular dynamic study.	J Biomol Struct Dyn
32410502	First comprehensive computational analysis of functional consequences of TMPRSS2 SNPs in susceptibility to SARS-CoV-2 among different populations.	J Biomol Struct Dyn
32410266	Immunoregulation with mTOR inhibitors to prevent COVID-19 severity: A novel intervention strategy beyond vaccines and specific antiviral medicines.	J Med Virol
32410229	Evidence of increasing diversification of emerging Severe Acute Respiratory Syndrome Coronavirus 2 strains.	J Med Virol
32410141	"Expressions and significances of the angiotensin-converting enzyme 2 gene, the receptor of SARS-CoV-2 for COVID-19."	Mol Biol Rep
32410003	Pathophysiology of COVID-19: Why Children Fare Better than Adults?	Indian J Pediatr
32409742	SARS-CoV-2 likes it cool.	Nat Rev Immunol
32409741	Modulation of immune crosstalk in COVID-19.	Nat Rev Immunol
32409547	Complete Genome Sequences of SARS-CoV-2 Strains Detected in Malaysia.	Microbiol Resour Announc
32409501	Issues of Cardiovascular Risk Management in People With Diabetes in the COVID-19 Era.	Diabetes Care
32409434	Renin-angiotensin system inhibitors in COVID-19.	Cleve Clin J Med
32408731	Covid-19 infection in kidney transplant recipients: endocrine and metabolic issues.	Minerva Endocrinol
32408699	Essential Oils as Antiviral Agents. Potential of Essential Oils to Treat SARS-CoV-2 Infection: An In-Silico Investigation.	Int J Mol Sci
32408547	"Virtual Screening of Natural Products against Type II Transmembrane Serine Protease (TMPRSS2), the Priming Agent of Coronavirus 2 (SARS-CoV-2)."	Molecules
32408338	Pathogenesis and transmission of SARS-CoV-2 in golden hamsters.	Nature
32408336	Proteomics of SARS-CoV-2-infected host cells reveals therapy targets.	Nature
32408070	Does zinc supplementation enhance the clinical efficacy of chloroquine/hydroxychloroquine to win today's battle against COVID-19?	Med Hypotheses
32408068	What about the original antigenic sin of the humans versus SARS-CoV-2?	Med Hypotheses
32407669	Heightened Innate Immune Responses in the Respiratory Tract of COVID-19 Patients.	Cell Host Microbe
32407507	"Genomic Epidemiology, Evolution, and Transmission Dynamics of Porcine Deltacoronavirus."	Mol Biol Evol
32407491	iBioProVis: interactive visualization and analysis of compound bioactivity space.	Bioinformatics
32407467	Clinical Features and Outcomes of Patients With Human Immunodeficiency Virus With COVID-19.	Clin Infect Dis
32407466	An Inflammatory Profile Correlates With Decreased Frequency of Cytotoxic Cells in Coronavirus Disease 2019.	Clin Infect Dis
32407364	Are pangolins the intermediate host of the 2019 novel coronavirus (SARS-CoV-2)?	PLoS Pathog
32407127	Why Aren't People Living with HIV at Higher Risk for Developing Severe Coronavirus Disease 2019 (COVID-19)?	AIDS Patient Care STDS
32406687	In Silico Exploration of the Molecular Mechanism of Clinically Oriented Drugs for Possibly Inhibiting SARS-CoV-2's Main Protease.	J Phys Chem Lett
32406522	COVID-19: Focus on the lungs but do not forget the gastrointestinal tract.	Eur J Clin Invest
32406512	Angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers are not associated with increased risk of SARS-CoV-2 infection.	J Travel Med
32406369	SARS-CoV-2 Shedding from Asymptomatic Patients: Contribution of Potential Extrapulmonary Tissue Reservoirs.	Am J Trop Med Hyg
32406317	Potential anti-viral activity of approved repurposed drug against main protease of SARS-CoV-2: an in silico based approach.	J Biomol Struct Dyn
32406282	"Tocilizumab: from the rheumatology practice to the fight against COVID-19, a virus infection with multiple faces."	Expert Opin Biol Ther
32406143	Could patients taking isotretinoin therapy be immune against SARS-CoV-2?	Dermatol Ther
32405877	A Review: Does Complement or the Contact System Have a Role in Protection or Pathogenesis of COVID-19?	Pulm Ther
32405622	The MERS-CoV Receptor DPP4 as a Candidate Binding Target of the SARS-CoV-2 Spike.	iScience
32405281	Sars-CoV-2 and black population: ACE2 as shield or blade?	Infect Genet Evol
32405269	Targeting T-cell senescence and cytokine storm with rapamycin to prevent severe progression in COVID-19.	Clin Immunol
32405236	Comparative review of respiratory diseases caused by coronaviruses and influenza A viruses during epidemic season.	Microbes Infect
32405159	May statins and PCSK9 inhibitors be protective from COVID-19 in familial hypercholesterolemia subjects?	Nutr Metab Cardiovasc Dis
32405156	Synergistic antiviral effect of hydroxychloroquine and azithromycin in combination against SARS-CoV-2: What molecular dynamics studies of virus-host interactions reveal.	Int J Antimicrob Agents
32405117	Identification of SARS-CoV RBD-targeting monoclonal antibodies with cross-reactive or neutralizing activity against SARS-CoV-2.	Antiviral Res
32405102	A Global Effort to Define the Human Genetics of Protective Immunity to SARS-CoV-2 Infection.	Cell
32405087	Continue ACE inhibitors / ARB'S till further evidence in coronavirus disease 2019 (COVID-19).	Indian Heart J
32405028	Infection of bat and human intestinal organoids by SARS-CoV-2.	Nat Med
32404960	A platform for RNA virus cloning.	Nat Rev Genet
32404898	"Diabetes and COVID-19: evidence, current status and unanswered research questions."	Eur J Clin Nutr
32404885	"The COVID-19 Host Genetics Initiative, a global initiative to elucidate the role of host genetic factors in susceptibility and severity of the SARS-CoV-2 virus pandemic."	Eur J Hum Genet
32404728	THE COVID-19 Pandemic: Overview and Integrative Health Approaches.	Holist Nurs Pract
32404529	"Comparison of Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein Binding to ACE2 Receptors from Human, Pets, Farm Animals, and Putative Intermediate Hosts."	J Virol
32404490	Is COVID-19 more severe in older men?	Postgrad Med J
32404477	A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2.	Science
32404436	TMPRSS2 and TMPRSS4 promote SARS-CoV-2 infection of human small intestinal enterocytes.	Sci Immunol
32404189	The role of passive immunization in the age of SARS-CoV-2: an update.	Eur J Med Res
32404011	Clinical characteristics of coronavirus disease 2019 (COVID-19) patients with hypertension on renin-angiotensin system inhibitors.	Clin Exp Hypertens
32403995	Development of multi-specific humanized llama antibodies blocking SARS-CoV-2/ACE2 interaction with high affinity and avidity.	Emerg Microbes Infect
32403977	The Renin-Angiotensin system and SARS-CoV-2 infection: A role for the ACE2 receptor?	J Renin Angiotensin Aldosterone Syst
32403318	Porcine Epidemic Diarrhea Virus and the Host Innate Immune Response.	Pathogens
32403255	"COVID-19, MERS and SARS with Concomitant Liver Injury-Systematic Review of the Existing Literature."	J Clin Med
32403217	"Hypertension, Thrombosis, Kidney Failure, and Diabetes: Is COVID-19 an Endothelial Disease? A Comprehensive Evaluation of Clinical and Basic Evidence."	J Clin Med
32403201	Increased Severity of COVID-19 in People with Obesity: Are We Overlooking Plausible Biological Mechanisms?	Obesity (Silver Spring)
32402576	Oxidative Stress as Key Player in Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) Infection.	Arch Med Res
32402329	Novel human coronavirus (SARS-CoV-2): A lesson from animal coronaviruses.	Vet Microbiol
32402186	Targeting the Dimerization of the Main Protease of Coronaviruses: A Potential Broad-Spectrum Therapeutic Strategy.	ACS Comb Sci
32402107	Letter: low population mortality from COVID-19 in countries south of latitude 35 degrees North supports vitamin D as a factor determining severity.	Aliment Pharmacol Ther
32401844	COVID-19: Updated Data and its Relation to the Cardiovascular System.	Arq Bras Cardiol
32401442	[Renin-angiotensin-aldosterone blockers and Covic-19 infection : friends or enemies ?]	Rev Med Suisse
32401346	SARS-CoV-2 immunogenicity at the crossroads.	Allergy
32401345	Genetic variants and source of introduction of SARS-CoV-2 in South America.	J Med Virol
32401043	Conserved High Free Energy Sites in Human Coronavirus Spike Glycoprotein Backbones.	J Comput Biol
32401039	Glycemic control of type 2 diabetic patients with coronavirus disease during hospitalization: a proposal for early insulin therapy.	Am J Physiol Endocrinol Metab
32400858	Are Patients With Alcohol Use Disorders at Increased Risk for Covid-19 Infection?	Alcohol Alcohol
32400017	COVID-19 and islet transplantation: Different twins.	Am J Transplant
32399954	SARS-CoV-2 and myocardial injury: a role for Nox2?	Intern Emerg Med
32399895	Possible role of low-dose etoposide therapy for hemophagocytic lymphohistiocytosis by COVID-19.	Int J Hematol
32399806	Is COVID-19 a New Hematologic Disease?	Stem Cell Rev Rep
32399719	Involvement of the Nervous System in SARS-CoV-2 Infection.	Neurotox Res
32399213	Dynamics of peripheral immune cells and their HLA-G and receptor expressions in a patient suffering from critical COVID-19 pneumonia to convalescence.	Clin Transl Immunology
32399097	Lessons learned from SARS-CoV and MERS-CoV: FDA-approved Abelson tyrosine-protein kinase 2 inhibitors may help us combat SARS-CoV-2.	Arch Med Sci
32399096	State-of-the-art tools unveil potent drug targets amongst clinically approved drugs to inhibit helicase in SARS-CoV-2.	Arch Med Sci
32399094	Statins and the COVID-19 main protease: in silico evidence on direct interaction.	Arch Med Sci
32399093	Lipid-lowering therapy and renin-angiotensin-aldosterone system inhibitors in the era of the COVID-19 pandemic.	Arch Med Sci
32398976	siRNA could be a potential therapy for COVID-19.	EXCLI J
32398875	Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19.	Nat Med
32398871	Perspective: improving vitamin D status in the management of COVID-19.	Eur J Clin Nutr
32398804	Is aberrant CD8+ T cell activation by hypertension associated with cardiac injury in severe cases of COVID-19?	Cell Mol Immunol
32398780	The role of the exposome in promoting resilience or susceptibility after SARS-CoV-2 infection.	J Expo Sci Environ Epidemiol
32398430	Rethinking Sedation During Prolonged Mechanical Ventilation for COVID-19 Respiratory Failure.	Anesth Analg
32398309	Could the smoking gun in the fight against COVID-19 be the (rh)ACE-2?	Eur Respir J
32398300	Will children reveal their secret? The coronavirus dilemma.	Eur Respir J
32398273	RNA genome conservation and secondary structure in SARS-CoV-2 and SARS-related viruses: a first look.	RNA
32398162	COVID-19 vulnerability: the potential impact of genetic susceptibility and airborne transmission.	Hum Genomics
32397951	The expression level of angiotensin-converting enzyme 2 determines the severity of COVID-19: lung and heart tissue as targets.	J Biomol Struct Dyn
32397940	Identification of bioactive molecules from tea plant as SARS-CoV-2 main protease inhibitors.	J Biomol Struct Dyn
32397906	Development of remdesivir repositioning as a nucleotide analog against COVID-19 RNA dependent RNA polymerase.	J Biomol Struct Dyn
32397688	"SARS-CoV-2/COVID-19: Viral Genomics, Epidemiology, Vaccines, and Therapeutic Interventions."	Viruses
32397684	SARS-CoV-2 Inflammatory Syndrome. Clinical Features and Rationale for Immunological Treatment.	Int J Mol Sci
32397643	Potential Drugs Targeting Early Innate Immune Evasion of SARS-Coronavirus 2 via 2'-O-Methylation of Viral RNA.	Viruses
32397011	"Epidemiological, clinical, and virological characteristics of 465 hospitalized cases of coronavirus disease 2019 (COVID-19) from Zhejiang province in China."	Influenza Other Respir Viruses
32396996	Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19.	Allergy
32396963	SARS-2 Coronavirus-Associated Hemostatic Lung Abnormality in COVID-19: Is It Pulmonary Thrombosis or Pulmonary Embolism?	Semin Thromb Hemost
32396922	Respiratory disease in rhesus macaques inoculated with SARS-CoV-2.	Nature
32396773	Truncated human angiotensin converting enzyme 2; a potential inhibitor of SARS-CoV-2 spike glycoprotein and potent COVID-19 therapeutic agent.	J Biomol Struct Dyn
32396769	Identification of potential molecules against COVID-19 main protease through structure-guided virtual screening approach.	J Biomol Struct Dyn
32396767	Elucidating biophysical basis of binding of inhibitors to SARS-CoV-2 main protease by using molecular dynamics simulations and free energy calculations.	J Biomol Struct Dyn
32396710	COVID-19 and neurodegeneration: what can we learn from the past?	Eur J Neurol
32395864	Can the 2019 Novel Coronavirus Cause Parkinson's Disease?	Mov Disord
32395713	Melatonin Inhibits COVID-19-induced Cytokine Storm by Reversing Aerobic Glycolysis in Immune Cells: A Mechanistic Analysis.	Med Drug Discov
32395606	Molecular docking and dynamic simulations for antiviral compounds against SARS-CoV-2: A computational study.	Inform Med Unlocked
32395541	Coronavirus disease 2019 (COVID-19): the portrait of a perfect storm.	Ann Transl Med
32395525	A profiling analysis on the receptor ACE2 expression reveals the potential risk of different type of cancers vulnerable to SARS-CoV-2 infection.	Ann Transl Med
32395474	The effect of RAS blockers on the clinical characteristics of COVID-19 patients with hypertension.	Ann Transl Med
32395098	Aluminum Nanoparticles Acting as a Pulmonary Vaccine Adjuvant-Delivery System (VADS) Able to Safely Elicit Robust Systemic and Mucosal Immunity.	J Inorg Organomet Polym Mater
32395093	Structure of the SARS-Unique Domain C From the Bat Coronavirus HKU4.	Nat Prod Commun
32394850	"[Role of age, comorbidity and renin- angiotensin-aldosterone system in COVID-19. Effects of ACE inhibitors and angiotensin receptor blockers]."	Kardiologiia
32394842	Epidemiological Features of the 2019 Novel Coronavirus Outbreak in China.	Curr Top Med Chem
32394689	"COVID-19, Renin-Angiotensin System, and Hematopoiesis"	Turk J Haematol
32394639	COVID-19 and comorbidities: A role for dipeptidyl peptidase 4 (DPP4) in disease severity?	J Diabetes
32394467	A global treatments for coronaviruses including COVID-19.	J Cell Physiol
32393985	Therapeutic targets and signaling mechanisms of vitamin C activity against sepsis: a bioinformatics study.	Brief Bioinform
32393823	BCG-induced trained immunity: can it offer protection against COVID-19?	Nat Rev Immunol
32393819	COVID-19 outcomes and the human genome.	Genet Med
32393592	Cytokine storm and the prospects for immunotherapy with COVID-19.	Cleve Clin J Med
32393438	Intelligent classification of platelet aggregates by agonist type.	Elife
32393419	Recent advances of therapeutic targets and potential drugs of COVID-19.	Pharmazie
32393136	Coronavirus Disease 2019 and the Cerebrovascular-Cardiovascular Systems: What Do We Know So Far?	J Am Heart Assoc
32392945	"[Comparison of pathological changes and pathogenic mechanisms caused by H1N1 influenza virus, highly pathogenic H5N1 avian influenza virus, SARS-CoV, MERS-CoV and 2019-nCoV]."	Zhonghua Bing Li Xue Za Zhi
32392759	Marine Algal Antioxidants as Potential Vectors for Controlling Viral Diseases.	Antioxidants (Basel)
32392562	JAK Inhibition as a New Treatment Strategy for Patients with COVID-19.	Int Arch Allergy Immunol
32392464	SARS-CoV-2: Combating Coronavirus Emergence.	Immunity
32392072	Novel Coronavirus Polymerase and Nucleotidyl-Transferase Structures: Potential to Target New Outbreaks.	J Phys Chem Lett
32391855	"COVID-19 and Postinfection Immunity: Limited Evidence, Many Remaining Questions."	JAMA
32391719	Cardiovascular disease and COVID-19: les liaisons dangereuses.	Eur J Prev Cardiol
32391393	Digesting the crisis: autophagy and coronaviruses.	Microb Cell
32391384	COVID and the Renin-Angiotensin System: Are Hypertension or Its Treatments Deleterious?	Front Cardiovasc Med
32391367	The Malnutritional Status of the Host as a Virulence Factor for New Coronavirus SARS-CoV-2.	Front Med (Lausanne)
32391309	Role of the Eye in Transmitting Human Coronavirus: What We Know and What We Do Not Know.	Front Public Health
32391299	COVID-19 Infection and Circulating ACE2 Levels: Protective Role in Women and Children.	Front Pediatr
32391184	Comprehensive Insights into the Catalytic Mechanism of Middle East Respiratory Syndrome 3C-Like Protease and Severe Acute Respiratory Syndrome 3C-Like Protease.	ACS Catal
32391169	Is the use of RAS inhibitors safe in the current era of COVID-19 pandemic?	Clin Hypertens
32391022	Serological Approaches for COVID-19: Epidemiologic Perspective on Surveillance and Control.	Front Immunol
32390064	COVID-19 in older adults.	Aging Clin Exp Res
32389847	Urgent need for evaluating agonists of angiotensin-(1-7)/Mas receptor axis for treating patients with COVID-19.	Int J Infect Dis
32389754	RILI model and the Covid-19 pneumonia: The radiation oncologist point of view.	Radiother Oncol
32389723	Computational screening of antagonists against the SARS-CoV-2 (COVID-19) coronavirus by molecular docking.	Int J Antimicrob Agents
32389704	Pain: A potential new label of COVID-19.	Brain Behav Immun
32389590	COVID-19: Unanswered questions on immune response and pathogenesis.	J Allergy Clin Immunol
32389499	Inflamm-aging: Why older men are the most susceptible to SARS-CoV-2 complicated outcomes.	Cytokine Growth Factor Rev
32389117	"A Viewpoint on Angiotensin-Converting Enzyme 2, Anti-Hypertensives and Coronavirus Disease 2019 (COVID-19)."	Infect Disord Drug Targets
32388565	Circulating plasma concentrations of angiotensin-converting enzyme 2 in men and women with heart failure and effects of renin-angiotensin-aldosterone inhibitors.	Eur Heart J
32388547	Plasma angiotensin-converting enzyme 2: novel biomarker in heart failure with implications for COVID-19.	Eur Heart J
32388537	Designing of improved drugs for COVID-19: Crystal structure of SARS-CoV-2 main protease M(pro).	Signal Transduct Target Ther
32388480	Can beta-adrenergic blockers be used in the treatment of COVID-19?	Med Hypotheses
32388476	Is copper beneficial for COVID-19 patients?	Med Hypotheses
32388390	The powerful immune system against powerful COVID-19: A hypothesis.	Med Hypotheses
32388330	Interactions between antihyperglycemic drugs and the renin-angiotensin system: Putative roles in COVID-19. A mini-review.	Diabetes Metab Syndr
32388326	Role of increasing the aerobic capacity on improving the function of immune and respiratory systems in patients with coronavirus (COVID-19): A review.	Diabetes Metab Syndr
32388138	Hypothesized behavioral host manipulation by SARS-CoV2/COVID-19 infection.	Med Hypotheses
32387864	SARS-CoV-2 infection and obesity: Common inflammatory and metabolic aspects.	Diabetes Metab Syndr
32387617	COVID-19: The first documented coronavirus pandemic in history.	Biomed J
32387564	Emergence of genomic diversity and recurrent mutations in SARS-CoV-2.	Infect Genet Evol
32387562	Coding potential and sequence conservation of SARS-CoV-2 and related animal viruses.	Infect Genet Evol
32387535	"Asthma, biologics, corticosteroids, and coronavirus disease 2019."	Ann Allergy Asthma Immunol
32387470	COVID-19 gone bad: A new character in the spectrum of the hyperferritinemic syndrome?	Autoimmun Rev
32387389	Study of combining virtual screening and antiviral treatments of the Sars-CoV-2 (Covid-19).	Microb Pathog
32387343	"SARS-CoV-2: ""Three-steps"" infection model and CSF diagnostic implication."	Brain Behav Immun
32387334	The Forrest Gump approach to preventing severe COVID-19 - reverse the predisposing pro-inflammatory state with exercise.	Microbes Infect
32387301	The CoV-2 outbreak: how hematologists could help to fight Covid-19.	Pharmacol Res
32387274	Coronavirus disease 2019 and men's reproductive health.	Fertil Steril
32387238	"Covid-19, induced activation of hemostasis, and immune reactions: Can an auto-immune reaction contribute to the delayed severe complications observed in some patients?"	Transfus Apher Sci
32386571	"Tropism, replication competence, and innate immune responses of the coronavirus SARS-CoV-2 in human respiratory tract and conjunctiva: an analysis in ex-vivo and in-vitro cultures."	Lancet Respir Med
32386570	Assessment of SARS-CoV-2 replication in the context of other respiratory viruses.	Lancet Respir Med
32386438	'Toxic erythema' and eosinophilia associated with tocilizumab therapy in a COVID-19 patient.	J Eur Acad Dermatol Venereol
32386428	Coronavirus Disease 2019: The Role of the Fibrinolytic System from Transmission to Organ Injury and Sequelae.	Semin Thromb Hemost
32386189	ACE Ins/Del genetic polymorphism and epidemiological findings in COVID-19.	Clin Chem Lab Med
32386188	No significant correlation between ACE Ins/Del genetic polymorphism and COVID-19 infection.	Clin Chem Lab Med
32385891	"Systemic immunobiological, immunosuppressant, and oncologic agents for the treatment of dermatologic diseases during the SARS-CoV-2 (COVID-19) pandemic emergency: A quick review for a quick consultation."	Dermatol Ther
32385869	COVID-19 with dermatologic manifestations and implications: An unfolding conundrum.	Dermatol Ther
32385712	Inflammation resolution: a dual-pronged approach to averting cytokine storms in COVID-19?	Cancer Metastasis Rev
32385549	"COVID-19, Angiotensin Receptor Blockers, and the Brain."	Cell Mol Neurobiol
32385052	HiJAKing SARS-CoV-2? The potential role of JAK inhibitors in the management of COVID-19.	Sci Immunol
32384908	"Chloroquine for COVID-19: rationale, facts, hopes."	Crit Care
32384820	Protocol and Reagents for Pseudotyping Lentiviral Particles with SARS-CoV-2 Spike Protein for Neutralization Assays.	Viruses
32384798	Potential Cytoprotective Activity of Ozone Therapy in SARS-CoV-2/COVID-19.	Antioxidants (Basel)
32383830	Association between Angiotensin Blockade and Incidence of Influenza in the United Kingdom.	N Engl J Med
32383758	SARS-CoV-2 receptor ACE2 expression in the human heart: cause of a post-pandemic wave of heart failure?	Eur Heart J
32383737	The tug-of-war between coagulopathy and anticoagulant agents in patients with COVID-19.	Eur Heart J Cardiovasc Pharmacother
32383626	Renin-Angiotensin-Aldosterone System Inhibitors and Outcome in Patients With SARS-CoV-2 Pneumonia: A Case Series Study.	Hypertension
32383624	Controversial Relationship Between Renin-Angiotensin System Inhibitors and Severity of COVID-19: Announcing a Large Multicentre Case-Control Study in Italy.	Hypertension
32383276	Chronic myeloid leukaemia and the use of tyrosine kinase inhibitors in the days of COVID-19 pandemic.	Br J Clin Pharmacol
32383269	In silico studies on the comparative characterization of the interactions of SARS-CoV-2 spike glycoprotein with ACE-2 receptor homologs and human TLRs.	J Med Virol
32383237	Effects of 5-alpha reductase inhibitors on lung function: A reason for discontinuation during COVID-19 pandemic?	Dermatol Ther
32383183	A comparison study of SARS-CoV-2 IgG antibody between male and female COVID-19 patients: A possible reason underlying different outcome between sex.	J Med Virol
32382776	Signals of Th2 immune response from COVID-19 patients requiring intensive care.	Ann Hematol
32382146	Expression of SARS-CoV-2 receptor ACE2 and TMPRSS2 in human primary conjunctival and pterygium cell lines and in mouse cornea.	Eye (Lond)
32382127	NKG2A and COVID-19: another brick in the wall.	Cell Mol Immunol
32382126	Protective humoral immunity in SARS-CoV-2 infected pediatric patients.	Cell Mol Immunol
32382072	Structural basis for the inhibition of SARS-CoV-2 main protease by antineoplastic drug carmofur.	Nat Struct Mol Biol
32381734	Sampling bias and incorrect rooting make phylogenetic network tracing of SARS-COV-2 infections unreliable.	Proc Natl Acad Sci U S A
32381733	Median-joining network analysis of SARS-CoV-2 genomes is neither phylogenetic nor evolutionary.	Proc Natl Acad Sci U S A
32381617	Near-Complete Genome Sequence of a 2019 Novel Coronavirus (SARS-CoV-2) Strain Causing a COVID-19 Case in Peru.	Microbiol Resour Announc
32381428	Clinical and histopathological study of skin dermatoses in patients affected by COVID-19 infection in the Northern part of Italy.	J Dermatol Sci
32380958	Extracellular HMGB1: a therapeutic target in severe pulmonary inflammation including COVID-19?	Mol Med
32380903	Lack of cross-neutralization by SARS patient sera towards SARS-CoV-2.	Emerg Microbes Infect
32380802	Cardiovascular system and COVID-19: perspectives from a developing country.	Monaldi Arch Chest Dis
32380787	Acute Kidney Injury in SARS-CoV-2 Infection: Direct Effect of Virus on Kidney Proximal Tubule Cells.	Int J Mol Sci
32380565	COVID-19 in Newborns and Infants-Low Risk of Severe Disease: Silver Lining or Dark Cloud?	Am J Perinatol
32380511	The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice.	Nature
32380510	Isolation of SARS-CoV-2-related coronavirus from Malayan pangolins.	Nature
32380316	Convalescent plasma in Covid-19: Possible mechanisms of action.	Autoimmun Rev
32380288	Genetic susceptibility for COVID-19-associated sudden cardiac death in African Americans.	Heart Rhythm
32380269	The COVID-19 Pandemic: Consideration for Brain Infection.	Neuroscience
32380209	A highly pathogenic GI-19 lineage infectious bronchitis virus originated from multiple recombination events with broad tissue tropism.	Virus Res
32380200	In silico design of antiviral peptides targeting the spike protein of SARS-CoV-2.	Peptides
32380023	Immunomodulation in COVID-19.	Lancet Respir Med
32379896	Knowledge-based structural models of SARS-CoV-2 proteins and their complexes with potential drugs.	FEBS Lett
32379894	Association between ABO blood groups and risk of SARS-CoV-2 pneumonia.	Br J Haematol
32379863	Metagenomic Analysis Reveals Clinical SARS-CoV-2 Infection and Bacterial or Viral Superinfection and Colonization.	Clin Chem
32379417	"Expression of the SARS-CoV-2 Entry Proteins, ACE2 and TMPRSS2, in Cells of the Olfactory Epithelium: Identification of Cell Types and Trends with Age."	ACS Chem Neurosci
32379350	Codon bias analysis may be insufficient for identifying host(s) of a novel virus.	J Med Virol
32378801	Comprehensive overview of COVID-19 based on current evidence.	Dermatol Ther
32378729	COVID-19 - Toward a comprehensive understanding of the disease.	Cardiol J
32378705	"A virus that has gone viral: amino acid mutation in S protein of Indian isolate of Coronavirus COVID-19 might impact receptor binding, and thus, infectivity."	Biosci Rep
32378647	Treat 2019 novel coronavirus (COVID-19) with IL-6 inhibitor: Are we already that far?	Drug Discov Ther
32378030	COVID-19-Related Stroke.	Transl Stroke Res
32377932	Animal-to-Human Viral Transitions: Is SARS-CoV-2 an Evolutionarily Successful One?	J Mol Evol
32377375	Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing.	Cell Discov
32376987	Inhibition of Influenza A virus propagation by benzoselenoxanthenes stabilizing TMPRSS2 Gene G-quadruplex and hence down-regulating TMPRSS2 expression.	Sci Rep
32376901	Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages.	Nat Rev Immunol
32376714	Gene of the month: the 2019-nCoV/SARS-CoV-2 novel coronavirus spike protein.	J Clin Pathol
32376697	An Extensive Meta-Metagenomic Search Identifies SARS-CoV-2-Homologous Sequences in Pangolin Lung Viromes.	mSphere
32376634	Cell entry mechanisms of SARS-CoV-2.	Proc Natl Acad Sci U S A
32376627	"Design of Potent Membrane Fusion Inhibitors against SARS-CoV-2, an Emerging Coronavirus with High Fusogenic Activity."	J Virol
32376613	Inhibition of SARS-CoV-2 Infection by the Cyclophilin Inhibitor Alisporivir (Debio 025).	Antimicrob Agents Chemother
32376535	[Analysis of variation and evolution of SARS-CoV-2 genome].	Nan Fang Yi Ke Da Xue Xue Bao
32376402	"Transcriptional landscape of SARS-CoV-2 infection dismantles pathogenic pathways activated by the virus, proposes unique sex-specific differences and predicts tailored therapeutic strategies."	Autoimmun Rev
32376401	Fatal COVID-19 infections: Is NK cell dysfunction a link with autoimmune HLH?	Autoimmun Rev
32376400	Cytokine storm syndrome in severe COVID-19.	Autoimmun Rev
32376393	"Interleukin-17A (IL-17A), a key molecule of innate and adaptive immunity, and its potential involvement in COVID-19-related thrombotic and vascular mechanisms."	Autoimmun Rev
32376392	Should we stimulate or suppress immune responses in COVID-19? Cytokine and anti-cytokine interventions.	Autoimmun Rev
32376099	Angiotensin-Converting Enzyme 2 and Antihypertensives (Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors) in Coronavirus Disease 2019.	Mayo Clin Proc
32376072	Beware: Gastrointestinal symptoms can be a manifestation of COVID-19.	Rev Gastroenterol Mex (Engl Ed)
32375574	Repurposing of chloroquine and some clinically approved antiviral drugs as effective therapeutics to prevent cellular entry and replication of coronavirus.	J Biomol Struct Dyn
32375200	Pneumomediastinum following intubation in COVID-19 patients: a case series.	Anaesthesia
32375153	HMGB1: A Possible Crucial Therapeutic Target for COVID-19?	Horm Res Paediatr
32375085	Pathophysiological characteristics and therapeutic approaches for pulmonary injury and cardiovascular complications of coronavirus disease 2019.	Cardiovasc Pathol
32375025	Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid Antibodies.	Cell
32375002	Deconvoluting Lipid Nanoparticle Structure for Messenger RNA Delivery.	Nano Lett
32374903	SARS-CoV-2 viral spike G614 mutation exhibits higher case fatality rate.	Int J Clin Pract
32374823	COVID-2019-associated overexpressed Prevotella proteins mediated host-pathogen interactions and their role in coronavirus outbreak.	Bioinformatics
32374537	"[SARS-CoV-2, a point in the storm]."	Rev Med Suisse
32374474	Natural antiviral compound silvestrol modulates human monocyte-derived macrophages and dendritic cells.	J Cell Mol Med
32374457	The anti-HIV drug nelfinavir mesylate (Viracept) is a potent inhibitor of cell fusion caused by the SARSCoV-2 spike (S) glycoprotein warranting further evaluation as an antiviral against COVID-19 infections.	J Med Virol
32374452	"SARS-CoV-2: Structural diversity, phylogeny, and potential animal host identification of spike glycoprotein."	J Med Virol
32374430	DC/L-SIGNs of hope in the COVID-19 pandemic.	J Med Virol
32374427	Expression of the COVID-19 receptor ACE2 in the human conjunctiva.	J Med Virol
32374416	ACE2 and prognosis of COVID-19: Insights from Bartter's and Gitelman's syndromes patients.	J Med Virol
32374218	Spotlight on avian coronaviruses.	Avian Pathol
32374208	A Critical Needs Assessment for Research in Companion Animals and Livestock Following the Pandemic of COVID-19 in Humans.	Vector Borne Zoonotic Dis
32374074	Potential anti-SARS-CoV-2 drug candidates identified through virtual screening of the ChEMBL database for compounds that target the main coronavirus protease.	FEBS Open Bio
32374032	"Letter: intestinal inflammation, COVID-19 and gastrointestinal ACE2-exploring RAS inhibitors."	Aliment Pharmacol Ther
32374009	Potential mechanisms by which the oxygen-ozone (O2-O3) therapy could contribute to the treatment against the coronavirus COVID-19.	Eur Rev Med Pharmacol Sci
32374001	"Clinical display, diagnostics and genetic implication of novel Coronavirus (COVID-19) epidemic."	Eur Rev Med Pharmacol Sci
32373999	Coronavirus disease 2019: a clinical review.	Eur Rev Med Pharmacol Sci
32373998	"The viral, epidemiologic, clinical characteristics and potential therapy options for COVID-19: a review."	Eur Rev Med Pharmacol Sci
32373995	Bioinformatic analysis indicates that SARS-CoV-2 is unrelated to known artificial coronaviruses.	Eur Rev Med Pharmacol Sci
32373994	Could host cell receptor alteration prevent SARS-CoV-2 viral entry? - Hype or hope.	Eur Rev Med Pharmacol Sci
32373991	In silico screening of natural compounds against COVID-19 by targeting Mpro and ACE2 using molecular docking.	Eur Rev Med Pharmacol Sci
32373989	Are Italy and Iran really suffering from COVID-19 epidemic? A controversial study.	Eur Rev Med Pharmacol Sci
32373791	Sex Differences in Mortality From COVID-19 Pandemic: Are Men Vulnerable and Women Protected?	JACC Case Rep
32373463	To the Editor-Is it really COVID-19?	HeartRhythm Case Rep
32373347	"The anti-influenza virus drug, arbidol is an efficient inhibitor of SARS-CoV-2 in vitro."	Cell Discov
32373134	Commentary: Origin and evolution of pathogenic coronaviruses.	Front Immunol
32372336	Pulmonary intravascular coagulation in COVID-19: possible pathogenesis and recommendations on anticoagulant/thrombolytic therapy.	J Thromb Thrombolysis
32372197	New challenges from Covid-19 pandemic: an unexpected opportunity to enlighten the link between viral infections and brain disorders?	Neurol Sci
32372149	SARS-CoV-2-mediated inflammatory response in lungs: should we look at RAGE?	Inflamm Res
32372051	Bioinformatic prediction of potential T cell epitopes for SARS-Cov-2.	J Hum Genet
32371949	Immune dysfunction leads to mortality and organ injury in patients with COVID-19 in China: insights from ERS-COVID-19 study.	Signal Transduct Target Ther
32371892	"COVID-19 Disease Map, building a computational repository of SARS-CoV-2 virus-host interaction mechanisms."	Sci Data
32371818	Hypertension and coronavirus disease 2019 mortality.	J Hypertens
32371817	Angiotensin-converting enzyme-2 in SARS-CoV-2 infection: good or bad?	J Hypertens
32371815	Hypertension and coronavirus disease 2019: what do we really know?	J Hypertens
32371813	Could renin-angiotensin-aldosterone system inhibitors be used for hypertensive patients with coronavirus disease 2019?	J Hypertens
32371812	"COVID-19, hypertension and angiotensin receptor-blocking drugs."	J Hypertens
32371811	"Angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers and coronavirus."	J Hypertens
32371557	"SARS-CoV-2 and myocardial injury: Few answers, many questions."	Cleve Clin J Med
32371479	Cytokine Storm Drugs Move from CAR T to COVID-19.	Cancer Discov
32371472	"SARS-CoV-2 and ORF3a: Nonsynonymous Mutations, Functional Domains, and Viral Pathogenesis."	mSystems
32371403	A personal historical perspective of HIV.	Postgrad Med J
32371230	Evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as coronavirus disease 2019 (COVID-19) pandemic: A global health emergency.	Sci Total Environ
32371168	The Topic of COVID-19-Related Liver Injury Needs More Rigorous Research.	Clin Gastroenterol Hepatol
32371101	The correlation between SARS-CoV-2 infection and rheumatic disease.	Autoimmun Rev
32371022	Controversy regarding ACE inhibitors / ARBs in COVID-19.	Rev Esp Cardiol (Engl Ed)
32370986	Renin-angiotensin-aldosterone system and COVID-19 infection.	Ann Endocrinol (Paris)
32370758	SARS-CoV-2 RNA polymerase as target for antiviral therapy.	J Transl Med
32370727	SARS-CoV-2 & Covid-19: Key-Roles of the 'Renin-Angiotensin' System / Vitamin D Impacting Drug and Vaccine Developments.	Infect Disord Drug Targets
32370269	Smoking and SARS-CoV-2 Disease (COVID-19): Dangerous Liaisons or Confusing Relationships?	J Clin Med
32370065	Hybridization Chain Reactions Targeting the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).	Int J Mol Sci
32369872	At the heart of COVID-19.	J Card Surg
32369678	"SARS-CoV-2, testosterone and frailty in males (PROTEGGIMI): A multidimensional research project."	Andrology
32369610	Severe COVID-19 infection and thrombotic microangiopathy: success does not come easily.	Br J Haematol
32369435	Canine Respiratory Coronavirus: A Naturally Occurring Model of COVID-19?	Vet Pathol
32369402	Coronavirus disease 2019 (COVID-19) and the renin-angiotensin system: A closer look at angiotensin-converting enzyme 2 (ACE2).	Ann Clin Biochem
32369211	What could be the better choice between ACE inhibitors and AT1R antagonists in coronavirus disease 2019 (COVID-19) patients?	J Med Virol
32369204	"Hepatic involvement in COVID-19 patients: Pathology, pathogenesis, and clinical implications."	J Med Virol
32369203	Smoking links to the severity of COVID-19: An update of a meta-analysis.	J Med Virol
32369190	"COVID-19, chronic inflammatory respiratory diseases and eosinophils-Observations from reported clinical case series."	Allergy
32368792	Potential therapeutic targets and promising drugs for combating SARS-CoV-2.	Br J Pharmacol
32368701	COVID-19-Associated Collapsing Glomerulopathy: An Emerging Entity.	Kidney Int Rep
32368569	The molecular biology of intracellular events during Coronavirus infection cycle.	Virusdisease
32368531	Hypertransaminasemia in the course of infection with SARS-CoV-2: Incidence and pathogenetic hypothesis.	World J Clin Cases
32367767	Potential inhibitors of coronavirus 3-chymotrypsin-like protease (3CL(pro)): an in silico screening of alkaloids and terpenoids from African medicinal plants.	J Biomol Struct Dyn
32367746	"ACE2 (Angiotensin-Converting Enzyme 2), COVID-19, and ACE Inhibitor and Ang II (Angiotensin II) Receptor Blocker Use During the Pandemic: The Pediatric Perspective."	Hypertension
32367648	"SARS-CoV-2 variants: Relevance for symptom granularity, epidemiology, immunity (herd, vaccines), virus origin and containment?"	Environ Microbiol
32367431	Neurological manifestations of patients with COVID-19: potential routes of SARS-CoV-2 neuroinvasion from the periphery to the brain.	Front Med
32367343	"COVID-19, Immuno-oncology and Cardiovascular Disease: Viewpoint from the Intersection."	J Cardiovasc Transl Res
32366817	A human monoclonal antibody blocking SARS-CoV-2 infection.	Nat Commun
32366740	COVID-19 and Avoiding Ibuprofen. How Good Is the Evidence?	Am J Ther
32366695	Site-specific glycan analysis of the SARS-CoV-2 spike.	Science
32366514	Acute Kidney Injury in COVID-19: Emerging Evidence of a Distinct Pathophysiology.	J Am Soc Nephrol
32366502	"COVID-19: Coronavirus replication, pathogenesis, and therapeutic strategies."	Cleve Clin J Med
32366279	"Genetic alteration, RNA expression, and DNA methylation profiling of coronavirus disease 2019 (COVID-19) receptor ACE2 in malignancies: a pan-cancer analysis."	J Hematol Oncol
32366161	Olfactory Dysfunction in COVID-19.	Otolaryngol Head Neck Surg
32366061	The COVID-19 Pandemic: Clinical Information for Ophthalmologists.	Turk J Ophthalmol
32366025	Codon Usage and Phenotypic Divergences of SARS-CoV-2 Genes.	Viruses
32365944	SARS Unique Domain (SUD) of Severe Acute Respiratory Syndrome Coronavirus Induces NLRP3 Inflammasome-Dependent CXCL10-Mediated Pulmonary Inflammation.	Int J Mol Sci
32365751	The SARS-CoV-2 Exerts a Distinctive Strategy for Interacting with the ACE2 Human Receptor.	Viruses
32365556	Pharmacological (or Synthetic) and Nutritional Agonists of PPAR-gamma as Candidates for Cytokine Storm Modulation in COVID-19 Disease.	Molecules
32365466	"The Human Coronavirus Disease COVID-19: Its Origin, Characteristics, and Insights into Potential Drugs and Its Mechanisms."	Pathogens
32365353	Rapid reconstruction of SARS-CoV-2 using a synthetic genomics platform.	Nature
32365214	[Bats and humans].	Lakartidningen
32365180	Potential influence of COVID-19/ACE2 on the female reproductive system.	Mol Hum Reprod
32364961	Severe respiratory SARS-CoV2 infection: Does ACE2 receptor matter?	Respir Med
32364527	"Immune environment modulation in pneumonia patients caused by coronavirus: SARS-CoV, MERS-CoV and SARS-CoV-2."	Aging (Albany NY)
32364442	Rigor before speculation in COVID-19 therapy.	Am J Physiol Lung Cell Mol Physiol
32364441	Don't judge too RAShly: the multifaceted role of the renin-angiotensin system and its therapeutic potential in COVID-19.	Am J Physiol Lung Cell Mol Physiol
32364119	Impact of SARS-CoV-2 infection on neurodegenerative and neuropsychiatric diseases: a delayed pandemic?	Neurologia (Engl Ed)
32364041	Using integrated computational approaches to identify safe and rapid treatment for SARS-CoV-2.	J Biomol Struct Dyn
32364011	"FDA-approved thiol-reacting drugs that potentially bind into the SARS-CoV-2 main protease, essential for viral replication."	J Biomol Struct Dyn
32363707	"Studies on viral pneumonia related to novel coronavirus SARS-CoV-2, SARS-CoV, and MERS-CoV: a literature review."	APMIS
32363391	Deducing the N- and O-glycosylation profile of the spike protein of novel coronavirus SARS-CoV-2.	Glycobiology
32363255	Investigation into SARS-CoV-2 Resistance of Compounds in Garlic Essential Oil.	ACS Omega
32363223	Genomics functional analysis and drug screening of SARS-CoV-2.	Genes Dis
32363221	"An overview of coronaviruses including the SARS-2 coronavirus - Molecular biology, epidemiology and clinical implications."	Curr Med Res Pract
32363219	Binding site analysis of potential protease inhibitors of COVID-19 using AutoDock.	Virusdisease
32363136	Crystal structure of SARS-CoV-2 nucleocapsid protein RNA binding domain reveals potential unique drug targeting sites.	Acta Pharm Sin B
32362921	Hypoxia in acute cardiac injury of coronavirus disease 2019: lesson learned from pathological studies.	J Geriatr Cardiol
32362868	Long-Term Neurological Threats of COVID-19: A Call to Update the Thinking About the Outcomes of the Coronavirus Pandemic.	Front Neurol
32362735	Insights into the inhibitory potential of selective phytochemicals against Mpro of 2019-nCoV: a computer-aided study.	Struct Chem
32362678	Baculovirus transit through insect cell membranes: A mechanistic approach.	Chem Eng Sci
32362649	First isolation of SARS-CoV-2 from clinical samples in India.	Indian J Med Res
32362340	COVID-19 patients with respiratory failure: what can we learn from aviation medicine?	Br J Anaesth
32362314	A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells.	Mol Cell
32362297	Angiotensin-converting-enzyme inhibitors (ACE inhibitors) and angiotensin II receptor blocker (ARB) use in COVID-19 prevention or treatment: A paradox.	Infect Control Hosp Epidemiol
32362245	An investigation into the identification of potential inhibitors of SARS-CoV-2 main protease using molecular docking study.	J Biomol Struct Dyn
32362243	Identification of new anti-nCoV drug chemical compounds from Indian spices exploiting SARS-CoV-2 main protease as target.	J Biomol Struct Dyn
32362235	Understanding the binding affinity of noscapines with protease of SARS-CoV-2 for COVID-19 using MD simulations at different temperatures.	J Biomol Struct Dyn
32362217	In silico study the inhibition of angiotensin converting enzyme 2 receptor of COVID-19 by Ammoides verticillata components harvested from Western Algeria.	J Biomol Struct Dyn
32362061	Dupilumab and COVID-19: What should we expect?	Dermatol Ther
32362036	Being African American and Rural: A Double Jeopardy From COVID-19.	J Rural Health
32361911	Single-cell transcriptome analysis of the novel coronavirus (SARS-CoV-2) associated gene ACE2 expression in normal and non-obstructive azoospermia (NOA) human male testes.	Sci China Life Sci
32361826	COVID-19 and the endocrine system: exploring the unexplored.	J Endocrinol Invest
32361692	How the COVID-19 Overcomes the Battle? An Approach to Virus Structure.	Iran J Kidney Dis
32361598	"Coronavirus in water environments: Occurrence, persistence and concentration methods - A scoping review."	Water Res
32361588	Plausible mechanisms of Niclosamide as an antiviral agent against COVID-19.	Med Hypotheses
32361409	Protective immunity after COVID-19 has been questioned: What can we do without SARS-CoV-2-IgG detection?	Cell Immunol
32361215	Delirium and sleep disturbances in COVID-19: a possible role for melatonin in hospitalized patients?	Sleep Med
32361195	SARS-CoV-2 infection complicated by inflammatory syndrome. Could high-dose human immunoglobulin for intravenous use (IVIG) be beneficial?	Autoimmun Rev
32361194	Molecular mimicry between SARS-CoV-2 and respiratory pacemaker neurons.	Autoimmun Rev
32361161	New understanding of the damage of SARS-CoV-2 infection outside the respiratory system.	Biomed Pharmacother
32361100	Amantadine as a drug to mitigate the effects of COVID-19.	Med Hypotheses
32361098	Does infection of 2019 novel coronavirus cause acute and/or chronic sialadenitis?	Med Hypotheses
32361028	Amantadine disrupts lysosomal gene expression: A hypothesis for COVID19 treatment.	Int J Antimicrob Agents
32361001	"Bioinformatic analysis and identification of single-stranded RNA sequences recognized by TLR7/8 in the SARS-CoV-2, SARS-CoV, and MERS-CoV genomes."	Microbes Infect
32360995	No evidence for an increased liver uptake of SARS-CoV-2 in metabolic-associated fatty liver disease.	J Hepatol
32360977	The role of Neutrophil Extracellular Traps in Covid-19: Only an hypothesis or a potential new field of research?	Thromb Res
32360703	SARS-CoV-2 receptor ACE2-dependent implications on the cardiovascular system: From basic science to clinical implications.	J Mol Cell Cardiol
32360697	Metformin in COVID-19: A possible role beyond diabetes.	Diabetes Res Clin Pract
32360608	Forecasting the timeframe of 2019-nCoV and human cells interaction with reverse engineering.	Prog Biophys Mol Biol
32360606	SARS-CoV2 entry and spread in the lymphatic drainage system of the brain.	Brain Behav Immun
32360580	Liu Shen capsule shows antiviral and anti-inflammatory abilities against novel coronavirus SARS-CoV-2 via suppression of NF-kappaB signaling pathway.	Pharmacol Res
32360499	"Comparative seasonalities of influenza A, B and 'common cold' coronaviruses - setting the scene for SARS-CoV-2 infections and possible unexpected host immune interactions."	J Infect
32360484	Chemical composition and pharmacological mechanism of Qingfei Paidu Decoction and Ma Xing Shi Gan Decoction against Coronavirus Disease 2019 (COVID-19): In silico and experimental study.	Pharmacol Res
32360480	Candidate drugs against SARS-CoV-2 and COVID-19.	Pharmacol Res
32360400	Hyperglycemia and the worse prognosis of COVID-19. Why a fast blood glucose control should be mandatory.	Diabetes Res Clin Pract
32360397	Letter to the Editor: Mechanisms of increased morbidity and mortality of SARS-CoV-2 infection in individuals with diabetes: what this means for an effective management strategy.	Metabolism
32360300	Natural product-derived phytochemicals as potential agents against coronaviruses: A review.	Virus Res
32360293	Endothelin receptor antagonists for pulmonary arterial hypertension and COVID-19: Friend or foe?	J Heart Lung Transplant
32360285	Type I IFN immunoprofiling in COVID-19 patients.	J Allergy Clin Immunol
32360231	Arbidol: A potential antiviral drug for the treatment of SARS-CoV-2 by blocking trimerization of the spike glycoprotein.	Int J Antimicrob Agents
32360182	Antiviral activities of type I interferons to SARS-CoV-2 infection.	Antiviral Res
32360140	Bee venom and SARS-CoV-2.	Toxicon
32360126	Myocardial injury and COVID-19: Possible mechanisms.	Life Sci
32360083	Modulation of Hb-O2 affinity to improve hypoxemia in COVID-19 patients.	Clin Nutr
32360010	The Renin-Angiotensin-Aldosterone System in Coronavirus Infection-Current Considerations During the Pandemic.	J Cardiothorac Vasc Anesth
32359765	Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and the Central Nervous System.	Trends Neurosci
32359479	"COVID-19: Epidemiology, Evolution, and Cross-Disciplinary Perspectives."	Trends Mol Med
32359424	"Genomic Epidemiology of SARS-CoV-2 in Guangdong Province, China."	Cell
32359396	A Dynamic Immune Response Shapes COVID-19 Progression.	Cell Host Microbe
32359201	"The first, holistic immunological model of COVID-19: Implications for prevention, diagnosis, and public health measures."	Pediatr Allergy Immunol
32359101	A hypothesized role for dysregulated bradykinin signaling in COVID-19 respiratory complications.	FASEB J
32359088	RAAS blockers in hypertension posing a higher risk toward the COVID-19.	Dermatol Ther
32359080	Off-target ACE2 ligands: Possible therapeutic option for CoVid-19?	Br J Clin Pharmacol
32358609	The COVID-19 outbreak and the angiotensin-converting enzyme 2: too little or too much?	Nephrol Dial Transplant
32358580	COVID-19: a case for inhibiting IL-17?	Nat Rev Immunol
32358579	Will helminth co-infection modulate COVID-19 severity in endemic regions?	Nat Rev Immunol
32358232	"Advanced Pulmonary and Cardiac Support of COVID-19 Patients: Emerging Recommendations From ASAIO-A ""Living Working Document""."	ASAIO J
32358203	Structural basis for inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by remdesivir.	Science
32358202	SARS-CoV-2 productively infects human gut enterocytes.	Science
32358120	How related is SARS-CoV-2 to other coronaviruses?	Vet Rec
32357959	An 81-Nucleotide Deletion in SARS-CoV-2 ORF7a Identified from Sentinel Surveillance in Arizona (January to March 2020).	J Virol
32357655	Growing networks with communities: A distributive link model.	Chaos
32357553	Repurposing Antiviral Protease Inhibitors Using Extracellular Vesicles for Potential Therapy of COVID-19.	Viruses
32357545	Emergence of Drift Variants That May Affect COVID-19 Vaccine Development and Antibody Treatment.	Pathogens
32357471	Feasibility of Known RNA Polymerase Inhibitors as Anti-SARS-CoV-2 Drugs.	Pathogens
32356926	Telmisartan as tentative angiotensin receptor blocker therapeutic for COVID-19.	Drug Dev Res
32356908	Mathematical modeling of interaction between innate and adaptive immune responses in COVID-19 and implications for viral pathogenesis.	J Med Virol
32356628	Renin-Angiotensin-Aldosterone System Inhibitors and Risk of Covid-19.	N Engl J Med
32356627	Renin-Angiotensin-Aldosterone System Blockers and the Risk of Covid-19.	N Engl J Med
32356626	"Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19."	N Engl J Med
32356625	Inhibitors of the Renin-Angiotensin-Aldosterone System and Covid-19.	N Engl J Med
32356603	Why the SARS-Cov-2 has prolonged spreading time in children?	Pediatr Pulmonol
32356516	Potential influences of obstructive sleep apnea and obesity on COVID-19 severity.	J Clin Sleep Med
32356307	From Hematologist's desk: The effect of COVID-19 on the blood system.	Am J Hematol
32356302	Antenatal corticosteroid therapy and COVID-19: Pathophysiological considerations.	Acta Obstet Gynecol Scand
32356294	Platelets in Coronavirus Disease 2019.	Semin Thromb Hemost
32356252	COVID-19: Therapeutics and Their Toxicities.	J Med Toxicol
32355869	The Potential Protective Effect of Estrogen: A Plausible Theory for why COVID-19 Mortality is Lower in Females.	Int J Womens Dermatol
32355837	Comprehensive update on current outbreak of novel coronavirus infection (2019-nCoV).	Ann Transl Med
32355638	Editorial: Nicotine and SARS-CoV-2: COVID-19 may be a disease of the nicotinic cholinergic system.	Toxicol Rep
32355329	SARS-CoV-2-reactive T cells in patients and healthy donors.	Nat Rev Immunol
32355260	Genetic diversity and ecology of coronaviruses hosted by cave-dwelling bats in Gabon.	Sci Rep
32355222	A novel COVID-19 and its effects on cardiovascular disease.	Hypertens Res
32354715	"Neuroradiologists, Be Mindful of the Neuroinvasive Potential of COVID-19."	AJNR Am J Neuroradiol
32354685	Why Choose Cyclosporin A as First-line Therapy in COVID-19 Pneumonia.	Reumatol Clin (Engl Ed)
32354636	Blockade of SARS-CoV-2 infection by recombinant soluble ACE2.	Kidney Int
32354030	Functional Role of Dietary Intervention to Improve the Outcome of COVID-19: A Hypothesis of Work.	Int J Mol Sci
32354022	ACE2: The key Molecule for Understanding the Pathophysiology of Severe and Critical Conditions of COVID-19: Demon or Angel?	Viruses
32353982	The Ocular Surface and the Coronavirus Disease 2019: Does a Dual 'Ocular Route' Exist?	J Clin Med
32353978	Structural and Evolutionary Analysis Indicate That the SARS-CoV-2 Mpro Is a Challenging Target for Small-Molecule Inhibitor Design.	Int J Mol Sci
32353898	Histopathology and genetic susceptibility in COVID-19 pneumonia.	Eur J Clin Invest
32353870	The many faces of the anti-COVID immune response.	J Exp Med
32353859	A SARS-CoV-2 protein interaction map reveals targets for drug repurposing.	Nature
32353634	COVID-19: Immunology and treatment options.	Clin Immunol
32353597	Severe Acute Respiratory Syndrome-Coronavirus-2 Infection and Patients With Lung Cancer: The Potential Role of Interleukin-17 Target Therapy.	J Thorac Oncol
32353523	SARS-CoV-2: A new virus but a familiar inflammation brain pattern.	Brain Behav Immun
32353474	Genotyping coronavirus SARS-CoV-2: methods and implications.	Genomics
32353371	Is SARS-CoV-2 Also an Enteric Pathogen With Potential Fecal-Oral Transmission? A COVID-19 Virological and Clinical Review.	Gastroenterology
32353370	"Gastrointestinal ACE2, COVID-19 and IBD: Opportunity in the Face of Tragedy?"	Gastroenterology
32353356	"Commentary: Obesity: The ""Achilles heel"" for COVID-19?"	Metabolism
32353355	"Commentary: Testosterone, a key hormone in the context of COVID-19 pandemic."	Metabolism
32353252	Development of CRISPR as an Antiviral Strategy to Combat SARS-CoV-2 and Influenza.	Cell
32353251	COVID-19 cytokine storm: the interplay between inflammation and coagulation.	Lancet Respir Med
32352576	COVID-19 in pregnancy: Risk of adverse neonatal outcomes.	J Med Virol
32352574	Coinfection in SARS-CoV-2 infected patients: Where are influenza virus and rhinovirus/enterovirus?	J Med Virol
32352535	"COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options."	Cardiovasc Res
32352517	Anticoagulation in COVID-19.	Eur Heart J Cardiovasc Pharmacother
32352407	Preventing cytokine storm syndrome in COVID-19 using alpha-1 adrenergic receptor antagonists.	J Clin Invest
32352224	SARS-CoV-2 virus and liver expression of host receptors: Putative mechanisms of liver involvement in COVID-19.	Liver Int
32352160	Covid-19-related pancreatic injury.	Br J Surg
32351121	Evidence for Use or Disuse of Renin-Angiotensin System Modulators in Patients Having COVID-19 With an Underlying Cardiorenal Disorder.	J Cardiovasc Pharmacol Ther
32351056	Decoding the evolution and transmissions of the novel pneumonia coronavirus (SARS-CoV-2 / HCoV-19) using whole genomic data.	Zool Res
32350632	Cardiovascular Risks in Patients with COVID-19: Potential Mechanisms and Areas of Uncertainty.	Curr Cardiol Rep
32350571	SARS-CoV-2 will continue to circulate in the human population: an opinion from the point of view of the virus-host relationship.	Inflamm Res
32350227	Characteristics of SARS-CoV-2 Isolated from Asymptomatic Carriers in Tokyo.	Jpn J Infect Dis
32350106	Current smoking is not associated with COVID-19.	Eur Respir J
32350105	Putative contributions of circadian clock and sleep in the context of SARS-CoV-2 infection.	Eur Respir J
32350104	COVID-19 and nicotine as a mediator of ACE-2.	Eur Respir J
32349055	Is COVID Evolution Due to Occurrence of Pulmonary Vascular Thrombosis?	J Thorac Imaging
32349035	Genomic analysis and comparative multiple sequences of SARS-CoV2.	J Chin Med Assoc
32349031	Role of dipeptidyl peptidase-4 inhibitors in patients with diabetes infected with coronavirus-19.	J Chin Med Assoc
32348783	Hyperinflammation and derangement of renin-angiotensin-aldosterone system in COVID-19: A novel hypothesis for clinically suspected hypercoagulopathy and microvascular immunothrombosis.	Clin Chim Acta
32348773	COVID-19 and ACE2 in the Liver and Gastrointestinal Tract: Putative Biological Explanations of Sexual Dimorphism.	Gastroenterology
32348715	"B Cells, Viruses, and the SARS-CoV-2/COVID-19 Pandemic of 2020."	Viral Immunol
32348692	COVID-19-related Genes in Sputum Cells in Asthma. Relationship to Demographic Features and Corticosteroids.	Am J Respir Crit Care Med
32348678	Respiratory Pathophysiology of Mechanically Ventilated Patients with COVID-19: A Cohort Study.	Am J Respir Crit Care Med
32348636	Hyposalivation as a potential risk for SARS-CoV-2 infection: Inhibitory role of saliva.	Oral Dis
32348495	Interferon-Induced Transmembrane Protein 3 Genetic Variant rs12252-C Associated With Disease Severity in Coronavirus Disease 2019.	J Infect Dis
32348474	Expanding our understanding of the role polyprotein conformation plays in the coronavirus life cycle.	Biochem J
32348472	A marker of systemic inflammation or direct cardiac injury: should cardiac troponin levels be monitored in COVID-19 patients?	Eur Heart J Qual Care Clin Outcomes
32348111	Is the Collapse of the Respiratory Center in the Brain Responsible for Respiratory Breakdown in COVID-19 Patients?	ACS Chem Neurosci
32347980	Prolonged SARS-CoV-2 RNA shedding: Not a rare phenomenon.	J Med Virol
32347925	Statin therapy in COVID-19 infection.	Eur Heart J Cardiovasc Pharmacother
32347747	Can melatonin reduce the severity of COVID-19 pandemic?	Int Rev Immunol
32347602	"Should we try the antiinflammatory natural product, celastrol, for COVID-19?"	Phytother Res
32347323	"Facing COVID-19 in the ICU: vascular dysfunction, thrombosis, and dysregulated inflammation."	Intensive Care Med
32347144	Current Perspectives on Coronavirus Disease 2019 and Cardiovascular Disease: A White Paper by the JAHA Editors.	J Am Heart Assoc
32347055	[Role of cyclophilin A during coronavirus replication and the antiviral activities of its inhibitors].	Sheng Wu Gong Cheng Xue Bao
32346813	"COVID-19, hypothalamo-pituitary-adrenal axis and clinical implications."	Endocrine
32346682	The New Challenge of Geriatrics: Saving Frail Older People from the SARS-COV-2 Pandemic Infection.	J Nutr Health Aging
32346658	SARS-CoV-2 and Bats: From Flight to Fighting COVID-19.	JACC Basic Transl Sci
32346493	Clinical presentations and outcomes of SARS-CoV-2 infected pneumonia in pregnant women and health status of their neonates.	Sci Bull (Beijing)
32346490	"Structural elucidation of SARS-CoV-2 vital proteins: Computational methods reveal potential drug candidates against main protease, Nsp12 polymerase and Nsp13 helicase."	J Pharm Anal
32346099	High-dimensional immune profiling by mass cytometry revealed immunosuppression and dysfunction of immunity in COVID-19 patients.	Cell Mol Immunol
32346094	COVID-19 vaccine design: the Janus face of immune enhancement.	Nat Rev Immunol
32346093	"The trinity of COVID-19: immunity, inflammation and intervention."	Nat Rev Immunol
32346092	Cancer therapy tool informs COVID-19 vaccines.	Nat Rev Immunol
32346091	Neutralizing antibody response in mild COVID-19.	Nat Rev Immunol
32346090	Does asthma make COVID-19 worse?	Nat Rev Immunol
32346073	COVID-19: towards understanding of pathogenesis.	Cell Res
32345857	COVID-19 and Neuroinvasion.	Anesth Analg
32345646	"BTK Inhibitors in Cancer Patients with COVID-19: ""The Winner Will be the One Who Controls That Chaos"" (Napoleon Bonaparte)."	Clin Cancer Res
32345362	Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues.	Infect Dis Poverty
32345140	Stilbene-based natural compounds as promising drug candidates against COVID-19.	J Biomol Struct Dyn
32345124	An in-silico evaluation of different Saikosaponins for their potency against SARS-CoV-2 using NSP15 and fusion spike glycoprotein as targets.	J Biomol Struct Dyn
32344708	"A Novel Combination of Vitamin C, Curcumin and Glycyrrhizic Acid Potentially Regulates Immune and Inflammatory Response Associated with Coronavirus Infections: A Perspective from System Biology Analysis."	Nutrients
32344679	"The COVID-19 Pandemic: A Comprehensive Review of Taxonomy, Genetics, Epidemiology, Diagnosis, Treatment, and Control."	J Clin Med
32344401	COVID-19: Possible Impact of the Genetic Background in IFNL Genes on Disease Outcomes.	J Innate Immun
32344395	The Role of the Renin-Angiotensin System in Severe Acute Respiratory Syndrome-CoV-2 Infection.	Blood Purif
32344315	N-acetyl-cysteine may prevent COVID-19-associated cytokine storm and acute respiratory distress syndrome.	Med Hypotheses
32344314	"Innate immunity in COVID-19 patients mediated by NKG2A receptors, and potential treatment using Monalizumab, Cholroquine, and antiviral agents."	Med Hypotheses
32344312	Potential effect of natural and anabolizan steroids in elderly patient with COVID-19.	Med Hypotheses
32344311	2019-nCoV-SARS-CoV-2 (COVID-19) infection: Cruciality of Furin and relevance with cancer.	Med Hypotheses
32344307	COVID-19 type III hypersensitivity reaction.	Med Hypotheses
32344305	A data-driven hypothesis on the epigenetic dysregulation of host metabolism by SARS coronaviral infection: Potential implications for the SARS-CoV-2 modus operandi.	Med Hypotheses
32344304	May patients receiving 5-alpha-reductase inhibitors be in higher risk of COVID-19 complications?	Med Hypotheses
32344303	Oxytocin as a potential defence against Covid-19?	Med Hypotheses
32344276	"COVID-19 and anosmia in Tehran, Iran."	Med Hypotheses
32344190	Debate on drugs that may aggravate COVID-19.	J Allergy Clin Immunol Pract
32344070	Reply: Calm before the storm: Understanding the role of Janus kinase inhibitors in COVID-19.	J Am Acad Dermatol
32344056	Eosinophil responses during COVID-19 infections and coronavirus vaccination.	J Allergy Clin Immunol
32343996	Rising Concern on Damaged Testis of COVID-19 Patients.	Urology
32343948	IgA-Ab response to spike glycoprotein of SARS-CoV-2 in patients with COVID-19: A longitudinal study.	Clin Chim Acta
32343658	Medication for COVID-19-an Overview of Approaches Currently Under Study.	Dtsch Arztebl Int
32343593	"COVID-19, coronavirus, SARS-CoV-2 and the small bowel."	Rev Esp Enferm Dig
32343510	COVID-19: are T lymphocytes simply watching?	Panminerva Med
32343415	Long-term coexistence of SARS-CoV-2 with antibody response in COVID-19 patients.	J Med Virol
32343152	ABO blood group predisposes to COVID-19 severity and cardiovascular diseases.	Eur J Prev Cardiol
32343122	Updates on What ACS Reported: Emerging Evidences of COVID-19 with Nervous System Involvement.	ACS Chem Neurosci
32342926	Properties of Coronavirus and SARS-CoV-2.	Malays J Pathol
32342636	Potential pathogenesis of ageusia and anosmia in COVID-19 patients.	Int Forum Allergy Rhinol
32342146	COVID-19 pandemic: is a gender-defined dosage effect responsible for the high mortality rate among males?	Immunogenetics
32342126	COVID-19: A primer for Neuroradiologists.	Neuroradiology
32341946	Chaos game representation dataset of SARS-CoV-2 genome.	Data Brief
32341622	SARS-CoV-2: Camazotz's Curse.	Med J Armed Forces India
32341442	"Interactions of coronaviruses with ACE2, angiotensin II, and RAS inhibitors-lessons from available evidence and insights into COVID-19."	Hypertens Res
32341103	Understanding the renin-angiotensin-aldosterone-SARS-CoV axis: a comprehensive review.	Eur Respir J
32341101	COVID-19 and smoking: is nicotine the hidden link?	Eur Respir J
32340833	Coronavirus disease 2019 (COVID-19): A literature review.	J Infect Public Health
32340759	Possible Cause of Inflammatory Storm and Septic Shock in Patients Diagnosed with (COVID-19).	Arch Med Res
32340678	Pathology of 2019 Novel Coronavirus Pneumonia: A Dynamic Disease Process.	J Thorac Oncol
32340654	On the Pharmacy Radar: COViD-19 and Older People.	Sr Care Pharm
32340562	A molecular modeling approach to identify effective antiviral phytochemicals against the main protease of SARS-CoV-2.	J Biomol Struct Dyn
32340551	Natural products may interfere with SARS-CoV-2 attachment to the host cell.	J Biomol Struct Dyn
32340531	Increasing the Signal-to-Noise Ratio: COVID-19 Clinical Synopsis for Outpatient Providers.	J Prim Care Community Health
32340389	Putative Inhibitors of SARS-CoV-2 Main Protease from A Library of Marine Natural Products: A Virtual Screening and Molecular Modeling Study.	Mar Drugs
32340096	[Preliminary clinical study of direct renin inhibitor aliskiren in the treatment of severe COVID-19 patients with hypertension].	Zhonghua Nei Ke Za Zhi
32340089	[Pathological changes of the spleen in ten patients with coronavirus disease 2019(COVID-19) by postmortem needle autopsy].	Zhonghua Bing Li Xue Za Zhi
32340070	ACE inhibitors and COVID-19: We don't know yet.	J Card Surg
32340044	The ACE-2 in COVID-19: Foe or Friend?	Horm Metab Res
32339915	Anti-CD20 immunosuppressive disease-modifying therapies and COVID-19.	Mult Scler Relat Disord
32339777	May IL-17 have a role in COVID-19 infection?	Med Hypotheses
32339776	"Covid-19, TMPRSS2, and whether android regulation affects pandemic virus gender incidence and age distribution of disease."	Med Hypotheses
32339706	Cutaneous manifestations in COVID-19: Lessons learned from current evidence.	J Am Acad Dermatol
32339701	Reply: Potential role of Janus kinase inhibitors in COVID-19.	J Am Acad Dermatol
32339565	"COVID-19 and cardiovascular disease: What we know, what we think we know, and what we need to know."	J Mol Cell Cardiol
32339534	COVID-19 and diabetes: Is metformin a friend or foe?	Diabetes Res Clin Pract
32339391	The Role of Adipocytes and Adipocyte-Like Cells in the Severity of COVID-19 Infections.	Obesity (Silver Spring)
32339387	"COVID-19, pulmonary mast cells, cytokine storms, and beneficial actions of luteolin."	Biofactors
32339307	Additional hypotheses about why COVID-19 is milder in children than adults.	Acta Paediatr
32339299	Is global BCG vaccination-induced trained immunity relevant to the progression of SARS-CoV-2 pandemic?	Allergy
32339250	A potential ex vivo infection model of human induced pluripotent stem cell-3D organoids beyond coronavirus disease 2019.	Histol Histopathol
32339215	Clinical Impact of Renin-angiotensin System Inhibitors on In-hospital Mortality of Patients With Hypertension Hospitalized for Coronavirus Disease 2019.	Clin Infect Dis
32339157	ACE2 correlated with immune infiltration serves as a prognostic biomarker in endometrial carcinoma and renal papillary cell carcinoma: implication for COVID-19.	Aging (Albany NY)
32339089	Letter to the Editor: Issues on COVID-19 Pathogenesis.	Viral Immunol
32338605	Kallikrein-kinin blockade in patients with COVID-19 to prevent acute respiratory distress syndrome.	Elife
32338533	"INFECTIONS IN PREGNANCY WITH COVID-19 AND OTHER RESPIRATORY RNA VIRUS DISEASES ARE RARELY, IF EVER, TRANSMITTED TO THE FETUS: EXPERIENCES WITH CORONAVIRUSES, HPIV, hMPV RSV, AND INFLUENZA."	Arch Pathol Lab Med
32338224	Focus on Receptors for Coronaviruses with Special Reference to Angiotensin- Converting Enzyme 2 as a Potential Drug Target - A Perspective.	Endocr Metab Immune Disord Drug Targets
32338164	SARS-CoV-2 RNA dependent RNA polymerase (RdRp) targeting: an in silico perspective.	J Biomol Struct Dyn
32337664	Rational Use of Tocilizumab in the Treatment of Novel Coronavirus Pneumonia.	Clin Drug Investig
32337113	Brief Review on COVID-19: The 2020 Pandemic Caused by SARS-CoV-2.	Cureus
32336957	Combination of Biodata Mining and Computational Modelling in Identification and Characterization of ORF1ab Polyprotein of SARS-CoV-2 Isolated from Oronasopharynx of an Iranian Patient.	Biol Proced Online
32336927	"Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Emergence, history, basic and clinical aspects."	Saudi J Biol Sci
32336612	The pivotal link between ACE2 deficiency and SARS-CoV-2 infection.	Eur J Intern Med
32336007	DPP4 inhibition: Preventing SARS-CoV-2 infection and/or progression of COVID-19?	Diabetes Metab Res Rev
32335749	How Could This Happen? : Narrowing Down the Contagion of COVID-19 and Preventing Acute Respiratory Distress Syndrome (ARDS).	Acta Biotheor
32335585	The Coronavirus Pandemic: What Does the Evidence Show?	J Nepal Health Res Counc
32335456	The old but new: Can unfractioned heparin and low molecular weight heparins inhibit proteolytic activation and cellular internalization of SARS-CoV2 by inhibition of host cell proteases?	Med Hypotheses
32335367	Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): An overview of viral structure and host response.	Diabetes Metab Syndr
32335366	Can dapagliflozin have a protective effect against COVID-19 infection? A hypothesis.	Diabetes Metab Syndr
32335337	Hypertension prevalence in human coronavirus disease: the role of ACE system in infection spread and severity.	Int J Infect Dis
32335336	SARS-CoV-2: Is it the newest spark in the TORCH?	J Clin Virol
32335334	Emerging genetic diversity among clinical isolates of SARS-CoV-2: Lessons for today.	Infect Genet Evol
32335209	"Correspondence: Angiotensin-converting enzyme 2 coated nanoparticles containing respiratory masks, chewing gums and nasal filters may be used for protection against COVID-19 infection."	Travel Med Infect Dis
32335161	In the search of potential epitopes for Wuhan seafood market pneumonia virus using high order nullomers.	J Immunol Methods
32335097	SARS-CoV-2 and DPP4 inhibition: Is it time to pray for Janus Bifrons?	Diabetes Res Clin Pract
32334502	The Mechanistic Target of Rapamycin (mTOR): Novel Considerations as an Antiviral Treatment.	Curr Neurovasc Res
32334082	ACE2 Expression in Pancreas May Cause Pancreatic Damage After SARS-CoV-2 Infection.	Clin Gastroenterol Hepatol
32334062	Current status of potential therapeutic candidates for the COVID-19 crisis.	Brain Behav Immun
32334052	Repurposing the mucolytic cough suppressant and TMPRSS2 protease inhibitor bromhexine for the prevention and management of SARS-CoV-2 infection.	Pharmacol Res
32333993	Does the pathogenesis of SARS-CoV-2 virus decrease at high-altitude?	Respir Physiol Neurobiol
32333991	The Use of Captopril-Angiotensin Converting Enzyme (ACE) Inhibitor for Cystinuria During COVID-19 Pandemic.	Urology
32333972	"Letter to the editor in response to the article ""COVID-19 and diabetes: Can DPP4 inhibition play a role?"""	Diabetes Res Clin Pract
32333969	Response to COVID-19 and diabetes: Can DPP4 inhibition play a role? - GLP-1 might play one too.	Diabetes Res Clin Pract
32333915	"Association of respiratory allergy, asthma, and expression of the SARS-CoV-2 receptor ACE2."	J Allergy Clin Immunol
32333914	A possible role for B cells in COVID-19? Lesson from patients with agammaglobulinemia.	J Allergy Clin Immunol
32333836	Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2.	Cell
32333818	COVID-19: lambda interferon against viral load and hyperinflammation.	EMBO Mol Med
32333601	Expression of SARS-CoV-2 Entry Molecules ACE2 and TMPRSS2 in the Gut of Patients With IBD.	Inflamm Bowel Dis
32333494	Racial variations in COVID-19 deaths may be due to androgen receptor genetic variants associated with prostate cancer and androgenetic alopecia. Are anti-androgens a potential treatment for COVID-19?	J Cosmet Dermatol
32333489	Is gustatory impairment the first report of an oral manifestation in COVID-19?	Oral Dis
32333487	Does SARS-Cov-2 invade the brain? Translational lessons from animal models.	Eur J Neurol
32333398	A hypothesis for pathobiology and treatment of COVID-19: The centrality of ACE1/ACE2 imbalance.	Br J Pharmacol
32333222	"The genetic sequence, origin, and diagnosis of SARS-CoV-2."	Eur J Clin Microbiol Infect Dis
32333199	Coronavirus in Hematologic Malignancies: Targeting Molecules Beyond the Angiotensin-Converting Enzyme 2 (ACE2) Wall in COVID-19.	Pathol Oncol Res
32332922	SARS-CoV-2 infection of kidney organoids prevented with soluble human ACE2.	Nat Rev Nephrol
32332765	Neutralization of SARS-CoV-2 spike pseudotyped virus by recombinant ACE2-Ig.	Nat Commun
32332039	Renin-angiotensin-aldosterone system inhibitors and COVID-19.	CMAJ
32331979	"Response to the editorial ""COVID-19 in patients with cardiovascular diseases"": Covid-19 treatment with hydroxychloroquine or chloroquine and azithromycin: A potential risk of Torsades de Pointes."	Arch Cardiovasc Dis
32331780	COVID-19-related cardiac involvement and potential implications for cardiothoracic imaging.	Clin Radiol
32331343	"Sex-Specific SARS-CoV-2 Mortality: Among Hormone-Modulated ACE2 Expression, Risk of Venous Thromboembolism and Hypovitaminosis D."	Int J Mol Sci
32331255	"Origin, Potential Therapeutic Targets and Treatment for Coronavirus Disease (COVID-19)."	Pathogens
32330414	The Architecture of SARS-CoV-2 Transcriptome.	Cell
32330332	SARS-CoV-2 infection in children - Understanding the immune responses and controlling the pandemic.	Pediatr Allergy Immunol
32330308	COVID19 coagulopathy in Caucasian patients.	Br J Haematol
32330302	"Comment on ""Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19""."	J Med Virol
32330208	Machine learning using intrinsic genomic signatures for rapid classification of novel pathogens: COVID-19 case study.	PLoS One
32329756	Neutrophil extracellular traps in COVID-19.	JCI Insight
32329629	"Tobacco Smoking Increases the Lung Gene Expression of ACE2, the Receptor of SARS-CoV-2."	Am J Respir Crit Care Med
32329419	Andrographolide as a potential inhibitor of SARS-CoV-2 main protease: an in silico approach.	J Biomol Struct Dyn
32329408	Discovery of potential multi-target-directed ligands by targeting host-specific SARS-CoV-2 structurally conserved main protease.	J Biomol Struct Dyn
32329276	[Spike protein in the detection and treatment of novel coronavirus].	Sheng Wu Yi Xue Gong Cheng Xue Za Zhi
32329083	COVID-19 transmission through host cell directed network of GPCR.	Drug Dev Res
32329044	Neurological complications of coronavirus and COVID-19.	Rev Neurol
32328234	Does the direct renin inhibitor have a role to play in attenuating severity of the outbreak coronavirus disease 2019 (COVID-19)?	Ther Adv Endocrinol Metab
32327758	SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes.	Nat Med
32327413	Genetic Roadmap for Kidney Involvement of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection.	Clin J Am Soc Nephrol
32327291	Bioactive Lipids and Coronavirus.	Arch Med Res
32327202	Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China.	Kidney Int
32327200	Covid-19 and the angiotensin-converting enzyme (ACE2): Areas for research.	Heart Lung
32326602	"Pharmacological Therapeutics Targeting RNA-Dependent RNA Polymerase, Proteinase and Spike Protein: From Mechanistic Studies to Clinical Trials for COVID-19."	J Clin Med
32325421	Increased expression of CD8 marker on T-cells in COVID-19 patients.	Blood Cells Mol Dis
32325252	COVID-19 pathophysiology: A review.	Clin Immunol
32325130	Bayesian phylodynamic inference on the temporal evolution and global transmission of SARS-CoV-2.	J Infect
32325025	"COVID-19: A New Virus, but a Familiar Receptor and Cytokine Release Syndrome."	Immunity
32324968	Does High Cardiorespiratory Fitness Confer Some Protection Against Proinflammatory Responses After Infection by SARS-CoV-2?	Obesity (Silver Spring)
32324641	Coronavirus disease 2019 infection and the cardiovascular system.	J Cardiovasc Med (Hagerstown)
32324209	"Association of Renin-Angiotensin System Inhibitors With Severity or Risk of Death in Patients With Hypertension Hospitalized for Coronavirus Disease 2019 (COVID-19) Infection in Wuhan, China."	JAMA Cardiol
32323279	[Renin-Angiotensin-System (RAS) and COVID-19 - On The Prescription of RAS Blockers].	Dtsch Med Wochenschr
32322993	"The emergence of SARS, MERS and novel SARS-2 coronaviruses in the 21st century."	Arch Virol
32322935	"SARS-CoV-2 as potential cause of cardiac inflammation and heart failure. Is it the virus, hyperinflammation, or MODS?"	Herz
32322401	"Novel coronavirus disease (COVID-19): a pandemic (epidemiology, pathogenesis and potential therapeutics)."	New Microbes New Infect
32322400	"Epidemiology, genome, and clinical features of the pandemic SARS-CoV-2: a recent view."	New Microbes New Infect
32321878	Is GSK3beta a molecular target of chloroquine treatment against COVID-19?	Drug Discov Ther
32321856	Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease.	Science
32321823	COVID-19: an Immunopathological View.	mSphere
32321524	Emerging SARS-CoV-2 mutation hot spots include a novel RNA-dependent-RNA polymerase variant.	J Transl Med
32321407	"Hispidin and Lepidine E: Two Natural Compounds and Folic Acid as Potential Inhibitors of 2019-novel Coronavirus Main Protease (2019- nCoVM(pro)), Molecular Docking and SAR Study."	Curr Comput Aided Drug Des
32321324	A deadly spillover: SARS-CoV-2 outbreak.	Expert Opin Ther Pat
32320687	Phylogenetic Analysis and Structural Modeling of SARS-CoV-2 Spike Protein Reveals an Evolutionary Distinct and Proteolytically Sensitive Activation Loop.	J Mol Biol
32320535	Mesenchymal stem cells as a potential treatment for critically ill patients with coronavirus disease 2019.	Stem Cells Transl Med
32320516	Scientific research progress of COVID-19/SARS-CoV-2 in the first five months.	J Cell Mol Med
32320478	Risks of ACE Inhibitor and ARB Usage in COVID-19: Evaluating the Evidence.	Clin Pharmacol Ther
32320270	Obesity Is a Risk Factor for Severe COVID-19 Infection: Multiple Potential Mechanisms.	Circulation
32320211	Neurological Insights of COVID-19 Pandemic.	ACS Chem Neurosci
32320059	Potential of live pathogen vaccines for defeating the COVID-19 pandemic: History and mechanism.	J Med Virol
32320031	Immune-mediated mechanism in coronavirus fulminant myocarditis.	Eur Heart J
32319538	Zinc and respiratory tract infections: Perspectives for COVID19 (Review).	Int J Mol Med
32319148	COVID-19: searching for clues among other respiratory viruses.	Immunol Cell Biol
32319118	Two X-linked agammaglobulinemia patients develop pneumonia as COVID-19 manifestation but recover.	Pediatr Allergy Immunol
32318865	Cardiovascular Complications in Patients with COVID-19: Consequences of Viral Toxicities and Host Immune Response.	Curr Cardiol Rep
32318855	Does COVID-19 affect male fertility?	World J Urol
32318665	Age-related rhesus macaque models of COVID-19.	Animal Model Exp Med
32317810	"Understanding SARS-CoV-2: Genetic Diversity, Transmission and Cure in Human."	Indian J Microbiol
32317431	Therapeutic opportunities to manage COVID-19/SARS-CoV-2 infection: Present and future.	Indian J Ophthalmol
32317409	Detection of coronaviruses in Pteropus & Rousettus species of bats from different States of India.	Indian J Med Res
32317217	Role of thymopoiesis and inflamm-aging in COVID-19 phenotype.	Pediatr Neonatol
32316719	[A special on epidemic prevention and control: analysis on expression of 2019-nCoV related ACE2 and TMPRSS2 in eye tissues].	Zhonghua Yan Ke Za Zhi
32316118	Global Spread of Coronavirus Disease 2019 and Malaria: An Epidemiological Paradox in the Early Stage of A Pandemic.	J Clin Med
32315733	Elevated Troponin in Patients With Coronavirus Disease 2019: Possible Mechanisms.	J Card Fail
32315281	Possible Bat Origin of Severe Acute Respiratory Syndrome Coronavirus 2.	Emerg Infect Dis
32315171	Fast Identification of Possible Drug Treatment of Coronavirus Disease-19 (COVID-19) through Computational Drug Repurposing Study.	J Chem Inf Model
32314850	"Melatonin: Roles in influenza, Covid-19, and other viral infections."	Rev Med Virol
32314811	Understanding evolution of SARS-CoV-2: A perspective from analysis of genetic diversity of RdRp gene.	J Med Virol
32314790	What's New With the Old Coronaviruses?	J Pediatric Infect Dis Soc
32314559	Zoonotic origins of human coronavirus 2019 (HCoV-19 / SARS-CoV-2): why is this work important?	Zool Res
32314538	Why is Coronavirus Disease 2019 not as severe in children?-A look at type 2 alveolar cells.	Pediatr Pulmonol
32314329	[ACE2 and coronavirus - a question of balance and dynamics?]	Lakartidningen
32313883	Inhaled biguanides and mTOR inhibition for influenza and coronavirus (Review).	World Acad Sci J
32313824	"Coronavirus as silent killer: recent advancement to pathogenesis, therapeutic strategy and future perspectives."	Virusdisease
32313822	Recent apprise on coronavirus and its terrible insinuations.	Virusdisease
32313806	2019 Novel coronavirus (COVID-19) overview.	Z Gesundh Wiss
32313804	Tracing New Clinical Manifestations in Patients with COVID-19 in Chile and Its Potential Relationship with the SARS-CoV-2 Divergence.	Curr Trop Med Rep
32313296	Identification of potential binders of the main protease 3CL(pro) of the COVID-19 via structure-based ligand design and molecular modeling.	Chem Phys Lett
32313207	Human monoclonal antibodies block the binding of SARS-CoV-2 spike protein to angiotensin converting enzyme 2 receptor.	Cell Mol Immunol
32312797	COVID-19 and Calcineurin Inhibitors: Should They Get Left Out in the Storm?	J Am Soc Nephrol
32312790	Faecal calprotectin indicates intestinal inflammation in COVID-19.	Gut
32312781	Nafamostat Mesylate Blocks Activation of SARS-CoV-2: New Treatment Option for COVID-19.	Antimicrob Agents Chemother
32312365	[Research advances in cardiovascular system damage caused by SARS-CoV-2 in children].	Zhongguo Dang Dai Er Ke Za Zhi
32312018	Imaging features and mechanisms of novel coronavirus pneumonia (COVID-19): Study Protocol Clinical Trial (SPIRIT Compliant).	Medicine (Baltimore)
32311651	Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may be harmful in patients with diabetes during COVID-19 pandemic.	Diabetes Metab Syndr
32311489	Weathering the Cytokine Storm in Susceptible Patients with Severe SARS-CoV-2 Infection.	J Allergy Clin Immunol Pract
32311462	On the molecular determinants of the SARS-CoV-2 attack.	Clin Immunol
32311451	Specific ACE2 expression in small intestinal enterocytes may cause gastrointestinal symptoms and injury after 2019-nCoV infection.	Int J Infect Dis
32311431	"Etiology and genetic evolution of canine coronavirus circulating in five provinces of China, during 2018-2019."	Microb Pathog
32311318	SARS-CoV-2 and viral sepsis: observations and hypotheses.	Lancet
32311107	Causes of hypogeusia/hyposmia in SARS-CoV2 infected patients.	J Med Virol
32311094	Distinct viral clades of SARS-CoV-2: Implications for modeling of viral spread.	J Med Virol
32310915	"[ACE-inhibitors, angiotensin receptor blockers and severe acute respiratory syndrome caused by coronavirus]."	G Ital Cardiol (Rome)
32310688	"Biological plausibility for interactions between dietary fat, resveratrol, ACE2, and SARS-CoV illness severity."	Am J Physiol Endocrinol Metab
32308266	Molecular docking and dynamics simulation of FDA approved drugs with the main protease from 2019 novel coronavirus.	Bioinformation
32307653	CD147 as a Target for COVID-19 Treatment: Suggested Effects of Azithromycin and Stem Cell Engagement.	Stem Cell Rev Rep
32307550	Downregulated Gene Expression Spectrum and Immune Responses Changed During the Disease Progression in Patients With COVID-19.	Clin Infect Dis
32307268	"Active constituents and mechanisms of Respiratory Detox Shot, a traditional Chinese medicine prescription, for COVID-19 control and prevention: Network-molecular docking-LC-MS(E) analysis."	J Integr Med
32307025	Could COVID-19 represent a negative prognostic factor in patients with stroke?	Infect Control Hosp Epidemiol
32306862	Drug repurposing for coronavirus (COVID-19): in silico screening of known drugs against coronavirus 3CL hydrolase and protease enzymes.	J Biomol Struct Dyn
32306860	Moroccan Medicinal plants as inhibitors against SARS-CoV-2 main protease: Computational investigations.	J Biomol Struct Dyn
32306854	Novel guanosine derivatives against MERS CoV polymerase: An in silico perspective.	J Biomol Struct Dyn
32306836	"Novel 2019 coronavirus structure, mechanism of action, antiviral drug promises and rule out against its treatment."	J Biomol Struct Dyn
32306822	Peptide-like and small-molecule inhibitors against Covid-19.	J Biomol Struct Dyn
32306751	"Novel 2019 coronavirus: Genome structure, clinical trials, and outstanding questions."	Exp Biol Med (Maywood)
32306500	Supporting pandemic response using genomics and bioinformatics: A case study on the emergent SARS-CoV-2 outbreak.	Transbound Emerg Dis
32306495	Potential implications of COVID-19 in non-alcoholic fatty liver disease.	Liver Int
32306452	Angiotensin-converting enzyme 2 in severe acute respiratory syndrome coronavirus and SARS-CoV-2: A double-edged sword?	FASEB J
32305506	Renin-angiotensin system at the heart of COVID-19 pandemic.	Biochimie
32305501	The potential role of Th17 immune responses in coronavirus immunopathology and vaccine-induced immune enhancement.	Microbes Infect
32305401	Clinical Implications of SARS-CoV-2 Interaction With Renin Angiotensin System: JACC Review Topic of the Week.	J Am Coll Cardiol
32304747	Angiotensin receptor blockers and COVID-19.	Pharmacol Res
32304276	The impact of coronavirus infectious disease 19 (COVID-19) on oral health.	Oral Dis
32304146	Response to recent commentaries regarding the involvement of angiotensin-converting enzyme 2 (ACE2) and renin-angiotensin system blockers in SARS-CoV-2 infections.	Drug Dev Res
32304108	Crystal structure of Nsp15 endoribonuclease NendoU from SARS-CoV-2.	Protein Sci
32303993	Recapitulation of SARS-CoV-2 infection and cholangiocyte damage with human liver ductal organoids.	Protein Cell
32303915	Should Patients Receiving ACE Inhibitors or Angiotensin Receptor Blockers be Switched to Other Antihypertensive Drugs to Prevent or Improve Prognosis of Novel Coronavirus Disease 2019 (COVID-19)?	Drug Saf
32303741	"Will COVID-19 Infection be Less Severe in Ulcerative Colitis Than in Crohn's Patients, Due to a Lower Rate of Smokers?"	J Crohns Colitis
32303698	A map of SARS-CoV-2 and host cell interactions.	Nat Rev Immunol
32303696	Macrophages: a Trojan horse in COVID-19?	Nat Rev Immunol
32303609	COVID-19 and immunomodulation in IBD.	Gut
32303592	Human Leukocyte Antigen Susceptibility Map for Severe Acute Respiratory Syndrome Coronavirus 2.	J Virol
32303590	"Comparative pathogenesis of COVID-19, MERS, and SARS in a nonhuman primate model."	Science
32303424	Assessing ACE2 expression patterns in lung tissues in the pathogenesis of COVID-19.	J Autoimmun
32303108	"Serological survey of SARS-CoV-2 for experimental, domestic, companion and wild animals excludes intermediate hosts of 35 different species of animals."	Transbound Emerg Dis
32302975	Androgen hazards with COVID-19.	Endocr Relat Cancer
32302707	Could IL-17 represent a new therapeutic target for the treatment and/or management of COVID-19-related respiratory syndrome?	Pharmacol Res
32302706	"Physiological and pathological regulation of ACE2, the SARS-CoV-2 receptor."	Pharmacol Res
32302675	Comparative computational analysis of SARS-CoV-2 nucleocapsid protein epitopes in taxonomically related coronaviruses.	Microbes Infect
32302401	Targeting potential drivers of COVID-19: Neutrophil extracellular traps.	J Exp Med
32302379	The BTK inhibitor ibrutinib may protect against pulmonary injury in COVID-19-infected patients.	Blood
32302265	Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19.	Circ Res
32302248	ACEing COVID-19: A Role for Angiotensin Axis Inhibition in SARS-CoV-2 Infection?	Circ Res
32302069	"SARS-CoV-2 Seroconversion in Humans: A Detailed Protocol for a Serological Assay, Antigen Production, and Test Setup."	Curr Protoc Microbiol
32301968	Binding of SARS-CoV-2 and angiotensin-converting enzyme 2: clinical implications.	Cardiovasc Res
32301957	Weak Induction of Interferon Expression by Severe Acute Respiratory Syndrome Coronavirus 2 Supports Clinical Trials of Interferon-lambda to Treat Early Coronavirus Disease 2019.	Clin Infect Dis
32301766	Cardiovascular Pharmacology in the Time of COVID-19: A Focus on Angiotensin-Converting Enzyme 2.	J Cardiovasc Pharmacol
32301390	Attenuated SARS-CoV-2 variants with deletions at the S1/S2 junction.	Emerg Microbes Infect
32301221	A preliminary observation: Male pattern hair loss among hospitalized COVID-19 patients in Spain - A potential clue to the role of androgens in COVID-19 severity.	J Cosmet Dermatol
32300796	A Geroscience Perspective on COVID-19 Mortality.	J Gerontol A Biol Sci Med Sci
32300673	Genomic characterization of a novel SARS-CoV-2.	Gene Rep
32299844	COVID-19 and rheumatology: first steps towards a different future?	Ann Rheum Dis
32299796	Antirheumatic agents in covid-19: is IL-6 the right target?	Ann Rheum Dis
32299780	Angiotensin-Converting Enzyme 2 as the Molecular Bridge Between Epidemiologic and Clinical Features of COVID-19.	Can J Cardiol
32299779	What Is the Role of Angiotensin-Converting Enzyme 2 (ACE2) in COVID-19 Infection in Hypertensive Patients With Diabetes?	Can J Cardiol
32299202	"COVID-19, immune system response, hyperinflammation and repurposing antirheumatic drugs"	Turk J Med Sci
32299010	Neurotropism of SARS-CoV 2: Mechanisms and manifestations.	J Neurol Sci
32298803	Are we facing a crashing wave of neuropsychiatric sequelae of COVID-19? Neuropsychiatric symptoms and potential immunologic mechanisms.	Brain Behav Immun
32298458	Is antibody-dependent enhancement playing a role in COVID-19 pathogenesis?	Swiss Med Wkly
32298273	The SARS-CoV-2 receptor ACE2 expression of maternal-fetal interface and fetal organs by single-cell transcriptome study.	PLoS One
32298218	Potential for developing a SARS-CoV receptor-binding domain (RBD) recombinant protein as a heterologous human vaccine against coronavirus infectious disease (COVID)-19.	Hum Vaccin Immunother
32297958	HLA studies in the context of coronavirus outbreaks.	Swiss Med Wkly
32297843	Oligonucleotides and the COVID-19 Pandemic: A Perspective.	Nucleic Acid Ther
32297796	Description and Proposed Management of the Acute COVID-19 Cardiovascular Syndrome.	Circulation
32297156	Computational Identification of Small Interfering RNA Targets in SARS-CoV-2.	Virol Sin
32296994	The double burden of disease of COVID-19 in cardiovascular patients: overlapping conditions could lead to overlapping treatments.	Eur J Epidemiol
32296910	Mechanism of thrombocytopenia in COVID-19 patients.	Ann Hematol
32296570	Structural basis of SARS-CoV-2 3CL(pro) and anti-COVID-19 drug discovery from medicinal plants.	J Pharm Anal
32296544	An emergent clade of SARS-CoV-2 linked to returned travellers from Iran.	Virus Evol
32296135	COVID-19: risk for cytokine targeting in chronic inflammatory diseases?	Nat Rev Immunol
32296069	Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study.	Signal Transduct Target Ther
32295300	Natural Bioactive Compounds from Fungi as Potential Candidates for Protease Inhibitors and Immunomodulators to Apply for Coronaviruses.	Molecules
32295237	Molecular Investigation of SARS-CoV-2 Proteins and Their Interactions with Antiviral Drugs.	Viruses
32294817	[What we learned from SARS may provide important insights into understanding and management of coronavirus disease 2019].	Zhonghua Jie He He Hu Xi Za Zhi
32294562	A search for medications to treat COVID-19 via in silico molecular docking models of the SARS-CoV-2 spike glycoprotein and 3CL protease.	Travel Med Infect Dis
32294518	A comprehensive analysis of genome composition and codon usage patterns of emerging coronaviruses.	Virus Res
32294179	Coronavirus Infections and Type 2 Diabetes-Shared Pathways with Therapeutic Implications.	Endocr Rev
32293875	Why Are Lopinavir and Ritonavir Effective against the Newly Emerged Coronavirus 2019? Atomistic Insights into the Inhibitory Mechanisms.	Biochemistry
32293710	"Hyperglycemia, hydroxychloroquine, and the COVID-19 pandemic."	J Med Virol
32293672	Cell type-specific expression of the putative SARS-CoV-2 receptor ACE2 in human hearts.	Eur Heart J
32293083	Pulmonary thrombosis in 2019-nCoV pneumonia?	J Thromb Haemost
32293003	"Hypertension, the renin-angiotensin system, and the risk of lower respiratory tract infections and lung injury: implications for COVID-19."	Cardiovasc Res
32292919	The Novel Coronavirus Disease (COVID-19) Threat for Patients With Cardiovascular Disease and Cancer.	JACC CardioOncol
32292906	The role of afferent pulmonary innervation in ARDS associated with COVID-19 and potential use of resiniferatoxin to improve prognosis: A review.	Med Drug Discov
32292901	Pathogenic priming likely contributes to serious and critical illness and mortality in COVID-19 via autoimmunity.	J Transl Autoimmun
32292884	Important Steps to Control COVID-19/SARS-CoV-2 Infection.	SN Compr Clin Med
32292865	COVID-19 and the Renin-Angiotensin System.	Kidney Int Rep
32292848	"COVID-19 for the Cardiologist: Basic Virology, Epidemiology, Cardiac Manifestations, and Potential Therapeutic Strategies."	JACC Basic Transl Sci
32292847	The Heart in COVID-19: Primary Target or Secondary Bystander?	JACC Basic Transl Sci
32292686	Coronavirus: Update Related to the Current Outbreak of COVID-19.	Infect Dis Ther
32292587	Mutated COVID-19 may foretell a great risk for mankind in the future.	New Microbes New Infect
32292248	NetNCSP: Nonoverlapping closed sequential pattern mining.	Knowl Based Syst
32292227	[Controversy regarding ACE inhibitors / ARBs in COVID-19].	Rev Esp Cardiol
32291894	Cytosine drives evolution of SARS-CoV-2.	Environ Microbiol
32291797	SARS-CoV-2: At the Crossroad Between Aging and Neurodegeneration.	Mov Disord
32291557	SARS-CoV-2-encoded nucleocapsid protein acts as a viral suppressor of RNA interference in cells.	Sci China Life Sci
32291449	ADAM17 inhibition may exert a protective effect on COVID-19.	Nephrol Dial Transplant
32291351	Repurposing Didanosine as a Potential Treatment for COVID-19 Using Single-Cell RNA Sequencing Data.	mSystems
32291196	Is low sodium intake a risk factor for severe and fatal COVID-19 infection?	Eur J Intern Med
32291076	EZH2-mediated H3K27me3 inhibits ACE2 expression.	Biochem Biophys Res Commun
32290680	"Severe acute respiratory syndrome coronavirus 2 infection, angiotensin-converting enzyme 2 and treatment with angiotensin-converting enzyme inhibitors or angiotensin II type 1 receptor blockers."	Eur J Prev Cardiol
32290077	Molecular Mechanism of Evolution and Human Infection with SARS-CoV-2.	Viruses
32289821	Extreme Genomic CpG Deficiency in SARS-CoV-2 and Evasion of Host Antiviral Defense.	Mol Biol Evol
32289478	Statins in coronavirus outbreak: It's time for experimental and clinical studies.	Pharmacol Res
32289321	Cardiovascular molecular mechanisms of disease with COVID-19.	J Mol Cell Cardiol
32289263	An Infectious cDNA Clone of SARS-CoV-2.	Cell Host Microbe
32289117	Novel decoy cellular vaccine strategy utilizing transgenic antigen-expressing cells as immune presenter and adjuvant in vaccine prototype against SARS-CoV-2 virus.	Med Drug Discov
32286926	Is glucose-6-phosphate dehydrogenase enzyme deficiency a factor in Coronavirus-19 (COVID-19) infections and deaths?	Pathog Glob Health
32286863	"COVID-19, Arrhythmic Risk, and Inflammation: Mind the Gap!"	Circulation
32286790	Computational Design of ACE2-Based Peptide Inhibitors of SARS-CoV-2.	ACS Nano
32286678	Inhibitors of the renin-angiotensin system: The potential role in the pathogenesis of COVID-19.	Cardiol J
32286607	Might renin-angiotensin system blockers play a role in the COVID-19 pandemic?	Eur Heart J Cardiovasc Pharmacother
32286538	Human antibodies can neutralize SARS-CoV-2.	Nat Rev Immunol
32285293	Searching therapeutic strategy of new coronavirus pneumonia from angiotensin-converting enzyme 2: the target of COVID-19 and SARS-CoV.	Eur J Clin Microbiol Infect Dis
32284615	The proximal origin of SARS-CoV-2.	Nat Med
32284379	Novel Ionophores Active against La Crosse Virus Identified through Rapid Antiviral Screening.	Antimicrob Agents Chemother
32284326	Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency.	J Biol Chem
32283876	[Scientific statement on using of renin angiotensin system blockers in patients with cardiovascular disease and COVID-19].	Zhonghua Xin Xue Guan Bing Za Zhi
32283711	"scRNA-seq Profiling of Human Testes Reveals the Presence of the ACE2 Receptor, A Target for SARS-CoV-2 Infection in Spermatogonia, Leydig and Sertoli Cells."	Cells
32283499	Comorbidities in COVID-19: Outcomes in hypertensive cohort and controversies with renin angiotensin system blockers.	Diabetes Metab Syndr
32283324	COVID-19 - Considerations for the paediatric rheumatologist.	Clin Immunol
32283245	Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is likely to be androgen mediated.	J Am Acad Dermatol
32283223	Plausibility of therapeutic effects of Rho kinase inhibitors against Severe Acute Respiratory Syndrome Coronavirus 2 (COVID-19).	Pharmacol Res
32283177	Coronavirus disease 2019 (COVID-19): first indication of efficacy of Gene-Eden-VIR/Novirin in SARS-CoV-2 infection.	Int J Antimicrob Agents
32283163	A potential inhibitory role for integrin in the receptor targeting of SARS-CoV-2.	J Infect
32283152	The pathogenesis and treatment of the `Cytokine Storm' in COVID-19.	J Infect
32283146	Evolutionary analysis of SARS-CoV-2: how mutation of Non-Structural Protein 6 (NSP6) could affect viral autophagy.	J Infect
32283128	Should anti-diabetic medications be reconsidered amid COVID-19 pandemic?	Diabetes Res Clin Pract
32283108	Remdesivir and SARS-CoV-2: Structural requirements at both nsp12 RdRp and nsp14 Exonuclease active-sites.	Antiviral Res
32283099	Why Does SARS-CoV-2 Invade the Gastrointestinal Epithelium?	Gastroenterology
32283006	"SARS-CoV-2: Olfaction, Brain Infection, and the Urgent Need for Clinical Samples Allowing Earlier Virus Detection."	ACS Chem Neurosci
32282224	COVID-19 and Renin Angiotensin Blockers: Current Evidence and Recommendations.	Circulation
32282032	Neprilysin inhibitor-angiotensin II receptor blocker combination (sacubitril/valsartan): rationale for adoption in SARS-CoV-2 patients.	Eur Heart J Cardiovasc Pharmacother
32281877	COVID-19 Lung Injury is Not High Altitude Pulmonary Edema.	High Alt Med Biol
32281695	Existing bitter medicines for fighting 2019-nCoV-associated infectious diseases.	FASEB J
32281368	"War on Terror Cells: Strategies to Eradicate ""Novel Coronavirus"" Effectively."	ACS Chem Neurosci
32281287	Risk of COVID-19 for patients with obesity.	Obes Rev
32281055	Cardiovascular Disease and Use of Renin-Angiotensin System Inhibitors in COVID-19.	Am J Cardiovasc Drugs
32280952	Good IgA Bad IgG in SARS-CoV-2 Infection?	Clin Infect Dis
32279908	Is the ACE2 Overexpression a Risk Factor for COVID-19 Infection?	Arch Med Res
32278800	Sexual transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): A new possible route of infection?	J Am Acad Dermatol
32278764	COVID-19 and diabetes: Knowledge in progress.	Diabetes Res Clin Pract
32278693	In silico studies on therapeutic agents for COVID-19: Drug repurposing approach.	Life Sci
32278338	Exploring possible mechanisms for COVID-19 induced thrombocytopenia: Unanswered questions.	J Thromb Haemost
32277970	Strategies to trace back the origin of COVID-19.	J Infect
32277969	The role of phylogenetic analysis in clarifying the infection source of a COVID-19 patient.	J Infect
32277065	Halting coronavirus polymerase.	J Biol Chem
32277040	Structure of the RNA-dependent RNA polymerase from COVID-19 virus.	Science
32276929	TMPRSS2 and COVID-19: Serendipity or Opportunity for Intervention?	Cancer Discov
32276773	Commentary: What is the relationship between Covid-19 and cardiovascular disease?	Int J Cardiol
32276140	Epigenetic dysregulation of ACE2 and interferon-regulated genes might suggest increased COVID-19 susceptibility and severity in lupus patients.	Clin Immunol
32275855	Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2.	Cell
32275259	"SARS-CoV-2, SARS-CoV, and MERS-COV: A comparative overview"	Infez Med
32275258	"Exploring the genetics, ecology of SARS-COV-2 and climatic factors as possible control strategies against COVID-19"	Infez Med
32275190	Chronic Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers Is High Among Intensive Care Unit Patients With Non-COVID-19 Sepsis but Carries a Moderately Increased Risk of Death.	Hypertension
32275082	Conjunctiva is not a preferred gateway of entry for SARS-CoV-2 to infect respiratory tract.	J Med Virol
32275079	SARS-CoV-2 may be related to conjunctivitis but not necessarily spread through the conjunctiva SARS-CoV-2 and conjunctiva.	J Med Virol
32274964	A review on the cleavage priming of the spike protein on coronavirus by angiotensin-converting enzyme-2 and furin.	J Biomol Struct Dyn
32274617	"SARS-CoV-2 and COVID-19 in older adults: what we may expect regarding pathogenesis, immune responses, and outcomes."	Geroscience
32274570	"COVID-19 in the heart and the lungs: could we ""Notch"" the inflammatory storm?"	Basic Res Cardiol
32274522	Inhibitors of the renin-angiotensin system and SARS-CoV-2 infection.	Herz
32274341	Characteristics and Mechanism of Liver Injury in 2019 Coronavirus Disease.	J Clin Transl Hepatol
32273607	Virological assessment of SARS-CoV-2.	Nat Med
32273603	Functionally assessing coronavirus entry.	Nat Med
32273594	COVID-19: immunopathology and its implications for therapy.	Nat Rev Immunol
32273593	Kidney involvement in COVID-19 and rationale for extracorporeal therapies.	Nat Rev Nephrol
32273490	Coronavirus Disease 2019 (COVID-19) in Children - What We Know So Far and What We Do Not.	Indian Pediatr
32272857	Role of Tissue Engineering in COVID-19 and Future Viral Outbreaks.	Tissue Eng Part A
32272550	Antiviral Agents: Discovery to Resistance.	Viruses
32272481	Structure of M(pro) from SARS-CoV-2 and discovery of its inhibitors.	Nature
32272173	Coronavirus membrane fusion mechanism offers a potential target for antiviral development.	Antiviral Res
32272142	More evidence is urgently needed to confirm the relation between angiotensin-converting enzyme inhibitors and COVID-19.	J Mol Cell Cardiol
32272081	Understanding pathways to death in patients with COVID-19.	Lancet Respir Med
32271768	Detection of novel coronaviruses in bats in Myanmar.	PLoS One
32271653	Salivary Glands: Potential Reservoirs for COVID-19 Asymptomatic Infection.	J Dent Res
32271490	A primer on viral-associated olfactory loss in the era of COVID-19.	Int Forum Allergy Rhinol
32271454	Utilizing integrating network pharmacological approaches to investigate the potential mechanism of Ma Xing Shi Gan Decoction in treating COVID-19.	Eur Rev Med Pharmacol Sci
32270884	Role of nonstructural proteins in the pathogenesis of SARS-CoV-2.	J Med Virol
32270184	Comparative Replication and Immune Activation Profiles of SARS-CoV-2 and SARS-CoV in Human Lungs: An Ex Vivo Study With Implications for the Pathogenesis of COVID-19.	Clin Infect Dis
32269766	In silico identification of vaccine targets for 2019-nCoV.	F1000Res
32269121	International Expansion of a Novel SARS-CoV-2 Mutant.	J Virol
32269089	ACE-2 expression in the small airway epithelia of smokers and COPD patients: implications for COVID-19.	Eur Respir J
32269085	Pathogenesis of COVID-19 from a cell biology perspective.	Eur Respir J
32269081	Phylogenetic network analysis of SARS-CoV-2 genomes.	Proc Natl Acad Sci U S A
32268662	[Analysis of coronavirus disease-19 (COVID-19) based on SARS autopsy].	Zhonghua Bing Li Xue Za Zhi
32268515	In Silico Discovery of Candidate Drugs against Covid-19.	Viruses
32268374	Keep taking your ACE inhibitors and ARBs during the COVID 19 pandemic.	J Travel Med
32268343	Possible causes for decreased susceptibility of children to coronavirus.	Pediatr Res
32268188	It is too soon to attribute ADE to COVID-19.	Microbes Infect
32267987	Immune responses and pathogenesis of SARS-CoV-2 during an outbreak in Iran: Comparison with SARS and MERS.	Rev Med Virol
32267164	COVID-19 and Lessons to Be Learned from Prior Coronavirus Outbreaks.	Ann Am Thorac Soc
32267139	"Hsa-miR-217 Inhibits the Proliferation, Migration, and Invasion in Non-small Cell Lung Cancer Cells Via Targeting SIRT1 and P53/KAI1 Signaling"	Balkan Med J
32267072	Intravenous Anakinra for Macrophage Activation Syndrome May Hold Lessons for Treatment of Cytokine Storm in the Setting of Coronavirus Disease 2019.	ACR Open Rheumatol
32267000	Patterns of heart injury in COVID-19 and relation to outcome.	J Med Virol
32266993	Reporting of all cardiac medications and their outcome in COVID-19.	J Med Virol
32266937	Inside the heart of COVID-19.	Cardiovasc Res
32266867	In-silico homology assisted identification of inhibitor of RNA binding against 2019-nCoV N-protein (N terminal domain).	J Biomol Struct Dyn
32266761	Neurological manifestations in COVID-19 caused by SARS-CoV-2.	CNS Neurosci Ther
32266754	"COVID-19: Risk groups, mechanistic insights and challenges."	Int J Clin Pract
32266708	Renin-Angiotensin System Inhibition in Cardiovascular Patients at the Time of COVID19: Much Ado for Nothing? A Statement of Activity from the Directors of the Board and the Scientific Directors of the Italian Society of Hypertension.	High Blood Press Cardiovasc Prev
32266501	Double Jeopardy: Methamphetamine Use and HIV as Risk Factors for COVID-19.	AIDS Behav
32266419	COVID-19 and drug-induced liver injury: a problem of plenty or a petty point?	Arch Toxicol
32266375	Inquiring Into Benefits of Independent Activation of Nonclassical Renin-angiotensin System in the Clinical Prognosis and Reduction of COVID-19 Mortality.	Clin Infect Dis
32265848	Subunit Vaccines Against Emerging Pathogenic Human Coronaviruses.	Front Microbiol
32265513	RETRACTED ARTICLE: SARS-CoV-2 infects T lymphocytes through its spike protein-mediated membrane fusion.	Cell Mol Immunol
32265372	Coronavirus Disease 2019 in Critically Ill Children: A Narrative Review of the Literature.	Pediatr Crit Care Med
32265331	"Single-Dose, Intranasal Immunization with Recombinant Parainfluenza Virus 5 Expressing Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Spike Protein Protects Mice from Fatal MERS-CoV Infection."	mBio
32265180	Genotype and phenotype of COVID-19: Their roles in pathogenesis.	J Microbiol Immunol Infect
32265007	Whole genome and phylogenetic analysis of two SARS-CoV-2 strains isolated in Italy in January and February 2020: additional clues on multiple introductions and further circulation in Europe.	Euro Surveill
32264922	COVID-19 and the RAAS-a potential role for angiotensin II?	Crit Care
32264791	Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System: Celebrating the 20th Anniversary of the Discovery of ACE2.	Circ Res
32259829	COVID-19 Outbreak: An Overview.	Chemotherapy
32259575	Janus kinase inhibitor baricitinib is not an ideal option for management of COVID-19.	Int J Antimicrob Agents
32259560	Interleukin-6 as a potential biomarker of COVID-19 progression.	Med Mal Infect
32257554	Mesenchymal Stem Cell Infusion Shows Promise for Combating Coronavirus (COVID-19)- Induced Pneumonia.	Aging Dis
32257431	"COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses."	J Adv Res
32256705	Associations between immune-suppressive and stimulating drugs and novel COVID-19-a systematic review of current evidence.	Ecancermedicalscience
32255491	ACE2 the Janus-faced protein - from cardiovascular protection to severe acute respiratory syndrome-coronavirus and COVID-19.	Clin Sci (Lond)
32254054	Visualizing an unseen enemy; mobilizing structural biology to counter COVID-19.	Acta Crystallogr D Struct Biol
32254048	Visualizing an unseen enemy; mobilizing structural biology to counter COVID-19.	Acta Crystallogr F Struct Biol Commun
32253888	Coronavirus COV-19/SARS-CoV-2 affects women less than men: clinical response to viral infection.	J Biol Regul Homeost Agents
32253400	Flavonoids isolated from loquat (Eriobotrya japonica) leaves inhibit oxidative stress and inflammation induced by cigarette smoke in COPD mice: the role of TRPV1 signaling pathways.	Food Funct
32253226	An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice.	Sci Transl Med
32253172	Hepatic and gastrointestinal involvement in coronavirus disease 2019 (COVID-19): What do we know till now?	Arab J Gastroenterol
32253068	Recommendations for coronavirus infection in rheumatic diseases treated with biologic therapy.	J Autoimmun
32252591	COVID-19 and the Heart.	Circ Res
32251768	The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro.	Antiviral Res
32251767	"Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro."	Antiviral Res
32251731	Structural and molecular modelling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against SARS-CoV-2 infection.	Int J Antimicrob Agents
32251718	ACE2 at the centre of COVID-19 from paucisymptomatic infections to severe pneumonia.	Autoimmun Rev
32251717	The Role of Cytokines including Interleukin-6 in COVID-19 induced Pneumonia and Macrophage Activation Syndrome-Like Disease.	Autoimmun Rev
32251634	Virtual screening and repurposing of FDA approved drugs against COVID-19 main protease.	Life Sci
32251539	COVID-19 and liver disease.	Liver Int
32251498	Hypertension and COVID-19.	Am J Hypertens
32250968	Kidney diseases in the time of COVID-19: major challenges to patient care.	J Clin Invest
32250244	Potential harmful effects of discontinuing ACE-inhibitors and ARBs in COVID-19 patients.	Elife
32249956	Structural variations in human ACE2 may influence its binding with SARS-CoV-2 spike protein.	J Med Virol
32249944	About the origin of the first two Sars-CoV-2 infections in Italy: Inference not supported by appropriate sequence analysis.	J Med Virol
32249845	Fighting COVID-19 exhausts T cells.	Nat Rev Immunol
32249203	Microneedle array delivered recombinant coronavirus vaccines: Immunogenicity and rapid translational development.	EBioMedicine
32249063	Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses.	Trends Immunol
32248966	The cardiovascular burden of coronavirus disease 2019 (COVID-19) with a focus on congenital heart disease.	Int J Cardiol
32248854	A potential protective role of losartan against coronavirus-induced lung damage.	Infect Control Hosp Epidemiol
32248575	Natural products and their derivatives against coronavirus: A review of the non-clinical and pre-clinical data.	Phytother Res
32247927	Remdesivir for severe acute respiratory syndrome coronavirus 2 causing COVID-19: An evaluation of the evidence.	Travel Med Infect Dis
32247212	Cardiovascular disease and COVID-19.	Diabetes Metab Syndr
32247050	Insight into 2019 novel coronavirus - An updated interim review and lessons from SARS-CoV and MERS-CoV.	Int J Infect Dis
32246845	SARS-CoV-2 receptor ACE2 and TMPRSS2 are primarily expressed in bronchial transient secretory cells.	EMBO J
32246834	Favipiravir: Pharmacokinetics and Concerns About Clinical Trials for 2019-nCoV Infection.	Clin Pharmacol Ther
32246784	An alteration of the dopamine synthetic pathway is possibly involved in the pathophysiology of COVID-19.	J Med Virol
32246722	Coronavirus SARS-CoV-2: filtering fact from fiction in the infodemic: Q&A with virologist Professor Urs Greber.	FEBS Lett
32246503	SARS-COV-2 and infectivity: Possible increase in infectivity associated to integrin motif expression.	J Med Virol
32246403	"The brain, another potential target organ, needs early protection from SARS-CoV-2 neuroinvasion."	Sci China Life Sci
32246101	Controversies of renin-angiotensin system inhibition during the COVID-19 pandemic.	Nat Rev Nephrol
32245885	Learning from our immunological history: What can SARS-CoV teach us about SARS-CoV-2?	Sci Immunol
32245784	A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV.	Science
32245656	COVID-19 in patients with cardiovascular diseases.	Arch Cardiovasc Dis
32245083	SARS-CoV-2 and Coronavirus Disease 2019: What We Know So Far.	Pathogens
32244852	Smoking Upregulates Angiotensin-Converting Enzyme-2 Receptor: A Potential Adhesion Site for Novel Coronavirus SARS-CoV-2 (Covid-19).	J Clin Med
32244779	Master Regulator Analysis of the SARS-CoV-2/Human Interactome.	J Clin Med
32244248	COVID-19 in children and altered inflammatory responses.	Pediatr Res
32244166	Why are pregnant women susceptible to COVID-19? An immunological viewpoint.	J Reprod Immunol
32244041	Shell disorder analysis predicts greater resilience of the SARS-CoV-2 (COVID-19) outside the body and in body fluids.	Microb Pathog
32243951	Inactivation of coronaviruses by heat.	J Hosp Infect
32243698	Immunosuppression drug-related and clinical manifestation of Coronavirus disease 2019: A therapeutical hypothesis.	Am J Transplant
32243668	A Practical Approach to the Management of Cancer Patients During the Novel Coronavirus Disease 2019 (COVID-19) Pandemic: An International Collaborative Group.	Oncologist
32243596	Global approaches for global challenges: The possible support of rehabilitation in the management of COVID-19.	J Med Virol
32243297	Coronaviruses and SARS-CoV-2: A Brief Overview.	Anesth Analg
32242890	Coronavirus Disease 2019 (COVID-19) Infection and Renin Angiotensin System Blockers.	JAMA Cardiol
32242873	Full-genome sequences of the first two SARS-CoV-2 viruses from India.	Indian J Med Res
32242749	Substituting Angiotensin-(1-7) to Prevent Lung Damage in SARS-CoV-2 Infection?	Circulation
32242236	COVID-19 and Smoking.	Nicotine Tob Res
32242202	Editorial: COVID-19 and Older Adults.	J Nutr Health Aging
32242182	A consensus statement on the use of angiotensin receptor blockers and angiotensin converting enzyme inhibitors in relation to COVID-19 (corona virus disease 2019).	N Z Med J
32242128	Mechano-genomic regulation of coronaviruses and its interplay with ageing.	Nat Rev Mol Cell Biol
32242089	Endocrine and metabolic link to coronavirus infection.	Nat Rev Endocrinol
32241833	Will children reveal their secret? The coronavirus dilemma.	Eur Respir J
32241182	2019 CORONAVIRUS: What are the implications for cardiology?	Eur J Prev Cardiol
32241072	[Comparison of clinical and pathological features between severe acute respiratory syndrome and coronavirus disease 2019].	Zhonghua Jie He He Hu Xi Za Zhi
32241056	[Suggestions for thoracic surgery clinical practice in non-epidemic area of 2019 coronavirus disease].	Zhonghua Wai Ke Za Zhi
32240876	Hyperglycemia and the novel Covid-19 infection: Possible pathophysiologic mechanisms.	Med Hypotheses
32240762	Nervous system involvement after infection with COVID-19 and other coronaviruses.	Brain Behav Immun
32240537	Post-donation COVID-19 identification in blood donors.	Vox Sang
32239628	Coronavirus disease 2019: Facts and controversies.	Dermatol Ther
32239522	SARS-CoV-2 spike protein favors ACE2 from Bovidae and Cricetidae.	J Med Virol
32238584	"Computational Inference of Selection Underlying the Evolution of the Novel Coronavirus, Severe Acute Respiratory Syndrome Coronavirus 2."	J Virol
32238438	"Does COVID19 Infect the Brain? If So, Smokers Might Be at a Higher Risk."	Mol Pharmacol
32238232	"[From SARS to COVID-19: pathogens, receptor, pathogenesis and principles of the treatment]."	Zhonghua Bing Li Xue Za Zhi
32238094	Identification of chymotrypsin-like protease inhibitors of SARS-CoV-2 via integrated computational approach.	J Biomol Struct Dyn
32238078	In-silico approaches to detect inhibitors of the human severe acute respiratory syndrome coronavirus envelope protein ion channel.	J Biomol Struct Dyn
32237901	Immune-epidemiological parameters of the novel coronavirus - a perspective.	Expert Rev Clin Immunol
32237278	Isolation and rapid sharing of the 2019 novel coronavirus (SARS-CoV-2) from the first patient diagnosed with COVID-19 in Australia.	Med J Aust
32236815	Inefficiency of Sera from Mice Treated with Pseudotyped SARS-CoV to Neutralize 2019-nCoV Infection.	Virol Sin
32236644	Identification of a potential mechanism of acute kidney injury during the COVID-19 outbreak: a study based on single-cell transcriptome analysis.	Intensive Care Med
32235945	Virological assessment of hospitalized patients with COVID-2019.	Nature
32235915	COVID-19: a new challenge for human beings.	Cell Mol Immunol
32235575	"The First 75 Days of Novel Coronavirus (SARS-CoV-2) Outbreak: Recent Advances, Prevention, and Treatment."	Int J Environ Res Public Health
32234837	COVID-19 and non-communicable diseases.	Postgrad Med J
32234504	"COVID-19, diabetes mellitus and ACE2: The conundrum."	Diabetes Res Clin Pract
32234467	Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality.	Int J Antimicrob Agents
32234466	Coronavirus disease 2019 (COVID-19): current status and future perspectives.	Int J Antimicrob Agents
32234465	"Recent progress in understanding 2019 novel coronavirus (SARS-CoV-2) associated with human respiratory disease: detection, mechanisms and treatment."	Int J Antimicrob Agents
32234451	"COVID-19, SARS and MERS: are they closely related?"	Clin Microbiol Infect
32234449	Molecular characterization of SARS-CoV-2 in the first COVID-19 cluster in France reveals an amino acid deletion in nsp2 (Asp268del).	Clin Microbiol Infect
32234303	Multiomics Evaluation of Gastrointestinal and Other Clinical Characteristics of COVID-19.	Gastroenterology
32234130	[Progress and challenge of vaccine development against 2019-novel coronavirus (2019-nCoV)].	Zhonghua Yu Fang Yi Xue Za Zhi
32233935	COVID-19: is the ACE2 just a foe?	Am J Physiol Lung Cell Mol Physiol
32233755	Coronavirus Disease 2019 (COVID-19) and Cardiovascular Disease: A Viewpoint on the Potential Influence of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers on Onset and Severity of Severe Acute Respiratory Syndrome Coronavirus 2 Infection.	J Am Heart Assoc
32233753	Coronavirus Disease 2019 (COVID-19): Do Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers Have a Biphasic Effect?	J Am Heart Assoc
32233641	Network pharmacology-based analysis of the role of traditional Chinese herbal medicines in the treatment of COVID-19.	Ann Palliat Med
32233018	Covid-19 and diabetes mellitus: unveiling the interaction of two pandemics.	Diabetes Metab Res Rev
32232480	Our Response to COVID-19 as Endocrinologists and Diabetologists.	J Clin Endocrinol Metab
32231345	Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion.	Cell Res
32231328	Interaction between RAAS inhibitors and ACE2 in the context of COVID-19.	Nat Rev Cardiol
32230900	"Virology, Epidemiology, Pathogenesis, and Control of COVID-19."	Viruses
32229706	COVID-19 and chronological aging: senolytics and other anti-aging drugs for the treatment or prevention of corona virus infection?	Aging (Albany NY)
32229288	Molecular characterization of SARS-CoV-2 from the first case of COVID-19 in Italy.	Clin Microbiol Infect
32229155	Can Bioactive Lipids Inactivate Coronavirus (COVID-19)?	Arch Med Res
32228827	[Exploration of omics mechanism and drug prediction of coronavirus-induced heart failure based on clinical bioinformatics].	Zhonghua Xin Xue Guan Bing Za Zhi
32228322	"COVID-19 pandemic, coronaviruses, and diabetes mellitus."	Am J Physiol Endocrinol Metab
32228252	"COVID-19, ACE2, and the cardiovascular consequences."	Am J Physiol Heart Circ Physiol
32228226	Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients.	Emerg Microbes Infect
32227760	Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19.	N Engl J Med
32227357	COVID-19 treatment by repurposing drugs until the vaccine is in sight.	Drug Dev Res
32227090	The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2.	Cardiovasc Res
32226946	COVID-19: a novel zoonotic disease caused by a coronavirus from China: what we know and what we don't.	Microbiol Aust
32226695	"Acetazolamide, Nifedipine and Phosphodiesterase Inhibitors: Rationale for Their Utilization as Adjunctive Countermeasures in the Treatment of Coronavirus Disease 2019 (COVID-19)."	Cureus
32226290	Targeting the Endocytic Pathway and Autophagy Process as a Novel Therapeutic Strategy in COVID-19.	Int J Biol Sci
32226286	Zoonotic origins of human coronaviruses.	Int J Biol Sci
32226285	SARS-CoV-2: an Emerging Coronavirus that Causes a Global Threat.	Int J Biol Sci
32225176	Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor.	Nature
32225175	Structural basis of receptor recognition by SARS-CoV-2.	Nature
32224308	Understanding COVID-19: what does viral RNA load really mean?	Lancet Infect Dis
32224164	COVID-19 and diabetes: Can DPP4 inhibition play a role?	Diabetes Res Clin Pract
32223555	Potential risk of the kidney vulnerable to novel coronavirus 2019 infection.	Am J Physiol Renal Physiol
32223077	Neuroinfection may contribute to pathophysiology and clinical manifestations of COVID-19.	Acta Physiol (Oxf)
32222995	Phylogenetic analysis of the first four SARS-CoV-2 cases in Chile.	J Med Virol
32222993	Genomic characterization and phylogenetic analysis of SARS-COV-2 in Italy.	J Med Virol
32222956	Prevalence and impact of diabetes among people infected with SARS-CoV-2.	J Endocrinol Invest
32222119	Clinical analysis of pregnant women with 2019 novel coronavirus pneumonia.	J Med Virol
32222113	Learning from history: Coronavirus outbreaks in the past.	Dermatol Ther
32222047	Coronavirus disease 2019 (COVID-19) outbreak: Could pigs be vectors for human infections?	Xenotransplantation
32222027	COVID-19 in the pediatric population.	Dermatol Ther
32221983	Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19.	J Med Virol
32221519	Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019.	Clin Infect Dis
32221306	Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV.	Nat Commun
32221278	Alcohol consumption in the COVID-19 era.	Minerva Gastroenterol Dietol
32221172	"Initial Clinical Impressions of the Critical Care of COVID-19 Patients in Seattle, New York City, and Chicago."	Anesth Analg
32221171	Neuraxial Procedures in COVID-19-Positive Parturients: A Review of Current Reports.	Anesth Analg
32221133	Detection of serum immunoglobulin M and immunoglobulin G antibodies in 2019 novel coronavirus infected patients from different stages.	Chin Med J (Engl)
32221132	In silico assessment of the impact of 2019 novel coronavirus genomic variation on the efficiency of published real-time quantitative polymerase chain reaction detection assays.	Chin Med J (Engl)
32221117	COVID-19 Outbreak and Surgical Practice: Unexpected Fatality in Perioperative Period.	Ann Surg
32220930	Sound Science before Quick Judgement Regarding RAS Blockade in COVID-19.	Clin J Am Soc Nephrol
32220710	Renin-angiotensin system: The unexpected flaw inside the human immune system revealed by SARS-CoV-2.	Med Hypotheses
32220650	"Clinical and epidemiological features of 36 children with coronavirus disease 2019 (COVID-19) in Zhejiang, China: an observational cohort study."	Lancet Infect Dis
32220633	Could Sars-coronavirus-2 trigger autoimmune and/or autoinflammatory mechanisms in genetically predisposed subjects?	Autoimmun Rev
32220612	"Diabetes patients with COVID-19 need better blood glucose management in Wuhan, China."	Metabolism
32220611	Commentary: COVID-19 in patients with diabetes.	Metabolism
32220574	Featuring COVID-19 cases via screening symptomatic patients with epidemiologic link during flu season in a medical center of central Taiwan.	J Microbiol Immunol Infect
32220422	The host's angiotensin-converting enzyme polymorphism may explain epidemiological findings in COVID-19 infections.	Clin Chim Acta
32220310	A Genomic Perspective on the Origin and Emergence of SARS-CoV-2.	Cell
32220285	Management of pregnant women infected with COVID-19.	Lancet Infect Dis
32220284	"Clinical features and obstetric and neonatal outcomes of pregnant patients with COVID-19 in Wuhan, China: a retrospective, single-centre, descriptive study."	Lancet Infect Dis
32220278	Immunosuppression for hyperinflammation in COVID-19: a double-edged sword?	Lancet
32220276	[Clinical and coagulation characteristics of 7 patients with critical COVID-2019 pneumonia and acro-ischemia].	Zhonghua Xue Ye Xue Za Zhi
32220035	SARS-CoV-2: What do we know so far?	Acta Physiol (Oxf)
32219362	Association of Coronavirus Disease 2019 (COVID-19) With Myocardial Injury and Mortality.	JAMA Cardiol
32218527	Identifying SARS-CoV-2-related coronaviruses in Malayan pangolins.	Nature
32218301	Synthesis and Biological Evaluation of Novel (thio)semicarbazone-Based Benzimidazoles as Antiviral Agents against Human Respiratory Viruses.	Molecules
32218151	Structural Genomics of SARS-CoV-2 Indicates Evolutionary Conserved Functional Regions of Viral Proteins.	Viruses
32217834	SARS-CoV-2: a storm is raging.	J Clin Invest
32216698	Elevated Plasmin(ogen) as a Common Risk Factor for COVID-19 Susceptibility.	Physiol Rev
32216172	Coronavirus uses as binding site in humans angiotensin-converting enzyme 2 functional receptor that is involved in arterial blood pressure control and fibrotic response to damage and is a drug target in cardiovascular disease. Is this just a phylogenetic coincidence?	J Med Virol
32216114	Structural and biochemical characterization of SADS-CoV papain-like protease 2.	Protein Sci
32215618	Self-reported Olfactory and Taste Disorders in Patients With Severe Acute Respiratory Coronavirus 2 Infection: A Cross-sectional Study.	Clin Infect Dis
32215613	Is There an Association Between COVID-19 Mortality and the Renin-Angiotensin System? A Call for Epidemiologic Investigations.	Clin Infect Dis
32215598	"Neonatal Early-Onset Infection With SARS-CoV-2 in 33 Neonates Born to Mothers With COVID-19 in Wuhan, China."	JAMA Pediatr
32215548	Are Patients with Inflammatory Bowel Disease at Increased Risk for Covid-19 Infection?	J Crohns Colitis
32213336	SARS-CoV-2: virus dynamics and host response.	Lancet Infect Dis
32212881	Controversies about COVID-19 and anticancer treatment with immune checkpoint inhibitors.	Immunotherapy
32212348	Why is COVID-19 so mild in children?	Acta Paediatr
32211809	An Acute Respiratory Infection Runs Into the Most Common Noncommunicable Epidemic-COVID-19 and Cardiovascular Diseases.	JAMA Cardiol
32210742	Role of changes in SARS-CoV-2 spike protein in the interaction with the human ACE2 receptor: An in silico analysis.	EXCLI J
32210741	Unrevealing sequence and structural features of novel coronavirus using in silico approaches: The main protease as molecular target.	EXCLI J
32210130	Evolutionary Trajectory for the Emergence of Novel Coronavirus SARS-CoV-2.	Pathogens
32209889	Advances in the relationship between coronavirus infection and coagulation function.	Chin Med J (Engl)
32209661	The Rheumatologist's Role in COVID-19.	J Rheumatol
32209382	The clinical characteristics of myocardial injury in severe and very severe patients with 2019 novel coronavirus disease.	J Infect
32209231	"Computers and viral diseases. Preliminary bioinformatics studies on the design of a synthetic vaccine and a preventative peptidomimetic antagonist against the SARS-CoV-2 (2019-nCoV, COVID-19) coronavirus."	Comput Biol Med
32209118	Using the spike protein feature to predict infection risk and monitor the evolutionary dynamic of coronavirus.	Infect Dis Poverty
32208987	Renin-Angiotensin System Blockers and the COVID-19 Pandemic: At Present There Is No Evidence to Abandon Renin-Angiotensin System Blockers.	Hypertension
32208975	Applying the Lessons of Influenza to COVID-19 During a Time of Uncertainty.	Circulation
32208485	COVID-19 and Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers: What Is the Evidence?	JAMA
32206694	"Structural, glycosylation and antigenic variation between 2019 novel coronavirus (2019-nCoV) and SARS coronavirus (SARS-CoV)."	Virusdisease
32205856	COVID-19 infection: the perspectives on immune responses.	Cell Death Differ
32205284	"Epidemiological, clinical characteristics of cases of SARS-CoV-2 infection with abnormal imaging findings."	Int J Infect Dis
32203970	Should COVID-19 Concern Nephrologists? Why and to What Extent? The Emerging Impasse of Angiotensin Blockade.	Nephron
32203672	Ventilatory Ratio in Hypercapnic Mechanically Ventilated Patients with COVID-19-associated Acute Respiratory Distress Syndrome.	Am J Respir Crit Care Med
32203189	Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine.	Cell Mol Immunol
32202240	"COVID-19, cytokines and immunosuppression: what can we learn from severe acute respiratory syndrome?"	Clin Exp Rheumatol
32201080	Spike protein recognition of mammalian ACE2 predicts the host range and an optimized ACE2 for SARS-CoV-2 infection.	Biochem Biophys Res Commun
32200663	COVID-19 and Cardiovascular Disease.	Circulation
32200645	Lung Recruitability in COVID-19-associated Acute Respiratory Distress Syndrome: A Single-Center Observational Study.	Am J Respir Crit Care Med
32200634	Protein Structure and Sequence Reanalysis of 2019-nCoV Genome Refutes Snakes as Its Intermediate Host and the Unique Similarity between Its Spike Protein Insertions and HIV-1.	J Proteome Res
32200613	COVID-19: gastrointestinal symptoms and potential sources of SARS-CoV-2 transmission.	Anaesthesiol Intensive Ther
32199943	Predicting the angiotensin converting enzyme 2 (ACE2) utilizing capability as the receptor of SARS-CoV-2.	Microbes Infect
32199880	Effect of Gastrointestinal Symptoms in Patients With COVID-19.	Gastroenterology
32199877	"Global epidemiology of coronavirus disease 2019 (COVID-19): disease incidence, daily cumulative index, mortality, and their association with country healthcare resources and economic status."	Int J Antimicrob Agents
32199864	"Clinical characteristics of novel coronavirus disease 2019 (COVID-19) in newborns, infants and children."	Pediatr Neonatol
32199619	The characteristics and clinical value of chest CT images of novel coronavirus pneumonia.	Clin Radiol
32199615	Single cell RNA sequencing of 13 human tissues identify cell types and receptors of human coronaviruses.	Biochem Biophys Res Commun
32199493	Viral dynamics in mild and severe cases of COVID-19.	Lancet Infect Dis
32199469	Prolonged presence of SARS-CoV-2 viral RNA in faecal samples.	Lancet Gastroenterol Hepatol
32199142	Asymptomatic SARS-CoV-2 infected patients with persistent negative CT findings.	Eur J Radiol
32198986	Review and Prospect of Pathological Features of Corona Virus Disease.	Fa Yi Xue Za Zhi
32198776	Clinical features and treatment of COVID-19 patients in northeast Chongqing.	J Med Virol
32198713	A Unique Protease Cleavage Site Predicted in the Spike Protein of the Novel Pneumonia Coronavirus (2019-nCoV) Potentially Related to Viral Transmissibility.	Virol Sin
32198708	2019 novel coronavirus outbreak: a quiz or final exam?	Front Med
32198291	Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved alpha-ketoamide inhibitors.	Science
32198201	Coronavirus endoribonuclease targets viral polyuridine sequences to evade activating host sensors.	Proc Natl Acad Sci U S A
32198191	Autopsy in suspected COVID-19 cases.	J Clin Pathol
32198164	Novel Coronavirus: What Neuroradiologists as Citizens of the World Need to Know.	AJNR Am J Neuroradiol
32198152	COVID-19 in gastroenterology: a clinical perspective.	Gut
32197957	What Should Gastroenterologists and Patients Know About COVID-19?	Clin Gastroenterol Hepatol
32197085	Probable Pangolin Origin of SARS-CoV-2 Associated with the COVID-19 Outbreak.	Curr Biol
32196995	Clinical features in pediatric COVID-19.	Pediatr Pulmonol
32196933	Coronaviruses and Immunosuppressed Patients: The Facts During the Third Epidemic.	Liver Transpl
32196707	"The clinical characteristics of pneumonia patients coinfected with 2019 novel coronavirus and influenza virus in Wuhan, China."	J Med Virol
32196678	Eleven faces of coronavirus disease 2019.	Allergy
32196628	Differences and similarities between Severe Acute Respiratory Syndrome (SARS)-CoronaVirus (CoV) and SARS-CoV-2. Would a rose by another name smell as sweet?	Eur Rev Med Pharmacol Sci
32196410	Hypothesis for potential pathogenesis of SARS-CoV-2 infection-a review of immune changes in patients with viral pneumonia.	Emerg Microbes Infect
32195887	Computed Tomography Manifestations of 5 Cases of the Novel Coronavirus Disease 2019 (COVID-19) Pneumonia From Patients Outside Wuhan.	J Thorac Imaging
32195698	COVID-19 Infection: Implications for Perioperative and Critical Care Physicians.	Anesthesiology
32194980	Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2.	Cell Discov
32194253	Molecular basis of COVID-19 relationships in different species: a one health perspective.	Microbes Infect
32193831	Clinical features of severe pediatric patients with coronavirus disease 2019 in Wuhan: a single center's observational study.	World J Pediatr
32193638	Chest CT manifestations of new coronavirus disease 2019 (COVID-19): a pictorial review.	Eur Radiol
32193037	CT manifestations of coronavirus disease-2019: A retrospective analysis of 73 cases by disease severity.	Eur J Radiol
32191764	"Association of radiologic findings with mortality of patients infected with 2019 novel coronavirus in Wuhan, China."	PLoS One
32191676	Natural small molecules as inhibitors of coronavirus lipid-dependent attachment to host cells: a possible strategy for reducing SARS-COV-2 infectivity?	Acta Biomed
32191587	Temporal Changes of CT Findings in 90 Patients with COVID-19 Pneumonia: A Longitudinal Study.	Radiology
32191259	Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State.	JAMA
32190908	A doubt of multiple introduction of SARS-CoV-2 in Italy: A preliminary overview.	J Med Virol
32190290	SARS-CoV-2 and COVID-19: The most important research questions.	Cell Biosci
32189489	[Angiotension converting enzyme 2 in the context of 2019 novel coronavirus infectionfriend or foe].	Zhonghua Xin Xue Guan Bing Za Zhi
32189428	Is nicotine exposure linked to cardiopulmonary vulnerability to COVID-19 in the general population?	FEBS J
32188753	"COVID-19: Knowns, Unknowns, and Questions."	mSphere
32188729	Coronavirus Endoribonuclease and Deubiquitinating Interferon Antagonists Differentially Modulate the Host Response during Replication in Macrophages.	J Virol
32188728	Structure-Guided Mutagenesis Alters Deubiquitinating Activity and Attenuates Pathogenesis of a Murine Coronavirus.	J Virol
32188484	Host susceptibility to severe COVID-19 and establishment of a host risk score: findings of 487 cases outside Wuhan.	Crit Care
32187929	[2019-nCoV: new challenges from coronavirus].	Zhonghua Yu Fang Yi Xue Za Zhi
32187887	Insight into COVID-2019 for pediatricians.	Pediatr Pulmonol
32187458	SARS-CoV-2 Infection in Children.	N Engl J Med
32186894	Pregnancy and Perinatal Outcomes of Women With Coronavirus Disease (COVID-19) Pneumonia: A Preliminary Analysis.	AJR Am J Roentgenol
32186711	Hypothesis: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may increase the risk of severe COVID-19.	J Travel Med
32184131	Comparison of clinical characteristics of coronavirus disease (COVID-19) and severe acute respiratory syndrome (SARS) as experienced in Taiwan.	Travel Med Infect Dis
32183941	A Sequence Homology and Bioinformatic Approach Can Predict Candidate Targets for Immune Responses to SARS-CoV-2.	Cell Host Microbe
32183901	"Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: a scoping review."	Infect Dis Poverty
32181901	"A guideline for homology modeling of the proteins from newly discovered betacoronavirus, 2019 novel coronavirus (2019-nCoV)."	J Med Virol
32179788	Ginkgolic acid inhibits fusion of enveloped viruses.	Sci Rep
32179122	"Viral loads of SARS-CoV, MERS-CoV and SARS-CoV-2 in respiratory specimens: What have we learned?"	Travel Med Infect Dis
32178975	Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis.	Clin Chim Acta
32178970	Composition of human-specific slow codons and slow di-codons in SARS-CoV and 2019-nCoV are lower than other coronaviruses suggesting a faster protein synthesis rate of SARS-CoV and 2019-nCoV.	J Microbiol Immunol Infect
32178593	Emerging WuHan (COVID-19) coronavirus: glycan shield and structure prediction of spike glycoprotein and its interaction with human CD26.	Emerg Microbes Infect
32176772	"Clinical Features of 69 Cases With Coronavirus Disease 2019 in Wuhan, China."	Clin Infect Dis
32175797	Can the Coronavirus Disease 2019 (COVID-19) Affect the Eyes? A Review of Coronaviruses and Ocular Implications in Humans and Animals.	Ocul Immunol Inflamm
32175637	Clinical features of deaths in the novel coronavirus epidemic in China.	Rev Med Virol
32174129	Coronavirus Disease 2019 (COVID-19): A Systematic Review of Imaging Findings in 919 Patients.	AJR Am J Roentgenol
32174128	"Clinical Features and Chest CT Manifestations of Coronavirus Disease 2019 (COVID-19) in a Single-Center Study in Shanghai, China."	AJR Am J Roentgenol
32174095	[Research advances in the mechanism of pulmonary fibrosis induced by coronavirus disease 2019 and the corresponding therapeutic measures].	Zhonghua Shao Shang Za Zhi
32173725	"Clinical characteristics of refractory COVID-19 pneumonia in Wuhan, China."	Clin Infect Dis
32173576	Patients of COVID-19 may benefit from sustained Lopinavir-combined regimen and the increase of Eosinophil may predict the outcome of COVID-19 progression.	Int J Infect Dis
32173256	SARS Coronavirus Redux.	Trends Immunol
32173241	"Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Facts and myths."	J Microbiol Immunol Infect
32172672	A tug-of-war between severe acute respiratory syndrome coronavirus 2 and host antiviral defence: lessons from other pathogenic viruses.	Emerg Microbes Infect
32172546	[A pathological report of three COVID-19 cases by minimal invasive autopsies].	Zhonghua Bing Li Xue Za Zhi
32172487	Back to the spring of 2020: facts and hope of COVID-19 outbreak.	Front Med
32172227	Laboratory abnormalities in children with novel coronavirus disease 2019.	Clin Chem Lab Med
32172226	Prominent changes in blood coagulation of patients with SARS-CoV-2 infection.	Clin Chem Lab Med
32171952	The SARS-CoV-2 outbreak: What we know.	Int J Infect Dis
32171869	"Clinical progression of patients with COVID-19 in Shanghai, China."	J Infect
32171867	Clinical characteristics of severe acute respiratory syndrome coronavirus 2 reactivation.	J Infect
32171866	Clinical features of COVID-19 in elderly patients: A comparison with young and middle-aged patients.	J Infect
32171865	Clinical and CT imaging features of the COVID-19 pneumonia: Focus on pregnant women and children.	J Infect
32171622	An update on the 2019-nCoV outbreak.	Am J Infect Control
32171450	Identification of potential cross-protective epitope between a new type of coronavirus (2019-nCoV) and severe acute respiratory syndrome virus.	J Genet Genomics
32171194	[Pathological changes with novel coronavirus infection in lung cancer surgical specimen].	Zhonghua Bing Li Xue Za Zhi
32171192	[Epidemiological characteristics of COVID-19 family clustering in Zhejiang Province].	Zhonghua Yu Fang Yi Xue Za Zhi
32171191	[Genomic analysis of a 2019-novel coronavirus (2019-nCoV) strain in the first COVID-19 patient found in Hangzhou].	Zhonghua Yu Fang Yi Xue Za Zhi
32171067	Sex difference and smoking predisposition in patients with COVID-19.	Lancet Respir Med
32170898	COVID-19 and rationally layered social distancing.	Int J Clin Pract
32170865	Coronavirus disease 2019: What we know?	J Med Virol
32170806	Liver injury during highly pathogenic human coronavirus infections.	Liver Int
32170625	Co-infections of SARS-CoV-2 with multiple common respiratory pathogens in infected patients.	Sci China Life Sci
32170560	Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection.	Front Med
32169673	Genetic evolution analysis of 2019 novel coronavirus and coronavirus from other species.	Infect Genet Evol
32169481	COVID-19 spike-host cell receptor GRP78 binding site prediction.	J Infect
32169119	"The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status."	Mil Med Res
32167747	"Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, Host-Virus Interaction, and Proposed Neurotropic Mechanisms."	ACS Chem Neurosci
32167181	"Initial clinical features of suspected coronavirus disease 2019 in two emergency departments outside of Hubei, China."	J Med Virol
32167180	The establishment of reference sequence for SARS-CoV-2 and variation analysis.	J Med Virol
32167173	The potential chemical structure of anti-SARS-CoV-2 RNA-dependent RNA polymerase.	J Med Virol
32167166	An exclusive 42 amino acid signature in pp1ab protein provides insights into the evolutive history of the 2019 novel human-pathogenic coronavirus (SARS-CoV-2).	J Med Virol
32166607	A Review of Coronavirus Disease-2019 (COVID-19).	Indian J Pediatr
32165541	Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells.	Proc Natl Acad Sci U S A
32165386	Complete Genome Sequence of a 2019 Novel Coronavirus (SARS-CoV-2) Strain Isolated in Nepal.	Microbiol Resour Announc
32164400	[Epidemiological characteristics of confirmed COVID-19 cases in Tianjin].	Zhonghua Liu Xing Bing Xue Za Zhi
32164092	[Inhibitors of RAS Might Be a Good Choice for the Therapy of COVID-19 Pneumonia].	Zhonghua Jie He He Hu Xi Za Zhi
32164089	[Analysis of clinical features of 29 patients with 2019 novel coronavirus pneumonia].	Zhonghua Jie He He Hu Xi Za Zhi
32163661	Surveillance and taxonomic analysis of the coronavirus dominant in pigeons in China.	Transbound Emerg Dis
32162702	"COVID-19 patients' clinical characteristics, discharge rate, and fatality rate of meta-analysis."	J Med Virol
32162081	Chest computed tomography in children with COVID-19 respiratory infection.	Pediatr Radiol
32161990	Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China.	Clin Res Cardiol
32161968	A Comparative Study on the Clinical Features of Coronavirus 2019 (COVID-19) Pneumonia With Other Pneumonias.	Clin Infect Dis
32160149	"Severe Acute Respiratory Syndrome Coronavirus 2 from Patient with Coronavirus Disease, United States."	Emerg Infect Dis
32159318	[Angiotensin-converting enzyme 2 and coronavirus: research update on pathogenesis of the infection induced by this indissoluble bond].	Zhonghua Xin Xue Guan Bing Za Zhi
32159237	From SARS and MERS CoVs to SARS-CoV-2: Moving toward more biased codon usage in viral structural and nonstructural genes.	J Med Virol
32159234	"Identification of coronavirus sequences in carp cDNA from Wuhan, China."	J Med Virol
32156648	2019 novel coronavirus (2019-nCoV) outbreak: A new challenge.	J Glob Antimicrob Resist
32155444	"Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein."	Cell
32154288	Which lessons shall we learn from the 2019 novel coronavirus outbreak?	Ann Transl Med
32154135	Clinical analysis of 10 neonates born to mothers with 2019-nCoV pneumonia.	Transl Pediatr
32153170	[Clinical characteristics and influencing factors of patients with novel coronavirus pneumonia combined with liver injury in Shaanxi region].	Zhonghua Gan Zang Bing Za Zhi
32151335	Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records.	Lancet
32149485	[Clinical features of respiratory coronavirus infections and relationship to otolaryngology].	Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi
32149484	[Epidemiological investigation of a family clustering of COVID-19].	Zhonghua Liu Xing Bing Xue Za Zhi
32149037	Early Epidemiological and Clinical Characteristics of 28 Cases of Coronavirus Disease in South Korea.	Osong Public Health Res Perspect
32149036	Identification of Coronavirus Isolated from a Patient in Korea with COVID-19.	Osong Public Health Res Perspect
32148173	Is SARS-CoV-2 originated from laboratory? A rebuttal to the claim of formation via laboratory recombination.	Emerg Microbes Infect
32147409	Are children less susceptible to COVID-19?	J Microbiol Immunol Infect
32146694	"Clinical characteristics of 24 asymptomatic infections with COVID-19 screened among close contacts in Nanjing, China."	Sci China Life Sci
32145715	[A case report of aplastic anemia accompanied with COVID-19].	Zhonghua Xue Ye Xue Za Zhi
32145714	[Analysis of the pregnancy outcomes in pregnant women with COVID-19 in Hubei Province].	Zhonghua Fu Chan Ke Za Zhi
32145275	Procalcitonin in patients with severe coronavirus disease 2019 (COVID-19): A meta-analysis.	Clin Chim Acta
32145217	Public health might be endangered by possible prolonged discharge of SARS-CoV-2 in stool.	J Infect
32145216	Withdrawn: Clinical manifestations and outcome of SARS-CoV-2 infection during pregnancy.	J Infect
32145215	Identification of the hyper-variable genomic hotspot for the novel coronavirus SARS-CoV-2.	J Infect
32145214	Lymphopenic community acquired pneumonia as signature of severe COVID-19 infection.	J Infect
32145185	Middle East respiratory syndrome.	Lancet
32144890	The Novel Coronavirus - A Snapshot of Current Knowledge.	Microb Biotechnol
32143990	The deadly coronaviruses: The 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China.	J Autoimmun
32143502	Insights into the Recent 2019 Novel Coronavirus (SARS-CoV-2) in Light of Past Human Coronavirus Outbreaks.	Pathogens
32142972	Coronavirus Disease 2019 (COVID-19): A critical care perspective beyond China.	Anaesth Crit Care Pain Med
32142938	Nonstructural proteins NS7b and NS8 are likely to be phylogenetically associated with evolution of 2019-nCoV.	Infect Genet Evol
32142930	Insights into the cross-species evolution of 2019 novel coronavirus.	J Infect
32142928	WITHDRAWN: Clinical and CT imaging features of 2019 novel coronavirus disease (COVID-19).	J Infect
32142785	COVID-19: Gastrointestinal Manifestations and Potential Fecal-Oral Transmission.	Gastroenterology
32142651	SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.	Cell
32141570	"Novel coronavirus 2019-nCoV: prevalence, biological and clinical characteristics comparison with SARS-CoV and MERS-CoV."	Eur Rev Med Pharmacol Sci
32141569	COVID-19 (Novel Coronavirus 2019) - recent trends.	Eur Rev Med Pharmacol Sci
32141280	[Analysis of myocardial injury in patients with COVID-19 and association between concomitant cardiovascular diseases and severity of COVID-19].	Zhonghua Xin Xue Guan Bing Za Zhi
32140732	SARS-CoV-2: a potential novel etiology of fulminant myocarditis.	Herz
32139904	COVID-19 and the cardiovascular system.	Nat Rev Cardiol
32139552	SARS-CoV-2 induced diarrhoea as onset symptom in patient with COVID-19.	Gut
32139464	"The clinical dynamics of 18 cases of COVID-19 outside of Wuhan, China."	Eur Respir J
32139462	"Epidemiological characteristics of SARS-CoV-2 infections in Shaanxi, China by 8 February 2020."	Eur Respir J
32139372	What we know so far: COVID-19 current clinical knowledge and research.	Clin Med (Lond)
32139299	SARS-CoV-2 infection in children: Transmission dynamics and clinical characteristics.	J Formos Med Assoc
32138266	Potential Factors Influencing Repeated SARS Outbreaks in China.	Int J Environ Res Public Health
32134800	Clinical and High-Resolution CT Features of the COVID-19 Infection: Comparison of the Initial and Follow-up Changes.	Invest Radiol
32134681	"CT Features of Coronavirus Disease 2019 (COVID-19) Pneumonia in 62 Patients in Wuhan, China."	AJR Am J Roentgenol
32134278	Perspectives on monoclonal antibody therapy as potential therapeutic intervention for Coronavirus disease-19 (COVID-19).	Asian Pac J Allergy Immunol
32134205	Clinical and CT features in pediatric patients with COVID-19 infection: Different points from adults.	Pediatr Pulmonol
32134116	Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measures.	J Med Virol
32133830	[Investigation and analysis on characteristics of a cluster of COVID-19 associated with exposure in a department store in Tianjin].	Zhonghua Liu Xing Bing Xue Za Zhi
32133578	Review of the Clinical Characteristics of Coronavirus Disease 2019 (COVID-19).	J Gen Intern Med
32133153	Comparative genetic analysis of the novel coronavirus (2019-nCoV/SARS-CoV-2) receptor ACE2 in different populations.	Cell Discov
32132669	Novel antibody epitopes dominate the antigenicity of spike glycoprotein in SARS-CoV-2 compared to SARS-CoV.	Cell Mol Immunol
32132184	Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2.	Science
32130973	A potential role for integrins in host cell entry by SARS-CoV-2.	Antiviral Res
32130405	2019 Novel Coronavirus Is Undergoing Active Recombination.	Clin Infect Dis
32130038	Coronavirus Disease 2019 (COVID-19): Role of Chest CT in Diagnosis and Management.	AJR Am J Roentgenol
32129843	Genomic Diversity of Severe Acute Respiratory Syndrome-Coronavirus 2 in Patients With Coronavirus Disease 2019.	Clin Infect Dis
32129842	A Glimpse Into the Origins of Genetic Diversity in the Severe Acute Respiratory Syndrome Coronavirus 2.	Clin Infect Dis
32129670	CT Imaging and Differential Diagnosis of COVID-19.	Can Assoc Radiol J
32129583	[Comparison of heart failure and COVID-19 in chest CT features and clinical characteristics].	Zhonghua Xin Xue Guan Bing Za Zhi
32129518	Angiotensin receptor blockers as tentative SARS-CoV-2 therapeutics.	Drug Dev Res
32129508	Hematologic parameters in patients with COVID-19 infection.	Am J Hematol
32127666	Therapeutic options for the 2019 novel coronavirus (2019-nCoV).	Nat Rev Drug Discov
32125873	Relation Between Chest CT Findings and Clinical Conditions of Coronavirus Disease (COVID-19) Pneumonia: A Multicenter Study.	AJR Am J Roentgenol
32125458	COVID-19: a novel coronavirus and a novel challenge for critical care.	Intensive Care Med
32125455	Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target.	Intensive Care Med
32125452	"Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China."	Intensive Care Med
32125362	Epidemiologic Features and Clinical Course of Patients Infected With SARS-CoV-2 in Singapore.	JAMA
32125131	[Novel coronavirus pneumonia (COVID-19) CT distribution and sign features].	Zhonghua Jie He He Hu Xi Za Zhi
32123347	The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2.	Nat Microbiol
32121543	Eco-Virological Preliminary Study of Potentially Emerging Pathogens in Hedgehogs (Erinaceus europaeus) Recovered at a Wildlife Treatment and Rehabilitation Center in Northern Italy.	Animals (Basel)
32120965	Outbreak of Novel Coronavirus (SARS-Cov-2): First Evidences From International Scientific Literature and Pending Questions.	Healthcare (Basel)
32120929	Antiviral Action of Tryptanthrin Isolated from Strobilanthes cusia Leaf against Human Coronavirus NL63.	Biomolecules
32120458	[Clinical characteristics and outcomes of 112 cardiovascular disease patients infected by 2019-nCoV].	Zhonghua Xin Xue Guan Bing Za Zhi
32119961	"Anti-HCV, nucleotide inhibitors, repurposing against COVID-19."	Life Sci
32119647	Laboratory abnormalities in patients with COVID-2019 infection.	Clin Chem Lab Med
32119409	"Neuroanatomy, Nucleus Gustatory"	StatPearls
32118645	Single-cell RNA sequencing data suggest a role for angiotensin-converting enzyme 2 in kidney impairment in patients infected with 2019-novel coronavirus.	Chin Med J (Engl)
32118642	Science in the fight against the novel coronavirus disease 2019 (COVID-19).	Chin Med J (Engl)
32118640	Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease.	Chin Med J (Engl)
32118639	Persistence and clearance of viral RNA in 2019 novel coronavirus disease rehabilitation patients.	Chin Med J (Engl)
32118615	The Clinical and Chest CT Features Associated With Severe and Critical COVID-19 Pneumonia.	Invest Radiol
32118393	[Myocardial injury in patients with COVID-19 pneumonia].	Zhonghua Xin Xue Guan Bing Za Zhi
32118392	[Cardiac manifestations of patients with COVID-19 pneumonia and related treatment recommendations].	Zhonghua Xin Xue Guan Bing Za Zhi
32118390	[Epidemiological characteristics of novel coronavirus pneumonia in Henan].	Zhonghua Jie He He Hu Xi Za Zhi
32118389	[Clinical analysis of 31 cases of 2019 novel coronavirus infection in children from six provinces (autonomous region) of northern China].	Zhonghua Er Ke Za Zhi
32116200	COVID-19: Perspectives on the Potential Novel Global Threat.	Rev Recent Clin Trials
32114748	[A special on epidemic prevention and control: precautions in ophthalmic practice in the prevention and control of the novel coronavirus pneumonia epidemic].	Zhonghua Yan Ke Za Zhi
32114747	[Advances in the research of mechanism and related immunotherapy on the cytokine storm induced by coronavirus disease 2019].	Zhonghua Shao Shang Za Zhi
32114745	[Characteristics of peripheral blood leukocyte differential counts in patients with COVID-19].	Zhonghua Nei Ke Za Zhi
32114074	"Clinical characteristics of laboratory confirmed positive cases of SARS-CoV-2 infection in Wuhan, China: A retrospective single center analysis."	Travel Med Infect Dis
32113704	The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak.	J Autoimmun
32112977	World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19).	Int J Surg
32112886	Characteristics of COVID-19 infection in Beijing.	J Infect
32112884	"Clinical characteristics and imaging manifestations of the 2019 novel coronavirus disease (COVID-19):A multi-center study in Wenzhou city, Zhejiang, China."	J Infect
32109444	Coronavirus 2019-nCoV: A brief perspective from the front line.	J Infect
32109443	Clinical and computed tomographic imaging features of novel coronavirus pneumonia caused by SARS-CoV-2.	J Infect
32109279	Clinical Characteristics of Imported Cases of Coronavirus Disease 2019 (COVID-19) in Jiangsu Province: A Multicenter Descriptive Study.	Clin Infect Dis
32109013	Clinical Characteristics of Coronavirus Disease 2019 in China.	N Engl J Med
32108862	Genome Detective Coronavirus Typing Tool for rapid identification and characterization of novel coronavirus genomes.	Bioinformatics
32108495	Radiology Perspective of Coronavirus Disease 2019 (COVID-19): Lessons From Severe Acute Respiratory Syndrome and Middle East Respiratory Syndrome.	AJR Am J Roentgenol
32108351	Clinical characteristics of hospitalized patients with SARS-CoV-2 infection: A single arm meta-analysis.	J Med Virol
32108160	Emergence of a novel human coronavirus threatening human health.	Nat Med
32108071	Where did SARS-CoV-2 come from?	Vet Rec
32107577	Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2.	Eur J Nucl Med Mol Imaging
32107200	"Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series."	BMJ
32106567	Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies.	Viruses
32105680	Coronavirus Disease 2019 (COVID-19) and pregnancy: what obstetricians need to know.	Am J Obstet Gynecol
32105637	"Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study."	Lancet Infect Dis
32105632	"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study."	Lancet Respir Med
32105562	Essentials for Radiologists on COVID-19: An Update-Radiology Scientific Expert Panel.	Radiology
32105468	Structure-Based Stabilization of Non-native Protein-Protein Interactions of Coronavirus Nucleocapsid Proteins in Antiviral Drug Design.	J Med Chem
32105304	Positive RT-PCR Test Results in Patients Recovered From COVID-19.	JAMA
32105090	Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic.	Asian Pac J Allergy Immunol
32104915	The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients.	J Med Virol
32104911	"Evolutionary history, potential intermediate animal host, and cross-species analyses of SARS-CoV-2."	J Med Virol
32104726	The 2019 Novel Coronavirus: A Crown Jewel of Pandemics?	J Crit Care Med (Targu Mures)
32103284	Severe SARS-CoV-2 infections: practical considerations and management strategy for intensivists.	Intensive Care Med
32102928	Diarrhoea may be underestimated: a missing link in 2019 novel coronavirus.	Gut
32100877	Composition and divergence of coronavirus spike proteins and host ACE2 receptors predict potential intermediate hosts of SARS-CoV-2.	J Med Virol
32100485	Chest Radiographic and CT Findings of the 2019 Novel Coronavirus Disease (COVID-19): Analysis of Nine Patients Treated in Korea.	Korean J Radiol
32098422	Systematic Comparison of Two Animal-to-Human Transmitted Human Coronaviruses: SARS-CoV-2 and SARS-CoV.	Viruses
32096567	Understanding of COVID-19 based on current evidence.	J Med Virol
32096366	[Dynamic changes of chest CT imaging in patients with corona virus disease-19 (COVID-19)].	Zhejiang Da Xue Xue Bao Yi Xue Ban
32094589	Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses.	Nat Microbiol
32094336	High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa.	Int J Oral Sci
32094225	The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus.	J Biol Chem
32093211	Characteristics of and Public Health Responses to the Coronavirus Disease 2019 Outbreak in China.	J Clin Med
32092748	COVID-19: Real-time dissemination of scientific information to fight a public health emergency of international concern.	Biosci Trends
32092539	Is COVID-19 receiving ADE from other coronaviruses?	Microbes Infect
32092483	Genetic diversity and evolution of SARS-CoV-2.	Infect Genet Evol
32092392	Analysis of angiotensin-converting enzyme 2 (ACE2) from different species sheds some light on cross-species receptor usage of a novel coronavirus 2019-nCoV.	J Infect
32092385	The continuous evolution and dissemination of 2019 novel human coronavirus.	J Infect
32092296	Coronavirus (COVID-19) Outbreak: What the Department of Radiology Should Know.	J Am Coll Radiol
32091533	Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72314 Cases From the Chinese Center for Disease Control and Prevention.	JAMA
32091414	Chest CT Findings in Patients With Coronavirus Disease 2019 and Its Relationship With Clinical Features.	Invest Radiol
32090448	Coronavirus disease 2019: Implications of emerging infections for transplantation.	Am J Transplant
32087623	[Comparison of the clinical characteristics between RNA positive and negative patients clinically diagnosed with coronavirus disease 2019].	Zhonghua Jie He He Hu Xi Za Zhi
32087216	A Novel Coronavirus (COVID-19) Outbreak: A Call for Action.	Chest
32086938	"The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned?"	Int J Epidemiol
32083985	Coronavirus Disease 2019 (COVID-19): A Perspective from China.	Radiology
32083831	The novel coronavirus (2019-nCoV) outbreak: think the unthinkable and be prepared to face the challenge.	Diagnosis (Berl)
32083328	COVID-2019: The role of the nsp2 and nsp3 in its pathogenesis.	J Med Virol
32081428	Structure analysis of the receptor binding of 2019-nCoV.	Biochem Biophys Res Commun
32079638	Complete Genome Sequences of Five Human Coronavirus NL63 Strains Causing Respiratory Illness in Hospitalized Children in China.	Microbiol Resour Announc
32077789	Chest CT Findings in Coronavirus Disease-19 (COVID-19): Relationship to Duration of Infection.	Radiology
32077660	[Preliminary study of the relationship between novel coronavirus pneumonia and liver function damage: a multicenter study].	Zhonghua Gan Zang Bing Za Zhi
32077659	[Exploring the mechanism of liver enzyme abnormalities in patients with novel coronavirus-infected pneumonia].	Zhonghua Gan Zang Bing Za Zhi
32077115	"Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China."	Allergy
32075877	Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation.	Science
32075786	"Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series."	BMJ
32075364	[Novel coronavirus pneumonia-related liver injury: etiological analysis and treatment strategy].	Zhonghua Gan Zang Bing Za Zhi
32073213	Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia.	J Thromb Haemost
32073157	Antibodies to coronaviruses are higher in older compared with younger adults and binding antibodies are more sensitive than neutralizing antibodies in identifying coronavirus-associated illnesses.	J Med Virol
32072569	2019 Novel coronavirus: where we are and what we know.	Infection
32065221	Coronaviruses: a paradigm of new emerging zoonotic diseases.	Pathog Dis
32065055	Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody.	Emerg Microbes Infect
32064855	[Analysis of the first cluster of cases in a family of novel coronavirus pneumonia in Gansu Province].	Zhonghua Yu Fang Yi Xue Za Zhi
32064853	[The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China].	Zhonghua Liu Xing Bing Xue Za Zhi
32062957	[Clinical characteristics of 30 medical workers infected with new coronavirus pneumonia].	Zhonghua Jie He He Hu Xi Za Zhi
32062875	[Retracted: Clinical and epidemiological characteristics of 34 children with 2019 novel coronavirus infection in Shenzhen].	Zhonghua Er Ke Za Zhi
32061200	[Analysis of CT features of 15 Children with 2019 novel coronavirus infection].	Zhonghua Er Ke Za Zhi
32061198	[Inhibitors of RAS Might Be a Good Choice for the Therapy of COVID-19 Pneumonia].	Zhonghua Jie He He Hu Xi Za Zhi
32061066	[Clinical features of 2019 novel coronavirus pneumonia in the early stage from a fever clinic in Beijing].	Zhonghua Jie He He Hu Xi Za Zhi
32060933	2019_nCoV/SARS-CoV-2: rapid classification of betacoronaviruses and identification of Traditional Chinese Medicine as potential origin of zoonotic coronaviruses.	Lett Appl Microbiol
32058570	Novel Coronavirus Infection in Hospitalized Infants Under 1 Year of Age in China.	JAMA
32057769	The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade.	Antiviral Res
32057211	[An update on the epidemiological characteristics of novel coronavirus pneumonia (COVID-19)].	Zhonghua Liu Xing Bing Xue Za Zhi
32057210	[The prevention and control of a new coronavirus infection in department of stomatology].	Zhonghua Kou Qiang Yi Xue Za Zhi
32056509	HIV-1 did not contribute to the 2019-nCoV genome.	Emerg Microbes Infect
32056249	"Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV."	J Med Virol
32056235	Does SARS-CoV-2 has a longer incubation period than SARS and MERS?	J Med Virol
32055945	"Initial CT findings and temporal changes in patients with the novel coronavirus pneumonia (2019-nCoV): a study of 63 patients in Wuhan, China."	Eur Radiol
32053579	"Persons Evaluated for 2019 Novel Coronavirus - United States, January 2020."	MMWR Morb Mortal Wkly Rep
32053470	Time Course of Lung Changes at Chest CT during Recovery from Coronavirus Disease 2019 (COVID-19).	Radiology
32053148	Three Emerging Coronaviruses in Two Decades.	Am J Clin Pathol
32051570	Novel coronavirus takes flight from bats?	Nat Rev Microbiol
32048818	Novel coronavirus (SARS-CoV-2) epidemic: a veterinary perspective.	Vet Ital
32048560	The global spread of 2019-nCoV: a molecular evolutionary analysis.	Pathog Glob Health
32048163	Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury.	Sci China Life Sci
32048160	Bat origin of a new human coronavirus: there and back again.	Sci China Life Sci
32047258	Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein.	Cell Mol Immunol
32045235	"alpha-Ketoamides as Broad-Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment."	J Med Chem
32044814	Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province.	Chin Med J (Engl)
32037473	New coronavirus: new challenges for pediatricians.	World J Pediatr
32037389	Clinical characteristics and therapeutic procedure for four cases with 2019 novel coronavirus pneumonia receiving combined Chinese and Western medicine treatment.	Biosci Trends
32036774	"Emerging novel coronavirus (2019-nCoV)-current scenario, evolutionary perspective based on genome analysis and recent developments."	Vet Q
32035997	Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents.	J Hosp Infect
32035811	Emerging threats from zoonotic coronaviruses-from SARS and MERS to 2019-nCoV.	J Microbiol Immunol Infect
32035431	Epidemiologic characteristics of early cases with 2019 novel coronavirus (2019-nCoV) disease in Korea.	Epidemiol Health
32035028	Genome Composition and Divergence of the Novel Coronavirus (2019-nCoV) Originating in China.	Cell Host Microbe
32034638	Compensation of ACE2 Function for Possible Clinical Management of 2019-nCoV-Induced Acute Lung Injury.	Virol Sin
32031570	"Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China."	JAMA
32031568	"Epidemiologic and Clinical Characteristics of Novel Coronavirus Infections Involving 13 Patients Outside Wuhan, China."	JAMA
32029004	A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version).	Mil Med Res
32027573	Emerging 2019 Novel Coronavirus (2019-nCoV) Pneumonia.	Radiology
32027036	Genomic variance of the 2019-nCoV coronavirus.	J Med Virol
32026671	[Analysis of clinical features of 29 patients with 2019 novel coronavirus pneumonia].	Zhonghua Jie He He Hu Xi Za Zhi
32023684	[Efficient management of novel coronavirus pneumonia by efficient prevention and control in scientific manner].	Zhonghua Jie He He Hu Xi Za Zhi
32023682	[2019-nCoV: new challenges from coronavirus].	Zhonghua Yu Fang Yi Xue Za Zhi
32023678	[Facing the pandemic of 2019 novel coronavirus infections: the pediatric perspectives].	Zhonghua Er Ke Za Zhi
32022836	2019 Novel Coronavirus-Important Information for Clinicians.	JAMA
32022276	Immunoinformatics-aided identification of T cell and B cell epitopes in the surface glycoprotein of 2019-nCoV.	J Med Virol
32022275	The first two cases of 2019-nCoV in Italy: Where they come from?	J Med Virol
32020915	The Novel Coronavirus: A Bird's Eye View.	Int J Occup Environ Med
32017662	"Chest CT Findings in 2019 Novel Coronavirus (2019-nCoV) Infections from Wuhan, China: Key Points for the Radiologist."	Radiology
32017661	CT Imaging Features of 2019 Novel Coronavirus (2019-nCoV).	Radiology
32015508	A new coronavirus associated with human respiratory disease in China.	Nature
32015507	A pneumonia outbreak associated with a new coronavirus of probable bat origin.	Nature
32013309	Mast cells contribute to coronavirus-induced inflammation: new anti-inflammatory strategy.	J Biol Regul Homeost Agents
32011673	Origin and Evolution of the 2019 Novel Coronavirus.	Clin Infect Dis
32009228	Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission.	Sci China Life Sci
32007627	Novel coronavirus: From discovery to clinical diagnostics.	Infect Genet Evol
32007145	Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding.	Lancet
32007143	"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study."	Lancet
32005086	"An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies."	Emerg Microbes Infect
32004758	Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event.	Infect Genet Evol
32004165	Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study.	Chin Med J (Engl)
32004066	Novel Wuhan (2019-nCoV) Coronavirus.	Am J Respir Crit Care Med
32003000	The novel Chinese coronavirus (2019-nCoV) infections: Challenges for fighting the storm.	Eur J Clin Invest
32001309	"Emergence of a novel coronavirus causing respiratory illness from Wuhan, China."	J Infect
31996437	Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus.	J Virol
31994742	"Updated understanding of the outbreak of 2019 novel coronavirus (2019-nCoV) in Wuhan, China."	J Med Virol
31994738	The 2019-new coronavirus epidemic: Evidence for virus evolution.	J Med Virol
31991541	Return of the Coronavirus: 2019-nCoV.	Viruses
31987001	Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan.	Emerg Microbes Infect
31986264	"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China."	Lancet
31981224	Coronavirus infections and immune responses.	J Med Virol
31978945	"A Novel Coronavirus from Patients with Pneumonia in China, 2019."	N Engl J Med
31978944	"Another Decade, Another Coronavirus."	N Engl J Med
31967327	"Emerging coronaviruses: Genome structure, replication, and pathogenesis."	J Med Virol
31967321	Cross-species transmission of the newly identified coronavirus 2019-nCoV.	J Med Virol
31953166	"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - The latest 2019 novel coronavirus outbreak in Wuhan, China."	Int J Infect Dis
31905842	Investigation of the Role of the Spike Protein in Reversing the Virulence of the Highly Virulent Taiwan Porcine Epidemic Diarrhea Virus Pintung 52 Strains and Its Attenuated Counterpart.	Viruses